chebi,name,definition,compound_id,type,accession_number,abbreviation_metabolite,casregistry_metabolite,cheblid_metabolite,description_metabolite,fullname_metabolite,hmdb_metabolite,inchikey_metabolite,inchistring_metabolite,keggid_metabolite,biocyc_metabolite,food_db_metabolite,reconmap3_metabolite,smile_metabolite,inchiKey_metabolite,inchiString_metabolite
0,5555,guanadrel,"A spiroketal resulting from the formal condensation of the keto group of cyclohexanone with the hydroxy groups of 1-(2,3-dihydroxypropyl)guanidine. A postganglionic adrenergic blocking agent formerly used (generally as the sulfate salt) for the management of hypertension, it has been largely superseded by other drugs less likely to cause orthostatic hypotension (dizzy spells on standing up or stretching).",2149,KEGG COMPOUND accession,C05468,,,,,,,,,,,,,,,
1,4331,dauricine,"A bisbenzylisoquinoline alkaloid resulting from the formal oxidative dimerisation of 4-{[(1R)-6,7-dimethoxy-2-methyl-1,2,3,4-tetrahydroisoquinolin-1-yl]methyl}phenol by attachment of the phenolic oxygen of one molecule to the benzene ring of the second (ortho to the phenolic hydroxy group of the latter).",28834,KEGG COMPOUND accession,C04483,dchac,83-44-3,28834.0,"Human Metabolome Database (HMDB): Deoxycholic acid is a secondary bile acid produced in the liver and is usually conjugated with glycine or taurine. It facilitates fat absorption and cholesterol excretion. Bile acids are steroid acids found predominantly in the bile of mammals. The distinction between different bile acids is minute, and depends only on the presence or absence of hydroxyl groups on positions 3, 7, and 12. Bile acids are physiological detergents that facilitate excretion, absorption, and transport of fats and sterols in the intestine and liver. Bile acids are also steroidal amphipathic molecules derived from the catabolism of cholesterol. They modulate bile flow and lipid secretion, are essential for the absorption of dietary fats and vitamins, and have been implicated in the regulation of all the key enzymes involved in cholesterol homeostasis. Bile acids recirculate through the liver, bile ducts, small intestine, and portal vein to form an enterohepatic circuit. They exist as anions at physiological pH, and consequently require a carrier for transport across the membranes of the enterohepatic tissues. The unique detergent properties of bile acids are essential for the digestion and intestinal absorption of hydrophobic nutrients. Bile acids have potent toxic properties (e.g. membrane disruption) and there are a plethora of mechanisms to limit their accumulation in blood and tissues (PMID: 11316487, 16037564, 12576301, 11907135). When present in sufficiently high levels, deoxycholic acid can act as a hepatotoxin, a metabotoxin, and an oncometabolite. A hepatotoxin causes damage to the liver or liver cells. A metabotoxin is an endogenously produced metabolite that causes adverse health effects at chronically high levels. An oncometabolite is a compound, when present at chronically high levels, that promotes tumour growth and survival. Among the primary bile acids, cholic acid is considered to be the least hepatotoxic while deoxycholic acid is the most hepatoxic (PMID: 1641875). The liver toxicity of bile acids appears to be due to their ability to peroxidate lipids and to lyse liver cells. High bile acid levels lead to the generation of reactive oxygen species and reactive nitrogen species, disruption of the cell membrane and mitochondria, induction of DNA damage, mutation and apoptosis, and the development of reduced apoptosis capability upon chronic exposure (PMID: 24884764). Chronically high levels of deoxycholic acid are associated with familial hypercholanemia. In hypercholanemia, bile acids, including deoxycholic acid, are elevated in the blood. This disease causes liver damage, extensive itching, poor fat absorption, and can lead to rickets due to lack of calcium in bones. The deficiency of normal bile acids in the intestines results in a deficiency of vitamin K, which also adversely affects clotting of the blood. The bile acid ursodiol (ursodeoxycholic acid) can improve symptoms associated with familial hypercholanemia. Chronically high levels of deoxycholic acid are also associated with several forms of cancer including colon cancer, pancreatic cancer, esophageal cancer, and many other GI cancers.",Deoxycholic acid,HMDB0000626,b,b,C04483,b,FDB012780,dchac,[H]O[C@]1([H])C([H])([H])C([H])([H])[C@@]2(C([H])([H])[H])[C@]([H])(C([H])([H])C([H])([H])[C@@]3([H])[C@]4([H])C([H])([H])C([H])([H])[C@]([H])([C@]([H])(C([H])([H])[H])C([H])([H])C([H])([H])C([O-])=O)[C@@]4(C([H])([H])[H])[C@@]([H])(O[H])C([H])([H])[C@]23[H])C1([H])[H],KXGVEGMKQFWNSR-LLQZFEROSA-M,"InChI=1S/C24H40O4/c1-14(4-9-22(27)28)18-7-8-19-17-6-5-15-12-16(25)10-11-23(15,2)20(17)13-21(26)24(18,19)3/h14-21,25-26H,4-13H2,1-3H3,(H,27,28)/p-1/t14-,15-,16-,17+,18-,19+,20+,21+,23+,24-/m1/s1"
2,3750,clofibrate,The ethyl ester of clofibric acid.,1472,KEGG COMPOUND accession,C03585,,,,,,,,,,,,,,,
3,8871,risperidone,"A member of the class of pyridopyrimidines that is 2-methyl-6,7,8,9-tetrahydropyrido[1,2-a]pyrimidin-4-one carrying an additional 2-[4-(6-fluoro-1,2-benzoxazol-3-yl)piperidin-1-yl]ethyl group at position 2.",16990,KEGG COMPOUND accession,C00486,bilirub,635-65-4,16990.0,"Human Metabolome Database (HMDB): Bilirubin is a bile pigment that is a degradation product of heme. In particular, bilirubin is a yellow breakdown product of normal heme catabolism. Its levels are elevated in certain diseases and it is responsible for the yellow color of bruises. Bilirubin is an excretion product, and the body does not control levels. Bilirubin levels reflect the balance between production and excretion. Thus, there is no ""normal"" level of bilirubin. Bilirubin consists of an open chain of four pyrroles (tetrapyrrole); by contrast, the heme molecule is a closed ring of four pyrroles, called porphyrin (Wikipedia). Bilirubin is found to be associated with crigler-najjar syndrome type I, which is an inborn error of metabolism.",Bilirubin,HMDB0000054,b,b,C00486,BILIRUBIN,FDB021886,bilirub,[H]C([H])=C([H])C1=C(\C(N([H])C1=O)=C(/[H])C1=C(C(=C(N1[H])C([H])([H])C1=C(C(=C(N1[H])C(\[H])=C1/N([H])C(=O)C(=C1C([H])=C([H])[H])C([H])([H])[H])C([H])([H])[H])C([H])([H])C([H])([H])C([O-])=O)C([H])([H])C([H])([H])C([O-])=O)C([H])([H])[H])C([H])([H])[H],BPYKTIZUTYGOLE-IFADSCNNSA-L,"InChI=1S/C33H36N4O6/c1-7-20-19(6)32(42)37-27(20)14-25-18(5)23(10-12-31(40)41)29(35-25)15-28-22(9-11-30(38)39)17(4)24(34-28)13-26-16(3)21(8-2)33(43)36-26/h7-8,13-14,34-35H,1-2,9-12,15H2,3-6H3,(H,36,43)(H,37,42)(H,38,39)(H,40,41)/p-2/b26-13-,27-14-"
4,2415,acetylcaranine,An organic heteropentacyclic compound that is caranine in which the hydroxy group is acetylated.,16720,KEGG COMPOUND accession,C10517,,,,,,,,,,,,,,,
5,8024,perindopril,"An alpha-amino acid ester that is the ethyl ester of N-{(2S)-1-[(2S,3aS,7aS)-2-carboxyoctahydro-1H-indol-1-yl]-1-oxopropan-2-yl}-L-norvaline",2719,KEGG COMPOUND accession,C02135,,,,,,,,,,,,,,,
6,4653,dipyridamole,"A pyrimidopyrimidine that is 2,2',2'',2'''-(pyrimido[5,4-d]pyrimidine-2,6-diyldinitrilo)tetraethanol substituted by piperidin-1-yl groups at positions 4 and 8 respectively. A vasodilator agent, it inhibits the formation of blood clots.",1808,KEGG COMPOUND accession,C07088,,,,,,,,,,,,,,,
7,4659,disulfiram,"An organic disulfide that results from the formal oxidative dimerisation of N,N-diethyldithiocarbamic acid.  A multi-enzyme inhibitor that is used in alcohol aversion therapy and also exhibits anticancer properties.",17346,KEGG COMPOUND accession,C03679,,,,,,,,,,,,,,,
8,7852,oxycodone,"A semisynthetic opioid of formula C18H21NO4 that is derived from thebaine.  It is a moderately potent opioid analgesic, generally used for relief of moderate to severe pain.",29016,KEGG COMPOUND accession,C02385,,,,,,,,,,,,,,,
9,10124,zolmitriptan,"A member of the class of tryptamines that is N,N-dimethyltryptamine in which the hydrogen at position 5 of the indole ring has been replaced by a [(4S)-2-oxo-1,3-oxazolidin-4-yl]methyl group. A serotonin 5-HT1 B and D receptor agonist, it is used for the treatment of migraine.",3490,KEGG COMPOUND accession,C08104,,,,,,,,,,,,,,,
10,2981,baicalin,The glycosyloxyflavone which is the 7-O-glucuronide of baicalein. It is an active ingredient of Chinese herbal medicine Scutellaria baicalensis.,15479,KEGG COMPOUND accession,C00630,ibcoa,15621-60-0,15479.0,"Human Metabolome Database (HMDB): Isobutyryl-CoA is a substrate for Acyl-CoA dehydrogenase (short-chain specific, mitochondrial), Acyl-CoA dehydrogenase (medium-chain specific, mitochondrial) and Acyl-CoA dehydrogenase (long-chain specific, mitochondrial).",Isobutyryl-CoA,HMDB0001243,b,b,C00630,ISOBUTYRYL-COA,FDB022508,ibcoa,[H]O[C@@]([H])(C(=O)N([H])C([H])([H])C([H])([H])C(=O)N([H])C([H])([H])C([H])([H])SC(=O)C([H])(C([H])([H])[H])C([H])([H])[H])C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])OP([O-])(=O)OP([O-])(=O)OC([H])([H])[C@@]1([H])O[C@@]([H])(N2C([H])=NC3=C(N=C([H])N=C23)N([H])[H])[C@]([H])(O[H])[C@]1([H])OP([O-])([O-])=O,AEWHYWSPVRZHCT-NDZSKPAWSA-J,"InChI=1S/C25H42N7O17P3S/c1-13(2)24(37)53-8-7-27-15(33)5-6-28-22(36)19(35)25(3,4)10-46-52(43,44)49-51(41,42)45-9-14-18(48-50(38,39)40)17(34)23(47-14)32-12-31-16-20(26)29-11-30-21(16)32/h11-14,17-19,23,34-35H,5-10H2,1-4H3,(H,27,33)(H,28,36)(H,41,42)(H,43,44)(H2,26,29,30)(H2,38,39,40)/p-4/t14-,17-,18-,19+,23-/m1/s1"
11,4356,desferrioxamine B,An acyclic desferrioxamine that is butanedioic acid in which one of the carboxy groups undergoes formal condensation with the primary amino group of N-(5-aminopentyl)-N-hydroxyacetamide and the second carboxy group undergoes formal condensation with the hydroxyamino group of N(1)-(5-aminopentyl)-N(1)-hydroxy-N(4)-[5-(hydroxyamino)pentyl]butanediamide. It is a siderophore native to Streptomyces pilosus biosynthesised by the DesABCD enzyme cluster as a high affinity Fe(III) chelator.,16466,KEGG COMPOUND accession,C01301,CE4872,b,16466.0,"Human Metabolome Database (HMDB): 3alpha,7alpha,12alpha-Trihydroxy-5beta-cholestan-26-al is an intermediate in bile acid biosynthesis. Bile acids are steroid acids found predominantly in bile of mammals. The distinction between different bile acids is minute, depends only on presence or absence of hydroxyl groups on positions 3, 7, and 12. Bile acids are physiological detergents that facilitate excretion, absorption, and transport of fats and sterols in the intestine and liver. Bile acids are also steroidal amphipathic molecules derived from the catabolism of cholesterol. They modulate bile flow and lipid secretion, are essential for the absorption of dietary fats and vitamins, and have been implicated in the regulation of all the key enzymes involved in cholesterol homeostasis. Bile acids recirculate through the liver, bile ducts, small intestine and portal vein to form an enterohepatic circuit. They exist as anions at physiological pH and, consequently, require a carrier for transport across the membranes of the enterohepatic tissues. The unique detergent properties of bile acids are essential for the digestion and intestinal absorption of hydrophobic nutrients. Bile acids have potent toxic properties (e.g., membrane disruption) and there are a plethora of mechanisms to limit their accumulation in blood and tissues. (PMID: 11316487, 16037564, 12576301, 11907135). 3a,7a,12a-trihydroxy-5b-cholestane-27-al is an enzymatically generated intermediate in the oxidation process of 5b-cholestane-3a,7a,12a,27-tetrol into 3a,7a,12a-trihydroxy-5b-cholestanoic acid in liver mitochondria. Mitochondrial sterol 27-hydroxylase (EC 1.14.13.60) appears to perform multiple monooxygenations in this conversion. (PMID: 8496170).","3a,7a,12a-Trihydroxy-5b-cholestan-26-al",HMDB0003533,b,b,C01301,b,FDB023188,CE4872,[H]O[C@@]1([H])C([H])([H])C([H])([H])C2(C([H])([H])[H])C([H])(C1([H])[H])C([H])([H])[C@]([H])(O[H])C1([H])C3([H])C([H])([H])C([H])([H])[C@]([H])([C@]([H])(C([H])([H])[H])C([H])([H])C([H])([H])C([H])([H])C([H])(C([H])=O)C([H])([H])[H])[C@@]3(C([H])([H])[H])[C@]([H])(O[H])C([H])([H])C21[H],USFJGINJGUIFSY-VQKUADTHSA-N,"InChI=1S/C27H46O4/c1-16(15-28)6-5-7-17(2)20-8-9-21-25-22(14-24(31)27(20,21)4)26(3)11-10-19(29)12-18(26)13-23(25)30/h15-25,29-31H,5-14H2,1-4H3/t16?,17-,18?,19+,20-,21?,22?,23+,24-,25?,26?,27-/m1/s1"
12,4356,desferrioxamine B,An acyclic desferrioxamine that is butanedioic acid in which one of the carboxy groups undergoes formal condensation with the primary amino group of N-(5-aminopentyl)-N-hydroxyacetamide and the second carboxy group undergoes formal condensation with the hydroxyamino group of N(1)-(5-aminopentyl)-N(1)-hydroxy-N(4)-[5-(hydroxyamino)pentyl]butanediamide. It is a siderophore native to Streptomyces pilosus biosynthesised by the DesABCD enzyme cluster as a high affinity Fe(III) chelator.,16466,KEGG COMPOUND accession,C01301,thcholst,b,48940.0,b,"3Alpha,7Alpha,12Alpha-Trihydroxy-5Beta-Cholestan-26-Al",b,b,b,C01301,b,b,thcholst,[H]O[C@]1([H])C([H])([H])C([H])([H])[C@@]2(C([H])([H])[H])[C@@]([H])(C1([H])[H])C([H])([H])[C@@]([H])(O[H])[C@@]1([H])[C@]3([H])C([H])([H])C([H])([H])[C@]([H])([C@]([H])(C([H])([H])[H])C([H])([H])C([H])([H])C([H])([H])C([H])(C([H])=O)C([H])([H])[H])[C@@]3(C([H])([H])[H])[C@@]([H])(O[H])C([H])([H])[C@]21[H],USFJGINJGUIFSY-XZULNKEGSA-N,"InChI=1S/C27H46O4/c1-16(15-28)6-5-7-17(2)20-8-9-21-25-22(14-24(31)27(20,21)4)26(3)11-10-19(29)12-18(26)13-23(25)30/h15-25,29-31H,5-14H2,1-4H3/t16?,17-,18+,19-,20-,21+,22+,23-,24+,25+,26+,27-/m1/s1"
13,2979,baicalein,"A trihydroxyflavone with the hydroxy groups at positions C-5, -6 and -7.",17402,KEGG COMPOUND accession,C03754,,,,,,,,,,,,,,,
14,5818,hydroxyzine,A N-alkylpiperazine that is piperzine in which the nitrogens atoms are substituted by 2-(2-hydroxyethoxy)ethyl and (4-chlorophenyl)(phenyl)methyl groups respectively.,2274,KEGG COMPOUND accession,C02242,,,,,,,,,,,,,,,
15,6980,monocrotaline,a,27750,KEGG COMPOUND accession,C00849,,,,,,,,,,,,,,,
16,4903,17alpha-ethynylestradiol,A 3-hydroxy steroid that is estradiol substituted by a ethynyl group at position 17. It is a  xenoestrogen synthesized from estradiol and has been shown to exhibit high estrogenic potency on oral administration.,17857,KEGG COMPOUND accession,C04327,,,,,,,,,,,,,,,
17,29321,sodium nitroprusside,An organic sodium salt that is the disodium salt of nitroprusside.,9171,KEGG COMPOUND accession,C08313,,,,,,,,,,,,,,,
18,2542,alatolide,A germacrane sesquiterpenoid laactone obtained by formal condensation of the carboxy group of isobutyric acid with the secondary hydroxy group of trihydroxygermaeranolide.,16166,KEGG COMPOUND accession,C02927,,,,,,,,,,,,,,,
19,3682,chrysazin,"A dihydroxyanthraquinone that is anthracene-9,10-dione substituted by hydroxy groups at positions 1 and 8.",16357,KEGG COMPOUND accession,C01162,,,,,,,,,,,,,,,
20,7640,nortriptyline,"An organic tricyclic compound that is 10,11-dihydro-5H-dibenzo[a,d][7]annulene substituted by a 3-(methylamino)propylidene group at position 5. It is an active metabolite of  amitriptyline.",2555,KEGG COMPOUND accession,C11015,,,,,,,,,,,,,,,
21,4754,econazole,"A racemate composed of equimolar amounts of (R)- and (S)-econazole. Used (as its nitrate salt) to treat skin infections such as athlete's foot, jock itch, ringworm and other fungal skin infections.",1845,KEGG COMPOUND accession,C05848,,,,,,,,,,,,,,,
22,9337,sulfathiazole,"A 1,3-thiazole compound having a 4-aminobenzenesulfonamido group at the 2-position.",16556,KEGG COMPOUND accession,C00128,cmpacna,b,16556.0,Human Metabolome Database (HMDB): Cytidine monophosphate N-acetylneuraminic acid is a nucleoside monophosphate sugar which donates N-acetylneuraminic acid to the terminal sugar of a ganglioside or glycoprotein.,Cytidine monophosphate N-acetylneuraminic acid,HMDB0001176,b,b,C00128,CMP-N-ACETYL-NEURAMINATE,FDB022466,cmpacna,[H]OC([H])([H])[C@@]([H])(O[H])[C@@]([H])(O[H])[C@]1([H])O[C@](OP([O-])(=O)OC([H])([H])[C@@]2([H])O[C@@]([H])(N3C([H])=C([H])C(=NC3=O)N([H])[H])[C@]([H])(O[H])[C@]2([H])O[H])(C([O-])=O)C([H])([H])[C@]([H])(O[H])[C@@]1([H])N([H])C(=O)C([H])([H])[H],TXCIAUNLDRJGJZ-BILDWYJOSA-L,"InChI=1S/C20H31N4O16P/c1-7(26)22-12-8(27)4-20(18(32)33,39-16(12)13(29)9(28)5-25)40-41(35,36)37-6-10-14(30)15(31)17(38-10)24-3-2-11(21)23-19(24)34/h2-3,8-10,12-17,25,27-31H,4-6H2,1H3,(H,22,26)(H,32,33)(H,35,36)(H2,21,23,34)/p-2/t8-,9+,10+,12+,13+,14+,15+,16+,17+,20+/m0/s1"
23,29377,sodium carbonate,a,9200,KEGG COMPOUND accession,C11300,,,,,,,,,,,,,,,
24,7466,nandrolone,A 3-oxo Delta(4)-steroid that is estr-4-en-3-one substituted by a beta-hydroxy group at position 17.,2490,KEGG COMPOUND accession,C06102,,,,,,,,,,,,,,,
25,2364,abrusoside A,"A triterpenoid saponin that is (22S,24Z)-3beta-hydroxy-26-oxo-22,26-epoxy-9beta,19-cyclolanost-24-en-28-oic acid having a beta-D-glucosyl residue attached at position 3 via a glycosidic bond.",28738,KEGG COMPOUND accession,C11004,,,,,,,,,,,,,,,
26,29484,"(S)-4,5-dihydroxypentane-2,3-dione","Pentane substituted at the 2- and 3-positions by oxo groups, at the 4- and 5-positions by hydroxy groups and with S stereoconfiguration at C-4.",9243,KEGG COMPOUND accession,C10618,,,,,,,,,,,,,,,
27,9642,N-tosyl-L-phenylalanyl chloromethyl ketone,The N-tosyl derivative of L-phenylalanyl chloromethyl ketone.,27732,KEGG COMPOUND accession,C07481,,,,,,,,,,,,,,,
28,10100,zafirlukast,a,3478,KEGG COMPOUND accession,C06877,,,,,,,,,,,,,,,
29,670,1-phenylethylamine,A phenylethylamine that is ethylamine substituted by a phenyl group at position 1.,300,KEGG COMPOUND accession,C09902,,,,,,,,,,,,,,,
30,4623,(carboxymethyl)(dimethyl)sulfonium,a,16754,KEGG COMPOUND accession,C04558,,,,,,,,,,,,,,,
31,5195,furazolidone,"A member of the class of oxazolidines that is 1,3-oxazolidin-2-one in which the hydrogen attached to the nitrogen is replaced by an N-{[(5-nitro-2-furyl)methylene]amino} group. It has antibacterial and antiprotozoal properties, and is used in the treatment of giardiasis and cholera.",17957,KEGG COMPOUND accession,C04294,,,,,,,,,,,,,,,
32,21285,erythro-4-hydroxy-L-glutamic acid,a,28282,KEGG COMPOUND accession,C04335,,,,,,,,,,,,,,,
33,29223,bromate,a,9131,KEGG COMPOUND accession,C10185,,,,,,,,,,,,,,,
34,25620,2-nitrobenzoic acid,A nitrobenzoic acid carrying the nitro substituent at position 2.,18394,KEGG COMPOUND accession,C01742,,,,,,,,,,,,,,,
35,10782,(S)-(-)-perillyl alcohol,A perillyl alcohol in which the chiral centre has S configuration.,3766,KEGG COMPOUND accession,C06924,,,,,,,,,,,,,,,
36,29851,phenylarsonic acid,a,17717,KEGG COMPOUND accession,C00593,sacald,b,b,b,Sulfoacetaldehyde,b,b,b,C00593,b,b,b,b,b,b
37,29571,dehydroabietic acid,"An abietane diterpenoid that is abieta-8,11,13-triene substituted at position 18 by a carboxy group.",27955,KEGG COMPOUND accession,C01854,,,,,,,,,,,,,,,
38,28,(R)-linalool,The (R)-enantiomer of linalool.,15392,KEGG COMPOUND accession,C03037,,,,,,,,,,,,,,,
39,3638,chloroquine,"An aminoquinoline that is quinoline which is substituted at position 4 by a [5-(diethylamino)pentan-2-yl]amino group at at position 7 by chlorine. It is used for the treatment of malaria, hepatic amoebiasis, lupus erythematosus, light-sensitive skin eruptions, and rheumatoid arthritis.",16122,KEGG COMPOUND accession,C04367,,,,,,,,,,,,,,,
40,1879,2-(4-hydroxyphenyl)ethanol,A phenol substituted at position 4 by a 2-hydroxyethyl group.,16790,KEGG COMPOUND accession,C11630,,,,,,,,,,,,,,,
41,4868,estramustine,A carbamate ester obtained by the formal condensation of the hydroxy group of 17beta-estradiol with the carboxy group of bis(2-chloroethyl)carbamic acid.,1879,KEGG COMPOUND accession,C06044,,,,,,,,,,,,,,,
42,4883,ethidium bromide,The organic bromide salt of ethidium.,27384,KEGG COMPOUND accession,C03680,4izp,17340-16-8,27384.0,Human Metabolome Database (HMDB): 4-Imidazolone-5-propanoate is a metabolite of histidine metabolism. It is produced from urocanic acid by the enzyme urocanate hydratase [EC:4.2.1.49]. 4-Imidazolone-5-propionic acid can spontaneously decay to 4-oxoglutaramate or formylisoglutamine. It is also converted to N-forminimo-L-glutamate by the enzyme imidazolonepropionase [EC:3.5.2.7].,4-Imidazolone-5-propionic acid,HMDB0001014,b,b,C03680,4-IMIDAZOLONE-5-PROPIONATE,FDB022371,4izp,[H]N1C([H])=[N+]([H])C(=O)[C-]1C([H])([H])C([H])([H])C([O-])=O,MYNHYKDPSRPBNZ-UHFFFAOYSA-N,"InChI=1S/C6H7N2O3/c9-5(10)2-1-4-6(11)8-3-7-4/h3H,1-2H2,(H,9,10)(H,7,8,11)/q-1"
43,5014,fenvalerate,A carboxylic ester obtained by formal condensation between 2-(4-chlorophenyl)-3-methylbutyric acid and cyano(3-phenoxyphenyl)methanol.,18312,KEGG COMPOUND accession,C06678,,,,,,,,,,,,,,,
44,2719,Ile(5)-angiotensin II,An angiotensin II that acts on the central nervous system (PDB entry: 1N9V).,27752,KEGG COMPOUND accession,C05803,,,,,,,,,,,,,,,
45,122,(-)-usnic acid,The (-)-enantiomer of usnic acid.,15388,KEGG COMPOUND accession,C11409,,,,,,,,,,,,,,,
46,5063,fipronil,A racemate comprising equimolar amounts of (R)- and (S)-fipronil.,17319,KEGG COMPOUND accession,C05198,dad_5,4754-39-6,17319.0,"Human Metabolome Database (HMDB): 5'-Deoxyadenosine is an oxidized nucleoside found in the urine of normal subjects. Oxidized nucleosides represent excellent biomarkers for determining the extent of damage in genetic material, which has long been of interest in understanding the mechanism of aging, neurodegenerative diseases, and carcinogenesis. (PMID 15116424). The normal form of deoxyadenosine used in DNA synthesis and repair is 2'-deoxyadenosine where the hydroxyl group (-OH) is at the 2' position of its ribose sugar moiety. 5'-deoxyadenosine has its hydroxyl group at the 5' position of the ribose sugar.",5'-Deoxyadenosine,HMDB0001983,b,b,C05198,CH33ADO,FDB022781,b,[H]O[C@@]1([H])[C@@]([H])(O[C@]([H])(C([H])([H])[H])[C@@]1([H])O[H])N1C([H])=NC2=C(N=C([H])N=C12)N([H])[H],XGYIMTFOTBMPFP-KQYNXXCUSA-N,"InChI=1S/C10H13N5O3/c1-4-6(16)7(17)10(18-4)15-3-14-5-8(11)12-2-13-9(5)15/h2-4,6-7,10,16-17H,1H3,(H2,11,12,13)/t4-,6-,7-,10-/m1/s1"
47,1911,4-nitroanisole,A member of the class of 4-nitroanisoles that is anisole in which one the hydrogen meta to the methoxy group is replaced by a nitro group.,771,KEGG COMPOUND accession,C06390,,,,,,,,,,,,,,,
48,12256,7-hydroxyisoflavone,The simplest member of the class of 7-hydroxyisoflavones that is isoflavone with a hydroxy substituent at position 7.,4188,KEGG COMPOUND accession,C11472,,,,,,,,,,,,,,,
49,3023,benzbromarone,"1-Benzofuran substituted at C-2 and C-3 by an ethyl group and a 3,5-dibromo-4-hydroxybenzoyl group respectively. An inhibitor of CYP2C9, it is used as an anti-gout medication.",1235,KEGG COMPOUND accession,C05812,,,,,,,,,,,,,,,
50,3605,chloramphenicol palmitate,a,28318,KEGG COMPOUND accession,C07094,,,,,,,,,,,,,,,
51,26911,oxolane,A cyclic ether that is butane in which one hydrogen from each methyl group is substituted by an oxygen.,8455,KEGG COMPOUND accession,C07631,,,,,,,,,,,,,,,
52,25094,lysine,A diamino acid that is caproic (hexanoic) acid bearing two amino substituents at positions 2 and 6.,16792,KEGG COMPOUND accession,C03797,,,,,,,,,,,,,,,
53,23995,N-ethyl-N-nitrosourea,A member of the class of N-nitrosoureas that is urea in which one of the nitrogens is substituted by ethyl and nitroso groups.,28819,KEGG COMPOUND accession,C09789,,,,,,,,,,,,,,,
54,25189,"1,4-dimercaptobutane-2,3-diol","A glycol that is butane-2,3-diol in which a hydrogen from each of the methyl groups is replaced by a thiol group.",7852,KEGG COMPOUND accession,C08018,,,,,,,,,,,,,,,
55,26271,proline,An alpha-amino acid that is pyrrolidine bearing a carboxy substituent at position 2.,16247,KEGG COMPOUND accession,C00865,M02740,b,16247.0,b,Phospholipids-Extracellular-Pool,b,b,b,C00865,b,b,b,[H]OP(=O)(O[*])OC([H])([H])C([H])(OC([*])=O)C([H])([H])OC([*])=O,b,b
56,2437,acronycine,An alkaloid antineoplastic agent isolated from Acronychia baueri.,17389,KEGG COMPOUND accession,C02112,,,,,,,,,,,,,,,
57,7775,ononin,A 4'-methoxyisoflavone that is formononetin attached to a beta-D-glucopyranosyl moiety at position 7 via a glycosidic linkage.,2621,KEGG COMPOUND accession,C08537,,,,,,,,,,,,,,,
58,4372,(6S)-dehydrovomifoliol,A dehydrovomifoliol that has S-configuration at the chiral centre.,27403,KEGG COMPOUND accession,C05448,thcholoylcoa,57458-60-3,15493.0,"Human Metabolome Database (HMDB): 3a,7a,12a-Trihydroxy-5b-cholestanoyl-CoA is an intermediate in the Bile acid biosynthesis pathway (KEGG). C27-bile acyl-CoAs are converted to their (S)-stereoisomers by the enzyme Alpha-methylacyl-CoA racemase (OMIM 604489).","3a,7a,12a-Trihydroxy-5b-cholestanoyl-CoA",HMDB0002178,b,b,C05448,b,FDB022888,thcholoylcoa,[H]O[C@@]([H])(C(=O)N([H])C([H])([H])C([H])([H])C(=O)N([H])C([H])([H])C([H])([H])SC(=O)C([H])(C([H])([H])[H])C([H])(O[H])C([H])([H])C([H])([H])[C@@]([H])(C([H])([H])[H])[C@@]1([H])C([H])([H])C([H])([H])[C@@]2([H])[C@]3([H])[C@]([H])(O[H])C([H])([H])[C@]4([H])C([H])([H])[C@]([H])(O[H])C([H])([H])C([H])([H])[C@]4(C([H])([H])[H])[C@@]3([H])C([H])([H])C([H])([H])[C@]12C([H])([H])[H])C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])OP([O-])(=O)OP([O-])(=O)OC([H])([H])[C@@]1([H])O[C@@]([H])(N2C([H])=NC3=C(N=C([H])N=C23)N([H])[H])[C@]([H])(O[H])[C@]1([H])OP([O-])([O-])=O,SZBMUAIJWNJARR-LUAYSRQUSA-J,"InChI=1S/C48H80N7O20P3S/c1-25(29-8-9-30-36-31(12-15-48(29,30)6)47(5)14-11-28(56)19-27(47)20-33(36)58)7-10-32(57)26(2)45(63)79-18-17-50-35(59)13-16-51-43(62)40(61)46(3,4)22-72-78(69,70)75-77(67,68)71-21-34-39(74-76(64,65)66)38(60)44(73-34)55-24-54-37-41(49)52-23-53-42(37)55/h23-34,36,38-40,44,56-58,60-61H,7-22H2,1-6H3,(H,50,59)(H,51,62)(H,67,68)(H,69,70)(H2,49,52,53)(H2,64,65,66)/p-4/t25-,26?,27+,28-,29-,30+,31+,32?,33-,34-,36+,38-,39-,40+,44-,47+,48-/m1/s1"
59,9169,sisomycin,a,30772,KEGG COMPOUND accession,C00246,but,107-92-6,30772.0,"Human Metabolome Database (HMDB): Butyric acid, a four-carbon fatty acid, is formed in the human colon by bacterial fermentation of carbohydrates (including dietary fiber), and putatively suppresses colorectal cancer (CRC). Butyrate has diverse and apparently paradoxical effects on cellular proliferation, apoptosis and differentiation that may be either pro-neoplastic or anti-neoplastic, depending upon factors such as the level of exposure, availability of other metabolic substrate and the intracellular milieu. In humans, the relationship between luminal butyrate exposure and CRC has been examined only indirectly in case-control studies, by measuring fecal butyrate concentrations, although this may not accurately reflect effective butyrate exposure during carcinogenesis. Perhaps not surprisingly, results of these investigations have been mutually contradictory. The direct effect of butyrate on tumorigenesis has been assessed in a no. of in vivo animal models, which have also yielded conflicting results. In part, this may be explained by methodology: differences in the amount and route of butyrate administration, which are likely to significantly influence delivery of butyrate to the distal colon. (PMID: 16460475) Butyric acid is a carboxylic acid found in rancid butter, parmesan cheese, and vomit, and has an unpleasant odor and acrid taste, with a sweetish aftertaste (similar to ether). Butyric acid is a fatty acid occurring in the form of esters in animal fats and plant oils. Interestingly, low-molecular-weight esters of butyric acid, such as methyl butyrate, have mostly pleasant aromas or tastes. As a consequence, they find use as food and perfume additives. Butyrate is produced as end-product of a fermentation process solely performed by obligate anaerobic bacteria.",Butyric acid,HMDB0000039,b,b,C00246,b,FDB012062,but,[H]C([H])([H])C([H])([H])C([H])([H])C([O-])=O,FERIUCNNQQJTOY-UHFFFAOYSA-M,"InChI=1S/C4H8O2/c1-2-3-4(5)6/h2-3H2,1H3,(H,5,6)/p-1"
60,5855,ibuprofen,A monocarboxylic acid that is propionic acid in which one of the hydrogens at position 2 is substituted by a 4-(2-methylpropyl)phenyl group.,2290,KEGG COMPOUND accession,C05451,xol7ah,b,2290.0,"Human Metabolome Database (HMDB): 7alpha-Hydroxy-5beta-cholestan-3-one is an intermediate in bile acid synthesis. Bile acids are steroid acids found predominantly in bile of mammals. The distinction between different bile acids is minute, depends only on presence or absence of hydroxyl groups on positions 3, 7, and 12. Bile acids are physiological detergents that facilitate excretion, absorption, and transport of fats and sterols in the intestine and liver. Bile acids are also steroidal amphipathic molecules derived from the catabolism of cholesterol. They modulate bile flow and lipid secretion, are essential for the absorption of dietary fats and vitamins, and have been implicated in the regulation of all the key enzymes involved in cholesterol homeostasis. Bile acids recirculate through the liver, bile ducts, small intestine and portal vein to form an enterohepatic circuit. They exist as anions at physiological pH and, consequently, require a carrier for transport across the membranes of the enterohepatic tissues. The unique detergent properties of bile acids are essential for the digestion and intestinal absorption of hydrophobic nutrients. Bile acids have potent toxic properties (e.g., membrane disruption) and there are a plethora of mechanisms to limit their accumulation in blood and tissues. (PMID: 11316487, 16037564, 12576301, 11907135).",7a-Hydroxy-5b-cholestan-3-one,HMDB0006892,b,b,C05451,b,FDB024139,xol7ah,[H]O[C@]1([H])C([H])([H])[C@]2([H])C([H])([H])C(=O)C([H])([H])C([H])([H])[C@]2(C([H])([H])[H])[C@@]2([H])C([H])([H])C([H])([H])[C@]3(C([H])([H])[H])[C@]([H])(C([H])([H])C([H])([H])[C@@]3([H])[C@]12[H])[C@]([H])(C([H])([H])[H])C([H])([H])C([H])([H])C([H])([H])C([H])(C([H])([H])[H])C([H])([H])[H],HWOOALPDOJHOPO-YREUSXKVSA-N,"InChI=1S/C27H46O2/c1-17(2)7-6-8-18(3)21-9-10-22-25-23(12-14-27(21,22)5)26(4)13-11-20(28)15-19(26)16-24(25)29/h17-19,21-25,29H,6-16H2,1-5H3/t18-,19+,21-,22+,23+,24-,25+,26+,27-/m1/s1"
61,1427,3-(3-hydroxyphenyl)propanoic acid,A monocarboxylic acid that is propionic acid carrying a 3-hydroxyphenyl substituent at C-3.,29081,KEGG COMPOUND accession,C04548,,,,,,,,,,,,,,,
62,8093,phenylephrine,A member of the class of the class of phenylethanolamines that is (1R)-2-(methylamino)-1-phenylethan-1-ol carrying an additional hydroxy substituent at position 3 on the phenyl ring.,16366,KEGG COMPOUND accession,C02003,,,,,,,,,,,,,,,
63,3380,captopril,A L-proline derivative in which L-proline is substituted on nitrogen with a (2S)-2-methyl-3-sulfanylpropanoyl group. It is used as an anti-hypertensive ACE inhibitor drug.,28931,KEGG COMPOUND accession,C01367,,,,,,,,,,,,,,,
64,2567,alendronic acid,"A 1,1-bis(phosphonic acid) that is methanebis(phosphonic acid) in which the two methylene hydrogens are replaced by hydroxy and 3-aminopropyl groups.",30793,KEGG COMPOUND accession,C02357,,,,,,,,,,,,,,,
65,2968,bacampicillin,"A penicillanic acid ester that is the 1-ethoxycarbonyloxyethyl ester of ampicillin. It is a semi-synthetic, microbiologically inactive prodrug of ampicillin.",16616,KEGG COMPOUND accession,C03982,,,,,,,,,,,,,,,
66,8736,(R)-(+)-propranolol,a,27388,KEGG COMPOUND accession,C07118,,,,,,,,,,,,,,,
67,3479,cefadroxil,"A cephalosporin bearing methyl and  (2R)-2-amino-2-(4-hydroxyphenyl)acetamido groups at positions 3 and 7, respectively, of the cephem skeleton.",27626,KEGG COMPOUND accession,C04445,,,,,,,,,,,,,,,
68,10577,gamma-terpinene,One of three isomeric monoterpenes differing in the positions of their two double bonds (alpha- and beta-terpinene being the others). In gamma-terpinene the double bonds are at the 1- and 4-positions of the p-menthane skeleton.,18250,KEGG COMPOUND accession,C00634,,,,,,,,,,,,,,,
69,8613,psilocin,"A tryptamine alkaloid that is N,N-dimethyltryptamine carrying an additional hydroxy substituent at position 4. A hallucinogenic alkaloid isolated in trace amounts from Psilocybe mushrooms (also known as Teonanacatl or ""magic mushrooms"").",2991,KEGG COMPOUND accession,C10305,,,,,,,,,,,,,,,
70,9622,tolterodine,a,3286,KEGG COMPOUND accession,C08187,,,,,,,,,,,,,,,
71,9635,toremifene,a,17395,KEGG COMPOUND accession,C01481,,,,,,,,,,,,,,,
72,9654,trazodone,"An N-arylpiperazine in which one nitrogen is substituted by a 3-chlorophenyl group, while the other is substituted by a 3-(3-oxo[1,2,4]triazolo[4,3-a]pyridin-2(3H)-yl)propyl group.",70034,KEGG COMPOUND accession,C10204,,,,,,,,,,,,,,,
73,2755,anthragallol,"A trihydroxyanthraquinone that is anthracene-9,10-dione substituted by hydroxy groups at positions 1, 2 and 3.",28646,KEGG COMPOUND accession,C08733,,,,,,,,,,,,,,,
74,6908,trichlorfon,"A phosphonic ester that is dimethyl phosphonate in which the hydrogen atom attched to the phosphorous is substituted by a 2,2,2-trichloro-1-hydroxyethyl group.",15366,KEGG COMPOUND accession,C00033,ac,64-19-7,15366.0,"Human Metabolome Database (HMDB): Acetic acid is one of the simplest carboxylic acids. It is an important chemical reagent and industrial chemical that is used in the production of plastic soft drink bottles, photographic film; and polyvinyl acetate for wood glue, as well as many synthetic fibres and fabrics. In households diluted acetic acid is often used as a cleaning agent. In the food industry acetic acid is used as an acidity regulator. The acetyl group, derived from acetic acid, is fundamental to the biochemistry of virtually all forms of life. When bound to coenzyme A it is central to the metabolism of carbohydrates and fats. However, the concentration of free acetic acid in cells is kept at a low level to avoid disrupting the control of the pH of the cell contents. Acetic acid is produced and excreted by certain bacteria, notably the Acetobacter genus and Clostridium acetobutylicum. These bacteria are found universally in foodstuffs, water, and soil, and acetic acid is produced naturally as fruits and some other foods spoil. Acetic acid is also a component of the vaginal lubrication of humans and other primates, where it appears to serve as a mild antibacterial agent. Acetic acid is found to be associated with phenylketonuria, which is an inborn error of metabolism.",Acetic acid,HMDB0000042,b,b,C00033,ACET,FDB008299,ac,[H]C([H])([H])C([O-])=O,QTBSBXVTEAMEQO-UHFFFAOYSA-M,"InChI=1S/C2H4O2/c1-2(3)4/h1H3,(H,3,4)/p-1"
75,3000,beauvericin,A trimeric cyclodepsipeptide composed from alternating methylphenylalanyl and hydroxyvaleryl residues.,27878,KEGG COMPOUND accession,C02227,,,,,,,,,,,,,,,
76,3061,bepridil,"A tertiary amine in which the substituents on nitrogen are benzyl, phenyl and 3-(2-methylpropoxy)-2-(pyrrolidin-1-yl)propyl.",18267,KEGG COMPOUND accession,C03586,,,,,,,,,,,,,,,
77,4913,etretinate,a,17254,KEGG COMPOUND accession,C06730,4mcat,452-86-8,17254.0,"Human Metabolome Database (HMDB): 4-methylcatechol is a metabolite of homoprotocatechuic acid. It is both a substrate and a suicide inhibitor of Catechol 2,3-dioxygenase [EC 1.3.11.2]. (PMID 15006807). 4-methylcatechol is known to induce the production of brain-derived neurotrophic factor (BDNF). Recent studies have suggested that a lack of brain-derived neurotrophic factor (BDNF) in the limbic system may cause neuropathic pain. (PMID: 22198556).",4-Methylcatechol,HMDB0000873,b,b,C06730,4-METHYLCATECHOL,FDB008861,b,b,ZBCATMYQYDCTIZ-UHFFFAOYSA-N,b
78,7777,ophiobolin A,"A sesterterpenoid that is ophiobolane with a hydroxy group at position 3, oxo groups at positions 5 and 25, double bonds at positions 7-8 and 19-20, and an oxygen link between positions 14 and 18.",2622,KEGG COMPOUND accession,C09767,,,,,,,,,,,,,,,
79,7781,orientin,A C-glycosyl compound that is luteolin substituted by a beta-D-glucopyranosyl moiety at position 8.,2624,KEGG COMPOUND accession,C01552,,,,,,,,,,,,,,,
80,4466,dexmedetomidine,a,28571,KEGG COMPOUND accession,C10256,,,,,,,,,,,,,,,
81,4488,diallyl disulfide,An organic disulfide where the organic group specified is allyl. It has been isolated from garlic and other species of the genus Allium.,1751,KEGG COMPOUND accession,C11323,,,,,,,,,,,,,,,
82,8357,pramocaine,A member of the class of morpholines that is morpholine substituted at the nitrogen atom by a 3-(4-butoxyphenoxy)propyl group.,2866,KEGG COMPOUND accession,C09836,,,,,,,,,,,,,,,
83,11060,(S)-carnitine,The (S)-enantiomer of carnitine.,33907,KEGG COMPOUND accession,C05773,cobya,b,b,b,Cobyrinate,b,b,b,C05773,b,b,b,b,b,b
84,1784,biphenyl-4-amine,An aminobiphenyl that is biphenyl substituted by an amino group at position 4.,16147,KEGG COMPOUND accession,C04318,,,,,,,,,,,,,,,
85,1883,4-hydroxystyrene,A member of the class of  phenols that is  styrene carrying a hydroxy substituent at position 4.,15628,KEGG COMPOUND accession,C05966,,,,,,,,,,,,,,,
86,5530,gramicidin S,a,16290,KEGG COMPOUND accession,C05439,chlstol,651-54-7,16290.0,"Human Metabolome Database (HMDB): 5alpha-Cholesta-7,24-dien-3beta-ol is involved in the biosynthesis of steroids. 5alpha-Cholesta-7,24-dien-3beta-ol is reversibly converted to 5alpha-Cholest-7-en-3beta-ol by delta24-sterol reductase [EC:1.3.1.72]. 5alpha-Cholesta-7,24-dien-3beta-ol is also converted to zymosterol by cholestenol delta-isomerase [EC:5.3.3.5]. 5alpha-Cholesta-7,24-dien-3beta-ol is also converted to 7-Dehydrodesmosterol. 5a-Cholesta-7,24-dien-3b-ol is a substrate for 3-beta-hydroxysteroid-delta(8),delta(7)-isomerase.","5a-Cholesta-7,24-dien-3b-ol",HMDB0006842,b,b,C05439,5-ALPHA-CHOLESTA-724-DIEN-3-BETA-OL,FDB024115,chlstol,[H]O[C@@]1([H])C([H])([H])C([H])([H])[C@]2(C([H])([H])[H])[C@]3([H])C(=C([H])C([H])([H])[C@@]2([H])C1([H])[H])[C@]1([H])C([H])([H])C([H])([H])[C@]([H])([C@]([H])(C([H])([H])[H])C([H])([H])C([H])([H])C([H])=C(C([H])([H])[H])C([H])([H])[H])[C@@]1(C([H])([H])[H])C([H])([H])C3([H])[H],PKEPPDGGTSZLBL-SKCNUYALSA-N,"InChI=1S/C27H44O/c1-18(2)7-6-8-19(3)23-11-12-24-22-10-9-20-17-21(28)13-15-26(20,4)25(22)14-16-27(23,24)5/h7,10,19-21,23-25,28H,6,8-9,11-17H2,1-5H3/t19-,20+,21+,23-,24+,25+,26+,27-/m1/s1"
87,5679,herniarin,A member of the class of coumarins that is coumarin substituted by a methoxy group at position 7.,15953,KEGG COMPOUND accession,C04584,,,,,,,,,,,,,,,
88,6731,melezitose,A trisaccharide produced by insects such as aphids.,2366,KEGG COMPOUND accession,C09286,,,,,,,,,,,,,,,
89,2512,agathisflavone,A biflavonoid that is obtained by oxidative coupling of two molecules of apigenin resulting in a bond between positions C-6 and C-8 of the two chromene rings.,1019,KEGG COMPOUND accession,C05683,,,,,,,,,,,,,,,
90,2555,aldicarb,"The oxime carbamate resulting from the addition of 2-methyl-2-(methylsulfanyl)propanaldoxime to methyl isocyanate. A member of the class of oxime carbamate insecticides, aldicarb is a mixture of E and Z isomers; it is not known which isomer is more active.",17605,KEGG COMPOUND accession,C03057,,,,,,,,,,,,,,,
91,2668,amlodipine,"A fully substituted dialkyl 1,4-dihydropyridine-3,5-dicarboxylate derivative, which is used for the treatment of hypertension, chronic stable angina and confirmed or suspected vasospastic angina.",28542,KEGG COMPOUND accession,C00672,2dr1p,17210-42-3,28542.0,Human Metabolome Database (HMDB): Deoxyribose 1-phosphate is an intermediate in the metabolism of Pyrimidine. It is a substrate for Purine nucleoside phosphorylase and Thymidine phosphorylase.,Deoxyribose 1-phosphate,HMDB0001351,b,b,C00672,DEOXY-RIBOSE-1P,FDB022571,2dr1p,[H]OC([H])([H])[C@@]1([H])OC([H])(OP([O-])([O-])=O)C([H])([H])[C@]1([H])O[H],KBDKAJNTYKVSEK-PYHARJCCSA-L,"InChI=1S/C5H11O7P/c6-2-4-3(7)1-5(11-4)12-13(8,9)10/h3-7H,1-2H2,(H2,8,9,10)/p-2/t3-,4+,5?/m0/s1"
92,3686,chrysophanol-9-anthrone,a,15851,KEGG COMPOUND accession,C03584,,,,,,,,,,,,,,,
93,5383,glimepiride,a,2082,KEGG COMPOUND accession,C02951,,,,,,,,,,,,,,,
94,151,D-threo-isocitric acid,The D-threo-diastereomer of isocitric acid.,75,KEGG COMPOUND accession,C11358,,,,,,,,,,,,,,,
95,2086,"5-methoxy-N,N-dimethyltryptamine","A tryptamine alkaloid that is N,N-dimethyltryptamine substituted by a methoxy group at position 5.",16516,KEGG COMPOUND accession,C04283,,,,,,,,,,,,,,,
96,3374,capsaicin,a,28074,KEGG COMPOUND accession,C00968,,,,,,,,,,,,,,,
97,5106,flunisolide,a,18272,KEGG COMPOUND accession,C04376,fgam,b,b,Human Metabolome Database (HMDB): 5'-Phosphoribosyl-N-formylglycineamide (also known as FGAR or N-Formyl-GAR) is a substrate for Phosphoribosylformylglycinamidine synthase. It is involved in aminoimidazole ribonucleotide biosynthesis and plays a vital role in purine metabolism as well as the conversion of glutamine to glutamate. 5'-Phosphoribosyl-N-formylglycineamide is described as a glycinamide ribonucleotide having a phosphate group at the 5-position and a formyl group on the glycine nitrogen.,5'-Phosphoribosyl-N-formylglycinamide,HMDB0001308,b,b,C04376,5-P-RIBOSYL-N-FORMYLGLYCINEAMIDE,FDB022544,fgam,[H]O[C@@]1([H])C([H])(O[C@]([H])(C([H])([H])OP([O-])([O-])=O)[C@@]1([H])O[H])N([H])C(=O)C([H])([H])N([H])C([H])=O,VDXLUNDMVKSKHO-LLRQIJQNSA-L,"InChI=1S/C8H15N2O9P/c11-3-9-1-5(12)10-8-7(14)6(13)4(19-8)2-18-20(15,16)17/h3-4,6-8,13-14H,1-2H2,(H,9,11)(H,10,12)(H2,15,16,17)/p-2/t4-,6-,7-,8?/m0/s1"
98,10112,zileuton,"A member of the class of 1-benzothiophenes that is 1-benzothiophene in which the hydrogen at position 2 is replaced by a 1-[carbamoyl(hydroxy)amino]ethyl group. A selective 5-lipoxygenase inhibitor, it inhibits the formation of leukotrienes LTB4, LTC4, LDT4, and LTE4. It is used for the management of chronic asthma.",3484,KEGG COMPOUND accession,C11202,,,,,,,,,,,,,,,
99,955,"2,6-dimethoxyphenol",A member of the class of phenols that is phenol substituted by methoxy groups at positions 2 and 6.,15453,KEGG COMPOUND accession,C01144,3hbcoa,b,b,Human Metabolome Database (HMDB): (S)-3-Hydroxybutyryl-CoA is classified as a member of the (S)-3-hydroxyacyl CoAs. (S)-3-hydroxyacyl CoAs are organic compounds containing a (S)-3-hydroxyl acylated coenzyme A derivative. (S)-3-Hydroxybutyryl-CoA is considered to be slightly soluble (in water) and acidic,(S)-3-Hydroxybutyryl-CoA,HMDB0062259,b,b,C01144,b,b,3hbcoa,[H]O[C@@]([H])(C(=O)N([H])C([H])([H])C([H])([H])C(=O)N([H])C([H])([H])C([H])([H])SC(=O)C([H])([H])[C@@]([H])(O[H])C([H])([H])[H])C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])OP([O-])(=O)OP([O-])(=O)OC([H])([H])[C@@]1([H])O[C@@]([H])(N2C([H])=NC3=C(N=C([H])N=C23)N([H])[H])[C@]([H])(O[H])[C@]1([H])OP([O-])([O-])=O,QHHKKMYHDBRONY-VKBDFPRVSA-J,"InChI=1S/C25H42N7O18P3S/c1-13(33)8-16(35)54-7-6-27-15(34)4-5-28-23(38)20(37)25(2,3)10-47-53(44,45)50-52(42,43)46-9-14-19(49-51(39,40)41)18(36)24(48-14)32-12-31-17-21(26)29-11-30-22(17)32/h11-14,18-20,24,33,36-37H,4-10H2,1-3H3,(H,27,34)(H,28,38)(H,42,43)(H,44,45)(H2,26,29,30)(H2,39,40,41)/p-4/t13-,14+,18+,19+,20-,24+/m0/s1"
100,2340,docebenone,"A member of the class of benzoquinones that is p-benzoquinone in which the hydrogens are substituted by three methyl groups and a 12-hydroxydodeca-5,10-diyn-1-yl group.",28435,KEGG COMPOUND accession,C10934,,,,,,,,,,,,,,,
101,2368,abyssinone V,"A trihydroxyflavanone that is flavanone substituted by hydroxy groups at positions 5, 7 and 4' and prenyl groups at positions 3' and 5' respectively.",15707,KEGG COMPOUND accession,C03750,,,,,,,,,,,,,,,
102,2401,acetophenazine,A member of the class of  phenothiazines that is 10H-phenothiazine substituted by a 3-[4-(2-hydroxyethyl)piperazin-1-yl]propyl group at the nitogen atom and an acetyl group at position 2.,17827,KEGG COMPOUND accession,C03920,mcom,b,17827.0,b,Methyl Coenzyme M,b,b,b,C03920,b,b,b,b,b,"InChI=1S/C3H8O3S2/c1-7-2-3-8(4,5)6/h2-3H2,1H3,(H,4,5,6)"
103,2404,acetosyringone,A member of the class of  acetophenones that is 1-phenylethanone substituted by a hydroxy group at position 4 and methoxy groups at positions 3 and 5.,17506,KEGG COMPOUND accession,C04641,,,,,,,,,,,,,,,
104,3219,bupropion,An aromatic ketone that is propiophenone carrying a tert-butylamino group at position 2 and a chloro substituent at position 3 on the phenyl ring.,32896,KEGG COMPOUND accession,C11536,pslac,b,32896.0,b,(2R)-O-phospho-3-sulfolactic acid,b,b,b,C11536,b,b,b,b,b,"InChI=1S/C3H7O9PS/c4-3(5)2(1-14(9,10)11)12-13(6,7)8/h2H,1H2,(H,4,5)(H2,6,7,8)(H,9,10,11)/t2-/m0/s1"
105,2896,astemizole,A piperidine compound having a 2-(4-methoxyphenyl)ethyl group at the 1-position and an N-[(4-fluorobenzyl)benzimidazol-2-yl]amino group at the 4-position.,36491,KEGG COMPOUND accession,C11131,,,,,,,,,,,,,,,
106,7872,oxytocin,"A cyclic nonapeptide hormone with amino acid sequence CYIQNCPLG that also acts as a neurotransmitter in the brain; the principal uterine-contracting and milk-ejecting hormone of the posterior pituitary. Together with the neuropeptide vasopressin, it is believed to influence social cognition and behaviour.",2654,KEGG COMPOUND accession,C07617,,,,,,,,,,,,,,,
107,9729,trimethaphan camsylate,The (S)-camphorsulfonate salt of trimethaphan.,17793,KEGG COMPOUND accession,C01562,,,,,,,,,,,,,,,
108,2654,aminoglutethimide,A dicarboximide that is a six-membered cyclic compound having ethyl and 4-aminophenyl substituents at the 3-position.,27972,KEGG COMPOUND accession,C06892,d5kg,b,27972.0,b,2-deoxy-5-keto-D-gluconic acid,b,b,b,C06892,b,b,b,b,b,"InChI=1S/C6H10O6/c7-2-4(9)6(12)3(8)1-5(10)11/h3,6-8,12H,1-2H2,(H,10,11)/t3-,6+/m1/s1"
109,2950,azelastine,"A phthalazine compound having an oxo substituent at the 1-position, a 1-methylazepan-4-yl group at the 2-position and a 4-chlorobenzyl substituent at the 4-position.",17059,KEGG COMPOUND accession,C02224,,,,,,,,,,,,,,,
110,2904,atenolol,An ethanolamine compound having a (4-carbamoylmethylphenoxy)methyl group at the 1-position and an N-isopropyl substituent.,1189,KEGG COMPOUND accession,C05299,C05299,362-08-3,1189.0,Human Metabolome Database (HMDB): 2-methoxyestrone is a steroid derivative that is a byproduct of estrone and 2-hydroxyestrone metabolism. It is part of the androgen and estrogen metabolic pathway. The acid ionization constant (pKa) of 2-methoxyestrone is 10.81 (PMID: 516114). 2-Methoxyestrone can be metabolized to a sulfated derivative (2-Methoxyestrone 3-sulfate) via steroid sulfotransferase (EC 2.8.2.15). It can also be glucuronidated to 2-Methoxyestrone 3-glucuronide by UDP glucuronosyltransferase (EC 2.4.1.17).,2-Methoxyestrone,HMDB0000010,b,b,C05299,ESTRONE-SULFATE,FDB021868,C05299,[H]OC1=C([H])C2=C(C([H])=C1OC([H])([H])[H])[C@@]1([H])C([H])([H])C([H])([H])[C@@]3(C(=O)C([H])([H])C([H])([H])[C@@]3([H])[C@]1([H])C([H])([H])C2([H])[H])C([H])([H])[H],WHEUWNKSCXYKBU-QPWUGHHJSA-N,"InChI=1S/C19H24O3/c1-19-8-7-12-13(15(19)5-6-18(19)21)4-3-11-9-16(20)17(22-2)10-14(11)12/h9-10,12-13,15,20H,3-8H2,1-2H3/t12-,13+,15-,19-/m0/s1"
111,3481,cefamandole nafate,A cephalosporin prodrug having (R)-O-formylmandelamido and N-methylthiotetrazole side-groups.,16767,KEGG COMPOUND accession,C02791,,,,,,,,,,,,,,,
112,7857,oxybutynin chloride,a,17628,KEGG COMPOUND accession,C06735,,,,,,,,,,,,,,,
113,5381,glepidotin B,"A trihydroxyflavanone that is (2S)-flavanone substituted by hydroxy groups at positions 3, 5 and 7 and a prenyl group at position 8 respectively.",28171,KEGG COMPOUND accession,C01017,5htrp,b,28171.0,"Human Metabolome Database (HMDB): 5-Hydroxy-L-tryptophan is an aromatic amino acid naturally produced by the body from the essential amino acid L-tryptophan. 5-Hydroxy-L-tryptophan is the immediate precursor of the neurotransmitter serotonin. The conversion to serotonin is catalyzed by the enzyme aromatic L-amino acid decarboxylase (EC 4.1.1.28) (AADC1 also known as DOPA decarboxylase), an essential enzyme in the metabolism of the monoamine neurotransmitters. An accumulation of 5-hydroxy-L-tryptophan in cerebrospinal fluid occurs in aromatic L-amino acid decarboxylase deficiency (AADC deficiency) (OMIM: 608643) accompanied by an increased excretion in the urine of the patients, which are indicative of the disorder but not specific. 5-Hydroxy-L-tryptophan is also increased in other disorders such as in Parkinson's patients with severe postural instability and gait disorders. The amount of endogenous 5-hydroxy-L-tryptophan available for serotonin synthesis depends on the availability of tryptophan and on the activity of various enzymes, especially tryptophan hydroxylase (EC 1.14.16.4), indoleamine 2,3-dioxygenase (EC 1.13.11.52), and tryptophan 2,3-dioxygenase (TDO) (EC 1.13.11.11). 5-Hydroxy-L-tryptophan has been used clinically for over 30 years. In addition to its use in the treatment of depression, the therapeutic administration of 5-hydroxy-L-tryptophan has been shown to be effective in treating a wide variety of conditions, including fibromyalgia, insomnia, binge eating associated with obesity, cerebellar ataxia, and chronic headaches. 5-Hydroxy-L-tryptophan easily crosses the blood-brain barrier and effectively increases central nervous system (CNS) synthesis of serotonin. Supplementation with 5-hydroxy-L-tryptophan is hypothesized to normalize serotonin synthesis, which is putatively related to its antidepressant properties (PMID: 9295177, 17240182, 16023217). When present in sufficiently high levels, 5-hydroxytryptophan can be a neurotoxin and a metabotoxin. A neurotoxin is a compound that disrupts or attacks neural cells or tissue. A metabotoxin is an endogenously produced metabolite that causes adverse health effects at chronically high levels. Signs and symptoms of AADC deficiency generally appear in the first year of life. Affected infants may have severe developmental delay, weak muscle tone (hypotonia), muscle stiffness, difficulty moving, and involuntary writhing movements of the limbs (athetosis). They may be lacking in energy (lethargic), feed poorly, startle easily, and have sleep disturbances. Since 5-hydroxytryptophan is a precursor to serotonin, altered levels of serotonin can accumulate in the brain, which leads to abnormal neural signalling. Infants with AADC deficiency have very low levels of neural signalling molecules while individuals who consume high levels of 5-hydroxytryptophan will have very high levels of neural signalling molecules. Both conditions can lead to vomiting, nausea, extreme drowsiness, and lethargy. 5-Hydroxytryptophan (5-HTP), also known as oxitriptan (INN) is sold over-the-counter in the United Kingdom, the United States, and Canada as a dietary supplement for use as an antidepressant, appetite suppressant, and sleep aid. It is also marketed in many European countries for the indication of major depression under trade names such as Cincofarm, Levothym, Levotonine, Oxyfan, Telesol, Tript-OH, and Triptum. Several double-blind placebo-controlled clinical trials have demonstrated the effectiveness of 5-HTP in the treatment of depression, though a lack of high-quality studies has been noted. More and larger studies are needed to determine if 5-HTP is truly effective in treating depression.",5-Hydroxy-L-tryptophan,HMDB0000472,b,b,C01017,5-HYDROXY-TRYPTOPHAN,FDB006231,5htrp,[H]OC1=C([H])C([H])=C2N([H])C([H])=C(C2=C1[H])C([H])([H])C([H])(C([O-])=O)[N+]([H])([H])[H],LDCYZAJDBXYCGN-UHFFFAOYSA-N,"InChI=1S/C11H12N2O3/c12-9(11(15)16)3-6-5-13-10-2-1-7(14)4-8(6)10/h1-2,4-5,9,13-14H,3,12H2,(H,15,16)"
114,8885,rocuronium bromide,"The organic bromide salt of a 5alpha androstane compound having 3alpha-hydroxy-, 17beta-acetoxy-, 2beta-morpholino- and 16beta-N-allyllyrrolidinium substituents.",17033,KEGG COMPOUND accession,C00500,biliverd,114-25-0,17033.0,"Human Metabolome Database (HMDB): Biliverdin is a green pigment formed as a byproduct of hemoglobin breakdown. It consists of four linearly connected pyrrole rings (a tetrapyrrole). Biliverdin is formed when the heme group in hemoglobin is cleaved at its alpha-methene bridge. The resulting biliverdin is then reduced to bilirubin, a yellow pigment, by the enzyme biliverdin reductase. The changing color of a bruise from deep purple to yellow over time is a graphical indicator of this reaction. Biosynthesized from hemoglobin as a precursor of bilirubin. Occurs in the bile of amphibia and of birds, but not in normal human bile or serum.",Biliverdin,HMDB0001008,b,b,C00500,BILIVERDINE,FDB022366,biliverd,[H]OC1=N\C(=C(\[H])C2=N\C(=C(\[H])C3=C(C(=C(N3[H])C(\[H])=C3/N=C(O[H])C(=C3C([H])=C([H])[H])C([H])([H])[H])C([H])([H])[H])C([H])([H])C([H])([H])C([O-])=O)\C(=C2C([H])([H])[H])C([H])([H])C([H])([H])C([O-])=O)C(=C1C([H])=C([H])[H])C([H])([H])[H],QBUVFDKTZJNUPP-BBROENKCSA-L,"InChI=1S/C33H34N4O6/c1-7-20-19(6)32(42)37-27(20)14-25-18(5)23(10-12-31(40)41)29(35-25)15-28-22(9-11-30(38)39)17(4)24(34-28)13-26-16(3)21(8-2)33(43)36-26/h7-8,13-15,35H,1-2,9-12H2,3-6H3,(H,36,43)(H,37,42)(H,38,39)(H,40,41)/p-2/b26-13-,27-14-,28-15-"
115,9047,schaftoside,A C-glycosyl compound that is apigenin substituted by beta-D-glucopyranosyl and an alpha-L-arabinopyranosyl moieties at positions 6 and 8 via C-glycosidic linkages.,3176,KEGG COMPOUND accession,C07760,,,,,,,,,,,,,,,
116,9159,sinensetin,"A pentamethoxyflavone that is flavone substituted by methoxy groups at positions 5, 6, 7, 3' and 4' respectively.",3230,KEGG COMPOUND accession,C10931,,,,,,,,,,,,,,,
117,11936,N-acetyl-beta-D-glucosaminyl-(1->4)-beta-D-mannosyl group,A group obtained by removing the hydroxy group from the hemiacetal function of N-acetyl-beta-D-glucosaminyl-(1->4)-beta-D-mannose.,16534,KEGG COMPOUND accession,C00880,galctn_D,13382-27-9,16534.0,"Human Metabolome Database (HMDB): Galactonic acid is a sugar acid that is a metabolic breakdown product of galactose. Galactose dehydrogenase is responsible for converting galactose to galactonolactone, which then spontaneously or enzymatically converts to galactonic acid. Once formed, galactonic acid may enter the pentose phosphate pathway. Galactonic acid is increased in red blood cells of galactosemic patients, due to a galactose-1-phosphate uridyltransferase (GALT) deficiency (PMID: 14680973, OMMBID: The Online Metabolic and Molecular Bases of Inherited Disease, Ch.72). When present in sufficiently high levels, galactonic acid can act as an acidogen and a metabotoxin. An acidogen is an acidic compound that induces acidosis, which has multiple adverse effects on many organ systems. A metabotoxin is an endogenously produced metabolite that causes adverse health effects at chronically high levels. Chronically high levels of galactonic acid are associated with at least two inborn errors of metabolism, including galactosemia and galactosemia type II. Galactonic acid is an organic acid. Abnormally high levels of organic acids in the blood (organic acidemia), urine (organic aciduria), the brain, and other tissues lead to general metabolic acidosis. Acidosis typically occurs when arterial pH falls below 7.35. In infants with acidosis, the initial symptoms include poor feeding, vomiting, loss of appetite, weak muscle tone (hypotonia), and lack of energy (lethargy). These can progress to heart abnormalities, liver abnormalities (jaundice), kidney abnormalities, seizures, coma, and possibly death. These are also the characteristic symptoms of untreated galactosemia. Many affected children with organic acidemias experience intellectual disability or delayed development. High levels of galactonic acid in infants are specifically associated with hepatomegaly (an enlarged liver), cirrhosis, renal failure, cataracts, vomiting, seizure, hypoglycemia, lethargy, brain damage, and ovarian failure.",Galactonic acid,HMDB0000565,b,b,C00880,b,FDB022122,b,b,RGHNJXZEOKUKBD-MGCNEYSASA-N,b
118,2131,5-methyl-3-isoxazolyl sulfate,"A heterocyclyl sulfate that is 1,2-oxazol-3-yl hydrogen sulfate substituted by a methyl group at position 5.",18380,KEGG COMPOUND accession,C04932,,,,,,,,,,,,,,,
119,3286,cabergoline,"An N-acylurea that is (8R)-ergoline-8-carboxamide in which the hydrogen attached to the piperidine nitrogen (position 6) is substituted by an allyl group and the hydrogens attached to the carboxamide nitrogen are substituted by a 3-(dimethylamino)propyl group and an N-ethylcarbamoyl group. A dopamine D2 receptor agonist, cabergoline is used in the management of Parkinson's disease and of disorders associated with hyperprolactinaemia.",28700,KEGG COMPOUND accession,C03577,C03577,111844-33-8,28700.0,"Human Metabolome Database (HMDB): 20-Hydroxy-leukotriene E4 is a metabolite that can originate from the lipid oxidation of leukotriene E4 (LTE4). LTE4 is a cysteinyl leukotriene. Cysteinyl leukotrienes (CysLTs) are a family of potent inflammatory mediators that appear to contribute to the pathophysiologic features of allergic rhinitis. Nasal blockage induced by CysLTs is mainly due to dilatation of nasal blood vessels which can be induced by the nitric oxide produced through CysLT1 receptor activation. LTE4 activates contractile and inflammatory processes via specific interactions with putative seven transmembrane-spanning receptors that couple to G proteins and subsequent intracellular signaling pathways. LTE4 is metabolized from leukotriene C4 in a reaction catalyzed by gamma-glutamyl transpeptidase and a particulate dipeptidase from kidney (PMID: 12607939, 12432945, 6311078). Leukotrienes are eicosanoids. The eicosanoids consist of the prostaglandins (PGs), thromboxanes (TXs), leukotrienes (LTs), and lipoxins (LXs). The PGs and TXs are collectively identified as prostanoids. Prostaglandins were originally shown to be synthesized in the prostate gland, thromboxanes from platelets (thrombocytes), and leukotrienes from leukocytes, hence the derivation of their names. All mammalian cells except erythrocytes synthesize eicosanoids. These molecules are extremely potent and are able to cause profound physiological effects at very dilute concentrations. All eicosanoids function locally at the site of synthesis through receptor-mediated G-protein linked signaling pathways.",20-Hydroxy-leukotriene E4,HMDB0012639,b,b,C03577,20-HYDROXY-LEUKOTRIENE-E4,FDB029162,b,[H]OC([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C(\[H])=C(\[H])C([H])([H])C(\[H])=C(\[H])/C(/[H])=C(\[H])/C(/[H])=C(\[H])[C@@]([H])(SC([H])([H])[C@@]([H])(C([O-])=O)[N+]([H])([H])[H])[C@@]([H])(O[H])C([H])([H])C([H])([H])C([H])([H])C([O-])=O,BJRMBXPQAMDCMG-CMJQBAFXSA-M,"InChI=1S/C23H37NO6S/c24-19(23(29)30)18-31-21(20(26)14-13-16-22(27)28)15-11-9-7-5-3-1-2-4-6-8-10-12-17-25/h2-5,7,9,11,15,19-21,25-26H,1,6,8,10,12-14,16-18,24H2,(H,27,28)(H,29,30)/p-1/b4-2-,5-3-,9-7+,15-11+/t19-,20-,21+/m0/s1"
120,3311,calcium carbonate,A calcium salt with formula CCaO3.,28043,KEGG COMPOUND accession,C05485,M00605,1164-98-3,28043.0,"Human Metabolome Database (HMDB): 21-hydroxypregnenolone is an essential intermediate in corticosterone synthesis. The hydrolysis of 21-hydroxypregnenolone of fetal origin by steryl-sulfatase (SOS, EC 3.1.6.2), may be important in the biosynthesis of deoxycorticosterone, which is present in the plasma of pregnant women in high concentration. 21-hydroxypregnenolone has been identified in follicular fluid from follicles of women. Pregnenolone is transformed to 21-hydroxypregnenolone by human adrenal microsomal preparations, suggesting the involvement of alternative paths via 17a,21-dihydroxypregnenolone in human. (PMID 974176, 3347051, 3495701, 7382480, 6247575).",21-Hydroxypregnenolone,HMDB0004026,b,b,C05485,b,FDB023281,M00605,[H]OC([H])([H])C(=O)[C@@]1([H])C([H])([H])C([H])([H])C2([H])C3([H])C([H])([H])C([H])=C4C([H])([H])[C@@]([H])(O[H])C([H])([H])C([H])([H])[C@]4(C([H])([H])[H])C3([H])C([H])([H])C([H])([H])[C@]12C([H])([H])[H],MOIQRAOBRXUWGN-ANWDBCJUSA-N,"InChI=1S/C21H32O3/c1-20-9-7-14(23)11-13(20)3-4-15-16-5-6-18(19(24)12-22)21(16,2)10-8-17(15)20/h3,14-18,22-23H,4-12H2,1-2H3/t14-,15?,16?,17?,18+,20-,21-/m0/s1"
121,3332,(+)-calycanthidine,a,27722,KEGG COMPOUND accession,C11049,,,,,,,,,,,,,,,
122,3378,capsorubin,a,27825,KEGG COMPOUND accession,C04444,,,,,,,,,,,,,,,
123,3469,catharanthine,An organic heteropentacyclic compound and monoterpenoid indole alkaloid produced by the medicinal plant Catharanthus roseus via strictosidine.,28774,KEGG COMPOUND accession,C07639,CE2754,b,28774.0,b,"3,3,5 - Triiodothyronine",b,b,b,C07639,b,b,b,[H]OC1=C(I)C([H])=C(OC2=C(I)C([H])=C(C([H])=C2[H])C([H])([H])[C@]([H])(C([O-])=O)[N+]([H])([H])[H])C([H])=C1I,HZCBWYNLGPIQRK-GFCCVEGCSA-N,"InChI=1S/C15H12I3NO4/c16-9-3-7(4-12(19)15(21)22)1-2-13(9)23-8-5-10(17)14(20)11(18)6-8/h1-3,5-6,12,20H,4,19H2,(H,21,22)/t12-/m1/s1"
124,3490,cefmetazole sodium,An organic sodium salt that is the sodium salt of cefmetazole.,15896,KEGG COMPOUND accession,C04793,,,,,,,,,,,,,,,
125,3492,cefonicid sodium,a,15765,KEGG COMPOUND accession,C00355,34dhphe,59-92-7,15765.0,"Human Metabolome Database (HMDB): L-Dopa is the naturally occurring form of dihydroxyphenylalanine and the immediate precursor of dopamine. Unlike dopamine itself, L-Dopa can be taken orally and crosses the blood-brain barrier. It is rapidly taken up by dopaminergic neurons and converted to dopamine. In particular, it is metabolized to dopamine by aromatic L-amino acid decarboxylase. Pyridoxal phosphate (vitamin B6) is a required cofactor for this decarboxylation, and may be administered along with levodopa, usually as pyridoxine. L-Dopa is used for the treatment of Parkinsonian disorders and Dopa-Responsive Dystonia and is usually given with agents that inhibit its conversion to dopamine outside of the central nervous system. Peripheral tissue conversion may be the mechanism of the adverse effects of levodopa. It is standard clinical practice to co-administer a peripheral DOPA decarboxylase inhibitor - carbidopa or benserazide - and often a catechol-O-methyl transferase (COMT) inhibitor, to prevent synthesis of dopamine in peripheral tissue.",L-Dopa,HMDB0000181,b,b,C00355,L-DOPA,FDB000567,34dhphe,[H]OC1=C([H])C([H])=C(C([H])=C1O[H])C([H])([H])[C@@]([H])(C([O-])=O)[N+]([H])([H])[H],WTDRDQBEARUVNC-LURJTMIESA-N,"InChI=1S/C9H11NO4/c10-6(9(13)14)3-5-1-2-7(11)8(12)4-5/h1-2,4,6,11-12H,3,10H2,(H,13,14)/t6-/m0/s1"
126,4116,D-erythrulose 4-phosphate,A ketotetrose phosphate that is D-erythrulose carrying a phosphono substituent at position O-4.,18084,KEGG COMPOUND accession,C04676,,,,,,,,,,,,,,,
127,4195,D-hexose 6-phosphate,a,28264,KEGG COMPOUND accession,C05267,HC01406,54684-64-9,28264.0,"Human Metabolome Database (HMDB): 3-Oxooctanoyl-CoA is the substrate of the acetyl-CoA C-acyltransferase/oxoacyl-CoA thiolase A (EC 2.3.1.16, SCP2/3-oxoacyl-CoA thiolase) present in peroxisomes from normal liver. Peroxisomes beta -oxidize a wide variety of substrates including straight chain fatty acids, 2-methyl-branched fatty acids, and the side chain of the bile acid intermediates di- and trihydroxycoprostanic acids. Peroxisomes contain several beta -oxidation pathways with different substrate specificities; or example, straight chain acyl-CoAs are desaturated by palmitoyl-CoA oxidase, and their enoyl-CoAs are then converted to 3-oxoacyl-CoAs by MFP-1, which forms (hydration) and dehydrogenates L-3(3S)-hydroxyacyl-CoAs; for example, straight chain acyl-CoAs are desaturated by palmitoyl-CoA oxidase (23), and their enoyl-CoAs are then converted to 3-oxoacyl-CoAs by 3-hydroxyacyl-CoA dehydrogenase (EC 1.1.1.35), which forms (hydration) and dehydrogenates L-3(3S)-hydroxyacyl-CoAs and their enoyl-CoAs are then converted to the corresponding 3-oxoacyl-CoAs by long-chain-enoyl-CoA hydratase(EC 4.2.1.74), which forms and dehydrogenates D-3(3R)-hydroxyacyl-CoAs. (PMID: 9325339).",3-Oxooctanoyl-CoA,HMDB0003941,b,b,C05267,7-METHYL-3-OXOOCTANOYL-COA,FDB023260,HC01406,[H]O[C@@]([H])(C(=O)N([H])C([H])([H])C([H])([H])C(=O)N([H])C([H])([H])C([H])([H])SC(=O)C([H])([H])C(=O)C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H])C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])OP([O-])(=O)OP([O-])(=O)OC([H])([H])[C@@]1([H])O[C@@]([H])(N2C([H])=NC3=C(N=C([H])N=C23)N([H])[H])[C@]([H])(O[H])[C@]1([H])OP([O-])([O-])=O,WPIVBCGRGVNDDT-CECATXLMSA-J,"InChI=1S/C29H48N7O18P3S/c1-4-5-6-7-17(37)12-20(39)58-11-10-31-19(38)8-9-32-27(42)24(41)29(2,3)14-51-57(48,49)54-56(46,47)50-13-18-23(53-55(43,44)45)22(40)28(52-18)36-16-35-21-25(30)33-15-34-26(21)36/h15-16,18,22-24,28,40-41H,4-14H2,1-3H3,(H,31,38)(H,32,42)(H,46,47)(H,48,49)(H2,30,33,34)(H2,43,44,45)/p-4/t18-,22-,23-,24+,28-/m1/s1"
128,1604,3-methylguanine,A methylguanine carrying the methyl substituent at position 3.,15723,KEGG COMPOUND accession,C04101,,,,,,,,,,,,,,,
129,1447,3-acylpyruvic acid,A dioxo monocarboxylic acid that is pyruvic acid substituted by an acyl group at position 3.,16805,KEGG COMPOUND accession,C04437,,,,,,,,,,,,,,,
130,1463,3-carboxy-1-hydroxypropylthiamine diphosphate,"A 1,3-thiazolium cation that is 1,3-thiazol-3-ium substituted by a methyl group at position 4, a (4-amino-2-methylpyrimidin-5-yl)methyl group at position 3, a 3-carboxy-1-hydroxypropyl at position 2 and a 2-{[hydroxy(phosphonooxy)phosphoryl]oxy}ethyl group at position 5.",17848,KEGG COMPOUND accession,C01282,,,,,,,,,,,,,,,
131,5922,ingenol,"A tetracyclic diterpenoid that is 1a,2,5,5a,6,9,10,10a-octahydro-1H-2,8a-methanocyclopenta[a]cyclopropa[e][10]annulen-11-one substituted at positions 5, 5a and 6 by hydroxy groups, positions 1, 1, 7 and 9 by methyl groups, position 4 by a hydroxymethyl group and position 1 by an oxo group (the 1aR,2S,5R,5aR,6S,8aS,9R,10aR diastereomer).",17206,KEGG COMPOUND accession,C04379,,,,,,,,,,,,,,,
132,5941,intermedine,"A carboxylic ester compound formed from condensation between retronecine and (2S,3R)-2,3-dihydroxy-2-isopropylbutanoic acid.",16761,KEGG COMPOUND accession,C00008,adp,58-64-0,16761.0,"Human Metabolome Database (HMDB): Adenosine diphosphate, abbreviated ADP, is a nucleotide. It is an ester of pyrophosphoric acid with the nucleotide adenine. ADP consists of the pyrophosphate group, the pentose sugar ribose, and the nucleobase adenine. ADP is the product of ATP dephosphorylation by ATPases. ADP is converted back to ATP by ATP synthases.",ADP,HMDB0001341,b,b,C00008,ADP,FDB021817,adp,[H]O[C@@]1([H])[C@@]([H])(O[C@]([H])(C([H])([H])OP([O-])(=O)OP([O-])([O-])=O)[C@@]1([H])O[H])N1C([H])=NC2=C(N=C([H])N=C12)N([H])[H],XTWYTFMLZFPYCI-KQYNXXCUSA-K,"InChI=1S/C10H15N5O10P2/c11-8-5-9(13-2-12-8)15(3-14-5)10-7(17)6(16)4(24-10)1-23-27(21,22)25-26(18,19)20/h2-4,6-7,10,16-17H,1H2,(H,21,22)(H2,11,12,13)(H2,18,19,20)/p-3/t4-,6-,7-,10-/m1/s1"
133,7219,beta-naphthyl N-acetylphenylalaninate,An alpha-amino acid ester obtained by the fromal condensation of N-acetylphenylalanine with 2-naphthol.,2431,KEGG COMPOUND accession,C08468,,,,,,,,,,,,,,,
134,7351,"N(4)-acetyl-L-2,4-diaminobutyric acid","The N(4)-acetyl derivative of L-2,4-diaminobutyric acid",15835,KEGG COMPOUND accession,C03372,adhap_hs,b,15835.0,b,Acyl-Dihydroxyacetone Phosphate,b,b,b,C03372,b,b,b,[H]C([H])(OC([*])=O)C(=O)C([H])([H])OP([O-])([O-])=O,b,b
135,7351,"N(4)-acetyl-L-2,4-diaminobutyric acid","The N(4)-acetyl derivative of L-2,4-diaminobutyric acid",15835,KEGG COMPOUND accession,C03372,C03372,b,15835.0,"Human Metabolome Database (HMDB): 1-acylglycerone 3-phosphate is found in the glycerophospholipid metabolism and ether lipid metabolism pathways. In the glycerophospholipid metabolism pathway, 1-acylglycerone 3-phosphate is created from glycerone phosphate, a reaction catalyzed by glyceronephosphate O-acyltransferase [EC:2.3.1.42]. 1-acylglycerone 3-phosphate is then converted to 1-acyl-sn-3-glycercol-phosphate or enters ether lipid metabolism. The conversion to 1-acyl-sn-3-glycercol-phosphate is catalyzed by 1-acylglycerone phosphate reductase [EC:1.1.1.101]. Within the ether lipid metabolism pathway, 1-acylglycerone 3-phosphate is converted to 1-alkyl-glycerone-3-phosphate through the action of alkyldihydroxyacetonephosphate synthase [EC:2.5.1.26].",Dihydroxyacetone Phosphate Acyl Ester,HMDB0011750,b,b,C03372,1-ACYL-GLYCERONE-3-PHOSPHATE,FDB028422,b,[H]OP(=O)(O[H])OC([H])([H])C(=O)C([H])([H])OC([*])=O,IWFZHMQFZRLGDQ-UHFFFAOYSA-N,b
136,4321,daphnetoxin,"A daphnane-type orthoester diterpene with potential cholesterol-lowering activity, found exclusively in plants of the family Thymelaeaceae.",27989,KEGG COMPOUND accession,C02944,dd3coa,2152-91-2,b,"Human Metabolome Database (HMDB): 3Z-dodecenoyl-CoA is an intermediate in fatty acid metabolism. 3Z-dodecenoyl-CoA is converted from trans-Dodec-2-enoyl-CoA via acyl-CoA oxidase, acyl-CoA dehydrogenase, and long-chain-acyl-CoA dehydrogenase [EC:1.3.3.6, 1.3.99.3, 1.3.99.13].",3Z-dodecenoyl-CoA,HMDB0004257,b,b,C02944,CPD-7221,FDB023353,dd3coa,[H]O[C@@]([H])(C(=O)N([H])C([H])([H])C([H])([H])C(=O)N([H])C([H])([H])C([H])([H])SC(=O)C([H])([H])C(\[H])=C(\[H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H])C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])OP([O-])(=O)OP([O-])(=O)OC([H])([H])[C@@]1([H])O[C@@]([H])(N2C([H])=NC3=C(N=C([H])N=C23)N([H])[H])[C@]([H])(O[H])[C@]1([H])OP([O-])([O-])=O,XEMIVMKTVGRFTD-YPWFGKPMSA-J,"InChI=1S/C33H56N7O17P3S/c1-4-5-6-7-8-9-10-11-12-13-24(42)61-17-16-35-23(41)14-15-36-31(45)28(44)33(2,3)19-54-60(51,52)57-59(49,50)53-18-22-27(56-58(46,47)48)26(43)32(55-22)40-21-39-25-29(34)37-20-38-30(25)40/h11-12,20-22,26-28,32,43-44H,4-10,13-19H2,1-3H3,(H,35,41)(H,36,45)(H,49,50)(H,51,52)(H2,34,37,38)(H2,46,47,48)/p-4/b12-11-/t22-,26-,27-,28+,32-/m0/s1"
137,7916,pantothenic acid,A member of the class of pantothenic acids that is an amide formed from pantoic acid and beta-alanine.,2676,KEGG COMPOUND accession,C06827,,,,,,,,,,,,,,,
138,7935,paromomycin sulfate,"An aminoglycoside sulfate salt resulting from the treatment of paromomycin with sulfuric acid. A broad-spectrum antibiotic, it is used for the treatment of acute and chronic intestinal protozoal infections, but is not effective for extraintestinal protozoal infections. It is also used as a therapeutic against visceral leishmaniasis.",2686,KEGG COMPOUND accession,C06829,,,,,,,,,,,,,,,
139,8062,phenethyl caffeate,An alkyl caffeate ester in which 2-phenylethyl is the alkyl component.,16579,KEGG COMPOUND accession,C01403,,,,,,,,,,,,,,,
140,5414,glucoputranjivin(1-),A alkylglucosinolate that is the conjugate base of glucoputranjivin.,15641,KEGG COMPOUND accession,C00440,5mthf,134-35-0,15641.0,"Human Metabolome Database (HMDB): 5 methyltetrahydrofolic acid (5-MTHF) is the most biologically active form of the B-vitamin known as folic acid, also known generically as folate. 5-MTHF functions, in concert with vitamin B12, as a methyl-group donor involved in the conversion of the amino acid homocysteine to methionine. Methyl (CH3) group donation is vital to many bodily processes, including serotonin, melatonin, and DNA synthesis. Therapeutically, 5-MTHF is instrumental in reducing homocysteine levels, preventing neural tube defects, and improving vascular endothelial function. Research on folate supplementation suggests it plays a key role in preventing cervical dysplasia and protecting against neoplasia in ulcerative colitis. Folic acid also shows promise as part of a nutritional protocol to treat vitiligo, and may reduce inflammation of the gingiva. Furthermore, certain neurological, cognitive, and psychiatric presentations may be secondary to folate deficiency. Such presentations include depression, peripheral neuropathy, myelopathy, restless legs syndrome, insomnia, dementia, forgetfulness, irritability, endogenous depression, organic psychosis, and schizophrenia-like syndromes. After ingestion, the process of conversion of folic acid to the metabolically active coenzyme forms is relatively complex. Synthesis of the active forms of folic acid requires several enzymes, adequate liver and intestinal function, and adequate supplies of riboflavin (B2), niacin (B3), pyridoxine (B6), zinc, vitamin C, and serine. After formation of the coenzyme forms of the vitamin in the liver, these metabolically active compounds are secreted into the small intestine with bile (the folate enterohepatic cycle), where they are reabsorbed and distributed to tissues throughout the body. Human pharmacokinetic studies indicate folic acid has high bioavailability, with large oral doses of folic acid substantially raising plasma levels in healthy subjects in a time and dose dependent manner. Red blood cells (RBCs) appear to be the storage depot for folic acid, as RBC levels remain elevated for periods in excess of 40 days following discontinuation of supplementation. Folic acid is poorly transported to the brain and rapidly cleared from the central nervous system. The primary methods of elimination of absorbed folic acid are fecal (through bile) and urinary. Despite the biochemical complexity of this process, evidence suggests oral supplementation with folic acid increases the body's pool of 5-MTHF in healthy individuals. However, enzyme defects, mal-absorption, digestive system pathology, and liver disease can result in impaired ability to activate folic acid. In fact, some individuals have a severe congenital deficiency of the enzyme Methyl tetrahydrofolate reductase (5-MTHFR), which is needed to convert folic acid to 5-MTHF. Milder forms of this enzyme defect likely interact with dietary folate status to determine risk for some disease conditions. In individuals with a genetic defect of this enzyme (whether mild or severe), supplementation with 5- MTHF might be preferable to folic acid supplementation. (PMID: 17176169).",5-Methyltetrahydrofolic acid,HMDB0001396,b,b,C00440,5-METHYL-THF,FDB022600,5mthf,[H]OC(=O)C([H])([H])C([H])([H])[C@@]([H])(N([H])C(=O)C1=C([H])C([H])=C(N([H])C([H])([H])C2([H])N(C3=C(N=C(N=C3O[H])N([H])[H])N([H])C2([H])[H])C([H])([H])[H])C([H])=C1[H])C([O-])=O,ZNOVTXRBGFNYRX-ABLWVSNPSA-M,"InChI=1S/C20H25N7O6/c1-27-12(9-23-16-15(27)18(31)26-20(21)25-16)8-22-11-4-2-10(3-5-11)17(30)24-13(19(32)33)6-7-14(28)29/h2-5,12-13,22H,6-9H2,1H3,(H,24,30)(H,28,29)(H,32,33)(H4,21,23,25,26,31)/p-1/t12?,13-/m0/s1"
141,5089,flavoxate hydrochloride,The hydrochloride salt of flavoxate.,27427,KEGG COMPOUND accession,C01993,,,,,,,,,,,,,,,
142,5202,fustin,"A dihydroflavonol that is the 2,3-dihydro derivative of fisetin.",2013,KEGG COMPOUND accession,C05656,,,,,,,,,,,,,,,
143,10102,zaleplon,"A pyrazolo[1,5-a]pyrimidine having a nitrile group at position 3 and a 3-(N-ethylacetamido)phenyl substituent at the 7-position.",3479,KEGG COMPOUND accession,C06878,,,,,,,,,,,,,,,
144,10136,gingerol,A beta-hydroxy ketone that is 5-hydroxydecan-3-one substituted by a 4-hydroxy-3-methoxyphenyl moiety at position 1; believed to inhibit adipogenesis. It is a constituent of fresh ginger.,3496,KEGG COMPOUND accession,C11210,,,,,,,,,,,,,,,
145,10150,[epicatechin-(4beta->8)]5-epicatechin,A  proanthocyanidin isolated from Cinnamomum cassia.,3503,KEGG COMPOUND accession,C11199,,,,,,,,,,,,,,,
146,11438,"2,4-dichloro-cis,cis-muconate(2-)",a,28064,KEGG COMPOUND accession,C08620,,,,,,,,,,,,,,,
147,4820,ergocornine,"Ergotaman bearing a hydroxy group at the 12' position, isopropyl groups at the 2' and 5'alpha positions, and oxo groups at positions 3', 6', and 18. It is a natural ergot alkaloid.",1865,KEGG COMPOUND accession,C08422,,,,,,,,,,,,,,,
148,9211,soyasaponin I,A triterpenoid saponin that is composed of soyasapogenol B having an alpha-L-rhamnopyranosyl-(1->2)-beta-D-galactopyranosyl-(1->2)-beta-D-glucopyranosiduronic acid moiety attached at the 3-position via a glycosidic linkage.,3244,KEGG COMPOUND accession,C09616,,,,,,,,,,,,,,,
149,9292,strobopinin,A dihydroxyflavanone that is (2S)-flavanone substituted by hydroxy groups at positions 5 and 7 and a methyl group at position 6 respectively.,16022,KEGG COMPOUND accession,C00789,,,,,,,,,,,,,,,
150,367,(+)-alpha-phellandrene,"The (5S)-stereoisomer of alpha-phellandrene (5-isopropyl-2-methylcyclohexa-1,3-diene).",27615,KEGG COMPOUND accession,C02909,,,,,,,,,,,,,,,
151,929,"2,5-diamino-6-ribosylamino-4(3H)pyrimidinone 5'-triphosphate","A ribose 5-triphosphate compound having a 2,5-diamino-6-oxo-1,6-dihydropyrimidin-4-ylamino substituent at the 1-position.",29003,KEGG COMPOUND accession,C02614,,,,,,,,,,,,,,,
152,8654,pyrantel,"A carboxamidine that is 1,4,5,6-tetrahydropyrimidine that is substituted at position 1 by a methyl group and at position 2 by an (E)-2-(2-thienyl)vinyl group. It is used, particularly as the embonate [4,4'-methylenebis(3-hydroxy-2-naphthoate)] salt, as an anthelmintic that is effective against intestinal nematodes including threadworms, roundworms and hookworms, and is included in the WHO 'Model List of Essential Medicines'.",3011,KEGG COMPOUND accession,C06843,,,,,,,,,,,,,,,
153,12266,8-amino-7-oxononanoate,a,4194,KEGG COMPOUND accession,C00738,,,,,,,,,,,,,,,
154,2233,6-phospho-beta-D-glucosyl-(1->4)-beta-D-glucose,A 6-phospho-beta-D-glucosyl-(1->4)-D-glucose in which the anomeric centre at the reducing end has beta-configuration.,27903,KEGG COMPOUND accession,C07100,,,,,,,,,,,,,,,
155,2268,7-hydroxyflavone,A hydroxyflavonoid in which the flavone nucleus is substituted at position 7 by a hydroxy group.,28134,KEGG COMPOUND accession,C08734,,,,,,,,,,,,,,,
156,2274,7-methylguanine,A methylguanine that is guanine substituted by a methyl group at position 7. It is a metabolite obtained during the methylation of DNA.,915,KEGG COMPOUND accession,C06201,24dhhed,b,58936.0,b,"2,4-Dihydroxyhept-2-enedioate",b,b,b,C06201,b,b,b,b,b,"InChI=1S/C7H10O6/c8-4(1-2-6(10)11)3-5(9)7(12)13/h3-4,8-9H,1-2H2,(H,10,11)(H,12,13)/p-2"
157,2380,acebutolol hydrochloride,"The hydrochloride salt of acebutolol, prepared using equimolar amounts of acebutolol and hydrogen chloride.",44576,KEGG COMPOUND accession,C06742,,,,,,,,,,,,,,,
158,2394,acetochlor,A monocarboxylic acid amide that is N-phenylacetamide carrying an ethyl and a methyl group at positions 2 and 6 respectively on the benzene ring while one of the methyl hydrogens as well as the hydrogen attached to the nitrogen atom have been replaced by a chloro and an ethoxymethyl group respectively.,16216,KEGG COMPOUND accession,C04690,,,,,,,,,,,,,,,
159,2422,acetohydrazide,A carbohydrazide that is hydrazine in which one of the hydrogens is replaced by an acetyl group.,16444,KEGG COMPOUND accession,C00900,,,,,,,,,,,,,,,
160,3206,buddledin A,A sesquiterpenoid based on a  humulane skeleton.,30820,KEGG COMPOUND accession,C00869,,,,,,,,,,,,,,,
161,3643,chlorphenesin carbamate,"The carbamate ester of the primary hydroxy group of chlorphenesin. A centrally acting skeletal muscle relaxant, it is used in the symptomatic treatment of painful muscle spasm.",16126,KEGG COMPOUND accession,C04794,ha_pre1,b,16126.0,Human Metabolome Database (HMDB): This compound belongs to the family of N-acyl-alpha-hexosamines. These are carbohydrate derivatives containing a hexose moeity in which the oxygen atom is replaced by an n-acyl group.,"Hyaluronan biosynthesis, precursor 1",HMDB0060071,b,b,C04794,b,b,ha_pre1,[H]OC([H])([H])[C@@]1([H])O[C@@]([H])(O[H])[C@]([H])(N([H])C(=O)C([H])([H])[H])[C@@]([H])(O[C@]2([H])OC(=C([H])[C@]([H])(O[H])[C@@]2([H])O[H])C([O-])=O)[C@]1([H])O[H],DLGJWSVWTWEWBJ-UCFDOFRFSA-M,"InChI=1S/C14H21NO11/c1-4(17)15-8-11(10(20)7(3-16)24-13(8)23)26-14-9(19)5(18)2-6(25-14)12(21)22/h2,5,7-11,13-14,16,18-20,23H,3H2,1H3,(H,15,17)(H,21,22)/p-1/t5-,7+,8+,9+,10+,11+,13+,14-/m0/s1"
162,3648,chlorpromazine N-oxide,An organochlorine compound that is chlorpromazine in which the acyclic tertiary amino group has been converted into the corresponding N-oxide.,15999,KEGG COMPOUND accession,C01179,34hpp,156-39-8,15999.0,"Human Metabolome Database (HMDB): 4-Hydroxyphenylpyruvic acid (4-HPPA) is a keto acid that is involved in the tyrosine catabolism pathway. It is a product of the enzyme (R)-4-hydroxyphenyllactate dehydrogenase (EC 1.1.1.222) and is formed during tyrosine metabolism. The conversion from tyrosine to 4-HPPA is catalyzed by tyrosine aminotransferase. Additionally, 4-HPPA can be converted to homogentisic acid which is one of the precursors to ochronotic pigment. The enzyme 4-hydroxyphenylpyruvic acid dioxygenase (HPD) catalyzes the reaction that converts 4-hydroxyphenylpyruvic acid to homogentisic acid. A deficiency in the catalytic activity of HPD is known to lead to tyrosinemia type III, an autosomal recessive disorder characterized by elevated levels of blood tyrosine and massive excretion of tyrosine derivatives into urine. It has been shown that hawkinsinuria, an autosomal dominant disorder characterized by the excretion of 'hawkinsin,' may also be a result of HPD deficiency (PMID: 11073718). Moreover, 4-hydroxyphenylpyruvic acid is also found to be associated in phenylketonuria, which is also an inborn error of metabolism. There are two isomers of HPPA, specifically 4HPPA and 3HPPA, of which 4HPPA is the most common.",4-Hydroxyphenylpyruvic acid,HMDB0000707,b,b,C01179,P-HYDROXY-PHENYLPYRUVATE,FDB022193,34hpp,[H]OC1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])C(=O)C([O-])=O,KKADPXVIOXHVKN-UHFFFAOYSA-M,"InChI=1S/C9H8O4/c10-7-3-1-6(2-4-7)5-8(11)9(12)13/h1-4,10H,5H2,(H,12,13)/p-1"
163,4349,decanoyl-[acyl-carrier protein],a,16359,KEGG COMPOUND accession,C00695,cholate,81-25-4,16359.0,"Human Metabolome Database (HMDB): Cholic acid is a major primary bile acid produced in the liver and is usually conjugated with glycine or taurine. It facilitates fat absorption and cholesterol excretion. Bile acids are steroid acids found predominantly in the bile of mammals. The distinction between different bile acids is minute, and depends only on the presence or absence of hydroxyl groups on positions 3, 7, and 12. Bile acids are physiological detergents that facilitate excretion, absorption, and transport of fats and sterols in the intestine and liver. Bile acids are also steroidal amphipathic molecules derived from the catabolism of cholesterol. They modulate bile flow and lipid secretion, are essential for the absorption of dietary fats and vitamins, and have been implicated in the regulation of all the key enzymes involved in cholesterol homeostasis. Bile acids recirculate through the liver, bile ducts, small intestine, and portal vein to form an enterohepatic circuit. They exist as anions at physiological pH, and consequently require a carrier for transport across the membranes of the enterohepatic tissues. The unique detergent properties of bile acids are essential for the digestion and intestinal absorption of hydrophobic nutrients. Bile acids have potent toxic properties (e.g. membrane disruption) and there are a plethora of mechanisms to limit their accumulation in blood and tissues (PMID: 11316487, 16037564, 12576301, 11907135). When present in sufficiently high levels, cholic acid can act as a hepatotoxin and a metabotoxin. A hepatotoxin causes damage to the liver or liver cells. A metabotoxin is an endogenously produced metabolite that causes adverse health effects at chronically high levels. Among the primary bile acids, cholic acid is considered to be the least hepatotoxic while deoxycholic acid is the most hepatoxic (PMID: 1641875). The liver toxicity of bile acids appears to be due to their ability to peroxidate lipids and to lyse liver cells. Chronically high levels of cholic acid are associated with familial hypercholanemia. In hypercholanemia, bile acids, including cholic acid, are elevated in the blood. This disease causes liver damage, extensive itching, poor fat absorption, and can lead to rickets due to lack of calcium in bones. The deficiency of normal bile acids in the intestines results in a deficiency of vitamin K, which also adversely affects clotting of the blood. The bile acid ursodiol (ursodeoxycholic acid) can improve symptoms associated with familial hypercholanemia.",Cholic acid,HMDB0000619,b,b,C00695,b,FDB012810,cholate,[H]O[C@]1([H])C([H])([H])C([H])([H])[C@@]2(C([H])([H])[H])[C@@]([H])(C1([H])[H])C([H])([H])[C@@]([H])(O[H])[C@@]1([H])[C@]3([H])C([H])([H])C([H])([H])[C@]([H])([C@]([H])(C([H])([H])[H])C([H])([H])C([H])([H])C([O-])=O)[C@@]3(C([H])([H])[H])[C@@]([H])(O[H])C([H])([H])[C@]21[H],BHQCQFFYRZLCQQ-OELDTZBJSA-M,"InChI=1S/C24H40O5/c1-13(4-7-21(28)29)16-5-6-17-22-18(12-20(27)24(16,17)3)23(2)9-8-15(25)10-14(23)11-19(22)26/h13-20,22,25-27H,4-12H2,1-3H3,(H,28,29)/p-1/t13-,14+,15-,16-,17+,18+,19-,20+,22+,23+,24-/m1/s1"
164,4508,diclofenac potassium,The potassium salt of diclofenac.,27593,KEGG COMPOUND accession,C05645,42A3HP24DB,b,b,"Human Metabolome Database (HMDB): 4-(2 Amino-3-hydroxyphenyl)-2,4-dioxobutanoate is found in the tryptophan metabolic pathway and is an intermediate in tryptophan degradation [Kegg: C05645]. More specifically it is an intermediate in the conversion of 3-hydroxy-L-kynurenine to xanthurenate. The conversion is catalyzed by kynurenine aminotransferase (EC 2.6.1.7).","4-(2-Amino-3-hydroxyphenyl)-2,4-dioxobutanoic acid",HMDB0004083,b,b,C05645,b,FDB023305,42A3HP24DB,[H]OC1=C([H])C([H])=C([H])C(C(=O)C([H])([H])C(=O)C([O-])=O)=C1N([H])[H],YCJNYHCCOXVYAF-UHFFFAOYSA-M,"InChI=1S/C10H9NO5/c11-9-5(2-1-3-6(9)12)7(13)4-8(14)10(15)16/h1-3,12H,4,11H2,(H,15,16)/p-1"
165,2435,acronidine,"An organic heterotetracyclic compound that is 3H-furo[2,3-b]pyrano[3,2-f]quinoline carrying a gem-dimethyl group at position 3 as well as two methoxy substituents at positions 5 and 11.",17936,KEGG COMPOUND accession,C03974,,,,,,,,,,,,,,,
166,6211,L-djenkolic acid,A dithioacetal consisting of two molecules of L-cysteine joined via their sulfanyl groups to methylene.,16864,KEGG COMPOUND accession,C01882,,,,,,,,,,,,,,,
167,6220,alpha-L-fucose 1-phosphate,a,17193,KEGG COMPOUND accession,C01547,,,,,,,,,,,,,,,
168,7479,Naratriptan hydrochloride,a,2495,KEGG COMPOUND accession,C05285,,,,,,,,,,,,,,,
169,10278,alpha-eudesmol,A eudesmane sesquiterpenoid in which the eudesmane skeleton carries a hydroxy substituent at C-11 and has a double bond between C-3 and C-4.,3561,KEGG COMPOUND accession,C07778,,,,,,,,,,,,,,,
170,10359,(-)-beta-chamigrene,The (6R)-enantiomer of beta-chamigrene.,28681,KEGG COMPOUND accession,C01674,HC00822,577-76-4,b,"Human Metabolome Database (HMDB): Chitobiose is a dimer of beta-1,4-linked glucosamine units. There is ambiguity as to which structure the name refers, owing to the method by which it was first isolated.",Chitobiose,HMDB0003556,b,b,C01674,CHITOBIOSE,FDB023196,HC00822,[H]OC([H])([H])[C@@]1([H])O[C@@]([H])(O[C@@]2([H])[C@]([H])(O[H])[C@@]([H])(N([H])C(=O)C([H])([H])[H])C([H])(O[H])O[C@]2([H])C([H])([H])O[H])[C@]([H])(N([H])C(=O)C([H])([H])[H])[C@@]([H])(O[H])[C@]1([H])O[H],CDOJPCSDOXYJJF-AGBFQKNOSA-N,"InChI=1S/C16H28N2O11/c1-5(21)17-9-13(25)14(8(4-20)27-15(9)26)29-16-10(18-6(2)22)12(24)11(23)7(3-19)28-16/h7-16,19-20,23-26H,3-4H2,1-2H3,(H,17,21)(H,18,22)/t7-,8-,9-,10-,11-,12-,13-,14-,15?,16+/m0/s1"
171,10363,beta-cubebene,"A tricyclic sesquiterpene, a constituent of the leaf oil cubebene obtained from a variety of species of flowering plant.",16261,KEGG COMPOUND accession,C00734,,,,,,,,,,,,,,,
172,10366,D-cymarose,a,28142,KEGG COMPOUND accession,C06899,,,,,,,,,,,,,,,
173,7496,nelfinavir,An aryl sulfide that is used (as its mesylate salt) for treatment of HIV and also exhibits some anticancer properties.,2504,KEGG COMPOUND accession,C06800,aflatoxin,1162-65-8,2504.0,"Human Metabolome Database (HMDB): Aflatoxins are naturally occurring mycotoxins that are produced by many species of Aspergillus, a fungus, most notably Aspergillus flavus and Aspergillus parasiticus. At least 13 different types of aflatoxin are produced in nature. Aflatoxin B1 is considered the most toxic and is produced by both Aspergillus flavus and Aspergillus parasiticus. The native habitat of Aspergillus is in soil, decaying vegetation, hay, and grains undergoing microbiological deterioration and it invades all types of organic substrates whenever conditions are favorable for its growth. Favorable conditions include high moisture content (at least 7%) and high temperature. Aflatoxins B1 (AFB1) are contaminants of improperly stored foods; they are potent genotoxic and carcinogenic compounds, exerting their effects through damage to DNA. They can also induce mutations that increase oxidative damage. (PMID: 17214555). Crops which are frequently affected by Aspergillus contamination include cereals (maize, sorghum, pearl millet, rice, wheat), oilseeds (peanut, soybean, sunflower, cotton), spices (chile peppers, black pepper, coriander, turmeric, ginger), and tree nuts (almond, pistachio, walnut, coconut, brazil nut).",Aflatoxin B1,HMDB0006552,b,b,C06800,CPD-4592,FDB014816,aflatoxin,[H]C1=C([H])[C@@]2([H])C3=C4OC(=O)C5=C(C4=C(OC([H])([H])[H])C([H])=C3O[C@@]2([H])O1)C([H])([H])C([H])([H])C5=O,OQIQSTLJSLGHID-WNWIJWBNSA-N,"InChI=1S/C17H12O6/c1-20-10-6-11-14(8-4-5-21-17(8)22-11)15-13(10)7-2-3-9(18)12(7)16(19)23-15/h4-6,8,17H,2-3H2,1H3/t8-,17+/m0/s1"
174,8386,pregnane,a,18091,KEGG COMPOUND accession,C01892,,,,,,,,,,,,,,,
175,8389,estrone sodium sulfate,a,2877,KEGG COMPOUND accession,C11045,,,,,,,,,,,,,,,
176,8412,primidone,"A pyrimidone that is dihydropyrimidine-4,6(1H,5H)-dione substituted by an ethyl and a phenyl group at position 5. It is used as an  anticonvulsant for treatment of various types of seizures.",28463,KEGG COMPOUND accession,C09042,,,,,,,,,,,,,,,
177,1729,4'-demethyldeoxypodophyllotoxin,"A member of the class of furonaphthodioxoles that is (5R,5aR,8aR)-5,8,8a,9-tetrahydro-2H-furo[3',4':6,7]naphtho[2,3-d][1,3]dioxol-6(5aH)-one substituted at position 5 by a 4-hydroxy-3,5-dimethoxyphenyl group.",15637,KEGG COMPOUND accession,C00234,10fthf,2800-34-2,15637.0,"Human Metabolome Database (HMDB): 10-Formyltetrahydrofolate (10-CHO-THF) is form of tetrahydrofolate that acts as a donor of formyl groups in anabolism. In particular, 10-CHO-THF is used as a substrate in a number of formyltransferase reactions. It plays an important role in purine biosynthesis, where 10-CHO-THF is a substrate for phosphoribosylaminoimidazolecarboxamide formyltransferase, as well as in the formylation of the methionyl initiator tRNA (fMet-tRNA), when 10-CHO-THF is a substrate for methionyl-tRNA formyltransferase. 10-Formyltetrahydrofolate is a substrate for Trifunctional purine biosynthetic protein adenosine-3, Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase (mitochondrial), 10-formyltetrahydrofolate dehydrogenase, Folylpolyglutamate synthase (mitochondrial), Bifunctional purine biosynthesis protein PURH and C-1-tetrahydrofolate synthase (cytoplasmic).",10-Formyltetrahydrofolate,HMDB0000972,b,b,C00234,10-FORMYL-THF,FDB022345,10fthf,[H]OC1=NC(=NC2=C1N([H])C([H])(C([H])([H])N(C([H])=O)C1=C([H])C([H])=C(C([H])=C1[H])C(=O)N([H])[C@]([H])(C([O-])=O)C([H])([H])C([H])([H])C([O-])=O)C([H])([H])N2[H])N([H])[H],AUFGTPPARQZWDO-YUZLPWPTSA-L,"InChI=1S/C20H23N7O7/c21-20-25-16-15(18(32)26-20)23-11(7-22-16)8-27(9-28)12-3-1-10(2-4-12)17(31)24-13(19(33)34)5-6-14(29)30/h1-4,9,11,13,23H,5-8H2,(H,24,31)(H,29,30)(H,33,34)(H4,21,22,25,26,32)/p-2/t11?,13-/m0/s1"
178,1749,"4,5-methylenedioxy-6-hydroxyaurone",A hydroxyaurone that is aurone substituted by a hydroxy group at position 6 and a methylenedioxy group across positions 4 and 5 respectively.,15878,KEGG COMPOUND accession,C05247,,,,,,,,,,,,,,,
179,1774,(E)-4-(trimethylammonio)but-2-enoic acid,A 4-(trimethylammonio)but-2-enoic acid with a (E)-configuration at the double bond.,28324,KEGG COMPOUND accession,C05488,11docrtsl,152-58-9,b,"Human Metabolome Database (HMDB): Cortexolone is also known as 11-Deoxy-17-hydroxy-corticosterone or 11-Deoxy-cortisol.  Cortexolone is considered to be practically insoluble (in water) and relatively neutral.  Cortexolone can be found throughout all human tissues; and in blood and urine. Cortexolone can be found throughout a human cell. Cortexolone is found in eukaryotic species, from E.coli to Humans",Cortexolone,HMDB0000015,b,b,C05488,11-DEOXY-CORTISOL,FDB021872,11docrtsl,[H]OC([H])([H])C(=O)[C@@]1(O[H])C([H])([H])C([H])([H])[C@@]2([H])[C@]3([H])C([H])([H])C([H])([H])C4=C([H])C(=O)C([H])([H])C([H])([H])[C@]4(C([H])([H])[H])[C@@]3([H])C([H])([H])C([H])([H])[C@]12C([H])([H])[H],WHBHBVVOGNECLV-OBQKJFGGSA-N,"InChI=1S/C21H30O4/c1-19-8-5-14(23)11-13(19)3-4-15-16(19)6-9-20(2)17(15)7-10-21(20,25)18(24)12-22/h11,15-17,22,25H,3-10,12H2,1-2H3/t15-,16+,17+,19+,20+,21+/m1/s1"
180,2691,isoamyl nitrite,A nitrite ester having isopentyl as the alkyl group.,16011,KEGG COMPOUND accession,C02498,,,,,,,,,,,,,,,
181,15266,triphosphate ion,a,28503,KEGG COMPOUND accession,C08866,,,,,,,,,,,,,,,
182,11812,3-hydroxy-3-methyl-2-oxobutanoate,a,15816,KEGG COMPOUND accession,C00792,arg_D,157-06-2,15816.0,Human Metabolome Database (HMDB): D-Arginine is an essential amino acid that is physiologically active in the L-form.,D-Arginine,HMDB0003416,b,b,C00792,CPD-220,FDB023167,arg_D,[H]N([H])C(N([H])C([H])([H])C([H])([H])C([H])([H])[C@]([H])(C([O-])=O)[N+]([H])([H])[H])=[N+]([H])[H],ODKSFYDXXFIFQN-SCSAIBSYSA-O,"InChI=1S/C6H14N4O2/c7-4(5(11)12)2-1-3-10-6(8)9/h4H,1-3,7H2,(H,11,12)(H4,8,9,10)/p+1/t4-/m1/s1"
183,5533,granaticin,a,17762,KEGG COMPOUND accession,C03238,,,,,,,,,,,,,,,
184,5542,grayanotoxin I,"A tetracyclic diterpenoid that is grayanotoxane in which the pro-R hydrogen at position 14 is substituted by an acetoxy group and in which the 3beta-, 5-, 6beta-, 10-, and 16- positions are substituted by hydroxy groups.",16985,KEGG COMPOUND accession,C03772,,,,,,,,,,,,,,,
185,5556,guanadrel sulfate,"An organic sulfate salt resulting from the reaction of 2 eq. guanadrel with 1 eq. sulfuric acid. A postganglionic adrenergic blocking agent formerly used for the management of hypertension, it has been largely superseded by other drugs less likely to cause orthostatic hypotension (dizzy spells on standing up or stretching).",2150,KEGG COMPOUND accession,C05293,,,,,,,,,,,,,,,
186,5649,helminthosporoside A,A sesquiterpenoid glycoside obtained from Helminthosporium sacchari with formula C39H64O22.,15505,KEGG COMPOUND accession,C06749,,,,,,,,,,,,,,,
187,5653,hemiacetal,A compound having the general formula RR'C(OH)OR'' (R'' =/= H).,17869,KEGG COMPOUND accession,C06103,,,,,,,,,,,,,,,
188,5683,hetacillin,a,28168,KEGG COMPOUND accession,C09821,,,,,,,,,,,,,,,
189,2495,adrenosterone,"A 3-oxo Delta(4)-steroid that is androst-4-ene carrying three oxo-substituents at positions 3, 11 and 17.",15998,KEGG COMPOUND accession,C04807,,,,,,,,,,,,,,,
190,2507,afzelechin,"A tetrahydroxyflavan that is  (2S)-flavan substituted by hydroxy groups at positions 3, 5, 7 and 4' respectively.",27822,KEGG COMPOUND accession,C10901,,,,,,,,,,,,,,,
191,2513,agavoside A,A steroid saponin that consists of (25R)-5alpha-spirostan-3beta-ol substituted by an oxo group at position 12 and a  beta-D-galactopyranosyl moiety at position 3 via a glycosidic linkage.,37012,KEGG COMPOUND accession,C11822,,,,,,,,,,,,,,,
192,2566,alendronate sodium trihydrate,A hydride that is the trihydrate of alendronate sodium,27895,KEGG COMPOUND accession,C03572,,,,,,,,,,,,,,,
193,2623,amaryllisine,"An isoquinoline alkaloid that is 3,4,4a,5,6,10b-hexahydro-5,10b-ethanophenanthridin-9-ol bearing three additional methoxy substituents at positions 3, 7 and 8.",1060,KEGG COMPOUND accession,C03826,,,,,,,,,,,,,,,
194,2653,aminocarb,A carbamate ester that is phenyl methylcarbamate substituted by a dimethylamino group at position 4 and a methyl group at position 3.,28062,KEGG COMPOUND accession,C04580,,,,,,,,,,,,,,,
195,2659,aminophylline,A mixture comprising of theophylline and ethylenediamine in a 2:1 ratio.,16138,KEGG COMPOUND accession,C02782,,,,,,,,,,,,,,,
196,3791,cobalt-precorrin-3,a,17947,KEGG COMPOUND accession,C00944,,,,,,,,,,,,,,,
197,4737,N-ethylphenylacetamide,A monocarboxylic acid amide obtained by formal condensation of the carboxy group of phenylacetic acid with the amino group of ethylamine.,18344,KEGG COMPOUND accession,C01717,kynate,492-27-3,18344.0,"Human Metabolome Database (HMDB): Kynurenic acid (KYNA) is a well-known endogenous antagonist of the glutamate ionotropic excitatory amino acid receptors N-methyl-D-aspartate (NMDA), alphaamino-3-hydroxy-5-methylisoxazole-4-propionic acid and kainate receptors and of the nicotine cholinergic subtype alpha 7 receptors. KYNA neuroprotective and anticonvulsive activities have been demonstrated in animal models of neurodegenerative diseases. Because of KYNA's neuromodulatory character, its involvement has been speculatively linked to the pathogenesis of a number of neurological conditions including those in the ageing process. Different patterns of abnormalities in various stages of KYNA metabolism in the CNS have been reported in Alzheimer's disease, Parkinson's disease and Huntington's disease. In HIV-1-infected patients and in patients with Lyme neuroborreliosis a marked rise of KYNA metabolism was seen. In the ageing process KYNA metabolism in the CNS of rats shows a characteristic pattern of changes throughout the life span. A marked increase of the KYNA content in the CNS occurs before the birth, followed by a dramatic decline on the day of birth. A low activity was seen during ontogenesis, and a slow and progressive enhancement occurs during maturation and ageing. This remarkable profile of KYNA metabolism alterations in the mammalian brain has been suggested to result from the development of the organisation of neuronal connections and synaptic plasticity, development of receptor recognition sites, maturation and ageing. There is significant evidence that KYNA can improve cognition and memory, but it has also been demonstrated that it interferes with working memory. Impairment of cognitive function in various neurodegenerative disorders is accompanied by profound reduction and/or elevation of KYNA metabolism. The view that enhancement of CNS KYNA levels could underlie cognitive decline is supported by the increased KYNA metabolism in Alzheimer's disease, by the increased KYNA metabolism in down's syndrome and the enhancement of KYNA function during the early stage of Huntington's disease. Kynurenic acid is the only endogenous N-methyl-D-aspartate (NMDA) receptor antagonist identified up to now, that mediates glutamatergic hypofunction. Schizophrenia is a disorder of dopaminergic neurotransmission, but modulation of the dopaminergic system by glutamatergic neurotransmission seems to play a key role. Despite the NMDA receptor antagonism, kynurenic acid also blocks, in lower doses, the nicotinergic acetycholine receptor, i.e., increased kynurenic acid levels can explain psychotic symptoms and cognitive deterioration. Kynurenic acid levels are described to be higher in the cerebrospinal fluid (CSF) and in critical central nervous system (CNS) regions of schizophrenics as compared to controls. (PMID: 17062375, 16088227).",Kynurenic acid,HMDB0000715,b,b,C01717,b,FDB022200,kynate,[H]OC1=C([H])C(=NC2=C([H])C([H])=C([H])C([H])=C12)C([O-])=O,HCZHHEIFKROPDY-UHFFFAOYSA-M,"InChI=1S/C10H7NO3/c12-9-5-8(10(13)14)11-7-4-2-1-3-6(7)9/h1-5H,(H,11,12)(H,13,14)/p-1"
198,4757,EDTA monocalcium diisodium salt,An organic calcium salt of EDTA diisodium. It is a chelating agent that is used for the treatment of lead poisoning.,17801,KEGG COMPOUND accession,C04184,,,,,,,,,,,,,,,
199,4604,dimenhydrinate,"The diphenhydramine salt of 8-chlorotheophylline. Its effects are similar to those of diphenhydramine, but it is less potent. It was thought that by combining the antiemetic effects of diphenhydramine with the mild stimulant effects of 8-chlorotheophyline, the extreme drowsiness induced by the former would be mitigated. However, the sedation caused by diphenhydramine is considerably stronger than the stimulation caused by 8-chlorotheophylline. Dimenhydrinate is used mainly as an antiemetic in the prevention and treatment of motion sickness.",17424,KEGG COMPOUND accession,C04324,,,,,,,,,,,,,,,
200,4610,dimethylselenide,An organoselenium compound of two methyl groups covalently bound to a selenium.,18046,KEGG COMPOUND accession,C04484,,,,,,,,,,,,,,,
201,4639,diphenoxylate,A piperidinecarboxylate ester that is the ethyl ester of difenoxin.,15498,KEGG COMPOUND accession,C06387,,,,,,,,,,,,,,,
202,5760,hopane-29-acetate,A hopanoid that is hopane substituted by an acetoxy group at position 29.,137822,KEGG COMPOUND accession,C11246,,,,,,,,,,,,,,,
203,5763,hordatine B,A member of the class of benzofurans that is a heterodimer of feruloylagmatine and para-coumarylagmatine where the former's hydroxy group has reacted across the latter's ethene double bond resulting in oxidative coupling to form a furan ring.,16861,KEGG COMPOUND accession,C03368,,,,,,,,,,,,,,,
204,5882,imipramine hydrochloride,a,2303,KEGG COMPOUND accession,C11581,,,,,,,,,,,,,,,
205,6741,meloxicam,"A benzothiazine that is piroxicam in which the pyridin-2-yl group is replaced by a 5-methyl-1,3-thiazol-2-yl group. A non-steroidal anti-inflammatory drug and selective inhibitor of COX-2, it is used particularly for the management of rheumatoid arthritis.",15335,KEGG COMPOUND accession,C01470,,,,,,,,,,,,,,,
206,10423,oleandrose,a,27871,KEGG COMPOUND accession,C06754,,,,,,,,,,,,,,,
207,10615,omega-hydroxy fatty acid,Any member of the class of naturally-occurring straight-chain fatty acids n carbon atoms long with a carboxyl group at position 1 and a hydroxyl at position n (omega).,3690,KEGG COMPOUND accession,C10031,,,,,,,,,,,,,,,
208,7570,nigerose,A glycosylglucose consisting of D-glucose with undefined anomeric stereochemistry and an alpha-D-glucosyl residue attached at the 3-position.,2537,KEGG COMPOUND accession,C09329,,,,,,,,,,,,,,,
209,8427,probucol,"A dithioketal that is propane-2,2-dithiol in which the hydrogens attached to both sulfur atoms are replaced by 3,5-di-tert-butyl-4-hydroxyphenyl groups. An anticholesteremic drug with antioxidant and anti-inflammatory properties, it is used to treat high levels of cholesterol in blood.",40968,KEGG COMPOUND accession,C08580,,,,,,,,,,,,,,,
210,8429,procainamide hydrochloride,A hydrochloride which has procainamide as the amino component.,2896,KEGG COMPOUND accession,C06832,,,,,,,,,,,,,,,
211,9666,triadimenol,"A member of the class of triazoles that is 3,3-dimethyl-1-(1,2,4-triazol-1-yl)butane-1,2-diol substituted at position O1 by a 4-chlorophenyl group. A fungicide for cereals, beet and brassicas used to control a range of diseases including powdery mildew, rusts, bunts and smuts.",17933,KEGG COMPOUND accession,C01561,25hvitd3,19356-17-3,17933.0,"Human Metabolome Database (HMDB): The major circulating metabolite of vitamin D3 (calciferon). It is produced in the liver and is the best indicator of the body's vitamin D stores. It is effective in the treatment of rickets and osteomalacia, both in azotemic and non-azotemic patients. Calcifediol also has mineralizing properties.",Calcidiol,HMDB0003550,b,b,C01561,CALCIDIOL,FDB021782,25hvitd3,[H]O[C@]1([H])C([H])([H])\C(=C(/[H])\C(\[H])=C2/C([H])([H])C([H])([H])C([H])([H])[C@@]3(C([H])([H])[H])[C@@]2([H])C([H])([H])C([H])([H])[C@]3([H])[C@]([H])(C([H])([H])[H])C([H])([H])C([H])([H])C([H])([H])C(O[H])(C([H])([H])[H])C([H])([H])[H])C(=C([H])[H])C([H])([H])C1([H])[H],JWUBBDSIWDLEOM-DTOXIADCSA-N,"InChI=1S/C27H44O2/c1-19-10-13-23(28)18-22(19)12-11-21-9-7-17-27(5)24(14-15-25(21)27)20(2)8-6-16-26(3,4)29/h11-12,20,23-25,28-29H,1,6-10,13-18H2,2-5H3/b21-11+,22-12-/t20-,23+,24-,25+,27-/m1/s1"
212,12350,beta-D-fructofuranose 2-phosphate,The beta-anomer of D-fructofuranose 2-phosphate.,133921,KEGG COMPOUND accession,C01683,,,,,,,,,,,,,,,
213,7621,norajmaline,An organonitrogen heterocyclic compound that is ajmaline which is lacking the methyl substituent attached to the nitrogen of the dihydroindole moiety.,17478,KEGG COMPOUND accession,C00071,,,,,,,,,,,,,,,
214,8633,puerarin,A hydroxyisoflavone that is  isoflavone substituted by hydroxy groups at positions 7 and 4' and a beta-D-glucopyranosyl residue at position 8 via a C-glycosidic linkage.,3000,KEGG COMPOUND accession,C11590,,,,,,,,,,,,,,,
215,11805,3-hydroxyisobutyrate,a,16241,KEGG COMPOUND accession,C01112,,,,,,,,,,,,,,,
216,11972,4-carboxymethylenebut-2-en-4-olide,A butenolide having a carboxymethylene group at the 4-position.,28525,KEGG COMPOUND accession,C01067,,,,,,,,,,,,,,,
217,2761,dipotassium bis[mu-tartrato(4-)]diantimonate(2-) trihydrate,A hydrate that is the trihydrate form of dipotassium bis[mu-tartrato(4-)]diantimonate(2-).,17142,KEGG COMPOUND accession,C04642,5cmhmsa,b,17142.0,b,5-Carboxymethyl-2-hydroxymuconate semialdehyde,b,b,b,C04642,b,b,b,b,b,"InChI=1S/C8H8O6/c9-4-5(3-7(11)12)1-2-6(10)8(13)14/h1-2,4,10H,3H2,(H,11,12)(H,13,14)/b5-1-,6-2-"
218,2941,axillarin,"A dimethoxyflavone that is the 3,6-dimethyl ether derivative of  quercetagetin.",16182,KEGG COMPOUND accession,C02223,,,,,,,,,,,,,,,
219,1228,2-O-methylswertianin,A member of the class of  xanthones that is  swertianin in which the hydroxy group at position 2 has been replaced by a methoxy group.,17253,KEGG COMPOUND accession,C02351,,,,,,,,,,,,,,,
220,1277,"(1S,6R)-2-succinyl-6-hydroxycyclohexa-2,4-diene-1-carboxylic acid","The (1S,6R)-stereoisomer of 2-succinyl-6-hydroxycyclohexa-2,4-diene-1-carboxylic acid.",16850,KEGG COMPOUND accession,C02771,,,,,,,,,,,,,,,
221,520,"1,3-dicaffeoylquinic acid",An alkyl caffeate ester obtained by the formal condensation of hydroxy groups at positions 1 and 3 of ()-quinic acid with two molecules of trans-caffeic acid.,15618,KEGG COMPOUND accession,C05912,,,,,,,,,,,,,,,
222,1307,24-methylenecycloartanol,"A pentacyclic triterpenoid that is (9beta)-24-methylene-9,19-cyclolanostane which carries a hydroxy group at position 3beta. It is isolated from several plant species including Euphorbia, Epidendrum, Psychotria and Sideritis.",18393,KEGG COMPOUND accession,C01173,,,,,,,,,,,,,,,
223,6750,(+)-menthofuran,"A menthofuran that is 4,5,6,7-tetrahydro-1-benzofuran substituted by methyl groups at positions 3 and 6 (the 6R-enantiomer).",2375,KEGG COMPOUND accession,C10543,,,,,,,,,,,,,,,
224,3884,corilagin,An ellagitannin with a hexahydroxydiphenoyl group bridging over the 3-O and 6-O of the glucose core.,32809,KEGG COMPOUND accession,C03066,,,,,,,,,,,,,,,
225,3929,cryogenine,A quinolizidine alkaloid isolated from the flowering plant Heimia salicifolia and exhibits anti-inflammatory properties.,27874,KEGG COMPOUND accession,C05997,,,,,,,,,,,,,,,
226,4935,eupatolide,"A germacranolide with formula C15H20O3, isolated from several Inula species. It exhibits anti-cancer properties.",1904,KEGG COMPOUND accession,C11584,,,,,,,,,,,,,,,
227,1579,3-methoxyapigenin,A trihydroxyflavone that is  apigenin substituted by a methoxy group at position 3.,28733,KEGG COMPOUND accession,C04100,,,,,,,,,,,,,,,
228,1582,3-methoxytyramine,A monomethoxybenzene that is dopamine in which the hydroxy group at position 3 is replaced by a methoxy group. It is a metabolite of the neurotransmitter dopamine and considered a potential biomarker of pheochromocytomas and paragangliomas.,17963,KEGG COMPOUND accession,C04599,,,,,,,,,,,,,,,
229,5032,ferrocyanide,a,18198,KEGG COMPOUND accession,C11355,,,,,,,,,,,,,,,
230,5263,"galangin 3,5,7-trimethyl ether","A trimethoxyflavone that is the 3,5,7-trimethyl ether derivative of galangin.",2038,KEGG COMPOUND accession,C11262,,,,,,,,,,,,,,,
231,5323,gentisein,"A member of the class of  xanthones that is 9H-xanthen-9-one substituted by hydroxy groups at positions 1, 3 and 7.",28116,KEGG COMPOUND accession,C03771,5g2oxpt,b,58489.0,"Human Metabolome Database (HMDB): 2-Oxoarginine is a guanidino compound metabolite of arginine catabolism. 2-Oxoarginine levels are increased in patients with argininemia (OMIM:207800). Argininemia, characterized by arginase deficiency (EC 3.5.3.1, catalyzes the last step of the urea cycle) is an autosomal recessive inborn error of metabolism caused by a defect in the final step in the urea cycle, the hydrolysis of arginine to urea and ornithine. Accumulation of arginine metabolites (such as guanidino compounds) especially 2-oxoarginine, may produce the central nervous system damage in argininemia. (PMID: 3433275, 1588833, 1690873, 819629).",2-Oxoarginine,HMDB0004225,b,b,C03771,CPD-824,FDB023338,5g2oxpt,[H]N([H])C(N([H])C([H])([H])C([H])([H])C([H])([H])C(=O)C([O-])=O)=[N+]([H])[H],ARBHXJXXVVHMET-UHFFFAOYSA-N,"InChI=1S/C6H11N3O3/c7-6(8)9-3-1-2-4(10)5(11)12/h1-3H2,(H,11,12)(H4,7,8,9)"
232,5331,geranyl acetate,A monoterpenoid that is the  acetate ester derivative of  geraniol.,15794,KEGG COMPOUND accession,C03840,,,,,,,,,,,,,,,
233,9746,tripteroside,A xanthone glycoside that is  norathyriol attached to a beta-D-glucopyranosyl residue at position 6 via a glycosidic linkage.,28623,KEGG COMPOUND accession,C01789,,,,,,,,,,,,,,,
234,9752,"tritriacontane-16,18-dione",A beta-diketone that is tritriacontane with oxo groups at positions 16 and 18.,609827,KEGG COMPOUND accession,C00308,,,,,,,,,,,,,,,
235,9940,vecuronium bromide,"The organic bromide salt of a 5alpha-androstane compound having 3alpha-acetoxy-, 17beta-acetoxy-, 2beta-piperidinino- and 16beta-N-methylpiperidinium substituents.",17040,KEGG COMPOUND accession,C03600,,,,,,,,,,,,,,,
236,7725,octanoyl-[acyl-carrier protein],a,17390,KEGG COMPOUND accession,C02134,,,,,,,,,,,,,,,
237,7020,multifidol,A butanone that is the 2-methylbutanoyl derivative of phloroglucinol.,28052,KEGG COMPOUND accession,C06806,,,,,,,,,,,,,,,
238,4067,cytochrome c1,a,15487,KEGG COMPOUND accession,C02939,ivcoa,6244-91-3,15487.0,"Human Metabolome Database (HMDB): Isovaleryl-CoA is an intermediate metabolite in the catabolic pathway of leucine. The accumulation of derivatives of isovaleryl-CoA occurs in patients affected with isovaleric acidemia (IVA, OMIM 243500) an autosomal recessive inborn error of leucine metabolism caused by a deficiency of the mitochondrial enzyme isovaleryl-CoA dehydrogenase (IVD, EC 1.3.99.10, a flavoenzyme that catalyzes the conversion of isovaleryl-CoA to 3-methylcrotonyl-CoA). IVA was the first organic acidemia recognized in humans and can cause significant morbidity and mortality. Early diagnosis and treatment with a protein restricted diet and supplementation with carnitine and glycine are effective in promoting normal development in severely affected individuals. Both intra- and interfamilial variability have been recognized. Initially, two phenotypes with either an acute neonatal or a chronic intermittent presentation were described. More recently, a third group of individuals with mild biochemical abnormalities who can be asymptomatic have been identified through newborn screening of blood spots by tandem mass spectrometry. The majority of patients with IVA today are diagnosed pre-symptomatically through newborn screening by use of MS/MS which reveals elevations of the marker metabolite C5 acylcarnitine in dried blood spots. C5 acylcarnitine represents a mixture of isomers (isovalerylcarnitine, 2-methylbutyrylcarnitine, and pivaloylcarnitine). (PMID: 16602101, Am J Med Genet C Semin Med Genet. 2006 May 15;142(2):95-103.).",Isovaleryl-CoA,HMDB0001113,b,b,C02939,ISOVALERYL-COA,FDB022430,ivcoa,[H]O[C@@]([H])(C(=O)N([H])C([H])([H])C([H])([H])C(=O)N([H])C([H])([H])C([H])([H])SC(=O)C([H])([H])C([H])(C([H])([H])[H])C([H])([H])[H])C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])OP([O-])(=O)OP([O-])(=O)OC([H])([H])[C@@]1([H])O[C@@]([H])(N2C([H])=NC3=C(N=C([H])N=C23)N([H])[H])[C@]([H])(O[H])[C@]1([H])OP([O-])([O-])=O,UYVZIWWBJMYRCD-VZEICDQOSA-J,"InChI=1S/C26H44N7O17P3S/c1-14(2)9-17(35)54-8-7-28-16(34)5-6-29-24(38)21(37)26(3,4)11-47-53(44,45)50-52(42,43)46-10-15-20(49-51(39,40)41)19(36)25(48-15)33-13-32-18-22(27)30-12-31-23(18)33/h12-15,19-21,25,36-37H,5-11H2,1-4H3,(H,28,34)(H,29,38)(H,42,43)(H,44,45)(H2,27,30,31)(H2,39,40,41)/p-4/t15-,19-,20-,21+,25-/m0/s1"
239,4077,"(4R,5S,6R)-2,4,5,6-tetrahydroxycyclohex-2-en-1-one","A member of the class of  cyclohexenones that is cyclohex-2-en-1-one substituted by hydroxy groups at positions 2, 4, 5 and 6 (the 4R,5S,6R-stereoisomer).",28254,KEGG COMPOUND accession,C05834,,,,,,,,,,,,,,,
240,8774,ramipril,"A dipeptide that is the prodrug for ramiprilat, the active metabolite obtained by hydrolysis of the ethyl ester group. An angiotensin-converting enzyme (ACE) inhibitor, used to treat high blood pressure and congestive heart failure.",16017,KEGG COMPOUND accession,C02660,,,,,,,,,,,,,,,
241,7799,oseltamivir phosphate,a,32988,KEGG COMPOUND accession,C00241,,,,,,,,,,,,,,,
242,18446,(+)-cucurbic acid,a,27945,KEGG COMPOUND accession,C01927,,,,,,,,,,,,,,,
243,18450,(R)-mandelonitrile,a,6015,KEGG COMPOUND accession,C07518,,,,,,,,,,,,,,,
244,13332,GDP-beta-L-fucose,A GDP-L-fucose in which the anomeric oxygen is on the same side of the fucose ring as the methyl substituent.,17437,KEGG COMPOUND accession,C00580,dms,75-18-3,17437.0,"Human Metabolome Database (HMDB): Dimethylsulfide is the predominant volatile sulfur compound (VSC) in breadth malodor, a metabolite of suplatast tosilate (a dimethylsulphonium compound for the treatment of asthma) in patients that regularly take that medication. (PMID 14628896). Dimethylsulfide is a sulfur containing organic chemical compound with a disagreeable odor. In vapor form it is produced by cooking of certain vegetables, notably corn and cabbage, and seafood. It is also an indication of bacterial infection in malt production and brewing. It is a breakdown product of dimethylsulfoniopropionate, and is also produced by the bacterial metabolism of methanethiol. Dimethyl sulfide in concentrated liquid form is insoluble and a flammable.-- Wikipedia.",Dimethylsulfide,HMDB0002303,b,b,C00580,REDUCED-DMSO,FDB003591,b,b,QMMFVYPAHWMCMS-UHFFFAOYSA-N,b
245,15333,zeatin,a,5397,KEGG COMPOUND accession,C08403,,,,,,,,,,,,,,,
246,4093,D-allopyranose,The D-enantiomer of allopyranose.,17397,KEGG COMPOUND accession,C02366,,,,,,,,,,,,,,,
247,8491,propiomazine,A member of the class of  phenothiazines that is 10H-phenothiazine substituted by a 2-(dimethylamino)propyl group at nitrogen atom and a propanoyl group at position 2.,18149,KEGG COMPOUND accession,C08576,,,,,,,,,,,,,,,
248,13714,1-O-acetylmaltose,An O-acyl carbohydrate consisting of maltose carrying an anomeric O-acetyl substituent.,4784,KEGG COMPOUND accession,C06977,,,,,,,,,,,,,,,
249,13757,n-alk-2-enal,An enal obtained by formal dehydrogenation across positions 2 and 3 of any n-alkanal,4806,KEGG COMPOUND accession,C09731,,,,,,,,,,,,,,,
250,13022,keto-D-sorbose,a,16583,KEGG COMPOUND accession,C00741,diact,431-03-8,16583.0,"Human Metabolome Database (HMDB): Diacetyl is a natural by-product of secondary or malolactic fermentation. It is a vicinal diketone (two C=O groups, side-by-side) with the molecular formula C4H6O2. Carrier of aroma of butter, vinegar, coffee, and other foods. Beer sometimes undergoes a diacetyl rest, which entails waiting two or three days after fermentation is complete, to allow the yeast to absorb the diacetyl it produced earlier in the fermentation cycle. The makers of some wines, such as chardonnay, deliberately promote the production of diacetyl because of the feel and flavors it imparts.",Diacetyl,HMDB0003407,b,b,C00741,DIACETYL,FDB011930,b,b,QSJXEFYPDANLFS-UHFFFAOYSA-N,b
251,7676,O-butanoylcarnitine,A C4-acylcarnitine  that is the O-butanoyl derivative of carnitine.,16866,KEGG COMPOUND accession,C01474,,,,,,,,,,,,,,,
252,8041,phantomolin,A  germacranolide isolated from Elephantopus mollis and has been shown to exhibit antineoplastic activity.,17146,KEGG COMPOUND accession,C02811,,,,,,,,,,,,,,,
253,4709,doxazosin mesylate,a,27677,KEGG COMPOUND accession,C02802,,,,,,,,,,,,,,,
254,9142,silver(1+) sulfadiazinate,a,3223,KEGG COMPOUND accession,C06861,,,,,,,,,,,,,,,
255,8824,trans-rhaponticin,"A rhaponticin in which the double bond adopts a trans-configuration. It possesses a range of pharmacological activities including antitumour, antiinflammatory, antilipemic and neuroprotective activities.",15870,KEGG COMPOUND accession,C07345,,,,,,,,,,,,,,,
256,10106,zearalenone,"A macrolide comprising a fourteen-membered lactone fused to 1,3-dihydroxybenzene; a potent estrogenic metabolite produced by some Giberella species.",3481,KEGG COMPOUND accession,C08102,,,,,,,,,,,,,,,
257,13488,UDP-D-galacturonic acid,a,4681,KEGG COMPOUND accession,C07751,,,,,,,,,,,,,,,
258,8617,psorospermin,"An organic heterotetracyclic compound that is 1,2-dihydro-6H-furo[2,3-c]xanthene substituted by a hydroxy group at position 10, a methoxy group at position 5 nad a 2-methyloxiran-2-yl group at position 2.",16294,KEGG COMPOUND accession,C00813,,,,,,,,,,,,,,,
259,5277,gardenoside,A cyclopentapyran that is 7-deoxyloganin with a methyl and hydrogen replaced by hydroxy and hydroxymethyl groups at position 7.,28288,KEGG COMPOUND accession,C03591,,,,,,,,,,,,,,,
260,9682,trichlopyr,"A monocarboxylic acid that is (pyridin-2-yloxy)acetic acid substituted by chloro groups at positions 3, 5 and 6. It is an agrochemical used as a herbicide.",3311,KEGG COMPOUND accession,C08129,,,,,,,,,,,,,,,
261,9369,swertiajaponin,A  flavone C-glycoside that is  isoorientin in which the hydroxy group at position 7 is replaced by a methoxy group.,16526,KEGG COMPOUND accession,C00011,co2,124-38-9,16526.0,"Human Metabolome Database (HMDB): Carbon dioxide is a colorless, odorless gas that can be formed by the body and is necessary for the respiration cycle of plants and animals. Carbon dioxide is produced during respiration by all animals, fungi and microorganisms that depend on living and decaying plants for food, either directly or indirectly. It is, therefore, a major component of the carbon cycle. Additionally, carbon dioxide is used by plants during photosynthesis to make sugars which may either be consumed again in respiration or used as the raw material to produce polysaccharides such as starch and cellulose, proteins and the wide variety of other organic compounds required for plant growth and development. When inhaled at concentrations much higher than usual atmospheric levels, it can produce a sour taste in the mouth and a stinging sensation in the nose and throat. These effects result from the gas dissolving in the mucous membranes and saliva, forming a weak solution of carbonic acid. Carbon dioxide is used by the food industry, the oil industry, and the chemical industry. Carbon dioxide is used to produce carbonated soft drinks and soda water. Traditionally, the carbonation in beer and sparkling wine comes about through natural fermentation, but some manufacturers carbonate these drinks artificially.",Carbon dioxide,HMDB0001967,b,b,C00011,b,FDB014084,co2,O=C=O,CURLTUGMZLYLDI-UHFFFAOYSA-N,InChI=1S/CO2/c2-1-3
262,41,(+)-piperitone,The (6S)-enantiomer of  piperitone.,15600,KEGG COMPOUND accession,C06562,,,,,,,,,,,,,,,
263,1461,3-butynoic acid,A monocarboxylic acid consisting of acetylene carrying a carboxymethyl group.,15726,KEGG COMPOUND accession,C04636,,,,,,,,,,,,,,,
264,5386,globin,a,15857,KEGG COMPOUND accession,C03363,,,,,,,,,,,,,,,
265,5407,glucoiberverin(1-),A thia-alkylglucosinolate resulting from the removal of the proton of the hydrogen sulfate group of glucoiberverin.,27551,KEGG COMPOUND accession,C02376,,,,,,,,,,,,,,,
266,5412,gluconapoleiferin(1-),A glucosinolate that is glucobrassicanapin which has been hydroxylated at the 3-position of the hex-5-enimidoyl chain.,27964,KEGG COMPOUND accession,C04187,,,,,,,,,,,,,,,
267,2082,5-hydroxyxanthotoxin,A member of the class of psoralens that is xanthotoxin substituted by a hydroxy group at position 5.,28806,KEGG COMPOUND accession,C06196,dimp,3393-18-8,28806.0,"Human Metabolome Database (HMDB): dIMP is a deoxyribonucleoside and is considered a derivative of the nucleoside inosine, differing from the latter by the replacement of a hydroxyl group (-OH) by hydrogen (-H) at the 2' position of its ribose sugar moiety. The hydrolytic deamination of dAMP residues in DNA yields dIMP residues. The deamination of adenine residues in DNA generates hypoxanthine, which is mutagenic since it can pair not only with thymine but also with cytosine and therefore would result in A-T to G-C transitions after DNA replication. Hypoxanthine DNA glycosylase (EC 3.2.2.15) excises hypoxanthine from DNA containing dIMP residues in mammalian cells. (PMID: 10684927, 8016081).",dIMP,HMDB0006555,b,b,C06196,DIMP,FDB023969,dimp,[H]O[C@@]1([H])C([H])([H])[C@@]([H])(O[C@]1([H])C([H])([H])OP([O-])([O-])=O)N1C([H])=NC2=C1N=C([H])N([H])C2=O,PHNGFPPXDJJADG-RRKCRQDMSA-L,"InChI=1S/C10H13N4O7P/c15-5-1-7(21-6(5)2-20-22(17,18)19)14-4-13-8-9(14)11-3-12-10(8)16/h3-7,15H,1-2H2,(H,11,12,16)(H2,17,18,19)/p-2/t5-,6+,7+/m0/s1"
268,13172,keto-L-sorbose,a,28431,KEGG COMPOUND accession,C08896,,,,,,,,,,,,,,,
269,15045,"riboflavin cyclic 4',5'-phosphate",A flavin mononucleotide that is riboflavin (vitamin B2) in which the 4' and 5' hydroxy groups have been converted into a cyclic hydrogen phosphate ester.,42944,KEGG COMPOUND accession,C08526,,,,,,,,,,,,,,,
270,2504,aflatoxin B1,"An aflatoxin having a tetrahydrocyclopenta[c]furo[3',2':4,5]furo[2,3-h]chromene skeleton with oxygen functionality at positions 1, 4 and 11.",1015,KEGG COMPOUND accession,C06333,,,,,,,,,,,,,,,
271,6746,menadiol,"A naphthalene-1,4-diol having a methyl substituent at the 2-position.",2373,KEGG COMPOUND accession,C10290,,,,,,,,,,,,,,,
272,6754,pethidine,"A piperidinecarboxylate ester that is piperidine which is substituted by a methyl group at position 1 and by phenyl and ethoxycarbonyl groups at position 4. It is an analgesic which is used for the treatment of moderate to severe pain, including postoperative pain and labour pain.",15339,KEGG COMPOUND accession,C00028,,,,,,,,,,,,,,,
273,13170,Ser-tRNA(Sec),a,28143,KEGG COMPOUND accession,C08862,,,,,,,,,,,,,,,
274,8087,N(2)-phenylacetylglutamine,a,2748,KEGG COMPOUND accession,C08327,,,,,,,,,,,,,,,
275,3086,betulin,A pentacyclic triterpenoid that is lupane having a double bond at position 20(29) as well as 3beta-hydroxy and 28-hydroxymethyl substituents.,30831,KEGG COMPOUND accession,C00109,2obut,600-18-0,30831.0,"Human Metabolome Database (HMDB): 2-Ketobutyric acid is a substance that is involved in the metabolism of many amino acids (glycine, methionine, valine, leucine, serine, threonine, isoleucine) as well as propanoate metabolism and C-5 branched dibasic acid metabolism. More specifically, alpha-ketobutyric acid is a product of the lysis of cystathionine. It is also one of the degradation products of threonine. It can be converted to propionyl-CoA (and subsequently methylmalonyl CoA, which can be converted to succinyl CoA, a citric acid cycle intermediate), and thus enter the citric acid cycle.",2-Ketobutyric acid,HMDB0000005,b,b,C00109,2-OXOBUTANOATE,FDB003359,2obut,[H]C([H])([H])C([H])([H])C(=O)C([O-])=O,TYEYBOSBBBHJIV-UHFFFAOYSA-M,"InChI=1S/C4H6O3/c1-2-3(5)4(6)7/h2H2,1H3,(H,6,7)/p-1"
276,11614,2-methylbut-2-enoyl-coenzyme A,An alk-2-enoyl-CoA that results from the formal condensation of the thiol group of coenzyme A with the carboxy group of 2-methylbut-2-enoic acid.,4034,KEGG COMPOUND accession,C10982,,,,,,,,,,,,,,,
277,3404,carboprost tromethamine,The tromethamine salt of carboprost. It is used as an abortifacient agent that is effective in both the first and second trimesters of pregnancy.,27741,KEGG COMPOUND accession,C02790,,,,,,,,,,,,,,,
278,18533,5alpha-campestan-3-one,A brassinosteroid that is 5alpha-campestane bearing an oxo substituent at position 3.,6052,KEGG COMPOUND accession,C10084,,,,,,,,,,,,,,,
279,2524,ajmalicine,"A monoterpenoid indole alkaloid with formula C21H24N2O3, isolated from several Rauvolfia and Catharanthus species. It is a selective alpha1-adrenoceptor antagonist used for the treatment of high blood pressure.",15849,KEGG COMPOUND accession,C06388,,,,,,,,,,,,,,,
280,2580,unsaturated fatty acid anion,Any fatty acid anion containing at least one C-C unsaturated bond; formed by deprotonation of the carboxylic acid moiety.,18125,KEGG COMPOUND accession,C01772,,,,,,,,,,,,,,,
281,8198,trans-piceid,A stilbenoid that is trans-resveratrol substituted at position 3 by a beta-D-glucosyl residue.,27569,KEGG COMPOUND accession,C00569,arabinogal,b,b,b,"Larch arabinogalactan, gal/ara 6:1, small amount of glcur, MW ~ 116000",b,b,b,C00569,b,b,b,b,b,b
282,8200,picolinamide,A  pyridinecarboxamide that is the  monocarboxylic acid amide derivative of picolinic acid.,28427,KEGG COMPOUND accession,C01889,,,,,,,,,,,,,,,
283,20051,3-hydroxy-5-oxohexanoate,A hydroxy monocarboxylic acid anion that is the conjugate base of 3-hydroxy-5-oxohexanoic acid obtained by deprotonation of the carboxy group.,30632,KEGG COMPOUND accession,C01512,,,,,,,,,,,,,,,
284,3703,cinchonidine,"8-epi-Cinchonan in which a hydrogen at position 9 is substituted by hydroxy (R configuration). A diasteroisomer of cinchonine, it occurs in the bark of most varieties of Cinchona shrubs, and is frequently used for directing chirality in asymmetric synthesis.",16939,KEGG COMPOUND accession,C04368,,,,,,,,,,,,,,,
285,3706,cinerin I,a,27764,KEGG COMPOUND accession,C06334,,,,,,,,,,,,,,,
286,18508,"(1R,2R)-1-amino-2-ethylcyclopropanecarboxylic acid",a,6041,KEGG COMPOUND accession,C02289,,,,,,,,,,,,,,,
287,3908,coumestrol,A member of the class of coumestans that is coumestan with hydroxy substituents at positions 3 and 9.,16207,KEGG COMPOUND accession,C03067,,,,,,,,,,,,,,,
288,3944,cucurbitacin E,"A cucurbitacin in which a lanostane skeleton is multi-substituted with hydroxy, methyl and oxo substituents, with unsaturation at positions 1, 5 and 23.",17871,KEGG COMPOUND accession,C00969,3hppnl,2134-29-4,17871.0,"Human Metabolome Database (HMDB): 3-Hydroxypropanal is a broad-spectrum antimicrobial substance termed reuterin produced by Lactobacillus reuteri. L. reuteri resides in the gastrointestinal tract of healthy humans and animals, and is believed to. function as a symbiont in the enteric ecosystem. Synthesis of such an antimicrobial substance by an enteric resident raises a number of interesting questions and possibilities as to the role these residents may play in the health of the host. (PMID 3245697). In vivo, glycerol is converted in one enzymatic step into 3-Hydroxypropanal. The 3-Hydroxypropanal -producing Lactobacillus reuteri is used as a probiotic in the health care of humans and animals. 3-Hydroxypropanal forms, together with Hydroxypropanal-hydrate and Hydroxypropanal-dimer, a dynamic, multi-component system (Hydroxypropanal system) used in food preservation, as a precursor for many modern chemicals such as acrolein, acrylic acid, and 1,3-propanediol (1,3-PDO), and for polymer production. 3-Hydroxypropanal can be obtained both through traditional chemistry and bacterial fermentation. To date, 3-HPA has been produced from petrochemical resources as an intermediate in 1,3-PDO production. The biotechnological production of 3-Hydroxypropanal from renewable resources is desirable both for use of 3-Hydroxypropanal in foods and for the production of bulk chemicals. The main challenge will be the efficient production and recovery of pure 3-Hydroxypropanal. (PMID 14669058).",3-Hydroxypropanal,HMDB0003453,b,b,C00969,HYDROXYPROPANAL,FDB023176,b,b,AKXKFZDCRYJKTF-UHFFFAOYSA-N,"InChI=1S/C3H6O2/c4-2-1-3-5/h2,5H,1,3H2"
289,21644,N-acyl-L-amino acid,Any N-acylamino acid having L-configuration.,7219,KEGG COMPOUND accession,C11341,,,,,,,,,,,,,,,
290,21650,N-acyl-L-glutamic acid,Any optically active N-acylglutamic acid having L-configuration.,17768,KEGG COMPOUND accession,C02714,aprut,18233-70-0,17768.0,"Human Metabolome Database (HMDB): N-Acetylputrescine is a polyamine commonly occurring excreted in normal human urine (PMID 7775374). N-Acetylputrescine is the most abundant of all polyamines both in normal individuals and in patients with leukemia (PMID 9464484). N-Acetylputrescine is the N-acetylated form of the naturally occurring polyamine called putrescine. The N-acetylation is mediated by the enzyme diamine N-acetyltransferase. Putrescine is related to cadaverine (another polyamine). Both are produced by the breakdown of amino acids in living and dead organisms and both are toxic in large doses. Putrescine and cadaverine are largely responsible for the foul odor of putrefying flesh, but also contribute to the odor of such processes as bad breath and bacterial vaginosis. Putrescine is also found in semen. Putrescine attacks s-adenosyl methionine and converts it to spermidine. Spermidine in turn attacks another s-adenosyl methionine and converts it to spermine. Putrescine is synthesized in small quantities by healthy living cells by the action of ornithine decarboxylase.",N-Acetylputrescine,HMDB0002064,b,b,C02714,CPD-569,FDB022827,aprut,[H]N(C(=O)C([H])([H])[H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[N+]([H])([H])[H],KLZGKIDSEJWEDW-UHFFFAOYSA-O,"InChI=1S/C6H14N2O/c1-6(9)8-5-3-2-4-7/h2-5,7H2,1H3,(H,8,9)/p+1"
291,21655,N-acylgalactosamine,a,17697,KEGG COMPOUND accession,C00978,Nacsertn,1210-83-9,17697.0,"Human Metabolome Database (HMDB): N-Acetylserotonin is an intermediate in the metabolic pathway of melatonin and indoleamine in the pineal gland of mammalians. Serotonin-N-acetyltransferase (SNAT), which regulates the rate of melatonin biosynthesis in the pineal gland, catalyzes the acetylation of 5HT to N-acetylserotonin (NAS). A methyl group from S-adenosylmethionine is transferred to NAS by hydroxyindole-O-methyltransferase (HIOMT), and finally NAS is converted to 5-methoxy-N-acetyltryptamine, or melatonin. In most mammalian species the content of NAS (and melatonin) in the pineal gland shows clear circadian changes with the highest level occurring during the dark period. This elevation of the contents of NAS (and melatonin) in the dark period is due to the increase of SNAT activity and the elevation of SNAT gene expression. Experimental studies show that N-acetylserotonin possess free radical scavenging activity. Acute administration of irreversible and reversible selective MAO-A inhibitors and high doses (or chronic administration of low doses) of relatively selective MAO-B inhibitors (but not of highly selective MAO-B inhibitors) suppressed MAO-A activity and stimulated N-acetylation of pineal serotonin into N-acetylserotonin, the immediate precursor of melatonin. N-acetylserotonin increase after MAO-A inhibitors might mediate their antidepressive and antihypertensive effects. N-Acetylserotonin is the product of the O-demethylation of melatonin mediated by cytochrome P-450 isoforms: Cytochrome p450, subfamily IIc, polypeptide 19 (CYP2C19, a clinically important enzyme that metabolizes a wide variety of drugs), with a minor contribution from Cytochrome p450, subfamily I, polypeptide (2CYP1A2, involved in O-deethylation of phenacetin). (PMID 15616152, 11103901, 10721079, 10591054).",N-Acetylserotonin,HMDB0001238,b,b,C00978,N-ACETYL-SEROTONIN,FDB022505,Nacsertn,[H]OC1=C([H])C2=C(N([H])C([H])=C2C([H])([H])C([H])([H])N([H])C(=O)C([H])([H])[H])C([H])=C1[H],MVAWJSIDNICKHF-UHFFFAOYSA-N,"InChI=1S/C12H14N2O2/c1-8(15)13-5-4-9-7-14-12-3-2-10(16)6-11(9)12/h2-3,6-7,14,16H,4-5H2,1H3,(H,13,15)"
292,15318,xanthine,A purine nucleobase found in humans and other organisms.,5390,KEGG COMPOUND accession,C01425,,,,,,,,,,,,,,,
293,3241,butoconazole nitrate,"An organic nitrate salt obtained by reaction of equimolar amounts of butaconazole and nitric acid.  An antifungal agent, it is used in gynaecology for treatment of vulvovaginal infections caused by Candida species, particularly Candida albicans.",16068,KEGG COMPOUND accession,C04524,,,,,,,,,,,,,,,
294,11641,2-oxopent-4-enoate,a,4047,KEGG COMPOUND accession,C01419,cgly,19246-18-5,4047.0,"Human Metabolome Database (HMDB): Cysteinylglycine is a naturally occurring dipeptide. It is derived from the breakdown of glutathione (a tripeptide). In plasma, cysteinylglycine is in a reduced, oxidized and protein-bound form (aminothiol) and interact via redox and disulphide exchange reactions, in a dynamic system referred to as redox thiol status (PMID 8642471). Spermatozoa of sub fertile men contain significantly higher thiol concentrations as compared with those of fertile men. The detrimental effect on embryo quality of a high homocysteine (Hcy, another member of the thiol group) concentration in the ejaculate and in follicular fluid is intriguing and may suggest that Hcy is inversely associated with fertility outcome (PMID 16556671). Rheumatoid arthritis (RA) is a chronic inflammatory disease which involves the synovial membrane of multiple diarthroidal joints causing damage to cartilage and bones. The damage process seems to be related to an overproduction of oxygen reactive species inducing an oxidative perturbation with an increase in some oxidized forms (disulfides and protein mixed disulfides) and a decrease in free thiols (PMID 15895891). Imipenem (thienamycin formamidine), is a broad-spectrum beta-lactam antibiotic, always used in combination with cilastatin in order to avoid the premature breakdown of imipenem by renal tubular dipeptidase. As this dipeptidase also hydrolyzes the glutathione metabolite cysteinylglycine, the therapeutic association of imipenem and cilastatin causes plasma levels of cysteinylglycine to increase significantly, while cysteine levels are decreased and homocysteine levels are unaffected. Therefore, antibiotic treatment using imipenem-cilastatin induces important metabolic changes that should not remain unrecognized (PMID 15843241). Moreover, cysteinylglycine is found to be associated with phenylketonuria, which is an inborn error of metabolism.",Cysteinylglycine,HMDB0000078,b,b,C01419,GLUTATHIONE,FDB021891,cgly,[H]SC([H])([H])[C@@]([H])(C(=O)N([H])C([H])([H])C([O-])=O)[N+]([H])([H])[H],ZUKPVRWZDMRIEO-VKHMYHEASA-N,"InChI=1S/C5H10N2O3S/c6-3(2-11)5(10)7-1-4(8)9/h3,11H,1-2,6H2,(H,7,10)(H,8,9)/t3-/m0/s1"
295,4194,D-hexose,A hexose that has D-configuration at position 5.,27973,KEGG COMPOUND accession,C06019,,,,,,,,,,,,,,,
296,4450,desmopressin,"A synthetic analogue of vasopressin in which 3-mercaptopropionic acid replaces the cysteine residue at position 1 and D-arginine replaces the residue at position 8. An antidiuretic, it increases urine concentration and decreases urine production, and is used (usually as the trihydrate of the acetic acid salt) to prevent and control excessive thirst, urination, and dehydration caused by injury, surgery, and certain medical conditions. It is also used in the diagnosis and treatment of cranial diabetes insipidus and in tests of renal function.",28032,KEGG COMPOUND accession,C10700,,,,,,,,,,,,,,,
297,4559,dihydroconiferyl alcohol,A member of class of phenols that is 2-methoxyphenol substituted by a 3-hydroxypropyl group at position 4.,18032,KEGG COMPOUND accession,C04556,,,,,,,,,,,,,,,
298,5791,hydromorphone hydrochloride,a,2255,KEGG COMPOUND accession,C07756,,,,,,,,,,,,,,,
299,5810,hydroxymethylphosphonic acid,A phosphonic acid having a hydroxymethyl group attached to the phosphorus.,2268,KEGG COMPOUND accession,C11264,,,,,,,,,,,,,,,
300,9207,sotalol hydrochloride,A hydrochloride salt that is the monohydrochloride of sotalol. It has both beta-adrenoreceptor blocking (Vaughan Williams Class II) and cardiac action potential duration prolongation (Vaughan Williams Class III) antiarrhythmic properties. It is used (usually as the hydrochloride salt) for the management of ventricular and supraventricular arrhythmias.,3242,KEGG COMPOUND accession,C06863,,,,,,,,,,,,,,,
301,15185,tRNA(Pyl),a,5331,KEGG COMPOUND accession,C09861,,,,,,,,,,,,,,,
302,15258,trichlorophenols,Any chlorophenol derivative that contains three covalently bonded chlorine atoms.,67987,KEGG COMPOUND accession,C08946,,,,,,,,,,,,,,,
303,3740,cleomiscosin A,"An organic heterotricyclic compound that is 2,3-dihydro-9H-[1,4]dioxino[2,3-h]chromen-9-one substituted by 4-hydroxy-3-methoxy phenyl group at position 3, a hydroxymethyl group at position 2 and a methoxy group at position 5 (the 2R,3R stereoisomer). It exhibits anti-inflammatory activity.",15749,KEGG COMPOUND accession,C01163,,,,,,,,,,,,,,,
304,3759,clopidogrel sulfate,a,17231,KEGG COMPOUND accession,C01467,,,,,,,,,,,,,,,
305,513,"1,3,4,6-tetrachlorocyclohexa-1,4-diene","A chloroolefin that is cyclohexa-1,4-diene substituted by chloro groups at positions 1, 3, 4 and 6.",15616,KEGG COMPOUND accession,C01186,,,,,,,,,,,,,,,
306,76,(-)-annonaine,"An aporphine alkaloid that exhibits anti-cancer, trypanocidal and antiplasmodial activites.",27934,KEGG COMPOUND accession,C04165,,,,,,,,,,,,,,,
307,99,(-)-maackiain,The (-)-enantiomer of maackiain.,28603,KEGG COMPOUND accession,C10890,,,,,,,,,,,,,,,
308,153,(-)-neoisodihydrocarveol,"A dihydrocarveol with a (1R,2S,4S)-configuration.",76,KEGG COMPOUND accession,C09339,,,,,,,,,,,,,,,
309,5010,fenoprofen calcium (anhydrous),The anhydrous form of the calcium salt of fenprofen. The dihydrate form is used as a non-steroidal anti-inflammatory drug for the management of mild to moderate pain and for the relief of pain and inflammation associated with disorders such as arthritis.,30789,KEGG COMPOUND accession,C02236,,,,,,,,,,,,,,,
310,5027,ferricytochrome c-552.5,a,28918,KEGG COMPOUND accession,C00788,adrnl,51-43-4,28918.0,"Human Metabolome Database (HMDB): Epinephrine is a catecholamine, a sympathomimetic monoamine derived from the amino acids phenylalanine and tyrosine. It is the active sympathomimetic hormone secreted from the adrenal medulla in most species. It stimulates both the alpha- and beta- adrenergic systems, causes systemic vasoconstriction and gastrointestinal relaxation, stimulates the heart, and dilates bronchi and cerebral vessels. It is used in asthma and cardiac failure and to delay absorption of local anesthetics. Epinephrine also constricts arterioles in the skin and gut while dilating arterioles in leg muscles. It elevates the blood sugar level by increasing hydrolysis of glycogen to glucose in the liver, and at the same time begins the breakdown of lipids in adipocytes. Epinephrine has a suppressive effect on the immune system.",Epinephrine,HMDB0000068,b,b,C00788,L-EPINEPHRINE,FDB021889,adrnl,[H]OC1=C([H])C([H])=C(C([H])=C1O[H])[C@@]([H])(O[H])C([H])([H])[N+]([H])([H])C([H])([H])[H],UCTWMZQNUQWSLP-VIFPVBQESA-O,"InChI=1S/C9H13NO3/c1-10-5-9(13)6-2-3-7(11)8(12)4-6/h2-4,9-13H,5H2,1H3/p+1/t9-/m0/s1"
311,4850,eschscholtzidine,A heteropentacyclic isoquinoline alkaloid having a tertiary amino bridging group.,18101,KEGG COMPOUND accession,C00642,4hphac,156-38-7,18101.0,"Human Metabolome Database (HMDB): P-hydroxyphenylacetic acid, also known as 4-Hydroxybenzeneacetate or Parahydroxy phenylacetate, is classified as a member of the 1-hydroxy-2-unsubstituted benzenoids. 1-hydroxy-2-unsubstituted benzenoids are phenols that a unsubstituted at the 2-position. P-hydroxyphenylacetic acid is considered to be slightly soluble (in water) and acidic.  P-hydroxyphenylacetic acid can be synthesized from acetic acid. It is also a parent compound for other transformation products, including but not limited to, methyl 2-(4-hydroxyphenyl)acetate, ixerochinolide, and lactucopicrin 15-oxalate.  P-hydroxyphenylacetic acid can be found throughout numerous foods such as Olives, Cocoa beans, Oats, and Mushrooms. P-hydroxyphenylacetic acid can be found throughout all human tissues; and in all biofluids. Within a cell, P-hydroxyphenylacetic acid is primarily located in the cytoplasm and in the extracellular space",p-Hydroxyphenylacetic acid,HMDB0000020,b,b,C00642,4-HYDROXYPHENYLACETATE,FDB010534,4hphac,[H]OC1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])C([O-])=O,XQXPVVBIMDBYFF-UHFFFAOYSA-M,"InChI=1S/C8H8O3/c9-7-3-1-6(2-4-7)5-8(10)11/h1-4,9H,5H2,(H,10,11)/p-1"
312,10440,(-)-beta-santalene,"A sesquiterpene and carbobicyclic compound that is bicyclo[2.2.1]heptane in which the hydrogens at position 3 are substituted by a methylidene group, while the 2-exo- and 2-endo- hydrogens are subsitituted by 2-methylpent-2-en-5-yl and methyl groups, respectively (the 1S,2R,4R enantiomer).",27675,KEGG COMPOUND accession,C06601,,,,,,,,,,,,,,,
313,20106,vanillylmandelic acid,"An aromatic ether that is the 3-O-methyl ether of 3,4-dihydroxymandelic acid.",6530,KEGG COMPOUND accession,C09699,,,,,,,,,,,,,,,
314,20114,3-methylquinolin-2(1H)-one,a,18378,KEGG COMPOUND accession,C08825,,,,,,,,,,,,,,,
315,14261,feruloyl-CoA,An acyl-CoA that results from the formal condensation of the thiol group of coenzyme A with the carboxy group of ferulic acid.,5004,KEGG COMPOUND accession,C06997,,,,,,,,,,,,,,,
316,13209,long-chain fatty acid ethyl ester,A fatty acid ethyl ester resulting from the formal condensation of the carboxy group of a long-chain fatty acid with the hydroxy group of ethanol.,16151,KEGG COMPOUND accession,C02274,,,,,,,,,,,,,,,
317,1848,4-hydroxy-4-methylglutamate,A glutamic acid derivative that is L-glutamic acid with a methyl and a hydroxy group replacing the two hydrogens at position 4.,744,KEGG COMPOUND accession,C09153,,,,,,,,,,,,,,,
318,1890,4-methoxyglucobrassicin,An  indolylmethylglucosinolic acid that is glucobrassicin bearing a methoxy substituent at position 4 on the indole ring.,27486,KEGG COMPOUND accession,C06392,,,,,,,,,,,,,,,
319,13115,L-gulonate,The L-enantiomer of gulonate.,17132,KEGG COMPOUND accession,C04586,,,,,,,,,,,,,,,
320,10037,wedelolactone,"A member of the class of coumestans that is coumestan with hydroxy substituents as positions 1, 8 and 9 and a methoxy substituent at position 3.",3454,KEGG COMPOUND accession,C08670,,,,,,,,,,,,,,,
321,1113,"cis-2-hydroxypenta-2,4-dienoic acid","The cis-isomer of 2-hydroxypenta-2,4-dienoic acid.",17729,KEGG COMPOUND accession,C06160,,,,,,,,,,,,,,,
322,3543,cephamycin C,"One of three naturally occurring cephamycin antibiotics, differing from the A and B forms in its carbamoyloxymethyl substituent at C-3.",41941,KEGG COMPOUND accession,C01161,34dhpha,102-32-9,41941.0,"Human Metabolome Database (HMDB): 3,4-dihydroxyphenylacetic acid (DOPAC) is a phenolic acid. DOPAC is a neuronal metabolite of dopamine (DA). DA undergoes monoamine oxidase-catalyzed oxidative deamination to 3,4-dihydroxyphenylacetaldehyde (DOPAL), which is metabolized primarily to DOPAC via aldehyde dehydrogenase (ALDH2). The biotransformation of DOPAL is critical as previous studies have demonstrated this DA-derived aldehyde to be a reactive electrophile and toxic to dopaminergic cells. Known inhibitors of mitochondrial ALDH2, such as 4-hydroxy-2-nonenal (4HNE) inhibit ALDH2-mediated oxidation of the endogenous neurotoxin DOPAL. 4HNE is one of the resulting products of oxidative stress, thus linking oxidative stress to the uncontrolled production of an endogenous neurotoxin relevant to Parkinson's disease. In early onset Parkinson disease there is markedly reduced activities of both monoamine oxidase (MAO) A and B. The amount of DOPAC, which is produced during dopamine oxidation by MAO, is greatly reduced as a result of increased parkin overexpression. Administration of methamphetamine to animals causes loss of DA terminals in the brain, and significant decreases in Dopamine and dihydroxyphenylacetic acid (DOPAC) in the striata. Renal dopamine produced in the residual tubular units may be enhanced during a sodium challenge, thus behaving appropriately as a compensatory natriuretic hormone; however the renal dopaminergic system in patients afflicted with renal parenchymal disorders should address parameters other than free urinary dopamine, namely the urinary excretion of L-DOPA and metabolites. DOPAC is one of the major phenolic acids formed during human microbial fermentation of tea, citrus, and soy flavonoid supplements. DOPAC exhibits a considerable antiproliferative effect in LNCaP prostate cancer and HCT116 colon cancer cells. The antiproliferative activity of DOPAC may be due to its catechol structure. A similar association of the catechol moiety in the B-ring with antiproliferative activity was demonstrated for flavanones. (PMID: 16956664, 16455660, 8561959, 11369822, 10443478, 16365058).","3,4-Dihydroxybenzeneacetic acid",HMDB0001336,b,b,C01161,CPD-782,FDB000316,34dhpha,[H]OC1=C([H])C([H])=C(C([H])=C1O[H])C([H])([H])C([O-])=O,CFFZDZCDUFSOFZ-UHFFFAOYSA-M,"InChI=1S/C8H8O4/c9-6-2-1-5(3-7(6)10)4-8(11)12/h1-3,9-10H,4H2,(H,11,12)/p-1"
323,7577,nisoldipine,"A racemate consisting of equimolar amounts of (R)- and (S)-nisoldipine. A calcium channel blocker, it is used in the treatment of hypertension and angina pectoris.",2540,KEGG COMPOUND accession,C09289,,,,,,,,,,,,,,,
324,7579,"(6S,7R)-2-azaspiro[5.5]undecan-7-ol",a,15338,KEGG COMPOUND accession,C03999,,,,,,,,,,,,,,,
325,12952,aldehydo-D-galacturonate,a,27478,KEGG COMPOUND accession,C06541,,,,,,,,,,,,,,,
326,3002,beclomethasone dipropionate,A steroid ester comprising beclomethasone having propionyl groups at the 17- and 21-positions.,1224,KEGG COMPOUND accession,C10923,,,,,,,,,,,,,,,
327,3018,bentazone,"A  benzothiadiazine that is 1H-2,1,3-benzothiadiazin-4(3H)-one 2,2-dioxide substituted by an isopropyl group at position 3.",27688,KEGG COMPOUND accession,C05815,,,,,,,,,,,,,,,
328,2160,"6-(3,3-dimethylallyl)galangin",A trihydroxyflavone that is  galangin substituted by a prenyl group at position 6.,15469,KEGG COMPOUND accession,C00605,,,,,,,,,,,,,,,
329,2198,6-hydroxymelatonin,A member of the class of  tryptamines  that is melatonin with a hydroxy group substituent at position 6.,17828,KEGG COMPOUND accession,C02775,,,,,,,,,,,,,,,
330,2305,"8-(3,3-dimethylallyl)chrysin",A dihydroxyflavone that is chrysin substituted by a prenyl group at position 8.,28975,KEGG COMPOUND accession,C06599,,,,,,,,,,,,,,,
331,1294,"(20R,22R)-20,22-dihydroxycholesterol","An  oxysterol that is cholesterol substituted  by hydroxy groups at positions 20 and 22 (the 20R,22R-stereoisomer).",27517,KEGG COMPOUND accession,C02490,,,,,,,,,,,,,,,
332,3576,chanoclavine-I,"An organic tricyclic compound that is 1,3,4,5-tetrahydrobenzo[cd]indole which is substituted at position 4 by a methylamino group and at position 5 by a 3-hydroxy-2-methylprop-1-en-1-yl group (the 4R,5R,E diastereoisomer). It is a precursor of the tetracyclic ergolines agroclavine, elymoclavine and lysergic acid amide.",28016,KEGG COMPOUND accession,C03347,,,,,,,,,,,,,,,
333,2805,arbusculin A,A sesquiterpene lactone isolated from Saussureae Radix and has been shown to exhibit inhibitory activity against melanogenesis.,17852,KEGG COMPOUND accession,C01251,hcit,3562-74-1,52222.0,Human Metabolome Database (HMDB): Homocitric acid is a normal urinary organic acid. (PMID: 14708889). Homocitric acid is a citric acid analogue found as a minor metabolite in urine samples from patients with propionic acidaemia. Homocitric acid is formed by citrate synthase due to propionyl CoA carboxylase deficiency (by the citrate synthase condensation reaction of a-ketoglutarate with acetyl coenzyme A and propionyl coenzyme A). (PMID: 7850997).,Homocitric acid,HMDB0003518,b,b,C01251,HOMO-CIT,FDB023186,b,b,XKJVEVRQMLKSMO-SSDOTTSWSA-N,"InChI=1S/C7H10O7/c8-4(9)1-2-7(14,6(12)13)3-5(10)11/h14H,1-3H2,(H,8,9)(H,10,11)(H,12,13)"
334,25572,nocardicin,a,27529,KEGG COMPOUND accession,C04307,,,,,,,,,,,,,,,
335,25580,nonanoyl group,a,15883,KEGG COMPOUND accession,C01261,M02671,4130-19-2,15883.0,"Human Metabolome Database (HMDB): Diguanosine tetraphosphate is a diguanosine polyphosphate. Diguanosine polyphosphates (GpnGs) are found in human platelets, among a number of dinucleoside polyphosphates, which vary with respect to the number of phosphate groups and the nucleoside moieties; not only diguanosine polyphosphates (GpnG) are found, but also mixed dinucleoside polyphosphates containing one adenosine and one guanosine moiety (ApnG). The vasoactive nucleotides that can be detected in human plasma contain shorter (n=2-3) and longer (n=4-6) polyphosphate chains. GpnGs have not yet been characterized so far with respect to their effects on kidney vasculature. (PMID: 11159696, 11682456, 11115507).",Diguanosine tetraphosphate,HMDB0001340,b,b,C01261,CPD-609,FDB022564,b,[H]O[C@]1([H])[C@]([H])(O[H])[C@]([H])(O[C@@]1([H])N1C([H])=NC2=C1N=C(N([H])[H])N([H])C2=O)C([H])([H])OP(=O)(O[H])OP(=O)(O[H])OP(=O)(O[H])OP(=O)(O[H])OC([H])([H])[C@@]1([H])O[C@@]([H])(N2C([H])=NC3=C2N=C(N([H])[H])N([H])C3=O)[C@]([H])(O[H])[C@]1([H])O[H],OLGWXCQXRSSQPO-MHARETSRSA-N,"InChI=1S/C20H28N10O21P4/c21-19-25-13-7(15(35)27-19)23-3-29(13)17-11(33)9(31)5(47-17)1-45-52(37,38)49-54(41,42)51-55(43,44)50-53(39,40)46-2-6-10(32)12(34)18(48-6)30-4-24-8-14(30)26-20(22)28-16(8)36/h3-6,9-12,17-18,31-34H,1-2H2,(H,37,38)(H,39,40)(H,41,42)(H,43,44)(H3,21,25,27,35)(H3,22,26,28,36)/t5-,6-,9-,10-,11-,12-,17-,18-/m1/s1"
336,25585,nonmetal atom,a,28400,KEGG COMPOUND accession,C04392,,,,,,,,,,,,,,,
337,25591,norcoclaurine,A benzylisoquinoline alkaloid based on a  benzyltetrahydroisoquinoline skeleton.,18315,KEGG COMPOUND accession,C00113,,,,,,,,,,,,,,,
338,27178,tyrosino group,a,16367,KEGG COMPOUND accession,C04087,,,,,,,,,,,,,,,
339,24385,glycoglycerolipid,a,16701,KEGG COMPOUND accession,C01117,,,,,,,,,,,,,,,
340,25901,pentose,A five-carbon monosaccharide which in its linear form contains either an aldehyde group at position 1 (aldopentose) or a ketone group at position 2 (ketopentose).,18122,KEGG COMPOUND accession,C03303,M02706,b,b,b,Peptidylamidoglycolate,b,b,b,C03303,b,b,b,[H]OC(=O)C([H])(O[H])N([H])C(=O)[C@]([H])([*])N([H])C(=O)[C@]([H])([*])N([H])[H],b,b
341,25640,octamethylcyclotetrasiloxane,A cyclosiloxane that is the octamethyl derivative of  cyclotetrasiloxane.,28716,KEGG COMPOUND accession,C08362,hdcea,373-49-9,28716.0,"Human Metabolome Database (HMDB): Palmitoleic acid, or 9-hexadecenoic acid, is an unsaturated fatty acid that is a common constituent of the glycerides of human adipose tissue. Present in all tissues, generally found in higher concentrations in the liver. Macadamia oil (Macadamia integrifolia) and Sea Buckthorn oil (Hippophae rhamnoides) are botanical sources of palmitoleic acid, containing 22 and 40% respectively (Wikipedia). Palmitoleic acid is found to be associated with isovaleric acidemia, which is an inborn error of metabolism.",Palmitoleic acid,HMDB0003229,b,b,C08362,CPD-724,FDB011675,hdcea,[H]\C(=C(/[H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([O-])=O)C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H],SECPZKHBENQXJG-FPLPWBNLSA-M,"InChI=1S/C16H30O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16(17)18/h7-8H,2-6,9-15H2,1H3,(H,17,18)/p-1/b8-7-"
342,26895,tetracyclines,"A subclass of polyketides having an octahydrotetracene-2-carboxamide skeleton, substituted with many hydroxy and other groups.",17026,KEGG COMPOUND accession,C00410,prgstrn,57-83-0,17026.0,"Human Metabolome Database (HMDB): The major progestational steroid that is secreted primarily by the corpus luteum and the placenta. Progesterone acts on the uterus, the mammary glands and the brain. It is required in embryo implantation, pregnancy maintenance, and the development of mammary tissue for milk production. Progesterone, converted from pregnenolone, also serves as an intermediate in the biosynthesis of gonadal steroid hormones and adrenal corticosteroids (Pubchem). Progesterone is a C-21 steroid hormone involved in the female menstrual cycle, pregnancy (supports gestation) and embryogenesis of humans and other species. Progesterone belongs to a class of hormones called progestagens, and is the major naturally occurring human progestagen (Wikipedia). During implantation and gestation, progesterone appears to decrease the maternal immune response to allow for the acceptance of the pregnancy. Progesterone decreases contractility of the uterine smooth muscle. The fetus metabolizes placental progesterone in the production of adrenal mineralo- and glucosteroids. A drop in progesterone levels is possibly one step that facilitates the onset of labor. In addition progesterone inhibits lactation during pregnancy. The fall in progesterone levels following delivery is one of the triggers for milk production (Wikipedia). Progesterone is found to be associated with pregnene hydroxylation deficiency, which is an inborn error of metabolism.",Progesterone,HMDB0001830,b,b,C00410,PROGESTERONE,FDB001871,prgstrn,[H]C1=C2C([H])([H])C([H])([H])[C@@]3([H])[C@]4([H])C([H])([H])C([H])([H])[C@]([H])(C(=O)C([H])([H])[H])[C@@]4(C([H])([H])[H])C([H])([H])C([H])([H])[C@]3([H])[C@@]2(C([H])([H])[H])C([H])([H])C([H])([H])C1=O,RJKFOVLPORLFTN-LEKSSAKUSA-N,"InChI=1S/C21H30O2/c1-13(22)17-6-7-18-16-5-4-14-12-15(23)8-10-20(14,2)19(16)9-11-21(17,18)3/h12,16-19H,4-11H2,1-3H3/t16-,17+,18-,19-,20-,21+/m0/s1"
343,24458,guanosines,Any purine ribonucleoside that is a derivative of guanosine.,15970,KEGG COMPOUND accession,C03015,,,,,,,,,,,,,,,
344,25978,phenylacetic acids,Any monocarboxylic acid that is phenylacetic acid or its substituted derivatives.,16760,KEGG COMPOUND accession,C03164,,,,,,,,,,,,,,,
345,26248,prenyl group,a,18021,KEGG COMPOUND accession,C00074,pep,138-08-9,44897.0,"Human Metabolome Database (HMDB): Phosphoenolpyruvate (PEP) is an important chemical compound in biochemistry. It has a high energy phosphate bond, and is involved in glycolysis and gluconeogenesis. In glycolysis, PEP is formed by the action of the enzyme enolase on 2-phosphoglycerate. Metabolism of PEP to pyruvate by pyruvate kinase (PK) generates 1 molecule of adenosine triphosphate (ATP) via substrate-level phosphorylation. ATP is one of the major currencies of chemical energy within cells. In gluconeogenesis, PEP is formed from the decarboxylation of oxaloacetate and hydrolysis of 1 guanosine triphosphate molecule. This reaction is catalyzed by the enzyme phosphoenolpyruvate carboxykinase (PEPCK). This reaction is a rate-limiting step in gluconeogenesis. (wikipedia).",Phosphoenolpyruvic acid,HMDB0000263,b,b,C00074,PHOSPHO-ENOL-PYRUVATE,FDB001451,pep,[H]C([H])=C(OP([O-])([O-])=O)C([O-])=O,DTBNBXWJWCWCIK-UHFFFAOYSA-K,"InChI=1S/C3H5O6P/c1-2(3(4)5)9-10(6,7)8/h1H2,(H,4,5)(H2,6,7,8)/p-3"
346,21099,D-tagaturonic acid,a,6970,KEGG COMPOUND accession,C07816,,,,,,,,,,,,,,,
347,20570,5-hydroxycamphor,A cyclic monoterpene ketone that is camphor bearing a hydroxy substituent at position 5.,28053,KEGG COMPOUND accession,C05402,,,,,,,,,,,,,,,
348,19065,1-methylinosine,Inosine carrying a methyl substituent at position 1 on the hypoxanthine ring.,17291,KEGG COMPOUND accession,C01720,,,,,,,,,,,,,,,
349,19074,"1-nitro-1,2-dihydro-1,3,5-triazine",a,6220,KEGG COMPOUND accession,C01099,,,,,,,,,,,,,,,
350,19333,"2,4,6-trichloroanisole","A monomethoxybenzene that is 1,3,5-trichlorobenzene in which one of the hydrogens is replaced by a methoxy group.",6263,KEGG COMPOUND accession,C01930,,,,,,,,,,,,,,,
351,27237,uridine phosphate,a,37396,KEGG COMPOUND accession,C00866,,,,,,,,,,,,,,,
352,27241,methyl uridin-5-yloxyacetate,A methyl ester that is uridine which is substituted at position 5 on the uracil ring by a methoxycarbonylmethoxy group.,28906,KEGG COMPOUND accession,C07090,,,,,,,,,,,,,,,
353,27247,urocanate,An monocarboxylic acid anion that is the conjugate base of urocanic acid.,16673,KEGG COMPOUND accession,C02880,,,,,,,,,,,,,,,
354,20184,3-phenanthrol,a,28193,KEGG COMPOUND accession,C10772,,,,,,,,,,,,,,,
355,20432,imidazolone,a,28460,KEGG COMPOUND accession,C02052,M02451,34612-38-9,61988.0,"Human Metabolome Database (HMDB): Maltotetraose is a normal human oligo saccharide present in plasma, but is elevated in cases of Pompe disease (PMID 15886040).",Maltotetraose,HMDB0001296,b,b,C02052,MALTOTETRAOSE,FDB001195,M02451,[H]OC([H])([H])[C@@]1([H])O[C@]([H])(O[C@@]2([H])[C@]([H])(O[H])[C@@]([H])(O[H])[C@@]([H])(O[C@@]3([H])[C@]([H])(O[H])[C@@]([H])(O[H])[C@@]([H])(O[C@@]4([H])[C@]([H])(O[H])[C@@]([H])(O[H])C([H])(O[H])O[C@]4([H])C([H])([H])O[H])O[C@]3([H])C([H])([H])O[H])O[C@]2([H])C([H])([H])O[H])[C@]([H])(O[H])[C@@]([H])(O[H])[C@]1([H])O[H],LUEWUZLMQUOBSB-AYQJAVFRSA-N,"InChI=1S/C24H42O21/c25-1-5-9(29)10(30)15(35)22(40-5)44-19-7(3-27)42-24(17(37)12(19)32)45-20-8(4-28)41-23(16(36)13(20)33)43-18-6(2-26)39-21(38)14(34)11(18)31/h5-38H,1-4H2/t5-,6-,7-,8-,9-,10+,11-,12-,13-,14-,15-,16-,17-,18-,19-,20-,21?,22-,23-,24-/m1/s1"
356,20440,4-methyl-L-glutamic acid,An amino dicarboxylic acid that is L-glutamic acid substituted by a methyl group at position 4.,75030,KEGG COMPOUND accession,C08718,,,,,,,,,,,,,,,
357,21457,N-[(9-beta-D-ribofuranosyl-2-methylthiopurin-6-yl)carbamoyl]threonine,An N-(adenosin-N(6)-ylcarbonyl)threonine in which the adenosine ring is carrying a 2-methylthio substituent.,27877,KEGG COMPOUND accession,C04904,,,,,,,,,,,,,,,
358,21787,N-seryl-glycosylphosphatidylinositolethanolamine,A glycosylphosphatidylinositolethanolamine in which the nitrogen is substituted by a seryl group.,18415,KEGG COMPOUND accession,C02718,,,,,,,,,,,,,,,
359,19252,2'-deoxyribonucleoside 3'-monophosphate,a,29155,KEGG COMPOUND accession,C02988,M02380,b,29155.0,b,L-Histidyl-tRNA(His),b,b,b,C02988,b,b,b,[H]OC([H])([H])[C@@]1([H])O[C@@]([H])([*])[C@]([H])(O[H])[C@]1([H])OP(=O)(O[H])OC([H])([H])[C@@]1([H])O[C@@]([H])([*])[C@]([H])(O[H])[C@]1([H])OP(=O)(O[H])OC([H])([H])[C@@]1([H])O[C@@]([H])([*])[C@]([H])(O[H])[C@]1([H])OC(=O)[C@@]([H])(N([H])[H])C([H])([H])C1=C([H])N([H])C([H])=N1,b,b
360,19254,purine 2'-deoxyribonucleoside,A 2'-deoxyribonucleoside that has a purine moiety as the nucleobase (the R group in the illustration).,17443,KEGG COMPOUND accession,C02427,hmcr,1190-49-4,17443.0,Human Metabolome Database (HMDB): Homocitrulline is a metabolite that can be detected in larger amounts in the urine of individuals with urea cycle disorders (OMIM 238970). The accumulation of carbamylphosphate due to depleted supply of ornithine for the urea cycle may be responsible for the enhanced synthesis of homocitrulline and homoarginine in some cases (PMID 2474087).,Homocitrulline,HMDB0000679,b,b,C02427,CPD-161,FDB022178,hmcr,[H]OC(=O)[C@@]([H])(N([H])[H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])N([H])C(=O)N([H])[H],XIGSAGMEBXLVJJ-YFKPBYRVSA-N,"InChI=1S/C7H15N3O3/c8-5(6(11)12)3-1-2-4-10-7(9)13/h5H,1-4,8H2,(H,11,12)(H3,9,10,13)/t5-/m0/s1"
361,19257,2'-deoxyribonucleoside monophosphate,a,17588,KEGG COMPOUND accession,C00155,hcys_L,454-29-5,17230.0,"Human Metabolome Database (HMDB): Homocysteine is a sulfur-containing amino acid that arises during methionine metabolism. Although its concentration in plasma is only about 10 micromolar (uM), even moderate hyperhomocysteinemia is associated with increased incidence of cardiovascular disease and Alzheimer's disease. Elevations in plasma homocysteine are commonly found as a result of vitamin deficiencies, polymorphisms of enzymes of methionine metabolism, and renal disease. Pyridoxal, folic acid, riboflavin, and Vitamin B(12) are all required for methionine metabolism, and deficiency of each of these vitamins result in elevated plasma homocysteine. A polymorphism of methylenetetrahydrofolate reductase (C677T), which is quite common in most populations with a homozygosity rate of 10-15 %, is associated with moderate hyperhomocysteinemia, especially in the context of marginal folate intake. Plasma homocysteine is inversely related to plasma creatinine in patients with renal disease. This is due to an impairment in homocysteine removal in renal disease. The role of these factors, and of modifiable lifestyle factors, in affecting methionine metabolism and in determining plasma homocysteine levels is discussed. Homocysteine is an independent cardiovascular disease (CVD) risk factor modifiable by nutrition and possibly exercise. Homocysteine was first identified as an important biological compound in 1932 and linked with human disease in 1962 when elevated urinary homocysteine levels were found in children with mental retardation. This condition, called homocysteinuria, was later associated with premature occlusive CVD, even in children. These observations led to research investigating the relationship of elevated homocysteine levels and CVD in a wide variety of populations including middle age and elderly men and women with and without traditional risk factors for CVD (PMID 17136938, 15630149). Moreover, homocysteine is found to be associated with cystathionine beta-synthase deficiency, cystathioninuria, methylenetetrahydrofolate reductase deficiency, and sulfite oxidase deficiency, which are inborn errors of metabolism.",Homocysteine,HMDB0000742,b,b,C00155,HOMO-CYS,FDB001491,hcys_L,[H]SC([H])([H])C([H])([H])[C@@]([H])(C([O-])=O)[N+]([H])([H])[H],FFFHZYDWPBMWHY-VKHMYHEASA-N,"InChI=1S/C4H9NO2S/c5-3(1-2-8)4(6)7/h3,8H,1-2,5H2,(H,6,7)/t3-/m0/s1"
362,19568,2-deoxyribose bisphosphate,a,16828,KEGG COMPOUND accession,C00078,trp_L,73-22-3,16828.0,"Human Metabolome Database (HMDB): Tryptophan is an essential amino acid that is the precursor of both serotonin and melatonin. Melatonin is a hormone that is produced by the pineal gland in animals, which regulates sleep and wakefulness. Serotonin is a brain neurotransmitter, platelet clotting factor, and neurohormone found in organs throughout the body. Metabolism of tryptophan into serotonin requires nutrients such as vitamin B6, niacin, and glutathione. Niacin (also known as vitamin B3) is an important metabolite of tryptophan. It is synthesized via kynurenine and quinolinic acids, which are products of tryptophan degradation. There are a number of conditions or diseases that are characterized tryptophan deficiencies. For instance, fructose malabsorption causes improper absorption of tryptophan in the intestine, which reduces levels of tryptophan in the blood and leads to depression. High corn or other tryptophan-deficient diets can cause pellagra, which is a niacin-tryptophan deficiency disease with symptoms of dermatitis, diarrhea, and dementia. Hartnup's disease is a disorder in which tryptophan and other amino acids are not absorbed properly. Symptoms of Hartnup's disease include skin rashes, difficulty coordinating movements (cerebellar ataxia), and psychiatric symptoms such as depression or psychosis. Tryptophan supplements may be useful for treating Hartnup's. Assessment of tryptophan deficiency is done through studying excretion of tryptophan metabolites in the urine or blood. Blood may be the most sensitive test because the amino acid tryptophan is transported in a unique way. Increased urination of tryptophan breakdown products (such as kynurenine) correlates with increased tryptophan degradation, which occurs with oral contraception, depression, mental retardation, hypertension, and anxiety states. The requirement for tryptophan and protein decreases with age. The minimum daily requirement for adults is 3 mg/kg/day or about 200 mg a day. There is 400 mg of tryptophan in a cup of wheat germ. A cup of low fat cottage cheese contains 300 mg of tryptophan and chicken and turkey contain up to 600 mg of tryptophan per pound (http://www.dcnutrition.com). Tryptophan plays a role in ""feast-induced"" drowsiness. Ingestion of a meal rich in carbohydrates triggers the release of insulin. Insulin, in turn, stimulates the uptake of large neutral branched-chain amino acids (BCAAs) into muscle, increasing the ratio of tryptophan to BCAA in the bloodstream. The increased tryptophan ratio reduces competition at the large neutral amino acid transporter (which transports both BCAAs and tryptophan), resulting in greater uptake of tryptophan across the blood-brain barrier into the cerebrospinal fluid (CSF). Once in the CSF, tryptophan is converted into serotonin and the resulting serotonin is further metabolized into melatonin by the pineal gland, which promotes sleep. Under certain situations, tryptophan can be a neurotoxin and a metabotoxin. A neurotoxin is a compound that causes damage to the brain and nerve tissues. A metabotoxin is an endogenously produced metabolite that causes adverse health effects at chronically high levels. Chronically high levels of tryptophan can be found in glutaric aciduria type I (glutaric acidemia type I or GA1). GA1 is an inherited disorder in which the body is unable to completely break down the amino acids lysine, hydroxylysine, and tryptophan. Babies with glutaric acidemia type I are often born with unusually large heads (macrocephaly). Affected individuals may also have difficulty moving and may experience spasms, jerking, rigidity or decreased muscle tone, and muscle weakness. High levels of tryptophan have also been implicated in eosinophilia-myalgia syndrome (EMS), an incurable and sometimes fatal flu-like neurological condition linked to the ingestion of large amounts of L-tryptophan. The risk of developing EMS increases with larger doses of tryptophan and increasing age. Some research suggests that certain genetic polymorphisms may be related to the development of EMS. The presence of eosinophilia is a core feature of EMS, along with unusually severe myalgia (muscle pain). It is thought that both tryptophan and certain unidentified tryptophan contaminants may contribute to EMS (PMID: 1763543). It has also been suggested that excessive tryptophan or elevation of its metabolites could play a role in amplifying some of the pathological features of EMS (PMID: 10721094). This pathological damage is further augmented by metabolites of the kynurenine pathway (a tryptophan degradation pathway).",L-Tryptophan,HMDB0000929,b,b,C00078,TRP,FDB002250,trp_L,[H]N1C([H])=C(C2=C([H])C([H])=C([H])C([H])=C12)C([H])([H])[C@@]([H])(C([O-])=O)[N+]([H])([H])[H],QIVBCDIJIAJPQS-VIFPVBQESA-N,"InChI=1S/C11H12N2O2/c12-9(11(14)15)5-7-6-13-10-4-2-1-3-8(7)10/h1-4,6,9,13H,5,12H2,(H,14,15)/t9-/m0/s1"
363,21717,N-formylglycine,An N-acylglycine resulting from the formal condensation of the amino group of glycine with formic acid.,17072,KEGG COMPOUND accession,C03139,,,,,,,,,,,,,,,
364,21726,N-glycoloyl-hexosamine,A N-acyl-hexosamine in which the acyl group specified is glycoloyl.,16820,KEGG COMPOUND accession,C03001,,,,,,,,,,,,,,,
365,21314,glutamyl phosphate,a,17741,KEGG COMPOUND accession,C03134,,,,,,,,,,,,,,,
366,21601,N-acetyl-D-hexosamine,Any N-acetylhexosamine in which the hexosamine has D-configuration. The structure provided is an illustrative example of the pyranose form of an N-acetyl-D-hexosamine.,15363,KEGG COMPOUND accession,C02298,,,,,,,,,,,,,,,
367,25699,organic ion,a,7916,KEGG COMPOUND accession,C00864,pnto_R,79-83-4,7916.0,"Human Metabolome Database (HMDB): Pantothenic acid, also called vitamin B5, is a water-soluble vitamin required to sustain life. Pantothenic acid is needed to form coenzyme-A (CoA), and is thus critical in the metabolism and synthesis of carbohydrates, proteins, and fats. Its name is derived from the Greek pantothen meaning ""from everywhere"" and small quantities of pantothenic acid are found in nearly every food, with high amounts in whole grain cereals, legumes, eggs, meat, and royal jelly.",Pantothenic acid,HMDB0000210,b,b,C00864,PANTOTHENATE,FDB011817,pnto_R,[H]OC([H])([H])C(C([H])([H])[H])(C([H])([H])[H])C([H])(O[H])C(=O)N([H])C([H])([H])C([H])([H])C([O-])=O,GHOKWGTUZJEAQD-UHFFFAOYSA-M,"InChI=1S/C9H17NO5/c1-9(2,5-11)7(14)8(15)10-4-3-6(12)13/h7,11,14H,3-5H2,1-2H3,(H,10,15)(H,12,13)/p-1"
368,25107,magnesium atom,a,16912,KEGG COMPOUND accession,C01119,dttOX,b,42147.0,Human Metabolome Database (HMDB): Oxidized dithiothreitol is part of the Ubiquinone and other terpenoid-quinone biosynthesis pathway. It is a substrate for: Vitamin K epoxide reductase complex subunit 1.,Oxidized dithiothreitol,HMDB0059664,b,b,C01119,OXIDIZED-DITHIOTHREITOL,b,b,[H]O[C@@]1([H])C([H])([H])SSC([H])([H])[C@]1([H])O[H],YPGMOWHXEQDBBV-IMJSIDKUSA-N,"InChI=1S/C4H8O2S2/c5-3-1-7-8-2-4(3)6/h3-6H,1-2H2/t3-,4-/m0/s1"
369,25111,magnesium porphyrin,a,17654,KEGG COMPOUND accession,C02177,,,,,,,,,,,,,,,
370,26375,pterins,a,8196,KEGG COMPOUND accession,C09709,,,,,,,,,,,,,,,
371,26708,sodium atom,a,28307,KEGG COMPOUND accession,C05772,pre3a,b,b,b,Precorrin 3 A,b,b,b,C05772,b,b,b,b,b,b
372,26710,sodium chloride,An inorganic chloride salt having sodium(1+) as the counterion.,27711,KEGG COMPOUND accession,C06406,pre3b,b,b,b,Precorrin 3B,b,b,b,C06406,b,b,b,b,b,b
373,26712,sodium molecular entity,a,16430,KEGG COMPOUND accession,C06407,pre4,b,b,b,Precorrin 4,b,b,b,C06407,b,b,b,b,b,b
374,26725,glucitol phosphate,a,8378,KEGG COMPOUND accession,C07369,,,,,,,,,,,,,,,
375,20476,4-sulfonatobenzoate(2-),A doubly-charged sulfonatobenzoate consisting of benzoate having a sufonato group at the 4-position.,28085,KEGG COMPOUND accession,C01728,,,,,,,,,,,,,,,
376,19760,2-phenanthrol,a,16521,KEGG COMPOUND accession,C01724,lanost,79-63-0,16521.0,"Human Metabolome Database (HMDB): Lanosterol is a tetracyclic triterpenoid which is the compound from which all steroids are derived. Lanosterol is biochemically synthesized starting from acetyl-CoA by the HMG-CoA reductase pathway. The critical step is the enzymatic conversion of the acyclic terpene squalene to the polycylic lanosterol via 2,3-squalene oxide.(wikipedia).",Lanosterin,HMDB0001251,b,b,C01724,LANOSTEROL,FDB013802,lanost,[H]O[C@@]1([H])C([H])([H])C([H])([H])[C@@]2(C3=C(C([H])([H])C([H])([H])[C@@]2([H])C1(C([H])([H])[H])C([H])([H])[H])[C@]1(C([H])([H])[H])C([H])([H])C([H])([H])[C@]([H])([C@]([H])(C([H])([H])[H])C([H])([H])C([H])([H])C([H])=C(C([H])([H])[H])C([H])([H])[H])[C@@]1(C([H])([H])[H])C([H])([H])C3([H])[H])C([H])([H])[H],CAHGCLMLTWQZNJ-BQNIITSRSA-N,"InChI=1S/C30H50O/c1-20(2)10-9-11-21(3)22-14-18-30(8)24-12-13-25-27(4,5)26(31)16-17-28(25,6)23(24)15-19-29(22,30)7/h10,21-22,25-26,31H,9,11-19H2,1-8H3/t21-,22-,25+,26+,28-,29-,30+/m1/s1"
377,23976,ethanediol,Any diol that is ethane or substituted ethane carrying two hydroxy groups.,7478,KEGG COMPOUND accession,C07792,,,,,,,,,,,,,,,
378,23997,ethyl 3-hydroxyhexanoate,A fatty acid ester that is the ethyl ester of 3-hydroxyhexanoic acid.,28705,KEGG COMPOUND accession,C09793,,,,,,,,,,,,,,,
379,24265,gluconate,a,44368,KEGG COMPOUND accession,C08042,,,,,,,,,,,,,,,
380,24267,gluconolactone,a,17997,KEGG COMPOUND accession,C00697,M02589,7727-37-9,17997.0,"Human Metabolome Database (HMDB): Elemental nitrogen is a colorless, odorless, tasteless and mostly inert diatomic gas at standard conditions, constituting 78% by volume of Earth's atmosphere. Nitrogen occurs in all living organisms. It is a constituent element of amino acids and therefore of proteins and nucleic acids (DNA and RNA). Nitrogen is found in the chemical structure of almost all neurotransmitters and is a key component of alkaloids. Specific bacteria (e.g. Rhizobium trifolium) possess nitrogenase enzymes which can fix atmospheric nitrogen into a form (ammonium ion) which is chemically useful to higher organisms. Animals use nitrogen-containing amino acids from plant sources, as starting materials for all nitrogen-compound animal biochemistry, including the manufacture of proteins and nucleic acids. Animal metabolism of NO (nitric oxide) results in production of nitrite. Animal metabolism of nitrogen in proteins generally results in excretion of urea, while animal metabolism of nucleic acids results in excretion of urea and uric acid. The characteristic odor of animal flesh decay is caused by nitrogen-containing long-chain amines, such as putrescine and cadaverine. Decay of organisms and their waste products may produce small amounts of nitrate, but most decay eventually returns nitrogen content to the atmosphere, as molecular nitrogen. The circulation of nitrogen from the atmosphere through organics and then back to the atmosphere is commonly referred to as the nitrogen cycle. Nitrogen can be measured in urine with the Kjeldahl method or by spectrophotometric methods (enzymic tests). Total urinary nitrogen is calculated based on urea urinary nitrogen quantified with these methods.",Nitrogen,HMDB0001371,b,b,C00697,NITROGEN-OXIDE,FDB013398,b,N#N,IJGRMHOSHXDMSA-UHFFFAOYSA-N,InChI=1S/N2/c1-2
381,24272,glucosaminyl group,"A glycosaminyl group obtained by removing the hydroxy group from the hemiacetal function of a glucosamine and, by extension, of a lower oligosaccharide having a glucosamine at the reducing end.",51143,KEGG COMPOUND accession,C06061,,,,,,,,,,,,,,,
382,24274,glucosaminylphosphodolichol,A polyprenyl glycosyl phosphate consisting of a glucosaminyl residue attached to dolichol phosphate.,28787,KEGG COMPOUND accession,C07455,,,,,,,,,,,,,,,
383,24980,ketotetrose phosphate,a,7799,KEGG COMPOUND accession,C08093,,,,,,,,,,,,,,,
384,26145,piperideine,a,16204,KEGG COMPOUND accession,C02183,,,,,,,,,,,,,,,
385,25167,mannosaminolactone,a,18191,KEGG COMPOUND accession,C00343,trdox,b,18191.0,b,Oxidized Thioredoxin,b,b,b,C00343,b,b,trdox,[H]N([*])[C@]([H])(C([*])=O)C([H])([H])SSC([H])([H])[C@]([H])(N([H])[*])C([*])=O,b,b
386,25195,mercury atom,a,7855,KEGG COMPOUND accession,C10116,,,,,,,,,,,,,,,
387,25197,mercury cation,a,7856,KEGG COMPOUND accession,C07360,,,,,,,,,,,,,,,
388,25205,meso-lanthionine,The meso-isomer of lanthionine. It is a key constituent of bacterial peptidoglycan type A51 and A3delta.,15379,KEGG COMPOUND accession,C00007,o2,7782-44-7,15379.0,"Human Metabolome Database (HMDB): Oxygen is the third most abundant element in the universe after hydrogen and helium and the most abundant element by mass in the Earth's crust. Diatomic oxygen gas constitutes 20.9% of the volume of air. All major classes of structural molecules in living organisms, such as proteins, carbohydrates, and fats, contain oxygen, as do the major inorganic compounds that comprise animal shells, teeth, and bone. Oxygen in the form of O2 is produced from water by cyanobacteria, algae and plants during photosynthesis and is used in cellular respiration for all living organisms. Green algae and cyanobacteria in marine environments provide about 70% of the free oxygen produced on earth and the rest is produced by terrestrial plants. Oxygen is used in mitochondria to help generate adenosine triphosphate (ATP) during oxidative phosphorylation. For animals, a constant supply of oxygen is indispensable for cardiac viability and function. To meet this demand, an adult human, at rest, inhales 1.8 to 2.4 grams of oxygen per minute. This amounts to more than 6 billion tonnes of oxygen inhaled by humanity per year. At a resting pulse rate, the heart consumes approximately 8-15 ml O2/min/100 g tissue. This is significantly more than that consumed by the brain (approximately 3 ml O2/min/100 g tissue) and can increase to more than 70 ml O2/min/100 g myocardial tissue during vigorous exercise. As a general rule, mammalian heart muscle cannot produce enough energy under anaerobic conditions to maintain essential cellular processes; thus, a constant supply of oxygen is indispensable to sustain cardiac function and viability. However, the role of oxygen and oxygen-associated processes in living systems is complex, and they and can be either beneficial or contribute to cardiac dysfunction and death (through reactive oxygen species). Reactive oxygen species (ROS) are a family of oxygen-derived free radicals that are produced in mammalian cells under normal and pathologic conditions. Many ROS, such as the superoxide anion (O2-)and hydrogen peroxide (H2O2), act within blood vessels, altering mechanisms mediating mechanical signal transduction and autoregulation of cerebral blood flow. Reactive oxygen species are believed to be involved in cellular signaling in blood vessels in both normal and pathologic states. The major pathway for the production of ROS is by way of the one-electron reduction of molecular oxygen to form an oxygen radical, the superoxide anion (O2-). Within the vasculature there are several enzymatic sources of O2-, including xanthine oxidase, the mitochondrial electron transport chain, and nitric oxide (NO) synthases. Studies in recent years, however, suggest that the major contributor to O2- levels in vascular cells is the membrane-bound enzyme NADPH-oxidase. Produced O2- can react with other radicals, such as NO, or spontaneously dismutate to produce hydrogen peroxide (H2O2). In cells, the latter reaction is an important pathway for normal O2- breakdown and is usually catalyzed by the enzyme superoxide dismutase (SOD). Once formed, H2O2 can undergo various reactions, both enzymatic and nonenzymatic. The antioxidant enzymes catalase and glutathione peroxidase act to limit ROS accumulation within cells by breaking down H2O2 to H2O. Metabolism of H2O2 can also produce other, more damaging ROS. For example, the endogenous enzyme myeloperoxidase uses H2O2 as a substrate to form the highly reactive compound hypochlorous acid. Alternatively, H2O2 can undergo Fenton or Haber-Weiss chemistry, reacting with Fe2+/Fe3+ ions to form toxic hydroxyl radicals (-.OH). (PMID: 17027622, 15765131).",Oxygen,HMDB0001377,b,b,C00007,OXYGEN-MOLECULE,FDB022589,o2,O=O,MYMOFIZGZYHOMD-UHFFFAOYSA-N,InChI=1S/O2/c1-2
389,26437,pyrimidine nucleoside diphosphate,a,8228,KEGG COMPOUND accession,C07675,,,,,,,,,,,,,,,
390,26447,pyrimidinemonocarboxylic acid,a,8233,KEGG COMPOUND accession,C07361,,,,,,,,,,,,,,,
391,26455,pyrroles,An azole that includes only one N atom and no other heteroatom as a part of the aromatic skeleton.,47858,KEGG COMPOUND accession,C06181,pprdn,b,47858.0,b,Piperideine,b,b,b,C06181,b,b,b,b,b,"InChI=1S/C5H9N/c1-2-4-6-5-3-1/h4H,1-3,5H2"
392,24043,flavones,A member of the class of flavonoid with a 2-aryl-1-benzopyran-4-one (2-arylchromen-4-one) skeleton and its substituted derivatives.,7508,KEGG COMPOUND accession,C01737,,,,,,,,,,,,,,,
393,24060,fluoride salt,a,32446,KEGG COMPOUND accession,C08606,,,,,,,,,,,,,,,
394,24062,fluorine molecular entity,a,7518,KEGG COMPOUND accession,C09791,,,,,,,,,,,,,,,
395,24070,fluorobenzoate,a,7522,KEGG COMPOUND accession,C08876,,,,,,,,,,,,,,,
396,24072,fluorobenzoyl-CoA,Any member of the class of benzoyl-CoAs having fluorobenzoyl as the aroyl substituent.,29452,KEGG COMPOUND accession,C09871,,,,,,,,,,,,,,,
397,24326,glutaramic acid,A dicarboxylic acid monoamide that is formally derived from glutaric acid by conversion of one of the two carboxylic acid groups to the corresponding amide.,7621,KEGG COMPOUND accession,C11810,,,,,,,,,,,,,,,
398,24347,glycerates,a,7632,KEGG COMPOUND accession,C10087,,,,,,,,,,,,,,,
399,25986,phenylalanino group,a,71416,KEGG COMPOUND accession,C07429,,,,,,,,,,,,,,,
400,26536,retinoic acid,"A retinoid consisting of 3,7-dimethylnona-2,4,6,8-tetraenoic acid substituted at position 9 by a 2,6,6-trimethylcyclohex-1-en-1-yl group (geometry of the four exocyclic double bonds is not specified).",28688,KEGG COMPOUND accession,C08832,,,,,,,,,,,,,,,
401,26544,rhamnonate,a,50305,KEGG COMPOUND accession,C10874,,,,,,,,,,,,,,,
402,26548,rhamnosylglucoside,a,27901,KEGG COMPOUND accession,C10876,,,,,,,,,,,,,,,
403,26561,ribonucleotide,a,16051,KEGG COMPOUND accession,C00653,,,,,,,,,,,,,,,
404,26573,ribulose phosphate,a,8298,KEGG COMPOUND accession,C11552,,,,,,,,,,,,,,,
405,26841,synthetic auxin,A synthetic compound exhibiting auxin activity.,8426,KEGG COMPOUND accession,C07372,,,,,,,,,,,,,,,
406,24278,glucoside,a,27986,KEGG COMPOUND accession,C06876,,,,,,,,,,,,,,,
407,24280,D-glucosyl group,The glucosyl group formed from D-glucopyranose.,17045,KEGG COMPOUND accession,C00887,,,,,,,,,,,,,,,
408,24108,fructosylglycine,a,63613,KEGG COMPOUND accession,C07263,,,,,,,,,,,,,,,
409,24111,fructoside,a,27960,KEGG COMPOUND accession,C03417,,,,,,,,,,,,,,,
410,24112,fructuronate,a,7549,KEGG COMPOUND accession,C04337,,,,,,,,,,,,,,,
411,24113,fructuronic acid,a,7550,KEGG COMPOUND accession,C07264,,,,,,,,,,,,,,,
412,24117,fuconolactone,a,28112,KEGG COMPOUND accession,C00291,,,,,,,,,,,,,,,
413,24126,(E)-3-carboxyprop-2-enoyl group,a,17154,KEGG COMPOUND accession,C00153,ncam,98-92-0,17154.0,"Human Metabolome Database (HMDB): Niacinamide or vitamin B3 is an important compound functioning as a component of the coenzyme NAD. Its primary significance is in the prevention and/or cure of blacktongue and pellagra. Most animals cannot manufacture this compound in amounts sufficient to prevent nutritional deficiency and it therefore must be supplemented through dietary intake. Niacinamide is used to increase the effect of radiation therapy on tumor cells. Niacin (nicotinic acid) and niacinamide, while both labeled as vitamin B3 also have different applications. Niacinamide is useful in arthritis and early-onset type I diabetes while niacin is an effective reducer of high cholesterol levels.",Niacinamide,HMDB0001406,b,b,C00153,NIACINAMIDE,FDB012485,ncam,[H]N([H])C(=O)C1=C([H])C([H])=C([H])N=C1[H],DFPAKSUCGFBDDF-UHFFFAOYSA-N,"InChI=1S/C6H6N2O/c7-6(9)5-2-1-3-8-4-5/h1-4H,(H2,7,9)"
414,24182,gallotannin,A class of hydrolysable tannins obtained by condensation of the carboxy group of gallic acid (and its polymeric derivatives) with the hydroxy groups of a monosaccharide (most commonly glucose).,7565,KEGG COMPOUND accession,C07266,hnifedipine,21829-25-4,7565.0,"Human Metabolome Database (HMDB): Nifedipine has been formulated as both a long- and short-acting 1,4-dihydropyridine calcium channel blocker. It acts primarily on vascular smooth muscle cells by stabilizing voltage-gated L-type calcium channels in their inactive conformation. By inhibiting the influx of calcium in smooth muscle cells, nifedipine prevents calcium-dependent myocyte contraction and vasoconstriction. A second proposed mechanism for the drug's vasodilatory effects involves pH-dependent inhibition of calcium influx via inhibition of smooth muscle carbonic anhydrase. Nifedipine is used to treat hypertension and chronic stable angina.",Nifedipine,HMDB0015247,b,b,C07266,b,b,hnifedipine,[H]N1C(=C(C(=O)OC([H])([H])[H])C([H])(C2=C(C([H])=C([H])C([H])=C2[H])[N+]([O-])=O)C(C(=O)OC([H])([H])[H])=C1C([H])([H])[H])C([H])([H])[H],HYIMSNHJOBLJNT-UHFFFAOYSA-N,"InChI=1S/C17H18N2O6/c1-9-13(16(20)24-3)15(14(10(2)18-9)17(21)25-4)11-7-5-6-8-12(11)19(22)23/h5-8,15,18H,1-4H3"
415,24182,gallotannin,A class of hydrolysable tannins obtained by condensation of the carboxy group of gallic acid (and its polymeric derivatives) with the hydroxy groups of a monosaccharide (most commonly glucose).,7565,KEGG COMPOUND accession,C07266,nifedipine,21829-25-4,7565.0,b,Nifedipine,b,b,b,C07266,b,b,nifedipine,[H]N1C(=C(C(=O)OC([H])([H])[H])C([H])(C2=C(C([H])=C([H])C([H])=C2[H])[N+]([O-])=O)C(C(=O)OC([H])([H])[H])=C1C([H])([H])[H])C([H])([H])[H],HYIMSNHJOBLJNT-UHFFFAOYSA-N,"InChI=1S/C17H18N2O6/c1-9-13(16(20)24-3)15(14(10(2)18-9)17(21)25-4)11-7-5-6-8-12(11)19(22)23/h5-8,15,18H,1-4H3"
416,24190,gamma-glutamyl group,a,7569,KEGG COMPOUND accession,C11609,,,,,,,,,,,,,,,
417,24221,"3,7-dimethylocta-2,6-dien-1-ol",a,7581,KEGG COMPOUND accession,C07487,,,,,,,,,,,,,,,
418,26845,tagaturonic acid,a,8428,KEGG COMPOUND accession,C07401,,,,,,,,,,,,,,,
419,26849,tartaric acid,a,8430,KEGG COMPOUND accession,C07375,,,,,,,,,,,,,,,
420,21622,N-acetylneuraminic acids,a,17012,KEGG COMPOUND accession,C00270,,,,,,,,,,,,,,,
421,21638,N-acylglucosamine,a,18163,KEGG COMPOUND accession,C04927,gd1a_hs,b,18163.0,b,N-Acetylneuraminosyl-D-Galactosyl-N-Acetyl-D-Galactosaminyl-(N-Acetylneuraminosyl)-D-Galactosyl-D-Glucosylceramide Dianion,b,b,b,C04927,b,b,gd1a_hs,[H]OC([H])([H])[C@@]([H])(O[H])[C@@]([H])(O[H])C1([H])O[C@@](O[C@]2([H])[C@@]([H])(O[H])[C@]([H])(O[C@@]3([H])[C@@]([H])(O[H])[C@]([H])(O[C@@]([H])(O[C@@]4([H])[C@]([H])(O[C@@]([H])(O[C@@]5([H])[C@]([H])(O[H])[C@@]([H])(O[H])[C@]([H])(OC([H])([H])[C@]([H])(N([H])C([*])=O)[C@]([H])(O[H])C(\[H])=C(/[H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H])O[C@]5([H])C([H])([H])O[H])[C@]([H])(O[H])[C@@]4([H])O[C@]4(OC([H])([C@]([H])(O[H])[C@]([H])(O[H])C([H])([H])O[H])[C@]([H])(N([H])C(=O)C([H])([H])[H])[C@@]([H])(O[H])C4([H])[H])C([O-])=O)C([H])([H])O[H])[C@]3([H])N([H])C(=O)C([H])([H])[H])C([H])([H])O[H])O[C@]([H])(C([H])([H])O[H])[C@]2([H])O[H])(C([O-])=O)C([H])([H])[C@]([H])(O[H])[C@@]1([H])N([H])C(=O)C([H])([H])[H],b,b
422,20832,9-phenanthryl sulfate,a,6851,KEGG COMPOUND accession,C01223,,,,,,,,,,,,,,,
423,20838,9-ribosylzeatin,An N-glycosylzeatin that is zeatin in which the hydrogen attached to the nitrogen at position 9 of the adenine moiety is replaced by a beta-D-ribofuranosyl group.,17540,KEGG COMPOUND accession,C03619,,,,,,,,,,,,,,,
424,20853,AMP-sugar,a,17512,KEGG COMPOUND accession,C04698,,,,,,,,,,,,,,,
425,20855,ATP-sugar,a,6863,KEGG COMPOUND accession,C07640,,,,,,,,,,,,,,,
426,21885,N(6)-glycyl-L-lysine,A L-lysine derivative with a glycyl group at the N(6)-position.,18123,KEGG COMPOUND accession,C01004,,,,,,,,,,,,,,,
427,21911,N(alpha)-methyl-L-histidines,A  N-methyl-L-alpha-amino acid that is L-histidine in which at least one of the amino hydrogens has been replaced by a methyl group.,32989,KEGG COMPOUND accession,C03624,,,,,,,,,,,,,,,
428,18859,"1,2,3-tribromopropane",a,17100,KEGG COMPOUND accession,C01114,,,,,,,,,,,,,,,
429,26645,semiochemical,A molecular messenger released by an organism that affects the behaviour within or between species.,8337,KEGG COMPOUND accession,C05113,,,,,,,,,,,,,,,
430,26916,tetrahydronicotinamide adenine dinucleotide,a,8459,KEGG COMPOUND accession,C07379,,,,,,,,,,,,,,,
431,20909,D-arabinarate(1-),a,6877,KEGG COMPOUND accession,C10478,,,,,,,,,,,,,,,
432,20656,5alpha-pregnane,a,27969,KEGG COMPOUND accession,C06028,mescoa,b,27969.0,Human Metabolome Database (HMDB): This compound belongs to the family of Acyl CoAs. These are organic compounds contaning a coenzyme A substructure linked to another moeity through an ester bond.,Mesaconyl-CoA,HMDB0060124,b,b,C06028,CPD-9408,b,mescoa,[H]O[C@@]([H])(C(=O)N([H])C([H])([H])C([H])([H])C(=O)N([H])C([H])([H])C([H])([H])SC(=O)C(=C(/[H])C([O-])=O)\C([H])([H])[H])C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])OP([O-])(=O)OP([O-])(=O)OC([H])([H])[C@@]1([H])O[C@@]([H])(N2C([H])=NC3=C(N=C([H])N=C23)N([H])[H])[C@]([H])(O[H])[C@]1([H])OP([O-])([O-])=O,LVBVWNJPMXCQJE-CBBDEUQJSA-I,"InChI=1S/C26H40N7O19P3S/c1-13(8-16(35)36)25(40)56-7-6-28-15(34)4-5-29-23(39)20(38)26(2,3)10-49-55(46,47)52-54(44,45)48-9-14-19(51-53(41,42)43)18(37)24(50-14)33-12-32-17-21(27)30-11-31-22(17)33/h8,11-12,14,18-20,24,37-38H,4-7,9-10H2,1-3H3,(H,28,34)(H,29,39)(H,35,36)(H,44,45)(H,46,47)(H2,27,30,31)(H2,41,42,43)/p-5/b13-8+/t14-,18-,19-,20+,24-/m1/s1"
433,20659,5beta-androstane,The 5beta-stereoisomer of androstane.,28346,KEGG COMPOUND accession,C06546,,,,,,,,,,,,,,,
434,22024,S-12-hydroxyfarnesyl-L-cysteine,"An L-cysteine thioether that is S-(2E,6E)-farnesyl-L-cysteine bearing a hydroxy substituent on the pro-Z-methyl group at the 12-position.",17358,KEGG COMPOUND accession,C02726,,,,,,,,,,,,,,,
435,20725,6-hydroxydopa,a,16183,KEGG COMPOUND accession,C01438,ch4,74-82-8,16183.0,"Human Metabolome Database (HMDB): Methane (CH4), is a gas produced by a group of colonic anaerobes, absorbed from the colon and excreted in expired air. As a result, breath CH4 excretion can be used as an indicator of the in situ activity of the methanogenic flora. All CH4 produced in human beings is a metabolic product of intestinal bacteria, and about 50% of CH4 produced in the gut is absorbed and excreted in expired air. Because there appears to be no catabolism of this gas by other colonic organisms or host cells, breath CH4 measurements provide a rapid, simple means of semi quantitatively assessing the ongoing in situ metabolism of the methanogenic flora. It could seem likely that the intracolonic activity of a variety of bacteria similarly might be assessed quantitatively via analysis of expired air. However, the application of this methodology has been confounded by the rapid catabolism of many volatile bacterial products by other bacteria or human tissue. A striking aspect of the studies of breath CH4 measurements is the enormous individual variations in the excretion of this gas. Virtually all children under 5 years of age and 66% of the adult population do not exhale appreciable quantities of CH4. The remaining 34% of the adult population has appreciable breath methane concentrations of up to 80 ppm (mean, 15.2 ppm; median, 11.8 ppm). On this basis the population can be divided into CH4 producers or nonproducers, although a more accurate term would be to define subjects as being low or high CH4 producers. The primary methanogen present in the human colon, Methanobrevibacter smithii, produces methane via a reaction that relies entirely on H2 produced by other organisms to reduce CO2 to CH4. Thus, breath CH4 concentrations might be expected to mirror breath H2 concentrations; however, the high levels of CH4 observed in the fasting state may result from H2 derived from endogenous rather than dietary substrates. A diverse assortment of conditions has been associated with a high prevalence of methane producers including diverticulosis, cystic fibrosis, high fasting serum cholesterol levels, encopresis in children, and aorto-iliac vascular disease, whereas obesity (measured as skin-fold thickness) was related inversely to methane production. The challenge that remains is to determine to what extent methanogens actively influence body physiology vs. simply serve as passive indicators of colonic function. (PMID: 16469670, Clinical Gastroenterology and Hepatology Volume 4, Issue 2, February 2006, Pages 123-129).",Methane,HMDB0002714,b,b,C01438,CH4,FDB023051,b,b,VNWKTOKETHGBQD-UHFFFAOYSA-N,InChI=1S/CH4/h1H4
436,25704,organic sulfate,Compounds of the general formula SO3HOR where R is an organyl group,27373,KEGG COMPOUND accession,C05944,,,,,,,,,,,,,,,
437,25706,organomercury compound,A compound containing at least one carbon-mercury bond.,28241,KEGG COMPOUND accession,C06533,,,,,,,,,,,,,,,
438,25710,organophosphorus compound,"An organophosphorus compound is formally a compound containing at least one carbon-phosphorus bond, but the term is often extended to include esters and thioesters.",27909,KEGG COMPOUND accession,C07834,,,,,,,,,,,,,,,
439,25717,organotin compound,a,27827,KEGG COMPOUND accession,C06606,,,,,,,,,,,,,,,
440,26971,thionucleotide,a,8478,KEGG COMPOUND accession,C02876,,,,,,,,,,,,,,,
441,25996,phenylhydrazines,Any member of the class of  hydrazines carrying a phenyl substituent.,8062,KEGG COMPOUND accession,C10484,,,,,,,,,,,,,,,
442,26036,phosphatidylinositol monophosphate,a,8075,KEGG COMPOUND accession,C02181,,,,,,,,,,,,,,,
443,24353,glycerol ether,Any ether having glyceryl as at least one of the O-substituents.,7635,KEGG COMPOUND accession,C10379,,,,,,,,,,,,,,,
444,21264,L-cysteine glutathione disulfide,An organic disulfide that is the L-cysteinyl derivative of glutathione.,17221,KEGG COMPOUND accession,C06074,,,,,,,,,,,,,,,
445,24532,organic heterocyclic compound,A cyclic compound having as ring members atoms of carbon and at least of one other element.,27549,KEGG COMPOUND accession,C05031,,,,,,,,,,,,,,,
446,25798,oxopentanoates,The conjugate base of any oxopentanoic acid.,17334,KEGG COMPOUND accession,C00395,,,,,,,,,,,,,,,
447,25812,ozone,"An elemental molecule with formula O3. An explosive, pale blue gas (b.p. -112degreeC) that has a characteristic, pleasant odour, it is continuously produced in the upper atmosphere by the action of solar ultraviolet radiation on atmospheric oxygen. It is an antimicrobial agent used in the production of bottled water, as well as in the treatment of meat, poultry and other foodstuffs.",7969,KEGG COMPOUND accession,C11746,,,,,,,,,,,,,,,
448,24621,hormone,"Originally referring to an endogenous compound that is formed in specialized organ or group of cells and carried to another organ or group of cells, in the same organism, upon which it has a specific regulatory function, the term is now commonly used to include non-endogenous, semi-synthetic and fully synthetic analogues of such compounds.",28285,KEGG COMPOUND accession,C11311,,,,,,,,,,,,,,,
449,25882,dihydrotricetin,"A pentahydroxyflavanone that is flavanone substituted by hydroxy groups at positions 5, 7, 3', 4' and 5'.",8005,KEGG COMPOUND accession,C00889,,,,,,,,,,,,,,,
450,26863,teasterone,a,15425,KEGG COMPOUND accession,C06658,,,,,,,,,,,,,,,
451,26889,tetrachlorocatechol,A chlorocatechol that is catechol in which all of the hydrogens attached to the benzene ring are replaced by chlorines.,8450,KEGG COMPOUND accession,C10986,,,,,,,,,,,,,,,
452,26893,tetracyclic triterpenoid,Any triterpenoid consisting of a tetracyclic skeleton.,8452,KEGG COMPOUND accession,C11181,,,,,,,,,,,,,,,
453,24685,hydroxybutanoyl-CoA,Any member of the class of  butanoyl-CoAs having hydroxybutanoyl as the acyl substituent.,69437,KEGG COMPOUND accession,C10510,,,,,,,,,,,,,,,
454,24698,hydroxyflavone,Any flavone in which one or more ring hydrogens are replaced by hydroxy groups.,7789,KEGG COMPOUND accession,C07935,,,,,,,,,,,,,,,
455,26094,benzenedicarboxylic acid,A member of the class of benzoic acids in that consists of benzene substituted by two carboxy groups (A closed class).,27924,KEGG COMPOUND accession,C02304,,,,,,,,,,,,,,,
456,24433,group,A defined linked collection of atoms or a single atom within a molecular entity.,17981,KEGG COMPOUND accession,C00979,acser,66638-22-0,17981.0,Human Metabolome Database (HMDB): O-Acetylserine (OASS) is an acylated amino acid derivative. It is an intermediate in the biosynthesis of the common amino acid cysteine in bacteria and plants. Its presence in humans arises from either microbial metabolism in the gut or through consumption of foods containing OASS.,O-Acetyl-L-serine,HMDB0003011,b,b,C00979,b,b,b,b,b,b
457,25604,nucleotide-(amino alcohol)s,a,70007,KEGG COMPOUND accession,C10117,,,,,,,,,,,,,,,
458,25608,nucleoside phosphate,A nucleobase-containing molecular entity that is a nucleoside in which one or more of the sugar hydroxy groups has been converted into a mono- or poly-phosphate. The term includes both nucleotides and non-nucleotide nucleoside phosphates.,45863,KEGG COMPOUND accession,C07394,taxol,33069-62-4,45863.0,"Human Metabolome Database (HMDB): A cyclodecane isolated from the bark of the Pacific yew tree, TAXUS brevifolia. It stabilizes microtubules in their polymerized form leading to cell death. [PubChem] ABI-007 (Abraxane) is the latest attempt to improve upon paclitaxel, one of the leading chemotherapy treatments. Both drugs contain the same active agent, but Abraxane is delivered by a nanoparticle technology that binds to albumin, a natural protein, rather than the toxic solvent known as Cremophor. It is thought that delivering paclitaxel with this technology will cause fewer hypersensitivity reactions and possibly lead to greater drug uptake in tumors.",Paclitaxel,HMDB0015360,b,b,C07394,b,b,taxol,[H]O[C@@]([H])(C(=O)O[C@]1([H])C(=C2[C@@]([H])(OC(=O)C([H])([H])[H])C(=O)[C@]3(C([H])([H])[H])[C@@]([H])(O[H])C([H])([H])[C@@]4([H])OC([H])([H])[C@@]4(OC(=O)C([H])([H])[H])[C@@]3([H])[C@]([H])(OC(=O)C3=C([H])C([H])=C([H])C([H])=C3[H])[C@](O[H])(C1([H])[H])C2(C([H])([H])[H])C([H])([H])[H])C([H])([H])[H])[C@@]([H])(N([H])C(=O)C1=C([H])C([H])=C([H])C([H])=C1[H])C1=C([H])C([H])=C([H])C([H])=C1[H],RCINICONZNJXQF-MZXODVADSA-N,"InChI=1S/C47H51NO14/c1-25-31(60-43(56)36(52)35(28-16-10-7-11-17-28)48-41(54)29-18-12-8-13-19-29)23-47(57)40(61-42(55)30-20-14-9-15-21-30)38-45(6,32(51)22-33-46(38,24-58-33)62-27(3)50)39(53)37(59-26(2)49)34(25)44(47,4)5/h7-21,31-33,35-38,40,51-52,57H,22-24H2,1-6H3,(H,48,54)/t31-,32-,33+,35-,36+,37+,38-,40-,45+,46-,47+/m0/s1"
459,25935,hydroperoxyl,a,28194,KEGG COMPOUND accession,C08363,,,,,,,,,,,,,,,
460,25953,"3,4-phenanthrenediyl bissulfate",a,8041,KEGG COMPOUND accession,C09527,,,,,,,,,,,,,,,
461,25962,phenanthrol,a,17465,KEGG COMPOUND accession,C05229,,,,,,,,,,,,,,,
462,26935,tetraterpenoid,Any terpenoid derived from a tetraterpene. The term includes compounds in which the C40 skeleton of the parent tetraterpene has been rearranged or modified by the removal of one or more skeletal atoms (generally methyl groups).,17153,KEGG COMPOUND accession,C00479,,,,,,,,,,,,,,,
463,26952,thioacetic acid,a,28831,KEGG COMPOUND accession,C05979,,,,,,,,,,,,,,,
464,24472,halohydrocarbon,A compound derived from a hydrocarbon by replacing a hydrogen atom with a halogen atom.,18013,KEGG COMPOUND accession,C02572,,,,,,,,,,,,,,,
465,24508,heparitins,a,28867,KEGG COMPOUND accession,C03017,pcrn,17298-37-2,28867.0,"Human Metabolome Database (HMDB): Propionylcarnitine is present in high abundance in the urine of patients with Methylmalonyl-CoA mutase (MUT) deficiency, (together with Methylmalonic acid). MUT is a mitochondrial enzyme that catalyzes the isomerization of methylmalonyl-CoA to succinyl-CoA (OMIM 609058 ). Propionylcarnitine is found to be associated with propionic acidemia, which is an inborn error of metabolism.",Propionylcarnitine,HMDB0000824,b,b,C03017,b,FDB022268,pcrn,[H]C([H])([H])C([H])([H])C(=O)OC([H])(C([H])([H])C([O-])=O)C([H])([H])[N+](C([H])([H])[H])(C([H])([H])[H])C([H])([H])[H],UFAHZIUFPNSHSL-UHFFFAOYSA-N,"InChI=1S/C10H19NO4/c1-5-10(14)15-8(6-9(12)13)7-11(2,3)4/h8H,5-7H2,1-4H3"
466,21484,N-(indole-3-acetyl)-L-aspartic acid,An N-acyl-L-aspartic acid in which the acyl group is specified as indole-3-acetyl.,28110,KEGG COMPOUND accession,C03776,,,,,,,,,,,,,,,
467,21498,N-acetyl-7-O-acetylneuraminic acid,a,17533,KEGG COMPOUND accession,C00624,acglu,1188-37-0,12575.0,"Human Metabolome Database (HMDB): N-acetylglutamic acid is an acetylated amino acid. N-Acetylglutamic acid (abbreviated NAcGlu) is biosynthesized from glutamic acid and acetyl-CoA by the enzyme N-acetylglutamate synthase (NAGS). NAcGlu activates carbamoyl phosphate synthetase in the urea cycle. A deficiency in N-Acetyl Glutamate Synthase or a genetic mutation in the gene coding for the enzyme, will lead to urea cycle failure in which ammonia is not converted to urea, but rather accumulated in blood leading to the condition called Type I Hyperammonemia. This is a severe neonatal disorder with fatal consequences, if not detected immediately upon birth.",N-Acetylglutamic acid,HMDB0001138,b,b,C00624,ACETYL-GLU,FDB022447,acglu,[H]N(C(=O)C([H])([H])[H])[C@]([H])(C([O-])=O)C([H])([H])C([H])([H])C([O-])=O,RFMMMVDNIPUKGG-YFKPBYRVSA-L,"InChI=1S/C7H11NO5/c1-4(9)8-5(7(12)13)2-3-6(10)11/h5H,2-3H2,1H3,(H,8,9)(H,10,11)(H,12,13)/p-2/t5-/m0/s1"
468,21347,L-lanthionine,The L-enantiomer of lanthionine.,16780,KEGG COMPOUND accession,C01255,,,,,,,,,,,,,,,
469,19168,17-oxo steroid,Any  oxo steroid carrying the oxo group at position 17.,17232,KEGG COMPOUND accession,C01165,glu5sa,496-92-4,17232.0,"Human Metabolome Database (HMDB): Glutamic gamma-semialdehyde is the metabolic precursor for proline biosynthesis. The conversion from L-Glutamate, an ATP- and NADPH-dependent reaction, is catalyzed by the enzyme Delta-1-pyrroline-5-carboxylate synthetase (P5CS) (OMIM 138250). L-Glutamic-gamma-semialdehyde can also be converted to or be formed from the amino acids L-ornithine (EC 2.6.1.13) and L-proline (EC 1.5.99.8 and EC 1.5.1.2). It is also one of the few metabolites that can be a precursor to other metabolites of both the urea cycle and the citric acid cycle (BioCyc).",L-Glutamic gamma-semialdehyde,HMDB0002104,b,b,C01165,L-GLUTAMATE_GAMMA-SEMIALDEHYDE,FDB022847,glu5sa,[H]C(=O)C([H])([H])C([H])([H])[C@@]([H])(C([O-])=O)[N+]([H])([H])[H],KABXUUFDPUOJMW-BYPYZUCNSA-N,"InChI=1S/C5H9NO3/c6-4(5(8)9)2-1-3-7/h3-4H,1-2,6H2,(H,8,9)/t4-/m0/s1"
470,19543,2-dehydro-L-idonic acid,a,16542,KEGG COMPOUND accession,C03872,,,,,,,,,,,,,,,
471,20408,"4-hydroxylamino-2,6-dinitrotoluene","A member of the class of nitrotoluenes that is 2,6-dinitrotoluene bearing an additional hydroxylamino substituent at position 4.",6664,KEGG COMPOUND accession,C05622,,,,,,,,,,,,,,,
472,19290,"2,22,25-trideoxyecdysone","A 3beta-hydroxy steroid that is 5beta-cholestane containing a double bond between positions 7 and 8, and substituted by an oxo group at position 6 and by hydroxy groups at the 3beta and 14alpha positions.",27890,KEGG COMPOUND accession,C03126,,,,,,,,,,,,,,,
473,19297,"2,3,5-trichloromaleylacetic acid",a,17191,KEGG COMPOUND accession,C00407,ile_L,73-32-5,17191.0,"Human Metabolome Database (HMDB): Branched chain amino acids (BCAA) are essential amino acids whose carbon structure is marked by a branch point. These three amino acids are critical to human life and are particularly involved in stress, energy and muscle metabolism. BCAA supplementation as therapy, both oral and intravenous, in human health and disease holds great promise. ""BCAA"" denotes valine, isoleucine and leucine which are branched chain essential amino acids. Despite their structural similarities, the branched amino acids have different metabolic routes, with valine going solely to carbohydrates, leucine solely to fats and isoleucine to both. The different metabolism accounts for different requirements for these essential amino acids in humans: 12 mg/kg, 14 mg/kg and 16 mg/kg of valine, leucine and isoleucine respectively. Furthermore, these amino acids have different deficiency symptoms. Valine deficiency is marked by neurological defects in the brain, while isoleucine deficiency is marked by muscle tremors. BCAA are decreased in patients with liver disease, such as hepatitis, hepatic coma, cirrhosis, extrahepatic biliary atresia or portacaval shunt; aromatic amino acids (AAA)-tyrosine, tryptophan and phenylalanine, as well as methionine-are increased in these conditions. Valine, in particular, has been established as a useful supplemental therapy to the ailing liver. All the BCAA probably compete with AAA for absorption into the brain. Supplemental BCAA with vitamin B6 and zinc help normalize the BCAA:AAA ratio. The BCAA are not without side effects. Leucine alone, for example, exacerbates pellagra and can cause psychosis in pellagra patients by increasing excretion of niacin in the urine. Leucine may lower brain serotonin and dopamine. A dose of 3 g of isoleucine added to the niacin regime has cleared leucine-aggravated psychosis in schizophrenic patients. Isoleucine may have potential as an antipsychotic treatment. Leucine is more highly concentrated in foods than other amino acids. A cup of milk contains 800 mg of leucine and only 500 mg of isoleucine and valine. A cup of wheat germ has about 1.6 g of leucine and 1 g of isoleucine and valine. The ratio evens out in eggs and cheese. One egg and an ounce of most cheeses each contain about 400 mg of leucine and 400 mg of valine and isoleucine. The ratio of leucine to other BCAA is greatest in pork, where leucine is 7 to 8 g and the other BCAA together are only 3 to 4 g (http://www.dcnutrition.com). Moreover, L-isoleucine is found to be associated with maple syrup urine disease, which is an inborn error of metabolism.",L-Isoleucine,HMDB0000172,b,b,C00407,ILE,FDB012397,ile_L,[H]C([H])([H])C([H])([H])[C@]([H])(C([H])([H])[H])[C@@]([H])(C([O-])=O)[N+]([H])([H])[H],AGPKZVBTJJNPAG-WHFBIAKZSA-N,"InChI=1S/C6H13NO2/c1-3-4(2)5(7)6(8)9/h4-5H,3,7H2,1-2H3,(H,8,9)/t4-,5-/m0/s1"
474,20502,"5,10-methylenetetrahydrofolic acid",a,6701,KEGG COMPOUND accession,C10606,,,,,,,,,,,,,,,
475,21354,methyl L-lysinate,The L-lysyl ester formed by conjugating L-lysine with methanol.,15569,KEGG COMPOUND accession,C06382,,,,,,,,,,,,,,,
476,21358,L-mannarate(1-),A mannarate(1-) that is the conjugate base of L-mannaric acid.,16481,KEGG COMPOUND accession,C06384,,,,,,,,,,,,,,,
477,19480,2-bromomaleylacetate,a,17937,KEGG COMPOUND accession,C02991,,,,,,,,,,,,,,,
478,26391,purine nucleoside diphosphate,a,8205,KEGG COMPOUND accession,C09528,,,,,,,,,,,,,,,
479,26410,pyrazoles,a,17187,KEGG COMPOUND accession,C06077,,,,,,,,,,,,,,,
480,26414,pyridazinone,a,8217,KEGG COMPOUND accession,C10165,,,,,,,,,,,,,,,
481,26420,pyridinemonocarboxylic acid,A monocarboxylic acid in which the carboxy group is attached to a pyridine (or substituted pyridine) ring.,28996,KEGG COMPOUND accession,C09884,,,,,,,,,,,,,,,
482,26668,sialosyl group,A glycosyl group derived by removal of the exomeric hydroxy group from any of the sialic acids.,8349,KEGG COMPOUND accession,C06784,,,,,,,,,,,,,,,
483,26670,sialoyl group,The acyl group derived from any of the sialic acids by removal of the hydroxy group from its carboxy group.,8351,KEGG COMPOUND accession,C06786,,,,,,,,,,,,,,,
484,23916,enoyl group,Acyl groups derived from alkenoic acids.,7448,KEGG COMPOUND accession,C08124,,,,,,,,,,,,,,,
485,23927,epi-inositol,a,7454,KEGG COMPOUND accession,C07251,,,,,,,,,,,,,,,
486,23931,epoxy monocarboxylic acid,Monocarboxylic acids containing at least one epoxy group.,100147,KEGG COMPOUND accession,C05079,,,,,,,,,,,,,,,
487,21569,N-acetyl-O-acetylneuraminic acid,a,16682,KEGG COMPOUND accession,C01073,,,,,,,,,,,,,,,
488,27353,xylulose,a,35596,KEGG COMPOUND accession,C09893,,,,,,,,,,,,,,,
489,26482,quercetin sulfate,a,67347,KEGG COMPOUND accession,C10516,,,,,,,,,,,,,,,
490,24012,farnesal,a,7492,KEGG COMPOUND accession,C07255,,,,,,,,,,,,,,,
491,26206,polysialic acid,Polymers of sialic acid and derivatives. The degree of polymerization is 8 to 200 Sia residues.,17517,KEGG COMPOUND accession,C00344,,,,,,,,,,,,,,,
492,26507,dihydroxyquinoline,Any hydroxyquinoline in which the number of hydroxy substituents is specified as two.,17757,KEGG COMPOUND accession,C02061,,,,,,,,,,,,,,,
493,24231,geranylgeranyl group,a,18379,KEGG COMPOUND accession,C00726,,,,,,,,,,,,,,,
494,26296,propanoyl-CoAs,Any short-chain fatty acyl-CoA  in which the the fatty acid specified is propanoic acid or its derivatives.,15907,KEGG COMPOUND accession,C02306,,,,,,,,,,,,,,,
495,25560,nitroglycerol,A nitrate ester that is glycerol in which nitro group(s) replace the hydrogen(s) attached to one or more of the hydroxy groups.,69830,KEGG COMPOUND accession,C09282,,,,,,,,,,,,,,,
496,29221,perchloric acid,a,9130,KEGG COMPOUND accession,C07520,,,,,,,,,,,,,,,
497,29227,orthoperiodate(5-),a,16119,KEGG COMPOUND accession,C00493,,,,,,,,,,,,,,,
498,29410,(hydridosulfido)dioxygen(.),a,9215,KEGG COMPOUND accession,C02078,,,,,,,,,,,,,,,
499,29412,oxonium,a,9216,KEGG COMPOUND accession,C11619,,,,,,,,,,,,,,,
500,29416,chlorine trioxide,a,16610,KEGG COMPOUND accession,C00315,spmd,124-20-9,16610.0,"Human Metabolome Database (HMDB): Spermidine is a polyamine formed from putrescine. It is found in almost all tissues in association with nucleic acids. It is found as a cation at all pH values, and is thought to help stabilize some membranes and nucleic acid structures. It is a precursor of spermine.",Spermidine,HMDB0001257,b,b,C00315,SPERMIDINE,FDB012039,spmd,[H][N+]([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[N+]([H])([H])C([H])([H])C([H])([H])C([H])([H])[N+]([H])([H])[H],ATHGHQPFGPMSJY-UHFFFAOYSA-Q,"InChI=1S/C7H19N3/c8-4-1-2-6-10-7-3-5-9/h10H,1-9H2/p+3"
501,30002,D-selenocysteine residue,a,9410,KEGG COMPOUND accession,C05463,tdechola,516-50-7,9410.0,"Human Metabolome Database (HMDB): Taurodeoxycholic acid is a bile salt formed in the liver by conjugation of deoxycholate with taurine, usually as the sodium salt. Bile acids are steroid acids found predominantly in bile of mammals. The distinction between different bile acids is minute, depends only on presence or absence of hydroxyl groups on positions 3, 7, and 12. Bile acids are physiological detergents that facilitate excretion, absorption, and transport of fats and sterols in the intestine and liver. Bile acids are also steroidal amphipathic molecules derived from the catabolism of cholesterol. They modulate bile flow and lipid secretion, are essential for the absorption of dietary fats and vitamins, and have been implicated in the regulation of all the key enzymes involved in cholesterol homeostasis. Bile acids recirculate through the liver, bile ducts, small intestine and portal vein to form an enterohepatic circuit. They exist as anions at physiological pH and, consequently, require a carrier for transport across the membranes of the enterohepatic tissues. The unique detergent properties of bile acids are essential for the digestion and intestinal absorption of hydrophobic nutrients. Bile acids have potent toxic properties (e.g., membrane disruption) and there are a plethora of mechanisms to limit their accumulation in blood and tissues. (PMID: 11316487, 16037564, 12576301, 11907135).",Taurodeoxycholic acid,HMDB0000896,b,b,C05463,b,FDB022304,tdechola,[H]O[C@]1([H])C([H])([H])C([H])([H])[C@@]2(C([H])([H])[H])[C@]([H])(C([H])([H])C([H])([H])[C@@]3([H])[C@]4([H])C([H])([H])C([H])([H])[C@]([H])([C@]([H])(C([H])([H])[H])C([H])([H])C([H])([H])C(=O)N([H])C([H])([H])C([H])([H])S([O-])(=O)=O)[C@@]4(C([H])([H])[H])[C@@]([H])(O[H])C([H])([H])[C@]23[H])C1([H])[H],AWDRATDZQPNJFN-VAYUFCLWSA-M,"InChI=1S/C26H45NO6S/c1-16(4-9-24(30)27-12-13-34(31,32)33)20-7-8-21-19-6-5-17-14-18(28)10-11-25(17,2)22(19)15-23(29)26(20,21)3/h16-23,28-29H,4-15H2,1-3H3,(H,27,30)(H,31,32,33)/p-1/t16-,17-,18-,19+,20-,21+,22+,23+,25+,26-/m1/s1"
502,30004,D-selenocysteinate residue,a,36259,KEGG COMPOUND accession,C02592,HC02192,516-90-5,36259.0,"Human Metabolome Database (HMDB): Lithocholyltaurine is a bile salt formed in the liver from lithocholic acid conjugation with taurine, usually as the sodium salt. It solubilizes fats for absorption and is itself absorbed. Lithocholic acid, a hydrophobic secondary bile acid, is well known to cause intrahepatic cholestasis. There have been extensive studies on the mechanisms of lithocholate-induced cholestasis in animals. Lithocholate diminishes both the bile acid-dependent and independent bile flow. In humans, elevated levels of lithocholic acid are found in patients with chronic cholestatic liver disease. Lithocholyltaurine impairs both the bile canalicular contractions and the canalicular bile secretion, possibly by acting directly on the canalicular membranes in lithocholyltaurine-induced cholestasis. Lithocholyltaurine induce acute cholestasis-associated with retrieval of the bile salt export pump. The bile salt export pump (BSEP) of hepatocyte secretes conjugated bile salts across the canalicular membrane in an ATP-dependent manner. Hepatic retention of bile acids may lead to liver injury by hepatocyte apoptosis and eventually deterioration of cholestatic liver diseases. One mechanism of induced apoptosis by lithocholyltaurine is the induction of transcriptional activity of AP-1 (activation protein-1). (PMID: 16981261, 15763547, 16332456, 18164257).",Lithocholyltaurine,HMDB0000722,b,b,C02592,TAUROLITHOCHOLATE,FDB022203,HC02192,[H]O[C@]1([H])C([H])([H])C([H])([H])[C@@]2(C([H])([H])[H])[C@]([H])(C([H])([H])C([H])([H])[C@@]3([H])[C@]4([H])C([H])([H])C([H])([H])[C@]([H])([C@]([H])(C([H])([H])[H])C([H])([H])C([H])([H])C(=O)N([H])C([H])([H])C([H])([H])S([O-])(=O)=O)[C@@]4(C([H])([H])[H])C([H])([H])C([H])([H])[C@]23[H])C1([H])[H],QBYUNVOYXHFVKC-GBURMNQMSA-M,"InChI=1S/C26H45NO5S/c1-17(4-9-24(29)27-14-15-33(30,31)32)21-7-8-22-20-6-5-18-16-19(28)10-12-25(18,2)23(20)11-13-26(21,22)3/h17-23,28H,4-16H2,1-3H3,(H,27,29)(H,30,31,32)/p-1/t17-,18-,19-,20+,21-,22+,23+,25+,26-/m1/s1"
503,30007,D-alloisoleucine residue,a,17864,KEGG COMPOUND accession,C03642,HC02198,15324-65-9,17864.0,"Human Metabolome Database (HMDB): Taurolithocholic acid 3-sulfate is a sulfated bile acid. Under normal circumstances, bile acid sulfation is a minor pathway. However in the presence of cholestasis, the fraction of the bile acid pool which is sulfated increases. Sulfation of bile acids increases the aqueous solubility of the amphipathic compounds and results in more efficient renal clearance as well as in decreased reabsorption from the intestinal lumen. Bile acids are steroid acids found predominantly in bile of mammals. The distinction between different bile acids is minute, depends only on presence or absence of hydroxyl groups on positions 3, 7, and 12. Bile acids are physiological detergents that facilitate excretion, absorption, and transport of fats and sterols in the intestine and liver. Bile acids are also steroidal amphipathic molecules derived from the catabolism of cholesterol. They modulate bile flow and lipid secretion, are essential for the absorption of dietary fats and vitamins, and have been implicated in the regulation of all the key enzymes involved in cholesterol homeostasis. Bile acids recirculate through the liver, bile ducts, small intestine and portal vein to form an enterohepatic circuit. They exist as anions at physiological pH and, consequently, require a carrier for transport across the membranes of the enterohepatic tissues. The unique detergent properties of bile acids are essential for the digestion and intestinal absorption of hydrophobic nutrients. Bile acids have potent toxic properties (e.g., membrane disruption) and there are a plethora of mechanisms to limit their accumulation in blood and tissues. (PMID: 11316487, 16037564, 12576301, 11907135).",Taurolithocholic acid 3-sulfate,HMDB0002580,b,b,C03642,TAUROLITHOCHOLATE-SULFATE,FDB023028,HC02198,[H]N(C(=O)C([H])([H])C([H])([H])[C@@]([H])(C([H])([H])[H])[C@@]1([H])C([H])([H])C([H])([H])[C@@]2([H])[C@]3([H])C([H])([H])C([H])([H])[C@]4([H])C([H])([H])[C@]([H])(OS([O-])(=O)=O)C([H])([H])C([H])([H])[C@]4(C([H])([H])[H])[C@@]3([H])C([H])([H])C([H])([H])[C@]12C([H])([H])[H])C([H])([H])C([H])([H])S([O-])(=O)=O,HSNPMXROZIQAQD-GBURMNQMSA-L,"InChI=1S/C26H45NO8S2/c1-17(4-9-24(28)27-14-15-36(29,30)31)21-7-8-22-20-6-5-18-16-19(35-37(32,33)34)10-12-25(18,2)23(20)11-13-26(21,22)3/h17-23H,4-16H2,1-3H3,(H,27,28)(H,29,30,31)(H,32,33,34)/p-2/t17-,18-,19-,20+,21-,22+,23+,25+,26-/m1/s1"
504,30009,L-isoleucine residue,a,16461,KEGG COMPOUND accession,C01616,,,,,,,,,,,,,,,
505,24096,dihydroxy(methyl)silanecarbaldehyde,a,7539,KEGG COMPOUND accession,C06469,,,,,,,,,,,,,,,
506,19591,2-hexenal,A hexenal having the double bond at the 2-position.,17895,KEGG COMPOUND accession,C00082,tyr_L,60-18-4,17895.0,"Human Metabolome Database (HMDB): Tyrosine is an essential amino acid that readily passes the blood-brain barrier. Once in the brain, it is a precursor for the neurotransmitters dopamine, norepinephrine and epinephrine, better known as adrenalin. These neurotransmitters are an important part of the body's sympathetic nervous system, and their concentrations in the body and brain are directly dependent upon dietary tyrosine. Tyrosine is not found in large concentrations throughout the body, probably because it is rapidly metabolized. Folic acid, copper and vitamin C are cofactor nutrients of these reactions. Tyrosine is also the precursor for hormones, thyroid, catecholestrogens and the major human pigment, melanin. Tyrosine is an important amino acid in many proteins, peptides and even enkephalins, the body's natural pain reliever. Valine and other branched amino acids, and possibly tryptophan and phenylalanine may reduce tyrosine absorption. A number of genetic errors of tyrosine metabolism occur, such as hawkinsinuria and tyrosinemia I. Most common is the increased amount of tyrosine in the blood of premature infants, which is marked by decreased motor activity, lethargy and poor feeding. Infection and intellectual deficits may occur. Vitamin C supplements reverse the disease. Some adults also develop elevated tyrosine in their blood. This indicates a need for more vitamin C. More tyrosine is needed under stress, and tyrosine supplements prevent the stress-induced depletion of norepinephrine and can cure biochemical depression. However, tyrosine may not be good for psychosis. Many antipsychotic medications apparently function by inhibiting tyrosine metabolism. L-dopa, which is directly used in Parkinson's, is made from tyrosine. Tyrosine, the nutrient, can be used as an adjunct in the treatment of Parkinson's. Peripheral metabolism of tyrosine necessitates large doses of tyrosine, however, compared to L-dopa (http://www.dcnutrition.com).",L-Tyrosine,HMDB0000158,b,b,C00082,TYR,FDB000446,tyr_L,[H]OC1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])[C@@]([H])(C([O-])=O)[N+]([H])([H])[H],OUYCCCASQSFEME-QMMMGPOBSA-N,"InChI=1S/C9H11NO3/c10-8(9(12)13)5-6-1-3-7(11)4-2-6/h1-4,8,11H,5,10H2,(H,12,13)/t8-/m0/s1"
507,26596,salicylates,"Any salt or ester arising from reaction of the carboxy group of salicylic acid, or any ester resulting from the condensation of the phenolic hydroxy group of salicylic acid with an organic acid.",16829,KEGG COMPOUND accession,C11632,,,,,,,,,,,,,,,
508,21681,N-benzoyl-D-arginines,Any D-arginine derivative in which at least one of the nitrogens has been benzoylated.,21645,KEGG COMPOUND accession,C02562,,,,,,,,,,,,,,,
509,21689,N-carbamoyl-amino acid,a,16180,KEGG COMPOUND accession,C02055,,,,,,,,,,,,,,,
510,19662,2-hydroxytetrahydrofuran,a,6331,KEGG COMPOUND accession,C05947,e4hglu,b,b,b,Erythro-4-Hydroxy-L-Glutamate,b,b,b,C05947,b,b,e4hglu,[H]OC([H])(C([O-])=O)C([H])([H])[C@@]([H])(C([O-])=O)[N+]([H])([H])[H],HBDWQSHEVMSFGY-SCQFTWEKSA-M,"InChI=1S/C5H9NO5/c6-2(4(8)9)1-3(7)5(10)11/h2-3,7H,1,6H2,(H,8,9)(H,10,11)/p-1/t2-,3?/m0/s1"
511,19680,2-methylacetoacetate,a,6339,KEGG COMPOUND accession,C11718,,,,,,,,,,,,,,,
512,30032,hexaaquamagnesium(2+),a,9421,KEGG COMPOUND accession,C07771,,,,,,,,,,,,,,,
513,20717,6-deoxotyphasterol,"Typhasterol in which the oxygen atom of the keto group has been substituted by two hydrogen atoms. A member of a biosynthetic pathway to castasterone, it has been isolated from the primary roots of maize.",6807,KEGG COMPOUND accession,C07163,,,,,,,,,,,,,,,
514,21753,N-methyl-L-asparagine,An L-asparagine derivative comprising L-asparagine carrying one or more N-methyl substituents.,15737,KEGG COMPOUND accession,C01043,,,,,,,,,,,,,,,
515,21766,N-methylglycines,An N-alkylglycine that is sarcosine and derivatives of sarcosine arising by replacement of the hydrogen attached to the nitrogen by a hydrocarbyl group.,7265,KEGG COMPOUND accession,C05680,,,,,,,,,,,,,,,
516,21780,N-palmitoyl-L-cysteine,A palmitoyl-L-cysteine in which the palmitoyl group is attached to the nitrogen via an amide linkage.,48427,KEGG COMPOUND accession,C03409,,,,,,,,,,,,,,,
517,19946,xylosylglycoside,a,6461,KEGG COMPOUND accession,C10602,,,,,,,,,,,,,,,
518,19981,"(1R,2R)-3-chlorocyclohexa-3,5-diene-1,2-diol",a,17351,KEGG COMPOUND accession,C01595,lnlc,60-33-3,17351.0,"Human Metabolome Database (HMDB): Linoleic acid is a doubly unsaturated fatty acid, also known as an omega-6 fatty acid, occurring widely in plant glycosides. In this particular polyunsaturated fatty acid (PUFA), the first double bond is located between the sixth and seventh carbon atom from the methyl end of the fatty acid (n-6). Linoleic acid is an essential fatty acid in human nutrition because it cannot be synthesized by humans. It is used in the biosynthesis of prostaglandins (via arachidonic acid) and cell membranes (From Stedman, 26th ed). Linoleic acid is found to be associated with isovaleric acidemia, which is an inborn error of metabolism.",Linoleic acid,HMDB0000673,b,b,C01595,b,FDB012760,lnlc,[H]\C(=C(/[H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H])C([H])([H])C(\[H])=C(\[H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([O-])=O,OYHQOLUKZRVURQ-HZJYTTRNSA-M,"InChI=1S/C18H32O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18(19)20/h6-7,9-10H,2-5,8,11-17H2,1H3,(H,19,20)/p-1/b7-6-,10-9-"
519,22050,S-glycyl-L-cysteine,An N-acyl-L-amino acid that is the S-glycyl derivative of L-cysteine.,17592,KEGG COMPOUND accession,C03153,,,,,,,,,,,,,,,
520,22058,S-(methylbutanoyl)dihydrolipoamide,a,28284,KEGG COMPOUND accession,C03416,,,,,,,,,,,,,,,
521,21816,N(2)-glutamino group,a,28255,KEGG COMPOUND accession,C03521,,,,,,,,,,,,,,,
522,27002,thymidyl group,A thymidyl group is a group formed by loss of a 3'- or 5'-hydroxy group from the deoxyribose moiety of thymidine.,16052,KEGG COMPOUND accession,C11505,,,,,,,,,,,,,,,
523,27020,tolualdehyde,A benzaldehyde compound having a methyl group in an unspecified position.,62415,KEGG COMPOUND accession,C05983,HC01668,b,62415.0,Human Metabolome Database (HMDB): Propinol adenylate is involved in the propanoate metabolism pathway. Propinol adenylate can be reversibly produced from propanoate or propanoyl-CoA by acetyl-CoA synthetase [EC:6.2.1.1] and propionyl-CoA synthetase [EC:6.2.1.17].,Propinol adenylate,HMDB0006806,b,b,C05983,b,FDB024092,HC01668,[H]O[C@@]1([H])[C@@]([H])(O[C@]([H])(C([H])([H])OP(=O)(O[H])OC(=O)C([H])([H])C([H])([H])[H])[C@@]1([H])O[H])N1C([H])=NC2=C1N=C([H])N=C2N([H])[H],ZGNGGJLVZZHLQM-ZRFIDHNTSA-N,"InChI=1S/C13H18N5O8P/c1-2-7(19)26-27(22,23)24-3-6-9(20)10(21)13(25-6)18-5-17-8-11(14)15-4-16-12(8)18/h4-6,9-10,13,20-21H,2-3H2,1H3,(H,22,23)(H2,14,15,16)/t6-,9-,10-,13-/m1/s1"
524,27023,toluene-4-sulfonate,An  arenesulfonate oxoanion that is the conjugate base of toluene-4-sulfonic acid.,8491,KEGG COMPOUND accession,C07405,,,,,,,,,,,,,,,
525,27031,"cis,trans-muconate","A muconate that is the dianion obtained by the deprotonation of both the carboxy groups of cis,trans-muconic acid.",44915,KEGG COMPOUND accession,C07523,,,,,,,,,,,,,,,
526,27295,violaxanthin,"An epoxycarotenol that is 5,5',6,6'-tetrahydro-5,6:5',6'-diepoxy-beta,beta-carotene substituted by hydroxy groups at positions 3 and 3'. It is the naturally occurring xanthophyll pigment found in a variety of plants.",15742,KEGG COMPOUND accession,C02066,,,,,,,,,,,,,,,
527,27311,volatile oil component,Any plant metabolite that is found naturally as a component of a volatile oil.,27616,KEGG COMPOUND accession,C09305,,,,,,,,,,,,,,,
528,24551,hexadienal,An  enal that is hexadiene carrying an oxo group at position 1.,28243,KEGG COMPOUND accession,C08387,,,,,,,,,,,,,,,
529,24553,hexadienedioic acid,a,17034,KEGG COMPOUND accession,C01838,,,,,,,,,,,,,,,
530,24556,"1,3,5-trinitro-1,3,5-triazinane","An N-nitro compound that is 1,3,5-triazinane in which all three of the hydrogens attached to the nitrogens have been replaced by nitro groups. It is widely used in both industrial and military explosives.",17590,KEGG COMPOUND accession,C01387,,,,,,,,,,,,,,,
531,24559,"1,3-dinitro-5-nitroso-1,3,5-triazinane",a,15533,KEGG COMPOUND accession,C01944,occoa,1264-52-4,15533.0,"Human Metabolome Database (HMDB): Octanoyl-CoA is a substrate for Trifunctional enzyme beta subunit (mitochondrial), Acyl-coenzyme A oxidase 1 (peroxisomal), 3-ketoacyl-CoA thiolase (mitochondrial), 3-ketoacyl-CoA thiolase (peroxisomal), Nuclear receptor-binding factor 1, Acyl-CoA dehydrogenase (long-chain specific, mitochondrial), Acyl-coenzyme A oxidase 3 (peroxisomal), HPDHase, Acyl-CoA dehydrogenase (medium-chain specific, mitochondrial), Acyl-coenzyme A oxidase 2 (peroxisomal) and Peroxisomal carnitine O-octanoyltransferase.",Octanoyl-CoA,HMDB0001070,b,b,C01944,CPD-196,FDB022409,occoa,[H]O[C@@]([H])(C(=O)N([H])C([H])([H])C([H])([H])C(=O)N([H])C([H])([H])C([H])([H])SC(=O)C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H])C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])OP([O-])(=O)OP([O-])(=O)OC([H])([H])[C@@]1([H])O[C@@]([H])(N2C([H])=NC3=C(N=C([H])N=C23)N([H])[H])[C@]([H])(O[H])[C@]1([H])OP([O-])([O-])=O,KQMZYOXOBSXMII-ISFBVWQPSA-J,"InChI=1S/C29H50N7O17P3S/c1-4-5-6-7-8-9-20(38)57-13-12-31-19(37)10-11-32-27(41)24(40)29(2,3)15-50-56(47,48)53-55(45,46)49-14-18-23(52-54(42,43)44)22(39)28(51-18)36-17-35-21-25(30)33-16-34-26(21)36/h16-18,22-24,28,39-40H,4-15H2,1-3H3,(H,31,37)(H,32,41)(H,45,46)(H,47,48)(H2,30,33,34)(H2,42,43,44)/p-4/t18-,22-,23-,24+,28-/m0/s1"
532,24577,hexaric acid,a,7729,KEGG COMPOUND accession,C09807,,,,,,,,,,,,,,,
533,24585,hexosamine sulfate,a,44658,KEGG COMPOUND accession,C01945,,,,,,,,,,,,,,,
534,24587,hexosaminide,a,7734,KEGG COMPOUND accession,C08724,,,,,,,,,,,,,,,
535,24589,monosaccharide sulfate,Any carbohydrate sulfate that is a monosaccharide carrying at least one O-sulfo substituent.,7735,KEGG COMPOUND accession,C07322,,,,,,,,,,,,,,,
536,24593,hexyl group,a,16869,KEGG COMPOUND accession,C01946,,,,,,,,,,,,,,,
537,27081,transition element atom,"An element whose atom has an incomplete d sub-shell, or which can give rise to cations with an incomplete d sub-shell.",36075,KEGG COMPOUND accession,C06476,,,,,,,,,,,,,,,
538,27082,trehalose,A disaccharide formed by a (1<->1)-glycosidic bond between two units of D-glucose.,27647,KEGG COMPOUND accession,C05956,HC02217,51982-36-6,27647.0,"Human Metabolome Database (HMDB): Prostaglandin G2 (PGG2) is synthesized from arachidonic acid on a cyclooxygenase (COX) metabolic pathway as a primary step; the COX biosynthesis of prostaglandin (PG) begins with the highly specific oxygenation of arachidonic acid in the 11R configuration and ends with a 15S oxygenation to form PGG2. The COX site activity that catalyzes the conversion of arachidonic acid to PGG2 is the target for nonsteroidal antiinflammatory drugs (NSAIDs). The peroxidase site activity catalyzes the two-electron reduction of the hydroperoxide bond of PGG2 to yield the corresponding alcohol prostaglandin H2 (PGH2). The formation of a phenoxyl radical on Tyr385 couples the activities of the two sites. The Tyr385 radical is produced via oxidation by compound I, an oxoferryl porphyrin -cation radical, which is generated by reaction of the hemin resting state with PGG2 or other hydroperoxides. The tyrosyl radical homolytically abstracts the 13proS hydrogen atom of arachidonic acid which initiates a radical cascade that ends with the stereoselective formation of PGG2. PGG2 then migrates from the cyclooxygenase (COX) site to the peroxidase (POX) site where it reacts with the hemin group to generate PGH2 and compound I. The heterolytic oxygen-oxygen bond cleavage is assisted by the conserved distal residues His207 and Gln203, mutation of which has been shown to severely impair enzyme activity. Compound I, upon reaction with Tyr385, gives compound II, which in turn is reduced to the hemin resting state by one-electron oxidation of reducing cosubstrates or undergoes reactions that result in enzyme self-inactivation. Prostaglandin endoperoxide H synthase (PGHS) 1 is a bifunctional membrane enzyme of the endoplasmic reticulum that converts arachidonic acid into prostaglandin H2 (PGH2), the precursor of all prostaglandins, thromboxanes, and prostacyclins. These lipid mediators are intricately involved in normal physiology, namely, in mitogenesis, fever generation, pain response, lymphocyte chemotaxis, fertility, and contradictory stimuli such as vasoconstriction and vasodilatation, as well as platelet aggregation and quiescence. PGHS is implicated in numerous pathologies, including inflammation, cancers of the colon, lung, and breast, Alzheimer's disease, Parkinson's disease, and numerous cardiovascular diseases including atherosclerosis, thrombosis, myocardial infarction, and stroke. (PMID: 14594816, 16552393, 16411757). Prostaglandins are eicosanoids. The eicosanoids consist of the prostaglandins (PGs), thromboxanes (TXs), leukotrienes (LTs) and lipoxins (LXs). The PGs and TXs are collectively identified as prostanoids. Prostaglandins were originally shown to be synthesized in the prostate gland, thromboxanes from platelets (thrombocytes) and leukotrienes from leukocytes, hence the derivation of their names. All mammalian cells except erythrocytes synthesize eicosanoids. These molecules are extremely potent, able to cause profound physiological effects at very dilute concentrations. All eicosanoids function locally at the site of synthesis, through receptor-mediated G-protein linked signaling pathways.",Prostaglandin G2,HMDB0003235,b,b,C05956,b,FDB023127,HC02217,[H]OO[C@]([H])(C(\[H])=C(/[H])[C@@]1([H])[C@]2([H])OO[C@@]([H])(C2([H])[H])[C@]1([H])C([H])([H])C(\[H])=C(\[H])C([H])([H])C([H])([H])C([H])([H])C([O-])=O)C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H],SGUKUZOVHSFKPH-YNNPMVKQSA-M,"InChI=1S/C20H32O6/c1-2-3-6-9-15(24-23)12-13-17-16(18-14-19(17)26-25-18)10-7-4-5-8-11-20(21)22/h4,7,12-13,15-19,23H,2-3,5-6,8-11,14H2,1H3,(H,21,22)/p-1/b7-4-,13-12+/t15-,16+,17+,18-,19+/m0/s1"
539,24307,D-glucuronoyl group,a,7610,KEGG COMPOUND accession,C08499,,,,,,,,,,,,,,,
540,24311,glutaconyl-CoA,A  2-enoyl-CoA that is the glutaconyl derivative of CoA.,7612,KEGG COMPOUND accession,C08386,,,,,,,,,,,,,,,
541,24317,L-glutamine derivative,"A proteinogenic amino acid derivative resulting from reaction of L-glutamine at the amino group, the carboxy group, or the carboxamide, or from the replacement of any hydrogen of L-glutamine by a heteroatom.",16111,KEGG COMPOUND accession,C02445,,,,,,,,,,,,,,,
542,24319,EC 6.3.1.2 (glutamate--ammonia ligase) inhibitor,An EC 6.3.* (C-N bond-forming ligase) inhibitor that interferes with the action of glutamate--ammonia ligase (EC 6.3.1.2).,29019,KEGG COMPOUND accession,C01601,C01601,112-05-0,29019.0,"Human Metabolome Database (HMDB): Pelargonic acid, or nonanoic acid, is a fatty acid which occurs naturally as esters is the oil of pelargonium. Synthetic esters, such as methyl nonanoate, are used as flavorings. Pelargonic acid is an organic compound composed of a nine-carbon chain terminating in a carboxylic acid. It is an oily liquid with an unpleasant, rancid odor. It is nearly insoluble in water, but well soluble in chloroform and ether. The derivative 4-nonanoylmorpholine is an ingredient in some pepper sprays.",Pelargonic acid,HMDB0000847,b,b,C01601,b,FDB003306,C01601,[H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([O-])=O,FBUKVWPVBMHYJY-UHFFFAOYSA-M,"InChI=1S/C9H18O2/c1-2-3-4-5-6-7-8-9(10)11/h2-8H2,1H3,(H,10,11)/p-1"
543,24321,glutamo group,a,27770,KEGG COMPOUND accession,C01942,M02616,17331-98-5,27770.0,"Human Metabolome Database (HMDB): Nonanoyl CoA is an acyl-CoA with the C-9 fatty acid Acyl chain moiety. Acyl-CoA (or formyl-CoA) is a coenzyme involved in the metabolism of fatty acids. It is a temporary compound formed when coenzyme A (CoA) attaches to the end of a long-chain fatty acid, inside living cells. The CoA is then removed from the chain, carrying two carbons from the chain with it, forming acetyl-CoA. This is then used in the citric acid cycle to start a chain of reactions, eventually forming many adenosine triphosphates. To be oxidatively degraded, a fatty acid must first be activated in a two-step reaction catalyzed by acyl-CoA synthetase. First, the fatty acid displaces the diphosphate group of ATP, then coenzyme A (HSCoA) displaces the AMP group to form an Acyl-CoA. The acyladenylate product of the first step has a large free energy of hydrolysis and conserves the free energy of the cleaved phosphoanhydride bond in ATP. The second step, transfer of the acyl group to CoA (the same molecule that carries acetyl groups as acetyl-CoA), conserves free energy in the formation of a thioester bond. Consequently, the overall reaction Fatty acid + CoA + ATP <=> Acyl-CoA + AMP + PPi has a free energy change near zero. Subsequent hydrolysis of the product PPi (by the enzyme inorganic pyrophosphatase) is highly exergonic, and this reaction makes the formation of acyl-CoA spontaneous and irreversible. Fatty acids are activated in the cytosol, but oxidation occurs in the mitochondria. Because there is no transport protein for CoA adducts, acyl groups must enter the mitochondria via a shuttle system involving the small molecule carnitine.",Nonanoyl-CoA,HMDB0013028,b,b,C01942,CPD-7302,FDB029254,M02616,[H]OC([H])(C(=O)N([H])C([H])([H])C([H])([H])C(=O)N([H])C([H])([H])C([H])([H])SC(=O)C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H])C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])OP(=O)(O[H])OP(=O)(O[H])OC([H])([H])[C@@]1([H])O[C@@]([H])(N2C([H])=NC3=C2N=C([H])N=C3N([H])[H])[C@]([H])(O[H])[C@]1([H])OP(=O)(O[H])O[H],WLDUTYVSAGSKIV-YUXRTGJASA-N,"InChI=1S/C30H52N7O17P3S/c1-4-5-6-7-8-9-10-21(39)58-14-13-32-20(38)11-12-33-28(42)25(41)30(2,3)16-51-57(48,49)54-56(46,47)50-15-19-24(53-55(43,44)45)23(40)29(52-19)37-18-36-22-26(31)34-17-35-27(22)37/h17-19,23-25,29,40-41H,4-16H2,1-3H3,(H,32,38)(H,33,42)(H,46,47)(H,48,49)(H2,31,34,35)(H2,43,44,45)/t19-,23-,24-,25?,29-/m1/s1"
544,24322,glutamoyl group,a,18162,KEGG COMPOUND accession,C03885,,,,,,,,,,,,,,,
545,24675,hydroxybenzoate,Any benzoate derivative carrying a single carboxylate group and at least one hydroxy substituent.,7781,KEGG COMPOUND accession,C10114,,,,,,,,,,,,,,,
546,25835,hexadecanoate ester,A fatty acid ester obtained by condensation of the carboxy group of palmitic acid with a hydroxy group of an alcohol or phenol.,16459,KEGG COMPOUND accession,C01842,,,,,,,,,,,,,,,
547,24175,galacturonate,a,17688,KEGG COMPOUND accession,C00745,,,,,,,,,,,,,,,
548,30217,helium atom,a,16563,KEGG COMPOUND accession,C02890,,,,,,,,,,,,,,,
549,30220,helion,Nucleus of the (3)He atom.,28889,KEGG COMPOUND accession,C05650,,,,,,,,,,,,,,,
550,30222,neutron,"Nuclear particle of zero charge, spin 1/2 and rest mass of 1.008664904(14) u.",17420,KEGG COMPOUND accession,C04144,M02979,b,17420.0,"Human Metabolome Database (HMDB): Tetrahydropteroyltri-L-glutamate is an intermediate in the synthesis of methionine by bacteria. It is a substrate for the enzyme 5-methyltetrahydropteroyltriglutamate--homocysteine methyltransferase which catalyzes the reaction 5-methyltetrahydropteroyltri-L-glutamate + L-homocysteine = tetrahydropteroyltri-L-glutamate + L-methionine. In humans, this compound is produced by the bacteria in the gut and may be found in feces or urine.",Tetrahydropteroyltri-L-glutamate,HMDB0012290,b,b,C04144,CPD-1302,FDB028919,b,[H]OC(=O)C([H])([H])C([H])([H])[C@]([H])(N([H])C(=O)C([H])([H])C([H])([H])[C@]([H])(N([H])C(=O)C([H])([H])C([H])([H])[C@]([H])(N([H])C(=O)C1=C([H])C([H])=C(N([H])C([H])([H])[C@]2([H])N([H])C3=C(N=C(N([H])[H])N([H])C3=O)N([H])C2([H])[H])C([H])=C1[H])C(=O)O[H])C(=O)O[H])C(=O)O[H],RXWVHRYZTWZATH-XSLAGTTESA-N,"InChI=1S/C29H37N9O12/c30-29-37-23-22(25(44)38-29)33-15(12-32-23)11-31-14-3-1-13(2-4-14)24(43)36-18(28(49)50)6-9-20(40)34-16(26(45)46)5-8-19(39)35-17(27(47)48)7-10-21(41)42/h1-4,15-18,31,33H,5-12H2,(H,34,40)(H,35,39)(H,36,43)(H,41,42)(H,45,46)(H,47,48)(H,49,50)(H4,30,32,37,38,44)/t15-,16-,17-,18-/m0/s1"
551,30226,azanidylidene group,a,28674,KEGG COMPOUND accession,C07912,,,,,,,,,,,,,,,
552,29102,natride,a,15721,KEGG COMPOUND accession,C00281,s7p,2646-35-7,15721.0,"Human Metabolome Database (HMDB): D-Sedoheptulose 7-phosphate is an intermediate of the Pentose phosphate pathway (PPP) that has two functions: the generation of NADPH for reductive syntheses and oxidative stress responses within cells, and the formation of ribose residues for nucleotide and nucleic acid biosynthesis (PMID 16055050). It is formed by transketolase and acted upon (degraded) by transaldolase. Sedoheptulose 7-phosphate can be increased in the blood of patients affected with a transaldolase deficiency (TALDO1; EC 2.2.1.2) (PMID 12881455), a genetic disorder. Sedoheptulose is a ketoheptose, a monosaccharide with seven carbon atoms and a ketone functional group. It is one of the few heptoses found in nature (Wikipedia).",D-Sedoheptulose 7-phosphate,HMDB0001068,b,b,C00281,D-SEDOHEPTULOSE-7-P,FDB022407,s7p,[H]OC([H])([H])C(=O)[C@@]([H])(O[H])[C@]([H])(O[H])[C@]([H])(O[H])[C@]([H])(O[H])C([H])([H])OP([O-])([O-])=O,JDTUMPKOJBQPKX-GBNDHIKLSA-L,"InChI=1S/C7H15O10P/c8-1-3(9)5(11)7(13)6(12)4(10)2-17-18(14,15)16/h4-8,10-13H,1-2H2,(H2,14,15,16)/p-2/t4-,5-,6-,7+/m1/s1"
553,29906,iodine trioxide,a,9368,KEGG COMPOUND accession,C10091,,,,,,,,,,,,,,,
554,29912,(SPY-5)-pentaoxoiodate(3-),a,9371,KEGG COMPOUND accession,C10092,,,,,,,,,,,,,,,
555,29914,diiodine pentaoxide,a,65478,KEGG COMPOUND accession,C10093,,,,,,,,,,,,,,,
556,29233,deuteron,Nucleus of the (2)H atom.,17052,KEGG COMPOUND accession,C03175,,,,,,,,,,,,,,,
557,29242,arsenite(1-),An arsenite ion resulting from the removal of a proton from one of the hydroxy groups of arsenous acid.,9138,KEGG COMPOUND accession,C08600,,,,,,,,,,,,,,,
558,29244,hypomanganate,A trivalent inorganic anion obtained by removal of all three protons from hypomanganic acid.,9139,KEGG COMPOUND accession,C07259,,,,,,,,,,,,,,,
559,29246,perbromate,A monovalent inorganic anion obtained by deprotonation of perbromic acid.,27573,KEGG COMPOUND accession,C06263,,,,,,,,,,,,,,,
560,29247,bromous acid,a,9141,KEGG COMPOUND accession,C06710,,,,,,,,,,,,,,,
561,29251,disulfite,a,9143,KEGG COMPOUND accession,C08717,,,,,,,,,,,,,,,
562,29253,dithionous acid,a,9144,KEGG COMPOUND accession,C07610,,,,,,,,,,,,,,,
563,29257,thiosulfite(2-),a,27496,KEGG COMPOUND accession,C11172,,,,,,,,,,,,,,,
564,29259,hydrogenphosphite,A divalent inorganic anion resulting from the removal of a proton from two of the hydroxy groups of phosphorous acid.,9147,KEGG COMPOUND accession,C07261,,,,,,,,,,,,,,,
565,30103,diazenide,a,9457,KEGG COMPOUND accession,C06075,,,,,,,,,,,,,,,
566,30105,diazo group,a,32876,KEGG COMPOUND accession,C02196,,,,,,,,,,,,,,,
567,30106,azo group,a,17525,KEGG COMPOUND accession,C01618,,,,,,,,,,,,,,,
568,30108,diazyn-1-ium-1-yl group,a,9460,KEGG COMPOUND accession,C02197,,,,,,,,,,,,,,,
569,29144,4-carboxy-1-hydroxybutylthiamine diphosphate,a,28553,KEGG COMPOUND accession,C05704,,,,,,,,,,,,,,,
570,29145,"2,6-diamino-5-formamido-4-hydroxypyrimidine",a,9096,KEGG COMPOUND accession,C05698,selhcys,29412-93-9,b,"Human Metabolome Database (HMDB): Selenohomocysteine is the precursor of selenocysteine, which is synthesized by catalysis of cystathionine beta-synthase (EC 4.2.1.22) and cystathionine gamma-lyase (EC 4.4.1.1), in mammalian systems (both enzymes require pyridoxal phosphate). Selenohomocysteine (lactone) has been found to be a competitive and irreversible inhibitor of lysyl oxidase; this may relate to the development of connective tissue defects seen in homocystinuria. L-Selenohomocysteine also can serve as a substituent donor in the beta-replacement reaction to yield selenocystathionine. (PMID: 10609891, 9405445, 6456763, 3338973).",Selenohomocysteine,HMDB0004119,b,b,C05698,SELENOHOMOCYSTEINE,FDB023315,b,[H][Se]C([H])([H])C([H])([H])[C@@]([H])(C([O-])=O)[N+]([H])([H])[H],RCWCGLALNCIQNM-VKHMYHEASA-N,"InChI=1S/C4H9NO2Se/c5-3(1-2-8)4(6)7/h3,8H,1-2,5H2,(H,6,7)/t3-/m0/s1"
571,29115,5-hydroxyuracil,a,18170,KEGG COMPOUND accession,C05697,,,,,,,,,,,,,,,
572,29275,dinitrogen(2+),a,27949,KEGG COMPOUND accession,C05610,,,,,,,,,,,,,,,
573,29279,sulfurothioic O-acid,a,15596,KEGG COMPOUND accession,C02887,,,,,,,,,,,,,,,
574,29287,gold atom,a,16353,KEGG COMPOUND accession,C00933,,,,,,,,,,,,,,,
575,29291,sulfuryl dichloride,a,16210,KEGG COMPOUND accession,C02750,,,,,,,,,,,,,,,
576,29293,dihydrogen(.1+),a,28813,KEGG COMPOUND accession,C02325,,,,,,,,,,,,,,,
577,29299,diprotium,a,9159,KEGG COMPOUND accession,C10186,,,,,,,,,,,,,,,
578,29301,deuteride,a,9160,KEGG COMPOUND accession,C00271,,,,,,,,,,,,,,,
579,29303,deuterium(.),a,9162,KEGG COMPOUND accession,C08427,,,,,,,,,,,,,,,
580,29894,trioxo-lambda(7)-bromanyloxy group,a,9362,KEGG COMPOUND accession,C07320,,,,,,,,,,,,,,,
581,29896,oxidoiodine(.),a,45906,KEGG COMPOUND accession,C07974,,,,,,,,,,,,,,,
582,30146,lithium hydride,An alkali metal hydride where the metal is specified as lithium.,17042,KEGG COMPOUND accession,C03434,,,,,,,,,,,,,,,
583,30149,borane,"The simplest borane, consisting of a single boron atom carrying three hydrogens.",9473,KEGG COMPOUND accession,C11274,,,,,,,,,,,,,,,
584,30151,aluminide(1-),a,27902,KEGG COMPOUND accession,C06570,,,,,,,,,,,,,,,
585,30152,carbonylidene group,a,15532,KEGG COMPOUND accession,C02593,tdcoa,3130-72-1,15532.0,"Human Metabolome Database (HMDB): Tetradecanoyl-CoA (or myristoyl-CoA) is an intermediate in fatty acid biosynthesis, fatty acid elongation and the beta oxidation of fatty acids. It is also used in the myristoylation of proteins. The first pass through the beta-oxidation process starts with the saturated fatty acid palmitoyl-CoA and produces myristoyl-CoA. A total of four enzymatic steps are required, starting with VLCAD CoA dehydrogenase (Very Long Chain) activity, followed by three enzymatic steps catalyzed by enoyl-CoA hydratase, 3-hydroxyacyl-CoA dehydrogenase, and ketoacyl-CoA thiolase, all present in the mitochondria. Myristoylation of proteins is also catalyzed by the presence of myristoyl-CoA along with Myristoyl-CoA:protein N-myristoyltransferase (NMT). Myristoylation is an irreversible, co-translational (during translation) protein modification found in animals, plants, fungi and viruses. In this protein modification a myristoyl group (derived from myristioyl CoA) is covalently attached via an amide bond to the alpha-amino group of an N-terminal amino acid of a nascent polypeptide. It is more common on glycine residues but also occurs on other amino acids. Myristoylation also occurs post-translationally, for example when previously internal glycine residues become exposed by caspase cleavage during apoptosis. Myristoylation plays a vital role in membrane targeting and signal transduction in plant responses to environmental stress. Compared to other species that possess a single functional myristoyl-CoA: protein N-myristoyltransferase (NMT) gene copy, human, mouse and cow possess 2 NMT genes, and more than 2 protein isoforms.",Tetradecanoyl-CoA ,HMDB0001521,b,b,C02593,TETRADECANOYL-COA,FDB022670,tdcoa,[H]O[C@@]([H])(C(=O)N([H])C([H])([H])C([H])([H])C(=O)N([H])C([H])([H])C([H])([H])SC(=O)C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H])C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])OP([O-])(=O)OP([O-])(=O)OC([H])([H])[C@@]1([H])O[C@@]([H])(N2C([H])=NC3=C(N=C([H])N=C23)N([H])[H])[C@]([H])(O[H])[C@]1([H])OP([O-])([O-])=O,DUAFKXOFBZQTQE-IXZUJZTPSA-J,"InChI=1S/C35H62N7O17P3S/c1-4-5-6-7-8-9-10-11-12-13-14-15-26(44)63-19-18-37-25(43)16-17-38-33(47)30(46)35(2,3)21-56-62(53,54)59-61(51,52)55-20-24-29(58-60(48,49)50)28(45)34(57-24)42-23-41-27-31(36)39-22-40-32(27)42/h22-24,28-30,34,45-46H,4-21H2,1-3H3,(H,37,43)(H,38,47)(H,51,52)(H,53,54)(H2,36,39,40)(H2,48,49,50)/p-4/t24-,28-,29-,30+,34-/m0/s1"
586,29326,hydroxidooxidocarbon(.),a,28933,KEGG COMPOUND accession,C08913,,,,,,,,,,,,,,,
587,29334,oxidocarbon(2+),a,28741,KEGG COMPOUND accession,C08142,,,,,,,,,,,,,,,
588,29340,hydridonitrate(2-),A divalent inorganic anion resulting from the removal of two protons from ammonia.,28148,KEGG COMPOUND accession,C07638,,,,,,,,,,,,,,,
589,29344,hydridonitrogen(1+),a,9183,KEGG COMPOUND accession,C10529,,,,,,,,,,,,,,,
590,29351,nitrogen(.),a,28374,KEGG COMPOUND accession,C06543,,,,,,,,,,,,,,,
591,29205,diphosphonic acid,a,9122,KEGG COMPOUND accession,C07567,,,,,,,,,,,,,,,
592,2482,"adenosylcob(III)yrinic acid a,c-diamide","A cobalt corrinoid that is cob(III)yrinic acid a,c-diamide having a 5'-adenosyl group attached to the central cobalt atom.",28155,KEGG COMPOUND accession,C05252,,,,,,,,,,,,,,,
593,21137,tri-mu-sulfido-mu3-sulfido-triiron,a,6988,KEGG COMPOUND accession,C09788,,,,,,,,,,,,,,,
594,10330,alpha-santalol,a,17031,KEGG COMPOUND accession,C06327,,,,,,,,,,,,,,,
595,29269,selenophosphoric acid,a,15714,KEGG COMPOUND accession,C00482,,,,,,,,,,,,,,,
596,29426,thiocyanato group,a,15746,KEGG COMPOUND accession,C00750,sprm,71-44-3,15746.0,"Human Metabolome Database (HMDB): Spermine is a biogenic polyamine formed from spermidine. It is found in a wide variety of organisms and tissues and is an essential growth factor in some bacteria. It is found as a polycation at all pH values. Spermine is associated with nucleic acids, particularly in viruses, and is thought to stabilize the helical structure.",Spermine,HMDB0001256,b,b,C00750,SPERMINE,FDB003225,sprm,[H][N+]([H])([H])C([H])([H])C([H])([H])C([H])([H])[N+]([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[N+]([H])([H])C([H])([H])C([H])([H])C([H])([H])[N+]([H])([H])[H],PFNFFQXMRSDOHW-UHFFFAOYSA-R,"InChI=1S/C10H26N4/c11-5-3-9-13-7-1-2-8-14-10-4-6-12/h13-14H,1-12H2/p+4"
597,29432,methanylylidene group,a,16566,KEGG COMPOUND accession,C00836,sphgn,764-22-7,16566.0,Human Metabolome Database (HMDB): Sphinganine is a blocker postlysosomal cholesterol transport by inhibition of low-density lipoprotein-induced esterification of cholesterol and cause unesterified cholesterol to accumulate in perinuclear vesicles. It has been suggested the possibility that endogenous sphinganine may inhibit cholesterol transport in Niemann-Pick Type C (NPC) disease. (PMID 1817037).,Sphinganine,HMDB0000269,b,b,C00836,b,FDB021924,sphgn,[H]OC([H])([H])[C@]([H])([N+]([H])([H])[H])[C@]([H])(O[H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H],OTKJDMGTUTTYMP-ZWKOTPCHSA-O,"InChI=1S/C18H39NO2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-18(21)17(19)16-20/h17-18,20-21H,2-16,19H2,1H3/p+1/t17-,18+/m0/s1"
598,29436,carbon(1+),a,16893,KEGG COMPOUND accession,C01120,sph1p,19794-97-9,16893.0,"Human Metabolome Database (HMDB): Sphinganine 1-phosphate is an intermediate in the metabolism of Glycosphingolipids and sphingolipids. It is a substrate for Sphingosine kinase 1, Lipid phosphate phosphohydrolase 2, Sphingosine kinase 2, Sphingosine-1-phosphate lyase 1, Lipid phosphate phosphohydrolase 1 and Lipid phosphate phosphohydrolase 3.",Sphinganine 1-phosphate,HMDB0001383,b,b,C01120,CPD-649,FDB022594,sph1p,[H]O[C@]([H])(C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H])[C@@]([H])([N+]([H])([H])[H])C([H])([H])OP([O-])([O-])=O,YHEDRJPUIRMZMP-ZWKOTPCHSA-M,"InChI=1S/C18H40NO5P/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-18(20)17(19)16-24-25(21,22)23/h17-18,20H,2-16,19H2,1H3,(H2,21,22,23)/p-1/t17-,18+/m0/s1"
599,29439,methaniumyl,a,17636,KEGG COMPOUND accession,C00550,,,,,,,,,,,,,,,
600,29444,isoselenocyanato group,a,16393,KEGG COMPOUND accession,C00319,sphings,123-78-4,16393.0,"Human Metabolome Database (HMDB): Sphingosine is a 18-carbon amino alcohol with a long unsaturated hydrocarbon chain. Sphingosine and its derivative sphinganine are the major bases of the sphingolipids in mammals. (Dorland, 28th ed.). Sphingosine can be phosphorylated in vivo via two kinases, sphingosine kinase type 1 and sphingosine kinase type 2. This leads to the formation of sphingosine-1-phosphate, a potent signaling lipid.(Wikipedia).",Sphingosine,HMDB0000252,b,b,C00319,SPHINGOSINE,FDB021919,sphings,[H]OC([H])([H])C([H])([N+]([H])([H])[H])C([H])(O[H])C([H])=C([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H],WWUZIQQURGPMPG-UHFFFAOYSA-O,"InChI=1S/C18H37NO2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-18(21)17(19)16-20/h14-15,17-18,20-21H,2-13,16,19H2,1H3/p+1"
601,29450,hexanitride(.1-),a,37550,KEGG COMPOUND accession,C06124,sphs1p,26993-30-6,392583.0,"Human Metabolome Database (HMDB): Sphingosine 1-phosphate (S1P) is a phosphorylated sphingolipid metabolite with potent bioactive actions in the Sphingolipid metabolism, Calcium signaling pathway and Neuroactive ligand-receptor interaction. Generated by sphingosine kinases and ceramide kinase, S1P control numerous aspects of cell physiology, including cell survival and mammalian inflammatory responses. S1P is involved in cyclooxygenase-2 induction (COX-2), and regulate production of eicosanoids (important inflammatory mediators). S1P functions mainly via G-protein-coupled receptors and probably also has intracellular targets. (PMID 16219683).",Sphingosine 1-phosphate,HMDB0000277,b,b,C06124,b,FDB021927,sphs1p,[H]O[C@]([H])(C(\[H])=C(/[H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H])[C@@]([H])([N+]([H])([H])[H])C([H])([H])OP([O-])([O-])=O,DUYSYHSSBDVJSM-KRWOKUGFSA-M,"InChI=1S/C18H38NO5P/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-18(20)17(19)16-24-25(21,22)23/h14-15,17-18,20H,2-13,16,19H2,1H3,(H2,21,22,23)/p-1/b15-14+/t17-,18+/m0/s1"
602,29311,chlorine(.),a,28599,KEGG COMPOUND accession,C00748,,,,,,,,,,,,,,,
603,29312,sulfanyl,a,18023,KEGG COMPOUND accession,C05778,,,,,,,,,,,,,,,
604,29315,phosphoryl,a,9168,KEGG COMPOUND accession,C07909,,,,,,,,,,,,,,,
605,29317,selanide,a,9169,KEGG COMPOUND accession,C00494,,,,,,,,,,,,,,,
606,29669,pyochelin,"A member of the class of thiazolidines that is (4R)-3-methyl-1,3-thiazolidine-4-carboxylic acid which is substituted at position 2 by a (4R)-2-(2-hydroxyphenyl)-4,5-dihydro-1,3-thiazol-4-yl group. A siderophore that is produced by Pseudomonas aeruginosa (via condensation of salicylic acid and two molecules of cysteine) as a mixture of two easily interconvertible diastereoisomers, pyochelin I (major) and pyochelin II (minor). The enantiomeric compounds, enant-pyochelin, are produced by Pseudomonas fluorescens.",16265,KEGG COMPOUND accession,C00232,sucsal,692-29-5,16265.0,"Human Metabolome Database (HMDB): Succinic acid semialdehyde (or succinate semialdehyde) is an intermediate in the catabolism of gamma-aminobutyrate or GABA (PMID: 16435183). It is formed from GABA by the action of GABA transaminase, which leads to the production of succinate semialdehyde and alanine. The resulting succinate semialdehyde is further oxidized by succinate semialdehyde dehydrogenase to become succinic acid, which also yields NADPH. Under certain situations, high levels of succinate semialdehyde can function as a neurotoxin and a metabotoxin. A neurotoxin is a compound that causes damage to the brain and nerve tissues. A metabotoxin is an endogenously produced metabolite that causes adverse health effects at chronically high levels. Elevated serum levels of succinate semialdehyde are found in succinic semialdehyde dehydrogenase (SSADH) deficiency (gamma-hydroxybutyric aciduria), a rare neurometabolic disorder of gamma-aminobutyric acid (GABA) degradation. Symptoms include motor delay, hypotonia, speech delay, autistic features, seizures, and ataxia. Patients also exhibit behavioural problems such as attention deficit, hyperactivity, anxiety, or aggression (PMID: 18622364). Succinate semialdehyde is considered a reactive carbonyl and may lead to increased oxidative stress. This stress is believed to contribute to the formation of free radicals in the brain tissue of animal models induced with SSADH deficiency, which further leads to secondary cell damage and death. Additionally, oxidative stress may be responsible for the loss of striatal dopamine, which may contribute to the neuropathology of SSADH deficiency.",Succinic acid semialdehyde,HMDB0001259,b,b,C00232,SUCC-S-ALD,FDB022516,sucsal,[H]C(=O)C([H])([H])C([H])([H])C([O-])=O,UIUJIQZEACWQSV-UHFFFAOYSA-M,"InChI=1S/C4H6O3/c5-3-1-2-4(6)7/h3H,1-2H2,(H,6,7)/p-1"
607,29357,methanediyl,a,9190,KEGG COMPOUND accession,C10822,,,,,,,,,,,,,,,
608,29361,methanidyl group,a,9192,KEGG COMPOUND accession,C09737,,,,,,,,,,,,,,,
609,29371,dioxygen(2+),a,27494,KEGG COMPOUND accession,C10530,,,,,,,,,,,,,,,
610,5641,heliosupine,An azabicycloalkane compound having angelyloxy and echimidinyloxymethyl substituents attached to the ring system.,2185,KEGG COMPOUND accession,C11574,,,,,,,,,,,,,,,
611,10126,zolpidem tartrate,The hemitartrate salt of zolpidem.,3491,KEGG COMPOUND accession,C06882,,,,,,,,,,,,,,,
612,10435,beta-obscurine,a,16112,KEGG COMPOUND accession,C00852,,,,,,,,,,,,,,,
613,29753,arsonite(2-),a,9322,KEGG COMPOUND accession,C11170,,,,,,,,,,,,,,,
614,29755,arsanide,a,15833,KEGG COMPOUND accession,C07288,,,,,,,,,,,,,,,
615,29765,arsanebis(ylium),a,9327,KEGG COMPOUND accession,C08051,,,,,,,,,,,,,,,
616,29767,aminoxyl,The parent compound of the aminoxyl group of radicals.,9328,KEGG COMPOUND accession,C07658,,,,,,,,,,,,,,,
617,29774,selanylium,a,9331,KEGG COMPOUND accession,C08050,,,,,,,,,,,,,,,
618,29778,selenocyanic acid,a,45373,KEGG COMPOUND accession,C07458,,,,,,,,,,,,,,,
619,29780,isochorismate(2-),a,9334,KEGG COMPOUND accession,C07316,,,,,,,,,,,,,,,
620,21957,O-glycosyl-L-serine,a,16837,KEGG COMPOUND accession,C04778,,,,,,,,,,,,,,,
621,21968,O-phosphoamino acid,a,27838,KEGG COMPOUND accession,C05843,M02506,769-49-3,27838.0,Human Metabolome Database (HMDB): N1-Methyl-4-pyridone-5-carboxamide (4PY ) is a normal human metabolite (one of the end products of nicotinamide-adenine dinucleotide (NAD) degradation). 4PY concentration in serum is elevated in non-dialyzed chronic renal failure (CRF) patients when compared with controls. (PMID 12694300).,N1-Methyl-4-pyridone-3-carboxamide,HMDB0004194,b,b,C05843,b,FDB023331,b,[H]N([H])C(=O)C1=C([H])N(C([H])=C([H])C1=O)C([H])([H])[H],KTLRWTOPTKGYQY-UHFFFAOYSA-N,"InChI=1S/C7H8N2O2/c1-9-3-2-6(10)5(4-9)7(8)11/h2-4H,1H3,(H2,8,11)"
622,21182,quinacrine mustard dihydrochloride,a,37395,KEGG COMPOUND accession,C05114,,,,,,,,,,,,,,,
623,21041,D-idaric acid,The D-enantiomer of idaric acid.,50694,KEGG COMPOUND accession,C07225,,,,,,,,,,,,,,,
624,30111,tetrafluoroaluminate(1-),a,17347,KEGG COMPOUND accession,C00535,tststerone,58-22-0,17347.0,"Human Metabolome Database (HMDB): Testosterone is the most important androgen in potency and quantity. Testosterone is synthesized and released by the Leydig cells that lie between the tubules and comprise less than 5% of the total testicular volume. testosterone diffuses into the seminiferous tubules where it is essential for maintaining spermatogenesis. Some binds to an androgen-binding protein (ABP) that is produced by the Sertoli cells and is homologous to the sex-hormone binding globulin that transports testosterone in the general circulation. The ABP carries testosterone in the testicular fluid where it maintains the activity of the accessory sex glands and may also help to retain testosterone within the tubule and bind excess free hormone. Some testosterone is converted to estradiol by Sertoli cell-derived aromatase enzyme. Leydig cell steroidogenesis is controlled primarily by luteinizing hormone with negative feedback of testosterone on the hypothalamic-pituitary axis. The requirement of spermatogenesis for high local concentrations of testosterone means that loss of androgen production is likely to be accompanied by loss of spermatogenesis. Indeed, if testicular androgen production is inhibited by the administration of exogenous androgens then spermatogenesis ceases. This is the basis of using exogenous testosterone as a male contraceptive. testosterone is converted to dihydrotestosterone by 5a-reductase type 2 (EC 1.3.1.22, SRD5A2), the androgen with the highest affinity for the androgen receptor. SRD5A2 deficiency illustrates the importance of dihydrotestosterone for external virilization, as individuals with this condition have normal male internal structures but their external genitalia are of female appearance. There is now clear evidence that the human fetal testis and also the fetal adrenal gland is capable of testosterone biosynthesis during the first trimester. Regardless of the source of androgen production, the target tissue responds by male sexual differentiation of the external genitalia by the end of the first trimester. It is clear that testicular damage may result in loss of testosterone production or the loss of spermatogenesis or both. Loss of androgen production results in hypogonadism, the symptoms of which reflect the functions of testosterone. Male hypogonadism is defined as failure of the testes to produce normal amounts of testosterone, combined with signs and symptoms of androgen deficiency. Systemic testosterone levels fall by about 1% each year in men. Therefore, with increasing longevity and the aging of the population, the number of older men with testosterone deficiency will increase substantially over the next several decades. Serum testosterone levels decrease progressively in aging men, but the rate and magnitude of decrease vary considerably. Approximately 1% of healthy young men have total serum testosterone levels below normal; in contrast, approximately 20% of healthy men over age 60 years have serum testosterone levels below normal. (PMID: 17904450, 17875487).",Testosterone,HMDB0000234,b,b,C00535,b,FDB011544,tststerone,[H]O[C@@]1([H])C([H])([H])C([H])([H])[C@@]2([H])[C@]3([H])C([H])([H])C([H])([H])C4=C([H])C(=O)C([H])([H])C([H])([H])[C@]4(C([H])([H])[H])[C@@]3([H])C([H])([H])C([H])([H])[C@]12C([H])([H])[H],MUMGGOZAMZWBJJ-DYKIIFRCSA-N,"InChI=1S/C19H28O2/c1-18-9-7-13(20)11-12(18)3-4-14-15-5-6-17(21)19(15,2)10-8-16(14)18/h11,14-17,21H,3-10H2,1-2H3/t14-,15-,16-,17-,18-,19-/m0/s1"
625,30122,fluoridochlorine(1+),a,16524,KEGG COMPOUND accession,C03027,,,,,,,,,,,,,,,
626,30126,tetrafluorochlorine(1+),a,9463,KEGG COMPOUND accession,C08156,,,,,,,,,,,,,,,
627,30130,oxidoaluminate(1-),a,28835,KEGG COMPOUND accession,C11134,tststeroneglc,1180-25-2,28835.0,"Human Metabolome Database (HMDB): Testosterone glucuronide is a natural human metabolite of testosterone. Testosterone is a steroid hormone from the androgen group. Testosterone is primarily secreted in the testes of males and the ovaries of females although small amounts are secreted by the adrenal glands. It is the principal male sex hormone and an anabolic steroid. In both males and females, it plays key roles in health and well-being. There is a sex difference in the median values of testosterone glucuronide in the amniotic fluid specimens 15-19 wk gestation between female (median 160 pM, range 64-465 pM) and male (median 817 pM, range 68-3707 pM). This difference, when used in conjunction with amniotic fluid unconjugated testosterone values, increase the predictive accuracy of fetal sexing from 95.4 to 98.9%. In human newborns and young infants, urinary testosterone sulfate is higher than glucuronide. The high sulfokinase activity in fetal and neonatal testes is more likely responsible for this phenomenon than an impaired glucuronizing capacity of the liver. Urinary excretion of testosterone glucuronide increases significantly during puberty. The level of testosterone glucuronide exceeds the level of unconjugated testosterone in human seminal plasma. Urinary testosterone glucuronide excretion is increased in women with virilizing adrenocortical tumors. Concentration of testosterone glucuronide in urine from women with breast tumor in urine samples is not different from patients with benign or malignant breast disease, either before or after the menopause. (PMID: 8327267, 3560942, 6246233, 871373, 133773, 947290).",Testosterone glucuronide,HMDB0003193,b,b,C11134,b,FDB023122,tststeroneglc,[H]OC(=O)[C@@]1([H])O[C@@]([H])(O[C@@]2([H])C([H])([H])C([H])([H])[C@@]3([H])[C@]4([H])C([H])([H])C([H])([H])C5=C([H])C(=O)C([H])([H])C([H])([H])[C@]5(C([H])([H])[H])[C@@]4([H])C([H])([H])C([H])([H])[C@]23C([H])([H])[H])[C@]([H])(O[H])[C@@]([H])(O[H])[C@]1([H])O[H],NIKZPECGCSUSBV-HMAFJQTKSA-N,"InChI=1S/C25H36O8/c1-24-9-7-13(26)11-12(24)3-4-14-15-5-6-17(25(15,2)10-8-16(14)24)32-23-20(29)18(27)19(28)21(33-23)22(30)31/h11,14-21,23,27-29H,3-10H2,1-2H3,(H,30,31)/t14-,15-,16-,17-,18-,19-,20+,21-,23+,24-,25-/m0/s1"
628,24337,glutathione derivative,Any organonitrogen compound derived from the Glu-Cys-Gly tripeptide glutathione.,7627,KEGG COMPOUND accession,C05028,,,,,,,,,,,,,,,
629,22099,UDP-D-galactosamine,a,17604,KEGG COMPOUND accession,C02728,,,,,,,,,,,,,,,
630,1643,3-oxohexobarbital,"An organic cation that is 1,2,4,6-tetraoxohexahydropyrimidin-1-ium substituted by a cyclohex-1-en-1-yl group at position 5 and methyl groups at positions 3 and 5.",15799,KEGG COMPOUND accession,C04036,,,,,,,,,,,,,,,
631,2536,alangimarckine,A member of the class of beta-carbolines that is tubulosan bearing methoxy groups at positions 10 and 11 as well as a hydroxy group at position 9.,18425,KEGG COMPOUND accession,C11453,,,,,,,,,,,,,,,
632,11408,"2,3,4,5-tetrahydrodipicolinate(2-)","A dicarboxylic acid dianion resulting from deprotonation of both carboxy groups of 2,3,4,5-tetrahydrodipicolinic acid.",27920,KEGG COMPOUND accession,C06521,,,,,,,,,,,,,,,
633,26658,sesquiterpenoid,Any terpenoid derived from a sesquiterpene. The term includes compounds in which the C15 skeleton of the parent sesquiterpene has been rearranged or modified by the removal of one or more skeletal atoms (generally methyl groups).,27709,KEGG COMPOUND accession,C08837,,,,,,,,,,,,,,,
634,29995,aspartate(2-),A C4-dicarboxylate that is the dianion obtained by the deprotonation of both the carboxy groups of aspartic acid.,28865,KEGG COMPOUND accession,C05122,tchola,81-24-3,28865.0,"Human Metabolome Database (HMDB): Taurocholic acid is a bile acid and is the product of conjugation of cholic acid with taurine. Its sodium salt is the chief ingredient of the bile of carnivorous animals. Bile acids are steroid acids found predominantly in bile of mammals. The distinction between different bile acids is minute, depends only on presence or absence of hydroxyl groups on positions 3, 7, and 12. Bile acids are physiological detergents that facilitate excretion, absorption, and transport of fats and sterols in the intestine and liver. Bile acids are also steroidal amphipathic molecules derived from the catabolism of cholesterol. They modulate bile flow and lipid secretion, are essential for the absorption of dietary fats and vitamins, and have been implicated in the regulation of all the key enzymes involved in cholesterol homeostasis. Bile acids recirculate through the liver, bile ducts, small intestine and portal vein to form an enterohepatic circuit. They exist as anions at physiological pH and, consequently, require a carrier for transport across the membranes of the enterohepatic tissues. The unique detergent properties of bile acids are essential for the digestion and intestinal absorption of hydrophobic nutrients. Bile acids have potent toxic properties (e.g., membrane disruption) and there are a plethora of mechanisms to limit their accumulation in blood and tissues. (PMID: 11316487 , 16037564 , 12576301 , 11907135 ) Taurocholic acid, as with all bile acids, acts as a detergent to solubilize fats for absorption and is itself absorbed. It is used as a cholagogue and cholerectic (a bile purging agent). Hydrolysis of taurocholic acid yields taurine, a nonessential amino acid. Taurocholic acid is one of the main components of urinary nonsulfated bile acids in biliary atresia. Raised levels of the bile acid taurocholate in the fetal serum in obstetric cholestasis may result in the development of a fetal dysrhythmia and in sudden intra-uterine death. (PMID: 3944741 , 11256973 ).",Taurocholic acid,HMDB0000036,b,b,C05122,CPD-3743,FDB012335,tchola,[H]O[C@]1([H])C([H])([H])C([H])([H])[C@@]2(C([H])([H])[H])C([H])(C1([H])[H])C([H])([H])[C@@]([H])(O[H])C1([H])C3([H])C([H])([H])C([H])([H])C([H])([C@]([H])(C([H])([H])[H])C([H])([H])C([H])([H])C(=O)N([H])C([H])([H])C([H])([H])S(=O)(=O)O[H])[C@@]3(C([H])([H])[H])[C@@]([H])(O[H])C([H])([H])C21[H],WBWWGRHZICKQGZ-DFXZFZLWSA-N,"InChI=1S/C26H45NO7S/c1-15(4-7-23(31)27-10-11-35(32,33)34)18-5-6-19-24-20(14-22(30)26(18,19)3)25(2)9-8-17(28)12-16(25)13-21(24)29/h15-22,24,28-30H,4-14H2,1-3H3,(H,27,31)(H,32,33,34)/t15-,16?,17-,18?,19?,20?,21-,22+,24?,25+,26-/m1/s1"
635,29925,hydroxidotrioxidophosphate(.1-),a,18215,KEGG COMPOUND accession,C11620,,,,,,,,,,,,,,,
636,29926,hydroxidooxidophosphate(.1-),a,68329,KEGG COMPOUND accession,C10833,,,,,,,,,,,,,,,
637,29928,(dioxido)hydroxidodioxidophosphate(.1-),a,9380,KEGG COMPOUND accession,C01533,,,,,,,,,,,,,,,
638,29932,tetraoxidophosphate(.2-),a,9381,KEGG COMPOUND accession,C09738,,,,,,,,,,,,,,,
639,30044,vanadium monoxide,a,9427,KEGG COMPOUND accession,C10405,,,,,,,,,,,,,,,
640,30046,oxidovanadium(2+),a,9428,KEGG COMPOUND accession,C10533,,,,,,,,,,,,,,,
641,30048,dioxidovanadium(1+),a,9429,KEGG COMPOUND accession,C10534,,,,,,,,,,,,,,,
642,30050,gold(0),a,9430,KEGG COMPOUND accession,C10992,,,,,,,,,,,,,,,
643,30084,dicarbon(1+),a,9448,KEGG COMPOUND accession,C08079,,,,,,,,,,,,,,,
644,30086,carbon suboxide,a,9449,KEGG COMPOUND accession,C07129,,,,,,,,,,,,,,,
645,30092,hydrazino group,a,15702,KEGG COMPOUND accession,C06337,,,,,,,,,,,,,,,
646,29942,phosphanediide,a,16776,KEGG COMPOUND accession,C09244,,,,,,,,,,,,,,,
647,30210,fluorophosphoric acid,a,27650,KEGG COMPOUND accession,C09332,,,,,,,,,,,,,,,
648,4109,cathine,"An amphetamine that is propylbenzene substituted by a hydroxy group at position 1 and by an amino group at position 2 (the 1S,2S-stereoisomer).",28343,KEGG COMPOUND accession,C06630,,,,,,,,,,,,,,,
649,30135,alumanyl group,a,9467,KEGG COMPOUND accession,C11168,,,,,,,,,,,,,,,
650,30137,trihydridoaluminium(.1+),a,9468,KEGG COMPOUND accession,C07526,,,,,,,,,,,,,,,
651,30141,sodium tetrahydroaluminate,a,9470,KEGG COMPOUND accession,C06801,,,,,,,,,,,,,,,
652,1449,3-amino-2-oxopropyl phosphate,A oxoalkyl phosphate having 3-amino-2-oxopropyl as the oxoalkyl group.,37754,KEGG COMPOUND accession,C01297,,,,,,,,,,,,,,,
653,1865,4-hydroxyglucobrassicin,An indolylmethylglucosinolic acid that is glucobrassicin bearing a hydroxy substituent at position 4 on the indole ring.,36486,KEGG COMPOUND accession,C04103,,,,,,,,,,,,,,,
654,29858,isopropylidene group,a,9347,KEGG COMPOUND accession,C11301,HC02197,15324-64-8,b,"Human Metabolome Database (HMDB): Sulfolithocholylglycine is an acyl glycine and a bile acid-glycine conjugate. It is a secondary bile acid produced by the action of enzymes existing in the microbial flora of the colonic environment. In hepatocytes, both primary and secondary bile acids undergo amino acid conjugation at the C-24 carboxylic acid on the side chain, and almost all bile acids in the bile duct therefore exist in a glycine conjugated form (PMID:16949895). Sulfolithocholylglycine is a sulfated bile acids which has a greater renal clearance rate than lithocholylglycine.",Sulfolithocholylglycine,HMDB0002639,b,b,C11301,b,FDB023034,HC02197,[H]N(C(=O)C([H])([H])C([H])([H])[C@@]([H])(C([H])([H])[H])[C@@]1([H])C([H])([H])C([H])([H])[C@@]2([H])[C@]3([H])C([H])([H])C([H])([H])[C@]4([H])C([H])([H])[C@]([H])(OS([O-])(=O)=O)C([H])([H])C([H])([H])[C@]4(C([H])([H])[H])[C@@]3([H])C([H])([H])C([H])([H])[C@]12C([H])([H])[H])C([H])([H])C([O-])=O,FHXBAFXQVZOILS-OETIFKLTSA-L,"InChI=1S/C26H43NO7S/c1-16(4-9-23(28)27-15-24(29)30)20-7-8-21-19-6-5-17-14-18(34-35(31,32)33)10-12-25(17,2)22(19)11-13-26(20,21)3/h16-22H,4-15H2,1-3H3,(H,27,28)(H,29,30)(H,31,32,33)/p-2/t16-,17-,18-,19+,20-,21+,22+,25+,26-/m1/s1"
655,1159,2-hydroxyethylphosphonic acid,A phosphonic acid consisting of ethanol with the phospho group at the 2-position.,15667,KEGG COMPOUND accession,C04353,,,,,,,,,,,,,,,
656,30188,hydroxidooxidoaluminium,a,15635,KEGG COMPOUND accession,C00101,thf,135-16-0,20506.0,"Human Metabolome Database (HMDB): Tetrahydrofolate is a soluble coenzyme (vitamin B9) that is synthesized de novo by plants and microorganisms, and absorbed from the diet by animals. It is composed of three distinct parts: a pterin ring, a p-ABA (p-aminobenzoic acid) and a polyglutamate chain with a number of residues varying between 1 and 8. Only the tetra-reduced form of the molecule serves as a coenzyme for C1 transfer reactions. In biological systems, the C1-units exist under various oxidation states and the different tetrahydrofolate derivatives constitute a family of related molecules named indistinctly under the generic term folate. (PMID 16042593). Folate is important for cells and tissues that rapidly divide. Cancer cells divide rapidly, and drugs that interfere with folate metabolism are used to treat cancer. Methotrexate is a drug often used to treat cancer because it inhibits the production of the active form, tetrahydrofolate. Unfortunately, methotrexate can be toxic, producing side effects such as inflammation in the digestive tract that make it difficult to eat normally. -- Wikipedia; Signs of folic acid deficiency are often subtle. Diarrhea, loss of appetite, and weight loss can occur. Additional signs are weakness, sore tongue, headaches, heart palpitations, irritability, and behavioral disorders. Women with folate deficiency who become pregnant are more likely to give birth to low birth weight and premature infants, and infants with neural tube defects. In adults, anemia is a sign of advanced folate deficiency. In infants and children, folate deficiency can slow growth rate. Some of these symptoms can also result from a variety of medical conditions other than folate deficiency. It is important to have a physician evaluate these symptoms so that appropriate medical care can be given. -- Wikipedia; Folinic acid is a form of folate that can help 'rescue' or reverse the toxic effects of methotrexate. Folinic acid is not the same as folic acid. Folic acid supplements have little established role in cancer chemotherapy. There have been cases of severe adverse effects of accidental substitution of folic acid for folinic acid in patients receiving methotrexate cancer chemotherapy. It is important for anyone receiving methotrexate to follow medical advice on the use of folic or folinic acid supplements. -- Wikipedia. Low concentrations of folate, vitamin B12, or vitamin B6 may increase the level of homocysteine, an amino acid normally found in blood. There is evidence that an elevated homocysteine level is an independent risk factor for heart disease and stroke. The evidence suggests that high levels of homocysteine may damage coronary arteries or make it easier for blood clotting cells called platelets to clump together and form a clot. However, there is currently no evidence available to suggest that lowering homocysteine with vitamins will reduce your risk of heart disease. Clinical intervention trials are needed to determine whether supplementation with folic acid, vitamin B12 or vitamin B6 can lower your risk of developing coronary heart disease. -- Wikipedia.",Tetrahydrofolic acid,HMDB0001846,b,b,C00101,THF,FDB022705,thf,[H]OC1=NC(=NC2=C1N([H])C([H])(C([H])([H])N([H])C1=C([H])C([H])=C(C([H])=C1[H])C(=O)N([H])C([H])(C([O-])=O)C([H])([H])C([H])([H])C([O-])=O)C([H])([H])N2[H])N([H])[H],MSTNYGQPCMXVAQ-UHFFFAOYSA-L,"InChI=1S/C19H23N7O6/c20-19-25-15-14(17(30)26-19)23-11(8-22-15)7-21-10-3-1-9(2-4-10)16(29)24-12(18(31)32)5-6-13(27)28/h1-4,11-12,21,23H,5-8H2,(H,24,29)(H,27,28)(H,31,32)(H4,20,22,25,26,30)/p-2"
657,2533,alachlor,"An aromatic amide that is N-(2,6-diethylphenyl)acetamide substituted by a methoxymethyl group at at the nitrogen atom while one of the hydrogens of the methyl group has been replaced by a chlorine atom.",16413,KEGG COMPOUND accession,C02497,,,,,,,,,,,,,,,
658,5731,hispidol,A hydroxyaurone that is aurone substituted by hydroxy groups at positions 6 and 4' respectively.,16925,KEGG COMPOUND accession,C04456,,,,,,,,,,,,,,,
659,3020,benzalkonium chloride,"A class of quaternary ammonium chloride salts in which the nitrogen is substituted by a benzyl group, two methyl groups and an even-numbered alkyl chain.",28636,KEGG COMPOUND accession,C05814,,,,,,,,,,,,,,,
660,3391,carbazole,a,15692,KEGG COMPOUND accession,C07349,,,,,,,,,,,,,,,
661,18638,"(N-acetyl-beta-D-glucosaminyl-1,2)-alpha-D-mannosyl-1,3-(beta-N-acetyl-D-glucosaminyl-1,2-alpha-D-mannosyl-1,6)-beta-D-mannosyl group",a,28499,KEGG COMPOUND accession,C05903,,,,,,,,,,,,,,,
662,13043,3-amino-L-alaninate,a,18044,KEGG COMPOUND accession,C02146,,,,,,,,,,,,,,,
663,5404,glucoerucin(1-),A thia-alkylglucosinolate that has a 4-(methylsulfanyl)butyl side chain attached to the sulfonated oxime group.,28492,KEGG COMPOUND accession,C05281,,,,,,,,,,,,,,,
664,29537,avermectin B1b,a,35341,KEGG COMPOUND accession,C00377,,,,,,,,,,,,,,,
665,9179,sodium nitroprusside dihydrate,A hydrate that is the dihydrate form of sodium nitroprusside.,15517,KEGG COMPOUND accession,C00136,btcoa,2140-48-9,57371.0,"Human Metabolome Database (HMDB): Butyryl-CoA is an intermediate in the metabolism of Butanoate. It is a substrate for Acyl-coenzyme A oxidase 3 (peroxisomal), 3-ketoacyl-CoA thiolase (mitochondrial), 3-ketoacyl-CoA thiolase (peroxisomal), Acyl-coenzyme A oxidase 1 (peroxisomal), Acyl-CoA dehydrogenase (medium-chain specific, mitochondrial), Acyl-CoA dehydrogenase (long-chain specific, mitochondrial), Acyl-coenzyme A oxidase 2 (peroxisomal), Acetyl-CoA acetyltransferase (mitochondrial), Acetyl-CoA acetyltransferase (cytosolic), Acyl-CoA dehydrogenase (short-chain specific, mitochondrial) and Trifunctional enzyme beta subunit (mitochondrial).",Butyryl-CoA,HMDB0001088,b,b,C00136,CPD-12174,FDB022419,btcoa,[H]O[C@@]([H])(C(=O)N([H])C([H])([H])C([H])([H])C(=O)N([H])C([H])([H])C([H])([H])SC(=O)C([H])([H])C([H])([H])C([H])([H])[H])C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])OP([O-])(=O)OP([O-])(=O)OC([H])([H])[C@@]1([H])O[C@@]([H])(N2C([H])=NC3=C(N=C([H])N=C23)N([H])[H])[C@]([H])(O[H])[C@]1([H])OP([O-])([O-])=O,CRFNGMNYKDXRTN-BTRAQTFYSA-J,"InChI=1S/C25H42N7O17P3S/c1-4-5-16(34)53-9-8-27-15(33)6-7-28-23(37)20(36)25(2,3)11-46-52(43,44)49-51(41,42)45-10-14-19(48-50(38,39)40)18(35)24(47-14)32-13-31-17-21(26)29-12-30-22(17)32/h12-14,18-20,24,35-36H,4-11H2,1-3H3,(H,27,33)(H,28,37)(H,41,42)(H,43,44)(H2,26,29,30)(H2,38,39,40)/p-4/t14-,18-,19-,20+,24-/m0/s1"
666,29325,oxidooxomethyl,An organic radical anion obtained from carbon dioxide. It is a metabolite of carbon tetrachloride.,9173,KEGG COMPOUND accession,C06185,,,,,,,,,,,,,,,
667,26178,polyester macromolecule,A macromolecule composed of units connected by carboxylic ester (-O-CO-) linkages.,15958,KEGG COMPOUND accession,C01241,C01241,b,15958.0,b,Phosphatidyl-N-Methylethanolamine,b,b,b,C01241,b,b,b,[H]OP(=O)(OC([H])([H])C([H])([H])N([H])C([H])([H])[H])OC([H])([H])C([H])(OC([*])=O)C([H])([H])OC([*])=O,b,b
668,26178,polyester macromolecule,A macromolecule composed of units connected by carboxylic ester (-O-CO-) linkages.,15958,KEGG COMPOUND accession,C01241,M02686,b,15958.0,b,Pe-Nme-Ld-Pool,b,b,b,C01241,b,b,M02686,[H]OP(=O)(OC([H])([H])C([H])([H])N([H])C([H])([H])[H])OC([H])([H])C([H])(OC([*])=O)C([H])([H])OC([*])=O,b,b
669,8497,propoxyphene,"A racemate of the (1R,2R)- and (1S,2R)- diastereoisomers.",2929,KEGG COMPOUND accession,C09478,,,,,,,,,,,,,,,
670,6364,laminarin,A polysaccharide composed of beta-(1->3)-linked glucose residues containing sporadic beta-(1->6)-linkages as branch points or inter-residue linkages and 2-3% D-mannitol at some reducing termini.,15422,KEGG COMPOUND accession,C00002,atp,56-65-5,15422.0,"Human Metabolome Database (HMDB): Adenosine triphosphate (ATP) is a nucleotide consisting of a purine base (adenine) attached to the first carbon atom of ribose (a pentose sugar). Three phosphate groups are esterified at the fifth carbon atom of the ribose. ATP is incorporated into nucleic acids by polymerases in the processes of DNA replication and transcription. ATP contributes to cellular energy charge and participates in overall energy balance, maintaining cellular homeostasis. ATP can act as an extracellular signaling molecule via interactions with specific purinergic receptors to mediate a wide variety of processes as diverse as neurotransmission, inflammation, apoptosis, and bone remodelling. Extracellular ATP and its metabolite adenosine have also been shown to exert a variety of effects on nearly every cell type in human skin, and ATP seems to play a direct role in triggering skin inflammatory, regenerative, and fibrotic responses to mechanical injury, an indirect role in melanocyte proliferation and apoptosis, and a complex role in Langerhans cell-directed adaptive immunity. During exercise, intracellular homeostasis depends on the matching of adenosine triphosphate (ATP) supply and ATP demand. Metabolites play a useful role in communicating the extent of ATP demand to the metabolic supply pathways. Effects as different as proliferation or differentiation, chemotaxis, release of cytokines or lysosomal constituents, and generation of reactive oxygen or nitrogen species are elicited upon stimulation of blood cells with extracellular ATP. The increased concentration of adenosine triphosphate (ATP) in erythrocytes from patients with chronic renal failure (CRF) has been observed in many studies but the mechanism leading to these abnormalities still is controversial. (PMID: 15490415, 15129319, 14707763, 14696970, 11157473).",Adenosine triphosphate,HMDB0000538,b,b,C00002,ATP,FDB021813,atp,[H]O[C@@]1([H])[C@@]([H])(O[C@]([H])(C([H])([H])OP([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O)[C@@]1([H])O[H])N1C([H])=NC2=C(N=C([H])N=C12)N([H])[H],ZKHQWZAMYRWXGA-KQYNXXCUSA-J,"InChI=1S/C10H16N5O13P3/c11-8-5-9(13-2-12-8)15(3-14-5)10-7(17)6(16)4(26-10)1-25-30(21,22)28-31(23,24)27-29(18,19)20/h2-4,6-7,10,16-17H,1H2,(H,21,22)(H,23,24)(H2,11,12,13)(H2,18,19,20)/p-4/t4-,6-,7-,10-/m1/s1"
671,6364,laminarin,A polysaccharide composed of beta-(1->3)-linked glucose residues containing sporadic beta-(1->6)-linkages as branch points or inter-residue linkages and 2-3% D-mannitol at some reducing termini.,15422,KEGG COMPOUND accession,C00002,HC02111,56-65-5,15422.0,"Human Metabolome Database (HMDB): Adenosine triphosphate (ATP) is a nucleotide consisting of a purine base (adenine) attached to the first carbon atom of ribose (a pentose sugar). Three phosphate groups are esterified at the fifth carbon atom of the ribose. ATP is incorporated into nucleic acids by polymerases in the processes of DNA replication and transcription. ATP contributes to cellular energy charge and participates in overall energy balance, maintaining cellular homeostasis. ATP can act as an extracellular signaling molecule via interactions with specific purinergic receptors to mediate a wide variety of processes as diverse as neurotransmission, inflammation, apoptosis, and bone remodelling. Extracellular ATP and its metabolite adenosine have also been shown to exert a variety of effects on nearly every cell type in human skin, and ATP seems to play a direct role in triggering skin inflammatory, regenerative, and fibrotic responses to mechanical injury, an indirect role in melanocyte proliferation and apoptosis, and a complex role in Langerhans cell-directed adaptive immunity. During exercise, intracellular homeostasis depends on the matching of adenosine triphosphate (ATP) supply and ATP demand. Metabolites play a useful role in communicating the extent of ATP demand to the metabolic supply pathways. Effects as different as proliferation or differentiation, chemotaxis, release of cytokines or lysosomal constituents, and generation of reactive oxygen or nitrogen species are elicited upon stimulation of blood cells with extracellular ATP. The increased concentration of adenosine triphosphate (ATP) in erythrocytes from patients with chronic renal failure (CRF) has been observed in many studies but the mechanism leading to these abnormalities still is controversial. (PMID: 15490415, 15129319, 14707763, 14696970, 11157473).",Adenosine triphosphate,HMDB0000538,b,b,C00002,ATP,FDB021813,b,[H]O[C@]1([H])[C@]([H])(O[H])[C@]([H])(O[C@@]1([H])N1C([H])=NC2=C1N=C([H])N=C2N([H])[H])C([H])([H])OP(=O)(O[H])OP(=O)(O[H])OP(=O)(O[H])O[H],ZKHQWZAMYRWXGA-KQYNXXCUSA-N,"InChI=1S/C10H16N5O13P3/c11-8-5-9(13-2-12-8)15(3-14-5)10-7(17)6(16)4(26-10)1-25-30(21,22)28-31(23,24)27-29(18,19)20/h2-4,6-7,10,16-17H,1H2,(H,21,22)(H,23,24)(H2,11,12,13)(H2,18,19,20)/t4-,6-,7-,10-/m1/s1"
672,13796,S-polyprenyl-L-cysteine,An S-hydrocarbyl-L-cysteine in which the hydrocarbyl component can be any polyprenyl group.,16933,KEGG COMPOUND accession,C01694,,,,,,,,,,,,,,,
673,29808,nitridooxidocarbon(.),a,9336,KEGG COMPOUND accession,C07659,,,,,,,,,,,,,,,
674,29810,isocyanato group,a,9337,KEGG COMPOUND accession,C11169,,,,,,,,,,,,,,,
675,29812,nitridooxidocarbonate(.2-),a,18318,KEGG COMPOUND accession,C06125,,,,,,,,,,,,,,,
676,29816,iminomethylidene group,a,9339,KEGG COMPOUND accession,C11125,,,,,,,,,,,,,,,
677,29818,hydroxidonitridocarbonate(.1-),a,16385,KEGG COMPOUND accession,C00297,,,,,,,,,,,,,,,
678,29826,disulfanediyl group,a,9341,KEGG COMPOUND accession,C01615,,,,,,,,,,,,,,,
679,29827,sulfinothioyl group,a,9342,KEGG COMPOUND accession,C07317,,,,,,,,,,,,,,,
680,29829,sulfinimidoyl group,a,102484,KEGG COMPOUND accession,C07318,,,,,,,,,,,,,,,
681,29831,sulfido group,a,48854,KEGG COMPOUND accession,C00094,so3,14265-45-3,17359.0,"Human Metabolome Database (HMDB): Endogenous sulfite is generated as a consequence of the body's normal processing of sulfur-containing amino acids. Sulfites occur as a consequence of fermentation and also occur naturally in a number of foods and beverages. As food additives, sulfiting agents were first used in 1664 and have been approved in the United States since the 1800s. Sulfite is an allergen, a neurotoxin, and a metabotoxin.  An allergen is a compound that causes allergic reactions such as wheezing, rash, or rhinitis. A neurotoxin is a substance that causes damage to nerves or brain tissues. A metabotoxin is an endogenously produced metabolite that causes adverse health effects at chronically high levels. As an allergen, sulfite is known to induce asthmatic reactions. Sulfite sensitivity occurs most often in asthmatic adults (predominantly women), but it is also occasionally reported in preschool children. Adverse reactions to sulfites in nonasthmatics are extremely rare. Asthmatics who are steroid-dependent or who have a higher degree of airway hyperreactivity may be at greater risk of experiencing a reaction to sulfite-containing foods. Sulfite sensitivity reactions vary widely, ranging from no reaction to severe. The majority of reactions are mild. These manifestations may include dermatologic, respiratory, or gastrointestinal signs and symptoms. The precise mechanisms of the sensitivity responses have not been completely elucidated: inhalation of sulfur dioxide (SO2) generated in the stomach following ingestion of sulfite-containing foods or beverages, a deficiency in a mitochondrial enzyme, and an IgE-mediated immune response have all been implicated. Exogenously supplied sulfite is detoxified by the enzyme sulfite oxidase. Sulfite oxidase (EC 1.8.3.1) is 1 of 3 enzymes in humans that require molybdenum as a cofactor. Under certain circumstances, chronically high levels of sulfite can lead to serious neurotoxicity. Sulfite oxidase deficiency (also called molybdenum cofactor deficiency) is a rare autosomal inherited disease that is typified by high concentrations of sulfite in the blood and urine. It is characterized by severe neurological symptoms such as untreatable seizures, attenuated growth of the brain, and mental retardation. It results from defects in the enzyme sulfite oxidase, which is responsible for the oxidation of sulfite to sulfate. This sulfite to sulfate reaction is the final step in the degradation of sulfur-containing metabolites (including the amino acids cysteine and methionine). The term ""isolated sulfite oxidase deficiency"" is used to define the deficiency caused by mutations in the sulfite oxidase gene. This differentiates it from another version of sulfite oxidase deficiency that is due to defects in the molybdenum cofactor biosynthetic pathway (with mutations in the MOCS1 or MOCS2 genes). Isolated sulfite oxidase deficiency is a rare but devastating neurologic disease that usually presents in early infancy with seizures and alterations in muscle tone (PMID: 16234925, 16140720, 8586770). Sulfite oxidase deficiency (as caused by MOCS1 or MOCS2) may be treated with cPMP, a precursor of the molybdenum cofactor (PMID: 20385644).  The mechanism behind sulfite neurotoxicity appears to be related to its ability to bind and inhibit glutamate dehydrogenase (GDH). Inhibition of GDH leads to a decrease in alpha-ketoglutarate and a diminished flux through the tricarboxylic acid cycle. This is accompanied by a decrease in NADH through the mitochondrial electron transport chain, which leads to a decrease in mitochondrial membrane potential and in ATP synthesis. Since glutamate is a major metabolite in the brain, inhibition of GDH by sulfite appears to contribute to neural damage characteristic of sulfite oxidase deficiency in human infants (PMID: 15273247).",Sulfite,HMDB0000240,b,b,C00094,SO3,FDB021915,so3,[O-]S([O-])=O,LSNNMFCWUKXFEE-UHFFFAOYSA-L,"InChI=1S/H2O3S/c1-4(2)3/h(H2,1,2,3)/p-2"
682,29951,D-cysteine residue,a,9391,KEGG COMPOUND accession,C11751,,,,,,,,,,,,,,,
683,29955,D-tryptophan residue,a,67492,KEGG COMPOUND accession,C10188,,,,,,,,,,,,,,,
684,29961,L-aspartate residue,a,41774,KEGG COMPOUND accession,C07108,,,,,,,,,,,,,,,
685,29965,L-argininium residue,a,9398,KEGG COMPOUND accession,C07124,,,,,,,,,,,,,,,
686,29969,L-lysinium residue,a,9400,KEGG COMPOUND accession,C10190,,,,,,,,,,,,,,,
687,29973,L-glutamate residue,a,9402,KEGG COMPOUND accession,C08637,,,,,,,,,,,,,,,
688,29977,L-tyrosinate residue,a,9405,KEGG COMPOUND accession,C07574,,,,,,,,,,,,,,,
689,29979,L-histidine residue,a,15891,KEGG COMPOUND accession,C00245,taur,107-35-7,15891.0,"Human Metabolome Database (HMDB): Taurine is a sulfur amino acid like methionine, cystine, cysteine and homocysteine. It is a lesser-known amino acid because it is not incorporated into the structural building blocks of protein. Yet taurine is an essential amino acid in pre-term and newborn infants of humans and many other species. Adults can synthesize their own taurine, yet are probably dependent in part on dietary taurine. Taurine is abundant in the brain, heart, breast, gallbladder and kidney and has important roles in health and disease in these organs. Taurine has many diverse biological functions serving as a neurotransmitter in the brain, a stabilizer of cell membranes and a facilitator in the transport of ions such as sodium, potassium, calcium and magnesium. Taurine is highly concentrated in animal and fish protein, which are good sources of dietary taurine. It can be synthesized by the body from cysteine when vitamin B6 is present. Deficiency of taurine occurs in premature infants and neonates fed formula milk, and in various disease states. Inborn errors of taurine metabolism have been described. OMIM 168605, an unusual neuropsychiatric disorder inherited in an autosomal dominant fashion through 3 generations of a family. Symptoms began late in the fifth decade in 6 affected persons and death occurred after 4 to 6 years. The earliest and most prominent symptom was mental depression not responsive to antidepressant drugs or electroconvulsive therapy. Sleep disturbances, exhaustion and marked weight loss were features. Parkinsonism developed later, and respiratory failure occurred terminally. OMIM 145350 describes congestive cardiomyopathy and markedly elevated urinary taurine levels (about 5 times normal). Other family members had late or holosystolic mitral valve prolapse and elevated urinary taurine values (about 2.5 times normal). In 2 with mitral valve prolapse, congestive cardiomyopathy eventually developed while the amounts of urinary taurine doubled. Taurine, after GABA, is the second most important inhibitory neurotransmitter in the brain. Its inhibitory effect is one source of taurine's anticonvulsant and antianxiety properties. It also lowers glutamic acid in the brain, and preliminary clinical trials suggest taurine may be useful in some forms of epilepsy. Taurine in the brain is usually associated with zinc or manganese. The amino acids alanine and glutamic acid, as well as pantothenic acid, inhibit taurine metabolism while vitamins A and B6, zinc and manganese help build taurine. Cysteine and B6 are the nutrients most directly involved in taurine synthesis. Taurine levels have been found to decrease significantly in many depressed patients. One reason that the findings are not entirely clear is because taurine is often elevated in the blood of epileptics who need it. It is often difficult to distinguish compensatory changes in human biochemistry from true metabolic or deficiency disease. Low levels of taurine are found in retinitis pigmentosa. Taurine deficiency in experimental animals produces degeneration of light-sensitive cells. Therapeutic applications of taurine to eye disease are likely to be forthcoming. Taurine has many important metabolic roles. Supplements can stimulate prolactin and insulin release. The parathyroid gland makes a peptide hormone called glutataurine (glutamic acid-taurine), which further demonstrates taurine's role in endocrinology. Taurine increases bilirubin and cholesterol excretion in bile, critical to normal gallbladder function. It seems to inhibit the effect of morphine and potentiates the effects of opiate antagonists. Low plasma taurine levels have been found in a variety of conditions, i.e., depression, hypertension, hypothyroidism, gout, institutionalized patients, infertility, obesity, kidney failure and others (http://www.dcnutrition.com/AminoAcids/). Moreover, taurine is found to be associated with maple syrup urine disease, which is an inborn error of metabolism.",Taurine,HMDB0000251,b,b,C00245,b,FDB003191,taur,[H][N+]([H])([H])C([H])([H])C([H])([H])S([O-])(=O)=O,XOAAWQZATWQOTB-UHFFFAOYSA-N,"InChI=1S/C2H7NO3S/c3-1-2-7(4,5)6/h1-3H2,(H,4,5,6)"
690,13392,NAD(P)H,A coenzyme that may be NADH or NADPH.,46761,KEGG COMPOUND accession,C00107,,,,,,,,,,,,,,,
691,29873,oxidobromine(1+),a,9352,KEGG COMPOUND accession,C01531,,,,,,,,,,,,,,,
692,29875,bromidodioxygen(.),a,16159,KEGG COMPOUND accession,C00495,,,,,,,,,,,,,,,
693,29881,bromyl group,a,9355,KEGG COMPOUND accession,C08730,,,,,,,,,,,,,,,
694,5717,high-mannose oligosaccharide,Any oligosaccharide derivative which typically contains unsubstituted terminal mannose sugars with between five and nine mannose residues attached to the chitobiose [(GlcNAc)2] core.,15944,KEGG COMPOUND accession,C05203,,,,,,,,,,,,,,,
695,5870,imidacloprid,An imidazolidine that is N-nitroimidazolidin-2-imine bearing a (6-chloro-3-pyridinyl)methyl substituent at position 1.,2295,KEGG COMPOUND accession,C05291,,,,,,,,,,,,,,,
696,4705,double-stranded DNA,a,28546,KEGG COMPOUND accession,C11014,,,,,,,,,,,,,,,
697,21977,O-(N-acetylglucosamine-1-phosphoryl)-L-serine,An N-acyl-D-glucosamine 1-phosphate in which the phosphate group of 2-(acetylamino)-2-deoxyglucose 1-phosphate is esterified by the alcoholic hydroxy group of L-serine.,15827,KEGG COMPOUND accession,C01201,M02496,b,15827.0,b,N(Omega)-(Adenosine-5'-Diphosphate-D-Ribosyl)-L-Arginine,b,b,b,C01201,b,b,b,[H]OC(=O)[C@@]([H])(N([H])[H])C([H])([H])C([H])([H])C([H])([H])N([H])C(=N[H])N([H])[C@@]1([H])O[C@]([H])(C([H])([H])OP(=O)(O[H])OP(=O)(O[H])OC([H])([H])[C@@]2([H])O[C@@]([H])(N3C([H])=NC4=C3N=C([H])N=C4N([H])[H])[C@]([H])(O[H])[C@]2([H])O[H])[C@@]([H])(O[H])[C@@]1([H])O[H],IWVSYNGKNZFSSA-PTDVUUCPSA-N,"InChI=1S/C21H35N9O15P2/c22-8(20(35)36)2-1-3-25-21(24)29-18-14(33)12(31)9(43-18)4-41-46(37,38)45-47(39,40)42-5-10-13(32)15(34)19(44-10)30-7-28-11-16(23)26-6-27-17(11)30/h6-10,12-15,18-19,31-34H,1-5,22H2,(H,35,36)(H,37,38)(H,39,40)(H2,23,26,27)(H3,24,25,29)/t8-,9+,10+,12+,13+,14+,15+,18-,19+/m0/s1"
698,19549,2-deoxy-20-hydroxyecdysone 22-phosphate,a,48649,KEGG COMPOUND accession,C00247,srb_L,87-79-6,10295.0,Human Metabolome Database (HMDB): Sorbose is a ketose belonging to the group of sugars known as monosaccharides. The commercial production of vitamin C (ascorbic acid) often begins with sorbose.,L-Sorbose,HMDB0001266,b,b,C00247,SORBOSE,FDB001126,b,[H]OC([H])([H])[C@@]1(O[H])OC([H])([H])[C@]([H])(O[H])[C@@]([H])(O[H])[C@]1([H])O[H],LKDRXBCSQODPBY-BGPJRJDNSA-N,"InChI=1S/C6H12O6/c7-2-6(11)5(10)4(9)3(8)1-12-6/h3-5,7-11H,1-2H2/t3-,4+,5-,6+/m0/s1"
699,19954,3-O-acetylecdysone 2-phosphate,a,35672,KEGG COMPOUND accession,C07271,,,,,,,,,,,,,,,
700,1406,"3,5-dimethoxy-1,6-dihydroxyxanthone",A member of the class of xanthones that is 9H-xanthen-9-one substituted by methoxy groups at positions 3 and 5 and hydroxy groups at positions 1 and 6.,16968,KEGG COMPOUND accession,C04277,,,,,,,,,,,,,,,
701,7448,nafcillin sodium,a,17709,KEGG COMPOUND accession,C00224,aps,485-84-7,17709.0,"Human Metabolome Database (HMDB): Adenosine phosphosulfate (also known as APS) is the initial compound formed by the action of ATP sulfurylase (or PAPS synthetase) on sulfate ions after sulfate uptake. PAPS synthetase 1 is a bifunctional enzyme with both ATP sulfurylase and APS kinase activity, which mediates two steps in the sulfate activation pathway. The first step is the transfer of a sulfate group to ATP to yield adenosine 5'-phosphosulfate (APS), and the second step is the transfer of a phosphate group from ATP to APS yielding 3'-phosphoadenylylsulfate (PAPS). In mammals, PAPS is the sole source of sulfate; APS appears to be only an intermediate in the sulfate-activation pathway.",Adenosine phosphosulfate,HMDB0001003,b,b,C00224,APS,FDB022362,aps,[H]O[C@@]1([H])[C@@]([H])(O[C@]([H])(C([H])([H])OP([O-])(=O)OS([O-])(=O)=O)[C@@]1([H])O[H])N1C([H])=NC2=C(N=C([H])N=C12)N([H])[H],IRLPACMLTUPBCL-KQYNXXCUSA-L,"InChI=1S/C10H14N5O10PS/c11-8-5-9(13-2-12-8)15(3-14-5)10-7(17)6(16)4(24-10)1-23-26(18,19)25-27(20,21)22/h2-4,6-7,10,16-17H,1H2,(H,18,19)(H2,11,12,13)(H,20,21,22)/p-2/t4-,6-,7-,10-/m1/s1"
702,24026,fatty alcohol,An aliphatic alcohol consisting of a chain of 3 to greater than 27 carbon atoms. Fatty alcohols may be saturated or unsaturated and may be branched or unbranched.,27669,KEGG COMPOUND accession,C09803,,,,,,,,,,,,,,,
703,10016,vobtusine,a,3443,KEGG COMPOUND accession,C09070,,,,,,,,,,,,,,,
704,19555,2-deoxy-D-glucoside,A D-glucoside compound with the 2-hydroxy substituent either absent or replaced by a different functional group.,6307,KEGG COMPOUND accession,C06312,,,,,,,,,,,,,,,
705,11893,"3alpha,12alpha-dihydroxy-7-oxo-5beta-cholanate",a,28602,KEGG COMPOUND accession,C00665,f26bp,b,28602.0,"Human Metabolome Database (HMDB): D-Fructose 2,6-bisphosphate is a regulatory molecule controlling the activity of the enzyme Phosphofructokinase-1 or PFK1 (in mammals). PFK1, in turn, is the key regulatory enzyme in the central metabolic pathway Glycolysis. D-Fructose 2,6-bisphosphate has the effect of increasing the activity of PFK1, thus increasing the rate at which the principle food molecule glucose is broken down. At the same time, this regulatory molecule also inhibits the opposing enzyme (FBPase1) in the reverse pathway (gluconeogenesis) so that the synthesis of glucose is not taking place in the same cell where glucose is being broken down (which would be wasteful) (Wikipedia).","D-Fructose 2,6-bisphosphate",HMDB0001047,b,b,C00665,CPD-535,FDB022390,f26bp,[H]OC([H])([H])[C@@]1(OP([O-])([O-])=O)O[C@]([H])(C([H])([H])OP([O-])([O-])=O)[C@@]([H])(O[H])[C@]1([H])O[H],YXWOAJXNVLXPMU-ZXXMMSQZSA-J,"InChI=1S/C6H14O12P2/c7-2-6(18-20(13,14)15)5(9)4(8)3(17-6)1-16-19(10,11)12/h3-5,7-9H,1-2H2,(H2,10,11,12)(H2,13,14,15)/p-4/t3-,4-,5+,6+/m1/s1"
706,26788,streptomycins,a,15442,KEGG COMPOUND accession,C03428,HC01118,29849-75-0,15442.0,Human Metabolome Database (HMDB): Presqualene diphosphate is an intermediate in the biosynthesis of Terpenoid. It is a substrate for Farnesyl-diphosphate farnesyltransferase.,Presqualene diphosphate,HMDB0001278,b,b,C03428,CPD-465,FDB022531,HC01118,[H]C(=C(C([H])([H])[H])C([H])([H])[H])C([H])([H])C([H])([H])C(=C(/[H])C([H])([H])C([H])([H])C(=C(/[H])[C@@]1([H])[C@]([H])(C([H])([H])OP([O-])(=O)OP([O-])([O-])=O)[C@@]1(C([H])([H])[H])C([H])([H])C([H])([H])C(\[H])=C(/C([H])([H])[H])C([H])([H])C([H])([H])C([H])=C(C([H])([H])[H])C([H])([H])[H])\C([H])([H])[H])\C([H])([H])[H],ATZKAUGGNMSCCY-VYCBRMPGSA-K,"InChI=1S/C30H52O7P2/c1-23(2)13-9-15-25(5)17-11-18-27(7)21-28-29(22-36-39(34,35)37-38(31,32)33)30(28,8)20-12-19-26(6)16-10-14-24(3)4/h13-14,17,19,21,28-29H,9-12,15-16,18,20,22H2,1-8H3,(H,34,35)(H2,31,32,33)/p-3/b25-17+,26-19+,27-21+/t28-,29-,30-/m0/s1"
707,19834,"3',5'-cyclic purine nucleotide",a,6408,KEGG COMPOUND accession,C08382,,,,,,,,,,,,,,,
708,25741,oxide,An oxide is a chemical compound of oxygen with other chemical elements.,7934,KEGG COMPOUND accession,C00832,,,,,,,,,,,,,,,
709,27258,uroporphyrinogen,a,15430,KEGG COMPOUND accession,C02191,ppp9,553-12-8,15430.0,"Human Metabolome Database (HMDB): Protoporphyrins are tetrapyrroles containing 4 methyl, 2 propionic, and 2 vinyl side chains. Protoporphyrin is produced by oxidation of the methylene bridge of protoporphyrinogen. Protoporphyrin IX is the only naturally occurring isomer; it is an intermediate in heme biosynthesis, combining with ferrous iron to form protoheme IX, the heme prosthetic group of hemoglobin. Protoporphyrin IX is created by the enzyme protoporphyrinogen oxidase. The enzyme ferrochelatase converts it into heme. Protoporphyrin IX naturally occurs in small amounts in feces. Protoporphyrin IX is also responsible for the brown pigment (ooporphyrin) of birds' eggs. Protoporphyrin IX is used as a branch point in the biosynthetic pathway leading to heme (by insertion of iron) and chlorophylls (by insertion of Mg and further side-chain transformation). Protoporphyrin IX can be used to treat liver disorders, mainly as the sodium salt. Under certain conditions, protoporphyrin IX can act as a neurotoxin, a phototoxin, and a metabotoxin. A neurotoxin causes damage to nerve cells and nerve tissues. A phototoxin causes cell damage upon exposure to light. A metabotoxin is an endogenously produced metabolite that causes adverse health effects at chronically high levels. Chronically high levels of porphyrins are associated with porphyrias such as porphyria variegate, acute intermittent porphyria, and hereditary coproporphyria (HCP). In particular, it is accumulated and excreted excessively in the feces in acute intermittent porphyria, protoporphyria, and variegate porphyria. There are several types of porphyrias (most are inherited). Hepatic porphyrias are characterized by acute neurological attacks (seizures, psychosis, extreme back and abdominal pain, and an acute polyneuropathy), while the erythropoietic forms present with skin problems (usually a light-sensitive blistering rash and increased hair growth). The neurotoxicity of porphyrins may be due to their selective interactions with tubulin, which disrupt microtubule formation and cause neural malformations (PMID: 3441503).",Protoporphyrin IX,HMDB0000241,b,b,C02191,PROTOPORPHYRIN_IX,FDB004277,ppp9,[H]C([H])=C([H])C1=C(C2=N\C\1=C([H])/C1=C(C(=C(N1[H])\C([H])=C1/N=C(/C(/[H])=C3\N([H])/C(=C\2/[H])C(C([H])=C([H])[H])=C3C([H])([H])[H])C(=C1C([H])([H])C([H])([H])C([O-])=O)C([H])([H])[H])C([H])([H])C([H])([H])C([O-])=O)C([H])([H])[H])C([H])([H])[H],KSFOVUSSGSKXFI-UJJXFSCMSA-L,"InChI=1S/C34H34N4O4/c1-7-21-17(3)25-13-26-19(5)23(9-11-33(39)40)31(37-26)16-32-24(10-12-34(41)42)20(6)28(38-32)15-30-22(8-2)18(4)27(36-30)14-29(21)35-25/h7-8,13-16,35,38H,1-2,9-12H2,3-6H3,(H,39,40)(H,41,42)/p-2/b25-13-,26-13-,27-14-,28-15-,29-14-,30-15-,31-16-,32-16-"
710,27349,xylose phosphate,a,8633,KEGG COMPOUND accession,C10524,,,,,,,,,,,,,,,
711,3367,capensinidin,"An anthocyanidin cation consisting of benzopyrylium with hydroxy substituents at positions 3 and 7, a methoxy group at  position 5 and a 4-hydroxy-3,5-dimethoxyphenyl group at position 2 respectively.",16356,KEGG COMPOUND accession,C00942,35cgmp,7665-99-8,16356.0,"Human Metabolome Database (HMDB): Guanosine cyclic 3',5'-(hydrogen phosphate). A guanine nucleotide containing one phosphate group which is esterified to the sugar moiety in both the 3'- and 5'-positions. It is a cellular regulatory agent and has been described as a second messenger. Its levels increase in response to a variety of hormones, including acetylcholine, insulin, and oxytocin and it has been found to activate specific protein kinases. (From Merck Index, 11th ed).",Cyclic GMP,HMDB0001314,b,b,C00942,CGMP,FDB022549,35cgmp,[H]O[C@@]1([H])[C@@]([H])(O[C@]2([H])C([H])([H])OP([O-])(=O)O[C@@]12[H])N1C([H])=NC2=C1N=C(N([H])[H])N([H])C2=O,ZOOGRGPOEVQQDX-UUOKFMHZSA-M,"InChI=1S/C10H12N5O7P/c11-10-13-7-4(8(17)14-10)12-2-15(7)9-5(16)6-3(21-9)1-20-23(18,19)22-6/h2-3,5-6,9,16H,1H2,(H,18,19)(H3,11,13,14,17)/p-1/t3-,5-,6-,9-/m1/s1"
712,3484,cefclidin,"A fourth-generation cephalosporin antibiotic having (4-carbamoyl-1-azoniabicyclo[2.2.2]octan-1-yl)methyl and [(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]amino side groups located at positions 3 and 7 respectively.",1372,KEGG COMPOUND accession,C04322,,,,,,,,,,,,,,,
713,8225,pinoresinol,"A lignan that is tetrahydro-1H,3H-furo[3,4-c]furan substituted at positions 1 and 4 by 4-hydroxy-3-methoxyphenyl groups.",2805,KEGG COMPOUND accession,C09295,,,,,,,,,,,,,,,
714,2013,"5-(3'-carboxy-3'-oxopropyl)-4,6-dihydroxypicolinate","An  oxo carboxylic acid anion that is the conjugate base of 5-(3'-carboxy-3'-oxopropyl)-4,6-dihydroxypicolinic acid.",16155,KEGG COMPOUND accession,C04477,mi1346p,110298-84-5,16155.0,"Human Metabolome Database (HMDB): 1D-Myo-inositol 1,3,4,6-tetrakisphosphate is a substrate for Tyrosine-protein kinase BTK and Inositol polyphosphate multikinase.","1D-Myo-inositol 1,3,4,6-tetrakisphosphate",HMDB0001187,b,b,C04477,CPD-505,FDB022475,b,[H]O[C@@]1([H])[C@]([H])(OP([O-])([O-])=O)[C@@]([H])(OP([O-])([O-])=O)[C@@]([H])(O[H])[C@@]([H])(OP([O-])([O-])=O)[C@]1([H])OP([O-])([O-])=O,ZAWIXNGTTZTBKV-JMVOWJSSSA-F,"InChI=1S/C6H16O18P4/c7-1-3(21-25(9,10)11)5(23-27(15,16)17)2(8)6(24-28(18,19)20)4(1)22-26(12,13)14/h1-8H,(H2,9,10,11)(H2,12,13,14)(H2,15,16,17)(H2,18,19,20)/p-8/t1-,2+,3-,4+,5-,6+"
715,2433,acrifoline,"A quinolizidine alkaloid that is lycopodine having a C=C double bond at the 11-position, a keto substituent at the 8-position and the keto group at position 5 replaced by a beta-hydroxy group.",37646,KEGG COMPOUND accession,C05974,,,,,,,,,,,,,,,
716,25955,"3,4-epoxy-3,4-dihydrophenanthrene",a,28205,KEGG COMPOUND accession,C09707,,,,,,,,,,,,,,,
717,2696,anacardic acid,A hydroxybenzoic acid that is salicylic acid substituted by a pentadecyl group at position 6. It is a major component of cashew nut shell liquid and exhibits an extensive range of bioactivities.,27526,KEGG COMPOUND accession,C11010,,,,,,,,,,,,,,,
718,2716,anethole,A monomethoxybenzene that is methoxybenzene substituted by a prop-1-en-1-yl group at position 4.,28753,KEGG COMPOUND accession,C05805,,,,,,,,,,,,,,,
719,2908,athyriol,"A member of the class of  xanthones that is 9H-xanthen-9-one substituted by hydroxy groups at positions 1, 6 and 7 and a methoxy group at position 3.",37450,KEGG COMPOUND accession,C11132,,,,,,,,,,,,,,,
720,2922,auranofin,"An S-glycosyl compound consisting of 2,3,4,6-tetra-O-acetyl-1-thio-beta-D-glucopyranose with the sufur atom coordinated to (triethylphosphoranylidene)gold. It is administered orally for the treatment of active progressive rheumatoid arthritis.",15476,KEGG COMPOUND accession,C03344,2maacoa,b,15476.0,"Human Metabolome Database (HMDB): 2-Methylacetoacetyl-CoA is a substrate for 3-hydroxyacyl-CoA dehydrogenase type II, 3-ketoacyl-CoA thiolase (mitochondrial), Peroxisomal bifunctional enzyme, Trifunctional enzyme beta subunit (mitochondrial), Short chain 3-hydroxyacyl-CoA dehydrogenase (mitochondrial) and 3-ketoacyl-CoA thiolase (peroxisomal).",2-Methylacetoacetyl-CoA,HMDB0001157,b,b,C03344,2-METHYL-ACETO-ACETYL-COA,FDB022455,2maacoa,[H]O[C@@]([H])(C(=O)N([H])C([H])([H])C([H])([H])C(=O)N([H])C([H])([H])C([H])([H])SC(=O)C([H])(C(=O)C([H])([H])[H])C([H])([H])[H])C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])OP([O-])(=O)OP([O-])(=O)OC([H])([H])[C@@]1([H])O[C@@]([H])(N2C([H])=NC3=C(N=C([H])N=C23)N([H])[H])[C@]([H])(O[H])[C@]1([H])OP([O-])([O-])=O,NHNODHRSCRALBF-NQNBQJKNSA-J,"InChI=1S/C26H42N7O18P3S/c1-13(14(2)34)25(39)55-8-7-28-16(35)5-6-29-23(38)20(37)26(3,4)10-48-54(45,46)51-53(43,44)47-9-15-19(50-52(40,41)42)18(36)24(49-15)33-12-32-17-21(27)30-11-31-22(17)33/h11-13,15,18-20,24,36-37H,5-10H2,1-4H3,(H,28,35)(H,29,38)(H,43,44)(H,45,46)(H2,27,30,31)(H2,40,41,42)/p-4/t13?,15-,18-,19-,20+,24-/m1/s1"
721,8005,peptidoglycan,A peptidoglycosaminoglycan formed by alternating residues of beta-(1->4)-linked N-acetylglucosamine and N-acetylmuramic acid {2-amino-3-O-[(S)-1-carboxyethyl]-2-deoxy-D-glucose} residues. Attached to the carboxy group of the muramic acid is a peptide chain of three to five amino acids.,28859,KEGG COMPOUND accession,C01554,,,,,,,,,,,,,,,
722,30052,copper(0),a,30049,KEGG COMPOUND accession,C06707,,,,,,,,,,,,,,,
723,30056,tetrachloroaurate(1-),a,9434,KEGG COMPOUND accession,C07710,,,,,,,,,,,,,,,
724,30062,sodium hexacyanoferrate(3-),a,9437,KEGG COMPOUND accession,C11730,,,,,,,,,,,,,,,
725,30068,ammonium hexacyanoferrate(3-),a,9440,KEGG COMPOUND accession,C08511,,,,,,,,,,,,,,,
726,14321,glutamate(1-),"An alpha-amino-acid anion that is the conjugate base of glutamic acid, having anionic carboxy groups and a cationic amino group",5027,KEGG COMPOUND accession,C05310,,,,,,,,,,,,,,,
727,30072,tetraoxidochromate(3-),a,9442,KEGG COMPOUND accession,C10535,,,,,,,,,,,,,,,
728,30074,dibromine(.1+),a,9443,KEGG COMPOUND accession,C09970,,,,,,,,,,,,,,,
729,30078,gold monochloride,A gold salt in which the counterion is chloride,9445,KEGG COMPOUND accession,C07127,,,,,,,,,,,,,,,
730,29386,cyclopentasulfur,a,27922,KEGG COMPOUND accession,C01452,,,,,,,,,,,,,,,
731,29392,disulfanediolate(2-),a,63622,KEGG COMPOUND accession,C07309,,,,,,,,,,,,,,,
732,29398,trisulfide(2-),a,9209,KEGG COMPOUND accession,C08980,,,,,,,,,,,,,,,
733,29402,tetrasulfur(2+),a,9211,KEGG COMPOUND accession,C08983,,,,,,,,,,,,,,,
734,29404,tetrathionate(.3-),a,9212,KEGG COMPOUND accession,C07662,,,,,,,,,,,,,,,
735,29595,gibberellin A36,a,9288,KEGG COMPOUND accession,C07313,,,,,,,,,,,,,,,
736,29612,cladinose,a,27452,KEGG COMPOUND accession,C07083,,,,,,,,,,,,,,,
737,29630,methymycin,A twelve-membered macrolide antibiotic that is biosynthesised by Streptomyces venezuelae.,15741,KEGG COMPOUND accession,C00042,succ,110-15-6,15741.0,"Human Metabolome Database (HMDB): Succinic acid is a dicarboxylic acid. The anion, succinate, is a component of the citric acid or TCA cycle and is capable of donating electrons to the electron transfer chain. Succinate dehydrogenase (SDH) plays an important role in mitochondrial function, being both part of the respiratory chain and the Krebs cycle. SDH with a covalently attached FAD prosthetic group, is able to bind several different enzyme substrates (succinate and fumarate) and physiological regulators (oxaloacetate and ATP). Oxidizing succinate links SDH to the fast-cycling Krebs cycle portion where it participates in the breakdown of acetyl-CoA throughout the entire Krebs cycle. Succinate can readily be imported into the mitochondrial matrix by the n-butylmalonate- (or phenylsuccinate-) sensitive dicarboxylate carrier in exchange with inorganic phosphate or another organic acid, e. g. malate (PMID 16143825). Mutations in the four genes encoding the subunits of the mitochondrial succinate dehydrogenase are associated with a wide spectrum of clinical presentations, i.e.: Huntington's disease (PMID 11803021 ). Moreover, succinic acid is found to be associated with D-2-hydroxyglutaric aciduria, which is an inborn error of metabolism. Succinic acid has recently been identified as an oncometabolite or an endogenous, cancer causing metabolite. High levels of this organic acid can be found in tumors or biofluids surrounding tumors. Its oncogenic action appears to due to its ability to inhibit prolyl hydroxylase-containing enzymes. In many tumours, oxygen availability becomes limited (hypoxia) very quickly due to rapid cell proliferation and limited blood vessel growth. The major regulator of the response to hypoxia is the HIF transcription factor (HIF-alpha). Under normal oxygen levels, protein levels of HIF-alpha are very low due to constant degradation, mediated by a series of post-translational modification events catalyzed by the prolyl hydroxylase domain-containing enzymes PHD1, 2 and 3, (also known as EglN2, 1 and 3) that hydroxylate HIF-alpha and lead to its degradation. All three of the PHD enzymes are inhibited by succinate. Succinic acid is found to be associated with D-2-hydroxyglutaric aciduria, which is an inborn error of metabolism.",Succinic acid,HMDB0000254,b,b,C00042,SUC,FDB001931,succ,[H]C([H])(C([O-])=O)C([H])([H])C([O-])=O,KDYFGRWQOYBRFD-UHFFFAOYSA-L,"InChI=1S/C4H6O4/c5-3(6)1-2-4(7)8/h1-2H2,(H,5,6)(H,7,8)/p-2"
738,29588,gibberellin A14,"A C20-gibberellin, initially identified in Gibberella fujikuroi. It differs from gibberellin A12 in the presence of a beta-OH at C-2 (gibbane numbering).",15715,KEGG COMPOUND accession,C03731,,,,,,,,,,,,,,,
739,29604,gibberellin A8-catabolite,A tetracyclic diterpenoid obtained by catabolism of gibberellin A8.,9292,KEGG COMPOUND accession,C09939,,,,,,,,,,,,,,,
740,30161,oxidoboron(1+),a,50651,KEGG COMPOUND accession,C05761,myrsACP,b,b,b,Myristoyl-ACP (N-C14:0ACP),b,b,b,C05761,b,b,b,[H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C(=O)S[*],b,b
741,30169,boranetriyl group,a,44296,KEGG COMPOUND accession,C07512,,,,,,,,,,,,,,,
742,30173,metaborate,a,15372,KEGG COMPOUND accession,C00272,thbpt,17528-72-2,15372.0,"Human Metabolome Database (HMDB): Tetrahydrobiopterin or BH4 is a cofactor in the synthesis of nitric oxide. In fact it is used by all three human nitric-oxide synthases (NOS) eNOS, nNOS, and iNOS as well as the enzyme glyceryl-ether monooxygenase. It is also essential in the conversion of phenylalanine to tyrosine by the enzyme phenylalanine-4-hydroxylase; the conversion of tyrosine to L-dopa by the enzyme tyrosine hydroxylase; and conversion of tryptophan to 5-hydroxytryptophan via tryptophan hydroxylase. Specifically, tetrahydrobiopterin is a cofactor for tryptophan 5-hydroxylase 1, tyrosine 3-monooxygenase, and phenylalanine hydroxylase all of which are essential for the formation of the neurotransmitters dopamine, noradrenaline and adrenaline. Tetrahydrobiopterin has been proposed to be involved in promotion of neurotransmitter release in the brain and the regulation of human melanogenesis. A defect in BH4 production and/or a defect in the enzyme dihydropteridine reductase (DHPR) causes phenylketonuria type IV, as well as dopa-responsive dystonias. BH4 is also implicated in Parkinson's disease, Alzheimer's disease and depression. Tetrahydrobiopterin is present in probably every cell or tissue of higher animals. On the other hand, most bacteria, fungi and plants do not synthesize tetrahydrobiopterin. -- Wikipedia.",Tetrahydrobiopterin,HMDB0000027,b,b,C00272,TETRA-H-BIOPTERIN,FDB021880,thbpt,[H]OC([H])(C([H])([H])[H])C([H])(O[H])C1([H])N([H])C2=C(N=C(N([H])[H])N([H])C2=O)N([H])C1([H])[H],FNKQXYHWGSIFBK-UHFFFAOYSA-N,"InChI=1S/C9H15N5O3/c1-3(15)6(16)4-2-11-7-5(12-4)8(17)14-9(10)13-7/h3-4,6,12,15-16H,2H2,1H3,(H4,10,11,13,14,17)"
743,4056,cytochrome,"A cytochrome is a hemoprotein whose characteristic mode of action involves transfer of reducing equivalents associated with a reversible change in oxidation state of the prosthetic group. Formally, this redox change involves a single-electron, reversible equilibrium between the Fe(II) and Fe(III) states of the central iron atom.",15825,KEGG COMPOUND accession,C07330,,,,,,,,,,,,,,,
744,3789,cobalt-precorrin-6B,a,17058,KEGG COMPOUND accession,C02513,,,,,,,,,,,,,,,
745,19229,2'-O-methylguanosine,Guanosine with the hydrogen on the hydroxyl at position C-2' substituted with a methyl group.,28378,KEGG COMPOUND accession,C06477,,,,,,,,,,,,,,,
746,19702,N(2)-methylguanosine,Guanosine with the hydrogen on the amine at position N-2 substituted with a methyl group.,18419,KEGG COMPOUND accession,C05999,,,,,,,,,,,,,,,
747,371,(S)-1-pyrroline-5-carboxylic acid,A 1-pyrroline-5-carboxylic acid in which the chiral centre has S configuration.,15575,KEGG COMPOUND accession,C04859,,,,,,,,,,,,,,,
748,12855,"(1S,2S)-cyclohexa-3,5-diene-1,2-diol",a,15698,KEGG COMPOUND accession,C00881,dcyt,951-77-9,15698.0,"Human Metabolome Database (HMDB): One of the principal nucleosides of DNA composed of cytosine and deoxyribose. A nucleoside consists of only a pentose sugar linked to a purine or pyrimidine base, without a phosphate group. When N1 is linked to the C1 of deoxyribose, deoxynucleosides and nucleotides are formed from cytosine and deoxyribose; deoxycytidine monophosphate (dCMP), deoxycytidine diphosphate (dCDP), deoxycytidine triphosphate (dCTP). CTP is the source of the cytidine in RNA (ribonucleic acid) and deoxycytidine triphosphate (dCTP) is the source of the deoxycytidine in DNA (deoxyribonucleic acid).",Deoxycytidine,HMDB0000014,b,b,C00881,DEOXYCYTIDINE,FDB021871,dcyt,[H]OC([H])([H])[C@@]1([H])O[C@@]([H])(N2C([H])=C([H])C(=NC2=O)N([H])[H])C([H])([H])[C@]1([H])O[H],CKTSBUTUHBMZGZ-SHYZEUOFSA-N,"InChI=1S/C9H13N3O4/c10-7-1-2-12(9(15)11-7)8-3-5(14)6(4-13)16-8/h1-2,5-6,8,13-14H,3-4H2,(H2,10,11,15)/t5-,6+,8+/m0/s1"
749,25959,phenanthrene oxide,a,17556,KEGG COMPOUND accession,C05230,,,,,,,,,,,,,,,
750,26666,short-chain fatty acid,"An aliphatic monocarboxylic acid with a chain length of less than C6. If any non-hydrocarbon substituent is present, the compound is not normally regarded as a short-chain fatty acid.",258351,KEGG COMPOUND accession,C11696,,,,,,,,,,,,,,,
751,19083,1-phenanthryl sulfate,a,28789,KEGG COMPOUND accession,C01722,,,,,,,,,,,,,,,
752,25753,oxo-5beta-cholanic acid,a,7940,KEGG COMPOUND accession,C09705,,,,,,,,,,,,,,,
753,19641,2-hydroxyisobutyrate,"A hydroxy fatty acid anion that is the conjugate base of 2-hydroxyisobutyric acid, arising from deprotonation of the carboxy group; major species at pH 7.3.",18118,KEGG COMPOUND accession,C02994,,,,,,,,,,,,,,,
754,26932,tetrapyrrole,A natural pigment containing four pyrrole rings joined by one-carbon units linking position 2 of one pyrrole ring to position 5 of the next.,17824,KEGG COMPOUND accession,C01845,,,,,,,,,,,,,,,
755,24521,heptenedioate,a,38266,KEGG COMPOUND accession,C03423,,,,,,,,,,,,,,,
756,25998,3-phenyllactic acid,A 2-hydroxy monocarboxylic acid that is lactic acid in which one of the methyl hydrogens is substituted by a phenyl group.,18397,KEGG COMPOUND accession,C05332,peamn,64-04-0,18397.0,"Human Metabolome Database (HMDB): Phenethylamine (PEA) is an aromatic amine, which is a colorless liquid at room temperature. It is soluble in water, ethanol, and ether. Similar to other low-molecular-weight amines, it has a fishy odor. Upon exposure to air, it forms a solid carbonate salt with carbon dioxide. Phenethylamine is strongly basic and forms a stable crystalline hydrochloride salt with a melting point of 217 oC. Phenethylamine is also a skin irritant and possible sensitizer. Phenethylamine also has a constitutional isomer (+)-phenylethylamine (1-phenylethylamine), which has two stereoisomers: (R)-(+)-1-phenylethylamine and (S)-(-)-1-phenylethylamine. In the human brain, 2-phenethylamine is believed to function as a neuromodulator or neurotransmitter (a trace amine). Phenethylamine can be biosynthesized from the amino acid phenylalanine by enzymatic decarboxylation. It is also found in many foods such as chocolate, especially after microbial fermentation. However trace amounts from food are quickly metabolized by the enzyme MAO-B (into phenylacetic acid), preventing significant concentrations from reaching the brain. Phenylethylamine is a precursor to the neurotransmitter phenylethanolamine. High levels of PEA have been found in the urine of schizophrenics but it is not significantly elevated in the serum or CSF of schizophrenics (PMID: 7906896, PMID: 7360842).  Urinary levels of PEA are significantly lower in children with attention deficit hyperactivity disorder (ADHD) (PMID: 12205654).  It has been found that PEA is the primary compound found in carnivore (especially cat) urine that leads to rodent (mouse and rat) avoidance. In other words, phenylethylamine is useful for scaring off rodent pests.  Quantitative HPLC analysis across 38 mammalian species has shown that PEA production in urine is especially enhanced in carnivores, with some producing >3,000-fold more than herbivores (PMID: 21690383).",Phenylethylamine,HMDB0012275,b,b,C05332,PHENYLETHYLAMINE,FDB010580,peamn,[H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])C([H])([H])[N+]([H])([H])[H],BHHGXPLMPWCGHP-UHFFFAOYSA-O,"InChI=1S/C8H11N/c9-7-6-8-4-2-1-3-5-8/h1-5H,6-7,9H2/p+1"
757,20857,C-glycosyl compound,"A glycosyl compound arising formally from the elimination of water from a glycosidic hydroxy group and an H atom bound to a carbon atom, thus creating a C-C bond.",16830,KEGG COMPOUND accession,C00218,mma,74-89-5,16830.0,"Human Metabolome Database (HMDB): Methylamine occurs endogenously from amine catabolism and its tissue levels increase in some pathological conditions, including diabetes. Interestingly, methylamine and ammonia levels are reciprocally controlled by a semicarbazide-sensitive amine oxidase activity that deaminates methylamine to formaldehyde with the production of ammonia and hydrogen peroxide. Methylamine also targets the voltage-operated neuronal potassium channels, probably inducing release of neurotransmitter(s). Semicarbazide-sensitive amine oxidase (SSAO) catalyzes the deamination of primary amines. Such deamination has been shown capable of regulating glucose transport in adipose cells. It has been independently discovered that the primary structure of vascular adhesion protein-1 (VAP-1) is identical to SSAO. Increased serum SSAO activities have been found in patients with diabetic mellitus, vascular disorders and Alzheimer's disease. The SSAO-catalyzed deamination of endogenous substrates like methylamine led to production of toxic formaldehyde. Chronic elevated methylamine increases the excretion of malondialdehyde and microalbuminuria. Amine oxidase substrates such as methylamine have been shown to stimulate glucose uptake by increasing the recruitment of the glucose transporter GLUT4 from vesicles within the cell to the cell surface. Inhibition of this effect by the presence of semicarbazide and catalase led to the suggestion that the process is mediated by the H (2) O (2) produced in the oxidation of these amines. (PMID: 16049393, 12686132, 17406961).",Methylamine,HMDB0000164,b,b,C00218,METHYLAMINE,FDB003958,mma,[H]C([H])([H])[N+]([H])([H])[H],BAVYZALUXZFZLV-UHFFFAOYSA-O,"InChI=1S/CH5N/c1-2/h2H2,1H3/p+1"
758,11173,"1,4-dihydroxy-2-naphthoate","A hydroxy monocarboxylic acid anion that is the conjugate base of 1,4-dihydroxy-2-naphthoic acid.",28322,KEGG COMPOUND accession,C06523,,,,,,,,,,,,,,,
759,26393,purine nucleoside triphosphate,a,8206,KEGG COMPOUND accession,C09529,,,,,,,,,,,,,,,
760,10002,visnagin,"A furanochromone that is furo[3,2-g]chromen-5-one which is substituted at positions 4 and 7 by methoxy and methyl groups, respectively. Found in the toothpick-plant, Ammi visnaga.",3436,KEGG COMPOUND accession,C11080,,,,,,,,,,,,,,,
761,10018,volkenin,A cyanogenic glycoside that is (4R)-4-hydroxycyclopent-2-ene-1-carbonitrile attached to a beta-D-glucopyranosyloxy at position 1.,17695,KEGG COMPOUND accession,C01414,,,,,,,,,,,,,,,
762,10583,kappa-carrageenan,a,37397,KEGG COMPOUND accession,C00607,,,,,,,,,,,,,,,
763,1905,4-methylumbelliferone sulfate,A member of the class of coumarins that is umbelliferone sulfate which carries a methyl group at position 4. It is a metabolite of 4-methylumbelliferone.,18430,KEGG COMPOUND accession,C04578,,,,,,,,,,,,,,,
764,2179,D-fucopyranose,The six-membered ring form of D-fucose.,46745,KEGG COMPOUND accession,C06650,,,,,,,,,,,,,,,
765,1606,1-methyl-4-imidazoleacetic acid,A monocarboxylic acid that is acetic acid in which one of the methyl hydrogens has been replaced by a 1-methyl-1H-imidazol-4-yl group.,17473,KEGG COMPOUND accession,C04361,,,,,,,,,,,,,,,
766,14178,1D-myo-inositol bis(diphosphate) tetrakisphosphate,A 1D-myo-inositol tetrakisphosphate compound of unknown isomeric configuration with diphosphate groups attached at the two remainig vacant positions.,28954,KEGG COMPOUND accession,C09438,,,,,,,,,,,,,,,
767,18657,(R)-2-trans-abscisic acid,A 2-trans-abscisic acid with (R)-configuration at the chiral centre.,28185,KEGG COMPOUND accession,C01823,,,,,,,,,,,,,,,
768,20244,3beta-hydroxy-4alpha-methyl-5alpha-cholest-7-ene-4beta-carboxylic acid,a,15948,KEGG COMPOUND accession,C05432,,,,,,,,,,,,,,,
769,18853,"1,1-dimethylhydrazine",A member of the class of  hydrazines that is  hydrazine substituted by two methyl groups at position 1.,6178,KEGG COMPOUND accession,C06115,,,,,,,,,,,,,,,
770,23696,dichloroaniline,a,16862,KEGG COMPOUND accession,C00454,,,,,,,,,,,,,,,
771,25193,mercuribenzoate,a,7854,KEGG COMPOUND accession,C10115,,,,,,,,,,,,,,,
772,4174,beta-D-glucosyl-(1->4)-beta-D-mannose,a,16404,KEGG COMPOUND accession,C02943,,,,,,,,,,,,,,,
773,25789,hexenedioic acid,a,7956,KEGG COMPOUND accession,C07417,,,,,,,,,,,,,,,
774,24068,fluoroamino acid,An organofluorine compound that consists of an amino acid substituted by a fluoro group.,7521,KEGG COMPOUND accession,C11474,,,,,,,,,,,,,,,
775,24098,trihydroxysilanecarbaldehyde,a,7540,KEGG COMPOUND accession,C08607,,,,,,,,,,,,,,,
776,25550,nitroaniline,A substituted aniline that carries one or more nitro groups.,7862,KEGG COMPOUND accession,C07363,,,,,,,,,,,,,,,
777,25576,nonadienedioic acid,a,17422,KEGG COMPOUND accession,C01260,ap4a,5542-28-9,17422.0,"Human Metabolome Database (HMDB): Diadenosine tetraphosphate (AP4A) is a diadenosine polyphosphate. Diadenosine polyphosphates (APnAs, n=3-6) are a family of endogenous vasoactive purine dinucleotides which have been isolated from thrombocytes. APnAs have been demonstrated to be involved in the control of vascular tone as well as the growth of vascular smooth muscle cells and hence, possibly, in atherogenesis. APnAs isolated substances are Ap3A, Ap4A, Ap5A, and Ap6A. APnAs are naturally occurring substances that facilitate tear secretion; they are released from the corneal epithelium, they stimulate tear production and therefore they may be considered as physiological modulators of tear secretion. The APnAs were discovered in the mid-sixties in the course of studies on aminoacyl-tRNA synthetases (aaRS). APnAs have emerged as intracellular and extracellular signalling molecules implicated in the maintenance and regulation of vital cellular functions and become considered as second messengers. Great variety of physiological and pathological effects in mammalian cells was found to be associated with alterations of APnAs. APnAs are polyphosphated nucleotidic substances which are found in the CNS and are known to be released in a calcium-dependent manner from storage vesicles in brain synaptosomes. AP5A is a specific adenylate kinase inhibitor in the hippocampus, decreasing the rate of decomposition of ADP and the formation of ATP; a pathway that influences the availability of purines in the central nervous system. AP4A is the only APnA that can induce a considerable increase in [Ca2+] in endothelial cells, indicating that its vasoactive effects are comparable to the known effects of arginine vasopressin, Angiotensin II, and ATP. AP4A is a ubiquitous ApnA is a signal molecule for DNA replication in mammalian cells. AP4A is a primer for oligoadenylate synthesis catalyzed by interferon-inducible 2-5A synthetase. AP4A is an avid inhibitor of eosinophil-derived neurotoxin (EDN). EDN is a catalytically proficient member of the pancreatic ribonuclease superfamily secreted along with other eosinophil granule proteins during innate host defense responses and various eosinophil-related inflammatory and allergic diseases. The ribonucleolytic activity of EDN is central to its antiviral and neurotoxic activities and possibly to other facets of its biological activity. (PMID: 11212966, 12738682, 11810214, 9607303, 8922753, 9187362, 16401072, 9694344, 9351706, 1953194).",Diadenosine tetraphosphate,HMDB0001211,b,b,C01260,ADENOSYL-P4,FDB022492,b,[H]O[C@@]1([H])[C@@]([H])(O[C@]([H])(C([H])([H])OP([O-])(=O)OP([O-])(=O)OP([O-])(=O)OP([O-])(=O)OC([H])([H])[C@@]2([H])O[C@@]([H])(N3C([H])=NC4=C(N=C([H])N=C34)N([H])[H])[C@]([H])(O[H])[C@]2([H])O[H])[C@@]1([H])O[H])N1C([H])=NC2=C(N=C([H])N=C12)N([H])[H],YOAHKNVSNCMZGQ-XPWFQUROSA-J,"InChI=1S/C20H28N10O19P4/c21-15-9-17(25-3-23-15)29(5-27-9)19-13(33)11(31)7(45-19)1-43-50(35,36)47-52(39,40)49-53(41,42)48-51(37,38)44-2-8-12(32)14(34)20(46-8)30-6-28-10-16(22)24-4-26-18(10)30/h3-8,11-14,19-20,31-34H,1-2H2,(H,35,36)(H,37,38)(H,39,40)(H,41,42)(H2,21,23,25)(H2,22,24,26)/p-4/t7-,8-,11-,12-,13-,14-,19-,20-/m1/s1"
778,29130,"2,3-didehydrosparteine","A quinolizidine alkaloid obtained by formal dehydrogenation at the 2,3-position of sparteine.",27568,KEGG COMPOUND accession,C01529,,,,,,,,,,,,,,,
779,29375,diprotium oxide,a,9199,KEGG COMPOUND accession,C08719,,,,,,,,,,,,,,,
780,24313,glutamic semialdehyde,An  aldehydic acid derived from the  formal reduction of one of the carboxy groups glutamic acid to a formyl group.,7613,KEGG COMPOUND accession,C08384,,,,,,,,,,,,,,,
781,24373,glycine derivative,"A proteinogenic amino acid derivative resulting from reaction of glycine at the amino group or the carboxy group, or from the replacement of any hydrogen of glycine by a heteroatom.",7645,KEGG COMPOUND accession,C11185,,,,,,,,,,,,,,,
782,24403,glycosyl group,"An organic group obtained by removing the hydroxy group from the hemiacetal function of a monosaccharide or monosaccharide derivative and, by extension, of a lower oligosaccharide or oligosaccharide derivative.",36976,KEGG COMPOUND accession,C00215,,,,,,,,,,,,,,,
783,24470,haloamino acid,Any non-proteinogenic amino acid carrying at least one halo group.,16590,KEGG COMPOUND accession,C03156,,,,,,,,,,,,,,,
784,1941,4-(trimethylammonio)butanoic acid,A quaternary ammonium ion that is the  conjugate acid of 4-(trimethylammonio)butanoate.,783,KEGG COMPOUND accession,C05499,M00405,b,783.0,"Human Metabolome Database (HMDB): 17alpha,20alpha-Dihydroxycholesterol is an intermediate in C21-Steroid hormone metabolism. 17alpha,20alpha-Dihydroxycholesterol is the 8th to last step in the synthesis of Cortolone and is converted from 20alpha-Hydroxycholesterol via the enzyme cytochrome P450 (EC 1.14.99.9). It is then converted to 17alpha-Hydroxypregnenolone via the enzyme cytochrome P450 (EC1.14.15.6).","17a,20a-Dihydroxycholesterol",HMDB0006764,b,b,C05499,b,FDB024067,b,[H]O[C@]1([H])C([H])([H])C2=C([H])C([H])([H])C3([H])C4([H])C([H])([H])C([H])([H])[C@](O[H])([C@@](O[H])(C([H])([H])[H])C([H])([H])C([H])([H])C([H])([H])C([H])(C([H])([H])[H])C([H])([H])[H])[C@@]4(C([H])([H])[H])C([H])([H])C([H])([H])C3([H])[C@@]2(C([H])([H])[H])C([H])([H])C1([H])[H],PRZXKPDANWDCNC-DEFXBDIRSA-N,"InChI=1S/C27H46O3/c1-18(2)7-6-13-26(5,29)27(30)16-12-23-21-9-8-19-17-20(28)10-14-24(19,3)22(21)11-15-25(23,27)4/h8,18,20-23,28-30H,6-7,9-17H2,1-5H3/t20-,21?,22?,23?,24-,25-,26+,27+/m0/s1"
785,2704,anastrozole,"A 1,2,4-triazole compound having a 3,5-bis(2-cyano-2-propyl)benzyl group at the 1-position.",18033,KEGG COMPOUND accession,C03574,,,,,,,,,,,,,,,
786,29593,gibberellin A34,a,9287,KEGG COMPOUND accession,C02081,,,,,,,,,,,,,,,
787,29769,hydroxyamino group,a,9329,KEGG COMPOUND accession,C07630,,,,,,,,,,,,,,,
788,29776,carbidoselanidonitrogen,a,9332,KEGG COMPOUND accession,C07315,,,,,,,,,,,,,,,
789,24613,homodetic cyclic peptide,A homodetic cyclic peptide is a cyclic peptide in which the ring consists solely of amino-acid residues in peptide linkages.,36475,KEGG COMPOUND accession,C03630,,,,,,,,,,,,,,,
790,24661,hydroxy-L-lysine,A hydroxy-amino acid that is L-lysine substituted by hydroxy groups.,7775,KEGG COMPOUND accession,C10509,,,,,,,,,,,,,,,
791,5724,hippeastrine,An indole alkaloid isolated from the Amaryllidaceae family and has been shown to exhibit cytotoxic activity.,28011,KEGG COMPOUND accession,C09825,,,,,,,,,,,,,,,
792,19566,2-deoxyecdysone,"A 3beta-hydroxy steroid that is 5beta-cholestane containing a double bond between positions 7 and 8, and substituted by an oxo group at position 6 and by hydroxy groups at the 3beta, 14alpha, 22 pro-R and 25 positions.",29163,KEGG COMPOUND accession,C02992,M02419,b,29163.0,b,L-Threonyl-tRNA(Thr),b,b,b,C02992,b,b,b,[H]OC([H])([H])[C@@]1([H])O[C@@]([H])([*])[C@]([H])(O[H])[C@]1([H])OP(=O)(O[H])OC([H])([H])[C@@]1([H])O[C@@]([H])([*])[C@]([H])(O[H])[C@]1([H])OP(=O)(O[H])OC([H])([H])[C@@]1([H])O[C@@]([H])([*])[C@]([H])(O[H])[C@]1([H])OC(=O)[C@@]([H])(N([H])[H])[C@@]([H])(O[H])C([H])([H])[H],b,b
793,29904,iodyl group,a,9367,KEGG COMPOUND accession,C10173,,,,,,,,,,,,,,,
794,29908,periodyl group,a,9369,KEGG COMPOUND accession,C10187,,,,,,,,,,,,,,,
795,1040,"6-chloro-1,3,5-triazine-2,4-diol","A dihydroxy-1,3,5-triazine that is 1,3,5-triazine-2,4-diol substituted by a chloro group at position 6.",28276,KEGG COMPOUND accession,C05268,HC01407,5060-32-2,28276.0,"Human Metabolome Database (HMDB): (S)-Hydroxyhexanoyl-CoA is an intermediate in fatty acid metabolism, being the substrate of the enzymes beta-hydroxyacyl-CoA dehydrogenase and 3-hydroxyacyl-CoA dehydrogenase [EC 1.1.1.211-1.1.1.35]; (S)-Hydroxyhexanoyl-CoA is an intermediate in fatty acid elongation in mitochondria, the substrate of the enzymes enoyl-CoA hydratase and long-chain-enoyl-CoA hydratase [EC 4.2.1.17-4.2.1.74]. (KEGG).",(S)-Hydroxyhexanoyl-CoA,HMDB0003942,b,b,C05268,b,FDB023261,HC01407,[H]O[C@@]([H])(C(=O)N([H])C([H])([H])C([H])([H])C(=O)N([H])C([H])([H])C([H])([H])SC(=O)C([H])([H])[C@@]([H])(O[H])C([H])([H])C([H])([H])C([H])([H])[H])C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])OP([O-])(=O)OP([O-])(=O)OC([H])([H])[C@@]1([H])O[C@@]([H])(N2C([H])=NC3=C(N=C([H])N=C23)N([H])[H])[C@]([H])(O[H])[C@]1([H])OP([O-])([O-])=O,VAAHKRMGOFIORX-IKTBLOROSA-J,"InChI=1S/C27H46N7O18P3S/c1-4-5-15(35)10-18(37)56-9-8-29-17(36)6-7-30-25(40)22(39)27(2,3)12-49-55(46,47)52-54(44,45)48-11-16-21(51-53(41,42)43)20(38)26(50-16)34-14-33-19-23(28)31-13-32-24(19)34/h13-16,20-22,26,35,38-39H,4-12H2,1-3H3,(H,29,36)(H,30,40)(H,44,45)(H,46,47)(H2,28,31,32)(H2,41,42,43)/p-4/t15-,16+,20+,21+,22-,26+/m0/s1"
796,7642,norwogonin,"A trihydroxyflavone with the hydroxy groups at positions C-5, -7 and -8.",17522,KEGG COMPOUND accession,C00717,,,,,,,,,,,,,,,
797,8811,resmethrin,a,28428,KEGG COMPOUND accession,C06988,,,,,,,,,,,,,,,
798,10502,"dTDP-3-amino-3,4,6-trideoxy-alpha-D-glucose","A dTDP-sugar having 3-amino-3,4,6-trideoxy-alpha-D-glucose as the sugar component.",16175,KEGG COMPOUND accession,C00599,,,,,,,,,,,,,,,
799,25098,lyxoside,a,16877,KEGG COMPOUND accession,C03888,,,,,,,,,,,,,,,
800,25697,organic cation,Any organic ion with a net positive charge.,7915,KEGG COMPOUND accession,C11806,,,,,,,,,,,,,,,
801,27039,"trans-1,2-dihydronaphthalene-1,2-diol",a,8499,KEGG COMPOUND accession,C07407,,,,,,,,,,,,,,,
802,27084,trehalose phosphate,a,15554,KEGG COMPOUND accession,C00427,prostgh2,42935-17-1,15554.0,"Human Metabolome Database (HMDB): Prostaglandin H2 (PGH2) is the first intermediate in the biosynthesis of all prostaglandins. Prostaglandins are synthesized from arachidonic acid by the enzyme COX-1 and COX-2, which are also called PGH synthase 1 and 2. These enzymes generate a reactive intermediate PGH2 which has a reasonably long half-life (90-100 s) but is highly lipophilic. PGH2 is converted into the biologically active prostaglandins by prostaglandin isomerases, yielding PGE2, PGD2, and PGF2, or by thromboxane synthase to make TxA2 or by prostacyclin synthase to make PGI2. Most nonsteroidal anti-inflammatory drugs such as aspirin and indomethacin inhibit both PGH synthase 1 and 2. A key feature for eicosanoid transcellular biosynthesis is the export of PGH2 or LTA4 from the donor cell as well as the uptake of these reactive intermediates by the acceptor cell. Very little is known about either process despite the demonstrated importance of both events. In cells, PGH2 rearranges nonenzymatically to LGs even in the presence of enzymes that use PGH2 as a substrate. When platelets form Thromboxane A2 (TXA2) from endogenous arachidonic acid (AA), PGH2 reaches concentrations very similar to those of TXA2 and high enough to produce strong platelet activation. Therefore, platelet activation by TXA2 appears to go along with an activation by PGH2. The agonism of PGH2 is limited by the formation of inhibitory prostaglandins, especially PGD2 at higher concentrations. That is why thromboxane synthase inhibitors in PRP and at a physiological HSA concentration do not augment platelet activation. (PMID: 2798452, 15650407, 16968946)Prostaglandins are eicosanoids. The eicosanoids consist of the prostaglandins (PGs), thromboxanes (TXs), leukotrienes (LTs) and lipoxins (LXs). The PGs and TXs are collectively identified as prostanoids. Prostaglandins were originally shown to be synthesized in the prostate gland, thromboxanes from platelets (thrombocytes) and leukotrienes from leukocytes, hence the derivation of their names. All mammalian cells except erythrocytes synthesize eicosanoids. These molecules are extremely potent, able to cause profound physiological effects at very dilute concentrations. All eicosanoids function locally at the site of synthesis, through receptor-mediated G-protein linked signaling pathways.",Prostaglandin H2,HMDB0001381,b,b,C00427,PROSTAGLANDIN-H2,FDB022592,prostgh2,[H]O[C@]([H])(C(\[H])=C(/[H])[C@@]1([H])[C@]2([H])OO[C@@]([H])(C2([H])[H])[C@]1([H])C([H])([H])C(\[H])=C(\[H])C([H])([H])C([H])([H])C([H])([H])C([O-])=O)C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H],YIBNHAJFJUQSRA-YNNPMVKQSA-M,"InChI=1S/C20H32O5/c1-2-3-6-9-15(21)12-13-17-16(18-14-19(17)25-24-18)10-7-4-5-8-11-20(22)23/h4,7,12-13,15-19,21H,2-3,5-6,8-11,14H2,1H3,(H,22,23)/p-1/b7-4-,13-12+/t15-,16+,17+,18-,19+/m0/s1"
803,27130,trimethylarsine,An arsine that is arsane in which each of the hydrogens is substituted by a methyl group.,15989,KEGG COMPOUND accession,C03895,M02703,b,15989.0,b,Peptide-L-Methionine-(S)-S-Oxide,b,b,b,C03895,b,b,b,[H]N([*])C(=O)[C@@]([H])(N([H])C([*])=O)C([H])([H])C([H])([H])[S@@](=O)C([H])([H])[H],b,b
804,20675,5beta-spirostan,a,6784,KEGG COMPOUND accession,C07618,,,,,,,,,,,,,,,
805,25939,permanganate,a,8034,KEGG COMPOUND accession,C09283,,,,,,,,,,,,,,,
806,9638,torulene,"A carotene that is beta,psi-carotene which has been been dehydrogenated to introduce an (E)-double bond at the 3'-4' position.",3293,KEGG COMPOUND accession,C10431,,,,,,,,,,,,,,,
807,26292,propanones,A ketone that is propane carrying at least one oxo substituent.,28915,KEGG COMPOUND accession,C06454,,,,,,,,,,,,,,,
808,26346,prostaglandins J,a,8182,KEGG COMPOUND accession,C10609,,,,,,,,,,,,,,,
809,26366,pseudouridines,a,8191,KEGG COMPOUND accession,C05413,,,,,,,,,,,,,,,
810,26373,pteridines,a,28824,KEGG COMPOUND accession,C05442,,,,,,,,,,,,,,,
811,26395,purine nucleotide,Any nucleotide that has a purine nucleobase.,8207,KEGG COMPOUND accession,C07474,,,,,,,,,,,,,,,
812,26456,pyrrolidine alkaloid,a,18049,KEGG COMPOUND accession,C01746,,,,,,,,,,,,,,,
813,26810,3-carboxypropanoyl group,a,32877,KEGG COMPOUND accession,C02580,,,,,,,,,,,,,,,
814,26825,sulfobenzoic acid,a,8417,KEGG COMPOUND accession,C11615,,,,,,,,,,,,,,,
815,20568,5-deoxyribose phosphate,a,27527,KEGG COMPOUND accession,C05399,,,,,,,,,,,,,,,
816,20598,5-methoxycarbonylmethyluridine,"A derivative of uridine, bearing an additional methoxycarbonylmethyl substituent at position 5 on the uracil ring.",6746,KEGG COMPOUND accession,C07126,,,,,,,,,,,,,,,
817,20602,5-methyl-2-thiouridine,a,18151,KEGG COMPOUND accession,C05819,mql7,b,b,b,Menaquinol 7,b,b,b,C05819,b,b,b,b,b,b
818,19068,1-methylpseudouridine,A methylpseudouridine in which the methyl group is located at position N-1 on the uracil ring.,28319,KEGG COMPOUND accession,C02985,fuc1p_L,16562-58-6,28319.0,"Human Metabolome Database (HMDB): Fucose-1-phosphate is an intermediate in the reversible synthesis of GDP-L-fucose, in a reaction catalyzed by the enzyme guanosine triphosphate fucose pyrophosphorylase (GFPP, E.C. 2.7.7.30). The reversible reaction is magnesium-dependent, although the enzyme is partially active when cobalt or manganese is substituted. The reaction is unusual in that, of the four canonical nucleoside triphosphates, only guanosine can be utilized efficiently to form a nucleotide-sugar. Free cytosolic fucose is phosphorylated by L-fucokinase (EC 2.7.1.52) to form fucose-1-phosphate in the salvage pathway of GDP-L-fucose. (PMID: 16185085, 14686921).",Fucose 1-phosphate,HMDB0001265,b,b,C02985,CPD-488,FDB022520,fuc1p_L,[H]O[C@]1([H])C([H])(OP([O-])([O-])=O)O[C@@]([H])(C([H])([H])[H])[C@@]([H])(O[H])[C@@]1([H])O[H],PTVXQARCLQPGIR-DHVFOXMCSA-L,"InChI=1S/C6H13O8P/c1-2-3(7)4(8)5(9)6(13-2)14-15(10,11)12/h2-9H,1H3,(H2,10,11,12)/p-2/t2-,3+,4+,5-,6?/m0/s1"
819,29600,gibberellin A51-catabolite,A tetracyclic diterpenoid obtained by catabolism of gibberellin A51.,9290,KEGG COMPOUND accession,C09190,,,,,,,,,,,,,,,
820,29999,L-serine residue,A serine residue that has L configuration.,17228,KEGG COMPOUND accession,C01959,,,,,,,,,,,,,,,
821,30014,D-threonine residue,a,17948,KEGG COMPOUND accession,C01617,,,,,,,,,,,,,,,
822,30128,oxidoaluminium,a,9464,KEGG COMPOUND accession,C08157,,,,,,,,,,,,,,,
823,30224,positronium,Atom-like pair of particles consisting of an anti-electron (positron) and an electron.,17410,KEGG COMPOUND accession,C03178,,,,,,,,,,,,,,,
824,20056,3-hydroxy-L-proline,The L-stereoisomer of 3-hydroxyproline.,15771,KEGG COMPOUND accession,C01433,,,,,,,,,,,,,,,
825,20129,3-methylcytidine,a,6541,KEGG COMPOUND accession,C07072,,,,,,,,,,,,,,,
826,21815,N2-acyl-L-ornithine,a,27459,KEGG COMPOUND accession,C03146,,,,,,,,,,,,,,,
827,20995,aldehydo-D-glucosamine 6-phosphate,a,6916,KEGG COMPOUND accession,C07220,,,,,,,,,,,,,,,
828,25818,"4-(2-aminoethyl)-N,N-bis(2-chloroethyl)aniline",a,17302,KEGG COMPOUND accession,C01948,,,,,,,,,,,,,,,
829,14272,fluoroacetaldehyde,An aldehyde that is acetaldehyde in which one of the hydrogens of the methyl group is replaced by fluorine.,5010,KEGG COMPOUND accession,C02539,,,,,,,,,,,,,,,
830,14885,prephytoene diphosphate,a,17383,KEGG COMPOUND accession,C00394,,,,,,,,,,,,,,,
831,18436,"(+)-9,10-dihydrojasmonic acid",a,18224,KEGG COMPOUND accession,C10469,,,,,,,,,,,,,,,
832,24651,hydroxides,Hydroxides are chemical compounds containing a hydroxy group or salts containing hydroxide (OH(-)).,7770,KEGG COMPOUND accession,C07323,,,,,,,,,,,,,,,
833,7967,phenoxymethylpenicillin potassium,a,2700,KEGG COMPOUND accession,C11695,C11695,94421-68-8,2700.0,"Human Metabolome Database (HMDB): Anandamide is a highly potent endogenous agonist of the cannabinoid CB1 and CB2 receptors. CB1 receptors are predominantly found in the central nervous system (CNS) where they mainly mediate the psychotropic effects of Tetrahydrocannabinol (THC) and endocannabinoids, whereas the expression of the CB2 receptor is thought to be restricted to cells of the immune system. It was suggested that AEA might inhibit tumor cell proliferation or induce apoptosis independently of CB1 and CB2 receptors, via interaction with the type 1 vanilloid receptor (VR1). VR1 is an ion channel expressed almost exclusively by sensory neurons, activated by pH, noxious heat (>48 degree centigrade) and plant toxins and is thought to play an important role in nociception. Cervical cancer cells are sensitive to AEA-induced apoptosis via VR1 that is aberrantly expressed in vitro and in vivo while CB1 and CB2 receptors play a protective role. (PMID 15047233). Novel prostaglandins (prostaglandin glycerol esters and prostaglandin ethanolamides) are COX-2 oxidative metabolites of endogenous cannabinoids (such as Anandamide). Recent evidence suggests that these new types of prostaglandins are likely novel signaling mediators involved in synaptic transmission and plasticity. (PMID 16957004).",Anandamide,HMDB0004080,b,b,C11695,CPD-7598,FDB023303,C11695,[H]OC([H])([H])C([H])([H])N([H])C(=O)C([H])([H])C([H])([H])C([H])([H])C(\[H])=C(\[H])C([H])([H])C(\[H])=C(\[H])C([H])([H])C(\[H])=C(\[H])C([H])([H])C(\[H])=C(\[H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H],LGEQQWMQCRIYKG-DOFZRALJSA-N,"InChI=1S/C22H37NO2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-22(25)23-20-21-24/h6-7,9-10,12-13,15-16,24H,2-5,8,11,14,17-21H2,1H3,(H,23,25)/b7-6-,10-9-,13-12-,16-15-"
834,5147,formoterol,"A racemate consisting of equal amounts of arformoterol (the active enantiomer) and (S,S)-formoterol (the inactive enantiomer). Its fumaric acid salt is used as a direct-acting sympathomimetic and bronchodilator for the treatment of chronic obstructive pulmonary disease (any progressive respiratory disease that makes it harder to breathe over time, such as chronic bronchitis and emphysema).",16274,KEGG COMPOUND accession,C03476,,,,,,,,,,,,,,,
835,29704,valiolone,"A cyclitol that is cyclohexanone which is substituted by hydroxy groups at positions 2, 3, 4, and 5, and by a hydroxymethyl group at position 5 (the 2R,3S,4S,5S stereoisomer).",45652,KEGG COMPOUND accession,C07546,,,,,,,,,,,,,,,
836,5720,himbacine,"A  piperidine alkaloid that is decahydronaphtho[2,3-c]furan-1(3H)-one substituted by a methyl group at position 3 and a 2-[(2R,6S)-1,6-dimethylpiperidin-2-yl]ethenyl group at position 4. It has been isolated from the bark of Australian magnolias.",28784,KEGG COMPOUND accession,C08245,,,,,,,,,,,,,,,
837,3024,benzenamine sulfate(1-),An organic sulfamate oxoanion obtained by deprotonation of the sulfamate OH group of benzenamine sulfate.,40407,KEGG COMPOUND accession,C05810,,,,,,,,,,,,,,,
838,8893,rosinidin,"An anthocyanidin cation consisting of benzopyrylium with hydroxy substituents at positions 3 and 5, a methoxy group at position 7 and a 4-hydroxy-3-methoxyphenyl group at position 2.",3103,KEGG COMPOUND accession,C07605,,,,,,,,,,,,,,,
839,5194,furalaxyl,"A racemate comprising equal amounts of (R)- and (S)-furalaxyl. A systemic fungicide with protective and curative properties. It is effective against damping-off and root rot diseases caused by Pythium and Phytophthora fungi which inhabit the soil and infect many ornamental flowers, shrubs and trees.",2010,KEGG COMPOUND accession,C05654,,,,,,,,,,,,,,,
840,24333,glutaryl-CoAs,Any  omega-carboxyacyl-CoA in which the acyl group specified is glutaryl or its substituted derivative.,7625,KEGG COMPOUND accession,C10719,,,,,,,,,,,,,,,
841,2149,5beta-cyprinol sulfate,A steroid sulfate that is the sulfuric ester derivative of 5beta-cyprinol.,28119,KEGG COMPOUND accession,C07557,,,,,,,,,,,,,,,
842,5018,ferreirin,"A hydroxyisoflavanone that is isoflavanone substituted by hydroxy groups at positions 5, 7 and 2' and a methoxy group at position 4' respectively.",28947,KEGG COMPOUND accession,C06676,,,,,,,,,,,,,,,
843,2814,arecoline,"A tetrahydropyridine that is 1,2,5,6-tetrahydropyridine with a methyl group at position 1, and a methoxycarbonyl group at position 3. An alkaloid found in the areca nut, it acts as an agonist of muscarinic acetylcholine.",17878,KEGG COMPOUND accession,C01147,,,,,,,,,,,,,,,
844,5537,granisetron,"A monocarboxylic acid amide resulting from the formal condensation of the carboxy group of 1-methyl-1H-indazole-3-carboxylic acid with the primary amino group of (3-endo)-9-methyl-9-azabicyclo[3.3.1]nonan-3-amine. A selective 5-HT3 receptor antagonist, it is used (generally as the monohydrochloride salt) to manage nausea and vomiting caused by cancer chemotherapy and radiotherapy, and to prevent and treat postoperative nausea and vomiting.",17938,KEGG COMPOUND accession,C04416,,,,,,,,,,,,,,,
845,3244,butrin,A flavanone glycoside that is  butin substituted by two beta-D-glucopyranosyl residues at positions 7 and 3' respectively.,17872,KEGG COMPOUND accession,C03671,,,,,,,,,,,,,,,
846,3613,chlorflavonin,"A  dihydroxyflavone that is flavone substituted by a chloro group at position 3', hydroxy groups at positions 5 and 2' and methoxy groups at positions 3, 7 band 8 respectively.",18136,KEGG COMPOUND accession,C04044,,,,,,,,,,,,,,,
847,3718,cirsilineol,"A trimethoxyflavone that is flavone substituted by methoxy groups at positions 6, 7 and 3' and hydroxy groups at positions 5 and 4' respectively.",28180,KEGG COMPOUND accession,C06145,,,,,,,,,,,,,,,
848,7500,neocarlinoside,"A flavone C-glycoside that is flavone substituted by hydroxy groups at positions 5, 7, 3' and 4' and a beta-D-glucopyranosyl and a beta-L-arabinopyranosyl residue via C-glycosidic linkages at positions 6 and 8 respectively",2506,KEGG COMPOUND accession,C10199,,,,,,,,,,,,,,,
849,4874,etaconazole,"A member of the class of dioxolanes that is 1,3-dioxolane substituted at position 2 by 2,4-dichlorophenyl and 1,2,4-triazol-1-ylmethyl groups and at position 4 by an ethyl group. An obsolete fungicide that was used to control powdery mildew on fruit and other crops.",27600,KEGG COMPOUND accession,C06680,,,,,,,,,,,,,,,
850,4393,(-)-demecolcine,"A secondary amino compound that is (S)-colchicine in which the N-acetyl group is replaced by an N-methyl group. Isolable from the autumn crocus, Colchicum autumnale, it is less toxic than colchicine and is used as an antineoplastic.",15494,KEGG COMPOUND accession,C04644,dhcholestancoa,2461-62-3,15494.0,"Human Metabolome Database (HMDB): First activated by a fatty acyl-CoA ligase activity, can then be converted to chenodeoxycholic acid by peroxisome rich fractions from rat and human liver (J Lipid Res. 1988 Aug;29(8):997-1004, PMID 3183523 ).","3a,7a-Dihydroxy-5b-cholestanoyl-CoA",HMDB0002159,b,b,C04644,b,FDB022875,dhcholestancoa,[H]O[C@@]([H])(C(=O)N([H])C([H])([H])C([H])([H])C(=O)N([H])C([H])([H])C([H])([H])SC(=O)C([H])(C([H])([H])[H])C([H])([H])C([H])([H])C([H])([H])[C@@]([H])(C([H])([H])[H])[C@@]1([H])C([H])([H])C([H])([H])[C@@]2([H])[C@]3([H])[C@]([H])(O[H])C([H])([H])[C@]4([H])C([H])([H])[C@]([H])(O[H])C([H])([H])C([H])([H])[C@]4(C([H])([H])[H])[C@@]3([H])C([H])([H])C([H])([H])[C@]12C([H])([H])[H])C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])OP([O-])(=O)OP([O-])(=O)OC([H])([H])[C@@]1([H])O[C@@]([H])(N2C([H])=NC3=C(N=C([H])N=C23)N([H])[H])[C@]([H])(O[H])[C@]1([H])OP([O-])([O-])=O,SBYLHTNKEWSLBA-UVNMPUASSA-J,"InChI=1S/C48H80N7O19P3S/c1-26(30-10-11-31-36-32(13-16-48(30,31)6)47(5)15-12-29(56)20-28(47)21-33(36)57)8-7-9-27(2)45(62)78-19-18-50-35(58)14-17-51-43(61)40(60)46(3,4)23-71-77(68,69)74-76(66,67)70-22-34-39(73-75(63,64)65)38(59)44(72-34)55-25-54-37-41(49)52-24-53-42(37)55/h24-34,36,38-40,44,56-57,59-60H,7-23H2,1-6H3,(H,50,58)(H,51,61)(H,66,67)(H,68,69)(H2,49,52,53)(H2,63,64,65)/p-4/t26-,27?,28+,29-,30-,31+,32+,33-,34-,36+,38-,39-,40+,44-,47+,48-/m1/s1"
851,9199,sophoranone,A dihydroxyflavanone that is (2S)-flavanone substituted by hydroxy groups at positions 7 and 4' and prenyl groups at positions 3' and 5' respectively.,3238,KEGG COMPOUND accession,C08067,,,,,,,,,,,,,,,
852,7513,neoschaftoside,A flavone C-glycoside that is  apigenin attached to a beta-D-glucopyranosyl and a beta-L-arabinopyranosyl residues at positions 6 and 8 respectively via C-glycosidic linkage.,2512,KEGG COMPOUND accession,C10017,,,,,,,,,,,,,,,
853,7502,neoeriocitrin,A flavanone glycoside that is  eriodictyol substituted by a 2-O-(6-deoxy-alpha-L-mannopyranosyl)-beta-D-glucopyranosyl residue at position 7 via a glycosidic linkage.,2507,KEGG COMPOUND accession,C09320,,,,,,,,,,,,,,,
854,8455,proguanil,"A biguanide compound which has isopropyl and p-chlorophenyl substituents on the terminal N atoms. A prophylactic antimalarial drug, it works by inhibiting the enzyme dihydrofolate reductase, which is involved in the reproduction of the malaria parasites Plasmodium falciparum and P. vivax within the red blood cells.",2909,KEGG COMPOUND accession,C08660,,,,,,,,,,,,,,,
855,5494,ritropirronium bromide,"A racemate composed of equimolar amounts of (2S,3R)- and (2S,3R)-glycopyrronium bromide. Used either alone or in combination therapy for maintenance treatment of airflow obstruction in patients with chronic obstructive pulmonary disease.",2124,KEGG COMPOUND accession,C06052,,,,,,,,,,,,,,,
856,5757,homostachydrine,"An ammonium betaine that is pipecolic acid zwitterion with methyl groups substituted for the two hydrogens at the nitrogen. It is found in in fruits, seeds, and leaves of orange, lemon, and bergamot.",17332,KEGG COMPOUND accession,C03848,,,,,,,,,,,,,,,
857,87,(-)-chimonanthine,"The (3aS,3a'S,8aS,8a'S)-stereoisomer of chimonanthine.",42,KEGG COMPOUND accession,C09611,,,,,,,,,,,,,,,
858,5728,hirsutidin,"An anthocyanidin cation consisting of benzopyrylium with hydroxy substituents at positions 3 and 5, a methoxy group at position 7 and a 4-hydroxy-3,5-dimethoxyphenyl group at position 2.",2229,KEGG COMPOUND accession,C01218,,,,,,,,,,,,,,,
859,26432,pyrimidine nucleobase,A nucleobase whose skeleton is derived from pyrimidine.,36011,KEGG COMPOUND accession,C01745,,,,,,,,,,,,,,,
860,7581,nitrazepam,"A 1,4-benzodiazepinone that is 1,3-dihydro-2H-1,4-benzodiazepin-2-one which is substituted at positions 5 and 7 by phenyl and nitro groups, respectively. It is used as a hypnotic for the short-term management of insomnia and for the treatment of epileptic spasms in infants (West's syndrome).",2542,KEGG COMPOUND accession,C09290,,,,,,,,,,,,,,,
861,2766,aphidicolin,"A tetracyclic diterpenoid that has an tetradecahydro-8,11a-methanocyclohepta[a]naphthalene skeleton with two hydroxymethyl substituents at positions 4 and 9, two methyl substituents at positions 4 and 11b and two hydroxy substituents at positions 3 and 9. An antibiotic with antiviral and antimitotical properties. Aphidicolin is a reversible inhibitor of eukaryotic nuclear DNA replication.",28249,KEGG COMPOUND accession,C07478,,,,,,,,,,,,,,,
862,3948,cucurbitacin J,"A  cucurbitacin that is 9,10,14-trimethyl-4,9-cyclo-9,10-secocholesta-2,5-diene substituted by hydroxy groups at positions 2, 16, 20, 24 and 25 and oxo groups at positions 1, 11 and 22.",33404,KEGG COMPOUND accession,C01013,3hpp,503-66-2,33404.0,"Human Metabolome Database (HMDB): 3-Hydroxypropionic acid is a carboxylic acid. It is an intermediate in the breakdown of branched-chain amino acids and propionic acid from the gut. Typically it originates from propionyl-CoA and a defect in the enzyme propionyl carboxylase. This leads to a buildup in propionyl-CoA in the mitochondria.  Such a buildup can lead to a disruption of the esterified CoA:free CoA ratio and ultimately to mitochondrial toxicity. Detoxification of these metabolic end products occurs via the transfer of the propionyl moiety to carnitine-forming propionyl-carnitine, which is then transferred across the inner mitochondrial membrane. 3-Hydroxypropionic acid is then released as the free acid. As an industrial chemical, it is used in the production of various chemicals such as acrylates in industry. When present in sufficiently high levels, 3-hydroxypropionic acid can act as an acidogen and a metabotoxin. An acidogen is an acidic compound that induces acidosis, which has multiple adverse effects on many organ systems. A metabotoxin is an endogenously produced metabolite that causes adverse health effects at chronically high levels. Chronically high levels of hydroxypropionic acid are associated with many inborn errors of metabolism including biotinidase deficiency, malonic aciduria, methylmalonate semialdehyde dehydrogenase deficiency, methylmalonic aciduria, methylmalonic aciduria due to cobalamin-related disorders, and propionic acidemia. Hydroxypropionic acid is an organic acid. Abnormally high levels of organic acids in the blood (organic acidemia), urine (organic aciduria), the brain, and other tissues lead to general metabolic acidosis. Acidosis typically occurs when arterial pH falls below 7.35. Infants with acidosis have symptoms that include poor feeding, vomiting, loss of appetite, weak muscle tone (hypotonia), and lack of energy (lethargy). These can progress to heart, liver, and kidney abnormalities, seizures, coma, and possibly death. These are also the characteristic symptoms of the IEMs mentioned above. Many affected children with organic acidemias experience intellectual disability or delayed development. In adults, acidosis or acidemia is characterized by headaches, confusion, feeling tired, tremors, sleepiness, and seizures.",Hydroxypropionic acid,HMDB0000700,b,b,C01013,b,FDB022189,3hpp,[H]OC([H])([H])C([H])([H])C([O-])=O,ALRHLSYJTWAHJZ-UHFFFAOYSA-M,"InChI=1S/C3H6O3/c4-2-1-3(5)6/h4H,1-2H2,(H,5,6)/p-1"
863,3201,bryotoxin A,"A bufadienolide glycoside that is 3,5,11,14-tetrahydroxy-12,19-dioxobufa-20,22-dienolide attached to a 3-O-acetyl-4,6-dideoxy-beta-D-arabino-hexopyranosyl residue at position 3 via a glycosidic linkage.",18168,KEGG COMPOUND accession,C02117,,,,,,,,,,,,,,,
864,7912,panose,A trisaccharide composed of D-glucopyranose units.,2674,KEGG COMPOUND accession,C07626,,,,,,,,,,,,,,,
865,8417,pristinamycin IA,"A cyclodepsipeptide that is (together with pristinamycin IIA) a component of pristinamycin, an oral streptogramin antibiotic produced by Streptomyces pristinaespiralis. Pristinamycin exhibits bactericidal activity against Gram positive organisms including methicillin-resistant Staphylococcus aureus.",17704,KEGG COMPOUND accession,C02006,,,,,,,,,,,,,,,
866,5100,flucytosine,"An organofluorine compound that is cytosine that is substituted at position 5 by a fluorine. A prodrug for the antifungal 5-fluorouracil, it is used for the treatment of systemic fungal infections.",16612,KEGG COMPOUND accession,C04292,,,,,,,,,,,,,,,
867,109,(-)-phaseollinisoflavan,"A member of the class of  hydroxyisoflavans that is (3R)-3,4-dihydro-2H,2'H-3,6'-bichromene substituted by two methyl groups at positions 2' and 2' and hydroxy groups at positions 5' and 7 respectively.",53,KEGG COMPOUND accession,C09877,,,,,,,,,,,,,,,
868,3394,carbetamide,A carbamate ester obtained by the formal condensation of  phenylcarbamic acid with the hydroxy group of N-ethyl-2-hydroxypropanamide.,27599,KEGG COMPOUND accession,C04526,,,,,,,,,,,,,,,
869,7587,nitroalkane,A nitrohydrocarbon that is an alkane in which one of the hydrogens has been replaced by a nitro group.,16664,KEGG COMPOUND accession,C01779,,,,,,,,,,,,,,,
870,2739,anisotropine methylbromide,A quaternary ammonium salt resulting from the reaction of the amino group of anisotropine with methyl bromide.,27683,KEGG COMPOUND accession,C05350,M00643,b,27683.0,Human Metabolome Database (HMDB): 2-Hydroxy-3-(4-hydroxyphenyl)propenoic acid is an intermediate in tyrosine metabolism. It is reversibly converted from 4-hydroxyphenylpyruvate via phenylpyruvate tautomerase. 2-Hydroxy-3-(4-hydroxyphenyl)propenoic acid is typically a terminal product of tyrosine metabolism.,2-Hydroxy-3-(4-hydroxyphenyl)propenoic acid,HMDB0006915,b,b,C05350,b,FDB024152,b,[H]OC(=O)C(\O[H])=C(/[H])C1=C([H])C([H])=C(O[H])C([H])=C1[H],GQYBCIHRWMPOOF-YVMONPNESA-N,"InChI=1S/C9H8O4/c10-7-3-1-6(2-4-7)5-8(11)9(12)13/h1-5,10-11H,(H,12,13)/b8-5-"
871,3347,candesartan,"A benzimidazolecarboxylic acid that is 1H-benzimidazole-7-carboxylic acid substituted by an ethoxy group at position 2 and a ({2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl}methyl) group at position 1. It is a angiotensin receptor antagonist used for the treatment of hypertension.",16860,KEGG COMPOUND accession,C04443,,,,,,,,,,,,,,,
872,18471,"(-)-11-hydroxy-9,10-dihydrojasmonic acid 11-beta-D-glucoside","A monosaccharide derivative that is (-)-11-hydroxy-9,10-dihydrojasmonic acid attached to a beta-D-glucopyranosyl residue at position 11 via a glycosidic linkage.",27649,KEGG COMPOUND accession,C02160,,,,,,,,,,,,,,,
873,5181,fucoidan,"A type of fucose-rich sulfated polysaccharide found in various species of brown algae, seaweed and sea-cucumbers.",27634,KEGG COMPOUND accession,C05423,,,,,,,,,,,,,,,
874,9011,salmeterol,"A racemate consisting of equal parts of (R)- and (S)-salmeterol.   It is a potent and selective beta2-adrenoceptor agonist (EC50 = 5.3 nM). Unlike other beta2 agonists, it binds to the exo-site domain of beta2 receptors, producing a slow onset of action and prolonged activation.",3157,KEGG COMPOUND accession,C09915,,,,,,,,,,,,,,,
875,3012,benazepril hydrochloride,A hydrochloride salt resulting from the reaction of benazepril with 1 mol eq. of hydrogen chloride. It is used as a prodrug for angiotensin-converting enzyme inhibitor benazeprilat in the treatment of hypertension and heart failure.,1228,KEGG COMPOUND accession,C10083,,,,,,,,,,,,,,,
876,4344,debromoaplysiatoxin,"A member of the class of aplysiatoxins that has the structure of the parent aplysiatoxin, but is lacking the bromo substituent on the benzene ring at the position para to the phenolic hydroxy group. It is a cyanotoxin produced by several species of freshwater and marine cyanobacteria, as well as algae and molluscs.",17278,KEGG COMPOUND accession,C05446,M01092,862-53-3,17278.0,"Human Metabolome Database (HMDB): 27-Deoxy-5b-cyprinol is an intermediate in Bile acid synthesis pathway, in a sequence of reactions catalyzed by sterol 27-hydroxylase (CYP27) in the oxidation of 5 beta-cholestane-3 alpha,7 alpha,12 alpha,27-tetrol into 3 alpha,7 alpha,12 alpha-trihydroxy-5 beta-cholestanoic acid (PMID: 8496170). 5 beta-cholestane-3 alpha,7 alpha,12 alpha,25-tetrol 3-glucuronide, a metabolite of 27-Deoxy-5b-cyprinol, is the major bile alcohol component in serum from cerebrotendinous xanthomatosis patients (PMID: 7920441).",27-Deoxy-5b-cyprinol,HMDB0001231,b,b,C05446,5-BETA-CHOLESTANE-3-ALPHA7-TETRAOL,FDB022502,b,[H]OC([H])([H])C([H])(C([H])([H])[H])C([H])([H])C([H])([H])C([H])([H])[C@@]([H])(C([H])([H])[H])C1([H])C([H])([H])C([H])([H])C2([H])C3([H])[C@]([H])(O[H])C([H])([H])C4([H])C([H])([H])[C@]([H])(O[H])C([H])([H])C([H])([H])[C@]4(C([H])([H])[H])C3([H])C([H])([H])[C@]([H])(O[H])[C@]12C([H])([H])[H],XJZGNVBLVFOSKJ-FXTKQEBRSA-N,"InChI=1S/C27H48O4/c1-16(15-28)6-5-7-17(2)20-8-9-21-25-22(14-24(31)27(20,21)4)26(3)11-10-19(29)12-18(26)13-23(25)30/h16-25,28-31H,5-15H2,1-4H3/t16?,17-,18?,19-,20?,21?,22?,23-,24+,25?,26+,27-/m1/s1"
877,4344,debromoaplysiatoxin,"A member of the class of aplysiatoxins that has the structure of the parent aplysiatoxin, but is lacking the bromo substituent on the benzene ring at the position para to the phenolic hydroxy group. It is a cyanotoxin produced by several species of freshwater and marine cyanobacteria, as well as algae and molluscs.",17278,KEGG COMPOUND accession,C05446,xoltetrol,b,17278.0,"Human Metabolome Database (HMDB): 27-Deoxy-5b-cyprinol is an intermediate in Bile acid synthesis pathway, in a sequence of reactions catalyzed by sterol 27-hydroxylase (CYP27) in the oxidation of 5 beta-cholestane-3 alpha,7 alpha,12 alpha,27-tetrol into 3 alpha,7 alpha,12 alpha-trihydroxy-5 beta-cholestanoic acid (PMID: 8496170). 5 beta-cholestane-3 alpha,7 alpha,12 alpha,25-tetrol 3-glucuronide, a metabolite of 27-Deoxy-5b-cyprinol, is the major bile alcohol component in serum from cerebrotendinous xanthomatosis patients (PMID: 7920441).",27-Deoxy-5b-cyprinol,HMDB0001231,b,b,C05446,5-BETA-CHOLESTANE-3-ALPHA7-TETRAOL,FDB022502,xoltetrol,[H]OC([H])([H])C([H])(C([H])([H])[H])C([H])([H])C([H])([H])C([H])([H])[C@@]([H])(C([H])([H])[H])[C@@]1([H])C([H])([H])C([H])([H])[C@@]2([H])[C@]3([H])[C@]([H])(O[H])C([H])([H])[C@]4([H])C([H])([H])[C@]([H])(O[H])C([H])([H])C([H])([H])[C@]4(C([H])([H])[H])[C@@]3([H])C([H])([H])[C@]([H])(O[H])[C@]12C([H])([H])[H],XJZGNVBLVFOSKJ-XZULNKEGSA-N,"InChI=1S/C27H48O4/c1-16(15-28)6-5-7-17(2)20-8-9-21-25-22(14-24(31)27(20,21)4)26(3)11-10-19(29)12-18(26)13-23(25)30/h16-25,28-31H,5-15H2,1-4H3/t16?,17-,18+,19-,20-,21+,22+,23-,24+,25+,26+,27-/m1/s1"
878,29505,A47934,A cyclic peptide antibiotic produced by a strain of Streptomyces toyocaensis.,28017,KEGG COMPOUND accession,C00369,,,,,,,,,,,,,,,
879,5693,hexachlorophene,"An organochlorine compound that is diphenylmethane in which each of the phenyl groups is substituted by chlorines at positions 2, 3, and 5, and by a hydroxy group at position 6. An antiseptic that is effective against Gram-positive organisms, it is used in soaps and creams for the treatment of various skin disorders. It is also used in agriculture as an acaricide and fungicide, but is not approved for such use within the European Union.",28314,KEGG COMPOUND accession,C10104,,,,,,,,,,,,,,,
880,3978,cyanin,An anthocyanin cation that is cyanidin(1+) carrying two beta-D-glucosyl residues at positions 3 and 5.,35121,KEGG COMPOUND accession,C04411,,,,,,,,,,,,,,,
881,3763,clorgyline,"An aromatic ether that is the 2,4-dichlorophenyl ether of 3-aminopropan-1-ol in which the nitrogen is substituted by a methyl group and a prop-1-yn-3-yl group. A monoamine oxidase inhibitor, it was formerly used as an antidepressant.",16934,KEGG COMPOUND accession,C02512,HC00955,b,16934.0,Human Metabolome Database (HMDB): This compound belongs to the family of Alpha Amino Acids. These are amino acids in which the amino group is attached to the carbon atom immediately adjacent to the carboxylate group (alpha carbon). ,L-3-Cyanoalanine,HMDB0060245,b,b,C02512,CPD-603,b,HC00955,[H][N+]([H])([H])[C@]([H])(C([O-])=O)C([H])([H])C#N,BXRLWGXPSRYJDZ-VKHMYHEASA-M,"InChI=1S/C4H6N2O2/c5-2-1-3(6)4(7)8/h3H,1,6H2,(H,7,8)/p-1/t3-/m0/s1"
882,26133,pinane monoterpenoid,"A monoterpenoid based on a pinane skeleton (2,6,6-trimethylbicyclo[3.1.1]heptane) skeleton and its substituted derivatives.",8108,KEGG COMPOUND accession,C05797,,,,,,,,,,,,,,,
883,1845,4-hydroxy-3-polyprenylbenzoic acid,A monohydroxybenzoic acid that is 4-hydroxybenzoic acid substituted at position 3 by any polyprenyl group.,27814,KEGG COMPOUND accession,C05949,,,,,,,,,,,,,,,
884,8361,pravastatin sodium,"An organic sodium salt that is the sodium salt of pravastatin. A reversible inhibitor of 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA), it is used for lowering cholesterol and preventing cardiovascular disease. It is one of the lower potency statins, but has the advantage of fewer side effects compared with lovastatin and simvastatin.",29073,KEGG COMPOUND accession,C00072,ascb_L,50-81-7,17208.0,"Human Metabolome Database (HMDB): Ascorbic acid is found naturally in citrus fruits and many vegetables and is an essential nutrient in human diets. It is necessary to maintain connective tissue and bone. The biologically active form of ascorbic acid is vitamin C. Vitamin C is a water soluble vitamin. Primates (including humans) and a few other species in all divisions of the animal kingdom, notably the guinea pig, have lost the ability to synthesize ascorbic acid and must obtain it in their food. Vitamin C functions as a reducing agent and coenzyme in several metabolic pathways. Vitamin C is considered an antioxidant (PubChem). Ascorbic acid is an electron donor for enzymes involved in collagen hydroxylation, biosynthesis of carnitine and norepinephrine, tyrosine metabolism, and amidation of peptide hormones. Ascrobic acid (vitamin C) deficiency causes scurvy. The amount of vitamin C necessary to prevent scurvy may not be adequate to maintain optimal health. The ability of vitamin C to donate electrons also makes it a potent water-soluble antioxidant that readily scavenges free radicals such as molecular oxygen, superoxide, hydroxyl radical, and hypochlorous acid. In this setting, several mechanisms could account for a link between vitamin C and heart disease. One is the relation between LDL oxidation and vitamins C and E. Vitamin C in vitro can recycle vitamin E, which can donate electrons to prevent LDL oxidation in vitro. As the lipid-phase vitamin E is oxidized, it can be regenerated by aqueous vitamin C. Other possibilities are that vitamin C could decrease cholesterol by mechanisms not well characterized, or could improve vasodilatation and vascular reactivity, perhaps by decreasing the interactions of nitric oxide with oxidants (PMID: 10799361). Moreover, ascorbic acid is found to be associated with hyperoxalemia, which is an inborn error of metabolism.",Ascorbic acid,HMDB0000044,b,b,C00072,ASCORBATE,FDB001224,ascb_L,[H]OC1=C([O-])[C@]([H])(OC1=O)[C@@]([H])(O[H])C([H])([H])O[H],CIWBSHSKHKDKBQ-JLAZNSOCSA-M,"InChI=1S/C6H8O6/c7-1-2(8)5-3(9)4(10)6(11)12-5/h2,5,7-10H,1H2/p-1/t2-,5+/m0/s1"
885,2509,agar,"A complex mixture of polysaccharides extracted from species of red algae. Its two main components are agarose and agaropectin. Agarose is the component responsible for the high-strength gelling properties of agar, while agaropectin provides the viscous properties.",17289,KEGG COMPOUND accession,C02926,,,,,,,,,,,,,,,
886,4828,ergothioneine,"A L-histidine derivative that is N(alpha),N(alpha),N(alpha)-trimethyl-L-histidine in which the hydrogen at position 2 on the imdazole ring is replaced by a mercapto group. A naturally occurring metabolite of histidine synthesized by bacteria and fungi with antioxidant properties. It is found ubiquitously in plants and animals and is present in many human foodstuffs.",16388,KEGG COMPOUND accession,C11527,,,,,,,,,,,,,,,
887,24020,fat-soluble vitamin (role),"Any vitamin that dissolves in fats and are stored in body tissues. Unlike the water-soluble vitamins, they are stored in the body for long periods of time and generally pose a greater risk for toxicity when consumed in excess.",7496,KEGG COMPOUND accession,C07257,,,,,,,,,,,,,,,
888,2564,aldrin,"An organochlorine compound resulting from the Diels-Alder reaction of hexachlorocyclopentadiene with norbornadiene. A proinsecticide (by epoxidation of the non-chlorinated double bond to give dieldrin), it was widely used as an insecticide before being banned in the 1970s as a persistent organic pollutant.",27797,KEGG COMPOUND accession,C08735,,,,,,,,,,,,,,,
889,3699,cimetidine,"A member of the class of  guanidines that consists of guanidine carrying a methyl substituent at position 1, a cyano group at position 2 and a 2-{[(5-methyl-1H-imidazol-4-yl)methyl]sulfanyl}ethyl group at position 3. It is a  H2-receptor antagonist that inhibits the production of acid in stomach.",40036,KEGG COMPOUND accession,C11261,,,,,,,,,,,,,,,
890,8121,phosalone,"A member of the class of  1,3-benzoxazoles carrying a [(diethoxyphosphorothioyl)sulfanyl]methyl group at the nitrogen atom, an oxo group at position 2 and a chloro group at position 6. It is an organothiophosphate insecticide.",15472,KEGG COMPOUND accession,C02247,,,,,,,,,,,,,,,
891,149,(-)-dihydrocarveol,"The (1R,2R,4R)-stereoisomer of  dihydrocarveol.",74,KEGG COMPOUND accession,C11357,,,,,,,,,,,,,,,
892,4305,dacarbazine,"A monocarboxylic acid amide that is 1H-imidazole-4-carboxamide which is substituted at position 5 by a 3,3-dimethyltriaz-1-en-1-yl group. It is used for the treatment of metastatic malignant melanoma, and in combination with other drugs for the treatment of Hodgkin's disease and soft-tissue sarcoma.",16775,KEGG COMPOUND accession,C03071,,,,,,,,,,,,,,,
893,1230,sophorose,A glycosylglucose that is D-glucopyranose attached to a beta-D-glucopyranosyl unit at position 2 via a glycosidic linkage.,27670,KEGG COMPOUND accession,C04597,,,,,,,,,,,,,,,
894,1403,"3,5-dihydroxyanthranilic acid","A dihydroxybenzoic acid that is 3,5-dihydroxybenzoic acid substituted by an amino group at position 2.",27380,KEGG COMPOUND accession,C02493,,,,,,,,,,,,,,,
895,7957,pencycuron,"A member of the class of phenylureas that is urea which is substituted by p-chlorobenzyl and cyclopentyl groups at position 1 and a phenyl group at position 3. A fungicide used to control diseases caused by Rhizoctonia solani and Pellicularia spp. It is not highly toxic to mammals but is moderately toxic to birds, most aquatic organisms, honeybees and earthworms.",28986,KEGG COMPOUND accession,C06180,,,,,,,,,,,,,,,
896,5576,guvacine,"A alpha,beta-unsaturated monocarboxylic acid that is nicotinic acid which has been hydrogenated at the 1-2 and 5-6 positions of the pyridine ring.",17651,KEGG COMPOUND accession,C05159,,,,,,,,,,,,,,,
897,5834,hyperforin,"A cyclic terpene ketone that is a prenylated carbobicyclic acylphloroglucinol derivative produced by St. John's Wort, Hypericum perforatum.",16778,KEGG COMPOUND accession,C04608,,,,,,,,,,,,,,,
898,3724,citalopram hydrobromide,"A racemate comprising equimolar amounts of (R)-citalopram hydrobromide and escitalopram hydrobromide. It is used for the treatment of depression. Only the (S)-enantiomer, (escitalopram hydrobromide) is active.",1461,KEGG COMPOUND accession,C06144,,,,,,,,,,,,,,,
899,4530,diethylpropion,"An  aromatic ketone that is propiophenone in which one of the hydrogens alpha- to the carbonyl is substituted by a diethylamino group. A central stimulant and indirect-acting sympathomimetic, it is an appetite depressant and is used as the hydrochloride as an anoretic in the short term management of obesity.",27450,KEGG COMPOUND accession,C06118,,,,,,,,,,,,,,,
900,2665,amitraz,"A tertiary amino compound that is 1,3,5-triazapenta-1,4-diene substituted by a methyl group at position 3 and 2,4-dimethylphenyl groups at positions 1 and 5.",16043,KEGG COMPOUND accession,C06369,,,,,,,,,,,,,,,
901,2155,"6,8-di-(3,3-dimethylallyl)chrysin",A dihydroxyflavone that is  chrysin substituted by prenyl groups at positions 6 and 8 respectively.,17720,KEGG COMPOUND accession,C01159,23dpg,138-81-8,17720.0,"Human Metabolome Database (HMDB): 2,3-Bisphosphoglycerate (2,3-BPG, also known as 2,3-diphosphoglycerate or 2,3-DPG) is a three carbon isomer of the glycolytic intermediate 1,3-bisphosphoglycerate and is present at high levels in the human red blood cell (RBC; erythrocyte)--at the same molar concentration as hemoglobin. It is notable because it binds to deoxygenated hemoglobin in RBCs. In doing so, it allosterically upregulates the ability of RBCs to release oxygen near tissues that need it most. Its function was discovered in 1967 by Reinhold Benesch and Ruth Benesch.","2,3-Diphosphoglyceric acid",HMDB0001294,b,b,C01159,23-DIPHOSPHOGLYCERATE,FDB022538,23dpg,[H]C([H])(OP([O-])([O-])=O)[C@@]([H])(OP([O-])([O-])=O)C([O-])=O,XOHUEYCVLUUEJJ-UWTATZPHSA-I,"InChI=1S/C3H8O10P2/c4-3(5)2(13-15(9,10)11)1-12-14(6,7)8/h2H,1H2,(H,4,5)(H2,6,7,8)(H2,9,10,11)/p-5/t2-/m1/s1"
902,29582,ascomycin,A macrolide that is produced by the fermentation of Streptomyces hygroscopicus and exhibits strong immunosuppressant properties.,17076,KEGG COMPOUND accession,C00413,,,,,,,,,,,,,,,
903,5396,glucoberteroin(1-),A thia-alkylglucosinolate that has a 5-(methylsulfanyl)pentyl side chain attached to the sulfonated oxime group.,47876,KEGG COMPOUND accession,C03592,,,,,,,,,,,,,,,
904,9700,tridemorph,"A mixture of 4-alkyl-2,6-dimethylmorpholines, where 'alkyl' is a mixture of C11 to C14 homologues of which 60-70% is tridecyl. A systemic fungicide, it is no longer approved for use within the European Union.",3319,KEGG COMPOUND accession,C11469,,,,,,,,,,,,,,,
905,4045,cyprodinil,"A member of the class of aminopyrimidine that is N-phenylpyrimidin-2-amine carrying additional cyclopropyl and methyl substituents at positions 4 and 6 respectively. A broad spectrum fungicide used to control a range of pathogens including Tapesia yallundae, Botrytis spp., Alternaria spp. and Rhynchospium secalis. Whilst it is a recognised irritant no serious human health concerns have been identified. It is moderately toxic to birds as well as most aquatic organisms and earthworms, but it is not considered toxic to honeybees.",38635,KEGG COMPOUND accession,C00913,,,,,,,,,,,,,,,
906,9715,triforine,"A member of the class of N-alkylpiperazines in which the two amino groups of piperazine are replaced by 1-formamido-2,2,2-trichloroethyl groups. A fungicide active against a range of diseases including powdery mildew, scab and rust.",3327,KEGG COMPOUND accession,C10054,,,,,,,,,,,,,,,
907,4710,doxepin,"A dibenzooxepine that is 6,11-dihydrodibenzo[b,e]oxepine substituted by a 3-(dimethylamino)propylidene group at position 11. It is used as an  antidepressant drug.",30907,KEGG COMPOUND accession,C01061,4fumacac,28613-33-4,30907.0,Human Metabolome Database (HMDB): Fumarylacetoacetate is an intermediate in the metabolism of tyrosine. Fumarylacetoacetate hydrolase (FAH) is an enzyme which catalyzes the hydrolysis of 4-fumarylacetoacetate into fumarate and acetoacetate. FAH is the last enzyme in the tyrosine catabolism pathway. FAH deficiency is associated with Type 1 hereditary tyrosinemia.,4-Fumarylacetoacetic acid,HMDB0001268,b,b,C01061,4-FUMARYL-ACETOACETATE,FDB022522,4fumacac,[H]\C(=C(\[H])C(=O)C([H])([H])C(=O)C([H])([H])C([O-])=O)C([O-])=O,GACSIVHAIFQKTC-OWOJBTEDSA-L,"InChI=1S/C8H8O6/c9-5(1-2-7(11)12)3-6(10)4-8(13)14/h1-2H,3-4H2,(H,11,12)(H,13,14)/p-2/b2-1+"
908,4808,epimelibiose,A alpha-D-Manp-(1->6)-D-Galp in which the carbon bearing the anomeric hydroxy group has alpha configuration.,30830,KEGG COMPOUND accession,C00989,4hdxbutn,591-81-1,30830.0,"Human Metabolome Database (HMDB): 4-Hydroxybutyric acid (also known as gamma-hydroxybutyrate or GHB) is a precursor and a metabolite of gamma-aminobutyric acid (GABA). GHB acts as a central nervous system (CNS) neuromodulator, mediating its effects through GABA and GHB-specific receptors, or by affecting dopamine transmission (PMID: 16620539). GHB occurs naturally in all mammals, but its function remains unknown. GHB is labeled as an illegal drug in most countries, but it also is used as a legal drug (Xyrem) in patients with narcolepsy. It is used illegally (under the street names juice, liquid ecstasy, or G) as an intoxicant for increasing athletic performance and as a date rape drug. In high doses, GHB inhibits the CNS, inducing sleep and inhibiting the respiratory drive. In lower doses, its euphoriant effect predominates (PMID: 17658710). When present in sufficiently high levels, 4-hydroxybutyric acid can act as an acidogen, a neurotoxin, and a metabotoxin. An acidogen is an acidic compound that induces acidosis, which has multiple adverse effects on many organ systems. A neurotoxin is a compound that adversely affects neural cells and tissues. A metabotoxin is an endogenously produced metabolite that causes adverse health effects at chronically high levels. Chronically high levels of 4-hydroxybutyric acid are associated with two inborn errors of metabolism: glutaric aciduria II and succinic semialdehyde dehydrogenase deficiency (SSADH). SSADH deficiency leads to a 30-fold increase of GHB and a 2-4 fold increase of GABA in the brains of patients with SSADH deficiency as compared to normal brain concentrations of the compounds. As an acidogen, 4-hydroxybutyric acid is an organic acid, and abnormally high levels of organic acids in the blood (organic acidemia), urine (organic aciduria), the brain, and other tissues lead to general metabolic acidosis. Acidosis typically occurs when arterial pH falls below 7.35. In infants with acidosis, the initial symptoms include poor feeding, vomiting, loss of appetite, weak muscle tone (hypotonia), and lack of energy (lethargy). These can progress to heart abnormalities, kidney abnormalities, liver damage, seizures, coma, and possibly death. Many affected children with organic acidemias experience intellectual disability or delayed development. These are also the characteristic symptoms of the untreated IEMs mentioned above. Particularly for SSADH deficiency, the most common features observed include developmental delay, hypotonia, and intellectual disability. Nearly half of patients exhibit ataxia, seizures, behaviour problems, and hyporeflexia. In adults, acidosis or acidemia is characterized by headaches, confusion, feeling tired, tremors, sleepiness, and seizures. As a neurotoxin, GHB appears to affect both GABA (a neurotransmitter) signaling and glutamate signaling (another neurotransmitter). Glutamine metabolism may also play a role in the pathophysiology of excessive levels of GHB. High levels of GHB have been shown to depress both the NMDA and AMPA/kainite receptor-mediated functions and may also alter glutamatergic excitatory synaptic transmission as well.",4-Hydroxybutyric acid,HMDB0000710,b,b,C00989,4-HYDROXY-BUTYRATE,FDB022196,b,b,SJZRECIVHVDYJC-UHFFFAOYSA-N,"InChI=1S/C4H8O3/c5-3-1-2-4(6)7/h5H,1-3H2,(H,6,7)"
909,4808,epimelibiose,A alpha-D-Manp-(1->6)-D-Galp in which the carbon bearing the anomeric hydroxy group has alpha configuration.,30830,KEGG COMPOUND accession,C00989,4ohbut,591-81-1,16724.0,"Gamma Hydroxybutyric Acid, commonly abbreviated GHB, is a therapeutic drug which is illegal in multiple countries. It is currently regulated in the US and sold by Jazz Pharmaceuticals under the name Xyrem. However, it is important to note that GHB is a designated Orphan drug (in 1985). Today Xyrem is a Schedule III drug. However, GHB remains a Schedule I drug and the illicit use of Xyrem falls under penalties of Schedule I. GHB is a naturally occurring substance found in the central nervous system, wine, beef, small citrus fruits and almost all other living creatures in small amounts. It is used illegally under the street names Juice, Liquid Ecstasy or simply G, either as an intoxicant, or as a date rape drug. Xyrem is a central nervous system depressant that reduces excessive daytime sleepiness and cataplexy in patients with narcolepsy. ",Gamma Hydroxybutyric Acid,HMDB0015507,b,b,C00989,b,b,4ohbut,[H]OC([H])([H])C([H])([H])C([H])([H])C([O-])=O,SJZRECIVHVDYJC-UHFFFAOYSA-M,"InChI=1S/C4H8O3/c5-3-1-2-4(6)7/h5H,1-3H2,(H,6,7)/p-1"
910,5384,glipizide,"An N-sulfonylurea that is glyburide in which the (5-chloro-2-methoxybenzoyl group is replaced by a (5-methylpyrazin-2-yl)carbonyl group. An oral hypoglycemic agent, it is used in the treatment of type 2 diabetes mellitus.",28470,KEGG COMPOUND accession,C06195,,,,,,,,,,,,,,,
911,5019,ferrichrome,A member of the class of ferrichromes that is an iron(III) chelate of a homodetic cyclic peptide made up of a tripeptide of glycine and a tripeptide of N(4)-acetyl-N(4)-hydroxy-L-ornithine.,18020,KEGG COMPOUND accession,C01149,4tmeabut,64595-66-0,18020.0,"Human Metabolome Database (HMDB): 4-Trimethylammoniobutanal is a substrate for Serine hydroxymethyltransferase (cytosolic), Serine hydroxymethyltransferase (mitochondrial), Aldehyde dehydrogenase (mitochondrial), Fatty aldehyde dehydrogenase, 4-trimethylaminobutyraldehyde dehydrogenase, Aldehyde dehydrogenase (dimeric NADP-preferring), Aldehyde dehydrogenase family 7 member A1, Aldehyde dehydrogenase 1A3 and Aldehyde dehydrogenase X (mitochondrial).",4-Trimethylammoniobutanal,HMDB0001345,b,b,C01149,4-TRIMETHYLAMMONIOBUTANAL,FDB022567,4tmeabut,[H]C(=O)C([H])([H])C([H])([H])C([H])([H])[N+](C([H])([H])[H])(C([H])([H])[H])C([H])([H])[H],OITBLCDWXSXNCN-UHFFFAOYSA-N,"InChI=1S/C7H16NO/c1-8(2,3)6-4-5-7-9/h7H,4-6H2,1-3H3/q+1"
912,8866,rimsulfuron,"A  N-sulfonylurea that is N-carbamoyl-3-(ethylsulfonyl)pyridine-2-sulfonamide substituted by a 4,6-dimethoxypyrimidin-2-yl group at the amino nitrogen atom.",3096,KEGG COMPOUND accession,C10306,,,,,,,,,,,,,,,
913,4811,epoxiconazole,"A racemate composed of equimolar amounts of (2S,3R)- and (2R,3S)-epoxiconazole. A broad-spectrum fungicide for control of diseases caused by Ascomycetes, Basidiomycetes and Deuteromycetes. Epoxiconazole is moderately toxic to birds, honeybees, earthworms and most aquatic organisms.",28522,KEGG COMPOUND accession,C11062,4hbutcoa,b,28522.0,b,4-Hydroxybutyryl-CoA,b,b,b,C11062,b,b,b,b,b,"InChI=1S/C25H42N7O18P3S/c1-25(2,20(37)23(38)28-6-5-15(34)27-7-9-54-16(35)4-3-8-33)11-47-53(44,45)50-52(42,43)46-10-14-19(49-51(39,40)41)18(36)24(48-14)32-13-31-17-21(26)29-12-30-22(17)32/h12-14,18-20,24,33,36-37H,3-11H2,1-2H3,(H,27,34)(H,28,38)(H,42,43)(H,44,45)(H2,26,29,30)(H2,39,40,41)/t14-,18-,19-,20+,24-/m1/s1"
914,2372,acalyphin,"A member of the class of tetrahydropyridines that is 2,3-dihydroxy-4-methoxy-1-methyl-6-oxo-1,2,3,6-tetrahydropyridine-3-carbonitrile having a beta-D-glucosyl residue attached at position 3 via a glycosidic bond.",28695,KEGG COMPOUND accession,C04521,,,,,,,,,,,,,,,
915,2373,acamelin,"A member of the class of 1-benzofurans that is 1-benzofuran-4,7-dione bearing additional methyl and methoxy substituents at positions 2 and 7 respectively.",961,KEGG COMPOUND accession,C08742,,,,,,,,,,,,,,,
916,26,(+)-iridodial lactol,"An iridoid monoterpenoid that is 1,4a,5,6,7,7a-hexahydrocyclopenta[c]pyran substituted by methyl groups at positions 4 and 7 and a hydroxy group at position 1 (the 1R,4aS,7S,7aR-stereoisomer).",15390,KEGG COMPOUND accession,C03036,,,,,,,,,,,,,,,
917,2366,absinthin,A dimeric sesquiterpene lactone that is produced by the plant Artemisia absinthium (Wormwood). The bitter tasting constituent of Absinthe.,957,KEGG COMPOUND accession,C11008,,,,,,,,,,,,,,,
918,2991,aloin A,"A C-glycosyl compound that is beta-D-glucopyranose in which the anomeric hydroxy group is replaced by a 4,5-dihydroxy-2-(hydroxymethyl)-10-oxo-9,10-dihydroanthracen-9-yl moiety (the 9S diastereoisomer).",1217,KEGG COMPOUND accession,C10910,,,,,,,,,,,,,,,
919,3932,cryptopleurine,"An organic heteropentacyclic compound that is (14aR)-11,12,13,14,14a,15-hexahydro-9H-dibenzo[f,h]pyrido[1,2-b]isoquinoline substituted at positions 2, 3 and 6 by methoxy groups.",27421,KEGG COMPOUND accession,C05636,3hxkynam,b,b,b,3-Hydroxykynurenamine,b,b,b,C05636,b,b,b,[H]OC1=C([H])C([H])=C([H])C(C(=O)C([H])([H])C([H])([H])[N+]([H])([H])[H])=C1N([H])[H],ODOPEICAGBYCFH-UHFFFAOYSA-O,"InChI=1S/C9H12N2O2/c10-5-4-7(12)6-2-1-3-8(13)9(6)11/h1-3,13H,4-5,10-11H2/p+1"
920,4685,dolichodial,A dialdehyde that is cyclopentanecarbaldehyde substituted by a methyl group at position 2 and a 3-oxo-prop-1-en-2yl group at position 5. It has been found to occur in pheromones of insects such as aphids.,17847,KEGG COMPOUND accession,C01468,pcresol,106-44-5,17847.0,"Human Metabolome Database (HMDB): p-Cresol (4-methylphenol), a 108.1 Da volatile low-molecular-weight compound, is a phenol. It is a partially lipophilic moiety which strongly binds to plasma protein (close to 100%) under normal conditions. p-Cresol is metabolized through conjugation, mainly sulphation and glucuronization, but removal of the unconjugated p-cresol is, at least in part, via the urine. Therefore it is not surprising that this compound, together with several other phenoles, is retained when the kidneys fail. P-Cresol is an end-product of protein breakdown, and an increase of the nutritional protein load in healthy individuals results in enhanced generation and urinary excretion. The serum p-cresol concentration in uremic patients can be decreased by changing to a low-protein diet. p-Cresol is one of the metabolites of the amino acid tyrosine, and to a certain extent also of phenylalanine, which are converted to 4-hydroxyphenylacetic acid by intestinal bacteria, before being decarboxylated to p-cresol (putrefaction). The main contributing bacteria are aerobes (mainly enterobacteria), but to a certain extent also anaerobes play a role (mainly Clostridium perfringens). In uremia, modifications in the intestinal flora result in the specific overgrowth of bacteria that are specific p-cresol producers. The administration of antibiotics reduces urinary excretion of p-cresol, as a result of the liquidation of the producing bacteria. Environmental factors might also contribute. The liver cytochrome P450 metabolizes toluene to benzyl alcohol, but also to o-cresol and p-cresol. Toluene is not only used industrially, but it is also the most widely abusively inhaled solvent. Furthermore, p-cresol is a metabolite of menthofuran, one of the metabolites of R-(+)-pulegone, which is found in extracts from the plants Mentha pulegium and Hedeoma pulegioides, commonly known as pennyroyal oil and pennyroyal tea. These extracts are popular as unconventional herbal therapeutic agents and are applied as abortiva, diaphoretics, emmenagogues, and psychedelic drugs. Pennyroyal oil is extensively used for its pleasant mint-like smell in the flavoring industry. The toxicity of pennyroyal oil and menthofuran is well known. Another compound used in traditional medicine, especially in Japan, which is a precursor of p-cresol is wood tar creosote. p-Cresol has been reported to affect several biochemical, biological and physiological functions: (i) it diminishes the oxygen uptake of rat cerebral cortex slices; (ii) it increases the free active drug concentration of warfarin and diazepam; (iii) it has been related to growth retardation in the weanling pig; (iv) it alters cell membrane permeability, at least in bacteria; (v) it induces LDH leakage from rat liver slices; (vi) it induces susceptibility to auditive epileptic crises; and (vii) it blocks cell K+ channels. (PMID: 10570076). p-Cresol is a uremic toxin that is at least partially removed by peritoneal dialysis in haemodialysis patients, and has been involved in the progression of renal failure. (MID: 11169029). At concentrations encountered during uremia, p-cresol inhibits phagocyte function and decreases leukocyte adhesion to cytokine-stimulated endothelial cells. (PMID: 14681860).",p-Cresol,HMDB0001858,b,b,C01468,CPD-108,FDB008789,pcresol,[H]C1=C([H])C(=C([H])C([H])=C1[O-])C([H])([H])[H],IWDCLRJOBJJRNH-UHFFFAOYSA-M,"InChI=1S/C7H8O/c1-6-2-4-7(8)5-3-6/h2-5,8H,1H3/p-1"
921,3224,buspirone hydrochloride,A hydrochloride salt resulting from the reaction of equimolar amounts of buspirone and hydrogen chloride.,17835,KEGG COMPOUND accession,C00631,2pg,b,17835.0,"Human Metabolome Database (HMDB): 2-Phospho-D-glycerate or 2PG is an intermediate in gluconeogenesis. It is a glyceric acid which serves as the substrate in the ninth step of glycolysis. 2PG is converted by enolase into phosphoenolpyruvate (PEP), the penultimate step in the conversion of glucose to pyruvate. More specifically, 2PG can be generated from Glycerate-3-phosphate via phosphoglycerate mutase or from phosphoenolpyrvate via alpha enolase.",2-Phospho-D-glyceric acid,HMDB0003391,b,b,C00631,2-PG,FDB001407,2pg,[H]OC([H])([H])[C@@]([H])(OP([O-])([O-])=O)C([O-])=O,GXIURPTVHJPJLF-UWTATZPHSA-K,"InChI=1S/C3H7O7P/c4-1-2(3(5)6)10-11(7,8)9/h2,4H,1H2,(H,5,6)(H2,7,8,9)/p-3/t2-/m1/s1"
922,5765,hoerhammericine,"An Aspidosperma alkaloid with formula C21H24N2O4 found in Catharantheus lanceus. Note that the stereoconfiguration of the epoxy group is based on CHEBI:144374, and of the 19 hydroxy group on CHEBI:144372 (the same enzyme produces the two).",2244,KEGG COMPOUND accession,C09646,,,,,,,,,,,,,,,
923,2612,alstonine,"An indole alkaloid with formula C21H20N2O3, isolated from several Rauvolfia species and exhibits antipsychotic activity.",17305,KEGG COMPOUND accession,C03921,,,,,,,,,,,,,,,
924,24527,herbicide,A substance used to destroy plant pests.,18421,KEGG COMPOUND accession,C00704,o2s,11062-77-4,18421.0,"Human Metabolome Database (HMDB): Superoxide is the anionic form O2. It is important as the product of the one-electron reduction of dioxygen (oxygen gas), which occurs widely in nature. With one unpaired electron, the superoxide ion is a free radical. It is also paramagnetic. The biological toxicity of superoxide is due to its capacity to inactivate iron-sulfur cluster containing enzymes (which are critical in a wide variety of metabolic pathways), thereby liberating free iron in the cell, which can undergo fenton-chemistry and generate the highly reactive hydroxyl radical. In its HO2 form, superoxide can also initiate lipid peroxidation of polyunsaturated fatty acids. It also reacts with carbonyl compounds and halogenated carbons to create toxic peroxy radicals. As such, superoxide is a main cause of oxidative stress. Highly reactive compounds produced when oxygen is reduced by a single electron. In biological systems, they may be generated during the normal catalytic function of a number of enzymes and during the oxidation of hemoglobin to Methemoglobin. Because superoxide is toxic, nearly all organisms living in the presence of oxygen contain isoforms of the superoxide scavenging enzyme, superoxide dismutase, or SOD. SOD is an extremely efficient enzyme; it catalyzes the neutralization of superoxide nearly as fast as the two can diffuse together spontaneously in solution. Genetic inactivation (""knockout"") of SOD produces deleterious phenotypes in organisms ranging from bacteria to mice. The latter species dies around 21 days after birth if the mitochondrial variant of SOD (Mn-SOD) is inactivated, and suffers from multiple pathologies, including reduced lifespan, liver cancer, muscle atrophy, cataracts and female infertility when the cytoplasmic (Cu, Zn -SOD) variant is inactivated. With one unpaired electron, the superoxide ion is a free radical and therefore paramagnetic. In living organisms, superoxide dismutase protects the cell from the deleterious effects of superoxides.",Superoxide,HMDB0002168,b,b,C00704,b,FDB022880,o2s,[O][O-],OUUQCZGPVNCOIJ-UHFFFAOYSA-M,InChI=1S/HO2/c1-2/h1H/p-1
925,6723,megestrol acetate,A steroid ester resulting from the formal condensation of the hydroxy group of megestrol with the carboxy group of acetic acid. It is an appetite stimulant used for the treatment of anorexia and cachexia. Also used for birth control and for the treatment of breast cancer.,27778,KEGG COMPOUND accession,C06471,,,,,,,,,,,,,,,
926,4537,difloxacin,"A quinolone that is pefloxacin in which the ethyl group at position 1 of the quinolone has been replaced by a p-fluorophenyl group. A broad-spectrum antibiotic effective against both Gram-positive and Gram-negative bacteria, it is used (usually as the monohydrochloride salt) for the treatment of bacterial infections in dogs.",16578,KEGG COMPOUND accession,C11435,,,,,,,,,,,,,,,
927,3209,buformin,A member of the class of biguanides that is biguanide substituted by a butyl group at position 1. It is an antidiabetic drug with potential antitumor effect.,16327,KEGG COMPOUND accession,C02362,,,,,,,,,,,,,,,
928,7859,oxycodone hydrochloride,"A hydrochloride obtained by reaction of oxycodone with one molar equivalent of hydrochloric acid.  It is a moderately potent opioid analgesic, generally used for relief of moderate to severe pain.",17906,KEGG COMPOUND accession,C01888,aact,298-08-8,17906.0,"Human Metabolome Database (HMDB): Threonine dehydrogenase catalyzes the oxidation of threonine by NAD+ to glycine and acetyl-CoA, but when the ratio acetyl-CoA/CoA increases in nutritional deprivation (e.g., in diabetes) the enzyme produces aminoacetone (Chem. Res. Toxicol., 14 (9), 1323 -1329, 2001). Aminoacetone is thought to be a substrate for SSAO (semicarbazide-sensitive amine oxidase), leading to the production of the toxic product methylglyoxal (Journal of Chromatography B. Volume 824, Issues 1-2 , 25 September 2005, Pages 116-122 ).",Aminoacetone,HMDB0002134,b,b,C01888,AMINO-ACETONE,FDB022860,aact,[H]C([H])([H])C(=O)C([H])([H])[N+]([H])([H])[H],BCDGQXUMWHRQCB-UHFFFAOYSA-O,"InChI=1S/C3H7NO/c1-3(5)2-4/h2,4H2,1H3/p+1"
929,2468,secondary alpha-hydroxy ketone,"An alpha-hydroxy ketone in which the carbonyl group and the hydroxy group are linked by a carbon bearing one hydrogen and one organyl group. Secondary alpha-hydroxy ketones are also known as acyloins, and are formally derived from reductive coupling of two carboxylic acid groups.",16713,KEGG COMPOUND accession,C03975,,,,,,,,,,,,,,,
930,9260,15alpha-stemmadenine,"A monoterpenoid indole alkaloid with formula C21H26N2O3, isolated from several plant species including Rhazya stricta, Tabernaemontana dichotoma and Aspidosperma pyricollum.",15868,KEGG COMPOUND accession,C03486,,,,,,,,,,,,,,,
931,4733,E3040 glucuronide,"A member of the class of benzothiazoles that is E3040 in which the hydroxy hydrogen at position 6 has been replaced by a beta-D-glucosiduronic acid group. It is a metabolite of the anti-inflammatory drug, E3040.",27530,KEGG COMPOUND accession,C06762,,,,,,,,,,,,,,,
932,8939,flumioxazin,"A benzoxazine that is N-(prop-2-yn-1-yl)-2H-1,4-benzoxazin-3(4H)-one which is substituted at position 6 by a 1,3-dioxo-1,3,4,5,6,7-hexahydro-2H-isoindol-2-yl group and at position 7 by a fluorine. A protoporphyrinogen oxidase inhibitor, it is used for the control of weeds in soya, peanuts, and a variety of vegetable and fruit crops.",28139,KEGG COMPOUND accession,C06640,,,,,,,,,,,,,,,
933,5356,ginkgolide B,"A ginkgolide in which the pro-R hydrogens at positions 6, 12, and 17 of the  8-tert-butyl-16-methyl-2,4,14,19-tetraoxahexacyclo[8.7.2.0(1,11).0(3,7).0(7,11).0(13,17)]nonadecane-5,15,18-trione ginkgolide skeleton have been replaced by hydroxy groups.",27823,KEGG COMPOUND accession,C05635,5hoxindoa,54-16-0,27823.0,"Human Metabolome Database (HMDB): 5-Hydroxyindoleacetic acid (5HIAA) is a breakdown product of serotonin that is excreted in the urine. Serotonin is a hormone found at high levels in many body tissues. Serotonin and 5HIAA are produced in excess amounts by carcinoid tumors, and levels of these substances may be measured in the urine to test for carcinoid tumors (NCI). 5-Hydroxyindoleacetic acid is found to be associated with aromatic L-amino acid decarboxylase deficiency, celiac disease, and sepiapterin reductase deficiency, which are inborn errors of metabolism.",5-Hydroxyindoleacetic acid,HMDB0000763,b,b,C05635,5-HYDROXYINDOLE_ACETATE,FDB001403,5hoxindoa,[H]OC1=C([H])C([H])=C2N([H])C([H])=C(C2=C1[H])C([H])([H])C([O-])=O,DUUGKQCEGZLZNO-UHFFFAOYSA-M,"InChI=1S/C10H9NO3/c12-7-1-2-9-8(4-7)6(5-11-9)3-10(13)14/h1-2,4-5,11-12H,3H2,(H,13,14)/p-1"
934,9673,triasulfuron,"An N-sulfonylurea that is N-[o-(2-chloroethoxy)phenyl]sulfonylurea in which one of the hydrogens attached to the non-sulfonylated nitrogen has been replaced by a 4-methoxy-6-methyl-1,3,5-triazin-2-yl group. A herbicide used to control broad-leaved weeds in cereals, its use within the EU has been banned after September 2017 on the grounds of potential groundwater contamination and risks to aquatic life.",17823,KEGG COMPOUND accession,C01673,1a25dhvitd3,32222-06-3,17823.0,"Human Metabolome Database (HMDB): The physiologically active form of vitamin D. It is formed primarily in the kidney by enzymatic hydroxylation of 25-hydroxycholecalciferol (calcifediol). Its production is stimulated by low blood calcium levels and parathyroid hormone. Calcitriol increases intestinal absorption of calcium and phosphorus, and in concert with parathyroid hormone increases bone resorption.--PubChem.",Calcitriol,HMDB0001903,b,b,C01673,CALCITRIOL,FDB021822,1a25dhvitd3,[H]O[C@]1([H])C(=C([H])[H])\C(=C(\[H])/C(/[H])=C2\C([H])([H])C([H])([H])C([H])([H])[C@@]3(C([H])([H])[H])[C@@]2([H])C([H])([H])C([H])([H])[C@]3([H])[C@]([H])(C([H])([H])[H])C([H])([H])C([H])([H])C([H])([H])C(O[H])(C([H])([H])[H])C([H])([H])[H])C([H])([H])[C@@]([H])(O[H])C1([H])[H],GMRQFYUYWCNGIN-NKMMMXOESA-N,"InChI=1S/C27H44O3/c1-18(8-6-14-26(3,4)30)23-12-13-24-20(9-7-15-27(23,24)5)10-11-21-16-22(28)17-25(29)19(21)2/h10-11,18,22-25,28-30H,2,6-9,12-17H2,1,3-5H3/b20-10+,21-11-/t18-,22-,23-,24+,25+,27-/m1/s1"
935,3708,cinmethylin,"A racemate composed of equimolar amounts of exo-(+)- and exo-(-)-cinmethylin. It is a soil-applied preemergence herbicide developed by Shell Chemical company and used to control annual grasses such as green foxtail and bamyardgrass, it also supresses the growth of several annual broadleaf weeds such as prickly sida and velvetleaf.",28317,KEGG COMPOUND accession,C05117,,,,,,,,,,,,,,,
936,1893,4-methyl-L-glutamate(1-),"An alpha-amino-acid anion that is the conjugate base of 4-methyl-L-glutamic acid, having anionic carboxy groups and a cationic amino group. Major species at pH 7.3.",18204,KEGG COMPOUND accession,C03207,,,,,,,,,,,,,,,
937,2718,angiotensin I,"A ten amino acid peptide formed by renin cleavage of angiotensinogen. Angiotensin I has no direct biological function except that high levels can stimulate catecholamine production. It is metabolized to its biologically active byproduct angiotensin II, a potent vasoconstrictor, by angiotensin converting enzyme (ACE) through cleavage of the two terminal amino acids.",1107,KEGG COMPOUND accession,C05801,,,,,,,,,,,,,,,
938,3556,cercosporin,"An organic heterohexacyclic compound that is perylo[1,12-def][1,3]dioxepine-6,11-dione substituted by hydroxy groups at positions 5 and 12, by methoxy groups at positions 7 and 10, and by 2-hydroxypropyl groups at positions 8 and 9 (the R,R-stereoisomer). It is a phytotoxin which was first isolated from the pathogenic soybean fungus, Cercospora kikuchii and later found in multiple members of the genus Cercospora.",29053,KEGG COMPOUND accession,C02932,,,,,,,,,,,,,,,
939,2515,agnuside,A benzoate ester resulting from the formal condensation of the carboxy group of 4-hydroxybenzoic acid with the primary hydroxy group of aucubin. It is an iridoid glycoside found in several Vitex plants including Vitex agnus-castus.,16886,KEGG COMPOUND accession,C02220,amuco,4548-99-6,15745.0,"Human Metabolome Database (HMDB): 2-Aminomuconic acid is a product of the Tryptophan metabolism degradation pathway (kinurenine pathway), in a reaction catabolized by the enzyme aminocarboxymuconate semialdehyde decarboxylase [EC:4.1.1.45]. The kynurenine pathway is the major route of L-tryptophan degradation in mammals. (BioCyc).",2-Aminomuconic acid,HMDB0001241,b,b,C02220,2-AMINO-MUCONATE,FDB022507,amuco,[H]\C(=C(\[H])C([O-])=O)\C(\[H])=C(\C([O-])=O)[N+]([H])([H])[H],ZRHONLCTYUYMIQ-TZFCGSKZSA-M,"InChI=1S/C6H7NO4/c7-4(6(10)11)2-1-3-5(8)9/h1-3H,7H2,(H,8,9)(H,10,11)/p-1/b3-1+,4-2-"
940,7542,neurotensin,"A 13 amino acid peptide hormone which is found in the central nervous system and the gastrointestinal tract. It behaves as a neurotransmitter in the brain, as a hormone in the gut, and also as a neuromodulator. It is implicated in the pathophysiology of several CNS disorders (including schizophrenia, Parkinson's disease, drug abuse, pain, cancer, inflammation, eating disorders and central control of blood pressure) due to its association with a wide variety of neurotransmitter systems such as dopaminergic, sertonergic, glutamatergic, GABAergic, and cholinergic systems.",2523,KEGG COMPOUND accession,C08656,,,,,,,,,,,,,,,
941,4601,diloxanide furoate,"A carboxylic ester resulting from the formal condensation of the carboxy group of furan-2-carboxylic acid with the hydroxy group of 2,2-dichloro-N-(4-hydroxyphenyl)-N-methylacetamide. It is a drug used for the treatment of asymptomatic amebiasis.",27565,KEGG COMPOUND accession,C02518,,,,,,,,,,,,,,,
942,3528,cellotriose,A glucotriose consisting of three,27852,KEGG COMPOUND accession,C05577,34dhmald,13023-73-9,27852.0,"Human Metabolome Database (HMDB): 3,4-Dihydroxymandelaldehyde is the monoamine oxidase (MAO) aldehyde metabolite of both norepinephrine and epinephrine. 3,4- dihydroxymandelaldehyde generates a free radical and activates mitochondrial permeability transition, a mechanism implicated in neuron death. There is an increasing body of evidence suggesting that these compounds are neurotoxic, and it has been recently hypothesized that neurodegenerative disorders may be associated with increased levels of this biogenic aldehyde. It is possible to speculate that reduced detoxification of 3,4- dihydroxymandelaldehyde from impaired or deficient aldehyde dehydrogenase function may be a contributing factor in the suggested neurotoxicity of these compounds. Aldehyde dehydrogenases are a group of NAD(P)+ -dependent enzymes that catalyze the oxidation of aldehydes, such as those derived from catecholamines, to their corresponding carboxylic acids. To date, 19 aldehyde dehydrogenase genes have been identified in the human genome. Mutations in these genes and subsequent inborn errors in aldehyde metabolism are the molecular basis of several diseases. Several pharmaceutical agents and environmental toxins are also known to disrupt or inhibit aldehyde dehydrogenase function. (PMID: 17379813, 14697885, 11164826).","3,4-Dihydroxymandelaldehyde",HMDB0006242,b,b,C05577,b,FDB023855,34dhmald,[H]OC1=C(O[H])C([H])=C(C([H])=C1[H])C([H])(O[H])C([H])=O,YUGMCLJIWGEKCK-UHFFFAOYSA-N,"InChI=1S/C8H8O4/c9-4-8(12)5-1-2-6(10)7(11)3-5/h1-4,8,10-12H"
943,3636,chloroprocaine,"Procaine in which one of the hydrogens ortho- to the carboxylic acid group is substituted by chlorine. It is used as its monohydrochloride salt as a local anaesthetic, particularly for oral surgery. It has the advantage over lidocaine of constricting blood vessels, so reducing bleeding.",17993,KEGG COMPOUND accession,C04446,,,,,,,,,,,,,,,
944,4707,doxacurium chloride,"The dichloride salt of doxacurium. It is a mixture of the (1R,2S,1'S,2'R), (1R,2S,1'R,2'S) and (1S,2R,1'S,2'R) stereoisomers (a meso isomer and two enantiomers, respectively) of 2,2'-[(1,4-dioxobutane-1,4-diyl)bis(oxypropane-3,1-diyl)]bis[6,7,8-trimethoxy-2-methyl-1-(3,4,5-trimethoxybenzyl)-1,2,3,4-tetrahydroisoquinolinium] dichloride, all of which are in a trans configuration at the 1 and 2 positions of the tetrahydroisoquinolinium rings. A competitive neuromuscular blocker, it is used to provide muscle relaxation in general anaesthesia and to facilitate mechanical ventilation in patients in intensive care.",27893,KEGG COMPOUND accession,C02371,,,,,,,,,,,,,,,
945,4953,exemestane,"A 17-oxo steroid that is androsta-1,4-diene-3,17-dione in which the hydrogens at position 6 are replaced by a double bond to a methylene group. A selective inhibitor of the aromatase (oestrogen synthase) system, it is used in the treatment of advanced breast cancer.",16318,KEGG COMPOUND accession,C02235,24nph,b,16318.0,"Human Metabolome Database (HMDB): 4-Nitrocatechol is the by-product of the hydroxylation of 4-Nitrophenol by the human cytochrome P450 (CYP) 2E1. This reaction is a useful metabolic marker for the presence of functional cytochrome P450 2E1 in mammalian cell microsomes. Hepatic and extrahepatic microsomal cytochrome P450 isozymes further catalyze the reduction of p-nitrocatechol to p-aminophenol. (PMID: 8267647, 8214571, 8267647).",4-Nitrocatechol,HMDB0002916,b,b,C02235,CPD-158,FDB023081,24nph,[H]OC1=C(O[H])C([H])=C(C([H])=C1[H])[N+]([O-])=O,XJNPNXSISMKQEX-UHFFFAOYSA-N,"InChI=1S/C6H5NO4/c8-5-2-1-4(7(10)11)3-6(5)9/h1-3,8-9H"
946,30351,"2,2'-bipyridine",A bipyridine in which the two pyridine moieties are linked by a bond between positions C-2 and C-2'.,16555,KEGG COMPOUND accession,C01857,,,,,,,,,,,,,,,
947,30825,elaidate,A long-chain fatty acid anion that is the conjugate base of elaidic acid; shown to exert detrimental effects on mitochondrial lipid composition and function.,9754,KEGG COMPOUND accession,C07182,,,,,,,,,,,,,,,
948,32401,15-crown-5,"A saturated organic heteromonocyclic parent that is cyclopentadecane in which the carbon atoms at positions 1, 4, 7, 10 and 13 have been replaced by oxygen atoms to give a crown ether.",28459,KEGG COMPOUND accession,C03734,,,,,,,,,,,,,,,
949,30669,"1,2-bis(diphenylphosphino)ethane",a,9682,KEGG COMPOUND accession,C11032,,,,,,,,,,,,,,,
950,32636,acetaminophen O-beta-D-glucosiduronic acid,A beta-D-glucosiduronic acid that is the O-glucuronide of paracetamol (acetaminophen).,10365,KEGG COMPOUND accession,C02899,,,,,,,,,,,,,,,
951,32905,hexafluoroethane,a,18371,KEGG COMPOUND accession,C04431,,,,,,,,,,,,,,,
952,33227,(E)-cinnamyl alcohol,The E (trans) stereoisomer of cinnamyl alcohol.,17851,KEGG COMPOUND accession,C01972,M02435,b,b,b,M7G(5')Pppam,b,b,b,C01972,b,b,b,[H]O[C@@]1([H])[C@]([H])([*])O[C@]([H])(C([H])([H])OP(=O)(O[H])O[C@@]2([H])[C@@]([H])(O[H])[C@]([H])([*])O[C@]2([H])C([H])([H])OP(=O)(O[H])O[C@@]2([H])[C@@]([H])(OC([H])([H])[H])[C@@]([H])(O[C@]2([H])C([H])([H])OP(=O)(O[H])OP(=O)(O[H])OP(=O)(O[H])OC([H])([H])[C@@]2([H])O[C@@]([H])(N3C([H])=[N+](C4=C3N=C(N([H])[H])N([H])C4=O)C([H])([H])[H])[C@]([H])(O[H])[C@]2([H])O[H])N2C([H])=NC3=C2N=C([H])N=C3N([H])[H])[C@@]1([H])O[H],b,b
953,32397,18-crown-6,"A crown ether that is cyclooctadecane in which the carbon atoms at positions 1, 4, 7, 10, 13 and 16 have been replaced by oxygen atoms.",27602,KEGG COMPOUND accession,C04508,,,,,,,,,,,,,,,
954,31530,edaravone,"A pyrazolone that is 2,4-dihydro-3H-pyrazol-3-one which is substituted at positions 2 and 5 by phenyl and methyl groups, respectively.",16199,KEGG COMPOUND accession,C00086,urea,57-13-6,16199.0,"Human Metabolome Database (HMDB): Urea is a highly soluble organic compound formed in the liver from ammonia produced by the deamination of amino acids. It is the principal end product of protein catabolism and constitutes about one half of the total urinary solids. Urea is formed in a cyclic pathway known simply as the urea cycle. In this cycle, amino groups donated by ammonia and L-aspartate are converted to urea. Urea is essentially a waste product; it has no physiological function. It is dissolved in blood (in humans in a concentration of 2.5 - 7.5 mmol/liter) and excreted by the kidney in the urine. In addition, a small amount of urea is excreted (along with sodium chloride and water) in human sweat. Urea is found to be associated with primary hypomagnesemia, which is an inborn error of metabolism.",Urea,HMDB0000294,b,b,C00086,UREA,FDB012174,urea,[H]N([H])C(=O)N([H])[H],XSQUKJJJFZCRTK-UHFFFAOYSA-N,"InChI=1S/CH4N2O/c2-1(3)4/h(H4,2,3,4)"
955,31697,indolin-2-one,An indolinone carrying an oxo group at position 2.,9955,KEGG COMPOUND accession,C09913,,,,,,,,,,,,,,,
956,31788,luteolin 7-O-neohesperidoside,A disaccharide derivative that is luteolin  substituted by a 2-O-(alpha-L-rhamnopyranosyl)-beta-D-glucopyranosyl moiety at position 7 via a glycosidic linkage.,46416,KEGG COMPOUND accession,C11269,,,,,,,,,,,,,,,
957,30863,5-azaorotic acid,a,27897,KEGG COMPOUND accession,C00806,,,,,,,,,,,,,,,
958,31889,nadifloxacin,a,10049,KEGG COMPOUND accession,C00700,xtp,6253-56-1,10049.0,"Human Metabolome Database (HMDB): Xanthosine 5-triphosphate (XTP) is a Guanosine triphosphate (GTP) analogue. The base of XTP, xanthine, bears a keto group instead of an amino group at C2 of the purine rings. XTP can substitute for GTP in supporting receptor-mediated adenylyl cyclase activation. XTP competitively inhibits the binding of GTP to the guanine nucleotide-binding site of retinal G-protein, transducin (TD). These suggests that GTP, ITP, and XTP are differential signal sorters and signal amplifiers at the G-protein level. G-proteins mediate signal transfer from receptors to effector systems. (PMID: 9337071). Xanthosine 5-triphosphate is an intermediate of the Purine metabolism pathway, a substrate of the enzymes dinucleoside tetraphosphatase (EC 3.6.1.17 ) and nucleoside-triphosphate pyrophosphatase (EC 3.6.1.19). (KEGG).",Xanthosine 5-triphosphate,HMDB0000293,b,b,C00700,b,FDB021932,b,[H]O[C@@]1([H])[C@@]([H])(O[C@]([H])(C([H])([H])OP([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O)[C@@]1([H])O[H])N1C([H])=NC2=C1N([H])C(=O)N([H])C2=O,CAEFEWVYEZABLA-UUOKFMHZSA-J,"InChI=1S/C10H15N4O15P3/c15-5-3(1-26-31(22,23)29-32(24,25)28-30(19,20)21)27-9(6(5)16)14-2-11-4-7(14)12-10(18)13-8(4)17/h2-3,5-6,9,15-16H,1H2,(H,22,23)(H,24,25)(H2,19,20,21)(H2,12,13,17,18)/p-4/t3-,5-,6-,9-/m1/s1"
959,33568,adrenaline,A catecholamine in which the aminoethyl side-chain is hydroxy-substituted at C-1 and methylated on nitrogen.,16817,KEGG COMPOUND accession,C04404,,,,,,,,,,,,,,,
960,32768,L-tyrosin-O(4)-yl group,a,28994,KEGG COMPOUND accession,C08351,,,,,,,,,,,,,,,
961,32771,3-fluorotyrosine,a,27507,KEGG COMPOUND accession,C02478,,,,,,,,,,,,,,,
962,32772,methyloxidanyl,An  organic radical derived from  methanol.,18396,KEGG COMPOUND accession,C05860,mpdol_L,b,18396.0,"Human Metabolome Database (HMDB): Beta-1,4-D-Mannosylchitobiosyldiphosphodolichol is a lipid-linked oligosaccharide. It is part of the N-glycan biosynthesis pathway. Beta-1,4-D-Mannosylchitobiosyldiphosphodolichol is formed by chitobiosyldiphosphodolichol beta-mannosyltransferase (EC 2.4.1.142) via the reaction: GDP-mannose + chitobiosyldiphosphodolichol = GDP + beta-(1->4)-D-mannosylchitobiosyldiphosphodolichol. It is also a reactant or product of glycolipid 3-alpha-mannosyltransferase or mannosyltransferase II. This enzyme transfers an alpha-D-mannosyl residue from GDP-mannose to a lipid-linked (dolichol) oligosaccharide, forming an alpha-(1->3)-D-mannosyl-D-mannose linkage.","Beta-1,4-D-Mannosylchitobiosyldiphosphodolichol",HMDB0011673,b,b,C05860,D-GALACTOSYL-14-D-GALACTOSYL-14-D-,FDB028362,b,[H]OC([H])([H])[C@@]1([H])O[C@@]([H])(O[C@@]2([H])[C@]([H])(O[H])[C@@]([H])(N([H])C(=O)C([H])([H])[H])[C@]([H])(O[C@@]3([H])[C@]([H])(O[H])[C@@]([H])(N([H])C(=O)C([H])([H])[H])[C@@]([H])(OP([O-])(=O)OP([O-])(=O)OC([H])([H])C([H])([H])C([H])(C([H])([H])[H])C([H])([H])C([H])([H])C(\[H])=C(/C([H])([H])[H])C([H])([H])C([H])([H])C(\[H])=C(/C([H])([H])[H])C([H])([H])C([H])([H])C(\[H])=C(/C([H])([H])[H])C([H])([H])C([H])([H])C([H])=C(C([H])([H])[H])C([H])([H])[H])O[C@]3([H])C([H])([H])O[H])O[C@]2([H])C([H])([H])O[H])[C@@]([H])(O[H])[C@@]([H])(O[H])[C@]1([H])O[H],CMBCFQGXXHOGEH-PPQHMIFUSA-L,"InChI=1S/C47H82N2O22P2/c1-26(2)13-9-14-27(3)15-10-16-28(4)17-11-18-29(5)19-12-20-30(6)21-22-64-72(60,61)71-73(62,63)70-46-37(49-32(8)54)40(57)43(35(25-52)67-46)68-45-36(48-31(7)53)39(56)44(34(24-51)66-45)69-47-42(59)41(58)38(55)33(23-50)65-47/h13,15,17,19,30,33-47,50-52,55-59H,9-12,14,16,18,20-25H2,1-8H3,(H,48,53)(H,49,54)(H,60,61)(H,62,63)/p-2/b27-15+,28-17+,29-19+/t30?,33-,34-,35-,36-,37-,38-,39-,40-,41+,42+,43-,44-,45+,46-,47+/m0/s1"
963,32775,D-tyrosinium,An optically active form of tyrosinium having D-configuration.,16402,KEGG COMPOUND accession,C04150,,,,,,,,,,,,,,,
964,32777,D-tyrosinyl radical,a,27476,KEGG COMPOUND accession,C08353,,,,,,,,,,,,,,,
965,32779,D-tyrosino group,a,27520,KEGG COMPOUND accession,C08355,,,,,,,,,,,,,,,
966,32781,D-tyrosinyl radical residue,a,28161,KEGG COMPOUND accession,C02096,,,,,,,,,,,,,,,
967,32782,D-tyrosinyl radical cation residue,a,27926,KEGG COMPOUND accession,C02337,,,,,,,,,,,,,,,
968,32785,tyrosinate(2-),a,10415,KEGG COMPOUND accession,C02210,,,,,,,,,,,,,,,
969,32786,tyrosinium,"An alpha-amino-acid cation that is the conjugate acid of tyrosine, arising from protonation of the amino group.",27795,KEGG COMPOUND accession,C06532,,,,,,,,,,,,,,,
970,32788,tyrosin-O(4)-yl group,a,10417,KEGG COMPOUND accession,C09664,,,,,,,,,,,,,,,
971,33515,transition element cation,a,17157,KEGG COMPOUND accession,C04512,,,,,,,,,,,,,,,
972,33517,copernicium atom,"A zinc group element atom with a symbol Cn and atomic number 112. All its isotopes are intensely radioactive. Prior to its discovery, it had the placeholder name ununbium (in accordance with IUPAC recommendations). Following its discovery (in Darmstadt, 1996) and subsequent confirmation, the name copernicium was adopted in 2010.",17407,KEGG COMPOUND accession,C00448,frdp,13058-04-3,17407.0,Human Metabolome Database (HMDB): Farnesyl pyrophosphate is an intermediate in the HMG-CoA reductase pathway used by organisms in the biosynthesis of terpenes and terpenoids. -- Wikipedia.,Farnesyl pyrophosphate,HMDB0000961,b,b,C00448,FARNESYL-PP,FDB022339,frdp,[H]C(=C(C([H])([H])[H])C([H])([H])[H])C([H])([H])C([H])([H])C(=C([H])C([H])([H])C([H])([H])C(=C([H])C([H])([H])OP([O-])(=O)OP([O-])([O-])=O)C([H])([H])[H])C([H])([H])[H],VWFJDQUYCIWHTN-UHFFFAOYSA-K,"InChI=1S/C15H28O7P2/c1-13(2)7-5-8-14(3)9-6-10-15(4)11-12-21-24(19,20)22-23(16,17)18/h7,9,11H,5-6,8,10,12H2,1-4H3,(H,19,20)(H2,16,17,18)/p-3"
973,32675,N(2)-D-glutamino group,a,27442,KEGG COMPOUND accession,C02095,,,,,,,,,,,,,,,
974,32676,N(5)-D-glutamino group,a,28419,KEGG COMPOUND accession,C00574,,,,,,,,,,,,,,,
975,32677,glutamine residue,a,27707,KEGG COMPOUND accession,C06372,,,,,,,,,,,,,,,
976,32685,N(2)-L-arginino group,a,546807,KEGG COMPOUND accession,C07278,,,,,,,,,,,,,,,
977,32687,piperonyl butoxide,a,27667,KEGG COMPOUND accession,C00962,,,,,,,,,,,,,,,
978,32690,D-argininium(2+),a,28034,KEGG COMPOUND accession,C00602,,,,,,,,,,,,,,,
979,32847,serino group,a,16508,KEGG COMPOUND accession,C02480,ccmuac,1119-72-8,16508.0,"Human Metabolome Database (HMDB): Cis-cis-muconic acid is a presumptive metabolite of benzene. Muconic acid was first isolated from the urine of rabbits and dogs in 1909 ( M. Jaffe, Z Physiol Chem 62:58-67). It was originally thought that if muconic acid were formed by opening of the benzene ring in vivo then the cis-cis isomer should be the initial (and primary) product. However subsequent studies conducted in the 1950's proved that trans-trans-muconic acid is a true metabolite of benzene in mammals (Parke DV, Williams RT. Biochem J 51:339-348 (1952)). Furthermore, dosing rabbits with phenol or catechol also resulted in the urinary excretion of trans-trans-muconic acid. The oxidative ring opening of benzene first gives rise to cis-cis-muconaldehyde, which then isomerizes to cis-trans- and trans-trans-muconaldehyde; the latter is oxidized in vivo to trans-trans-muconic acid. Isomerization of the trans-trans form may take place in vivo to yield small amounts if the cis-cis and cis-trans form of muconic acid. Cis-cis muconic acid may also be generated from microbial fermentation of benzoic acid. Certain strains of arthobacter are particularly efficient at this process.","cis,cis-Muconic acid",HMDB0006331,b,b,C02480,b,FDB023893,b,b,TXXHDPDFNKHHGW-CCAGOZQPSA-N,"InChI=1S/C6H6O4/c7-5(8)3-1-2-4-6(9)10/h1-4H,(H,7,8)(H,9,10)/b3-1-,4-2-"
980,32851,L-valinate,The L-enantiomer of valinate.,18301,KEGG COMPOUND accession,C06603,,,,,,,,,,,,,,,
981,32853,L-valyl group,a,27671,KEGG COMPOUND accession,C03647,,,,,,,,,,,,,,,
982,32854,L-valino group,a,10454,KEGG COMPOUND accession,C11191,,,,,,,,,,,,,,,
983,32856,D-valinium,The D-enantiomer of valinium.,28805,KEGG COMPOUND accession,C06792,,,,,,,,,,,,,,,
984,32858,D-valino group,a,16843,KEGG COMPOUND accession,C06727,,,,,,,,,,,,,,,
985,32861,valine residue,a,16190,KEGG COMPOUND accession,C04091,,,,,,,,,,,,,,,
986,30819,cis-urocanate,a,9751,KEGG COMPOUND accession,C08393,,,,,,,,,,,,,,,
987,30829,petroselaidic acid,"The trans-isomer of octadec-6-enoic acid, a long-chain fatty acid.",30765,KEGG COMPOUND accession,C01456,,,,,,,,,,,,,,,
988,30834,aldosterone hemiacetal,a,15884,KEGG COMPOUND accession,C00729,,,,,,,,,,,,,,,
989,30840,dicarbonyldinitrosyliron,a,16656,KEGG COMPOUND accession,C00783,,,,,,,,,,,,,,,
990,30847,3-furoate,a,9763,KEGG COMPOUND accession,C07664,,,,,,,,,,,,,,,
991,31762,lanperisone hydrochloride,The hydrochloride salt of lanperisone. It is a muscle relaxant.,9986,KEGG COMPOUND accession,C10981,,,,,,,,,,,,,,,
992,30720,2-deoxyribosyl group,a,28621,KEGG COMPOUND accession,C06771,,,,,,,,,,,,,,,
993,30722,tetraperoxidochromate(2-),a,27919,KEGG COMPOUND accession,C07642,,,,,,,,,,,,,,,
994,30724,dioxidodiperoxidochromate(2-),a,45951,KEGG COMPOUND accession,C07168,,,,,,,,,,,,,,,
995,30736,trichloromethyl group,a,9715,KEGG COMPOUND accession,C10960,,,,,,,,,,,,,,,
996,32812,4-hydroxy-L-glutamate(1-),An L-alpha-amino acid anion resulting from deprotonation of the carboxy groups and protonation of the amino group of 4-hydroxy-L-glutamic acid,18147,KEGG COMPOUND accession,C01971,,,,,,,,,,,,,,,
997,32823,L-threonyl group,a,50025,KEGG COMPOUND accession,C09882,,,,,,,,,,,,,,,
998,32827,D-threoninate,The D-enantiomer of threoninate.,10440,KEGG COMPOUND accession,C09718,,,,,,,,,,,,,,,
999,32829,D-threonyl group,a,10441,KEGG COMPOUND accession,C09720,,,,,,,,,,,,,,,
1000,32831,D-threonin-O(3)-yl group,a,28356,KEGG COMPOUND accession,C09545,,,,,,,,,,,,,,,
1001,32833,threoninium,a,10443,KEGG COMPOUND accession,C09723,,,,,,,,,,,,,,,
1002,32726,D-tryptophanyl radical cation residue,a,28793,KEGG COMPOUND accession,C00551,,,,,,,,,,,,,,,
1003,32728,tryptophanium,"An alpha-amino-acid cation that is the conjugate acid of tryptophan, arising from protonation of the alpha-amino group.",28860,KEGG COMPOUND accession,C08350,,,,,,,,,,,,,,,
1004,32732,tryptophan residue,a,15903,KEGG COMPOUND accession,C00221,M01388,492-61-5,15903.0,"Human Metabolome Database (HMDB): Beta-D-Glucose is a primary source of energy for living organisms. It is naturally occurring and is found in fruits and other parts of plants in its free state. It is used therapeutically in fluid and nutrient replacement. A glucoside is a glycoside that is derived from glucose. Glucosides are common in plants, but rare in animals. Glucose is produced when a glucoside is hydrolysed by purely chemical means, or decomposed by fermentation or enzymes. This group contains a benzene and also an ethylene group, being derived from styrolene. Coniferin, C16H22O8, occurs in the cambium of conifer wood. Emulsin converts it into glucose and coniferyl alcohol, while oxidation gives glycovanillin, which yields with emulsin glucose and vanillin. Syringin, which occurs in the bark of Syringe vulgaris, is a methoxyconiferin. Phloridzus occurs in the root-bark of various fruit trees; it hydrolyses to glucose and phloretin, which is the phloroglucin ester of paraoxyhydratropic acid. It is related to the pentosides naringin, C21HEOi1, which hydrolyses to rhamnose and naringenin, the phioroglucin ester of para-oxycinnamic acid, and hesperidin, which hydrolyses to rhamnose and hesperetin, the phloroglucin ester of meta-oxy-para-methoxycinnamic acid or isoferulic acid, C10H10O4. Classification of the glucosides is a matter of some difficulty. One based on the chemical constitution of the non-glucose part of the molecules has been proposed that frames four groups: (I) ethylene derivatives, (2) benzene derivatives, (3) styrolene derivatives, (4) anthracene derivatives. A group may also be made to include the cyanogenetic glucosides, i.e. those containing prussic acid. Other classifications follow a botanical classification, which has several advantages; in particular, plants of allied genera contain similar compounds. In this article the chemical classification will be followed, and only the more important compounds will be discussed here.",Beta-D-Glucose,HMDB0000516,b,b,C00221,b,FDB011824,b,[H]OC([H])([H])[C@@]1([H])O[C@@]([H])(O[H])[C@]([H])(O[H])[C@@]([H])(O[H])[C@]1([H])O[H],WQZGKKKJIJFFOK-VFUOTHLCSA-N,"InChI=1S/C6H12O6/c7-1-2-3(8)4(9)5(10)6(11)12-2/h2-11H,1H2/t2-,3-,4+,5-,6-/m1/s1"
1005,33464,elemental phosphorus,a,29186,KEGG COMPOUND accession,C01638,M03066,b,b,b,TRNA(Asp),b,b,b,C01638,b,b,b,b,b,b
1006,30898,"naphthalene-2,7-disulfonic acid",A naphthalenesulfonic acid in which the sulfo groups are attached to positions 2 and 7 of the naphthalene ring.,17658,KEGG COMPOUND accession,C01457,,,,,,,,,,,,,,,
1007,30787,phenylmercury(1+),a,17434,KEGG COMPOUND accession,C01008,,,,,,,,,,,,,,,
1008,31680,hydroxyzine pamoate,a,9947,KEGG COMPOUND accession,C10828,,,,,,,,,,,,,,,
1009,32864,L-prolinium,An optically active form of prolinium having L-configuration.,15561,KEGG COMPOUND accession,C04314,,,,,,,,,,,,,,,
1010,32867,D-prolinate,An optically active form of prolinate having D-configuration.,16941,KEGG COMPOUND accession,C06721,,,,,,,,,,,,,,,
1011,32869,D-prolyl group,a,17095,KEGG COMPOUND accession,C06729,,,,,,,,,,,,,,,
1012,32881,pentan-3-yl group,a,46743,KEGG COMPOUND accession,C06649,,,,,,,,,,,,,,,
1013,32882,3-methylbutan-2-yl group,a,18242,KEGG COMPOUND accession,C06579,,,,,,,,,,,,,,,
1014,32234,titanium dioxide,"A titanium oxide with the formula TiO2.  A naturally occurring oxide sourced from ilmenite, rutile and anatase, it has a wide range of applications.",16551,KEGG COMPOUND accession,C01083,tre,99-20-7,16551.0,"Human Metabolome Database (HMDB): Trehalose, also known as mycose, is a 1-alpha (disaccharide) sugar found extensively but not abundantly in nature. It is thought to be implicated in anhydrobiosis - the ability of plants and animals to withstand prolonged periods of desiccation. The sugar is thought to form a gel phase as cells dehydrate, which prevents disruption of internal cell organelles by effectively splinting them in position. Rehydration then allows normal cellular activity to be resumed without the major, generally lethal damage that would normally follow a dehydration/reyhdration cycle. Trehalose is a non-reducing sugar formed from two glucose units joined by a 1-1 alpha bond giving it the name of alpha-D-glucopyranoglucopyranosyl-1,1-alpha-D-glucopyranoside. The bonding makes trehalose very resistant to acid hydrolysis, and therefore stable in solution at high temperatures even under acidic conditions. The bonding also keeps non-reducing sugars in closed-ring form, such that the aldehyde or ketone end-groups do not bind to the lysine or arginine residues of proteins (a process called glycation). The enzyme trehalase, present but not abundant in most people, breaks it into two glucose molecules, which can then be readily absorbed in the gut. Trehalose is an important components of insects circulating fluid.It acts as a storage form of insect circulating fluid and it is important in respiration.",Trehalose,HMDB0000975,b,b,C01083,TREHALOSE,FDB001114,tre,[H]OC([H])([H])[C@@]1([H])O[C@]([H])(O[C@@]2([H])O[C@]([H])(C([H])([H])O[H])[C@@]([H])(O[H])[C@]([H])(O[H])[C@@]2([H])O[H])[C@]([H])(O[H])[C@@]([H])(O[H])[C@]1([H])O[H],HDTRYLNUVZCQOY-LIZSDCNHSA-N,"InChI=1S/C12H22O11/c13-1-3-5(15)7(17)9(19)11(21-3)23-12-10(20)8(18)6(16)4(2-14)22-12/h3-20H,1-2H2/t3-,4-,5-,6-,7+,8+,9-,10-,11-,12-/m1/s1"
1015,30621,diarsenic trioxide,An arsenic oxide in which arsenic and oxygen atoms are present in the ratio 2:3.,16458,KEGG COMPOUND accession,C02752,,,,,,,,,,,,,,,
1016,30230,azanylidyne group,a,9493,KEGG COMPOUND accession,C06083,,,,,,,,,,,,,,,
1017,30231,nitrogen trifluoride,a,9494,KEGG COMPOUND accession,C11622,,,,,,,,,,,,,,,
1018,32900,undecyl group,a,17692,KEGG COMPOUND accession,C04783,,,,,,,,,,,,,,,
1019,32909,pentadecyl group,a,16231,KEGG COMPOUND accession,C03440,4hpro_D,b,16231.0,"Human Metabolome Database (HMDB): This compound belongs to the family of Alpha Amino Acids and Derivatives. These are amino acids in which the amino group is attached to the carbon atom immediately adjacent to the carboxylate group (alpha carbon), or a derivative thereof[1].[1] Amino Acid: http://en.wikipedia.org/wiki/Amino_acid",cis-4-Hydroxy-D-proline,HMDB0060460,b,b,C03440,b,b,b,b,PMMYEEVYMWASQN-QWWZWVQMSA-N,"InChI=1S/C5H9NO3/c7-3-1-4(5(8)9)6-2-3/h3-4,6-7H,1-2H2,(H,8,9)/t3-,4-/m1/s1"
1020,32915,cetylpyridinium chloride,A pyridinium salt that has N-hexadecylpyridinium as the cation and chloride as the anion. It has antiseptic properties and is used in solutions or lozenges for the treatment of minor infections of the mouth and throat.,28993,KEGG COMPOUND accession,C07091,,,,,,,,,,,,,,,
1021,32927,nonadecane,A straight-chain alkane with 19 carbon atoms. It has been found as a component of essential oils isolated from Artemisia armeniaca.,50537,KEGG COMPOUND accession,C05318,,,,,,,,,,,,,,,
1022,32933,behenyl group,a,17450,KEGG COMPOUND accession,C06738,,,,,,,,,,,,,,,
1023,32935,tricosyl group,a,16174,KEGG COMPOUND accession,C00206,dadp,b,16174.0,"Human Metabolome Database (HMDB): Deoxyadenosine diphosphate has been identified in the mononuclear cells of a patient affected with in inherited adenosine deaminase deficiency (OMIM 102700) (PMID 6980023), and in in mononuclear cells of hemodialyzed patients. (PMID 11461945).",dADP,HMDB0001508,b,b,C00206,DADP,FDB022662,dadp,[H]O[C@@]1([H])C([H])([H])[C@@]([H])(O[C@]1([H])C([H])([H])OP([O-])(=O)OP([O-])([O-])=O)N1C([H])=NC2=C(N=C([H])N=C12)N([H])[H],DAEAPNUQQAICNR-RRKCRQDMSA-K,"InChI=1S/C10H15N5O9P2/c11-9-8-10(13-3-12-9)15(4-14-8)7-1-5(16)6(23-7)2-22-26(20,21)24-25(17,18)19/h3-7,16H,1-2H2,(H,20,21)(H2,11,12,13)(H2,17,18,19)/p-3/t5-,6+,7+/m0/s1"
1024,32315,zopiclone,"A pyrrolo[3,4-b]pyrazine compound having a 4-methylpiperazine-1-carboxyl group at the 5-position, a 5-chloropyridin-2-yl group at the 6-position and an oxo-substituent at the 7-position.",17734,KEGG COMPOUND accession,C03032,,,,,,,,,,,,,,,
1025,32333,"dTDP-5,5-di-C-methyl-beta-L-lyxose","A dTDP-sugar having 5,5-di-C-methyl-beta-L-lyxose as the sugar component.",17954,KEGG COMPOUND accession,C04703,,,,,,,,,,,,,,,
1026,30671,dimethyl(phenyl)phosphine,a,9683,KEGG COMPOUND accession,C07767,,,,,,,,,,,,,,,
1027,30675,(dimethylcarbamoyl)ferrocene,a,28094,KEGG COMPOUND accession,C07490,M03043,115-20-8,28094.0,"Human Metabolome Database (HMDB): 2,2,2-trichloroethanol belongs to the family of Primary Alcohols. These are compounds comprising the primary alcohol functional group, with the general strucuture RCOH (R=alkyl, aryl).","2,2,2-Trichloroethanol",HMDB0041796,b,b,C07490,CPD-9673,b,b,[H]OC([H])([H])C(Cl)(Cl)Cl,KPWDGTGXUYRARH-UHFFFAOYSA-N,"InChI=1S/C2H3Cl3O/c3-2(4,5)1-6/h6H,1H2"
1028,30677,chromocene,a,16602,KEGG COMPOUND accession,C06790,M03044,79-01-6,16602.0,"Human Metabolome Database (HMDB): Trichloroethylene is a solvent and extractive in the manufacture of foods. One recent review of the epidemiology of kidney cancer rated cigarette smoking and obesity as more important risk factors for kidney cancer than exposure to solvents such as trichloroethylene. In contrast, the most recent overall assessment of human health risks associated with trichloroethylene states, ""[t]here is concordance between animal and human studies, which supports the conclusion that trichloroethylene is a potential kidney carcinogen"". The evidence appears to be less certain at this time regarding the relationship between humans and liver cancer observed in mice, with the NAS suggesting that low-level exposure might not represent a significant liver cancer risk in the general population. The chemical compound trichloroethylene is a chlorinated hydrocarbon commonly used as an industrial solvent. It is a clear non-flammable liquid with a sweet smell. The first known report of TCE in groundwater was given in 1949 by two English public chemists who described two separate instances of well contamination by industrial releases of TCE. Based on available federal and state surveys, between 9% to 34% of the drinking water supply sources tested in the U.S. may have some TCE contamination, though EPA has reported that most water supplies are in compliance with the Maximum Contaminant Level (MCL) of 5 ppb. In addition, a growing concern in recent years at sites with TCE contamination in soil or groundwater has been vapor intrusion in buildings, which has resulted in indoor air exposures, such is in a recent case in the McCook Field Neighborhood of Dayton, Ohio. Trichloroethylene has been detected in 852 Superfund sites across the United States, according to the Agency for Toxic Substances and Disease Registry (ATSDR). Under the Safe Drinking Water Act of 1974, and as amended annual water quality testing is required for all public drinking water distributors. The EPA'S current guidelines for TCE can be found here. It should be noted that the EPA's table of ""TCE Releases to Ground"" is dated 1987 to 1993, thereby omitting one of the largest Superfund Cleanup sites in the nation, the NIBW in Scottsdale, Arizona. The TCE ""released"" here occurred prior to its appearance in the municipal drinking wells in 1982. This reaction can be catalyzed by a variety of substances. The most commonly used catalyst is a mixture of potassium chloride and aluminum chloride. However, various forms of porous carbon can also be used. This reaction produces tetrachloroethylene as a byproduct, and depending on the amount of chlorine fed to the reaction, tetrachloroethylene can even be the major product. Typically, trichloroethylene and tetrachloroethylene are collected together and then separated by distillation.Trichloroethylene: Parkinsonism and complex 1 mitochondrial neurotoxicity). Trichloroethylene is an effective solvent for a variety of organic materials",Trichloroethylene,HMDB0029593,b,b,C06790,b,FDB000752,b,[H]C(Cl)=C(Cl)Cl,XSTXAVWGXDQKEL-UHFFFAOYSA-N,InChI=1S/C2HCl3/c3-1-2(4)5/h1H
1029,30682,ruthenium atom,a,9688,KEGG COMPOUND accession,C09741,,,,,,,,,,,,,,,
1030,30257,carbonothioylidene group,a,9509,KEGG COMPOUND accession,C09655,,,,,,,,,,,,,,,
1031,30265,"2-{[4-chloro-6-(ethylamino)-1,3,5-triazin-2-yl]amino}-2-methylbutanenitrile",a,9513,KEGG COMPOUND accession,C07910,,,,,,,,,,,,,,,
1032,30275,arsorylidene group,a,9518,KEGG COMPOUND accession,C09972,,,,,,,,,,,,,,,
1033,30277,arsinoyl group,a,9519,KEGG COMPOUND accession,C06173,,,,,,,,,,,,,,,
1034,30281,trihydridophosphate(.1-),a,28946,KEGG COMPOUND accession,C07480,,,,,,,,,,,,,,,
1035,30283,phosphanuide,a,9522,KEGG COMPOUND accession,C10834,,,,,,,,,,,,,,,
1036,30285,phosphorane,A phosphorus hydride consisting of a single pentavalent phosphorus carrying five hydrogens. The parent hydride of the phosphorane class.,28177,KEGG COMPOUND accession,C07130,,,,,,,,,,,,,,,
1037,30289,trihydridoantimonate(.1-),a,28841,KEGG COMPOUND accession,C08882,,,,,,,,,,,,,,,
1038,30240,fluorine(1+),a,9499,KEGG COMPOUND accession,C09560,,,,,,,,,,,,,,,
1039,30243,fluoridooxygen(1+),a,9501,KEGG COMPOUND accession,C11316,,,,,,,,,,,,,,,
1040,30427,gallane,a,15908,KEGG COMPOUND accession,C01620,thrnt,b,49059.0,Human Metabolome Database (HMDB): Threonic acid is probably derived from glycated proteins or from degradation of ascorbic acid. It is a normal component is aqeous humour and blood (PMID 10420182). Threonic acid is a substrate of L-threonate 3-dehydrogenase [EC 1.1.1.129] in ascorbate and aldarate metabolism pathway (KEGG).,Threonic acid,HMDB0000943,b,b,C01620,b,FDB022331,thrnt,[H]OC([H])([H])[C@]([H])(O[H])[C@@]([H])(O[H])C([O-])=O,JPIJQSOTBSSVTP-STHAYSLISA-M,"InChI=1S/C4H8O5/c5-1-2(6)3(7)4(8)9/h2-3,5-7H,1H2,(H,8,9)/p-1/t2-,3+/m0/s1"
1041,30433,indium(1+),a,15627,KEGG COMPOUND accession,C02198,txa2,57576-52-0,15627.0,"Human Metabolome Database (HMDB): Thromboxane A2 is an unstable intermediate between the prostaglandin endoperoxides and thromboxane B2. The compound has a bicyclic oxaneoxetane structure. It is a potent inducer of platelet aggregation and causes vasoconstriction. It is the principal component of rabbit aorta contracting substance (RCS).Thromboxanes are eicosanoids. The eicosanoids consist of the prostaglandins (PGs), thromboxanes (TXs), leukotrienes (LTs) and lipoxins (LXs). The PGs and TXs are collectively identified as prostanoids. Prostaglandins were originally shown to be synthesized in the prostate gland, thromboxanes from platelets (thrombocytes) and leukotrienes from leukocytes, hence the derivation of their names. All mammalian cells except erythrocytes synthesize eicosanoids. These molecules are extremely potent, able to cause profound physiological effects at very dilute concentrations. All eicosanoids function locally at the site of synthesis, through receptor-mediated G-protein linked signaling pathways.",Thromboxane A2,HMDB0001452,b,b,C02198,ALPHA11-ALPHA-EPOXY-15-HYDROXYTHROMBA,FDB022632,txa2,[H]O[C@]([H])(C([H])=C([H])[C@@]1([H])O[C@]2([H])O[C@@]([H])(C2([H])[H])[C@]1([H])C([H])([H])C([H])=C([H])C([H])([H])C([H])([H])C([H])([H])C([O-])=O)C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H],DSNBHJFQCNUKMA-UJIKMVLPSA-M,"InChI=1S/C20H32O5/c1-2-3-6-9-15(21)12-13-17-16(18-14-20(24-17)25-18)10-7-4-5-8-11-19(22)23/h4,7,12-13,15-18,20-21H,2-3,5-6,8-11,14H2,1H3,(H,22,23)/p-1/b7-4+,13-12-/t15-,16+,17+,18-,20+/m0/s1"
1042,30437,thallane,a,9577,KEGG COMPOUND accession,C09906,,,,,,,,,,,,,,,
1043,30439,thallium(3+),a,9578,KEGG COMPOUND accession,C09740,,,,,,,,,,,,,,,
1044,30441,germanium atom,a,17748,KEGG COMPOUND accession,C00214,thymd,50-89-5,17748.0,"Human Metabolome Database (HMDB): Thymidine is non-toxic and is a naturally occurring compound that exists in all living organisms and DNA viruses. 25% of DNA is composed of thymidine. RNA does not have thymidine and has uridine instead. Thymidine is a chemical compound which is a pyrimidine nucleoside. Thymidine is the DNA base T, which pairs with adenosine in double stranded DNA.",Thymidine,HMDB0000273,b,b,C00214,THYMIDINE,FDB012757,thymd,[H]OC([H])([H])[C@@]1([H])O[C@@]([H])(N2C([H])=C(C(=O)N([H])C2=O)C([H])([H])[H])C([H])([H])[C@]1([H])O[H],IQFYYKKMVGJFEH-XLPZGREQSA-N,"InChI=1S/C10H14N2O5/c1-5-3-12(10(16)11-9(5)15)8-2-6(14)7(4-13)17-8/h3,6-8,13-14H,2,4H2,1H3,(H,11,15,16)/t6-,7+,8+/m0/s1"
1045,30304,antimony(0),a,18306,KEGG COMPOUND accession,C02892,,,,,,,,,,,,,,,
1046,30466,telluronic acid,a,9584,KEGG COMPOUND accession,C08215,,,,,,,,,,,,,,,
1047,30468,tellurium tetrafluoride,a,35940,KEGG COMPOUND accession,C03958,C03958,24305-27-9,35940.0,b,Thyrotropin Releasing Hormone,HMDB05763,b,b,C03958,b,b,b,[H]N([H])C(=O)[C@@]1([H])N(C(=O)[C@@]([H])(N([H])C(=O)[C@@]2([H])N([H])C(=O)C([H])([H])C2([H])[H])C([H])([H])C2=C([H])N=C([H])N2[H])C([H])([H])C([H])([H])C1([H])[H],XNSAINXGIQZQOO-SRVKXCTJSA-N,"InChI=1S/C16H22N6O4/c17-14(24)12-2-1-5-22(12)16(26)11(6-9-7-18-8-19-9)21-15(25)10-3-4-13(23)20-10/h7-8,10-12H,1-6H2,(H2,17,24)(H,18,19)(H,20,23)(H,21,25)/t10-,11-,12-/m0/s1"
1048,30470,heptafluorotellurate(1-),a,9586,KEGG COMPOUND accession,C07503,,,,,,,,,,,,,,,
1049,30472,triphenylstannate(1-),a,9587,KEGG COMPOUND accession,C07139,,,,,,,,,,,,,,,
1050,30474,trichlorostannate(1-),a,9588,KEGG COMPOUND accession,C07140,,,,,,,,,,,,,,,
1051,30478,trioxidotellurate(.1-),a,9590,KEGG COMPOUND accession,C11702,,,,,,,,,,,,,,,
1052,30482,telluronium,a,9592,KEGG COMPOUND accession,C08279,,,,,,,,,,,,,,,
1053,30488,sulfonium,a,9595,KEGG COMPOUND accession,C08914,,,,,,,,,,,,,,,
1054,30358,neopentane,a,29200,KEGG COMPOUND accession,C01755,tcynt,302-04-5,18022.0,"Human Metabolome Database (HMDB): Thiocyanate is analogous to the cyanate ion, [OCN]-, wherein oxygen is replaced by sulfur. [SCN]- is one of the pseudohalogens, due to the similarity of its reactions to that of halide ions. Thiocyanate was formerly known as rhodanide (from a Greek word for rose) because of the red color of its complexes with iron. Thiocyanates are typically colorless. Cyanide ions can react with cystine to yield thicocyanate. This reaction occurs to a slight extent even in neutral solution, but is more pronounced in alkaline solutions of cystine. In addition to this non-enzymatic route, cyanide produced in vivo can be converted in part to thiocyanate by sulfur transferase systems. The thiocyanate ion can be oxidized at acid pH by hydrogen peroxide to generate sulfate and cyanide. The reaction is catalyzed by hemoglobin acting as a peroxidase. Thiocyanate is analogous to the cyanate ion, [OCN]-, wherein oxygen is replaced by sulfur. [SCN]- is one of the pseudohalogens, due to the similarity of its reactions to that of halide ions. Thiocyanate was formerly known as rhodanide (from a Greek word for rose) because of the red color of its complexes with iron. Thiocyanates are typically colorless. Cyanide ions can react with cystine to yield thicocyanate. This reaction occurs to a slight extent even in neutral solution, but is more pronounced in alkaline solutions of cystine. In addition to this non-enzymatic route, cyanide produced in vivo can be converted in part to thiocyanate by sulfur transferase systems. The thiocyanate ion can be oxidized at acid pH by hydrogen peroxide to generate sulfate and cyanide. The reaction is catalyzed by hemoglobin acting as a peroxidase. A study shows that thiocyanate has a protective effect in lung in cystic fibrosis, and an anti-inflammatory effect in arterial endothelial cells, a neuronal cell line, and a pancreatic beta cell line (PMID: 19918082).",Thiocyanate,HMDB0001453,b,b,C01755,HSCN,FDB013883,tcynt,[S-]C#N,ZMZDMBWJUHKJPS-UHFFFAOYSA-M,InChI=1S/CHNS/c2-1-3/h3H/p-1
1055,30363,isobutane,An alkane that is propane substituted by a methyl group at position 2.,28839,KEGG COMPOUND accession,C01962,thcys,5652-32-4,28839.0,"Human Metabolome Database (HMDB): The reactive species in the phosphofructokinase modulation system could be considered thiocysteine (R-S-S-) or cystine trisulfide (R-S-S-S-R) produced from cystine in the presence of gamma-Cystathionase (CST, EC 4.4.1.1). The desulfuration reaction of cystine in vivo produces thiocysteine containing a bound sulfur atom. Persulfide generated from L-cysteine inactivates tyrosine aminotransferase. Thiocysteine is the reactive (unstable) intermediate of thiocystine which functions as a persulfide in transferring its sulfane sulfur to thiophilic acceptors. Thiocystine conversion to unstable thiocysteine is accelerated by sulfhydryl compounds, or reagents that cleave sulfur-sulfur bonds to yield sulfhydryl groups. Thiocystine is proposed as the storage form of sulfane sulfur in biological systems. Liver cytosols contain factors that produce an inhibitor of tyrosine aminotransferase in 3 steps: initial oxidation of cysteine to form cystine; desulfurization of cystine catalyzed by cystathionase to form the persulfide, thiocysteine; and reaction of thiocysteine (or products of its decomposition) with proteins to form protein-bound sulfane. (PMID: 2903161, 454618, 7287665).",Thiocysteine,HMDB0003585,b,b,C01962,THIOCYSTEINE,FDB023203,b,[H]SSC([H])([H])[C@@]([H])(C([O-])=O)[N+]([H])([H])[H],XBKONSCREBSMCS-REOHCLBHSA-N,"InChI=1S/C3H7NO2S2/c4-2(1-8-7)3(5)6/h2,7H,1,4H2,(H,5,6)/t2-/m0/s1"
1056,30370,(TBPY-5)-pentacyanonickelate(3-),a,30065,KEGG COMPOUND accession,C02086,,,,,,,,,,,,,,,
1057,30373,hexaamminenickel(2+),a,9555,KEGG COMPOUND accession,C07648,,,,,,,,,,,,,,,
1058,30375,hexaaquanickel(2+),a,29256,KEGG COMPOUND accession,C00145,M02988,b,29256.0,b,Thiol,b,b,b,C00145,b,b,b,[H]S[*],b,b
1059,30318,(S)-dihydrolipoic acid,The (S)-enantiomer of dihydrolipoic acid.,9533,KEGG COMPOUND accession,C01081,thmmp,495-23-8,37574.0,"Human Metabolome Database (HMDB): Thiamine monophosphate is a thiamine derivative. It is a monophosphate ester of thiamine. Thiamine monophosphate (ThMP) is one of the five known natural thiamine phosphate derivatives. Thiamine (vitamin B1) is the transport form of the vitamin, while the phosphorylated derivatives are the active forms. There is no known physiological role of thiamine monophosphate.",Thiamine monophosphate,HMDB0002666,b,b,C01081,THIAMINE-P,FDB023043,thmmp,[H]N([H])C1=C(C([H])=NC(=N1)C([H])([H])[H])C([H])([H])[N+]1=C([H])SC(=C1C([H])([H])[H])C([H])([H])C([H])([H])OP([O-])([O-])=O,HZSAJDVWZRBGIF-UHFFFAOYSA-M,"InChI=1S/C12H17N4O4PS/c1-8-11(3-4-20-21(17,18)19)22-7-16(8)6-10-5-14-9(2)15-12(10)13/h5,7H,3-4,6H2,1-2H3,(H3-,13,14,15,17,18,19)/p-1"
1060,30324,tetracyanoaurate(1-),a,9534,KEGG COMPOUND accession,C03028,thmtp,3475-65-8,9534.0,"Human Metabolome Database (HMDB): Thiamine triphosphate is the triphosphate ester of thiamine. Thiamine triphosphate (ThTP) was previously considered to be a specific neuroactive form of thiamine. However, it was recently shown that ThTP exists in bacteria, fungi, plants and animals suggesting a much more general cellular role. In particular, it seems to play a role in response to amino acid starvation. In mammals, ThTP is hydrolyzed by a specific thiamine triphosphatase. In Leigh's disease, this compound is present in decreased amounts in the brain due to a metabolic block in its formation.",Thiamine triphosphate,HMDB0001512,b,b,C03028,CPD-611,FDB022666,thmtp,[H]N([H])C1=C(C([H])=NC(=N1)C([H])([H])[H])C([H])([H])[N+]1=C([H])SC(=C1C([H])([H])[H])C([H])([H])C([H])([H])OP([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O,IWLROWZYZPNOFC-UHFFFAOYSA-K,"InChI=1S/C12H19N4O10P3S/c1-8-11(30-7-16(8)6-10-5-14-9(2)15-12(10)13)3-4-24-28(20,21)26-29(22,23)25-27(17,18)19/h5,7H,3-4,6H2,1-2H3,(H5-,13,14,15,17,18,19,20,21,22,23)/p-3"
1061,30329,tetrabromoaurate(1-),a,27824,KEGG COMPOUND accession,C05856,,,,,,,,,,,,,,,
1062,30331,hexacyanocobaltate(3-),a,9536,KEGG COMPOUND accession,C07846,,,,,,,,,,,,,,,
1063,30339,tetrafluoroargentate(1-),a,45807,KEGG COMPOUND accession,C02595,,,,,,,,,,,,,,,
1064,30341,silver monochloride,a,27382,KEGG COMPOUND accession,C03311,,,,,,,,,,,,,,,
1065,30343,tetrakis(pyridine)silver(2+),a,9543,KEGG COMPOUND accession,C09245,,,,,,,,,,,,,,,
1066,30345,tetrakis(pyridine)copper(2+),a,9544,KEGG COMPOUND accession,C07132,,,,,,,,,,,,,,,
1067,30530,arsenic pentafluoride,a,27999,KEGG COMPOUND accession,C07148,tolbutamide,64-77-7,27999.0,"Human Metabolome Database (HMDB): Tolbutamide is an oral antihyperglycemic agent used for the treatment of non-insulin-dependent diabetes mellitus (NIDDM). It is structurally similar to acetohexamide, chlorpropamide and tolazamide and belongs to the sulfonylurea class of insulin secretagogues, which act by stimulating cells of the pancreas to release insulin. Sulfonylureas increase both basal insulin secretion and meal-stimulated insulin release. Medications in this class differ in their dose, rate of absorption, duration of action, route of elimination and binding site on their target pancreatic cell receptor. Sulfonylureas also increase peripheral glucose utilization, decrease hepatic gluconeogenesis and may increase the number and sensitivity of insulin receptors. Sulfonylureas are associated with weight gain, though less so than insulin. Due to their mechanism of action, sulfonylureas may cause hypoglycemia and require consistent food intake to decrease this risk. The risk of hypoglycemia is increased in elderly, debilitated and malnourished individuals. Tolbutamide appears to be metabolized in the liver. Tolbutamide and its metabolites are excreted in urine (75-85%) and feces. ",Tolbutamide,HMDB0015256,b,b,C07148,b,b,tolbutamide,[H]N(C(=O)N([H])S(=O)(=O)C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])[H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H],JLRGJRBPOGGCBT-UHFFFAOYSA-N,"InChI=1S/C12H18N2O3S/c1-3-4-9-13-12(15)14-18(16,17)11-7-5-10(2)6-8-11/h5-8H,3-4,9H2,1-2H3,(H2,13,14,15)"
1068,30534,tetrakis(thiocyanato)argentate(3-),a,71941,KEGG COMPOUND accession,C07149,,,,,,,,,,,,,,,
1069,30536,stannanide,a,9619,KEGG COMPOUND accession,C02328,,,,,,,,,,,,,,,
1070,30386,tetrabromonickelate(2-),a,102166,KEGG COMPOUND accession,C07521,,,,,,,,,,,,,,,
1071,30390,hexafluoronickelate(2-),a,15542,KEGG COMPOUND accession,C07347,,,,,,,,,,,,,,,
1072,30394,hexakis(pyridine)nickel(2+),a,28279,KEGG COMPOUND accession,C03542,,,,,,,,,,,,,,,
1073,30579,hydridosilicon(1+),a,9638,KEGG COMPOUND accession,C08613,,,,,,,,,,,,,,,
1074,30584,silicon(4+),a,9642,KEGG COMPOUND accession,C02088,,,,,,,,,,,,,,,
1075,30596,disilanide,a,9648,KEGG COMPOUND accession,C07153,,,,,,,,,,,,,,,
1076,32205,tetracenomycin F1,"A tetracenomycin that is 1-methyl-11-oxo-6,11-dihydrotetracene-2-carboxylic acid bearing four hydroxy substituents at positions 3, 8, 10 and 12.",28537,KEGG COMPOUND accession,C05918,,,,,,,,,,,,,,,
1077,32207,tetracenomycin F2,a,17613,KEGG COMPOUND accession,C04216,,,,,,,,,,,,,,,
1078,32213,((201)Tl)thallium monochloride,a,18144,KEGG COMPOUND accession,C04145,atnodp,b,18144.0,b,All-trans-Nonaprenyl diphosphate; solanesyl diphosphate,b,b,b,C04145,b,b,b,b,b,"InChI=1S/C45H76O7P2/c1-37(2)19-11-20-38(3)21-12-22-39(4)23-13-24-40(5)25-14-26-41(6)27-15-28-42(7)29-16-30-43(8)31-17-32-44(9)33-18-34-45(10)35-36-51-54(49,50)52-53(46,47)48/h19,21,23,25,27,29,31,33,35H,11-18,20,22,24,26,28,30,32,34,36H2,1-10H3,(H,49,50)(H2,46,47,48)/b38-21+,39-23+,40-25+,41-27+,42-29+,43-31+,44-33+,45-35+"
1079,32216,thiethylperazine maleate,a,16818,KEGG COMPOUND accession,C04217,,,,,,,,,,,,,,,
1080,32223,tibolone,"Estran-3-one with a double bond between positions 5 and 10, and bearing both an ethynyl group and a hydroxy group at position 17 (R-configuration). A synthetic steroid hormone drug which acts as an agonist at all five type I steroid hormone receptors, it is used in the prevention of postmenopausal osteoporosis and for treatment of endometriosis.",18195,KEGG COMPOUND accession,C04465,,,,,,,,,,,,,,,
1081,32420,gadoleate,"A unsaturated fatty acid anion that is the conjugate base of gadoleic acid, formed by deprotonation of the carboxylic acid group.",28067,KEGG COMPOUND accession,C05861,m1mpdol_L,b,b,"Human Metabolome Database (HMDB): alpha-D-Mannosyl-beta-D-mannosyl-diacetylchitobiosyldiphosphodolichol, also known as Man-a1->3man-b1->4glcnac-b1->4glcnac-PP-dol, is classified as a member of the Polyprenyl phospho carbohydrates. Polyprenyl phospho carbohydrates are polyprenyl phosphates with a carbohydrate moiety attached to it. alpha-D-Mannosyl-beta-D-mannosyl-diacetylchitobiosyldiphosphodolichol is considered to be practically insoluble (in water) and acidic",alpha-D-Mannosyl-beta-D-mannosyl-diacetylchitobiosyldiphosphodolichol,HMDB0062446,b,b,C05861,b,b,b,[H]OC(=N[C@@]1([H])[C@]([H])(O[C@@]2([H])[C@]([H])(O[H])[C@@]([H])(N=C(O[H])C([H])([H])[H])[C@@]([H])(OP(=O)(O[H])OP(=O)(O[H])OC([H])([H])C([H])([H])C([H])(C([H])([H])[H])C([H])([H])C([H])([H])C(\[H])=C(/C([H])([H])[H])C([H])([H])C([H])([H])C(\[H])=C(/C([H])([H])[H])C([H])([H])C([H])([H])C(\[H])=C(/C([H])([H])[H])C([H])([H])C([H])([H])C([H])=C(C([H])([H])[H])C([H])([H])[H])O[C@]2([H])C([H])([H])O[H])O[C@]([H])(C([H])([H])O[H])[C@@]([H])(O[C@]2([H])O[C@]([H])(C([H])([H])O[H])[C@@]([H])(O[H])[C@]([H])(O[C@@]3([H])O[C@]([H])(C([H])([H])O[H])[C@@]([H])(O[H])[C@]([H])(O[H])[C@]3([H])O[H])[C@]2([H])O[H])[C@]1([H])O[H])C([H])([H])[H],LXNPFZYOWOXRQK-WPFSCCOBSA-N,"InChI=1S/C53H92N2O27P2/c1-27(2)13-9-14-28(3)15-10-16-29(4)17-11-18-30(5)19-12-20-31(6)21-22-73-83(69,70)82-84(71,72)81-51-39(55-33(8)61)43(65)47(37(26-59)77-51)78-50-38(54-32(7)60)42(64)48(36(25-58)76-50)79-53-46(68)49(41(63)35(24-57)75-53)80-52-45(67)44(66)40(62)34(23-56)74-52/h13,15,17,19,31,34-53,56-59,62-68H,9-12,14,16,18,20-26H2,1-8H3,(H,54,60)(H,55,61)(H,69,70)(H,71,72)/b28-15+,29-17+,30-19+/t31?,34-,35-,36-,37-,38-,39-,40-,41-,42-,43-,44+,45+,46+,47-,48-,49+,50+,51-,52-,53+/m1/s1"
1082,32423,gadelaidate,"An unsaturated fatty acid anion that is the conjugate base of gadelaidic acid, arising from deprotonation of the carboxy group.",42606,KEGG COMPOUND accession,C08352,,,,,,,,,,,,,,,
1083,32425,(11Z)-icos-11-enoic acid,An icosenoic acid having a cis- double bond at position 11.,28764,KEGG COMPOUND accession,C05511,,,,,,,,,,,,,,,
1084,32431,L-alaninate,The L-enantiomer of alaninate.,18189,KEGG COMPOUND accession,C03736,,,,,,,,,,,,,,,
1085,32433,L-alanyl group,a,28552,KEGG COMPOUND accession,C08354,,,,,,,,,,,,,,,
1086,32435,D-alaninate,The D-enantiomer of alaninate.,28518,KEGG COMPOUND accession,C02205,,,,,,,,,,,,,,,
1087,32436,D-alaninium,An alaninium that is the conjugate acid of D-alanine.,15902,KEGG COMPOUND accession,C03737,,,,,,,,,,,,,,,
1088,32442,L-cysteinate(1-),The L-enantiomer of cysteinate(1-).,10276,KEGG COMPOUND accession,C07545,,,,,,,,,,,,,,,
1089,32540,desosamine,a,10330,KEGG COMPOUND accession,C09719,,,,,,,,,,,,,,,
1090,32542,garosamine,a,16363,KEGG COMPOUND accession,C02206,,,,,,,,,,,,,,,
1091,32549,epsilon-carotene,a,10334,KEGG COMPOUND accession,C09898,,,,,,,,,,,,,,,
1092,32551,L-lysinium(1+),An optically active form of lysinium having L-configuration.,10335,KEGG COMPOUND accession,C08460,,,,,,,,,,,,,,,
1093,32553,L-lysyl group,a,18145,KEGG COMPOUND accession,C02477,avite1,59-02-9,18145.0,"Human Metabolome Database (HMDB): Alpha-tocopherol is traditionally recognized as the most active form of vitamin E in humans, and is a powerful biological antioxidant. The measurement of ""vitamin E"" activity in international units (IU) was based on fertility enhancement by the prevention of spontaneous abortions in pregnant rats relative to alpha tocopherol. Natural vitamin E exists in eight different forms or isomers, four tocopherols and four tocotrienols. In foods, the most abundant sources of vitamin E are vegetable oils such as palm oil, sunflower, corn, soybean and olive oil. Nuts, sunflower seeds, and wheat germ are also good sources. --Wikipedia.",Alpha-Tocopherol,HMDB0001893,b,b,C02477,CPD-1125,FDB000565,b,[H]OC1=C(C(=C2O[C@](C([H])([H])[H])(C([H])([H])C([H])([H])C([H])([H])[C@]([H])(C([H])([H])[H])C([H])([H])C([H])([H])C([H])([H])[C@]([H])(C([H])([H])[H])C([H])([H])C([H])([H])C([H])([H])C([H])(C([H])([H])[H])C([H])([H])[H])C([H])([H])C([H])([H])C2=C1C([H])([H])[H])C([H])([H])[H])C([H])([H])[H],GVJHHUAWPYXKBD-IEOSBIPESA-N,"InChI=1S/C29H50O2/c1-20(2)12-9-13-21(3)14-10-15-22(4)16-11-18-29(8)19-17-26-25(7)27(30)23(5)24(6)28(26)31-29/h20-22,30H,9-19H2,1-8H3/t21-,22-,29-/m1/s1"
1094,32566,N(2)-lysino group,a,16958,KEGG COMPOUND accession,C00099,ala_B,107-95-9,16958.0,"Human Metabolome Database (HMDB): beta-Alanine is the only naturally occurring beta-amino acid - an amino acid in which the amino group is at the beta-position from the carboxylate group. It is formed in vivo by the degradation of dihydrouracil and carnosine. It is a component of the naturally occurring peptides carnosine and anserine and also of pantothenic acid (vitamin B-5), which itself is a component of coenzyme A. Under normal conditions, beta-alanine is metabolized into acetic acid. beta-Alanine can undergo a transanimation reaction with pyruvate to form malonate-semialdehyde and L-alanine. The malonate semialdehyde can then be converted into malonate via malonate-semialdehyde dehydrogenase. Malonate is then converted into malonyl-CoA and enter fatty acid biosynthesis. Since neuronal uptake and neuronal receptor sensitivity to beta-alanine have been demonstrated, beta-alanine may act as a false transmitter replacing gamma-aminobutyric acid. When present in sufficiently high levels, beta-alanine can act as a neurotoxin, a mitochondrial toxin, and a metabotoxin. A neurotoxin is a compound that damages the brain or nerve tissue. A mitochondrial toxin is a compound that damages mitochondria and reduces cellular respiration as well as oxidative phosphorylation. A metabotoxin is an endogenously produced metabolite that causes adverse health effects at chronically high levels. Chronically high levels of beta-alanine are associated with at least three inborn errors of metabolism, including GABA-transaminase deficiency, hyper-beta-alaninemia, and methylmalonate semialdehyde dehydrogenase deficiency. beta-Alanine is a central nervous system (CNS) depressant and is an inhibitor of GABA transaminase. The associated inhibition of GABA transaminase and displacement of GABA from CNS binding sites can also lead to GABAuria (high levels of GABA in the urine) and convulsions. In addition to its neurotoxicity, beta-alanine reduces cellular levels of taurine, which are required for normal respiratory chain function. Cellular taurine depletion is known to reduce respiratory function and elevate mitochondrial superoxide generation, which damages mitochondria and increases oxidative stress (PMID: 27023909). Individuals suffering from mitochondrial defects or mitochondrial toxicity typically develop neurotoxicity, hypotonia, respiratory distress, and cardiac failure. beta-Alanine is a biomarker for the consumption of meat, especially red meat.",beta-Alanine,HMDB0000056,b,b,C00099,B-ALANINE,FDB002253,ala_B,[H][N+]([H])([H])C([H])([H])C([H])([H])C([O-])=O,UCMIRNVEIXFBKS-UHFFFAOYSA-N,"InChI=1S/C3H7NO2/c4-2-1-3(5)6/h1-2,4H2,(H,5,6)"
1095,33237,vitamin D4,It is present in mushrooms.,17894,KEGG COMPOUND accession,C04833,M02436,b,17894.0,b,"M7G(5')Pppm6Am (Mrna Containing An N6,2'-O-Dimethyladenosine Cap)",b,b,b,C04833,b,b,b,[H]O[C@@]1([H])[C@]([H])([*])O[C@]([H])(C([H])([H])OP(=O)(O[H])O[C@@]2([H])[C@@]([H])(O[H])[C@]([H])([*])O[C@]2([H])C([H])([H])OP(=O)(O[H])O[C@]2([H])[C@]([H])(O[C@@]([H])(N3C([H])=NC4=C3N=C([H])N=C4N([H])C([H])([H])[H])[C@]2([H])OC([H])([H])[H])C([H])([H])OP(=O)(O[H])OP(=O)(O[H])OP(=O)(O[H])OC([H])([H])[C@@]2([H])O[C@@]([H])(N3C([H])=[N+](C4=C3N=C(N([H])[H])N([H])C4=O)C([H])([H])[H])[C@]([H])(O[H])[C@]2([H])O[H])[C@@]1([H])O[H],b,b
1096,32390,gamma-linolenoyl group,a,16295,KEGG COMPOUND accession,C04909,,,,,,,,,,,,,,,
1097,32399,12-crown-4,"A crown ether that is cyclododecane in which the carbon atoms at positions 1, 4, 7 and 10 have been replaced by oxygen atoms.",52773,KEGG COMPOUND accession,C06370,,,,,,,,,,,,,,,
1098,32403,thien-2-ylacetate,a,16326,KEGG COMPOUND accession,C01171,,,,,,,,,,,,,,,
1099,32408,parinaric acid,"An octadecatetraenoic acid containing a conjugated system of  double bonds at positions 9, 11, 13 and 15.",28543,KEGG COMPOUND accession,C02204,,,,,,,,,,,,,,,
1100,32410,trans-parinaric acid,The all-trans- isomer of parinaric acid.,28657,KEGG COMPOUND accession,C08236,,,,,,,,,,,,,,,
1101,32412,phosphorothioyl group,a,28729,KEGG COMPOUND accession,C00936,,,,,,,,,,,,,,,
1102,32286,alfuzosin hydrochloride,a,27959,KEGG COMPOUND accession,C05714,,,,,,,,,,,,,,,
1103,32296,vinorelbine L-tartrate,The L-(+)-tartrate salt of vinorelbine.,10217,KEGG COMPOUND accession,C09631,,,,,,,,,,,,,,,
1104,31387,cetrorelix acetate,"The acetic acid salt of cetrorelix. A gonadotrophin-releasing hormone (GnRH) antagonist, it is used for treatment of infertility and of hormone-sensitive cancers of the prostate and breast.",15713,KEGG COMPOUND accession,C00075,utp,63-39-8,15713.0,"Human Metabolome Database (HMDB): Uridine 5'-(tetrahydrogen triphosphate). A uracil nucleotide containing three phosphate groups esterified to the sugar moiety. Uridine triphosphate has the role of a source of energy or an activator of substrates in metabolic reactions, like that of adenosine triphosphate, but more specific. When Uridine triphosphate activates a substrate, UDP-substrate is usually formed and inorganic phosphate is released. (Wikipedia).",Uridine triphosphate,HMDB0000285,b,b,C00075,UTP,FDB021929,utp,[H]O[C@@]1([H])[C@@]([H])(O[C@]([H])(C([H])([H])OP([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O)[C@@]1([H])O[H])N1C([H])=C([H])C(=O)N([H])C1=O,PGAVKCOVUIYSFO-XVFCMESISA-J,"InChI=1S/C9H15N2O15P3/c12-5-1-2-11(9(15)10-5)8-7(14)6(13)4(24-8)3-23-28(19,20)26-29(21,22)25-27(16,17)18/h1-2,4,6-8,13-14H,3H2,(H,19,20)(H,21,22)(H,10,12,15)(H2,16,17,18)/p-4/t4-,6-,7-,8-/m1/s1"
1105,33355,bohrium atom,a,18063,KEGG COMPOUND accession,C04315,,,,,,,,,,,,,,,
1106,33358,cobalt group element atom,a,16206,KEGG COMPOUND accession,C04590,,,,,,,,,,,,,,,
1107,33361,meitnerium atom,a,18321,KEGG COMPOUND accession,C01225,M02911,b,18321.0,"Human Metabolome Database (HMDB): 1-(sn-Glycero-3-phospho)-1D-myo-inositol or glycerophosphoinositol is produced through deacylation by phospholipase B of the essential phospholipid phosphatidylinositol. Glycerophosphoinositols are ubiquitous phosphoinositide metabolites involved in the control of several cell functions. They exert their actions both intracellularly and by rapidly equilibrating across the plasma membrane. Their transport is mediated by the Glut2 transporter, the human ortholog of GIT1 (PMID: 17141226). Glycerophosphoinositol is a substrate for glycerophosphoinositol inositolphosphodiesterase (EC 3.1.4.43) and is involved in the following reaction: 1-(sn-glycero-3-phospho)-1D-myo-inositol + H2O = glycerol + 1D-myo-inositol 1-phosphate. It is also a substrate for glycerophosphoinositol glycerophosphodiesterase (EC 3.1.4.44) which catalyzes the chemical reaction:. 1-(sn-glycero-3-phospho)-1D-myo-inositol + H2O = myo-inositol + sn-glycerol 3-phosphate.",1-(sn-Glycero-3-phospho)-1D-myo-inositol ,HMDB0011649,b,b,C01225,CPD-541,FDB011624,b,[H]OC([H])([H])[C@@]([H])(O[H])C([H])([H])OP(=O)(O[H])O[C@@]1([H])[C@]([H])(O[H])[C@@]([H])(O[H])[C@]([H])(O[H])[C@@]([H])(O[H])[C@@]1([H])O[H],BMVUIWJCUQSHLZ-UJGXJMNGSA-N,"InChI=1S/C9H19O11P/c10-1-3(11)2-19-21(17,18)20-9-7(15)5(13)4(12)6(14)8(9)16/h3-16H,1-2H2,(H,17,18)/t3-,4-,5-,6+,7-,8-,9-/m1/s1"
1108,33364,platinum,a,16870,KEGG COMPOUND accession,C00670,g3pc,28319-77-9,16870.0,"Human Metabolome Database (HMDB): Glycerophosphorylcholine (GPC) is a choline derivative and one of the two major forms of choline storage (along with phosphocholine) in the cytosol. Glycerophosphorylcholine is also one of the four major organic osmolytes in renal medullary cells, changing their intracellular osmolyte concentration in parallel with extracellular tonicity during cellular osmoadaptation. As an osmolyte, Glycerophosphorylcholine counteracts the effects of urea on enzymes and other macromolecules. Kidneys (especially medullar cells), which are exposed under normal physiological conditions to widely fluctuating extracellular solute concentrations, respond to hypertonic stress by accumulating the organic osmolytes glycerophosphorylcholine (GPC), betaine, myo-inositol, sorbitol and free amino acids. Increased intracellular contents of these osmolytes are achieved by a combination of increased uptake (myo-inositol and betaine) and synthesis (sorbitol, GPC), decreased degradation (GPC) and reduced osmolyte release. GPC is formed in the breakdown of phosphatidylcholine (PtC). This pathway is active in many body tissues, including mammary tissue.",Glycerophosphocholine,HMDB0000086,b,b,C00670,GLYCERYLPHOSPHORYLCHOLINE,FDB021802,g3pc,[H]OC([H])([H])[C@@]([H])(O[H])C([H])([H])OP([O-])(=O)OC([H])([H])C([H])([H])[N+](C([H])([H])[H])(C([H])([H])[H])C([H])([H])[H],SUHOQUVVVLNYQR-MRVPVSSYSA-N,"InChI=1S/C8H20NO6P/c1-9(2,3)4-5-14-16(12,13)15-7-8(11)6-10/h8,10-11H,4-7H2,1-3H3/t8-/m1/s1"
1109,33374,samarium atom,a,15978,KEGG COMPOUND accession,C00093,glyc3p,57-03-4,15978.0,"Human Metabolome Database (HMDB): Glycerol 3-phosphate is a chemical intermediate in the glycolysis metabolic pathway. It is commonly confused with the similarly named glycerate 3-phosphate or glyceraldehyde 3-phosphate. Glycerol 3-phosphate is produced from glycerol, the triose sugar backbone of triglycerides and glycerophospholipids, by the enzyme glycerol kinase. Glycerol 3-phospate may then be converted by dehydrogenation to dihydroxyacetone phosphate (DHAP) by the enzyme glycerol-3-phosphate dehydrogenase. DHAP can then be rearranged into glyceraldehyde 3-phosphate (GA3P) by triose phosphate isomerase (TIM), and feed into glycolysis. The glycerol 3-phosphate shuttle is used to rapidly regenerate NAD+ in the brain and skeletal muscle cells of mammals (wikipedia).",Glycerol 3-phosphate,HMDB0000126,b,b,C00093,GLYCEROL-3P,FDB021800,glyc3p,[H]OC([H])([H])[C@@]([H])(O[H])C([H])([H])OP([O-])([O-])=O,AWUCVROLDVIAJX-GSVOUGTGSA-L,"InChI=1S/C3H9O6P/c4-1-3(5)2-9-10(6,7)8/h3-5H,1-2H2,(H2,6,7,8)/p-2/t3-/m1/s1"
1110,32449,D-cysteinate(1-),The D-enantiomer of cysteinate(1-).,10280,KEGG COMPOUND accession,C09665,,,,,,,,,,,,,,,
1111,32451,D-cysteinium,The D-enantiomer of cysteinium.,28554,KEGG COMPOUND accession,C08238,,,,,,,,,,,,,,,
1112,32457,cysteinate(2-),a,10284,KEGG COMPOUND accession,C09690,,,,,,,,,,,,,,,
1113,32465,L-asparto group,a,28226,KEGG COMPOUND accession,C06239,,,,,,,,,,,,,,,
1114,32466,D-alpha-aspartyl group,a,35376,KEGG COMPOUND accession,C01032,,,,,,,,,,,,,,,
1115,32467,D-beta-aspartyl group,a,28349,KEGG COMPOUND accession,C02475,,,,,,,,,,,,,,,
1116,32468,D-aspartoyl group,a,16124,KEGG COMPOUND accession,C04467,,,,,,,,,,,,,,,
1117,32470,aspartic acid residue,a,27907,KEGG COMPOUND accession,C02476,,,,,,,,,,,,,,,
1118,31556,esatenolol,The (S)-enantiomer of atenolol.,17967,KEGG COMPOUND accession,C01537,,,,,,,,,,,,,,,
1119,32371,myristoleoyl group,a,18148,KEGG COMPOUND accession,C01231,M01966,10139-18-1,18148.0,"Human Metabolome Database (HMDB): Glucose 1,6-diphosphate (G-1,6-P2) is considered to be a major regulator of carbohydrate metabolism. It has been demonstrated that G-1,6-P2 is a potent activator (deinhibitor) of skeletal muscle phosphofructokinase (PFK) and phosphoglucomutase, while being an inhibitor of hexokinase (see Ref. 2). In addition, G-1,6-P2 has been shown to inhibit 6-phosphogluconate dehydrogenase in various rat tissues and fructose 1,6-bisphosphatase in bovine liver. Various factors and conditions affect the tissue content of G-1,6-P2. Specifically, anoxia induce a rapid fall in the content of G-l,6-P2 in brain. Glucose 1,6-diphosphate have been recognized as a regulatory signal implicated in the control of metabolism, oxygen affinity of red cells and other cellular functions. The levels of G 1,6-P2 are reduced in the liver and in the muscle of rats with experimentally induced diabetes. In muscle of genetically dystrophic mice a decrease in the levels of G 1,6-P2 has been found, probably resulting from enhancement of glucose 1,6-P2 phosphatase activity. G 1,6-P2 is an inhibitor of hexokinase and its level is increased significantly after 5 min of exercise (~ 25%) and then decreased continuously. G 1,6-P2 is a potent allosteric activator of phosphofructokinase, and is markedly decreased in muscles of patients with glycogenosis type VII (muscle phosphofructokinase deficiency) and type V (muscle phosphorylase deficiency). Chronic alcohol intake produces an increase in the concentration of G 1,6-P2 in human muscle before the first sign of myopathy appears. When myopathy is present the level decreases to be similar of healthy humans. These changes could contribute to the decline in skeletal muscle performance. (PMID: 1449560, 2018547, 2003594, 3407759).","Alpha-D-Glucose 1,6-bisphosphate",HMDB0003514,b,b,C01231,ALPHA-GLUCOSE-16-BISPHOSPHATE,FDB023185,M01966,[H]O[C@@]1([H])[C@@]([H])(OP(=O)(O[H])O[H])O[C@]([H])(C([H])([H])OP(=O)(O[H])O[H])[C@@]([H])(O[H])[C@]1([H])O[H],RWHOZGRAXYWRNX-QYESYBIKSA-K,"InChI=1S/C6H14O12P2/c7-3-2(1-16-19(10,11)12)17-6(5(9)4(3)8)18-20(13,14)15/h2-9H,1H2,(H2,10,11,12)(H2,13,14,15)/p-3/t2-,3-,4+,5-,6-/m0/s1"
1120,33252,atomic nucleus,"A nucleus is the positively charged central portion of an atom, excluding the orbital electrons.",17268,KEGG COMPOUND accession,C00137,inost,87-89-8,17268.0,"Human Metabolome Database (HMDB): myo-Inositol is an inositol isoform. Inositol is a derivative of cyclohexane with six hydroxyl groups, making it a polyol. It also is known as a sugar alcohol, having exactly the same molecular formula as glucose or other hexoses. Inositol exists in nine possible stereoisomers, of which cis-1,2,3,5-trans-4,6-cyclohexanehexol, or myo-inositol is the most widely occurring form in nature. The other known inositols include scyllo-inositol, muco-inositol, D-chiro-inositol, L-chiro-inositol, neo-inositol, allo-inositol, epi-inositol and cis-inositol. myo-Inositol is found naturally in many foods (particularly in cereals with high bran content) and can be used as a sweetner as it has half the sweetness of sucrose (table sugar). myo-Inositol was once considered a member of the vitamin B complex and given the name: vitamin B8. However, because it is produced by the human body from glucose, it is not an essential nutrient, and therefore cannot be called a vitamin. myo-Inositol is a precursor molecule for a number of secondary messengers including various inositol phosphates. In addition, inositol/myo-inositol is an important component of the lipids known as phosphatidylinositol (PI) phosphatidylinositol phosphate (PIP). myo-Inositol is synthesized from glucose, via glucose-6-phosphate (G-6-P) in two steps. First, G-6-P is isomerised by an inositol-3-phosphate synthase enzyme to myo-inositol 1-phosphate, which is then dephosphorylated by an inositol monophosphatase enzyme to give free myo-inositol. In humans, myo-inositol is primarily synthesized in the kidneys at a rate of a few grams per day. myo-Inositol can be used in the management of preterm babies who have or are at a risk of infant respiratory distress syndrome. It is also used as a treatment for polycystic ovary syndrome (PCOS). It works by increasing insulin sensitivity, which helps to improve ovarian function and reduce hyperandrogenism. Reduced levels of myo-inositol have been found in the spinal fluid of depressed patients and levels are significantly reduced in brain samples of suicide victims.",myo-Inositol,HMDB0000211,b,b,C00137,MYO-INOSITOL,FDB010547,inost,[H]O[C@@]1([H])[C@]([H])(O[H])[C@@]([H])(O[H])[C@]([H])(O[H])[C@]([H])(O[H])[C@]1([H])O[H],CDAISMWEOUEBRE-GPIVLXJGSA-N,"InChI=1S/C6H12O6/c7-1-2(8)4(10)6(12)5(11)3(1)9/h1-12H/t1-,2-,3-,4+,5-,6-"
1121,32475,L-glutamoyl group,a,28771,KEGG COMPOUND accession,C08319,,,,,,,,,,,,,,,
1122,32480,D-gamma-glutamyl group,a,18167,KEGG COMPOUND accession,C00897,,,,,,,,,,,,,,,
1123,31620,flumethasone pivalate,a,75988,KEGG COMPOUND accession,C11153,,,,,,,,,,,,,,,
1124,31635,neomycin sulfate,"A mixture of the sulfates of substances produced by the growth of certain selected strains of Streptomyces fradiae, the main component being the sulfate of neomycin B.",9925,KEGG COMPOUND accession,C07842,,,,,,,,,,,,,,,
1125,31643,gadoteridol,A non-ionic gadolinium chelate having a macrocyclic tetraamine framework. It is used as a paramagnetic contrast agent in magnetic resonance imaging (MRI).,30528,KEGG COMPOUND accession,C00754,,,,,,,,,,,,,,,
1126,32494,D-phenylalaninate,The D-enantiomer of phenylalaninate.,16565,KEGG COMPOUND accession,C04901,sT_antigen,b,16565.0,b,Sialyl-T Antigen,b,b,b,C04901,b,b,sT_antigen,[H]OC([H])([H])[C@@]([H])(O[H])[C@@]([H])(O[H])C1([H])O[C@@](O[C@]2([H])[C@@]([H])(O[H])[C@]([H])(O[C@@]3([H])[C@@]([H])(O[H])[C@]([H])(O[C@]([H])([*])[C@]3([H])N([H])C(=O)C([H])([H])[H])C([H])([H])O[H])O[C@]([H])(C([H])([H])O[H])[C@]2([H])O[H])(C([O-])=O)C([H])([H])[C@]([H])(O[H])[C@@]1([H])N([H])C(=O)C([H])([H])[H],b,b
1127,32500,D-phenylalanyl group,a,16361,KEGG COMPOUND accession,C04683,,,,,,,,,,,,,,,
1128,32504,phenylalaninate,"An aromatic amino-acid anion that is the conjugate base of phenylalanine, arising from deprotonation of the carboxy group.",17725,KEGG COMPOUND accession,C04886,,,,,,,,,,,,,,,
1129,32508,glycinate,"An alpha-amino-acid anion that is the conjugate base of glycine, arising from deprotonation of the carboxy group.",17483,KEGG COMPOUND accession,C04887,,,,,,,,,,,,,,,
1130,32514,L-histidyl group,a,17884,KEGG COMPOUND accession,C04148,pheacgln,28047-15-6,17884.0,"Human Metabolome Database (HMDB): Phenylacetylglutamine is a product formed by the conjugation of phenylacetate and glutamine. Technically it is the amino acid acetylation product of phenylacetate (or phenylbutyrate after beta-oxidation). Phenylacetylglutamine is a normal constituent of human urine, but other mammals including the dog, cat, rat, monkey, sheep and horse do not excrete this compound. Phenylacetyl CoA and glutamine react to form phenylacetyl glutamine and Coenzyme A. The enzyme (Glutamine N-acetyl transferase) that catalyzes this reaction has been purified from human liver mitochondria and shown to be a distinct polypeptide species from glycine-N-acyltransferase. Phenylacetylglutamine is a major nitrogenous metabolite that accumulates in uremia. (PMID: 2791363; PMID: 8972626). It has been shown that over 50% of urine phenylacetylglutamine may be derived from kidney conjugation of free plasma phenylacetic acid and/or from the kidney's preferential filtration of conjugated phenylacetic acid (PMID: 6420430). In enzymology, a glutamine N-phenylacetyltransferase (EC 2.3.1.14) is an enzyme that catalyzes the chemical reaction. phenylacetyl-CoA + L-glutamine CoA + alpha-N-phenylacetyl-L-glutamine. Thus, the two substrates of this enzyme are phenylacetyl-CoA and L-glutamine, whereas its two products are CoA and alpha-N-phenylacetyl-L-glutamine.(Wikipedia).",Alpha-N-Phenylacetyl-L-glutamine,HMDB0006344,b,b,C04148,CPD-1097,FDB023896,pheacgln,[H]OC(=O)[C@@]([H])(N([H])C(=O)C([H])([H])C1=C([H])C([H])=C([H])C([H])=C1[H])C([H])([H])C([H])([H])C(=O)N([H])[H],JFLIEFSWGNOPJJ-JTQLQIEISA-N,"InChI=1S/C13H16N2O4/c14-11(16)7-6-10(13(18)19)15-12(17)8-9-4-2-1-3-5-9/h1-5,10H,6-8H2,(H2,14,16)(H,15,17)(H,18,19)/t10-/m0/s1"
1131,32516,N(pros)-L-histidino group,a,22440,KEGG COMPOUND accession,C04026,,,,,,,,,,,,,,,
1132,32517,N(tele)-L-histidino group,a,10319,KEGG COMPOUND accession,C11714,M00538,90-15-3,10319.0,"Human Metabolome Database (HMDB): 1-naphthol (1N) is a metabolite of carbaryl and naphthalene that is an intermediate in Metabolism of xenobiotics by cytochrome P450. It is generated by spontaneous reaction from (1R,2S)-Naphthalene epoxide then is it converted to 1,4-Dihydroxynaphthalene. Although 1-Naphthol is not persistent in the body, a single urine sample may adequately predict exposure over several months to chlorpyrifos, which is a broad-spectrum organophosphate insecticide. In adult men, TCPY and 1N were associated with reduced testosterone levels (PMID: 16357596, 15579421).",1-Naphthol,HMDB0012138,b,b,C11714,b,FDB005841,b,[H]OC1=C([H])C([H])=C([H])C2=C([H])C([H])=C([H])C([H])=C12,KJCVRFUGPWSIIH-UHFFFAOYSA-N,"InChI=1S/C10H8O/c11-10-7-3-5-8-4-1-2-6-9(8)10/h1-7,11H"
1133,32525,trehalosamine,a,18280,KEGG COMPOUND accession,C02137,,,,,,,,,,,,,,,
1134,33470,heteroaryl group,A heterocyclyl group derived from a heteroarene by removal of a hydrogen atom from any ring atom.,29167,KEGG COMPOUND accession,C01639,M03067,b,b,b,TRNA(Cys),b,b,b,C01639,b,b,b,b,b,b
1135,33472,diphosphorus,a,29168,KEGG COMPOUND accession,C01640,M03068,b,b,b,TRNA(Gln),b,b,b,C01640,b,b,b,b,b,b
1136,33475,diatomic phosphorus,a,29175,KEGG COMPOUND accession,C01641,M03069,b,b,b,TRNA(Glu),b,b,b,C01641,b,b,b,b,b,b
1137,33477,vinylic group,The vinyl or ethenyl group (CH2=CH-) and derivatives formed by substitution.,29176,KEGG COMPOUND accession,C01642,M03070,b,b,b,TRNA(Gly),b,b,b,C01642,b,b,b,b,b,b
1138,33480,diphosphide(.1-),a,29178,KEGG COMPOUND accession,C01643,M03071,b,b,b,TRNA(His),b,b,b,C01643,b,b,b,b,b,b
1139,33482,sulfur oxoanion,a,29174,KEGG COMPOUND accession,C01644,M03072,b,b,b,TRNA(Ile),b,b,b,C01644,b,b,b,b,b,b
1140,33484,chalcogen oxoacid,a,29169,KEGG COMPOUND accession,C01645,M03073,b,b,b,TRNA(Leu),b,b,b,C01645,b,b,b,b,b,b
1141,33486,dithionate(1-),a,29185,KEGG COMPOUND accession,C01646,M03074,b,b,b,TRNA(Lys),b,b,b,C01646,b,b,b,b,b,b
1142,33488,selenium oxoanion,a,29173,KEGG COMPOUND accession,C01647,M03075,b,b,b,TRNA(Met),b,b,b,C01647,b,b,b,b,b,b
1143,33490,hydrogenselenate,a,29184,KEGG COMPOUND accession,C01648,M03076,b,b,b,TRNA(Phe),b,b,b,C01648,b,b,b,b,b,b
1144,33492,radon-222 atom,a,29177,KEGG COMPOUND accession,C01649,M03077,b,b,b,TRNA(Pro),b,b,b,C01649,b,b,b,b,b,b
1145,32529,histidinate(1-),a,10324,KEGG COMPOUND accession,C10729,,,,,,,,,,,,,,,
1146,32532,histidinium(2+),a,36740,KEGG COMPOUND accession,C09880,appnn,7785-70-8,36740.0,"Human Metabolome Database (HMDB): &#945;-Pinene is an organic compound of the terpene class, one of two isomers of pinene. It is an alkene and it contains a reactive four-membered ring. It is found in the oils of many species of many coniferous trees, notably the pine. It is also found in the essential oil of rosemary (Rosmarinus officinalis). Both enantiomers are known in nature; 1S,5S- or (&#8722;)-&#945;-pinene is more common in European pines, whereas the 1R,5R- or (+)-&#945;-isomer is more common in North America. The racemic mixture is present in some oils such as eucalyptus oil. The four-membered ring in &#945;-pinene 1 makes it a reactive hydrocarbon, prone to skeletal rearrangements such as the Wagner-Meerwein rearrangement. For example, attempts to perform hydration or hydrogen halide addition with the alkene functionality typically lead to rearranged products. of under acidic conditions. With concentrated sulfuric acid and ethanol the major products are terpineol 2 and its ethyl ether 3, while glacial acetic acid gives the corresponding acetate ester 4. With dilute acids, terpin hydrate 5 becomes the major product. With one molar equivalent of anhydrous HCl, the simple addition product 6a can be formed at low temperature in the presence of ether, but it is very unstable. At normal temperatures, or if no ether is present, the major product is bornyl chloride 6b, along with a small amount of fenchyl chloride 6c. For many years 6b (also called ""artificial camphor"") was referred to as ""pinene hydrochloride"", until it was confirmed as identical with bornyl chloride made from camphene. If more HCl is used, achiral 7 (dipentene hydrochloride) is the major product along with some 6b. Nitrosyl chloride followed by base leads to the oxime 8 which can be reduced to ""pinylamine"" 9. Both 8 and 9 are stable compounds containing an intact four-membered ring, and these compounds helped greatly in identifying this important component of the pinene skeleton. (Wikipedia).",(+)-a-Pinene,HMDB0006525,b,b,C09880,CPD-8754,FDB013765,appnn,[H]C1=C(C([H])([H])[H])C2([H])C([H])([H])C([H])(C1([H])[H])C2(C([H])([H])[H])C([H])([H])[H],GRWFGVWFFZKLTI-UHFFFAOYSA-N,"InChI=1S/C10H16/c1-7-4-5-8-6-9(7)10(8,2)3/h4,8-9H,5-6H2,1-3H3"
1147,32534,N(tele)-histidino group,a,29060,KEGG COMPOUND accession,C02759,apnnox,1686-14-2,29060.0,"Human Metabolome Database (HMDB): Alpha-pinene oxide is cheap monoterpene, which is important compound for the fragnance industry. Biocatalytic method is used to convert monoterpenes into terpenoids. The biotransformation of alpha-pinene oxide using resting cells of Pseudomonas fluorescens NCIMB 11671 produces isonovalal (cis-2-methyl-5-isopropylhexa-2,5-dienal), which is a fragrance. However, this biotransformation has technical problems including the following: alpha-pinene oxide undergoes autoxidation in water and light; it is hydrophobic and relatively toxic to the biocatalyst; and it suffers from product inhibition. the influence of other terpene byproducts on the flux of alpha-pinene oxide was investigated and found to decrease the flux into the organic phase by up to 10%. (PMID: 16321051).",Alpha-Pinene-oxide,HMDB0003667,b,b,C02759,ALPHA-PINENE-OXIDE,FDB023213,apnnox,[H]C([H])([H])C12OC1([H])C([H])([H])C1([H])C([H])([H])C2([H])C1(C([H])([H])[H])C([H])([H])[H],NQFUSWIGRKFAHK-UHFFFAOYSA-N,"InChI=1S/C10H16O/c1-9(2)6-4-7(9)10(3)8(5-6)11-10/h6-8H,4-5H2,1-3H3"
1148,32539,daunosamine,a,10329,KEGG COMPOUND accession,C05775,,,,,,,,,,,,,,,
1149,30504,hydridoberyllium,a,9603,KEGG COMPOUND accession,C09201,,,,,,,,,,,,,,,
1150,30506,hydridoberyllate(1-),a,9604,KEGG COMPOUND accession,C08082,,,,,,,,,,,,,,,
1151,30508,hexacarbonylmolybdenum,a,9605,KEGG COMPOUND accession,C07965,,,,,,,,,,,,,,,
1152,30540,stannyl group,a,48549,KEGG COMPOUND accession,C01621,,,,,,,,,,,,,,,
1153,30542,germyl group,a,9622,KEGG COMPOUND accession,C07750,,,,,,,,,,,,,,,
1154,30547,germanetetrayl group,a,17578,KEGG COMPOUND accession,C01455,,,,,,,,,,,,,,,
1155,30552,germanide,a,27849,KEGG COMPOUND accession,C06677,,,,,,,,,,,,,,,
1156,30554,germanediyl group,a,15565,KEGG COMPOUND accession,C04592,,,,,,,,,,,,,,,
1157,30559,stannyl,a,27982,KEGG COMPOUND accession,C02596,,,,,,,,,,,,,,,
1158,30561,silanide,a,9629,KEGG COMPOUND accession,C10826,,,,,,,,,,,,,,,
1159,30563,silicon dioxide,A silicon oxide made up of linear triatomic molecules in which a silicon atom is covalently bonded to two oxygens.,9630,KEGG COMPOUND accession,C10827,,,,,,,,,,,,,,,
1160,30604,disulfanide,a,9652,KEGG COMPOUND accession,C07155,,,,,,,,,,,,,,,
1161,30608,pentasulfanyl group,a,9654,KEGG COMPOUND accession,C07156,,,,,,,,,,,,,,,
1162,33302,pnictogen molecular entity,A p-block molecular entity containing any pnictogen.,46442,KEGG COMPOUND accession,C11627,,,,,,,,,,,,,,,
1163,33306,carbon group element atom,a,28235,KEGG COMPOUND accession,C10761,,,,,,,,,,,,,,,
1164,33530,altronate,a,10702,KEGG COMPOUND accession,C04221,,,,,,,,,,,,,,,
1165,33535,sulfur hydride,a,50998,KEGG COMPOUND accession,C00658,,,,,,,,,,,,,,,
1166,31498,dimethicone macromolecule,"A polydimethylsiloxane macromolecule, composed of dimethylsiloxane repeating units.",17568,KEGG COMPOUND accession,C00106,ura,66-22-8,17568.0,"Human Metabolome Database (HMDB): Uracil is a common naturally occurring pyrimidine found in RNA, it base pairs with adenine and is replaced by thymine in DNA. Methylation of uracil produces thymine. Uracil's use in the body is to help carry out the synthesis of many enzymes necessary for cell function through bonding with riboses and phosphates. Uracil serves as allosteric regulator and coenzyme for many important biochemical reactions. UDP and UTP regulate CPSase II activity in animals. UDP-glucose regulates the conversion of glucose to galactose in the liver and other tissues in the process of carbohydrate metabolism. Uracil is also involved in the biosynthesis of polysaccharides and the transportation of sugars containing aldehydes. Uracil is found to be associated with argininemia and carbamoyl phosphate synthetase deficiency, which are inborn errors of metabolism.",Uracil,HMDB0000300,b,b,C00106,URACIL,FDB006426,ura,[H]N1C([H])=C([H])C(=O)N([H])C1=O,ISAKRJDGNUQOIC-UHFFFAOYSA-N,"InChI=1S/C4H4N2O2/c7-3-1-2-5-4(8)6-3/h1-2H,(H2,5,6,7,8)"
1167,32586,sodium sulfate decahydrate,a,28825,KEGG COMPOUND accession,C08263,,,,,,,,,,,,,,,
1168,32588,potassium chloride,A metal chloride salt with a K(+) counterion.,15337,KEGG COMPOUND accession,C02207,,,,,,,,,,,,,,,
1169,31772,levobupivacaine hydrochloride (anhydrous),The monohydrochloride salt of levobupivacaine.,28509,KEGG COMPOUND accession,C06793,,,,,,,,,,,,,,,
1170,33396,nobelium,a,16890,KEGG COMPOUND accession,C03189,,,,,,,,,,,,,,,
1171,33398,platinum(3+),a,10650,KEGG COMPOUND accession,C07319,,,,,,,,,,,,,,,
1172,33400,platinum(0),a,16554,KEGG COMPOUND accession,C06366,,,,,,,,,,,,,,,
1173,33403,elemental sulfur,a,17843,KEGG COMPOUND accession,C00066,M03083,b,17843.0,b,TRNA,b,b,b,C00066,b,b,b,[H]OC([H])([H])[C@@]1([H])O[C@@]([H])([*])[C@]([H])(O[H])[C@]1([H])OP(=O)(O[H])OC([H])([H])[C@@]1([H])O[C@@]([H])([*])[C@]([H])(O[H])[C@]1([H])OP(=O)(O[H])OC([H])([H])[C@@]1([H])O[C@@]([H])([*])[C@]([H])(O[H])[C@]1([H])O[H],b,b
1174,33588,boron hydride,a,16279,KEGG COMPOUND accession,C04164,,,,,,,,,,,,,,,
1175,33591,pentaborane(9),a,16931,KEGG COMPOUND accession,C03739,,,,,,,,,,,,,,,
1176,33594,dodecahydro-closo-dodecaborate(2-),a,10723,KEGG COMPOUND accession,C05275,dc2coa,10018-95-8,10723.0,"Human Metabolome Database (HMDB): (2E)-Decenoyl-CoA is a beta-oxidation intermediate, the substrate of the enzyme peroxisomal acyl-CoA thioesterase 2 (PTE-2, 3.1.2.2), which is localized in the peroxisome. The peroxisomal beta-oxidation system contains two sets of enzymes, one of which is involved in the oxidation of branched chain fatty acids and intermediates in the hepatic bile acid biosynthetic pathway and consists of one or two branched-chain acyl-CoA oxidase(s), a D-specific bifunctional protein and the sterol carrier-like protein x (SCPx). Peroxisomes are cellular organelles present in all eukaryotic cells. They play an indispensable role in the metabolism of a variety of lipids including very long-chain fatty acids, dicarboxylic fatty acids, bile acids, prostaglandins, leukotrienes, thromboxanes, pristanic acid, and xenobiotic fatty acids. (PMID: 11673457).",(2E)-Decenoyl-CoA,HMDB0003948,b,b,C05275,T2-DECENOYL-COA,FDB023267,dc2coa,[H]O[C@@]([H])(C(=O)N([H])C([H])([H])C([H])([H])C(=O)N([H])C([H])([H])C([H])([H])SC(=O)C(\[H])=C(/[H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H])C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])OP([O-])(=O)OP([O-])(=O)OC([H])([H])[C@@]1([H])O[C@@]([H])(N2C([H])=NC3=C(N=C([H])N=C23)N([H])[H])[C@]([H])(O[H])[C@]1([H])OP([O-])([O-])=O,MGNBGCRQQFMNBM-YJHHLLFWSA-J,"InChI=1S/C31H52N7O17P3S/c1-4-5-6-7-8-9-10-11-22(40)59-15-14-33-21(39)12-13-34-29(43)26(42)31(2,3)17-52-58(49,50)55-57(47,48)51-16-20-25(54-56(44,45)46)24(41)30(53-20)38-19-37-23-27(32)35-18-36-28(23)38/h10-11,18-20,24-26,30,41-42H,4-9,12-17H2,1-3H3,(H,33,39)(H,34,43)(H,47,48)(H,49,50)(H2,32,35,36)(H2,44,45,46)/p-4/b11-10+/t20-,24-,25-,26+,30-/m1/s1"
1177,31593,fasudil hydrochloride,A hydrochloride obtained by reaction of fasudil with one equivalent of hydrochloric acid.,15437,KEGG COMPOUND accession,C01051,uppg3,1976-85-8,15437.0,"Human Metabolome Database (HMDB): Uroporphyrinogens are porphyrinogen variants in which each pyrrole ring has one acetate side chain and one propionate side chain; it is formed by condensation 4 four molecules of porphobilinogen. 4 isomers are possible but only 2 commoly are found, types I and III. Uroporphyrinogen III is a functional intermediate in heme biosynthesis while Uroporphyrinogen I is produced in an abortive side reaction.",Uroporphyrinogen III,HMDB0001086,b,b,C01051,UROPORPHYRINOGEN-III,FDB022417,uppg3,[H]N1C2=C(C(=C1C([H])([H])C1=C(C(=C(N1[H])C([H])([H])C1=C(C(=C(N1[H])C([H])([H])C1=C(C(=C(N1[H])C2([H])[H])C([H])([H])C([O-])=O)C([H])([H])C([H])([H])C([O-])=O)C([H])([H])C([H])([H])C([O-])=O)C([H])([H])C([O-])=O)C([H])([H])C([H])([H])C([O-])=O)C([H])([H])C([O-])=O)C([H])([H])C([H])([H])C([O-])=O)C([H])([H])C([O-])=O,HUHWZXWWOFSFKF-UHFFFAOYSA-F,"InChI=1S/C40H44N4O16/c45-33(46)5-1-17-21(9-37(53)54)29-14-27-19(3-7-35(49)50)22(10-38(55)56)30(43-27)15-28-20(4-8-36(51)52)24(12-40(59)60)32(44-28)16-31-23(11-39(57)58)18(2-6-34(47)48)26(42-31)13-25(17)41-29/h41-44H,1-16H2,(H,45,46)(H,47,48)(H,49,50)(H,51,52)(H,53,54)(H,55,56)(H,57,58)(H,59,60)/p-8"
1178,32638,D-methioninium,The D-enantiomer of methioninium.,10366,KEGG COMPOUND accession,C08234,,,,,,,,,,,,,,,
1179,32640,D-methionyl group,a,27672,KEGG COMPOUND accession,C08346,,,,,,,,,,,,,,,
1180,33554,organosulfonate oxoanion,An organic anion obtained by deprotonation of the sufonate group(s) of any organosulfonic acid.,28960,KEGG COMPOUND accession,C06611,,,,,,,,,,,,,,,
1181,33558,alpha-amino-acid anion,An amino-acid anion obtained by deprotonation of any alpha-amino acid.,27700,KEGG COMPOUND accession,C05067,,,,,,,,,,,,,,,
1182,33560,p-block element atom,Any main group element atom belonging to the p-block of the periodic table.,18095,KEGG COMPOUND accession,C01157,4hpro_LT,51-35-4,18095.0,"Human Metabolome Database (HMDB): 4-Hydroxyproline (hydroxyproline or Hyp) is a major component of the protein collagen. Hydroxyproline is produced by hydroxylation of the amino acid proline and is, therefore, a post-translationally modified amino acid. Hydroxyproline and proline play key roles for collagen stability. In particular, they permit the sharp twisting of the collagen helix. Hydroxyproline is found in few proteins other than collagen. The only other mammalian protein which includes hydroxyproline is elastin. For this reason, hydroxyproline content has been used as an indicator to determine collagen and/or gelatin amount in tissue or biological samples. Increased serum and urine levels of hydroxyproline have been found in Paget's disease (PMID: 436278). Hydroxyproline (Hyp) content in biological fluids is used as a parameter of collagen catabolism, especially bone resorption or tissue degradation. Bedridden and elderly individuals show significantly elevated serum levels of hydroxyproline in comparison to normal, active individuals (PMID: 10706420). Elevated levels of urinary hydroxyproline are also indicative of muscle damage (PMID: 21988268). Increased reactive oxygen species (ROS) are also known to accelerate collagen degradation. Hydroxyproline levels increase in cases of depression and stress (PMID: 21483218). 4-Hydroxyproline is found to be associated with Alzheimer's disease, and also hydroxyprolinemia and iminoglycinuria which are both inborn errors of metabolism. 4-Hydroxyproline is also involved in metabolic disorders such as hyperprolinemia type I, hyperornithinemia with gyrate atrophy (HOGA), L-arginine:glycine amidinotransferase deficiency, creatine deficiency, and guanidinoacetate methyltransferase deficiency. A deficiency in ascorbic acid can result in impaired hydroxyproline formation (PubChem). trans-4-Hydroxy-L-proline is a biomarker for the consumption of processed meat.",4-Hydroxyproline,HMDB0000725,b,b,C01157,L-4-HYDROXY-PROLINE,FDB013511,4hpro_LT,[H]O[C@@]1([H])C([H])([H])[N+]([H])([H])[C@]([H])(C([O-])=O)C1([H])[H],PMMYEEVYMWASQN-DMTCNVIQSA-N,"InChI=1S/C5H9NO3/c7-3-1-4(5(8)9)6-2-3/h3-4,6-7H,1-2H2,(H,8,9)/t3-,4+/m1/s1"
1183,30799,dioxosuccinic acid,a,47923,KEGG COMPOUND accession,C00316,,,,,,,,,,,,,,,
1184,30802,isophthalic acid,"A benzenedicarboxylic acid that is benzene substituted by carboxy groups at position 1 and 3. One of three possible isomers of benzenedicarboxylic acid, the others being phthalic and terephthalic acids.",18036,KEGG COMPOUND accession,C00536,pppi,14127-68-5,18036.0,"Human Metabolome Database (HMDB): Triphosphate is a triphosphate is salt or ester containing three phosphate groups. It is the ionic form of triphosphoric acid, a condensed form of phosphoric acid. Triphosphate is an intermediate in the biosynthesis of Folate, the metabolism of Purine, the metabolism of Porphyrin and chlorophyll, the metabolism of Pyrimidine and the metabolism of Thiamine. It is a substrate for Transforming protein p21/H-Ras-1, Bis(5'-adenosyl)-triphosphatase, Ectonucleoside triphosphate diphosphohydrolase 5, Ectonucleoside triphosphate diphosphohydrolase 2, DNA polymerase gamma subunit 1, DNA nucleotidylexotransferase, Inosine triphosphate pyrophosphatase, Cob(I)yrinic acid a,c-diamide adenosyltransferase (mitochondrial), Ectonucleoside triphosphate diphosphohydrolase 1, Ectonucleoside triphosphate diphosphohydrolase 3, Hypothetical protein FLJ13970, Deoxyuridine 5'-triphosphate nucleotidohydrolase (mitochondrial), Thiamine-triphosphatase, DNA-directed RNA polymerase III 32 kDa polypeptide, Ectonucleoside triphosphate diphosphohydrolase 4, 6-pyruvoyl tetrahydrobiopterin synthase and Ectonucleoside triphosphate diphosphohydrolase 6.",Triphosphate,HMDB0003379,b,b,C00536,b,FDB023159,pppi,[H]OP([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O,UNXRWKVEANCORM-UHFFFAOYSA-J,"InChI=1S/H5O10P3/c1-11(2,3)9-13(7,8)10-12(4,5)6/h(H,7,8)(H2,1,2,3)(H2,4,5,6)/p-4"
1185,33457,phosphorus oxoacid,"A pnictogen oxoacid which contains phosphorus and oxygen, at least one hydrogen atom bound to oxygen, and forms an ion by the loss of one or more protons.",29170,KEGG COMPOUND accession,C01635,M03063,b,b,b,TRNA(Ala),b,b,b,C01635,b,b,b,b,b,b
1186,33459,pnictogen oxoanion,a,29171,KEGG COMPOUND accession,C01636,M03064,b,b,b,TRNA(Arg),b,b,b,C01636,b,b,b,b,b,b
1187,33461,phosphorus oxoanion,a,29172,KEGG COMPOUND accession,C01637,M03065,b,b,b,TRNA(Asn),b,b,b,C01637,b,b,b,b,b,b
1188,30684,alpha-D-glucosyl group,The glycosyl group formed from alpha-D-glucopyranose.,15861,KEGG COMPOUND accession,C01860,,,,,,,,,,,,,,,
1189,30687,osmium atom,a,9690,KEGG COMPOUND accession,C08298,,,,,,,,,,,,,,,
1190,33630,diatomic aluminium,a,28935,KEGG COMPOUND accession,C05272,hdd2coa,4460-95-1,61526.0,"Human Metabolome Database (HMDB): (2E)-Hexadecenoyl-CoA is an intermediate in fatty acid metabolism, the substrate of the enzyme enoyl-CoA hydratase [EC:4.2.1.17]; (2E)-Hexadecenoyl-CoA is also the substrate of the enzyme trans-2-enoyl-CoA reductase [EC:1.3.1.38], in the fatty acid elongation pathway in mitochondria. (PMID: 1278159, KEGG).",(2E)-Hexadecenoyl-CoA,HMDB0003945,b,b,C05272,b,FDB023264,hdd2coa,[H]O[C@@]([H])(C(=O)N([H])C([H])([H])C([H])([H])C(=O)N([H])C([H])([H])C([H])([H])SC(=O)C(\[H])=C(/[H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H])C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])OP([O-])(=O)OP([O-])(=O)OC([H])([H])[C@@]1([H])O[C@@]([H])(N2C([H])=NC3=C(N=C([H])N=C23)N([H])[H])[C@]([H])(O[H])[C@]1([H])OP([O-])([O-])=O,JUPAQFRKPHPXLD-JSJBGSCHSA-J,"InChI=1S/C37H64N7O17P3S/c1-4-5-6-7-8-9-10-11-12-13-14-15-16-17-28(46)65-21-20-39-27(45)18-19-40-35(49)32(48)37(2,3)23-58-64(55,56)61-63(53,54)57-22-26-31(60-62(50,51)52)30(47)36(59-26)44-25-43-29-33(38)41-24-42-34(29)44/h16-17,24-26,30-32,36,47-48H,4-15,18-23H2,1-3H3,(H,39,45)(H,40,49)(H,53,54)(H,55,56)(H2,38,41,42)(H2,50,51,52)/p-4/b17-16+/t26-,30-,31-,32+,36-/m0/s1"
1191,31776,lisuride maleate,a,9992,KEGG COMPOUND accession,C10196,,,,,,,,,,,,,,,
1192,31786,loxoprofen sodium hydrate,"A hydrate that is the dihydrate form of loxoprofen sodium. The parent acid, loxoprofen, is a prodrug that is rapidly converted into its active trans-alcohol metabolite following oral administration.",9997,KEGG COMPOUND accession,C11299,,,,,,,,,,,,,,,
1193,31823,mercury dichloride,"A mercury coordination entity made up of linear triatomic molecules in which a mercury atom is bonded to two chlorines. Water-soluble, it is highly toxic. Once used in a wide variety of applications, including preserving wood and anatomical specimens, embalming and disinfecting, as an intensifier in photography, as a mordant for rabbit and beaver furs, and freeing gold from lead, its use has markedly declined as less toxic alternatives have been developed.",10015,KEGG COMPOUND accession,C09253,,,,,,,,,,,,,,,
1194,32790,tyrosinate residue,a,10418,KEGG COMPOUND accession,C09666,,,,,,,,,,,,,,,
1195,31672,hydralazine hydrochloride,The hydrochloride salt of hydralazine; a direct-acting vasodilator that is used as an antihypertensive agent.,9943,KEGG COMPOUND accession,C07187,,,,,,,,,,,,,,,
1196,32692,4-(N-nitrosomethylamino)-1-(3-pyridyl)butan-1-one,a,17723,KEGG COMPOUND accession,C04889,,,,,,,,,,,,,,,
1197,31923,novobiocic acid,A hydroxycoumarin that is the aglycone of novobiocin.,16550,KEGG COMPOUND accession,C01969,,,,,,,,,,,,,,,
1198,33494,nucleosidyl group,A nucleosidyl group is a group formed by loss of OH from a nucleoside molecule.,29179,KEGG COMPOUND accession,C01650,M03078,b,b,b,TRNA(Ser),b,b,b,C01650,b,b,b,b,b,b
1199,33496,rubidide,a,29180,KEGG COMPOUND accession,C01651,M03079,b,b,b,TRNA(Thr),b,b,b,C01651,b,b,b,b,b,b
1200,33498,actinoid molecular entity,a,29181,KEGG COMPOUND accession,C01652,M03080,b,b,b,TRNA(Trp),b,b,b,C01652,b,b,b,b,b,b
1201,33500,uranium cation,a,29182,KEGG COMPOUND accession,C00787,M03081,b,b,b,TRNA(Tyr),b,b,b,C00787,b,b,b,b,b,b
1202,33505,adenosyl group,"An adenosyl group is a group formed by loss of a 2'-, 3'- or 5'-hydroxy group from the ribose moiety of adenosine.",29183,KEGG COMPOUND accession,C01653,M03082,b,b,b,TRNA(Val),b,b,b,C01653,b,b,b,b,b,b
1203,33512,5'-inosinylyl group,a,28387,KEGG COMPOUND accession,C05279,C05279,b,b,"Human Metabolome Database (HMDB): trans,cis-Lauro-2,6-dienoyl-CoA participates in fatty acid metabolism. trans,cis-Lauro-2,6-dienoyl-CoA is converted from cis,cis-3,6-Dodecadienoyl-CoA via dodecenoyl-CoA delta-isomerase [EC:5.3.3.8] and vice-versa. Fatty acid degradation is the process in which fatty acids are broken down, resulting in release of energy. It includes three major steps:Activation and transport into mitochondria, &#946;-oxidation and Electron transport chain. Fatty acids are transported across the outer mitochondrial membrane by carnitine-palmitoyl transferase I (CPT-I), and then couriered across the inner mitochondrial membrane by carnitine[1]. Once inside the mitochondrial matrix, fatty acyl-carnitine reacts with coenzyme A to release the fatty acid and produce acetyl-CoA. CPT-I is believed to be the rate limiting step in fatty acid oxidation. Once inside the mitochondrial matrix, fatty acids undergo &#946;-oxidation. During this process, two-carbon molecules acetyl-CoA are repeatedly cleaved from the fatty acid. Acetyl-CoA can then enter the TCA cycle, which produces NADH and FADH. NADH and FADH are subsequently used in the electron transport chain to produce ATP, the energy currency of the cell. (Wikipedia).","trans,cis-Lauro-2,6-dienoyl-CoA",HMDB0011123,b,b,C05279,b,FDB027905,C05279,[H]O[C@@]([H])(C(=O)N([H])C([H])([H])C([H])([H])C(=O)N([H])C([H])([H])C([H])([H])SC(=O)C(\[H])=C(/[H])C([H])([H])C([H])([H])C(\[H])=C(\[H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H])C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])OP([O-])(=O)OP([O-])(=O)OC([H])([H])[C@@]1([H])O[C@@]([H])(N2C([H])=NC3=C(N=C([H])N=C23)N([H])[H])[C@]([H])(O[H])[C@]1([H])OP([O-])([O-])=O,BNPQDIKRZDRREL-GQUYLXGASA-J,"InChI=1S/C33H54N7O17P3S/c1-4-5-6-7-8-9-10-11-12-13-24(42)61-17-16-35-23(41)14-15-36-31(45)28(44)33(2,3)19-54-60(51,52)57-59(49,50)53-18-22-27(56-58(46,47)48)26(43)32(55-22)40-21-39-25-29(34)37-20-38-30(25)40/h8-9,12-13,20-22,26-28,32,43-44H,4-7,10-11,14-19H2,1-3H3,(H,35,41)(H,36,45)(H,49,50)(H,51,52)(H2,34,37,38)(H2,46,47,48)/p-4/b9-8-,13-12+/t22-,26-,27-,28+,32-/m1/s1"
1204,33660,inorganic aromatic compound,a,27721,KEGG COMPOUND accession,C05273,HC01412,b,27721.0,b,(2E)-Tetradecenoyl Coenzyme A,b,b,b,C05273,b,b,HC01412,[H]O[C@@]([H])(C(=O)N([H])C([H])([H])C([H])([H])C(=O)N([H])C([H])([H])C([H])([H])SC(=O)C(\[H])=C(/[H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H])C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])OP([O-])(=O)OP([O-])(=O)OC([H])([H])[C@@]1([H])O[C@@]([H])(N2C([H])=NC3=C(N=C([H])N=C23)N([H])[H])[C@]([H])(O[H])[C@]1([H])OP([O-])([O-])=O,MBCVYCOKMMMWLX-YYMFEJJQSA-J,"InChI=1S/C35H60N7O17P3S/c1-4-5-6-7-8-9-10-11-12-13-14-15-26(44)63-19-18-37-25(43)16-17-38-33(47)30(46)35(2,3)21-56-62(53,54)59-61(51,52)55-20-24-29(58-60(48,49)50)28(45)34(57-24)42-23-41-27-31(36)39-22-40-32(27)42/h14-15,22-24,28-30,34,45-46H,4-13,16-21H2,1-3H3,(H,37,43)(H,38,47)(H,51,52)(H,53,54)(H2,36,39,40)(H2,48,49,50)/p-4/b15-14+/t24-,28-,29-,30+,34-/m1/s1"
1205,33660,inorganic aromatic compound,a,27721,KEGG COMPOUND accession,C05273,tetdece1coa,38795-33-4,27721.0,"Human Metabolome Database (HMDB): (2E)-Tetradecenoyl-CoA is an intermediate in fatty acid metabolism, the substrate of the enzymes acyl-CoA oxidase and Oxidoreductases [EC 1.3.3.6-1.3.99.-] and enzymes acyl-CoA dehydrogenase, long-chain-acyl-CoA dehydrogenase [EC 1.3.99.3-1.3.99.13]; (2E)-Tetradecenoyl-CoA is an intermediate in fatty acid elongation in mitochondria, being the substrate of the enzyme trans-2-enoyl-CoA reductase (NADPH) [EC 1.3.1.38]. (KEGG).",(2E)-Tetradecenoyl-CoA,HMDB0003946,b,b,C05273,b,FDB023265,tetdece1coa,[H]OC([H])(C(=O)N([H])C([H])([H])C([H])([H])C(=O)N([H])C([H])([H])C([H])([H])SC(=O)C(\[H])=C(/[H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H])C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])OP(=O)(O[H])OP(=O)(O[H])OC([H])([H])[C@@]1([H])O[C@@]([H])(N2C([H])=NC3=C2N=C([H])N=C3N([H])[H])[C@]([H])(O[H])[C@]1([H])OP(=O)(O[H])O[H],MBCVYCOKMMMWLX-IKUURZALSA-N,"InChI=1S/C35H60N7O17P3S/c1-4-5-6-7-8-9-10-11-12-13-14-15-26(44)63-19-18-37-25(43)16-17-38-33(47)30(46)35(2,3)21-56-62(53,54)59-61(51,52)55-20-24-29(58-60(48,49)50)28(45)34(57-24)42-23-41-27-31(36)39-22-40-32(27)42/h14-15,22-24,28-30,34,45-46H,4-13,16-21H2,1-3H3,(H,37,43)(H,38,47)(H,51,52)(H,53,54)(H2,36,39,40)(H2,48,49,50)/b15-14+/t24-,28-,29-,30?,34-/m1/s1"
1206,33672,heterobicyclic compound,A bicyclic compound in which at least one of the rings contains at least one skeletal heteroatom.,17531,KEGG COMPOUND accession,C05158,,,,,,,,,,,,,,,
1207,33674,s-block molecular entity,An s-block molecular entity is a molecular entity containing one or more atoms of an s-block element.,28068,KEGG COMPOUND accession,C05430,,,,,,,,,,,,,,,
1208,31899,nemonapride,"A racemate composed of (2S,3S)- and (2R,3R)-enantiomers of nemonapride. Highly potent dopamine D2-like receptor antagonist; selective over D1-like receptors (Ki values are 0.1 and 740 nM for D2-like and D1-like receptors respectively). Also potent 5-HT1A receptor agonist (IC50 = 34 nM) and has affinity for sigma receptors.",10056,KEGG COMPOUND accession,C11767,,,,,,,,,,,,,,,
1209,32840,D-serinate,The D-enantiomer of serinate.,10447,KEGG COMPOUND accession,C09904,,,,,,,,,,,,,,,
1210,32995,uranium(4+),a,16497,KEGG COMPOUND accession,C00286,dgtp,2564-35-4,16497.0,"Human Metabolome Database (HMDB): Under normal physiologic conditions, deoxyguanosine (dGuo) undergoes phosphorolysis by purine nucleoside phosphorylase (PNP, EC 2.4.2.1, an enzyme involved in the recycling of nucleosides and deoxynucleosides in cellular remodeling). However, when PNP is inhibited, deoxycytidine kinase (dCK, EC 2.7.1.74) shunts unmetabolized dGuo into deoxyguanosine triphosphate (dGTP), which accumulates and blocks DNA synthesis. Deficiency of purine nucleoside phosphorylase results in defective T-cell immunity. A correlation between the degree of T cell inhibition and the level of dCK activity is observed. (PMID: 11287638, 402573).",dGTP,HMDB0001440,b,b,C00286,DGTP,FDB022623,dgtp,[H]O[C@@]1([H])C([H])([H])[C@@]([H])(O[C@]1([H])C([H])([H])OP([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O)N1C([H])=NC2=C1N=C(N([H])[H])N([H])C2=O,HAAZLUGHYHWQIW-KVQBGUIXSA-J,"InChI=1S/C10H16N5O13P3/c11-10-13-8-7(9(17)14-10)12-3-15(8)6-1-4(16)5(26-6)2-25-30(21,22)28-31(23,24)27-29(18,19)20/h3-6,16H,1-2H2,(H,21,22)(H,23,24)(H2,18,19,20)(H3,11,13,14,17)/p-4/t4-,5+,6+/m0/s1"
1211,33004,vanadium(2+),a,28823,KEGG COMPOUND accession,C01344,didp,26575-15-5,28823.0,Human Metabolome Database (HMDB): dIDP (deoxyinoside diphosphate) is a nucleoside. Deoxyinosine diphosphate appears in the urine of patients with purine metabolism abnormalities in purine nucleoside phosphorylase deficiency(OMIM 164050).,dIDP,HMDB0003536,b,b,C01344,b,FDB023189,didp,[H]O[C@@]1([H])C([H])([H])[C@@]([H])(O[C@]1([H])C([H])([H])OP([O-])(=O)OP([O-])([O-])=O)N1C([H])=NC2=C1N=C([H])N([H])C2=O,BKUSIKGSPSFQAC-RRKCRQDMSA-K,"InChI=1S/C10H14N4O10P2/c15-5-1-7(14-4-13-8-9(14)11-3-12-10(8)16)23-6(5)2-22-26(20,21)24-25(17,18)19/h3-7,15H,1-2H2,(H,20,21)(H,11,12,16)(H2,17,18,19)/p-3/t5-,6+,7+/m0/s1"
1212,33006,chromium(2+),a,28807,KEGG COMPOUND accession,C01345,ditp,16595-02-1,28807.0,"Human Metabolome Database (HMDB): 2'-Deoxyinosine triphosphate (dITP) is a deoxyribonucleotide that may be generated from dATP by slow, non-enzymatic hydrolysis or by reduction of ITP. Normally, the cellular dITP concentration is very low. The inability to demonstrate the synthesis of dITP in cellular preparations has been attributed to the presence in the cytoplasm of an inosine triphosphatase pyrophosphatase (ITPase, EC 3.6.1.19), an enzyme that does not permit accumulation of these nucleotides. dITP can be incorporated into DNA by polymerases. The deoxyribonucleotide dITP behaves as a dGTP analogue and is incorporated opposite cytosine with about 50% efficiency. Both isolated nuclei and purified DNA polymerases rapidly incorporated dITP into DNA. In the presence of ATP, dITP is stabilized in extracts of nuclei. dITP exist in all cells and is potentially mutagenic, and the levels of these nucleotides are controlled by ITPase. The function of this ubiquitous protein family is proposed to be the elimination of minor potentially mutagenic or clastogenic purine nucleoside triphosphates from the cell. (PMID: 11278832).",2'-Deoxyinosine triphosphate,HMDB0003537,b,b,C01345,b,FDB023190,ditp,[H]O[C@@]1([H])C([H])([H])[C@@]([H])(O[C@]1([H])C([H])([H])OP([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O)N1C([H])=NC2=C1N=C([H])N([H])C2=O,UFJPAQSLHAGEBL-RRKCRQDMSA-J,"InChI=1S/C10H15N4O13P3/c15-5-1-7(14-4-13-8-9(14)11-3-12-10(8)16)25-6(5)2-24-29(20,21)27-30(22,23)26-28(17,18)19/h3-7,15H,1-2H2,(H,20,21)(H,22,23)(H,11,12,16)(H2,17,18,19)/p-4/t5-,6+,7+/m0/s1"
1213,33009,chromium(4+),a,18075,KEGG COMPOUND accession,C00363,dtdp,491-97-4,18075.0,Human Metabolome Database (HMDB): Is an intermediate in the Thymidylate kinase (EC 2.7.4.9; ATP:dTMP phosphotransferase) catalyzes the phosphorylation of dTMP (to form dTDP) in the dTTP synthesis pathway for DNA synthesis. (OMIM 188345 ),dTDP,HMDB0001274,b,b,C00363,TDP,b,dtdp,[H]O[C@@]1([H])C([H])([H])[C@@]([H])(O[C@]1([H])C([H])([H])OP([O-])(=O)OP([O-])([O-])=O)N1C([H])=C(C(=O)N([H])C1=O)C([H])([H])[H],UJLXYODCHAELLY-XLPZGREQSA-K,"InChI=1S/C10H16N2O11P2/c1-5-3-12(10(15)11-9(5)14)8-2-6(13)7(22-8)4-21-25(19,20)23-24(16,17)18/h3,6-8,13H,2,4H2,1H3,(H,19,20)(H,11,14,15)(H2,16,17,18)/p-3/t6-,7+,8+/m0/s1"
1214,31739,josamycin,A macrolide antibiotic produced by certain strains of Streptomyces narbonensis var. josamyceticus.,16177,KEGG COMPOUND accession,C01625,,,,,,,,,,,,,,,
1215,31748,3-amino-3-deoxy-6-O-phosphono-D-glucopyranose,An amino sugar phosphate that is the 6-O-phosphate of 3-amino-3-deoxy-D-glucopyranose.,63638,KEGG COMPOUND accession,C07500,,,,,,,,,,,,,,,
1216,32016,pirfenidone,A pyridone that is 2-pyridone substituted at positions 1 and 5 by phenyl and methyl groups respectively. An anti-inflammatory drug used for the treatment of idiopathic pulmonary fibrosis.,50663,KEGG COMPOUND accession,C08095,,,,,,,,,,,,,,,
1217,32028,poly(vinyl acetate),A polymer composed of repeating acetoxyethylene units.,27547,KEGG COMPOUND accession,C06098,,,,,,,,,,,,,,,
1218,33642,cyclic olefin,The inclusive term for any cyclic hydrocarbon having any number of double bonds.,16889,KEGG COMPOUND accession,C05147,,,,,,,,,,,,,,,
1219,33645,acyclic olefin,Acyclic branched or unbranched hydrocarbons having one or more carbon-carbon double bond.,27537,KEGG COMPOUND accession,C05276,HC01415,10018-94-7,27537.0,"Human Metabolome Database (HMDB): (2E)-Octenoyl-CoA is the main metabolite produced in medium-chain acyl-CoA dehydrogenase (EC 1.3.99.3, MCAD) deficiency; however the product of the enzymatic reaction is not directly detected in several methods for screening of inborn errors of fatty acid oxidation. In order to aid the timely follow-up of screening results that suggest abnormalities in MCAD, rapid and simple confirmatory tests for the enzyme activity and/or gene mutation analysis should be available. Medium-chain fatty acyl-CoA dehydrogenase (MCAD) catalyzes the conversion of different chain length fatty acyl- CoAs into their corresponding trans-enoyl-CoA moieties via two consecutive sequences of steps. The first step involves the concerted abstraction of a proton and a hydride ion from the a- and 8-carbon chains of the fatty acyl-CoA substrates, concomitant with the reduction of the enzyme (E)-bound FAD to FADH2. The reoxidation of EFADH2, to propagate further rounds of catalysis, is accomplished via transfer of electrons to a variety of organic electron acceptors; the natural electron acceptor for this process, under physiological conditions, is the electron-transferring flavoprotein. Of the different chain length fatty acyl-CoA substrates, octanoyl-CoA/octenoyl-CoA have been known as the most efficient (and physiological) substrates for the medium-chain fatty acyl-CoA dehydrogenase (MCAD)-catalyzed reaction. (PMID: 16046200, 1390638, 8038175).",(2E)-Octenoyl-CoA,HMDB0003949,b,b,C05276,b,FDB023268,HC01415,[H]O[C@@]([H])(C(=O)N([H])C([H])([H])C([H])([H])C(=O)N([H])C([H])([H])C([H])([H])SC(=O)C(\[H])=C(/[H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H])C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])OP([O-])(=O)OP([O-])(=O)OC([H])([H])[C@@]1([H])O[C@@]([H])(N2C([H])=NC3=C(N=C([H])N=C23)N([H])[H])[C@]([H])(O[H])[C@]1([H])OP([O-])([O-])=O,CPSDNAXXKWVYIY-IKYZEIRISA-J,"InChI=1S/C29H48N7O17P3S/c1-4-5-6-7-8-9-20(38)57-13-12-31-19(37)10-11-32-27(41)24(40)29(2,3)15-50-56(47,48)53-55(45,46)49-14-18-23(52-54(42,43)44)22(39)28(51-18)36-17-35-21-25(30)33-16-34-26(21)36/h8-9,16-18,22-24,28,39-40H,4-7,10-15H2,1-3H3,(H,31,37)(H,32,41)(H,45,46)(H,47,48)(H2,30,33,34)(H2,42,43,44)/p-4/b9-8+/t18-,22-,23-,24+,28-/m0/s1"
1220,31966,pelargonidin 3-O-(6-O-caffeoyl-beta-D-glucoside) 5-O-beta-D-glucoside,a,37166,KEGG COMPOUND accession,C00707,,,,,,,,,,,,,,,
1221,31968,pelargonidin 3-O-rutinoside,An anthocyanin cation consisting of pelargonidin having a rutinosyl [6-deoxy-alpha-L-mannosyl-(1->6)-beta-D-glucosyl] residue attached at the 3-hydroxy position.,17151,KEGG COMPOUND accession,C00379,xylt,87-99-0,1305691.0,"Human Metabolome Database (HMDB): Xylitol is a five-carbon sugar alcohol that is obtained through the diet. It is not endogenously produced by humans. Xylitol is used as a diabetic sweetener which is roughly as sweet as sucrose with 33% fewer calories. Xylitol is naturally found in many fruits (strawberries, plums, raspberries) and vegetables (e.g. cauliflower). Because of fruit and vegetable consumption the human body naturally processes 15 grams of xylitol per day. Xylitol can be produced industrially starting from primary matters rich in xylan which is hydrolyzed to obtain xylose. It is extracted from hemicelluloses present in the corn raids, the almond hulls or the barks of birch (or of the by-products of wood: shavings hard, paper pulp). Of all polyols, it is the one that has the sweetest flavor (it borders that of saccharose). It gives a strong refreshing impression, making xylitol an ingredient of choice for the sugarless chewing gum industry. In addition to his use in confectionery, it is used in the pharmaceutical industry for certain mouthwashes and toothpastes and in cosmetics (creams, soaps, etc.). Xylitol is produced starting from xylose, the isomaltose, by enzymatic transposition of the saccharose (sugar). Xylitol is not metabolized by cariogenic (cavity-causing) bacteria and gum chewing stimulates the flow of saliva; as a result, chewing xylitol gum may prevent dental caries. Chewing xylitol gum for 4 to 14 days reduces the amount of dental plaque. The reduction in the amount of plaque following xylitol gum chewing within 2 weeks may be a transient phenomenon. Chewing xylitol gum for 6 months reduced mutans streptococci levels in saliva and plaque in adults (PMID: 17426399 , 15964535 ). Studies have also shown xylitol chewing gum can help prevent acute otitis media (ear aches and infections) as the act of chewing and swallowing assists with the disposal of earwax and clearing the middle ear, while the presence of xylitol prevents the growth of bacteria in the eustachian tubes. Xylitol is well established as a life-threatening toxin to dogs. The number of reported cases of xylitol toxicosis in dogs has significantly increased since the first reports in 2002. Dogs that have ingested foods containing xylitol (greater than 100 milligrams of xylitol consumed per kilogram of bodyweight) have presented with low blood sugar (hypoglycemia), which can be life-threatening. Xylitol is found to be associated with ribose-5-phosphate isomerase deficiency, which is an inborn error of metabolism.",D-Xylitol,HMDB0002917,b,b,C00379,CPD-496,FDB001134,xylt,[H]OC([H])([H])[C@]([H])(O[H])[C@@]([H])(O[H])[C@]([H])(O[H])C([H])([H])O[H],HEBKCHPVOIAQTA-SCDXWVJYSA-N,"InChI=1S/C5H12O5/c6-1-3(8)5(10)4(9)2-7/h3-10H,1-2H2/t3-,4+,5+"
1222,33052,1H-inden-1-ylidene,A carbene that is derived from 1H-indene.,17262,KEGG COMPOUND accession,C03034,,,,,,,,,,,,,,,
1223,33054,2H-indene,a,28504,KEGG COMPOUND accession,C06017,,,,,,,,,,,,,,,
1224,33055,4H-indene,a,16081,KEGG COMPOUND accession,C03442,,,,,,,,,,,,,,,
1225,33059,"benzene-1,3,5-tricarboxylate(3-)",a,15848,KEGG COMPOUND accession,C02097,M01750,5817-97-0,14086.0,Human Metabolome Database (HMDB): dTDP-D-galactose is an intermediate involved in nucleotide sugar metabolism. It can be generated by dTDP-D-glucose through the action of the enzyme UDP-glucose 4-epimerase.,dTDP-D-galactose,HMDB0006876,b,b,C02097,b,FDB024130,b,[H]OC([H])([H])[C@@]1([H])O[C@]([H])(OP(=O)(O[H])OP(=O)(O[H])OC([H])([H])[C@@]2([H])O[C@@]([H])(N3C([H])=C(C(=O)N([H])C3=O)C([H])([H])[H])C([H])([H])[C@]2([H])O[H])[C@]([H])(O[H])[C@@]([H])(O[H])[C@@]1([H])O[H],YSYKRGRSMLTJNL-OAOVJFGZSA-N,"InChI=1S/C16H26N2O16P2/c1-6-3-18(16(25)17-14(6)24)10-2-7(20)9(31-10)5-30-35(26,27)34-36(28,29)33-15-13(23)12(22)11(21)8(4-19)32-15/h3,7-13,15,19-23H,2,4-5H2,1H3,(H,26,27)(H,28,29)(H,17,24,25)/t7-,8+,9+,10+,11-,12-,13+,15+/m0/s1"
1226,33068,1H-indol-7-amine,a,17013,KEGG COMPOUND accession,C00364,dtmp,365-07-1,17013.0,"Human Metabolome Database (HMDB): 5-Thymidylic acid is a thymine nucleotide. Also known as thymidine monophosphate, and abbreviated TMP, is a nucleotide that is found in DNA. It is an ester of phosphoric acid with the nucleoside thymidine. TMP consists of a phosphate group, esterified to the the pentose sugar deoxyribose moiety, and the nucleobase thymine. In mammalian cells, thymidine deprivation induces chromosome aberrations such as chromatid breaks, chromatid interchanges, and chromosome fragmentation. (PMID 3888175).",5-Thymidylic acid,HMDB0001227,b,b,C00364,TMP,FDB022499,dtmp,[H]O[C@@]1([H])C([H])([H])[C@@]([H])(O[C@]1([H])C([H])([H])OP([O-])([O-])=O)N1C([H])=C(C(=O)N([H])C1=O)C([H])([H])[H],GYOZYWVXFNDGLU-XLPZGREQSA-L,"InChI=1S/C10H15N2O8P/c1-5-3-12(10(15)11-9(5)14)8-2-6(13)7(20-8)4-19-21(16,17)18/h3,6-8,13H,2,4H2,1H3,(H,11,14,15)(H2,16,17,18)/p-2/t6-,7+,8+/m0/s1"
1227,30626,molybdenum trichloride,a,9662,KEGG COMPOUND accession,C08463,,,,,,,,,,,,,,,
1228,30628,"1,2-phenylenebis(dimethylarsane)",a,28409,KEGG COMPOUND accession,C08392,,,,,,,,,,,,,,,
1229,30630,propylenediamine,A diamine that is propane substituted by amino groups at positions 1 and 2. Propylenediamine is commonly used as a bidentate ligand in the formation of coordination complexes.,17855,KEGG COMPOUND accession,C00422,M02956,b,17855.0,b,Tags-Chylomicron-Pool,b,b,b,C00422,b,b,M02956,[H]C([H])(OC([*])=O)C([H])(OC([*])=O)C([H])([H])OC([*])=O,b,b
1230,30630,propylenediamine,A diamine that is propane substituted by amino groups at positions 1 and 2. Propylenediamine is commonly used as a bidentate ligand in the formation of coordination complexes.,17855,KEGG COMPOUND accession,C00422,M02957,b,b,"Human Metabolome Database (HMDB): TG(16:0/16:0/18:0) is a dipalmitic acid triglyceride. Triglycerides (TGs) are also known as triacylglycerols or triacylglycerides, meaning that they are glycerides in which the glycerol is esterified with three fatty acid groups (i.e. fatty acid tri-esters of glycerol). TGs may be divided into three general types with respect to their acyl substituents. They are simple or monoacid if they contain only one type of fatty acid, diacid if they contain two types of fatty acids and triacid if three different acyl groups. Chain lengths of the fatty acids in naturally occurring triglycerides can be of varying lengths and saturations but 16, 18 and 20 carbons are the most common. TG(16:0/16:0/18:0), in particular, consists of one chain of palmitic acid at the C-1 position, one chain of palmitic acid at the C-2 position and one chain of stearic acid at the C-3 position. TGs are the main constituent of vegetable oil and animal fats. TGs are major components of very low density lipoprotein (VLDL) and chylomicrons, play an important role in metabolism as energy sources and transporters of dietary fat. They contain more than twice the energy (9 kcal/g) of carbohydrates and proteins. In the intestine, triglycerides are split into glycerol and fatty acids (this process is called lipolysis) with the help of lipases and bile secretions, which can then move into blood vessels. The triglycerides are rebuilt in the blood from their fragments and become constituents of lipoproteins, which deliver the fatty acids to and from fat cells among other functions. Various tissues can release the free fatty acids and take them up as a source of energy. Fat cells can synthesize and store triglycerides. When the body requires fatty acids as an energy source, the hormone glucagon signals the breakdown of the triglycerides by hormone-sensitive lipase to release free fatty acids. As the brain cannot utilize fatty acids as an energy source, the glycerol component of triglycerides can be converted into glucose for brain fuel when it is broken down. (www.cyberlipid.org, www.wikipedia.org)TAGs can serve as fatty acid stores in all cells, but primarily in adipocytes of adipose tissue. The major building block for the synthesis of triacylglycerides, in non-adipose tissue, is glycerol. Adipocytes lack glycerol kinase and so must use another route to TAG synthesis. Specifically, dihydroxyacetone phosphate (DHAP), which is produced during glycolysis, is the precursor for TAG synthesis in adipose tissue. DHAP can also serve as a TAG precursor in non-adipose tissues, but does so to a much lesser extent than glycerol. The use of DHAP for the TAG backbone depends on whether the synthesis of the TAGs occurs in the mitochondria and ER or the ER and the peroxisomes. The ER/mitochondria pathway requires the action of glycerol-3-phosphate dehydrogenase to convert DHAP to glycerol-3-phosphate. Glycerol-3-phosphate acyltransferase then esterifies a fatty acid to glycerol-3-phosphate thereby generating lysophosphatidic acid. The ER/peroxisome reaction pathway uses the peroxisomal enzyme DHAP acyltransferase to acylate DHAP to acyl-DHAP which is then reduced by acyl-DHAP reductase. The fatty acids that are incorporated into TAGs are activated to acyl-CoAs through the action of acyl-CoA synthetases. Two molecules of acyl-CoA are esterified to glycerol-3-phosphate to yield 1,2-diacylglycerol phosphate (also known as phosphatidic acid). The phosphate is then removed by phosphatidic acid phosphatase (PAP1), to generate 1,2-diacylglycerol. This diacylglycerol serves as the substrate for addition of the third fatty acid to make TAG. Intestinal monoacylglycerols, derived from dietary fats, can also serve as substrates for the synthesis of 1,2-diacylglycerols.",TG(16:0/16:0/18:0),HMDB0005357,b,b,C00422,Triacylglycerols,FDB023637,b,[H]C([H])(OC([*])=O)C([H])(OC([*])=O)C([H])([H])OC([*])=O,DQKMNCLZNGAXNX-DPDRHGIRSA-N,b
1231,30630,propylenediamine,A diamine that is propane substituted by amino groups at positions 1 and 2. Propylenediamine is commonly used as a bidentate ligand in the formation of coordination complexes.,17855,KEGG COMPOUND accession,C00422,M02958,b,17855.0,b,Triacylglycerol-Ld-Pool,b,b,b,C00422,b,b,b,[H]C([H])(OC([*])=O)C([H])(OC([*])=O)C([H])([H])OC([*])=O,b,b
1232,32041,pratosartan,a,10115,KEGG COMPOUND accession,C09750,,,,,,,,,,,,,,,
1233,32049,premithramycin A3',A tetracenomycin that is an intermediate in the biosynthesis of the antitumour drug mithramycin by Streptomyces argillaceus.,10119,KEGG COMPOUND accession,C07568,,,,,,,,,,,,,,,
1234,30251,pentacarbonyliron,a,9506,KEGG COMPOUND accession,C11692,,,,,,,,,,,,,,,
1235,33079,biphenylene,a,18077,KEGG COMPOUND accession,C00459,dttp,365-08-2,18077.0,"Human Metabolome Database (HMDB): Thymidine triphosphate or TTP is one of the four nucleoside triphosphates that make up DNA. It can be used by DNA ligase to create overlapping ""sticky ends"" so that protruding ends of opened microbial plasmids maybe closed up.",Thymidine 5'-triphosphate,HMDB0001342,b,b,C00459,TTP,FDB022565,dttp,[H]O[C@@]1([H])C([H])([H])[C@@]([H])(O[C@]1([H])C([H])([H])OP([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O)N1C([H])=C(C(=O)N([H])C1=O)C([H])([H])[H],NHVNXKFIZYSCEB-XLPZGREQSA-J,"InChI=1S/C10H17N2O14P3/c1-5-3-12(10(15)11-9(5)14)8-2-6(13)7(24-8)4-23-28(19,20)26-29(21,22)25-27(16,17)18/h3,6-8,13H,2,4H2,1H3,(H,19,20)(H,21,22)(H,11,14,15)(H2,16,17,18)/p-4/t6-,7+,8+/m0/s1"
1236,33095,rubicene,a,17622,KEGG COMPOUND accession,C00365,dump,964-26-1,17622.0,"Human Metabolome Database (HMDB): dUMP is formed by the reduction of ribonucleotides to deoxyribonucleotides by ribonucleoside diphosphate reductase [EC 1.17.4.1]. dUMP by the action of by thymidylate synthetase [EC 2.1.1.45] produces dTMP (5,10-Methylene-5,6,7,8-tetrahydrofolate is a cofactor for the reaction). The nuclear form of uracil-DNA glycosylase (UNG2), that its major role is to remove misincorporated dUMP residues (cells deficient in removal of misincorporated dUMP accumulate uracil residues). (PMID 11554311).",dUMP,HMDB0001409,b,b,C00365,DUMP,FDB022604,dump,[H]O[C@@]1([H])C([H])([H])[C@@]([H])(O[C@]1([H])C([H])([H])OP([O-])([O-])=O)N1C([H])=C([H])C(=O)N([H])C1=O,JSRLJPSBLDHEIO-SHYZEUOFSA-L,"InChI=1S/C9H13N2O8P/c12-5-3-8(11-2-1-7(13)10-9(11)14)19-6(5)4-18-20(15,16)17/h1-2,5-6,8,12H,3-4H2,(H,10,13,14)(H2,15,16,17)/p-2/t5-,6+,8+/m0/s1"
1237,31243,atazanavir sulfate,a,18199,KEGG COMPOUND accession,C04882,,,,,,,,,,,,,,,
1238,31255,bekanamycin sulfate,a,9837,KEGG COMPOUND accession,C04700,,,,,,,,,,,,,,,
1239,31263,bentiromide,"The dipeptide obtained by condensation of N-benzoyl-L-tyrosine with 4-aminobenzoic acid. Used as a noninvasive screening test for exocrine pancreatic insufficiency and to monitor the adequacy of supplemental pancreatic therapy, it is given by mouth: the amount of 4-aminobenzoic acid and its metabolites excreted in the urine is taken as a measure of the chymotrypsin-secreting activity of the pancreas.",17297,KEGG COMPOUND accession,C05227,,,,,,,,,,,,,,,
1240,33114,disulfane,a,28496,KEGG COMPOUND accession,C05556,,,,,,,,,,,,,,,
1241,33115,iodine(.),a,28130,KEGG COMPOUND accession,C05958,,,,,,,,,,,,,,,
1242,33116,iodine(1+),a,27705,KEGG COMPOUND accession,C08586,,,,,,,,,,,,,,,
1243,33310,neon atom,a,28122,KEGG COMPOUND accession,C06578,,,,,,,,,,,,,,,
1244,33313,polonium atom,"A radioactive metallic element discovered in 1898 by Marie Sklodowska Curie and named after her home country, Poland (Latin Polonia).",27628,KEGG COMPOUND accession,C06576,,,,,,,,,,,,,,,
1245,33316,helium(2+),a,28671,KEGG COMPOUND accession,C06577,,,,,,,,,,,,,,,
1246,33320,actinoid atom,a,28768,KEGG COMPOUND accession,C06575,,,,,,,,,,,,,,,
1247,33017,diphosphate(1-),A monovalent inorganic anion obtained by deprotonation of one of the phosphate OH groups in diphosphoric acid.,28511,KEGG COMPOUND accession,C06620,,,,,,,,,,,,,,,
1248,33026,[Eu(ep-atta)](-),a,15952,KEGG COMPOUND accession,C04268,,,,,,,,,,,,,,,
1249,33030,tetracarbonylchromium,a,16128,KEGG COMPOUND accession,C00687,,,,,,,,,,,,,,,
1250,33035,tris(acetylacetonato)chromium,a,15744,KEGG COMPOUND accession,C00688,dtdp4d6dm,b,15744.0,b,Dtdp-4-Dehydro-6-Deoxy-L-Mannose,b,b,b,C00688,b,b,b,[H]O[C@@]1([H])C([H])([H])[C@@]([H])(O[C@]1([H])C([H])([H])OP([O-])(=O)OP([O-])(=O)OC1([H])O[C@]([H])(C(=O)[C@@]([H])(O[H])[C@@]1([H])O[H])C([H])([H])[H])N1C([H])=C(C(=O)N([H])C1=O)C([H])([H])[H],PSXWNITXWWECNY-WPTIAVDBSA-L,"InChI=1S/C16H24N2O15P2/c1-6-4-18(16(24)17-14(6)23)10-3-8(19)9(31-10)5-29-34(25,26)33-35(27,28)32-15-13(22)12(21)11(20)7(2)30-15/h4,7-10,12-13,15,19,21-22H,3,5H2,1-2H3,(H,25,26)(H,27,28)(H,17,23,24)/p-2/t7-,8-,9+,10+,12+,13+,15?/m0/s1"
1251,33041,chromium pentafluoride,a,28176,KEGG COMPOUND accession,C06622,,,,,,,,,,,,,,,
1252,33042,pentafluorochromate(1-),a,27498,KEGG COMPOUND accession,C06623,,,,,,,,,,,,,,,
1253,33045,hexafluorochromate(3-),a,15774,KEGG COMPOUND accession,C03319,dtdprmn,2147-59-3,35452.0,"Human Metabolome Database (HMDB): Deoxythymidine diphosphate (dTDP)-l-rhamnose is the precursor of l-rhamnose, a saccharide required for the virulence of some pathogenic bacteria. In gram negative bacteria such as Salmonella enterica, Vibrio cholerae or Escherichia coli 075:K5, l-rhamnose is an important residue in the O-antigen of lipopolysaccharides, which are essential for resistance to serum killing and for colonization. In gram positive bacteria, such as streptococci, the capsule is a recognized virulence factor, for example, l-rhamnose is known to be present in the capsule of Streptococcus suis, a causative agent of meningitis in humans. In Streptococcus mutans, l-rhamnose containing polysaccharides have been implicated in tooth surface colonization and adherence to kidney, muscle and heart tissues. In mycobacteria, l-rhamnose is fundamental to the structural integrity of the cell wall since it connects the inner peptidoglycan layer to the arabinogalactan polysaccharides. dTDP-l-rhamnose is synthesized from glucose-1-phosphate and deoxythymidine triphosphate (dTTP) via a pathway involving four distinct enzymes. Whereas common sugars such as glucose, fructose and mannose are all D-configured, bacteria commonly utilize the L-configured carbohydrates in pharmacologically active compounds and in their cell-wall structures. The bacterial cell wall is unique to bacteria; neither the cell wall nor the enzymes and chemical intermediates in its formation have analogues in humans. The enzymes involved in dTDP-l-rhamnose synthesis are potential targets for the design of new therapeutic agents. (PMID: 10802738, 12773151).",Deoxythymidine diphosphate-l-rhamnose,HMDB0006354,b,b,C03319,DTDP-RHAMNOSE,FDB023902,b,[H]O[C@@]1([H])C([H])([H])[C@@]([H])(O[C@]1([H])C([H])([H])OP([O-])(=O)OP([O-])(=O)OC1([H])O[C@@]([H])(C([H])([H])[H])[C@]([H])(O[H])[C@@]([H])(O[H])[C@@]1([H])O[H])N1C([H])=C(C(=O)N([H])C1=O)C([H])([H])[H],ZOSQFDVXNQFKBY-CZRCVJRHSA-L,"InChI=1S/C16H26N2O15P2/c1-6-4-18(16(24)17-14(6)23)10-3-8(19)9(31-10)5-29-34(25,26)33-35(27,28)32-15-13(22)12(21)11(20)7(2)30-15/h4,7-13,15,19-22H,3,5H2,1-2H3,(H,25,26)(H,27,28)(H,17,23,24)/p-2/t7-,8-,9+,10+,11-,12+,13+,15?/m0/s1"
1254,31159,aceclofenac,"A monocarboxylic acid that is the carboxymethyl ester of diclofenac. A non-steroidal anti-inflammatory drug related to diclofenac, it is used in the management of osteoarthritis, rheumatoid arthritis, and ankylosing spondylitis.",15886,KEGG COMPOUND accession,C04573,,,,,,,,,,,,,,,
1255,32375,petroselinate,An unsaturated fatty acid anion resulting from the deprotonation of the carboxy group of petroselinic acid. The major species at pH 7.3.,17665,KEGG COMPOUND accession,C00668,,,,,,,,,,,,,,,
1256,33127,sulfadiazinate,a,10545,KEGG COMPOUND accession,C05359,,,,,,,,,,,,,,,
1257,33129,di-mu-bromidobis(dibromidoaluminium),a,27997,KEGG COMPOUND accession,C01712,,,,,,,,,,,,,,,
1258,33133,phospholane,a,32815,KEGG COMPOUND accession,C02763,M00647,5801-57-0,16815.0,"Human Metabolome Database (HMDB): Enol-phenylpyruvate is reversibly produced from keto-phenylpyruvate, a reaction catalyzed by phenylpyruvate tautomerase [EC:5.3.2.1]. Phenylpyruvate tautomerase, also known as macrophage migration inhibitory factor (glycosylation-inhibiting factor), is involved in the tyrosine and phenylalanine metabolism pathways.",Enol-phenylpyruvate,HMDB0012225,b,b,C02763,ENOL-PHENYLPYRUVATE,FDB028869,b,[H]OC(=O)C(\O[H])=C(/[H])C1=C([H])C([H])=C([H])C([H])=C1[H],DEDGUGJNLNLJSR-VURMDHGXSA-N,"InChI=1S/C9H8O3/c10-8(9(11)12)6-7-4-2-1-3-5-7/h1-6,10H,(H,11,12)/b8-6-"
1259,33140,pyrazolium,a,10552,KEGG COMPOUND accession,C09566,,,,,,,,,,,,,,,
1260,33146,vanadyl sulfate,a,28579,KEGG COMPOUND accession,C06593,,,,,,,,,,,,,,,
1261,33148,pentacene,An acene that consists of five ortho-fused benzene rings in a rectilinear arrangement.,10556,KEGG COMPOUND accession,C10289,,,,,,,,,,,,,,,
1262,33150,hexahelicene,a,17576,KEGG COMPOUND accession,C03961,,,,,,,,,,,,,,,
1263,33153,heptahelicene,a,28474,KEGG COMPOUND accession,C05715,,,,,,,,,,,,,,,
1264,33156,heptacene,An acene that consists of seven ortho-fused benzene rings in a rectilinear arrangement.,27740,KEGG COMPOUND accession,C05435,,,,,,,,,,,,,,,
1265,33161,cis-obtusilate,"A medium-chain fatty acid anion and the conjugate base of obtusilic acid, arising from deprotonation of the carboxylic acid group.",28776,KEGG COMPOUND accession,C05695,,,,,,,,,,,,,,,
1266,33165,octacene,a,10565,KEGG COMPOUND accession,C05711,HC01577,b,10565.0,Human Metabolome Database (HMDB): This compound belongs to the family of N-acyl-Alpha Amino Acids. These are amino acids in which the amino group is attached to the carbon atom immediately adjacent to the carboxylate group (alpha carbon). ,gamma-Glutamyl-beta-cyanoalanine,HMDB0060478,b,b,C05711,b,b,HC01577,[H]N(C(=O)C([H])([H])C([H])([H])[C@@]([H])(C([O-])=O)[N+]([H])([H])[H])[C@]([H])(C([O-])=O)C([H])([H])C#N,QUAADUAOVLZBJM-WDSKDSINSA-M,"InChI=1S/C9H13N3O5/c10-4-3-6(9(16)17)12-7(13)2-1-5(11)8(14)15/h5-6H,1-3,11H2,(H,12,13)(H,14,15)(H,16,17)/p-1/t5-,6-/m0/s1"
1267,33170,nonacene,An acene that consists of nine ortho-fused benzene rings in a rectilinear arrangement.,32888,KEGG COMPOUND accession,C06595,,,,,,,,,,,,,,,
1268,33172,octaphenylene,a,47815,KEGG COMPOUND accession,C08284,,,,,,,,,,,,,,,
1269,33174,tetrafluoromagnesate(2-),a,16834,KEGG COMPOUND accession,C03738,,,,,,,,,,,,,,,
1270,33176,octogen,"A tetrazocane that is 1,3,5,7-tetrazocane in which the hydrogen atom attached to each of the nitrogens is replaced by a nitro group.",17515,KEGG COMPOUND accession,C00669,glucys,636-58-8,17515.0,"Human Metabolome Database (HMDB): gamma-Glutamylcysteine is a dipeptide composed of gamma-glutamate and cysteine, and is a proteolytic breakdown product of larger proteins. It belongs to the family of N-acyl-alpha amino acids and derivatives. These are compounds containing an alpha amino acid which bears an acyl group at its terminal nitrogen atom. gamma-Glutamylcysteine is an incomplete breakdown product of protein digestion or protein catabolism. Some dipeptides are known to have physiological or cell-signaling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis. gamma-Glutamylcysteine is a product of enzyme glutamate-cysteine ligase [EC 6.3.2.2] and a substrate of enzyme glutathione synthase [EC 6.3.2.3] in the glutamate metabolism pathway (KEGG).",gamma-Glutamylcysteine,HMDB0001049,b,b,C00669,L-GAMMA-GLUTAMYLCYSTEINE,FDB003603,glucys,[H]SC([H])([H])[C@]([H])(N([H])C(=O)C([H])([H])C([H])([H])[C@@]([H])(C([O-])=O)[N+]([H])([H])[H])C([O-])=O,RITKHVBHSGLULN-WHFBIAKZSA-M,"InChI=1S/C8H14N2O5S/c9-4(7(12)13)1-2-6(11)10-5(3-16)8(14)15/h4-5,16H,1-3,9H2,(H,10,11)(H,12,13)(H,14,15)/p-1/t4-,5-/m0/s1"
1271,32590,barium sulfide,a,15507,KEGG COMPOUND accession,C02335,,,,,,,,,,,,,,,
1272,32592,barium dihydroxide,a,28712,KEGG COMPOUND accession,C05340,,,,,,,,,,,,,,,
1273,32595,barium(0),a,27749,KEGG COMPOUND accession,C05341,,,,,,,,,,,,,,,
1274,32598,calcium diphosphate,a,18323,KEGG COMPOUND accession,C01262,,,,,,,,,,,,,,,
1275,33268,monoatomic nitrogen,a,18384,KEGG COMPOUND accession,C03546,mi4p_D,46495-39-0,18384.0,"Human Metabolome Database (HMDB): D-Myo-inositol 4-phosphate is a substrate for Inositol monophosphatase, Inositol polyphosphate 1-phosphatase and Inositol monophosphatase 2.",D-Myo-inositol 4-phosphate,HMDB0001313,b,b,C03546,D-MYO-INOSITOL-4-PHOSPHATE,FDB022548,mi4p_D,[H]O[C@]1([H])[C@]([H])(O[H])[C@]([H])(O[H])[C@@]([H])(OP([O-])([O-])=O)[C@]([H])(O[H])[C@@]1([H])O[H],INAPMGSXUVUWAF-CNWJWELYSA-L,"InChI=1S/C6H13O9P/c7-1-2(8)4(10)6(5(11)3(1)9)15-16(12,13)14/h1-11H,(H2,12,13,14)/p-2/t1-,2-,3-,4+,5-,6-/m0/s1"
1276,33272,ketimine,Any imine derived from a ketone.,17401,KEGG COMPOUND accession,C01204,minohp,83-86-3,17401.0,"Human Metabolome Database (HMDB): Myo-Inositol hexakisphosphate is an intermediate in inositol phosphate metabolism. It can be generated from D-myo-Inositol 1,3,4,5,6-pentakisphosphate via the enzyme inositol-pentakisphosphate 2-kinase (EC:2.7.1.158). Myo-Inositol hexakisphosphate is also known as phytic acid. It can be used clinically as a complexing agent for removal of traces of heavy metal ions. It acts also as a hypocalcemic agent. Phytic acid is a strong chelator of important minerals such as calcium, magnesium, iron and zinc and can therefore contribute to mineral deficiencies in developing countries. For people with a particularly low intake of essential minerals, especially young children and those in developing countries, this effect can be undesirable. However, dietary mineral chelators help prevent over-mineralization of joints, blood vessels, and other parts of the body, which is most common in older persons. The Journal of Environmental Nutrition (April 2004 volume 27 issue 4) has also stated phytic acid may be considered a phytonutrient, providing an antioxidant effect.",Myo-inositol hexakisphosphate,HMDB0003502,b,b,C01204,MI-HEXAKISPHOSPHATE,FDB000374,minohp,[H][C@]1(OP([O-])([O-])=O)[C@]([H])(OP([O-])([O-])=O)[C@@]([H])(OP([O-])([O-])=O)[C@]([H])(OP([O-])([O-])=O)[C@]([H])(OP([O-])([O-])=O)[C@]1([H])OP([O-])([O-])=O,IMQLKJBTEOYOSI-GPIVLXJGSA-B,"InChI=1S/C6H18O24P6/c7-31(8,9)25-1-2(26-32(10,11)12)4(28-34(16,17)18)6(30-36(22,23)24)5(29-35(19,20)21)3(1)27-33(13,14)15/h1-6H,(H2,7,8,9)(H2,10,11,12)(H2,13,14,15)(H2,16,17,18)(H2,19,20,21)(H2,22,23,24)/p-12/t1-,2-,3-,4+,5-,6-"
1277,31270,beraprost sodium,The organic sodium salt of beraprost. It is used in the treatment of chronic arterial occlusive disease and primary pulmonary hypertension in Japan.,16846,KEGG COMPOUND accession,C02467,,,,,,,,,,,,,,,
1278,32414,cis-parinarate,"A straight-chain, unsaturated, long-chain fatty acid anion that is the conjugate base of cis-parinaric acid, arising from deprotonation of the carboxylic acid group.",18205,KEGG COMPOUND accession,C03812,,,,,,,,,,,,,,,
1279,31135,(E)-5-hydroxyconiferyl alcohol,A 5-hydroxyconiferyl alcohol in which the double bond has E geochemistry.,16085,KEGG COMPOUND accession,C00617,,,,,,,,,,,,,,,
1280,33222,corrole,A tetrapyrrole fundamental parent that is the octadehydro drivative of corrin.,10589,KEGG COMPOUND accession,C07211,,,,,,,,,,,,,,,
1281,33225,isochromane,a,28488,KEGG COMPOUND accession,C07208,,,,,,,,,,,,,,,
1282,32646,methioninium,"A sulfur-containing amino-acid anion that is the conjugate acid of methionine, arising from protonation of the amino group.",28586,KEGG COMPOUND accession,C08252,,,,,,,,,,,,,,,
1283,32648,methionine residue,a,28782,KEGG COMPOUND accession,C08239,,,,,,,,,,,,,,,
1284,32650,L-asparaginate,An optically active form of asparaginate having L-configuration.,28645,KEGG COMPOUND accession,C02336,fru,53188-23-1,28645.0,"Human Metabolome Database (HMDB): Fructose, or levulose, is a levorotatory monosaccharide and an isomer of glucose (C6H12O6). The chemical composition of fructose is (C6H12O6). Pure fructose has a sweet taste similar to cane sugar, but with a ""fruity"" aroma. Although fructose is a hexose (6 carbon sugar), it generally exists as a 5-member hemiketal ring (a furanose). This structure is responsible for the long metabolic pathway and high reactivity compared to glucose. Fructose is found in many foods and is one of the three most important blood sugars along with glucose and galactose. Honey; tree fruits; berries; melons; and some root vegetables, such as beets, sweet potatoes, parsnips and onions, contain fructose, usually in combination with sucrose and glucose. Fructose is also derived from the digestion of sucrose, a disaccharide consisting of glucose and fructose that is broken down by enzymes during digestion. Fructose is the sweetest naturally occurring sugar, estimated to be twice as sweet as sucrose. It is used as a preservative and an intravenous infusion in parenteral feeding. Fructose is a reducing sugar, as are all monosaccharides. The spontaneous addition of single sugar molecules to proteins, known as glycation, is a significant cause of damage in diabetics. Fructose appears to be as dangerous as glucose in this regard and so does not seem to be the answer for diabetes (McPherson et al, 1988). This may be an important contribution to senescence and many age-related chronic diseases (Levi & Werman 1998).",D-Fructose,HMDB0000660,b,b,C02336,BETA-D-FRUCTOSE,FDB012528,fru,[H]OC([H])([H])[C@@]1([H])O[C@](O[H])(C([H])([H])O[H])[C@@]([H])(O[H])[C@]1([H])O[H],RFSUNEUAIZKAJO-ARQDHWQXSA-N,"InChI=1S/C6H12O6/c7-1-3-4(9)5(10)6(11,2-8)12-3/h3-5,7-11H,1-2H2/t3-,4-,5+,6-/m1/s1"
1285,32656,D-asparaginate,a,28013,KEGG COMPOUND accession,C05378,,,,,,,,,,,,,,,
1286,32662,N(2)-asparagino group,a,16084,KEGG COMPOUND accession,C05345,,,,,,,,,,,,,,,
1287,30689,alpha-mannosyl group,a,9691,KEGG COMPOUND accession,C10174,,,,,,,,,,,,,,,
1288,30691,osmium(2+),a,69621,KEGG COMPOUND accession,C09742,,,,,,,,,,,,,,,
1289,30695,trichloridonitridomolybdenum,a,59979,KEGG COMPOUND accession,C10193,,,,,,,,,,,,,,,
1290,30705,octafluoromolybdate(2-),a,9699,KEGG COMPOUND accession,C08464,,,,,,,,,,,,,,,
1291,30709,hexafluoromolybdate(2-),a,9701,KEGG COMPOUND accession,C07861,,,,,,,,,,,,,,,
1292,30711,molybdenum pentafluoride,a,9702,KEGG COMPOUND accession,C11761,,,,,,,,,,,,,,,
1293,30714,tetrafluoro(selenoxo)molybdenum,a,9704,KEGG COMPOUND accession,C07862,,,,,,,,,,,,,,,
1294,33279,vitamin D5,A vitamin D in which the side-chain at position 17 consists of a (5R)-5-ethyl-6-methylheptan-2-yl group.,28903,KEGG COMPOUND accession,C01633,,,,,,,,,,,,,,,
1295,33286,agrochemical,An agrochemical is a substance that is used in agriculture or horticulture.,28054,KEGG COMPOUND accession,C01542,,,,,,,,,,,,,,,
1296,33289,avicide,A substance used to destroy bird pests (class Aves).,36632,KEGG COMPOUND accession,C07215,,,,,,,,,,,,,,,
1297,33292,fuel,An energy-rich substance that can be transformed with release of usable energy.,28063,KEGG COMPOUND accession,C07212,,,,,,,,,,,,,,,
1298,33296,alkali metal molecular entity,A molecular entity containing one or more atoms of an alkali metal.,37555,KEGG COMPOUND accession,C03188,,,,,,,,,,,,,,,
1299,33298,lithium molecular entity,a,10615,KEGG COMPOUND accession,C03547,,,,,,,,,,,,,,,
1300,33300,pnictogen,"Any p-block element atom that is in group 15 of the periodic table: nitrogen, phosphorus, arsenic, antimony and bismuth.",39567,KEGG COMPOUND accession,C08317,whddca,505-95-3,39567.0,"Human Metabolome Database (HMDB): 12-hydroxydodecanoic acid is the substrate of the human glutathione-dependent formaldehyde dehydrogenase (EC1.1.1.1). The enzyme that catalyzes the conversion of alcohols to aldehydes is a zinc-containing dimeric enzyme responsible for the oxidation of long-chain alcohols and omega-hydroxy fatty acids. (OMIM). The human glutathione-dependent formaldehyde dehydrogenase is unique among the structurally studied members of the alcohol dehydrogenase family in that it follows a random bi kinetic mechanism forming a binary complex, and a ternary complex with NAD+. (PMID 12196016).",12-Hydroxydodecanoic acid,HMDB0002059,b,b,C08317,b,FDB022822,whddca,[H]OC([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([O-])=O,ZDHCZVWCTKTBRY-UHFFFAOYSA-M,"InChI=1S/C12H24O3/c13-11-9-7-5-3-1-2-4-6-8-10-12(14)15/h13H,1-11H2,(H,14,15)/p-1"
1301,32694,N(omega)-D-arginino group,a,15876,KEGG COMPOUND accession,C04902,,,,,,,,,,,,,,,
1302,32696,argininium(1+),a,16117,KEGG COMPOUND accession,C04750,T_antigen,b,16117.0,b,T-Antigen (Core 1),b,b,b,C04750,b,b,T_antigen,[H]OC([H])([H])[C@@]1([H])O[C@@]([H])(O[C@@]2([H])[C@@]([H])(O[H])[C@]([H])(OC([H])([*])[C@]2([H])N([H])C(=O)C([H])([H])[H])C([H])([H])O[H])[C@]([H])(O[H])[C@@]([H])(O[H])[C@@]1([H])O[H],b,b
1303,32713,L-tryptophanyl radical cation,a,17950,KEGG COMPOUND accession,C01290,C01290,4682-48-8,b,"Human Metabolome Database (HMDB): Lactosylceramide (d18:1/12:0) is a lactosylceramide or LacCer. Lactosylceramides are the most important and abundant of the diosylceramides. Lactosylceramides (LacCer) were originally called 'cytolipin H'. It is found in small amounts only in most animal tissues, but it has a number of significant biological functions and it is of great importance as the biosynthetic precursor of most of the neutral oligoglycosylceramides, sulfatides and gangliosides. In animal tissues, biosynthesis of lactosylceramide involves addition of the second monosaccharides unit (galactose) as its nucleotide derivative to monoglucosylceramide, catalysed by a specific beta-1,4-galactosyltransferase on the lumenal side of the Golgi apparatus. The glucosylceramide precursor must first cross from the cytosolic side of the membrane, possibly via the action of a flippase. The lactosylceramide produced can be further glycosylated or transferred to the plasma membrane. Lactosylceramide may assist in stabilizing the plasma membrane and activating receptor molecules in the special micro-domains or rafts, as with the cerebrosides. It may also have its own specialized function in the immunological system in that it is known to bind to specific bacteria. In addition, it is believed that a number of pro-inflammatory factors activate lactosylceramide synthase to generate lactosylceramide, which in turn activates ""oxygen-sensitive"" signalling pathways that affect such cellular processes as proliferation, adhesion, migration and angiogenesis. Dysfunctions in these pathways can affect several diseases of the cardiovascular system, cancer and inflammatory states, so lactosylceramide metabolism is a potential target for new therapeutic treatments. beta-D-galactosyl-1,4-beta-D-glucosylceramide is the second to last step in the synthesis of N-Acylsphingosine and is converted. from Glucosylceramide via the enzyme beta-1,4-galactosyltransferase 6 (EC:2.4.1.-). It can be converted to Glucosylceramide via the enzyme beta-galactosidase (EC:3.2.1.23). Moreover, lactosylceramide (D18:1/12:0) is found to be associated with abetalipoproteinemia and hypobetalipoproteinemia, which are inborn errors of metabolism.",Lactosylceramide (d18:1/12:0),HMDB0004866,b,b,C01290,CYTOLIPIN_H,FDB023465,b,[H]OC([H])([H])[C@@]1([H])O[C@@]([H])(O[C@@]2([H])[C@]([H])(O[H])[C@@]([H])(O[H])[C@]([H])(OC([H])([H])[C@]([H])(N([H])C([*])=O)[C@]([H])(O[H])C(\[H])=C(/[H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H])O[C@]2([H])C([H])([H])O[H])[C@]([H])(O[H])[C@@]([H])(O[H])[C@@]1([H])O[H],KNWHKVBHCLQVFX-QXWNENIHSA-N,b
1304,30451,hexachloridostannide(2-),a,17821,KEGG COMPOUND accession,C00178,thym,65-71-4,17821.0,"Human Metabolome Database (HMDB): One of the pyrimidine bases of living matter. Derivation: Hydrolysis of deoxyribonucleic acid, from methylcyanoacetylurea by catalytic reduction. Use: Biochemical research. (Hawley's Condensed Chemical Dictionary). Thymine is a pyrimidine nucleobase. As the name implies, thymine may be derived by methylation of uracil at the 5th carbon. Thymine is found in the nucleic acid DNA. In RNA thymine is replaced with uracil in most cases. In DNA, thymine binds to adenine via two hydrogen bonds to assist in stabilizing the nucleic acid structures.",Thymine,HMDB0000262,b,b,C00178,THYMINE,FDB021922,thym,[H]N1C([H])=C(C(=O)N([H])C1=O)C([H])([H])[H],RWQNBRDOKXIBIV-UHFFFAOYSA-N,"InChI=1S/C5H6N2O2/c1-3-2-6-5(9)7-4(3)8/h2H,1H3,(H2,6,7,8,9)"
1305,30460,tellanide,a,27607,KEGG COMPOUND accession,C09908,,,,,,,,,,,,,,,
1306,30462,orthotellurate(6-),a,9582,KEGG COMPOUND accession,C10191,,,,,,,,,,,,,,,
1307,30618,hydroxypropyl methylcellulose,a,16558,KEGG COMPOUND accession,C01757,,,,,,,,,,,,,,,
1308,30514,caesium atom,a,63629,KEGG COMPOUND accession,C07452,,,,,,,,,,,,,,,
1309,30520,octafluorotungstate(2-),a,9611,KEGG COMPOUND accession,C07142,,,,,,,,,,,,,,,
1310,30643,heptacyanomolybdate(5-),a,71418,KEGG COMPOUND accession,C08183,,,,,,,,,,,,,,,
1311,30651,hexakis(pyridine)iron(2+),a,9672,KEGG COMPOUND accession,C10410,,,,,,,,,,,,,,,
1312,30653,homoserine,An alpha-amino acid that is glycine substituted at the alpha-position by a 2-hydroxyethyl group.,9673,KEGG COMPOUND accession,C10961,,,,,,,,,,,,,,,
1313,30657,D-homoserine lactone,The D-enantiomer of homoserine lactone.,9675,KEGG COMPOUND accession,C11345,,,,,,,,,,,,,,,
1314,30661,thyronine,A tyrosine derivative where the phenolic hydrogen of tyrosine is substituted by 4-hydroxyphenyl.,9678,KEGG COMPOUND accession,C10962,,,,,,,,,,,,,,,
1315,30663,cyclopentadienyl group,a,9679,KEGG COMPOUND accession,C08136,,,,,,,,,,,,,,,
1316,30665,carbonylbis(eta(5)-cyclopentadienyl)molybdenum,a,507499,KEGG COMPOUND accession,C10192,,,,,,,,,,,,,,,
1317,30569,silylidene group,a,63631,KEGG COMPOUND accession,C07502,,,,,,,,,,,,,,,
1318,30571,stannylidyne group,a,63632,KEGG COMPOUND accession,C11158,,,,,,,,,,,,,,,
1319,30573,plumbylidyne group,a,9635,KEGG COMPOUND accession,C08166,,,,,,,,,,,,,,,
1320,33335,scandium group element atom,a,28617,KEGG COMPOUND accession,C06758,,,,,,,,,,,,,,,
1321,33339,arylene group,A bivalent group derived from an arene by removal of a hydrogen atom from each of two ring carbon atoms.,27417,KEGG COMPOUND accession,C06756,,,,,,,,,,,,,,,
1322,33341,titanium atom,a,16663,KEGG COMPOUND accession,C04093,,,,,,,,,,,,,,,
1323,33345,titanium group element atom,a,18111,KEGG COMPOUND accession,C00240,,,,,,,,,,,,,,,
1324,32745,L-selenocysteinyl group,a,16218,KEGG COMPOUND accession,C00663,g1p_B,b,b,b,Beta D-Glucose 1-phosphate,b,b,b,C00663,b,b,b,b,b,b
1325,32750,D-selenocysteinate(2-),a,17719,KEGG COMPOUND accession,C01172,g6p_B,b,17719.0,"Human Metabolome Database (HMDB): Beta-D-Glucose 6 phosphate (b-G6P) is the beta-anomer of glucose-6-phosphate. There are two anomers of glucose 6 phosphate, the alpha anomer and the beta anomer. Specifically, beta-D-Glucose 6-phosphate is glucose sugar phosphorylated on carbon 6. It is a very common metabolite in cells as the vast majority of glucose entering a cell will become phosphorylated in this way. The primary reason for the immediate phosphorylation of glucose is to prevent diffusion out of the cell. The phosphorylation adds a charged phosphate group so the glucose 6-phosphate cannot easily cross the cell membrane. b-G6P is involved in the glycolysis, gluconeogenesis, pentose phosphate, and glycogen and sucrose metabolic pathways [Kegg ID: C01172]. Beta-D-Glucose 6 phosphate can be generated through beta-D-fructose phosphate or alpha-D-glucose 6 phosphate (via glucose-6-phosphate isomerase) or beta-D glucose (via hexokinase). It can then be sent off to the pentose phosphate pathway which generates the useful cofactor NADPH as well as ribulose 5-phosphate, a carbon source for the synthesis of other molecules. Alternately if the cell needs energy or carbon skeletons for synthesis then glucose 6-phosphate is targeted for glycolysis. A third route is to have glucose 6 phosphate stored or converted to glycogen, especially if blood glucose levels are high.",Beta-D-Glucose 6-phosphate,HMDB0003498,b,b,C01172,b,FDB023183,b,b,NBSCHQHZLSJFNQ-VFUOTHLCSA-N,b
1326,32750,D-selenocysteinate(2-),a,17719,KEGG COMPOUND accession,C01172,M01389,b,17719.0,b,Beta-D-Glucose-6-Phosphate,b,b,b,C01172,b,b,M01389,[H]O[C@]1([H])O[C@]([H])(C([H])([H])OP(=O)(O[H])O[H])[C@@]([H])(O[H])[C@]([H])(O[H])[C@@]1([H])O[H],NBSCHQHZLSJFNQ-VFUOTHLCSA-N,"InChI=1S/C6H13O9P/c7-3-2(1-14-16(11,12)13)15-6(10)5(9)4(3)8/h2-10H,1H2,(H2,11,12,13)/t2-,3-,4+,5-,6-/m1/s1"
1327,32763,L-tyrosinyl radical cation,a,27863,KEGG COMPOUND accession,C04429,,,,,,,,,,,,,,,
1328,30809,tetraaquadicyanoiron,a,9746,KEGG COMPOUND accession,C10095,,,,,,,,,,,,,,,
1329,32607,L-isoleucino group,a,27413,KEGG COMPOUND accession,C05670,,,,,,,,,,,,,,,
1330,32611,D-isoleucino group,a,10353,KEGG COMPOUND accession,C10430,,,,,,,,,,,,,,,
1331,32613,isoleucinium,a,27723,KEGG COMPOUND accession,C09625,,,,,,,,,,,,,,,
1332,32620,L-leucinium,The L-enantiomer of leucinium.,10357,KEGG COMPOUND accession,C09629,,,,,,,,,,,,,,,
1333,32622,L-leucino group,a,36217,KEGG COMPOUND accession,C06422,,,,,,,,,,,,,,,
1334,32624,D-leucinium,The D-enantiomer of leucinium.,10359,KEGG COMPOUND accession,C09637,,,,,,,,,,,,,,,
1335,32626,D-leucino group,a,10360,KEGG COMPOUND accession,C09849,,,,,,,,,,,,,,,
1336,32630,leucine residue,a,10362,KEGG COMPOUND accession,C08591,,,,,,,,,,,,,,,
1337,33348,tantalum atom,a,18143,KEGG COMPOUND accession,C04153,,,,,,,,,,,,,,,
1338,33350,chromium group element atom,a,15731,KEGG COMPOUND accession,C04779,,,,,,,,,,,,,,,
1339,33353,technetium atom,a,10642,KEGG COMPOUND accession,C06153,,,,,,,,,,,,,,,
1340,31520,doxapram hydrochloride monohydrate,"The monohydrate form of doxapram hydrochloride. A central and respiratory stimulant with a brief duration of action, it is used as a temporary treatment of acute respiratory failure, particularly when superimposed on chronic obstructive pulmonary disease, and of postoperative respiratory depression. It has also been used for treatment of postoperative shivering.",17775,KEGG COMPOUND accession,C00366,urate,69-93-2,17775.0,"Human Metabolome Database (HMDB): Uric acid is a heterocyclic purine derivative that is the final oxidation product of purine metabolism. It is produced by the enzyme xanthine oxidase, which oxidizes oxypurines such as xanthine into uric acid. In most mammals, except humans and higher primates, the enzyme uricase further oxidizes uric acid to allantoin. Uric acid is also the end product of nitrogen metabolism in birds and reptiles. In such species, it is excreted in feces as a dry mass. Humans produce only small quantities of uric acid with excess accumulation leading to a type of arthritis known as gout. The loss of uricase in higher primates parallels the similar loss of the ability to synthesize ascorbic acid vitamin C. This may be because in higher primates uric acid partially replaces ascorbic acid. Uric acid is found to be associated with Lesch-Nyhan syndrome and xanthinuria type I, which are inborn errors of metabolism.",Uric acid,HMDB0000289,b,b,C00366,URATE,FDB015350,urate,[H]N1C(=O)N([H])C2=C1N([H])C(=O)N([H])C2=O,LEHOTFFKMJEONL-UHFFFAOYSA-N,"InChI=1S/C5H4N4O3/c10-3-1-2(7-4(11)6-1)8-5(12)9-3/h(H4,6,7,8,9,10,11,12)"
1341,30872,oxaloamino group,a,9774,KEGG COMPOUND accession,C07547,,,,,,,,,,,,,,,
1342,30874,oxalosulfanyl group,a,9775,KEGG COMPOUND accession,C09248,,,,,,,,,,,,,,,
1343,30876,3-oxalobenzoic acid,a,9776,KEGG COMPOUND accession,C09564,,,,,,,,,,,,,,,
1344,31555,erythromycin ethylsuccinate,A erythromycin derivative that is erythromycin A in which the hydroxy group at position 3R is substituted by a (4-ethoxy-4-oxobutanoyl)oxy group. It is used for the treatment of a wide variety of bacterial infections.,49050,KEGG COMPOUND accession,C05241,,,,,,,,,,,,,,,
1345,31568,profenamine hydrochloride,"The monohydrochloride salt of profenamine. An antimuscarinic, it is used for the symptomatic treatment of Parkinson's disease.",28070,KEGG COMPOUND accession,C03031,,,,,,,,,,,,,,,
1346,32014,pirenzepine hydrochloride,a,10103,KEGG COMPOUND accession,C09606,,,,,,,,,,,,,,,
1347,32020,pitavastatin,"A dihydroxy monocarboxylic acid that is (6E)-7-[2-cyclopropyl-4-(4-fluorophenyl)quinolin-3-yl]hept-6-enoic acid in which the two hydroxy groups are located at positions 3 and 5 (the 3R,5S-stereoisomer). Used as its calcium salt for treatment of hypercholesterolemia (elevated levels of cholesterol in the blood) on patients unable to sufficiently lower their cholesterol levels by diet and exercise.",10106,KEGG COMPOUND accession,C09981,,,,,,,,,,,,,,,
1348,33187,oxomalononitrile,a,28661,KEGG COMPOUND accession,C06426,dlnlcgcrn,506-26-3,28661.0,"Human Metabolome Database (HMDB): Gamma-Linolenic acid is an omega-6 fatty acid produced in the body as the delta 6-desaturase metabolite of linoleic acid. It is converted to dihomo-gamma-linolenic acid, a biosynthetic precursor of monoenoic prostaglandins such as PGE1. (From Merck Index, 11th ed) -- Pubchem.",Gamma-Linolenic acid,HMDB0003073,b,b,C06426,5Z13E-15S-91115-TRIHYDROXYPROSTA-,FDB002943,dlnlcgcrn,[H]OC(=O)C([H])([H])C([H])([H])C([H])([H])C([H])([H])C(\[H])=C(\[H])C([H])([H])C(\[H])=C(\[H])C([H])([H])C(\[H])=C(\[H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H],VZCCETWTMQHEPK-NPLRDPCCSA-N,"InChI=1S/C18H30O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18(19)20/h6-7,9-10,12-13H,2-5,8,11,14-17H2,1H3,(H,19,20)/b7-6-,10-9?,13-12-"
1349,33187,oxomalononitrile,a,28661,KEGG COMPOUND accession,C06426,lnlncg,506-26-3,28661.0,"Human Metabolome Database (HMDB): Gamma-Linolenic acid is an omega-6 fatty acid produced in the body as the delta 6-desaturase metabolite of linoleic acid. It is converted to dihomo-gamma-linolenic acid, a biosynthetic precursor of monoenoic prostaglandins such as PGE1. (From Merck Index, 11th ed) -- Pubchem.",Gamma-Linolenic acid,HMDB0003073,b,b,C06426,5Z13E-15S-91115-TRIHYDROXYPROSTA-,FDB002943,lnlncg,[H]\C(=C(/[H])C([H])([H])C(\[H])=C(\[H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H])C([H])([H])C(\[H])=C(\[H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([O-])=O,VZCCETWTMQHEPK-NPLRDPCCSA-M,"InChI=1S/C18H30O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18(19)20/h6-7,9-10,12-13H,2-5,8,11,14-17H2,1H3,(H,19,20)/p-1/b7-6-,10-9?,13-12-"
1350,33189,hydrazonomalononitrile,a,15508,KEGG COMPOUND accession,C03035,lnlncgcoa,b,15508.0,"Human Metabolome Database (HMDB): Gamma-linolenoyl-CoA is the product of a chemical reaction that involves linoleoyl-CoA desaturase which acts as a catalyst. In enzymology, linoleoyl-CoA desaturase (EC 1.14.19.3) is an enzyme that catalyzes the chemical reaction. linoleoyl-CoA + AH2 + O2 gamma-linolenoyl-CoA + A + 2 H2O. The 3 substrates of this enzyme are linoleoyl-CoA, AH2, and O2, whereas its 3 products are gamma-linolenoyl-CoA, A, and H2O. (Wikipedia).",Gamma-linolenoyl-CoA,HMDB0006368,b,b,C03035,GAMMA-LINOLENOYL-COA,FDB023905,lnlncgcoa,[H]O[C@@]([H])(C(=O)N([H])C([H])([H])C([H])([H])C(=O)N([H])C([H])([H])C([H])([H])SC(=O)C([H])([H])C([H])([H])C([H])([H])C([H])([H])C(\[H])=C(\[H])C([H])([H])C(\[H])=C(\[H])C([H])([H])C(\[H])=C(\[H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H])C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])OP([O-])(=O)OP([O-])(=O)OC([H])([H])[C@@]1([H])O[C@@]([H])(N2C([H])=NC3=C(N=C([H])N=C23)N([H])[H])[C@]([H])(O[H])[C@]1([H])OP([O-])([O-])=O,XZQYPTBYQYZGRU-FHDVEODPSA-J,"InChI=1S/C39H64N7O17P3S/c1-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-30(48)67-23-22-41-29(47)20-21-42-37(51)34(50)39(2,3)25-60-66(57,58)63-65(55,56)59-24-28-33(62-64(52,53)54)32(49)38(61-28)46-27-45-31-35(40)43-26-44-36(31)46/h8-9,11-12,14-15,26-28,32-34,38,49-50H,4-7,10,13,16-25H2,1-3H3,(H,41,47)(H,42,51)(H,55,56)(H,57,58)(H2,40,43,44)(H2,52,53,54)/p-4/b9-8-,12-11-,15-14-/t28-,32-,33-,34+,38-/m1/s1"
1351,33195,C70 fullerene,a,10577,KEGG COMPOUND accession,C09900,,,,,,,,,,,,,,,
1352,33202,2-thiobarbituric acid,"A barbiturate, the structure of which is that of barbituric acid in which the oxygen at C-2 is replaced by sulfur.",30212,KEGG COMPOUND accession,C00205,,,,,,,,,,,,,,,
1353,33211,mercury diacetate,a,10583,KEGG COMPOUND accession,C02607,,,,,,,,,,,,,,,
1354,33215,ethylmercurithiosalicylate,a,28924,KEGG COMPOUND accession,C05058,,,,,,,,,,,,,,,
1355,30242,fluoridooxygen(.),a,48030,KEGG COMPOUND accession,C01960,,,,,,,,,,,,,,,
1356,32298,vitexin 2''-O-alpha-L-rhamnoside,A derivative of vitexin having an alpha-L-rhamnosyl residue attached at the 2''-position of the glucitol moiety.,28676,KEGG COMPOUND accession,C06421,,,,,,,,,,,,,,,
1357,32388,alpha-linolenoyl group,a,27554,KEGG COMPOUND accession,C04147,glc1man,b,27554.0,Human Metabolome Database (HMDB): This compound belongs to the family of Dihexoses. These are disaccharides containing two hexose carbohydrates,"Glucose-1,3-mannose oligosaccharide",HMDB0060068,b,b,C04147,b,b,b,[H]OC([H])([H])[C@@]1([H])O[C@]([H])(O[C@]2([H])[C@]([H])(O[H])[C@]([H])(O[H])O[C@]([H])(C([H])([H])O[H])[C@@]2([H])O[H])[C@]([H])(O[H])[C@@]([H])(O[H])[C@]1([H])O[H],QIGJYVCQYDKYDW-WPMDEUETSA-N,"InChI=1S/C12H22O11/c13-1-3-5(15)7(17)8(18)12(22-3)23-10-6(16)4(2-14)21-11(20)9(10)19/h3-20H,1-2H2/t3-,4-,5-,6-,7+,8-,9+,10+,11-,12-/m1/s1"
1358,30544,germanetriyl group,a,36635,KEGG COMPOUND accession,C01454,,,,,,,,,,,,,,,
1359,30639,hexacyanomolybdate(3-),a,9666,KEGG COMPOUND accession,C11127,,,,,,,,,,,,,,,
1360,30707,hexafluoromolybdate(1-),a,9700,KEGG COMPOUND accession,C11285,,,,,,,,,,,,,,,
1361,30716,tetrafluoro(oxo)molybdenum,a,39501,KEGG COMPOUND accession,C07166,,,,,,,,,,,,,,,
1362,32615,isoleucine residue,a,17579,KEGG COMPOUND accession,C02094,caro,7235-40-7,17579.0,"Human Metabolome Database (HMDB): B-Carotene is a carotenoid that is a precursor of vitamin A. It is administered to reduce the severity of photosensitivity reactions in patients with erythropoietic protoporphyria (porphyria, erythropoietic). (From Reynolds JEF(Ed): Martindale: The Extra Pharmacopoeia (electronic version). Micromedex, Inc, Engewood, CO, 1995.) -- Pubchem; Carotene is an orange photosynthetic pigment important for photosynthesis. It is responsible for the orange colour of the carrot and many other fruits and vegetables. It contributes to photosynthesis by transmitting the light energy it absorbs to chlorophyll. Chemically, carotene is a terpene. It is the dimer of retinol (vitamin A) and comes in two primary forms: alpha- and beta-carotene. gamma-, delta- and epsilon-carotene also exist. Carotene can be stored in the liver and converted to vitamin A as needed. Beta-carotene is an anti-oxidant and such can be useful for curbing the excess of damaging free radicals in the body. However, the usefulness of beta-carotene as a dietary supplement (i.e. taken as a pill) is still subject to debate. Beta-carotene is fat-soluble, so a small amount of fat is needed to absorb it into the body. -- Wikipedia.",B-Carotene,HMDB0000561,b,b,C02094,CPD1F-129,FDB014613,caro,[H]/C(=C(/[H])\C(\[H])=C(\C(\[H])=C(/[H])\C(\[H])=C(\C(\[H])=C(/[H])C1=C(C([H])([H])[H])C([H])([H])C([H])([H])C([H])([H])C1(C([H])([H])[H])C([H])([H])[H])/C([H])([H])[H])/C([H])([H])[H])/C(/[H])=C(/C(/[H])=C(\[H])/C(/[H])=C(/C(/[H])=C(\[H])C1=C(C([H])([H])[H])C([H])([H])C([H])([H])C([H])([H])C1(C([H])([H])[H])C([H])([H])[H])\C([H])([H])[H])\C([H])([H])[H],OENHQHLEOONYIE-JLTXGRSLSA-N,"InChI=1S/C40H56/c1-31(19-13-21-33(3)25-27-37-35(5)23-15-29-39(37,7)8)17-11-12-18-32(2)20-14-22-34(4)26-28-38-36(6)24-16-30-40(38,9)10/h11-14,17-22,25-28H,15-16,23-24,29-30H2,1-10H3/b12-11+,19-13+,20-14+,27-25+,28-26+,31-17+,32-18+,33-21+,34-22+"
1363,31633,formoterol fumarate,"A racemate consisting of equal amounts of arformoterol fumarate (the active enantiomer) and (S,S)-formoterol fumarate (the inactive enantiomer). It is used (particularly in its dihydrate form) as a direct-acting sympathomimetic and bronchodilator for the treatment of chronic obstructive pulmonary disease (any progressive respiratory disease that makes it harder to breathe over time, such as chronic bronchitis and emphysema).",28545,KEGG COMPOUND accession,C06684,,,,,,,,,,,,,,,
1364,32440,alaninium,An alpha-amino-acid cation that is the conjugate acid of alanine.,10275,KEGG COMPOUND accession,C08315,,,,,,,,,,,,,,,
1365,31835,methylparaben,"A 4-hydroxybenzoate ester resulting from the formal condensation of the carboxy group of 4-hydroxybenzoic acid with methanol. It is the most frequently used antimicrobial preservative in cosmetics. It occurs naturally in several fruits, particularly in blueberries.",16408,KEGG COMPOUND accession,C01761,,,,,,,,,,,,,,,
1366,31744,kaempferol 3-O-beta-D-glucosyl-(1->2)-beta-D-glucosyl-(1->2)-beta-D-glucoside,A kaempferol O-glucoside that is kaempferol attached to a beta-D-sophorotriosyl residue at position 3 via a glycosidic linkage.,73154,KEGG COMPOUND accession,C08443,,,,,,,,,,,,,,,
1367,32845,serinate,An alpha-amino-acid anion that is the conjugate base of serine.,28002,KEGG COMPOUND accession,C05280,C05280,b,28002.0,"Human Metabolome Database (HMDB): cis,cis-3,6-Dodecadienoyl-CoA is an intermediate in Fatty acid metabolism. cis,cis-3,6-Dodecadienoyl-CoA is produced from trans,cis-Lauro-2,6-dienoyl-CoA via the enzyme dodecenoyl-CoA delta-isomerase (EC 5.3.3.8).","cis,cis-3,6-Dodecadienoyl-CoA",HMDB0003952,b,b,C05280,b,FDB023271,C05280,[H]O[C@@]([H])(C(=O)N([H])C([H])([H])C([H])([H])C(=O)N([H])C([H])([H])C([H])([H])SC(=O)C([H])([H])C(\[H])=C(\[H])C([H])([H])C(\[H])=C(\[H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H])C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])OP([O-])(=O)OP([O-])(=O)OC([H])([H])[C@@]1([H])O[C@@]([H])(N2C([H])=NC3=C(N=C([H])N=C23)N([H])[H])[C@]([H])(O[H])[C@]1([H])OP([O-])([O-])=O,KEPSPLQXVPROMK-ASJCJLDXSA-J,"InChI=1S/C33H54N7O17P3S/c1-4-5-6-7-8-9-10-11-12-13-24(42)61-17-16-35-23(41)14-15-36-31(45)28(44)33(2,3)19-54-60(51,52)57-59(49,50)53-18-22-27(56-58(46,47)48)26(43)32(55-22)40-21-39-25-29(34)37-20-38-30(25)40/h8-9,11-12,20-22,26-28,32,43-44H,4-7,10,13-19H2,1-3H3,(H,35,41)(H,36,45)(H,49,50)(H,51,52)(H2,34,37,38)(H2,46,47,48)/p-4/b9-8-,12-11-/t22-,26-,27-,28+,32-/m1/s1"
1368,32409,"(9Z,11E,13E,15Z)-octadecatetraenoic acid","The (9Z,11E,13E,15Z)-isomer of parinaric acid.",28539,KEGG COMPOUND accession,C02473,,,,,,,,,,,,,,,
1369,32292,vedaprofen,A racemate composed of equal amounts of (R)- and (S)-vedaprofen. Used for control of pain and inflammation particularly associated with chronic musculoskeletal disorders and soft tissue trauma in dogs and horses and for treatment of pain due to horse colic.,28425,KEGG COMPOUND accession,C05433,,,,,,,,,,,,,,,
1370,31644,gadoversetamide,"A gadolinium coordination entity that consists of Gd(3+) coordinated to 3,6,9-triazaundecadiamide in which each of the amide nitrogens is substituted by a 2-methoxyethyl group and in which the nitrogens at positions 3, 6, and 9 are each substituted by carboxylatomethyl group. The gadolinium is coordinated to the three tertiary amino groups as well as to the carboxylate groups. A white odourless powder that is freely soluble in water, gadoversetamide has paramagnetic properties and is used as a contrast agent in magnetic resonance imaging. It distributes mainly in extracellular fluid, but does not cross the blood-brain barrier. It is used particularly in imaging the brain, spine and liver.",27698,KEGG COMPOUND accession,C06267,,,,,,,,,,,,,,,
1371,31781,lopinavir,"A dicarboxylic acid diamide that is amphetamine is substituted on nitrogen by a (2,6-dimethylphenoxy)acetyl group and on the carbon alpha- to nitrogen by a (1S,3S)-1-hydroxy-3-{[(2S)-3-methyl-2-(2-oxotetrahydropyrimidin-1-yl)butanoyl]amino}-4-phenylbutyl group. An antiretroviral of the protease inhibitor class, it is used against HIV infections as a fixed-dose combination with another protease inhibitor, ritonavir.",15782,KEGG COMPOUND accession,C01540,,,,,,,,,,,,,,,
1372,31622,flunitrazepam,"A 1,4-benzodiazepinone that is nitrazepam substituted by a methyl group at position 1 and by a fluoro group at position 2'. It is a potent hypnotic, sedative, and amnestic drug used to treat chronic insomnia.",28727,KEGG COMPOUND accession,C08367,vacc,693-72-1,28727.0,"Human Metabolome Database (HMDB): Vaccenic acid is present in all tissues. Present in virtually all lipid classes at a low concentration, 18:1n7 is present at about 25% of the concentration of 18:1n9 in most phospholipids. A notable exception is the phospholipid cardiolipin, which often contains as much 18:1n7 as 18:1n9 (www.lipomics.com).",Vaccenic acid,HMDB0003231,b,b,C08367,b,FDB002952,vacc,[H]OC(=O)C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])=C([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H],UWHZIFQPPBDJPM-UHFFFAOYSA-N,"InChI=1S/C18H34O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18(19)20/h7-8H,2-6,9-17H2,1H3,(H,19,20)"
1373,31479,sodium dibunate,The sodium salt of dibunic acid. It is used as a cough suppressant.,27692,KEGG COMPOUND accession,C05893,,,,,,,,,,,,,,,
1374,31348,capecitabine,A carbamate ester that is cytidine in which the hydrogen at position 5 is replaced by fluorine and in which the amino group attached to position 4 is converted into its N-(penyloxy)carbonyl derivative. Capecitabine is a antineoplastic agent used in the treatment of cancers.,17200,KEGG COMPOUND accession,C00167,udpglcur,2616-64-0,17200.0,"Human Metabolome Database (HMDB): Uridine diphosphate glucuronic acid is a nucleoside diphosphate sugar which serves as a source of glucuronic acid for polysaccharide biosynthesis. It may also be epimerized to UDP Iduronic acid, which donates Iduronic acid to polysaccharides. In animals, UDP glucuronic acid is used for formation of many glucosiduronides with various aglycones. The transfer of glucuronic acid from UDP-alpha-D-glucuronic acid onto a terminal galactose residue is done by beta1,3-glucuronosyltransferases, responsible for the completion of the protein-glycosaminoglycan linkage region of proteoglycans and of the HNK1 epitope of glycoproteins and glycolipids. In humans the enzyme galactose-beta-1,3-glucuronosyltransferase I completes the synthesis of the common linker region of glycosaminoglycans (GAGs) by transferring glucuronic acid (GlcA) onto the terminal galactose of the glycopeptide primer of proteoglycans. The GAG chains of proteoglycans regulate major biological processes such as cell proliferation and recognition, extracellular matrix deposition, and morphogenesis. (PMID: 16815917).",Uridine diphosphate glucuronic acid,HMDB0000935,b,b,C00167,UDP-GLUCURONATE,FDB022325,udpglcur,[H]O[C@@]1([H])[C@@]([H])(O[C@]([H])(C([H])([H])OP([O-])(=O)OP([O-])(=O)O[C@@]2([H])O[C@]([H])(C([O-])=O)[C@@]([H])(O[H])[C@]([H])(O[H])[C@@]2([H])O[H])[C@@]1([H])O[H])N1C([H])=C([H])C(=O)N([H])C1=O,HDYANYHVCAPMJV-LXQIFKJMSA-K,"InChI=1S/C15H22N2O18P2/c18-5-1-2-17(15(26)16-5)12-9(22)6(19)4(32-12)3-31-36(27,28)35-37(29,30)34-14-10(23)7(20)8(21)11(33-14)13(24)25/h1-2,4,6-12,14,19-23H,3H2,(H,24,25)(H,27,28)(H,29,30)(H,16,18,26)/p-3/t4-,6-,7+,8+,9-,10-,11+,12-,14-/m1/s1"
1375,32770,3-fluoro-D-tyrosine,A member of the class of  monofluorobenzenes that is D-tyrosine substituted by a fluoro group at position 3.,28563,KEGG COMPOUND accession,C02209,,,,,,,,,,,,,,,
1376,31859,modafinil,"A racemate comprising equimolar amounts of armodafinil and (S)-modafinil. A central nervous system stimulant, it is used for the treatment of sleeping disorders such as narcolepsy, obstructive sleep apnoea, and shift-work sleep disorder. The optical enantiomers of modafinil have similar pharmacological actions in animals.",10033,KEGG COMPOUND accession,C01541,,,,,,,,,,,,,,,
1377,31892,naloxone hydrochloride,"A hydrochloride resulting from the formal reaction of equimolar amounts of naloxone and hydrogen chloride. A specific opioid antagonist, it is used to reverse the effects of opioids, both following their use of opioids during surgery and in cases of known or suspected opioid overdose.",10050,KEGG COMPOUND accession,C06488,,,,,,,,,,,,,,,
1378,32632,L-methioninium,The L-enantiomer of methioninium.,10363,KEGG COMPOUND accession,C09648,,,,,,,,,,,,,,,
1379,32609,D-isoleucinium,The D-enantiomer of isoleucinium.,10352,KEGG COMPOUND accession,C08616,,,,,,,,,,,,,,,
1380,31905,nicorandil,"A pyrimidinecarboxamide that is nicotinamide in which one of the hydrogens attached to the carboxamide nitrogen is replaced by a 2-(nitrooxy)ethyl group. It has both nitrate-like and ATP-sensitive potassium channel activator properties, and is used for the prevention and treatment of angina pectoris.",17712,KEGG COMPOUND accession,C00385,xan,69-89-6,17712.0,"Human Metabolome Database (HMDB): Xanthine is a purine base found in most body tissues and fluids, certain plants, and some urinary calculi. It is an intermediate in the degradation of adenosine monophosphate to uric acid, being formed by oxidation of hypoxanthine. The methylated xanthine compounds caffeine, theobromine, and theophylline and their derivatives are used in medicine for their bronchodilator effects (Dorland, 28th ed.). Xanthine is found to be associated with Lesch-Nyhan syndrome and xanthinuria type I, which are inborn errors of metabolism.",Xanthine,HMDB0000292,b,b,C00385,XANTHINE,FDB001977,xan,[H]N1C([H])=NC2=C1N([H])C(=O)N([H])C2=O,LRFVTYWOQMYALW-UHFFFAOYSA-N,"InChI=1S/C5H4N4O2/c10-4-2-3(7-1-6-2)8-5(11)9-4/h1H,(H3,6,7,8,9,10,11)"
1381,32323,beta-D-glucuronamide,A monosaccharide derivative that is the carboxamide of beta-D-glucuronic acid,28061,KEGG COMPOUND accession,C00984,gal,59-23-4,28061.0,"Human Metabolome Database (HMDB): D-Galactose is an aldohexose that occurs naturally in the D-form in lactose, cerebrosides, gangliosides, and mucoproteins. D-Galactose is an energy-providing nutrient and also a necessary basic substrate for the biosynthesis of many macromolecules in the body. Metabolic pathways for D-Galactose are important not only for the provision of these pathways but also for the prevention of D-Galactose and D-Galactose metabolite accumulation. The main source of D-Galactose is lactose in the milk of mammals, but it can also be found in some fruits and vegetables. Utilization of D-Galactose in all living cells is initiated by the phosphorylation of the hexose by the enzyme galactokinase (E.C. 2.7.1.6) (GALK) to form D-Galactose-1-phosphate. In the presence of D-Galactose-1-phosphate uridyltransferase (E.C. 2.7.7.12) (GALT) D-Galactose-1-phosphate is exchanged with glucose-1-phosphate in UDP-glucose to form UDP-galactose. Glucose-1-phosphate will then enter the glycolytic pathway for energy production. Deficiency of the enzyme GALT in galactosemic patients leads to the accumulation of D-Galactose-1-phosphate. Classic galactosemia-a term that denotes the presence of D-Galactose in the blood is the rare inborn error of D-Galactose metabolism, diagnosed by the deficiency of the second enzyme of the D-Galactose assimilation pathway, GALT, which, in turn, is caused by mutations at the GALT gene. (PMID: 15256214, 11020650, 10408771). Galactose in the urine is a biomarker for the consumption of milk.",D-Galactose,HMDB0000143,b,b,C00984,GALACTOSE,FDB012703,gal,[H]OC([H])([H])[C@@]1([H])O[C@]([H])(O[H])[C@]([H])(O[H])[C@@]([H])(O[H])[C@@]1([H])O[H],WQZGKKKJIJFFOK-PHYPRBDBSA-N,"InChI=1S/C6H12O6/c7-1-2-3(8)4(9)5(10)6(11)12-2/h2-11H,1H2/t2-,3+,4+,5-,6+/m1/s1"
1382,33163,dec-9-enoate,"A medium-chain, unsaturated, straight-chain fatty acid anion and the conjugate base of  dec-9-enoic acid (caproleic acid), arising from deprotonation of the carboxylic acid group.",28092,KEGG COMPOUND accession,C06114,HC01700,b,28092.0,Human Metabolome Database (HMDB): This compound belongs to the family of Alpha Amino Acids. These are amino acids in which the amino group is attached to the carbon atom immediately adjacent to the carboxylate group (alpha carbon). ,gamma-Glutamyl-beta-aminopropiononitrile,HMDB0060477,b,b,C06114,b,b,HC01700,[H]OC(=O)[C@@]([H])(N([H])[H])C([H])([H])C([H])([H])C(=O)N([H])C([H])([H])C([H])([H])C#N,VQPVVWAFTIFKDD-LURJTMIESA-N,"InChI=1S/C8H13N3O3/c9-4-1-5-11-7(12)3-2-6(10)8(13)14/h6H,1-3,5,10H2,(H,11,12)(H,13,14)/t6-/m0/s1"
1383,32943,octacosane,A straight-chain alkane containing 28 carbon atoms.,17713,KEGG COMPOUND accession,C00360,damp,653-63-4,17713.0,"Human Metabolome Database (HMDB): Adenosine is a nucleoside comprised of adenine attached to a ribose (ribofuranose) moiety via a -N9-glycosidic bond. Deoxyadenosine monophosphate is a derivative of the common nucleic acid ATP, or adenosine triphosphate, in which the -OH (hydroxyl) group on the 2' carbon on the nucleotide's pentose has been removed (hence the deoxy- part of the name). Additionally, the monophosphate of the name indicates that two of the phosphoryl groups of GTP have been removed, most likely by hydrolysis. Deoxyadenosine monophosphate is abbreviated dAMP. (Wikipedia).",Deoxyadenosine monophosphate,HMDB0000905,b,b,C00360,DAMP,FDB022311,damp,[H]O[C@@]1([H])C([H])([H])[C@@]([H])(O[C@]1([H])C([H])([H])OP([O-])([O-])=O)N1C([H])=NC2=C(N=C([H])N=C12)N([H])[H],KHWCHTKSEGGWEX-RRKCRQDMSA-L,"InChI=1S/C10H14N5O6P/c11-9-8-10(13-3-12-9)15(4-14-8)7-1-5(16)6(21-7)2-20-22(17,18)19/h3-7,16H,1-2H2,(H2,11,12,13)(H2,17,18,19)/p-2/t5-,6+,7+/m0/s1"
1384,31526,(S)-duloxetine hydrochloride,A duloxetine hydrochloride in which the duloxetine moiety has S configuration.,17145,KEGG COMPOUND accession,C03312,,,,,,,,,,,,,,,
1385,32730,tryptophanyl radical,An alpha-amino-acid radical derived from tryptophan.,28393,KEGG COMPOUND accession,C08349,,,,,,,,,,,,,,,
1386,30297,antimonite,A trivalent inorganic anion obtained by removal of all three protons from antimonous acid.,18385,KEGG COMPOUND accession,C00378,thm,59-43-8,18385.0,"Human Metabolome Database (HMDB): Thiamine or thiamin, also known as vitamin B1, is a colorless compound with the chemical formula C12H17N4OS. It is soluble in water and insoluble in alcohol. Thiamine decomposes if heated. Thiamine was first discovered by Umetaro Suzuki in Japan when researching how rice bran cured patients of Beriberi. Thiamine plays a key role in intracellular glucose metabolism and it is thought that thiamine inhibits the effect of glucose and insulin on arterial smooth muscle cell proliferation. thiamine plays an important role in helping the body convert carbohydrates and fat into energy. It is essential for normal growth and development and helps to maintain proper functioning of the heart and the nervous and digestive systems. Thiamine cannot be stored in the body; however, once absorbed, the vitamin is concentrated in muscle tissue.",Thiamine,HMDB0000235,b,b,C00378,THIAMINE,FDB008425,thm,[H]OC([H])([H])C([H])([H])C1=C([N+](=C([H])S1)C([H])([H])C1=C([H])N=C(N=C1N([H])[H])C([H])([H])[H])C([H])([H])[H],JZRWCGZRTZMZEH-UHFFFAOYSA-N,"InChI=1S/C12H17N4OS/c1-8-11(3-4-17)18-7-16(8)6-10-5-14-9(2)15-12(10)13/h5,7,17H,3-4,6H2,1-2H3,(H2,13,14,15)/q+1"
1387,31843,mianserin hydrochloride,"The hydrochloride salt of mianserin, a tetracyclic compound with antidepressant effects.",10023,KEGG COMPOUND accession,C07622,,,,,,,,,,,,,,,
1388,32471,aspartate residue,An alpha-amino-acid residue anion resulting from the deprotonation of the carboxy group of an aspartic acid residue.,27848,KEGG COMPOUND accession,C02757,,,,,,,,,,,,,,,
1389,30496,sulfur hexafluoride,"A sulfur coordination entity consisting of six fluorine atoms attached to a central sulfur atom. It is the most potent greenhouse gas currently known, with a global warming potential of 23,900 times that of CO2 over a 100 year period (SF6 has an estimated lifetime in the atmosphere of between 800 and 3,000 years).",9599,KEGG COMPOUND accession,C07141,,,,,,,,,,,,,,,
1390,31429,colforsin daropate hydrochloride,The hydrochloride salt of colforsin daropate. It is a drug used for the treatment of acute heart failure. It directly stimulates adenylate cyclase and produces positive inotropic and vasodilator effects accompanied by the increase in cellular cAMP.,18160,KEGG COMPOUND accession,C01967,,,,,,,,,,,,,,,
1391,65274,5-methylcytosin-1-yl group,An organic group obtained by removal of the hydrogen attached to the nitrogen at position 1 from 5-methylcytosine.,14737,KEGG COMPOUND accession,C00522,,,,,,,,,,,,,,,
1392,65288,phosphatidylcholine 28:6,"A 1,2-diacyl-sn-glycero-3-phosphocholine in which the acyl groups at C-1 and C-2 contain 28 carbons in total with 6 double bonds.",28261,KEGG COMPOUND accession,C06306,,,,,,,,,,,,,,,
1393,65290,phosphatidylcholine 28:4,"A 1,2-diacyl-sn-glycero-3-phosphocholine in which the acyl groups at C-1 and C-2 contain 28 carbons in total with 4 double bonds.",15390,KEGG COMPOUND accession,C03036,,,,,,,,,,,,,,,
1394,65295,N-alkylphthalic monoamide(1-),A benzoate anion formed by deprotonation of the carboxy OH group of N-alkylphthalic monoamide. Major structure at pH 7.3.,15393,KEGG COMPOUND accession,C01765,,,,,,,,,,,,,,,
1395,65297,phosphatidylcholine 30:6,"A 1,2-diacyl-sn-glycero-3-phosphocholine in which the acyl groups at C-1 and C-2 contain 30 carbons in total with 6 double bonds.",15395,KEGG COMPOUND accession,C03190,,,,,,,,,,,,,,,
1396,65300,phosphatidylcholine 30:3,"A 1,2-diacyl-sn-glycero-3-phosphocholine in which the acyl groups at C-1 and C-2 contain 30 carbons in total with 3 double bonds.",15396,KEGG COMPOUND accession,C00808,,,,,,,,,,,,,,,
1397,65308,thionitrous acid,A nitroso compound that is hydrogen sulfide in which one of the hydrogens is replaced by a nitroso group.,15387,KEGG COMPOUND accession,C02213,,,,,,,,,,,,,,,
1398,65311,corticotropin-releasing hormone,"A family of peptide hormones derived from a 191-membered prehormone, secreted by the paraventricular nucleus (PVN) of the hypothalamus in response to stress. The first full sequence was discovered in sheep, those in rats and humans differ from the ovine sequence by 7 amino acids.",18446,KEGG COMPOUND accession,C08482,,,,,,,,,,,,,,,
1399,65322,hemiterpenoid indole alkaloid,A terpenoid indole alkaloid which is biosynthesised from L-tryptophan and monoisoprenoid (usually dimethylallyl pyrophosphate or isopentenyl pyrophosphate) building blocks,15402,KEGG COMPOUND accession,C00553,,,,,,,,,,,,,,,
1400,65329,LY294002,A chromone substituted with a phenyl group at position 8 and a morpholine group at position 2.,15403,KEGG COMPOUND accession,C01868,,,,,,,,,,,,,,,
1401,65356,abacopterin C,"An organic heterotetracyclic compound resulting from cyclocondensation of the 4- and 5-hydroxy groups of (2S,4S)-2-(4-methoxyphenyl)-6,8-dimethylchromane-4,5,7-triol across the 1- and 2-positions of 1,2-didehydro-D-glucose. A natural product found in Abacopteris penangiana.",28395,KEGG COMPOUND accession,C04167,,,,,,,,,,,,,,,
1402,65368,aculeatol E,"An oxaspiro compound that is 1,7-dioxadispiro[5.1.5.2]pentadec-9-en-11-one substituted by hydroxy groups at positions 4 and 13 and a tridecyl group at position 2 (the (2R,4R,6S,8R,13S stereoisomer). It is isolated from the leaves of Amomum aculeatum and exhibits toxicity against some cancer cell lines like human lung carcinoma, hormone-dependent lung carcinoma and human breast carcinoma.",28660,KEGG COMPOUND accession,C06308,,,,,,,,,,,,,,,
1403,65375,agrochelin,"A member of the class thiazolidines that is (3S)-3-hydroxy-2,2-dimethyl-3-[(4R)-3-methyl-1,3-thiazolidin-4-yl]propanoic acid which is substituted at position 2 by a (4R)-2-(2-hydroxy-6-pentylphenyl)-4,5-dihydro-1,3-thiazol-4-yl group. A cytotoxic antibiotic, it is produced by the fermentation of Agrobacterium.",15394,KEGG COMPOUND accession,C01766,,,,,,,,,,,,,,,
1404,65378,albibrissinoside A,A disaccharide derivative isolated from the stems of Albizia julibrissin that exhibits antioxidant activity.,15397,KEGG COMPOUND accession,C00809,,,,,,,,,,,,,,,
1405,65416,aplysiallene,"A furofuran that is hexahydrofuro[3,2-b]furan which is substituted at position 2 by a (1E,3E)-4-bromohexa-1,3-dien-1-yl  group and at position 5 by a (1R)-3-bromopropadienyl group (the 2R,3aS,5R,6aS diastereoisomer). A natural product first isolated from the red alga Laurencia okamurai Yamada and subsequently found in the sea hare Aplysia kurodai, aplysiallene is an inhibitor of sodium-potassium adenosine triphosphatase.",15411,KEGG COMPOUND accession,C03962,,,,,,,,,,,,,,,
1406,65428,ardisianoside D,"A triterpenoid saponin that is composed of (3beta,16alpha)-13,28-epoxyoleanane-3,16-diol having a beta-D-Xylp-(1->2)-beta-D-Glcp-(1->4)-alpha-L-Arap moiety attached to position 3 by a glycosidic linkage. It is isolated from the whole plants of Ardisia japonica and exhibits significant cytotoxicity against a panel of human cancer cell lines.",15412,KEGG COMPOUND accession,C00603,M03122,b,15412.0,Human Metabolome Database (HMDB): (S)-Ureidoglycolic acid is a substrate of enzyme ureidoglycolate dehydrogenase [EC 1.1.1.154] in purine metabolism pathway (KEGG).,(S)-Ureidoglycolic acid,HMDB0001005,b,b,C00603,CPD-1091,FDB022364,b,[H]OC(=O)[C@]([H])(O[H])N([H])C(=O)N([H])[H],NWZYYCVIOKVTII-SFOWXEAESA-N,"InChI=1S/C3H6N2O4/c4-3(9)5-1(6)2(7)8/h1,6H,(H,7,8)(H3,4,5,9)/t1-/m0/s1"
1407,65437,arisugacin C,"An organic heterotetracyclic compound that is 4,4,6a,12b-tetramethyl-1,4a,5,6,6a,12,12a,12b-octahydro-2H,11H-benzo[f]pyrano[4,3-b]chromene-3,11(4H)-dione substituted at position 4a by a hydroxy and and at position 9 by 4-methoxyphenyl group (the 4aS,6aR,12aR,12bR stereoisomer). Isolated from the culture broth of Penicillium, it acts as a selective inhibitor of acetylcholinesterase.",15444,KEGG COMPOUND accession,C00277,,,,,,,,,,,,,,,
1408,65442,artoindonesianin P,"An extended flavonoid that is 5a,6-dihydro-5H,7H-[1]benzofuro[3,4-bc]xanthen-7-one substituted by hydroxy groups at positions 1, 3, 8 and 10 and geminal methyl groups at position 5. It is isolated from the tree barks of Artocarpus lanceifolius and exhibits cytotoxicity against human murine leukemia cells.",15448,KEGG COMPOUND accession,C04316,,,,,,,,,,,,,,,
1409,65444,AS-186b,A dibenzodioxocine that is the 1'-O-acetyl derivative of penicillide. It is isolated from Penicillium purpurogenum and acts as an acyl-CoA:cholesterol acyltransferase inhibitor.,15558,KEGG COMPOUND accession,C04742,,,,,,,,,,,,,,,
1410,65449,ascidiathiazone B,"An organic heterotricyclic compound, that is 5,10-dioxo-5,10-dihydro-1H-[1,4]thiazino[3,2-g]quinoline 4,4-dioxide substituted at position 7 by a carboxy group. It is an anti-inflmmatory alkaloid obtained from Aplidium.",15562,KEGG COMPOUND accession,C00451,,,,,,,,,,,,,,,
1411,65453,asphodelin A,"A hydroxycoumarin that is 4,7-dihydroxy-2H-chromen-2-one substituted by a 2,4-dihydroxyphenyl group at position 3. It is isolated from the roots of Asphodelus microcarpus and exhibits antimicrobial activity against bacteria like Staphylococcus aureus, Escherichia coli and Pseudomonas aeruginosa and fungal microorganisms like Candida albicans and Botrytis cinerea.",15565,KEGG COMPOUND accession,C04592,,,,,,,,,,,,,,,
1412,65458,aureoquinone,"A naphthoquinone that is 1,4-naphthoquinone substituted by hydroxy groups at positions 2, 5, 7,and 8 and methyl groups at positions 3 and 6. It is isolated from surface cultures of Aureobasidium and acts as a protease inhibitor.",15563,KEGG COMPOUND accession,C04617,,,,,,,,,,,,,,,
1413,65463,ballodiolic acid,"A diterpenoid that is 3,4,4a,5,6,7,8,8a-octahydronaphthalene-1-carboxylic acid substituted by methyl groups at positions 5, 6 and 8a and a 5-hydroxy-3-(hydroxymethyl)pentyl group at position 5 (the 4aR,5S,6R,8aR stereoisomer). It is isolated from the whole plant of Ballota limbata (Syn.Otostegia limbata) and acts as a lipoxygenase inhibitor.",15566,KEGG COMPOUND accession,C04687,,,,,,,,,,,,,,,
1414,65468,bauhinoxepin A,"An organic heterotetracyclic compound that is 3H-chromeno[6,5-b][1]benzoxepine substituted by geminal methyl groups at position 3, a single methyl group at position 5 and hydroxy groups at positions 6 and 11. It is isolated from the roots of Bauhinia saccocalyx and exhibits antimycobacterial activity.",15567,KEGG COMPOUND accession,C04670,,,,,,,,,,,,,,,
1415,65490,BF 6,"An organic heterotetracyclic compound that is 8,12-dihydro-2H,9H-pyrano[2,3-a]xanthene-4,9,11(3H,10H)-trione substituted by methyl groups at positions 6, 8, 8, 10 and 10 and phenyl groups at positions 2 and 12 respectively (the S-enantiomer). It is isolated from the leaves of Baeckea frutescens and exhibits cytotoxicity against leukemia cells.",15574,KEGG COMPOUND accession,C04715,,,,,,,,,,,,,,,
1416,65512,brartemicin,"A glycosyl glycoside derivative that consists of alpha,alpha-trehalose substituted at positions 6 and 6' by O-2,4-dihydroxy-6-methylbenzoyl groups. It is isolated from the culture broth of actinomycete, Nonomuraea, and has antitumor activity.",15580,KEGG COMPOUND accession,C04834,,,,,,,,,,,,,,,
1417,65516,brasiliquinone A,"A carbopolycyclic compound that is (3S)-3-ethyl-6,8-dihydroxy-3,4-dihydrotetraphene-1,7,12(2H)-trione substituted at position 8 by a 3-amino-2,3,6-trideoxy-alpha-L-ribo-hexopyranosyl group. It is isolated from the culture broth of Nocardia brasiliensis and exhibits antibacterial activity against Gram-positive bacteria. It is also active against the multiple drug-resistant P388/ADR tumour cells.",15582,KEGG COMPOUND accession,C03652,,,,,,,,,,,,,,,
1418,65521,brasixanthone D,"A member of the class of pyranoxanthones that is 2H,6H-pyrano[3,2-b]xanthen-6-one substituted by a 2-[(2S)-3,3-dimethyloxiran-2-yl]-2-hydroxyethyl group at position 12, hydroxy groups at positions 5 and 8 and geminal methyl groups at position 2. It is isolated from the stem bark of Calophyllum brasiliense and exhibits significant inhibitory activity against 12-O-tetradecanoylphorbol-13-acetate induced Epstein-Barr virus early antigen activation in Raji cells.",15605,KEGG COMPOUND accession,C02345,,,,,,,,,,,,,,,
1419,65528,bruceanol F,A quassinoid isolated from Brucea antidysenterica and has been shown to exhibit in vitro cytotoxicity towards several human tumour cell lines.,15607,KEGG COMPOUND accession,C04593,,,,,,,,,,,,,,,
1420,65530,15-O-acetylbruceolide,A  quassinoid that is the 15-O-acetyl derivative of bruceolide. It has been isolated from Brucea javanica and Brucea sumatrana.,15608,KEGG COMPOUND accession,C04655,,,,,,,,,,,,,,,
1421,65552,(+)-calanolide A,"An organic heterotetracyclic compound that is 11,12-dihydro-2H,6H,10H-dipyrano[2,3-f:2',3'-h]chromen-2-one substituted by a hydroxy group at position 12, methyl groups at positions 6, 6, 10 and 11 and a propyl group at position 4 (the 10R,11S,12S stereoisomer). Isolated from Calophyllum lanigerum var austrocoriaceum and Calophyllum brasiliense, it exhibits potent activity against HIV-1 reverse transcriptase.",30934,KEGG COMPOUND accession,C02612,,,,,,,,,,,,,,,
1422,65569,camellianoside,A quercetin O-glucoside consisting of quercetin having a beta-D-xylopyranosyl-(1->3)-6-deoxy-alpha-L-mannopyranosyl-(1->6)-beta-D-glucopyranosyl residue at position 3. It is isolated from the leaves of Camellia japonica and exhibits antioxidant activity.,15459,KEGG COMPOUND accession,C00566,,,,,,,,,,,,,,,
1423,65572,candelalide B,A diterpenoid isolated from Sesquicillium candelabrum and has been shown to act as a blocker of the voltage-gated potassium channel Kv1.3.,15564,KEGG COMPOUND accession,C06318,,,,,,,,,,,,,,,
1424,65578,cardivin C,"A germacranolide isolated from the aerial parts of Carpesium divaricatum. It exhibits cytotoxicity against the human tumor cells, A-549 (nonsmall cell lung), SK-OV-3 (ovary), SK-MEL-2 (skin), XF-498 (central nervous system) and HCT-15 (colon).",15577,KEGG COMPOUND accession,C03910,,,,,,,,,,,,,,,
1425,65581,caribenol B,"A cyclic terpene ketone that is 2a,3,4,5,5a,6,7,8-octahydroacenaphthylen-1(2H)-one substituted by hydroxy groups at positions 2 and 2a, methyl groups at positions 2, 5 and 8 and a 2-methylprop-1-en-1-yl group at position 3. It is isolated from the the West Indian gorgonian octocoral Pseudopterogorgia elisabethae and exhibits antitubercular and antimalarial activity.",17431,KEGG COMPOUND accession,C00179,agm,306-60-5,17431.0,"Human Metabolome Database (HMDB): Agmatine ((4-aminobutyl)guanidine, NH2-CH2-CH2-CH2-CH2-NH-C(-NH2)(=NH)) is the decarboxylation product of the amino acid arginine and is an intermediate in polyamine biosynthesis. It is a putative neurotransmitter. It is synthesized in the brain, stored in synaptic vesicles, accumulated by uptake, released by membrane depolarization, and inactivated by agmatinase. Agmatine binds to 2-adrenergic receptor and imidazoline binding sites, and blocks NMDA receptors and other cation ligand-gated channels. Agmatine inhibits nitric oxide synthase (NOS), and induces the release of some peptide hormones. Treatment with exogenous agmatine exerts neuroprotective effects in animal models of neurotrauma. -- Wikipedia.",Agmatine,HMDB0001432,b,b,C00179,AGMATHINE,FDB008310,agm,[H]N([H])C(N([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[N+]([H])([H])[H])=[N+]([H])[H],QYPPJABKJHAVHS-UHFFFAOYSA-P,"InChI=1S/C5H14N4/c6-3-1-2-4-9-5(7)8/h1-4,6H2,(H4,7,8,9)/p+2"
1426,65588,caseanigrescen A,A diterpenoid of the clerodane group isolated from the leaves and flowers of Casearia nigrescens. It exhibits cytotoxicity against A2780 human ovarian cancer cell line.,15623,KEGG COMPOUND accession,C04349,,,,,,,,,,,,,,,
1427,65592,caseargrewiin A,A diterpenoid of the clerodane group isolated from the bark of Casearia grewiifolia and has been shown to exhibit antimalarial and antimycobacterial activity.,15624,KEGG COMPOUND accession,C04471,,,,,,,,,,,,,,,
1428,65622,3beta-[(beta-D-glucopyranosyl)oxy]-17alpha-hydroxy-16beta-[(O-beta-D-xylopyranosyl)-(1->3)-2-O-acetyl-alpha-L-arabinopyranosyloxy]cholest-5-en-22-one,"A steroid saponin that is 3,16,17-trihydroxycholest-5-en-22-one attached to a beta-D-glucopyranosyl residue at position 3 and a 2-O-acetyl-3-O-(beta-D-xylopyranosyl)-alpha-L-arabinopyranosyl residue at position 16 via a glycosidic linkage. Isolated from Ornithogalum thyrsoides and Galtonia candicans, it exhibits cytotoxic activity.",15648,KEGG COMPOUND accession,C04271,,,,,,,,,,,,,,,
1429,65631,ciliatamide B,"A lipopeptide that contains N-methylphenylalanine and lysine as the amino acid residues linked to a octanoyl moiety via an amide linkage (the R,R stereoisomer). It is isolated from the deep sea sponge Aaptos ciliata and exhibits antileishmanial and moderate cytotoxicity towards HeLa cells.",15639,KEGG COMPOUND accession,C00664,5forthf,2311-81-1,15639.0,Human Metabolome Database (HMDB): 5-Formiminotetrahydrofolic acid is a substrate for Formimidoyltransferase-cyclodeaminase.,5-Formiminotetrahydrofolic acid,HMDB0001534,b,b,C00664,5-FORMIMINO-THF,FDB022676,5forthf,[H]OC1=NC(=NC2=C1N(C([H])=N[H])C([H])(C([H])([H])N([H])C1=C([H])C([H])=C(C([H])=C1[H])C(=O)N([H])C([H])(C([O-])=O)C([H])([H])C([H])([H])C([O-])=O)C([H])([H])N2[H])N([H])[H],YCWUVLPMLLBDCU-ZVBGSRNCSA-L,"InChI=1S/C20H24N8O6/c21-9-28-12(8-24-16-15(28)18(32)27-20(22)26-16)7-23-11-3-1-10(2-4-11)17(31)25-13(19(33)34)5-6-14(29)30/h1-4,9,12-13,21,23H,5-8H2,(H,25,31)(H,29,30)(H,33,34)(H4,22,24,26,27,32)/p-2/b21-9+"
1430,65635,citrafungin A,"A carboxylic ester obtained by the formal condensation of 4-carboxy group of (2R)-2-hydroxy-2-{(3R,5R)-2-oxo-5-[(1E,5Z)-tetradeca-1,5-dien-1-yl]tetrahydrofuran-3-yl}butanedioic acid with the hydroxy group of 3-carboxy-2,3-dideoxy-L-threo-pentaric acid. It is a fungal metabolite that acts as an inhibitor of geranylgeranyltransferase type I(GGTase I) of pathogenic fungal species.",15643,KEGG COMPOUND accession,C06487,,,,,,,,,,,,,,,
1431,65644,clionastatin A,"An androstanoid  that is androsta-3,5,8,16-tetraene substituted by chloro groups at positions 1, 12 and 19 and oxo groups at positions 7 and 15 (the 1beta,2alpha stereoisomer). It is isolated from burrowing sponge Cliona nigricans and exhibits cytotoxic efficacy.",15644,KEGG COMPOUND accession,C04856,,,,,,,,,,,,,,,
1432,65648,cochinchinone C,A polycyclic cage that is a prenylated-caged xanthone isolated from Cratoxylum cochinchinense and has been shown to exhibit antimalarial and antioxidant activities.,15645,KEGG COMPOUND accession,C03325,,,,,,,,,,,,,,,
1433,65654,conferol B,"A member of the class of isoflavans that is isoflavan with a hydroxy group at position 4, a methyl group at position 7 and a methoxy group at position 2'   (the 3R,4S stereoisomer). It is isolated from Caragana conferta and exhibits significant anti-inflammatory activity in the respiratory burst assay.",36438,KEGG COMPOUND accession,C04672,,,,,,,,,,,,,,,
1434,65669,crassolide,A cembrane diterpenoid isolated from Lobophytum michaelae and has been shown to exhibit cytotoxic activity.,18624,KEGG COMPOUND accession,C06609,,,,,,,,,,,,,,,
1435,65674,cratoxyarborenone D,"An organic heterotetracyclic compound that is 2,3-dihydro-5H-furo[3,2-b]xanthen-5-one substituted by hydroxy groups at positions 4, 7, 8 and 9, an isoprenyl group at position 6 and a prop-1-en-2-yl group at position 2. It is isolated from Cratoxylum Sumatranum and exhibits cytotoxicity towards the KB (human oral epidermoid) cancer cell line.",15659,KEGG COMPOUND accession,C04621,,,,,,,,,,,,,,,
1436,65678,CT2108A,"An azaphilone that is 7,8-dihydro-6H-oxireno[j]isochromene substituted by a hepta-1,3,5-trien-1-yl group at position 3, a [3-hydroxybutanoyl]oxy group at position 7, a methyl group at position 7 and oxo groups at positions 6 and 8 respectively (the 3S,7S stereoisomer). A fungal metabolite, it is isolated from the fermentation broth of Penicillium solitum strain CT2108 and exhibits inhibitory activity against fatty acid synthase as well as fungicidal activity.",15666,KEGG COMPOUND accession,C04350,,,,,,,,,,,,,,,
1437,65680,"(2S)-6-(gamma,gamma-dimethylallyl)-5-hydroxy-3',4'-dimethoxy-6'',6''-dimethylpyran[2'',3'':7,8]flavanone","An extended flavonoid that consists of (2S)-flavanone substituted by a hydroxy group at position 5, methoxy groups at positions 3' and 4' , a prenyl group at position 6 and a gem-dimethylpyran ring fused across positions 7 and 8. Isolated from  Lonchocarpus utilis and Lonchocarpus urucu, it acts as a NADH:ubiquinone reductase inhibitor.",15668,KEGG COMPOUND accession,C04434,,,,,,,,,,,,,,,
1438,65687,cudranian 1,"A flavonol 7-O-beta-D-glucoside that is kaempferol substituted by a p-hydroxybenzyl group at position 6 and a beta-D-glucopyranosyl moiety at position 7 via a glycosidic linkage. It is isolated from the root barks of Cudrania tricuspidata and exhibits radical scavenging effects against 1, 1-diphenyl-2-picrylhydrazyl (DPPH) and anti-lipid peroxidation efficacy on human low-density lipoprotein by TBARS assay.",15464,KEGG COMPOUND accession,C02611,,,,,,,,,,,,,,,
1439,65690,cumingianoside B,"A triterpenoid saponin that is 13,30-cyclodammarane-3,7,23,24,25-pentol esterified to the corresponding acetate at position 3 and attached to a beta-D-glucopyranosyl residue at position 7 via a glycosidic linkage. Isolated from Dysoxylum cumingianum, it exhibits antileukemic activity.",46762,KEGG COMPOUND accession,C09094,,,,,,,,,,,,,,,
1440,65708,cyclomontanin D,"A homodetic cyclic peptide composed of L-alanyl, Lasparaginyl, L-prolylglycyl, L-leucyl, L-prolyl and L-tyrosyl residues linked in a sequence. It is isolated from the seeds of Annona montana and has been shown to exhibit anti-inflammatory activity.",15675,KEGG COMPOUND accession,C03194,,,,,,,,,,,,,,,
1441,65710,cystodytin D,"An alkaloid that is an enamide obtained by the formal condensation of 3-methylbut-2-enoic acid with 6-(2-amino-1-hydroxyethyl)-4H-pyrido[2,3,4-kl]acridin-4-one. It is isolated from the Okinawan marine tunicate Cystodytes dellechiajei and exhibits cytotoxicity against human epidermoid carcinoma KB cells.",15683,KEGG COMPOUND accession,C03195,,,,,,,,,,,,,,,
1442,65719,cytosporic acid,"A monocarboxylic acid that is 3,8-dimethyl-5-oxo-1,2,3,4,4a,8a-hexahydronaphthalene-1-carboxylic acid substituted by a (2R)-hexan-2-yl at position 7, a hydroxy group at position 6 and a 3-hydroxypropanoyl group at position 8. It is a fungal metabolite produced by Cytospora with HIV-1 integrase inhibitory activity.",15583,KEGG COMPOUND accession,C02488,,,,,,,,,,,,,,,
1443,65729,decatromicin B,A carbohydrate-containing antibiotic isolated from Actinomadura sp. MK73-NF4. It specifically inhibits the growth of gram-positive bacteria including multi-drug resistant strains such as Staphylococcus aureus MS9610 and menthicilin-resistant S.aureus (MRSA).,15913,KEGG COMPOUND accession,C03042,,,,,,,,,,,,,,,
1444,65738,(-)-demethoxylpinoresinol,"A lignane that is the demethoxy derivative of (-)-pinoresinol. Isolated from Balanophora abbreviata, it exhibits inhibitory activity against nitric oxide synthase.",15587,KEGG COMPOUND accession,C01088,,,,,,,,,,,,,,,
1445,65742,5-O-demethylpaxanthonin,"A member of the class of xanthones consisting of paxanthonin in which the methoxy group at position 5 is replaced by a hydroxy group. Isolated from the roots of Hypericum roeperianum and leaves of Hypericum styphelioides, it exhibits antioxidant and antifungal activities.",16003,KEGG COMPOUND accession,C03964,,,,,,,,,,,,,,,
1446,65764,dicerandrol A,"A biaryl that is 5,5',7,7',9,9',10a,10a'-octahydro-6H,6'H-2,2'-bixanthene substituted by acetoxy groups at C-5 and C-5', hydroxy groups at C-1, C-1', C-8 and C-8', hydroxymethyl groups at C-10a and C-10a', methyl groups at C-6 and C-6' and oxo groups at C-9 and C-9' respectively. A dimeric tetrahydroxanthone derivative isolated from Phomopsis longicolla, it exhibits antibacterial and cytotoxic activities.",16654,KEGG COMPOUND accession,C01053,,,,,,,,,,,,,,,
1447,65766,dicerandrol C,"A biaryl that is 5,5',7,7',9,9',10a,10a'-octahydro-6H,6'H-2,2'-bixanthene substituted by acetyloxy groups at C-5 and C-5', (acetyloxy)methyl group at C-10a and C-10a', hydroxy groups at C-1, C-1', C-8 and C-8', methyl groups at C-6 and C-6' and oxo groups at C-9 and C-9' respectively. A dimeric tetrahydroxanthone derivative isolated from Phomopsis longicolla, it exhibits antibacterial and cytotoxic activities.",27996,KEGG COMPOUND accession,C05343,,,,,,,,,,,,,,,
1448,65771,"6'',7''-dihydro-5',5'''-dicapsaicin","A capsaicinoid that is a dimer obtained by replacement of the hydrogen at position 5' of capsaicin with 6'',7''-dihydrocapsaicin. It is isolated from the dried fruits of Capsicum annuum and exhibits antioxidant activity.",15899,KEGG COMPOUND accession,C01143,5dpmev,1492-08-6,15899.0,"Human Metabolome Database (HMDB): 5-pyrophosphomevalonate is a metabolic intermediate in the mevalonate pathway, catalyzed by the enzyme phosphomevalonate kinase from 5-phosphomevalonate. (wikipedia).",(S)-5-Diphosphomevalonic acid,HMDB0001090,b,b,C01143,CPD-641,FDB022420,5dpmev,[H]O[C@@](C([H])([H])[H])(C([H])([H])C([O-])=O)C([H])([H])C([H])([H])OP([O-])(=O)OP([O-])([O-])=O,SIGQQUBJQXSAMW-ZCFIWIBFSA-J,"InChI=1S/C6H14O10P2/c1-6(9,4-5(7)8)2-3-15-18(13,14)16-17(10,11)12/h9H,2-4H2,1H3,(H,7,8)(H,13,14)(H2,10,11,12)/p-4/t6-/m1/s1"
1449,65773,"3,5-dihydroxy-2-(1'-oxo-3'-hexadecenyl)-2-cyclohexene-1-one",A polyketide that consists of cyclohex-2-en-1-one substituted by hydroxy groups at positions 3 and 5 and a hexadec-3-enoyl group at position 2 (the 3E stereoisomer). It is isolated form the leaves of Virola sebifera an exhibits cytotoxic activity against human tumour cells.,17436,KEGG COMPOUND accession,C01107,5pmev,73566-35-5,17436.0,"Human Metabolome Database (HMDB): 5-Phosphomevalonate is a metabolic intermediate in the mevalonate pathway, catalyzed by the enzyme mevalonate kinase from Mevalonate. (wikipedia).",Mevalonic acid-5P,HMDB0001343,b,b,C01107,CPD-499,FDB022566,5pmev,[H]O[C@@](C([H])([H])[H])(C([H])([H])C([O-])=O)C([H])([H])C([H])([H])OP([O-])([O-])=O,OKZYCXHTTZZYSK-ZCFIWIBFSA-K,"InChI=1S/C6H13O7P/c1-6(9,4-5(7)8)2-3-13-14(10,11)12/h9H,2-4H2,1H3,(H,7,8)(H2,10,11,12)/p-3/t6-/m1/s1"
1450,65778,"16beta,17-dihydroxy-ent-kaurane-19-oic acid",A ent-kaurane diterpenoid that is ent-kaurane-19-oic acid substituted by hydroxy groups at positions 16 and 17 (the 16beta stereoisomer). It is isolated from Helianthus sp. and Annona squamosa and exhibits anti-HIV activity.,16387,KEGG COMPOUND accession,C05243,,,,,,,,,,,,,,,
1451,65781,"3beta,12-dihydroxy-13-methyl-5,8,11,13-podocarpatetraene-7-one","A diterpenoid that is podocarpa-5,8,11,13-tetraen-7-one substituted by hydroxy groups at positions 3 and 12 and a methyl group at position 13 (the 3beta stereoisomer). Isolated from Securinega suffruticosa, it exhibits antineoplastic activity.",15694,KEGG COMPOUND accession,C03451,lgt_S,25138-66-3,15694.0,"Human Metabolome Database (HMDB): S-Lactoylglutathione is a substrate of lactoylglutathione lyase [EC 4.4.1.5] in pyruvate metabolism (KEGG). Another enzyme, glyoxalase I, synthesizes this compound by converting methylglyoxal and reduced glutathione to S-lactoylglutathione. S-D-lactoylglutathione can be hydrolysed by thiolesterases to reduced glutathione and D-lactate but also converted to N-D-lactoylcysteinylglycine and N-D-lactoylcysteine by gamma-glutamyl transferase and dipeptidase (PMID: 8632674). S-lactoylglutathione has also been shown to modulate microtubule assembly (PMID: 690442).",S-Lactoylglutathione,HMDB0001066,b,b,C03451,S-LACTOYL-GLUTATHIONE,FDB022405,lgt_S,[H]O[C@@]([H])(C(=O)SC([H])([H])[C@]([H])(N([H])C(=O)C([H])([H])C([H])([H])[C@@]([H])(C([O-])=O)[N+]([H])([H])[H])C(=O)N([H])C([H])([H])C([O-])=O)C([H])([H])[H],VDYDCVUWILIYQF-CSMHCCOUSA-M,"InChI=1S/C13H21N3O8S/c1-6(17)13(24)25-5-8(11(21)15-4-10(19)20)16-9(18)3-2-7(14)12(22)23/h6-8,17H,2-5,14H2,1H3,(H,15,21)(H,16,18)(H,19,20)(H,22,23)/p-1/t6-,7+,8+/m1/s1"
1452,65785,"2-(2,4-dihydroxy-5-prenylphenyl)-5,6-methylenedioxybenzofuran","An organic heterotricyclic compound that is 5,6-methylenedioxybenzofuran substituted by a 2,4-dihydroxy-5-prenylphenyl moiety at position 2. Isolated from the roots of Sophora flavescens, it exhibits cytotoxic activity against the KB epidermoid carcinoma cell line.",15686,KEGG COMPOUND accession,C00810,,,,,,,,,,,,,,,
1453,65787,"7,8-dihydroxyflavanone","A dihydroxyflavanone with hydroxy substituents at positions 7 and 8. Isolated from the seeds of Alpinia katsumadai, it acts as a an inhibitor for Jun-Fos-DNA complex formation and exhibits antineoplastic activity.",17019,KEGG COMPOUND accession,C08325,,,,,,,,,,,,,,,
1454,65792,diinsininol,A biflavonoid isolated from the rhizome of Sarcophyte piriei and exhibits anti-inflammatory activity.,17167,KEGG COMPOUND accession,C00937,lald_D,b,17167.0,"Human Metabolome Database (HMDB): D- and L-lactaldehyde are also good substrates for aldose reductase. The aldose reductase-catalyzed reduction of methylglyoxal produces 95% acetol, 5% D-lactaldehyde. (PMID: 1537826). D-lactaldehyde is an intermediate in the pyruvate metabolic pathway. Pyruvaldehyde is irreversibly produced from D-lactaldehyde via the enzyme glyoxylate reductase (NADP+, Swiss-Prot: Q5T945).",D-Lactaldehyde,HMDB0006458,b,b,C00937,CPD-358,FDB023918,lald_D,[H]O[C@@]([H])(C([H])=O)C([H])([H])[H],BSABBBMNWQWLLU-GSVOUGTGSA-N,"InChI=1S/C3H6O2/c1-3(5)2-4/h2-3,5H,1H3/t3-/m1/s1"
1455,65795,"(2S)-5,7-dimethoxy-8-formylflavanone","A dimethoxyflavanone that is 5,7-dimethoxyflavanone substituted by a formyl group at position 8. Isolated from the stem bark of Pongamia pinnata, it acts as a an inducer of quinone reductase, a phase II enzyme that protects cells against reactive, toxic and potentially carcinogenic species.",16004,KEGG COMPOUND accession,C00256,lac_D,10326-41-7,341.0,"Human Metabolome Database (HMDB): Lactic acid is an organic acid. It is a chiral molecule, consisting of two optical isomers, L-lactic acid and D-lactic acid, with the L-isomer being the most common in living organisms. Lactic acid plays a role in several biochemical processes and is produced in the muscles during intense activity. D-Lactic acid is the end product of the enzyme glyoxalase II (or hydroxyacyl-glutathione hydrolase) (EC 3.1.2.6), which converts the intermediate substrate S-lactoyl-glutathione to reduced glutathione and D-lactate (OMIM: 138790).",D-Lactic acid,HMDB0001311,b,b,C00256,D-LACTATE,FDB003293,lac_D,[H]O[C@@]([H])(C([O-])=O)C([H])([H])[H],JVTAAEKCZFNVCJ-REOHCLBHSA-M,"InChI=1S/C3H6O3/c1-2(4)3(5)6/h2,4H,1H3,(H,5,6)/p-1/t2-/m0/s1"
1456,65798,"3,21-dioxoolean-18-en-28-oic acid","A pentacyclic triterpenoid that is olean-18-ene substituted by a carboxy group at position 28 and oxo groups at positions 3 and 21 respectively. Isolated from the leaves of Acacia aulacocarpa, it exhibits inhibitory activity against Tie2 kinase (EC 2.7.10.1) as well as modest activity against a variety of cultured mammalian cells.",15588,KEGG COMPOUND accession,C00497,,,,,,,,,,,,,,,
1457,65804,dorsilurin G,"A 7-hydroxyflavonol substituted by additional hydroxy groups at positions 5 and 3', prenyl groups at positions 6 and 8 and a (2S)-2-hydroxy-3-methylbut-3-en-1-yl group at position  4'. Isolated from the roots of Dorstenia psilurus, it exhibits alpha-glucosidase inhibitory activity.",32382,KEGG COMPOUND accession,C01983,,,,,,,,,,,,,,,
1458,65810,drummondin E,"A member of the class of resorcinols that is a derivative of filicinic acid. Isolated from the stems and leaves of Hypericum drummondii, it exhibits antibacterial activity against Gram-positive bacteria Staphylococcus aureus and Bacillus subtilis and the acid fast bacterium Mycobacterium smegmatis.",17710,KEGG COMPOUND accession,C00418,mev_R,150-97-0,25351.0,"Human Metabolome Database (HMDB): Mevalonic acid is a key organic compound in biochemistry. It is a precursor in the biosynthetic pathway, known as the HMG-CoA reductase pathway, that produces terpenes and steroids. Mevalonate is produced by NADPH from 3-hydroxy-3-methylglutaryl CoA via reduction. This reaction occurs in the cytosol. It is the committed step in cholesterol synthesis, -- Wikipedia The production of mevalonic acid (MVA) by the enzyme 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase, is the rate-limiting step in the biosynthesis of cholesterol. (Jemal et. al, Rapid Communications in Mass Spectrometry, 2003, 17:1715) Plasma concentrations and urinary excretion of MVA are decreased by HMG-CoA reductase inhibitor drugs such as pravastatin, simvastatin and atorvastatin. Naoumova RP, Marais AD, Mountney J, Firth JC, Rendell NB, Taylor GW, Thompson GR. Atherosclerosis 1996; 119: 203.",Mevalonic acid,HMDB0000227,b,b,C00418,MEVALONATE,FDB005126,mev_R,[H]OC([H])([H])C([H])([H])[C@](O[H])(C([H])([H])[H])C([H])([H])C([O-])=O,KJTLQQUUPVSXIM-ZCFIWIBFSA-M,"InChI=1S/C6H12O4/c1-6(10,2-3-7)4-5(8)9/h7,10H,2-4H2,1H3,(H,8,9)/p-1/t6-/m1/s1"
1459,65813,drymaritin,"An indole alkaloid that is canthin-6-one substituted by a methoxy group at position 4. Isolated from the whole plants of Drymaria diandra, it exhibits anti-HIV activity.",27751,KEGG COMPOUND accession,C06347,,,,,,,,,,,,,,,
1460,65826,elaeodendroside F,A steroid lactone isolated from Elaeodendron tangenala and Elaeodendron glaucum and exhibits antiproliferative activity against A2780 human ovarian cancer cells.,16719,KEGG COMPOUND accession,C01012,,,,,,,,,,,,,,,
1461,65845,"1R,4S,6R-1,4-endoperoxy-bisabola-2,10-diene","A sesquiterpenoid that is bisabola-2,10-diene substituted by a peroxy group between positions 2 and 10 (the 1R,4S,6R stereoisomer). Isolated from Artemisia stolonifera and Eupatorium rufescens, it exhibits antineoplastic and antiplasmodial activity.",16358,KEGG COMPOUND accession,C01870,,,,,,,,,,,,,,,
1462,65895,fattiviracin A1,"A carbohydrate-containing antibiotic isolated from the fermentation broth of Streptomyces microflavus strain No. 2445 and exhibits antiviral activity against herpes simplex virus type 1 (HSV-1), varicella-zoster virus (VZV), influenza A virus and human immunodeficiency virus type 1 (HIV-1).",17388,KEGG COMPOUND accession,C03912,1pyr5c,64199-88-8,371.0,b,1-Pyrroline-5-Carboxylate,b,b,b,C03912,b,b,1pyr5c,[H]C1=NC([H])(C([O-])=O)C([H])([H])C1([H])[H],DWAKNKKXGALPNW-UHFFFAOYSA-M,"InChI=1S/C5H7NO2/c7-5(8)4-2-1-3-6-4/h3-4H,1-2H2,(H,7,8)/p-1"
1463,65898,flavaspidic acid PB,A polyphenol that is a phloroglucinol derivative isolated from the rhizomes of Dryopteris crassirhizoma and has been shown to exhibit radical scavenging and antibacterial activity.,15441,KEGG COMPOUND accession,C01054,Ssq23epx,9029-62-3,15441.0,"Human Metabolome Database (HMDB): (S)-2,3-Epoxysqualene is an intermediate in the biosynthesis of Terpenoid. It is a substrate for Squalene monooxygenase and Lanosterol synthase.","(S)-2,3-Epoxysqualene",HMDB0001188,b,b,C01054,EPOXYSQUALENE,FDB022476,Ssq23epx,[H]C(=C(C([H])([H])[H])C([H])([H])[H])C([H])([H])C([H])([H])C(=C([H])C([H])([H])C([H])([H])C(=C([H])C([H])([H])C([H])([H])C([H])=C(C([H])([H])[H])C([H])([H])C([H])([H])C([H])=C(C([H])([H])[H])C([H])([H])C([H])([H])[C@]1([H])OC1(C([H])([H])[H])C([H])([H])[H])C([H])([H])[H])C([H])([H])[H],QYIMSPSDBYKPPY-RSKUXYSASA-N,"InChI=1S/C30H50O/c1-24(2)14-11-17-27(5)20-12-18-25(3)15-9-10-16-26(4)19-13-21-28(6)22-23-29-30(7,8)31-29/h14-16,20-21,29H,9-13,17-19,22-23H2,1-8H3/b25-15+,26-16+,27-20+,28-21+/t29-/m0/s1"
1464,65900,fleephilone,A organic heterotetracyclic compound isolated from the fermentation broth of Trichoderma harzianum and exhibits anti-HIV activity.,17943,KEGG COMPOUND accession,C02914,,,,,,,,,,,,,,,
1465,65904,fomitoside F,"A triterpene glycoside that consists of lanost-8,24-dien-21-oic acid substituted at by a alpha-acetyloxy group at position 3 and a beta-D-xylopyranosyl moiety at position 21 via a glycosidic linkage. Isolated from the fruit body of Fomitopsis pinicola, it exhibits inhibitory activity against COX-1 and COX-2.",18409,KEGG COMPOUND accession,C06010,,,,,,,,,,,,,,,
1466,65907,forskoditerpenoside C,"A diterpene glycoside that is labd-14-en-11-one substituted by beta-acetoxy group at position 6, an epoxy group between positions 8 and 13, a beta-hydroxy group at position 7 and a beta-D-glucopyranosyloxy group at position 1 (the 1alpha stereoisomer). Isolated from the whole plant of Coleus forskohlii, it shows relaxative effects on isolated guinea pig tracheal spirals in vitro.",29063,KEGG COMPOUND accession,C04771,,,,,,,,,,,,,,,
1467,65918,fucodiphloroethol G,"A phlorotannin that consists of biphenyl-2,2',4,4',6-pentol substituted by a 2,4-dihydroxy-6-(2,4,6-trihydroxyphenoxy)phenoxy substituent at position 6'. Isolated from the marine brown alga Ecklonia cava, it exhibits anti-allergic, antioxidant and hypoglycemic activities.",16782,KEGG COMPOUND accession,C03196,,,,,,,,,,,,,,,
1468,65923,fukanefuromarin C,"A furanocoumarin that is 2,3-dihydrofuro[3,2-c]coumarin substituted by a hydroxy group at position 7, methyl groups at positions 2 and 3 (relatively cis configuration) and a 4,8-dimethyl-4(Z),7-nonadien-6-onyl moiety at position 2. Isolated from the roots of Ferula fukanensis, it inhibits production of nitric oxide (NO).",18129,KEGG COMPOUND accession,C03045,,,,,,,,,,,,,,,
1469,65928,"(2R*,3R*)-2,3-dihydro-7-hydroxy-2,3-dimethyl-2-[4,8-dimethyl-3(E)-7-nonadien-6-onyl]furo[3,2-c]coumarin","A furanocoumarin that is 2,3-dihydrofuro[3,2-c]coumarin substituted by a hydroxy group at position 7, methyl groups at positions 2 and 3 (relatively trans configuration) and a 4,8-dimethyl-3(E)-7-nonadien-6-onyl moiety at position 2. Isolated from the roots of  Ferula fukanensis, it exhibits inhibitory effect on the production of nitric oxide (NO).",16373,KEGG COMPOUND accession,C03817,,,,,,,,,,,,,,,
1470,65935,"19-(2-furyl)nonadeca-5,7-diynoic acid","An acetylenic fatty acid that is nonadeca-5,7-diynoic acid substituted by a furan-2-yl group at position 19. Isolated from Polyalthia evecta, it exhibits anti-HSV-1 and antiplasmodial activity.",15467,KEGG COMPOUND accession,C00356,hmgcoa,1553-55-5,15467.0,"Human Metabolome Database (HMDB): 3-hydroxy-3-methylglutaryl CoA (HMG-CoA) is formed when Acetyl-CoA condenses with acetoacetyl-CoA in a reaction that is catalyzed by the enzyme HMG-CoA synthase in the mevalonate pathway or mevalonate-dependent (MAD) route, an important cellular metabolic pathway present in virtually all organisms. HMG-CoA reductase (EC 1.1.1.34) inhibitors, more commonly known as statins, are cholesterol-lowering drugs that have been widely used for many years to reduce the incidence of adverse cardiovascular events. HMG-CoA reductase catalyzes the rate-limiting step in the mevalonate pathway and these agents lower cholesterol by inhibiting its synthesis in the liver and in peripheral tissues. Androgen also stimulates lipogenesis in human prostate cancer cells directly by increasing transcription of the fatty acid synthase and HMG-CoA-reductase genes. (PMID: 14689582).",3-Hydroxy-3-methylglutaryl-CoA,HMDB0001375,b,b,C00356,3-HYDROXY-3-METHYL-GLUTARYL-COA,FDB022587,hmgcoa,[H]O[C@@]([H])(C(=O)N([H])C([H])([H])C([H])([H])C(=O)N([H])C([H])([H])C([H])([H])SC(=O)C([H])([H])[C@](O[H])(C([H])([H])[H])C([H])([H])C([O-])=O)C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])OP([O-])(=O)OP([O-])(=O)OC([H])([H])[C@@]1([H])O[C@@]([H])(N2C([H])=NC3=C(N=C([H])N=C23)N([H])[H])[C@]([H])(O[H])[C@]1([H])OP([O-])([O-])=O,CABVTRNMFUVUDM-VRHQGPGLSA-I,"InChI=1S/C27H44N7O20P3S/c1-26(2,21(40)24(41)30-5-4-15(35)29-6-7-58-17(38)9-27(3,42)8-16(36)37)11-51-57(48,49)54-56(46,47)50-10-14-20(53-55(43,44)45)19(39)25(52-14)34-13-33-18-22(28)31-12-32-23(18)34/h12-14,19-21,25,39-40,42H,4-11H2,1-3H3,(H,29,35)(H,30,41)(H,36,37)(H,46,47)(H,48,49)(H2,28,31,32)(H2,43,44,45)/p-5/t14-,19-,20-,21+,25-,27+/m1/s1"
1471,65937,futokadsurin B,"A lignan that is tetrahydrofuran substituted by methyl groups at positions 3 and 4, a 3,4-dimethoxyphenyl group at position 5 and a 1,3-benzodioxol-5-yl moiety at position 2 (the 2S,3R,4R,5R stereoisomer). Isolated from the aerial parts of Piper futokadsura, it exhibits inhibitory activity against production of nitric oxide (NO).",17290,KEGG COMPOUND accession,C03197,,,,,,,,,,,,,,,
1472,65952,gaudichaudiic acid H,An organic heteroheptacyclic compound isolated from the bark of Indonesian Garcinia gaudichaudii and exhibits cytotoxic activity.,35146,KEGG COMPOUND accession,C00671,,,,,,,,,,,,,,,
1473,65956,gelomulide M,"An abietane diterpenoid that is ent-abieta-2(3),13(15)-diene-16,12-olide substituted by beta-acetoxy groups at positions 1 and 7 and a beta-epoxy group across positions 8 and 14. Isolated from the leaves of Gelonium aequoreum, it exhibits moderate cytotoxicity against lung (A549), breast (MDAMB-231 and MCF7), and liver (HepG2) cancer cell lines.",17210,KEGG COMPOUND accession,C03198,,,,,,,,,,,,,,,
1474,65963,gigantrionenin,"A member of the class of oxolanes that is tetrahydrofuran substituted by a 7-[5-methyl-2-oxo-2,5-dihydrofuran-3-yl]heptyl at position 2 and a 1,4,5-trihydroxyhenicos-8-en-1-yl group at position 5. Isolated from Goniothalamus giganteus, it exhibits cytotoxic activity.",27713,KEGG COMPOUND accession,C03656,5a3ohex,19355-90-9,27713.0,"Human Metabolome Database (HMDB): (S)-5-Amino-3-oxohexanoate is an intermediate in lysine degradation. L-Lysine is an essential amino acid that is a necessary building block for all protein in the body and It plays a major role in calcium absorption; building muscle protein; recovering from surgery or sports injuries; and the body's production of hormones, enzymes, and antibodies. In lysine degradation pathway, (S)-5-Amino-3-oxohexanoate is a substrate for the enzyme L-erythro-3,5-diaminohexanoate dehydrogenase (EC 1.4.1.11) and can be generated from L-erythro-3,5-Diaminohexanoate.",(S)-5-Amino-3-oxohexanoate,HMDB0012131,b,b,C03656,CPD-159,FDB028795,b,b,FAASBXNEOGMQHS-BYPYZUCNSA-N,b
1475,65978,gnidilatimonoein,A diterpenoid isolated from the leaves of Daphne mucronata and exhibits anti-tumour and anti-metastatic activities.,17041,KEGG COMPOUND accession,C05176,,,,,,,,,,,,,,,
1476,65982,guangsangon K,"A member of the class of polyphenols consisting of a methylcyclohexene ring attached to a 2,4-dihydroxyphenyl, 2,4-dihydroxybenzoyl and dihydroflavonol moieties at positions 5'', 4'' and 3'' respectively. Regarded biogenetically as a Diels-Alder adduct, it is isolated from the stem barks of Morus macroura and exhibits antioxidant activity.",15687,KEGG COMPOUND accession,C01769,,,,,,,,,,,,,,,
1477,65992,gypsosaponin A,A triterpenoid saponin with quillaic acid as the aglycone species. It is isolated from the roots of Gypsophila oldhamiana and exhibits inhibitory activity against pancreatic lipase.,16233,KEGG COMPOUND accession,C05174,,,,,,,,,,,,,,,
1478,66000,hamacanthin A,"A member of the class of pyrazinones that is 5,6-dihydropyrazin-2(1H)-one substituted  at positions 3 and 6 by 6-bromo-1H-indol-3-yl groups. It is an antifungal drug isolated from deep water marine sponge Hamacantha sp.",17025,KEGG COMPOUND accession,C00337,dhor_S,155-54-4,30865.0,"Human Metabolome Database (HMDB): 4,5-Dihydroorotic acid is a substrate of the enzyme orotate reductase [EC 1.3.1.14], which is part of the pyrimidine metabolism pathway. (KEGG) Dihydroorotate is oxidized by Dihydroorotate dehydrogenases (DHODs) to orotate. These dehydrogenases use their FMN (flavin mononucleotide) prosthetic group to abstract a hydride equivalent from C6 to deprotonate C5.","4,5-Dihydroorotic acid",HMDB0000528,b,b,C00337,DI-H-OROTATE,FDB022096,dhor_S,[H]N1C(=O)N([H])[C@]([H])(C([O-])=O)C([H])([H])C1=O,UFIVEPVSAGBUSI-REOHCLBHSA-M,"InChI=1S/C5H6N2O4/c8-3-1-2(4(9)10)6-5(11)7-3/h2H,1H2,(H,9,10)(H2,6,7,8,11)/p-1/t2-/m0/s1"
1479,66009,hedychilactone D,"A labdane diterpenoid that is 7,11,13-labdatrien-16,15-olide substituted by a hydroxy group at position 7 and an oxo group at position 6. Isolated from the rhizomes of Hedychium spicatum, it exhibits cytotoxicity against the Colo-205 (Colo-cancer), A-431 (skin cancer), MCF-7 (breast cancer), A-549 (lung cancer) and Chinese hamster ovary cells (CHO).",18041,KEGG COMPOUND accession,C00424,lald_L,598-35-6,18041.0,Human Metabolome Database (HMDB): L-lactaldehyde is an intermediate metabolite in the pyruvate metabolism pathway. L-lactaldehyde is irreversibly produced from pyruvaldehyde via the enzyme aldehyde reductase (EC:1.1.1.21) which is then irreversibly converted to propylene glycol via aldehyde reductase (EC:1.1.1.21).,Lactaldehyde,HMDB0003052,b,b,C00424,LACTALD,FDB023101,lald_L,[H]O[C@]([H])(C([H])=O)C([H])([H])[H],BSABBBMNWQWLLU-VKHMYHEASA-N,"InChI=1S/C3H6O2/c1-3(5)2-4/h2-3,5H,1H3/t3-/m0/s1"
1480,66012,herquline B,"An alkaloid comprising of  a piperazine and cyclohexenone ring systems. Isolated from Penicillium herquei, it exhibits inhibitory activity against platelet aggregation.",16651,KEGG COMPOUND accession,C00186,lac_L,79-33-4,422.0,"Human Metabolome Database (HMDB): Lactic acid is an organic acid. It is a chiral molecule, consisting of two optical isomers, L-lactic acid and D-lactic acid, with the L-isomer being the most common in living organisms. Lactic acid plays a role in several biochemical processes and is produced in the muscles during intense activity. In animals, L-lactate is constantly produced from pyruvate via the enzyme lactate dehydrogenase (LDH) in a process of fermentation during normal metabolism and exercise. It does not increase in concentration until the rate of lactate production exceeds the rate of lactate removal. This is governed by a number of factors, including monocarboxylate transporters, lactate concentration, the isoform of LDH, and oxidative capacity of tissues. The concentration of blood lactate is usually 1-2 mmol/L at rest, but can rise to over 20 mmol/L during intense exertion. There are some indications that lactate, and not glucose, is preferentially metabolized by neurons in the brain of several mammalian species, including mice, rats, and humans. Glial cells, using the lactate shuttle, are responsible for transforming glucose into lactate, and for providing lactate to the neurons. Lactate measurement in critically ill patients has been traditionally used to stratify patients with poor outcomes. However, plasma lactate levels are the result of a finely tuned interplay of factors that affect the balance between its production and its clearance. When the oxygen supply does not match its consumption, organisms adapt in many different ways, up to the point when energy failure occurs. Lactate, being part of the adaptive response, may then be used to assess the severity of the supply/demand imbalance. In such a scenario, the time to intervention becomes relevant: early and effective treatment may allow tissues and cells to revert to a normal state, as long as the oxygen machinery (i.e. mitochondria) is intact. Conversely, once the mitochondria are deranged, energy failure occurs even in the presence of normoxia. The lactate increase in critically ill patients may, therefore, be viewed as an early marker of a potentially reversible state (PMID: 16356243). When present in sufficiently high levels, lactic acid can act as an oncometabolite, an immunosuppressant, an acidogen, and a metabotoxin. An oncometabolite is a compound that promotes tumor growth and survival. An immunosuppressant reduces or arrests the activity of the immune system. An acidogen is an acidic compound that induces acidosis, which has multiple adverse effects on many organ systems. A metabotoxin is an endogenously produced metabolite that causes adverse health effects at chronically high levels. Chronically high levels of lactic acid are associated with at least a dozen inborn errors of metabolism, including 2-methyl-3-hydroxybutyryl CoA dehydrogenase deficiency, biotinidase deficiency, fructose-1,6-diphosphatase deficiency, glycogen storage disease type 1A (GSD1A) or Von Gierke disease, glycogenosis type IB, glycogenosis type IC, glycogenosis type VI, Hers disease, lactic acidemia, Leigh syndrome, methylmalonate semialdehyde dehydrogenase deficiency, pyruvate decarboxylase E1 component deficiency, pyruvate dehydrogenase complex deficiency, pyruvate dehydrogenase deficiency, and short chain acyl CoA dehydrogenase deficiency (SCAD deficiency). Locally high concentrations of lactic acid or lactate are found near many tumors due to the upregulation of lactate dehydrogenase (PMID: 15279558). Lactic acid produced by tumors through aerobic glycolysis acts as an immunosuppressant and tumor promoter (PMID: 23729358). Indeed, lactic acid has been found to be a key player or regulator in the development and malignant progression of a variety of cancers (PMID: 22084445). A number of studies have demonstrated that malignant transformation is associated with an increase in aerobic cellular lactate excretion. Lactate concentrations in various carcinomas (e.g. uterine cervix, head and neck, colorectal region) at first diagnosis of the disease, can be relatively low or extremely high (up to 40 mol/g) in different individual tumors or within the same lesion (PMID: 15279558). High molar concentrations of lactate are correlated with a high incidence of distant metastasis. Low lactate tumors (< median of approximately 8 mol/g) are associated with both an overall longer and disease-free survival compared to high lactate lesions (lactate > approximately 8 mol/g). Lactate-induced secretion of hyaluronan by tumor-associated fibroblasts creates a milieu favourable for cell migration and metastases (PMID: 22084445). An acidic environment (pH 6-6.5), which is common in many tumors, allows tumor cells to evade the immune response, and therefore allows them to grow unchecked. Locally high concentrations of lactic acid are known to markedly impede the function of normal immune cells and will lead to a loss of T-cell function of human tumor-infiltrating lymphocytes (PMID: 22084445). Lactic acid is also an organic acid and acts as a general acidogen. Abnormally high levels of organic acids in the blood (organic acidemia), urine (organic aciduria), the brain, and other tissues lead to general metabolic acidosis. Acidosis typically occurs when arterial pH falls below 7.35. In infants with acidosis, the initial symptoms include poor feeding, vomiting, loss of appetite, weak muscle tone (hypotonia), and lack of energy (lethargy). These can progress to heart abnormalities, kidney abnormalities, liver damage, seizures, coma, and possibly death. These are also the characteristic symptoms of the untreated IEMs mentioned above. Many affected children with organic acidemias experience intellectual disability or delayed development.",L-Lactic acid,HMDB0000190,b,b,C00186,L-LACTATE,FDB003294,lac_L,[H]O[C@]([H])(C([O-])=O)C([H])([H])[H],JVTAAEKCZFNVCJ-REOHCLBHSA-M,"InChI=1S/C3H6O3/c1-2(4)3(5)6/h2,4H,1H3,(H,5,6)/p-1/t2-/m0/s1"
1481,66016,hirsutellide A,A cyclodepsipeptide isolated from the cell extract of the entomopathogenic fungus Hirsutella kobayasii BCC 1660 and exhibits antimycobacterial and antimalarial activities.,15589,KEGG COMPOUND accession,C00149,mal_L,97-67-6,30797.0,"Human Metabolome Database (HMDB): Malic acid is a tart-tasting organic dicarboxylic acid that plays a role in many sour or tart foods. Apples contain malic acid, which contributes to the sourness of a green apple. Malic acid can make a wine taste tart, although the amount decreases with increasing fruit ripeness. (wikipedia). In its ionized form malic acid is called malate. Malate is an intermediate of the TCA cycle along with fumarate. It can also be formed from pyruvate as one of the anaplerotic reactions. In humans, malic acid is both derived from food sources and synthesized in the body through the citric acid cycle or Krebs cycle which takes place in the mitochondria. Malate's importance to the production of energy in the body during both aerobic and anaerobic conditions is well established. Under aerobic conditions, the oxidation of malate to oxaloacetate provides reducing equivalents to the mitochondria through the malate-aspartate redox shuttle. During anaerobic conditions, where a buildup of excess of reducing equivalents inhibits glycolysis, malic acid's simultaneous reduction to succinate and oxidation to oxaloacetate is capable of removing the accumulating reducing equivalents. This allows malic acid to reverse hypoxia's inhibition of glycolysis and energy production. In studies on rats it has been found that only tissue malate is depleted following exhaustive physical activity. Other key metabolites from the citric acid cycle needed for energy production were found to be unchanged. Because of this, a deficiency of malic acid has been hypothesized to be a major cause of physical exhaustion. Notably, the administration of malic acid to rats has been shown to elevate mitochondrial malate and increase mitochondrial respiration and energy production.",L-Malic acid,HMDB0000156,b,b,C00149,b,FDB001044,mal_L,[H]O[C@]([H])(C([O-])=O)C([H])([H])C([O-])=O,BJEPYKJPYRNKOW-REOHCLBHSA-L,"InChI=1S/C4H6O5/c5-2(4(8)9)1-3(6)7/h2,5H,1H2,(H,6,7)(H,8,9)/p-2/t2-/m0/s1"
1482,66022,hookerianamide J,"A steroid alkaloid that is 5alpha-preg-16-ene substituted by a hydroxy group at position 4, a N,N-dimethylamino group at position 20 and a N-senecoylamino group at position 3 (the 3beta,4beta,20S stereoisomer). Isolated from Sarcococca hookeriana, it exhibits antileishmanial and antibacterial activities.",17756,KEGG COMPOUND accession,C01984,,,,,,,,,,,,,,,
1483,66053,"1,3,5-trihydroxy-2-(2',2'-dimethyl-4'-isopropenyl)cyclopentanylxanthone","A member of the class of xanthones that is 5-O-demethylpaxanthonin, in which hydroxy group at position 6 is replaced by a hydrogen. Isolated from the leaves of Hypericum styphelioides, it exhibits antioxidant activity.",17129,KEGG COMPOUND accession,C02106,,,,,,,,,,,,,,,
1484,66056,hyperixanthone A,"A member of the class of xanthones that is 1H-xanthene-2,9-dione substituted by hydroxy groups at positions 3, 6 and 8, a 2-methylbut-3-en-2-yl group at position 5 and two prenyl groups at position 1. IT has been isolated from Hypericum erectum and Hypericum sampsonii.",18285,KEGG COMPOUND accession,C05175,,,,,,,,,,,,,,,
1485,66059,hypocrellin D,An organic polycyclic compound that is a cytotoxic fungal pigment isolated from the fruiting bodies of the ascomycete Shiraia bambusicola.,17772,KEGG COMPOUND accession,C04118,,,,,,,,,,,,,,,
1486,66073,1-[(3-methylbutanoyl)phloroglucinyl]-beta-D-glucopyranoside,"A beta-D-glucoside compound having a (3-methylbutanoyl)phloroglucinyl moiety at the anomeric position. Isolated from the whole plant of Indigofera heterantha, it exhibits lipoxygenase inhibitory activity.",18809,KEGG COMPOUND accession,C06610,,,,,,,,,,,,,,,
1487,66077,integracin B,"A benzoate ester obtained by the formal condensation of the hydroxy group of 5-(8-hydroxyundecyl)benzene-1,3-diol with 4,6-dihydroxy benzoic acid which is also substituted by a 8-hydroxyundecyl group at position 2. It is isolated from Cytonaema sp. and has anti-HIV-1 activity.",15660,KEGG COMPOUND accession,C04622,,,,,,,,,,,,,,,
1488,66083,interiotherin B,A lignan with a dibenzocyclooctadiene skeleton attached to a fatty acid ester side chain. It is isolated from Kadsura interior and has been shown to exhibit anti-HIV activity.,17546,KEGG COMPOUND accession,C04435,,,,,,,,,,,,,,,
1489,66089,isosecotanapartholide,A sesquiterpene lactone isolated from Artemisia rutifolia and Artemisia iwayomogi and has been shown to inhibit nitric oxide synthase.,15667,KEGG COMPOUND accession,C04353,,,,,,,,,,,,,,,
1490,66091,isochamaejasmenin B,"A biflavonoid that consists of two units of 5,7-dihydroxy-4'-methoxyflavanone attached at the C-3 position (the meso-isomer). Isolated from Stellera chamaejasme, it exhibits antimitotic and antifungal activity.",16967,KEGG COMPOUND accession,C03453,,,,,,,,,,,,,,,
1491,66094,isoiguesterin,A pentacyclic triterpenoid that is a bisnortriterpene isolated from Salacia madagascariensis and exhibits antileishmanial and antileukemic activities.,16717,KEGG COMPOUND accession,C04225,,,,,,,,,,,,,,,
1492,66098,isotanshinone IIB,"A diterpenoid that is  1,2,3,4-tetrahydrophenanthro[3,2-b]furan-7,11-dione substituted by a hydroxymethyl group at position 4 and methyl groups at positions 4 and 8 respectively. Isolated from Salvia miltiorrhiza, it exhibits platelet aggregation inhibitory activity.",28627,KEGG COMPOUND accession,C08375,,,,,,,,,,,,,,,
1493,66151,(2S)-2'-methoxykurarinone,"A dimethoxyflavanone that is (2S)-(-)-kurarinone in which the hydroxy group at position 2' is replaced by a methoxy group. Isolated from the roots of Sophora flavescens, it exhibits cytotoxicity against human myeloid leukemia HL-60 cells.",18350,KEGG COMPOUND accession,C06324,,,,,,,,,,,,,,,
1494,66154,salvileucalin B,A diterpenoid with a rearranged neo-clerodane skeleton isolated from Salvia leucantha and has been shown exhibit antineoplastic activity.,16130,KEGG COMPOUND accession,C04623,,,,,,,,,,,,,,,
1495,66179,sch 725432,"A sesquiterpenoid based on the caryophyllene ring system. Isolated from the fungal fermentation broth of Chrysosporium pilosum, it exhibits antifungal activity.",16746,KEGG COMPOUND accession,C03743,,,,,,,,,,,,,,,
1496,66190,tanariflavanone C,"A tetrahydroxyflavanone that is (2S)-flavanone substituted by hydroxy groups at positions 5,7, 3' and 4', a geranyl group at position 2' and a 2-hydroxy-3-methylbut-3-en-1yl group at position 6. Isolated from Macaranga tanarius, it exhibits radical scavenging activity.",28222,KEGG COMPOUND accession,C06594,,,,,,,,,,,,,,,
1497,66236,TMC-1C,"A polyene antibiotic that is TMC-1A in which the 2,4-dimethyloct-2-enoyl group has been replaced by an (E,E)-4,6-dimethyldeca-2,4-dienoyl group. TMC-1C is an antitumour antibiotic isolated from Streptomyces sp. A-230.",16187,KEGG COMPOUND accession,C01258,,,,,,,,,,,,,,,
1498,66243,TMC-86B,An epoxide that is oxiran-2-ylmethanol which is acylated at position 2 by N-(6-hydroxy-6-methylheptanoyl)-L-seryl-4-methylidenenorvalinyl group. It is a proteasome inhibitor isolated from Streptomyces.,16100,KEGG COMPOUND accession,C06731,,,,,,,,,,,,,,,
1499,66260,trachyspic acid,"An  oxaspiro compound that is 1,6-dioxaspiro[4.4]non-2-en-4-one substituted by a carboxymethyl group at position 2, carboxy groups at positions 2 and 3, an oxo group at position 9 and a nonyl group at position 8. Isolated from the culture broth of the fungus Talaromyces trachyspermus, it exhibits inhibitory activity against the enzyme heparanase.",17435,KEGG COMPOUND accession,C03012,,,,,,,,,,,,,,,
1500,66288,quercetin 3-O-beta-D-glucopyranosyl-(1->2)-rhamnopyranoside,"A  quercetin O-glycoside that consists of quercetin substituted by a beta-D-glucopyranosyl-(1->2)-rhamnopyranosyl moiety at position 3 via a glycosidic linkage. Isolated from the leaves of Ginkgo biloba, it exhibits antioxidant activity.",18393,KEGG COMPOUND accession,C01173,,,,,,,,,,,,,,,
1501,66290,quillaic acid alpha-L-Arap-(1->4)-alpha-L-Arap-(1->3)-beta-D-Xylp-(1->4)-alpha-L-Rhap-(1->2)-beta-D-fucopyranosyl ester,"A triterpenoid saponin that is the pentasaccharide derivative of quillaic acid. Isolated from the roots of Gypsophila oldhamiana, it exhibits immunomodulatory activity.",27734,KEGG COMPOUND accession,C04473,,,,,,,,,,,,,,,
1502,66294,rediocide E,A diterpenoid of the class of daphnane-type terpenes. It is isolated from Trigonostemon reidioides and has been shown to exhibit insecticidal activity.,29111,KEGG COMPOUND accession,C04923,,,,,,,,,,,,,,,
1503,66366,6-O-methyl-2-deprenylrheediaxanthone B,"An organic heterotetracyclic compound that is 1,2-dihydro-6H-furo[2,3-c]xanthene substituted by hydroxy groups at positions 5 and 10, a methoxy group at position 9 and methyl groups at positions 1, 1 and 2 and an oxo group at position 6. Isolated from the stem barks of Garcinia vieillardii, it exhibits antioxidant activity.",16070,KEGG COMPOUND accession,C07326,,,,,,,,,,,,,,,
1504,66379,michaolide F,A cembrane diterpenoid with cytotoxic activity isolated from the soft coral Lobophytum michaelae.,17641,KEGG COMPOUND accession,C06720,,,,,,,,,,,,,,,
1505,66391,millewanin G,"A member of the class of 7-hydroxyisoflavones that is isoflavone substituted by hydroxy groups at positions 5, 7, 3' and 4', a prenyl group at position 8 and a 2-hydroxy-3-methylbut-3-enyl moiety at position 6. Isolated from the leaves of Millettia pachycarpa, it exhibits antiestrogenic activity.",16968,KEGG COMPOUND accession,C04277,,,,,,,,,,,,,,,
1506,66402,"8,8a-epoxymorellic acid","An epoxide that is the 8,8a-epoxy derivative of morellic acid. Isolated from  Garcinia hanburyi it exhibits cytotoxic and anti-HIV activity..",16986,KEGG COMPOUND accession,C04908,,,,,,,,,,,,,,,
1507,66408,12-demethylmulticaulin,"A diterpenoid that is multicaulin in which the methoxy group at position 12 is replaced by a hydroxy group. A norabietane derivative, it is isolated from the roots of Salvia multicaulis and exhibits antitubercular activity.",18406,KEGG COMPOUND accession,C04677,aicar,3031-94-5,18406.0,Human Metabolome Database (HMDB): AICAR also known as ZMP is an analog of AMP that is capable of stimulating AMP-dependent protein kinase activity(AMPK). AICAR is an intermediate in the generation of inosine monophosphate. AICAR is being clinically used to treat and protect against cardiac ischemic injury. AICAR can enter cardiac cells to inhibit adenosine kinase and adenosine deaminase. It enhances the rate of nucleotide re-synthesis increasing adenosine generation from adenosine monophosphate only during conditions of myocardial ischemia. AICAR increases glucose uptake by inducing translocation of GLUT4 and/or by activating the p38 MAPK pathway.,AICAR,HMDB0001517,b,b,C04677,AICAR,FDB001213,aicar,[H]O[C@@]1([H])[C@@]([H])(O[C@]([H])(C([H])([H])OP([O-])([O-])=O)[C@@]1([H])O[H])N1C([H])=NC(C(=O)N([H])[H])=C1N([H])[H],NOTGFIUVDGNKRI-UUOKFMHZSA-L,"InChI=1S/C9H15N4O8P/c10-7-4(8(11)16)12-2-13(7)9-6(15)5(14)3(21-9)1-20-22(17,18)19/h2-3,5-6,9,14-15H,1,10H2,(H2,11,16)(H2,17,18,19)/p-2/t3-,5-,6-,9-/m1/s1"
1508,66410,12-demethylmultiorthoquinone,"A diterpenoid that is multiorthoquinone in which the methoxy group at position 12 is replaced by a hydroxy group. A norabietane derivative, it is isolated from Salvia multicaulis and exhibits antitubercular activity.",18381,KEGG COMPOUND accession,C04734,fprica,b,18381.0,"Human Metabolome Database (HMDB): This compound is an intermediate in purine metabolism, where it is the byproduct of phosphoribosylaminoimidazolecarboxamide formyltransferase (EC 2.1.2.3) and IMP cyclohydrolase (EC 3.5.4.10). It is also a byproduct of Ligases (EC 6.3.4.-).",Phosphoribosyl formamidocarboxamide,HMDB0001439,b,b,C04734,PHOSPHORIBOSYL-FORMAMIDO-CARBOXAMIDE,FDB022622,fprica,[H]O[C@@]1([H])[C@@]([H])(O[C@]([H])(C([H])([H])OP([O-])([O-])=O)[C@@]1([H])O[H])N1C([H])=NC(C(=O)N([H])[H])=C1N([H])C([H])=O,ABCOOORLYAOBOZ-DEGSGYPDSA-L,"InChI=1S/C10H15N4O9P/c11-8(18)5-9(13-3-15)14(2-12-5)10-7(17)6(16)4(23-10)1-22-24(19,20)21/h2-4,6-7,10,16-17H,1H2,(H2,11,18)(H,13,15)(H2,19,20,21)/p-2/t4-,6-,7-,10-/m0/s1"
1509,66412,multiplolide B,"A 10-membered lactone obtained from 10-methyl-9,10-dihydro-2H-oxecin-2-one by the epoxidation of the double bond at position 3-4 and cis-dihydroxylation of the double bond at position 7-8, with further acylation of the hydroxy group at position 8 by a but-2-enoyl group. Multiplolide B was first isolated from the fungus Xylaria multiplex BCC 1111. It shows antifungal activity against Candida albicans. The epoxide group has cis-configuration, but its configuration relative to the other substituents was not established.",28413,KEGG COMPOUND accession,C04751,5aizc,6001-14-5,28413.0,Human Metabolome Database (HMDB): 5-amino-1-(5-phospho-D-ribosyl) imidazole-4-carboxylate is an intermediate in purine metabolism. 5-amino-1-(5-phospho-D-ribosyl) imidazole-4-carboxylate is converted from aminoimidazole ribotide via phosphoribosylaminoimidazole carboxylase [EC: 4.1.1.21].,5-amino-1-(5-phospho-D-ribosyl)imidazole-4-carboxylate,HMDB0006273,b,b,C04751,PHOSPHORIBOSYL-CARBOXY-AMINOIMIDAZOLE,FDB023871,5aizc,[H]O[C@@]1([H])[C@@]([H])(O[C@]([H])(C([H])([H])OP([O-])([O-])=O)[C@@]1([H])O[H])N1C([H])=NC(C([O-])=O)=C1N([H])[H],XFVULMDJZXYMSG-ZIYNGMLESA-K,"InChI=1S/C9H14N3O9P/c10-7-4(9(15)16)11-2-12(7)8-6(14)5(13)3(21-8)1-20-22(17,18)19/h2-3,5-6,8,13-14H,1,10H2,(H,15,16)(H2,17,18,19)/p-3/t3-,5-,6-,8-/m1/s1"
1510,66421,myrciacitrin V,"A flavanone glycoside that is (2S)-flavanone substituted by hydroxy groups at positions 5, 2' and 5', methyl groups at positions 6 and 8 and a (6''-O-p-hydroxybenzoyl)-beta-D-glucopyranosyloxy residue at position 7. Isolated from the leaves of Myrcia multiflora, it exhibits inhibitory activity against aldose reductase.",16805,KEGG COMPOUND accession,C04437,,,,,,,,,,,,,,,
1511,66431,schisanlactone A,A tetracyclic triterpenoid isolated from Schisandra and Kadsura longipedunculata. It has been shown to exhibit inhibitory activity against HIV protease.,15723,KEGG COMPOUND accession,C04101,,,,,,,,,,,,,,,
1512,66443,scutebarbatine C,A  diterpene alkaloid of group of neo-clerodanes isolated from the whole plants of Scutellaria barbata and has been shown to exhibit neoplastic activity.,17505,KEGG COMPOUND accession,C01235,,,,,,,,,,,,,,,
1513,66445,scutebarbatine E,A diterpene alkaloid of group of neo-clerodanes isolated from the whole plants of Scutellaria barbata and has been shown to exhibit neoplastic activity.,15834,KEGG COMPOUND accession,C01158,,,,,,,,,,,,,,,
1514,66462,semicochliodinol B,"A bisindole alkaloid that is quinone bearing hydroxy substituents at positions 2 and 5 and two indol-3-yl groups at positions 3 and 6, one of which is carrying a prenyl group at position 6. Isolated from the culture broth of Chrysosporium merdarium, it acts as an inhibitor of HIV-1 protease and EGF-R protein tyrosine kinase.",16975,KEGG COMPOUND accession,C00681,HC02038,b,16975.0,b,1-Acylglycerol-3P-Ld-Pc-Pool,b,b,b,C00681,b,b,b,[H]O[C@]([H])(C([H])([H])OC([*])=O)C([H])([H])OP(=O)(O[H])O[H],b,b
1515,66462,semicochliodinol B,"A bisindole alkaloid that is quinone bearing hydroxy substituents at positions 2 and 5 and two indol-3-yl groups at positions 3 and 6, one of which is carrying a prenyl group at position 6. Isolated from the culture broth of Chrysosporium merdarium, it acts as an inhibitor of HIV-1 protease and EGF-R protein tyrosine kinase.",16975,KEGG COMPOUND accession,C00681,HC02039,b,16975.0,b,1-Acylglycerol-3P-Ld-Pe-Pool,b,b,b,C00681,b,b,b,[H]O[C@]([H])(C([H])([H])OC([*])=O)C([H])([H])OP(=O)(O[H])O[H],b,b
1516,66462,semicochliodinol B,"A bisindole alkaloid that is quinone bearing hydroxy substituents at positions 2 and 5 and two indol-3-yl groups at positions 3 and 6, one of which is carrying a prenyl group at position 6. Isolated from the culture broth of Chrysosporium merdarium, it acts as an inhibitor of HIV-1 protease and EGF-R protein tyrosine kinase.",16975,KEGG COMPOUND accession,C00681,HC02040,b,16975.0,b,1-Acylglycerol-3P-Ld-Ps-Pool,b,b,b,C00681,b,b,b,[H]O[C@]([H])(C([H])([H])OC([*])=O)C([H])([H])OP(=O)(O[H])O[H],b,b
1517,66462,semicochliodinol B,"A bisindole alkaloid that is quinone bearing hydroxy substituents at positions 2 and 5 and two indol-3-yl groups at positions 3 and 6, one of which is carrying a prenyl group at position 6. Isolated from the culture broth of Chrysosporium merdarium, it acts as an inhibitor of HIV-1 protease and EGF-R protein tyrosine kinase.",16975,KEGG COMPOUND accession,C00681,HC02041,b,16975.0,b,1-Acylglycerol-3P-Ld-Pi-Pool,b,b,b,C00681,b,b,b,[H]O[C@]([H])(C([H])([H])OC([*])=O)C([H])([H])OP(=O)(O[H])O[H],b,b
1518,66462,semicochliodinol B,"A bisindole alkaloid that is quinone bearing hydroxy substituents at positions 2 and 5 and two indol-3-yl groups at positions 3 and 6, one of which is carrying a prenyl group at position 6. Isolated from the culture broth of Chrysosporium merdarium, it acts as an inhibitor of HIV-1 protease and EGF-R protein tyrosine kinase.",16975,KEGG COMPOUND accession,C00681,HC02042,b,16975.0,b,1-Acylglycerol-3P-Ld-Sm-Pool,b,b,b,C00681,b,b,HC02042,[H]O[C@]([H])(C([H])([H])OC([*])=O)C([H])([H])OP(=O)(O[H])O[H],b,b
1519,66462,semicochliodinol B,"A bisindole alkaloid that is quinone bearing hydroxy substituents at positions 2 and 5 and two indol-3-yl groups at positions 3 and 6, one of which is carrying a prenyl group at position 6. Isolated from the culture broth of Chrysosporium merdarium, it acts as an inhibitor of HIV-1 protease and EGF-R protein tyrosine kinase.",16975,KEGG COMPOUND accession,C00681,HC02084,b,16975.0,b,1-Acylglycerol-3P-Bile-Pc-Pool,b,b,b,C00681,b,b,b,[H]O[C@]([H])(C([H])([H])OC([*])=O)C([H])([H])OP(=O)(O[H])O[H],b,b
1520,66462,semicochliodinol B,"A bisindole alkaloid that is quinone bearing hydroxy substituents at positions 2 and 5 and two indol-3-yl groups at positions 3 and 6, one of which is carrying a prenyl group at position 6. Isolated from the culture broth of Chrysosporium merdarium, it acts as an inhibitor of HIV-1 protease and EGF-R protein tyrosine kinase.",16975,KEGG COMPOUND accession,C00681,HC02091,b,16975.0,b,1-Acylglycerol-3P-Cl-Pool,b,b,b,C00681,b,b,b,[H]O[C@]([H])(C([H])([H])OC([*])=O)C([H])([H])OP(=O)(O[H])O[H],b,b
1521,66492,yinyanghuo A,"An extended flavonoid that is 2',2'-dimethyl-2'H,4H-2,6'-bichromen-4-one substituted by hydroxy groups at positions 5 and 7 and a 2-hydroxy-3-methylbut-3-en-1-yl group at position 8'. Isolated from Epimedium sagittatum, it exhibits inhibitory activity against platelet aggregation.",36712,KEGG COMPOUND accession,C04475,ak2gpe_hs,b,b,b,1-Alkyl 2-Acylglycerol 3-Phosphoethanolamine,b,b,b,C04475,b,b,b,[H]OP(=O)(OC([H])([H])C([H])([H])N([H])[H])OC([H])([H])C([H])(OC(*)=O)C([H])([H])O*,b,b
1522,66505,zhankuic acid C,"A steroid acid that is ergosta-8,24(28)-dien-26-oic acid substituted by hydroxy groups at positions 3 and 12, a methyl group at position 4 and oxo groups at positions 7 and 11 (the 3alpha,4alpha,5alpha,12alpha stereoisomer). Isolated from Antrodia cinnamomea and Antrodia camphorata, it exhibits antineoplastic activity.",30909,KEGG COMPOUND accession,C04317,ak2lgchol_hs,b,560225.0,"Human Metabolome Database (HMDB): 1-Octadecyl-sn-glycero-3-phosphocholine is an intermediate in the ether lipid metabolism pathway. 1-Octadecyl-sn-glycero-3-phosphocholine is irreversibly produced from 2-acetyl-1-(9Z-octadecenyl)-sn-glycero-3-phosphocholine via the enzyme 1-alkyl-2-acetylglycerophosphocholine esterase (EC 3.1.1.47). 1-Octadecyl-sn-glycero-3-phosphocholine is an ether phospho-ether lipid. Ether lipids are lipids in which one or more of the carbon atoms on glycerol are bonded to an alkyl chain via an ether linkage, as opposed to the usual ester linkage. Plasmalogens are glycerol ether phospholipids. They are of two types, alkyl ether (-O-CH2-) and alkenyl ether (-O-CH=CH-). Dihydroxyacetone phosphate (DHAP) serves as the glycerol precursor for the synthesis of plasmalogens. Three major classes of plasmalogens have been identified: choline, ethanolamine and serine derivatives. Ethanolamine plasmalogen is prevalent in myelin. Choline plasmalogen is abundant in cardiac tissue. Usually, the highest proportion of the plasmalogen form is in the ethanolamine class with rather less in choline, and commonly little or none in other phospholipids such as phosphatidylinositol. In choline plasmalogens of most tissues, a higher proportion is often of the O-alkyl rather than the O-alkenyl form, but the reverse tends to be true in heart lipids. In animal tissues, the alkyl and alkenyl moieties in both non-polar and phospholipids tend to be rather simple in composition with 16:0, 18:0 and 18:1 (double bond in position 9) predominating. Ether analogues of triacylglycerols, i.e. 1-alkyldiacyl-sn-glycerols, are present at trace levels only if at all in most animal tissues, but they can be major components of some marine lipids.",LysoPC(O-18:0),HMDB0011149,b,b,C04317,b,FDB027924,ak2lgchol_hs,[H]O[C@]([H])(C([H])([H])O[*])C([H])([H])OP(=O)(O[H])OC([H])([H])C([H])([H])[N+](C([H])([H])[H])(C([H])([H])[H])C([H])([H])[H],XKBJVQHMEXMFDZ-AREMUKBSSA-N,b
1523,66507,sinularolide B,A cembrane diterpenoid isolated from Sinularia gibberosa and has been found to exhibit antineoplastic activity.,18244,KEGG COMPOUND accession,C04476,,,,,,,,,,,,,,,
1524,66517,SPF-32629A,A carboxylic ester obtained by the formal condensation of the secondary hydroxy group of 4-hydroxy-6-[hydroxy(phenyl)methyl]pyridin-2(1H)-one with 3-methylbutanoic acid. It is isolated from the culture broth of Penicillium sp. SPF-32629 and acts as an inhibitor of the enzyme chymase (EC 3.4.21.39).,17928,KEGG COMPOUND accession,C01283,,,,,,,,,,,,,,,
1525,66523,stevastelin B3,A 13-membered cyclodepsipeptide isolated from the culture broth of Penicillium sp. It exhibits significant immunosuppressive effect on T-cell activiation.,17906,KEGG COMPOUND accession,C01888,aact,298-08-8,17906.0,"Human Metabolome Database (HMDB): Threonine dehydrogenase catalyzes the oxidation of threonine by NAD+ to glycine and acetyl-CoA, but when the ratio acetyl-CoA/CoA increases in nutritional deprivation (e.g., in diabetes) the enzyme produces aminoacetone (Chem. Res. Toxicol., 14 (9), 1323 -1329, 2001). Aminoacetone is thought to be a substrate for SSAO (semicarbazide-sensitive amine oxidase), leading to the production of the toxic product methylglyoxal (Journal of Chromatography B. Volume 824, Issues 1-2 , 25 September 2005, Pages 116-122 ).",Aminoacetone,HMDB0002134,b,b,C01888,AMINO-ACETONE,FDB022860,aact,[H]C([H])([H])C(=O)C([H])([H])[N+]([H])([H])[H],BCDGQXUMWHRQCB-UHFFFAOYSA-O,"InChI=1S/C3H7NO/c1-3(5)2-4/h2,4H2,1H3/p+1"
1526,66526,strongylin A,"A sesquiterpenoid that is 1,2,3,4,4a,5,6,7,7a,8-decahydrobenzo[d]xanthene substituted by a hydroxy group at position 12, methyl groups at positions 4, 4, 7 and 7a and a methoxy group at position 9 (the 4aS,7S,7aR,13aS stereoisomer). Isolated from  Strongylophora hartmani, it exhibits activity against the influenza virus.",30526,KEGG COMPOUND accession,C01234,,,,,,,,,,,,,,,
1527,66538,swertipunicoside,"A C-glycosyl compound that is the 2'-C-beta-D-glucopyranosyl derivative of 1,5,8-trihydroxy-3-methoxy-7-(1',3',6',7'-tetrahydroxy-9'-oxo-4'-xanthyl)xanthone; isolated from Swertia punicea.",17056,KEGG COMPOUND accession,C06367,,,,,,,,,,,,,,,
1528,66558,8-lavandulylkaempferol,"A tetrahydroxyflavone that is kaempferol substituted by a lavandulyl group at position 8. Isolated from Sophora flavescens, it exhibits antioxidant activity.",17110,KEGG COMPOUND accession,C04280,,,,,,,,,,,,,,,
1529,66564,lespeflorin C3,"A member of the class of dihydrochalcones that is alpha-hydroxydihydrochalcone substituted by hydroxy groups at positions 4 and 4', a methoxy group at position 2' and a prenyl group at position 5'. Isolated from the roots of Lespedeza floribunda, it acts as a melanin synthesis inhibitor.",27712,KEGG COMPOUND accession,C04873,,,,,,,,,,,,,,,
1530,66572,leucosesterterpenone,A sesterterpenoid isolated from Leucosceptrum canum. It has been shown to exhibit anti-angiogenic and inhibitory activity against prolyl endopeptidase ( EC 3.4.21.26 ).,15992,KEGG COMPOUND accession,C03203,,,,,,,,,,,,,,,
1531,66597,lupulin A,A  diterpenoid isolated from Ajuga lupulina and has been shown to exhibit anti-inflammatory and antibacterial activities.,17963,KEGG COMPOUND accession,C04599,,,,,,,,,,,,,,,
1532,66599,luzonial B,"An iridoid monoterpenoid that is hexahydro-1H-cyclopenta[c]furan substituted by hydroxy groups at positions 1 and 3a, a 3-oxopropen-2yl group at position 6 and a cis-4-coumaroyloxy moiety at position 4 (the 1S,3aS,4S,6S,6aS stereoisomer). Isolated from the leaves of Viburnum luzonicum, it exhibits antineoplastic activity.",17472,KEGG COMPOUND accession,C04731,,,,,,,,,,,,,,,
1533,66602,lychnostatin 2,A germacranolide isolated from Lychnophora antillana and has been shown to exhibit antineoplastic activity.,16020,KEGG COMPOUND accession,C02494,,,,,,,,,,,,,,,
1534,66605,"(+)-lyoniresinol 4,4'-bis-O-beta-D-glucopyranoside","A lignan that consists of (+)-lyoniresinol attached to two beta-D-glucopyranosyl units at positions 4 and 4' via glycosidic linkages. Isolated from Indigofera heterantha, it exhibits inhibitory activity against lipoxygenase.",28104,KEGG COMPOUND accession,C05827,3mldz,19639-03-3,28104.0,"Human Metabolome Database (HMDB): Methyimidazole acetaldehyde is a metabolite of histamine. The metabolites of ethanol and acetaldehyde can successfully compete with methylimidazole acetaldehyde, since the alcohol and histamine metabolic pathways in the body have two enzymes in common, aldehyde dehydrogenase and aldehyde oxidase. (PMID: 10344773).",Methylimidazole acetaldehyde,HMDB0004181,b,b,C05827,b,FDB023327,3mldz,[H]C(=O)C([H])([H])C1=C([H])N(C([H])=N1)C([H])([H])[H],GCQHUBANENYTLB-UHFFFAOYSA-N,"InChI=1S/C6H8N2O/c1-8-4-6(2-3-9)7-5-8/h3-5H,2H2,1H3"
1535,66637,nostocarboline,A member of the class of beta-carbolines that is 9H-beta-carbolin-2-ium substituted by a chloro group at position 6 and a methyl group at position 2. It is isolated from a fresh water cyanobacterium Nostoc 78-12A and acts as an inhibitor of butyrylcholinesterase.,15799,KEGG COMPOUND accession,C04036,,,,,,,,,,,,,,,
1536,66652,madhucoside A,"A triterpenoid saponin that consists of protobassic acid as the aglycone moiety. Isolated from the barks of Madhuca indica, it exhibits radical scavenging activity.",17526,KEGG COMPOUND accession,C01277,pail4p_hs,b,17526.0,b,1-Phosphatidyl-1D-Myo-Inositol 4-Phosphate,b,b,b,C01277,b,b,pail4p_hs,[H]O[C@@]1([H])[C@@]([H])(O[H])[C@@]([H])(OP([O-])(=O)OC([H])([H])[C@]([H])(OC([*])=O)C([H])([H])OC([*])=O)[C@]([H])(O[H])[C@@]([H])(O[H])[C@]1([H])OP([O-])([O-])=O,b,b
1537,66667,manzamine A,An alkaloid of the class of beta-carbolines isolated from Haliclona and Acanthostrongylophora. It exhibits inhibitory activity against Glycogen Synthase Kinase-3 (EC 2.7.11.26).,17425,KEGG COMPOUND accession,C03564,1p2cbxl,b,36761.0,Human Metabolome Database (HMDB): 1-Pyrroline-2-carboxylic acid is a terminal product of D-proline metabolism. Specifically D-proline is converted to 1-Pyrroline-2-carboxylic acid via D-amino acid oxidase. This spontaneously breaks down to 2-oxo-5-amino-valerate.,1-Pyrroline-2-carboxylic acid,HMDB0006875,b,b,C03564,DELTA1-PYRROLINE_2-CARBOXYLATE,FDB024129,b,[H]C1([H])N=C(C([O-])=O)C([H])([H])C1([H])[H],RHTAIKJZSXNELN-UHFFFAOYSA-M,"InChI=1S/C5H7NO2/c7-5(8)4-2-1-3-6-4/h1-3H2,(H,7,8)/p-1"
1538,66669,8-hydroxymanzamine A,"An alkaloid that is manzamine A with a hydroxy substituent at position 8. Isolated from Pachypellina and Acanthostrongylophora, it exhibits inhibitory activity against Glycogen Synthase Kinase-3 (EC 2.7.11.26).",16352,KEGG COMPOUND accession,C04282,,,,,,,,,,,,,,,
1539,66710,"methyl 4-amino-2-(2,3-dihydroxy-3-methylbutyl)benzoate","A benzoate ester that is methyl 4-aminobenzoate substituted by a 2,3-dihydroxy-3-methylbutyl group at position 2. It is isolated from the wood-decayed fungus Xylaria sp.BCC9653 and exhibits potent cytotoxicity against African green monkey kidney fibroblast (Vero) cells.",16147,KEGG COMPOUND accession,C04318,,,,,,,,,,,,,,,
1540,66742,phakellistatin 14,A homodetic cyclic peptide isolated from a marine sponge Phakellia sp. It exhibits cytotoxic activity against murine P388 lymphocytic leukemia cells and moderate cancer cell growth inhibitory activity against a panel of human cancer cells.,27967,KEGG COMPOUND accession,C05284,C05284,382-44-5,27967.0,"Human Metabolome Database (HMDB): 11beta-Hydroxyandrost-4-ene-3,17-dione is an intermediate in adrenosterone production. 11beta-Hydroxyandrost-4-ene-3,17-dione is produced from androst-4-ene-3,17-dione, a reaction catalyzed by the enzyme cytochrome P450 B [EC:1.14.15.4]. 11beta-Hydroxyandrost-4-ene-3,17-dione is then converted into adrenosterone by the enzyme 11beta-hydroxysteroid dehydrogenase [EC:1.1.1.146].","11b-Hydroxyandrost-4-ene-3,17-dione",HMDB0006773,b,b,C05284,b,FDB024075,b,[H]O[C@@]1([H])C([H])([H])[C@@]2(C(=O)C([H])([H])C([H])([H])[C@@]2([H])[C@]2([H])C([H])([H])C([H])([H])C3=C([H])C(=O)C([H])([H])C([H])([H])[C@]3(C([H])([H])[H])[C@@]12[H])C([H])([H])[H],WSCUHXPGYUMQEX-KCZNZURUSA-N,"InChI=1S/C19H26O3/c1-18-8-7-12(20)9-11(18)3-4-13-14-5-6-16(22)19(14,2)10-15(21)17(13)18/h9,13-15,17,21H,3-8,10H2,1-2H3/t13-,14-,15-,17+,18-,19-/m0/s1"
1541,66749,phomoxanthone A,"A member of the class of  xanthones that is a dimer isolated from Phomopsis. It exhibits cytotoxic, antimalarial and antitubercular activities.",15808,KEGG COMPOUND accession,C03206,,,,,,,,,,,,,,,
1542,66766,PM-94128,"A a monocarboxylic acid amide obtained by the formal condensation of the amino group of 3-[(1S)-1-amino-3-methylbutyl]-8-hydroxy-3,4-dihydro-1H-isochromen-1-one with the carboxy group of 4-amino-2,3-dihydroxy-6-methylheptanoic acid (the 2S,3S,4S stereoisomer). It is isolated from the culture broth of Bacillus sp.PhM-PHD-090 and exhibits potent antitumour activity.",17314,KEGG COMPOUND accession,C03049,,,,,,,,,,,,,,,
1543,66771,polyketomycin,A carbohydrate-containing antibiotic isolated from the culture broth of Streptomyces sp.MK277-AF1. It exhibits potent antibacterial activity against several Gram-positive bacterial strains and is also found to be cytotoxic against a number of tumour cell lines.,36487,KEGG COMPOUND accession,C04103,,,,,,,,,,,,,,,
1544,66794,pyripyropene I,"A  sesquiterpenoid that consists of a heterotetracyclic system linked to a pyridine moiety. Isolated from the fungus, Aspergillus fumigatus, it exhibits inhibitory activity against  acyl-CoA:cholesterol acyltransferase 2.",18430,KEGG COMPOUND accession,C04578,,,,,,,,,,,,,,,
1545,66810,ochrocarpinone C,A beta-diketone isolated from Ochrocarpos punctatus and has been shown to exhibit antineoplastic activity.,18362,KEGG COMPOUND accession,C01091,,,,,,,,,,,,,,,
1546,66863,phosphatidylcholine 40:3,"A 1,2-diacyl-sn-glycero-3-phosphocholine in which the acyl groups at C-1 and C-2 contain 40 carbons in total with 3 double bonds.",16595,KEGG COMPOUND accession,C01245,mi145p,88269-39-0,16595.0,"Human Metabolome Database (HMDB): Intracellular messenger formed by the action of phospholipase C on phosphatidylinositol 4,5-bisphosphate, which is one of the phospholipids that make up the cell membrane. Inositol 1,4,5-trisphosphate is released into the cytoplasm where it releases calcium ions from internal stores within the cell's endoplasmic reticulum. These calcium ions stimulate the activity of B kinase or calmodulin. (PubChem). Inositol 1,4,5-trisphosphate (InsP3) is traditionally considered to be the messenger that initiates the increase and spreading of the activating Ca2+ wave. In line with this hypothesis, recent evidence suggests that the penetrating sperm delivers into mammalian eggs a novel isoform of phospholipase C (PLC), which promotes the formation of InsP3. The mechanism by which the interacting sperm triggers the production of NAADP and subsequently that of InsP3 remains obscure. (PMID: 15362223).","Inositol 1,4,5-trisphosphate",HMDB0001498,b,b,C01245,"inositol_1,4,5-trisphosphate",FDB022657,mi145p,[H]O[C@]1([H])[C@]([H])(O[H])[C@@]([H])(OP([O-])([O-])=O)[C@]([H])(OP([O-])([O-])=O)[C@@]([H])(O[H])[C@]1([H])OP([O-])([O-])=O,MMWCIQZXVOZEGG-HOZKJCLWSA-H,"InChI=1S/C6H15O15P3/c7-1-2(8)5(20-23(13,14)15)6(21-24(16,17)18)3(9)4(1)19-22(10,11)12/h1-9H,(H2,10,11,12)(H2,13,14,15)(H2,16,17,18)/p-6/t1-,2+,3+,4-,5-,6-/m0/s1"
1547,66872,potassium fluoride,A fluoride salt having K+ as the counterion.,18169,KEGG COMPOUND accession,C04006,mi3p_D,573-35-3,18169.0,"Human Metabolome Database (HMDB): Myo-inositol 1-phosphate is a metabolite of the Inositol phosphate metabolism and the Phosphatidylinositol signaling system. Inositol phosphatases [EC:3.1.3.25] play a crucial role in the phosphatidylinositol signaling pathway; in brain, the expression is substantially higher in the subcortical regions, most prominently in the caudate. The phosphatidylinositol pathway is thought to be modified by lithium, a commonly prescribed medication in treating bipolar disorder. (OMIM 605922).",Myo-inositol 1-phosphate,HMDB0000213,b,b,C04006,1-L-MYO-INOSITOL-1-P,FDB021907,mi3p_D,[H]O[C@@]1([H])[C@]([H])(O[H])[C@]([H])(O[H])[C@]([H])(OP([O-])([O-])=O)[C@@]([H])(O[H])[C@]1([H])O[H],INAPMGSXUVUWAF-PTQMNWPWSA-L,"InChI=1S/C6H13O9P/c7-1-2(8)4(10)6(5(11)3(1)9)15-16(12,13)14/h1-11H,(H2,12,13,14)/p-2/t1-,2-,3+,4-,5-,6-/m0/s1"
1548,66948,isoglutamate(1-),"A beta-amino-acid anion that is the conjugate base of isoglutamic acid, obtained by deprotonation of the carboxy groups and protonation of the amino group; major species at pH 7.3.",16174,KEGG COMPOUND accession,C00206,dadp,b,16174.0,"Human Metabolome Database (HMDB): Deoxyadenosine diphosphate has been identified in the mononuclear cells of a patient affected with in inherited adenosine deaminase deficiency (OMIM 102700) (PMID 6980023), and in in mononuclear cells of hemodialyzed patients. (PMID 11461945).",dADP,HMDB0001508,b,b,C00206,DADP,FDB022662,dadp,[H]O[C@@]1([H])C([H])([H])[C@@]([H])(O[C@]1([H])C([H])([H])OP([O-])(=O)OP([O-])([O-])=O)N1C([H])=NC2=C(N=C([H])N=C12)N([H])[H],DAEAPNUQQAICNR-RRKCRQDMSA-K,"InChI=1S/C10H15N5O9P2/c11-9-8-10(13-3-12-9)15(4-14-8)7-1-5(16)6(23-7)2-22-26(20,21)24-25(17,18)19/h3-7,16H,1-2H2,(H,20,21)(H2,11,12,13)(H2,17,18,19)/p-3/t5-,6+,7+/m0/s1"
1549,66955,olivetolic acid,"A member of the class of benzoic acids that is salicylic acid in which the hydrogens ortho- and para- to the carboxy group are replaced by a pentyl and a hydroxy group, respectively.",16284,KEGG COMPOUND accession,C00131,datp,1927-31-7,16284.0,"Human Metabolome Database (HMDB): Deoxyadenosine triphosphate (dATP) is a purine nucleoside triphosphate used in cells for DNA synthesis. A nucleoside triphosphate is a molecule type that contains a nucleoside with three phosphates bound to it. dATP contains the sugar deoxyribose, a precursor to DNA synthesis whereby the two existing phosphate groups are cleaved with the remaining deoxyadenosine monophosphate being incorporated into DNA during replication. Due to its enzymatic incorporation into DNA, photoreactive dATP analogs such as N6-[4-azidobenzoyl(2-aminoethyl)]-2-deoxyadenosine-5-triphosphate (AB-dATP) and N6-[4-[3-(trifluoromethyl)-diazirin-3-yl]benzoyl-(2-aminoethyl)]-2-deoxyadenosine-5-triphosphate (DB-dATP) have been used for DNA photoaffinity labeling. When present in sufficiently high levels, dATP can act as an immunotoxin and a metabotoxin. An immunotoxin disrupts, limits the function, or destroys immune cells. A metabotoxin is an endogenous metabolite that causes adverse health effects at chronically high levels. Chronically high levels of deoxyadenosine triphosphate are associated with adenosine deaminase (ADA) deficiency, an inborn error of metabolism. ADA deficiency damages the immune system and causes severe combined immunodeficiency (SCID). People with SCID lack virtually all immune protection from bacteria, viruses, and fungi. They are prone to repeated and persistent infections that can be very serious or life-threatening. These infections are often caused by ""opportunistic"" organisms that ordinarily do not cause illness in people with a normal immune system. The main symptoms of ADA deficiency are pneumonia, chronic diarrhea, and widespread skin rashes. The mechanism by which dATP functions as an immunotoxin is as follows: a buildup of dATP in cells inhibits ribonucleotide reductase and prevents DNA synthesis, so cells are unable to divide. Since developing T cells and B cells are some of the most mitotically active cells, they are unable to divide and propagate to respond to immune challenges.",Deoxyadenosine triphosphate,HMDB0001532,b,b,C00131,DATP,FDB022674,datp,[H]O[C@@]1([H])C([H])([H])[C@@]([H])(O[C@]1([H])C([H])([H])OP([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O)N1C([H])=NC2=C(N=C([H])N=C12)N([H])[H],SUYVUBYJARFZHO-RRKCRQDMSA-J,"InChI=1S/C10H16N5O12P3/c11-9-8-10(13-3-12-9)15(4-14-8)7-1-5(16)6(25-7)2-24-29(20,21)27-30(22,23)26-28(17,18)19/h3-7,16H,1-2H2,(H,20,21)(H,22,23)(H2,11,12,13)(H2,17,18,19)/p-4/t5-,6+,7+/m0/s1"
1550,66965,phosphatidylcholine 42:6,"A 1,2-diacyl-sn-glycero-3-phosphocholine in which the acyl groups at C-1 and C-2 contain 42 carbons in total with 6 double bonds.",16311,KEGG COMPOUND accession,C00458,dctp,2056-98-6,16311.0,"Human Metabolome Database (HMDB): Deoxycytidine triphosphate (dCTP) is a cytidine nucleotide triphosphate that is used whenever DNA is synthesized, such as in the polymerase chain reaction. e.g.:.",dCTP,HMDB0000998,b,b,C00458,DCTP,FDB022359,dctp,[H]O[C@@]1([H])C([H])([H])[C@@]([H])(O[C@]1([H])C([H])([H])OP([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O)N1C([H])=C([H])C(=NC1=O)N([H])[H],RGWHQCVHVJXOKC-SHYZEUOFSA-J,"InChI=1S/C9H16N3O13P3/c10-7-1-2-12(9(14)11-7)8-3-5(13)6(23-8)4-22-27(18,19)25-28(20,21)24-26(15,16)17/h1-2,5-6,8,13H,3-4H2,(H,18,19)(H,20,21)(H2,10,11,14)(H2,15,16,17)/p-4/t5-,6+,8+/m0/s1"
1551,66968,phosphatidylcholine 42:3,"A 1,2-diacyl-sn-glycero-3-phosphocholine in which the acyl groups at C-1 and C-2 contain 42 carbons in total with 3 double bonds.",17172,KEGG COMPOUND accession,C00330,dgsn,961-07-9,17172.0,"Human Metabolome Database (HMDB): Deoxyguanosine is a nucleoside consisting of the base guanine and the sugar deoxyribose. It is like guanosine, but with one oxygen atom removed. It is a nucleoside component of DNA. Deoxyguanosine can be converted to 8-hydroxy-deoxyguanosine (8-OHdG) due to hydroxyl radical attack at the C8 of guanine. 8-OHdG is a sensitive marker of the DNA damage This damage, if left unrepaired, has been proposed to contribute to mutagenicity and cancer promotion. Deoxyguanosine is found to be associated with purine nucleoside phosphorylase (PNP) deficiency, which is an inborn error of metabolism.",Deoxyguanosine,HMDB0000085,b,b,C00330,DEOXYGUANOSINE,FDB012064,dgsn,[H]OC([H])([H])[C@@]1([H])O[C@@]([H])(N2C([H])=NC3=C2N=C(N([H])[H])N([H])C3=O)C([H])([H])[C@]1([H])O[H],YKBGVTZYEHREMT-KVQBGUIXSA-N,"InChI=1S/C10H13N5O4/c11-10-13-8-7(9(18)14-10)12-3-15(8)6-1-4(17)5(2-16)19-6/h3-6,16-17H,1-2H2,(H3,11,13,14,18)/t4-,5+,6+/m0/s1"
1552,66970,phosphatidylcholine 42:1,"A 1,2-diacyl-sn-glycero-3-phosphocholine in which the acyl groups at C-1 and C-2 contain 42 carbons in total with 1 double bond.",28862,KEGG COMPOUND accession,C00361,dgdp,b,28862.0,"Human Metabolome Database (HMDB): dGDP is a derivative of the common nucleic acid GTP, or guanosine triphosphate, in which the -OH (hydroxyl) group on the 2' carbon on the nucleotide's pentose has been removed (hence the deoxy- part of the name). Additionally, the diphosphate of the name indicates that one of the phosphoryl groups of GTP has been removed, most likely by hydrolysis (Wikipedia).",dGDP,HMDB0000960,b,b,C00361,DGDP,FDB022338,dgdp,[H]O[C@@]1([H])C([H])([H])[C@@]([H])(O[C@]1([H])C([H])([H])OP([O-])(=O)OP([O-])([O-])=O)N1C([H])=NC2=C1N=C(N([H])[H])N([H])C2=O,CIKGWCTVFSRMJU-KVQBGUIXSA-K,"InChI=1S/C10H15N5O10P2/c11-10-13-8-7(9(17)14-10)12-3-15(8)6-1-4(16)5(24-6)2-23-27(21,22)25-26(18,19)20/h3-6,16H,1-2H2,(H,21,22)(H2,18,19,20)(H3,11,13,14,17)/p-3/t4-,5+,6+/m0/s1"
1553,67000,N-(eicosanoyl)-4-hydroxyeicosasphinganine,A ceramide that is the N-eicosanoyl derivative of 4-hydroxyeicosasphinganine.,16450,KEGG COMPOUND accession,C00526,duri,951-78-0,16450.0,"Human Metabolome Database (HMDB): 2'-Deoxyuridine is a naturally occurring nucleoside. It is similar in chemical structure to uridine, but without the 2'-hydroxyl group. It is considered to be an antimetabolite that is converted to deoxyuridine triphosphate during DNA synthesis. Laboratory suppression of deoxyuridine is used to diagnose megaloblastic anemia due to vitamin B12 and folate deficiencies.",Deoxyuridine,HMDB0000012,b,b,C00526,DEOXYURIDINE,FDB021870,duri,[H]OC([H])([H])[C@@]1([H])O[C@@]([H])(N2C([H])=C([H])C(=O)N([H])C2=O)C([H])([H])[C@]1([H])O[H],MXHRCPNRJAMMIM-SHYZEUOFSA-N,"InChI=1S/C9H12N2O5/c12-4-6-5(13)3-8(16-6)11-2-1-7(14)10-9(11)15/h1-2,5-6,8,12-13H,3-4H2,(H,10,14,15)/t5-,6+,8+/m0/s1"
1554,67023,N-(2-hydroxydocosanoyl)sphinganine,A dihydroceramide in which the ceramide N-acyl group is specified as 2-hydroxydocosanoyl.,17808,KEGG COMPOUND accession,C00104,idp,86-04-4,17808.0,Human Metabolome Database (HMDB): IDP is an inosine nucleotide containing a pyrophosphate group esterified to C5 of the sugar moiety.,IDP,HMDB0003335,b,b,C00104,IDP,FDB023146,idp,[H]O[C@@]1([H])[C@@]([H])(O[C@]([H])(C([H])([H])OP([O-])(=O)OP([O-])([O-])=O)[C@@]1([H])O[H])N1C([H])=NC2=C1N=C([H])N([H])C2=O,JPXZQMKKFWMMGK-KQYNXXCUSA-K,"InChI=1S/C10H14N4O11P2/c15-6-4(1-23-27(21,22)25-26(18,19)20)24-10(7(6)16)14-3-13-5-8(14)11-2-12-9(5)17/h2-4,6-7,10,15-16H,1H2,(H,21,22)(H,11,12,17)(H2,18,19,20)/p-3/t4-,6-,7-,10-/m1/s1"
1555,67029,N-eicosanoyl-4-hydroxysphinganine,A phytoceramide in which the ceramide N-acyl group is specified as eicosanoyl.,16039,KEGG COMPOUND accession,C00081,itp,132-06-9,16039.0,"Human Metabolome Database (HMDB): Inosine triphosphate (ITP) is an intermediate in the purine metabolism pathway. Relatively high levels of ITP in red cells are found in individuals as result of deficiency of inosine triphosphatase (EC 3.1.3.56, ITPase) ITPase is a cytosolic nucleoside triphosphate pyrophosphohydrolase specific for ITP catalysis to inosine monophosphate (IMP) and deoxy-inosine triphosphate (dITP) to deoxy-inosine monophosphate. ITPase deficiency is not associated with any defined pathology other than the characteristic and abnormal accumulation of ITP in red blood cells. Nevertheless, ITPase deficiency may have pharmacogenomic implications, and the abnormal metabolism of 6-mercaptopurine in ITPase-deficient patients may lead to thiopurine drug toxicity. ITPase's function is not clearly understood but possible roles for ITPase could be to prevent the accumulation of rogue nucleotides which would be otherwise incorporated into DNA and RNA, or compete with nucleotides such as GTP in signalling processes. (PMID: 170291, 1204209, 17113761, 17924837).",Inosine triphosphate,HMDB0000189,b,b,C00081,ITP,FDB021902,itp,[H]O[C@@]1([H])[C@@]([H])(O[C@]([H])(C([H])([H])OP([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O)[C@@]1([H])O[H])N1C([H])=NC2=C1N=C([H])N([H])C2=O,HAEJPQIATWHALX-KQYNXXCUSA-J,"InChI=1S/C10H15N4O14P3/c15-6-4(1-25-30(21,22)28-31(23,24)27-29(18,19)20)26-10(7(6)16)14-3-13-5-8(14)11-2-12-9(5)17/h2-4,6-7,10,15-16H,1H2,(H,21,22)(H,23,24)(H,11,12,17)(H2,18,19,20)/p-4/t4-,6-,7-,10-/m1/s1"
1556,67037,D-octopine(1-),An D-alpha-amino acid anion  arising from deprotonation of the carboxy groups and protonation of the guanidino group of D-octopine.,28517,KEGG COMPOUND accession,C03569,,,,,,,,,,,,,,,
1557,67057,lysophosphatidylcholine 20:1,A lysophosphatidylcholine in which the remaining acyl group contains 20 carbons and 1 double bond. If R1 is the acyl group and R2 is a hydrogen then the molecule is a 1-acyl-sn-glycero-3-phosphocholine. If R1 is a hydrogen and R2 is the acyl group then the molecule is a 2-acyl-sn-glycero-3-phosphocholine.,17560,KEGG COMPOUND accession,C03210,,,,,,,,,,,,,,,
1558,67071,phosphatidylcholine O-38:0,"A glycerophosphocholine that is an alkyl,acyl-sn-glycero-3-phosphocholine in which the alkyl or acyl groups at positions 1 and 2 contain a total of 38 carbons and 0 double bonds.",15718,KEGG COMPOUND accession,C06355,,,,,,,,,,,,,,,
1559,67091,N-(acyl)-heptadecasphinganine-1-phosphocholine,A sphingomyelin in which the sphingoid component is specified as C17-sphinganine.,28263,KEGG COMPOUND accession,C07099,,,,,,,,,,,,,,,
1560,67105,insect sterilant,A chemosterilant intended to sterilize insects.,16266,KEGG COMPOUND accession,C04638,,,,,,,,,,,,,,,
1561,67119,UDP-alpha-D-galactose,A UDP-D-galactose in which the anomeric centre of the galactose moiety has alpha-configuration.,30620,KEGG COMPOUND accession,C03340,,,,,,,,,,,,,,,
1562,67132,"ditrans,polycis-polyprenol","A polyprenol in which all linkages of the isoprene units are cis, except for the two furthest from the hydroxy group which are trans.",36647,KEGG COMPOUND accession,C06580,,,,,,,,,,,,,,,
1563,67136,cannabidiolate,"A dihydroxybenzoate that is the conjugate base of cannabidiolic acid, obtained by deprotonation of the carboxy group.",36654,KEGG COMPOUND accession,C00196,,,,,,,,,,,,,,,
1564,67145,fumigaclavine A(1+),An ammonium ion obtained by the protonation of the tertiary amino group of fumigaclavine A; major species at pH 7.3.,17828,KEGG COMPOUND accession,C02775,,,,,,,,,,,,,,,
1565,67147,fumigaclavine C(1+),An ammonium ion obtained by the protonation of the tertiary amino group of fumigaclavine C; major species at pH 7.3.,15590,KEGG COMPOUND accession,C02624,,,,,,,,,,,,,,,
1566,67183,pyochelin I,"A pyochelin that has R-stereochemistry at the thioaminal centre; the diastereoisomer with S-stereochemistry at this centre is pyochelin II. Pseudomonas aeruginosa produces a mixture of pyochelin I (major) and pyochelin II (minor) via condensation of salicylic acid and two molecules of cysteine. The enantiomeric compounds, enant-pyochelin I and II, are produced by Pseudomonas fluorescens.",17811,KEGG COMPOUND accession,C00691,,,,,,,,,,,,,,,
1567,67193,4-methylheptane,"A branched C8 alkane, comprising heptane with a methyl group attached at C-4. It has been found in Amaranth seeds.",16106,KEGG COMPOUND accession,C04625,,,,,,,,,,,,,,,
1568,67233,"1-D-1,2-anhydro-myo-inositol",A conduritol epoxide resulting from the formal epoxidation of the double bond of (+)-conduritol B.,16489,KEGG COMPOUND accession,C03212,,,,,,,,,,,,,,,
1569,67248,4-(3-methylbut-2-enyl)-L-abrine zwitterion,An amino acid zwitterion arising from transfer of a proton from the carboxy to the amino group of 4-(3-methylbut-2-enyl)-L-abrine.,17244,KEGG COMPOUND accession,C06339,,,,,,,,,,,,,,,
1570,67255,2-(2-methoxyethoxy)propanoic acid,A monocarboxylic acid that is propanoic acid substituted at C-2 by a 2-methoxyethoxy group.,16926,KEGG COMPOUND accession,C05161,,,,,,,,,,,,,,,
1571,67290,azadiradionolide,"A tetracyclic triterpenoid that is 4,4,8-trimethylandrosta-1,14-diene substituted by a oxo groups at positions 3 and 16, an acetoxy group at position 7 and a 2-oxo-2,5-dihydrofuran-3-yl group at position 17. It has been isolated from Azadirachta indica.",16364,KEGG COMPOUND accession,C01059,,,,,,,,,,,,,,,
1572,67365,pisonivanol,A dihydroxyflavanone that is (2S)-flavanone substituted by hydroxy groups at positions 3 and 7 and methoxy groups at positions 5 and 6. It has been isolated from Pisonia aculeata.,16216,KEGG COMPOUND accession,C04690,,,,,,,,,,,,,,,
1573,67372,"(2R,3R)-3-hydroxy-5-methoxy-6,7- methylenedioxyflavanone","An extended flavonoid that consists of (2S)-flavanone substituted by a hydroxy group at position 3, a methoxy group at position 5 and a methylenedioxy group across positions 6 and 7. It has been isolated from Pisonia aculeata.",16720,KEGG COMPOUND accession,C10517,,,,,,,,,,,,,,,
1574,67401,"3,3''-dihydroxy-6'-O-desmethylterphenyllin","A para-terphenyl that is 6'-O-desmethylterphenyllin substituted by additional hydroxy groups at positions 3 and 3''. Isolated from Penicillium chermesinum, it exhibits inhibitory activity against alpha-glucosidase.",16444,KEGG COMPOUND accession,C00900,,,,,,,,,,,,,,,
1575,67441,ananolignan D,A lignan with a dibenzocyclooctadiene skeleton isolated from Kadsura ananosma.,16713,KEGG COMPOUND accession,C03975,,,,,,,,,,,,,,,
1576,67445,ananolignan H,A lignan with a dibenzocyclooctadiene skeleton isolated from Kadsura ananosma.,18372,KEGG COMPOUND accession,C04895,ahdt,20574-65-6,18372.0,"Human Metabolome Database (HMDB): The biosynthesis of tetrahydrobiopterin (BH4) from dihydroneopterin triphosphate (NH2P3) was studied in human liver extract. The phosphate-eliminating enzyme (PEE) was purified approximately 750-fold. The conversion of NH2P3 to BH4 was catalyzed by this enzyme in the presence of partially purified sepiapterin reductase, Mg2+ and NADPH. The PEE is heat stable when heated at 80 degrees C for 5 min. It has a molecular weight of 63 000 daltons. One possible intermediate 6-(1'-hydroxy-2'-oxopropyl)5,6,7,8-tetrahydropterin(2'-oxo-tetrahydropte rin) was formed upon incubation of BH4 in the presence of sepiapterin reductase and NADP+ at pH 9.0. Reduction of this compound with NaBD4 yielded monodeutero threo and erythro-BH4, the deuterium was incorporated at the 2' position. This and the UV spectra were consistent with a 2'-oxo-tetrahydropterin structure. Dihydrofolate reductase (DHFR) catalyzed the reduction of BH2 to BH4 and was found to be specific for the pro-R-NADPH side. The sepiapterin reductase catalyzed the transfer of the pro-S hydrogen of NADPH during the reduction of sepiapterin to BH2. In the presence of crude liver extracts the conversion of NH2P3 to BH4 requires NADPH. Two deuterium atoms were incorporated from (4S-2H)NADHP in the 1' and 2' position of the BH4 side chain. Incorporation of one hydrogen from the solvent was found at position C(6). These results are consistent with the occurrence of an intramolecular redox exchange between the pteridine nucleus and the side chain and formation of 6-pyruvoyl-5,6,7,8-tetrahydropterin(tetrahydro-1'-2'-dioxopterin) as intermediate. PMID: 3930838.",Dihydroneopterin triphosphate,HMDB0000980,b,b,C04895,6-1S2R-12-DIHYDROXY-3-TRIPHOSPHOOXY,FDB022349,ahdt,[H]O[C@@]([H])(C1=NC2=C(N=C(N([H])[H])N([H])C2=O)N([H])C1([H])[H])[C@]([H])(O[H])C([H])([H])OP([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O,DGGUVLXVLHAAGT-UJURSFKZSA-J,"InChI=1S/C9H16N5O13P3/c10-9-13-7-5(8(17)14-9)12-3(1-11-7)6(16)4(15)2-25-29(21,22)27-30(23,24)26-28(18,19)20/h4,6,15-16H,1-2H2,(H,21,22)(H,23,24)(H2,18,19,20)(H4,10,11,13,14,17)/p-4/t4-,6+/m0/s1"
1577,67447,ananolignan J,A lignan with a dibenzocyclooctadiene skeleton isolated from Kadsura ananosma,17083,KEGG COMPOUND accession,C01300,2ahhmp,b,b,b,"2-Amino-4-hydroxy-6-hydroxymethyl-7,8-dihydropteridine",b,b,b,C01300,b,b,b,b,b,b
1578,67460,ajubractin D,A  diterpenoid isolated from the aerial parts of  Ajuga bracteosa.,15914,KEGG COMPOUND accession,C03341,,,,,,,,,,,,,,,
1579,67470,14-hydro-15-hydroxyajugachin A,A  diterpenoid isolated from Ajuga bracteosa and has been shown to exhibit antifeedant activity.,15942,KEGG COMPOUND accession,C06333,,,,,,,,,,,,,,,
1580,67477,lamesticumin D,A triterpenoid of the class of onoceranoid-type terpenoids isolated from the twigs of Lansium domesticum.,15573,KEGG COMPOUND accession,C03557,2aeppn,2041-14-7,15573.0,Human Metabolome Database (HMDB): Ciliatine is an organophosphorus compound isolated from human and animal tissues.,Ciliatine,HMDB0011747,b,b,C03557,CPD-1106,FDB028420,b,b,QQVDJLLNRSOCEL-UHFFFAOYSA-N,"InChI=1S/C2H8NO3P/c3-1-2-7(4,5)6/h1-3H2,(H2,4,5,6)"
1581,67477,lamesticumin D,A triterpenoid of the class of onoceranoid-type terpenoids isolated from the twigs of Lansium domesticum.,15573,KEGG COMPOUND accession,C03557,2ameph,2041-14-7,15573.0,Human Metabolome Database (HMDB): Ciliatine is an organophosphorus compound isolated from human and animal tissues.,Ciliatine,HMDB0011747,b,b,C03557,CPD-1106,FDB028420,b,[H][N+]([H])([H])C([H])([H])C([H])([H])P([O-])([O-])=O,QQVDJLLNRSOCEL-UHFFFAOYSA-M,"InChI=1S/C2H8NO3P/c3-1-2-7(4,5)6/h1-3H2,(H2,4,5,6)/p-1"
1582,67482,lansic acid,A triterpenoid of the class of onoceranoid-type terpenoids isolated from the twigs of Lansium domesticum.,16886,KEGG COMPOUND accession,C02220,amuco,4548-99-6,15745.0,"Human Metabolome Database (HMDB): 2-Aminomuconic acid is a product of the Tryptophan metabolism degradation pathway (kinurenine pathway), in a reaction catabolized by the enzyme aminocarboxymuconate semialdehyde decarboxylase [EC:4.1.1.45]. The kynurenine pathway is the major route of L-tryptophan degradation in mammals. (BioCyc).",2-Aminomuconic acid,HMDB0001241,b,b,C02220,2-AMINO-MUCONATE,FDB022507,amuco,[H]\C(=C(\[H])C([O-])=O)\C(\[H])=C(\C([O-])=O)[N+]([H])([H])[H],ZRHONLCTYUYMIQ-TZFCGSKZSA-M,"InChI=1S/C6H7NO4/c7-4(6(10)11)2-1-3-5(8)9/h1-3H,7H2,(H,8,9)(H,10,11)/p-1/b3-1+,4-2-"
1583,67484,methyl lansiolate,A triterpenoid that is the methyl ester of lansiolic acid. It has been isolated from the twigs of Lansium domesticum.,15745,KEGG COMPOUND accession,C03824,am6sa,245128-91-0,15745.0,"Human Metabolome Database (HMDB): 2-aminomuconic semialdehyde is an intermediate in the oxidative metabolism of tryptophan in mammals, and takes place via the kynurenine pathway, which is also used for NAD biosynthesis in all eukaryotic organisms. 2-Aminomuconic semialdehyde is reported to be unstable and spontaneously converted to picolinic acid (regarded as metabolically inert and is excreted in the urine as a glycine conjugate), and enzymatically converted to 2-aminomuconic acid through the action of 2-aminomuconic semialdehyde dehydrogenase. (PMID: 10510494, 16267312, 14275129).",2-Aminomuconic acid semialdehyde,HMDB0001280,b,b,C03824,2-AMINOMUCONATE_SEMIALDEHYDE,FDB022532,am6sa,[H]C(=O)C(\[H])=C(\[H])/C(/[H])=C(\C([O-])=O)[N+]([H])([H])[H],QCGTZPZKJPTAEP-REDYYMJGSA-N,"InChI=1S/C6H7NO3/c7-5(6(9)10)3-1-2-4-8/h1-4H,7H2,(H,9,10)/b2-1-,5-3+"
1584,67495,"4,6,3',4'-tetramethoxyaurone","A  methoxyaurone that is  aureusidin in which the hydroxy groups at positions  4, 6, 3' and 4' have been replaced by methoxy groups respectively. It has been isolated from the roots of Cyperus teneriffae.",28861,KEGG COMPOUND accession,C03579,,,,,,,,,,,,,,,
1585,67532,prenylcandidusin C,"A member of the class of dibenzofurans that is 3,6,9-trimethoxydibenzo[b,d]furan-2-ol substituted by a 4-hydroxy-3-(3-methylbut-2-en-1-yl)phenyl substituent at position 3. It has been isolated from Aspergillus taichungensis.",28160,KEGG COMPOUND accession,C03753,,,,,,,,,,,,,,,
1586,67534,terprenin,"A para-terphenyl that is 1,1':4',1''-terphenyl substituted by methoxy groups at positions 3' and 6', hydroxy groups at positions 2', 3 and 4'' and a prenyloxy group at position 4. It has been isolated from Aspergillus taichungensis.",17337,KEGG COMPOUND accession,C04522,,,,,,,,,,,,,,,
1587,67551,cochinchinone G,"A member of the class of xanthones that is 9H-xanthene substituted by hydroxy group at positions 1 and 7, an oxo group at position 9 and a geranyloxy group at position 3. It has been isolated from the stems of Cratoxylum cochinchinense.",28303,KEGG COMPOUND accession,C02357,,,,,,,,,,,,,,,
1588,67587,fruticoside D,"A steroid saponin that is 4-methylergosta-7,24(28)-dien-21-oic acid attached to an acetyloxy group at position 2, and a alpha-L-quinovopyranosyloxy group at position 3 (the 2alpha,3beta,4alpha,5alpha stereoisomer). It has been isolated from the roots of Breynia fruticosa.",18104,KEGG COMPOUND accession,C06159,,,,,,,,,,,,,,,
1589,67591,zizyberanalic acid,A steroid acid isolated from the roots of Breynia fruticosa.,17860,KEGG COMPOUND accession,C01286,,,,,,,,,,,,,,,
1590,67593,"stigmastane-3beta,5alpha,6beta-triol","A  3beta-hydroxy steroid that is  stigmastane substituted by hydroxy groups at positions 3, 5 and 6 (the 3beta,5alpha,6beta stereoisomer). It has been isolated from the roots of Breynia fruticosa.",17305,KEGG COMPOUND accession,C03921,,,,,,,,,,,,,,,
1591,67600,"2alpha,3beta-dihydroxy-20(29)-lupen-28-oic acid",A pentacyclic triterpenoid that is  betulinic acid carrying an additional  alpha-hydroxy group at position 2. It has been isolated from Breynia fruticosa.,17647,KEGG COMPOUND accession,C00684,,,,,,,,,,,,,,,
1592,67615,5'-epichaetoviridin A,An  azaphilone that is the 5'-epimer of chaetoviridin A. It has been isolated from Chaetomium globosum.,16609,KEGG COMPOUND accession,C02779,,,,,,,,,,,,,,,
1593,67640,"(-)-(7''R,8''S)-4'',5,7-trihydroxy-3',5'-dimethoxy-4',8''-oxyflavonolignan-7'',9''-diol",A  flavonolignan isolated from the stems of Sinocalamus affinis.,16043,KEGG COMPOUND accession,C06369,,,,,,,,,,,,,,,
1594,67650,"(+)-(7S,8R,8'R)-5,5'-dimethoxylariciresinol",A lignan that is  (+)-lariciresinol substituted by additional methoxy groups at positions 5 and 5'. It has been  isolated from them stems of Sinocalamus affinis.,16132,KEGG COMPOUND accession,C00673,2dr5p,102916-66-5,16132.0,"Human Metabolome Database (HMDB): Deoxyribose 5-phosphate is a a metabolite in the pentose phosphate pathway. It can be generated from D-glyceraldehdye-3 phosphate via the enzyme 2-Deoxyribose 5-phosphate aldolase (DERA). Alternately Deoxyribose 5-phosphate can be converted to D-glyceraldehyde-3 phosphate that can then feed into the pentose phosphate pathway. Deoxyribose 5-phosphate can also be generated from 2-Deoxy-D-ribose via the enzyme Ribokinase (EC 2.7.1.15). It has been shown in a number of organisms that deoxynucleosides or deoxyriboses cause the induction of aldolases (such as DERA) involved in their catabolism, leading to the utilisation of the pentose moiety as carbon and energy source.",Deoxyribose 5-phosphate,HMDB0001031,b,b,C00673,DEOXY-RIBOSE-5P,FDB022380,2dr5p,[H]OC1([H])O[C@]([H])(C([H])([H])OP([O-])([O-])=O)[C@@]([H])(O[H])C1([H])[H],KKZFLSZAWCYPOC-PYHARJCCSA-L,"InChI=1S/C5H11O7P/c6-3-1-5(7)12-4(3)2-11-13(8,9)10/h3-7H,1-2H2,(H2,8,9,10)/p-2/t3-,4+,5?/m0/s1"
1595,67695,"(+)-(5E,12E,2S,3S,4S,9S,11S,15R)-3-cinnamoyloxylathyra-5,12-dien-15-ol-14-one",A lathyrane diterpenoid isolated from the roots of Euphorbia micractina.,18033,KEGG COMPOUND accession,C03574,,,,,,,,,,,,,,,
1596,67698,"(-)-(6Z,12E,2S,3S,4R,5R,9S,11S,15R)-3-cinnamoyloxylathyra-6,12-diene-5,15-diol-14-one",A  lathyrane diterpenoid isolated from the roots of Euphorbia micractina.,16739,KEGG COMPOUND accession,C01546,,,,,,,,,,,,,,,
1597,67701,"(-)-(6Z,12E,2S,3S,4R,5R,9S,11S,15R)-5-acetoxy-15-benzoyloxylathyra-6,12-dien-3-ol-14-one",A lathyrane diterpenoid isolated from the roots of Euphorbia micractina.,15474,KEGG COMPOUND accession,C00845,,,,,,,,,,,,,,,
1598,67763,brugunin A,A  lignan isolated from the stems of Sinocalamus affinis.,28027,KEGG COMPOUND accession,C06760,,,,,,,,,,,,,,,
1599,67854,pescaprein XXIV,"A resin glycoside that is the pentasaccharide derivative of jalapinolic acid. Isolated from the aerial parts of  Ipomoea pes-caprae, it has been found to exhibit potential inhibitory effect against multidrug resistance in the human breast cancer cell line.",17236,KEGG COMPOUND accession,C00682,,,,,,,,,,,,,,,
1600,67914,euscaphic acid,"A pentacyclic triterpenoid that is urs-12-en-28-oic acid substituted by hydroxy groups at positions 2, 3 and 19 respectively (the 2alpha,3alpha-stereoisomer). It has been isolated from the leaves of Rosa laevigata.",16256,KEGG COMPOUND accession,C00349,2mop,b,16256.0,"Human Metabolome Database (HMDB): 2-Methyl-3-oxopropanoic acid is an intermediate in the metabolism of Propanoate. It is a substrate for 3-hydroxyisobutyrate dehydrogenase (mitochondrial), Alanine--glyoxylate aminotransferase 2 (mitochondrial) and Methylmalonate-semialdehyde dehydrogenase (mitochondrial).",2-Methyl-3-oxopropanoic acid,HMDB0001172,b,b,C00349,CH3-MALONATE-S-ALD,FDB022464,2mop,[H]C(=O)C([H])(C([O-])=O)C([H])([H])[H],VOKUMXABRRXHAR-UHFFFAOYSA-M,"InChI=1S/C4H6O3/c1-3(2-5)4(6)7/h2-3H,1H3,(H,6,7)/p-1"
1601,67941,"1-oxo-3beta,23-dihydroxyolean-12-en-28-oic acid 28-O-beta-D-glucopyranoside","A triterpenoid saponin that is olean-12-ene attached to hydroxy groups at positions 3 and 23, oxo groups at positions 1 and 28 and a beta-D-glucopyranosyloxy group at position 28. It has been isolated from the leaves and twigs of Juglans sinensis.",17059,KEGG COMPOUND accession,C02224,,,,,,,,,,,,,,,
1602,67943,"3beta,23-dihydroxyurs-12-en-28-oic acid 28-O-beta-D-glucopyranoside",A triterpenoid saponin that is 28-O-beta-D-glucopyranosyl derivative of 23-hydroxyursolic acid. It has been isolated from the leaves and twigs of Juglans sinensis.,15598,KEGG COMPOUND accession,C02225,,,,,,,,,,,,,,,
1603,67949,3beta-acetoxyolean-18-en-28-oic acid,A pentacyclic triterpenoid that is olean-18-ene substituted by an acetyloxy group at position 3 and a carboxy group at position 28. It has been isolated from Juglans sinensis.,16093,KEGG COMPOUND accession,C02295,,,,,,,,,,,,,,,
1604,67951,3-oxo-23-hydroxyurs-12-en-28-oic acid,"A pentacyclic triterpenoid that is urs-12-ene substituted by an oxo group at position 3, a carboxy group at position 28 and a hydroxy group at position 23. It has been isolated from Juglans sinensis.",17207,KEGG COMPOUND accession,C02930,,,,,,,,,,,,,,,
1605,67954,"2alpha,3beta-dihydroxylup-20(29)-ene","A pentacyclic triterpenoid that is lup-20(29)-ene substituted by hydroxy groups at positions 2 and 3 (the 2alpha,3beta stereoisomer). It has been isolated from Juglans sinensis.",36986,KEGG COMPOUND accession,C01732,mescon,498-24-8,16600.0,"Human Metabolome Database (HMDB): Mesaconic acid is one of several isomeric carboxylic acids obtained from citric acid. Is used as a fire retardant, recent studies revealed this acid is a competitive inhibitor of fumarate reduction.",Mesaconic acid,HMDB0000749,b,b,C01732,b,FDB022221,mescon,[H]\C(C([O-])=O)=C(/C([O-])=O)C([H])([H])[H],HNEGQIOMVPPMNR-NSCUHMNNSA-L,"InChI=1S/C5H6O4/c1-3(5(8)9)2-4(6)7/h2H,1H3,(H,6,7)(H,8,9)/p-2/b3-2+"
1606,68010,lehualide J,"A member of the class of 2-pyranones that is 2H-pyran-2-one substituted by methoxy groups at positions 3 and 4, a methyl group at position 5 and a 10-(methylsulfinyl)decyl group at position 6. It has been isolated from the marine sponge of the genus Plakortis.",16037,KEGG COMPOUND accession,C02116,,,,,,,,,,,,,,,
1607,68041,12-epi-deoxoscalarin,"A  scalarane sesterterpenoid that is the deoxo derivative of 12-epi-scalarin. It has been isolated from the sponge,Hyattella species.",16763,KEGG COMPOUND accession,C00109,2obut,600-18-0,30831.0,"Human Metabolome Database (HMDB): 2-Ketobutyric acid is a substance that is involved in the metabolism of many amino acids (glycine, methionine, valine, leucine, serine, threonine, isoleucine) as well as propanoate metabolism and C-5 branched dibasic acid metabolism. More specifically, alpha-ketobutyric acid is a product of the lysis of cystathionine. It is also one of the degradation products of threonine. It can be converted to propionyl-CoA (and subsequently methylmalonyl CoA, which can be converted to succinyl CoA, a citric acid cycle intermediate), and thus enter the citric acid cycle.",2-Ketobutyric acid,HMDB0000005,b,b,C00109,2-OXOBUTANOATE,FDB003359,2obut,[H]C([H])([H])C([H])([H])C(=O)C([O-])=O,TYEYBOSBBBHJIV-UHFFFAOYSA-M,"InChI=1S/C4H6O3/c1-2-3(5)4(6)7/h2H2,1H3,(H,6,7)/p-1"
1608,68049,pierreione C,"A methoxyisoflavone that is isoflavone substituted by methoxy groups at positions 5 and 3', a prenyloxy group at position 4' and a dimethylpyran ring fused across positions 6 and 7. Isolated from Antheroporum pierrei, it exhibits antineoplastic activity.",16769,KEGG COMPOUND accession,C00940,HC00591,18465-19-5,30882.0,Human Metabolome Database (HMDB): deaminated metabolite of glutamine in csf of patients with hepatic coma; intermediate in the detoxification of ammonia in brain; structure.,2-Keto-glutaramic acid,HMDB0001552,b,b,C00940,2-KETO-GLUTARAMATE,FDB022686,HC00591,[H]N([H])C(=O)C([H])([H])C([H])([H])C(=O)C([O-])=O,COJBGNAUUSNXHX-UHFFFAOYSA-M,"InChI=1S/C5H7NO4/c6-4(8)2-1-3(7)5(9)10/h1-2H2,(H2,6,8)(H,9,10)/p-1"
1609,68056,protuboxepin B,"An organic heterotricyclic compound that is 10,11-dihydro-6H-oxepino[2,3-d]pyrazino[1,2-a]pyrimidine-6,9(8H)-dione substituted by a benzyl group at position 8 and an isopropyl group at position 11. It has been isolated from Aspergillus species.",17205,KEGG COMPOUND accession,C03063,2ohed,b,1254.0,b,"2-Oxohept-3-ene-1,7-dioate",b,b,b,C03063,b,b,b,b,b,"InChI=1S/C7H8O5/c8-5(7(11)12)3-1-2-4-6(9)10/h1,3H,2,4H2,(H,9,10)(H,11,12)/b3-1-"
1610,68083,cerevisterol,"An ergostanoid that is (22E)-ergosta-7,22-diene substituted by hydroxy groups at positions 3, 5 and 6 (the 3beta,5alpha,6beta stereoisomer). It has been isolated from the fungus, Xylaria species.",17150,KEGG COMPOUND accession,C00988,2pglyc,13147-57-4,17150.0,Human Metabolome Database (HMDB): Phosphoglycolic acid is a substrate for triose-phosphate isomerase. This compound belongs to the family of Organophosphate Esters. These are organic compounds containing phosphoric acid ester functional group.,Phosphoglycolic acid,HMDB0000816,b,b,C00988,CPD-67,FDB022263,b,[H]C([H])(OP([O-])([O-])=O)C([O-])=O,ASCFNMCAHFUBCO-UHFFFAOYSA-K,"InChI=1S/C2H5O6P/c3-2(4)1-8-9(5,6)7/h1H2,(H,3,4)(H2,5,6,7)/p-3"
1611,68131,"(Z)-3-(3,4-dihydroxybenzylidene)-5-(3,4-dihydroxyphenyl)-2(3H)-furanone","A butenolide that is furan-2(3H)-one substituted by a 3,4-dihydroxybenzylidene group at position 3 and a 3,4-dihydroxyphenyl group at position 5. It has been isolated from the roots of Scorzonera judaica.",15471,KEGG COMPOUND accession,C03221,dd2coa,1066-12-2,57330.0,"Human Metabolome Database (HMDB): (2E)-Dodecenoyl-CoA is an intermediate in fatty acid metabolism, the substrate of the enzyme acyl-CoA oxidase [EC-1.3.3.6], and enzymes acyl-CoA dehydrogenase, long-chain-acyl-CoA dehydrogenase [EC 1.3.99.3-1.3.99.13]; (2E)-Dodecenoyl-CoA is an intermediate in fatty acid elongation in mitochondria, being the substrate of the enzyme enoyl-CoA hydratase and [EC 4.2.1.17]. (KEGG).",(2E)-Dodecenoyl-CoA,HMDB0003712,b,b,C03221,CPD-7222,FDB023218,dd2coa,[H]O[C@@]([H])(C(=O)N([H])C([H])([H])C([H])([H])C(=O)N([H])C([H])([H])C([H])([H])SC(=O)C(\[H])=C(/[H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H])C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])OP([O-])(=O)OP([O-])(=O)OC([H])([H])[C@@]1([H])O[C@@]([H])(N2C([H])=NC3=C(N=C([H])N=C23)N([H])[H])[C@]([H])(O[H])[C@]1([H])OP([O-])([O-])=O,IRFYVBULXZMEDE-KDPBKMHJSA-J,"InChI=1S/C33H56N7O17P3S/c1-4-5-6-7-8-9-10-11-12-13-24(42)61-17-16-35-23(41)14-15-36-31(45)28(44)33(2,3)19-54-60(51,52)57-59(49,50)53-18-22-27(56-58(46,47)48)26(43)32(55-22)40-21-39-25-29(34)37-20-38-30(25)40/h12-13,20-22,26-28,32,43-44H,4-11,14-19H2,1-3H3,(H,35,41)(H,36,45)(H,49,50)(H,51,52)(H2,34,37,38)(H2,46,47,48)/p-4/b13-12+/t22-,26-,27-,28+,32-/m0/s1"
1612,68133,hydrangenol 8-O-beta-D-glucopyranoside,A member of the class of dihydroisocoumarins that is hydrangenol attached to a beta-D-glucopyranosyl residue at position 8 via a glycosidic linkage. It has been isolated from the roots of   Scorzonera judaica.,17585,KEGG COMPOUND accession,C02788,,,,,,,,,,,,,,,
1613,68136,hydramacrophyllol A,An isobenzofuranone that is 2-benzofuran-1(3H)-one substituted by a hydroxy group at position 7 and a (S)-hydroxy(4-hydroxyphenyl)methyl group at position 3. It has been isolated from the roots of Scorzonera judaica.,17700,KEGG COMPOUND accession,C01875,,,,,,,,,,,,,,,
1614,68245,platensimycin B3,A polycyclic cage that is the decarboxy derivative of  platensimycin. It is isolated from Streptomyces platensis.,17079,KEGG COMPOUND accession,C05202,,,,,,,,,,,,,,,
1615,68260,13-hydroxyplatencinic acid methyl ester,A polycyclic cage with a 3-methoxy-3-oxopropyl side chain. It is isolated from Streptomyces platensis.,17980,KEGG COMPOUND accession,C00053,paps,482-67-7,17980.0,"Human Metabolome Database (HMDB): 3'-Phosphoadenosine-5'-phosphosulfate. Key intermediate in the formation by living cells of sulfate esters of phenols, alcohols, steroids, sulfated polysaccharides, and simple esters, such as choline sulfate. It is formed from sulfate ion and ATP in a two-step process. This compound also is an important step in the process of sulfur fixation in plants and microorganisms.",Phosphoadenosine phosphosulfate,HMDB0001134,b,b,C00053,PAPS,FDB022445,paps,[H]O[C@@]1([H])[C@@]([H])(O[C@]([H])(C([H])([H])OP([O-])(=O)OS([O-])(=O)=O)[C@@]1([H])OP([O-])([O-])=O)N1C([H])=NC2=C(N=C([H])N=C12)N([H])[H],GACDQMDRPRGCTN-KQYNXXCUSA-J,"InChI=1S/C10H15N5O13P2S/c11-8-5-9(13-2-12-8)15(3-14-5)10-6(16)7(27-29(17,18)19)4(26-10)1-25-30(20,21)28-31(22,23)24/h2-4,6-7,10,16H,1H2,(H,20,21)(H2,11,12,13)(H2,17,18,19)(H,22,23,24)/p-4/t4-,6-,7-,10-/m1/s1"
1616,68272,jasplakinolide Q,A cyclodepsipeptide isolated from Jaspis splendens.,28774,KEGG COMPOUND accession,C07639,CE2754,b,28774.0,b,"3,3,5 - Triiodothyronine",b,b,b,C07639,b,b,b,[H]OC1=C(I)C([H])=C(OC2=C(I)C([H])=C(C([H])=C2[H])C([H])([H])[C@]([H])(C([O-])=O)[N+]([H])([H])[H])C([H])=C1I,HZCBWYNLGPIQRK-GFCCVEGCSA-N,"InChI=1S/C15H12I3NO4/c16-9-3-7(4-12(19)15(21)22)1-2-13(9)23-8-5-10(17)14(20)11(18)6-8/h1-3,5-6,12,20H,4,19H2,(H,21,22)/t12-/m1/s1"
1617,68291,inumakal,"An abietane diterpenoid that is podocarpa-8,11,13-triene substituted by a propan-2-yl group at position 14, a hydroxy group at position 11 and a formyl group at position 16. It is isolated from Podocarpus latifolius.",27626,KEGG COMPOUND accession,C04445,,,,,,,,,,,,,,,
1618,68296,bunodosine 391,"A N-acylamino acid that is L-histidine acylated at the nitrogen atom of the amino group by a (6-bromo-1H-indol-3-yl)acetyl residue. Isolated from the venom of the sea anemone Bunodosoma cangicum, it exhibits analgesic activity.",15893,KEGG COMPOUND accession,C04322,,,,,,,,,,,,,,,
1619,68333,"robinetinidol-(4alpha,8)-catechin",A ring assembly that consists of robinetinidol attached to a (+)-catechin unit resulting in a bond between C-4 of the pyran ring and C-8 of the benzopyran ring. It is isolated from Acacia mearnsii.,17612,KEGG COMPOUND accession,C01161,34dhpha,102-32-9,41941.0,"Human Metabolome Database (HMDB): 3,4-dihydroxyphenylacetic acid (DOPAC) is a phenolic acid. DOPAC is a neuronal metabolite of dopamine (DA). DA undergoes monoamine oxidase-catalyzed oxidative deamination to 3,4-dihydroxyphenylacetaldehyde (DOPAL), which is metabolized primarily to DOPAC via aldehyde dehydrogenase (ALDH2). The biotransformation of DOPAL is critical as previous studies have demonstrated this DA-derived aldehyde to be a reactive electrophile and toxic to dopaminergic cells. Known inhibitors of mitochondrial ALDH2, such as 4-hydroxy-2-nonenal (4HNE) inhibit ALDH2-mediated oxidation of the endogenous neurotoxin DOPAL. 4HNE is one of the resulting products of oxidative stress, thus linking oxidative stress to the uncontrolled production of an endogenous neurotoxin relevant to Parkinson's disease. In early onset Parkinson disease there is markedly reduced activities of both monoamine oxidase (MAO) A and B. The amount of DOPAC, which is produced during dopamine oxidation by MAO, is greatly reduced as a result of increased parkin overexpression. Administration of methamphetamine to animals causes loss of DA terminals in the brain, and significant decreases in Dopamine and dihydroxyphenylacetic acid (DOPAC) in the striata. Renal dopamine produced in the residual tubular units may be enhanced during a sodium challenge, thus behaving appropriately as a compensatory natriuretic hormone; however the renal dopaminergic system in patients afflicted with renal parenchymal disorders should address parameters other than free urinary dopamine, namely the urinary excretion of L-DOPA and metabolites. DOPAC is one of the major phenolic acids formed during human microbial fermentation of tea, citrus, and soy flavonoid supplements. DOPAC exhibits a considerable antiproliferative effect in LNCaP prostate cancer and HCT116 colon cancer cells. The antiproliferative activity of DOPAC may be due to its catechol structure. A similar association of the catechol moiety in the B-ring with antiproliferative activity was demonstrated for flavanones. (PMID: 16956664, 16455660, 8561959, 11369822, 10443478, 16365058).","3,4-Dihydroxybenzeneacetic acid",HMDB0001336,b,b,C01161,CPD-782,FDB000316,34dhpha,[H]OC1=C([H])C([H])=C(C([H])=C1O[H])C([H])([H])C([O-])=O,CFFZDZCDUFSOFZ-UHFFFAOYSA-M,"InChI=1S/C8H8O4/c9-6-2-1-5(3-7(6)10)4-8(11)12/h1-3,9-10H,4H2,(H,11,12)/p-1"
1620,68339,multifidol glucoside,"A monosaccharide derivative that consists of multifidol attached to a  beta-D-glucopyranosyl residue at position 1 via a glycosidic linkage. Isolated from Acacia mearnsii, it exhibits anti-inflammatory activity.",17416,KEGG COMPOUND accession,C03223,,,,,,,,,,,,,,,
1621,68362,15-acetyltrichagmalin C,A limonoid with a phragmalin skeleton isolated from the leaves of Trichilia connaroides.,28335,KEGG COMPOUND accession,C03224,,,,,,,,,,,,,,,
1622,68374,"(-)-(2S)-5,7,2'-trihydroxy-8,3'-diprenylflavanone","A trihydroxyflavanone that is (2S)-5,7,2'-trihydroxyflavanone substituted by prenyl groups at positions 8 and 3'. Isolated from Dalea boliviana, it exhibits inhibitory activity against  tyrosinase.",15788,KEGG COMPOUND accession,C02933,,,,,,,,,,,,,,,
1623,68380,11alpha-hydroxyasiatic acid,"A pentacyclic triterpenoid that is the 11alpha-hydroxy derivative of  asiatic acid. Isolated from the methanolic extract of the leaves of Symplocos lancifolia, it exhibits antibacterial activity.",17136,KEGG COMPOUND accession,C04110,,,,,,,,,,,,,,,
1624,68391,"(22E)-24,26-cyclo-19-norcholesta-1,3,5(10),22-tetraen-3-ol","A 3-hydroxy steroid that is 24,26-cyclo-19-norcholesta-1,3,5(10),22-tetraene substituted by a hydroxy group at position 3. It is isolated from the Hainan soft coral Dendronephthya studeri.",16145,KEGG COMPOUND accession,C04287,,,,,,,,,,,,,,,
1625,68408,plakortolide K,An organic heterobicyclic compound that is a cyclic peroxy compound isolated from the Australian marine sponge Plakinastrella clathrata.,46951,KEGG COMPOUND accession,C04044,,,,,,,,,,,,,,,
1626,68412,plakortolide O,An organic heterobicyclic compound that is a cyclic peroxy compound isolated from the Australian marine sponge Plakinastrella clathrata.,16281,KEGG COMPOUND accession,C04366,,,,,,,,,,,,,,,
1627,68421,plakortone N,An organic heterobicyclic compound consisting of a gamma-lactone ring fused onto a substituted tetrahydrofuran ring. It is isolated from the Australian marine sponge Plakinastrella clathrata.,17807,KEGG COMPOUND accession,C01207,,,,,,,,,,,,,,,
1628,68424,beta-D-QuiN4Fm-(1->4)-alpha-D-GalNAcAN-(1->4)-alpha-D-GalNAcAN-(1->3)-beta-D-QuiNAc-(1->2)-beta-D-QuiN4Fm-(1->4)-alpha-D-GalNAcAN-(1->4)-alpha-D-GalNAcAN-(1->3)-beta-D-QuiNAc-(1->4)-[alpha-D-GalN-(1->2)]-[alpha-D-Glc-(1->3)]-beta-D-Man-(1->4)-[beta-D-Glc-(1->2)]-alpha-D-Man-(1->5)-alpha-Kdo,"An amino oligosaccharide that is a branched tetradecasaccharide derivative comprised of a mannose residue to which is linked an N-acetylgalactosaminyl residue at O-2, a glucosyl residue at O-3 and a beta-D-QuiN4Fm-(1->4)-alpha-D-GalNAcAN-(1->2)-alpha-D-GalNAcAN-(1->3)-beta-D-QuiNAc-(1->2)-beta-D-QuiN4Fm-(1->4)-alpha-D-GalNAcAN-(1->4)-alpha-D-GalNAcAN-(1->3)-beta-D-QuiNAc octasaccharide chain at O-4, all linked to an [alpha-D-Glc-(1->2)]-alpha-D-Man-(1->5)-alpha-Kdo branched trisaccharide unit.",16122,KEGG COMPOUND accession,C04367,,,,,,,,,,,,,,,
1629,68428,maltitol,An alpha-D-glucoside consisting of D-glucitol having an alpha-D-glucosyl residue attached at the 4-position. Used as a sugar substitute.,37393,KEGG COMPOUND accession,C03892,,,,,,,,,,,,,,,
1630,68430,alpha-D-GalpNAc-(1->3)-[alpha-L-Fucp-(1->2)]-beta-D-Galp-(1->4)-beta-D-GlcpNAc-(1->3)-beta-D-Galp-(1->4)-beta-D-GlcpNAc,An amino hexasaccharide in which an alpha-L-fucosyl residue is linked (1->2) to the mannosyl residue furthest from the reducing end of an alpha-D-GalNAc-(1->3)-beta-D-Gal-(1->4)-beta-D-GlcNAc-(1->3)-beta-D-Gal-(1->4)-beta-D-GlcNAc linear pentasaccharide.,16126,KEGG COMPOUND accession,C04794,ha_pre1,b,16126.0,Human Metabolome Database (HMDB): This compound belongs to the family of N-acyl-alpha-hexosamines. These are carbohydrate derivatives containing a hexose moeity in which the oxygen atom is replaced by an n-acyl group.,"Hyaluronan biosynthesis, precursor 1",HMDB0060071,b,b,C04794,b,b,ha_pre1,[H]OC([H])([H])[C@@]1([H])O[C@@]([H])(O[H])[C@]([H])(N([H])C(=O)C([H])([H])[H])[C@@]([H])(O[C@]2([H])OC(=C([H])[C@]([H])(O[H])[C@@]2([H])O[H])C([O-])=O)[C@]1([H])O[H],DLGJWSVWTWEWBJ-UCFDOFRFSA-M,"InChI=1S/C14H21NO11/c1-4(17)15-8-11(10(20)7(3-16)24-13(8)23)26-14-9(19)5(18)2-6(25-14)12(21)22/h2,5,7-11,13-14,16,18-20,23H,3H2,1H3,(H,15,17)(H,21,22)/p-1/t5-,7+,8+,9+,10+,11+,13+,14-/m0/s1"
1631,68435,alpha-D-GalpNAc-(1->4)-[alpha-D-Fucp-(1->2)]-beta-D-Galp-(1->4)-beta-D-GlcpNAc,An amino tetrasaccharide in which an alpha-L-fucosyl residue is linked (1->2) to the middle galactosyl residue of an N-acetyl-alpha-D-galactosaminyl-(1->4)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosamine trisaccharide.,16331,KEGG COMPOUND accession,C01744,phppa,501-97-3,32980.0,Human Metabolome Database (HMDB): Desaminotyrosine is a normal constituent of human urine. A product of tyrosine metabolism; concentration in urine increases in patients with gastrointestinal diseases. (Dictionary of Organic Compounds). It is considered also that may result from metabolism to phenolic acids by colonic bacteria. (PMID 15315398).,Desaminotyrosine,HMDB0002199,b,b,C01744,2-3-DIHYDROXYPHENYL-PROPIONATE,FDB000849,b,b,NMHMNPHRMNGLLB-UHFFFAOYSA-N,b
1632,68438,Fe-coproporphyrin III(4-),A cyclic tetrapyrrole anion obtained by the deprotonation of the four carboxy functions of Fe-coproporphyrin III.,15480,KEGG COMPOUND accession,C01291,,,,,,,,,,,,,,,
1633,68440,2-methylnicotinamide,A pyridinecarboxamide that is nicotinamide substituted by a methyl group at C-2.,18117,KEGG COMPOUND accession,C03673,,,,,,,,,,,,,,,
1634,68448,beta-D-GalpNAc-(1->4)-beta-D-GlcpNAc,beta-D-GalpNAc-(1->4)-D-GlcpNAc with beta configuration at the reducing-end anomeric centre.,16426,KEGG COMPOUND accession,C01267,,,,,,,,,,,,,,,
1635,68451,alpha-hydroxyhippuric acid,An N-acyl-amino acid that is N-benzoylglycine substituted by a hydroxy group at C-2.,16357,KEGG COMPOUND accession,C01162,,,,,,,,,,,,,,,
1636,68478,everolimus,A macrocyclic lactone that is rapamycin in which the hydroxy group attached to the cyclohexyl moiety has been converted into the corresponding 2-hydroxyethyl ether. It is an immunosuppressant and antineoplastic agent.,17559,KEGG COMPOUND accession,C03470,,,,,,,,,,,,,,,
1637,68484,alpha-D-Galp-(1->4)-beta-D-Galp-(1->4)-beta-D-GlcpNAc-(1->3)-beta-D-Galp-(1->4)-beta-DGlcp,"An amino pentasaccharide consisting of alpha-D-galactose, beta-D-galactose N-acetyl-alpha-D-glucosamine, beta-D-galactose, and beta-D-glucose residues joined in sequence with ((1->4)-, (1->4)-, (1->3)- and (1->4)-linkages, respectively.",16939,KEGG COMPOUND accession,C04368,,,,,,,,,,,,,,,
1638,68493,"dTDP-4-acetamido-4,6-dideoxy-alpha-D-galactose(2-)","A dTDP-4-acetamido-4,6-dideoxy-D-galactose(2-) in which the anomeric centre of the pyranose fragment has alpha-configuration.",28924,KEGG COMPOUND accession,C05058,,,,,,,,,,,,,,,
1639,68504,naphthochromene,An organic heterotetracyclic compound resulting from the formal fusion of a naphthalene with a chromene.,16989,KEGG COMPOUND accession,C04553,,,,,,,,,,,,,,,
1640,68508,diethyl maleate,"A maleate ester resulting from the formal condensation of both carboxy groups of maleic acid with ethanol. A colourless liquid at room temperature (m.p. -10degreeC) with boiling point 220degreeC at 1 atm., it is commonly used as a dienophile for Diels-Alder-type cycloaddition reactions in organic synthesis.",18003,KEGG COMPOUND accession,C04480,,,,,,,,,,,,,,,
1641,68510,lysophosphatidylserine,"An acylglycerophosphoserine resulting from partial hydrolysis of a phosphatidylserine, which removes one of the fatty acid groups. The structure is depicted in the image where R(1) = acyl, R(2) = H or where R(1) = H, R(2) = acyl. Formula C7H13NO9PR, where R represents the hydrocarbon chain of the fatty acyl group.",17693,KEGG COMPOUND accession,C04447,,,,,,,,,,,,,,,
1642,68515,tetrahydrofolyl-poly(glutamic acid) polymer,A polymer composed of tetrahydrofolyl-poly(glutamic acid) macromolecules,15749,KEGG COMPOUND accession,C01163,,,,,,,,,,,,,,,
1643,68521,"alkyl,acyl-sn-glycero-3-phosphoserine","A glycerophosphoserine that is sn-glycero-3-phospho-L-serine in which positions 1 and 2 are substituted by unspecified acyl and alkyl groups, and in which the positions of the acyl and alkyl groups are also unspecified.",17092,KEGG COMPOUND accession,C02634,,,,,,,,,,,,,,,
1644,68542,EC 1.3.98.1 [dihydroorotate oxidase (fumarate)] inhibitor,"An EC 1.3.98.* (oxidoreductase acting on CH-CH group of donors, with other, known, acceptors) inhibitor that interferes with the action of dihydroorotate oxidase (fumarate), EC 1.3.98.1 (formerly EC 1.3.3.1).",27715,KEGG COMPOUND accession,C05618,,,,,,,,,,,,,,,
1645,68554,deferiprone,A member of the class of 4-pyridones that is pyridin-4(1H)-one substituted at positions 1 and 2 by methyl groups and at position 3 by a hydroxy group. A lipid-soluble iron-chelator used for treatment of thalassaemia.,16622,KEGG COMPOUND accession,C03926,,,,,,,,,,,,,,,
1646,68559,beta-D-Gal-(1->3)-[alpha-L-Fuc-(1->4)]-beta-D-GlcNAc-(1->2)-alpha-DMan-(1->3)-{beta-D-Gal-(1->3)-[alpha-L-Fuc-(1->4)]-beta-D-GlcNAc-(1->2)-alpha-DMan-(1->6)}-beta-D-Man-(1->4)-beta-D-GlcNAc-(1->4)-beta-D-GlcNAc,"An amino oligosaccharide that is a dodecasaccharide derivative in which two tetrasaccharide branches, each formed from alpha-L-fucosyl-(1->4)-[beta-D-galactosyl-(1->3)]-N-acetyl-beta-D-glucosaminyl-(1->2)-alpha-D-mannose, are linked (1->3) and (1->6) to the mannose residue of a linear trisaccharide chain consisting of mannose linked beta(1->4) to an N-acetyl-beta-D-glucosamine residue which is itself linked beta(1->4) to an N-acetyl-beta-D-glucosamine residue at the reducing end.",16943,KEGG COMPOUND accession,C03064,,,,,,,,,,,,,,,
1647,68564,icatibant acetate,An acetate salt obtained by combining icatibant with acetic acid. Used for the treatment of acute attacks of hereditary angioedema in adult patients.,16758,KEGG COMPOUND accession,C02636,,,,,,,,,,,,,,,
1648,68572,2-aminonicotinic acid,An aminonicotinic acid in which the amino group is situated at position 2 of the pyridine ring.,16630,KEGG COMPOUND accession,C02637,,,,,,,,,,,,,,,
1649,68584,ezogabine,"A substituted aniline that is benzene-1,2,4-triamine bearing ethoxycarbonyl and 4-fluorobenzyl substituents at positions N-1 and N-4 respectively. An  anticonvulsant used to treat seizures associated with epilepsy in adults.",16064,KEGG COMPOUND accession,C01187,,,,,,,,,,,,,,,
1650,68600,beta-Asp-Leu,A dipeptide that is the N-(L-beta-aspartyl) derivative of L-leucine.,27990,KEGG COMPOUND accession,C02363,,,,,,,,,,,,,,,
1651,68607,steroid phosphate oxoanion,An organophosphate oxoanion obtained by the deprotonation of one or more oxygen atoms of the phosphate group(s) of a steroid phosphoric acid.,15591,KEGG COMPOUND accession,C01989,,,,,,,,,,,,,,,
1652,68624,cis-abienol,A labdane diterpenoid in which the labdane skeleton has double bonds at C-12 and C-14 (the former with Z-stereochemistry) and carries a hydroxy group at position C-8.,16854,KEGG COMPOUND accession,C02514,,,,,,,,,,,,,,,
1653,68628,tartrazine(3-),An organosulfonate oxoanion which is also a monocarboxylic acid anion obtained by deprotonation of the sulfo and carboxy groups of tartrazine acid.,15968,KEGG COMPOUND accession,C03065,,,,,,,,,,,,,,,
1654,68630,tetrasulfocyanine(3-),An organosulfonate oxoanion which is the trianion obtained by the deprotonation of the sulfo groups of tetrasulfocyanine acid.,18081,KEGG COMPOUND accession,C05200,,,,,,,,,,,,,,,
1655,68632,poly(acrylate) macromolecule,A polyanionic polymer obtained by global deprotonation of the carboxy groups of poly(acrylic acid).,16835,KEGG COMPOUND accession,C05313,,,,,,,,,,,,,,,
1656,68637,dexamethasone phosphate,A steroid phosphate that is the 21-O-phospho derivative of dexamethasone.,28630,KEGG COMPOUND accession,C03927,,,,,,,,,,,,,,,
1657,68649,pentalenate,"A hydroxy monocarboxylic acid anion that is the conjugate base of pentalenic acid, obtained by deprotonation of the carboxy group; major species at pH 7.3.",15481,KEGG COMPOUND accession,C04047,3hibutcoa,b,15481.0,b,(S)-3-Hydroxyisobutyryl Coenzyme A,b,b,b,C04047,b,b,3hibutcoa,[H]OC([H])([H])[C@@]([H])(C(=O)SC([H])([H])C([H])([H])N([H])C(=O)C([H])([H])C([H])([H])N([H])C(=O)[C@]([H])(O[H])C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])OP([O-])(=O)OP([O-])(=O)OC([H])([H])[C@@]1([H])O[C@@]([H])(N2C([H])=NC3=C(N=C([H])N=C23)N([H])[H])[C@]([H])(O[H])[C@]1([H])OP([O-])([O-])=O)C([H])([H])[H],WWEOGFZEFHPUAM-UQCJFRAESA-J,"InChI=1S/C25H42N7O18P3S/c1-13(8-33)24(38)54-7-6-27-15(34)4-5-28-22(37)19(36)25(2,3)10-47-53(44,45)50-52(42,43)46-9-14-18(49-51(39,40)41)17(35)23(48-14)32-12-31-16-20(26)29-11-30-21(16)32/h11-14,17-19,23,33,35-36H,4-10H2,1-3H3,(H,27,34)(H,28,37)(H,42,43)(H,44,45)(H2,26,29,30)(H2,39,40,41)/p-4/t13-,14+,17+,18+,19-,23+/m0/s1"
1658,68649,pentalenate,"A hydroxy monocarboxylic acid anion that is the conjugate base of pentalenic acid, obtained by deprotonation of the carboxy group; major species at pH 7.3.",15481,KEGG COMPOUND accession,C04047,HC01223,b,15481.0,b,3-Hydroxyisobutyryl Coenzyme A,b,b,b,C04047,b,b,HC01223,[H]OC([H])([H])C([H])(C(=O)SC([H])([H])C([H])([H])N([H])C(=O)C([H])([H])C([H])([H])N([H])C(=O)[C@]([H])(O[H])C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])OP([O-])(=O)OP([O-])(=O)OC([H])([H])[C@@]1([H])O[C@@]([H])(N2C([H])=NC3=C(N=C([H])N=C23)N([H])[H])[C@]([H])(O[H])[C@]1([H])OP([O-])([O-])=O)C([H])([H])[H],WWEOGFZEFHPUAM-MIZDRFBCSA-J,"InChI=1S/C25H42N7O18P3S/c1-13(8-33)24(38)54-7-6-27-15(34)4-5-28-22(37)19(36)25(2,3)10-47-53(44,45)50-52(42,43)46-9-14-18(49-51(39,40)41)17(35)23(48-14)32-12-31-16-20(26)29-11-30-21(16)32/h11-14,17-19,23,33,35-36H,4-10H2,1-3H3,(H,27,34)(H,28,37)(H,42,43)(H,44,45)(H2,26,29,30)(H2,39,40,41)/p-4/t13?,14-,17-,18-,19+,23-/m1/s1"
1659,68653,"[alpha-D-GalNAc-(1->4)]4-alpha-D-GalNAc-(1->3)-alpha-D-diNAcBac-tritrans,heptacis-undecaprenyl diphosphate(2-)","An organophosphate oxoanion obtained by deprotonation of the diphosphate OH groups of [alpha-D-GalNAc-(1->4)]4-alpha-D-GalNAc-(1->3)-alpha-D-diNAcBac-tritrans,heptacis-undecaprenyl diphosphate; major species at pH 7.3.",15821,KEGG COMPOUND accession,C01270,,,,,,,,,,,,,,,
1660,68655,Delta(6)-protoilludene,"A tricyclic sesquiterpene that is 2,4,4a,5,6,7,7a,7b-octahydro-1H-cyclobuta[e]indene bearing four methyl substituents at positions 3, 6, 6 and 7b.",15482,KEGG COMPOUND accession,C07302,,,,,,,,,,,,,,,
1661,68663,D-ethionine,An S-ethylhomocysteine that has R-configuration at the chiral centre.,17325,KEGG COMPOUND accession,C03761,,,,,,,,,,,,,,,
1662,68669,"N,N-diacetyllegionaminate","A carbohydrate acid derivative anion that is the conjugate base of N,N-diacetyllegionaminic acid, obtained by deprotonation of the carboxy group; major species at pH 7.3.",36558,KEGG COMPOUND accession,C03986,,,,,,,,,,,,,,,
1663,68674,alpha-L-Fucp-(1->2)-[beta-D-Galp-(1->3)-alpha-D-GalpNAc-(1->3)]-beta-D-Galp-(1->4)-D-GlcpNAc,"An amino pentasaccharide comprised of a tetrasaccharide chain of beta-D-galactosyl, N-acetyl-alpha-D-galactosaminyl, beta-D-galactosyl and N-acetyl-D-glucosaminyl residues linked sequentially (1->3), (1->3) and (1->4), with an alpha-L-fucosyl residue linked (1->2) to the galactosyl residue proximal to the reducing-end glucosaminyl residue.",29086,KEGG COMPOUND accession,C04844,,,,,,,,,,,,,,,
1664,68684,methylphosphonate(1-),"An organophosphonate oxoanion that is the conjugate base of methylphosphonic acid, obtained by deprotonation of one of the two phosphonate OH groups.",17652,KEGG COMPOUND accession,C03066,,,,,,,,,,,,,,,
1665,68692,decasaccharide derivative,An oligosaccharide derivative that is formally obtained from a decasaccharide.,17419,KEGG COMPOUND accession,C03676,,,,,,,,,,,,,,,
1666,68699,(-)-rotiorin,"An azaphilone that is 9,9a-dihydro-2H-furo[3,2-g]isochromen-2-one substituted by an acetyl group at position 3, an oxo group  at position 9, a 3,5-dimethylhepta-1,3-dien-1-yl group at position 6 and a methyl group at position 9a. It has been isolated from Chaetomium cupreum and exhibits antifungal activity.",36559,KEGG COMPOUND accession,C00632,3hanthrn,548-93-6,15793.0,Human Metabolome Database (HMDB): 3-Hydroxyanthranilic acid is an oxidation product of tryptophan metabolism. It may be a free radical scavenger and a carcinogen.,3-Hydroxyanthranilic acid,HMDB0001476,b,b,C00632,3-HYDROXY-ANTHRANILATE,FDB010582,3hanthrn,[H]OC1=C([H])C([H])=C([H])C(C([O-])=O)=C1[N+]([H])([H])[H],WJXSWCUQABXPFS-UHFFFAOYSA-N,"InChI=1S/C7H7NO3/c8-6-4(7(10)11)2-1-3-5(6)9/h1-3,9H,8H2,(H,10,11)"
1667,68706,globosumone B,"A benzoate ester obtained by the formal condensation of o-orsellinic acid with (4S)-1,4-dihydroxypentan-2-one. Isolated from Chaetomium globosum, it exhibits cytotoxic activity towards cancer cell lines.",16193,KEGG COMPOUND accession,C00587,,,,,,,,,,,,,,,
1668,68710,"7,8-dihydroxy-1-methoxy-3-methyl-10-oxo-1H,10H-pyrano[4,3-b]chromene-9-carboxylic acid","An organic heterotricyclic compound that is 1H,10H-pyrano[4,3-b]chromene substituted by hydroxy groups at positions 7 and 8, a methoxy group at position 1, a methyl group at position 3 and an oxo group at position 10. Isolated from Chaetomium funicola, it exhibits inhibitory activity against metallo-beta-lactamases.",15484,KEGG COMPOUND accession,C05195,,,,,,,,,,,,,,,
1669,68719,chaetochromin B,"A biaryl that is 2,2',3,3'-tetrahydro-4H,4'H-9,9'-bibenzo[g]chromene-4,4'-dione substituted by hydroxy groups at positions 5, 5', 6, 6', 8 and 8' and methyl groups at positions 2, 2', 3 and 3' (the 2R,2'S,3R,3'R stereoisomer). It has been isolated from Chaetomium gracile.",17611,KEGG COMPOUND accession,C03228,,,,,,,,,,,,,,,
1670,68738,chaetoglobosin T,A cytochalasan alkaloid found in Chaetomium globosum.,17871,KEGG COMPOUND accession,C00969,3hppnl,2134-29-4,17871.0,"Human Metabolome Database (HMDB): 3-Hydroxypropanal is a broad-spectrum antimicrobial substance termed reuterin produced by Lactobacillus reuteri. L. reuteri resides in the gastrointestinal tract of healthy humans and animals, and is believed to. function as a symbiont in the enteric ecosystem. Synthesis of such an antimicrobial substance by an enteric resident raises a number of interesting questions and possibilities as to the role these residents may play in the health of the host. (PMID 3245697). In vivo, glycerol is converted in one enzymatic step into 3-Hydroxypropanal. The 3-Hydroxypropanal -producing Lactobacillus reuteri is used as a probiotic in the health care of humans and animals. 3-Hydroxypropanal forms, together with Hydroxypropanal-hydrate and Hydroxypropanal-dimer, a dynamic, multi-component system (Hydroxypropanal system) used in food preservation, as a precursor for many modern chemicals such as acrolein, acrylic acid, and 1,3-propanediol (1,3-PDO), and for polymer production. 3-Hydroxypropanal can be obtained both through traditional chemistry and bacterial fermentation. To date, 3-HPA has been produced from petrochemical resources as an intermediate in 1,3-PDO production. The biotechnological production of 3-Hydroxypropanal from renewable resources is desirable both for use of 3-Hydroxypropanal in foods and for the production of bulk chemicals. The main challenge will be the efficient production and recovery of pure 3-Hydroxypropanal. (PMID 14669058).",3-Hydroxypropanal,HMDB0003453,b,b,C00969,HYDROXYPROPANAL,FDB023176,b,b,AKXKFZDCRYJKTF-UHFFFAOYSA-N,"InChI=1S/C3H6O2/c4-2-1-3-5/h2,5H,1,3H2"
1671,68741,chetomin,"An organic heteropentacyclic compound of the class of epipolythiodioxopiperazine. Isolated from Chaetomium globosum and Farrowia seminuda, it exhibits immunosuppressive activity.",16510,KEGG COMPOUND accession,C01013,3hpp,503-66-2,33404.0,"Human Metabolome Database (HMDB): 3-Hydroxypropionic acid is a carboxylic acid. It is an intermediate in the breakdown of branched-chain amino acids and propionic acid from the gut. Typically it originates from propionyl-CoA and a defect in the enzyme propionyl carboxylase. This leads to a buildup in propionyl-CoA in the mitochondria.  Such a buildup can lead to a disruption of the esterified CoA:free CoA ratio and ultimately to mitochondrial toxicity. Detoxification of these metabolic end products occurs via the transfer of the propionyl moiety to carnitine-forming propionyl-carnitine, which is then transferred across the inner mitochondrial membrane. 3-Hydroxypropionic acid is then released as the free acid. As an industrial chemical, it is used in the production of various chemicals such as acrylates in industry. When present in sufficiently high levels, 3-hydroxypropionic acid can act as an acidogen and a metabotoxin. An acidogen is an acidic compound that induces acidosis, which has multiple adverse effects on many organ systems. A metabotoxin is an endogenously produced metabolite that causes adverse health effects at chronically high levels. Chronically high levels of hydroxypropionic acid are associated with many inborn errors of metabolism including biotinidase deficiency, malonic aciduria, methylmalonate semialdehyde dehydrogenase deficiency, methylmalonic aciduria, methylmalonic aciduria due to cobalamin-related disorders, and propionic acidemia. Hydroxypropionic acid is an organic acid. Abnormally high levels of organic acids in the blood (organic acidemia), urine (organic aciduria), the brain, and other tissues lead to general metabolic acidosis. Acidosis typically occurs when arterial pH falls below 7.35. Infants with acidosis have symptoms that include poor feeding, vomiting, loss of appetite, weak muscle tone (hypotonia), and lack of energy (lethargy). These can progress to heart, liver, and kidney abnormalities, seizures, coma, and possibly death. These are also the characteristic symptoms of the IEMs mentioned above. Many affected children with organic acidemias experience intellectual disability or delayed development. In adults, acidosis or acidemia is characterized by headaches, confusion, feeling tired, tremors, sleepiness, and seizures.",Hydroxypropionic acid,HMDB0000700,b,b,C01013,b,FDB022189,3hpp,[H]OC([H])([H])C([H])([H])C([O-])=O,ALRHLSYJTWAHJZ-UHFFFAOYSA-M,"InChI=1S/C3H6O3/c4-2-1-3(5)6/h4H,1-2H2,(H,5,6)/p-1"
1672,68761,cytoglobosin C,A cytochalasan alkaloid found in Chaetomium globosum.,27847,KEGG COMPOUND accession,C02515,3ityr_L,70-78-0,27847.0,"Human Metabolome Database (HMDB): Iodotyrosine is an iodated derivative of L-tyrosine. This is an early precursor to L-thyroxine, one of the primary thyroid hormones. In the thyroid gland, iodide is trapped, transported, and concentrated in the follicular lumen for thyroid hormone synthesis. Before trapped iodide can react with tyrosine residues, it must be oxidized by thyroid peroxidase. Iodotyrosine is made from tyrosine via thyroid peroxidase and then further iodinated by this enzyme to make the di-iodo and tri-iodo variants. Two molecules of di-iodotyrosine combine to form T4, and one molecule of mono-iodotyrosine combines with one molecule of di-iodotyrosine to form T3.",Iodotyrosine,HMDB0000021,b,b,C02515,IODO-L-TYROSINE,FDB021875,3ityr_L,[H]OC1=C([H])C([H])=C(C([H])=C1I)C([H])([H])[C@@]([H])(C([O-])=O)[N+]([H])([H])[H],UQTZMGFTRHFAAM-ZETCQYMHSA-N,"InChI=1S/C9H10INO3/c10-6-3-5(1-2-8(6)12)4-7(11)9(13)14/h1-3,7,12H,4,11H2,(H,13,14)/t7-/m0/s1"
1673,68777,chaetoglobosin V,A cytochalasan alkaloid  found in Chaetomium globosum.,20096,KEGG COMPOUND accession,C06121,,,,,,,,,,,,,,,
1674,68787,rubrorotiorin,"An  azaphilone that is 6,6a-dihydro-8H-furo[2,3-h]isochromen-6,8(6aH)-dione substituted by an acetyl group at position 9, a chloro group a position 5, a 3,5-dimethylhepta-1,3-dien-1-yl group at position 3 and a methyl group at position 6a.  Isolated from Chaetomium cupreum, it exhibits antifungal activity.",17919,KEGG COMPOUND accession,C04371,,,,,,,,,,,,,,,
1675,68798,chaetoglobosin A,A  cytochalasan alkaloid isolated from Chaetomium globosum and Calonectria morganii.,28111,KEGG COMPOUND accession,C05581,3mox4hpac,5703-24-2,28111.0,"Human Metabolome Database (HMDB): 3 -Methoxy-4-hydroxyphenylacetaldehyde is an intermediary aldehyde of dopamine metabolism, metabolized by the class I human liver alcohol dehydrogenases (ADHs). ADH catalyzes both ethanol and acetaldehyde, and the dopamine intermediates compete for the same site of ADH, a basis for the ethanol-induced in vivo alterations of dopamine metabolism. (PMID 2432930).",Homovanillin,HMDB0005175,b,b,C05581,b,FDB023632,3mox4hpac,[H]OC1=C([H])C([H])=C(C([H])=C1OC([H])([H])[H])C([H])([H])C([H])=O,GOQGGGANVKPMNH-UHFFFAOYSA-N,"InChI=1S/C9H10O3/c1-12-9-6-7(4-5-10)2-3-8(9)11/h2-3,5-6,11H,4H2,1H3"
1676,68802,mollicellin C,"A member of the class of depsidones that is 11H-dibenzo[b,e][1,4]dioxepine substituted by hydroxy groups at positions 3 and 9, a methoxy group at position 8, methyl groups at positions 1 and 6, a 3-methylbut-2-enoyl group at position 7, an oxo group at position 11 and a formyl group at position 4. Isolated from Chaetomium brasiliense, it exhibits antimalarial and cytotoxic activities.",20109,KEGG COMPOUND accession,C05831,,,,,,,,,,,,,,,
1677,68807,chaetoglobosin D,A cytochalasan alkaloid found in Chaetomium globosum and Chaetomium brasiliense.,15951,KEGG COMPOUND accession,C07350,,,,,,,,,,,,,,,
1678,68837,pectate,An polyanionic polymer obtained by global deprotonation of the carboxy groups of pectin.,16638,KEGG COMPOUND accession,C07329,,,,,,,,,,,,,,,
1679,68844,phosphodiesterase IV inhibitor,"An EC 3.1.4.53 (3',5'-cyclic-AMP phosphodiesterase) inhibitor that specifically blocks the action of phosphodiesterase IV.",18404,KEGG COMPOUND accession,C02923,,,,,,,,,,,,,,,
1680,68852,all-trans-polyprenol phosphate(2-),Major structure at pH 7.3 of all-trans-polyprenol phosphate.,17920,KEGG COMPOUND accession,C02796,,,,,,,,,,,,,,,
1681,68881,kaempferol 3-O-beta-D-galactopyranosyl-7-O-alpha-L-rhamnopyranoside,"A glycosyloxyflavone that is kaempferol attached to a beta-D-galactopyranosyl residue at position 3 and a alpha-L-rhamnopyranosyl residue at position 7 via glycosidic linkages. Isolated from the aerial parts of Vicia faba and Lotus edulis, it exhibits inhibitory activity against topoisomerase I.",17610,KEGG COMPOUND accession,C02231,,,,,,,,,,,,,,,
1682,68920,bruceolline I,"An indole alkaloid that is 1,2,3,4-tetrahydrocyclopenta[b]indole substituted by hydroxy groups at positions 2 and 6, geminal-methyl groups at position 3 and an oxo group at position 1. It has been isolated from the ethanol extract of the stems of Brucea mollis.",15490,KEGG COMPOUND accession,C02232,oxadpcoa,b,15490.0,Human Metabolome Database (HMDB): This compound belongs to the family of 3-Oxo-acyl CoAs. These are organic compounds containing a 3-oxo acylated coenzyme A derivative.,3-Oxoadipyl-CoA,HMDB0060378,b,b,C02232,b,b,b,b,VKKKAAPGXHWXOO-BIEWRJSYSA-N,b
1683,68925,bruceolline N,"An indole alkaloid that is 2,3-dihydro-1H-indole substituted by hydroxy group at position 3, a  2,3-dihydroxy-3-methylbutyl group at position 3, an oxo group at position 2 and a beta-D-glucopyranosyl group attached to the indolic nitrogen. It has been isolated from the ethanol extract of the stems of Brucea mollis.",29743,KEGG COMPOUND accession,C02367,,,,,,,,,,,,,,,
1684,68930,yadanziolide V,A  quassinoid  isolated from he ethanol extract of the stem of Brucea mollis.,16404,KEGG COMPOUND accession,C02943,,,,,,,,,,,,,,,
1685,68999,dysolenticin C,A tetracyclic triterpenoid isolated from Dysoxylum lenticellatum.,28795,KEGG COMPOUND accession,C07211,,,,,,,,,,,,,,,
1686,69126,withalongolide G,"A  withanolide that is 2,3-dihydrowithaferin A substituted by a hydroxy group at position 19 and a sulfoxy group at position 3. Isolated from Physalis longifolia, it exhibits antineoplastic activity.",18267,KEGG COMPOUND accession,C03586,,,,,,,,,,,,,,,
1687,69134,laulimalide,"A macrolide with formula C30H42O7 that is isolated from the marine sponges, Cacospongia mycofijiensis and Hyattella sp.",17204,KEGG COMPOUND accession,C02800,,,,,,,,,,,,,,,
1688,69218,fatsicarpain C,"A pentacyclic triterpenoid that is oleana-11,13(18)-diene substituted by a alpha-hydroxy group at position 3, an oxo group at position 23 and a carboxy group at position 28. Isolated from the leaves and twigs of Fatsia polycarpa, it exhibits anti-HBV activity.",17836,KEGG COMPOUND accession,C00568,,,,,,,,,,,,,,,
1689,69222,fatsicarpain G,"A terpene lactone that is 13,28-epoxyolean-11-en-28-one substituted by hydroxy groups at positions 3 and 23. Isolated from the leaves and twigs of Fatsia polycarpa, it exhibits anti-HBV activity.",17769,KEGG COMPOUND accession,C00555,4abutn,4390-05-0,17769.0,Human Metabolome Database (HMDB): 4-Aminobutyraldehyde is a metabolite of putrescine. It is a substrate of human liver aldehyde dehydrogenase (EC 1.2.1.3) cytoplasmic (E1) and mitochondrial (E2) isozymes (PMID 3324802).,4-Aminobutyraldehyde,HMDB0001080,b,b,C00555,4-AMINO-BUTYRALDEHYDE,FDB022412,4abutn,[H]C(=O)C([H])([H])C([H])([H])C([H])([H])[N+]([H])([H])[H],DZQLQEYLEYWJIB-UHFFFAOYSA-O,"InChI=1S/C4H9NO/c5-3-1-2-4-6/h4H,1-3,5H2/p+1"
1690,69225,caerulomycin F,"A  pyridine alkaloid that is 2,2'-bipyridine substituted at position 6 by a hydroxymethyl group and at position 4 by a methoxy group. Isolated from the marine-derived actinomycete Actinoalloteichus cyanogriseus, it exhibits antineoplastic activity.",30566,KEGG COMPOUND accession,C00334,4abut,56-12-2,16865.0,"Human Metabolome Database (HMDB): gamma-Aminobutyric acid (GABA) is an inhibitory neurotransmitter found in the nervous systems of widely divergent species, including humans. It is the chief inhibitory neurotransmitter in the vertebrate central nervous system. In vertebrates, GABA acts at inhibitory synapses in the brain. It acts by binding to specific transmembrane receptors in the plasma membrane of both pre- and postsynaptic neurons. This binding causes the opening of ion channels to allow either the flow of negatively-charged chloride ions into the cell or positively-charged potassium ions out of the cell. This will typically result in a negative change in the transmembrane potential, usually causing hyperpolarization. Three general classes of GABA receptor are known (PMID: 10561820). These include GABA-A and GABA-C ionotropic receptors, which are ion channels themselves, and GABA-B metabotropic receptors, which are G protein-coupled receptors that open ion channels via intermediaries known as G proteins (PMID: 10561820). Activation of the GABA-B receptor by GABA causes neuronal membrane hyperpolarization and a resultant inhibition of neurotransmitter release. In addition to binding sites for GABA, the GABA-A receptor has binding sites for benzodiazepines, barbiturates, and neurosteroids. GABA-A receptors are coupled to chloride ion channels. Therefore, activation of the GABA-A receptor induces increased inward chloride ion flux, resulting in membrane hyperpolarization and neuronal inhibition (PMID: 10561820). After release into the synapse, free GABA that does not bind to either the GABA-A or GABA-B receptor complexes can be taken up by neurons and glial cells. Four different GABA membrane transporter proteins (GAT-1, GAT-2, GAT-3, and BGT-1), which differ in their distribution in the CNS, are believed to mediate the uptake of synaptic GABA into neurons and glial cells. The GABA-A receptor subtype regulates neuronal excitability and rapid changes in fear arousal, such as anxiety, panic, and the acute stress response (PMID: 10561820). Drugs that stimulate GABA-A receptors, such as the benzodiazepines and barbiturates, have anxiolytic and anti-seizure effects via GABA-A-mediated reduction of neuronal excitability, which effectively raises the seizure threshold. GABA-A antagonists produce convulsions in animals and there is decreased GABA-A receptor binding in a positron emission tomography (PET) study of patients with panic disorder. Neurons that produce GABA as their output are called GABAergic neurons and have chiefly inhibitory action at receptors in the vertebrate. Medium spiny neurons (MSNs) are a typical example of inhibitory CNS GABAergic cells. GABA has been shown to have excitatory roles in the vertebrate, most notably in the developing cortex. Organisms synthesize GABA from glutamate using the enzyme L-glutamic acid decarboxylase and pyridoxal phosphate as a cofactor (PMID: 12467378). It is worth noting that this involves converting the principal excitatory neurotransmitter (glutamate) into the principal inhibitory one (GABA). Drugs that act as agonists of GABA receptors (known as GABA analogs or GABAergic drugs), or increase the available amount of GABA typically have relaxing, anti-anxiety, and anti-convulsive effects. GABA is found to be deficient in cerebrospinal fluid and the brain in many studies of experimental and human epilepsy. Benzodiazepines (such as Valium) are useful in status epilepticus because they act on GABA receptors. GABA increases in the brain after administration of many seizure medications. Hence, GABA is clearly an antiepileptic nutrient. Inhibitors of GAM metabolism can also produce convulsions. Spasticity and involuntary movement syndromes, such as Parkinson's, Friedreich's ataxia, tardive dyskinesia, and Huntington's chorea, are all marked by low GABA when amino acid levels are studied. Trials of 2 to 3 g of GABA given orally have been effective in various epilepsy and spasticity syndromes. Agents that elevate GABA are also useful in lowering hypertension. Three grams orally have been effective in controlling blood pressure. GABA is decreased in various encephalopathies. GABA can reduce appetite and is decreased in hypoglycemics. GABA reduces blood sugar in diabetics. Chronic brain syndromes can also be marked by deficiencies of GABA. Vitamin B6, manganese, taurine, and lysine can increase both GABA synthesis and effects, while aspartic acid and glutamic acid probably inhibit GABA effects. Low plasma GABA has been reported in some depressed patients and may be a useful trait marker for mood disorders. GABA has an important role in embryonic development, especially facial development, as substantiated by the association of a cleft palate in transgenic mice deficient in GAD67 (glutamate decarboxylase). A recent Japanese population study reported linkage in patients with a nonsyndromic cleft lip with or without a cleft palate and specific GAD67 haplotypes (PMID: 23842532). Unusually high levels of GABA (especially in the brain) can be toxic and GABA can function as both a neurotoxin and a metabotoxin. A neurotoxin is a compound that damages the brain and/or nerve tissue. A metabotoxin is an endogenously produced metabolite that causes adverse health effects at chronically high levels. Chronically high levels of GABA are associated with at least five inborn errors of metabolism, including D-2-hydroxyglutaric aciduria, 4-hydroxybutyric aciduria/succinic semialdehyde dehydrogenase deficiency, GABA-transaminase deficiency, homocarnosinosis, and hyper beta-alaninemia. Nearly all of these conditions are associated with seizures, hypotonia, intellectual deficits, macrocephaly, encephalopathy, and other serious neurological or neuromuscular problems. Increased levels of GABA seem to alter the function of the GABA-B receptor, which may play a role in the tonic-clonic seizures that are often seen in patients with the above disorders.",gamma-Aminobutyric acid,HMDB0000112,b,b,C00334,4-AMINO-BUTYRATE,FDB008937,4abut,[H][N+]([H])([H])C([H])([H])C([H])([H])C([H])([H])C([O-])=O,BTCSSZJGUNDROE-UHFFFAOYSA-N,"InChI=1S/C4H9NO2/c5-3-1-2-4(6)7/h1-3,5H2,(H,6,7)"
1691,69228,caerulomycin I,"A pyridine alkaloid that is 2,2'-bipyridine-6-carboxamide substituted by methoxy groups at position 4 and carbamoyl nitrogen respectively. Isolated from the marine-derived actinomycete Actinoalloteichus cyanogriseus, it exhibits antineoplastic activity.",15496,KEGG COMPOUND accession,C02801,,,,,,,,,,,,,,,
1692,69250,"2-(2,4-dihydroxyphenyl)-5-(E)-propenylbenzofuran","A member of the class of benzofurans that is 1-benzofuran substituted by a 2,4-dihydroxyphenyl group at position 2 and a prop-1-en-1-yl group at position 5. It is a lignan derivative isolated from the roots of Krameria lappacea.",16754,KEGG COMPOUND accession,C04558,,,,,,,,,,,,,,,
1693,69252,2-(4-hydroxyphenyl)-5-(E)-propenylbenzofuran,A member of the class of benzofurans that is 1-benzofuran substituted by a 4-hydroxyphenyl group at position 2 and a prop-1-en-1-yl group at position 5. It is a lignan derivative isolated from the roots of Krameria lappacea.,16766,KEGG COMPOUND accession,C04559,,,,,,,,,,,,,,,
1694,69305,cinnamtannin D-1,A proanthocyanidin found in Cinnamomum cassia.,16428,KEGG COMPOUND accession,C02947,,,,,,,,,,,,,,,
1695,69326,"(1R,5R,6S,7S,8S,10R,11S)-6-hydroxy-4-oxopseudoguai-2(3)-en-12,8-olide",A pseudoguaianolide with anti-inflammatory activity isolated from the aerial parts of Inula hupehensis.,15931,KEGG COMPOUND accession,C04864,,,,,,,,,,,,,,,
1696,69328,"(1S,2R,5R,6S,7S,8S,10R)-6-hydroxy-2-methoxy-4-oxopseudoguai-11(13)-en-12,8-olide",A pseudoguaianolide with anti-inflammatory activity isolated from the aerial parts of Inula hupehensis.,16735,KEGG COMPOUND accession,C04865,,,,,,,,,,,,,,,
1697,69341,6alpha-acetoxyisoinuviscolide,"A sesquiterpene lactone that is 3a,4,4a,5,6,7,7a,9a-octahydroazuleno[6,5-b]furan-2(3H)-one substituted by a hydroxy group at position 5, methyl groups at positions 5 and 8, a methylidene group at position 3 and an acetoxy group at position 4. It has been isolated from the aerial parts of Inula hupehensis.",18256,KEGG COMPOUND accession,C06679,,,,,,,,,,,,,,,
1698,69347,4-epiisoinuviscolide,"A sesquiterpene lactone that is 3a,4,4a,5,6,7,7a,9a-octahydroazuleno[6,5-b]furan-2(3H)-one substituted by a hydroxy group at position 5, methyl groups at positions 5 and 8 and a methylidene group at position 3 (the 3aR,4aR,5S,7aR,9aS stereoisomer). It has been isolated from the aerial parts of Inula hupehensis.",18034,KEGG COMPOUND accession,C01061,4fumacac,28613-33-4,30907.0,Human Metabolome Database (HMDB): Fumarylacetoacetate is an intermediate in the metabolism of tyrosine. Fumarylacetoacetate hydrolase (FAH) is an enzyme which catalyzes the hydrolysis of 4-fumarylacetoacetate into fumarate and acetoacetate. FAH is the last enzyme in the tyrosine catabolism pathway. FAH deficiency is associated with Type 1 hereditary tyrosinemia.,4-Fumarylacetoacetic acid,HMDB0001268,b,b,C01061,4-FUMARYL-ACETOACETATE,FDB022522,4fumacac,[H]\C(=C(\[H])C(=O)C([H])([H])C(=O)C([H])([H])C([O-])=O)C([O-])=O,GACSIVHAIFQKTC-OWOJBTEDSA-L,"InChI=1S/C8H8O6/c9-5(1-2-7(11)12)3-6(10)4-8(13)14/h1-2H,3-4H2,(H,11,12)(H,13,14)/p-2/b2-1+"
1699,69351,mitchellene C,A sesquiterpene lactone isolated from the leaves of Eremophila mitchellii.,16671,KEGG COMPOUND accession,C02647,,,,,,,,,,,,,,,
1700,69353,mitchellene E,A sesquiterpenoid isolated from the leaves of Eremophila mitchellii.,18062,KEGG COMPOUND accession,C03078,,,,,,,,,,,,,,,
1701,69355,casticin,"A tetramethoxyflavone that consists of quercetagetin in which the hydroxy groups at positions 3, 6, 7 and 4' have been replaced by methoxy groups. It has been isolated from Eremophila mitchellii.",15728,KEGG COMPOUND accession,C01035,,,,,,,,,,,,,,,
1702,69372,kalopanaxsaponin C,A triterpenoid saponin with hederagenin as the aglycone part. It has been isolated from the stem bark of Kalopanax pictus.,18351,KEGG COMPOUND accession,C02948,,,,,,,,,,,,,,,
1703,69375,cauloside D,A triterpenoid saponin with hederagenin as the aglycone part. It has been isolated from the stem bark of Kalopanax pictus.,18346,KEGG COMPOUND accession,C00755,,,,,,,,,,,,,,,
1704,69408,nygerone A,A member of the class of 4-pyridones that is nigerone B in which the nitrogen of the carboxamide has been acylated by a (3S)-3-carboxybutanoyl group. It has been isolated from  Aspergillus niger ATCC 1015.,17602,KEGG COMPOUND accession,C02372,,,,,,,,,,,,,,,
1705,69427,cordysinin C,A member of the class of beta-carbolines that is beta-carboline substituted by a 1-hydroxyethyl group at position 1 (the R enantiomer). It has been isolated from the mycelia of Cordyceps sinensis.,16724,KEGG COMPOUND accession,C00989,4hdxbutn,591-81-1,30830.0,"Human Metabolome Database (HMDB): 4-Hydroxybutyric acid (also known as gamma-hydroxybutyrate or GHB) is a precursor and a metabolite of gamma-aminobutyric acid (GABA). GHB acts as a central nervous system (CNS) neuromodulator, mediating its effects through GABA and GHB-specific receptors, or by affecting dopamine transmission (PMID: 16620539). GHB occurs naturally in all mammals, but its function remains unknown. GHB is labeled as an illegal drug in most countries, but it also is used as a legal drug (Xyrem) in patients with narcolepsy. It is used illegally (under the street names juice, liquid ecstasy, or G) as an intoxicant for increasing athletic performance and as a date rape drug. In high doses, GHB inhibits the CNS, inducing sleep and inhibiting the respiratory drive. In lower doses, its euphoriant effect predominates (PMID: 17658710). When present in sufficiently high levels, 4-hydroxybutyric acid can act as an acidogen, a neurotoxin, and a metabotoxin. An acidogen is an acidic compound that induces acidosis, which has multiple adverse effects on many organ systems. A neurotoxin is a compound that adversely affects neural cells and tissues. A metabotoxin is an endogenously produced metabolite that causes adverse health effects at chronically high levels. Chronically high levels of 4-hydroxybutyric acid are associated with two inborn errors of metabolism: glutaric aciduria II and succinic semialdehyde dehydrogenase deficiency (SSADH). SSADH deficiency leads to a 30-fold increase of GHB and a 2-4 fold increase of GABA in the brains of patients with SSADH deficiency as compared to normal brain concentrations of the compounds. As an acidogen, 4-hydroxybutyric acid is an organic acid, and abnormally high levels of organic acids in the blood (organic acidemia), urine (organic aciduria), the brain, and other tissues lead to general metabolic acidosis. Acidosis typically occurs when arterial pH falls below 7.35. In infants with acidosis, the initial symptoms include poor feeding, vomiting, loss of appetite, weak muscle tone (hypotonia), and lack of energy (lethargy). These can progress to heart abnormalities, kidney abnormalities, liver damage, seizures, coma, and possibly death. Many affected children with organic acidemias experience intellectual disability or delayed development. These are also the characteristic symptoms of the untreated IEMs mentioned above. Particularly for SSADH deficiency, the most common features observed include developmental delay, hypotonia, and intellectual disability. Nearly half of patients exhibit ataxia, seizures, behaviour problems, and hyporeflexia. In adults, acidosis or acidemia is characterized by headaches, confusion, feeling tired, tremors, sleepiness, and seizures. As a neurotoxin, GHB appears to affect both GABA (a neurotransmitter) signaling and glutamate signaling (another neurotransmitter). Glutamine metabolism may also play a role in the pathophysiology of excessive levels of GHB. High levels of GHB have been shown to depress both the NMDA and AMPA/kainite receptor-mediated functions and may also alter glutamatergic excitatory synaptic transmission as well.",4-Hydroxybutyric acid,HMDB0000710,b,b,C00989,4-HYDROXY-BUTYRATE,FDB022196,b,b,SJZRECIVHVDYJC-UHFFFAOYSA-N,"InChI=1S/C4H8O3/c5-3-1-2-4(6)7/h5H,1-3H2,(H,6,7)"
1706,69427,cordysinin C,A member of the class of beta-carbolines that is beta-carboline substituted by a 1-hydroxyethyl group at position 1 (the R enantiomer). It has been isolated from the mycelia of Cordyceps sinensis.,16724,KEGG COMPOUND accession,C00989,4ohbut,591-81-1,16724.0,"Gamma Hydroxybutyric Acid, commonly abbreviated GHB, is a therapeutic drug which is illegal in multiple countries. It is currently regulated in the US and sold by Jazz Pharmaceuticals under the name Xyrem. However, it is important to note that GHB is a designated Orphan drug (in 1985). Today Xyrem is a Schedule III drug. However, GHB remains a Schedule I drug and the illicit use of Xyrem falls under penalties of Schedule I. GHB is a naturally occurring substance found in the central nervous system, wine, beef, small citrus fruits and almost all other living creatures in small amounts. It is used illegally under the street names Juice, Liquid Ecstasy or simply G, either as an intoxicant, or as a date rape drug. Xyrem is a central nervous system depressant that reduces excessive daytime sleepiness and cataplexy in patients with narcolepsy. ",Gamma Hydroxybutyric Acid,HMDB0015507,b,b,C00989,b,b,4ohbut,[H]OC([H])([H])C([H])([H])C([H])([H])C([O-])=O,SJZRECIVHVDYJC-UHFFFAOYSA-M,"InChI=1S/C4H8O3/c5-3-1-2-4(6)7/h5H,1-3H2,(H,6,7)/p-1"
1707,69475,TAN-931,"A member of the class of benzoic acids that is benzoic acid substituted by a formyl group at position 3, a hydroxy group at position 5 and a 2,6-dihydroxybenzoyl group at position 4. Isolated from Penicillium purpurogenum, it exhibits antiviral activity.",28719,KEGG COMPOUND accession,C03590,,,,,,,,,,,,,,,
1708,69477,cannabigerol,"A member of the class of resorcinols that is resorcinol which is substituted by a (2E)-3,7-dimethylocta-2,6-dien-1-yl group at position 2 and by a pentyl group at position 5. It is a natural product found in Cannabis sativa and Helichrysum species.",36242,KEGG COMPOUND accession,C01179,34hpp,156-39-8,15999.0,"Human Metabolome Database (HMDB): 4-Hydroxyphenylpyruvic acid (4-HPPA) is a keto acid that is involved in the tyrosine catabolism pathway. It is a product of the enzyme (R)-4-hydroxyphenyllactate dehydrogenase (EC 1.1.1.222) and is formed during tyrosine metabolism. The conversion from tyrosine to 4-HPPA is catalyzed by tyrosine aminotransferase. Additionally, 4-HPPA can be converted to homogentisic acid which is one of the precursors to ochronotic pigment. The enzyme 4-hydroxyphenylpyruvic acid dioxygenase (HPD) catalyzes the reaction that converts 4-hydroxyphenylpyruvic acid to homogentisic acid. A deficiency in the catalytic activity of HPD is known to lead to tyrosinemia type III, an autosomal recessive disorder characterized by elevated levels of blood tyrosine and massive excretion of tyrosine derivatives into urine. It has been shown that hawkinsinuria, an autosomal dominant disorder characterized by the excretion of 'hawkinsin,' may also be a result of HPD deficiency (PMID: 11073718). Moreover, 4-hydroxyphenylpyruvic acid is also found to be associated in phenylketonuria, which is also an inborn error of metabolism. There are two isomers of HPPA, specifically 4HPPA and 3HPPA, of which 4HPPA is the most common.",4-Hydroxyphenylpyruvic acid,HMDB0000707,b,b,C01179,P-HYDROXY-PHENYLPYRUVATE,FDB022193,34hpp,[H]OC1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])C(=O)C([O-])=O,KKADPXVIOXHVKN-UHFFFAOYSA-M,"InChI=1S/C9H8O4/c10-7-3-1-6(2-4-7)5-8(11)9(12)13/h1-4,10H,5H2,(H,12,13)/p-1"
1709,69503,"19,28-didehydroxyrubiarbonol A",A pentacyclic triterpenoid of the class of arborinane-type terpenoids isolated from the roots of Rubia yunnanensis.,16639,KEGG COMPOUND accession,C02519,,,,,,,,,,,,,,,
1710,69506,2-hydroxyrubiarbonone E,A pentacyclic triterpenoid of the class of arborinane-type terpenoids isolated from the roots of Rubia yunnanensis.,17865,KEGG COMPOUND accession,C00233,4mop,816-66-0,48430.0,"Human Metabolome Database (HMDB): Ketoleucine is an abnormal metabolite that arises from the incomplete breakdown of branched-chain amino acids. Ketoleucine is both a neurotoxin and a metabotoxin. A neurotoxin causes damage to nerve cells and nerve tissues. A metabotoxin is an endogenously produced metabolite that causes adverse health effects at chronically high levels. Chronically high levels of ketoleucine are associated with maple syrup urine disease (MSUD). MSUD is a metabolic disorder caused by a deficiency of the branched-chain alpha-keto acid dehydrogenase complex (BCKDC), leading to a buildup of the branched-chain amino acids (leucine, isoleucine, and valine) and their toxic by-products (ketoacids) in the blood and urine. The symptoms of MSUD often show in infancy and lead to severe brain damage if untreated. MSUD may also present later depending on the severity of the disease. If left untreated in older individuals, during times of metabolic crisis, symptoms of the condition include uncharacteristically inappropriate, extreme, or erratic behaviour and moods, hallucinations, anorexia, weight loss, anemia, diarrhea, vomiting, dehydration, lethargy, oscillating hypertonia and hypotonia, ataxia, seizures, hypoglycemia, ketoacidosis, opisthotonus, pancreatitis, rapid neurological decline, and coma.  In maple syrup urine disease, the brain concentration of branched-chain ketoacids can increase 10- to 20-fold. This leads to a depletion of glutamate and a consequent reduction in the concentration of brain glutamine, aspartate, alanine, and other amino acids. The result is a compromise of energy metabolism because of a failure of the malate-aspartate shuttle and a diminished rate of protein synthesis (PMID: 15930465).",Ketoleucine,HMDB0000695,b,b,C00233,2K-4CH3-PENTANOATE,FDB012607,4mop,[H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])C(=O)C([O-])=O,BKAJNAXTPSGJCU-UHFFFAOYSA-M,"InChI=1S/C6H10O3/c1-4(2)3-5(7)6(8)9/h4H,3H2,1-2H3,(H,8,9)/p-1"
1711,69508,rubiarboside G 28-acetate,A triterpenoid saponin with an arborinane-type terpenoid as the aglycone. It has been isolated from the roots of Rubia yunnanensis.,17857,KEGG COMPOUND accession,C04327,,,,,,,,,,,,,,,
1712,69510,rubiarboside G 28-al,A triterpenoid saponin with an arborinane-type terpenoid as the aglycone. It has been isolated from the roots of Rubia yunnanensis.,20440,KEGG COMPOUND accession,C06234,,,,,,,,,,,,,,,
1713,69516,rubiarbonol K,A pentacyclic triterpenoid of the class of arborinane-type terpenoids isolated from the roots of Rubia yunnanensis.,17254,KEGG COMPOUND accession,C06730,4mcat,452-86-8,17254.0,"Human Metabolome Database (HMDB): 4-methylcatechol is a metabolite of homoprotocatechuic acid. It is both a substrate and a suicide inhibitor of Catechol 2,3-dioxygenase [EC 1.3.11.2]. (PMID 15006807). 4-methylcatechol is known to induce the production of brain-derived neurotrophic factor (BDNF). Recent studies have suggested that a lack of brain-derived neurotrophic factor (BDNF) in the limbic system may cause neuropathic pain. (PMID: 22198556).",4-Methylcatechol,HMDB0000873,b,b,C06730,4-METHYLCATECHOL,FDB008861,b,b,ZBCATMYQYDCTIZ-UHFFFAOYSA-N,b
1714,69524,rubiarbonol F,A pentacyclic triterpenoid of the class of arborinane-type terpenoids isolated from the roots of Rubia yunnanensis.,16747,KEGG COMPOUND accession,C01109,,,,,,,,,,,,,,,
1715,69532,"1,6-dihydroxy-2-methyl-9,10-anthraquinone","A member of the class of hydroxyanthraquinones that is anthracene-9,10-dione substituted by hydroxy groups at positions 1 and 6 and a methyl group at position 2. It has been isolated from the roots of Rubia yunnanensis.",17998,KEGG COMPOUND accession,C02373,4mptnl,1119-16-0,17998.0,Human Metabolome Database (HMDB): 4-Methylpentanal is an intermediate in the metabolism of C21-Steroid hormone. It is a substrate for Cytochrome P450 11A1 (mitochondrial).,4-Methylpentanal,HMDB0001318,b,b,C02373,4-METHYLPENTANAL,FDB022551,4mptnl,[H]C(=O)C([H])([H])C([H])([H])C([H])(C([H])([H])[H])C([H])([H])[H],JGEGJYXHCFUMJF-UHFFFAOYSA-N,"InChI=1S/C6H12O/c1-6(2)4-3-5-7/h5-6H,3-4H2,1-2H3"
1716,69537,"1,3,6-trihydroxy-2-methyl-9,10-anthraquinone-3-O-alpha-L-rhamnopyranosyl-(1->2)-beta-D-glucopyranoside","A disaccharide derivative that is 1,3,6-trihydroxy-2-methyl-9,10-anthraquinone attached to a alpha-L-rhamnopyranosyl-(1->2)-beta-D-glucopyranosyl residue at position 3 via a glycosidic linkage. It has been isolated from the roots of Rubia yunnanensis.",16723,KEGG COMPOUND accession,C01180,2kmb,583-92-6,33574.0,"Human Metabolome Database (HMDB): 2-oxo-4-methylthiobutanoate, also known as 2-keto-4-methylthiobutyric acid, 2-keto-4-methylthiobutyrate or 4-(methylsulfanyl)-2-oxobutanoic acid, is a member of the class of compounds known as thia- fatty acids. Thia-fatty acids are fatty acid derivatives obtained by insertion of a sulfur atom at specific positions in the chain. Thus, 2-oxo-4-methylthiobutanoate is a fatty acid lipid molecule. 2-oxo-4-methylthiobutanoate is slightly soluble (in water) and a weakly acidic compound (based on its pKa). 2-oxo-4-methylthiobutanoate can be synthesized from L-methionine and butyric acid. 2-oxo-4-methylthiobutanoate can also be synthesized into S-adenosyl-4-methylthio-2-oxobutanoic acid. 2-oxo-4-methylthiobutanoate can be found in a number of food items such as cloves, highbush blueberries, common beets, and cashew nuts. 2-oxo-4-methylthiobutanoate can be found in urine. Within the cell, 2-oxo-4-methylthiobutanoate is primarily located in the cytoplasm and in the membrane. 2-oxo-4-methylthiobutanoate has been found in all living species, from bacteria to humans. In humans, 2-oxo-4-methylthiobutanoate is found to be involved in several metabolic disorders, some of those are S-adenosylhomocysteine (SAH) hydrolase deficiency, methylenetetrahydrofolate reductase deficiency (MTHFRD), methionine adenosyltransferase deficiency, and glycine N-methyltransferase deficiency. 4-Methylthio-2-oxobutanoic acid is the direct precursor of methional, which is a potent inducer of apoptosis in a BAF3 murine lymphoid cell line which is interleukin-3 (IL3)-dependent (PMID: 7848263).",2-Oxo-4-methylthiobutanoic acid,HMDB0001553,b,b,C01180,CPD-479,FDB011626,2kmb,[H]C([H])([H])SC([H])([H])C([H])([H])C(=O)C([O-])=O,SXFSQZDSUWACKX-UHFFFAOYSA-M,"InChI=1S/C5H8O3S/c1-9-3-2-4(6)5(7)8/h2-3H2,1H3,(H,7,8)/p-1"
1717,69549,7-demethoxyegonol oleate,"A fatty acid ester that is egonol oleate in which the methoxy group at position 7 is replaced by a hydrogen. Isolated from the fruits of Styrax agrestis, it exhibits inhibitory activity against acetylcholinesterase.",17064,KEGG COMPOUND accession,C02126,,,,,,,,,,,,,,,
1718,69552,7-demethoxylegonol acetate,An acetate ester of 7-demethoxylegonol that has been isolated from the fruits of Styrax agrestis.,16318,KEGG COMPOUND accession,C02235,24nph,b,16318.0,"Human Metabolome Database (HMDB): 4-Nitrocatechol is the by-product of the hydroxylation of 4-Nitrophenol by the human cytochrome P450 (CYP) 2E1. This reaction is a useful metabolic marker for the presence of functional cytochrome P450 2E1 in mammalian cell microsomes. Hepatic and extrahepatic microsomal cytochrome P450 isozymes further catalyze the reduction of p-nitrocatechol to p-aminophenol. (PMID: 8267647, 8214571, 8267647).",4-Nitrocatechol,HMDB0002916,b,b,C02235,CPD-158,FDB023081,24nph,[H]OC1=C(O[H])C([H])=C(C([H])=C1[H])[N+]([O-])=O,XJNPNXSISMKQEX-UHFFFAOYSA-N,"InChI=1S/C6H5NO4/c8-5-2-1-4(7(10)11)3-6(5)9/h1-3,8-9H"
1719,69607,clethroidoside G,"A triterpenoid saponin that is (3beta,16alpha)-3,16-dihydroxy-12-oxooleanan-28-al attached to a beta-D-glucopyranosyl-(1->2)-[beta-D-glucopyranosyl-(1->4)]-alpha-L-arabinopyranosyl residue at position 3 via a glycosidic linkage. It has been isolated from the aerial parts of Lysimachia clethroides.",28856,KEGG COMPOUND accession,C01454,,,,,,,,,,,,,,,
1720,69612,ardisimamiloside E,"A triterpenoid saponin that is (3beta,16alpha)-13,28-epoxyoleanane-3,16,29-triol attached to a tetrasaccharide residue at position 3 via a glycosidic linkage. It has been isolated from the aerial parts of Lysimachia clethroides.",18020,KEGG COMPOUND accession,C01149,4tmeabut,64595-66-0,18020.0,"Human Metabolome Database (HMDB): 4-Trimethylammoniobutanal is a substrate for Serine hydroxymethyltransferase (cytosolic), Serine hydroxymethyltransferase (mitochondrial), Aldehyde dehydrogenase (mitochondrial), Fatty aldehyde dehydrogenase, 4-trimethylaminobutyraldehyde dehydrogenase, Aldehyde dehydrogenase (dimeric NADP-preferring), Aldehyde dehydrogenase family 7 member A1, Aldehyde dehydrogenase 1A3 and Aldehyde dehydrogenase X (mitochondrial).",4-Trimethylammoniobutanal,HMDB0001345,b,b,C01149,4-TRIMETHYLAMMONIOBUTANAL,FDB022567,4tmeabut,[H]C(=O)C([H])([H])C([H])([H])C([H])([H])[N+](C([H])([H])[H])(C([H])([H])[H])C([H])([H])[H],OITBLCDWXSXNCN-UHFFFAOYSA-N,"InChI=1S/C7H16NO/c1-8(2,3)6-4-5-7-9/h7H,4-6H2,1-3H3/q+1"
1721,69629,"7beta,15alpha-dihydroxy-22(29)-hopene",A  hopanoid that is hop-22(29)-ene substituted by hydroxy groups at positions 7 and 15 respectively. It has been isolated from Hypocrella species.,17319,KEGG COMPOUND accession,C05198,dad_5,4754-39-6,17319.0,"Human Metabolome Database (HMDB): 5'-Deoxyadenosine is an oxidized nucleoside found in the urine of normal subjects. Oxidized nucleosides represent excellent biomarkers for determining the extent of damage in genetic material, which has long been of interest in understanding the mechanism of aging, neurodegenerative diseases, and carcinogenesis. (PMID 15116424). The normal form of deoxyadenosine used in DNA synthesis and repair is 2'-deoxyadenosine where the hydroxyl group (-OH) is at the 2' position of its ribose sugar moiety. 5'-deoxyadenosine has its hydroxyl group at the 5' position of the ribose sugar.",5'-Deoxyadenosine,HMDB0001983,b,b,C05198,CH33ADO,FDB022781,b,[H]O[C@@]1([H])[C@@]([H])(O[C@]([H])(C([H])([H])[H])[C@@]1([H])O[H])N1C([H])=NC2=C(N=C([H])N=C12)N([H])[H],XGYIMTFOTBMPFP-KQYNXXCUSA-N,"InChI=1S/C10H13N5O3/c1-4-6(16)7(17)10(18-4)15-3-14-5-8(11)12-2-13-9(5)15/h2-4,6-7,10,16-17H,1H3,(H2,11,12,13)/t4-,6-,7-,10-/m1/s1"
1722,69657,kaempferol-3-rutinoside,A kaempferol O-glucoside that is  kaempferol attached to a rutinosyl [6-deoxy-alpha-L-mannosyl-(1->6)-beta-D-glucosyl] residue at position 3 via a glycosidic linkage. It has been isolated from the leaves of Solanum campaniforme.,20506,KEGG COMPOUND accession,C00101,thf,135-16-0,20506.0,"Human Metabolome Database (HMDB): Tetrahydrofolate is a soluble coenzyme (vitamin B9) that is synthesized de novo by plants and microorganisms, and absorbed from the diet by animals. It is composed of three distinct parts: a pterin ring, a p-ABA (p-aminobenzoic acid) and a polyglutamate chain with a number of residues varying between 1 and 8. Only the tetra-reduced form of the molecule serves as a coenzyme for C1 transfer reactions. In biological systems, the C1-units exist under various oxidation states and the different tetrahydrofolate derivatives constitute a family of related molecules named indistinctly under the generic term folate. (PMID 16042593). Folate is important for cells and tissues that rapidly divide. Cancer cells divide rapidly, and drugs that interfere with folate metabolism are used to treat cancer. Methotrexate is a drug often used to treat cancer because it inhibits the production of the active form, tetrahydrofolate. Unfortunately, methotrexate can be toxic, producing side effects such as inflammation in the digestive tract that make it difficult to eat normally. -- Wikipedia; Signs of folic acid deficiency are often subtle. Diarrhea, loss of appetite, and weight loss can occur. Additional signs are weakness, sore tongue, headaches, heart palpitations, irritability, and behavioral disorders. Women with folate deficiency who become pregnant are more likely to give birth to low birth weight and premature infants, and infants with neural tube defects. In adults, anemia is a sign of advanced folate deficiency. In infants and children, folate deficiency can slow growth rate. Some of these symptoms can also result from a variety of medical conditions other than folate deficiency. It is important to have a physician evaluate these symptoms so that appropriate medical care can be given. -- Wikipedia; Folinic acid is a form of folate that can help 'rescue' or reverse the toxic effects of methotrexate. Folinic acid is not the same as folic acid. Folic acid supplements have little established role in cancer chemotherapy. There have been cases of severe adverse effects of accidental substitution of folic acid for folinic acid in patients receiving methotrexate cancer chemotherapy. It is important for anyone receiving methotrexate to follow medical advice on the use of folic or folinic acid supplements. -- Wikipedia. Low concentrations of folate, vitamin B12, or vitamin B6 may increase the level of homocysteine, an amino acid normally found in blood. There is evidence that an elevated homocysteine level is an independent risk factor for heart disease and stroke. The evidence suggests that high levels of homocysteine may damage coronary arteries or make it easier for blood clotting cells called platelets to clump together and form a clot. However, there is currently no evidence available to suggest that lowering homocysteine with vitamins will reduce your risk of heart disease. Clinical intervention trials are needed to determine whether supplementation with folic acid, vitamin B12 or vitamin B6 can lower your risk of developing coronary heart disease. -- Wikipedia.",Tetrahydrofolic acid,HMDB0001846,b,b,C00101,THF,FDB022705,thf,[H]OC1=NC(=NC2=C1N([H])C([H])(C([H])([H])N([H])C1=C([H])C([H])=C(C([H])=C1[H])C(=O)N([H])C([H])(C([O-])=O)C([H])([H])C([H])([H])C([O-])=O)C([H])([H])N2[H])N([H])[H],MSTNYGQPCMXVAQ-UHFFFAOYSA-L,"InChI=1S/C19H23N7O6/c20-19-25-15-14(17(30)26-19)23-11(8-22-15)7-21-10-3-1-9(2-4-10)16(29)24-12(18(31)32)5-6-13(27)28/h1-4,11-12,21,23H,5-8H2,(H,24,29)(H,27,28)(H,31,32)(H4,20,22,25,26,30)/p-2"
1723,69701,griffithane B,"A dimethoxybenzene that is 2,6-dimethoxyphenol substituted by a 3-(4-hydroxy-3-methoxyphenyl)propyl group at position 3. It has been isolated from the stems of Combretum griffithii and has been shown to exhibit anticancer activity.",16685,KEGG COMPOUND accession,C04826,,,,,,,,,,,,,,,
1724,69749,isowighteone,"A member of the class of 7-hydroxyisoflavones that is isoflavone substituted by hydroxy groups at positions 5, 7 and 4' and a prenyl group at position 3'. It has been isolated from Ficus mucuso.",18120,KEGG COMPOUND accession,C00990,,,,,,,,,,,,,,,
1725,69869,ajugaciliatin H,A diterpene lactone isolated from the whole plants of  Ajuga ciliata.,16764,KEGG COMPOUND accession,C03495,,,,,,,,,,,,,,,
1726,69871,ajugaciliatin J,A diterpene lactone isolated from the whole plant Ajuga ciliata.,27964,KEGG COMPOUND accession,C04187,,,,,,,,,,,,,,,
1727,69875,ajugamarin H1,A diterpene lactone isolated from the whole plants of Ajuga ciliata.,17614,KEGG COMPOUND accession,C04489,M01114,b,17614.0,"Human Metabolome Database (HMDB): 5-Methyltetrahydropteroyltri-L-glutamate is formed under reaction between carbonyl group of 5-Methyltetrahydropteroate and amine group on one end of three replicates of glutamate. It is involved in several pathways such as tetrahydrofolate biosynthesis II, methionine biosynthesis I,II,III as a product of enzymatic reduction; while in pathways folate polyglutamylation I and carbon tetrachloride degradation II as a product of enzymatic oxidation. In humans, this compound is produced by the bacteria in the gut and may be found in feces or urine.",5-Methyltetrahydropteroyltri-L-glutamate,HMDB0012177,b,b,C04489,CPD-1302,FDB028831,b,[H]OC(=O)C([H])([H])C([H])([H])[C@]([H])(N([H])C(=O)C([H])([H])C([H])([H])[C@]([H])(N([H])C(=O)C([H])([H])C([H])([H])[C@]([H])(N([H])C(=O)C1=C([H])C([H])=C(N([H])C([H])([H])[C@]2([H])N(C3=C(N=C(N([H])[H])N([H])C3=O)N([H])C2([H])[H])C([H])([H])[H])C([H])=C1[H])C(=O)O[H])C(=O)O[H])C(=O)O[H],HVRNKDVLFAVCJF-VJANTYMQSA-N,"InChI=1S/C30H39N9O12/c1-39-16(13-33-24-23(39)26(45)38-30(31)37-24)12-32-15-4-2-14(3-5-15)25(44)36-19(29(50)51)7-10-21(41)34-17(27(46)47)6-9-20(40)35-18(28(48)49)8-11-22(42)43/h2-5,16-19,32H,6-13H2,1H3,(H,34,41)(H,35,40)(H,36,44)(H,42,43)(H,46,47)(H,48,49)(H,50,51)(H4,31,33,37,38,45)/t16-,17-,18-,19-/m0/s1"
1728,70011,comazaphilone B,"An azaphilone that is 5,6,7,8-tetrahydro-1H-isochromene substituted by a hydroxy group at position 6, a methyl group at position 7, an oxo group at position 8, a propyl group at position 3 and a (3,4-dihydroxy-2-methoxy-6-methylbenzoyl)oxy group at position 7. It has been isolated from Penicillium commune.",17125,KEGG COMPOUND accession,C03846,,,,,,,,,,,,,,,
1729,70013,comazaphilone D,"An azaphilone that is 5,6,7,8-tetrahydro-1H-isochromene substituted by a hydroxy and methyl group at position 7, an oxo group at position 8, a prop-1-en-1-yl group at position 3 and a (2,4-dihydroxy-6-methylbenzoyl)oxy group at position 6.Isolated from Penicillium commune, it exhibits antibacterial and antineoplastic activities.",17982,KEGG COMPOUND accession,C03682,,,,,,,,,,,,,,,
1730,70015,comazaphilone F,"An azaphilone that is 5,6,7,8-tetrahydro-1H-isochromene substituted by a hydroxy group and a methyl group at position 7, an oxo group at position 8, a propyl group at position 3 and a (3,4-dihydroxy-2-methoxy-6-methylbenzoyl)oxy group at position 6. Isolated from Penicillium commune, it exhibits antibacterial and antineoplastic activities.",17901,KEGG COMPOUND accession,C02655,,,,,,,,,,,,,,,
1731,70021,"(S)-5,7-dihydroxy-2-(4-methoxyphenyl)-8-(3-methylbut-2-enyl)chroman-4-one","A dihydroxyflavanone that is (2S)-flavanone substituted by hydroxy groups at positions 5 and 7, a methoxy group at position 4' and a prenyl group at position 8. It has been isolated from Macaranga bicolor.",28191,KEGG COMPOUND accession,C03367,,,,,,,,,,,,,,,
1732,70109,cornusalterin A,"A tirucallane triterpenoid that is (13alpha,14beta,17alpha,20S,23E)-lanosta-7,23-diene substituted by a beta-hydroxy group at position 3 and a methoxy group at position 25. It has been isolated from the stem and stem barks of Cornus walteri.",17248,KEGG COMPOUND accession,C04244,HC01254,33405-80-0,17248.0,"Human Metabolome Database (HMDB): 6-Lactoyltetrahydropterin is a putative intermediate in the de novo synthesis of tetrahydrobiopterin (BH4) pathway, in a reaction involving the enzyme sepiapterin reductase (E.C. 1.1.1.153) in human liver. In brain, an enzyme distinct from sepiapterin reductase catalyzes the TPNH-dependent reduction of 6-pyruvoyl-tetrahydropterin to 6-lactoyl-tetrahydropterin. (PMID: 4004850). In brain, the expression of other enzymes involved in BH4 biosynthesis includes aldose reductase, carbonyl reductase, GTP-cyclohydrolase I, and 6-pyruvoyltetrahydrobiopterin. Sepiapterin reductase expression is increased in Parkinson's disease brain tissue. (PMID: 17270157).",6-Lactoyltetrahydropterin,HMDB0002065,b,b,C04244,6-LACTOYL-5678-TETRAHYDROPTERIN,FDB022828,HC01254,[H]OC([H])(C(=O)C1([H])N([H])C2=C(N=C(N([H])[H])N([H])C2=O)N([H])C1([H])[H])C([H])([H])[H],HKCYZTKHPLJZDR-UHFFFAOYSA-N,"InChI=1S/C9H13N5O3/c1-3(15)6(16)4-2-11-7-5(12-4)8(17)14-9(10)13-7/h3-4,12,15H,2H2,1H3,(H4,10,11,13,14,17)"
1733,70120,cornusalterin L,"A  tirucallane triterpenoid that is (13alpha,14beta,17alpha,20S,23S)-21,23-epoxylanosta-7,24-diene substituted by an oxo group at position 3. It has been isolated from the stem and stem barks of Cornus walteri.",17637,KEGG COMPOUND accession,C02657,,,,,,,,,,,,,,,
1734,70137,smenospongines C,A  sesquiterpenoid isolated from the marine sponge Dactylospongia elegans.,16925,KEGG COMPOUND accession,C04456,,,,,,,,,,,,,,,
1735,70159,(+)-(S)-ar-turmerone,A sesquiterpenoid that is 2-methylhept-2-en-4-one substituted by a 4-methylphenyl group at position 6. It has been isolated from Peltophorum dasyrachis.,16784,KEGG COMPOUND accession,C03935,,,,,,,,,,,,,,,
1736,70164,eutypoid B,A  butenolide that is furan-2(5H)-one substituted by a 4-hydroxybenzyl group at position 4 and a 4-hydroxyphenyl group at position 3. It has been isolated from Penicillium species.,17830,KEGG COMPOUND accession,C01037,dann,b,17830.0,b,"7,8-Diaminononanoate",b,b,b,C01037,b,b,b,b,b,b
1737,70166,eutypoid D,"A butenolide that is furan-2(5H)-one substituted by a 3,5-dihydroxyphenyl group at position 3 and a 4-hydroxybenzyl group at position 4. It has been isolated from Penicillium species.",17109,KEGG COMPOUND accession,C01249,,,,,,,,,,,,,,,
1738,70569,"(+)-(1R)-1,12-dihydroxy-20-norabieta-5(10),8,11,13-tetraene",A tricyclic diterpenoid isolated from the stem bark of Fraxinus sieboldiana.,30612,KEGG COMPOUND accession,C00818,glcr,25525-21-7,16002.0,Human Metabolome Database (HMDB): Glucaric acid is a sugar acid derived from D-glucose in which both the aldehydic carbon atom and the carbon atom bearing the primary hydroxyl group are oxidized to carboxylic acid groups.,Glucaric acid,HMDB0000663,b,b,C00818,D-GLUCARATE,FDB022169,b,[H]O[C@@]([H])(C([O-])=O)[C@@]([H])(O[H])[C@]([H])(O[H])[C@]([H])(O[H])C([O-])=O,DSLZVSRJTYRBFB-LLEIAEIESA-L,"InChI=1S/C6H10O8/c7-1(3(9)5(11)12)2(8)4(10)6(13)14/h1-4,7-10H,(H,11,12)(H,13,14)/p-2/t1-,2-,3-,4+/m0/s1"
1739,70574,7-dehydroabietanone,"An  abietane diterpenoid that is abieta-8,11,13-triene substituted by an oxo group at position 7. It has been isolated from the stem bark of Fraxinus sieboldiana.",18391,KEGG COMPOUND accession,C00257,glcn,526-95-4,33198.0,"Human Metabolome Database (HMDB): Gluconic acid occurs naturally in fruit, honey and wine and is used as a food additive, an acidity regulator. It is also used in cleaning products where it helps cleaning up mineral deposits. It is a strong chelating agent, especially in alkaline solution. It chelates the anions of calcium, iron, aluminium, copper, and other heavy metals. Glucono delta lactone is a cyclic ester of D-gluconic acid.",Gluconic acid,HMDB0000625,b,b,C00257,GLUCONATE,FDB001980,glcn,[H]OC([H])([H])[C@@]([H])(O[H])[C@@]([H])(O[H])[C@]([H])(O[H])[C@@]([H])(O[H])C([O-])=O,RGHNJXZEOKUKBD-SQOUGZDYSA-M,"InChI=1S/C6H12O7/c7-1-2(8)3(9)4(10)5(11)6(12)13/h2-5,7-11H,1H2,(H,12,13)/p-1/t2-,3-,4+,5-/m1/s1"
1740,70662,(2S)-7-hydroxy-5-methoxy-8-methylflavanone,"A  monohydroxyflavanone that is (2S)-flavanone substituted by a hydroxy group at position 7, a methoxy group at position 5 and a methyl group at position 8. It has been isolated from the buds of Cleistocalyx operculatus.",16659,KEGG COMPOUND accession,C00258,glyc_R,473-81-4,32398.0,"Human Metabolome Database (HMDB): Glyceric acid is a colourless syrupy acid, obtained from oxidation of glycerol. It is a compound that is secreted excessively in the urine by patients suffering from D-glyceric aciduria, an inborn error of metabolism, and D-glycerate anemia. Deficiency of human glycerate kinase leads to D-glycerate acidemia/D-glyceric aciduria. Symptoms of the disease include progressive neurological impairment, hypotonia, seizures, failure to thrive, and metabolic acidosis. At sufficiently high levels, glyceric acid can act as an acidogen and a metabotoxin. An acidogen is an acidic compound that induces acidosis, which has multiple adverse effects on many organ systems. A metabotoxin is an endogenously produced metabolite that causes adverse health effects at chronically high levels. Glyceric acid is an organic acid. Abnormally high levels of organic acids in the blood (organic acidemia), urine (organic aciduria), the brain, and other tissues lead to general metabolic acidosis. Acidosis typically occurs when arterial pH falls below 7.35. In infants with acidosis, the initial symptoms include poor feeding, vomiting, loss of appetite, weak muscle tone (hypotonia), and lack of energy (lethargy). These can progress to heart abnormalities, seizures, coma, and possibly death. These are also the characteristic symptoms of untreated glyceric aciduria. Many affected children with organic acidemias experience intellectual disability or delayed development. In adults, acidosis or acidemia is characterized by headaches, confusion, feeling tired, tremors, sleepiness, and seizures.",Glyceric acid,HMDB0000139,b,b,C00258,GLYCERATE,FDB012242,glyc_R,[H]OC([H])([H])[C@@]([H])(O[H])C([O-])=O,RBNPOMFGQQGHHO-REOHCLBHSA-M,"InChI=1S/C3H6O4/c4-1-2(5)3(6)7/h2,4-5H,1H2,(H,6,7)/p-1/t2-/m0/s1"
1741,70664,"(2S)-5,7-dihydroxy-6,8-dimethylflavanone","A dihydroxyflavanone that is (2S)-flavanone substituted by hydroxy groups at positions 5 and 7 and methyl groups at positions 6 and 8. Isolated from the buds of Cleistocalyx operculatus, it has been shown to exhibit inhibitory effects on the viral neuraminidases from two influenza viral strains, H1N1 and H9N2.",17835,KEGG COMPOUND accession,C00631,2pg,b,17835.0,"Human Metabolome Database (HMDB): 2-Phospho-D-glycerate or 2PG is an intermediate in gluconeogenesis. It is a glyceric acid which serves as the substrate in the ninth step of glycolysis. 2PG is converted by enolase into phosphoenolpyruvate (PEP), the penultimate step in the conversion of glucose to pyruvate. More specifically, 2PG can be generated from Glycerate-3-phosphate via phosphoglycerate mutase or from phosphoenolpyrvate via alpha enolase.",2-Phospho-D-glyceric acid,HMDB0003391,b,b,C00631,2-PG,FDB001407,2pg,[H]OC([H])([H])[C@@]([H])(OP([O-])([O-])=O)C([O-])=O,GXIURPTVHJPJLF-UWTATZPHSA-K,"InChI=1S/C3H7O7P/c4-1-2(3(5)6)10-11(7,8)9/h2,4H,1H2,(H,5,6)(H2,7,8,9)/p-3/t2-/m1/s1"
1742,70699,1-(4-hydroxyphenyl)-7-phenyl-(6E)-hept-6-en-3-one,A  diarylheptanoid that is hept-6-en-3-one substituted by a 4-hydroxyphenyl group at position 1 and a phenyl group at position 7 respectively. It has been isolated from the rhizomes of Curcuma kwangsiensis.,27730,KEGG COMPOUND accession,C06418,,,,,,,,,,,,,,,
1743,70702,"1,7-bis(4-hydroxyphenyl)hepta-4E-6E-dien-3-one",A  diarylheptanoid that is 4E-6E-dien-3-one substituted by 4-hydroxyphenyl group at positions 1 and 7. It has been isolated from the rhizomes of Curcuma kwangsiensis.,28225,KEGG COMPOUND accession,C01570,,,,,,,,,,,,,,,
1744,70737,angucycline antibiotic,Any angucycline that exhibits antibiotic activity.,16224,KEGG COMPOUND accession,C02024,,,,,,,,,,,,,,,
1745,70743,dabigatran etexilate methanesulfonate,"A methanesulfonate salt obtained by reaction of dabigatran etexilate with one equivalent of dabigatran etexilate. A prodrug for dabigatran, a thrombin inhibitor and anticoagulant which is used for the prevention of stroke and systemic embolism.",16176,KEGG COMPOUND accession,C00515,orn_D,348-66-3,16176.0,"Human Metabolome Database (HMDB): D-Ornithine is an amino acid produced in the urea cycle by the splitting off of urea from arginine. Ornithine is one of the products of the action of the enzyme arginase on L-arginine, creating urea. Therefore, ornithine is a central part of the urea cycle, which allows for the disposal of excess nitrogen.",D-Ornithine,HMDB0003374,b,b,C00515,CPD-217,FDB023157,orn_D,[H][N+]([H])([H])C([H])([H])C([H])([H])C([H])([H])[C@]([H])(C([O-])=O)[N+]([H])([H])[H],AHLPHDHHMVZTML-SCSAIBSYSA-O,"InChI=1S/C5H12N2O2/c6-3-1-2-4(7)5(8)9/h4H,1-3,6-7H2,(H,8,9)/p+1/t4-/m1/s1"
1746,70746,dabigatran etexilate,"An aromatic amide obtained by formal condensation of the carboxy group of 2-{[(4-{N'-[(hexyloxy)carbonyl]carbamimidoyl}phenyl)amino]methyl}-1-methyl-1H-benzimidazole-5-carboxylic acid with the secondary amino group of ethyl N-pyridin-2-yl-beta-alaninate. A prodrug for dabigatran, a thrombin inhibitor and anticoagulant which is used for the prevention of stroke and systemic embolism.",16998,KEGG COMPOUND accession,C02265,,,,,,,,,,,,,,,
1747,70781,PPAR modulator,Any compound which acts on the peroxisome proliferator-activated receptor.,17797,KEGG COMPOUND accession,C00117,r5p,3615-55-2,52742.0,"Human Metabolome Database (HMDB): D-Ribose 5-phosphate is an important intermediate metabolite in the Pentose phosphate pathway (KEGG, map00030) and in the Purine metabolism pathway (KEGG, map00230). The intracellular ribose 5-phosphate concentration is an important determinant of the rate of de novo purine synthesis. (PMID 6699001).",D-Ribose 5-phosphate,HMDB0001548,b,b,C00117,RIBOSE-5P,FDB001615,r5p,[H]O[C@@]1([H])O[C@]([H])(C([H])([H])OP([O-])([O-])=O)[C@@]([H])(O[H])[C@@]1([H])O[H],KTVPXOYAKDPRHY-NEEWWZBLSA-L,"InChI=1S/C5H11O8P/c6-3-2(1-12-14(9,10)11)13-5(8)4(3)7/h2-8H,1H2,(H2,9,10,11)/p-2/t2-,3-,4-,5+/m0/s1"
1748,70793,cob(II)yrinate c monoamide(5-),A precorrin carboxylic acid anion obtained by global deprotonation of the carboxy groups of cob(II)yrinic acid c monoamide.,17363,KEGG COMPOUND accession,C00199,ru5p_D,4151-19-3,17363.0,"Human Metabolome Database (HMDB): D-Ribulose 5-phosphate is a metabolite in the Pentose phosphate pathway, Pentose and glucuronate interconversions, and in the Riboflavin metabolism (KEGG).",D-Ribulose 5-phosphate,HMDB0000618,b,b,C00199,RIBULOSE-5P,FDB022145,ru5p_D,[H]OC([H])([H])C(=O)[C@]([H])(O[H])[C@]([H])(O[H])C([H])([H])OP([O-])([O-])=O,FNZLKVNUWIIPSJ-UHNVWZDZSA-L,"InChI=1S/C5H11O8P/c6-1-3(7)5(9)4(8)2-13-14(10,11)12/h4-6,8-9H,1-2H2,(H2,10,11,12)/p-2/t4-,5+/m1/s1"
1749,70827,isopentadecanoyl-CoA(4-),A saturated fatty acyl-CoA(4-) arising from deprotonation of the phosphate and diphosphate functions of isopentadecanoyl-CoA.,28991,KEGG COMPOUND accession,C16581,,,,,,,,,,,,,,,
1750,70842,methyl 4-hydroxypiperidine-3-carboxylate,A piperidinecarboxylate ester that is the methyl ester of 4-hydroxypiperidine-3-carboxylic acid.,28479,KEGG COMPOUND accession,C06420,,,,,,,,,,,,,,,
1751,70853,beta-D-Gal-(1->4)-beta-D-GlcNAc-(1->2)-[beta-D-Gal-(1->4)-beta-D-GlcNAc-(1->4)]-alpha-D-Man-(1->3)-[beta-D-Gal-(1->4)-beta-D-GlcNAc-(1->2)-alpha-D-Man-(1->6)]-beta-D-Man-(1->4)-beta-D-GlcNAc-(1->4)-D-GlcNAc,"An amino oligosaccharide that is a branched tridecasaccharide in which two beta-D-Gal-(1->4)-beta-D-GlcNAc disaccharide units are linked (1->2) and (1->4) to the terminal mannose residue of an alpha-D-Man-(1->3)-beta-D-Man-(1->4)-beta-D-GlcNAc-(1->4)-D-GlcNAc tetrasaccharide chain, to the beta-D-mannose residue of which is also linked (1->6) a beta-D-Gal-(1->4)-beta-D-GlcNAc-(1->3)-alpha-D-Man trisaccharide unit.",15867,KEGG COMPOUND accession,C02266,M01757,b,15867.0,Human Metabolome Database (HMDB): D-xylonolactone is a lactone derivative of xylonic acid. It is an intermediate in the pentose and glucuronate interconversion pathway and can be formed from either D-xylonic acid or D-xylose. D-xylose is a simple 5 carbon sugar that is found in a variety of edible plants. It is also frequently used in intestinal absorption tests to help diagnose problems that prevent the small intestine from absorbing nutrients in food. Xylose is also the first saccharide added to the serine or threonine in the proteoglycan type O-glycosylation and so it is the first saccharide in biosynthetic pathways of most anionic polysaccharides such as heparan sulfate and chondroitin sulfate. D-xylose is normally easily absorbed by the intestines where it can be converted to D-xylonolactone by intestinal D-xylose 1-dehydrogenase (EC 1.1.1.175).,"D-Xylono-1,5-lactone",HMDB0011676,b,b,C02266,D-XYLONO-14-LACTONE,FDB028364,b,[H]O[C@@]1([H])C(=O)OC([H])([H])[C@@]([H])(O[H])[C@]1([H])O[H],XXBSUZSONOQQGK-FLRLBIABSA-N,"InChI=1S/C5H8O5/c6-2-1-10-5(9)4(8)3(2)7/h2-4,6-8H,1H2/t2-,3+,4-/m1/s1"
1752,70873,N-(2-hydroxyhexadecatetraenoyl)-15-methylhexadecasphing-4-enine-1-phosphocholine,An N-acyl-15-methylhexadecasphing-4-enine-1-phosphocholine in which the acyl group has 16 carbons and 4 double bonds and is 2-hydroxylated.,16238,KEGG COMPOUND accession,C00016,fad,146-14-5,16238.0,"Human Metabolome Database (HMDB): FAD is a condensation product of riboflavin and adenosine diphosphate. The coenzyme of various aerobic dehydrogenases, e.g., D-amino acid oxidase and L-amino acid oxidase. (Lehninger, Principles of Biochemistry, 1982, p972).",FAD,HMDB0001248,b,b,C00016,FAD,FDB022511,fad,[H]O[C@]([H])(C([H])([H])OP([O-])(=O)OP([O-])(=O)OC([H])([H])[C@@]1([H])O[C@@]([H])(N2C([H])=NC3=C(N=C([H])N=C23)N([H])[H])[C@]([H])(O[H])[C@]1([H])O[H])[C@@]([H])(O[H])[C@@]([H])(O[H])C([H])([H])N1C2=NC(=O)N([H])C(=O)C2=NC2=C1C([H])=C(C(=C2[H])C([H])([H])[H])C([H])([H])[H],VWWQXMAJTJZDQX-UYBVJOGSSA-L,"InChI=1S/C27H33N9O15P2/c1-10-3-12-13(4-11(10)2)35(24-18(32-12)25(42)34-27(43)33-24)5-14(37)19(39)15(38)6-48-52(44,45)51-53(46,47)49-7-16-20(40)21(41)26(50-16)36-9-31-17-22(28)29-8-30-23(17)36/h3-4,8-9,14-16,19-21,26,37-41H,5-7H2,1-2H3,(H,44,45)(H,46,47)(H2,28,29,30)(H,34,42,43)/p-2/t14-,15+,16+,19-,20+,21+,26+/m0/s1"
1753,70875,N-heptadecenoyl-15-methylhexadecasphing-4-enine-1-phosphocholine,An N-acyl-15-methylhexadecasphing-4-enine-1-phosphocholine in which the acyl group has 17 carbons and 1 double bond.,17877,KEGG COMPOUND accession,C01352,fadh2,146-14-5,17877.0,"Human Metabolome Database (HMDB): FADH is the reduced form of flavin adenine dinucleotide (FAD). FAD is synthesized from riboflavin and two molecules of ATP. Riboflavin is phosphorylated by ATP to give riboflavin 5-phosphate (FMN). FAD is then formed from FMN by the transfer of an AMP moiety from a second molecule of ATP. FADH is generated in each round of fatty acid oxidation, and the fatty acyl chain is shortened by two carbon atoms as a result of these reactions; because oxidation is on the beta carbon, this series of reactions is called the beta-oxidation pathway. In the citric acid cycle FADH is involved in harvesting of high-energy electrons from carbon fuels; citric acid cycle itself neither generates a large amount of ATP nor includes oxygen as a reactant. Instead, the citric acid cycle removes electrons from acetyl CoA and uses these electrons to form FADH. (Biochemistry. Berg, Jeremy M. Tymoczko, John L. and Stryer, Lubert. New York: W. H. Freeman and Co. 2002.).",FADH,HMDB0001197,b,b,C01352,FADH2,FDB022483,fadh2,[H]O[C@]([H])(C([H])([H])OP([O-])(=O)OP([O-])(=O)OC([H])([H])[C@@]1([H])O[C@@]([H])(N2C([H])=NC3=C(N=C([H])N=C23)N([H])[H])[C@]([H])(O[H])[C@]1([H])O[H])[C@@]([H])(O[H])[C@@]([H])(O[H])C([H])([H])N1C2=C(N([H])C3=C1C([H])=C(C(=C3[H])C([H])([H])[H])C([H])([H])[H])C(=O)N([H])C(=O)N2[H],YPZRHBJKEMOYQH-UYBVJOGSSA-L,"InChI=1S/C27H35N9O15P2/c1-10-3-12-13(4-11(10)2)35(24-18(32-12)25(42)34-27(43)33-24)5-14(37)19(39)15(38)6-48-52(44,45)51-53(46,47)49-7-16-20(40)21(41)26(50-16)36-9-31-17-22(28)29-8-30-23(17)36/h3-4,8-9,14-16,19-21,26,32,37-41H,5-7H2,1-2H3,(H,44,45)(H,46,47)(H2,28,29,30)(H2,33,34,42,43)/p-2/t14-,15+,16+,19-,20+,21+,26+/m0/s1"
1754,70875,N-heptadecenoyl-15-methylhexadecasphing-4-enine-1-phosphocholine,An N-acyl-15-methylhexadecasphing-4-enine-1-phosphocholine in which the acyl group has 17 carbons and 1 double bond.,17877,KEGG COMPOUND accession,C01352,HC02114,1910-41-4,17877.0,"Human Metabolome Database (HMDB): FADH is the reduced form of flavin adenine dinucleotide (FAD). FAD is synthesized from riboflavin and two molecules of ATP. Riboflavin is phosphorylated by ATP to give riboflavin 5-phosphate (FMN). FAD is then formed from FMN by the transfer of an AMP moiety from a second molecule of ATP. FADH is generated in each round of fatty acid oxidation, and the fatty acyl chain is shortened by two carbon atoms as a result of these reactions; because oxidation is on the beta carbon, this series of reactions is called the beta-oxidation pathway. In the citric acid cycle FADH is involved in harvesting of high-energy electrons from carbon fuels; citric acid cycle itself neither generates a large amount of ATP nor includes oxygen as a reactant. Instead, the citric acid cycle removes electrons from acetyl CoA and uses these electrons to form FADH. (Biochemistry. Berg, Jeremy M. Tymoczko, John L. and Stryer, Lubert. New York: W. H. Freeman and Co. 2002.).",FADH,HMDB0001197,b,b,C01352,FADH2,FDB022483,b,[H]O[C@]([H])(C([H])([H])OP(=O)(O[H])OP(=O)(O[H])OC([H])([H])[C@@]1([H])O[C@@]([H])(N2C([H])=NC3=C2N=C([H])N=C3N([H])[H])[C@]([H])(O[H])[C@]1([H])O[H])[C@@]([H])(O[H])[C@@]([H])(O[H])C([H])([H])N1C2=C(N([H])C3=C1C([H])=C(C(=C3[H])C([H])([H])[H])C([H])([H])[H])C(=O)N([H])C(=O)N2[H],YPZRHBJKEMOYQH-UYBVJOGSSA-N,"InChI=1S/C27H35N9O15P2/c1-10-3-12-13(4-11(10)2)35(24-18(32-12)25(42)34-27(43)33-24)5-14(37)19(39)15(38)6-48-52(44,45)51-53(46,47)49-7-16-20(40)21(41)26(50-16)36-9-31-17-22(28)29-8-30-23(17)36/h3-4,8-9,14-16,19-21,26,32,37-41H,5-7H2,1-2H3,(H,44,45)(H,46,47)(H2,28,29,30)(H2,33,34,42,43)/t14-,15+,16+,19-,20+,21+,26+/m0/s1"
1755,70878,N-hexadecanoyl-4-hydroxy-15-methylhexadecasphinganine-1-phosphocholine,An N-hexadecanoyl-4-hydroxy-15-methylhexadecasphinganine-1-phosphocholine in which the acyl group has 16 carbons and 0 double bonds.,17621,KEGG COMPOUND accession,C00061,fmn,146-17-8,17621.0,"Human Metabolome Database (HMDB): Flavin mononucleotide (FMN), or riboflavin-5-phosphate, is a biomolecule produced from riboflavin (vitamin B2) by the enzyme riboflavin kinase and functions as prosthetic group of various oxidoreductases including NADH dehydrogenase as well as cofactor in biological blue-light photo receptors. During the catalytic cycle, the reversible interconversion of oxidized (FMN), semiquinone (FMNH) and reduced (FMNH2) forms occurs in the various oxidoreductases. FMN is a stronger oxidizing agent than NAD and is particularly useful because it can take part in both one- and two-electron transfers. Flavin mononucleotide is also used as an orange-red food colour additive. It is the principal form in which riboflavin is found in cells and tissues.",Flavin Mononucleotide,HMDB0001520,b,b,C00061,FMN,FDB001984,fmn,[H]O[C@]([H])(C([H])([H])OP([O-])([O-])=O)[C@@]([H])(O[H])[C@@]([H])(O[H])C([H])([H])N1C2=NC(=O)N([H])C(=O)C2=NC2=C([H])C(=C(C([H])=C12)C([H])([H])[H])C([H])([H])[H],FVTCRASFADXXNN-SCRDCRAPSA-L,"InChI=1S/C17H21N4O9P/c1-7-3-9-10(4-8(7)2)21(15-13(18-9)16(25)20-17(26)19-15)5-11(22)14(24)12(23)6-30-31(27,28)29/h3-4,11-12,14,22-24H,5-6H2,1-2H3,(H,20,25,26)(H2,27,28,29)/p-2/t11-,12+,14-/m0/s1"
1756,70880,N-octadecadienoyl-15-methylhexadecasphing-4-enine-1-phosphocholine,An N-acyl-15-methylhexadecasphing-4-enine-1-phosphocholine in which the acyl group has 18 carbons and 2 double bonds.,16048,KEGG COMPOUND accession,C01847,,,,,,,,,,,,,,,
1757,70923,N-tetracosenoyl-15-methylhexadecasphing-4-enine-1-phosphocholine,An N-acyl-15-methylhexadecasphing-4-enine-1-phosphocholine in which the acyl group has 24 carbons and 1 double bond.,17661,KEGG COMPOUND accession,C03117,,,,,,,,,,,,,,,
1758,70925,N-(2-hydroxytricosanoyl)-15-methylhexadecasphing-4-enine-1-phosphocholine,An N-acyl-15-methylhexadecasphing-4-enine-1-phosphocholine in which the acyl group has 23 carbons and 0 double bonds and is 2-hydroxylated.,16097,KEGG COMPOUND accession,C02977,,,,,,,,,,,,,,,
1759,70929,N-pentacosadienoyl-15-methylhexadecasphing-4-enine-1-phosphocholine,An N-acyl-15-methylhexadecasphing-4-enine-1-phosphocholine in which the acyl group has 25 carbons and 2 double bonds.,15820,KEGG COMPOUND accession,C00096,gdpmann,3123-67-9,15820.0,"Human Metabolome Database (HMDB): GDP-mannose is a nucleoside diphosphate sugar that is important in the production of fucosylated oligosaccharides. In particular, GDP-mannose is converted to GDP-fucose, which is the fucose donor in the construction of all mammalian fucosylated glycans. GDP-mannose is transformed to GDP-fucose via three enzymatic reactions carried out by two proteins, GDP-mannose 4,6-dehydratase (GMD) and a second enzyme, GDP-keto-6-deoxymannose 3,5-epimerase, 4-reductase. GDP-mannose 4,6-dehydratase (EC 4.2.1.47) catalyzes the chemical reaction: GDP-mannose <--> GDP-4-dehydro-6-deoxy-D-mannose + H2O. The epimerase converts the GDP-4-dehydro-6-deoxy-D-mannose to GDP-fucose. (PMID: 12651883). GDP-mannose is also synthesized from mannose 1-phosphate via the enzyme ATP-mannose-1-phosphate-guanyltransferase and GTP.",Guanosine diphosphate mannose,HMDB0001163,b,b,C00096,GDP-MANNOSE,FDB012326,gdpmann,[H]OC([H])([H])[C@@]1([H])O[C@]([H])(OP([O-])(=O)OP([O-])(=O)OC([H])([H])[C@@]2([H])O[C@@]([H])(N3C([H])=NC4=C3N=C(N([H])[H])N([H])C4=O)[C@]([H])(O[H])[C@]2([H])O[H])[C@@]([H])(O[H])[C@@]([H])(O[H])[C@]1([H])O[H],MVMSCBBUIHUTGJ-GDJBGNAASA-L,"InChI=1S/C16H25N5O16P2/c17-16-19-12-6(13(28)20-16)18-3-21(12)14-10(26)8(24)5(34-14)2-33-38(29,30)37-39(31,32)36-15-11(27)9(25)7(23)4(1-22)35-15/h3-5,7-11,14-15,22-27H,1-2H2,(H,29,30)(H,31,32)(H3,17,19,20,28)/p-2/t4-,5-,7-,8-,9+,10-,11+,14-,15-/m1/s1"
1760,70976,N-acetyltryptophan,An N-acetylamino acid that is the N-acetyl derivative of tryptophan.,27391,KEGG COMPOUND accession,C04281,1p3h5c,22573-88-2,27391.0,"Human Metabolome Database (HMDB): Pyrroline hydroxycarboxylic acid is a metabolite identified in the urine of patients with type II hyperprolinemia. (OMIM 239510). The urinary excretion of Pyrroline hydroxycarboxylic acid increased in hyperprolinemic patients but not in healthy controls during oral loading of hydroxyproline and hydroxyproline-ornithine. (PMID: 533224). Hyperprolinemia type II (HP II) is a rare inherited metabolic disease due to the deficiency of pyroline-5-carboxylate dehydrogenase. It is generally believed to be a benign condition although some patients have neurological problems such as refractory convulsions. (PMID: 15214748). The oxidation of pyrroline-carboxylate generates glutamate and pyrroline-hydroxycarboxylate, a reaction catalyzed by hydroxyproline oxidase (PMID: 500817).",Pyrroline hydroxycarboxylic acid,HMDB0001369,b,b,C04281,PYRROLINE-HYDROXY-CARBOXYLATE,FDB022582,1p3h5c,[H]O[C@@]1([H])C([H])=N[C@]([H])(C([O-])=O)C1([H])[H],WFOFKRKDDKGRIK-IUYQGCFVSA-M,"InChI=1S/C5H7NO3/c7-3-1-4(5(8)9)6-2-3/h2-4,7H,1H2,(H,8,9)/p-1/t3-,4+/m0/s1"
1761,70981,6-formylpterin,Pterin carrying a formyl group at position 6.,16845,KEGG COMPOUND accession,C03972,,,,,,,,,,,,,,,
1762,70999,"6-[(8Z)-pentadec-8-en-1-yl]benzene-1,2,4-triol","A benzenetriol that is benzene-1,2,4-triol substituted by a (8Z)-pentadec-8-en-1-yl group at position 6.",15885,KEGG COMPOUND accession,C04075,,,,,,,,,,,,,,,
1763,71015,perampanel hydrate,A hydrate obtained by combining four molecules of perampanel with three molecules of water. Used as an adjunctive therapy for the treatment of partial-onset seizures in patients with epilepsy.,18314,KEGG COMPOUND accession,C01826,,,,,,,,,,,,,,,
1764,71039,beta-D-Galp-(1->4)-beta-D-GlcpNAc-(1->2)-alpha-D-Manp-(1->3)-beta-D-Manp-(1->4)-beta-D-GlcpNAc-(1->4)-D-GlcpNAc,"A linear amino hexasaccharide comprised of beta-D-galactose, N-acetyl-beta-D-glucosamine, alpha-D-mannose, beta-D-mannose, N-acetyl-beta-D-glucosamine and N-acetyl-D-glucosamine residues linked sequentially (1->4), (1->2), (1->3), (1->4) and (1->4).",16977,KEGG COMPOUND accession,C00041,ala_L,56-41-7,16977.0,"Human Metabolome Database (HMDB): Alanine is a nonessential amino acid made in the body from the conversion of the carbohydrate pyruvate or the breakdown of DNA and the dipeptides carnosine and anserine. It is highly concentrated in muscle and is one of the most important amino acids released by muscle, functioning as a major energy source. Plasma alanine is often decreased when the BCAA (Branched Chain Amino Acids) are deficient. This finding may relate to muscle metabolism. Alanine is highly concentrated in meat products and other high-protein foods like wheat germ and cottage cheese. Alanine is an important participant as well as regulator in glucose metabolism. Alanine levels parallel blood sugar levels in both diabetes and hypoglycemia, and alanine reduces both severe hypoglycemia and the ketosis of diabetes. It is an important amino acid for lymphocyte reproduction and immunity. Alanine therapy has helped dissolve kidney stones in experimental animals. Normal alanine metabolism, like that of other amino acids, is highly dependent upon enzymes that contain vitamin B6. Alanine, like GABA, taurine and glycine, is an inhibitory neurotransmitter in the brain (http://www.dcnutrition.com/AminoAcids/). L-Alanine is found to be associated with glucagon deficiency, which is an inborn error of metabolism.",L-Alanine,HMDB0000161,b,b,C00041,L-ALPHA-ALANINE,FDB000556,ala_L,[H]C([H])([H])[C@@]([H])(C([O-])=O)[N+]([H])([H])[H],QNAYBMKLOCPYGJ-REOHCLBHSA-N,"InChI=1S/C3H7NO2/c1-2(4)3(5)6/h2H,4H2,1H3,(H,5,6)/t2-/m0/s1"
1765,71047,3-hydroxybenzenesulfonic acid,An arenesulfonic acid that is phenol substituted by a sulfo group at C-3.,28718,KEGG COMPOUND accession,C05519,,,,,,,,,,,,,,,
1766,71053,beta-D-Galp-(1->4)-beta-D-GlcpNAc-(1->3)-D-GalpNAc,"A linear amino trisaccharide consisting of a chain of beta-D-galactose, N-acetyl-beta-D-glucosamine and N-acetyl-D-galactosamine residues linked sequentially (1->4) and (1->3).",15705,KEGG COMPOUND accession,C00151,,,,,,,,,,,,,,,
1767,71072,N-2-hydroxyhexadecanoyl-1-O-beta-D-glucosyl-15-methylhexadecasphing-4-enine,An N-acyl-1-O-beta-D-glucosyl-15-methylhexadecasphing-4-enine in which the acyl group has 16 carbons and 0 double bonds and is 2-hydroxylated.,18403,KEGG COMPOUND accession,C00532,abt,7643-75-6,18403.0,"Human Metabolome Database (HMDB): L-arabitol has been reported in pentosuric acidemia (PMID 13525419). L-arabinosinuia has been described in a patient, presented at the age of 16 months with delayed motor development and facial dysmorphism (PMID 12359133). Congenital liver cirrhosis has been recently described in a patient with highly elevated plasma and urine levels of arabitol due to transaldolase deficiency (Inherit Metab Dis 23(Suppl. 1):172, 2000.). Moreover, L-arabitol is found to be associated with ribose-5-phosphate isomerase deficiency, which is an inborn error of metabolism.",L-Arabitol,HMDB0001851,b,b,C00532,L-ARABITOL,FDB022709,abt,[H]OC([H])([H])[C@]([H])(O[H])C([H])(O[H])[C@@]([H])(O[H])C([H])([H])O[H],HEBKCHPVOIAQTA-IMJSIDKUSA-N,"InChI=1S/C5H12O5/c6-1-3(8)5(10)4(9)2-7/h3-10H,1-2H2/t3-,4-/m0/s1"
1768,71100,N-icosanoyl-1-O-beta-D-glucosyl-4-hydroxy-15-methylhexadecasphinganine,An N-acyl-1-O-beta-D-glucosyl-4-hydroxy-15-methylhexadecasphinganine in which the acyl group has 20 carbons and 0 double bonds.,17053,KEGG COMPOUND accession,C00049,asp_L,56-84-8,17053.0,"Human Metabolome Database (HMDB): Aspartic acid (Asp, D), also known as aspartate, the name of its anion, is one of the 20 natural proteinogenic amino acids which are the building blocks of proteins. As its name indicates, aspartic acid is the carboxylic acid analog of asparagine. As a neurotransmitter, aspartic acid may provide resistance to fatigue and thus lead to endurance, although the evidence to support this idea is not strong. (http://en.wikipedia.org/wiki/Aspartic_acid) Aspartic acid is a nonessential amino acid which is made from glutamic acid by enzymes using vitamin B6. The amino acid has important roles in the urea cycle and DNA metabolism. Aspartic acid is a major excitatory neurotransmitter, which is sometimes found to be increased in epileptic and stroke patients. It is decreased in depressed patients and in patients with brain atrophy. Aspartic acid supplements are being evaluated. Five grams can raise blood levels. Magnesium and zinc may be natural inhibitors of some of the actions of aspartic acid. Aspartic acid, with the amino acid phenylalanine, is a part of a new natural sweetener, aspartame. This sweetener is an advance in artificial sweeteners, and is probably safe in normal doses to all except phenylketonurics. The jury is still out on the long term effects it has on many brain neurohormones. Aspartic acid may be a significant immunostimulant of the thymus and can protect against some of the damaging effects of radiation. Many claims have been made for the special value of administering aspartic acid in the form of potassium and magnesium salts. Since aspartic acid is relatively nontoxic, studies are now in progress to elucidate its pharmacological and therapeutic roles. (http://www.dcnutrition.com/AminoAcids).",L-Aspartic acid,HMDB0000191,b,b,C00049,L-ASPARTATE,FDB012567,asp_L,[H][N+]([H])([H])[C@]([H])(C([O-])=O)C([H])([H])C([O-])=O,CKLJMWTZIZZHCS-REOHCLBHSA-M,"InChI=1S/C4H7NO4/c5-2(4(8)9)1-3(6)7/h2H,1,5H2,(H,6,7)(H,8,9)/p-1/t2-/m0/s1"
1769,71133,N-hexacosanoyl-1-O-beta-D-glucosyl-15-methylhexadecasphing-4-enine,An N-acyl-1-O-beta-D-glucosyl-15-methylhexadecasphing-4-enine in which the acyl group has 26 carbons and 0 double bonds.,17561,KEGG COMPOUND accession,C00097,cys_L,52-90-4,17561.0,"Human Metabolome Database (HMDB): Cysteine is a naturally occurring, sulfur-containing amino acid that is found in most proteins, although only in small quantities. Cysteine is unique amongst the twenty natural amino acids as it contains a thiol group. Thiol groups can undergo oxidation/reduction (redox) reactions; when cysteine is oxidized it can form cystine, which is two cysteine residues joined by a disulfide bond. This reaction is reversible: as reduction of this disulphide bond regenerates two cysteine molecules. The disulphide bonds of cystine are crucial to defining the structures of many proteins. Cysteine is often involved in electron-transfer reactions, and help the enzyme catalyze its reaction. Cysteine is also part of the antioxidant glutathione. N-acetyl-L-cysteine (NAC) is a form of cysteine where an acetyl group is attached to cysteine's nitrogen atom and is sold as a dietary supplement. Cysteine is named after cystine, which comes from the Greek word kustis meaning bladder - cystine was first isolated from kidney stones. As cysteine contains a sulphydryl group, it can undergo redox reactions. Oxidation of cysteine can produce a disulfide bond with another thiol, or further oxidation can produce sulphfinic or sulfonic acids. The cysteine thiol group is also a nucleophile and can undergo addition and substitution reactions. Thiol groups become much more reactive when they are ionized, and cysteine residues in proteins have pKa values close to neutrality, so are often in their reactive thiolate form in the cell. The thiol group also has a high affinity for heavy metals and proteins containing cysteine will bind metals such as mercury, lead and cadmium tightly. Due to this ability to undergo redox reactions, cysteine has antioxidant properties. Cysteine is an important source of sulfur in human metabolism, and although it is classified as a non-essential amino acid, cysteine may be essential for infants, the elderly, and individuals with certain metabolic disease or who suffer from malabsorption syndromes, Although, L-cysteine is found to be associated with sulfite oxidase deficiency, which is a genetic disorder. Cysteine may at some point be recognized as an essential or conditionally essential amino acid (http://en.wikipedia.org/wiki/Cysteine). Cysteine is important in energy metabolism. As cystine, it is a structural component of many tissues and hormones. Cysteine has clinical uses ranging from baldness to psoriasis to preventing smoker's hack. In some cases, oral cysteine therapy has proved excellent for treatment of asthmatics, enabling them to stop theophylline and other medications. Cysteine also enhances the effect of topically applied silver, tin and zinc salts in preventing dental cavities. In the future, cysteine may play a role in the treatment of cobalt toxicity, diabetes, psychosis, cancer and seizures (http://www.dcnutrition.com/AminoAcids/).",L-Cysteine,HMDB0000574,b,b,C00097,CYS,FDB012678,cys_L,[H]SC([H])([H])[C@@]([H])(C([O-])=O)[N+]([H])([H])[H],XUJNEKJLAYXESH-REOHCLBHSA-N,"InChI=1S/C3H7NO2S/c4-2(1-7)3(5)6/h2,7H,1,4H2,(H,5,6)/t2-/m0/s1"
1770,71138,N-(2-hydroxyhexacosadienoyl)-1-O-beta-D-glucosyl-15-methylhexadecasphing-4-enine,An N-acyl-1-O-beta-D-glucosyl-15-methylhexadecasphing-4-enine in which the acyl group has 26 carbons and 2 double bonds and is 2-hydroxylated.,21264,KEGG COMPOUND accession,C05526,,,,,,,,,,,,,,,
1771,71173,H1-receptor agonist,A histamine agonist that binds to and activates H1-receptors.,21285,KEGG COMPOUND accession,C05947,e4hglu,b,b,b,Erythro-4-Hydroxy-L-Glutamate,b,b,b,C05947,b,b,e4hglu,[H]OC([H])(C([O-])=O)C([H])([H])[C@@]([H])(C([O-])=O)[N+]([H])([H])[H],HBDWQSHEVMSFGY-SCQFTWEKSA-M,"InChI=1S/C5H9NO5/c6-2(4(8)9)1-3(7)5(10)11/h2-3,7H,1,6H2,(H,8,9)(H,10,11)/p-1/t2-,3?/m0/s1"
1772,71189,iminodiacetonitrile,A secondary amino compound that is ammonia in which two of the hydrogens are substituted by cyanomethyl groups.,17291,KEGG COMPOUND accession,C01720,,,,,,,,,,,,,,,
1773,71213,3-oxocyclopentanecarboxylic acid,An alicyclic ketone that is oxocyclopentanone substituted at position 3 by a carboxy group.,16015,KEGG COMPOUND accession,C00025,glu_L,56-86-0,16015.0,"Human Metabolome Database (HMDB): Glutamic acid (Glu), also referred to as glutamate (the anion), is one of the 20 proteinogenic amino acids. It is not among the essential amino acids. Glutamate is a key molecule in cellular metabolism. In humans, dietary proteins are broken down by digestion into amino acids, which serves as metabolic fuel or other functional roles in the body. Glutamate is the most abundant fast excitatory neurotransmitter in the mammalian nervous system. At chemical synapses, glutamate is stored in vesicles. Nerve impulses trigger release of glutamate from the pre-synaptic cell. In the opposing post-synaptic cell, glutamate receptors, such as the NMDA receptor, bind glutamate and are activated. Because of its role in synaptic plasticity, it is believed that glutamic acid is involved in cognitive functions like learning and memory in the brain. Glutamate transporters are found in neuronal and glial membranes. They rapidly remove glutamate from the extracellular space. In brain injury or disease, they can work in reverse and excess glutamate can accumulate outside cells. This process causes calcium ions to enter cells via NMDA receptor channels, leading to neuronal damage and eventual cell death, and is called excitotoxicity. The mechanisms of cell death include: Damage to mitochondria from excessively high intracellular Ca2+. Glu/Ca2+-mediated promotion of transcription factors for pro-apoptotic genes, or downregulation of transcription factors for anti-apoptotic genes. Excitotoxicity due to glutamate occurs as part of the ischemic cascade and is associated with stroke and diseases like amyotrophic lateral sclerosis, lathyrism, and Alzheimer's disease. glutamic acid has been implicated in epileptic seizures. Microinjection of glutamic acid into neurons produces spontaneous depolarization around one second apart, and this firing pattern is similar to what is known as paroxysmal depolarizing shift in epileptic attacks. This change in the resting membrane potential at seizure foci could cause spontaneous opening of voltage activated calcium channels, leading to glutamic acid release and further depolarization (http://en.wikipedia.org/wiki/Glutamic_acid). Moreover, glutamic acid is found to be associated with N-acetylglutamate synthetase deficiency, which is an inborn error of metabolism.",L-Glutamic acid,HMDB0000148,b,b,C00025,GLT,FDB012535,glu_L,[H][N+]([H])([H])[C@]([H])(C([O-])=O)C([H])([H])C([H])([H])C([O-])=O,WHUUTDBJXJRKMK-VKHMYHEASA-M,"InChI=1S/C5H9NO4/c6-3(5(9)10)1-2-4(7)8/h3H,1-2,6H2,(H,7,8)(H,9,10)/p-1/t3-/m0/s1"
1774,71252,"(S,S)-asenapine(1+)","An organic cation that is the conjugate acid of (S,S)-asenapine, obtained by protonation of the tertiary amino group.",27676,KEGG COMPOUND accession,C01929,,,,,,,,,,,,,,,
1775,71255,"5-chloro-2-methyl-2,3,3a,12b-tetrahydrodibenzo[2,3:6,7]oxepino[4,5-c]pyrrole","An organic heterotetracyclic compound that is 2,3,3a,12b-tetrahydrodibenzo[2,3:6,7]oxepino[4,5-c]pyrrole bearing methyl and chloro substituents at positions 2 and 5 respectively.",15971,KEGG COMPOUND accession,C00135,his_L,71-00-1,15971.0,"Human Metabolome Database (HMDB): Histidine is an alpha-amino acid with an imidazole functional group. It is one of the 22 proteinogenic amino acids. Histidine was first isolated by German physician Albrecht Kossel in 1896. Histidine is an essential amino acid in humans and other mammals. It was initially thought that it was only essential for infants, but longer-term studies established that it is also essential for adults. Infants four to six months old require 33 mg/kg of histidine. It is not clear how adults make small amounts of histidine, and dietary sources probably account for most of the histidine in the body. Histidine is a precursor for histamine and carnosine biosynthesis. Inborn errors of histidine metabolism, including histidinemia, maple syrup urine disease, propionic acidemia, and tyrosinemia I, exist and are marked by increased histidine levels in the blood. Elevated blood histidine is accompanied by a wide range of symptoms, from mental and physical retardation to poor intellectual functioning, emotional instability, tremor, ataxia and psychosis. Histidine and other imidazole compounds have anti-oxidant, anti-inflammatory and anti-secretory properties (PMID: 9605177). The efficacy of L-histidine in protecting inflamed tissue is attributed to the capacity of the imidazole ring to scavenge reactive oxygen species (ROS) generated by cells during acute inflammatory response (PMID: 9605177). Histidine, when administered in therapeutic quantities is able to inhibit cytokines and growth factors involved in cell and tissue damage (US patent 6150392). Histidine in medical therapies has its most promising trials in rheumatoid arthritis where up to 4.5 g daily have been used effectively in severely affected patients. Arthritis patients have been found to have low serum histidine levels, apparently because of very rapid removal of histidine from their blood (PMID: 1079527). Other patients besides arthritis patients that have been found to be low in serum histidine are those with chronic renal failure. Urinary levels of histidine are reduced in pediatric patients with pneumonia (PMID: 2084459). Asthma patients exhibit increased serum levels of histidine over normal controls (PMID: 23517038).  Serum histidine levels are lower and are negatively associated with inflammation and oxidative stress in obese women (PMID: 23361591).  Histidine supplementation has been shown to reduce insulin resistance, reduce BMI and fat mass and suppress inflammation and oxidative stress in obese women with metabolic syndrome.  Histidine appears to suppress pro-inflammatory cytokine expression, possibly via the NF-B pathway, in adipocytes (PMID: 23361591). Low plasma concentrations of histidine are associated with protein-energy wasting, inflammation, oxidative stress, and greater mortality in chronic kidney disease patients (PMID: 18541578). Histidine may have many other possible functions because it is the precursor of the ubiquitous neurohormone-neurotransmitter histamine. Histidine increases histamine in the blood and probably in the brain. Low blood histamine with low serum histidine occurs in rheumatoid arthritis patients. Low blood histamine also occurs in some manic, schizophrenic, high copper and hyperactive groups of psychiatric patients. Histidine is a useful therapy in all patients with low histamine levels (http://www.dcnutrition.com ).",L-Histidine,HMDB0000177,b,b,C00135,HIS,FDB011856,his_L,[H]N1C([H])=NC(=C1[H])C([H])([H])[C@@]([H])(C([O-])=O)[N+]([H])([H])[H],HNDVDQJCIGZPNO-YFKPBYRVSA-N,"InChI=1S/C6H9N3O2/c7-5(6(10)11)1-4-2-8-3-9-4/h2-3,5H,1,7H2,(H,8,9)(H,10,11)/t5-/m0/s1"
1776,71268,beta-D-GlcpA-(1->6)-beta-D-Galp,A glycosylgalactose consisting of beta-D-galactose substituted on O-6 with a beta-D-glucopyranuronosyl (beta-D-glucopyranosyluronic acid) group.,17588,KEGG COMPOUND accession,C00155,hcys_L,454-29-5,17230.0,"Human Metabolome Database (HMDB): Homocysteine is a sulfur-containing amino acid that arises during methionine metabolism. Although its concentration in plasma is only about 10 micromolar (uM), even moderate hyperhomocysteinemia is associated with increased incidence of cardiovascular disease and Alzheimer's disease. Elevations in plasma homocysteine are commonly found as a result of vitamin deficiencies, polymorphisms of enzymes of methionine metabolism, and renal disease. Pyridoxal, folic acid, riboflavin, and Vitamin B(12) are all required for methionine metabolism, and deficiency of each of these vitamins result in elevated plasma homocysteine. A polymorphism of methylenetetrahydrofolate reductase (C677T), which is quite common in most populations with a homozygosity rate of 10-15 %, is associated with moderate hyperhomocysteinemia, especially in the context of marginal folate intake. Plasma homocysteine is inversely related to plasma creatinine in patients with renal disease. This is due to an impairment in homocysteine removal in renal disease. The role of these factors, and of modifiable lifestyle factors, in affecting methionine metabolism and in determining plasma homocysteine levels is discussed. Homocysteine is an independent cardiovascular disease (CVD) risk factor modifiable by nutrition and possibly exercise. Homocysteine was first identified as an important biological compound in 1932 and linked with human disease in 1962 when elevated urinary homocysteine levels were found in children with mental retardation. This condition, called homocysteinuria, was later associated with premature occlusive CVD, even in children. These observations led to research investigating the relationship of elevated homocysteine levels and CVD in a wide variety of populations including middle age and elderly men and women with and without traditional risk factors for CVD (PMID 17136938, 15630149). Moreover, homocysteine is found to be associated with cystathionine beta-synthase deficiency, cystathioninuria, methylenetetrahydrofolate reductase deficiency, and sulfite oxidase deficiency, which are inborn errors of metabolism.",Homocysteine,HMDB0000742,b,b,C00155,HOMO-CYS,FDB001491,hcys_L,[H]SC([H])([H])C([H])([H])[C@@]([H])(C([O-])=O)[N+]([H])([H])[H],FFFHZYDWPBMWHY-VKHMYHEASA-N,"InChI=1S/C4H9NO2S/c5-3(1-2-8)4(6)7/h3,8H,1-2,5H2,(H,6,7)/t3-/m0/s1"
1777,71287,4-hydroxy-3-nitrophenylacetaldehyde(1-),A phenolate anion that is the conjugate base of 4-hydroxy-3-nitrophenylacetaldehyde; major species at pH 7.3,27890,KEGG COMPOUND accession,C03126,,,,,,,,,,,,,,,
1778,71295,arabinan derivative,A homopolysaccharide derivative which is formally derived from an arabinan.,17191,KEGG COMPOUND accession,C00407,ile_L,73-32-5,17191.0,"Human Metabolome Database (HMDB): Branched chain amino acids (BCAA) are essential amino acids whose carbon structure is marked by a branch point. These three amino acids are critical to human life and are particularly involved in stress, energy and muscle metabolism. BCAA supplementation as therapy, both oral and intravenous, in human health and disease holds great promise. ""BCAA"" denotes valine, isoleucine and leucine which are branched chain essential amino acids. Despite their structural similarities, the branched amino acids have different metabolic routes, with valine going solely to carbohydrates, leucine solely to fats and isoleucine to both. The different metabolism accounts for different requirements for these essential amino acids in humans: 12 mg/kg, 14 mg/kg and 16 mg/kg of valine, leucine and isoleucine respectively. Furthermore, these amino acids have different deficiency symptoms. Valine deficiency is marked by neurological defects in the brain, while isoleucine deficiency is marked by muscle tremors. BCAA are decreased in patients with liver disease, such as hepatitis, hepatic coma, cirrhosis, extrahepatic biliary atresia or portacaval shunt; aromatic amino acids (AAA)-tyrosine, tryptophan and phenylalanine, as well as methionine-are increased in these conditions. Valine, in particular, has been established as a useful supplemental therapy to the ailing liver. All the BCAA probably compete with AAA for absorption into the brain. Supplemental BCAA with vitamin B6 and zinc help normalize the BCAA:AAA ratio. The BCAA are not without side effects. Leucine alone, for example, exacerbates pellagra and can cause psychosis in pellagra patients by increasing excretion of niacin in the urine. Leucine may lower brain serotonin and dopamine. A dose of 3 g of isoleucine added to the niacin regime has cleared leucine-aggravated psychosis in schizophrenic patients. Isoleucine may have potential as an antipsychotic treatment. Leucine is more highly concentrated in foods than other amino acids. A cup of milk contains 800 mg of leucine and only 500 mg of isoleucine and valine. A cup of wheat germ has about 1.6 g of leucine and 1 g of isoleucine and valine. The ratio evens out in eggs and cheese. One egg and an ounce of most cheeses each contain about 400 mg of leucine and 400 mg of valine and isoleucine. The ratio of leucine to other BCAA is greatest in pork, where leucine is 7 to 8 g and the other BCAA together are only 3 to 4 g (http://www.dcnutrition.com). Moreover, L-isoleucine is found to be associated with maple syrup urine disease, which is an inborn error of metabolism.",L-Isoleucine,HMDB0000172,b,b,C00407,ILE,FDB012397,ile_L,[H]C([H])([H])C([H])([H])[C@]([H])(C([H])([H])[H])[C@@]([H])(C([O-])=O)[N+]([H])([H])[H],AGPKZVBTJJNPAG-WHFBIAKZSA-N,"InChI=1S/C6H13NO2/c1-3-4(2)5(7)6(8)9/h4-5H,3,7H2,1-2H3,(H,8,9)/t4-,5-/m0/s1"
1779,71305,WO2-molybdopterin cofactor(2-),An organophosphate oxoanion obtained by deprotonation of the phosphate OH groups of WO2-molybdopterin cofactor.,15603,KEGG COMPOUND accession,C00123,leu_L,61-90-5,15603.0,"Human Metabolome Database (HMDB): L-leucine, also known as leu or 2-amino-4-methylvaleric acid, belongs to leucine and derivatives class of compounds. Those are compounds containing leucine or a derivative thereof resulting from reaction of leucine at the amino group or the carboxy group, or from the replacement of any hydrogen of glycine by a heteroatom. L-leucine is soluble (in water) and a moderately acidic compound (based on its pKa). L-leucine can be found primarily in most biofluids, including blood, cerebrospinal fluid (CSF), feces, and sweat, as well as throughout most human tissues. Within the cell, L-leucine is primarily located in the mitochondria. It can also be found in the extracellular space. L-leucine exists in all living species, ranging from bacteria to humans. L-leucine is a non-carcinogenic (not listed by IARC) potentially toxic compound. Leucine (abbreviated as Leu or L) is an -amino acid that is used in the biosynthesis of proteins. It contains an -amino group (which is in the protonated NH3+ form under biological conditions), an -carboxylic acid group (which is in the deprotonated COO form under biological conditions), and a side chain isobutyl group, making it a non-polar aliphatic amino acid. It is essential in humans, meaning the body cannot synthesize it: it must be obtained from the diet. Human dietary sources are foods that contain protein, such as meats, dairy products, soy products, beans and legumes. In the genetic code it is encoded by the six codons UUA, UUG, CUU, CUC, CUA, and CUG (Wikipedia). This group of essential amino acids are identified as the branched-chain amino acids, BCAAs. Branched chain amino acids (BCAA) are essential amino acids whose carbon structure is marked by a branch point. These three amino acids are critical to human life and are particularly involved in stress, energy and muscle metabolism. BCAA supplementation as therapy, both oral and intravenous, in human health and disease holds great promise. 'BCAA' denotes valine, isoleucine and leucine which are branched chain essential amino acids. Despite their structural similarities, the branched amino acids have different metabolic routes, with valine going solely to carbohydrates, leucine solely to fats and isoleucine to both. The different metabolism accounts for different requirements for these essential amino acids in humans: 12 mg/kg, 14 mg/kg and 16 mg/kg of valine, leucine and isoleucine respectively. Furthermore, these amino acids have different deficiency symptoms. Valine deficiency is marked by neurological defects in the brain, while isoleucine deficiency is marked by muscle tremors. Many types of inborn errors of BCAA metabolism exist, and are marked by various abnormalities. The most common form is the maple syrup urine disease, marked by a characteristic urinary odor. Other abnormalities are associated with a wide range of symptoms, such as mental retardation, ataxia, hypoglycemia, spinal muscle atrophy, rash, vomiting and excessive muscle movement. Most forms of BCAA metabolism errors are corrected by dietary restriction of BCAA and at least one form is correctable by supplementation with 10 mg of biotin daily. BCAA are useful because they are metabolized primarily by muscle. Stress stat- e.g surgery, trauma, cirrhosis, infections, fever and starvation--require proportionately more BCAA than other amino acids and probably proportionately more leucine than either valine or isoleucine. BCAA and other amino acids are frequently fed intravenously (TPN) to malnourished surgical patients and in some cases of severe trauma. BCAA, particularly leucine, stimulate protein synthesis, increase reutilization of amino acids in many organs and reduce protein breakdown. Furthermore, leucine can be an important source of calories, and is superior as fuel to the ubiquitous intravenous glucose (dextrose). Leucine also stimulates insulin release, which in turn stimulates protein synthesis and inhibits protein breakdown. These effects are particularly useful in athletic training. BCAA should also replace the use of steroids as commonly used by weightlifters. Huntington's chorea and anorexic disorders both are characterized by low serum BCAA. These diseases, as well as forms of Parkinson's, may respond to BCAA therapy. BCAA, and particularly leucine, are among the amino acids most essential for muscle health (http://www.dcnutrition.com).",L-Leucine,HMDB0000687,b,b,C00123,LEU,FDB001946,leu_L,[H]OC(=O)[C@@]([H])(N([H])[H])C([H])([H])C([H])(C([H])([H])[H])C([H])([H])[H],ROHFNLRQFUQHCH-YFKPBYRVSA-N,"InChI=1S/C6H13NO2/c1-4(2)3-5(7)6(8)9/h4-5H,3,7H2,1-2H3,(H,8,9)/t5-/m0/s1"
1780,71356,norsolorinic acid,"A polyketide that is anthraquinone bearing four hydroxy substituents at positions 1, 3, 6 and 8 as well as a hexanoyl substituent at position 2.",17203,KEGG COMPOUND accession,C00148,pro_L,147-85-3,17203.0,"Human Metabolome Database (HMDB): L-proline is one of the twenty amino acids used in living organisms as the building blocks of proteins. Proline is sometimes called an imino acid, although the IUPAC definition of an imine requires a carbon-nitrogen double bond. Proline is a non-essential amino acid that is synthesized from glutamic acid. It is an essential component of collagen and is important for proper functioning of joints and tendons. Proline is derived from the amino acid L-glutamate in which glutamate-5-semialdehyde is first formed by glutamate 5-kinase and glutamate-5-semialdehyde dehydrogenase (which requires NADH or NADPH). This semialdehyde can then either spontaneously cyclize to form 1-pyrroline-5-carboxylic acid, which is reduced to proline by pyrroline-5-carboxylate reductase, or turned into ornithine by ornithine aminotransferase, followed by cyclization by ornithine cyclodeaminase to form proline. L-Proline has been found to act as a weak agonist of the glycine receptor and of both NMDA and non-NMDA ionotropic glutamate receptors. It has been proposed to be a potential endogenous excitotoxin/neurotoxin. Studies in rats have shown that when injected into the brain, proline non-selectively destroys pyramidal and granule cells (PMID: 3409032). Therefore, under certain conditions proline can act as a neurotoxin and a metabotoxin. A neurotoxin causes damage to nerve cells and nerve tissues. A metabotoxin is an endogenously produced metabolite that causes adverse health effects at chronically high levels. Chronically high levels of proline are associated with at least five inborn errors of metabolism, including hyperprolinemia type I, hyperprolinemia type II, iminoglycinuria, prolinemia type II, and pyruvate carboxylase deficiency. People with hyperprolinemia type I often do not show any symptoms even though they have proline levels in their blood between 3 and 10 times the normal level. Some individuals with hyperprolinemia type I exhibit seizures, intellectual disability, or other neurological or psychiatric problems. Hyperprolinemia type II results in proline levels in the blood between 10 and 15 times higher than normal, and high levels of a related compound called pyrroline-5-carboxylate. Hyperprolinemia type II has signs and symptoms that vary in severity, and is more likely than type I to involve seizures or intellectual disability.",L-Proline,HMDB0000162,b,b,C00148,PRO,FDB000570,pro_L,[H]C1([H])C([H])([H])[N+]([H])([H])[C@]([H])(C([O-])=O)C1([H])[H],ONIBWKKTOPOVIA-BYPYZUCNSA-N,"InChI=1S/C5H9NO2/c7-5(8)4-2-1-3-6-4/h4,6H,1-3H2,(H,7,8)/t4-/m0/s1"
1781,71426,3-oxoisooctadecanoyl-CoA(4-),A 3-oxo-fatty acyl-CoA(4-) arising from deprotonation of the phosphate and diphosphate functions of 3-oxoisooctadecanoyl-CoA.,18332,KEGG COMPOUND accession,C01829,thyox_L,51-48-9,18332.0,"Human Metabolome Database (HMDB): The thyronamines function via some unknown mechanism to inhibit neuronal activity; this plays an important role in the hibernation cycles of mammals. One effect of administering the thyronamines is a severe drop in body temperature. Iodide is actively absorbed from the bloodstream and concentrated in the thyroid follicles. (If there is a deficiency of dietary iodine, the thyroid enlarges in an attempt to trap more iodine, resulting in goitre.) Via a reaction with the enzyme thyroperoxidase, iodine is covalently bound to tyrosine residues in the thyroglobulin molecules, forming monoiodotyrosine (MIT) and diiodotyrosine (DIT). Linking two moieties of DIT produces thyroxine. Combining one particle of MIT and one particle of DIT produces triiodothyronine. Both T3 and T4 are used to treat thyroid hormone deficiency (hypothyroidism). They are both absorbed well by the gut, so can be given orally. Levothyroxine, the most commonly used synthetic thyroxine form, is a stereoisomer of physiological thyroxine, which is metabolized more slowly and hence usually only needs once-daily administration. Natural desiccated thyroid hormones, which are derived from pig thyroid glands, are a ""natural"" hypothyroid treatment containing 20% T3 and traces of T2, T1 and calcitonin. this plays an important role in the hibernation cycles of mammals. One effect of administering the thyronamines is a severe drop in body temperature. The major hormone derived from the thyroid gland. Thyroxine is synthesized via the iodination of tyrosines (monoiodotyrosine) and the coupling of iodotyrosines (diiodotyrosine) in the thyroglobulin. Thyroxine is released from thyroglobulin by proteolysis and secreted into the blood. Thyroxine is peripherally deiodinated to form triiodothyronine which exerts a broad spectrum of stimulatory effects on cell metabolism. The thyronamines function via some unknown mechanism to inhibit neuronal activity.",Thyroxine,HMDB0000248,b,b,C01829,L-THYROXINE,FDB021829,thyox_L,[H]OC1=C(I)C([H])=C(OC2=C(I)C([H])=C(C([H])=C2I)C([H])([H])[C@@]([H])(C([O-])=O)[N+]([H])([H])[H])C([H])=C1I,XUIIKFGFIJCVMT-LBPRGKRZSA-N,"InChI=1S/C15H11I4NO4/c16-8-4-7(5-9(17)13(8)21)24-14-10(18)1-6(2-11(14)19)3-12(20)15(22)23/h1-2,4-5,12,21H,3,20H2,(H,22,23)/t12-/m0/s1"
1782,71474,alpha-D-Manp-(1->2)-alpha-D-Manp-(1->2)-alpha-D-Manp-(1->3)-[alpha-D-Manp-(1->3)-[alpha-D-Manp-(1->2)-alpha-D-Manp-(1->6)]-alpha-D-Manp-(1->6)]-alpha-D-Manp,A branched mannooligosaccharide comprised of eight alpha-D-mannose residues arrangedin the configuration shown.,17269,KEGG COMPOUND accession,C02293,,,,,,,,,,,,,,,
1783,71494,cis-trans-nepetalactol,"A cyclopentapyran that is 1,4a,5,6,7,7a-hexahydrocyclopenta[c]pyran substituted at position 1 by a hydroxy group and at positions 4 and 7 by methyl groups (the 4aS,7S,7aR-diastereomer)",30307,KEGG COMPOUND accession,C04138,,,,,,,,,,,,,,,
1784,71513,"cyanidin 3,7-di-O-beta-D-glucoside betaine","An oxonium betaine that is the conjugate base of cyanidin 3,7-di-O-beta-D-glucoside, arising from regioselective deprotonation of the 5-hydroxy group. Major structure at pH 7.3",15783,KEGG COMPOUND accession,C04203,,,,,,,,,,,,,,,
1785,71525,"7,8-dimethylisoalloxazine-10-carbaldehyde",A flavin carrying a formyl group at C-10.,17724,KEGG COMPOUND accession,C01026,dmgly,1118-68-9,17724.0,"Human Metabolome Database (HMDB): Dimethylglycine (DMG) is an amino acid derivative found in the cells of all plants and animals and can be obtained in the diet in small amounts from grains and meat. The human body produces DMG when metabolizing choline into Glycine. Dimethylglycine that is not metabolized in the liver is transported by the circulatory system to body tissue. Dimethylglycine was popular with Russian athletes and cosmonauts owing to its reputed ability to increase endurance and reduce fatigue. DMG is also a byproduct of homocysteine metabolism. Homocysteine and betaine are converted to methionine and N, N-dimethylglycine by betaine-homocysteine methyltransferase. Dimethylglycine in the urine is a biomarker for the consumption of legumes.",Dimethylglycine,HMDB0000092,b,b,C01026,DIMETHYL-GLYCINE,FDB021893,dmgly,[H]C([H])([H])[N+]([H])(C([H])([H])[H])C([H])([H])C([O-])=O,FFDGPVCHZBVARC-UHFFFAOYSA-N,"InChI=1S/C4H9NO2/c1-5(2)3-4(6)7/h3H2,1-2H3,(H,6,7)"
1786,71534,(S)-averantin,An optically active form of averantin having S-configuration.,15769,KEGG COMPOUND accession,C04352,4ppcys,7196-09-0,15769.0,"Human Metabolome Database (HMDB): 4-Phosphopantothenoylcysteine (PPC) is an intermediate in the biosynthetic machinery (pathway) that converts pantothenate (vitamin B5) into coenzyme A (CoA). The enzyme Phosphopantothenoylcysteine decarboxylase catalyzes the decarboxylation of PPC to 4'-phosphopantetheine. Coenzyme A is the principal acyl carrier and is required for many synthetic and degradative reactions in intermediary metabolism, and is an essential cofactor in all living systems. (PMID: 15450493, 16371361, 14501115).",4-Phosphopantothenoylcysteine,HMDB0001117,b,b,C04352,R-4-PHOSPHOPANTOTHENOYL-L-CYSTEINE,FDB022432,4ppcys,[H]O[C@@]([H])(C(=O)N([H])C([H])([H])C([H])([H])C(=O)N([H])[C@]([H])(C([O-])=O)C([H])([H])S[H])C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])OP([O-])([O-])=O,XQYALQVLCNHCFT-CBAPKCEASA-K,"InChI=1S/C12H23N2O9PS/c1-12(2,6-23-24(20,21)22)9(16)10(17)13-4-3-8(15)14-7(5-25)11(18)19/h7,9,16,25H,3-6H2,1-2H3,(H,13,17)(H,14,15)(H,18,19)(H2,20,21,22)/p-3/t7-,9-/m0/s1"
1787,71548,dihydroagarofuran sesquiterpenoid,Any sesquiterpenoid with a dihydroagarofuran skeleton.,32818,KEGG COMPOUND accession,C04498,,,,,,,,,,,,,,,
1788,71552,alpha-D-Manp-(1->6)-beta-D-Manp,alpha-D-Manp-(1->6)-D-Manp in which the anomeric configuration at the reducing end is beta.,18277,KEGG COMPOUND accession,C04302,,,,,,,,,,,,,,,
1789,71558,alpha-L-Fucp-(1->3)-[alpha-Neup5Ac-(2->3)-beta-D-Galp6S-(1->4)]-beta-D-GlcpNAc,"A branched amino tetrasaccharide comprised of a trisaccharide chain of N-acetyl-alpha-neuraminic acid, 6-O-sulfo-beta-D-glactose and N-acetyl-beta-D-glucosamine residues linked sequentially (2->3) and (1->4), to the GlcNAC residue of which is also linked (1->3) an alpha-L-fucose residue.",15682,KEGG COMPOUND accession,C03406,argsuc,2387-71-5,15682.0,"Human Metabolome Database (HMDB): Arginosuccinic acid is a basic amino acid. Some cells synthesize it from citrulline, aspartic acid and use it as a precursor for arginine in the urea cycle or Citrulline-NO cycle. The enzyme that catalyzes the reaction is argininosuccinate synthetase. Argininosuccinic acid is a precursor to fumarate in the citric acid cycle via argininosuccinate lyase. Defects in the argininosuccinate lyase enzyme can lead to argininosuccinate lyase deficiency, which is an inborn error of metabolism. Argininosuccinate (ASA) lyase deficiency results in defective cleavage of ASA. This leads to an accumulation of ASA in cells and an excessive excretion of ASA in urine (argininosuccinic aciduria). In virtually all respects, this disorder shares the characteristics of other urea cycle defects. The most important characteristic of ASA lyase deficiency is its propensity to cause hyperammonemia in affected individuals. ASA in affected individuals is excreted by the kidney at a rate practically equivalent to the glomerular filtration rate (GFR). Whether ASA itself causes a degree of toxicity due to hepatocellular accumulation is unknown; such an effect could help explain hyperammonemia development in affected individuals. Regardless, the name of the disease is derived from the rapid clearance of ASA in urine, although elevated levels of ASA can be found in plasma. ASA lyase deficiency is associated with high mortality and morbidity rates. Symptoms of ASA lyase deficiency include anorexia, irritability rapid breathing, lethargy and vomiting. Extreme symptoms include coma and cerebral edema.",Argininosuccinic acid,HMDB0000052,b,b,C03406,b,FDB021885,argsuc,[H]N(C(N([H])C([H])(C([O-])=O)C([H])([H])C([O-])=O)=[N+]([H])[H])C([H])([H])C([H])([H])C([H])([H])[C@@]([H])(C([O-])=O)[N+]([H])([H])[H],KDZOASGQNOPSCU-ZBHICJROSA-M,"InChI=1S/C10H18N4O6/c11-5(8(17)18)2-1-3-13-10(12)14-6(9(19)20)4-7(15)16/h5-6H,1-4,11H2,(H,15,16)(H,17,18)(H,19,20)(H3,12,13,14)/p-1/t5-,6?/m0/s1"
1790,71578,cyclic di-AMP,"A cyclic purine dinucleotide that is the 3',5'-cyclic dimer of AMP.",21489,KEGG COMPOUND accession,C03142,,,,,,,,,,,,,,,
1791,71590,"(3E,5Z)-tetradecadienoate","A long-chain unsaturated fatty acid anion that is the conjugate base of (3E,5Z)-tetradecadienoic acid, obtained by deprotonation of the carboxy group; major species at pH 7.3.",32844,KEGG COMPOUND accession,C04015,,,,,,,,,,,,,,,
1792,71593,filicinic acid,"An enone that is cyclohexa-2,5-dien-1-one substituted by hydroxy groups at positions 3 and 5 and geminal methyl groups at position 4.",21498,KEGG COMPOUND accession,C04016,,,,,,,,,,,,,,,
1793,71596,mycocyclosin,An organic heterotetracyclic compound obtained via intramolecular oxidative aromatic coupling of cyclo(L-tyrosyl-L-tyrosyl).,21500,KEGG COMPOUND accession,C04017,,,,,,,,,,,,,,,
1794,71625,sarmentologenin,"A steroid lactone that is card-20(22)-enolide substituted by hydroxy groups at positions 3, 5, 11, 14 and 19.",16948,KEGG COMPOUND accession,C01133,,,,,,,,,,,,,,,
1795,71636,versiconol acetate(1-),"An organic anion that is the conjugate base of versiconol acetate, obtained by selective deprotonation of the 2-hydroxy group.",15784,KEGG COMPOUND accession,C00357,acgam6p,18191-20-3,15784.0,Human Metabolome Database (HMDB): N-Acetyl-D-Glucosamine 6-Phosphate is an intermediate in the metabolism of Aminosugars. It is a substrate for Glucosamine 6-phosphate N-acetyltransferase.,N-Acetyl-D-Glucosamine 6-Phosphate,HMDB0001062,b,b,C00357,N-ACETYL-D-GLUCOSAMINE-6-P,FDB022401,acgam6p,[H]OC1([H])O[C@]([H])(C([H])([H])OP([O-])([O-])=O)[C@@]([H])(O[H])[C@]([H])(O[H])[C@@]1([H])N([H])C(=O)C([H])([H])[H],BRGMHAYQAZFZDJ-RTRLPJTCSA-L,"InChI=1S/C8H16NO9P/c1-3(10)9-5-7(12)6(11)4(18-8(5)13)2-17-19(14,15)16/h4-8,11-13H,2H2,1H3,(H,9,10)(H2,14,15,16)/p-2/t4-,5-,6-,7-,8?/m1/s1"
1796,71690,staphyloxanthin,"A xanthophyll that is beta-D-glucopyranose in which the hydroxy groups at positions 1 and 6 have been acylated by an all-trans-2,6,10,15,19,23-hexamethyltetracosa-2,4,6,8,10,12,14,16,18,22-decaenoyl group and a 12-methyltetradecanoyl group, respectively. Staphyloxanthin is responsible for the characteristic yellow-golden colour which gives the bacterium Staphylococcus aureus its name.",16878,KEGG COMPOUND accession,C04133,acg5p,15383-57-0,16878.0,Human Metabolome Database (HMDB): N-Acetyl-L-glutamyl 5-phosphate is an intermediate in urea cycle and metabolism of amino groups. The enzyme N-acetyl-gamma-glutamyl-phosphate reductase [EC:1.2.1.38] catalyzes the conversion of this metabolite into N-acetyl-L-glutamate 5-semialdehyde. This reaction is irreversible and occurs in the mitochondria. (BiGG database).,N-Acetyl-L-glutamyl 5-phosphate,HMDB0006456,b,b,C04133,N-ACETYL-GLUTAMYL-P,FDB023917,b,[H]N(C(=O)C([H])([H])[H])[C@]([H])(C([O-])=O)C([H])([H])C([H])([H])C(=O)OP([O-])([O-])=O,FCVIHFVSXHOPSW-YFKPBYRVSA-K,"InChI=1S/C7H12NO8P/c1-4(9)8-5(7(11)12)2-3-6(10)16-17(13,14)15/h5H,2-3H2,1H3,(H,8,9)(H,11,12)(H2,13,14,15)/p-3/t5-/m0/s1"
1797,71708,phosphatidylethanolamine 30:4,"A 1,2-diacyl-sn-glycero-3-phosphoethanolamine zwitterion in which the acyl groups at C-1 and C-2 contain 30 carbons in total with 4 double bonds.",21557,KEGG COMPOUND accession,C02712,C02712,65-82-7,165927.0,"Human Metabolome Database (HMDB): N-acetyl-L-methionine is nutritionally and metabolically equivalent to L-methionine. Methionine is a dietary indispensable amino acid required for normal growth and development of humans, other mammals, and avian species. In addition to being a substrate for protein synthesis, it is an intermediate in transmethylation reactions, serving as the major methyl group donor in vivo, including the methyl groups for DNA and RNA intermediates. Methionine is a methyl acceptor for 5-methyltetrahydrofolate-homocysteine methyl transferase (methionine synthase), the only reaction that allows for the recycling of this form of folate, and is also a methyl acceptor for the catabolism of betaine. Methionine is also required for synthesis of cysteine. Methionine is accepted as the metabolic precursor for cysteine. Only the sulfur atom from methionine is transferred to cysteine; the carbon skeleton of cysteine is donated by serine. (PMID 16702340). The adequacy range of dietary requirements of specific amino acids in disease states is difficult to determine. Requirements may not be similar in disease with regard to protein synthesis. Requirements for this purpose can be assessed only when such a function can be measured and related to clinical outcome. There is apparent consensus concerning normal sulfur amino acid (SAA) requirements. WHO recommendations amount to 13 mg/kg per 24 h in healthy adults. This amount is roughly doubled in artificial nutrition regimens. In disease or after trauma, requirements may be altered for methionine, cysteine, and taurine. Although in specific cases of congenital enzyme deficiency, prematurity, or diminished liver function, hypermethionemia or hyperhomocysteinemia may occur, SAA supplementation can be considered safe in amounts exceeding 2-3 times the minimal recommended daily intake. Apart from some very specific indications (e.g., acetaminophen poisoning) the usefulness of SAA supplementation is not yet established.(PMID 16702341). Methionine is known to exacerbate psychopathological symptoms in schizophrenic patients, there is no evidence of similar effects in healthy subjects. The role of methionine as a precursor of homocysteine is the most notable cause for concern. A ""loading dose"" of methionine (0.1 g/kg) has been given, and the resultant acute increase in plasma homocysteine has been used as an index of the susceptibility to cardiovascular disease. Although this procedure results in vascular dysfunction, this is acute and unlikely to result in permanent damage. However, a 10-fold larger dose, given mistakenly, resulted in death. Longer-term studies in adults have indicated no adverse consequences of moderate fluctuations in dietary methionine intake, but intakes higher than 5 times normal resulted in elevated homocysteine levels. These effects of methionine on homocysteine and vascular function are moderated by supplements of vitamins B-6, B-12, C, and folic acid. In infants, methionine intakes of 2 to 5 times normal resulted in impaired growth and extremely high plasma methionine levels, but no adverse long-term consequences were observed. (PMID 16702346).",N-Acetyl-L-methionine,HMDB0011745,b,b,C02712,b,FDB001089,C02712,[H]N(C(=O)C([H])([H])[H])[C@]([H])(C([O-])=O)C([H])([H])C([H])([H])SC([H])([H])[H],XUYPXLNMDZIRQH-LURJTMIESA-M,"InChI=1S/C7H13NO3S/c1-5(9)8-6(7(10)11)3-4-12-2/h6H,3-4H2,1-2H3,(H,8,9)(H,10,11)/p-1/t6-/m0/s1"
1798,71744,phosphatidylethanolamine 40:4 zwitterion,"A 1,2-diacyl-sn-glycero-3-phosphoethanolamine zwitterion in which the acyl groups at C-1 and C-2 contain 40 carbons in total with 4 double bonds.",21575,KEGG COMPOUND accession,C02847,,,,,,,,,,,,,,,
1799,71746,phosphatidylethanolamine 40:6 zwitterion,"A 1,2-diacyl-sn-glycero-3-phosphoethanolamine zwitterion in which the acyl groups at C-1 and C-2 contain 40 carbons in total with 6 double bonds.",28497,KEGG COMPOUND accession,C05021,,,,,,,,,,,,,,,
1800,71834,phosphatidylethanolamine O-32:2 zwitterion,"An alkyl,acyl-sn-glycero-3-phosphoethanolamine zwitterion in which the alkyl or acyl groups at positions 1 and 2 contain a total of 32 carbons and 2 double bonds.",18177,KEGG COMPOUND accession,C06746,,,,,,,,,,,,,,,
1801,71859,phosphatidylethanolamine O-38:6 zwitterion,"An alkyl,acyl-sn-glycero-3-phosphoethanolamine zwitterion in which the alkyl or acyl groups at positions 1 and 2 contain a total of 38 carbons and 6 double bonds.",16062,KEGG COMPOUND accession,C00625,,,,,,,,,,,,,,,
1802,71869,phosphatidylethanolamine O-42:2 zwitterion,"An alkyl,acyl-sn-glycero-3-phosphoethanolamine zwitterion in which the alkyl or acyl groups at positions 1 and 2 contain a total of 42 carbons and 2 double bonds.",21647,KEGG COMPOUND accession,C02715,,,,,,,,,,,,,,,
1803,71963,5-amino-5-deoxy-3-dehydroshikimic acid zwitterion,An amino acid zwitterion obtained by transfer of a proton from the carboxy to the amino group of 5-amino-5-deoxy-3-dehydroshikimic acid; major species at pH 7.3.,18327,KEGG COMPOUND accession,C00439,forglu,816-90-0,7274.0,Human Metabolome Database (HMDB): Measurement of this acid in the urine after oral administration of histidine provides the basis for the diagnostic test of folic acid deficiency and of megaloblastic anemia of pregnancy.,Formiminoglutamic acid,HMDB0000854,b,b,C00439,N-FORMIMINO-L-GLUTAMATE,FDB022280,forglu,[H]N=C([H])N([H])[C@]([H])(C([O-])=O)C([H])([H])C([H])([H])C([O-])=O,NRXIKWMTVXPVEF-BYPYZUCNSA-L,"InChI=1S/C6H10N2O4/c7-3-8-4(6(11)12)1-2-5(9)10/h3-4H,1-2H2,(H2,7,8)(H,9,10)(H,11,12)/p-2/t4-/m0/s1"
1804,72016,N-(2-hydroxytetradecanoyl)icosasphinganine,A C20 dihydroceramide in which the ceramide N-acyl group is specified as 2-hydroxytetradecanoyl.,17931,KEGG COMPOUND accession,C03954,,,,,,,,,,,,,,,
1805,72026,N-(2-hydroxytriacontanoyl)sphinganine,A dihydroceramide in which the ceramide N-acyl group is specified as 2-hydroxytriacontanoyl.,50760,KEGG COMPOUND accession,C05710,,,,,,,,,,,,,,,
1806,72060,phosphatidylserine 34:3(1-),A 3-sn-phosphatidyl-L-serine(1-) in which the acyl groups at C-1 and C-2 contain 34 carbons in total and 3 double bonds.,16440,KEGG COMPOUND accession,C01046,,,,,,,,,,,,,,,
1807,72396,lysophosphatidylethanolamine zwitterion 24:0,A lysophosphatidylethanolamine zwitterion in which the remaining acyl group (position not specified) contains 24 carbons and 0 double bonds.,17981,KEGG COMPOUND accession,C00979,acser,66638-22-0,17981.0,Human Metabolome Database (HMDB): O-Acetylserine (OASS) is an acylated amino acid derivative. It is an intermediate in the biosynthesis of the common amino acid cysteine in bacteria and plants. Its presence in humans arises from either microbial metabolism in the gut or through consumption of foods containing OASS.,O-Acetyl-L-serine,HMDB0003011,b,b,C00979,b,b,b,b,b,b
1808,72400,lysophosphatidylethanolamine zwitterion 26:1,A lysophosphatidylethanolamine zwitterion in which the remaining acyl group (position not specified) contains 26 carbons and 1 double bond.,75659,KEGG COMPOUND accession,C02301,,,,,,,,,,,,,,,
1809,72411,lysophosphatidylserine 20:0(1-),A lysophosphatidylserine(1-) in which the remaining acyl group (position not specified) contains 20 carbons and 0 double bonds.,17438,KEGG COMPOUND accession,C03300,,,,,,,,,,,,,,,
1810,72439,phosphatidylcholine 44:2-OH,"A 1,2-diacyl-sn-glycero-3-phosphocholine in which the acyl groups at C-1 and C-2 contain 44 carbons in total with 2 double bonds and 1 hydroxy group.",18336,KEGG COMPOUND accession,C06055,,,,,,,,,,,,,,,
1811,72443,tetramethylrosamine chloride,The chloride salt of tetramethylrosamine. Used as a red-orange fluorescent dye.,15961,KEGG COMPOUND accession,C01102,phom,4210-66-6,15961.0,"Human Metabolome Database (HMDB): O-phosphohomoserine is a naturally occurring analogue of phosphonate amino acids. O-phosphohomoserine has been found in trace amounts in shotgun-metabolomics analysis in mouse tissue extracts, and is the substrate of a threonine analog enzyme in murine species. O-phosphohomoserine, an analogue of the excitatory amino acid antagonist 2-amino-phosphonovalerate is an N-methyl-D-aspartate (NMDA) antagonist. (PMID: 3528930, 17034760, 17665876).",O-Phosphohomoserine,HMDB0003484,b,b,C01102,O-PHOSPHO-L-HOMOSERINE,FDB023182,phom,[H][N+]([H])([H])[C@]([H])(C([O-])=O)C([H])([H])C([H])([H])OP([O-])([O-])=O,FXDNYOANAXWZHG-VKHMYHEASA-L,"InChI=1S/C4H10NO6P/c5-3(4(6)7)1-2-11-12(8,9)10/h3H,1-2,5H2,(H,6,7)(H2,8,9,10)/p-2/t3-/m0/s1"
1812,72464,alpha-Neup5Gc-(2->3)-beta-D-Galp-(1->3)-[alpha-L-Fucp-(1->4)]-beta-D-GlcNAcp,"A branched amino tetrasaccharide comprising alpha-N-glycoloylneuraminyl, beta-D-galactosyl and N-acetyl-beta-D-glucosamine residues linked sequentially (2->3) and (1->3), to the galactosyl residue of which is also linked (1->4) an alpha-L-fucosyl residue.",16160,KEGG COMPOUND accession,C01118,,,,,,,,,,,,,,,
1813,72510,sphingomyelin 32:2,A sphingomyelin in which the total number of carbons in the sphingoid base and fatty acyl groups is 32 with 2 double bonds.,17165,KEGG COMPOUND accession,C02740,,,,,,,,,,,,,,,
1814,72512,sphingomyelin 32:4,A sphingomyelin in which the total number of carbons in the sphingoid base and fatty acyl groups is 32 with 4 double bonds.,17021,KEGG COMPOUND accession,C02320,,,,,,,,,,,,,,,
1815,72534,sphingomyelin 42:2,A sphingomyelin in which the total number of carbons in the sphingoid base and fatty acyl groups is 42 with 2 double bonds.,17468,KEGG COMPOUND accession,C04264,,,,,,,,,,,,,,,
1816,72536,sphingomyelin 42:4,A sphingomyelin in which the total number of carbons in the sphingoid base and fatty acyl groups is 42 with 4 double bonds.,15510,KEGG COMPOUND accession,C03724,,,,,,,,,,,,,,,
1817,72563,"(3S,4S)-3-hydroxy-4-methyloctanoic acid",A hydroxy fatty acid that is caprylic (octanoic) acid substituted at positions 3 and 4 by hydroxy and methyl grous respectively.,18126,KEGG COMPOUND accession,C02589,,,,,,,,,,,,,,,
1818,72573,triazene derivative,A nitrogen molecular entity resulting from the formal substitution of one or more of the hydrogens of triazene.,15414,KEGG COMPOUND accession,C00019,amet,29908-03-0,15414.0,"Human Metabolome Database (HMDB): Physiologic methyl radical donor involved in enzymatic transmethylation reactions and present in all living organisms. It possesses anti-inflammatory activity and has been used in treatment of chronic liver disease. (From Merck, 11th ed)",S-Adenosylmethionine,HMDB0001185,b,b,C00019,S-ADENOSYLMETHIONINE,FDB022473,amet,[H]O[C@@]1([H])[C@@]([H])(O[C@]([H])(C([H])([H])[S+](C([H])([H])[H])C([H])([H])C([H])([H])[C@@]([H])(C([O-])=O)[N+]([H])([H])[H])[C@@]1([H])O[H])N1C([H])=NC2=C(N=C([H])N=C12)N([H])[H],MEFKEPWMEQBLKI-AIRLBKTGSA-O,"InChI=1S/C15H22N6O5S/c1-27(3-2-7(16)15(24)25)4-8-10(22)11(23)14(26-8)21-6-20-9-12(17)18-5-19-13(9)21/h5-8,10-11,14,22-23H,2-4,16H2,1H3,(H2-,17,18,19,24,25)/p+1/t7-,8+,10+,11+,14+,27?/m0/s1"
1819,72592,alpha-Neup5Ac-(2->3)-beta-D-Galp-(1->3)-[alpha-L-Fucp-(1->4)]-beta-D-GlcpNAc-(1->3)-beta-D-Galp-(1->3)-[alpha-L-Fucp-(1->4)]-beta-D-GlcpNAc,"A branched amino heptasaccharide consisting of a linear sequence of N-acetyl-alpha-neuraminyl, beta-D-galactosyl, N-acetyl-beta-D-glucosaminyl, beta-D-galactosyl and N-acetyl-beta-D-glucosamine residues linked respectively (2->3), (1->3), (1->3) and (1->4), to each N-acetyl-beta-D-glucosamine residue of which is also linked (1->4) an alpha-L-fucosyl residue.",15735,KEGG COMPOUND accession,C06718,,,,,,,,,,,,,,,
1820,72651,9-HODE,"A HODE that consists of (10E,12Z)-octadecadienoic acid with the hydroxy substituent located at position 9.",28513,KEGG COMPOUND accession,C05690,,,,,,,,,,,,,,,
1821,72755,kanamycin C(4+),An organic cation obtained by protonation of the primary amino groups of kanamycin C.,28289,KEGG COMPOUND accession,C04700,,,,,,,,,,,,,,,
1822,72769,2'-oxokanamycin,A kanamycin obtained by dehydrogenation at position 2' of kanamycin A.,17675,KEGG COMPOUND accession,C02894,,,,,,,,,,,,,,,
1823,72776,kunzeaol,A germacrane sesquiterpenoid derived from germacrane by dehydrogenation between the 1-10 and 4-5 positions as well as hydroxylation at position 6.,27778,KEGG COMPOUND accession,C06471,,,,,,,,,,,,,,,
1824,72794,11-HDoHE,"A hydroxydocosahexaenoic acid that consists of 4Z,7Z,9E,13Z,16Z,19Z-docosahexaenoic acid with the hydroxy group located at position 11.",15342,KEGG COMPOUND accession,C02807,,,,,,,,,,,,,,,
1825,72816,L-alanyl-L-alanine,A dipeptide consisting of two L-alanine units joined by a peptide linkage.,30089,KEGG COMPOUND accession,C00033,ac,64-19-7,15366.0,"Human Metabolome Database (HMDB): Acetic acid is one of the simplest carboxylic acids. It is an important chemical reagent and industrial chemical that is used in the production of plastic soft drink bottles, photographic film; and polyvinyl acetate for wood glue, as well as many synthetic fibres and fabrics. In households diluted acetic acid is often used as a cleaning agent. In the food industry acetic acid is used as an acidity regulator. The acetyl group, derived from acetic acid, is fundamental to the biochemistry of virtually all forms of life. When bound to coenzyme A it is central to the metabolism of carbohydrates and fats. However, the concentration of free acetic acid in cells is kept at a low level to avoid disrupting the control of the pH of the cell contents. Acetic acid is produced and excreted by certain bacteria, notably the Acetobacter genus and Clostridium acetobutylicum. These bacteria are found universally in foodstuffs, water, and soil, and acetic acid is produced naturally as fruits and some other foods spoil. Acetic acid is also a component of the vaginal lubrication of humans and other primates, where it appears to serve as a mild antibacterial agent. Acetic acid is found to be associated with phenylketonuria, which is an inborn error of metabolism.",Acetic acid,HMDB0000042,b,b,C00033,ACET,FDB008299,ac,[H]C([H])([H])C([O-])=O,QTBSBXVTEAMEQO-UHFFFAOYSA-M,"InChI=1S/C2H4O2/c1-2(3)4/h1H3,(H,3,4)/p-1"
1826,72842,9-oxo-ODE,"An oxooctadecadienoic acid that consists of (10E,12Z)-octadecadienoic acid with the oxo substituent located at position 9.",27777,KEGG COMPOUND accession,C06808,,,,,,,,,,,,,,,
1827,72860,"1-hexadecanoyl-2-(9Z,12Z-octadecadienoyl)-sn-glycero-3-phosphate(2-)","A 1,2-diacyl-sn-glycerol 3-phosphate(2-) in which the 1- and 2-acyl groups are specified as hexadecanoyl (palmitoyl) and 9Z,12Z-octadecadienoyl (linoleoyl) respectively; major species at pH 7.3.",27632,KEGG COMPOUND accession,C07113,,,,,,,,,,,,,,,
1828,72886,cardiolipin 68:3(2-),A cardiolipin(2-) derivative in which the four phosphatidyl acyl groups contain a total of 68 carbons and 3 double bonds.,27518,KEGG COMPOUND accession,C01548,,,,,,,,,,,,,,,
1829,72892,cardiolipin 70:6(2-),A cardiolipin(2-) derivative in which the four phosphatidyl acyl groups contain a total of 70 carbons and 6 double bonds.,15360,KEGG COMPOUND accession,C02132,,,,,,,,,,,,,,,
1830,72911,cardiolipin 76:5(2-),A cardiolipin(2-) derivative in which the four phosphatidyl acyl groups contain a total of 76 carbons and 5 double bonds.,15368,KEGG COMPOUND accession,C01471,,,,,,,,,,,,,,,
1831,72927,cardiolipin 80:10(2-),A cardiolipin(2-) derivative in which the four phosphatidyl acyl groups contain a total of 80 carbons and 10 double bonds.,15369,KEGG COMPOUND accession,C01775,,,,,,,,,,,,,,,
1832,72955,N-decanoylsphingosine,A N-acylsphingosine in which the ceramide N-acyl group is specified as decanoyl.,16708,KEGG COMPOUND accession,C00147,ade,73-24-5,16708.0,"Human Metabolome Database (HMDB): Adenine is a purine base. Adenine is found in both DNA and RNA. Adenine is a fundamental component of adenine nucleotides. Adenine forms adenosine, a nucleoside, when attached to ribose, and deoxyadenosine when attached to deoxyribose; it forms adenosine triphosphate (ATP), a nucleotide, when three phosphate groups are added to adenosine. Adenosine triphosphate is used in cellular metabolism as one of the basic methods of transferring chemical energy between chemical reactions. Purine inborn errors of metabolism (IEM) are serious hereditary disorders, which should be suspected in any case of neonatal fitting, failure to thrive, recurrent infections, neurological deficit, renal disease, self-mutilation and other manifestations. Investigation usually starts with uric acid (UA) determination in urine and plasma. (OMIM 300322, 229600, 603027, 232400, 232600, 232800, 201450, 220150, 232200, 162000, 164050, 278300). (PMID: 17052198, 17520339).",Adenine,HMDB0000034,b,b,C00147,ADENINE,FDB012266,ade,[H]N([H])C1=C2N=C([H])N([H])C2=NC([H])=N1,GFFGJBXGBJISGV-UHFFFAOYSA-N,"InChI=1S/C5H5N5/c6-4-3-5(9-1-7-3)10-2-8-4/h1-2H,(H3,6,7,8,9,10)"
1833,72966,N-docosanoylsphingosine,A N-acylsphingosine in which the ceramide N-acyl group is specified as docosanoyl.,17985,KEGG COMPOUND accession,C00054,pap,1053-73-2,17985.0,"Human Metabolome Database (HMDB): Adenosine 3', 5'-diphosphate or PAP is a nucleotide that is closely related to ADP. It has two phosphate groups attached to the 5' and 3' positions of the pentose sugar ribose (instead of pyrophosphoric acid at the 5' position, as found in ADP), and the nucleobase adenine. PAP is converted to PAPS by Sulfotransferase and then back to PAP after the sulfotransferase reaction. Sulfotransferase (STs) catalyze the transfer reaction of the sulfate group from the ubiquitous donor 3'-phosphoadenosine 5'-phosphosulfate (PAPS) to an acceptor group of numerous substrates. This reaction, often referred to as sulfuryl transfer, sulfation, or sulfonation, is widely observed from bacteria to humans and plays a key role in various biological processes such as cell communication, growth and development, and defense. PAP also appears to a role in bipolar depression. Phosphatases converting 3'-phosphoadenosine 5'-phosphate (PAP) into adenosine 5'-phosphate are of fundamental importance in living cells as the accumulation of PAP is toxic to several cellular systems. These enzymes are lithium-sensitive and we have characterized a human PAP phosphatase as a potential target of lithium therapy.","Adenosine 3',5'-diphosphate",HMDB0000061,b,b,C00054,3-5-ADP,FDB021887,pap,[H]O[C@@]1([H])[C@@]([H])(O[C@]([H])(C([H])([H])OP([O-])([O-])=O)[C@@]1([H])OP([O-])([O-])=O)N1C([H])=NC2=C(N=C([H])N=C12)N([H])[H],WHTCPDAXWFLDIH-KQYNXXCUSA-J,"InChI=1S/C10H15N5O10P2/c11-8-5-9(13-2-12-8)15(3-14-5)10-6(16)7(25-27(20,21)22)4(24-10)1-23-26(17,18)19/h2-4,6-7,10,16H,1H2,(H2,11,12,13)(H2,17,18,19)(H2,20,21,22)/p-4/t4-,6-,7-,10-/m1/s1"
1834,73004,1-hexadecanoyl-sn-glycero-3-phosphoethanolamine zwitterion,A lysophosphatidylethanolamine zwitterion 16:0 obtained by transfer of a proton from the phosphate to the amino group of 1-hexadecanoyl-sn-glycero-3-phosphoethanolamine.,18322,KEGG COMPOUND accession,C06102,,,,,,,,,,,,,,,
1835,73017,O-isobutyrylcarnitine,An O-acylcarnitine having isobutyryl as the acyl substituent.,15336,KEGG COMPOUND accession,C01550,,,,,,,,,,,,,,,
1836,73022,Ac-His-D-Pro-NH2,A dipeptide that is the N(1)-(N(alpha)-acetyl-L-histidyl) derivative of D-prolinamide.,28462,KEGG COMPOUND accession,C06542,,,,,,,,,,,,,,,
1837,73026,2-methylbutyrylcarnitine,A C5-acylcarnitine having 2-methylbutyryl as the acyl substituent.,16449,KEGG COMPOUND accession,C01401,,,,,,,,,,,,,,,
1838,73119,"(11Z,14Z)-eicosadienoylcarnitine","An O-acylcarnitine having (11Z,14Z)-eicosadienoyl as the acyl substituent.",17613,KEGG COMPOUND accession,C04216,,,,,,,,,,,,,,,
1839,73121,"1-hexadecanoyl-2-(9Z,12Z-octadecadienoyl)-sn-glycero-3-phosphoethanolamine","A 1,2-diacyl-sn-glycero-3-phosphoethanolamine in which the 1- and 2-acyl groups are specified as hexadecanoyl (palmitoyl) and 9Z,12Z-octadecadienoyl (linoleoyl) respectively.",17528,KEGG COMPOUND accession,C01230,,,,,,,,,,,,,,,
1840,73128,horminone,"An abietane diterpenoid that is abieta-8,12-diene substituted by hydroxy groups at positions 7 and 12 and oxo groups at positions 11 and 14 (the 7alpha stereoisomer) .",16275,KEGG COMPOUND accession,C04146,,,,,,,,,,,,,,,
1841,73144,N-octadecanoylsphingosine 1-phosphate,A ceramide 1-phosphate that is the N-octadecananoyl (stearoyl) derivative of sphingosine.,17536,KEGG COMPOUND accession,C00499,alltt,99-16-1,30837.0,"Human Metabolome Database (HMDB): Allantoic acid is the END product of Allantoicase [EC:3.5.3.4], an enzyme involved in uric acid degradation (Purine metabolism). Although it is commonly accepted that allantoicase is lost in mammals, it has been identified in mice and humans. (PMID 11852104). A crystalline, transparent, colorless substance found in the allantoic liquid of the fetal calf; -- formerly called allantoic acid and amniotic acid.",Allantoic acid,HMDB0001209,b,b,C00499,ALLANTOATE,FDB012646,b,[H]N([H])C(=O)N([H])C([H])(N([H])C(=O)N([H])[H])C([O-])=O,NUCLJNSWZCHRKL-UHFFFAOYSA-M,"InChI=1S/C4H8N4O4/c5-3(11)7-1(2(9)10)8-4(6)12/h1H,(H,9,10)(H3,5,7,11)(H3,6,8,12)/p-1"
1842,73152,"2,6-dimethyldeca-2,4,6,8-tetraenedial","An apo carotenoid compound arising from oxidative degradation of the beta,beta-carotene skeleton at the 8'- and 13-positions.",28411,KEGG COMPOUND accession,C07600,,,,,,,,,,,,,,,
1843,73232,ethylpyrazine,"A member of the class of pyrazines that is pyrazine in which one of the hydrogens is replaced by an ethyl group. Found particularly in cereals and cereal products, it is present in baked or fried potato, bread, roasted peanuts, and cooked shrimp, as well as cocoa, coffee, and tea. It has a musty, nutty, buttery, peanut odor and a chocolate-peanut taste.",28459,KEGG COMPOUND accession,C03734,,,,,,,,,,,,,,,
1844,73248,deglymidodrine,"An aromatic ether that is 1,4-dimethoxybenzene which is substituted at position 2 by a 2-amino-1-hydroxyethyl group. The immediate and active metabolite of midrodine, it is a direct-acting sympathomimetic with selective alpha-adrenergic agonist activity. Midrodine is used (generally as its hydrochloride salt) as a prodrug for deglymidodrine, which acts as a peripheral vasoconstrictor in the treatment of certain hypotensive states.",18205,KEGG COMPOUND accession,C03812,,,,,,,,,,,,,,,
1845,73263,cyclooxygenase 3 inhibitor,A cyclooxygenase inhibitor that interferes with the action of cyclooxygenase 3.,16300,KEGG COMPOUND accession,C00620,r1p,14075-00-4,16300.0,"Human Metabolome Database (HMDB): Ribose 1-phosphate is an intermediate in the metabolism of Pyrimidine and the metabolism of Nicotinate and nicotinamide. It is a substrate for Uridine phosphorylase 2, Phosphoglucomutase, Purine nucleoside phosphorylase and Uridine phosphorylase 1. Ribose 1-phosphate can be formed from guanosine through the action of purine nucleoside phosphorylase. Ribose 1-phosphate can also act as a ribose donor in the synthesis of xanthosine as catalyzed by the same enzyme (purine nucleoside phosphorylase). The presence of guanase, which irreversibly converts guanine to xanthine, affects the overall process of guanosine transformation. As a result of this purine pathway, guanosine is converted into xanthosine, thus overcoming the lack of guanosine deaminase in mammals. The activated ribose moiety in Ribose 1-phosphate which stems from the catabolism of purine nucleosides can be transferred to uracil and, in the presence of ATP, used for the synthesis of pyrimidine nucleotides; therefore, purine nucleosides can act as ribose donors for the salvage of pyrimidine bases. (PMID: 9133638).",Ribose 1-phosphate,HMDB0001489,b,b,C00620,RIBOSE-1P,FDB022650,r1p,[H]OC([H])([H])[C@@]1([H])O[C@]([H])(OP([O-])([O-])=O)[C@]([H])(O[H])[C@]1([H])O[H],YXJDFQJKERBOBM-TXICZTDVSA-L,"InChI=1S/C5H11O8P/c6-1-2-3(7)4(8)5(12-2)13-14(9,10)11/h2-8H,1H2,(H2,9,10,11)/p-2/t2-,3-,4-,5-/m1/s1"
1846,73323,Ala-Ala-Pro,A tripeptide composed of two L-alanyl units and an L-proline joined by peptide linkages.,28425,KEGG COMPOUND accession,C05433,,,,,,,,,,,,,,,
1847,73357,U69593,"A monocarboxylic acid amide obtained by formal condensation between the carboxy group of phenylacetic acid and the secodary amino group of (5R,7S,8S)-N-methyl-7-(pyrrolidin-1-yl)-1-oxaspiro[4.5]decan-8-amine.",29060,KEGG COMPOUND accession,C02759,apnnox,1686-14-2,29060.0,"Human Metabolome Database (HMDB): Alpha-pinene oxide is cheap monoterpene, which is important compound for the fragnance industry. Biocatalytic method is used to convert monoterpenes into terpenoids. The biotransformation of alpha-pinene oxide using resting cells of Pseudomonas fluorescens NCIMB 11671 produces isonovalal (cis-2-methyl-5-isopropylhexa-2,5-dienal), which is a fragrance. However, this biotransformation has technical problems including the following: alpha-pinene oxide undergoes autoxidation in water and light; it is hydrophobic and relatively toxic to the biocatalyst; and it suffers from product inhibition. the influence of other terpene byproducts on the flux of alpha-pinene oxide was investigated and found to decrease the flux into the organic phase by up to 10%. (PMID: 16321051).",Alpha-Pinene-oxide,HMDB0003667,b,b,C02759,ALPHA-PINENE-OXIDE,FDB023213,apnnox,[H]C([H])([H])C12OC1([H])C([H])([H])C1([H])C([H])([H])C2([H])C1(C([H])([H])[H])C([H])([H])[H],NQFUSWIGRKFAHK-UHFFFAOYSA-N,"InChI=1S/C10H16O/c1-9(2)6-4-7(9)10(3)8(5-6)11-10/h6-8H,4-5H2,1-3H3"
1848,73391,Ala-Val-Asp-Tyr,"A tetrapeptide composed of L-alanine, L-valine, L-aspartic acid, and L-tyrosine joined in sequence by peptide linkages.",17628,KEGG COMPOUND accession,C06735,,,,,,,,,,,,,,,
1849,73420,fingolimod phosphate,A primary amino compound that is fingolimod in which one on the hydroxy groups has been converted into its dihydrogen phosphate derivative. It is the active metabolite of fingolimod.,17475,KEGG COMPOUND accession,C00872,,,,,,,,,,,,,,,
1850,73451,Asp-His,A dipeptide composed of L-aspartic acid and L-histidine joined by a peptide linkage.,28938,KEGG COMPOUND accession,C01342,,,,,,,,,,,,,,,
1851,73454,Asp-Ser,A dipeptide composed of L-aspartic acid and L-serine joined by a peptide linkage.,18219,KEGG COMPOUND accession,C01358,,,,,,,,,,,,,,,
1852,73487,Glu-Lys-Trp-Ala,"A tetrapeptide composed of L-glutamic acid, L-lysine, L-tryptophan and L-alanine joined in sequence by peptide linkages.",17146,KEGG COMPOUND accession,C02811,,,,,,,,,,,,,,,
1853,73511,hex-5-ynoic acid,A hexynoic acid in which the triple bond is between the carbons at positions 5 and 6.,16366,KEGG COMPOUND accession,C02003,,,,,,,,,,,,,,,
1854,73516,Gly-Ser,A dipeptide composed of glycine and L-serine joined by a peptide linkage.,16567,KEGG COMPOUND accession,C00108,anth,118-92-3,30754.0,Human Metabolome Database (HMDB): 2-Aminobenzoic acid is an organic compound. It is a substrate of enzyme anthranilate hydroxylase [EC 1.14.13.35] in benzoate degradation via hydroxylation pathway (KEGG).,2-Aminobenzoic acid,HMDB0001123,b,b,C00108,ANTHRANILATE,FDB000896,anth,[H]N([H])C1=C(C([H])=C([H])C([H])=C1[H])C([O-])=O,RWZYAGGXGHYGMB-UHFFFAOYSA-M,"InChI=1S/C7H7NO2/c8-6-4-2-1-3-5(6)7(9)10/h1-4H,8H2,(H,9,10)/p-1"
1855,73522,Leu-Ser-Ser-Tyr,"A tetrapeptide composed of L-leucine, two L-serine units and L-tyrosine joined in sequence by peptide linkages.",15472,KEGG COMPOUND accession,C02247,,,,,,,,,,,,,,,
1856,73603,7-(2-hydroxy-3-amino-3-carboxypropyl)wyosine 5'-monophosphate(1-) residue,An organic anionic group obtained by deprotonation of 7-(2-hydroxy-3-amino-3-carboxypropyl)wyosine 5'-monophosphate residue.,49900,KEGG COMPOUND accession,C06697,aso3,b,29866.0,"Human Metabolome Database (HMDB): In chemistry an arsenite is a chemical compound containing an arsenic oxoanion where arsenic has oxidation state +3. Examples of arsenites include sodium arsenite which contains a polymeric linear anion, [AsO2&#8722;]n, silver arsenite, Ag3AsO3, which contains the trigonal, [AsO3]3&#8722; anion, sometimes called ortho-arsenite. Arsenite contrasts to the corresponding anions of the lighter members of group 15, phosphite which has the structure [HPO3]2&#8722; and nitrite, NO2&#8722; which is planar. Sodium arsenite is used in the water gas shift reaction to remove carbon dioxide. Arsenic Trioxide is indicated for induction of remission and consolidation in patients with acute promyelocytic leukemia (APL) who are refractory to, or have relapsed from, retinoid and anthracycline chemotherapy.(Wikipedia).",Arsenite,HMDB0011620,b,b,C06697,b,b,b,b,b,b
1857,73603,7-(2-hydroxy-3-amino-3-carboxypropyl)wyosine 5'-monophosphate(1-) residue,An organic anionic group obtained by deprotonation of 7-(2-hydroxy-3-amino-3-carboxypropyl)wyosine 5'-monophosphate residue.,49900,KEGG COMPOUND accession,C06697,M01367,15502-74-6,29866.0,"Human Metabolome Database (HMDB): In chemistry an arsenite is a chemical compound containing an arsenic oxoanion where arsenic has oxidation state +3. Examples of arsenites include sodium arsenite which contains a polymeric linear anion, [AsO2&#8722;]n, silver arsenite, Ag3AsO3, which contains the trigonal, [AsO3]3&#8722; anion, sometimes called ortho-arsenite. Arsenite contrasts to the corresponding anions of the lighter members of group 15, phosphite which has the structure [HPO3]2&#8722; and nitrite, NO2&#8722; which is planar. Sodium arsenite is used in the water gas shift reaction to remove carbon dioxide. Arsenic Trioxide is indicated for induction of remission and consolidation in patients with acute promyelocytic leukemia (APL) who are refractory to, or have relapsed from, retinoid and anthracycline chemotherapy.(Wikipedia).",Arsenite,HMDB0011620,b,b,C06697,CPD-763,FDB028324,b,[H]O[As](O[H])O[H],GCPXMJHSNVMWNM-UHFFFAOYSA-N,InChI=1S/AsH3O3/c2-1(3)4/h2-4H
1858,73611,Met-Gly,A dipeptide formed from L-methionine and glycine residues.,28506,KEGG COMPOUND accession,C06550,,,,,,,,,,,,,,,
1859,73659,Thr-Thr-Asp,A tripeptide composed of two L-threonine units and L-aspartic acid joined by peptide linkages.,17099,KEGG COMPOUND accession,C02008,,,,,,,,,,,,,,,
1860,73667,Thr-Tyr,A dipeptide composed of L-threonine and L-tyrosine joined by a peptide linkage.,15930,KEGG COMPOUND accession,C06551,,,,,,,,,,,,,,,
1861,73696,Val-Pro-Pro,A tripeptide composed of L-valine and two L-proline units joined by peptide linkages.,29745,KEGG COMPOUND accession,C00813,,,,,,,,,,,,,,,
1862,73706,bromosuccinate,A dicarboxylic acid dianion obtained by deprotonation of the two carboxy goups of bromosuccinic acid.,17169,KEGG COMPOUND accession,C00261,,,,,,,,,,,,,,,
1863,73718,tridecanedioic acid,"An alpha,omega-dicarboxylic acid that is undecane substituted by carboxylic acid groups at positions C-1 and C-11.",16716,KEGG COMPOUND accession,C01407,,,,,,,,,,,,,,,
1864,73726,GW 501516,"An aromatic ether that is phenoxyacetic acid in which the phenyl group is substituted at position 2 by a methyl group and at position 4 by a (1,3-thiazol-5-ylmethyl)sulfanediyl group, and in which the 1,3-thiazolyl group is substituted at positions 2 and 4 by p-trifluoromethylphenyl and methyl groups, respectively.",16164,KEGG COMPOUND accession,C01108,,,,,,,,,,,,,,,
1865,73734,tricosenoic acid,Any C23 monounsaturated fatty acid containing one double bond at an unspecified position.,16204,KEGG COMPOUND accession,C02183,,,,,,,,,,,,,,,
1866,73747,uridine residue,The nucleoside residue formed from uridine with linkages at the 3' and 5' positions.,16150,KEGG COMPOUND accession,C00180,bz,65-85-0,30746.0,"Human Metabolome Database (HMDB): Benzoic acid, C6H5COOH, is a colourless crystalline solid and the simplest aromatic carboxylic acid. Benzoic acid occurs naturally free and bound as benzoic acid esters in many plant and animal species. Appreciable amounts have been found in most berries (around 0.05%). Cranberries contain as much as 300-1300 mg free benzoic acid per kg fruit. Benzoic acid is a fungistatic compound that is widely used as a food preservative. It often is conjugated to glycine in the liver and excreted as hippuric acid. Benzoic acid is a byproduct of phenylalanine metabolism in bacteria. It is also produced when gut bacteria process polyphenols (from ingested fruits or beverages).",Benzoic acid,HMDB0001870,b,b,C00180,BENZOATE,FDB008739,bz,[H]C1=C([H])C([H])=C(C([H])=C1[H])C([O-])=O,WPYMKLBDIGXBTP-UHFFFAOYSA-M,"InChI=1S/C7H6O2/c8-7(9)6-4-2-1-3-5-6/h1-5H,(H,8,9)/p-1"
1867,73757,Ala-Gly,A dipeptide formed from L-alanyl and glycine residues.,17682,KEGG COMPOUND accession,C01408,,,,,,,,,,,,,,,
1868,73760,"1,2-dimethylhydrazine(2+)","An organic cation resulting from the protonation of both of the nitrogens of 1,2-dimethylhydrazine.",27991,KEGG COMPOUND accession,C09814,,,,,,,,,,,,,,,
1869,73784,Gly-Glu(1-),"A peptide anion that is the conjugate base of Gly-Glu, obtained by deprotonation of the terminal and side-chain carboxy groups and protonation of the terminal amino group.",16270,KEGG COMPOUND accession,C02253,,,,,,,,,,,,,,,
1870,73817,Arg-Met,A dipeptide formed from L-arginine and L-methionine residues.,16777,KEGG COMPOUND accession,C05177,,,,,,,,,,,,,,,
1871,73824,Asn-Glu,A dipeptide formed from L-asparagine and L-glutamic acid residues.,17377,KEGG COMPOUND accession,C00758,,,,,,,,,,,,,,,
1872,73828,Asp-Glu,A dipeptide formed from L-alpha-aspartyl and L-glutamic acid residues.,28428,KEGG COMPOUND accession,C06988,,,,,,,,,,,,,,,
1873,73844,N(4)-{alpha-Neu5Ac-(2->6)-beta-D-Gal-(1->4)-beta-D-GlcNAc-(1->2)-alpha-D-Man-(1->3)-[alpha-Neu5Ac-(2->6)-beta-D-Gal-(1->4)-beta-D-GlcNAc-(1->2)-alpha-D-Man-(1->6)]-beta-D-Man-(1->4)-beta-D-GlcNAc-(1->4)-[alpha-L-Fuc-(1->6)]-D-GlcNAc}-L-Asn residue,"An N(4)-glycosylated L-asparagine residue in which the glycosyl element is a branched  dodecasaccharide comprising a beta-D-mannosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->4)-[alpha-L-fucosyl (1->6)]-N-acetyl-D-glucosaminyl chain, to the mannosyl residue of which are linked (1->3) and (1->6) two alpha-sialyl-(1->6)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->2)-alpha-D-mannosyl units.",28782,KEGG COMPOUND accession,C08239,,,,,,,,,,,,,,,
1874,73849,Glu-Ala,A dipeptide formed from L-alpha-glutamyl and L-alanine residues.,28013,KEGG COMPOUND accession,C05378,,,,,,,,,,,,,,,
1875,73903,prosopinine,"A  piperidine alkaloid that is a hydroxypiperidine with a hydroxy group at position C-3, a hydroxymethyl group at C-2, and an 8-hydroxydecyl group at C-6.",22798,KEGG COMPOUND accession,C00963,,,,,,,,,,,,,,,
1876,73913,antifolate,An antimetabolite that impairs the action of folic acids,15341,KEGG COMPOUND accession,C03033,dca3g,72504-58-6,b,"Human Metabolome Database (HMDB): Deoxycholic acid 3-glucuronide is a natural human metabolite of Deoxycholic acid generated in the liver by UDP glucuonyltransferase. Glucuronidated conjugate of deoxycholic acid: one of the 4 main acids produced by the liver used in the emulsification of fats for the absorption in the intestine. (Wikipedia). Glucuronidation is used to assist in the excretion of toxic substances, drugs or other substances that cannot be used as an energy source. Glucuronic acid is attached via a glycosidic bond to the substance, and the resulting glucuronide, which has a much higher water solubility than the original substance, is eventually excreted by the kidneys.",Deoxycholic acid 3-glucuronide,HMDB0002596,b,b,C03033,Beta-D-Glucuronides,FDB023032,dca3g,b,NNEIBJNHWVDJBA-WJQHFXMBSA-N,"InChI=1S/C30H48O10/c1-14(4-9-22(32)33)18-7-8-19-17-6-5-15-12-16(10-11-29(15,2)20(17)13-21(31)30(18,19)3)39-28-25(36)23(34)24(35)26(40-28)27(37)38/h14-21,23-26,28,31,34-36H,4-13H2,1-3H3,(H,32,33)(H,37,38)/t14-,15-,16-,17+,18?,19+,20+,21+,23+,24+,25-,26+,28?,29+,30-/m1/s1"
1877,73934,(S)-2-chloropropanoate,A monocarboxylic acid anion that is the conjugate base of (S)-2-chloropropanoic acid obtained by deprotonation of the carboxy group.,28161,KEGG COMPOUND accession,C02096,,,,,,,,,,,,,,,
1878,73958,methylhypoxanthine,An oxopurine that is hypoxanthine with at least one methyl group substituted on to the ring.,15507,KEGG COMPOUND accession,C02335,,,,,,,,,,,,,,,
1879,74028,"beta-D-Gal-(1->3)-alpha-D-GlcNAc-diphospho-ditrans,octacis-undecaprenol","A polyprenyl phospho oligosaccharide that consists of a beta-D-Gal-(1->3)-alpha-D-GlcNAc moiety linked via a diphospho group to ditrans,octacis-undecaprenol.",17750,KEGG COMPOUND accession,C00719,glyb,107-43-7,17750.0,"Human Metabolome Database (HMDB): Betaine, (or N,N,N-trimethylglycine) was named after its discovery in sugar beet (Beta vulgaris) in the 19th century. It is a small N-trimethylated amino acid, existing in zwitterionic form at neutral pH. It is now often called glycine betaine to distinguish it from other betaines that are widely distributed in microorganisms, plants and animals.  Many naturally occurring betaines serve as organic osmolytes, substances synthesized or taken up from the environment by cells for protection against osmotic stress, drought, high salinity or high temperature. Intracellular accumulation of betaines permits water retention in cells, thus protecting from the effects of dehydration (Wikipedia). Betaine functions as a methyl donor in that it carries and donates methyl functional groups to facilitate necessary chemical processes. In particular it methylates homocysteine to methionine, also producing N,N-dimethylglycine. The donation of methyl groups is important to proper liver function, cellular replication, and detoxification reactions. Betaine also plays a role in the manufacture of carnitine and serves to protect the kidneys from damage. Betaine comes from either the diet or by the oxidation of choline. Betaine insufficiency is associated with the metabolic syndrome, lipid disorders and diabetes, and may have a role in vascular and other diseases (PMID: 20346934). Betaine is found to be associated with propionic acidemia, which is an inborn error of metabolism. Betaine is important in development, from the pre-implantation embryo to infancy. Betaine is also widely regarded as an anti-oxidant.  Betaine has been shown to have an inhibitory effect on NO release in activated microglial cells and may be an effective therapeutic component to control neurological disorders (PMID: 22801281).  As a drug, betaine hydrochloride has been used as a source of hydrochloric acid in the treatment of hypochlorhydria. Betaine has also been used in the treatment of liver disorders, for hyperkalemia, for homocystinuria, and for gastrointestinal disturbances (From Martindale, The Extra Pharmacopoeia, 30th Ed, p1341).",Betaine,HMDB0000043,b,b,C00719,BETAINE,FDB009020,glyb,[H]C([H])([H])[N+](C([H])([H])[H])(C([H])([H])[H])C([H])([H])C([O-])=O,KWIUHFFTVRNATP-UHFFFAOYSA-N,"InChI=1S/C5H11NO2/c1-6(2,3)4-5(7)8/h4H2,1-3H3"
1880,74030,3'-N-debenzoyl-2'-deoxytaxol,A taxane diterpenoid that is 3'-N-debenzoyltaxol which is lacking the 2-hydroxy group.,15710,KEGG COMPOUND accession,C00576,betald,7418-61-3,15710.0,"Human Metabolome Database (HMDB): Betaine aldehyde is an intermediate in the metabolism of glycine, serine and threonine. The human aldehyde dehydrogenase (EC 1.2.1.3) facilitates the conversion of betaine aldehyde to glycine betaine. Betaine aldehyde is a substrate for Choline dehydrogenase (mitochondrial). (PMID: 12467448, 7646513).",Betaine aldehyde,HMDB0001252,b,b,C00576,BETAINE_ALDEHYDE,FDB022513,betald,[H]C(=O)C([H])([H])[N+](C([H])([H])[H])(C([H])([H])[H])C([H])([H])[H],SXKNCCSPZDCRFD-UHFFFAOYSA-N,"InChI=1S/C5H12NO/c1-6(2,3)4-5-7/h5H,4H2,1-3H3/q+1"
1881,74056,His-Ser,A dipeptide formed from L-histidine and L-serine residues.,17033,KEGG COMPOUND accession,C00500,biliverd,114-25-0,17033.0,"Human Metabolome Database (HMDB): Biliverdin is a green pigment formed as a byproduct of hemoglobin breakdown. It consists of four linearly connected pyrrole rings (a tetrapyrrole). Biliverdin is formed when the heme group in hemoglobin is cleaved at its alpha-methene bridge. The resulting biliverdin is then reduced to bilirubin, a yellow pigment, by the enzyme biliverdin reductase. The changing color of a bruise from deep purple to yellow over time is a graphical indicator of this reaction. Biosynthesized from hemoglobin as a precursor of bilirubin. Occurs in the bile of amphibia and of birds, but not in normal human bile or serum.",Biliverdin,HMDB0001008,b,b,C00500,BILIVERDINE,FDB022366,biliverd,[H]OC1=N\C(=C(\[H])C2=N\C(=C(\[H])C3=C(C(=C(N3[H])C(\[H])=C3/N=C(O[H])C(=C3C([H])=C([H])[H])C([H])([H])[H])C([H])([H])[H])C([H])([H])C([H])([H])C([O-])=O)\C(=C2C([H])([H])[H])C([H])([H])C([H])([H])C([O-])=O)C(=C1C([H])=C([H])[H])C([H])([H])[H],QBUVFDKTZJNUPP-BBROENKCSA-L,"InChI=1S/C33H34N4O6/c1-7-20-19(6)32(42)37-27(20)14-25-18(5)23(10-12-31(40)41)29(35-25)15-28-22(9-11-30(38)39)17(4)24(34-28)13-26-16(3)21(8-2)33(43)36-26/h7-8,13-15,35H,1-2,9-12H2,3-6H3,(H,36,43)(H,37,42)(H,38,39)(H,40,41)/p-2/b26-13-,27-14-,28-15-"
1882,74061,Ile-Arg,A dipeptide formed from L-isoleucine and L-arginine residues.,28751,KEGG COMPOUND accession,C05376,,,,,,,,,,,,,,,
1883,74065,Ile-Gln,A dipeptide formed from L-isoleucine and L-glutamine residues.,15373,KEGG COMPOUND accession,C06313,,,,,,,,,,,,,,,
1884,74083,"(9Z,12Z,15Z,18Z,21Z)-tetracosapentaenoyl-CoA(4-)","A polyunsaturated fatty acyl-CoA(4-) obtained by deprotonation of the phosphate and diphosphate OH groups of (9Z,12Z,15Z,18Z,21Z)-tetracosapentaenoyl-CoA; major species at pH 7.3.",17747,KEGG COMPOUND accession,C03690,,,,,,,,,,,,,,,
1885,74101,N-acetylglycine-N-methylamide,An amino acid amide that is methylglycinamide with an acetyl group substituent on the amino group.,17257,KEGG COMPOUND accession,C03646,,,,,,,,,,,,,,,
1886,74115,2-hydroxypalmitoyl-CoA(4-),An acyl-CoA(4-) arising from deprotonation of the phosphate and diphosphate functions of 2-hydroxypalmitoyl-CoA.,15353,KEGG COMPOUND accession,C02010,,,,,,,,,,,,,,,
1887,74129,gamma-thiomethyl glutamate,A glutamic acid derivative with a methylsulfanyl group  at position 4.,28093,KEGG COMPOUND accession,C01411,,,,,,,,,,,,,,,
1888,74133,(15Z)-3-oxotetracosenoyl-CoA,A 3-oxo-fatty acyl-CoA that results from the formal condensation of the thiol group of coenzyme A with the carboxy group of (15Z)-3-oxotetracosenoic acid.,27560,KEGG COMPOUND accession,C06266,,,,,,,,,,,,,,,
1889,74161,C26:1-CoA(4-),An acyl-CoA(4-)in which the acyl moiety contains 26 carbons and 1 double bond. Major species at pH 7.3.,17516,KEGG COMPOUND accession,C04002,,,,,,,,,,,,,,,
1890,74163,dTDP-4-dehydro-6-deoxy-beta-D-gulose,A dTDP-sugar having 4-dehydro-6-deoxy-beta-D-gulose as the sugar component.,28885,KEGG COMPOUND accession,C06142,btoh,71-36-3,28885.0,"Human Metabolome Database (HMDB): 1-Butanol, which is also known as n-butanol or 1-butanol or butyl alcohol (sometimes also called biobutanol when produced biologically), is an alcohol with a 4 carbon structure and the molecular formula of C4H10O. It is primarily used as a solvent, as an intermediate in chemical synthesis, and as a fuel. There are four isomeric structures for butanol. The straight chain isomer with the alcohol at an internal carbon is sec-butanol or 2-butanol. The branched isomer with the alcohol at a terminal carbon is isobutanol, and the branched isomer with the alcohol at the internal carbon is tert-butanol. 1-Butanol is produced in small amounts by gut microbial fermenetation through the butanoate metabolic pathway.",1-Butanol,HMDB0004327,b,b,C06142,BUTANOL,FDB012614,b,b,LRHPLDYGYMQRHN-UHFFFAOYSA-N,b
1891,74167,N-tetracosanoyl-C17-sphingosine,A ceramide that is the N-tetracosanoyl derivative of C17-sphingosine.,15743,KEGG COMPOUND accession,C01412,,,,,,,,,,,,,,,
1892,74177,N-henicosanoyl-15-methylhexadecasphinganine,A N-acyl-15-methylhexadecasphinganine in which the acyl group has 21 carbons and 0 double bonds.,17968,KEGG COMPOUND accession,C00246,but,107-92-6,30772.0,"Human Metabolome Database (HMDB): Butyric acid, a four-carbon fatty acid, is formed in the human colon by bacterial fermentation of carbohydrates (including dietary fiber), and putatively suppresses colorectal cancer (CRC). Butyrate has diverse and apparently paradoxical effects on cellular proliferation, apoptosis and differentiation that may be either pro-neoplastic or anti-neoplastic, depending upon factors such as the level of exposure, availability of other metabolic substrate and the intracellular milieu. In humans, the relationship between luminal butyrate exposure and CRC has been examined only indirectly in case-control studies, by measuring fecal butyrate concentrations, although this may not accurately reflect effective butyrate exposure during carcinogenesis. Perhaps not surprisingly, results of these investigations have been mutually contradictory. The direct effect of butyrate on tumorigenesis has been assessed in a no. of in vivo animal models, which have also yielded conflicting results. In part, this may be explained by methodology: differences in the amount and route of butyrate administration, which are likely to significantly influence delivery of butyrate to the distal colon. (PMID: 16460475) Butyric acid is a carboxylic acid found in rancid butter, parmesan cheese, and vomit, and has an unpleasant odor and acrid taste, with a sweetish aftertaste (similar to ether). Butyric acid is a fatty acid occurring in the form of esters in animal fats and plant oils. Interestingly, low-molecular-weight esters of butyric acid, such as methyl butyrate, have mostly pleasant aromas or tastes. As a consequence, they find use as food and perfume additives. Butyrate is produced as end-product of a fermentation process solely performed by obligate anaerobic bacteria.",Butyric acid,HMDB0000039,b,b,C00246,b,FDB012062,but,[H]C([H])([H])C([H])([H])C([H])([H])C([O-])=O,FERIUCNNQQJTOY-UHFFFAOYSA-M,"InChI=1S/C4H8O2/c1-2-3-4(5)6/h2-3H2,1H3,(H,5,6)/p-1"
1893,74185,N-tetracosenoyl-C17-sphingosine,"A ceramide in which the N-acyl moiety contains 24 carbons and 1 double bond, with the sphingoid base specified as C17-sphingosine.",17260,KEGG COMPOUND accession,C02527,butpi,b,b,b,Butanoyl phosphate,b,b,b,C02527,b,b,b,b,b,b
1894,74220,C17 sphingosine,A sphingoid that is the C17 analogue of sphingosine.,22977,KEGG COMPOUND accession,C01413,,,,,,,,,,,,,,,
1895,74224,genistein(1-),"An organic anion that is the conjugate base of genistein, obtained by selective deprotonation of the 7-hydroxy group.",17395,KEGG COMPOUND accession,C01481,,,,,,,,,,,,,,,
1896,74231,phosphatidylinositol 32:0(1-),A 1-phosphatidyl-1D-myo-inositol(1-) in which the acyl groups at C-1 and C-2 contain 32 carbons in total and 0 double bonds.,15518,KEGG COMPOUND accession,C00323,,,,,,,,,,,,,,,
1897,74234,"EC 1.1.1.153 [sepiapterin reductase (L-erythro-7,8-dihydrobiopterin forming)] inhibitor","An EC 1.1.1.* (oxidoreductase acting on donor CH-OH group, NAD(+) or NADP(+) acceptor) inhibitor that interferes with the activity of sepiapterin reductase (L-erythro-7,8-dihydrobiopterin forming), EC 1.1.1.153, which plays an important part in the biosynthesis of tetrahydrobiopterin.",22984,KEGG COMPOUND accession,C00076,ca2,7440-70-2,29108.0,"Human Metabolome Database (HMDB): Calcium is essential for the normal growth and maintenance of bones and teeth, and calcium requirements must be met throughout life. Requirements are greatest during periods of growth, such as childhood, during pregnancy and when breast-feeding. Long-term calcium deficiency can lead to osteoporosis, in which the bone deteriorates and there is an increased risk of fractures. Adults need between 1,000 and 1,300 mg of calcium in their daily diet. Calcium is essential for living organisms, particularly in cell physiology, and is the most common metal in many animals. Physiologically, it exists as an ion in the body. Calcium combines with phosphorus to form calcium phosphate in the bones and teeth. It is essential for the normal functioning of nerves and muscles and plays a role in blood coagulation (as factor IV) and in many enzymatic processes. Calcium is an important component of a healthy diet. A deficit can affect bone and tooth formation, while overretention can cause kidney stones. Vitamin D is needed to absorb calcium. Dairy products, such as milk and cheese, are a well-known source of calcium. However, some individuals are allergic to dairy products and even more people, particularly those of non-European descent, are lactose-intolerant, leaving them unable to consume dairy products. Fortunately, many other good sources of calcium exist. These include: seaweeds such as kelp, wakame and hijiki; nuts and seeds (like almonds and sesame); beans; amaranth; collard greens; okra; rutabaga; broccoli; kale; and fortified products such as orange juice and soy milk. Calcium has also been found to assist in the production of lymphatic fluids. Furthermore, calcium is found to be associated with primary hypomagnesemia, which is an inborn error of metabolism.",Calcium,HMDB0000464,b,b,C00076,CA%2b2,FDB003513,ca2,[Ca++],BHPQYMZQTOCNFJ-UHFFFAOYSA-N,InChI=1S/Ca/q+2
1898,74269,guanosine 5'-monophosphate(1-) residue,An organic anionic group obtained by deprotonation of the phosphate OH group of GMP residue.,17672,KEGG COMPOUND accession,C00169,cbp,590-55-6,17672.0,"Human Metabolome Database (HMDB): Carbamoyl phosphate is a precursor of both arginine and pyrimidine biosynthesis. It is a labile and potentially toxic intermediate. Carbamoyl phosphate is a molecule that is involved in ridding the body of excess nitrogen in the urea cycle, and also in the synthesis of pyrimidines. It is produced from carbon dioxide, ammonia, and phosphate (from ATP) by the enzyme carbamoyl phosphate synthase. -- Wikipedia.",Carbamoyl phosphate,HMDB0001096,b,b,C00169,CARBAMOYL-P,FDB022424,cbp,[H]N([H])C(=O)OP([O-])([O-])=O,FFQKYPRQEYGKAF-UHFFFAOYSA-L,"InChI=1S/CH4NO5P/c2-1(3)7-8(4,5)6/h(H2,2,3)(H2,4,5,6)/p-2"
1899,74278,(R)-3-hydroxypalmitoyl-CoA(4-),A 3-hydroxy fatty acyl-CoA(4-) obtained by deprotonation of the phosphate and diphosphate OH groups of (R)-3-hydroxypalmitoyl-CoA.,27594,KEGG COMPOUND accession,C06265,,,,,,,,,,,,,,,
1900,74288,"(17Z,20Z,23Z,26Z)-3-oxodotriacontatetraenoyl-CoA(4-)","A 3-oxo-fatty acyl-CoA(4-) arising from deprotonation of the phosphate and diphosphate functions of (17Z,20Z,23Z,26Z)-3-oxodotriacontatetraenoyl-CoA.",17245,KEGG COMPOUND accession,C00237,co,630-08-0,17245.0,"Human Metabolome Database (HMDB): Carbon monoxide, with the chemical formula CO, is a colorless, odorless, and tasteless gas. It is the product of the incomplete combustion of carbon-containing compounds, notably in internal-combustion engines. It consists of one carbon atom covalently bonded to one oxygen atom. It is a gas at room temperature. Carbon monoxide is a significantly toxic gas and is the most common type of fatal poisoning in many countries. Exposures can lead to significant toxicity of the central nervous system and heart. Carbon monoxide has a higher diffusion coefficient compared to oxygen and the only enzyme in the human body that produces carbon monoxide is heme oxygenase which is located in all cells and breaks down heme. Because it has a higher diffusion coefficient than oxygen the body easily gets rid of any CO made. When CO is not ventilated it binds to hemoglobin, which is the principal oxygen-carrying compound in blood; this produces a compound known as carboxyhemoglobin. The traditional belief is that carbon monoxide toxicity arises from the formation of carboxyhemoglobin, which decreases the oxygen-carrying capacity of the blood and inhibits the transport, delivery, and utilization of oxygen by the body. The affinity between hemoglobin and carbon monoxide is approximately 230 times stronger than the affinity between hemoglobin and oxygen so hemoglobin binds to carbon monoxide in preference to oxygen. Following poisoning, long-term sequelae often occur. Carbon monoxide can also have severe effects on the fetus of a pregnant woman. Despite its serious toxicity, CO is extremely useful and underpins much modern technology, being a precursor to a myriad of useful - even life-saving - products. Carbon monoxide, though thought of as a pollutant today, has always been present in the atmosphere, chiefly as a product of volcanic activity. It occurs dissolved in molten volcanic rock at high pressures in the earth's mantle. Carbon monoxide contents of volcanic gases vary from less than 0.01% to as much as 2% depending on the volcano. It also occurs naturally in bushfires. Because natural sources of carbon monoxide are so variable from year to year, it is extremely difficult to accurately measure natural emissions of the gas. (wikipedia).",Carbon monoxide,HMDB0001361,b,b,C00237,b,FDB022578,co,[C-]#[O+],UGFAIRIUMAVXCW-UHFFFAOYSA-N,InChI=1S/CO/c1-2
1901,74317,"(14Z,17Z,20Z,23Z,26Z,29Z)-dotriacontahexaenoyl-CoA(4-)","An acyl-CoA(4-) arising from deprotonation of the phosphate and diphosphate functions of (14Z,17Z,20Z,23Z,26Z,29Z)-dotriacontahexaenoyl-CoA.",17040,KEGG COMPOUND accession,C03600,,,,,,,,,,,,,,,
1902,74326,Ile-Tyr,A dipeptide formed from L-isoleucine and L-tyrosine residues.,17126,KEGG COMPOUND accession,C00487,,,,,,,,,,,,,,,
1903,74353,aclacinomycin A(1+),"An anthracycline cation that is the conjugate acid of aclacinomycin A, obtained by protonation of the tertiary amino group.",18135,KEGG COMPOUND accession,C00090,catechol,120-80-9,18135.0,"Human Metabolome Database (HMDB): Pyrocatechol, often known as catechol or benzene-1,2-diol, is a benzenediol, with formula C6H4(OH)2. It was first prepared in 1839 by H. Reinsch by distilling catechin (the juice of Mimosa catechu). This colourless compound occurs naturally, but about 20000 tons are manufactured each year, mainly as precursors to pesticides, flavors, and fragrances. Its sulfonic acid is often present in the urine of many mammals. Small amounts of catechol occur naturally in fruits and vegetables, along with the enzyme polyphenol oxidase. Upon mixing the enzyme with the substrate and exposure to oxygen (as when a potato or apple is cut), the colorless catechol oxidizes to reddish-brown benzoquinone derivatives. The enzyme is inactivated by adding an acid, such as lemon juice, or by refrigeration. Excluding oxygen also prevents the browning reaction. Catechol melts at 28 oC and boils at 250 oC. It is employed in medicine as an expectorant. The dimethyl ether or veratrol is also used in medicine. Many other pyrocatechin derivatives have been suggested for therapeutic application.",Pyrocatechol,HMDB0000957,b,b,C00090,CATECHOL,FDB001512,b,b,YCIMNLLNPGFGHC-UHFFFAOYSA-N,"InChI=1S/C6H6O2/c7-5-3-1-2-4-6(5)8/h1-4,7-8H"
1904,74363,Ala-Asp(1-),A peptide anion obtained by protonation of the amino group and deprotonation of the two carboxy groups of Ala-Asp.,17863,KEGG COMPOUND accession,C01093,,,,,,,,,,,,,,,
1905,74430,N-decanoylglycine,An N-acylglycine with an acyl group that is decanoyl.,16525,KEGG COMPOUND accession,C05465,tdchola,516-35-8,16525.0,"Human Metabolome Database (HMDB): Taurochenodesoxycholic acid is a bile acid formed in the liver by conjugation of chenodeoxycholate with taurine, usually as the sodium salt. Bile acids are steroid acids found predominantly in bile of mammals. The distinction between different bile acids is minute, depends only on presence or absence of hydroxyl groups on positions 3, 7, and 12. Bile acids are physiological detergents that facilitate excretion, absorption, and transport of fats and sterols in the intestine and liver. Bile acids are also steroidal amphipathic molecules derived from the catabolism of cholesterol. They modulate bile flow and lipid secretion, are essential for the absorption of dietary fats and vitamins, and have been implicated in the regulation of all the key enzymes involved in cholesterol homeostasis. Bile acids recirculate through the liver, bile ducts, small intestine and portal vein to form an enterohepatic circuit. They exist as anions at physiological pH and, consequently, require a carrier for transport across the membranes of the enterohepatic tissues. The unique detergent properties of bile acids are essential for the digestion and intestinal absorption of hydrophobic nutrients. Bile acids have potent toxic properties (e.g., membrane disruption) and there are a plethora of mechanisms to limit their accumulation in blood and tissues. (PMID: 11316487, 16037564, 12576301, 11907135).",Taurochenodesoxycholic acid,HMDB0000951,b,b,C05465,CHENODEOXYCHOLOYLTAURINE,FDB022335,tdchola,[H]O[C@]1([H])C([H])([H])C([H])([H])[C@@]2(C([H])([H])[H])C([H])(C1([H])[H])C([H])([H])[C@@]([H])(O[H])C1([H])C3([H])C([H])([H])C([H])([H])C([H])([C@]([H])(C([H])([H])[H])C([H])([H])C([H])([H])C(=O)N([H])C([H])([H])C([H])([H])S(=O)(=O)O[H])[C@@]3(C([H])([H])[H])C([H])([H])C([H])([H])C21[H],BHTRKEVKTKCXOH-QPRHXUMOSA-N,"InChI=1S/C26H45NO6S/c1-16(4-7-23(30)27-12-13-34(31,32)33)19-5-6-20-24-21(9-11-26(19,20)3)25(2)10-8-18(28)14-17(25)15-22(24)29/h16-22,24,28-29H,4-15H2,1-3H3,(H,27,30)(H,31,32,33)/t16-,17?,18-,19?,20?,21?,22-,24?,25+,26-/m1/s1"
1906,74436,"(21Z,24Z,27Z,30Z,33Z)-hexatriacontapentaenoyl-CoA","An unsaturated fatty acyl-CoA that results from the formal condensation of the thiol group of coenzyme A with the carboxy group of (21Z,24Z,27Z,30Z,33Z)-hexatriacontapentaenoic acid.",17029,KEGG COMPOUND accession,C00461,M01436,1398-61-4,17029.0,"Human Metabolome Database (HMDB): Chitin is one of the main components in the cell walls of fungi, the exoskeletons of insects and other arthropods (such as crustaceans) as well as fish and frogs. It is a polysaccharide that is constructed from units of acetylglucosamine (more completely, N-acetyl-D-glucose-2-amine). These are linked together in beta-1,4 fashion (in a similar manner to the glucose units which form cellulose). In effect, chitin may be described as cellulose with one hydroxyl group on each monomer replaced by an acetylamine group. This allows for increased hydrogen bonding between adjacent polymers, giving the polymer increased strength. Chitin is the second most abundant polysaccharide in the world (after cellulose). Chitinases break down chitin and are a part of the defence mechanism of mammals against chitin-containing parasites in lower life forms. Under certain circumstances, chitin can act as an allergen. Research using murine models has shown that chitin is a size-dependent microbial-associated molecular pattern (MAMP) that can induce an immunological response via pattern recognition receptors. Medium-sized chitin micro-particles (CMPs) have been shown to induce inflammation, while small-sized CMPs reduce inflammation. Additionally, mammalian chitinases may play a key role in mediating the T-helper 2 cell-driven inflammatory response that is commonly associated with asthma. The high prevalence of asthma among people working with chitinous substances, such as crabs and fungi, suggests that chitin might be an allergen playing a significant role in the development of asthma.",Chitin,HMDB0003362,b,b,C00461,14-N-ACETYL-BETA-D-GLUCOSAMINYLN1,FDB023154,b,[H]OC([H])([H])[C@@]1([H])O[C@@]([H])(-*)[C@]([H])(N([H])C(=O)C([H])([H])[H])[C@@]([H])(O[H])[C@]1([H])O-*,DJHJJVWPFGHIPH-OODMECLYSA-N,b
1907,74436,"(21Z,24Z,27Z,30Z,33Z)-hexatriacontapentaenoyl-CoA","An unsaturated fatty acyl-CoA that results from the formal condensation of the thiol group of coenzyme A with the carboxy group of (21Z,24Z,27Z,30Z,33Z)-hexatriacontapentaenoic acid.",17029,KEGG COMPOUND accession,C00461,M01437,b,17029.0,b,Chitin,b,b,b,C00461,b,b,b,[H]OC([H])([H])[C@@]1([H])O[C@@]([H])(O[C@@]2([H])[C@]([H])(O[H])[C@@]([H])(N([H])C(=O)C([H])([H])[H])[C@]([H])(O[C@@]3([H])[C@]([H])(O[H])[C@@]([H])(N([H])C(=O)C([H])([H])[H])[C@]([H])(O[H])O[C@]3([H])C([H])([H])O[H])O[C@]2([H])C([H])([H])O[H])[C@]([H])(N([H])C(=O)C([H])([H])[H])[C@@]([H])(O[H])[C@]1([H])O[H],WZZVUHWLNMNWLW-VFCSDQTKSA-N,"InChI=1S/C24H41N3O16/c1-7(31)25-13-18(36)20(11(5-29)39-22(13)38)42-24-15(27-9(3)33)19(37)21(12(6-30)41-24)43-23-14(26-8(2)32)17(35)16(34)10(4-28)40-23/h10-24,28-30,34-38H,4-6H2,1-3H3,(H,25,31)(H,26,32)(H,27,33)/t10-,11-,12-,13-,14-,15-,16-,17-,18-,19-,20-,21-,22-,23+,24+/m1/s1"
1908,74453,senegasaponin a,A triterpenoid saponin isolated from Polygala senega var latifolia and has been shown to exhibit hypoglycemic activity.,16730,KEGG COMPOUND accession,C03601,,,,,,,,,,,,,,,
1909,74494,pyrimidine 5'-deoxyribonucleoside,A pyrimidine deoxyribonucleoside that is a pyrimidine ribonucleoside in which the hydroxy group at the 5' position is replaced by a hydrogen.,28097,KEGG COMPOUND accession,C06990,,,,,,,,,,,,,,,
1910,74514,6-aminonicotinamide,"A  monocarboxylic acid amide resulting from the formal condensation of the carboxy group of 6-aminonicotinic acid with ammonia. An inhibitor of the NADP(+)-dependent enzyme, 6-phosphogluconate dehydrogenase, it interferes with glycolysis, resulting in ATP depletion and synergizes with DNA-crosslinking chemotherapy drugs, such as cisplatin, in killing cancer cells.",16112,KEGG COMPOUND accession,C00852,,,,,,,,,,,,,,,
1911,74554,1-heptadecanoyl-sn-glycero-3-phosphate(2-),A 1-acyl-sn-glycerol 3-phosphate(2-) obtained by deprotonation of the phosphate OH groups of 1-heptadecanoyl-sn-glycero-3-phosphate.,28940,KEGG COMPOUND accession,C05443,vitd3,67-97-0,283119.0,"Human Metabolome Database (HMDB): Vitamin D3 is a steroid hormone that has long been known for its important role in regulating body levels of calcium and phosphorus, in mineralization of bone, and for the assimilation of Vitamin A. It is structurally similar to steroids such as testosterone, cholesterol, and cortisol (though vitamin D3 itself is a secosteroid).",Vitamin D3,HMDB0000876,b,b,C05443,VITAMIN_D_%7B3%7D,FDB012732,vitd3,[H]O[C@]1([H])C([H])([H])\C(=C(/[H])C([H])=C2C([H])([H])C([H])([H])C([H])([H])[C@@]3(C([H])([H])[H])[C@@]2([H])C([H])([H])C([H])([H])[C@]3([H])[C@]([H])(C([H])([H])[H])C([H])([H])C([H])([H])C([H])([H])C([H])(C([H])([H])[H])C([H])([H])[H])C(=C([H])[H])C([H])([H])C1([H])[H],QYSXJUFSXHHAJI-YRZJJWOYSA-N,"InChI=1S/C27H44O/c1-19(2)8-6-9-21(4)25-15-16-26-22(10-7-17-27(25,26)5)12-13-23-18-24(28)14-11-20(23)3/h12-13,19,21,24-26,28H,3,6-11,14-18H2,1-2,4-5H3/b22-12+,23-13-/t21-,24+,25-,26+,27-/m1/s1"
1912,74557,Lys-Glu,A dipeptide formed from L-lysine and L-glutamic acid residues.,16175,KEGG COMPOUND accession,C00599,,,,,,,,,,,,,,,
1913,74615,Ins-1-P-Cer B/B' 44:0(1-),"An Ins-1-P-Cer B/B'(1-) in which the acyl group and the ceramide base contain a total of 44 carbons and 0 double bonds, and in which either the acyl group is hydroxylated at position 2 or the ceramide base is hydroxylated at position 4.",15354,KEGG COMPOUND accession,C00114,chol,62-49-7,15354.0,"Human Metabolome Database (HMDB): Choline is a basic constituent of lecithin that is found in many plants and animal organs. It is important as a precursor of acetylcholine, as a methyl donor in various metabolic processes, and in lipid metabolism. Choline is now considered to be an essential vitamin. While humans can synthesize small amounts (by converting phosphatidylethanolamine to phosphatidylcholine), it must be consumed in the diet to maintain health. Required levels are between 425 mg/day (female) and 550 mg/day (male). Milk, eggs, liver and peanuts are especially rich in choline. Most choline is found in phospholipids, namely phosphatidylcholine or lecithin. Choline can be oxidized to form betaine, which is a methyl source for many reactions (i.e. conversion of homocysteine e to methionine). Lack of sufficient amounts of choline in the diet can lead to a fatty liver condition and general liver damage. This arises from the lack of VLDL, which is necessary to transport fats away from the liver. Choline deficiency also leads to elevated serum levels of alanine amino transferase and is associated with increased incidence of liver cancer.",Choline,HMDB0000097,b,b,C00114,CPD-563,FDB000710,chol,[H]OC([H])([H])C([H])([H])[N+](C([H])([H])[H])(C([H])([H])[H])C([H])([H])[H],OEYIOHPDSNJKLS-UHFFFAOYSA-N,"InChI=1S/C5H14NO/c1-6(2,3)4-5-7/h7H,4-5H2,1-3H3/q+1"
1914,74620,15-demethylaclacinomycin T,An anthracycline obtained by hydrolysis of the methyl ester group of aclacinomycin T.,18132,KEGG COMPOUND accession,C00588,cholp,b,18132.0,"Human Metabolome Database (HMDB): Phosphorylcholine is a small haptenic molecule, is found in a wide variety of organisms. Human hepatic tumors undergo an elevation in the concentration of phosphorylcholine as the principal metabolic change is observed (PMID: 11076016). Phosphorylcholine is the precursor metabolite of choline in the glycine, serine and threonine metabolism pathways (KEGG, map00260) and in intermediate between choline and cytidine-diphosphate choline in the glycerophospholipid metabolism pathway (KEGG, map00564).",Phosphorylcholine,HMDB0001565,b,b,C00588,PHOSPHORYL-CHOLINE,FDB022692,cholp,[H]C([H])([H])[N+](C([H])([H])[H])(C([H])([H])[H])C([H])([H])C([H])([H])OP([O-])([O-])=O,YHHSONZFOIEMCP-UHFFFAOYSA-M,"InChI=1S/C5H14NO4P/c1-6(2,3)4-5-10-11(7,8)9/h4-5H2,1-3H3,(H-,7,8,9)/p-1"
1915,74622,15-oxo-beta-bilirubin,A biladiene that is the 15-oxo derivative of beta-bilirubin.,16822,KEGG COMPOUND accession,C00919,,,,,,,,,,,,,,,
1916,74658,"N(2),N(2),N(7)-trimethylguanosine 5'-triphosphate group","An organic cationic group derived from N(2),N(2),N(7)-trimethylguanosine 5'-triphosphate.",28073,KEGG COMPOUND accession,C06268,,,,,,,,,,,,,,,
1917,74700,Met-beta-Ala,A dipeptide formed from L-methionine and beta-alanine residues.,18301,KEGG COMPOUND accession,C06603,,,,,,,,,,,,,,,
1918,74754,Pro-Asn,A dipeptide formed from L-proline and L-asparagine residues.,16211,KEGG COMPOUND accession,C04706,,,,,,,,,,,,,,,
1919,74801,Ser-Ala,A dipeptide formed from L-serine and L-alanine residues.,18242,KEGG COMPOUND accession,C06579,,,,,,,,,,,,,,,
1920,74810,delphinidin 3-O-beta-D-sambubioside,An anthocyanidin 3-O-beta-D-sambubioside having delphinidin as the anthocyanidin component.,16383,KEGG COMPOUND accession,C00417,HC00342,585-84-2,32805.0,Human Metabolome Database (HMDB): cis-Aconitic acid is an intermediate in the tricarboxylic acid cycle produced by the dehydration of citric acid. The enzyme aconitase (aconitate hydratase; EC 4.2.1.3) catalyses the stereo-specific isomerization of citrate to isocitrate via cis-aconitate in the tricarboxylic acid cycle.,cis-Aconitic acid,HMDB0000072,b,b,C00417,CIS-ACONITATE,FDB008306,HC00342,[H]\C(C([O-])=O)=C(\C([O-])=O)C([H])([H])C([O-])=O,GTZCVFVGUGFEME-IWQZZHSRSA-K,"InChI=1S/C6H6O6/c7-4(8)1-3(6(11)12)2-5(9)10/h1H,2H2,(H,7,8)(H,9,10)(H,11,12)/p-3/b3-1-"
1921,74834,12-aminolauroyl tripalmitoyl cardiolipin diammonium salt,The ammonium salt formed from association of two ammonium cations with the dianion of 12-aminolauroyl tripalmitoyl cardiolipin.,16947,KEGG COMPOUND accession,C00158,cit,77-92-9,30769.0,"Human Metabolome Database (HMDB): Citric acid (citrate) is a weak acid that is formed in the tricarboxylic acid cycle or that may be introduced with diet. The evaluation of plasma citric acid is scarcely used in the diagnosis of human diseases. On the contrary urinary citrate excretion is a common tool in the differential diagnosis of kidney stones, renal tubular acidosis and it plays also a role in bone diseases. The importance of hypocitraturia should be considered with regard to bone mass, urine crystallization and urolithiasis. (PMID 12957820) The secretory epithelial cells of the prostate gland of humans and other animals posses a unique citrate-related metabolic pathway regulated by testosterone and prolactin. This specialized hormone-regulated metabolic activity is responsible for the major prostate function of the production and secretion of extraordinarily high levels of citrate. The key regulatory enzymes directly associated with citrate production in the prostate cells are mitochondrial aspartate aminotransferase, pyruvate dehydrogenase, and mitochondrial aconitase. testosterone and prolactin are involved in the regulation of the corresponding genes associated with these enzymes. The regulatory regions of these genes contain the necessary response elements that confer the ability of both hormones to control gene transcription. Protein kinase C (PKC) is the signaling pathway for the prolactin regulation of the metabolic genes in prostate cells. testosterone and prolactin regulation of these metabolic genes (which are constitutively expressed in all mammalian cells is specific for these citrate-producing cells (PMID 12198595). Citric acid is found in citrus fruits, most concentrated in lemons and limes, where it can comprise as much as 8% of the dry weight of the fruit. Citric acid is a natural preservative and is also used to add an acidic (sour) taste to foods and soft drinks. The salts of citric acid (citrates) can be used as anticoagulants due to their calcium chelating ability. Intolerance to citric acid in the diet is known to exist. Little information is available as the condition appears to be rare, but like other types of food intolerance it is often described as a ""pseudo-allergic"" reaction. Moreover, citric acid is found to be associated with maple syrup urine disease, primary hypomagnesemia, propionic acidemia, and tyrosinemia I, which are inborn errors of metabolism.",Citric acid,HMDB0000094,b,b,C00158,CIT,FDB012586,cit,[H]OC(C([O-])=O)(C([H])([H])C([O-])=O)C([H])([H])C([O-])=O,KRKNYBCHXYNGOX-UHFFFAOYSA-K,"InChI=1S/C6H8O7/c7-3(8)1-6(13,5(11)12)2-4(9)10/h13H,1-2H2,(H,7,8)(H,9,10)(H,11,12)/p-3"
1922,74849,1-oleoyl-2-linoleoyl-sn-glycero-3-phosphate,"A 1,2-diacyl-sn-glycerol 3-phosphate in which the acyl substituents at positions 1 and 2 are specified as oleoyl and linoleoyl respectively.",16304,KEGG COMPOUND accession,C00541,cbl2,14463-33-3,16304.0,Human Metabolome Database (HMDB): Cob(II)alamin is the product of the reduction catalyzed by microsomal cob(III)alamin reductase (PMID: 8507652). It binds to human methionine synthase (PMID: 1744096).,Cob(II)alamin,HMDB0006316,b,b,C00541,CPD-1829,FDB023883,cbl2,Cc1cc2c(cc1C)[n+](c[nH]2)[C@@H]1[C@@H]([C@@H]([C@@H](CO)O1)OP(=O)(O)O[C@H](C)CN=C(CC[C@]1(C)[C@@H](CC(=N)O)[C@@H]2[C@@]3(C)[C@@](C)(CC(=N)O)[C@H](CCC(=N)[O-])C(=C(C)C4=NC(=CC5=NC(=C(C)C1=N2)[C@@H](CCC(=N)[O-])C5(C)C)[C@@H](CCC(=N)[O-])[C@]4(C)CC(=N)O)N3)O)O.[Co+2],ASARMUCNOOHMLO-DSRCUDDDSA-L,"InChI=1S/C62H90N13O14P.Co/c1-29-20-39-40(21-30(29)2)75(28-70-39)57-52(84)53(41(27-76)87-57)89-90(85,86)88-31(3)26-69-49(83)18-19-59(8)37(22-46(66)80)56-62(11)61(10,25-48(68)82)36(14-17-45(65)79)51(74-62)33(5)55-60(9,24-47(67)81)34(12-15-43(63)77)38(71-55)23-42-58(6,7)35(13-16-44(64)78)50(72-42)32(4)54(59)73-56;/h20-21,23,28,31,34-37,41,52-53,56-57,76,84H,12-19,22,24-27H2,1-11H3,(H15,63,64,65,66,67,68,69,71,72,73,74,77,78,79,80,81,82,83,85,86);/q;+2/p-2/t31-,34-,35-,36-,37+,41-,52-,53-,56-,57+,59-,60+,61+,62+;/m1./s1"
1923,74858,GCB,"An organic disulfide that is L-685,458 in which the C-terminal amide group is coupled to a biotin moiety via a long linker containing the disulfide group.",27638,KEGG COMPOUND accession,C00175,cobalt2,b,48828.0,"Human Metabolome Database (HMDB): Cobalt has a molecular weight of 58.9 and an atomic number of 27. In the Periodic Table, close to other transition metals, it is situated in group 8, together with rhodium and iridium and it can occur in four oxidation states (0, +2, +3 and +4). The +2 and the ground state are the most common. Cobalt occurs in the minerals cobaltite (Co, Fe) AsS, smaltite (CoAs2), and erythrite Co3(AsO4)2.8H2O, and is often associated with nickel, silver, lead, copper, and iron ores, from which it is most frequently obtained as a by-product. Depending on the considered species, cobalt has multiple industrial applications including the production of alloys and hard metal, diamond polishing, drying agents, pigments and catalysts. Hard metal or cemented carbide is a powder metallurgical product consisting of hard, wear-resistant carbide particles bound together (cemented) with a ductile metal binder (i.e. metallic Co) by liquid phase sintering. Tungsten carbide (WC) is produced by mixing tungsten powder with pure carbon powder at high temperature; hereafter WC is mixed with Co powder to which paraffin is added as a binder. Depending on specific requirements related to their use, hard metals might additionally contain small quantities of chromium, niobium, molybdenum, titanium, tantalum or vanadium carbides. Inhalation and skin contact are the main occupational exposure routes. Occupational exposure to cobalt may result in adverse health effects in different organs or tissues, including the respiratory tract, the skin, the hemapoietic tissues, the myocardium or the thyroid gland. In addition, teratogenic and carcinogenic effects have been observed in experimental systems and/or in humans. For the general population, the diet constitutes the main route of exposure to cobalt, since it is an essential component of Vitamin B12 (hydroxycolalamin). Cobalt functions as a co-factor in enzyme catalysed reactions and is involved in the production of erythropoietin, a hormone that stimulates the formation of erythrocytes. This last property of cobalt was applied in the past as a therapy for anaemia. The carcinogenic potential of cobalt and its compounds was evaluated in 1991 by the International Agency for Research on Cancer (IARC), which concluded that there was inadequate evidence for carcinogenicity in humans (lung cancer) but sufficient evidence in experimental animal studies. In most experimental studies considered, the routes of exposure were, however, of questionable relevance for cancer risk assessment in humans for example, local sarcomas after intra-muscular injection. The general conclusion was that cobalt and its compounds are possibly carcinogenic to humans (group 2B). Since this evaluation, additional data have been accumulated which generally indicate that, depending on the considered cobalt species, different outcomes regarding toxicity, mutagenicity and carcinogenicity can be observed. Physiologically, it exists as an ion in the body. Co(II) ions are genotoxic in vitro and in vivo, and carcinogenic in rodents. Co metal is genotoxic in vitro. Hard metal dust, of which occupational exposure is linked to an increased lung cancer risk, is proven to be genotoxic in vitro and in vivo. Possibly, production of active oxygen species and/or DNA repair inhibition are mechanisms involved. Given the recently provided proof for in vitro and in vivo genotoxic potential of hard metal dust, the mechanistic evidence of elevated production of active oxygen species and the epidemiological data on increased cancer risk, it may be advisable to consider the possibility of a new evaluation by IARC.(PMID: 14643417).",Cobalt,HMDB0000608,b,b,C00175,COBALT-FACTOR-III,FDB003581,b,b,b,b
1924,74883,Tyr-Glu,A dipeptide formed from L-tyrosine and L-glutamic acid residues.,18399,KEGG COMPOUND accession,C06171,,,,,,,,,,,,,,,
1925,74889,1-dodecylguanidine acetate,"An acetate salt resulting from the reaction of equimolar amounts of 1-dodecylguanidine and acetic acid. It is used as a fungicide to control black spot and foliar diseases on apples, pears, peaches, nectarines and strawberries.",28265,KEGG COMPOUND accession,C05777,,,,,,,,,,,,,,,
1926,74909,1-oleoyl-2-palmitoyl-sn-glycero-3-phospho-L-serine(1-),"A phosphatidylserine 34:1 that is the conjugate base of 1-oleoyl-2-palmitoyl-sn-glycero-3-phospho-L-serine, in which the carboxy and phosphate groups are anionic and the amino group is cationic.",15920,KEGG COMPOUND accession,C01795,,,,,,,,,,,,,,,
1927,74920,1-acyl-2-linoleoyl-sn-glycero-3-phosphate(2-),"A 1,2-diacyl-sn-glycerol 3-phosphate(2-) obtained by deprotonation of the phosphate OH groups of any 1-acyl-2-linoleoyl-sn-glycero-3-phosphate.",16220,KEGG COMPOUND accession,C00761,,,,,,,,,,,,,,,
1928,74926,patulin,"A furopyran and lactone that is (2H-pyran-3(6H)-ylidene)acetic acid which is substituted by hydroxy groups at positions 2 and 4 and in which the hydroxy group at position 4 has condensed with the carboxy group to give the corresponding bicyclic lactone. A mycotoxin produced by several species of Aspergillus and Penicillium, it has antibiotic properties but has been shown to be carcinogenic and mutagenic.",16547,KEGG COMPOUND accession,C02666,,,,,,,,,,,,,,,
1929,74934,tetracenomycin D3(1-),"A hydroxy monocarboxylic acid anion that is the conjugate base of tetracenomycin F1, obtained by deprotonation of the carboxy group.",23375,KEGG COMPOUND accession,C06089,,,,,,,,,,,,,,,
1930,74945,"1,5-bis(diphospho)-1D-myo-inositol 2,3,4,6-tetrakisphosphate(14-)","An inositol phosphate oxoanion obtained by global deprotonation of the phosphate and diphosphate OH groups of 1,5-bis(diphospho)-1D-myo-inositol 2,3,4,6-tetrakisphosphate.",28421,KEGG COMPOUND accession,C05769,C05769,531-14-6,28421.0,"Human Metabolome Database (HMDB): Coproporphyrin I is a porphyrin metabolite arising from heme synthesis. Porphyrins are pigments found in both animal and plant life. Coproporphyrin I is a tetrapyrrole dead-end product from the spontaneous oxidation of the methylene bridges of coproporphynogen, arising from heme synthesis and secreted in feces and urine. Increased levels of coproporphyrins can indicate congenital erythropoietic porphyria or sideroblastic anaemia. Porphyria is a pathological state characterised by abnormalities of porphyrin metabolism and results in the excretion of large quantities of porphyrins in the urine and in extreme sensitivity to light. A large number of factors are capable of increasing porphyrin excretion, owing to different and multiple causes and etiologies: 1) the main site of the chronic hepatic porphyria disease process concentrates on the liver, 2) a functional and morphologic liver injury is almost regularly associated with this chronic porphyria, 3) the toxic form due to occupational and environmental exposure takes mainly a subclinical course. Hepatic factors includes disturbance in coproporphyrinogen metabolism, which results from inhibition of coproporphyrinogen oxidase as well as from the rapid loss from, and diminished utilization of coproporphyrinogen in the hepatocytes, which may also explain why coproporphyrin, its autoxidation product, predominates physiologically in the urine; decreased biliary excretion of coproporphyrin leading to a compensatory urinary excretion, so that the coproporphyrin ring isomer ratio (1:III) becomes a sensitive index for impaired liver function and intrahepatic cholestasis; and disturbed activity of hepatic uroporphyrinogen decarboxylase. In itself, secondary coproporphyrinuria is not associated with porphyria symptoms of a hepatologic-gastroenterologic, neurologic, or dermatologic order, even though coproporphyrinuria can occur with such symptoms. (PMID: 3327428).",Coproporphyrin I,HMDB0000643,b,b,C05769,b,FDB022159,C05769,[H]N1\C2=C([H])/C3=N/C(=C([H])\C4=C(C(=C(N4[H])\C([H])=C4/N=C(/C(/[H])=C1/C(=C2C([H])([H])[H])C([H])([H])C([H])([H])C([O-])=O)C(=C4C([H])([H])C([H])([H])C([O-])=O)C([H])([H])[H])C([H])([H])[H])C([H])([H])C([H])([H])C([O-])=O)/C(=C3C([H])([H])C([H])([H])C([O-])=O)C([H])([H])[H],VORBHEGMEBOMMB-JRHDEHKPSA-J,"InChI=1S/C36H38N4O8/c1-17-21(5-9-33(41)42)29-14-26-19(3)23(7-11-35(45)46)31(39-26)16-28-20(4)24(8-12-36(47)48)32(40-28)15-27-18(2)22(6-10-34(43)44)30(38-27)13-25(17)37-29/h13-16,37,40H,5-12H2,1-4H3,(H,41,42)(H,43,44)(H,45,46)(H,47,48)/p-4/b25-13-,26-14-,27-15-,28-16-,29-14-,30-13-,31-16-,32-15-"
1931,74947,"2-(2,6-dioxopiperidin-3-yl)-1H-isoindole-1,3(2H)-dione","A dicarboximide that is isoindole-1,3(2H)-dione in which the hydrogen attached to the nitrogen is substituted by a 2,6-dioxopiperidin-3-yl group.",27609,KEGG COMPOUND accession,C05770,C05770,14643-66-4,27609.0,"Human Metabolome Database (HMDB): Coproporphyrin III is a porphyrin metabolite arising from heme synthesis. Porphyrins are pigments found in both animal and plant life. Coproporphyrin III is a tetrapyrrole dead-end product from the spontaneous oxidation of the methylene bridges of coproporphynogen, arising from heme synthesis and secreted in feces and urine. Increased levels of coproporphyrins can indicate congenital erythropoietic porphyria or sideroblastic anaemia, which are inherited disorders. Porphyria is a pathological state characterised by abnormalities of porphyrin metabolism and results in the excretion of large quantities of porphyrins in the urine and in extreme sensitivity to light. A large number of factors are capable of increasing porphyrin excretion, owing to different and multiple causes and etiologies: 1) the main site of the chronic hepatic porphyria disease process concentrates on the liver, 2) a functional and morphologic liver injury is almost regularly associated with this chronic porphyria, 3) the toxic form due to occupational and environmental exposure takes mainly a subclinical course. Hepatic factors includes disturbance in coproporphyrinogen metabolism, which results from inhibition of coproporphyrinogen oxidase as well as from the rapid loss from, and diminished utilization of coproporphyrinogen in the hepatocytes, which may also explain why coproporphyrin, its autoxidation product, predominates physiologically in the urine; decreased biliary excretion of coproporphyrin leading to a compensatory urinary excretion, so that the coproporphyrin ring isomer ratio (1:III) becomes a sensitive index for impaired liver function and intrahepatic cholestasis; and disturbed activity of hepatic uroporphyrinogen decarboxylase. In itself, secondary coproporphyrinuria is not associated with porphyria symptoms of a hepatologic-gastroenterologic, neurologic, or dermatologic order, even though coproporphyrinuria can occur with such symptoms. (PMID: 3327428).",Coproporphyrin III,HMDB0000570,b,b,C05770,b,FDB005557,C05770,[H]N1\C2=C([H])/C3=N/C(=C([H])\C4=C(C(=C(N4[H])\C([H])=C4/N=C(/C(/[H])=C1/C(=C2C([H])([H])[H])C([H])([H])C([H])([H])C([O-])=O)C(=C4C([H])([H])[H])C([H])([H])C([H])([H])C([O-])=O)C([H])([H])[H])C([H])([H])C([H])([H])C([O-])=O)/C(=C3C([H])([H])C([H])([H])C([O-])=O)C([H])([H])[H],JWFCYWSMNRLXLX-UJJXFSCMSA-J,"InChI=1S/C36H38N4O8/c1-17-21(5-9-33(41)42)29-14-27-19(3)22(6-10-34(43)44)30(39-27)15-28-20(4)24(8-12-36(47)48)32(40-28)16-31-23(7-11-35(45)46)18(2)26(38-31)13-25(17)37-29/h13-16,37,40H,5-12H2,1-4H3,(H,41,42)(H,43,44)(H,45,46)(H,47,48)/p-4/b25-13-,26-13-,27-14-,28-15-,29-14-,30-15-,31-16-,32-16-"
1932,74959,O(4)-phospho-D-tyrosine,A D-tyrosine derivative that is D-tyrosine phosphorylated at the phenolic hydroxy group.,33913,KEGG COMPOUND accession,C06021,cfesp,b,b,b,Corrinoid Iron sulfur protein,b,b,b,C06021,b,b,b,b,b,b
1933,75007,Tyr-Val,A dipeptide formed from L-tyrosine and L-valine residues.,23417,KEGG COMPOUND accession,C07299,,,,,,,,,,,,,,,
1934,75014,Val-Lys,A dipeptide formed from L-valine and L-lysine residues.,29195,KEGG COMPOUND accession,C01417,cynt,71000-82-3,29195.0,"Human Metabolome Database (HMDB): The cyanate ion is an anion consisting of one oxygen atom, one carbon atom, and one nitrogen atom, [OCN], in that order. The cyanate ion possesses 1 unit of negative charge, borne mainly by the nitrogen atom. In organic compounds the cyanate group is a functional group. The cyanate ion is an ambident nucleophile in nucleophilic substitution because it can react to form an alkyl cyanate R-OCN (exception) or an alkyl isocyanate R-NCO (rule). Aryl cyanates (C6H5OCN) can be formed by a reaction of phenol with cyanogen chloride (ClCN) in the presence of a base. The cyanate ion is relatively non-toxic in comparison with cyanides. Use of this fact is made in cyanide decontamination processes where a permanganate oxidation converts toxic cyanide to safer cyanate. Cyanate can be decomposed by the enzyme cyanate lyase (or cyanase), which is found in bacteria and plants. In particular cyanate can be decomposed to carbamate (ammonia) and carbon dioxide. Alternately the same enzyme can be used to synthesize cyanate using carbamate and carbon dioxide.",Cyanate,HMDB0002078,b,b,C01417,b,FDB022835,cynt,[O-]C#N,XLJMAIOERFSOGZ-UHFFFAOYSA-M,InChI=1S/CHNO/c2-1-3/h3H/p-1
1935,75058,4-nitrophenyl phthalimidoacetate,A carboxylic ester obtained by formal condensation of the carboxy group of phthalimidoacetic acid with the phenolic hydroxy group of 4-nitrophenol.,17074,KEGG COMPOUND accession,C01418,,,,,,,,,,,,,,,
1936,75079,N(3)-methylcytidine 5'-monophosphate residue,A nucleotide residue derived from N(3)-methylcytidine 5'-monophosphate.,16653,KEGG COMPOUND accession,C02141,,,,,,,,,,,,,,,
1937,75108,linoelaidic acid,An octadecadienoic acid containing two E (trans) double bonds at positions 9 and 12.,17766,KEGG COMPOUND accession,C01066,,,,,,,,,,,,,,,
1938,75130,alpha-N-acetylneuraminyl-(2->8)-alpha-N-acetylneuraminyl group,A sialosyl group derived from the disaccharide alpha-N-acetylneuraminyl-(2->8)-alpha-N-acetylneuraminic acid.,15773,KEGG COMPOUND accession,C00571,,,,,,,,,,,,,,,
1939,75134,1-oleoyl-2-icosanoyl-sn-glycero-3-phosphate,"A 1,2-diacyl-sn-glycerol 3-phosphate in which the acyl substituents at positions 1 and 2 are specified as oleoyl and icosanoyl (arachidoyl) respectively.",15964,KEGG COMPOUND accession,C02824,,,,,,,,,,,,,,,
1940,75145,2-aminooctanoic acid,An alpha-amino fatty acid that is caprylic acid which is substituted at position 2 by an amino group.,16133,KEGG COMPOUND accession,C02020,,,,,,,,,,,,,,,
1941,75193,tetrazolium violet,An organic chloride salt having tetrazolium violet(1+) as the counterion.,17361,KEGG COMPOUND accession,C00055,cmp,63-37-6,17361.0,"Human Metabolome Database (HMDB): Cytidine monophosphate, also known as 5'-cytidylic acid and abbreviated CMP, is a nucleotide. It is an ester of phosphoric acid with the nucleoside cytidine. CMP consists of the phosphate group, the pentose sugar ribose, and the nucleobase cytosine. Cytidine monophosphate (CMP) is derived from cytidine triphosphate (CTP) with subsequent loss of two phosphates. The synthesis of the pyrimidines CTP and UTP occurs in the cytoplasm and starts with the formation of carbamoyl phosphate from glutamine and CO2. Next, aspartate undergoes a condensation reaction with carbamoyl-phosphate to form orotic acid. In a subsequent cyclization reaction, the enzyme Aspartate carbamoyltransferase forms N-carbamoyl-aspartate which is converted into dihydroorotic acid by Dihydroorotase. The latter is converted to orotate by Dihydroorotate oxidase. Orotate is covalently linked with a phosphorylated ribosyl unit with Orotate phosphoribosyltransferase (aka ""PRPP transferase"") catalyzing reaction, yielding orotidine monophosphate (OMP). Orotidine-5-phosphate is decarboxylated by Orotidine-5'-phosphate decarboxylase to form uridine monophosphate (UMP). UMP is phosphorylated by two kinases to uridine triphosphate (UTP) via two sequential reactions with ATP. CTP is subsequently formed by amination of UTP by the catalytic activity of CTP synthetase. Cytosine monophosphate (CMP) and uridine monophosphate (UMP) have been prescribed for the treatment of neuromuscular affections in humans. Patients treated with CMP/UMP recover from altered neurological functions. Additionally, the administration of CMP/UMP appears to favour the entry of glucose in the muscle and CMP/UMP may be important in maintaining the level of hepatic glycogen constant during exercise. [PMID:18663991].",Cytidine monophosphate,HMDB0000095,b,b,C00055,CMP,FDB011882,cmp,[H]O[C@@]1([H])[C@@]([H])(O[C@]([H])(C([H])([H])OP([O-])([O-])=O)[C@@]1([H])O[H])N1C([H])=C([H])C(=NC1=O)N([H])[H],IERHLVCPSMICTF-XVFCMESISA-L,"InChI=1S/C9H14N3O8P/c10-5-1-2-12(9(15)11-5)8-7(14)6(13)4(20-8)3-19-21(16,17)18/h1-2,4,6-8,13-14H,3H2,(H2,10,11,15)(H2,16,17,18)/p-2/t4-,6-,7-,8-/m1/s1"
1942,75209,2-linoleoyl-2'-monolysocardiolipin(2-),A 2-monolysocardiolipin(2-) in which the acyl group at position 2 is specified as linoleoyl while those at positions 1 and 1' remain unspecified.,16040,KEGG COMPOUND accession,C00380,csn,71-30-7,16040.0,Human Metabolome Database (HMDB): Cytosine is a pyrimidine base that is a fundamental unit of nucleic acids. The deamination of cytosine alone is apparent and the nucleotide of cytosine is the prime mutagenic nucleotide in leukaemia and cancer.,Cytosine,HMDB0000630,b,b,C00380,CYTOSINE,FDB022151,csn,[H]N([H])C1=NC(=O)N([H])C([H])=C1[H],OPTASPLRGRRNAP-UHFFFAOYSA-N,"InChI=1S/C4H5N3O/c5-3-1-2-6-4(8)7-3/h1-2H,(H3,5,6,7,8)"
1943,75263,1-acyl-2-octanoyl-sn-glycero-3-phosphoethanolamine zwitterion,"A 1,2-diacyl-sn-glycero-3-phosphoethanolamine zwitterion in which the 2-acyl group is specified as octanoyl while the 1-acyl group remains unspecified.",28197,KEGG COMPOUND accession,C10208,,,,,,,,,,,,,,,
1944,75272,splitomicin,"A benzochromenone that is 2,3-dihydro-1H-benzo[f]chromene substituted by an oxo group at position 3. It has been found to exhibit potential inhibitory activity against Sir2 proteins.",16957,KEGG COMPOUND accession,C02673,,,,,,,,,,,,,,,
1945,75274,tetradecyl sulfate,"An organosulfate oxoanion that is the conjugate base of tetradecyl sulfonic acid, obtained by deprotonation of the O-sulfo group.",18065,KEGG COMPOUND accession,C03112,,,,,,,,,,,,,,,
1946,75276,ikarugamycin,"A polyketide macrolactam containing a tetramic acid (pyrrolidine-2,4-dione) ring system. It is isolated from Streptomyces as an antibiotic with  antiprotozoal and cytotoxic activities.",18106,KEGG COMPOUND accession,C07307,,,,,,,,,,,,,,,
1947,75278,N-acetyl-D-glucosaminitol,A 2-deoxyhexitol derivative that is D-glucitol in which the 2-hydroxy substituent is replaced by an acetamido group.,17286,KEGG COMPOUND accession,C07304,,,,,,,,,,,,,,,
1948,75282,ergosterol biosynthesis inhibitor,Any compound that inhibits one or more steps in the pathway leading to the synthesis of ergosterol.,16251,KEGG COMPOUND accession,C03860,,,,,,,,,,,,,,,
1949,75284,(R)-2-(4-chloro-2-methylphenoxy)propanoate,"A monocarboxylic acid anion that is the conjugate base of (R)-2-(4-chloro-2-methylphenoxy)propanoic acid, obtained by deprotonation of the carboxy group.",28903,KEGG COMPOUND accession,C01633,,,,,,,,,,,,,,,
1950,75287,(S)-dichlorprop(1-),A monocarboxylic acid anion resulting from the removal of a proton from the carboxy group of (S)-dichlorprop. The major species at pH 7.3,27689,KEGG COMPOUND accession,C01571,dca,334-48-5,30813.0,"Human Metabolome Database (HMDB): Capric acid is a member of the series of fatty acids found in oils and animal fats. The names of Caproic, Caprylic, and Capric acids are all derived from the word caper (Latin: 'goat'). These are colorless light yellowish transparent oily liquids with unconfortable smells. These are used in organic synthesis, manufacture of perfume, medicine, lubricating grease, rubber and dye.(ChemicalLAND21).",Capric acid,HMDB0000511,b,b,C01571,3-OXODODECANOATE,FDB012027,dca,[H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([O-])=O,GHVNFZFCNZKVNT-UHFFFAOYSA-M,"InChI=1S/C10H20O2/c1-2-3-4-5-6-7-8-9-10(11)12/h2-9H2,1H3,(H,11,12)/p-1"
1951,75295,compound 48/80,"R1, R2 = H or CH2OH; n is normally between 1 and 10. An alternating copolymer resulting from the condensation of N,O-dimethyltyramine with formaldehyde. It is a potent histamine releasing agent, primarily from mast cells, with subsequent depletion of tissue histamine.",16477,KEGG COMPOUND accession,C02970,,,,,,,,,,,,,,,
1952,75347,1-(10Z)-heptadecenoyl-sn-glycero-3-phospho-1D-myo-inositol,A 1-acyl-sn-glycero-3-phospho-1D-myo-inositol in which the 1-acyl group is specified as (10Z)-heptadecenoyl.,27705,KEGG COMPOUND accession,C08586,,,,,,,,,,,,,,,
1953,75383,(R)-monastrol,"An ethyl 4-(3-hydroxyphenyl)-6-methyl-2-thioxo-1,2,3,4-tetrahydropyrimidine-5-carboxylate that has R configuration.",15787,KEGG COMPOUND accession,C04251,,,,,,,,,,,,,,,
1954,75394,N-acetyl-beta-D-glucosaminyl-(1->4)-alpha-D-mannose,An amino disaccharide comprised of N-acetyl-beta-D-glucosamine linked (1->4) to D-mannose.,15468,KEGG COMPOUND accession,C00882,dpcoa,3633-59-8,15468.0,"Human Metabolome Database (HMDB): Dephospho-CoA is an intermediate in Pantothenate and CoA biosynthesis. It is a substrate for Bifunctional coenzyme A synthase which contains the dephospho-CoA kinase (EC:2.7.1.24), This enzyme catalyzes the final step in CoA biosynthesis, the phosphorylation of the 3'-hydroxyl group of ribose using ATP as a phosphate donor. The reaction is: ATP + 3'-dephospho-CoA = ADP + CoA.",Dephospho-CoA,HMDB0001373,b,b,C00882,DEPHOSPHO-COA,FDB022585,dpcoa,[H]O[C@@]([H])(C(=O)N([H])C([H])([H])C([H])([H])C(=O)N([H])C([H])([H])C([H])([H])S[H])C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])OP([O-])(=O)OP([O-])(=O)OC([H])([H])[C@@]1([H])O[C@@]([H])(N2C([H])=NC3=C(N=C([H])N=C23)N([H])[H])[C@]([H])(O[H])[C@]1([H])O[H],KDTSHFARGAKYJN-IBOSZNHHSA-L,"InChI=1S/C21H35N7O13P2S/c1-21(2,16(32)19(33)24-4-3-12(29)23-5-6-44)8-39-43(36,37)41-42(34,35)38-7-11-14(30)15(31)20(40-11)28-10-27-13-17(22)25-9-26-18(13)28/h9-11,14-16,20,30-32,44H,3-8H2,1-2H3,(H,23,29)(H,24,33)(H,34,35)(H,36,37)(H2,22,25,26)/p-2/t11-,14-,15-,16+,20-/m1/s1"
1955,75406,2-methyl-6-phytylhydroquinone,"A member of the class of hydroquinones that is 2-methylbenzene-1,4-diol substituted by a phytyl group at position 6.",15911,KEGG COMPOUND accession,C01069,,,,,,,,,,,,,,,
1956,75422,iodonitrotetrazolium,An organic cation that is the cationic component of iodonitrotetrazolium violet.,18197,KEGG COMPOUND accession,C04574,,,,,,,,,,,,,,,
1957,75461,4'-O-beta-glucosyl-7-O-(6-O-sinapoylglucosyl)tricin,A glycosyloxyflavone that is tricin substituted at positions 4 and 7 by beta-glucosyl 6-O-sinapoylglucosyl residues respectively.,28145,KEGG COMPOUND accession,C07729,,,,,,,,,,,,,,,
1958,75506,5-bromo-4-chloro-3-indolyl alpha-D-galactoside,"An indolyl carbohydrate that is the alpha-D-galactoside of indoxyl in which the indole moiety is substituted at positions 4 and 5 by chlorine and bromine, respectively.",28123,KEGG COMPOUND accession,C06772,,,,,,,,,,,,,,,
1959,75509,7-O-(6-p-coumaroylglucosyl)chrysoeriol,A glycosyloxyflavone that is chrysoeriol in which the hydroxyl hydrogen at position 7 is replaced by a 6-p-coumaroylglucosyl residue.,17132,KEGG COMPOUND accession,C04586,,,,,,,,,,,,,,,
1960,75514,isoorientin 7-O-glucoside,A C-glycosyl compound that is isoorientin in which the hydroxyl hydrogen at position 7 is replaced by a glucosyl residue.,16879,KEGG COMPOUND accession,C04067,,,,,,,,,,,,,,,
1961,75545,2-keto-3-deoxy-L-galactonate,"A carbohydrate acid anion that is the conjugate base of 2-keto-3-deoxy-L-galactonic acid, obtained by deprotonation of the carboxy group.",17866,KEGG COMPOUND accession,C01572,,,,,,,,,,,,,,,
1962,75602,dT4,An oligonucleotide comprised of four thymidine residues connected via 3'->5' phosphodiester linkages.,18029,KEGG COMPOUND accession,C05316,,,,,,,,,,,,,,,
1963,75612,1-arachidonoylglycerol,A 1-monoglyceride where the acyl group is arachidonoyl.,16370,KEGG COMPOUND accession,C06719,,,,,,,,,,,,,,,
1964,75617,N(3')-acetylgentamycin C(4+),An organic cation obtained by protonation of the four amino groups of any N(3')-acetylgentamicin C.,17839,KEGG COMPOUND accession,C00921,,,,,,,,,,,,,,,
1965,75631,palmityl stearate,A  wax ester obtained by the formal condensation of palmityl alcohol with stearic acid.,17751,KEGG COMPOUND accession,C01280,,,,,,,,,,,,,,,
1966,75649,5-(2-methoxy-2-oxoethyl)uridine 5'-monophosphate residue,A nucleotide residue derived from  5-(2-methoxy-2-oxoethyl)uridine 5'-monophosphate.,17795,KEGG COMPOUND accession,C00975,,,,,,,,,,,,,,,
1967,75670,(-)-epicatechin-(4beta->8)-(-)-epigallocatechin,A proanthocyanidin consisting of (-)-epicatechin and (-)-epigallocatechin units joined by a (4beta->8)-linkage.,16785,KEGG COMPOUND accession,C03113,,,,,,,,,,,,,,,
1968,75677,delphinidin 3-O-(6-O-(E)-4-coumaroyl-beta-D-glucoside),An anthocyanin cation that is delphinidin substituted at position 3 by a 6-O-(trans-4 coumaryl)-beta-D-glucosyl residue,17437,KEGG COMPOUND accession,C00580,dms,75-18-3,17437.0,"Human Metabolome Database (HMDB): Dimethylsulfide is the predominant volatile sulfur compound (VSC) in breadth malodor, a metabolite of suplatast tosilate (a dimethylsulphonium compound for the treatment of asthma) in patients that regularly take that medication. (PMID 14628896). Dimethylsulfide is a sulfur containing organic chemical compound with a disagreeable odor. In vapor form it is produced by cooking of certain vegetables, notably corn and cabbage, and seafood. It is also an indication of bacterial infection in malt production and brewing. It is a breakdown product of dimethylsulfoniopropionate, and is also produced by the bacterial metabolism of methanethiol. Dimethyl sulfide in concentrated liquid form is insoluble and a flammable.-- Wikipedia.",Dimethylsulfide,HMDB0002303,b,b,C00580,REDUCED-DMSO,FDB003591,b,b,QMMFVYPAHWMCMS-UHFFFAOYSA-N,b
1969,75690,"(8R)-hydroxy-(11R,12R)-epoxyicosa-(5Z,9E,14Z)-trienoic acid","An epoxy(hydroxy)icosatrienoic acid consisting of (5Z,9E,14Z)-icosa-5,9,14-trienoic acid having additional (8R)-hydroxy- and (11R,12R)-epoxy groups.",17170,KEGG COMPOUND accession,C00543,dma,124-40-3,17170.0,"Human Metabolome Database (HMDB): Dimethylamine (DMA) is an organic secondary amine. It is a colorless, liquefied and flammable gas with an ammonia and fish-like odor. Dimethylamine is abundantly present in human urine. Main sources of urinary DMA have been reported to include trimethylamine N-oxide, a common food component, and asymmetric dimethylarginine (ADMA), an endogenous inhibitor of nitric oxide (NO) synthesis. ADMA is excreted in the urine in part unmetabolized and in part after hydrolysis to DMA by dimethylarginine dimethylaminohydrolase (DDAH). Statistically significant increases in urinary DMA have been found in individuals after the consumption of fish and seafoods. The highest values were obtained for individuals that consumed coley, squid and whiting with cod, haddock, sardine, skate and swordfish (PMID: 18282650). As a pure chemical substance Dimethylamine is used as dehairing agent in tanning, in dyes, in rubber accelerators, in soaps and cleaning compounds and as an agricultural fungicide. In the body, DMA also undergoes nitrosation under weak acid conditions to give dimethlynitrosamine.",Dimethylamine,HMDB0000087,b,b,C00543,DIMETHYLAMINE,FDB012589,b,[H]N(C([H])([H])[H])C([H])([H])[H],ROSDSFDQCJNGOL-UHFFFAOYSA-N,"InChI=1S/C2H7N/c1-3-2/h3H,1-2H3"
1970,75702,dU5,An oligonucleotide comprised of five 2-deoxyuridine residues connected via 3'->5' phosphodiester linkages.,17081,KEGG COMPOUND accession,C00922,,,,,,,,,,,,,,,
1971,75747,(-)-epitaxifolin,"A taxifolin that has (2R,3S)-configuration.",18054,KEGG COMPOUND accession,C01573,,,,,,,,,,,,,,,
1972,75763,eukaryotic metabolite,"Any  metabolite produced during a metabolic reaction in eukaryotes, the taxon that include members of the fungi, plantae and animalia kingdoms.",17456,KEGG COMPOUND accession,C00950,,,,,,,,,,,,,,,
1973,75813,myricetin 3-O-beta-D-glucopyranoside,A myricetin O-glucoside that is myricetin with a beta-D-glucosyl residue attached at position 3.,15812,KEGG COMPOUND accession,C01246,dolglcp_L,220496-27-5,15812.0,Human Metabolome Database (HMDB): Dolichyl &#946;-D-glucosyl phosphate is a polyisoprenyl phosphate monosaccharide. Biosynthesis is by Glucosyltransferase in liver mitochondria. (PubMed ID 6450044 ).,Dolichyl b-D-glucosyl phosphate,HMDB0001054,b,b,C01246,b,FDB022394,dolglcp_L,[H]OC([H])([H])[C@@]1([H])O[C@@]([H])(OP(=O)(O[H])OC([H])([H])C([H])([H])C([H])(C([H])([H])[H])C([H])([H])C([H])([H])C(\[H])=C(\C([H])([H])[H])C([H])([H])C([H])([H])C(\[H])=C(/C([H])([H])[H])C([H])([H])C([H])([H])C(\[H])=C(/C([H])([H])[H])C([H])([H])C([H])([H])C([H])=C(C([H])([H])[H])C([H])([H])[H])[C@]([H])(O[H])[C@@]([H])(O[H])[C@]1([H])O[H],AGLXCEGQRIYVRV-DVDHLLHCSA-N,"InChI=1S/C31H55O9P/c1-22(2)11-7-12-23(3)13-8-14-24(4)15-9-16-25(5)17-10-18-26(6)19-20-38-41(36,37)40-31-30(35)29(34)28(33)27(21-32)39-31/h11,13,15,17,26-35H,7-10,12,14,16,18-21H2,1-6H3,(H,36,37)/b23-13+,24-15+,25-17-/t26?,27-,28-,29+,30-,31+/m1/s1"
1974,75821,myricetin 3-O-alpha-L-glucopyranoside,A myricetin O-glucoside that is myricetin with a alpha-L-glucosyl residue attached at position 3.,29074,KEGG COMPOUND accession,C02536,,,,,,,,,,,,,,,
1975,75829,5'-CTGCAGAATTCTGGTACCA-3',"A single-stranded DNA oligonucleotide comprised of five deoxyadenosine, five deoxycytidine, five thymidine and four deoxyguanidine residues connected by 3'->5' phosphodiester linkages in the sequence CTGCAGAATTCTGGTACCA.",16852,KEGG COMPOUND accession,C00822,dopaqn,4430-97-1,16852.0,"Human Metabolome Database (HMDB): Dopaquinone, also known as o-dopaquinone or L-dopaquinone, is a member of the class of compounds known as L-alpha-amino acids. L-alpha-amino acids are alpha-amino acids which have the L-configuration of the alpha-carbon atom. Dopaquinone is slightly soluble (in water) and a moderately acidic compound (based on its pKa). L-Dopaquinone is a metabolite of L-DOPA and a precursor of melanin. Melanin is synthesized from tyrosine by hydroxylation to dihydroxyphenylalanine (DOPA) and subsequent oxidation to dopaquinone. Both reactions are catalyzed by the enzyme tyrosinase, which is the rate-limiting step. Dopaquinone has an ortho-quinone ring, which is known to be neurotoxic and highly reactive with many other compounds (PMID: 413870). Dopaquinone typically combines with cysteine to form pheomelanin (a pigment-polymer). Alternatively, dopaquinone can be converted to leucodopachrome and eventually to eumelanin (also a pigment-polymer). Dopaquinone can be found in skin and feces. Within the cell, dopaquinone is primarily located in the cytoplasm. Dopaquinone is involved in several metabolic disorders, some of which include transient tyrosinemia, hawkinsinuria, tyrosinemia type I, and alkaptonuria. Chronically high levels of dopaquinone are associated with Parkinson's disease (PD). Many Parkinson's patients are treated with L-DOPA. However, long-term treatment with L-DOPA may actually worsen symptoms or result in neurotic and psychotic symptoms. These may be due to dopachrome and dopaquinone accumulating in the brain of L-DOPA treated patients (PMID: 19131041, PMID: 12373519).",Dopaquinone,HMDB0001229,b,b,C00822,DOPAQUINONE,FDB022501,dopaqn,[H]C1=C([H])C(=C([H])C(=O)C1=O)C([H])([H])[C@@]([H])(C([O-])=O)[N+]([H])([H])[H],AHMIDUVKSGCHAU-LURJTMIESA-N,"InChI=1S/C9H9NO4/c10-6(9(13)14)3-5-1-2-7(11)8(12)4-5/h1-2,4,6H,3,10H2,(H,13,14)/t6-/m0/s1"
1976,75833,"(8E,10S,12Z)-10-hydroperoxyoctadeca-8,12-dienoic acid","(8E,12Z)-10-hydroperoxy-8,12-octadecadienoic acid with S-configuration at C-10.",16688,KEGG COMPOUND accession,C00477,,,,,,,,,,,,,,,
1977,75838,phytyl phosphate,A polyprenol phosphate that is the monophosphate derivative of phytol.,17551,KEGG COMPOUND accession,C02681,,,,,,,,,,,,,,,
1978,75856,3-methylfumaryl-CoA,An omega-carboxyacyl-CoA that results from the formal condensation of the thiol group of coenzyme A with the least hindered carboxy group of mesaconic acid.,27997,KEGG COMPOUND accession,C01712,,,,,,,,,,,,,,,
1979,75867,1-oleoyl-3-palmitoyl-sn-glycerol,"A 1,3-diglyceride in which the acyl groups at positions 1 and 3 are specified as oleoyl and palmitoyl respectively (the S-stereoisomer).",16815,KEGG COMPOUND accession,C02763,M00647,5801-57-0,16815.0,"Human Metabolome Database (HMDB): Enol-phenylpyruvate is reversibly produced from keto-phenylpyruvate, a reaction catalyzed by phenylpyruvate tautomerase [EC:5.3.2.1]. Phenylpyruvate tautomerase, also known as macrophage migration inhibitory factor (glycosylation-inhibiting factor), is involved in the tyrosine and phenylalanine metabolism pathways.",Enol-phenylpyruvate,HMDB0012225,b,b,C02763,ENOL-PHENYLPYRUVATE,FDB028869,b,[H]OC(=O)C(\O[H])=C(/[H])C1=C([H])C([H])=C([H])C([H])=C1[H],DEDGUGJNLNLJSR-VURMDHGXSA-N,"InChI=1S/C9H8O3/c10-8(9(11)12)6-7-4-2-1-3-5-7/h1-6,10H,(H,11,12)/b8-6-"
1980,75952,rac-1-oleoyl-3-palmitoylglycerol,A racemate comprising equimolar amounts of 1-palmitoyl-3-oleoyl-sn-glycerol and 1-oleoyl-3-palmitoyl-sn-glycerol.,16469,KEGG COMPOUND accession,C00951,estradiol,50-28-2,16469.0,"Human Metabolome Database (HMDB): Estradiol is the most potent form of mammalian estrogenic steroids. Estradiol is produced in the ovaries. The ovary requires both luteinizing hormone (LH) and follicle-stimulating hormone (FSH) to produce sex steroids. LH stimulates the cells surrounding the follicle to produce progesterone and androgens. The androgens diffuse across the basement membrane to the granulosa cell layer, where, under the action of FSH, they are aromatized to estrogens, mainly estradiol. The ovary shows cyclical activity, unlike the testis that is maintained in a more or less constant state of activity. Hormone secretions vary according to the phase of the menstrual cycle. In the developing follicle LH receptors (LH-R) are only located on the thecal cells and FSH receptors (FSHR) on the granulosa cells. The dominant pre-ovulatory follicle develops LH-Rs on the granulosa cells prior to the LH surge. Thecal cells of the preovulatory follicle also develop the capacity to synthesize estradiol and this persists when the thecal cells become incorporated into the corpus luteum. After ovulation, the empty follicle is remodelled and plays an important role in the second half or luteal phase of the menstrual cycle. This phase is dominated by progesterone and, to a lesser extent, estradiol secretion by the corpus luteum. estradiol is also synthesized locally from cholesterol through testosterone in the hippocampus and acts rapidly to modulate neuronal synaptic plasticity. Localization of estrogen receptor alpha (ERalpha) in spines in addition to nuclei of principal neurons implies that synaptic ERalpha is responsible for rapid modulation of synaptic plasticity by endogenous estradiol. estradiol is a potent endogenous antioxidant which suppresses hepatic fibrosis in animal models, and attenuates induction of redox sensitive transcription factors, hepatocyte apoptosis and hepatic stellate cells activation by inhibiting a generation of reactive oxygen species in primary cultures. This suggests that the greater progression of hepatic fibrosis and hepatocellular carcinoma in men and postmenopausal women may be due, at least in part, to lower production of estradiol and a reduced response to the action of estradiol. estradiol has been reported to induce the production of interferon (INF)-gamma in lymphocytes, and augments an antigen-specific primary antibody response in human peripheral blood mononuclear cells. IFN-gamma is a potent cytokine with immunomodulatory and antiproliferative properties. Therefore, female subjects, particularly before menopause, may produce antibodies against hepatitis B virus e antigen and hepatitis B virus surface antigen at a higher frequency than males with chronic hepatitis B virus infection. The estradiol-Dihydrotestosterone model of prostate cancer (PC) proposes that the first step in the development of most PC and breast cancer (BC) occurs when aromatase converts testosterone to estradiol. (PMID: 17708600, 17678531, 17644764).",Estradiol,HMDB0000151,b,b,C00951,CPD-352,FDB000362,estradiol,[H]OC1=C([H])C([H])=C2C(=C1[H])C([H])([H])C([H])([H])[C@@]1([H])[C@]3([H])C([H])([H])C([H])([H])[C@]([H])(O[H])[C@@]3(C([H])([H])[H])C([H])([H])C([H])([H])[C@]21[H],VOXZDWNPVJITMN-ZBRFXRBCSA-N,"InChI=1S/C18H24O2/c1-18-9-8-14-13-5-3-12(19)10-11(13)2-4-15(14)16(18)6-7-17(18)20/h3,5,10,14-17,19-20H,2,4,6-9H2,1H3/t14-,15-,16+,17+,18+/m1/s1"
1981,75965,1-(beta-D-galactosyl)-N-[(2R)-2-hydroxybehenoyl]sphingosine,A D-galactosyl-N-acylsphingosine in which the ceramide N-acyl group is specified as (R)-2-hydroxybehenoyl.,17263,KEGG COMPOUND accession,C00468,estrone,53-16-7,17263.0,"Human Metabolome Database (HMDB): Estrone is a major mammalian estrogen. The conversion of the natural C19 steroids, testosterone and androstenedione into estrone is dependent on a complex key reaction catalyzed by the cytochrome P450 aromatase (EC 1.14.14.1, unspecific monooxygenase), which is expressed in many tissues of the adult human (e.g. ovary, fat tissue), but not in the liver. The ovaries after menopause continue to produce androstenedione and testosterone in significant amounts and these androgens are converted in fat, muscle, and skin into estrone. When women between the ages of 45 and 64 years have prophylactic oophorectomy (when hysterectomy is performed for benign disease to prevent the development of ovarian cancer), evidence suggests that oophorectomy increases the subsequent risk of coronary heart disease (CHD) and osteoporosis. Whereas 14,000 women die of ovarian cancer every year nearly 490,000 women die of heart disease and 48,000 women die within 1 year after hip fracture. Therefore, the decision to perform prophylactic oophorectomy should be approached with great caution for the majority of women who are at low risk of developing ovarian cancer. Steroid sulfatase (EC 3.1.6.2, STS) hydrolyzes steroid sulfates, such as estrone sulfate to estrone which can be converted to steroids with potent estrogenic properties, that is, estradiol; STS activity is much higher in breast tumors and high levels of STS mRNA expression in tumors are associated with a poor prognosis. The biological roles of estrogens in tumorigenesis are certainly different between the endometrium and breast, although both are considered ""estrogen-dependent tissues"". 17beta-hydroxysteroid dehydrogenases (EC 1.1.1.62, 17-HSDs) are enzymes involved in the formation of active sex steroids. estrone is interconverted by two enzymes 17-HSD types. Type 1 converts estrone to estradiol and Type 2 catalyzes the reverse reaction. (PMID: 17653961, 17513923, 17470679, 17464097).",Estrone,HMDB0000145,b,b,C00468,ESTRONE,FDB012798,estrone,[H]OC1=C([H])C2=C(C([H])=C1[H])[C@@]1([H])C([H])([H])C([H])([H])[C@@]3(C(=O)C([H])([H])C([H])([H])[C@@]3([H])[C@]1([H])C([H])([H])C2([H])[H])C([H])([H])[H],DNXHEGUUPJUMQT-CBZIJGRNSA-N,"InChI=1S/C18H22O2/c1-18-9-8-14-13-5-3-12(19)10-11(13)2-4-15(14)16(18)6-7-17(18)20/h3,5,10,14-16,19H,2,4,6-9H2,1H3/t14-,15-,16+,18+/m1/s1"
1982,75993,2-capryloyl-2'-monolysocardiolipin(2-),A 2-monolysocardiolipin(2-) obtained by deprotonation of both free phosphate OH groups of 2-capryloyl-2'-monolysocardiolipin.,16036,KEGG COMPOUND accession,C03865,,,,,,,,,,,,,,,
1983,75996,2-arachidonoyl-2'-monolysocardiolipin(2-),A 2-monolysocardiolipin(2-) obtained by deprotonation of both free phosphate OH groups of 2-arachidonoyl-2'-monolysocardiolipin.,18119,KEGG COMPOUND accession,C02975,,,,,,,,,,,,,,,
1984,76014,dolutegravir(1-),"An organic anion that is the conjugate base of dolutegravir, obtained by deptotonation of the 7-hydroxy group.",15862,KEGG COMPOUND accession,C00797,,,,,,,,,,,,,,,
1985,76051,"glutamic acid-2,3,3,4,4-d5","A deuterated compound that is glutamic acid in which the hydrogens at positions 2, 3, 3, 4 and 4 are replaced by deuterium.",17961,KEGG COMPOUND accession,C03115,,,,,,,,,,,,,,,
1986,76055,1-palmityl-2-acetyl-3-oleoyl-sn-glycerol,A 1-alkyl-2-acetyl-3-acyl-sn-glycerol in which the alkyl and acyl groups are specified as palmityl and oleoyl.,28868,KEGG COMPOUND accession,C02403,,,,,,,,,,,,,,,
1987,76071,2-oleoyl-sn-glycero-3-phosphocholine,A lysophosphatidylcholine 18:1 in which the acyl group is specified as oleoyl and is located at position 2.,15511,KEGG COMPOUND accession,C00406,,,,,,,,,,,,,,,
1988,76085,"2-(4Z,7Z,10Z,13Z,16Z,19Z)-docosahexaenoyl-sn-glycero-3-phosphocholine","A lysophosphatidylcholine 22:6 in which the acyl group is specified as (4Z,7Z,10Z,13Z,16Z,19Z)-docosahexaenoyl and is located at position 2.",30527,KEGG COMPOUND accession,C00176,,,,,,,,,,,,,,,
1989,76121,tryptophan N-glucoside,A L-tryptophan derivative that is L-tryptophan in which the hydrogen attached to the indole nitrogen replaced by a beta-D-glucosyl residue.,28266,KEGG COMPOUND accession,C07715,,,,,,,,,,,,,,,
1990,76131,(-)-catechin-3-O-gallate,A gallate ester obtained by formal condensation of the carboxy group of gallic acid with the (3R)-hydroxy group of (-)-catechin.,18172,KEGG COMPOUND accession,C06108,,,,,,,,,,,,,,,
1991,76164,lonazolac,A monocarboxylic acid that is acetic acid in which one of the methyl hydrogens is replaced by a 3-(4-chlorophenyl)-1-phenylpyrazol-4-yl group.,15740,KEGG COMPOUND accession,C00058,for,64-18-6,30751.0,"Human Metabolome Database (HMDB): Formic acid is the simplest carboxylic acid. Formate is an intermediate in normal metabolism. It takes part in the metabolism of one-carbon compounds and its carbon may appear in methyl groups undergoing transmethylation. It is eventually oxidized to carbon dioxide. Formate is typically produced as a byproduct in the production of acetate. It is responsible for both metabolic acidosis and disrupting mitochondrial electron transport and energy production by inhibiting cytochrome oxidase activity, the terminal electron acceptor of the electron transport chain. Cell death from cytochrome oxidase inhibition by formate is believed to result partly from depletion of ATP, reducing energy concentrations so that essential cell functions cannot be maintained. Furthermore, inhibition of cytochrome oxidase by formate may also cause cell death by increased production of cytotoxic reactive oxygen species (ROS) secondary to the blockade of the electron transport chain. In nature, formic acid is found in the stings and bites of many insects of the order Hymenoptera, including bees and ants. The principal use of formic acid is as a preservative and antibacterial agent in livestock feed. When sprayed on fresh hay or other silage, it arrests certain decay processes and causes the feed to retain its nutritive value longer.",Formic acid,HMDB0000142,b,b,C00058,FORMATE,FDB012804,for,[H]C([O-])=O,BDAGIHXWWSANSR-UHFFFAOYSA-M,"InChI=1S/CH2O2/c2-1-3/h1H,(H,2,3)/p-1"
1992,76247,"4-hydroxy-2,5-dimethylfuran-3-one","A member of the class of furans that is 2,5-dimethylfuran carrying additional oxo and hydroxy groups at positions 3 and 4 respectively. It has been found particularly in strawberries and other such fruits.",16813,KEGG COMPOUND accession,C01697,galt,608-66-2,16813.0,"Human Metabolome Database (HMDB): Galactitol or dulcitol is a sugar alcohol that is a metabolic breakdown product of galactose. Galactose is derived from lactose in food (such as dairy products). When lactose is broken down by the enzyme lactase it produces glucose and galactose. Galactitol has a slightly sweet taste. It is produced from galactose in a reaction catalyzed by aldose reductase. When present in sufficiently high levels, galactitol can act as a metabotoxin, a neurotoxin, and a hepatotoxin. A neurotoxin is a compound that disrupts or attacks neural cells and neural tissue. A hepatotoxin as a compound that disrupts or attacks liver tissue or liver cells. A metabotoxin is an endogenously produced metabolite that causes adverse health effects at chronically high levels. Chronically high levels of galactitol are associated with at least two inborn errors of metabolism, including galactosemia and galactosemia type II. Galactosemia is a rare genetic metabolic disorder that affects an individual's ability to metabolize the sugar galactose properly. Excess lactose consumption in individuals with galactose intolerance or galactosemia activates aldose reductase to produce galactitol, thus depleting NADPH and leading to lowered glutathione reductase activity. As a result, hydrogen peroxide or other free radicals accumulate causing serious oxidative damage to various cells and tissues. In individuals with galactosemia, the enzymes needed for the further metabolism of galactose (galactose-1-phosphate uridyltransferase) are severely diminished or missing entirely, leading to toxic levels of galactose 1-phosphate, galactitol, and galactonate. High levels of galactitol in infants are specifically associated with hepatomegaly (an enlarged liver), cirrhosis, renal failure, cataracts, vomiting, seizure, hypoglycemia, lethargy, brain damage, and ovarian failure.",Galactitol,HMDB0000107,b,b,C01697,15-DIDEOXY-15-IMINO-D-GALACTITOL,FDB006453,galt,[H]OC([H])([H])[C@]([H])(O[H])[C@@]([H])(O[H])[C@@]([H])(O[H])[C@]([H])(O[H])C([H])([H])O[H],FBPFZTCFMRRESA-GUCUJZIJSA-N,"InChI=1S/C6H14O6/c7-1-3(9)5(11)6(12)4(10)2-8/h3-12H,1-2H2/t3-,4+,5+,6-"
1993,76298,22-oxodocosanoate,"An oxo fatty acid anion that is the conjugate base of 22-ketodocosanoic acid, obtained by deprotonation of the carboxy group; major species at pH 7.3.",16918,KEGG COMPOUND accession,C01424,,,,,,,,,,,,,,,
1994,76307,omega-hydroxy fatty acid anion,A hydroxy fatty acid anion obtained by deprotonation of the carboxy group of any omega-hydroxy fatty acid; major species at pH 7.3.,32888,KEGG COMPOUND accession,C06595,,,,,,,,,,,,,,,
1995,76319,docosanedioic acid,"An alpha,omega-dicarboxylic acid that is docosane in which the methyl groups have been oxidised to the corresponding carboxylic acids.",27740,KEGG COMPOUND accession,C05435,,,,,,,,,,,,,,,
1996,76333,(S)-3-hydroxyoctanedioyl-CoA(5-),"An acyl-CoA oxoanion that is the pentaanion of (S)-3-hydroxyoctanedioyl-CoA, arising from deprotonation of phosphate, diphosphate and carboxylic acid functions; major species at pH 7.3.",28661,KEGG COMPOUND accession,C06426,dlnlcgcrn,506-26-3,28661.0,"Human Metabolome Database (HMDB): Gamma-Linolenic acid is an omega-6 fatty acid produced in the body as the delta 6-desaturase metabolite of linoleic acid. It is converted to dihomo-gamma-linolenic acid, a biosynthetic precursor of monoenoic prostaglandins such as PGE1. (From Merck Index, 11th ed) -- Pubchem.",Gamma-Linolenic acid,HMDB0003073,b,b,C06426,5Z13E-15S-91115-TRIHYDROXYPROSTA-,FDB002943,dlnlcgcrn,[H]OC(=O)C([H])([H])C([H])([H])C([H])([H])C([H])([H])C(\[H])=C(\[H])C([H])([H])C(\[H])=C(\[H])C([H])([H])C(\[H])=C(\[H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H],VZCCETWTMQHEPK-NPLRDPCCSA-N,"InChI=1S/C18H30O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18(19)20/h6-7,9-10,12-13H,2-5,8,11,14-17H2,1H3,(H,19,20)/b7-6-,10-9?,13-12-"
1997,76333,(S)-3-hydroxyoctanedioyl-CoA(5-),"An acyl-CoA oxoanion that is the pentaanion of (S)-3-hydroxyoctanedioyl-CoA, arising from deprotonation of phosphate, diphosphate and carboxylic acid functions; major species at pH 7.3.",28661,KEGG COMPOUND accession,C06426,lnlncg,506-26-3,28661.0,"Human Metabolome Database (HMDB): Gamma-Linolenic acid is an omega-6 fatty acid produced in the body as the delta 6-desaturase metabolite of linoleic acid. It is converted to dihomo-gamma-linolenic acid, a biosynthetic precursor of monoenoic prostaglandins such as PGE1. (From Merck Index, 11th ed) -- Pubchem.",Gamma-Linolenic acid,HMDB0003073,b,b,C06426,5Z13E-15S-91115-TRIHYDROXYPROSTA-,FDB002943,lnlncg,[H]\C(=C(/[H])C([H])([H])C(\[H])=C(\[H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H])C([H])([H])C(\[H])=C(\[H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([O-])=O,VZCCETWTMQHEPK-NPLRDPCCSA-M,"InChI=1S/C18H30O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18(19)20/h6-7,9-10,12-13H,2-5,8,11,14-17H2,1H3,(H,19,20)/p-1/b7-6-,10-9?,13-12-"
1998,76335,3-oxooctanedioyl-CoA(5-),"An acyl-CoA oxoanion that is the pentaanion of 3-oxooctanedioyl-CoA, arising from deprotonation of phosphate, diphosphate and carboxylic acid functions; major species at pH 7.3.",15508,KEGG COMPOUND accession,C03035,lnlncgcoa,b,15508.0,"Human Metabolome Database (HMDB): Gamma-linolenoyl-CoA is the product of a chemical reaction that involves linoleoyl-CoA desaturase which acts as a catalyst. In enzymology, linoleoyl-CoA desaturase (EC 1.14.19.3) is an enzyme that catalyzes the chemical reaction. linoleoyl-CoA + AH2 + O2 gamma-linolenoyl-CoA + A + 2 H2O. The 3 substrates of this enzyme are linoleoyl-CoA, AH2, and O2, whereas its 3 products are gamma-linolenoyl-CoA, A, and H2O. (Wikipedia).",Gamma-linolenoyl-CoA,HMDB0006368,b,b,C03035,GAMMA-LINOLENOYL-COA,FDB023905,lnlncgcoa,[H]O[C@@]([H])(C(=O)N([H])C([H])([H])C([H])([H])C(=O)N([H])C([H])([H])C([H])([H])SC(=O)C([H])([H])C([H])([H])C([H])([H])C([H])([H])C(\[H])=C(\[H])C([H])([H])C(\[H])=C(\[H])C([H])([H])C(\[H])=C(\[H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H])C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])OP([O-])(=O)OP([O-])(=O)OC([H])([H])[C@@]1([H])O[C@@]([H])(N2C([H])=NC3=C(N=C([H])N=C23)N([H])[H])[C@]([H])(O[H])[C@]1([H])OP([O-])([O-])=O,XZQYPTBYQYZGRU-FHDVEODPSA-J,"InChI=1S/C39H64N7O17P3S/c1-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-30(48)67-23-22-41-29(47)20-21-42-37(51)34(50)39(2,3)25-60-66(57,58)63-65(55,56)59-24-28-33(62-64(52,53)54)32(49)38(61-28)46-27-45-31-35(40)43-26-44-36(31)46/h8-9,11-12,14-15,26-28,32-34,38,49-50H,4-7,10,13,16-25H2,1-3H3,(H,41,47)(H,42,51)(H,55,56)(H,57,58)(H2,40,43,44)(H2,52,53,54)/p-4/b9-8-,12-11-,15-14-/t28-,32-,33-,34+,38-/m1/s1"
1999,76343,4-acetylaminofluorene,A member of the class of acetamides that is acetamide in which one of the hydrogens attached to the nitrogen is replaced by a 9H-fluoren-4-yl group.,17037,KEGG COMPOUND accession,C02151,,,,,,,,,,,,,,,
2000,76473,"(3R,17Z,20Z,23Z,26Z,29Z)-3-hydroxydotriacontapentaenoyl-CoA(4-)","A 3-hydroxy fatty acyl-CoA(4-) obtained by deprotonation of the phosphate and diphosphate OH groups of (3R,17Z,20Z,23Z,26Z,29Z)-3-hydroxydotriacontapentaenoyl-CoA; major species at pH 7.3.",17234,KEGG COMPOUND accession,C00293,,,,,,,,,,,,,,,
2001,76537,"1,2-dibutyrin",A dibutyrin resulting from the condensation the secondary hydroxy group and one of the primary hydroxy groups of glycerol with butyric acid.,16120,KEGG COMPOUND accession,C03273,oxptn,b,39153.0,"Human Metabolome Database (HMDB): In the lysine degradation IV pathway, glutarate semialdehyde reacts with NADP+ and H2O to produce glutarate, NADPH, and H+. In this pathway, glutarate semialdehyde is produced by the reaction between 5-aminopentanoate and 2-ketoglutarate, with L-glutamate as a byproduct. The enzyme responsible for this reaction is 5-aminovalerate aminotransferase. In the lysine degradation III pathway, glutarate semialdehyde reacts with NAD+ and H2O to produce glutarate and NADH. In this pathway, glutarate semialdehyde is produced by the reaction between 5-aminopentanoate and 2-ketoglutarate, with L-glutamate as a byproduct. The enzyme responsible for this reaction is 5-aminovalerate aminotransferase.",Glutarate semialdehyde,HMDB0012233,b,b,C03273,CPD-654,FDB028876,b,b,VBKPPDYGFUZOAJ-UHFFFAOYSA-N,"InChI=1S/C5H8O3/c6-4-2-1-3-5(7)8/h4H,1-3H2,(H,7,8)"
2002,76541,"(3R,7Z,10Z,13Z,16Z)-3-hydroxydocosatetraenoyl-CoA","A 3-hydroxy fatty acyl-CoA that results from the formal condensation of the thiol group of coenzyme A with the carboxy group of (3R,7Z,10Z,13Z,16Z)-3-hydroxydocosatetraenoic acid.",17859,KEGG COMPOUND accession,C00489,glutar,110-94-1,17859.0,"Human Metabolome Database (HMDB): Glutaric acid is a simple five-carbon linear dicarboxylic acid. Glutaric acid is naturally produced in the body during the metabolism of some amino acids, including lysine and tryptophan. Glutaric acid may cause irritation to the skin and eyes. When present in sufficiently high levels, glutaric acid can act as an acidogen and a metabotoxin. An acidogen is an acidic compound that induces acidosis, which has multiple adverse effects on many organ systems. A metabotoxin is an endogenously produced metabolite that causes adverse health effects at chronically high levels. Chronically high levels of glutaric acid are associated with at least three inborn errors of metabolism, including glutaric aciduria type I, malonyl-CoA decarboxylase deficiency, and glutaric aciduria type III. Glutaric aciduria type I (glutaric acidemia type I, glutaryl-CoA dehydrogenase deficiency, GA1, or GAT1) is an inherited disorder in which the body is unable to completely break down the amino acids lysine, hydroxylysine, and tryptophan due to a deficiency of mitochondrial glutaryl-CoA dehydrogenase (EC 1.3.99.7, GCDH). Excessive levels of their intermediate breakdown products (e.g. glutaric acid, glutaryl-CoA, 3-hydroxyglutaric acid, glutaconic acid) can accumulate and cause damage to the brain (and also other organs). Babies with glutaric acidemia type I are often born with unusually large heads (macrocephaly). Macrocephaly is amongst the earliest signs of GA1. GA1 also causes secondary carnitine deficiency because glutaric acid, like other organic acids, is detoxified by carnitine. Abnormally high levels of organic acids in the blood (organic acidemia), urine (organic aciduria), the brain, and other tissues lead to general metabolic acidosis. Acidosis typically occurs when arterial pH falls below 7.35. In infants with acidosis, the initial symptoms include poor feeding, vomiting, loss of appetite, weak muscle tone (hypotonia), and lack of energy (lethargy). These can progress to heart, liver, and kidney abnormalities, seizures, coma, and possibly death. These are also the characteristic symptoms of untreated glutaric aciduria. Many affected children with organic acidemias experience intellectual disability or delayed development. In adults, acidosis or acidemia is characterized by headaches, confusion, feeling tired, tremors, sleepiness, and seizures. Treatment of glutaric aciduria is mainly based on the restriction of lysine intake, supplementation of carnitine, and an intensification of therapy during intercurrent illnesses. The major principle of dietary treatment is to reduce the production of glutaric acid and 3-hydroxyglutaric acid by restriction of natural protein, in general, and of lysine, in particular (PMID: 17465389, 15505398).",Glutaric acid,HMDB0000661,b,b,C00489,b,FDB001477,b,[H]C([H])(C([O-])=O)C([H])([H])C([H])([H])C([O-])=O,JFCQEDHGNNZCLN-UHFFFAOYSA-L,"InChI=1S/C5H8O4/c6-4(7)2-1-3-5(8)9/h1-3H2,(H,6,7)(H,8,9)/p-2"
2003,76567,polyunsaturated fatty acid anion,Any unsaturated fatty acid anion containing more than one C-C unsaturated bond.  Major species at pH 7.3.,16470,KEGG COMPOUND accession,C01701,,,,,,,,,,,,,,,
2004,76571,"(2E,21Z,24Z,27Z,30Z)-hexatriacontapentaenoyl-CoA","An unsaturated fatty acyl-CoA that results from the formal condensation of the thiol group of coenzyme A with the carboxy group of (2E,21Z,24Z,27Z,30Z)-hexatriacontapentaenoic acid.",17050,KEGG COMPOUND accession,C00597,,,,,,,,,,,,,,,
2005,76622,6-(hydroxymethyl)-8-(1-D-ribityl)lumazine,The pteridine that is lumazine substituted with a hydroxymethyl group at C-6 and a 1-D-ribityl group at N-8.,29746,KEGG COMPOUND accession,C01921,gchola,475-31-0,29746.0,"Human Metabolome Database (HMDB): Glycocholic acid is an acyl glycine and a bile acid-glycine conjugate. It is a secondary bile acid produced by the action of enzymes existing in the microbial flora of the colonic environment. In hepatocytes, both primary and secondary bile acids undergo amino acid conjugation at the C-24 carboxylic acid on the side chain, and almost all bile acids in the bile duct therefore exist in a glycine conjugated form (PMID:16949895). More specifically, glycocholic acid or cholylglycine, is a crystalline bile acid involved in the emulsification of fats. It occurs as a sodium salt in the bile of mammals. Its anion is called glycocholate. As the glycine conjugate of cholic acid, this compound acts as a detergent to solubilize fats for absorption and is itself absorbed (PubChem). Bile acids are steroid acids found predominantly in bile of mammals. The distinction between different bile acids is minute, depends only on presence or absence of hydroxyl groups on positions 3, 7, and 12. Bile acids are physiological detergents that facilitate excretion, absorption, and transport of fats and sterols in the intestine and liver. Bile acids are also steroidal amphipathic molecules derived from the catabolism of cholesterol. They modulate bile flow and lipid secretion, are essential for the absorption of dietary fats and vitamins, and have been implicated in the regulation of all the key enzymes involved in cholesterol homeostasis. Bile acids recirculate through the liver, bile ducts, small intestine and portal vein to form an enterohepatic circuit. They exist as anions at physiological pH and, consequently, require a carrier for transport across the membranes of the enterohepatic tissues. The unique detergent properties of bile acids are essential for the digestion and intestinal absorption of hydrophobic nutrients. Bile acids have potent toxic properties (e.g., membrane disruption) and there are a plethora of mechanisms to limit their accumulation in blood and tissues (PMID: 11316487 , 16037564 , 12576301 , 11907135 ). Glycocholic acid is found to be associated with alpha-1-antitrypsin deficiency, which is an inborn error of metabolism.",Glycocholic acid,HMDB0000138,b,b,C01921,GLYCOCHOLIC_ACID,FDB012346,gchola,[H]OC(=O)C([H])([H])N([H])C(=O)C([H])([H])C([H])([H])[C@@]([H])(C([H])([H])[H])[C@@]1([H])C([H])([H])C([H])([H])[C@@]2([H])[C@]3([H])[C@]([H])(O[H])C([H])([H])[C@]4([H])C([H])([H])[C@]([H])(O[H])C([H])([H])C([H])([H])[C@]4(C([H])([H])[H])[C@@]3([H])C([H])([H])[C@]([H])(O[H])[C@]12C([H])([H])[H],RFDAIACWWDREDC-FRVQLJSFSA-N,"InChI=1S/C26H43NO6/c1-14(4-7-22(31)27-13-23(32)33)17-5-6-18-24-19(12-21(30)26(17,18)3)25(2)9-8-16(28)10-15(25)11-20(24)29/h14-21,24,28-30H,4-13H2,1-3H3,(H,27,31)(H,32,33)/t14-,15+,16-,17-,18+,19+,20-,21+,24+,25+,26-/m1/s1"
2006,76638,"(2E,11Z,14Z,17Z)-icosatetraenoyl-CoA","An unsaturated fatty acyl-CoA that results from the formal condensation of the thiol group of coenzyme A with the carboxy group of (2E,11Z,14Z,17Z)-icosatetraenoic acid.",17071,KEGG COMPOUND accession,C00266,gcald,141-46-8,17071.0,"Human Metabolome Database (HMDB): Glycolaldehyde (HOCH2-CH=O, IUPAC name 2-hydroxyethanal) is a type of diose (2-carbon monosaccharide). Glycolaldehyde is readily converted to acetyl coenzyme A. It has an aldehyde and a hydroxyl group. However, it is not actually a sugar, because there is only one hydroxyl group. Glycolaldehyde is formed from many sources, including the amino acid glycine and from purone catabolism. It can form by action of ketolase on fructose 1,6-bisphosphate in an alternate glycolysis pathway. This compound is transferred by thiamin pyrophosphate during the pentose phosphate shunt.",Glycolaldehyde,HMDB0003344,b,b,C00266,DIHYDROXYPHENYLGLYCOLALDEHYDE,FDB003297,gcald,[H]OC([H])([H])C([H])=O,WGCNASOHLSPBMP-UHFFFAOYSA-N,"InChI=1S/C2H4O2/c3-1-2-4/h1,4H,2H2"
2007,76642,"(3R,7Z,10Z,13Z,16Z,19Z)-3-hydroxydocosapentaenoyl-CoA","An unsaturated fatty acyl-CoA that results from the formal condensation of the thiol group of coenzyme A with the carboxy group of (3R,7Z,10Z,13Z,16Z,19Z)-3-hydroxydocosapentaenoic acid.",29805,KEGG COMPOUND accession,C00160,glyclt,79-14-1,17497.0,"Human Metabolome Database (HMDB): Glycolic acid (or hydroxyacetic acid) is the smallest alpha-hydroxy acid (AHA). This colourless, odourless, and hygroscopic crystalline solid is highly soluble in water. Due to its excellent capability to penetrate skin, glycolic acid is often used in skin care products, most often as a chemical peel. It may reduce wrinkles, acne scarring, and hyperpigmentation and improve many other skin conditions, including actinic keratosis, hyperkeratosis, and seborrheic keratosis. Once applied, glycolic acid reacts with the upper layer of the epidermis, weakening the binding properties of the lipids that hold the dead skin cells together. This allows the outer skin to dissolve, revealing the underlying skin. It is thought that this is due to the reduction of calcium ion concentrations in the epidermis and the removal of calcium ions from cell adhesions, leading to desquamation. Glycolic acid is a known inhibitor of tyrosinase. This can suppress melanin formation and lead to a lightening of skin colour. Acute doses of glycolic acid on skin or eyes leads to local effects that are typical of a strong acid (e.g. dermal and eye irritation). Glycolate is a nephrotoxin if consumed orally. A nephrotoxin is a compound that causes damage to the kidney and kidney tissues. Glycolic acid's renal toxicity is due to its metabolism to oxalic acid. Glycolic and oxalic acid, along with excess lactic acid, are responsible for the anion gap metabolic acidosis. Oxalic acid readily precipitates with calcium to form insoluble calcium oxalate crystals. Renal tissue injury is caused by widespread deposition of oxalate crystals and the toxic effects of glycolic acid. Glycolic acid does exhibit some inhalation toxicity and can cause respiratory, thymus, and liver damage if present in very high levels over long periods of time.",Glycolic acid,HMDB0000115,b,b,C00160,GLYCOLLATE,FDB003298,glyclt,[H]OC([H])([H])C([O-])=O,AEMRFAOFKBGASW-UHFFFAOYSA-M,"InChI=1S/C2H4O3/c3-1-2(4)5/h3H,1H2,(H,4,5)/p-1"
2008,76649,astressin,"A 30-membered homodetic cyclic peptide comprising the sequence D-Phe-His-Leu-Leu-Arg-Glu-Val-Leu-Glu-Nle-Ala-Arg-Ala-Glu-Gln-Leu-Ala-Gln-Glu-Ala-His-Lys-Asn-Arg-Lys-Leu-Nle-Glu-Ile-Ile-NH2 cyclised by an amide bridge, formed by condensation of the side-chain carboxy group of the Glu residue at position 19 and the side-chain amino group of the Lys residue at position 22.",33563,KEGG COMPOUND accession,C05005,,,,,,,,,,,,,,,
2009,76680,"(2E,12Z,15Z,18Z,21Z,24Z,27Z)-triacontaheptaenoyl-CoA","An unsaturated fatty acyl-CoA that results from the formal condensation of the thiol group of coenzyme A with the carboxy group of (2E,12Z,15Z,18Z,21Z,24Z,27Z)-triacontaheptaenoic acid.",17573,KEGG COMPOUND accession,C02283,,,,,,,,,,,,,,,
2010,76686,"(3R,18Z,21Z,24Z,27Z,30Z,33Z)-3-hydroxyhexatriacontahexaenoyl-CoA","An unsaturated fatty acyl-CoA that results from the formal condensation of the thiol group of coenzyme A with the carboxy group of (3R,18Z,21Z,24Z,27Z,30Z,33Z)-3-hydroxyhexatriacontahexaenoic acid.",29807,KEGG COMPOUND accession,C02284,,,,,,,,,,,,,,,
2011,76694,EC 5.3.* (intramolecular oxidoreductase) inhibitor,An isomerase inhibitor that interferes with the action of an intramolecular oxidoreductase (EC 5.3.*.*).,27744,KEGG COMPOUND accession,C01705,,,,,,,,,,,,,,,
2012,76722,2-hydroxybehenate,"A 2-hydroxy fatty acid anion that is the conjugate base of 2-hydroxybehenic acid, obtained by deprotonation of the carboxy group; major species at pH 7.3.",16344,KEGG COMPOUND accession,C00581,gudac,352-97-6,16344.0,"Human Metabolome Database (HMDB): Guanidoacetic acid is a metabolite in the Urea cycle and metabolism of amino groups, and in the metabolic pathways of several amino acids. This includes glycine, serine, threonine, arginine and proline metabolism. Guanidinoacetic acid is also a precursor of creatine, an essential substrate for muscle energy metabolism.",Guanidoacetic acid,HMDB0000128,b,b,C00581,GUANIDOACETIC_ACID,FDB021898,gudac,[H]N([H])C(N([H])C([H])([H])C([O-])=O)=[N+]([H])[H],BPMFZUMJYQTVII-UHFFFAOYSA-N,"InChI=1S/C3H7N3O2/c4-3(5)6-1-2(7)8/h1H2,(H,7,8)(H4,4,5,6)"
2013,76728,2-hydroxyhexacosanoate,"A 2-hydroxy fatty acid anion that is the conjugate base of 2-hydroxyhexacosanoic acid (2-hydroxycerotic acid), obtained by deprotonation of the carboxy group; major species at pH 7.3.",16235,KEGG COMPOUND accession,C00242,gua,73-40-5,16235.0,"Human Metabolome Database (HMDB): Guanine is one of the five main nucleobases found in the nucleic acids DNA and RNA. Guanine is a derivative of purine, consisting of a fused pyrimidine-imidazole ring system with conjugated double bonds. Being unsaturated, the bicyclic molecule is planar. The guanine nucleoside is called guanosine. The first isolation of guanine was reported in 1844 from the excreta of sea birds, known as guano, which was used as a source of fertilizer. High affinity binding of guanine nucleotides and the ability to hydrolyze bound GTP to GDP are characteristics of an extended family of intracellular proteins. Guanine nucleotide-binding regulatory proteins may be involved in the activation of phospholipases C and A2 by hormones and other ligands. The binding of hormones to receptors that activate phospholipase C is decreased by guanine nucleotides and these hormones also stimulate a high-affinity GTPase activity in cell membranes. Effects of hormones on phospholipase C activity in cell-free preparations are dependent on the presence of guanine nucleotides. Hypoxanthine-guanine phosphoribosyltransferase (HPRT, EC 2.4.2.8) is a purine salvage enzyme that catalyses the conversion of hypoxanthine and guanine to their respective mononucleotides. Partial deficiency of this enzyme can result in the overproduction of uric acid leading to a severe form of gout, whilst a virtual absence of HPRT activity causes the Lesch-Nyhan syndrome, an inborn error of metabolism, which is characterised by hyperuricaemia, mental retardation, choreoathetosis and compulsive self-mutilation. Peroxynitrite induces DNA base damage predominantly at guanine (G) and 8-oxoguanine (8-oxoG) nucleobases via oxidation reactions. G and 8-oxoG are the most reactive bases toward Peroxynitrite and possibly the major contributors to peroxynitrite-derived genotoxic and mutagenic lesions. The neutral G radical, reacts with NO2 to yield 8-nitroguanine and 5-nitro-4-guanidinohydantoin (PMID: 16352449, 2435586, 2838362, 1487231).",Guanine,HMDB0000132,b,b,C00242,GUANINE,FDB004222,gua,[H]N([H])C1=NC2=C(N=C([H])N2[H])C(=O)N1[H],UYTPUPDQBNUYGX-UHFFFAOYSA-N,"InChI=1S/C5H5N5O/c6-5-9-3-2(4(11)10-5)7-1-8-3/h1H,(H4,6,7,8,9,10,11)"
2014,76740,EC 1.13.* [oxidoreductase acting on single donors with incorporation of molecular oxygen (oxygenases)] inhibitor,"An oxidoreductase inhibitor which interferes with the action of an oxidoreductase acting on single donors with incorporation of molecular oxygen (oxygenases), EC 1.13.*.*.",17552,KEGG COMPOUND accession,C00035,gdp,146-91-8,17552.0,"Human Metabolome Database (HMDB): Guanosine 5'-(trihydrogen diphosphate). A guanine nucleotide containing two phosphate groups esterified to the sugar moiety. It is an ester of pyrophosphoric acid with the nucleoside guanosine. GDP consists of the pyrophosphate group, the pentose sugar ribose, and the nucleobase guanine. GDP is the product of GTP dephosphorylation by GTPases, e.g. the G-proteins that are involved in signal transduction.",Guanosine diphosphate,HMDB0001201,b,b,C00035,GDP,FDB022487,gdp,[H]O[C@@]1([H])[C@@]([H])(O[C@]([H])(C([H])([H])OP([O-])(=O)OP([O-])([O-])=O)[C@@]1([H])O[H])N1C([H])=NC2=C1N=C(N([H])[H])N([H])C2=O,QGWNDRXFNXRZMB-UUOKFMHZSA-K,"InChI=1S/C10H15N5O11P2/c11-10-13-7-4(8(18)14-10)12-2-15(7)9-6(17)5(16)3(25-9)1-24-28(22,23)26-27(19,20)21/h2-3,5-6,9,16-17H,1H2,(H,22,23)(H2,19,20,21)(H3,11,13,14,18)/p-3/t3-,5-,6-,9-/m1/s1"
2015,76800,pikromycin(1+),"An organic cation that is the conjugate acid of pikromycin, obtained by protonation of the tertiary amino group; major species at pH 7.3.",30413,KEGG COMPOUND accession,C00032,pheme,14875-96-8,17627.0,"Human Metabolome Database (HMDB): Heme is the color-furnishing portion of hemoglobin. It is found free in tissues and as the prosthetic group in many hemeproteins. A heme or haem is a prosthetic group that consists of an iron atom contained in the center of a large heterocyclic organic ring called a porphyrin. Not all porphyrins contain iron, but a substantial fraction of porphyrin-containing metalloproteins have heme as their prosthetic subunit; these are known as hemoproteins.",Heme,HMDB0003178,b,b,C00032,HEME_A,FDB016272,pheme,[H]C([H])=C([H])C1=C(C2=C([H])C3=[N+]4C(=C([H])C5=C(C(=C6C([H])=C7C(C([H])=C([H])[H])=C(C8=[N+]7[Fe--]4(N2C1=C8[H])N56)C([H])([H])[H])C([H])([H])[H])C([H])([H])C([H])([H])C([O-])=O)C(=C3C([H])([H])[H])C([H])([H])C([H])([H])C([O-])=O)C([H])([H])[H],KABFMIBPWCXCRK-RGGAHWMASA-J,"InChI=1S/C34H34N4O4.Fe/c1-7-21-17(3)25-13-26-19(5)23(9-11-33(39)40)31(37-26)16-32-24(10-12-34(41)42)20(6)28(38-32)15-30-22(8-2)18(4)27(36-30)14-29(21)35-25;/h7-8,13-16H,1-2,9-12H2,3-6H3,(H4,35,36,37,38,39,40,41,42);/q;+2/p-4/b25-13-,26-13-,27-14-,28-15-,29-14-,30-15-,31-16-,32-16-;"
2016,76815,EC 2.7.7.* (nucleotidyltransferase) inhibitor,An EC 2.7.* (P-containing group transferase) inhibitor that interferes with the action of any nucleotidyltransferase (EC 2.7.7.*).,28304,KEGG COMPOUND accession,C00374,,,,,,,,,,,,,,,
2017,76870,"EC 1.9.3.* (oxidoreductase acting on donor heme group, oxygen as acceptor) inhibitor",An EC 1.9.* (oxidoreductase acting on donor heme group) inhibitor that interferes with the action of any such enzyme using oxygen as acceptor (EC 1.9.3.*).,28415,KEGG COMPOUND accession,C08381,,,,,,,,,,,,,,,
2018,76881,EC 2.7.1.* (phosphotransferases with an alcohol group as acceptor) inhibitor,An EC 2.7.* (P-containing group transferase) inhibitor that interferes with the action of any phosphotransferase with an alcohol group as acceptor (EC 2.7.1.*).,15525,KEGG COMPOUND accession,C00154,pmtcoa,b,15525.0,Human Metabolome Database (HMDB): Palmityl-CoA is a fatty acid coenzyme derivative which plays a key role in fatty acid oxidation and biosynthesis.,Palmityl-CoA,HMDB0001338,b,b,C00154,PALMITYL-COA,FDB022562,pmtcoa,[H]O[C@@]([H])(C(=O)N([H])C([H])([H])C([H])([H])C(=O)N([H])C([H])([H])C([H])([H])SC(=O)C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H])C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])OP([O-])(=O)OP([O-])(=O)OC([H])([H])[C@@]1([H])O[C@@]([H])(N2C([H])=NC3=C(N=C([H])N=C23)N([H])[H])[C@]([H])(O[H])[C@]1([H])OP([O-])([O-])=O,MNBKLUUYKPBKDU-BBECNAHFSA-J,"InChI=1S/C37H66N7O17P3S/c1-4-5-6-7-8-9-10-11-12-13-14-15-16-17-28(46)65-21-20-39-27(45)18-19-40-35(49)32(48)37(2,3)23-58-64(55,56)61-63(53,54)57-22-26-31(60-62(50,51)52)30(47)36(59-26)44-25-43-29-33(38)41-24-42-34(29)44/h24-26,30-32,36,47-48H,4-23H2,1-3H3,(H,39,45)(H,40,49)(H,53,54)(H,55,56)(H2,38,41,42)(H2,50,51,52)/p-4/t26-,30-,31-,32+,36-/m1/s1"
2019,76881,EC 2.7.1.* (phosphotransferases with an alcohol group as acceptor) inhibitor,An EC 2.7.* (P-containing group transferase) inhibitor that interferes with the action of any phosphotransferase with an alcohol group as acceptor (EC 2.7.1.*).,15525,KEGG COMPOUND accession,C00154,ptth,1763-10-6,15525.0,Human Metabolome Database (HMDB): Palmityl-CoA is a fatty acid coenzyme derivative which plays a key role in fatty acid oxidation and biosynthesis.,Palmityl-CoA,HMDB0001338,b,b,C00154,PALMITYL-COA,FDB022562,ptth,[H]OC([H])([H])C(C([H])([H])[H])(C([H])([H])[H])[C@@]([H])(O[H])C(=O)N([H])C([H])([H])C([H])([H])C(=O)N([H])C([H])([H])C([H])([H])S[H],ZNXZGRMVNNHPCA-VIFPVBQESA-N,"InChI=1S/C11H22N2O4S/c1-11(2,7-14)9(16)10(17)13-4-3-8(15)12-5-6-18/h9,14,16,18H,3-7H2,1-2H3,(H,12,15)(H,13,17)/t9-/m0/s1"
2020,76918,(R)-nisoldipine,"A methyl 2-methylpropyl 2,6-dimethyl-4-(2-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate that has R configuration.",17120,KEGG COMPOUND accession,C01585,,,,,,,,,,,,,,,
2021,76950,(-)-ent-copalol,A labdane diterpenoid in which the labdane skeleton has double bonds at positions 8(17) and 13 (the latter with E-stereochemistry) and carries a hydroxy group at the terminal C-15 position.,18089,KEGG COMPOUND accession,C01586,bgly,495-69-2,18089.0,"Human Metabolome Database (HMDB): Hippuric acid is an acyl glycine formed by the conjugation of benzoic aicd with glycine. Acyl glycines are produced through the action of glycine N-acyltransferase (EC 2.3.1.13) which is an enzyme that catalyzes the chemical reaction: acyl-CoA + glycine < -- > CoA + N-acylglycine. Hippuric acid is a normal component of urine and is typically increased with increased consumption of phenolic compounds (tea, wine, fruit juices). These phenols are converted to benzoic acid which is then converted to hippuric acid and excreted in the urine. Hippuric acid is the most frequently used biomarker in the biological monitoring of occupational exposure to toluene. This product of solvent biotransformation may be also found in the urine of individuals who have not been exposed to the solvent. A smaller fraction of the absorbed toluene is oxidized to aromatic compounds including ortho-cresol, which is not found significantly in the urine of nonexposed individuals. The concentration of hippuric acid in the urine of individuals exposed to a low toluene concentration does not differ from that of individuals not exposed to the solvent. This has led to the conclusion that hippuric acid should not be utilized in the biological monitoring of occupational exposure to low levels of toluene in the air. Protein-bound organic acids such as hippuric acid are markedly accumulated in uremic plasma and produce defective protein binding of drugs (PMID: 9120876, 8734460). Hippuric acid is found to be associated with phenylketonuria, propionic acidemia, and tyrosinemia I, which are inborn errors of metabolism.",Hippuric acid,HMDB0000714,b,b,C01586,b,FDB001819,bgly,[H]N(C(=O)C1=C([H])C([H])=C([H])C([H])=C1[H])C([H])([H])C([O-])=O,QIAFMBKCNZACKA-UHFFFAOYSA-M,"InChI=1S/C9H9NO3/c11-8(12)6-10-9(13)7-4-2-1-3-5-7/h1-5H,6H2,(H,10,13)(H,11,12)/p-1"
2022,76950,(-)-ent-copalol,A labdane diterpenoid in which the labdane skeleton has double bonds at positions 8(17) and 13 (the latter with E-stereochemistry) and carries a hydroxy group at the terminal C-15 position.,18089,KEGG COMPOUND accession,C01586,CE2934,42013-20-7,613303.0,"Human Metabolome Database (HMDB): Methylhippuric acid is an acyl glycine. Acyl glycines are normally minor metabolites of fatty acids. However, the excretion of certain acyl glycines is increased in several inborn errors of metabolism. In certain cases the measurement of these metabolites in body fluids can be used to diagnose disorders associated with mitochondrial fatty acid beta-oxidation. Acyl glycines are produced through the action of glycine N-acyltransferase (EC 2.3.1.13) which is an enzyme that catalyzes the chemical reaction:. acyl-CoA + glycine < -- > CoA + N-acylglycine. Methylhippuric acid is a metabolite of xylene which is an aromatic hydrocarbon widely used as a solvant. It's level can be measured in urine of workers exposed to xylene (PMID 8689499).",2-Methylhippuric acid,HMDB0011723,b,b,C01586,b,FDB028406,CE2934,[H]OC(=O)C([H])([H])N([H])C(=O)C1=C([H])C([H])=C([H])C([H])=C1C([H])([H])[H],YOEBAVRJHRCKRE-UHFFFAOYSA-N,"InChI=1S/C10H11NO3/c1-7-4-2-3-5-8(7)10(14)11-6-9(12)13/h2-5H,6H2,1H3,(H,11,14)(H,12,13)"
2023,76953,"17(R),18(S)-EETeTr","A 17(18)-EpETE in which the epoxy group has (17R,18S)-configuration.",18295,KEGG COMPOUND accession,C00388,hista,51-45-6,18295.0,"Human Metabolome Database (HMDB): Histamine is an amine derived by enzymatic decarboxylation of histidine. It is a powerful stimulant of gastric secretion, a constrictor of bronchial smooth muscle, a vasodilator, and also a centrally acting neurotransmitter.",Histamine,HMDB0000870,b,b,C00388,HISTAMINE,FDB012596,hista,[H]N1C([H])=NC(=C1[H])C([H])([H])C([H])([H])[N+]([H])([H])[H],NTYJJOPFIAHURM-UHFFFAOYSA-O,"InChI=1S/C5H9N3/c6-2-1-5-3-7-4-8-5/h3-4H,1-2,6H2,(H,7,8)/p+1"
2024,76965,20-oxoarachidonic acid,A polyunsaturated fatty acid that is arachidonic acid substituted at position 20 by an oxo group.,27747,KEGG COMPOUND accession,C01924,,,,,,,,,,,,,,,
2025,76983,N-sulfonylurea,"A urea in which one of the hydrogens attached to a nitrogen of the urea group is replaced by a sulfonyl group. The N-sulfonylurea moiety is a key group in various herbicides, as well as in a number of antidiabetic drugs used in the management of type 2 diabetis mellitus.",16169,KEGG COMPOUND accession,C00544,hgentis,451-13-8,44747.0,"Human Metabolome Database (HMDB): Homogentisic acid, also known as melanic acid, is an intermediate in the breakdown or catabolism of tyrosine and phenylalanine. It is generated from the compound p-hydroxyphenylpyruvate through the enzyme p-hydroxyphenylpyruvate dehydrogenase. The resulting homogentisic acid is then broken down into 4-maleylacetoacetate via the enzyme homogentisate 1,2-dioxygenase. Homogentisic acid is also found in other organisms. For instance, it can found in Arbutus unedo (strawberry-tree) honey, in the bacterial plant pathogen Xanthomonas campestris as well as in the yeast Yarrowia lipolytica where it is associated with the production of brown pigments. Homogentisic acid can be oxidatively dimerized to form hipposudoric acid, one of the main constituents of the 'blood sweat' of hippopotamuses. When present in sufficiently high levels, homogentisic acid can function as an osteotoxin and a renal toxin. An osteotoxin is a substance that causes damage to bones and/or joints. A renal toxin causes damage to the kidneys. Chronically high levels of homogentisic acid are associated with alkaptonuria (OMIM: 203500), an inborn error of metabolism. Alkaptonuria is a rare inherited genetic disorder in which the body cannot process the amino acids phenylalanine and tyrosine. It is caused by a mutation in the enzyme homogentisate 1,2-dioxygenase (EC 1.13.11.5), which leads to an accumulation of homogentisic acid in the blood and tissues. Homogentisic acid and its oxidized form benzoquinone acetic acid are excreted in the urine, giving it an unusually dark color. The accumulating homogentisic acid (and benzoquinone acetic acid) causes damage to cartilage (ochronosis, leading to osteoarthritis) and heart valves as well as precipitating as kidney stones and stones in other organs. More specifically, homogentisic acid can be converted to benzoquinone acetic acid (BQA), and the resulting BQA can be readily converted to polymers that resemble the dark skin pigment melanin. These polymers are deposited in the collagen, a connective tissue protein, of particular tissues such as cartilage. This process is called ochronosis (as the tissue looks ochre); ochronotic tissue is stiffened and unusually brittle, impairing its normal function and causing damage. Homogentisic acid is the primary precursor of melanin synthesis in Vibrio cholerae.",Homogentisic acid,HMDB0000130,b,b,C00544,b,FDB021899,hgentis,[H]OC1=C([H])C([H])=C(O[H])C(=C1[H])C([H])([H])C([O-])=O,IGMNYECMUMZDDF-UHFFFAOYSA-M,"InChI=1S/C8H8O4/c9-6-1-2-7(10)5(3-6)4-8(11)12/h1-3,9-10H,4H2,(H,11,12)/p-1"
2026,76987,metacetamol,"A derivative of phenol which has an acetamido substituent located meta to the phenolic -OH group. It is a non-toxic regioisomer of paracetamol with analgesic properties, but has never been marketed as a drug.",30904,KEGG COMPOUND accession,C05662,,,,,,,,,,,,,,,
2027,76995,alpha-naphthoflavone,"An extended flavonoid resulting from the formal fusion of a benzene ring with the h side of flavone. A synthetic compound, it is an inhibitor of aromatase (EC 1.14.14.14).",16336,KEGG COMPOUND accession,C00518,ha,9004-61-9,b,"Human Metabolome Database (HMDB): Hyaluronic acid (HA), is the most abundant glycosaminoglycan (GAG) in mammalian tissue. It is present in high concentrations in connective tissue, such as skin, vitreous humor, cartilage, and umbilical cord, but the largest single reservoir is the synovial fluid (SF) of the diarthrodial joints, where concentrations of 0.5-4 mg/mL are achieved. Hyaluronic acid, is the major hydrodynamic nonprotein component of joint SF. Its unique viscoelastic properties confer remarkable shock absorbing and lubricating abilities to SF, while its enormous macromolecular size and hydrophilicity serve to retain fluid in the joint cavity during articulation. HA restricts the entry of large plasma proteins and cells into SF but facilitates solute exchange between the synovial capillaries and cartilage and other joint tissues. In addition, HA can form a pericellular coat around cells, interact with proinflammatory mediators, and bind to cell receptors, such as cluster determinant (CD)44 and receptor for hyaluronate-mediated motility (RHAMM), where it modulates cell proliferation, migration, and gene expression. All these physicochemical and biologic properties of HA have been shown to be molecular weight (MW) dependent. The diverse physicochemical properties of HA arise from its unique macromolecular structure. The HA is an exceptionally long (3-30 &#956;m) and unbranched nonsulfated GAG composed of repeating disaccharide units of N-acetylglucosamine, and glucuronic acid glycosidically linked through their respective 1-4 ring positions. Hydroxyl group oxygens at the glucuronyl-1 and glucosamine 3-positions are used for further polymerization of the HA disaccharide units to form chains that, when released from the cell plasma membrane, are of variable length and thus polydispersity. Despite the simplicity of the HA primary structure, this linear polyelectrolyte adopts complex conformations in solution, which engender it with diverse biologic properties. Within the joint cavity, HA molecules are predominately synthesized by the type B synovial cells. (PMID 12219318).",Hyaluronic acid,HMDB0002061,b,b,C00518,b,FDB022824,ha,[Na+].[H]OC(=O)[C@@]1([H])O[C@@]([H])(O[C@@]2([H])[C@]([H])(O[H])[C@]([H])(O[C@@]([H])(O[C@]3([H])[C@]([H])(O[C@@]([H])(O[C@@]4([H])[C@]([H])(O[H])[C@]([H])(O[C@@]([H])(O[H])[C@]4([H])N=C(O[H])C([H])([H])[H])C([H])([H])O[H])[C@]([H])(O[H])[C@@]3([H])O[H])C(=O)O[H])[C@]2([H])N=C(O[H])C([H])([H])[H])C([H])([H])O[H])[C@]([H])(O[H])[C@@]([H])(O[H])[C@]1([H])O[H],YWIVKILSMZOHHF-QJZPQSOGSA-N,"InChI=1S/C28H44N2O23.Na/c1-5(33)29-9-18(11(35)7(3-31)47-25(9)46)49-28-17(41)15(39)20(22(53-28)24(44)45)51-26-10(30-6(2)34)19(12(36)8(4-32)48-26)50-27-16(40)13(37)14(38)21(52-27)23(42)43;/h7-22,25-28,31-32,35-41,46H,3-4H2,1-2H3,(H,29,33)(H,30,34)(H,42,43)(H,44,45);/q;+1/t7-,8-,9-,10-,11-,12-,13+,14+,15-,16-,17-,18-,19-,20+,21+,22+,25-,26+,27-,28-;/m1./s1"
2028,77000,1-oleoyl-2-lauroyl-sn-glycero-3-phospho-(1'-sn-glycerol)(1-),"A 1,2-diacyl-sn-glycero-3-phospho-(1'-sn-glycerol)(1-) obtained by deprotonation of the phosphate group of 1-oleoyl-2-lauroyl-sn-glycero-3-phospho-(1'-sn-glycerol); major species at pH 7.3.",27612,KEGG COMPOUND accession,C05146,,,,,,,,,,,,,,,
2029,77020,EC 1.10.99.2 [ribosyldihydronicotinamide dehydrogenase (quinone)] inhibitor,"An EC 1.10.99.* (oxidoreductases acting on diphenols and related substances as donors, other acceptors) inhibitor that interferes with the action of ribosyldihydronicotinamide dehydrogenase (quinone), EC 1.10.99.2.",24636,KEGG COMPOUND accession,C00080,h,12408-02-5,15378.0,"Human Metabolome Database (HMDB): Hydrogen ion is recommended by IUPAC as a general term for all ions of hydrogen and its isotopes.  Depending on the charge of the ion, two different classes can be distinguished: positively charged ions and negatively charged ions. Under aqueous conditions found in biochemistry, hydrogen ions exist as the hydrated form hydronium, H3O+, but these are often still referred to as hydrogen ions or even protons by biochemists. [Wikipedia])",Hydrogen Ion,HMDB0059597,b,b,C00080,b,b,h,[H+],GPRLSGONYQIRFK-UHFFFAOYSA-N,InChI=1S/p+1
2030,77030,3-(5-oxoisoxazolin-4-yl)-L-alanine,A member of the class of isoxazoles that is L-alanine in which one of the methyl hydrogens is replaced by a 5-oxoisoxazolin-4-yl group.,16136,KEGG COMPOUND accession,C00283,HC00250,b,16136.0,"Human Metabolome Database (HMDB): Hydrogen sulfide is a highly toxic and flammable gas. Because it is heavier than air it tends to accumulate at the bottom of poorly ventilated spaces. Although very pungent at first, it quickly deadens the sense of smell, so potential victims may be unaware of its presence until it is too late. H2S arises from virtually anywhere where elemental sulfur comes into contact with organic material, especially at high temperatures. Hydrogen sulfide is a covalent hydride chemically related to water (H2O) since oxygen and sulfur occur in the same periodic table group. It often results when bacteria break down organic matter in the absence of oxygen, such as in swamps, and sewers (alongside the process of anaerobic digestion). It also occurs in volcanic gases, natural gas and some well waters. It is also important to note that Hydrogen sulfide is a central participant in the sulfur cycle, the biogeochemical cycle of sulfur on Earth. As mentioned above, sulfur-reducing and sulfate-reducing bacteria derive energy from oxidizing hydrogen or organic molecules in the absence of oxygen by reducing sulfur or sulfate to hydrogen sulfide. Other bacteria liberate hydrogen sulfide from sulfur-containing amino acids. Several groups of bacteria can use hydrogen sulfide as fuel, oxidizing it to elemental sulfur or to sulfate by using oxygen or nitrate as oxidant. The purple sulfur bacteria and the green sulfur bacteria use hydrogen sulfide as electron donor in photosynthesis, thereby producing elemental sulfur. (In fact, this mode of photosynthesis is older than the mode of cyanobacteria, algae and plants which uses water as electron donor and liberates oxygen).",Hydrogen sulfide,HMDB0003276,b,b,C00283,HS,FDB009599,HC00250,[S-][H],RWSOTUBLDIXVET-UHFFFAOYSA-M,InChI=1S/H2S/h1H2/p-1
2031,77071,(R)-eperisone,A 1-(4-ethylphenyl)-2-methyl-3-(piperidin-1-yl)propan-1-one that has R configuration.,27957,KEGG COMPOUND accession,C05235,acetol,116-09-6,27957.0,"Human Metabolome Database (HMDB): Hydroxyacetone is an intermediate in glycine, serine and threonine metabolism (KEGG: C05235). It is generated from methylglyoxal via the oxidoreductases [EC 1.1.1.-].",Hydroxyacetone,HMDB0006961,b,b,C05235,ACETOL,FDB012041,acetol,[H]OC([H])([H])C(=O)C([H])([H])[H],XLSMFKSTNGKWQX-UHFFFAOYSA-N,"InChI=1S/C3H6O2/c1-3(5)2-4/h4H,2H2,1H3"
2032,77126,"1,2-diarachidonoyl-sn-glycero-3-phosphate(2-)","A 1-acyl-2-arachidonoyl-sn-glycerol 3-phosphate(2-) obtained by deprotonation of the phosphate OH groups of 1,2-diarachidonoyl-sn-glycero-3-phosphate; major species at pH 7.3.",28902,KEGG COMPOUND accession,C02720,,,,,,,,,,,,,,,
2033,77209,"(10Z,13Z,16Z,19Z,22Z,25Z)-octacosahexaenoate","A polyunsaturated fatty acid anion that is the conjugate base of (10Z,13Z,16Z,19Z,22Z,25Z)-octacosahexaenoic acid, obtained by deprotonation of the carboxy group; major species at pH 7.3.",17406,KEGG COMPOUND accession,C03277,,,,,,,,,,,,,,,
2034,77212,"(17Z,20Z,23Z,26Z,29Z)-dotriacontapentaenoate","A polyunsaturated fatty acid anion that is the conjugate base of (17Z,20Z,23Z,26Z,29Z)-dotriacontapentaenoic acid, obtained by deprotonation of the carboxy group; major species at pH 7.3.",16069,KEGG COMPOUND accession,C01589,,,,,,,,,,,,,,,
2035,77214,"(19Z,22Z,25Z,28Z,31Z)-tetratriacontapentaenoate","A polyunsaturated fatty acid anion that is the conjugate base of (19Z,22Z,25Z,28Z,31Z)-tetratriacontapentaenoic acid, obtained by deprotonation of the carboxy group; major species at pH 7.3.",24773,KEGG COMPOUND accession,C05568,,,,,,,,,,,,,,,
2036,77219,"(9Z,12Z)-hexadecadienoate","A polyunsaturated fatty acid anion that is the conjugate base of (9Z,12Z)-hexadecadienoic acid, obtained by deprotonation of the carboxy group; major species at pH 7.3.",16974,KEGG COMPOUND accession,C02835,im4ac,645-65-8,16974.0,Human Metabolome Database (HMDB): Imidazoleacetic acid is a metabolite product of Histamine metabolism. It is present in normal urine and increased in histidinemic patients. (PMID 6530403).,Imidazoleacetic acid,HMDB0002024,b,b,C02835,4-IMIDAZOLEACETATE,FDB012464,im4ac,[H]N1C([H])=NC(=C1[H])C([H])([H])C([O-])=O,PRJKNHOMHKJCEJ-UHFFFAOYSA-M,"InChI=1S/C5H6N2O2/c8-5(9)1-4-2-6-3-7-4/h2-3H,1H2,(H,6,7)(H,8,9)/p-1"
2037,77236,"(23Z,26Z,29Z,32Z)-octatriacontatetraenoate","An octatriacontatetraenoate that is the conjugate base of (23Z,26Z,29Z,32Z)-octatriacontatetraenoic acid, obtained by deprotonation of the carboxy group; major species at pH 7.3.",16697,KEGG COMPOUND accession,C01710,,,,,,,,,,,,,,,
2038,77244,"(10Z,13Z,16Z,19Z,22Z)-octacosapentaenoyl-CoA(4-)","An acyl-CoA(4-) obtained by deprotonation of the phosphate and diphosphate OH groups of (10Z,13Z,16Z,19Z,22Z)-octacosapentaenoyl-CoA; major species at pH 7.3.",16881,KEGG COMPOUND accession,C00463,indole,120-72-9,16881.0,"Human Metabolome Database (HMDB): Indole is an aromatic heterocyclic organic compound. It has a bicyclic structure, consisting of a six-membered benzene ring fused to a five-membered nitrogen-containing pyrrole ring. It can be produced by bacteria as a degradation product of the amino acid tryptophan. It occurs naturally in human feces and has an intense fecal smell. At very low concentrations, however, it has a flowery smell, and is a constituent of many flower scents (such as orange blossoms) and perfumes. Natural jasmine oil, used in the perfume industry, contains around 2.5% of indole. Indole also occurs in coal tar. The participation of the nitrogen lone electron pair in the aromatic ring means that indole is not a base, and it does not behave like a simple amine.",Indole,HMDB0000738,b,b,C00463,INDOLE,FDB012008,b,[H]N1C([H])=C([H])C2=C1C([H])=C([H])C([H])=C2[H],SIKJAQJRHWYJAI-UHFFFAOYSA-N,"InChI=1S/C8H7N/c1-2-4-8-7(3-1)5-6-9-8/h1-6,9H"
2039,77251,"(25S)-3alpha,7alpha,12alpha-trihydroxy-5beta-cholestan-26-oyl-CoA(4-)","An acyl-CoA(4-) oxoanion arising from deprotonation of the phosphate and diphosphate OH groups of (25S)-3alpha,7alpha,12alpha-trihydroxy-5beta-cholestan-26-oyl-CoA; major species at pH 7.3.",18086,KEGG COMPOUND accession,C00637,id3acald,2591-98-2,18086.0,"Human Metabolome Database (HMDB): Indoleacetaldehyde is a substrate for Retina-specific copper amine oxidase, Aldehyde dehydrogenase X (mitochondrial), Amine oxidase B, Amiloride-sensitive amine oxidase, Aldehyde dehydrogenase (mitochondrial), Fatty aldehyde dehydrogenase, 4-trimethylaminobutyraldehyde dehydrogenase, Aldehyde dehydrogenase (dimeric NADP-preferring), Aldehyde dehydrogenase family 7 member A1, Amine oxidase A, Aldehyde dehydrogenase 1A3 and Membrane copper amine oxidase.",Indoleacetaldehyde,HMDB0001190,b,b,C00637,INDOLE_ACETALDEHYDE,FDB013950,id3acald,[H]N1C([H])=C(C2=C([H])C([H])=C([H])C([H])=C12)C([H])([H])C([H])=O,WHOOUMGHGSPMGR-UHFFFAOYSA-N,"InChI=1S/C10H9NO/c12-6-5-8-7-11-10-4-2-1-3-9(8)10/h1-4,6-7,11H,5H2"
2040,77260,"5-methoxy-2-{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl}-1H-benzimidazole","A member of the class of benzimidazoles that is 1H-benzimidazole which is substituted by a [4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl group at position 2 and a methoxy group at position 5.",16411,KEGG COMPOUND accession,C00954,ind3ac,87-51-4,16411.0,"Human Metabolome Database (HMDB): Indoleacetic acid (IAA) is a breakdown product of tryptophan metabolism and is often produced by the action of bacteria in the mammalian gut. Some endogenous production of IAA in mammalian tissues also occurs. It may be produced by the decarboxylation of tryptamine or the oxidative deamination of tryptophan. IAA frequently occurs at low levels in urine and has been found in elevated levels in the urine of patients with phenylketonuria ((PMID: 13610897). Using material extracted from human urine, it was discovered by Kogl in 1933 that Indoleacetic acid is also an important plant hormone (PMID: 13610897). Specifically IAA is a member of the group of phytohormones called auxins. IAA is generally considered to be the most important native auxin. Plant cells synthesize IAA from tryptophan. (wikipedia) IAA and some derivatives can be oxidised by horseradish peroxidase (HRP) to cytotoxic species. IAA is only toxic after oxidative decarboxylation; the effect of IAA/HRP is thought to be due in part to the formation of methylene-oxindole, which may conjugate with DNA bases and protein thiols. IAA/HRP could be used as the basis for targeted cancer, a potential new role for plant auxins in cancer therapy. (PMID: 11163327).",Indoleacetic acid,HMDB0000197,b,b,C00954,b,FDB000933,ind3ac,[H]N1C([H])=C(C2=C([H])C([H])=C([H])C([H])=C12)C([H])([H])C([O-])=O,SEOVTRFCIGRIMH-UHFFFAOYSA-M,"InChI=1S/C10H9NO2/c12-10(13)5-7-6-11-9-4-2-1-3-8(7)9/h1-4,6,11H,5H2,(H,12,13)/p-1"
2041,77276,"1-stearoyl-2-arachidonoyl-sn-glycero-3-phospho-1D-myo-inositol 4,5-biphosphate","A 1-phosphatidyl-1D-myo-inositol 4,5-bisphosphate in which the phosphatidyl acyl groups at positions 1 and 2 are specified as stearoyl and arachidonoyl respectively.",17890,KEGG COMPOUND accession,C00955,,,,,,,,,,,,,,,
2042,77286,1-(Z)-alk-1-enyl-2-acyl-sn-glycero-3-phosphocholine,A 1-O-(alk-1-enyl)-2-O-acyl-sn-glycero-3-phosphocholine in which the alkenyl group has Z geochemistry.,29750,KEGG COMPOUND accession,C00331,,,,,,,,,,,,,,,
2043,77290,1-(Z)-alk-1-enyl-2-acyl-sn-glycero-3-phosphoethanolamine zwitterion,A 1-(alk-1-enyl)-2-acyl-sn-glycero-3-phosphoethanolamine zwitterion in which the alkenyl group has Z geochemistry.,27406,KEGG COMPOUND accession,C05579,M03163,b,27406.0,"Human Metabolome Database (HMDB): Indole-5,6-quinone is involved in the tyrosine metabolism pathway. More specifically, indole-5,6-quinone is an intermediate in the production of melanin. Indole-5,6-quinone is produced from 5,6-dihydroxyindole by tyrosinase [EC:1.14.18.1].","Indole-5,6-quinone",HMDB0006779,b,b,C05579,b,FDB024077,b,[H]N1C([H])=C([H])C2=C([H])C(=O)C(=O)C([H])=C12,IGGVVGHJSQSLFO-UHFFFAOYSA-N,"InChI=1S/C8H5NO2/c10-7-3-5-1-2-9-6(5)4-8(7)11/h1-4,9H"
2044,77296,1-(Z)-alk-1-enyl-2-acyl-sn-glycerol,A 1-(alk-1-enyl)-2-acyl-sn-glycerol in which the alk-1-enyl group has Z geochemistry.,28626,KEGG COMPOUND accession,C01819,,,,,,,,,,,,,,,
2045,77371,"(8Z,11Z,14Z,17Z,20Z,23Z)-hexacosahexaenoic acid","A very long-chain omega-3 fatty acid that is hexacosanoic acid having six double bonds located at positions 8, 11, 14, 17, 20, 23 (the 8Z,11Z,14Z,17Z,20Z,23Z-isomer).",30408,KEGG COMPOUND accession,C00824,,,,,,,,,,,,,,,
2046,77374,beta-D-GlcpNAc-(1->3)-beta-D-Galp-(1->4)-beta-D-Glcp-(1->4)-[alpha-D-GlcpNAc-(1->2)-3-PEA-L-alpha-D-Hepp-(1->3)]-L-alpha-D-Hepp-(1->5)-Kdo,"A branched oligosaccharide phosphate comprising a D-galactose residue, two N-acetyl-D-glucosamine residues, a D-glucose residue, two L-glycero-D-manno-heptose residues (one of which is phosphoethanolamine-substituted on O-3), with linkages as shown and with a 3-deoxy-D-manno-oct-2-ulosonic acid (2-keto-3-deoxy-D-mannooctanoic acid, Kdo) residue at the reducing end. Corresponds to the lgtB mutant of the core oligosaccharide of Neisseria meningitidis.",27539,KEGG COMPOUND accession,C11129,,,,,,,,,,,,,,,
2047,77386,tricaproin,A triglyceride obtained by condensation of each of the three hydroxy groups of glycerol with hexanoic (caproic) acid.,16087,KEGG COMPOUND accession,C00311,icit,320-77-4,30887.0,Human Metabolome Database (HMDB): The citrate oxidation to isocitrate is catalyzed by the enzyme aconitase. Human prostatic secretion is remarkably rich in citric acid and low aconitase activity will therefore play a significant role in enabling accumulation of high citrate levels (PubMed ID 8115279).,Isocitric acid,HMDB0000193,b,b,C00311,threo-d(s)-iso-citrate,FDB003281,icit,[H]OC([H])(C([O-])=O)C([H])(C([O-])=O)C([H])([H])C([O-])=O,ODBLHEXUDAPZAU-UHFFFAOYSA-K,"InChI=1S/C6H8O7/c7-3(8)1-2(5(10)11)4(9)6(12)13/h2,4,9H,1H2,(H,7,8)(H,10,11)(H,12,13)/p-3"
2048,77423,escitalopram hydrobromide,"A 1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-1,3-dihydro-2-benzofuran-5-carbonitrile hydrobromide resulting from the reaction of equimolar amounts of escitalopram and hydrogen bromide.",16483,KEGG COMPOUND accession,C00927,,,,,,,,,,,,,,,
2049,77430,alpha-L-Rhap-(1->3)-beta-D-Glcp-(1->4)-alpha-D-Glcp,"A linear trisaccharide comprised of alpha-L-rhamnose, beta-D-glucose and alpha-D-glucose residues linked sequentially (1->3) and (1->4).",16584,KEGG COMPOUND accession,C00129,ipdp,358-71-4,16584.0,"Human Metabolome Database (HMDB): Isopentenyl pyrophosphate, IPP or isopentenyl diphosphate, is an intermediate in the HMG-CoA reductase pathway used by organisms in the biosynthesis of terpenes and terpenoids. IPP is formed from Mevalonate-5-pyrophosphate, in a reaction catalyzed by the enzyme mevalonate-5-pyrophosphate decarboxylase. (wikipedia).",Isopentenyl pyrophosphate,HMDB0001347,b,b,C00129,b,FDB022569,ipdp,[H]C([H])=C(C([H])([H])[H])C([H])([H])C([H])([H])OP([O-])(=O)OP([O-])([O-])=O,NUHSROFQTUXZQQ-UHFFFAOYSA-K,"InChI=1S/C5H12O7P2/c1-5(2)3-4-11-14(9,10)12-13(6,7)8/h1,3-4H2,2H3,(H,9,10)(H2,6,7,8)/p-3"
2050,77434,15-methylhexadecan-1-ol,A long-chain fatty alcohol that is hexadecan-1-ol bearing a methyl substituent at position 15.,17293,KEGG COMPOUND accession,C02161,,,,,,,,,,,,,,,
2051,77441,"1-butyl-N-(2,6-dimethylphenyl)piperidine-2-carboxamide hydrochloride","A hydrochloride obtained by combining 1-butyl-N-(2,6-dimethylphenyl)piperidine-2-carboxamide with one molar equivalent of hydrochloric acid.",15739,KEGG COMPOUND accession,C06748,,,,,,,,,,,,,,,
2052,77450,dicarboxylic acid monoamide(1-),A monocarboxylic acid anion obtained by deprotonation of the carboxy group of any dicarboxylic acid monoamide; major species at pH 7.3.,17889,KEGG COMPOUND accession,C06051,,,,,,,,,,,,,,,
2053,77453,levobupivacaine hydrochloride hydrate,"The monohydrate form of levobupivacaine hydrochloride. A piperidinecarboxamide-based local anaesthetic, it has a slow onset and long duration of action.",16092,KEGG COMPOUND accession,C06323,,,,,,,,,,,,,,,
2054,77459,dextrobupivacaine(1+),The (R)-(+)-enantiomer of bupivacaine(1+).,18200,KEGG COMPOUND accession,C10096,,,,,,,,,,,,,,,
2055,77472,1-octadecylglycerone 3-phosphate(2-),A 1-alkylglycerone 3-phosphate(2-) obtained by deprotonation of the phosphate OH groups of 1-octadecylglycerone 3-phosphate; major species at pH 7.3.,17240,KEGG COMPOUND accession,C00490,itacon,97-65-4,30838.0,"Human Metabolome Database (HMDB): Itaconic acid is an intermediate in the C5-Branched dibasic acid metabolism, a substrate for the enzyme Succinate-CoA ligase (ADP-forming) (EC:6.2.1.5)(Kegg).",Itaconic acid,HMDB0002092,b,b,C00490,ITACONATE,FDB012645,itacon,[H]C([H])=C(C([O-])=O)C([H])([H])C([O-])=O,LVHBHZANLOWSRM-UHFFFAOYSA-L,"InChI=1S/C5H6O4/c1-3(5(8)9)2-4(6)7/h1-2H2,(H,6,7)(H,8,9)/p-2"
2056,77551,trans-2-heptadecenoyl-CoA(4-),An acyl-CoA(4-) arising from deprotonation of the phosphate and diphosphate functions of trans-2-heptadecenoyl-CoA; major species at pH 7.3.,27407,KEGG COMPOUND accession,C08272,,,,,,,,,,,,,,,
2057,77562,"3-[1-(2,6-dichloro-3-fluorophenyl)ethoxy]-5-[1-(piperidin-4-yl)pyrazol-4-yl]pyridin-2-amine","A pyrazolylpiperidine that consists of 4-(pyrazol-1-yl)piperidine carrying a 2-amino-3-[1-(2,6-dichloro-3-fluorophenyl)ethoxy]pyridin-5-yl group at the 4-position of the pyrazole ring.",18419,KEGG COMPOUND accession,C05999,,,,,,,,,,,,,,,
2058,77567,eugeroic,"A phsychotropic drug that improves wakefulness and alertness, and reduces tiredness, drowsiness, and the need for sleep. Eugeroics are relatively non-addictive and are used in the treatment of narcolepsy and other sleep disorders.",24996,KEGG COMPOUND accession,C01432,,,,,,,,,,,,,,,
2059,77584,(R)-tosufloxacin,"A 7-(3-aminopyrrolidin-1-yl)-1-(2,4-difluorophenyl)-6-fluoro-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxylic acid that is the (R)-enantiomer of tosufloxacin.",15529,KEGG COMPOUND accession,C00827,laccoa,1926-57-4,15529.0,Human Metabolome Database (HMDB): Lactyl-CoA is involved in both propanoate metabolism and styrene degradation pathways. It is a product in styrene degradation pathway. (KEGG).,Lactyl-CoA,HMDB0002346,b,b,C00827,CPD-5922,FDB022973,b,b,VIWKEBOLLIEAIL-FBMOWMAESA-N,b
2060,77601,"(3S,5R)-fluvastatin(1-)","A monocarboxylic acid anion resulting from the removal of a proton from the carboxy group of (3S,5R)-fluvastatin.",25016,KEGG COMPOUND accession,C06696,,,,,,,,,,,,,,,
2061,77647,"2,3',4,6-tetrahydroxybenzophenone(1-)","A phenolate anion that is the conjugate base of 2,3',4,6-tetrahydroxybenzophenone, obtained by deprotonation of the phenolic hydroxy group at position 2; major species at pH 7.3.",16419,KEGG COMPOUND accession,C01593,,,,,,,,,,,,,,,
2062,77652,novamethymycin,A twelve-membered macrolide antibiotic that is biosynthesised by Streptomyces venezuelae.,16441,KEGG COMPOUND accession,C01594,,,,,,,,,,,,,,,
2063,77692,peloruside A,"A macrolide that is a novel secondary metabolite isolated from a New Zealand marine sponge, Mycale hentscheli.",18052,KEGG COMPOUND accession,C01512,,,,,,,,,,,,,,,
2064,77718,carboxamidinium ion,Any iminium ion resulting from the protonation of a carboxamidine.,17706,KEGG COMPOUND accession,C02555,,,,,,,,,,,,,,,
2065,77727,delta-lactam,"A lactam in which the amide bond is contained within a six-membered ring, which includes the amide nitrogen and the carbonyl carbon.",15877,KEGG COMPOUND accession,C01513,,,,,,,,,,,,,,,
2066,77731,p53 activator,Any activator of tumour protein p53.,28012,KEGG COMPOUND accession,C10773,,,,,,,,,,,,,,,
2067,77774,SCH-351591,"An aromatic amide resulting from the formal condensation of the carboxy group of 8-methoxy-2-(trifluoromethyl)quinoline-5-carboxylic acid with the primary amino group of 3,5-dichloropyridin-4-amine 1-oxide. It is a potent inhibitor of phosphodiesterase IV (PDE4).",25107,KEGG COMPOUND accession,C00305,,,,,,,,,,,,,,,
2068,77781,EC 1.14.13.181 (13-deoxydaunorubicin hydroxylase) inhibitor,"An EC 1.14.13.* (oxidoreductase acting on paired donors, incorporating 1 atom of oxygen, with NADH or NADPH as one donor) inhibitor that interferes with the action of 13-deoxydaunorubicin hydroxylase (EC 1.14.13.181).",15432,KEGG COMPOUND accession,C04536,,,,,,,,,,,,,,,
2069,77788,temafloxacin,"A racemate comprising equimolar amounts of (R)- and (S)-temafloxacin. Both enantiomers both exhibit similar pharmacological profiles. Temafloxacin was briefly used (either as the free base or as the hydrochloride salt) as an antibacterial drug but was withdrawn worldwide in 1992 following reports of serious side effects, including severe hypoglycaemia, haemolytic anaemia, liver and kidney dysfunction, anaphylaxis, and death.",15595,KEGG COMPOUND accession,C00711,,,,,,,,,,,,,,,
2070,77798,melamine(1+),An organic cation obtained by protonation of one of the three ring nitrogens of melamine. It is the major microspecies at pH 7.3 (according to Marvin v 6.2.0.).,18300,KEGG COMPOUND accession,C01384,,,,,,,,,,,,,,,
2071,77806,"(13Z,16Z)-docosadienoate","A long-chain unsaturated fatty acid anion that is the conjugate base of (13Z,16Z)-docosadienoic acid, obtained by deprotonation of the carboxy group; major species at pH 7.3.",16727,KEGG COMPOUND accession,C02167,,,,,,,,,,,,,,,
2072,77813,"8-cyclohexyl-2,3,3a,4,5,6-hexahydropyrazino[3,2,1-jk]carbazole","An organic heterotetracyclic compound that is 2,3,3a,4,5,6-hexahydropyrazino[3,2,1-jk]carbazole carrying a cyclohexyl substituent at position 8.",15792,KEGG COMPOUND accession,C00383,HC00319,141-82-2,30794.0,"Human Metabolome Database (HMDB): Malonic acid (IUPAC systematic name: propanedioic acid) is a dicarboxylic acid with structure CH2(COOH)2. The ionised form of malonic acid, as well as its esters and salts, are known as malonates. For example, diethyl malonate is malonic acid's ethyl ester. The name originates from Latin malum, meaning apple. Malonic acid is the archetypal example of a competitive inhibitor: it acts against succinate dehydrogenase (complex II) in the respiratory electron transport chain. Malonic acid is found to be associated with malonyl-CoA decarboxylase deficiency, which is an inborn error of metabolism.",Malonic acid,HMDB0000691,b,b,C00383,MALONATE,FDB008117,HC00319,[H]C([H])(C([O-])=O)C([O-])=O,OFOBLEOULBTSOW-UHFFFAOYSA-L,"InChI=1S/C3H4O4/c4-2(5)1-3(6)7/h1H2,(H,4,5)(H,6,7)/p-2"
2073,77854,"D-glycero-D-altro-octulose-1,8-bisphosphate",A ketooctose derivative that is D-glycero-D-altro-octulose carrying two phosphate substituents at positions 1 and 8.,18291,KEGG COMPOUND accession,C00034,,,,,,,,,,,,,,,
2074,77926,"alpha-Kdo-(2->8)-alpha-Kdo-OAll II(1),I(7)-lactone",A carbohydrate lactone formed from alpha-Kdo-(2->8)-alpha-Kdo-OAll by lactone formation between the carboxy group of the non-reducing alpha-Kdo residue and O-7 of the alpha-Kdo-OAll residue.,30308,KEGG COMPOUND accession,C00680,26dap_M,b,b,b,"Meso-2,6-Diaminoheptanedioate",HMDB01370,b,b,C00680,b,b,b,b,b,b
2075,77962,food antioxidant,An antioxidant that used as a food additives to help guard against food deterioration.,16007,KEGG COMPOUND accession,C00409,ch4s,74-93-1,16007.0,"Human Metabolome Database (HMDB): Methanethiol (also known as methyl mercaptan) is a colorless gas that smells like rotten cabbage. It is a natural substance found in the blood, brain, and other tissues of people and animals. It is released from animal feces. It occurs naturally in certain foods, such as some nuts and cheese. It is also one of the main chemicals responsible for bad breath and flatulence. At very high concentrations methanethiol is highly toxic and affects the central nervous system. The chemical formula for methanethiol is CH3SH; it is classified as a thiol. Methanethiol is also considered to be a weak acid, with a pKa of ~10.4. This acidic property makes it reactive with dissolved metals in aqueous solutions. The environmental chemistry of these interactions in seawater or fresh water environments such as lakes has yet to be fully investigated. -- Wikipedia.",Methanethiol,HMDB0003227,b,b,C00409,METHANETHIOL,FDB011886,b,[H]SC([H])([H])[H],LSDPWZHWYPCBBB-UHFFFAOYSA-N,"InChI=1S/CH4S/c1-2/h2H,1H3"
2076,78022,1-stearoyl-2-(alpha-linolenoyl)-sn-glycero-3-phosphocholine,"A 1,2-diacyl-sn-glycero-3-phosphocholine in which the two acyl substituents at positions 1 and 2 are specified as stearoyl and alpha-linolenoyl respectively.",17760,KEGG COMPOUND accession,C02704,,,,,,,,,,,,,,,
2077,78045,2-acetyl-sn-glycero-3-phosphocholine,A 2-acyl-sn-glycero-3-phosphocholine in which the acyl group at position 2 is specified as acetyl.,16005,KEGG COMPOUND accession,C07294,M02474,124-58-3,29852.0,"Human Metabolome Database (HMDB): Methylarsonate is used as a contact herbicide in either the monosodium or disodium salt form. It goes by the trade names Weed-E-Rad, Ansar 170 H.C., Ansar 529 H.C., DiTac and others. Methylarsonate is considered only slightly toxic, having an oral LD50 of 2200 mg/Kg for rats. The inhalation risk is greater with LD50 Rats >20 mg. Long term studies with people exposed to organoarsenicals has shown an increased risk of skin cancer (Spiewak, 2001), lung cancer and some liver cancers, although some recent studies have shown some arsenic containing compounds (specifically Arsine trioxide) may have anticarcinogenic properties (Wang, 2001). In mammals, Methylarsonate is also an intermediate in the detoxification of inorganic arsenic. In the arsenate detoxification I pathway, arsenite reacts with S-adenosyl-L-methionine to produce methylarsonate and S-adenosyl-L-homocysteine. Arsenite methyltransferase catalyzes this reaction. Methylarsonate then reacts with 2 glutathione molecules to produce glutathione disulfide and methylarsonite. This reaction is catalyzed by methylarsonate reductase. Methylarsonate is an organic arsenic compound with adverse effects similar to those of arsenic trioxide. Arsenic is found in the environment primarily as arsenate and arsenite species. Arsenate is reduced to arsenite by arsenate reductase and can be subsequently methylated to Methylarsonate. This is then reduced and methylated to Dimethylarsinate, which can excreted and is considerably less toxic to the organism than any of the previous intermediate compounds. Methylarsonate was formerly included in some vitamin and mineral preparations. It was once used to treat tuberculosis, chorea, and other affections in which the cacodylates were used.",Methylarsonate,HMDB0012258,b,b,C07294,METHYLARSONATE,FDB028897,b,[H]O[As](=O)(O[H])C([H])([H])[H],QYPPRTNMGCREIM-UHFFFAOYSA-N,"InChI=1S/CH5AsO3/c1-2(3,4)5/h1H3,(H2,3,4,5)"
2078,78100,trioxilin A3(1-),The trioxilin anion that is the anion formed from trioxilin A3 by deprotonation of its carboxylic acid moiety; major microspecies present at pH 7.3.,17453,KEGG COMPOUND accession,C02170,HC00900,516-05-2,30860.0,"Human Metabolome Database (HMDB): Methylmalonic acid is a malonic acid derivative, which is a vital intermediate in the metabolism of fat and protein. In particular, the coenzyme A-linked form of methylmalonic acid, methylmalonyl-CoA, is converted into succinyl-CoA by methylmalonyl-CoA mutase in a reaction that requires vitamin B12 as a cofactor. In this way, methylmalonic acid enters the Krebs cycle and is thus part of one of the anaplerotic reactions. Abnormalities in methylmalonic acid metabolism lead to methylmalonic aciduria. This inborn error of metabolism is attributed to a block in the enzymatic conversion of methylmalonyl CoA to succinyl CoA. Methylmalonic acid is also found to be associated with other inborn errors of metabolism, including cobalamin deficiency, cobalamin malabsorption, malonyl-CoA decarboxylase deficiency, and transcobalamin II deficiency. When present in sufficiently high levels, methylmalonic acid can act as an acidogen and a metabotoxin. An acidogen is an acidic compound that induces acidosis, which has multiple adverse effects on many organ systems. A metabotoxin is an endogenously produced metabolite that causes adverse health effects at chronically high levels. Chronically high levels of methylmalonic acid are associated with at least 5 inborn errors of metabolism, including Malonyl CoA decarboxylase deficiency, Malonic Aciduria, Methylmalonate Semialdehyde Dehydrogenase Deficiency, Methylmalonic Aciduria and Methylmalonic Aciduria Due to Cobalamin-Related Disorders. Methylmalonic acid is an organic acid and abnormally high levels of organic acids in the blood (organic acidemia), urine (organic aciduria), the brain, and other tissues lead to general metabolic acidosis. Acidosis typically occurs when arterial pH falls below 7.35. In infants with acidosis, the initial symptoms include poor feeding, vomiting, loss of appetite, weak muscle tone (hypotonia), and lack of energy (lethargy). These can progress to heart abnormalities, kidney abnormalities, liver damage, seizures, coma, and possibly death. These are also the characteristic symptoms of the untreated IEMs mentioned above. Many affected children with organic acidemias experience intellectual disability or delayed development. In adults, acidosis or acidemia is characterized by headaches, confusion, feeling tired, tremors, sleepiness, and seizures.",Methylmalonic acid,HMDB0000202,b,b,C02170,b,FDB021905,HC00900,[H]C([H])([H])C([H])(C([O-])=O)C([O-])=O,ZIYVHBGGAOATLY-UHFFFAOYSA-L,"InChI=1S/C4H6O4/c1-2(3(5)6)4(7)8/h2H,1H3,(H,5,6)(H,7,8)/p-2"
2079,78141,1-heptadecylglycerone 3-phosphate,A 1-alkylglycerone 3-phosphate in which the alkyl group is specified as heptadecyl.,17646,KEGG COMPOUND accession,C00772,,,,,,,,,,,,,,,
2080,78150,fatty alcohol 18:2,Any fatty alcohol containing 18 carbons and 2 double bonds.,27504,KEGG COMPOUND accession,C06681,,,,,,,,,,,,,,,
2081,78189,alkylacylglycero-3-phosphocholine,A glycerophosphocholine that is glycero-3-phosphocholine carrying one alkyl and one acyl group in unspecified positions. Major species at pH 7.3.,16504,KEGG COMPOUND accession,C01041,C01041,b,16504.0,b,Monodehydroascorbate,b,b,b,C01041,b,b,C01041,[H]OC([H])([H])[C@]([H])(O[H])[C@@]1([H])OC(=O)C([O-])=C1[O],LHFJOBMTAJJOTB-JLAZNSOCSA-M,"InChI=1S/C6H7O6/c7-1-2(8)5-3(9)4(10)6(11)12-5/h2,5,7-8,10H,1H2/p-1/t2-,5+/m0/s1"
2082,78306,ambrein,"A triterpenoid alcohol that is a constituent of ambergris, an intestinal secretion of the sperm whale Physeter catodon.",28817,KEGG COMPOUND accession,C08374,,,,,,,,,,,,,,,
2083,78309,alpha-asarone,The trans-isomer of  asarone.,17590,KEGG COMPOUND accession,C01387,,,,,,,,,,,,,,,
2084,78313,"5,10-dihydro-9-dimethylallylphenazine 1-carboxylate","A monocarboxylic acid anion that is the conjugate base of 5,10-9-dimethylallyldihydrophenazine-1-carboxylic acid, obtained by deprotonation of the carboxy group; major species at pH 7.3.",28897,KEGG COMPOUND accession,C08388,,,,,,,,,,,,,,,
2085,78320,2-hydroxypropanoic acid,A 2-hydroxy monocarboxylic acid that is propanoic acid in which one of the alpha-hydrogens is replaced by a hydroxy group.,16482,KEGG COMPOUND accession,C00829,npthl,91-20-3,16482.0,"Human Metabolome Database (HMDB): Naphthalene is found in black walnut. Naphthalene is found in many essential oils.Naphthalene is an organic compound with formula C10H8. It is a white crystalline solid with a characteristic odor that is detectable at concentrations as low as 0.08 ppm by mass. Trace amounts of naphthalene are produced by magnolias and specific types of deer, as well as the Formosan subterranean termite. Some strains of the endophytic fungus Muscodor albus produce naphthalene among a range of volatile organic compounds, while Muscodor vitigenus produces naphthalene almost exclusively (Wikipedia",Naphthalene,HMDB0029751,b,b,C00829,b,FDB000954,npthl,[H]C1=C([H])C2=C([H])C([H])=C([H])C([H])=C2C([H])=C1[H],UFWIBTONFRDIAS-UHFFFAOYSA-N,InChI=1S/C10H8/c1-2-6-10-8-4-3-7-9(10)5-1/h1-8H
2086,78381,EC 5.1.2.* (racemases acting on hydroxy acids and derivatives) inhibitor,An EC 5.1.* (racemase/epimerase) inhibitor that interferes with the action of any such enzyme acting on hydroxy acids and their derivatives (EC 5.1.2.*).,16172,KEGG COMPOUND accession,C02569,,,,,,,,,,,,,,,
2087,78398,5-(2-oxopropylideneamino)-6-D-ribitylaminouracil,"An aminouracil that is D-ribitol in which the hydroxy group at position 1 is substituted by the 6-amino group of 6-amino-5-(2-oxopropylideneamino)uracil. Unstable mucosal-associated invariant T (MAIT)-activating antigen, formed by non-enzymatic reaction between 5-amino-6-D-ribitylaminouracil and methylglyoxal.",28112,KEGG COMPOUND accession,C00291,,,,,,,,,,,,,,,
2088,78424,18-hydroxyoleate,"An omega-hydroxy fatty acid anion that is the conjugate base of 18-hydroxyoleic acid, obtained by deprotonation of the carboxy group; major species at pH 7.3.",15763,KEGG COMPOUND accession,C01185,nicrnt,321-02-8,15763.0,"Human Metabolome Database (HMDB): Nicotinic acid mononucleotide is an intermediate in the metabolism of Nicotinate and nicotinamide. It is a substrate for Ectonucleotide pyrophosphatase/phosphodiesterase 2, Ectonucleotide pyrophosphatase/phosphodiesterase 1, Nicotinamide mononucleotide adenylyltransferase 3, Cytosolic 5'-nucleotidase IA, Cytosolic 5'-nucleotidase IB, Nicotinate-nucleotide pyrophosphorylase, 5'(3')-deoxyribonucleotidase (cytosolic type), Cytosolic purine 5'-nucleotidase, Nicotinamide mononucleotide adenylyltransferase 2, Ectonucleotide pyrophosphatase/phosphodiesterase 3, 5'-nucleotidase, 5'(3')-deoxyribonucleotidase (mitochondrial) and Nicotinamide mononucleotide adenylyltransferase 1.",Nicotinic acid mononucleotide,HMDB0001132,b,b,C01185,NICOTINATE_NUCLEOTIDE,FDB022444,nicrnt,[H]O[C@]1([H])[C@]([H])(O[H])[C@]([H])(O[C@@]1([H])[N+]1=C([H])C(=C([H])C([H])=C1[H])C([O-])=O)C([H])([H])OP([O-])([O-])=O,JOUIQRNQJGXQDC-ZYUZMQFOSA-L,"InChI=1S/C11H14NO9P/c13-8-7(5-20-22(17,18)19)21-10(9(8)14)12-3-1-2-6(4-12)11(15)16/h1-4,7-10,13-14H,5H2,(H2-,15,16,17,18,19)/p-2/t7-,8-,9-,10-/m1/s1"
2089,78457,O-[S-(3R)-hydroxyhexanoylpantetheine-4'-phosphoryl]serine(1-) residue,An O-(S-acylpantetheine-4'-phosphoryl)serine(1-) residue in which the S-acyl group is specified as (3R)-hydroxyhexanoyl.,27798,KEGG COMPOUND accession,C06813,,,,,,,,,,,,,,,
2090,78473,O-(S-3-oxotetradecanoylpantetheine-4-phosphoryl)serine(1-) residue,An O-(S-acylpantetheine-4'-phosphoryl)serine(1-) residue in which the S-acyl group is specified as 3-oxotetradecanoyl.,28787,KEGG COMPOUND accession,C07455,,,,,,,,,,,,,,,
2091,78493,organic trisulfide,An organosulfur compound with structure Compounds of structure R(1)SSSR(2) in which R(1) and R(2) are organic groups.,17711,KEGG COMPOUND accession,C01941,,,,,,,,,,,,,,,
2092,78520,3'-(L-glutamate)adenylyl(1-) group,An organic anionic group obtained by deprotonation of the phosphate and carboxy functions as well as protonation of the amino function of 3'-(L-glutamyl)adenylyl group; major species at 7.3.,18357,KEGG COMPOUND accession,C00547,nrpphr,51-41-2,18357.0,Human Metabolome Database (HMDB): Precursor of epinephrine that is secreted by the adrenal medulla and is a widespread central and autonomic neurotransmitter. Norepinephrine is the principal transmitter of most postganglionic sympathetic fibers and of the diffuse projection system in the brain arising from the locus ceruleus. It is also found in plants and is used pharmacologically as a sympathomimetic. Norepinephrine is elevated in the urine of people who consume bananas.,Norepinephrine,HMDB0000216,b,b,C00547,NOREPINEPHRINE,FDB000895,nrpphr,[H]OC1=C([H])C([H])=C(C([H])=C1O[H])[C@@]([H])(O[H])C([H])([H])[N+]([H])([H])[H],SFLSHLFXELFNJZ-QMMMGPOBSA-O,"InChI=1S/C8H11NO3/c9-4-8(12)5-1-2-6(10)7(11)3-5/h1-3,8,10-12H,4,9H2/p+1/t8-/m0/s1"
2093,78532,3'-(L-prolyl)adenylyl zwitterionic group,A zwitterionic group obtained by transfer of a proton from the phosphate to the amino group of 3'-(L-prolyl)adenylyl group,28368,KEGG COMPOUND accession,C05080,,,,,,,,,,,,,,,
2094,78588,"6-linalyl-2-O,3-dimethylflaviolin-7-olate","An organic anion that is the conjugate base of 6-linalyl-2-O,3-dimethylflaviolin, obtained by deprotonation of the 7-hydroxy group. It is the major microspecies at pH 7.3 (according to Marvin v 6.2.0.).",17034,KEGG COMPOUND accession,C01838,,,,,,,,,,,,,,,
2095,78593,dolichyl diphosphate group(2-),An organic anionic group obtained by deprotonation of the diphosphate function of dolichyl diphosphate group. It is the major structure at pH 7.3 (according to Marvin v 6.2.0.).,28842,KEGG COMPOUND accession,C01530,ocdca,57-11-4,28842.0,"Human Metabolome Database (HMDB): Stearic acid, also called octadecanoic acid, is one of the useful types of saturated fatty acids that comes from many animal and vegetable fats and oils. It is a waxy solid, and its chemical formula is CH3(CH2)16COOH. Its name comes from the Greek word stear, which means tallow. Its IUPAC name is octadecanoic acid. -- Wikipedia.",Stearic acid,HMDB0000827,b,b,C01530,STEARIC_ACID,FDB002941,ocdca,[H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([O-])=O,QIQXTHQIDYTFRH-UHFFFAOYSA-M,"InChI=1S/C18H36O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18(19)20/h2-17H2,1H3,(H,19,20)/p-1"
2096,78641,fatty alcohol 28:1,A fatty alcohol containing 28 carbons and 1 double bond.,16869,KEGG COMPOUND accession,C01946,,,,,,,,,,,,,,,
2097,78643,fatty alcohol 20:2,A fatty alcohol containing 20 carbons and 2 double bonds.,16021,KEGG COMPOUND accession,C03796,,,,,,,,,,,,,,,
2098,78650,N-hexadecanoylphytosphingosine-1-phosphocholine,A sphingomyelin 34:0 in which the N-acyl group and sphingoid base are specified as hexadecanoyl and phytosphingosine respectively.,16196,KEGG COMPOUND accession,C00712,elaid,112-79-8,27997.0,"Human Metabolome Database (HMDB): Elaidic acid is the major trans fat found in hydrogenated vegetable oils and occurs in small amounts in caprine and bovine milk (very roughly 0.1 % of the fatty acids) [1] and some meats. It is the trans isomer of oleic acid. The name of the elaidinization reaction comes from elaidic acid. Elaidic acid increases CETP activity, which in turn raises VLDL and lowers HDL cholesterol. (Wiki).",Elaidic acid,HMDB0000573,b,b,C00712,b,FDB002951,elaid,[H]\C(=C(/[H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([O-])=O,ZQPPMHVWECSIRJ-KTKRTIGZSA-M,"InChI=1S/C18H34O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18(19)20/h9-10H,2-8,11-17H2,1H3,(H,19,20)/p-1/b10-9-"
2099,78650,N-hexadecanoylphytosphingosine-1-phosphocholine,A sphingomyelin 34:0 in which the N-acyl group and sphingoid base are specified as hexadecanoyl and phytosphingosine respectively.,16196,KEGG COMPOUND accession,C00712,M00127,112-79-8,27997.0,"Human Metabolome Database (HMDB): Elaidic acid is the major trans fat found in hydrogenated vegetable oils and occurs in small amounts in caprine and bovine milk (very roughly 0.1 % of the fatty acids) [1] and some meats. It is the trans isomer of oleic acid. The name of the elaidinization reaction comes from elaidic acid. Elaidic acid increases CETP activity, which in turn raises VLDL and lowers HDL cholesterol. (Wiki).",Elaidic acid,HMDB0000573,b,b,C00712,b,FDB002951,M00127,[H]OC(=O)C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C(\[H])=C(/[H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H],ZQPPMHVWECSIRJ-MDZDMXLPSA-N,"InChI=1S/C18H34O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18(19)20/h9-10H,2-8,11-17H2,1H3,(H,19,20)/b10-9+"
2100,78650,N-hexadecanoylphytosphingosine-1-phosphocholine,A sphingomyelin 34:0 in which the N-acyl group and sphingoid base are specified as hexadecanoyl and phytosphingosine respectively.,16196,KEGG COMPOUND accession,C00712,ocdcea,112-80-1,16196.0,"Human Metabolome Database (HMDB): Oleic acid is an unsaturated fatty acid that is the most widely distributed and abundant fatty acid in nature. It is used commercially in the preparation of oleates and lotions, and as a pharmaceutical solvent (Stedman, 26th ed). Biological source: Major constituent of plant oils e.g. olive oil (about 80%), almond oil (about 80%) and many others, mainly as glyceride. Constituent of tall oil and present in fruits Use/Importance: Food additive. Oleic acid is used in manufacturing of surfactants, soaps, plasticizers. Emulsifying agent in foods and pharmaceuticals. Biological Use/Importance: Skin penetrant. Herbicide, insecticide, fungicide (Dictionary of Organic Compounds). Oleic acid is a fatty acid that occurs naturally in various animal and vegetable fats and oils. It is an odorless, colourless oil, although commercial samples may be yellowish. In chemical terms, oleic acid is classified as a monounsaturated omega-9 fatty acid. It has the formula CH3(CH2)7CH=CH(CH2)7COOH. The term ""oleic"" means related to, or derived from, oil or olive, the oil that is predominantly composed of oleic acid (Wikipedia). Oleic acid is found to be associated with isovaleric acidemia, which is an inborn error of metabolism.",Oleic acid,HMDB0000207,b,b,C00712,OLEATE-CPD,FDB012858,ocdcea,[H]\C(=C(/[H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([O-])=O,ZQPPMHVWECSIRJ-KTKRTIGZSA-M,"InChI=1S/C18H34O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18(19)20/h9-10H,2-8,11-17H2,1H3,(H,19,20)/p-1/b10-9-"
2101,78703,2-arachidonoyl-sn-glycero-3-phospho-L-serine,A 2-acyl-sn-glycero-3-phosphoserine in which the 2-acyl group is specified as arachidonoyl.,16536,KEGG COMPOUND accession,C00727,,,,,,,,,,,,,,,
2102,78738,"2,4,5-trimethylthiazole","A 1,3-thiazole that is thiazole in which all three hydrogens are replaced by methyl groups. A Maillard reaction product, it is a flavour component in many cooked foods, including cooked meats and potatoes.",15842,KEGG COMPOUND accession,C01103,orot5p,2149-82-8,15842.0,"Human Metabolome Database (HMDB): Orotidylic acid (OMP), is a pyrimidine nucleotide which is the last intermediate in the biosynthesis of uridine monophosphate. Decarboxylation by Orotidylate decarboxylase affords Uridine 5'-phosphate which is the route to Uridine and its derivatives de novo and consequently one of the most important processes in nucleic acid synthesis (Dictionary of Organic Compounds). In humans, the enzyme UMP synthase converts OMP into uridine 5'- monophosphate. If UMP synthase is defective, orotic aciduria can result. (Wikipedia).",Orotidylic acid,HMDB0000218,b,b,C01103,OROTIDINE-5-PHOSPHATE,FDB012321,orot5p,[H]O[C@@]1([H])[C@@]([H])(O[C@]([H])(C([H])([H])OP([O-])([O-])=O)[C@@]1([H])O[H])N1C(=O)N([H])C(=O)C([H])=C1C([O-])=O,KYOBSHFOBAOFBF-XVFCMESISA-K,"InChI=1S/C10H13N2O11P/c13-5-1-3(9(16)17)12(10(18)11-5)8-7(15)6(14)4(23-8)2-22-24(19,20)21/h1,4,6-8,14-15H,2H2,(H,16,17)(H,11,13,18)(H2,19,20,21)/p-3/t4-,6-,7-,8-/m1/s1"
2103,78756,EC 2.5.1.6 (methionine adenosyltransferase) inhibitor,An EC 2.5.1.* (non-methyl-alkyl or aryl transferase) inhibitor that interferes with the action of methionine adenosyltransferase (EC 2.5.1.6).,16859,KEGG COMPOUND accession,C03716,,,,,,,,,,,,,,,
2104,78766,LLP-3,"A pyridone that is pyridin-2(1H)-one which is substituted at positions 3, 4, and 6 by cyano, 3,5-bis(benzyloxy)phenyl, and 5-chloro-2-hydroxyphenyl groups, respectively. It is an inhibitor for Survivin-Ran protein complex.",15535,KEGG COMPOUND accession,C00313,,,,,,,,,,,,,,,
2105,78770,ethylene glycol monododecyl ether,A hydroxyether that is ethylene glycol substituted on one of the oxygens by a dodecyl group.,18058,KEGG COMPOUND accession,C01444,,,,,,,,,,,,,,,
2106,78773,beta-ascarylopyranose,An ascarylopyranose that has beta configuration at the anomeric centre.,17216,KEGG COMPOUND accession,C03887,,,,,,,,,,,,,,,
2107,78781,(6S)-6-hydroxyheptanoic acid,A 6-hydroxyheptanoic acid that has S configuration at the chiral centre.,16877,KEGG COMPOUND accession,C03888,,,,,,,,,,,,,,,
2108,78830,ascr#7,"An (omega-1)-hydroxy fatty acid ascaroside obtained by formal condensation of the alcoholic hydroxy group of (2E,6R)-6-hydroxyhept-2-enoic acid with ascarylopyranose (the alpha anomer). A metabolite of the nematode Caenorhabditis elegans, it is weakly dauer inducing and a weak male-attractant.",17121,KEGG COMPOUND accession,C00830,,,,,,,,,,,,,,,
2109,78845,O-[S-(methoxycarbonylacetyl)pantetheine-4'-phosphoryl]serine(1-) residue,An O-(S-acylpantetheine-4'-phosphoryl)-L-serine(1-) residue in which the S-acyl group is specified as methoxycarbonylacetyl.,25805,KEGG COMPOUND accession,C00007,o2,7782-44-7,15379.0,"Human Metabolome Database (HMDB): Oxygen is the third most abundant element in the universe after hydrogen and helium and the most abundant element by mass in the Earth's crust. Diatomic oxygen gas constitutes 20.9% of the volume of air. All major classes of structural molecules in living organisms, such as proteins, carbohydrates, and fats, contain oxygen, as do the major inorganic compounds that comprise animal shells, teeth, and bone. Oxygen in the form of O2 is produced from water by cyanobacteria, algae and plants during photosynthesis and is used in cellular respiration for all living organisms. Green algae and cyanobacteria in marine environments provide about 70% of the free oxygen produced on earth and the rest is produced by terrestrial plants. Oxygen is used in mitochondria to help generate adenosine triphosphate (ATP) during oxidative phosphorylation. For animals, a constant supply of oxygen is indispensable for cardiac viability and function. To meet this demand, an adult human, at rest, inhales 1.8 to 2.4 grams of oxygen per minute. This amounts to more than 6 billion tonnes of oxygen inhaled by humanity per year. At a resting pulse rate, the heart consumes approximately 8-15 ml O2/min/100 g tissue. This is significantly more than that consumed by the brain (approximately 3 ml O2/min/100 g tissue) and can increase to more than 70 ml O2/min/100 g myocardial tissue during vigorous exercise. As a general rule, mammalian heart muscle cannot produce enough energy under anaerobic conditions to maintain essential cellular processes; thus, a constant supply of oxygen is indispensable to sustain cardiac function and viability. However, the role of oxygen and oxygen-associated processes in living systems is complex, and they and can be either beneficial or contribute to cardiac dysfunction and death (through reactive oxygen species). Reactive oxygen species (ROS) are a family of oxygen-derived free radicals that are produced in mammalian cells under normal and pathologic conditions. Many ROS, such as the superoxide anion (O2-)and hydrogen peroxide (H2O2), act within blood vessels, altering mechanisms mediating mechanical signal transduction and autoregulation of cerebral blood flow. Reactive oxygen species are believed to be involved in cellular signaling in blood vessels in both normal and pathologic states. The major pathway for the production of ROS is by way of the one-electron reduction of molecular oxygen to form an oxygen radical, the superoxide anion (O2-). Within the vasculature there are several enzymatic sources of O2-, including xanthine oxidase, the mitochondrial electron transport chain, and nitric oxide (NO) synthases. Studies in recent years, however, suggest that the major contributor to O2- levels in vascular cells is the membrane-bound enzyme NADPH-oxidase. Produced O2- can react with other radicals, such as NO, or spontaneously dismutate to produce hydrogen peroxide (H2O2). In cells, the latter reaction is an important pathway for normal O2- breakdown and is usually catalyzed by the enzyme superoxide dismutase (SOD). Once formed, H2O2 can undergo various reactions, both enzymatic and nonenzymatic. The antioxidant enzymes catalase and glutathione peroxidase act to limit ROS accumulation within cells by breaking down H2O2 to H2O. Metabolism of H2O2 can also produce other, more damaging ROS. For example, the endogenous enzyme myeloperoxidase uses H2O2 as a substrate to form the highly reactive compound hypochlorous acid. Alternatively, H2O2 can undergo Fenton or Haber-Weiss chemistry, reacting with Fe2+/Fe3+ ions to form toxic hydroxyl radicals (-.OH). (PMID: 17027622, 15765131).",Oxygen,HMDB0001377,b,b,C00007,OXYGEN-MOLECULE,FDB022589,o2,O=O,MYMOFIZGZYHOMD-UHFFFAOYSA-N,InChI=1S/O2/c1-2
2110,78874,"alkyl,acylglycerophosphoinositol(1-)","An anionic phospholipid obtained by deprotonation of the phosphate OH group of any alkyl,acylglycerophosphoinositol. Major species at pH 7.3.",28420,KEGG COMPOUND accession,C03444,,,,,,,,,,,,,,,
2111,78877,"1,3-indandione",A member of the class of indanones that is indane in which the hydrogens at positions 2 and 4 have been replaced by oxo groups.,25822,KEGG COMPOUND accession,C06578,,,,,,,,,,,,,,,
2112,78888,beta-D-Manp-(1->2)-beta-D-Manp-(1->2)-alpha-D-Manp-O[CH2]2NH2,A glycoside that consists of the linear trisaccharide beta-D-Manp-(1->2)-beta-D-Manp-(1->2)-alpha-D-Manp having a 2-aminoethoxy moiety at the reducing-end anomeric centre.,28768,KEGG COMPOUND accession,C06575,,,,,,,,,,,,,,,
2113,78953,"(2E,10R)-10-hydroxyundec-2-enoic acid",An (omega-1)-hydroxy fatty acid that is trans-undec-2-enoic acid in which the 10-pro-R hydrogen is replaced by a hydroxy group.,27928,KEGG COMPOUND accession,C06604,,,,,,,,,,,,,,,
2114,78963,ascr#25,"An (omega-1)-hydroxy fatty acid ascaroside obtained by formal condensation of the alcoholic hydroxy group of (2E,14R)-14-hydroxypentadec-2-enoic acid with ascarylopyranose (the alpha anomer). It is a metabolite of the nematode Caenorhabditis elegans.",25863,KEGG COMPOUND accession,C05904,,,,,,,,,,,,,,,
2115,79007,tricosanoate,"A very long-chain fatty acid anion that is the conjugate base of tricosanoic acid, obtained by deprotonation of the carboxy group; major species at pH 7.3.",16472,KEGG COMPOUND accession,C01949,,,,,,,,,,,,,,,
2116,79031,dihydromonacolin L carboxylate,"A hydroxy monocarboxylic acid anion that is the conjugate base of dihydromonacolin L acid, obtained by deprotonation of the carboxy group; major species at pH 7.3.",16670,KEGG COMPOUND accession,C00012,,,,,,,,,,,,,,,
2117,79058,D-arabinose 5-phosphate,An  arabinose phosphate that is D-arabinose having a phosphate substituent at position 5.,17392,KEGG COMPOUND accession,C03633,M02709,b,b,b,Peptidylproline-(Omega=0),b,b,b,C03633,b,b,b,[H]N([*])C(=O)[C@@]1([H])N(C([*])=O)C([H])([H])C([H])([H])C1([H])[H],b,b
2118,79095,N(5)-hydroxy-L-ornithine,A member of the class of hydroxylamines that is L-ornithine in which one of the N(5)-amino hydrogens is replaced by a hydroxy group.,17465,KEGG COMPOUND accession,C05229,,,,,,,,,,,,,,,
2119,79124,icos#18,A 4-O-(1H-indol-3-ylcarbonyl)ascaroside derived from 11-hydroxyundecanoic acid. It is a metabolite of the nematode Caenorhabditis elegans.,18397,KEGG COMPOUND accession,C05332,peamn,64-04-0,18397.0,"Human Metabolome Database (HMDB): Phenethylamine (PEA) is an aromatic amine, which is a colorless liquid at room temperature. It is soluble in water, ethanol, and ether. Similar to other low-molecular-weight amines, it has a fishy odor. Upon exposure to air, it forms a solid carbonate salt with carbon dioxide. Phenethylamine is strongly basic and forms a stable crystalline hydrochloride salt with a melting point of 217 oC. Phenethylamine is also a skin irritant and possible sensitizer. Phenethylamine also has a constitutional isomer (+)-phenylethylamine (1-phenylethylamine), which has two stereoisomers: (R)-(+)-1-phenylethylamine and (S)-(-)-1-phenylethylamine. In the human brain, 2-phenethylamine is believed to function as a neuromodulator or neurotransmitter (a trace amine). Phenethylamine can be biosynthesized from the amino acid phenylalanine by enzymatic decarboxylation. It is also found in many foods such as chocolate, especially after microbial fermentation. However trace amounts from food are quickly metabolized by the enzyme MAO-B (into phenylacetic acid), preventing significant concentrations from reaching the brain. Phenylethylamine is a precursor to the neurotransmitter phenylethanolamine. High levels of PEA have been found in the urine of schizophrenics but it is not significantly elevated in the serum or CSF of schizophrenics (PMID: 7906896, PMID: 7360842).  Urinary levels of PEA are significantly lower in children with attention deficit hyperactivity disorder (ADHD) (PMID: 12205654).  It has been found that PEA is the primary compound found in carnivore (especially cat) urine that leads to rodent (mouse and rat) avoidance. In other words, phenylethylamine is useful for scaring off rodent pests.  Quantitative HPLC analysis across 38 mammalian species has shown that PEA production in urine is especially enhanced in carnivores, with some producing >3,000-fold more than herbivores (PMID: 21690383).",Phenylethylamine,HMDB0012275,b,b,C05332,PHENYLETHYLAMINE,FDB010580,peamn,[H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])C([H])([H])[N+]([H])([H])[H],BHHGXPLMPWCGHP-UHFFFAOYSA-O,"InChI=1S/C8H11N/c9-7-6-8-4-2-1-3-5-8/h1-5H,6-7,9H2/p+1"
2120,79151,oscr#29,An omega-hydroxy fatty acid ascaroside obtained by formal condensation of the alcoholic hydroxy group of (2E)-17-hydroxyheptadec-2-enoic acid with ascarylopyranose (the alpha anomer). It is a metabolite of the nematode Caenorhabditis elegans.,30745,KEGG COMPOUND accession,C07086,pac,103-82-2,30745.0,"Human Metabolome Database (HMDB): Phenyl acetate (or phenylacetate) is a carboxylic acid ester that has been found in the biofluids of patients with nephritis and/or hepatitis as well as patients with phenylketonuria (PKU), an inborn error of metabolism. Excess phenylalanine in the body can be disposed of through a transamination process leading to the production of phenylpyruvate. The phenylpyruvate can be further metabolized into a number of products. Decarboxylation of phenylpyruvate gives phenylacetate, while a reduction reaction gives phenyllactate. The phenylacetate can be further conjugated with glutamine to give phenylacetyl glutamine. All of these metabolites can be detected in serum and urine of PKU patients. Phenyl acetate is also produced endogenously as the metabolite of 2-Phenylethylamine, which is mainly metabolized by monoamine oxidase to form phenyl acetate. 2-phenylethylamine is an ""endogenous amphetamine"" which may modulate central adrenergic functions, and the urinary phenyl acetate levels have been postulated as a marker for depression. (PMID: 17978765, 476920, 6857245). Phenylacetate is also found in essential oils, e.g. neroli, rose oil, free and as esters' and in many fruits. As a result it is used as a perfumery and flavoring ingredient.",Phenylacetic acid,HMDB0000209,b,b,C07086,PHENYLACETATE,FDB010558,pac,[H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])C([O-])=O,WLJVXDMOQOGPHL-UHFFFAOYSA-M,"InChI=1S/C8H8O2/c9-8(10)6-7-4-2-1-3-5-7/h1-5H,6H2,(H,9,10)/p-1"
2121,79202,ascaroside,Any glycoside derived from alpha-ascarylopyranose or its derivatives.,18005,KEGG COMPOUND accession,C00166,phpyr,156-06-9,30851.0,"Human Metabolome Database (HMDB): Phenylpyruvic acid is a keto-acid that is an intermediate or catabolic byproduct of phenylalanine metabolism. It has a slight honey-like odor. Levels of phenylpyruvate are normally very low in blood or urine. High levels of phenylpyruvic acid can be found in the urine of individuals with phenylketonuria (PKU), an inborn error of metabolism. PKU is due to lack of the enzyme phenylalanine hydroxylase (PAH), so that phenylalanine is converted not to tyrosine but to phenylpyruvic acid. In particular, excessive phenylalanine can be metabolized into phenylketones through, a transaminase pathway route involving glutamate. Metabolites of this transamination reaction include phenylacetate, phenylpyruvate and phenethylamine. In persons with PKU, dietary phenylalanine either accumulates in the body or some of it is converted to phenylpyruvic acid. Individuals with PKU tend to excrete large quantities of phenylpyruvate, phenylacetate and phenyllactate, along with phenylalanine, in their urine. If untreated, mental retardation effects and microcephaly are evident by the first year along with other symptoms which include: unusual irritability, epileptic seizures and skin lesions. Hyperactivity, EEG abnormalities and seizures, and severe learning disabilities are major clinical problems later in life. A ""musty or mousy"" odor of skin, hair, sweat and urine (due to phenylacetate accumulation); and a tendency to hypopigmentation and eczema are also observed. The neural-development effects of PKU are primarily due to the disruption of neurotransmitter synthesis. In particular, phenylalanine is a large, neutral amino acid which moves across the blood-brain barrier (BBB) via the large neutral amino acid transporter (LNAAT). Excessive phenylalanine in the blood saturates the transporter. Thus, excessive levels of phenylalanine significantly decrease the levels of other LNAAs in the brain. But since these amino acids are required for protein and neurotransmitter synthesis, phenylalanine accumulation disrupts brain development, leading to mental retardation.",Phenylpyruvic acid,HMDB0000205,b,b,C00166,PHENYL-PYRUVATE,FDB020197,phpyr,[H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])C(=O)C([O-])=O,BTNMPGBKDVTSJY-UHFFFAOYSA-M,"InChI=1S/C9H8O3/c10-8(9(11)12)6-7-4-2-1-3-5-7/h1-5H,6H2,(H,11,12)/p-1"
2122,79213,alpha-N-acetylneuraminosyl-(2->8)-alpha-N-acetylneuraminosyl-(2->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1)-ceramide,A sialodiosylceramide consisting of the tetrasaccharide alpha-N-acetylneuraminyl-(2->8)-alpha-N-acetylneuraminyl-(2->3)-beta-D-galactosyl-(1->4)-beta-D-glucose attached to the primary hydroxy function of a ceramide with undefined sphingoid base.,17276,KEGG COMPOUND accession,C00774,,,,,,,,,,,,,,,
2123,79220,N-acetyl-beta-D-galactosaminyl-(1->4)-[alpha-N-acetylneuraminyl-(2->8)-alpha-N-acetylneuraminyl-(2->3)]-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1)-ceramide(2-),An anionic ganglioside obtained by deprotonation of the neuraminosyl carboxy groups of N-acetyl-beta-D-galactosaminyl-(1->4)-[alpha-N-acetylneuraminyl-(2->8)-alpha-N-acetylneuraminyl-(2->3)]-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1)-ceramide; major species at pH 7.3.,17727,KEGG COMPOUND accession,C03019,,,,,,,,,,,,,,,
2124,79287,"(3R)-3,16-dihydroxyhexadecanoic acid","A 3,16-dihydroxyhexadecanoic acid in which the chiral centre has R configuration.",16034,KEGG COMPOUND accession,C03166,,,,,,,,,,,,,,,
2125,79293,2-hydroxy-7-methoxy-5-methyl-1-naphthoyl-CoA,An acyl-CoA that results from the formal condensation of the thiol group of coenzyme A with the carboxy group of 2-hydroxy-7-methoxy-5-methyl-1-naphthoic acid.,16247,KEGG COMPOUND accession,C00865,M02740,b,16247.0,b,Phospholipids-Extracellular-Pool,b,b,b,C00865,b,b,b,[H]OP(=O)(O[*])OC([H])([H])C([H])(OC([*])=O)C([H])([H])OC([*])=O,b,b
2126,79313,glycosinolic acid,An organic sulfate that is the oxime hydrogen sulfate of an S-acyl thioglycoside.,29920,KEGG COMPOUND accession,C02306,,,,,,,,,,,,,,,
2127,79322,thia-alkylglucosinolic acid,A glucosinolic acid that is an alkylglucosinolic acid in which one on the carbons in the alkyl side-chain has been replaced by a sulfur or an oxidised sulfur.,28659,KEGG COMPOUND accession,C06262,,,,,,,,,,,,,,,
2128,79334,ibha#10,A 4-O-(1H-indol-3-ylcarbonyl)ascaroside that is icas#10 in which the pro-R hydrogen beta to the carboxy group is replaced by a hydroxy group.  It is a metabolite of the nematode Caenorhabditis elegans.,17563,KEGG COMPOUND accession,C01606,,,,,,,,,,,,,,,
2129,79377,elesclomol-Cu(II),The copper coordination entity formed from elesclomol by coordination to copper via the thiocarbonyl and hydrazino groups.,15538,KEGG COMPOUND accession,C02060,CE5122,146622-45-9,15538.0,"Human Metabolome Database (HMDB): Phytanoyl CoA is a coenzyme A derivative of phytanic acid. Phytanic acid is present in human diet or in animal tissues where it may be derived from chlorophyll in plant extracts. Specifically it is an epimeric metabolite of the isoprenoid side chain of chlorophyll. Owing to the presence of its epimeric beta-methyl group, phytanic acid cannot be metabolized by beta-oxidation. Instead, it is metabolized in peroxisomes via alpha-oxidation to give pristanic acid, which is then oxidized by beta-oxidation. PhyH (phytanoyl-CoA 2-hydroxylase) catalyses hydroxylation of phytanoyl-CoA. Mutations of PhyH can lead to phytanic acid accumulation. High levels of phytanic acid are found in patients suffering from Refsum's syndrome. This inherited neurological disorder is characterized by an accumulation of phytanic acid in blood and tissues. Clinically it is characterized by adult onset retinitis pigmentosa, anosmia, sensory neuropathy, and phytanic acidaemia. This disorder has been found to be related to deficiency in the &#945;-oxidation pathway in the liver. (PMID: 17956235). Phytanoyl CoA and other branched-chain fatty acid CoA products are potent inducers of the peroxisome proliferator-activated receptor PPARalpha, a nuclear receptor that enhances transcription of peroxisomal enzymes mediating beta-oxidation of these potentially toxic fatty acids (PMID: 16768463). Pyruvate dehydrogenase and 2-oxoglutarate dehydrogenase are strongly inhibited by phytanoyl-CoA. Decreased activity of these important mitochondrial metabolism complexes might therefore contribute to neurological symptoms upon accumulation of phytanic acid in Refsum disease (PMID: 16737698).",Phytanoyl-CoA,HMDB0001359,b,b,C02060,CPD-206,FDB022577,b,[H]OC([H])(C(=O)N([H])C([H])([H])C([H])([H])C(=O)N([H])C([H])([H])C([H])([H])SC(=O)C([H])([H])C([H])(C([H])([H])[H])C([H])([H])C([H])([H])C([H])([H])[C@]([H])(C([H])([H])[H])C([H])([H])C([H])([H])C([H])([H])[C@]([H])(C([H])([H])[H])C([H])([H])C([H])([H])C([H])([H])C([H])(C([H])([H])[H])C([H])([H])[H])C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])OP([O-])(=O)OP([O-])(=O)OC([H])([H])C1([H])O[C@]([H])(N2C([H])=NC3=C2N=C([H])N=C3N([H])[H])C([H])(O[H])C1([H])OP([O-])([O-])=O,NRJQGHHZMSOUEN-BJETZBMBSA-J,"InChI=1S/C41H74N7O17P3S/c1-26(2)11-8-12-27(3)13-9-14-28(4)15-10-16-29(5)21-32(50)69-20-19-43-31(49)17-18-44-39(53)36(52)41(6,7)23-62-68(59,60)65-67(57,58)61-22-30-35(64-66(54,55)56)34(51)40(63-30)48-25-47-33-37(42)45-24-46-38(33)48/h24-30,34-36,40,51-52H,8-23H2,1-7H3,(H,43,49)(H,44,53)(H,57,58)(H,59,60)(H2,42,45,46)(H2,54,55,56)/p-4/t27-,28-,29?,30?,34?,35?,36?,40+/m0/s1"
2130,79377,elesclomol-Cu(II),The copper coordination entity formed from elesclomol by coordination to copper via the thiocarbonyl and hydrazino groups.,15538,KEGG COMPOUND accession,C02060,phytcoa,b,15538.0,b,Phytanoyl Coenzyme A,b,b,b,C02060,b,b,phytcoa,[H]O[C@@]([H])(C(=O)N([H])C([H])([H])C([H])([H])C(=O)N([H])C([H])([H])C([H])([H])SC(=O)C([H])([H])C([H])(C([H])([H])[H])C([H])([H])C([H])([H])C([H])([H])C([H])(C([H])([H])[H])C([H])([H])C([H])([H])C([H])([H])C([H])(C([H])([H])[H])C([H])([H])C([H])([H])C([H])([H])C([H])(C([H])([H])[H])C([H])([H])[H])C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])OP([O-])(=O)OP([O-])(=O)OC([H])([H])[C@@]1([H])O[C@@]([H])(N2C([H])=NC3=C(N=C([H])N=C23)N([H])[H])[C@]([H])(O[H])[C@]1([H])OP([O-])([O-])=O,NRJQGHHZMSOUEN-ZJGVPSKGSA-J,"InChI=1S/C41H74N7O17P3S/c1-26(2)11-8-12-27(3)13-9-14-28(4)15-10-16-29(5)21-32(50)69-20-19-43-31(49)17-18-44-39(53)36(52)41(6,7)23-62-68(59,60)65-67(57,58)61-22-30-35(64-66(54,55)56)34(51)40(63-30)48-25-47-33-37(42)45-24-46-38(33)48/h24-30,34-36,40,51-52H,8-23H2,1-7H3,(H,43,49)(H,44,53)(H,57,58)(H,59,60)(H2,42,45,46)(H2,54,55,56)/p-4/t27?,28?,29?,30-,34-,35-,36+,40-/m1/s1"
2131,80489,desmethylxanthohumol,"A member of the class of chalcones that is trans-chalcone substituted by hydroxy groups at positions 4, 2', 4', and 6'  and a 3-methylbut-2-en-1-yl group at position 3'.",18227,KEGG COMPOUND accession,C00961,,,,,,,,,,,,,,,
2132,80658,"5,6-epoxyretinoic acid","A retinoid obtained by epoxidation across the 5,6-double bond of retinoic acid.",17179,KEGG COMPOUND accession,C02592,HC02192,516-90-5,36259.0,"Human Metabolome Database (HMDB): Lithocholyltaurine is a bile salt formed in the liver from lithocholic acid conjugation with taurine, usually as the sodium salt. It solubilizes fats for absorption and is itself absorbed. Lithocholic acid, a hydrophobic secondary bile acid, is well known to cause intrahepatic cholestasis. There have been extensive studies on the mechanisms of lithocholate-induced cholestasis in animals. Lithocholate diminishes both the bile acid-dependent and independent bile flow. In humans, elevated levels of lithocholic acid are found in patients with chronic cholestatic liver disease. Lithocholyltaurine impairs both the bile canalicular contractions and the canalicular bile secretion, possibly by acting directly on the canalicular membranes in lithocholyltaurine-induced cholestasis. Lithocholyltaurine induce acute cholestasis-associated with retrieval of the bile salt export pump. The bile salt export pump (BSEP) of hepatocyte secretes conjugated bile salts across the canalicular membrane in an ATP-dependent manner. Hepatic retention of bile acids may lead to liver injury by hepatocyte apoptosis and eventually deterioration of cholestatic liver diseases. One mechanism of induced apoptosis by lithocholyltaurine is the induction of transcriptional activity of AP-1 (activation protein-1). (PMID: 16981261, 15763547, 16332456, 18164257).",Lithocholyltaurine,HMDB0000722,b,b,C02592,TAUROLITHOCHOLATE,FDB022203,HC02192,[H]O[C@]1([H])C([H])([H])C([H])([H])[C@@]2(C([H])([H])[H])[C@]([H])(C([H])([H])C([H])([H])[C@@]3([H])[C@]4([H])C([H])([H])C([H])([H])[C@]([H])([C@]([H])(C([H])([H])[H])C([H])([H])C([H])([H])C(=O)N([H])C([H])([H])C([H])([H])S([O-])(=O)=O)[C@@]4(C([H])([H])[H])C([H])([H])C([H])([H])[C@]23[H])C1([H])[H],QBYUNVOYXHFVKC-GBURMNQMSA-M,"InChI=1S/C26H45NO5S/c1-17(4-9-24(29)27-14-15-33(30,31)32)21-7-8-22-20-6-5-18-16-19(28)10-12-25(18,2)23(20)11-13-26(21,22)3/h17-23,28H,4-16H2,1-3H3,(H,27,29)(H,30,31,32)/p-1/t17-,18-,19-,20+,21-,22+,23+,25+,26-/m1/s1"
2133,81308,allocholic acid,"An allo-bile acid that is 5alpha-cholan-24-oic acid bearing three alpha-hydroxy substituents at position 3, 7 and 12.",17659,KEGG COMPOUND accession,C00015,udp,58-98-0,17659.0,"Human Metabolome Database (HMDB): Uridine 5'-diphosphate is a uracil nucleotide containing a pyrophosphate group esterified to C5 of the sugar moiety. UDP is an important extracellular pyrimidine signaling molecule that mediates diverse biological effects via P1 and P2 purinergic receptors, such as the uptake of thymidine and proliferation of gliomas. (PMID: 14558596). UDP induces intracellular Ca(2+) responses and oscillations in HeLa cells, due to the activation of P2Ys (G-protein coupled ATP receptors). (PMID: 1257952).",Uridine 5'-diphosphate,HMDB0000295,b,b,C00015,UDP,FDB007509,udp,[H]O[C@@]1([H])[C@@]([H])(O[C@]([H])(C([H])([H])OP([O-])(=O)OP([O-])([O-])=O)[C@@]1([H])O[H])N1C([H])=C([H])C(=O)N([H])C1=O,XCCTYIAWTASOJW-XVFCMESISA-K,"InChI=1S/C9H14N2O12P2/c12-5-1-2-11(9(15)10-5)8-7(14)6(13)4(22-8)3-21-25(19,20)23-24(16,17)18/h1-2,4,6-8,13-14H,3H2,(H,19,20)(H,10,12,15)(H2,16,17,18)/p-3/t4-,6-,7-,8-/m1/s1"
2134,81378,beta-nootkatol,"A 4,4a-dimethyl-6-(prop-1-en-2-yl)-2,3,4,4a,5,6,7,8-octahydronaphthalen-2-ol with (2S,4R,4aS,6R) stereochemistry.",27698,KEGG COMPOUND accession,C06267,,,,,,,,,,,,,,,
2135,81462,"dTDP-4-amino-2,3,4,6-tetradeoxy-alpha-D-glucose","A pyrimidine nucleotide-sugar having thymine as the nucleobase and 4-amino-2,3,4,6-tetradeoxy-alpha-D-glucose as the sugar component.",16408,KEGG COMPOUND accession,C01761,,,,,,,,,,,,,,,
2136,81546,bacteriochlorophyllide a,A chlorophyllide obtained by hydrolysis of the terpenoid ester moiety of bacteriochlorophyll a.,27362,KEGG COMPOUND accession,C05430,,,,,,,,,,,,,,,
2137,81807,quizalofop-ethyl,"A racemate coprising equimolar amounts of  quizalofop-P-ethyl and its enantiomer, (S)-quizalofop-ethyl. A proherbicide for quizalofop.",36492,KEGG COMPOUND accession,C11952,,,,,,,,,,,,,,,
2138,81812,benzobicyclon,"A racemate comprising equimolar amounts of (1R,5S) and (1S,5R)-benzobicyclon. It is a pro-herbicide (by hydroyltic loss of the phenylthio group to afford the corresponding meso-triketone) used for the control of both annual and perennial weeds in rice.",37047,KEGG COMPOUND accession,C11951,,,,,,,,,,,,,,,
2139,81823,mepronil,"A member of the class of benzamides, obtained by formal condensation of the carboxy group of 2-methylbenzoic acid with the amino group of 3-(ispropyloxy)aniline. A fungicide used to control diseases caused by Basidomycetes including Rhizoctonia and Puccinia spp.",30306,KEGG COMPOUND accession,C12093,,,,,,,,,,,,,,,
2140,81833,trifloxystrobin,"The methyl ester of (2E)-(methoxyimino)[2-({[(E)-{1-[3-(trifluoromethyl)phenyl]ethylidene}amino]oxy}methyl)phenyl]acetic acid. A foliar applied fungicide for cereals which is particularly active against Ascomycetes, Deuteromycetes and Oomycetes",29461,KEGG COMPOUND accession,C11993,,,,,,,,,,,,,,,
2141,81836,thallium sulfate,"A metal sulfate in which the counterion is thallium  and the ratio of thallium to sulfate is 2:1. It is a rodenticide used to control rats, squirrels, mice, moles, prairie dogs, ants and cockroaches. It is no longer registered for pesticide use in the United States.",15434,KEGG COMPOUND accession,C11829,,,,,,,,,,,,,,,
2142,81838,chloridazon,"A pyridazinone that is pyridazin-3(2H)-one substituted by an amino group at position 5, a chloro group at position 4 and a phenyl group at position 2.",15433,KEGG COMPOUND accession,C11830,,,,,,,,,,,,,,,
2143,81844,ferimzone,"A member of the class of pyrimidines that is 2-hydrazino-4,6-dimethylpyrimidine in which the two amino hydrogens are replaced by a 1-(2-methylphenyl)ethylidene group. It is used for the control of fungal diseases in rice.",29467,KEGG COMPOUND accession,C11866,,,,,,,,,,,,,,,
2144,81846,amisulbrom,"A member of the class of bromoindoles that is 3-bromo-6-fluoro-2-methylindole substituted at position 1 by a 1-(dimethylsulfamyl)-1,2,4-triazole-3-sulfonyl group. A fungicide for use on potatoes to control late blight (Phytophthora infestans) and downy mildew [Plasmopara viticola). It has a low mammalian toxicity but it is considered to be a reproduction toxicant, is moderately toxic to birds and honey bees but poses a greater risk to aquatic species and earthworms.",29468,KEGG COMPOUND accession,C12025,,,,,,,,,,,,,,,
2145,81852,pentoxazone,"An oxazolidinone that is 1,3-oxazolidine-2,4-dione which is substituted on the nitrogen (position 3) by a 4-chloro-5-(cyclopentyloxy)-2-fluorophenyl group, and at position 5 by an isopropylidene group. A protoporphyrinogen oxidase inhibitor, it is used as a pre- and post-emergence herbicide to control weeds in rice.",29473,KEGG COMPOUND accession,C11934,,,,,,,,,,,,,,,
2146,81857,imazamox,"A racemate composed of equimolar amounts of (S)- and (R)-imazamox. An inhibitor of acetohydroxyacid synthase, it is used (particularly as the corresponding ammonium salt, known as imazamox-ammonium) as a herbicide for the control of grass, broad-leaf weeds, and pond weed.",29474,KEGG COMPOUND accession,C12026,,,,,,,,,,,,,,,
2147,81936,octhilinone,"A member of the class of 1,2-thiazole that is 1,2-thiazol-3-one substituted on the nitrogen (position 2) by an octyl group. A fungicide and antibacterial agent, it is used for treatment of canker and other fungal and bacterial diseases in fruit trees. It is no longer approved for use within the European Union.",30232,KEGG COMPOUND accession,C11878,,,,,,,,,,,,,,,
2148,81941,prosulfocarb,A monothiocarbamic ester that is carbamothioic S-acid substituted by two propyl groups at the nitrogen atom and a benzyl group at the the sulfur atom.,29510,KEGG COMPOUND accession,C11882,,,,,,,,,,,,,,,
2149,81960,dodemorph,"A member of the class of morpholines that is 2,6-dimethylmorpholine in which the hydrogen attached to the nitrogen is replaced by a cyclododecyl group. It is a fungicide used for the control of powdery mildew, particularly in rose culture.",29514,KEGG COMPOUND accession,C12108,,,,,,,,,,,,,,,
2150,81969,ofurace,A racemate comprising equal amounts of (R)- and (S)-ofurace.,29519,KEGG COMPOUND accession,C11890,,,,,,,,,,,,,,,
2151,82012,fluometuron,"A member of the class of 3-(3,4-substituted-phenyl)-1,1-dimethylureas that is urea in which one of the nitrogens is substituted by a 3-(trifluoromethyl)phenyl group while the other is substituted by two methyl groups. It is a herbicide used for the control of broadleaf weeds and annual grasses in cotton.",32898,KEGG COMPOUND accession,C11900,,,,,,,,,,,,,,,
2152,82043,tebutam,A monocarboxylic acid amide that is propanamide substituted by a benzyl and an isopropyl group at the nitrogen atom and two methyl groups at position 2. It is an agrochemical used as a herbicide.,29556,KEGG COMPOUND accession,C12014,,,,,,,,,,,,,,,
2153,82076,anilazine,"A member of the class of triazenes that is dichlorotriazene in which the hydrogen is replaced by an o-chloroanilino group. A fungicide formerly used to control leaf spots and downy mildew, it is no longer approved for use within the European Union.",29568,KEGG COMPOUND accession,C11913,,,,,,,,,,,,,,,
2154,82153,binapacryl,"A racemate comprising equimolar amounts of (R)- and (S)-binapacryl.  An obsolete fungicide and acaricide once used to control of panonychid and tetranychid mites on certain fruits, mainly apple, and vegetables.",29588,KEGG COMPOUND accession,C11858,,,,,,,,,,,,,,,
2155,82163,"rac-1,2-dichloropropane","A racemate comprising equimolar amounts of (R)- and (S)-1,2-dichloropropane. It is used as a fumigant to control nematodes in soil and insects in stored grain.",29593,KEGG COMPOUND accession,C11868,,,,,,,,,,,,,,,
2156,82297,carbon black,"An elemental carbon in the form of virtually pure colloidal particles that are produced by incomplete combustion or thermal decomposition of gaseous or liquid hydrocarbons under controlled conditions. A black, finely divided pellet or powder, its properties of specific surface area, particle size and structure, conductivity and colour can be varied by varying the exact conditions for its production. It is used in tyres, rubber and plastic products, printing inks and coatings.",29614,KEGG COMPOUND accession,C11991,,,,,,,,,,,,,,,
2157,82569,4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol,"A member of the class of nitrosamines that is butan-1-ol substituted by a pyridin-3-yl group at position 1 and by a methyl(nitroso)amino group at position 4. It is a major metabolite of nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK), which is a carcinogen found in tobacco and responsible for inducing lung cancer in smokers.",29694,KEGG COMPOUND accession,C12105,,,,,,,,,,,,,,,
2158,82596,eprinomectin,A mixture of semisynthetic avermectin derivatives comprising >=90% eprinomectin component B1a (R = CH3) and <=10% eprinomectin component B1b (R = H). It is used for the treatment of internal and external parasites in cattle.,29706,KEGG COMPOUND accession,C11994,,,,,,,,,,,,,,,
2159,82598,eprinomectin component B1b,An avermectin analogue that is eprinomectin B1a in which the butan-2-yl substituent of the spiroketal moiety is replaced by an isopropyl group.,29707,KEGG COMPOUND accession,C12038,,,,,,,,,,,,,,,
2160,82615,diminazene diaceturate,An N-acetylglycinate salt resulting from the reaction of diminazene with 2 mol eq. of N-acetylglycine.,90167,KEGG COMPOUND accession,C11930,,,,,,,,,,,,,,,
2161,82622,leucascandrolide A congener,A synthetic macrolide that is an analogue of the marine metabolite leucascandrolide A that exhibits comparable antiproliferative properties.,30906,KEGG COMPOUND accession,C11909,,,,,,,,,,,,,,,
2162,82624,"trehalose 6,6'-dimycolate","A trehalose mycolate compound consisting of two C58 mycolate groups attached to the 6- and 6'-positions of alpha,alpha'-trehalose. A mycobacterial cell wall glycolipid.",30940,KEGG COMPOUND accession,C11922,,,,,,,,,,,,,,,
2163,82627,15(R)-HPETE,"A HPETE that is (5Z,8Z,11Z,13E,15R)-icosa-5,8,11,13-tetraenoic acid with the hydroperoxy group located at position 15 (the R-enantiomer).",29726,KEGG COMPOUND accession,C11912,,,,,,,,,,,,,,,
2164,82629,prostaglandin G2(1-),"A prostaglandin carboxylic acid anion that is the conjugate base of prostaglandin G2, obtained by deprotonation of the carboxy group; major species at pH 7.3.",29728,KEGG COMPOUND accession,C11933,,,,,,,,,,,,,,,
2165,82632,phytochrome chromophore,"A chromophore that is a linear tetrapyrrolic prosthetic group covalently attached to a large soluble protein phytochrome. Light absorption by the phytochrome chromophore triggers photoconversion between two spectrally distinct forms of the photoreceptor: Pr, the red light absorbing form, and Pfr, the far-red light absorbing form.",27801,KEGG COMPOUND accession,C11916,,,,,,,,,,,,,,,
2166,82650,BODIPY-3823,"A BODIPY compound that is 4,4-difluoro-4-bora-3a,4a-diaza-s-indacene substituted at position 5 by a methyl group and at position 3 by a 11-carboxyundecyl group.",29737,KEGG COMPOUND accession,C12033,,,,,,,,,,,,,,,
2167,82652,4-[(1S)-1-hydroxy-2-{[(2R)-4-(4-hydroxyphenyl)butan-2-yl]amino}ethyl]phenol,A 4-(1-hydroxy-2-{[4-(4-hydroxyphenyl)butan-2-yl]amino}ethyl)phenol in which the carbon bearing the hydroxy group has S configuration while the remaining stereocentre has R configuration.,29739,KEGG COMPOUND accession,C11902,,,,,,,,,,,,,,,
2168,82654,nolinospiroside F,A spirostanyl glycoside that is isolated from Ophiopogon japonicus and exhibits antioxidant properties.,27049,KEGG COMPOUND accession,C11942,,,,,,,,,,,,,,,
2169,82689,"2,3-diacyl-1-(3-O-sulfo-beta-D-galactosyl)-sn-glycerol","A 1,2-diacyl-3-(3-O-sulfo-beta-D-galactosyl)glycerol in which the configuration of the glycerol moiety is such that the acyl groups are at positions 2 and 3 using the Stereospecific Numbering convention.",29780,KEGG COMPOUND accession,C00885,,,,,,,,,,,,,,,
2170,82745,"(9Z,12Z)-tetradecadienoyl-CoA","An unsaturated fatty acyl-CoA that results from the formal condensation of the thiol group of coenzyme A with the carboxy group of (9Z,12Z)-tetradecadienoic acid.",44897,KEGG COMPOUND accession,C00074,pep,138-08-9,44897.0,"Human Metabolome Database (HMDB): Phosphoenolpyruvate (PEP) is an important chemical compound in biochemistry. It has a high energy phosphate bond, and is involved in glycolysis and gluconeogenesis. In glycolysis, PEP is formed by the action of the enzyme enolase on 2-phosphoglycerate. Metabolism of PEP to pyruvate by pyruvate kinase (PK) generates 1 molecule of adenosine triphosphate (ATP) via substrate-level phosphorylation. ATP is one of the major currencies of chemical energy within cells. In gluconeogenesis, PEP is formed from the decarboxylation of oxaloacetate and hydrolysis of 1 guanosine triphosphate molecule. This reaction is catalyzed by the enzyme phosphoenolpyruvate carboxykinase (PEPCK). This reaction is a rate-limiting step in gluconeogenesis. (wikipedia).",Phosphoenolpyruvic acid,HMDB0000263,b,b,C00074,PHOSPHO-ENOL-PYRUVATE,FDB001451,pep,[H]C([H])=C(OP([O-])([O-])=O)C([O-])=O,DTBNBXWJWCWCIK-UHFFFAOYSA-K,"InChI=1S/C3H5O6P/c1-2(3(4)5)9-10(6,7)8/h1H2,(H,4,5)(H2,6,7,8)/p-3"
2171,84149,4-hydroxy-6-undecylpyran-2-one,A 2-pyranone in which the hydrogens at positions 4 and 6 of 2H-pyran-2-one are replaced by hydroxy and undecyl groups respectively.,30531,KEGG COMPOUND accession,C02656,pime,111-16-0,30531.0,"Human Metabolome Database (HMDB): Pimelic acid is a group of compounds that are derivatives of heptanedioic acid with the general formula R-C7H11O4. Pimelic acid is the organic compound with the formula HO2C(CH2)5CO2H. Derivatives of pimelic acid are involved in the biosynthesis of the amino acid called lysine. Pimelic acid is one methylene longer than a related dicarboxylic acid, adipic acid, a precursor to many polyesters and polyamides. Pimelic acid has been synthesized from cyclohexanone and from salicylic acid.[1] In the former route, the additional carbon is suppled by dimethyloxalate, which reacts with the enolate. (Wikipedia).",Pimelic acid,HMDB0000857,b,b,C02656,b,FDB022283,b,b,WLJVNTCWHIRURA-UHFFFAOYSA-N,b
2172,84232,thienotriazolodiazepine,"Any organic heterotricyclic compound constructed from fused thiophene, triazole and diazepeine rings.",50375,KEGG COMPOUND accession,C11904,,,,,,,,,,,,,,,
2173,84461,1-heptadecanoyl-2-arachidonoyl-sn-glycero-3-phosphoserine(1-),A 3-sn-phosphatidyl-L-serine(1-) that is the conjugate base of 1-heptadecanoyl-2-arachidonoyl-sn-glycero-3-phosphoserine; major species at pH 7.3.,30633,KEGG COMPOUND accession,C00408,Lpipecol,3105-95-1,30913.0,"Human Metabolome Database (HMDB): L-pipecolic acid is a normal human metabolite present in human blood, where is present as the primary enantiomer of pipecolic acid. L-pipecolic acid is a cyclic imino acid (contains both imino (>C=NH) and carboxyl (-C(=O)-OH) functional groups) produced during the degradation of lysine, accumulates in body fluids of infants with generalized genetic peroxisomal disorders, including Zellweger syndrome (OMIM 214100), neonatal adrenoleukodystrophy (OMIM 202370), and infantile Refsum disease (OMIM 266510). L-pipecolic acid levels are also elevated in patients with chronic liver diseases. L-pipecolic acid is the substrate of delta1-piperideine-2-carboxylate reductase (EC 1.5.1.21) in the pathway of lysine degradation (PMID: 2717271, 8305590, 1050990).",L-Pipecolic acid,HMDB0000716,b,b,C00408,L-PIPECOLATE,FDB000546,Lpipecol,[H]C1([H])C([H])([H])C([H])([H])[C@@]([H])(C([O-])=O)[N+]([H])([H])C1([H])[H],HXEACLLIILLPRG-YFKPBYRVSA-N,"InChI=1S/C6H11NO2/c8-6(9)5-3-1-2-4-7-5/h5,7H,1-4H2,(H,8,9)/t5-/m0/s1"
2174,84686,aminoacyl oligopeptide,Any oligopeptide having an aminoacyl group attached to the N-terminal.,30719,KEGG COMPOUND accession,C02226,,,,,,,,,,,,,,,
2175,84842,(R)-3-hydroxybutyrylcarnitine,An O-hydroxybutyryl-L-carnitine in which the acyl group is specified as 3-hydroxybutyryl.,29123,KEGG COMPOUND accession,C01250,acg5sa,13074-21-0,16319.0,Human Metabolome Database (HMDB): N-Acetyl-L-glutamate 5-semialdehyde is an intermediate in Urea cycle and metabolism of amino groups. N-Acetyl-L-glutamate 5-semialdehyde is the. second to last step in the synthesis of L-Ornithine and is converted. from N-Acetyl-L-glutamate 5-phosphate via the enzyme N-acetyl-gamma-glutamyl-phosphate reductase (EC 1.2.1.38). It is then converted to N-Acetylornithine via the enzyme acetylornithine aminotransferase (EC 2.6.1.11).,N-Acetyl-L-glutamate 5-semialdehyde,HMDB0006488,b,b,C01250,b,FDB023938,b,[H]N(C(=O)C([H])([H])[H])[C@]([H])(C([O-])=O)C([H])([H])C([H])([H])C([H])=O,BCPSFKBPHHBDAI-LURJTMIESA-M,"InChI=1S/C7H11NO4/c1-5(10)8-6(7(11)12)3-2-4-9/h4,6H,2-3H2,1H3,(H,8,10)(H,11,12)/p-1/t6-/m0/s1"
2176,85250,"N-(4Z,7Z,10Z,13Z,16Z,19Z)-docosahexaenoyl-sn-glycero-3-phosphoethanolamine(1-)","An N-acyl-sn-glycero-3-phosphoethanolamine(1-) in which the N-acyl group is specified as (4Z,7Z,10Z,13Z,16Z,19Z)-docosahexaenoyl; major species at pH 7.3.",30836,KEGG COMPOUND accession,C02225,,,,,,,,,,,,,,,
2177,85569,phosphatidylcholine O-40:0,"An alkyl,acyl-sn-glycero-3-phosphocholine in which the alkyl or acyl groups at positions 1 and 2 contain a total of 40 carbons and 0 double bonds.",30924,KEGG COMPOUND accession,C00898,,,,,,,,,,,,,,,
2178,85576,"3,4,17-trihydroxy-9,10-secoandrosta-1,3,5(10)-triene-9-one","A seco-androstane that is 9,10-secoandrostane which is substituted by hydroxy groups at position 3, 4 and 17 and an oxo group at position 9 and in which the A-ring is aromatic.",30936,KEGG COMPOUND accession,C02614,,,,,,,,,,,,,,,
2179,85607,N-heptanoyl-L-homoserine,An N-acyl-L-amino acid that is the N-heptanoyl derivative of L-homoserine.,38290,KEGG COMPOUND accession,C00072,ascb_L,50-81-7,17208.0,"Human Metabolome Database (HMDB): Ascorbic acid is found naturally in citrus fruits and many vegetables and is an essential nutrient in human diets. It is necessary to maintain connective tissue and bone. The biologically active form of ascorbic acid is vitamin C. Vitamin C is a water soluble vitamin. Primates (including humans) and a few other species in all divisions of the animal kingdom, notably the guinea pig, have lost the ability to synthesize ascorbic acid and must obtain it in their food. Vitamin C functions as a reducing agent and coenzyme in several metabolic pathways. Vitamin C is considered an antioxidant (PubChem). Ascorbic acid is an electron donor for enzymes involved in collagen hydroxylation, biosynthesis of carnitine and norepinephrine, tyrosine metabolism, and amidation of peptide hormones. Ascrobic acid (vitamin C) deficiency causes scurvy. The amount of vitamin C necessary to prevent scurvy may not be adequate to maintain optimal health. The ability of vitamin C to donate electrons also makes it a potent water-soluble antioxidant that readily scavenges free radicals such as molecular oxygen, superoxide, hydroxyl radical, and hypochlorous acid. In this setting, several mechanisms could account for a link between vitamin C and heart disease. One is the relation between LDL oxidation and vitamins C and E. Vitamin C in vitro can recycle vitamin E, which can donate electrons to prevent LDL oxidation in vitro. As the lipid-phase vitamin E is oxidized, it can be regenerated by aqueous vitamin C. Other possibilities are that vitamin C could decrease cholesterol by mechanisms not well characterized, or could improve vasodilatation and vascular reactivity, perhaps by decreasing the interactions of nitric oxide with oxidants (PMID: 10799361). Moreover, ascorbic acid is found to be associated with hyperoxalemia, which is an inborn error of metabolism.",Ascorbic acid,HMDB0000044,b,b,C00072,ASCORBATE,FDB001224,ascb_L,[H]OC1=C([O-])[C@]([H])(OC1=O)[C@@]([H])(O[H])C([H])([H])O[H],CIWBSHSKHKDKBQ-JLAZNSOCSA-M,"InChI=1S/C6H8O6/c7-1-2(8)5-3(9)4(10)6(11)12-5/h2,5,7-10H,1H2/p-1/t2-,5+/m0/s1"
2180,85697,diacylglycerol 35:1,A diglyceride in which the two acyl groups contain a total of 35 carbons and 1 double bond.,30960,KEGG COMPOUND accession,C04773,,,,,,,,,,,,,,,
2181,85874,triacylglycerol 50:0,A triglyceride in which the three acyl groups contain a total of 50 carbons and 0 double bonds.,31018,KEGG COMPOUND accession,C12127,,,,,,,,,,,,,,,
2182,85888,"N,N,N-trimethylglycyl-CoA",An acyl-CoA that results from the formal condensation of the thiol group of coenzyme A with the carboxy group of glycine betaine.,31028,KEGG COMPOUND accession,C12128,,,,,,,,,,,,,,,
2183,85891,N-isopropyl-L-glutamine,A N(5)-alkylglutamine where the alkyl group is isopropyl.,42255,KEGG COMPOUND accession,C12136,,,,,,,,,,,,,,,
2184,85894,N-(gamma-L-glutamyl)-L-alaninol,A N(5)-alkylglutamine obtained by formal condensation of the side-chain carboxy group of L-glutamic acid with the amino group of L-alaninol.,31030,KEGG COMPOUND accession,C12260,,,,,,,,,,,,,,,
2185,85895,4-amino-5-formamidomethyl-2-methylpyrimidine,A member of the class of aminopyrimidine with the amino group at position 4 with additional methyl and formamidomethyl substituents at positions 2 and 5 respectively.,31031,KEGG COMPOUND accession,C12433,,,,,,,,,,,,,,,
2186,85901,epivancomycin,A glyopeptide that is vancomycin in which the terminal vancosamine of the disaccharide moiety is replaced by 4-epi-vancosamine.,46816,KEGG COMPOUND accession,C12329,,,,,,,,,,,,,,,
2187,85905,cobalt(II)-factor IV,A cobalt-corrinoid heptacarboxylic acid that is produced by Salmonella typhimurium.,31034,KEGG COMPOUND accession,C12434,,,,,,,,,,,,,,,
2188,85912,"9alpha-hydroxy-3-oxo-23,24-bisnorchola-1,4-dien-22-oic acid","A steroid acid that is 23,24-bisnor-chol-1,4-dien-22-oic acid bearing additional oxo and hydroxy substituent at positions 3 and 9 respectively.",31035,KEGG COMPOUND accession,C13629,,,,,,,,,,,,,,,
2189,85915,"(5Z,9Z,12Z,15Z)-octadecatetraenoyl group","A fatty-acyl group derived from (5Z,9Z,12Z,15Z)-octadecatetraenoic acid.",31036,KEGG COMPOUND accession,C12263,,,,,,,,,,,,,,,
2190,85920,"[(1R,2S)-2-hydroxy-1-thiopropyl]phosphonic acid","A member of the class of phosphonic acids that is propylphosphonic acid substituted by thio and hydroxy groups at positions 1 and 2 respectively (the 1R,2S-stereoisomer)",31039,KEGG COMPOUND accession,C12345,,,,,,,,,,,,,,,
2191,85924,"(1S,2S)-1,2-dihydroxypropylphosphonic acid","A member of the class of phosphonic acids that is propylphosphonic acid substituted by hydroxy groups at positions 1 and 2 (the 1S,2S-stereoisomer).",31042,KEGG COMPOUND accession,C13638,,,,,,,,,,,,,,,
2192,85933,"(4Z,7Z,10Z,13Z,16Z)-docosapentaenoyl group","A fatty-acyl group derived from (4Z,7Z,10Z,13Z,16Z)-docosapentaenoic acid.",32918,KEGG COMPOUND accession,C13014,,,,,,,,,,,,,,,
2193,85943,"(5Z,8Z,11Z,14Z,17Z)-icosapentaenoyl group","A fatty-acyl group derived from (5Z,8Z,11Z,14Z,17Z)-icosapentaenoic acid.",31047,KEGG COMPOUND accession,C12427,,,,,,,,,,,,,,,
2194,85954,"(6Z,9Z,12Z,15Z)-octadecatetraenoyl group","A fatty-acyl group derived from (6Z,9Z,12Z,15Z)-octadecatetraenoic acid.",31056,KEGG COMPOUND accession,C12428,,,,,,,,,,,,,,,
2195,85956,"(5Z,11E)-octadecadienoyl-CoA","An  octadecadienoyl-CoA that results from the formal condensation of the thiol group of coenzyme A with the carboxy group of (5Z,11E)-octadecadienoic acid.",31057,KEGG COMPOUND accession,C12429,,,,,,,,,,,,,,,
2196,85958,5'-(N(7)-methyl 5'-triphosphoguanosine)-2'-O-methyladenosine(2-) residue,An organic anionic group obtained by deprotonation of the triphosphate OH groups of 5'-(N(7)-methyl 5'-triphosphoguanosine)-2'-O-methyladenosine residue; major species at pH 7.3.,31058,KEGG COMPOUND accession,C12431,,,,,,,,,,,,,,,
2197,85960,(3E)-nonenoyl-CoA,An unsaturated fatty acyl-CoA that results from the formal condensation of the thiol group of coenzyme A with the carboxy group of (3E)-nonenoic acid.,31059,KEGG COMPOUND accession,C12430,,,,,,,,,,,,,,,
2198,85964,"UDP-N-acetylgalactosamine-5,6-ene","A UDP-amino sugar having N-acetylgalactosamine-5,6-ene as the amino sugar component.",31062,KEGG COMPOUND accession,C12400,,,,,,,,,,,,,,,
2199,85965,UDP-N-acetyltunicamine-uracil,A UDP-amino sugar that is an intermediate in the biosynthesis of the tunicamycins.,31063,KEGG COMPOUND accession,C12399,,,,,,,,,,,,,,,
2200,85966,ivabradine,"A member of the class of benzazepines that is 7,8-dimethoxy-1,3,4,5-tetrahydro-3-benzazepin-2-one in which the amide hydrogen is replaced by a [{[(7S)-3,4-dimethoxybicyclo[4.2.0]octa-1,3,5-trien-7-yl]methyl}(methyl)amino]propyl} group. Used (as its hydrochloride salt) to treat patients with angina who have intolerance to beta blockers and/or heart failure.",31064,KEGG COMPOUND accession,C12135,,,,,,,,,,,,,,,
2201,85970,hydroxyaurone,Any member of the class of  aurones in which one or more ring hydrogens are replaced by hydroxy groups.,70031,KEGG COMPOUND accession,C12134,,,,,,,,,,,,,,,
2202,85972,ivabradine(1+),An organic cation obtained by protonation of the tertiary amino group of ivabradine.,33613,KEGG COMPOUND accession,C13631,,,,,,,,,,,,,,,
2203,85978,isavuconazonium,"An organic cation that is the cationic portion of isavuconazonium sulfate (a prodrug for isavuconazole, an antifungal agent used for the treatment of invasive aspergillosis and invasive mucormycosis).",31069,KEGG COMPOUND accession,C12833,,,,,,,,,,,,,,,
2204,85982,avibactam sodium,An organic sodium salt that is the monosodium salt of avibactam. Used in combination with ceftazidime pentahydrate for the treatment of complicated urinary tract infections including pyelonephritis.,31071,KEGG COMPOUND accession,C12330,,,,,,,,,,,,,,,
2205,85991,panobinostat lactate,A lactate salt having panobinostat(1+) as the counterion. A histone deacetylase inhibitor used in combination with bortezomib and dexamethasone for the treatment of multiple myeloma.,31074,KEGG COMPOUND accession,C12835,,,,,,,,,,,,,,,
2206,86006,"6-oxo-2-hydroxy-7-(4'-chlorophenyl)-3,8,8-trichloroocta-2E,4E,7E-trienoic acid","An  oxo monocarboxylic acid that is 3,8,8-trichloroocta-2,4,7-trienoic acid substituted by a 4-chlorophenyl group at position 7, a hydroxy group at position 2 and an oxo group at position 6.",19500,KEGG COMPOUND accession,C12836,,,,,,,,,,,,,,,
2207,86021,S-geranylgeranyl-L-cysteine residue,An alpha-amino-acid residue derived from S-geranylgeranyl-L-cysteine,31082,KEGG COMPOUND accession,C12624,,,,,,,,,,,,,,,
2208,86026,tRNA threonylcarbamoyladenosine,A threonylcarbamoyladenosine that is incorporated into a tRNA molecule.,31085,KEGG COMPOUND accession,C13665,,,,,,,,,,,,,,,
2209,86040,3-hydroxyoctanoyl-CoA(4-),A 3-hydroxy fatty acyl-CoA(4-) arising from deprotonation of the phosphate and diphosphate OH groups of 3-hydroxyoctanoyl-CoA; major species at pH 7.3.,32971,KEGG COMPOUND accession,C12831,,,,,,,,,,,,,,,
2210,86058,aldehydo-L-talose,The acyclic form of L-talose.,31104,KEGG COMPOUND accession,C12325,,,,,,,,,,,,,,,
2211,86063,O-decenoylcarnitine,An O-acylcarnitine in which the acyl group is specified as decenoyl (position of double bond not specified).,74154,KEGG COMPOUND accession,C12466,,,,,,,,,,,,,,,
2212,86064,O-decadienoylcarnitine,An O-acylcarnitine in which the acyl group specified is decadienoyl in which the positions of the double bonds is unspecified..,31107,KEGG COMPOUND accession,C12468,,,,,,,,,,,,,,,
2213,86073,O-propenoylcarnitine,An O-acyl carnitine in which the acyl group specified is propenoyl.,31111,KEGG COMPOUND accession,C12458,,,,,,,,,,,,,,,
2214,86074,"(24S,25)-dihydroxycholesterol",An oxysterol that is cholesterol which is substituted by hydroxy groups at positions 24S and 25.,31112,KEGG COMPOUND accession,C12457,,,,,,,,,,,,,,,
2215,86075,"(24S,26)-dihydroxycholesterol",An oxysterol that is cholesterol which is substituted by hydroxy groups at positions 24S and 26.,31113,KEGG COMPOUND accession,C12456,,,,,,,,,,,,,,,
2216,86078,(E)-p-coumaroylagmatine(1+),A p-coumaroylagmatine(1+) in which the double bond of the coumaroyl component has E-geochemistry.,31116,KEGG COMPOUND accession,C13425,,,,,,,,,,,,,,,
2217,86086,N-[(11Z)-octadecenoyl]-sphingosine-1-phosphocholine,A N-octadecenoylsphingosine-1-phosphocholine in which the acyl group specified is (11Z)-octadecenoyl.,31121,KEGG COMPOUND accession,C12641,,,,,,,,,,,,,,,
2218,86089,1-stearoyl-2-myristoyl-sn-glycero-3-phosphocholine,A phosphatidylcholine 32:0 in which the acyl group specified at positions 1 and 2 are stearoyl and myristoyl respectively.,36028,KEGG COMPOUND accession,C13632,,,,,,,,,,,,,,,
2219,86091,4-hydroxy-3-methoxycinnamoylagmatine,A member of the class of cinnamamides obtained by formal condensation of the carboxy group of 4-hydroxy-3-methoxycinnamid with the amino group of agmatine.,31123,KEGG COMPOUND accession,C12262,,,,,,,,,,,,,,,
2220,86099,"1-[(9Z,12Z)-octadecadienoyl]-2-hexadecanoyl-sn-glycero-3-phosphocholine","A  phosphatidylcholine 34:2 in which the acyl groups specified at positions 1 and 2 are (9Z,12Z)-octadecadienoyl and linoleoyl respectively.",49584,KEGG COMPOUND accession,C13637,,,,,,,,,,,,,,,
2221,86102,"1-tetradecanoyl-2-[(5Z,8Z,11Z,14Z)-eicosatetraenoyl]-sn-glycero-3-phosphocholine","A phosphatidylcholine 34:4 in which teh acyl groups specified at positions 1 and 2 are tetradecanoyl and (5Z,8Z,11Z,14Z)-eicosatetraenoyl respectively.",35164,KEGG COMPOUND accession,C13635,,,,,,,,,,,,,,,
2222,86104,"(7Z,10Z)-hexadecadienoyl group","A fatty-acyl group derived from (7Z,10Z)-hexadecadienoic acid.",31128,KEGG COMPOUND accession,C13636,,,,,,,,,,,,,,,
2223,86112,"1-[(9Z,12Z)-octadecadienoyl]-2-octadecanoyl-sn-glycero-3-phosphocholine","A phosphatidylcholine 36:2 in which the acyl groups specified at positions 1 and 2 are (9Z,12Z)-octadecadienoyl and octadecanoyl respectively.",31130,KEGG COMPOUND accession,C12455,,,,,,,,,,,,,,,
2224,86116,"(25R)-3beta,4beta-dihydroxycholest-5-en-26-oate(1-)","A steroid acid anion that is the conjugate base of (25R)-3beta,4beta-dihydroxycholest-5-en-26-oic acid, obtained by deprotonation of the carboxy group; major species at pH 7.3.",31132,KEGG COMPOUND accession,C12248,,,,,,,,,,,,,,,
2225,86118,"(8E,10E,12Z)-octadecatrienoyl group","A fatty-acyl group derived from (8E,10E,12Z)-octadecatrienoic acid",31133,KEGG COMPOUND accession,C13626,,,,,,,,,,,,,,,
2226,86130,"1-[(9Z)-octadecenoyl]-2-[(6Z,9Z,12Z)-octadecatrienoyl]-sn-glycero-3-phosphocholine","A phosphatidylcholine 36:4 in which the acyl groups specified at positions 1 and 2 are (9Z)-octadecenoyl and (6Z,9Z,12Z)-octadecatrienoyl respectively.",31136,KEGG COMPOUND accession,C12203,,,,,,,,,,,,,,,
2227,86139,N-methyl-L-alpha-amino acid zwitterion,An amino acid zwitterion obtained by transfer of a proton from the amino to the carboxy group of any N-methyl-L-alpha-amino acid; major species at pH 7.3.,18329,KEGG COMPOUND accession,C12525,,,,,,,,,,,,,,,
2228,86156,cadmium nitrate tetrahydrate,A hydrate that is the tetrahydrate form of cadmium nitrate.,31144,KEGG COMPOUND accession,C12379,,,,,,,,,,,,,,,
2229,86157,cadmium sulfate hydrate,A hydrate composed of cadmium sulfate and water in a 3:8 ratio.,31145,KEGG COMPOUND accession,C12398,,,,,,,,,,,,,,,
2230,86158,calcium chloride dihydrate,A hydrate that is the dihydrate form of calcium chloride.,35306,KEGG COMPOUND accession,C13431,,,,,,,,,,,,,,,
2231,86169,1-tetradecanoyl-2-tetracosanoyl-sn-glycero-3-phosphocholine,A phosphatidylcholine 38:0 in which the acyl groups specified at positions 1 and 2 are tetradecanoyl and tetracosanoyl respectively.,35305,KEGG COMPOUND accession,C13433,,,,,,,,,,,,,,,
2232,86183,"1-[(5Z,8Z,11Z,14Z,17Z)-eicosapentaenoyl]-2-[(9Z)-octadecenoyl]-sn-glycero-3-phosphocholine","A phosphatidylcholine 38:6 in which the acyl groups specified at positions 1 and 2 are (5Z,8Z,11Z,14Z,17Z)-eicosapentaenoyl and (9Z)-octadecenoyl respectively.",31157,KEGG COMPOUND accession,C13455,,,,,,,,,,,,,,,
2233,86208,1-tetracosanoyl-2-octadecanoyl-sn-glycero-3-phosphocholine,A phosphatidylcholine 42:0 in which the acyl groups specified at positions 1 and 2 are tetracosanoyl and octadecanoyl respectively.,31168,KEGG COMPOUND accession,C12891,,,,,,,,,,,,,,,
2234,86210,1-docosanoyl-2-eicosanoyl-sn-glycero-3-phosphocholine,A phosphatidylcholine 42:0 in which the acyl groups specified at positions 1 and 2 are docosanoyl and eicosanoyl respectively.,31169,KEGG COMPOUND accession,C13061,,,,,,,,,,,,,,,
2235,86238,greigite,An iron sulfide mineral with formula Fe3S4.,31178,KEGG COMPOUND accession,C12421,,,,,,,,,,,,,,,
2236,86240,1-hexadecyl-2-eicosanoyl-sn-glycero-3-phosphocholine,A phosphatidylcholine O-36:0 in which the alkyl and acyl groups specified at positions 1 and 2 are hexadecyl and eicosanoyl respectively.,75311,KEGG COMPOUND accession,C12422,,,,,,,,,,,,,,,
2237,86241,1-[(1Z)-octadecenyl]-2-[(9Z)-octadecenoyl]-sn-glycero-3-phosphocholine,A 1-(Z)-alk-1-enyl-2-acyl-sn-glycero-3-phosphocholine in which the alkeny and acyl group specified at positions 1 and 2 are (1Z)-octadecenyl and (9Z)-octadecenoyl respectively.,75244,KEGG COMPOUND accession,C12423,,,,,,,,,,,,,,,
2238,86243,1-hexadecyl-2-docosanoyl-sn-glycero-3-phosphocholine,A phosphatidylcholine O-38:0 in which the alkyl and acyl groups specified at positions 1 and 2 are hexadecyl and docosanoyl respectively.,31181,KEGG COMPOUND accession,C12424,,,,,,,,,,,,,,,
2239,86276,1-tetradecanoyl-2-decanoyl-sn-glycero-3-phosphocholine,A phosphatidylcholine 24:0 in which the acyl groups specified at positions 1 and 2 are tetradecanoyl and decanoyl respectively.,33130,KEGG COMPOUND accession,C13391,,,,,,,,,,,,,,,
2240,86299,O-[S-5-hexynoylpantetheine-4'-phosphoryl]serine(1-) residue,An O-(S-acylpantetheine-4'-phosphoryl)serine(1-) residue in which the S-acyl group is specified as 5-hexynoyl.,31206,KEGG COMPOUND accession,C12538,,,,,,,,,,,,,,,
2241,86327,antifungal drug,Any antifungal agent used to prevent or treat fungal infections in humans or animals.,47943,KEGG COMPOUND accession,C13355,,,,,,,,,,,,,,,
2242,86331,N-acetyl-beta-D-galactosaminyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->2)-alpha-D-mannosyl group,A mannosyl group derived from N-acetyl-beta-D-galactosaminyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->2)-alpha-D-mannose.,31225,KEGG COMPOUND accession,C13244,antipyrene,60-80-0,31225.0,"Human Metabolome Database (HMDB): An analgesic and antipyretic that has been given by mouth and as ear drops. Antipyrine is often used in testing the effects of other drugs or diseases on drug-metabolizing enzymes in the liver. (From Martindale, The Extra Pharmacopoeia, 30th ed, p29)",Antipyrine,HMDB0015503,b,b,C13244,b,b,antipyrene,[H]C1=C(N(N(C1=O)C1=C([H])C([H])=C([H])C([H])=C1[H])C([H])([H])[H])C([H])([H])[H],VEQOALNAAJBPNY-UHFFFAOYSA-N,"InChI=1S/C11H12N2O/c1-9-8-11(14)13(12(9)2)10-6-4-3-5-7-10/h3-8H,1-2H3"
2243,86343,1-propanoylproline,A N-acylpyrrolidine that is proline substituted by a propanoyl group at the nitrogen atom.,31227,KEGG COMPOUND accession,C12627,,,,,,,,,,,,,,,
2244,86362,N-acetyl-beta-D-glucosaminyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->4)-N-acetyl-beta-D-glucosaminyl group,An N-acetyl-D-glucosaminyl group derived from N-acetyl-beta-D-glucosaminyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->4)-N-acetyl-beta-D-glucosamine. A trisaccharide group formed from the hydrolysis of chitin (a linear polymer of repeated GlcNAc units).,31236,KEGG COMPOUND accession,C12564,,,,,,,,,,,,,,,
2245,86420,imidazole antifungal agent,A compound that has significant antifungal properties whose structure contains an imidazole moiety.,31264,KEGG COMPOUND accession,C12539,,,,,,,,,,,,,,,
2246,86430,EC 1.14.13.78 (ent-kaurene oxidase) inhibitor,"An EC 1.14.13.* (oxidoreductase acting on paired donors, incorporating 1 atom of oxygen, with NADH or NADPH as one donor) inhibitor that interferes with the action of ent-kaurene oxidase (E.C. 1.14.13.78).",31268,KEGG COMPOUND accession,C12865,,,,,,,,,,,,,,,
2247,86472,phosphatidylcholine 33:1,"A 1,2-diacyl-sn-glycero-3-phosphocholine in which the acyl groups specified at C-1 and C-2 contain 33 carbons in total with 1 double bond.",28556,KEGG COMPOUND accession,C12625,,,,,,,,,,,,,,,
2248,86491,spirit blue base,An aromatic amime that is the base component of spirit blue dye (the hydrochloride salt).,33216,KEGG COMPOUND accession,C13624,,,,,,,,,,,,,,,
2249,86500,N-myristoylglycinate,"An N-acylglycinate that is the conjugate base of N-myristoylglycine, obtained by deprotonation of the carboxy group; major species at pH 7.3.",33118,KEGG COMPOUND accession,C12486,,,,,,,,,,,,,,,
2250,86510,"N-[(2S,3S,4R)-1-(alpha-D-galactosyloxy)-3,4-dihydroxyoctadecan-2-yl]hexacosanethioamide",A glycosphingolipid identical with alpha-galactosylceramide (alpha-GalCer) with the exception of the replacement of the C-2 carbonyl oxygen on the acyl chain with a sulfur atom.,31304,KEGG COMPOUND accession,C12829,,,,,,,,,,,,,,,
2251,86553,3-hydroxymandelic acid,A 2-hydroxy monocarboxylic acid that is mandelic acid substituted by a hydroxy group at position 3'.,31325,KEGG COMPOUND accession,C12490,,,,,,,,,,,,,,,
2252,86558,4-acetoxy acetophenone,A methyl ketone that is acetophenone substituted by an acetoxy group at position 4.,31328,KEGG COMPOUND accession,C12304,,,,,,,,,,,,,,,
2253,86584,methyl p-coumarate acetate,A phenyl acetate obtained by the formal condensation of the hydroxy group of trans-4-coumaric acid with acetic acid.,31336,KEGG COMPOUND accession,C12935,,,,,,,,,,,,,,,
2254,86588,"3,4-dimethoxybenzyl acetate","An acetate ester obtained by the formal condensation of  (3,4-dimethoxyphenyl)methanol (veratryl alcohol) with acetic acid.",31338,KEGG COMPOUND accession,C13189,,,,,,,,,,,,,,,
2255,86899,"methyl-3,4-dimethoxycinnamate","An alkyl cinnamate obtained by the formal condensation of carboxy group of 3,4-dimethoxycinnamic acid with methanol.",31463,KEGG COMPOUND accession,C12138,,,,,,,,,,,,,,,
2256,86904,4-coumaric acid methyl ester,A cinnamate ester that is the methyl ester of 4-coumaric acid.,31464,KEGG COMPOUND accession,C12347,,,,,,,,,,,,,,,
2257,86910,N-acetylhistidine,A histidine derivative that is histidine in which one of the hydrogens of the alpha-amino group is substituted by an acetyl group.,31467,KEGG COMPOUND accession,C12476,,,,,,,,,,,,,,,
2258,86951,syringylresinol diacetate,A lignin that is the diacetate ester of syringylresinol.,31487,KEGG COMPOUND accession,C13167,,,,,,,,,,,,,,,
2259,86958,vanillyl beta-D-glucopyranoside,A monosaccharide derivative that is vanillyl alcohol attached to a beta-D-glucopyranosyl residue at position 1.,31490,KEGG COMPOUND accession,C13168,,,,,,,,,,,,,,,
2260,86972,"4-[2-(2-methyl-1,3-thiazol-4-yl)ethyl]-3-(non-8-en-1-yl)oxetan-2-one","A beta-lactone carrying non-8-en-1-yl and 2-(2-methyl-1,3-thiazol-4-yl)ethyl substituents at positions 3 and 4 respectively.",31493,KEGG COMPOUND accession,C12954,,,,,,,,,,,,,,,
2261,86996,(R)-fluoxetine hydrochloride,A hydrochloride obtained by reaction of (R)-fluoxetine with one equivalent of hydrochloric acid.,31503,KEGG COMPOUND accession,C12339,,,,,,,,,,,,,,,
2262,86997,(S)-fluoxetine hydrochloride,A hydrochloride obtained by reaction of (S)-fluoxetine with one equivalent of hydrochloric acid.,31504,KEGG COMPOUND accession,C12336,,,,,,,,,,,,,,,
2263,86999,1-acyl-2-palmitoylglycerolipid,Any glycerolipid in which the acyl group at position 2 of the glycerol moiety is specified as palmitoyl.,31505,KEGG COMPOUND accession,C12337,,,,,,,,,,,,,,,
2264,87045,4alpha-hydroxymethyl-4beta-methyl-5alpha-8-cholesten-3beta-ol,A 3beta-sterol that is 5alpha-cholest-8-en-3beta-ol carrying hydroxymethyl and methyl substituents at position 4.,31529,KEGG COMPOUND accession,C12448,egme,b,708640.0,"Human Metabolome Database (HMDB): Ecgonine methyl ester is a major metabolite of cocaine. It is generally not measured by HPLC because it is poorly detectable by UV, and its water solubility makes recovery from urine difficult. Using modified solid-phase extraction procedures, recoveries of 85% for ecgonine methyl ester could be obtained from urine. (PMID:1298401).",Ecgonine methyl ester,HMDB0006406,b,b,C12448,b,FDB023911,egme,[H]O[C@@]1([H])C([H])([H])[C@@]2([H])N(C([H])([H])[H])[C@]([H])(C([H])([H])C2([H])[H])[C@@]1([H])C(=O)OC([H])([H])[H],QIQNNBXHAYSQRY-UYXSQOIJSA-N,"InChI=1S/C10H17NO3/c1-11-6-3-4-7(11)9(8(12)5-6)10(13)14-2/h6-9,12H,3-5H2,1-2H3/t6-,7+,8-,9+/m0/s1"
2265,87050,4alpha-methyl-5alpha-cholest-8-en-3-one,A 3-oxo steroid that is 5alpha-cholest-8-en-3-one carrying an additional methyl substituent at position 4alpha.,31530,KEGG COMPOUND accession,C13008,dmantipyrine,89-25-8,31530.0,"Human Metabolome Database (HMDB): Demethylated antipyrine is a novel potent free radical scavenger that has been clinically used to reduce the neuronal damage following ischemic stroke. Demethylated antipyrine exerts neuroprotective effects by inhibiting endothelial injury and by ameliorating neuronal damage in brain ischemia. Demethylated antipyrine provides the desirable features of NOS: it increases eNOS (beneficial NOS for rescuing ischemic stroke) and decreases nNOS and iNOS (detrimental NOS). Post- reperfusion brain edema and hemorrhagic events induced by thrombolytic therapy may be reduced by demethylated antipyrine pretreatment. Increased productions of superoxide and NO in the brain after reperfusion and a concomitant surge in oxygen free radicals with increased NO during recirculation lead to formation of peroxynitrite, a super potent radical. Demethylated antipyrine, which inhibits oxidation and enhances NO production derived from increased eNOS expression, may improve and conserve cerebral blood flow without peroxynitrite generation during reperfusion. Clinical experience with demethylated antipyrine suggests that this drug has a wide therapeutic time window. Demethylated antipyrine can exert a wide range of inhibitory effects on water-soluble and lipid soluble peroxyl radical-induced peroxidation systems, and appears to display combined properties of both, vitamin C and E. Demethylated antipyrine can scavenge not only hydroxyl radicals but also other free radicals, although it has no major effect on superoxide anion radicals. Demethylated antipyrine apparently traps hydroxyl radicals and inhibits OH-dependent lipid peroxidation or tyrosine nitration induced by peroxynitrite (ONOO-). Lipid peroxidation starts with lipid radical (L) production after free radical-mediated extraction of proton from unsaturated fatty acid. Subsequently lipid peroxyl radical (LOO) is generated by addition of oxygen atom, and a further L is produced by LOO-mediated extraction of proton from another unsaturated fatty acid. Demethylated antipyrine can inhibit lipid peroxidation by scavenging not only hydroxyl radicals but also other free radicals including LOO. Under physiological conditions, 50% of demethylated antipyrine is present as an anion form, and electrons released from demethylated antipyrine anion exert radical scavenging. Subsequently, demethylated antipyrine radicals are generated. They react readily with oxygen atoms, and form peroxyl radical of demethylated antipyrine, and eventually 2-oxo-3-(phenylhydrazone)- butanoic acid (OPB). (PMID: 16834755, CNS Drug Rev. 2006 Spring;12(1):9-20.).",Demethylated antipyrine,HMDB0006240,b,b,C13008,b,FDB023854,dmantipyrine,[H]N1N(C(=O)C([H])=C1C([H])([H])[H])C1=C([H])C([H])=C([H])C([H])=C1[H],KZQYIMCESJLPQH-UHFFFAOYSA-N,"InChI=1S/C10H10N2O/c1-8-7-10(13)12(11-8)9-5-3-2-4-6-9/h2-7,11H,1H3"
2266,87059,acid fuchsin (free acid form),"An arenesulfonic acid that is 3-[(4-amino-3-methylphenyl)(4-aminophenyl)methylidene]-6-iminocyclohexa-1,4-diene-1-sulfonic acid in which the hydrogens ortho to the amino functions are replaced by phenyl groups. The disodium salt is the biological stain 'acid fuchsin'.",78288,KEGG COMPOUND accession,C12381,,,,,,,,,,,,,,,
2267,87064,benzimidazolylcarbamate fungicide,Any carbamate fungicide that contains a benzimidazolyl group attached to the nitrogen of the carbamate moiety.,31536,KEGG COMPOUND accession,C12599,,,,,,,,,,,,,,,
2268,87086,"35-amino-3-methylbacteriohopane-30,31,32,33,34-pentol","A member of the class of hopanoids that is bacteriohopane-30,31,32,33,34-pentol carrying additional methyl and amino substituents at positions 3 and 35 respectively. Isolated from Methylococcus capsulatus.",31547,KEGG COMPOUND accession,C12512,,,,,,,,,,,,,,,
2269,87090,(7R)-6-deoxy-D-manno-oct-7-ulosuronate,A carbohydrate acid anion obtained by deprotonation of the carboxy group of (7R)-6-deoxy-D-manno-oct-7-ulosuronic acid; major species at pH 7.3.,31549,KEGG COMPOUND accession,C12153,,,,,,,,,,,,,,,
2270,87091,"8-amino-3,8-dideoxy-alpha-D-manno-oct-2-ulosonic acid zwitterion","An amino acid zwitterion obtained by transfer of a proton from the carboxy to the amino group of 8-amino-3,8-dideoxy-alpha-D-manno-octulosonic acid; major species at pH 7.3.",31550,KEGG COMPOUND accession,C12154,,,,,,,,,,,,,,,
2271,87103,"2-tert-butyl-9-fluoro-1,6-dihydrobenzo[h]imidazo[4,5-f]isoquinolin-7-one","An organic heterotetracyclic compound that is 1,6-dihydrobenzo[h]imidazo[4,5-f]isoquinolin-7-one bearing additional tert-butyl and fluoro substituents at positions 2 and 9 respectively.",31555,KEGG COMPOUND accession,C12796,,,,,,,,,,,,,,,
2272,87115,"7-hydroxy-8-[(naphthalen-1-yl)diazenyl]naphthalene-1,3-disulfonic acid","A naphthalenesulfonic acid that is naphthalene-1,3-disulfonic acid carrying additional hydroxy and (naphthalen-1-yl)diazenylsubstituents at positions 7 and 8 respectively. The disodium salt is the biological stain 'acid red 44'.",31562,KEGG COMPOUND accession,C13031,,,,,,,,,,,,,,,
2273,87123,tulipalin B,A member of the class of butan-4-olides that is 3-methylidenebutan-4-olide carrying an additional hydroxy substituent at position 4 (the 4R-enantiomer),35702,KEGG COMPOUND accession,C13240,,,,,,,,,,,,,,,
2274,87135,morpholine antifungal drug,Any morpholine antifungal agent used to treat fungal infections in humans or animals.,31571,KEGG COMPOUND accession,C12290,,,,,,,,,,,,,,,
2275,87141,"3-oxocholesta-4,24-dien-26-oyl-CoA","A steroidal acyl-CoA that results from the formal condensation of the thiol group of coenzyme A with the carboxy group of 3-oxocholesta-4,24-dien-26-oic acid.",87426,KEGG COMPOUND accession,C12292,,,,,,,,,,,,,,,
2276,87154,N-[(Z)-dodec-2-enoyl]pyrrolidine,A fatty amide resulting from the formal condensation of the carboxy group of (Z)-dodec-2-enoic acid with the amino group of pyrrolidine.,31580,KEGG COMPOUND accession,C12724,,,,,,,,,,,,,,,
2277,87164,6-hydroxy-N-methylmyosmine(1+),An organic cation obtained by protonation of the tertiary amino function of 6-hydroxy-N-methylmyosmine; major species at pH 7.3.,31585,KEGG COMPOUND accession,C13042,,,,,,,,,,,,,,,
2278,87187,Biebrich scarlet (acid form),An arenesulfonic acid that is m-[(4-sulfophenyl)diazenyl]benzene-1-sulfonic acid carrying a (2-hydroxynaphthalen-1-yl)diazenyl substituent at position 2. The disodium salt is the biological stain 'Biebrich scarlet'.,31595,KEGG COMPOUND accession,C12217,,,,,,,,,,,,,,,
2279,87238,3-[(4-anilinophenyl)diazenyl]benzene-1-sulfonate,An organosulfonate oxoanion obtained by deprotonation of the sulfo group of 3-[(4-anilinophenyl)diazenyl]benzene-1-sulfonic acid.,42638,KEGG COMPOUND accession,C13038,,,,,,,,,,,,,,,
2280,87294,3-ethoxypropyl acetate,An acetate ester that is propyl acetate substituted by an ethoxy group at position 3.,31642,KEGG COMPOUND accession,C13106,,,,,,,,,,,,,,,
2281,87311,7-tridecanol,A secondary alcohol that s tridecane substituted by a hydroxy group at position 7.,31648,KEGG COMPOUND accession,C12294,,,,,,,,,,,,,,,
2282,87313,"8-amino-3,8-dideoxy-alpha-D-manno-oct-2-ulosonic acid",An amino monosaccharide obtained by replacement of the 8-hydroxy group of 3-deoxy-alpha-D-manno-oct-2-ulopyranosonic acid by an amino group.,31649,KEGG COMPOUND accession,C13297,,,,,,,,,,,,,,,
2283,87328,benzocyclobutene,A carbobicyclic compound that is benzene fused to a cyclobutane ring.,28211,KEGG COMPOUND accession,C12308,,,,,,,,,,,,,,,
2284,87440,3-pyridinol,"A monohydroxypyridine that is pyridine in which the hydrogen at position 3 has been replaced by a hydroxy group. It has been detected as a thermal degradation product from the smoke of the burning leaves of Salvia divinorum, a Mexican psychoactive plant.",47266,KEGG COMPOUND accession,C13645,M02143,10035-10-6,47266.0,b,Hydrobromic Acid,b,b,b,C13645,b,b,b,Br[H],CPELXLSAUQHCOX-UHFFFAOYSA-N,InChI=1S/BrH/h1H
2285,87446,alpha-D-Galp-(1->3)-beta-D-Galp-(1->3)-[alpha-L-Fucp-(1->4)]-beta-D-GlcpNAc-(1->2)-alpha-D-Manp-(1->3)-{alpha-D-Galp-(1->3)-beta-D-Galp-(1->3)-[alpha-L-Fucp-(1->4)]-beta-D-GlcpNAc-(1->2)-alpha-D-Manp-(1->6)}-beta-D-Manp-(1->4)-beta-D-GlcpNAc-(1->4)-D-GlcpNAc,An amino oligosaccharide that is a tridecasaccharide derivative in which two alpha-D-galactosyl-(1->3)-beta-D-galactosyl-(1->3)-[alpha-L-fucosyl-(1->4)]-N-acetyl-beta-D-glucosaminyl-(1->2)-alpha-D-mannosyl branched pentasaccharide chains are linked (1->3) and (1->6) to the mannose residue of a beta-D-mannosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->4)-N-acetyl-D-glucosamine trisaccharide.,31676,KEGG COMPOUND accession,C13422,,,,,,,,,,,,,,,
2286,87448,beta-D-GlcpNAc-(1->2)-alpha-D-Manp-(1->6)-[beta-D-Galp-(1->4)-beta-D-GlcpNAc-(1->2)-alpha-D-Manp-(1->3)]-beta-D-Manp-(1->4)-beta-D-GlcpNAc-(1->4)-D-GlcpNAc,An amino octasaccharide in which an N-acetyl-beta-D-glucosaminyl-(1->2)-alpha-D-mannosyl disaccharide chain and a beta-D-galactosyl-(1->3)-N-acetyl-beta-D-glucosaminyl-(1->2)-alpha-D-mannosyl chain are linked (1->6) and (1->3) respectively to the mannose residue of a beta-D-mannosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->4)-N-acetyl-D-glucosamine trisaccharide.,31677,KEGG COMPOUND accession,C12888,,,,,,,,,,,,,,,
2287,87496,octyl formate,A formate ester of  octan-1-ol.,31697,KEGG COMPOUND accession,C12312,,,,,,,,,,,,,,,
2288,87553,isoxazoline,An organic heteromonocyclic compound that is a dihydro derivative of any isoxazole.,31725,KEGG COMPOUND accession,C12296,,,,,,,,,,,,,,,
2289,87555,(R)-fluxametamide,"A 4-[5-(3,5-dichlorophenyl)-5-(trifluoromethyl)-4,5-dihydro-1,2-oxazol-3-yl]-N-[(methoxyamino)methylidene]-2-methylbenzamide that is the (R)-enantiomer of fluxametamide.",31726,KEGG COMPOUND accession,C12293,,,,,,,,,,,,,,,
2290,87584,N(2)-acyl-L-glutaminate,"An N-acyl-L-alpha-amino acid anion that is the conjugate base of N(2)-acyl-L-glutamine, obtained by deprotonation of the carboxy group; major structure at pH 7.3.",31738,KEGG COMPOUND accession,C12395,,,,,,,,,,,,,,,
2291,87586,7-octen-2-ol,An olefinic compound that octan-2-ol carrying a double bond at position 7.,31739,KEGG COMPOUND accession,C12662,,,,,,,,,,,,,,,
2292,87597,"1,3-dioxolane",A cyclic acetal that is pentane in which the carbon atoms at positions 1 and 3 are replaced by oxygen atoms respectively.,31741,KEGG COMPOUND accession,C12636,,,,,,,,,,,,,,,
2293,87600,"2,6-dimethyl-1,3,5,7-octatetraene","An alkatetraene that is 1,3,5,7-octatetraene substituted by methyl groups at positions 2 and 6 respectively.",31742,KEGG COMPOUND accession,C12626,,,,,,,,,,,,,,,
2294,87602,4-hydroxyestrone,A 4-hydroxy steroid that is estrone substituted by a hydroxy group at position 4.,31743,KEGG COMPOUND accession,C12634,,,,,,,,,,,,,,,
2295,87606,N-icosanoylglycine,A N-acylglycine in which the acyl group is specified as icosanoyl.,31744,KEGG COMPOUND accession,C12635,,,,,,,,,,,,,,,
2296,87610,alpha-L-Fucp-(1->2)-[alpha-D-Galp-(1->3)]-beta-D-Galp-(1->4)-beta-D-GlcpNAc-(1->3)-{alpha-L-Fucp-(1->2)-[alpha-D-Galp-(1->3)]-beta-D-Galp-(1->4)-beta-D-GlcpNAc-(1->6)}-D-GalpNAc,An amino nonasaccharide in which two alpha-L-fucosyl-(1->2)-[beta-D-galactosyl-(1->3)]-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl chains are linked (1->3) and (1->6) to D-galactose.,30200,KEGG COMPOUND accession,C12249,,,,,,,,,,,,,,,
2297,87613,alpha-L-Fucp-(1->2)-[alpha-D-GalpNAc-(1->3)]-beta-D-Galp-(1->4)-beta-D-GlcpNAc-(1->3)-{alpha-L-Fucp-(1->2)-[alpha-D-GalpNAc-(1->3)]-beta-D-Galp-(1->4)-beta-D-GlcpNAc-(1->6)}-D-GalpNAc,An amino oligosaccharide that is an undecaasaccharide derivative in which two alpha-L-fucosyl-(1->2)-[N-acetyl-beta-D-galactosaminyl-(1->3)]-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl chains are linked (1->3) and (1->6) to D-galactose.,31746,KEGG COMPOUND accession,C12819,,,,,,,,,,,,,,,
2298,87616,alpha-D-GalpNAc-(1->3)-[alpha-L-Fucp-(1->2)]-beta-D-Galp-(1->4)-beta-D-GlcpNAc-(1->2)-alpha-D-Manp-(1->3)-{alpha-D-GalpNAc-(1->3)-[alpha-L-Fucp-(1->2)]-beta-D-Galp-(1->4)-beta-D-GlcpNAc-(1->2)-alpha-D-Manp-(1->6)}-beta-D-Manp-(1->4)-beta-D-GlcpNAc-(1->4)-[alpha-L-Fucp-(1->6)]-beta-D-GlcpNAc,An amino oligosaccharide that is a tetradecasaccharide derivative in which two N-acetyl-alpha-D-galactosaminyl-(1->3)-[alpha-L-fucosyl-(1->2)]-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->2)-alpha-D-mannosyl branched pentasaccharide units are linked (1->3) and (1->6) to the mannose residue of a beta-D-mannosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->4)-[alpha-L-fucosyl-(1->6)]-N-acetyl-D-glucosamine branched tetrasaccharide.,31748,KEGG COMPOUND accession,C12213,,,,,,,,,,,,,,,
2299,87621,beta-D-GlcpNAc-(1->4)-[alpha-Neup5Ac-(2->3)-beta-D-Galp-(1->4)-beta-D-GlcpNAc-(1->2)-alpha-D-Manp-(1->3)]-[alpha-Neup5Ac-(2->3)-beta-DGalp-(1->4)-beta-D-GlcpNAc-(1->2)-alpha-D-Manp-(1->6)]-beta-D-Manp-(1->4)-beta-D-GlcpNAc-(1->4)-beta-D-GlcpNAc,"A branched amino oligosaccharide comprising a linear trisaccharide of beta-D-mannose and two N-acetyl-beta-D-glucosamine residues all linked in sequence (1->4), to the mannosyl residue of which is (1->4)-linked an Nacetyl-beta-D-glucosaminyl residue, together with two N-acetyl-alpha-neuraminyl-(2->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->2)-alpha-D-mannosyl tetrasaccharide units linked (1->3) and (1->6).",31751,KEGG COMPOUND accession,C12394,,,,,,,,,,,,,,,
2300,87623,methanediimine,A carbodiimide in which both nitrogens are unsubstituted.,31752,KEGG COMPOUND accession,C12391,,,,,,,,,,,,,,,
2301,87624,beta-D-GlcpNAc-(1->4)-[alpha-Neup5Ac-(2->3)-beta-D-Galp-(1->4)-beta-D-GlcpNAc-(1->2)-[alpha-Neup5Ac-(2->3)-beta-D-Galp-(1->4)-beta-D-GlcpNAc-(1->4)]-alpha-D-Manp-(1->3)]-[alpha-Neup5Ac-(2->3)-beta-D-Galp-(1->4)-beta-D-GlcpNAc-(1->4)-alpha-D-Manp-(1->6)]-beta-D-Manp-(1->4)-beta-D-GlcpNAc-(1->4)-beta-D-GlcpNAc,"A branched amino oligosaccharide that is a pentasaccharide comprising a linear trisaccharide of beta-D-mannose and two N-acetyl-beta-D-glucosamine residues all linked in sequence (1->4), to the mannosyl residue of which are linked an N-acetyl-beta-D-glucosaminyl residue [via a (1->4) linkage], an N-acetyl-alpha-neuraminyl-(2->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->4)-alpha-D-mannosyl(1->6) linear  tetrasaccharide chain [linked (1->6)], and an N-acetyl-alpha-neuraminyl-(2->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->4)-[N-acetyl-alpha-neuraminyl-(2->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->2)]-alpha-D-mannosyl branched heptasaccharide unit [linked (1->3)].",31753,KEGG COMPOUND accession,C13103,,,,,,,,,,,,,,,
2302,87627,fast blue salt B,"An organic chloride salt composed of 3,3'-dimethoxy[1,1'-biphenyl]-4,4'-bis(diazonium), zinc and chloride ions in a ratio of 1:1:4. Used for detection of marijuana metabolites in urine.",31755,KEGG COMPOUND accession,C12323,,,,,,,,,,,,,,,
2303,87643,victoria blue 4R,"An iminium salt composed of 4-([4-(dimethylamino)phenyl]{4-[methyl(phenyl)amino]naphthalen-1-yl}methylidene)-N,N-dimethylcyclohexa-2,5-dien-1-iminium and chloride ions in a 1:1 ratio. It binds to nucleic acids and can be used in standardised staining techniques suitable for automated cell-pattern recognition.",37525,KEGG COMPOUND accession,C12147,,,,,,,,,,,,,,,
2304,87652,victoria blue B(1+),An iminium ion that forms the cationic portion of the histological dye 'victoria blue B'.,31762,KEGG COMPOUND accession,C13320,,,,,,,,,,,,,,,
2305,87654,basic brown 1,"A bis(azo) compound that is 1,1'-(1,3-phenylene)bis(diazene) in which both azene hydrogens are replaced by 2,4-diaminophenyl groups. A metachromatic dye which stains acid mucins yellow. It is also a constituent of Papanicolaou's EA solutions, used for cervical, and other smears. Its dihydrochloride salt is also a biological dye known as Bismark brown Y.",31763,KEGG COMPOUND accession,C12633,,,,,,,,,,,,,,,
2306,87668,magenta II,"A hydrochloride that is the monohydrochloride of 4-[(4-aminophenyl)(4-iminocyclohexa-2,5-dien-1-ylidene)methyl]-2-methylaniline. One of the minor constituents of Basic fuchsin, together with pararosanilin, rosanilin and new fuchsin.",31770,KEGG COMPOUND accession,C13156,,,,,,,,,,,,,,,
2307,87702,"(24R,25R)-3alpha,7alpha,24-trihydroxy-5beta-cholestan-26-oyl-CoA(4-)","An acyl-CoA(4-) arising from deprotonation of phosphate and diphosphate OH groups of (24R,25R)-3alpha,7alpha,24-trihydroxy-5beta-cholestan-26-oyl-CoA; major species at pH 7.3.",31781,KEGG COMPOUND accession,C12871,,,,,,,,,,,,,,,
2308,87719,(7Z)-3-oxohexadecenoyl-CoA(4-),A 3-oxo-fatty acyl CoA(4-) obtained by deprotonation of phosphate and diphosphate OH groups of (7Z)-3-oxohexadecenoyl-CoA; major species at pH 7.3.,16559,KEGG COMPOUND accession,C12632,,,,,,,,,,,,,,,
2309,87724,(S)-prasugrel,"An 5-[2-cyclopropyl-1-(2-fluorophenyl)-2-oxoethyl]-4,5,6,7-tetrahydrothieno[3,2-c]pyridin-2-yl acetate that is the (S)-enantiomer of prasugrel (the racemate is a cardiovascular drug).",31788,KEGG COMPOUND accession,C12630,,,,,,,,,,,,,,,
2310,87734,12alpha-hydroxy-3-oxo-5beta-cholan-24-oate,"A bile acid anion that is the conjugate base of 12alpha-hydroxy-3-oxo-5beta-cholan-24-oic acid, obtained by deprotonation of the carboxy group; major species at pH 7.3.",31793,KEGG COMPOUND accession,C12893,,,,,,,,,,,,,,,
2311,87736,"7alpha,12alpha-dihydroxy-3-oxo-5beta-cholan-24-oate","A bile acid anion that is the conjugate base of 7alpha,12alpha-dihydroxy-3-oxo-5beta-cholan-24-oic acid, obtained by deprotonation of the carboxy group; major species at pH 7.3.",31794,KEGG COMPOUND accession,C12567,,,,,,,,,,,,,,,
2312,87739,(R)-warfarin sodium,"An organic sodium salt having 2-oxo-3-[(1R)-3-oxo-1-phenylbutyl]-2H-1-benzopyran-4-olate as the counterion (the racemate is warfarin sodium, an anticoagulant drug and rodenticide).",31795,KEGG COMPOUND accession,C12505,,,,,,,,,,,,,,,
2313,87749,prenyl-FMN,A flavin mononucleotide resulting from the formal dehydrogenation of prenyl-FMNH2. It is an essential cofactor for the decarboxylase enzymes UbiD (Fdc1).,31799,KEGG COMPOUND accession,C12140,,,,,,,,,,,,,,,
2314,87774,16alpha-hydroxydehydroepiandrosterone 3-sulfate,An androstanoid that is dehydroepiandrosterone 3-sulfate substituted by a hydroxy group at the 16alpha-position.,31810,KEGG COMPOUND accession,C13179,,,,,,,,,,,,,,,
2315,87800,alpha-L-Fucp-(1->2)-beta-D-Galp-(1->3)-beta-D-GlcpNAc-(1->3)-[alpha-L-Fucp-(1->2)-beta-D-Galp-(1->3)-beta-D-GlcpNAc-(1->6)]-alpha-D-GalpNAc,An amino heptasaccharide in which two alpha-L-fucosyl-(1->2)-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-glucosaminyl chains are linked (1->3) and (1->6) to alpha-D-galactose.,31823,KEGG COMPOUND accession,C13377,,,,,,,,,,,,,,,
2316,87821,"17-phenyl-18,19,20-trinor-prostaglandin D2","A prostanoid that is 18,19,20-trinor-prostaglandin D2 in which one of the terminal methyl hydrogens has been replaced by a phenyl group.",31832,KEGG COMPOUND accession,C12305,,,,,,,,,,,,,,,
2317,87859,"O-[S-(2E,7Z-hexacosadienoylpantetheine)-4'-phosphoryl]-L-serine(1-) residue","An O-[S-(2E)-2-enoylpantetheine-4'-phosphoryl]-L-serine(1-) residue in which the S-acyl group is specified as (2E,5Z)-hexacosadienoyl.",31850,KEGG COMPOUND accession,C12333,,,,,,,,,,,,,,,
2318,87866,"O-{S-[(3R,11Z)-3-hydroxytriacontenoylpantetheine]-4'-phosphoryl}-L-serine(1-) residue","An O-[S-(3R)-3-hydroxyacylpantetheine-4'-phosphoryl]serine(1-) residue in which the S-acyl group is specified as (3R,11Z)-3-hydroxytriacontenoyl.",31856,KEGG COMPOUND accession,C12389,,,,,,,,,,,,,,,
2319,87881,"O-[S-(5Z,17Z-hexatriacontadienoylpantetheine)-4'-phosphoryl]-L-serine(1-) residue","An O-(S-acylpantetheine-4'-phosphoryl)serine(1-) residue in which the S-acyl group is specified as (5Z,17Z)-hexatriacontadienoyl.",33220,KEGG COMPOUND accession,C13623,,,,,,,,,,,,,,,
2320,87913,"O-{S-[(3R,19Z,31Z)-3-hydroxypentacontadienoylpantetheine]-4'-phosphoryl}-L-serine(1-) residue","An O-[S-(3R)-3-hydroxyacylpantetheine-4'-phosphoryl]serine(1-) residue in which the S-acyl group is specified as (3R,19Z,31Z)-3-hydroxypentacontadienoyl.",7061,KEGG COMPOUND accession,C12221,,,,,,,,,,,,,,,
2321,87926,"O-{S-[(3R,5Z,21Z)-3-hydroxytetracontadienoylpantetheine]-4'-phosphoryl}-L-serine(1-) residue","An O-[S-(3R)-3-hydroxyacylpantetheine-4'-phosphoryl]serine(1-) residue in which the S-acyl group is specified as (3R,5Z,21Z)-3-hydroxytetracontadienoyl.",31882,KEGG COMPOUND accession,C12269,,,,,,,,,,,,,,,
2322,87927,"O-[S-(2E,5Z,21Z-tetracontatrienoylpantetheine)-4'-phosphoryl]-L-serine(1-) residue","An O-[S-(2E)-2-enoylpantetheine-4'-phosphoryl]-L-serine(1-) residue in which the S-acyl group is specified as (2E,5Z,21Z)-tetracontatrienoyl.",31883,KEGG COMPOUND accession,C12272,,,,,,,,,,,,,,,
2323,87930,"O-{S-[(3R,7Z,23Z)-3-hydroxydotetracontadienoylpantetheine]-4'-phosphoryl}-L-serine(1-) residue","An O-[S-(3R)-3-hydroxyacylpantetheine-4'-phosphoryl]serine(1-) residue in which the S-acyl group is specified as (3R,7Z,23Z)-3-hydroxydotetracontadienoyl.",31885,KEGG COMPOUND accession,C12986,,,,,,,,,,,,,,,
2324,87932,"O-[S-(7Z,23Z-dotetracontadienoylpantetheine)-4'-phosphoryl]-L-serine(1-) residue","An O-(S-acylpantetheine-4'-phosphoryl)serine(1-) residue in which the S-acyl group is specified as (7Z,23Z)-dotetracontadienoyl.",31887,KEGG COMPOUND accession,C12987,,,,,,,,,,,,,,,
2325,87933,"O-{S-[(9Z,25Z)-3-oxotetratetracontadienoylpantetheine]-4'-phosphoryl}-L-serine(1-) residue","An O-(S-3-oxoacylpantetheine-4'-phosphoryl)-L-serine(1-) residue in which the S-acyl group is specified as (9Z,25Z)-3-oxotetratetracontadienoyl.",35704,KEGG COMPOUND accession,C12989,,,,,,,,,,,,,,,
2326,87986,p-tolyl beta-D-glucuronide,A glucosiduronic acid that is beta-D-glucuronic acid in which the anomeric hydroxyl hydrogen is replaced by a p-tolyl group.,31897,KEGG COMPOUND accession,C12508,,,,,,,,,,,,,,,
2327,87990,alpha-Neu5Ac-(2->8)-alpha-Neu5Ac-(2->3)-beta-Gal-(1->3)-beta-GalNAc-(1->4)-beta-Gal-(1->4)-beta-Glc-(1<->1')-Cer,"A sialotetraosylceramide consisting of a linear hexasaccharide made up from two sialyl residues, two galactose residues, one N-acetylgalactosamine residue and a glucose residue at the reducing end attached to the ceramide portion via a beta-linkage.",31898,KEGG COMPOUND accession,C12862,,,,,,,,,,,,,,,
2328,87992,beta-Gal-(1->3)-beta-GalNAc-(1->4)-[alpha-Neu5Ac-(2->8)-alpha-Neu5Ac-(2->8)-alpha-Neu5Ac-(2->3)]-beta-Gal-(1->4)-beta-Glc-(1<->1')-Cer,"A sialotetraosylceramide consisting of a branched heptasaccharide made up from three sialyl residues, two galactose residues, one N-acetylglucosamine residue and a glucose residue at the reducing end attached to the ceramide portion via a beta-linkage.",31899,KEGG COMPOUND accession,C12915,,,,,,,,,,,,,,,
2329,88005,3-phosphoglycerate(2-),A phosphoglycerate obtained by deprotonation of the carboxy group and one of the phosphate OH groups of 3-phosphoglyceric acid.,31905,KEGG COMPOUND accession,C13280,,,,,,,,,,,,,,,
2330,88008,(7Z)-hexadecenoyl-CoA,A hexadecenoyl-CoA that results from the formal condensation of the thiol group of coenzyme A with the carboxy group of (7Z)-hexadecenoic acid.,76072,KEGG COMPOUND accession,C13051,,,,,,,,,,,,,,,
2331,88027,beta-D-Galp-(1->4)-beta-D-GlcpNAc-(1->3)-beta-D-Galp-(1->4)-beta-D-GlcpNAc-(1->2)-alpha-D-Manp-(1->3)-[beta-D-Galp-(1->4)-beta-D-GlcpNAc-(1->3)-beta-D-Galp-(1->4)-beta-D-GlcpNAc-(1->2)-alpha-D-Manp-(1->6)]-beta-D-Manp-(1->4)-beta-D-GlcpNAc-(1->4)-beta-D-GlcpNAc,"A branched amino oligosaccharide that is a tridecasaccharide derivative consisting of a linear trisaccharide of beta-D-mannose and two N-acetyl-beta-D-glucosamine residues (one of which is at the reducing end) all linked in sequence (1->4), to the mannosyl residue of which are linked (1->3) and (1->6) two beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->2)-alpha-D-mannosyl linear pentasaccharide units.",31915,KEGG COMPOUND accession,C12416,,,,,,,,,,,,,,,
2332,88045,cylindrospermopsins,A class of organic heterotricyclic compounds that consists of cylindrospermopsin and its structural analogues.,31927,KEGG COMPOUND accession,C12156,,,,,,,,,,,,,,,
2333,88125,(2R)-2-[(1R)-1-hydroxy-20-{2-[10-(2-octadecylcyclopropyl)decyl]cyclopropyl}icosyl]tetracosanoic acid,A C78 mycolic acid having a C54 meromycolic chain with two cis cyclopropyl functions and a saturated C24 alpha-branch. It is produced by Mycobacterium tuberculosis H37Ra.,31958,KEGG COMPOUND accession,C12186,,,,,,,,,,,,,,,
2334,88126,(2R)-2-[(1R)-1-hydroxy-20-{2-[10-(2-octadecylcyclopropyl)decyl]cyclopropyl}icosyl]hexacosanoic acid,A C80 mycolic acid having a C54 meromycolic chain with two cis cyclopropyl functions and a saturated C26 alpha-branch. It is produced by Mycobacterium tuberculosis H37Ra.,31959,KEGG COMPOUND accession,C12661,,,,,,,,,,,,,,,
2335,88132,alpha-L-Fucp-(1->2)-[alpha-D-Galp-(1->3)]-beta-D-Galp-(1->3)-alpha-D-GalpNAc-yl group,"A branched tetrasaccharide glucosaminyl group consisting of alpha-L-fucosyl, beta-D-galactosyl and N-acetyl-alpha-D-D-galactosaminyl residues linked sequentially (1->2) and (1->3), to the beta-D-galactosyl residue of which is also linked (1->3) an alpha-D-galactosyl residue. Blood group type-III B determinant.",31962,KEGG COMPOUND accession,C12942,,,,,,,,,,,,,,,
2336,88143,"(3,4-dimethoxyphenyl)methyloxidanyl","An organic radical obtained by abstraction of the hydroxy proton from (3,4-dimethoxyphenyl)methanol.",31965,KEGG COMPOUND accession,C12642,,,,,,,,,,,,,,,
2337,88146,2''-O-malonyl-ADP-D-ribose,A nucleotide-sugar having ADP as the nucleotide fragment and 2-O-malonyl-D-ribofuranos-5-yl as the sugar component.,31966,KEGG COMPOUND accession,C12640,,,,,,,,,,,,,,,
2338,88149,(S)-4-hydroxy-1-pyrroline-2-carboxylic acid,A 4-hydroxy-1-pyrroline-2-carboxylic acid in which the 4-hydroxy group has S-configuration.,31967,KEGG COMPOUND accession,C12137,,,,,,,,,,,,,,,
2339,88154,alpha-D-galactosyl-(1->4)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1)-ceramide,A glycotriaosylceramide having alpha-D-galactosyl-(1->4)-beta-D-galactosyl-(1->4)-beta-D-glucosyl component attached to the primary hydroxy function of a ceramide with undefined sphingoid base.,31968,KEGG COMPOUND accession,C12644,,,,,,,,,,,,,,,
2340,88156,diacetin,"A diglyceride resulting from the formal condensation of any two of the hydroxy groups of glycerol with the carboxy groups of two molecules of acetic acid (either R1 = H and R2 = Ac, or R1 = Ac and R2 = H).",31969,KEGG COMPOUND accession,C12645,,,,,,,,,,,,,,,
2341,88176,brilliant green cation,An iminium ion that is the cationic component of the histological dye 'brilliant green'.,74793,KEGG COMPOUND accession,C12141,,,,,,,,,,,,,,,
2342,88191,Sirius red 4B,An organic sodium salt resulting from the formal condensation of Sirius red 4B (acid form) with two equivalents of sodium hydroxide. Used as the plasma stain in some trichrome staining methods.,31985,KEGG COMPOUND accession,C12139,,,,,,,,,,,,,,,
2343,88196,Pontamine sky blue 5B(4-),An organosulfonate oxoanion obtained by deprotonation of the sulfonic acid groups of Pontamine sky blue 5B (acid form).,31988,KEGG COMPOUND accession,C12303,,,,,,,,,,,,,,,
2344,88202,Congo corinth,An organic sodium salt resulting from the formal condensation of Congo corinth (acid form) with two equivalents of sodium hydroxide. A histological dye used to stain frozen sections for rapid diagnosis and to demonstrate amuloid.,31991,KEGG COMPOUND accession,C12600,,,,,,,,,,,,,,,
2345,88219,TTT-3002,"An organic heterooctacyclic compound that is 1H,1'H-2,2'-biindole in which the nitrogens have undergone formal oxidative coupling to positions 2 and 5 of 3-amino-N,2-dimethyloxolane-3-carboxamide (the 2R,3R,5S product), and in which the 3 and 3' positions of the biindole moiety have also undergone formal oxidative coupling to positions 3 and 4 of 1,5-dihydro-2H-pyrrol-2-one.",31997,KEGG COMPOUND accession,C13482,HC01842,6909-62-2,31997.0,b,Phosphodimethylethanolamine,b,b,b,C13482,b,b,HC01842,[H]C([H])([H])N(C([H])([H])[H])C([H])([H])C([H])([H])OP([O-])([O-])=O,BLHVJAAEHMLMOI-UHFFFAOYSA-L,"InChI=1S/C4H12NO4P/c1-5(2)3-4-9-10(6,7)8/h3-4H2,1-2H3,(H2,6,7,8)/p-2"
2346,88222,N(5)-methyl-argininium(1+) residue,An alpha-amino-acid residue cation obtained by protonation of the guanidino group of N(5)-methyl-argininium residue.,31998,KEGG COMPOUND accession,C12145,M02748,b,31998.0,b,Phytoceramide-Pool,b,b,b,C12145,b,b,b,[H]OC([H])([H])[C@]([H])(N([H])C([*])=O)[C@]([H])(O[H])[C@]([H])(O[H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H],b,b
2347,88226,"(2E,6E)-farnesyl monophosphate(2-)","An organophosphate oxoanion that is the dianion obtained by removal of the two protons from the monophosphate group of (2E,6E)-farnesyl monophosphate. Major species at pH 7.3.",46961,KEGG COMPOUND accession,C12144,M02749,554-62-1,46961.0,"Human Metabolome Database (HMDB): Phytosphingosine is a phospholipid. Phospholipids are a class of lipids and a major component of all biological membranes; sphingolipid metabolites, such as sphingosine and ceramide, are highly bioactive compounds and are involved in diverse cell processes, including cell-cell interaction, cell proliferation, differentiation, and apoptosis. Phytosphingosine is also one of the most widely distributed natural sphingoid bases, which is abundant in fungi and plants, and also found in animals including humans. Phytosphingosine is structurally similar to sphingosine; phytosphingosine possesses a hydroxyl group at C-4 of the sphingoid long-chain base. The physiological roles of phytosphingosine are largely unknown. Phytosphingosine induces apoptosis in human T-cell lymphoma and non-small cell lung cancer cells, and induces caspase-independent cytochrome c release from mitochondria. In the presence of caspase inhibitors, phytosphingosine-induced apoptosis is almost completely suppressed, suggesting that phytosphingosine-induced apoptosis is largely dependent on caspase activities. (PMID: 12576463, 12531554, 8046331, 8048941,8706124).",Phytosphingosine,HMDB0004610,b,b,C12144,PHYTOSPINGOSINE,FDB023381,b,[H]OC([H])([H])[C@]([H])(N([H])[H])[C@]([H])(O[H])[C@]([H])(O[H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H],AERBNCYCJBRYDG-KSZLIROESA-N,"InChI=1S/C18H39NO3/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-17(21)18(22)16(19)15-20/h16-18,20-22H,2-15,19H2,1H3/t16-,17+,18-/m0/s1"
2348,88279,Sirius red F3B,An organic sodium salt resulting from the formal condensation of Sirius red F3B (acid form) with six equivalents of sodium hydroxide. A polyazo dye used principally in staining methods for collagen and amyloid.,32023,KEGG COMPOUND accession,C13273,,,,,,,,,,,,,,,
2349,88289,ethyl green(1+),An iminium ion that forms the cationic portion of the histological dye 'ethyl green'.,32028,KEGG COMPOUND accession,C12282,,,,,,,,,,,,,,,
2350,88291,hydroxyimidazole,Any member of the class of imidazoles in which the imidazole ring is substituted by one or more hydroxy groups.,32029,KEGG COMPOUND accession,C12554,,,,,,,,,,,,,,,
2351,88293,Fast green FCF(1+),An iminium ion that is the free acid form of Fast green FCF.,32030,KEGG COMPOUND accession,C13198,,,,,,,,,,,,,,,
2352,88303,(S)-lorglumide sodium,"An organic sodium salt obtained by formal condensation of N(2)-(3,4-dichlorobenzoyl)-N,N-dipentyl-L-alpha-glutamine with one equivalent of sodium hydroxide. The racemate is lorglumide sodium, a CCK antagonist.",32035,KEGG COMPOUND accession,C12568,,,,,,,,,,,,,,,
2353,88305,lorglumide,A racemate comprising equal amounts of (R)- and (S)-lorglumide.,32036,KEGG COMPOUND accession,C13192,,,,,,,,,,,,,,,
2354,88327,dafadine A,"An N-acylpiperidine obtained by formal condensation of the carboxy group of 5-[(2,6-dimethylphenoxy)methyl]-1,2-oxazole-3-carboxylic acid with the secondary amino group of 4-(pyridin-4-yl)piperidine.",32044,KEGG COMPOUND accession,C12666,,,,,,,,,,,,,,,
2355,88334,CD437,"A naphthoic acid that is 6-phenylnaphthylene-2-carboxyic acid in which the phenyl substituent has been substituted at positions 3 and 4 by adamant-1-yl and hydroxy groups, respectively. It acts as a selective agonist of retinoic acid receptor (RAR)gamma and induces cell cycle arrest and apoptosis in various cancer cells.",32049,KEGG COMPOUND accession,C12386,,,,,,,,,,,,,,,
2356,88342,"(3R,3aS,6aR)-hexahydrofuro[2,3-b]furan-3-yl glycolate","A furofuran that is (3R,3aS,6aR)-hexahydrofuro[2,3-b]furan-3-ol in which the hydroxyl hydrogen is replaced by a glycolate group.",71970,KEGG COMPOUND accession,C12176,,,,,,,,,,,,,,,
2357,88356,3-methylphenylacetic acid,A monocarboxylic acid that is acetic acid in which one of the methyl hydrogens is replaced by a 3-methylphenyl group.,32062,KEGG COMPOUND accession,C13110,,,,,,,,,,,,,,,
2358,88653,hexan-3-ol,A hexanol in which the hydroxy group is at position 3.,32176,KEGG COMPOUND accession,C12919,,,,,,,,,,,,,,,
2359,88705,DG(15:0/15:0/0:0),"A 1,2-diacyl-sn-glycerol that has pentadecanoyl as 1- and 2-acyl groups.",32200,KEGG COMPOUND accession,C12369,,,,,,,,,,,,,,,
2360,88814,"2,6,8-trimethyldecane","An alkane that is decane substituted by a methyl group at positions 2,6 and 8. It is a combustion product of natural gas.",32253,KEGG COMPOUND accession,C13410,,,,,,,,,,,,,,,
2361,88824,N-acetylcadaverine,An N-substituted cadaverine that is cadaverine in which one of the amino groups has been converted to the corresponding acetamide.,76978,KEGG COMPOUND accession,C13044,,,,,,,,,,,,,,,
2362,90097,alpha-Neup5Gc-(2->3)-beta-D-Galp-(1->4)-beta-D-GlcpNAc-(1->3)-beta-D-Galp-(1->4)-beta-D-GlcpNAc-(1->2)-alpha-D-Manp-(1->3)-[alpha-Neup5Gc-(2->3)-beta-D-Galp-(1->4)-beta-D-GlcpNAc-(1->3)-beta-D-Galp-(1->4)-beta-D-GlcpNAc-(1->2)-alpha-D-Manp-(1->6)]-beta-D-Manp-(1->4)-beta-D-GlcpNAc-(1->4)-beta-D-GlcpNAc,"A branched amino oligosaccharide that is a pentadecasaccharide derivative consisting of a linear trisaccharide of beta-D-mannose and two N-acetyl-beta-D-glucosamine residues (one of which is at the reducing end) all linked in sequence (1->4), to the mannosyl residue of which are linked (1->3) and (1->6) two N-glycoloyl-alpha-neuraminyl-(2->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->2)-alpha-D-mannosyl linear hexasaccharide units.",18348,KEGG COMPOUND accession,C04637,pail45p_hs,b,28910.0,b,"Phosphatidylinositol 4,5-Bisphosphate",b,b,b,C04637,b,b,pail45p_hs,[H]O[C@]1([H])[C@]([H])(O[H])[C@@]([H])(OP([O-])([O-])=O)[C@]([H])(OP([O-])([O-])=O)[C@@]([H])(O[H])[C@]1([H])OP([O-])(=O)OC([H])([H])[C@]([H])(OC([*])=O)C([H])([H])OC([*])=O,b,b
2363,93940,"1,2,3,4,5,6-hexabromocyclohexane","A bromohydrocarbon that is cyclohexane in which the hydrogen at positions 1,2,3,4,5 and 6 have been replaced by bromo groups. It is a potent inhibitor of JAK2 tyrosine kinase autophosphorylation.",34507,KEGG COMPOUND accession,C13699,,,,,,,,,,,,,,,
2364,94621,sulfaguanidine,A sulfonamide incorporating a guanidine moiety used to block the synthesis of folic acid; mostly used in veterinary medicine,34699,KEGG COMPOUND accession,C14706,,,,,,,,,,,,,,,
2365,94686,orlistat,"A carboxylic ester resulting from the formal condensation of the carboxy group of N-formyl-L-leucine with the hydroxy group of (3S,4S)-3-hexyl-4-[(2S)-2-hydroxytridecyl]oxetan-2-one. A pancreatic lipase inhibitor, it is used as an anti-obesity drug.",34725,KEGG COMPOUND accession,C13737,,,,,,,,,,,,,,,
2366,94714,doxofylline,"An oxopurine that is a derivative of xanthine, methylated at N-1 and N-3 and carrying a 1,3-dioxolan-2-ylmethyl group at N-7, used in the treatment of asthma.",34735,KEGG COMPOUND accession,C14436,,,,,,,,,,,,,,,
2367,91138,"5(S),15(R)-DiHETE","A DiHETE that is (6E,8Z,11Z,13E)-icosatetraenoic acid in which the two hydroxy substituents are placed at the 5S- and 15R-positions.",33094,KEGG COMPOUND accession,C03284,3aib,4249-19-8,33094.0,"Human Metabolome Database (HMDB): Beta-Aminoisobutyric acid is a non-protein amino acid originating from the catabolism of thymine and valine. The concentration of beta-Aminoisobutyric acid is normally low in urine as beta-Aminoisobutyric acid is further catabolized by b-aminoisobutyrate aminotransferases to methylmalonic acid semialdehyde and propionyl-CoA. beta-Aminoisobutyric acid occurs in two isomeric forms and both enantiomers of beta-Aminoisobutyric acid can be detected in human urine and plasma. In plasma, the S-enantiomer is the predominant type due to active renal reabsorption. In contrast, urine almost exclusively contains the R-enantiomer of beta-Aminoisobutyric acid, which is eliminated both by filtration and tubular secretion. Persistently increased levels of beta-Aminoisobutyric acid have been observed in individuals with a deficiency of R (-) -b-aminoisobutyrate-pyruvate aminotransferase. In addition, transient high levels of beta-Aminoisobutyric acid have been observed under a variety of pathological conditions such as lead poisoning, starvation, in total body irradiation and in a number of malignancies. The S-enantiomer of beta-Aminoisobutyric acid is predominantly derived from the catabolism of valine. It has been suggested that an altered homoeostasis of b-alanine underlies some of the clinical abnormalities encountered in patients with a dihydropyrimidine dehydrogenase (DPD) deficiency. DPD constitutes the first step of the pyrimidine degradation pathway, in which the pyrimidine bases uracil and thymine are catabolized to b-alanine and the R-enantiomer of beta-Aminoisobutyric acid respectively. In normal individuals with an intact pyrimidine degradation pathway, R-methylmalonic acid semialdehyde can be synthesized directly from the catabolism of thymine. Hence, there might be less cross-over between the valine and thymine pathway, allowing the conversion of S-methylmalonic acid semialdehyde into S-beta-Aminoisobutyric acid and the subsequent accumulation of S-beta-Aminoisobutyric acid in plasma. (PMID: 14705962, 14292857, 14453202).",(S)-b-aminoisobutyric acid,HMDB0002166,b,b,C03284,b,FDB022878,3aib,[H]C([H])([H])[C@]([H])(C([O-])=O)C([H])([H])[N+]([H])([H])[H],QCHPKSFMDHPSNR-VKHMYHEASA-N,"InChI=1S/C4H9NO2/c1-3(2-5)4(6)7/h3H,2,5H2,1H3,(H,6,7)/t3-/m0/s1"
2368,91044,phosphatidylinositol 31:1(1-),A 1-phosphatidyl-1D-myo-inositol(1-) in which the two phosphatidyl acyl groups contain a total of 31 carbons and 1 double bond.,12931,KEGG COMPOUND accession,C00880,galctn_D,13382-27-9,16534.0,"Human Metabolome Database (HMDB): Galactonic acid is a sugar acid that is a metabolic breakdown product of galactose. Galactose dehydrogenase is responsible for converting galactose to galactonolactone, which then spontaneously or enzymatically converts to galactonic acid. Once formed, galactonic acid may enter the pentose phosphate pathway. Galactonic acid is increased in red blood cells of galactosemic patients, due to a galactose-1-phosphate uridyltransferase (GALT) deficiency (PMID: 14680973, OMMBID: The Online Metabolic and Molecular Bases of Inherited Disease, Ch.72). When present in sufficiently high levels, galactonic acid can act as an acidogen and a metabotoxin. An acidogen is an acidic compound that induces acidosis, which has multiple adverse effects on many organ systems. A metabotoxin is an endogenously produced metabolite that causes adverse health effects at chronically high levels. Chronically high levels of galactonic acid are associated with at least two inborn errors of metabolism, including galactosemia and galactosemia type II. Galactonic acid is an organic acid. Abnormally high levels of organic acids in the blood (organic acidemia), urine (organic aciduria), the brain, and other tissues lead to general metabolic acidosis. Acidosis typically occurs when arterial pH falls below 7.35. In infants with acidosis, the initial symptoms include poor feeding, vomiting, loss of appetite, weak muscle tone (hypotonia), and lack of energy (lethargy). These can progress to heart abnormalities, liver abnormalities (jaundice), kidney abnormalities, seizures, coma, and possibly death. These are also the characteristic symptoms of untreated galactosemia. Many affected children with organic acidemias experience intellectual disability or delayed development. High levels of galactonic acid in infants are specifically associated with hepatomegaly (an enlarged liver), cirrhosis, renal failure, cataracts, vomiting, seizure, hypoglycemia, lethargy, brain damage, and ovarian failure.",Galactonic acid,HMDB0000565,b,b,C00880,b,FDB022122,b,b,RGHNJXZEOKUKBD-MGCNEYSASA-N,b
2369,91048,phenyl hydrogen phosphonate,An aryl phosphate resulting from the formal condensation of phosphonic acid with 1 mol eq. of phenol,12952,KEGG COMPOUND accession,C00333,,,,,,,,,,,,,,,
2370,90837,3-O-(N-acetyl-beta-D-glucosaminyl)-L-serine,An O-glycosyl-L-serine having N-acetyl-beta-D-glucosaminyl as the glycosyl component.,35265,KEGG COMPOUND accession,C02855,,,,,,,,,,,,,,,
2371,90838,O-(N-acetyl-beta-D-glucosaminyl)-L-serine residue,The L-alpha-amino acid residue formed from O-(N-acetyl-beta-D-glucosaminyl)-L-serine.,32969,KEGG COMPOUND accession,C01726,,,,,,,,,,,,,,,
2372,90839,3-O-(N-acetyl-beta-D-glucosaminyl)-L-threonine,An O-glycosyl-L-threonine having N-acetyl-beta-D-glucosaminyl as the glycosyl component.,16585,KEGG COMPOUND accession,C14177,,,,,,,,,,,,,,,
2373,90840,O-(N-acetyl-beta-D-glucosaminyl)-L-threonine residue,The L-alpha-amino acid residue formed from O-(N-acetyl-beta-D-glucosaminyl)-L-threonine.,18039,KEGG COMPOUND accession,C14178,,,,,,,,,,,,,,,
2374,119470,N-henicosanoyl-14-methylhexadecasphingosine-1-phosphocholine,A sphingomyelin 38:1 obtained by formal condensation of the carboxy group of henicosanoic acid with the amino group of 14-methylhexadecasphingosine-1-phosphocholine. It is a metabolite of the nematode Caenorhabditis elegans.,52086,KEGG COMPOUND accession,C15511,,,,,,,,,,,,,,,
2375,114249,sodium dihydrogenphosphate monohydrate,A hydrate that is the monohydrate form of sodium dihydrogenphosphate.,49044,KEGG COMPOUND accession,C16142,,,,,,,,,,,,,,,
2376,165,"(1S,4R)-fenchone","A fenchone that has 1S,4R stereochemistry. A colourless, oily liquid found in fennel oil, it is used in perfumery and as flavour in foods.",15391,KEGG COMPOUND accession,C03040,,,,,,,,,,,,,,,
2377,776,16alpha-hydroxyestrone,The 16alpha-hydroxy derivative of estrone; a minor estrogen metabolite.,18146,KEGG COMPOUND accession,C11818,,,,,,,,,,,,,,,
2378,2303,"8-(1,1-dimethylallyl)galangin","A trihydroxyflavone that is galangin substituted by a 1,1-dimethylallyl moiety at position 8. It is isolated from the buds of Platanus acerifolia.",929,KEGG COMPOUND accession,C05923,HC01652,b,929.0,"Human Metabolome Database (HMDB): 2,5-Diaminopyrimidine nucleoside triphosphate is involved in folate biosynthesis. 2,5-Diaminopyrimidine nucleoside triphosphate is created from 2,5-Diaminopyrimidine nucleoside triphosphate by GTP cyclohydrolase I [EC:3.5.4.16].","2,5-Diaminopyrimidine nucleoside triphosphate ",HMDB0006821,b,b,C05923,b,FDB024101,b,[H]O[C@@]1([H])[C@@]([H])(O[C@]([H])(C([H])([H])OP([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O)[C@@]1([H])O[H])N([H])C1=C(N([H])[H])C(=O)N([H])C(=N1)N([H])[H],CRXOALRUOMUPMC-UMMCILCDSA-J,"InChI=1S/C9H18N5O14P3/c10-3-6(13-9(11)14-7(3)17)12-8-5(16)4(15)2(26-8)1-25-30(21,22)28-31(23,24)27-29(18,19)20/h2,4-5,8,15-16H,1,10H2,(H,21,22)(H,23,24)(H2,18,19,20)(H4,11,12,13,14,17)/p-4/t2-,4-,5-,8-/m1/s1"
2379,2676,amoxicillin,A penicillin in which the substituent at position 6 of the penam ring is a 2-amino-2-(4-hydroxyphenyl)acetamido group.,18274,KEGG COMPOUND accession,C03216,,,,,,,,,,,,,,,
2380,2679,amphetamine,A racemate comprising equimolar amounts of (R)-amphetamine (also known as levamphetamine or levoamphetamine) and (S)-amphetamine (also known as dexamfetamine or dextroamphetamine.,37449,KEGG COMPOUND accession,C03573,,,,,,,,,,,,,,,
2381,2700,anandamide,An N-acylethanolamine 20:4 resulting from the formal condensation of carboxy group of arachidonic acid with the amino group of ethanolamine.,27490,KEGG COMPOUND accession,C02784,,,,,,,,,,,,,,,
2382,2873,asiatic acid,"A pentacyclic triterpenoid that is ursane substituted by a carboxy group at position 28 and hydroxy groups at positions 2, 3 and 23 (the 2alpha,3beta stereoisomer). It is isolated from Symplocos lancifolia and Vateria indica and exhibits anti-angiogenic activity.",1178,KEGG COMPOUND accession,C02504,,,,,,,,,,,,,,,
2383,2914,atracurium,"A diester compound consisting of pentane-1,5-diol with both hydroxyls bearing 3-[1-(3,4-dimethoxybenzyl)-6,7-dimethoxy-2-methyl-3,4-dihydroisoquinolinium-2(1H)-yl]propanoyl groups.",16256,KEGG COMPOUND accession,C00349,2mop,b,16256.0,"Human Metabolome Database (HMDB): 2-Methyl-3-oxopropanoic acid is an intermediate in the metabolism of Propanoate. It is a substrate for 3-hydroxyisobutyrate dehydrogenase (mitochondrial), Alanine--glyoxylate aminotransferase 2 (mitochondrial) and Methylmalonate-semialdehyde dehydrogenase (mitochondrial).",2-Methyl-3-oxopropanoic acid,HMDB0001172,b,b,C00349,CH3-MALONATE-S-ALD,FDB022464,2mop,[H]C(=O)C([H])(C([O-])=O)C([H])([H])[H],VOKUMXABRRXHAR-UHFFFAOYSA-M,"InChI=1S/C4H6O3/c1-3(2-5)4(6)7/h2-3H,1H3,(H,6,7)/p-1"
2384,3082,betaxolol,"A  propanolamine that is 3-aminopropane-1,2-diol in which the hydrogen of the primary hydoxy is substituted by a 4-[2-(cyclopropylmethoxy)ethyl]phenyl group and one of the hydrogens attached to the amino group is substituted by isopropyl. It is a selective  beta1-receptor blocker and is used in the treatment of glaucoma as well as hypertension, arrhythmias, and coronary heart disease. It is also used to reduce non-fatal cardiac events in patients with heart failure.",27659,KEGG COMPOUND accession,C00538,,,,,,,,,,,,,,,
2385,3238,butenafine,"Trimethylamine in which hydrogen atoms attached to different methyl groups are substituted by 1-naphthyl and 4-tert-butylphenyl groups. It is an inhibitor of squalene epoxidase, an enzyme responsible for the creation of sterols needed in fungal cell membranes, and is used as its hydrochloride salt for treatment of dermatological fungal infections.",28905,KEGG COMPOUND accession,C05986,,,,,,,,,,,,,,,
2386,3303,calcein am,An organic heteropentacyclic compound that is  calcein in which all four carboxy group hydrogens have been substituted by (acetyloxy)methoxy groups and the hyrodgens of the two hydroxy groups have been substituted by acetyl groups. It is a a non-fluorescent probe cleaved to a fluorescent probe by non-specific intracellular esterases.,28697,KEGG COMPOUND accession,C05497,M00603,641-77-0,b,"Human Metabolome Database (HMDB): Plasma 21-deoxycortisol (21DF) is an excellent marker of 21-hydroxylase deficiency. Currently, it is the only marker able to detect heterozygous carriers with 21-hydroxylase deficiency after Adrenocorticotropic Hormone (ACTH) stimulation. The syndrome of congenital adrenal hyperplasia (CAH) comprises the spectrum of autosomal recessive enzymatic disorders that impair cortisol biosynthesis. The hormonal pattern and clinical manifestations result from hyperstimulation of the adrenal cortex by excessive production of ACTH, untied from the negative feedback exerted by reduced cortisol levels, and the ultimate accumulation of F precursors and androgens. These abnormalities predispose the female newborn to ambiguous genitalia (female pseudohermaphroditism) and precocious puberty that may occur in both sexes. CAH due to 21-hydroxylase deficiency (21OHD) comprises nearly 90% of all cases, with an estimated worldwide incidence of 1 in 14,000 live births. Because 21-deoxycortisol (21DF) is an 11b-hydroxylase (11bOH) derivative of 17-hydroxyprogesterone (17OHP), its serum levels are parallel and proportionally elevated in patients with 21OHD but decreased or undetectable in those with 11b-hydroxylase deficiency (11bOHD), another genetic disorder. Due to the marked buildup of 17OHP in 21OHD, this precursor steroid can proceed directly to 11-hydroxylation, producing distinct elevations of 21DF (PMID: 16551734, 10731638).",21-Deoxycortisol,HMDB0004030,b,b,C05497,b,FDB023283,M00603,[H]O[C@@]1([H])C([H])([H])[C@@]2(C([H])([H])[H])C([H])(C([H])([H])C([H])([H])[C@]2(O[H])C(=O)C([H])([H])[H])C2([H])C([H])([H])C([H])([H])C3=C([H])C(=O)C([H])([H])C([H])([H])[C@]3(C([H])([H])[H])C12[H],LCZBQMKVFQNSJR-AWYSGOOKSA-N,"InChI=1S/C21H30O4/c1-12(22)21(25)9-7-16-15-5-4-13-10-14(23)6-8-19(13,2)18(15)17(24)11-20(16,21)3/h10,15-18,24-25H,4-9,11H2,1-3H3/t15?,16?,17-,18?,19-,20-,21-/m0/s1"
2387,3385,carbachol,a,53013,KEGG COMPOUND accession,C05822,,,,,,,,,,,,,,,
2388,3395,carbidopa,"The hydrate of 3-(3,4-dihydroxyphenyl)propanoic acid in which the hydrogens alpha- to the carboxyl group are substituted by hydrazinyl and methyl groups (S-configuration). Carbidopa is a dopa decarboxylase inhibitor, so prevents conversion of levodopa to dopamine. It has no antiparkinson activity by itself, but is used in the management of Parkinson's disease to reduce peripheral adverse effects of levodopa.",27553,KEGG COMPOUND accession,C04709,,,,,,,,,,,,,,,
2389,3504,cefpodoxime,"A third-generation cephalosporin antibiotic with methoxymethyl and (2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetamino substituents at positions 3 and 7, respectively, of the cephem skeleton. Given by mouth as its proxetil ester prodrug, it is used to treat acute otitis media, pharyngitis, and sinusitis.",16433,KEGG COMPOUND accession,C01197,34dhcinm,501-16-6,16433.0,"Human Metabolome Database (HMDB): 3,4-Dihydroxy-trans-cinnamate is a polyphenol present in normal human urine positively correlated to coffee consumption and influenced by the dietary intake of diverse types of food. (PMID:16870009).","3,4-Dihydroxy-trans-cinnamate",HMDB0003501,b,b,C01197,CPD-676,FDB002559,b,[H]OC1=C(O[H])C([H])=C(\C([H])=C(/[H])C([O-])=O)C([H])=C1[H],QAIPRVGONGVQAS-DUXPYHPUSA-M,"InChI=1S/C9H8O4/c10-7-3-1-6(5-8(7)11)2-4-9(12)13/h1-5,10-11H,(H,12,13)/p-1/b4-2+"
2390,3567,cetyltrimethylammonium bromide,The organic bromide salt that is the bromide salt of cetyltrimethylammonium; one of the components of the topical antiseptic cetrimide.,1395,KEGG COMPOUND accession,C03925,,,,,,,,,,,,,,,
2391,3640,chlorothiazide,"4H-1,2,4-benzothiadiazine 1,1-dioxide in which the hydrogen at position is substituted by chlorine and that at position 7 is substituted by a sulfonamide group. A diuretic, it is used for treatment of oedema and hypertension.",1427,KEGG COMPOUND accession,C11457,,,,,,,,,,,,,,,
2392,3716,cinoxacin,"A member of the class of  cinnolines  that is 6,7-methylenedioxycinnolin-4(1H)-one bearing an ethyl group at position 1 and a carboxylic acid group at position 3. An analogue of oxolinic acid, it has similar antibacterial actions. It was formerly used for the treatment of urinary tract infections.",1458,KEGG COMPOUND accession,C09921,,,,,,,,,,,,,,,
2393,3732,clarithromycin,"The 6-O-methyl ether of erythromycin A, clarithromycin is a macrolide antibiotic used in the treatment of respiratory-tract, skin and soft-tissue infections. It is also used to eradicate Helicobacter pylori in the treatment of peptic ulcer disease. It prevents bacteria from growing by interfering with their protein synthesis.",16989,KEGG COMPOUND accession,C04553,,,,,,,,,,,,,,,
2394,3738,clemastine,"2-[(2R)-1-Methylpyrrolidin-2-yl]ethanol in which the hydrogen of the hydroxy group is substituted by a 1-(4-chlorophenyl)-1-phenylethyl group (R configuration). An antihistamine with antimuscarinic and moderate sedative properties, it is used as its fumarate salt for the symptomatic relief of allergic conditions such as rhinitis, urticaria, conjunctivitis and in pruritic (severe itching) skin conditions.",1467,KEGG COMPOUND accession,C04236,,,,,,,,,,,,,,,
2395,3745,clindamycin,"A carbohydrate-containing antibiotic that is the  semisynthetic derivative of lincomycin, a natural antibiotic.",28251,KEGG COMPOUND accession,C05592,,,,,,,,,,,,,,,
2396,3756,clonazepam,"1,3-Dihydro-2H-1,4-benzodiazepin-2-one in which the hydrogens at positions 5 and 7 are substituted by 2-chlorophenyl and nitro groups, respectively. It is used in the treatment of all types of epilepsy and seizures, as well as myoclonus and associated abnormal movements, and panic disorders. However, its use can be limited by the development of tolerance and by sedation.",27715,KEGG COMPOUND accession,C05618,,,,,,,,,,,,,,,
2397,3900,costunolide,"A germacranolide with anthelminthic, antiparasitic and antiviral activities.",15793,KEGG COMPOUND accession,C00632,3hanthrn,548-93-6,15793.0,Human Metabolome Database (HMDB): 3-Hydroxyanthranilic acid is an oxidation product of tryptophan metabolism. It may be a free radical scavenger and a carcinogen.,3-Hydroxyanthranilic acid,HMDB0001476,b,b,C00632,3-HYDROXY-ANTHRANILATE,FDB010582,3hanthrn,[H]OC1=C([H])C([H])=C([H])C(C([O-])=O)=C1[N+]([H])([H])[H],WJXSWCUQABXPFS-UHFFFAOYSA-N,"InChI=1S/C7H7NO3/c8-6-4(7(10)11)2-1-3-5(6)9/h1-3,9H,8H2,(H,10,11)"
2398,3930,cryptolepine,"An organic heterotetracyclic compound that is 5H-indolo[3,2-b]quinoline in which the hydrogen at position N-5 is replaced by a methyl group.",28291,KEGG COMPOUND accession,C05998,,,,,,,,,,,,,,,
2399,4379,delavirdine mesylate,"The monomethanesulfonic acid salt of delavirdine, a non-nucleoside reverse transcriptase inhibitor with activity specific for HIV-1. Viral resistance emerges rapidly when delavirdine is used alone, so it is therefore used (as the methanesulfonic acid salt) with other antiretrovirals for combination therapy of HIV infection.",28533,KEGG COMPOUND accession,C05449,M00754,b,28533.0,"Human Metabolome Database (HMDB): 3alpha,7alpha-Dihydroxy-5beta-24-oxocholestanoyl-CoA is an intermediate involved in the synthesis of Chenodeoxyglycocholoyl-CoA, which is is a coenzyme A derivative of chenodeoxyglycocholate. It is involved in bile acid synthesis and is the second-to-last component in the synthesis of chenodeoxyglycocholate. 3a,7a-dihydroxy-5b-24-oxocholestanoyl-CoA is synthesized from 3a,7a,24-trihydroxy-5b-cholestanoyl-CoA and then transformed via acetyl-CoA acyltransferase to chenodeoxyglycocholoyl-CoA and then finally to chenodeoxyglycocholate. Chenodeoxyglycocholate is a glycine conjugated bile acid. Bile acids are steroid acids found predominantly in bile of mammals. The distinction between different bile acids is minute, depends only on presence or absence of hydroxyl groups on positions 3, 7, and 12. Bile acids are physiological detergents that facilitate excretion, absorption, and transport of fats and sterols in the intestine and liver. Bile acids are also steroidal amphipathic molecules derived from the catabolism of cholesterol. They modulate bile flow and lipid secretion, are essential for the absorption of dietary fats and vitamins, and have been implicated in the regulation of all the key enzymes involved in cholesterol homeostasis. Bile acids recirculate through the liver, bile ducts, small intestine and portal vein to form an enterohepatic circuit. They exist as anions at physiological pH and, consequently, require a carrier for transport across the membranes of the enterohepatic tissues. The unique detergent properties of bile acids are essential for the digestion and intestinal absorption of hydrophobic nutrients. Bile acids have potent toxic properties (e.g., membrane disruption) and there are a plethora of mechanisms to limit their accumulation in blood and tissues. (PMID: 11316487, 16037564, 12576301, 11907135).","3a,7a-Dihydroxy-5b-24-oxocholestanoyl-CoA",HMDB0006896,b,b,C05449,b,FDB024143,b,[H]O[C@@]([H])(C(=O)N([H])C([H])([H])C([H])([H])C(=O)N([H])C([H])([H])C([H])([H])SC(=O)C([H])(C(=O)C([H])([H])C([H])([H])[C@@]([H])(C([H])([H])[H])[C@@]1([H])C([H])([H])C([H])([H])[C@@]2([H])[C@]3([H])[C@]([H])(O[H])C([H])([H])[C@]4([H])C([H])([H])[C@]([H])(O[H])C([H])([H])C([H])([H])[C@]4(C([H])([H])[H])[C@@]3([H])C([H])([H])C([H])([H])[C@]12C([H])([H])[H])C([H])([H])[H])C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])OP(=O)(O[H])OP(=O)(O[H])OC([H])([H])[C@@]1([H])O[C@@]([H])(N2C([H])=NC3=C2N=C([H])N=C3N([H])[H])[C@]([H])(O[H])[C@]1([H])OP(=O)(O[H])O[H],QWTJBRPOHKIMDT-MVFHLHSISA-N,"InChI=1S/C48H78N7O20P3S/c1-25(29-8-9-30-36-31(12-15-48(29,30)6)47(5)14-11-28(56)19-27(47)20-33(36)58)7-10-32(57)26(2)45(63)79-18-17-50-35(59)13-16-51-43(62)40(61)46(3,4)22-72-78(69,70)75-77(67,68)71-21-34-39(74-76(64,65)66)38(60)44(73-34)55-24-54-37-41(49)52-23-53-42(37)55/h23-31,33-34,36,38-40,44,56,58,60-61H,7-22H2,1-6H3,(H,50,59)(H,51,62)(H,67,68)(H,69,70)(H2,49,52,53)(H2,64,65,66)/t25-,26?,27+,28-,29-,30+,31+,33-,34-,36+,38-,39-,40+,44-,47+,48-/m1/s1"
2400,4470,dextromethorphan,"A 6-methoxy-11-methyl-1,3,4,9,10,10a-hexahydro-2H-10,4a-(epiminoethano)phenanthrene in which the sterocenters at positions 4a, 10 and 10a have S-configuration. It is a prodrug of dextrorphan and used as an antitussive drug for suppressing cough.",16455,KEGG COMPOUND accession,C04530,,,,,,,,,,,,,,,
2401,4495,diazoxide,"A benzothiadiazine that is the S,S-dioxide of 2H-1,2,4-benzothiadiazine which is substituted at position 3 by a methyl group and at position 7 by chlorine. A peripheral vasodilator, it increases the concentration of glucose in the plasma and inhibits the secretion of insulin by the beta- cells of the pancreas. It is used orally in the management of intractable hypoglycaemia and intravenously in the management of hypertensive emergencies.",28799,KEGG COMPOUND accession,C05639,46dhoxquin,3517-61-1,28799.0,"Human Metabolome Database (HMDB): 4,6-Dihydroxyquinoline is the product of the conversion of 5-hydroxykynurenamine by the enzyme monoamine oxidase, both metabolites from the 5-hydroxytryptophan metabolism. (PMIDs 7160021, 312499).","4,6-Dihydroxyquinoline",HMDB0004077,b,b,C05639,b,FDB023301,b,[H]OC1=C([H])C([H])=C2N=C([H])C([H])=C(O[H])C2=C1[H],XFALURCRIGINGT-UHFFFAOYSA-N,"InChI=1S/C9H7NO2/c11-6-1-2-8-7(5-6)9(12)3-4-10-8/h1-5,11H,(H,10,12)"
2402,4551,digoxin,"A  cardenolide glycoside that is digitoxin beta-hydroxylated at C-12. A cardiac glycoside extracted from the foxglove plant, Digitalis lanata, it is used to control ventricular rate in atrial fibrillation and in the management of congestive heart failure with atrial fibrillation, but the margin between toxic and therapeutic doses is small.",28483,KEGG COMPOUND accession,C05135,,,,,,,,,,,,,,,
2403,4562,dihydroergotamine,"Ergotamine in which a single bond replaces the double bond between positions 9 and 10. A semisynthetic ergot alkaloid with weaker oxytocic and vasoconstrictor properties than ergotamine, it is used (as the methanesulfonic or tartaric acid salts) for the treatment of migraine and orthostatic hypotension.",16080,KEGG COMPOUND accession,C03678,,,,,,,,,,,,,,,
2404,4670,dobutamine,"A  catecholamine that is 4-(3-aminobutyl)phenol in which one of the hydrogens attached to the nitrogen is substituted by a 2-(3,4-dihydroxyphenyl)ethyl group. A beta1-adrenergic receptor agonist that has cardiac stimulant action without evoking vasoconstriction or tachycardia, it is used as the hydrochloride to increase the contractility of the heart in the management of acute heart failure.",15499,KEGG COMPOUND accession,C00223,coucoa,b,15499.0,b,P-Coumaroyl Coenzyme A,b,b,b,C00223,b,b,coucoa,[H]OC1=C([H])C([H])=C(C([H])=C([H])C(=O)SC([H])([H])C([H])([H])N([H])C(=O)C([H])([H])C([H])([H])N([H])C(=O)[C@]([H])(O[H])C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])OP([O-])(=O)OP([O-])(=O)OC([H])([H])[C@@]2([H])O[C@@]([H])(N3C([H])=NC4=C(N=C([H])N=C34)N([H])[H])[C@]([H])(O[H])[C@]2([H])OP([O-])([O-])=O)C([H])=C1[H],DMZOKBALNZWDKI-FUEUKBNZSA-J,"InChI=1S/C30H42N7O18P3S/c1-30(2,25(42)28(43)33-10-9-20(39)32-11-12-59-21(40)8-5-17-3-6-18(38)7-4-17)14-52-58(49,50)55-57(47,48)51-13-19-24(54-56(44,45)46)23(41)29(53-19)37-16-36-22-26(31)34-15-35-27(22)37/h3-8,15-16,19,23-25,29,38,41-42H,9-14H2,1-2H3,(H,32,39)(H,33,43)(H,47,48)(H,49,50)(H2,31,34,35)(H2,44,45,46)/p-4/t19-,23-,24-,25+,29-/m1/s1"
2405,4702,dorzolamide,"5,6-Dihydro-4H-thieno[2,3-b]thiopyran-2-sulfonamide 7,7-dioxide in which hydrogens at the 4 and 6 positions are substituted by ethylamino and methyl groups, respectively (4S, trans-configuration). A carbonic anhydrase inhibitor, it is used as the hydrochloride in ophthalmic solutions to lower increased intraocular pressure in the treatment of open-angle glaucoma and ocular hypertension.",16735,KEGG COMPOUND accession,C04865,,,,,,,,,,,,,,,
2406,4717,droperidol,"An organofluorine compound that is haloperidol in which the hydroxy group has been eliminated with the introduction of a double bond in the piperidine ring, and the 4-chlorophenyl group has been replaced by a benzimidazol-2-on-1-yl group. It is used in the management of chemotherapy-induced nausea and vomiting, and in conjunction with an opioid analgesic such as fentanyl to maintain the patient in a calm state of neuroleptanalgesia with indifference to surroundings but still able to cooperate with the surgeon.",18062,KEGG COMPOUND accession,C03078,,,,,,,,,,,,,,,
2407,4759,edrophonium chloride,"The chloride salt of edrophonium. A reversible inhibitor of cholinesterase with a rapid onset (30-60 seconds after injection) but a short duration of action (5-15 minutes), it is used in myasthenia gravis both diagnostically and to distinguish between under- or over-treatment with other anticholinesterases. It has also been used for the reversal of neuromuscular blockade in anaesthesia, and for the management of poisoning due to tetrodotoxin, a neuromuscular blocking toxin found in puffer fish and other marine animals.",1848,KEGG COMPOUND accession,C06034,,,,,,,,,,,,,,,
2408,4786,enalaprilat (anhydrous),"Enalapril in which the ethyl ester group has been hydrolysed to the corresponding carboxylic acid. Enalaprilat is an angiotensin-converting enzyme (ACE) inhibitor and is used (often in the form of its prodrug, enalapril) in the treatment of hypertension and heart failure, for reduction of proteinuria and renal disease in patients with nephropathies, and for the prevention of stroke, myocardial infarction, and cardiac death in high-risk patients. Unlike enalapril, enalaprilat is not absorbed by mouth but is given by intravenous injection, usually as the dihydrate.",30763,KEGG COMPOUND accession,C00156,4hbz,99-96-7,30763.0,"Human Metabolome Database (HMDB): 4-Hydroxybenzoic acid, or p-hydroxybenzoic acid, is a phenolic derivative of benzoic acid. It a white crystalline solid that is slightly soluble in water and chloroform, but well soluble in alcohols, ether, and acetone.",4-Hydroxybenzoic acid,HMDB0000500,b,b,C00156,b,FDB010508,4hbz,[H]OC1=C([H])C([H])=C(C([H])=C1[H])C([O-])=O,FJKROLUGYXJWQN-UHFFFAOYSA-M,"InChI=1S/C7H6O3/c8-6-3-1-5(2-4-6)7(9)10/h1-4,8H,(H,9,10)/p-1"
2409,4822,ergometrine,"A monocarboxylic acid amide that  is lysergamide in which one of the hydrogens attached to the amide nitrogen is substituted by a 1-hydroxypropan-2-yl group (S-configuration). An ergot alkaloid that has a particularly powerful action on the uterus, its maleate (and formerly tartrate) salt is used in the active management of the third stage of labour, and to prevent or treat postpartum of postabortal haemorrhage caused by uterine atony: by maintaining uterine contraction and tone, blood vessels in the uterine wall are compressed and blood flow reduced.",18351,KEGG COMPOUND accession,C02948,,,,,,,,,,,,,,,
2410,4877,ethambutol,"An ethylenediamine derivative that is ethane-1,2-diamine in which one hydrogen attached to each of the nitrogens is sutstituted by a 1-hydroxybutan-2-yl group (S,S-configuration). It is a bacteriostatic antimycobacterial drug, effective against Mycobacterium tuberculosis and some other mycobacteria. It is used (as the dihydrochloride salt) in combination with other antituberculous drugs in the treatment of pulmonary and extrapulmonary tuberculosis; resistant strains of M. tuberculosis are readily produced if ethambutol is used alone.",1883,KEGG COMPOUND accession,C05627,,,,,,,,,,,,,,,
2411,4888,ethotoin,"An imidazolidine-2,4-dione that is hydantoin substituted by ethyl and phenyl at positions 3 and 5, respectively. An antiepileptic, it is less toxic than phenytoin but also less effective.",47904,KEGG COMPOUND accession,C01036,4mlacac,5698-52-2,47904.0,"Human Metabolome Database (HMDB): 4-Maleylacetoacetate is an intermediate in the metabolism of tyrosine. Homogentisate 1,2-dioxygenase is the enzyme, which catalyzes the conversion of homogentisate to 4-maleylacetoacetate. Homogentisate 1,2-dioxygenase or HGD is involved in the catabolism of aromatic rings, more specifically in the break down of the amino acids tyrosine and phenylalanine.",Maleylacetoacetic acid,HMDB0002052,b,b,C01036,4-MALEYL-ACETOACETATE,FDB022817,4mlacac,[H]\C(=C(/[H])C(=O)C([H])([H])C(=O)C([H])([H])C([O-])=O)C([O-])=O,GACSIVHAIFQKTC-UPHRSURJSA-L,"InChI=1S/C8H8O6/c9-5(1-2-7(11)12)3-6(10)4-8(13)14/h1-2H,3-4H2,(H,11,12)(H,13,14)/p-2/b2-1-"
2412,4909,etodolac,"A monocarboxylic acid that is acetic acid in which one of the methyl hydrogens is substituted by a 1,8-diethyl-1,3,4,9-tetrahydropyrano[3,4-b]indol-1-yl moiety. A preferential inhibitor of cyclo-oxygenase 2 and non-steroidal anti-inflammatory, it is used for the treatment of rheumatoid arthritis and osteoarthritis, and for the alleviation of postoperative pain. Administered as the racemate, only the (S)-enantiomer is active.",1895,KEGG COMPOUND accession,C06757,,,,,,,,,,,,,,,
2413,4932,eupatilin,"A trimethoxyflavone that is flavone substituted by hydroxy groups at C-5 and C-7 and methoxy groups at C-6, C-3' and C-4' respectively. Isolated from Citrus reticulata and Salvia tomentosa, it exhibits anti-inflammatory, anti-ulcer and antineoplastic activities.",17224,KEGG COMPOUND accession,C03081,,,,,,,,,,,,,,,
2414,4974,famciclovir,"2-Amino-9H-purine in which the hydrogen at position 9 is substituted by a 4-acetoxy-3-(acetoxymethyl)but-1-yl group. A prodrug of the antiviral penciclovir, it is used for the treatment of acute herpes zoster (shingles), for the treatment or suppression of recurrent genital herpes in immunocompetent patients and for the treatment of recurrent mucocutaneous herpes simplex infections in HIV infected patients.",18266,KEGG COMPOUND accession,C06352,,,,,,,,,,,,,,,
2415,5000,fenfluramine,"A  secondary amino compound that is 1-phenyl-propan-2-amine in which one of the meta-hydrogens is substituted by trifluoromethyl, and one of the hydrogens attached to the nitrogen is substituted by an ethyl group. It binds to the serotonin reuptake pump, causing inhbition of serotonin uptake and release of serotonin. The resulting increased levels of serotonin lead to greater serotonin receptor activation which in turn lead to enhancement of serotoninergic transmission in the centres of feeding behavior located in the hypothalamus. This suppresses the appetite for carbohydrates. Fenfluramine was used as the hydrochloride for treatment of diabetes and obesity. It was withdrawn worldwide after reports of heart valve disease and pulmonary hypertension.",18311,KEGG COMPOUND accession,C06414,,,,,,,,,,,,,,,
2416,5280,gatifloxacin,"A monocarboxylic acid that is 4-oxo-1,4-dihydroquinoline-3-carboxylic acid which is substituted on the nitrogen by a cyclopropyl group and at positions 6, 7, and 8 by fluoro, 3-methylpiperazin-1-yl, and methoxy groups, respectively. Gatifloxacin is an antibiotic of the fourth-generation fluoroquinolone family, that like other members of that family, inhibits the bacterial topoisomerase type-II enzymes.",16694,KEGG COMPOUND accession,C04815,,,,,,,,,,,,,,,
2417,5292,geldanamycin,An ansamycin consisting of a 19-membered macrocyle incorporating a benzoquinone ring and a lactam functionality. It shows antimicrobial activity against many Gram-positive and some Gram-negative bacteria.,17011,KEGG COMPOUND accession,C00273,,,,,,,,,,,,,,,
2418,5706,hexobarbital,A member of the class of barbiturates taht is barbituric acid substituted at N-1 by methyl and at C-5 by methyl and cyclohex-1-enyl groups.,17637,KEGG COMPOUND accession,C02657,,,,,,,,,,,,,,,
2419,5722,hinokinin,"A lignan that is dihydrofuran-2(3H)-one (gamma-butyrolactone) substituted by a 3,4-methylenedioxybenzyl group at positions 3 and 4 (the 3R,4R-diastereoisomer).",29000,KEGG COMPOUND accession,C06651,,,,,,,,,,,,,,,
2420,7438,N-methylformamide,A member of the class of formamides  having a N-methyl substituent.,2482,KEGG COMPOUND accession,C06506,adcobdam,b,b,"Human Metabolome Database (HMDB): Adenosyl cobyrinic acid a,c diamide is an intermediate in the metabolism of Porphyrin and chlorophyll. It is a substrate for Cob(I)yrinic acid a,c-diamide adenosyltransferase (mitochondrial).",Adenosyl cobyrinate diamide,HMDB0001083,b,b,C06506,b,b,b,b,b,b
2421,7438,N-methylformamide,A member of the class of formamides  having a N-methyl substituent.,2482,KEGG COMPOUND accession,C06506,adcobhex,b,b,"Human Metabolome Database (HMDB): Adenosyl cobyrinic acid a,c diamide is an intermediate in the metabolism of Porphyrin and chlorophyll. It is a substrate for Cob(I)yrinic acid a,c-diamide adenosyltransferase (mitochondrial).","Adenosyl cobyrinic acid a,c diamide",HMDB0001083,b,b,C06506,CPD-690,FDB022414,b,b,OCNLJCZKGHKJGF-QOCQOLRHSA-M,b
2422,7508,framycetin,"A tetracyclic antibacterial agent derived from neomycin, being a glycoside ester of neamine and neobiosamine B.",15336,KEGG COMPOUND accession,C01550,,,,,,,,,,,,,,,
2423,7747,oleuropein,"A secoiridoid glycoside that is the methyl ester of 3,4-dihydro-2H-pyran-5-carboxylic acid which is substituted at positions 2, 3, and 4 by hydroxy, ethylidene, and carboxymethyl groups, respectively and in which the anomeric hydroxy group at position 2 has been converted into its beta-D-glucoside and the carboxylic acid moiety of the carboxymethyl substituent has been converted to the corresponding 3,4-dihydroxyphenethyl ester (the 2S,3E,4S stereoisomer). The most important phenolic compound present in olive cultivars.",2607,KEGG COMPOUND accession,C10294,,,,,,,,,,,,,,,
2424,7896,hexadecanoate,A long-chain fatty acid anion that is the conjugate base of hexadecanoic acid (palmitic acid); major species at pH 7.3.,2666,KEGG COMPOUND accession,C06824,,,,,,,,,,,,,,,
2425,7959,D-penicillamine,An optically active form of penicillamine having D-configuration. Pharmaceutical form (L-form is toxic) of chelating agent used to treat heavy metal poisoning.,2696,KEGG COMPOUND accession,C10759,,,,,,,,,,,,,,,
2426,8069,phenobarbital,"A member of the class of barbiturates, the structure of which is that of barbituric acid substituted at C-5 by ethyl and phenyl groups.",2739,KEGG COMPOUND accession,C06830,,,,,,,,,,,,,,,
2427,8435,prochlorperazine,A member of the class of phenothiazines that is 10H-phenothiazine having a chloro substituent at the 2-position and a 3-(4-methylpiperazin-1-yl)propyl group at the N-10 position.,2899,KEGG COMPOUND accession,C10245,,,,,,,,,,,,,,,
2428,8691,quassimarin,A quassinoid isolated from Quassia amara and Leitneria floridana and has been shown to exhibit antitumour activity.,16716,KEGG COMPOUND accession,C01407,,,,,,,,,,,,,,,
2429,9023,santamarin,A sesquiterpene lactone of the eudesmanolide group.,3163,KEGG COMPOUND accession,C08577,,,,,,,,,,,,,,,
2430,9118,sermorelin,A 29 amino acid polypeptide that is used to treat growth problems (usually in children) due to growth hormone deficiency. It is the biologically active fragment of human growth hormone-releasing factor (GHRH).,3211,KEGG COMPOUND accession,C09367,,,,,,,,,,,,,,,
2431,9671,triamterene,"Pteridine substituted at positions 2, 4 and 7 with amino groups and at position 6 with a phenyl group. A sodium channel blocker, it is used as a diuretic in the treatment of hypertension and oedema.",3306,KEGG COMPOUND accession,C06865,,,,,,,,,,,,,,,
2432,9678,tribenuron methyl,The methyl ester of tribenuron.,3309,KEGG COMPOUND accession,C08133,,,,,,,,,,,,,,,
2433,9727,trimethadione,"An oxazolidinone that is 1,3-oxazolidine-2,4-dione substituted by methyl groups at positions 3, 5 and 5. It is an antiepileptic agent.",3333,KEGG COMPOUND accession,C10573,,,,,,,,,,,,,,,
2434,11230,1-acylglycerophosphocholine(1+),A glycerophosphocholine having an unspecified O-acyl substituent at the 1-position of the glycerol fragment.,33913,KEGG COMPOUND accession,C06021,cfesp,b,b,b,Corrinoid Iron sulfur protein,b,b,b,C06021,b,b,b,b,b,b
2435,11515,2-amino-5-formylamino-6-(1-D-ribosylamino)pyrimidin-4(3H)-one 5'-phosphate,"The 5-N-formyl derivative of 2,5-diamino-6-ribosylamino-4(3H)-pyrimidinone 5'-phosphate.",3992,KEGG COMPOUND accession,C02019,,,,,,,,,,,,,,,
2436,11714,"3-(2,4-bis[N-acetyl-beta-D-glucosaminyl]-alpha-D-mannosyl)-beta-D-mannosyl group","A group obtained by removing the hydroxy group from the hemiacetal function of 3-(2,4-bis[N-acetyl-beta-D-glucosaminyl]-alpha-D-mannosyl)-beta-D-mannose.",29090,KEGG COMPOUND accession,C05328,,,,,,,,,,,,,,,
2437,12257,7-methoxyisoflavone,A methoxyisoflavone that is isoflavone substituted by a methoxy group at position 7.,28137,KEGG COMPOUND accession,C07838,,,,,,,,,,,,,,,
2438,13614,"6,7-dihydropteridines",Any member of the class of pteridines in which the the pteridine ring has been reduced by the formal addition of one molecule of hydrogen to positions 6 and 7.,4733,KEGG COMPOUND accession,C11595,,,,,,,,,,,,,,,
2439,13769,aminohydroquinone,a,32955,KEGG COMPOUND accession,C00722,,,,,,,,,,,,,,,
2440,13790,N-acetylarylamine,An acetamide where at at least one of the amide hydrogens is substituted by an aryl group. RNHAc where R is an aryl group.,4822,KEGG COMPOUND accession,C07543,,,,,,,,,,,,,,,
2441,13792,N-hydroxyarylamine,Any hydroxylamine where the nitrogen is attached directly to an aryl group.,4823,KEGG COMPOUND accession,C09167,,,,,,,,,,,,,,,
2442,15335,"5,7-dihydroxy-4'-methoxyflavone",A monomethoxyflavone that is the 4'-methyl ether derivative of apigenin.,29028,KEGG COMPOUND accession,C05837,,,,,,,,,,,,,,,
2443,15337,beta-alanopine,a,5399,KEGG COMPOUND accession,C08404,,,,,,,,,,,,,,,
2444,15339,acceptor,"A molecular entity that can accept an electron, a pair of electrons, an atom or a group from another molecular entity.",5400,KEGG COMPOUND accession,C08405,,,,,,,,,,,,,,,
2445,15341,beta-D-glucosiduronic acid,A glucosiduronic acid resulting from the formal condensation of any substance with beta-D-glucuronic acid to form a glycosidic bond.,5401,KEGG COMPOUND accession,C08406,,,,,,,,,,,,,,,
2446,15343,acetaldehyde,The aldehyde formed from acetic acid by reduction of the carboxy group. It is the most abundant carcinogen in tobacco smoke.,5402,KEGG COMPOUND accession,C08407,,,,,,,,,,,,,,,
2447,15345,acetoacetyl-CoA,A 3-oxoacyl-CoA that results from the formal condensation of the thiol group of coenzyme A with the carboxy group of acetoacetic acid.,5403,KEGG COMPOUND accession,C08408,,,,,,,,,,,,,,,
2448,15347,acetone,A methyl ketone that consists of propane bearing an oxo group at C2.,5404,KEGG COMPOUND accession,C08409,,,,,,,,,,,,,,,
2449,15349,acetone oxime,a,5405,KEGG COMPOUND accession,C08410,,,,,,,,,,,,,,,
2450,15351,acetyl-CoA,An acyl-CoA having acetyl as its S-acetyl component.,5406,KEGG COMPOUND accession,C08411,,,,,,,,,,,,,,,
2451,15353,blasticidin S,A blasticidin that is an antibiotic obtained from Streptomyces griseochromogene.,5407,KEGG COMPOUND accession,C08412,,,,,,,,,,,,,,,
2452,15355,acetylcholine,"Actylcholine is an ester of acetic acid and choline, which acts as a neurotransmitter.",5408,KEGG COMPOUND accession,C08413,,,,,,,,,,,,,,,
2453,15357,acetylenedicarboxylate(2-),A dicarboxylic acid dianion obtained by the deprotonation of both the carboxy groups of acetylenedicarboxylic acid.,5409,KEGG COMPOUND accession,C08414,,,,,,,,,,,,,,,
2454,15360,acetylpyruvate,a,5411,KEGG COMPOUND accession,C08415,,,,,,,,,,,,,,,
2455,15362,hydroxyacetone phosphate,a,5412,KEGG COMPOUND accession,C08416,,,,,,,,,,,,,,,
2456,15364,propynoate,"An acetylenic fatty acid anion and the conjugate base of propynoic acid, arising from deprotonation of the carboxylic acid group.",5413,KEGG COMPOUND accession,C08417,,,,,,,,,,,,,,,
2457,15366,acetic acid,A simple monocarboxylic acid containing two carbons.,5414,KEGG COMPOUND accession,C08418,,,,,,,,,,,,,,,
2458,15372,"5,6,7,8-tetrahydrobiopterin",a,5417,KEGG COMPOUND accession,C01811,,,,,,,,,,,,,,,
2459,15373,biopterin,"A pterin derivative that consists of pterin bearing amino, oxo and 1,2-dihydroxypropyl substituents at positions 2, 4 and 6 respectively. The parent of the class of biopterins; the L-erythro isomer occurs widely in nature.",17234,KEGG COMPOUND accession,C00293,,,,,,,,,,,,,,,
2460,15380,succinyl-CoA,An omega-carboxyacyl-CoA having succinoyl as the S-acyl component.,16063,KEGG COMPOUND accession,C06740,,,,,,,,,,,,,,,
2461,15384,limonene,A monoterpene that is cyclohex-1-ene substituted by a methyl group at position 1 and a prop-1-en-2-yl group at position 4 respectively.,18368,KEGG COMPOUND accession,C01190,gluside_hs,52050-17-6,18368.0,"Glucosylsphingosine is a cytotoxic compound. Accumulation of glucosylsphingosine in the brain and other tissues occurs in patients with Gaucher disease, which is an inherited deficiency of lysosomal glucocerebrosidase. Glucocerebrosidase converts glucosylsphingosine to glucose and sphingosine.",D-Glucosyl-N-Acylsphingosine,HMDB0000596,b,b,C01190,Glucosyl-acyl-sphingosines,FDB022135,gluside_hs,[H]OC([H])([H])[C@@]1([H])OC([H])(OC([H])([H])[C@]([H])(N([H])C([*])=O)[C@]([H])(O[H])C([H])=C([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H])[C@]([H])(O[H])[C@@]([H])(O[H])[C@]1([H])O[H],HHJTWTPUPVQKNA-KEVGHMQTSA-N,"InChI=1S/C24H47NO7/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-19(27)18(25)17-31-24-23(30)22(29)21(28)20(16-26)32-24/h14-15,18-24,26-30H,2-13,16-17,25H2,1H3/b15-14+/t18?,19?,20-,21-,22+,23-,24?/m1/s1"
2462,15390,(+)-bisdechlorogeodin,a,24293,KEGG COMPOUND accession,C03503,,,,,,,,,,,,,,,
2463,15392,"(1R)-bornane-2,5-dione",a,17127,KEGG COMPOUND accession,C02153,,,,,,,,,,,,,,,
2464,15402,(+)-neomenthol,a,15497,KEGG COMPOUND accession,C02411,glutaccoa,b,b,b,Glutaconoyl-CoA,b,b,b,C02411,b,b,b,b,b,b
2465,15406,(-)-trans-isopiperitenol,a,18237,KEGG COMPOUND accession,C00302,,,,,,,,,,,,,,,
2466,15411,(-)-menthyl beta-D-glucoside,a,28300,KEGG COMPOUND accession,C00303,,,,,,,,,,,,,,,
2467,15413,"2',4,4',6'-tetrahydroxychalcone","A member of the class of chalcones that is trans-chalcone substituted by hydroxy groups at positions 2' ,4, 4', and 6' respectively.",29166,KEGG COMPOUND accession,C02282,M02376,b,29166.0,b,Glutaminyl-tRNA,b,b,b,C02282,b,b,b,[H]OC([H])([H])[C@@]1([H])O[C@@]([H])([*])[C@]([H])(O[H])[C@]1([H])OP(=O)(O[H])OC([H])([H])[C@@]1([H])O[C@@]([H])([*])[C@]([H])(O[H])[C@]1([H])OP(=O)(O[H])OC([H])([H])[C@@]1([H])O[C@@]([H])(N2C([H])=NC3=C(N=C([H])N=C23)N([H])[H])[C@]([H])(OC(=O)[C@@]([H])(N([H])[H])C([H])([H])C([H])([H])C(=O)N([H])[H])[C@]1([H])O[H],b,b
2468,15415,ent-kaurene,"A tetracyclic diterpene consisting of ent-kaurane, where the 6-methyl group is replaced by methylene.",17859,KEGG COMPOUND accession,C00489,glutar,110-94-1,17859.0,"Human Metabolome Database (HMDB): Glutaric acid is a simple five-carbon linear dicarboxylic acid. Glutaric acid is naturally produced in the body during the metabolism of some amino acids, including lysine and tryptophan. Glutaric acid may cause irritation to the skin and eyes. When present in sufficiently high levels, glutaric acid can act as an acidogen and a metabotoxin. An acidogen is an acidic compound that induces acidosis, which has multiple adverse effects on many organ systems. A metabotoxin is an endogenously produced metabolite that causes adverse health effects at chronically high levels. Chronically high levels of glutaric acid are associated with at least three inborn errors of metabolism, including glutaric aciduria type I, malonyl-CoA decarboxylase deficiency, and glutaric aciduria type III. Glutaric aciduria type I (glutaric acidemia type I, glutaryl-CoA dehydrogenase deficiency, GA1, or GAT1) is an inherited disorder in which the body is unable to completely break down the amino acids lysine, hydroxylysine, and tryptophan due to a deficiency of mitochondrial glutaryl-CoA dehydrogenase (EC 1.3.99.7, GCDH). Excessive levels of their intermediate breakdown products (e.g. glutaric acid, glutaryl-CoA, 3-hydroxyglutaric acid, glutaconic acid) can accumulate and cause damage to the brain (and also other organs). Babies with glutaric acidemia type I are often born with unusually large heads (macrocephaly). Macrocephaly is amongst the earliest signs of GA1. GA1 also causes secondary carnitine deficiency because glutaric acid, like other organic acids, is detoxified by carnitine. Abnormally high levels of organic acids in the blood (organic acidemia), urine (organic aciduria), the brain, and other tissues lead to general metabolic acidosis. Acidosis typically occurs when arterial pH falls below 7.35. In infants with acidosis, the initial symptoms include poor feeding, vomiting, loss of appetite, weak muscle tone (hypotonia), and lack of energy (lethargy). These can progress to heart, liver, and kidney abnormalities, seizures, coma, and possibly death. These are also the characteristic symptoms of untreated glutaric aciduria. Many affected children with organic acidemias experience intellectual disability or delayed development. In adults, acidosis or acidemia is characterized by headaches, confusion, feeling tired, tremors, sleepiness, and seizures. Treatment of glutaric aciduria is mainly based on the restriction of lysine intake, supplementation of carnitine, and an intensification of therapy during intercurrent illnesses. The major principle of dietary treatment is to reduce the production of glutaric acid and 3-hydroxyglutaric acid by restriction of natural protein, in general, and of lysine, in particular (PMID: 17465389, 15505398).",Glutaric acid,HMDB0000661,b,b,C00489,b,FDB001477,b,[H]C([H])(C([O-])=O)C([H])([H])C([H])([H])C([O-])=O,JFCQEDHGNNZCLN-UHFFFAOYSA-L,"InChI=1S/C5H8O4/c6-4(7)2-1-3-5(8)9/h1-3H2,(H,6,7)(H,8,9)/p-2"
2469,15419,ent-7alpha-hydroxykaur-16-en-19-oic acid,An ent-kaurane diterpenoid that is ent-kaur-16-en-19-oic acid carrying an additional 7alpha-hydroxy substituent.,5435,KEGG COMPOUND accession,C07275,,,,,,,,,,,,,,,
2470,15421,perillyl aldehyde,An aldehyde that is cyclohex-1-ene-1-carbaldehyde substituted by a prop-1-en-2-yl group at position 4.,15524,KEGG COMPOUND accession,C00527,glutcoa,103192-48-9,15524.0,"Human Metabolome Database (HMDB): Glutaryl-CoA is a substrate for 2-oxoglutarate dehydrogenase E1 component (mitochondrial), Dihydrolipoyllysine-residue succinyltransferase component of 2- oxoglutarate dehydrogenase complex (mitochondrial) and Glutaryl-CoA dehydrogenase (mitochondrial).",Glutaryl-CoA,HMDB0001339,b,b,C00527,GLUTARYL-COA,FDB022563,glutcoa,[H]O[C@@]([H])(C(=O)N([H])C([H])([H])C([H])([H])C(=O)N([H])C([H])([H])C([H])([H])SC(=O)C([H])([H])C([H])([H])C([H])([H])C([O-])=O)C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])OP([O-])(=O)OP([O-])(=O)OC([H])([H])[C@@]1([H])O[C@@]([H])(N2C([H])=NC3=C(N=C([H])N=C23)N([H])[H])[C@]([H])(O[H])[C@]1([H])OP([O-])([O-])=O,SYKWLIJQEHRDNH-CKRMAKSASA-I,"InChI=1S/C26H42N7O19P3S/c1-26(2,21(39)24(40)29-7-6-15(34)28-8-9-56-17(37)5-3-4-16(35)36)11-49-55(46,47)52-54(44,45)48-10-14-20(51-53(41,42)43)19(38)25(50-14)33-13-32-18-22(27)30-12-31-23(18)33/h12-14,19-21,25,38-39H,3-11H2,1-2H3,(H,28,34)(H,29,40)(H,35,36)(H,44,45)(H,46,47)(H2,27,30,31)(H2,41,42,43)/p-5/t14-,19-,20-,21+,25-/m1/s1"
2471,15427,N(2)-(2-carboxyethyl)-L-arginine,a,16856,KEGG COMPOUND accession,C00051,gthrd,70-18-8,16856.0,"Human Metabolome Database (HMDB): Glutathione is a compound synthesized from cysteine, perhaps the most important member of the body's toxic waste disposal team. Like cysteine, glutathione contains the crucial thiol (-SH) group that makes it an effective antioxidant. There are virtually no living organisms on this planet-animal or plant whose cells don't contain some glutathione. Scientists have speculated that glutathione was essential to the very development of life on earth. glutathione has many roles; in none does it act alone. It is a coenzyme in various enzymatic reactions. The most important of these are redox reactions, in which the thiol grouping on the cysteine portion of cell membranes protects against peroxidation; and conjugation reactions, in which glutathione (especially in the liver) binds with toxic chemicals in order to detoxify them. glutathione is also important in red and white blood cell formation and throughout the immune system. glutathione's clinical uses include the prevention of oxygen toxicity in hyperbaric oxygen therapy, treatment of lead and other heavy metal poisoning, lowering of the toxicity of chemotherapy and radiation in cancer treatments, and reversal of cataracts. (http://www.dcnutrition.com/AminoAcids/) glutathione participates in leukotriene synthesis and is a cofactor for the enzyme glutathione peroxidase. It is also important as a hydrophilic molecule that is added to lipophilic toxins and waste in the liver during biotransformation before they can become part of the bile. glutathione is also needed for the detoxification of methylglyoxal, a toxin produced as a by-product of metabolism. This detoxification reaction is carried out by the glyoxalase system. Glyoxalase I (EC 4.4.1.5) catalyzes the conversion of methylglyoxal and reduced glutathione to S-D-Lactoyl-glutathione. Glyoxalase II (EC 3.1.2.6) catalyzes the hydrolysis of S-D-Lactoyl-glutathione to glutathione and D-lactate. GSH is known as a substrate in both conjugation reactions and reduction reactions, catalyzed by glutathione S-transferase enzymes in cytosol, microsomes, and mitochondria. However, it is also capable of participating in non-enzymatic conjugation with some chemicals, as in the case of n-acetyl-p-benzoquinone imine (NAPQI), the reactive cytochrome P450-reactive metabolite formed by acetaminophen, that becomes toxic when GSH is depleted by an overdose (of acetaminophen). glutathione in this capacity binds to NAPQI as a suicide substrate and in the process detoxifies it, taking the place of cellular protein thiol groups which would otherwise be covalently modified; when all GSH has been spent, NAPQI begins to react with the cellular proteins, killing the cells in the process. The preferred treatment for an overdose of this painkiller is the administration (usually in atomized form) of N-acetylcysteine, which is used by cells to replace spent GSSG and renew the usable GSH pool. (http://en.wikipedia.org/wiki/glutathione).",Glutathione,HMDB0000125,b,b,C00051,GLUTATHIONE,FDB001498,gthrd,[H]SC([H])([H])[C@]([H])(N([H])C(=O)C([H])([H])C([H])([H])[C@@]([H])(C([O-])=O)[N+]([H])([H])[H])C(=O)N([H])C([H])([H])C([O-])=O,RWSXRVCMGQZWBV-WDSKDSINSA-M,"InChI=1S/C10H17N3O6S/c11-5(10(18)19)1-2-7(14)13-6(4-20)9(17)12-3-8(15)16/h5-6,20H,1-4,11H2,(H,12,17)(H,13,14)(H,15,16)(H,18,19)/p-1/t5-,6-/m0/s1"
2472,15459,(3S)-citryl-CoA,An (S)-3-hydroxyacyl-CoA having (3S)-citryl as the S-acyl group,16613,KEGG COMPOUND accession,C05730,,,,,,,,,,,,,,,
2473,15467,(3S)-3-hydroxy-3-methylglutaryl-CoA,A 3-hydroxy-3-methylglutaryl-CoA where the 3-hydroxy-3-methylglutaryl component has (S)-configuration.,5441,KEGG COMPOUND accession,C07022,,,,,,,,,,,,,,,
2474,15473,crotonoyl-CoA,The (E)-isomer of but-2-enoyl-CoA.,16470,KEGG COMPOUND accession,C01701,,,,,,,,,,,,,,,
2475,15476,2-methylacetoacetyl-CoA,A 3-oxoacyl-CoA that results from the formal condensation of the thiol group of coenzyme A with the carboxy group of 2-methylacetoacetic acid.,5445,KEGG COMPOUND accession,C02154,glyald,56-82-6,5445.0,"Human Metabolome Database (HMDB): Glyceraldehyde is a triose monosaccharide with chemical formula C3H6O3. It is the simplest of all common aldoses. It is a sweet, colourless crystalline solid that is an intermediate compound in carbohydrate metabolism. The word ""glyceraldehyde"" comes from combining glycerine and aldehyde, as glyceraldehyde is merely glycerine with one hydroxide changed to an aldehyde. Glyceraldehyde is produced from the action of the enzyme glyceraldehyde dehydrogenase, which converts glycerol to glyceraldehyde using NADP as a cofactor. When present at sufficiently high levels, glyceraldehyde can be a cytotoxin and a mutagen. A cytotoxin is a compound that kills cells. A mutagen is a compound that causes mutations in DNA. Glyceraldehyde is a highly reactive compound that can modify and cross-link proteins. Glyceraldehyde-modified proteins appear to be cytotoxic, depress intracellular glutathione levels, and induce reactive oxygen species (ROS) production (PMID: 14981296). Glyceraldehyde has been shown to cause chromosome damage to human cells in culture and is mutagenic in the Ames bacterial test.",Glyceraldehyde,HMDB0001051,b,b,C02154,GLYCERALD,FDB022392,glyald,[H]OC([H])([H])[C@@]([H])(O[H])C([H])=O,MNQZXJOMYWMBOU-VKHMYHEASA-N,"InChI=1S/C3H6O3/c4-1-3(6)2-5/h1,3,5-6H,2H2/t3-/m0/s1"
2476,15478,2-methylcrotonoyl-CoA,a,17138,KEGG COMPOUND accession,C00661,,,,,,,,,,,,,,,
2477,15483,3-hydroxy-3-(4-methylpent-3-en-1-yl)glutaryl-CoA,The S-3-hydroxy-3-(4-methylpent-3-en-1-yl)glutaryl derivative of CoA.,17754,KEGG COMPOUND accession,C00116,glyc,56-81-5,17522.0,"Human Metabolome Database (HMDB): Glycerol or glycerin is a colourless, odourless, viscous liquid that is sweet-tasting and mostly non-toxic. It is widely used in the food industry as a sweetener and humectant and in pharmaceutical formulations. Glycerol is an important component of triglycerides (i.e. fats and oils) and of phospholipids. Glycerol is a three-carbon substance that forms the backbone of fatty acids in fats. When the body uses stored fat as a source of energy, glycerol and fatty acids are released into the bloodstream. The glycerol component can be converted into glucose by the liver and provides energy for cellular metabolism. Normally, glycerol shows very little acute toxicity and very high oral doses or acute exposures can be tolerated. On the other hand, chronically high levels of glycerol in the blood are associated with glycerol kinase deficiency (GKD). GKD causes the condition known as hyperglycerolemia, an accumulation of glycerol in the blood and urine. There are three clinically distinct forms of GKD: infantile, juvenile, and adult. The infantile form is the most severe and is associated with vomiting, lethargy, severe developmental delay, and adrenal insufficiency. The mechanisms of glycerol toxicity in infants are not known, but it appears to shift metabolism towards chronic acidosis. Acidosis typically occurs when arterial pH falls below 7.35. In infants with acidosis, the initial symptoms include poor feeding, vomiting, loss of appetite, weak muscle tone (hypotonia), and lack of energy (lethargy). These can progress to heart, liver, and kidney abnormalities, seizures, coma, and possibly death. These are also the characteristic symptoms of untreated GKD. Many affected children with organic acidemias experience intellectual disability or delayed development. Patients with the adult form of GKD generally have no symptoms and are often detected fortuitously.",Glycerol,HMDB0000131,b,b,C00116,GLYCEROL,FDB000756,glyc,[H]OC([H])([H])C([H])(O[H])C([H])([H])O[H],PEDCQBHIVMGVHV-UHFFFAOYSA-N,"InChI=1S/C3H8O3/c4-1-3(6)2-5/h3-6H,1-2H2"
2478,15505,6-hydroxycyclohex-1-ene-1-carbonyl-CoA,The S-(6-hydroxycyclohex-1-ene-1-carbonyl) derivative of coenzyme A.,16597,KEGG COMPOUND accession,C03947,,,,,,,,,,,,,,,
2479,15507,beta-alanyl-CoA,An acyl-CoA that is the S-(beta-alanyl) derivative of coenzyme A.,16221,KEGG COMPOUND accession,C00623,,,,,,,,,,,,,,,
2480,15511,trans-feruloyl-CoA,A feruloyl-CoA that results from the formal condensation of the thiol group of coenzyme A with the carboxy group of trans-feruloic acid.,17270,KEGG COMPOUND accession,C02979,,,,,,,,,,,,,,,
2481,15514,arachidonoyl-CoA,An unsaturated fatty acyl-CoA that results from the formal condensation of the thiol group of coenzyme A with the carboxy group of arachidononic acid.,16016,KEGG COMPOUND accession,C00184,dha,96-26-4,16016.0,"Human Metabolome Database (HMDB): Dihydroxyacetone is a ketotriose compound. Its addition to blood preservation solutions results in better maintenance of 2,3-diphosphoglycerate levels during storage. It is readily phosphorylated to dihydroxyacetone phosphate by triokinase in erythrocytes. In combination with naphthoquinones it acts as a sunscreening agent. -- Pubchem; Dihydroxyacetone (also known as DHA) is a triose carbohydrate with chemical formula C3H6O3. It is the simplest of all ketoses and, having no chiral centre, is the only one that has no optical activity. -- Wikipedia; Dihydroxyacetone is a simple non-toxic sugar. It is often derived from plant sources such as sugar beets and sugar cane, by the fermentation of glycerin; it is a white crystalline powder which is water soluble. -- Wikipedia.",Dihydroxyacetone,HMDB0001882,b,b,C00184,DIHYDROXYACETONE,FDB009294,dha,[H]OC([H])([H])C(=O)C([H])([H])O[H],RXKJFZQQPQGTFL-UHFFFAOYSA-N,"InChI=1S/C3H6O3/c4-1-3(6)2-5/h4-5H,1-2H2"
2482,15523,cis-geranoyl-CoA,The S-geranoyl derivative of coenzyme A.,16108,KEGG COMPOUND accession,C00111,dhap,57-04-5,16108.0,"Human Metabolome Database (HMDB): Dihydroxyacetone phosphate is an important intermediate in lipid biosynthesis and in glycolysis. Dihydroxyacetone phosphate is found to be associated with transaldolase deficiency, which is an inborn error of metabolism.",Dihydroxyacetone phosphate,HMDB0001473,b,b,C00111,DIHYDROXY-ACETONE-PHOSPHATE,FDB001618,dhap,[H]OC([H])([H])C(=O)C([H])([H])OP([O-])([O-])=O,GNGACRATGGDKBX-UHFFFAOYSA-L,"InChI=1S/C3H7O6P/c4-1-3(5)2-9-10(6,7)8/h4H,1-2H2,(H2,6,7,8)/p-2"
2483,15542,thiophene-2-carbonyl-CoA,An acyl-CoA that results from the formal condensation of the thiol group of coenzyme A with the carboxy group of thiophene-2-carboxylic acid.,27894,KEGG COMPOUND accession,C02543,,,,,,,,,,,,,,,
2484,15545,prostaglandin A1,a,5457,KEGG COMPOUND accession,C03274,,,,,,,,,,,,,,,
2485,15548,15-dehydro-prostaglandin E1,a,30966,KEGG COMPOUND accession,C10920,,,,,,,,,,,,,,,
2486,15550,"13,14-dihydro-15-oxo-prostaglandin E2","The 13,14-dihydro derivative of 15-oxo-prostaglandin E2.",15428,KEGG COMPOUND accession,C00037,gly,56-40-6,15428.0,"Human Metabolome Database (HMDB): Glycine is a simple, nonessential amino acid, although experimental animals show reduced growth on low-glycine diets. The average adult ingests 3 to 5 grams of glycine daily. Glycine is involved in the body's production of DNA, phospholipids and collagen, and in release of energy. Glycine levels are effectively measured in plasma in both normal patients and those with inborn errors of glycine metabolism (http://www.dcnutrition.com/AminoAcids/). Nonketotic hyperglycinaemia (OMIM 606899) is an autosomal recessive condition caused by deficient enzyme activity of the glycine cleavage enzyme system (EC 2.1.1.10). The glycine cleavage enzyme system comprises four proteins: P-, T-, H- and L-proteins (EC 1.4.4.2, EC 2.1.2.10 and EC 1.8.1.4 for P-, T- and L-proteins). Mutations have been described in the GLDC (OMIM 238300), AMT (OMIM 238310), and GCSH (OMIM 238330) genes encoding the P-, T-, and H-proteins respectively. The glycine cleavage system catalyses the oxidative conversion of glycine into carbon dioxide and ammonia, with the remaining one-carbon unit transferred to folate as methylenetetrahydrofolate. It is the main catabolic pathway for glycine and it also contributes to one-carbon metabolism. Patients with a deficiency of this enzyme system have increased glycine in plasma, urine and cerebrospinal fluid (CSF) with an increased CSF: plasma glycine ratio (PMID 16151895). Glycine is also found to be associated with carbamoyl phosphate synthetase deficiency, iminoglycinuria, maple syrup urine disease, phenylketonuria, propionic acidemia, sarcosinemia, and tyrosinemia I, which are inborn errors of metabolism.",Glycine,HMDB0000123,b,b,C00037,GLY,FDB000484,gly,[H][N+]([H])([H])C([H])([H])C([O-])=O,DHMQDGOQFOQNFH-UHFFFAOYSA-N,"InChI=1S/C2H5NO2/c3-1-2(4)5/h1,3H2,(H,4,5)"
2487,15595,malate(2-),A C4-dicarboxylate resulting from deprotonation of both carboxy groups of malic acid.,36274,KEGG COMPOUND accession,C05466,dgchol,640-79-9,b,"Human Metabolome Database (HMDB): Chenodeoxycholic acid glycine conjugate is an acyl glycine and a bile acid-glycine conugate. It is a secondary bile acid produced by the action of enzymes existing in the microbial flora of the colonic environment. In hepatocytes, both primary and secondary bile acids undergo amino acid conjugation at the C-24 carboxylic acid on the side chain, and almost all bile acids in the bile duct therefore exist in a glycine conjugated form (PMID:16949895). This compound usually exists as the sodium salt and acts as a detergent to solubilize fats for absorption and is itself absorbed. It is a cholagogue and choleretic.",Chenodeoxycholic acid glycine conjugate,HMDB0000637,b,b,C05466,b,FDB022157,dgchol,[H]OC(=O)C([H])([H])N([H])C(=O)C([H])([H])C([H])([H])[C@@]([H])(C([H])([H])[H])[C@@]1([H])C([H])([H])C([H])([H])[C@@]2([H])[C@]3([H])[C@]([H])(O[H])C([H])([H])[C@]4([H])C([H])([H])[C@]([H])(O[H])C([H])([H])C([H])([H])[C@]4(C([H])([H])[H])[C@@]3([H])C([H])([H])C([H])([H])[C@]12C([H])([H])[H],GHCZAUBVMUEKKP-GYPHWSFCSA-N,"InChI=1S/C26H43NO5/c1-15(4-7-22(30)27-14-23(31)32)18-5-6-19-24-20(9-11-26(18,19)3)25(2)10-8-17(28)12-16(25)13-21(24)29/h15-21,24,28-29H,4-14H2,1-3H3,(H,27,30)(H,31,32)/t15-,16+,17-,18-,19+,20+,21-,24+,25+,26-/m1/s1"
2488,15597,(2R)-2-O-phosphonato-3-sulfonatolactate(4-),A quadruply-charged carboxyalkyl phosphate oxoanion resulting from global deprotonation of (2R)-O-phospho-3-sulfolactic acid.,17687,KEGG COMPOUND accession,C01921,gchola,475-31-0,29746.0,"Human Metabolome Database (HMDB): Glycocholic acid is an acyl glycine and a bile acid-glycine conjugate. It is a secondary bile acid produced by the action of enzymes existing in the microbial flora of the colonic environment. In hepatocytes, both primary and secondary bile acids undergo amino acid conjugation at the C-24 carboxylic acid on the side chain, and almost all bile acids in the bile duct therefore exist in a glycine conjugated form (PMID:16949895). More specifically, glycocholic acid or cholylglycine, is a crystalline bile acid involved in the emulsification of fats. It occurs as a sodium salt in the bile of mammals. Its anion is called glycocholate. As the glycine conjugate of cholic acid, this compound acts as a detergent to solubilize fats for absorption and is itself absorbed (PubChem). Bile acids are steroid acids found predominantly in bile of mammals. The distinction between different bile acids is minute, depends only on presence or absence of hydroxyl groups on positions 3, 7, and 12. Bile acids are physiological detergents that facilitate excretion, absorption, and transport of fats and sterols in the intestine and liver. Bile acids are also steroidal amphipathic molecules derived from the catabolism of cholesterol. They modulate bile flow and lipid secretion, are essential for the absorption of dietary fats and vitamins, and have been implicated in the regulation of all the key enzymes involved in cholesterol homeostasis. Bile acids recirculate through the liver, bile ducts, small intestine and portal vein to form an enterohepatic circuit. They exist as anions at physiological pH and, consequently, require a carrier for transport across the membranes of the enterohepatic tissues. The unique detergent properties of bile acids are essential for the digestion and intestinal absorption of hydrophobic nutrients. Bile acids have potent toxic properties (e.g., membrane disruption) and there are a plethora of mechanisms to limit their accumulation in blood and tissues (PMID: 11316487 , 16037564 , 12576301 , 11907135 ). Glycocholic acid is found to be associated with alpha-1-antitrypsin deficiency, which is an inborn error of metabolism.",Glycocholic acid,HMDB0000138,b,b,C01921,GLYCOCHOLIC_ACID,FDB012346,gchola,[H]OC(=O)C([H])([H])N([H])C(=O)C([H])([H])C([H])([H])[C@@]([H])(C([H])([H])[H])[C@@]1([H])C([H])([H])C([H])([H])[C@@]2([H])[C@]3([H])[C@]([H])(O[H])C([H])([H])[C@]4([H])C([H])([H])[C@]([H])(O[H])C([H])([H])C([H])([H])[C@]4(C([H])([H])[H])[C@@]3([H])C([H])([H])[C@]([H])(O[H])[C@]12C([H])([H])[H],RFDAIACWWDREDC-FRVQLJSFSA-N,"InChI=1S/C26H43NO6/c1-14(4-7-22(31)27-13-23(32)33)17-5-6-18-24-19(12-21(30)26(17,18)3)25(2)9-8-16(28)10-15(25)11-20(24)29/h14-21,24,28-30H,4-13H2,1-3H3,(H,27,31)(H,32,33)/t14-,15+,16-,17-,18+,19+,20-,21+,24+,25+,26-/m1/s1"
2489,15601,"(2R,4S)-2,4-diaminopentanoate","A 2,4-diaminopentanoate that is the conjugate base of (2R,4S)-2,4-diaminopentanoic acid.",27471,KEGG COMPOUND accession,C05464,M01989,360-65-6,27471.0,"Human Metabolome Database (HMDB): Deoxycholic acid glycine conjugate, or Deoxygcholylglycine, is an acyl glycine and a bile acid-glycine conjugate. It is a secondary bile acid produced by the action of enzymes existing in the microbial flora of the colonic environment. In hepatocytes, both primary and secondary bile acids undergo amino acid conjugation at the C-24 carboxylic acid on the side chain, and almost all bile acids in the bile duct therefore exist in a glycine conjugated form (PMID:16949895). As a bile salt it acts as a detergent to solubilize fats for absorption and is itself absorbed. It is used as a cholagogue and choleretic.",Deoxycholic acid glycine conjugate,HMDB0000631,b,b,C05464,b,FDB022152,M01989,[H]OC(=O)C([H])([H])N([H])C(=O)C([H])([H])C([H])([H])[C@@]([H])(C([H])([H])[H])C1([H])C([H])([H])C([H])([H])C2([H])C3([H])C([H])([H])C([H])([H])C4([H])C([H])([H])[C@]([H])(O[H])C([H])([H])C([H])([H])[C@]4(C([H])([H])[H])C3([H])C([H])([H])[C@]([H])(O[H])[C@]12C([H])([H])[H],WVULKSPCQVQLCU-CMWIOBKGSA-N,"InChI=1S/C26H43NO5/c1-15(4-9-23(30)27-14-24(31)32)19-7-8-20-18-6-5-16-12-17(28)10-11-25(16,2)21(18)13-22(29)26(19,20)3/h15-22,28-29H,4-14H2,1-3H3,(H,27,30)(H,31,32)/t15-,16?,17-,18?,19?,20?,21?,22+,25+,26-/m0/s1"
2490,15603,L-leucine,The L-enantiomer of leucine.,28087,KEGG COMPOUND accession,C00182,M03161,9005-79-2,28087.0,"Human Metabolome Database (HMDB): Glycogen is a highly-branched polymer of about 30,000 glucose residues and has a molecular weight between 106 and 107 daltons (4.8 million approx.). Most of Glc units are linked by alpha-1,4 glycosidic bonds, approximately 1 in 12 Glc residues also makes -1,6 glycosidic bond with a second Glc which results in the creation of a branch. Glycogen only has one reducing end and a large number of non-reducing ends with a free hydroxyl group at carbon 4. The glycogen granules contain both glycogen and the enzymes of glycogen synthesis (glycogenesis) and degradation (glycogenolysis). The enzymes are nested between the outer branches of the glycogen molecules and act on the non-reducing ends. Therefore, the many non-reducing end-branches of glycogen facilitate its rapid synthesis and breakdown. In hypoglycemia caused by excessive insulin, liver glycogen levels are high, but the high insulin level prevents the glycogenolysis necessary to maintain normal blood sugar levels. Glucagon is a common treatment for this type of hypoglycemia. Glycogen is a polysaccharide that is the principal storage form of glucose (Glc) in animal and human cells. Glycogen is found in the form of granules in the cytosol in many cell types. Hepatocytes (liver cells) have the highest concentration of it - up to 8% of the fresh weight in well fed state, or 100 to 120 g in an adult - giving liver a distinctive, 'starchy taste'. In the muscles, glycogen is found in a much lower concentration (1% of the muscle mass), but the total amount exceeds that in liver. Small amounts of glycogen are found in the kidneys, and even smaller amounts in certain glial cells in the brain and white blood cells.",Glycogen,HMDB0000757,b,b,C00182,CPD0-971,FDB022227,b,[H]OC([H])([H])[C@@]1([H])O[C@]([H])(OC([H])([H])[C@@]2([H])O[C@]([H])(O[C@@]3([H])[C@]([H])(O[H])[C@@]([H])(O[H])[C@@]([H])(O[H])O[C@]3([H])C([H])([H])O[H])[C@]([H])(O[H])[C@@]([H])(O[H])[C@]2([H])O[C@@]2([H])O[C@]([H])(C([H])([H])O[H])[C@@]([H])(O[H])[C@]([H])(O[H])[C@@]2([H])O[H])[C@]([H])(O[H])[C@@]([H])(O[H])[C@]1([H])O[H],BYSGBSNPRWKUQH-UJDJLXLFSA-N,"InChI=1S/C24H42O21/c25-1-5-9(28)11(30)16(35)22(41-5)39-4-8-20(45-23-17(36)12(31)10(29)6(2-26)42-23)14(33)18(37)24(43-8)44-19-7(3-27)40-21(38)15(34)13(19)32/h5-38H,1-4H2/t5-,6-,7-,8-,9-,10-,11+,12+,13-,14-,15-,16-,17-,18-,19-,20-,21+,22+,23-,24-/m1/s1"
2491,15613,"(3S)-3,6-diaminohexanoic acid",A chiral diamino acid consisting of hexanoic acid having amino substituents at the 3- and 6-positions and (S)-configuration.,30742,KEGG COMPOUND accession,C01380,,,,,,,,,,,,,,,
2492,15617,"(2R,3Z)-phycocyanobilin",The (3Z)-isomer of (2R)-phycocyanobilin.,17071,KEGG COMPOUND accession,C00266,gcald,141-46-8,17071.0,"Human Metabolome Database (HMDB): Glycolaldehyde (HOCH2-CH=O, IUPAC name 2-hydroxyethanal) is a type of diose (2-carbon monosaccharide). Glycolaldehyde is readily converted to acetyl coenzyme A. It has an aldehyde and a hydroxyl group. However, it is not actually a sugar, because there is only one hydroxyl group. Glycolaldehyde is formed from many sources, including the amino acid glycine and from purone catabolism. It can form by action of ketolase on fructose 1,6-bisphosphate in an alternate glycolysis pathway. This compound is transferred by thiamin pyrophosphate during the pentose phosphate shunt.",Glycolaldehyde,HMDB0003344,b,b,C00266,DIHYDROXYPHENYLGLYCOLALDEHYDE,FDB003297,gcald,[H]OC([H])([H])C([H])=O,WGCNASOHLSPBMP-UHFFFAOYSA-N,"InChI=1S/C2H4O2/c3-1-2-4/h1,4H,2H2"
2493,15627,thromboxane A2,A thromboxane which is produced by activated platelets and has prothrombotic properties: it stimulates activation of new platelets as well as increases platelet aggregation.,17497,KEGG COMPOUND accession,C00160,glyclt,79-14-1,17497.0,"Human Metabolome Database (HMDB): Glycolic acid (or hydroxyacetic acid) is the smallest alpha-hydroxy acid (AHA). This colourless, odourless, and hygroscopic crystalline solid is highly soluble in water. Due to its excellent capability to penetrate skin, glycolic acid is often used in skin care products, most often as a chemical peel. It may reduce wrinkles, acne scarring, and hyperpigmentation and improve many other skin conditions, including actinic keratosis, hyperkeratosis, and seborrheic keratosis. Once applied, glycolic acid reacts with the upper layer of the epidermis, weakening the binding properties of the lipids that hold the dead skin cells together. This allows the outer skin to dissolve, revealing the underlying skin. It is thought that this is due to the reduction of calcium ion concentrations in the epidermis and the removal of calcium ions from cell adhesions, leading to desquamation. Glycolic acid is a known inhibitor of tyrosinase. This can suppress melanin formation and lead to a lightening of skin colour. Acute doses of glycolic acid on skin or eyes leads to local effects that are typical of a strong acid (e.g. dermal and eye irritation). Glycolate is a nephrotoxin if consumed orally. A nephrotoxin is a compound that causes damage to the kidney and kidney tissues. Glycolic acid's renal toxicity is due to its metabolism to oxalic acid. Glycolic and oxalic acid, along with excess lactic acid, are responsible for the anion gap metabolic acidosis. Oxalic acid readily precipitates with calcium to form insoluble calcium oxalate crystals. Renal tissue injury is caused by widespread deposition of oxalate crystals and the toxic effects of glycolic acid. Glycolic acid does exhibit some inhalation toxicity and can cause respiratory, thymus, and liver damage if present in very high levels over long periods of time.",Glycolic acid,HMDB0000115,b,b,C00160,GLYCOLLATE,FDB003298,glyclt,[H]OC([H])([H])C([O-])=O,AEMRFAOFKBGASW-UHFFFAOYSA-M,"InChI=1S/C2H4O3/c3-1-2(4)5/h3H,1H2,(H,4,5)/p-1"
2494,15638,"(6R)-5,10-methenyltetrahydrofolic acid","The 5,10-methenyl derivative of tetrahydrofolic acid arising from enzymatic cyclisation of 5-formyltetrahydrofolic acid.",33563,KEGG COMPOUND accession,C05005,,,,,,,,,,,,,,,
2495,15645,(6S)-6-hydroxyhyoscyamine,a,17089,KEGG COMPOUND accession,C00326,,,,,,,,,,,,,,,
2496,15653,"(9Z,13S,15Z)-12,13-epoxyoctadeca-9,11,15-trienoic acid","A long-chain trienoic fatty acid consisting of octadecanoic acid having the three double bonds at positions 9, 11 and 15 as well as an epoxy ring linking positions 12 and 13.",16124,KEGG COMPOUND accession,C04648,,,,,,,,,,,,,,,
2497,15671,L-tartaric acid,a,18085,KEGG COMPOUND accession,C02545,,,,,,,,,,,,,,,
2498,15683,(R)-10-hydroxyoctadecanoate,A hydroxy monocarboxylic acid anion resulting from the removal of the proton from the carboxy group of (R)-10-hydroxyoctadecanoic acid.,29156,KEGG COMPOUND accession,C02412,M02006,b,29156.0,b,Glycyl-tRNA(Gly),b,b,b,C02412,b,b,b,[H]OC([H])([H])[C@@]1([H])O[C@@]([H])([*])[C@]([H])(O[H])[C@]1([H])OP(=O)(O[H])OC([H])([H])[C@@]1([H])O[C@@]([H])([*])[C@]([H])(O[H])[C@]1([H])OP(=O)(O[H])OC([H])([H])[C@@]1([H])O[C@@]([H])([*])[C@]([H])(O[H])[C@]1([H])OC(=O)C([H])([H])N([H])[H],b,b
2499,15686,(R)-acetoin,a,17201,KEGG COMPOUND accession,C02037,glygly,556-50-3,17201.0,"Human Metabolome Database (HMDB): The simplest peptide, made of two glycine molecules; used in the synthesis of more complicated peptides. Glycine is a simple, nonessential amino acid, although experimental animals show reduced growth on low-glycine diets. The average adult ingests 3 to 5 grams of glycine daily. Glycine is involved in the body's production of DNA, phospholipids and collagen, and in release of energy. Glycine levels are effectively measured in plasma in both normal patients and those with inborn errors of glycine metabolism. (http://www.dcnutrition.com/AminoAcids/) Nonketotic hyperglycinaemia (OMIM 606899) is an autosomal recessive condition caused by deficient enzyme activity of the glycine cleavage enzyme system (EC 2.1.1.10). The glycine cleavage enzyme system comprises four proteins: P-, T-, H- and L-proteins (EC 1.4.4.2, EC 2.1.2.10 and EC 1.8.1.4 for P-, T- and L-proteins). Mutations have been described in the GLDC (OMIM 238300), AMT (OMIM 238310), and GCSH (OMIM 238330) genes encoding the P-, T-, and H-proteins respectively. The glycine cleavage system catalyses the oxidative conversion of glycine into carbon dioxide and ammonia, with the remaining one-carbon unit transferred to folate as methylenetetrahydrofolate. It is the main catabolic pathway for glycine and it also contributes to one-carbon metabolism. Patients with a deficiency of this enzyme system have increased glycine in plasma, urine and cerebrospinal fluid (CSF) with an increased CSF: plasma glycine ratio. (PMID 16151895).",Glycyl-glycine,HMDB0011733,b,b,C02037,DIOXOPIPERAZINE,FDB028413,b,[H]N(C(=O)C([H])([H])[N+]([H])([H])[H])C([H])([H])C([O-])=O,YMAWOPBAYDPSLA-UHFFFAOYSA-N,"InChI=1S/C4H8N2O3/c5-1-3(7)6-2-4(8)9/h1-2,5H2,(H,6,7)(H,8,9)"
2500,15689,"2,3-dihydroxy-3-methylbutanoic acid",A dihydroxy monocarboxylic acid that is isovaleric acid which is substituted by hydroxy groups at positions 2 and 3.,16462,KEGG COMPOUND accession,C02038,M02005,b,16462.0,b,Glycylpeptide,b,b,b,C02038,b,b,b,[H]OC(=O)[C@]([H])([*])N([H])C(=O)C([H])([H])N([H])[H],b,b
2501,15691,ferricytochrome c3,a,27400,KEGG COMPOUND accession,C09754,,,,,,,,,,,,,,,
2502,15693,aldose,"Aldehydic parent sugars (polyhydroxy aldehydes H[CH(OH)]nC(=O)H, n >= 2) and their intramolecular hemiacetals.",30853,KEGG COMPOUND accession,C02283,,,,,,,,,,,,,,,
2503,15696,beta-D-glucosyl-(1->4)-N-acetyl-D-glucosaminyl undecaprenyl diphosphate,A polyprenyl glycosyl diphosphate having eleven prenyl units and with beta-D-glucosyl-(1->4)-N-acetyl-D-glucosamine as the glycosyl fragment.,15939,KEGG COMPOUND accession,C02284,,,,,,,,,,,,,,,
2504,15699,L-homoserine,The L-enantiomer of homoserine.,16891,KEGG COMPOUND accession,C00048,glx,298-12-4,16891.0,"Human Metabolome Database (HMDB): Glyoxylic acid or oxoacetic acid is an organic compound that is both an aldehyde and a carboxylic acid. Glyoxylic acid is a liquid with a melting point of -93C and a boiling point of 111C. It is an intermediate of the glyoxylate cycle, which enables certain organisms to convert fatty acids into carbohydrates. The conjugate base of glyoxylic acid is known as glyoxylate (PMID: 16396466). In humans, glyoxylate is produced via two pathways: (1) through the oxidation of glycolate in peroxisomes and (2) through the catabolism of hydroxyproline in mitochondria. In the peroxisomes, glyoxylate is converted into glycine by glyoxylate aminotransferase (AGT1) or into oxalate by glycolate oxidase. In the mitochondria, glyoxylate is converted into glycine by mitochondrial glyoxylate aminotransferase AGT2 or into glycolate by glycolate reductase. A small amount of glyoxylate is converted into oxalate by cytoplasmic lactate dehydrogenase. Glyoxylic acid is found to be associated with primary hyperoxaluria I, which is an inborn error of metabolism. Under certain circumstances, glyoxylate can be a nephrotoxin and a metabotoxin. A nephrotoxin is a compound that causes damage to the kidney and kidney tissues. A metabotoxin is an endogenously produced metabolite that causes adverse health effects at chronically high levels. High levels of glyoxylate are involved in the development of hyperoxaluria, a key cause of nephrolithiasis (commonly known as kidney stones). Glyoxylate is both a substrate and inductor of sulfate anion transporter-1 (SAT-1), a gene responsible for oxalate transportation, allowing it to increase SAT-1 mRNA expression, and as a result oxalate efflux from the cell. The increased oxalate release allows the buildup of calcium oxalate in the urine, and thus the eventual formation of kidney stones. As an aldehyde, glyoxylate is also highly reactive and will modify proteins to form advanced glycation products (AGEs).",Glyoxylic acid,HMDB0000119,b,b,C00048,GLYOX,FDB001478,glx,[H]C(=O)C([O-])=O,HHLFWLYXYJOTON-UHFFFAOYSA-M,"InChI=1S/C2H2O3/c3-1-2(4)5/h1H,(H,4,5)/p-1"
2505,15735,S-formylmycothiol,a,27744,KEGG COMPOUND accession,C01705,,,,,,,,,,,,,,,
2506,15755,"3alpha,7alpha,12beta-trihydroxy-5beta-cholanate","A bile acid anion that is the conjugate base of 3alpha,7alpha,12beta-trihydroxy-5beta-cholanic acid, obtained by deprotonation of the carboxy group.",5520,KEGG COMPOUND accession,C07607,,,,,,,,,,,,,,,
2507,15763,nicotinic acid D-ribonucleotide,A D-ribonucleotide having nicotinic acid as the nucleobase.,28086,KEGG COMPOUND accession,C10050,,,,,,,,,,,,,,,
2508,15765,L-dopa,"An optically active form of dopa having L-configuration. Used to treat the stiffness, tremors, spasms, and poor muscle control of Parkinson's disease",5525,KEGG COMPOUND accession,C10051,,,,,,,,,,,,,,,
2509,15775,3-oxoadipate(2-),A dicarboxylic acid dianion resuting from deprotonation of both carboxy groups of 3-oxoadipic acid.,5530,KEGG COMPOUND accession,C11218,,,,,,,,,,,,,,,
2510,15777,4-oxocyclohexanecarboxylate,a,28948,KEGG COMPOUND accession,C08304,,,,,,,,,,,,,,,
2511,15781,"N(alpha),N(alpha),N(alpha)-trimethyl-L-histidine",a,5533,KEGG COMPOUND accession,C06799,,,,,,,,,,,,,,,
2512,15789,2'-O-methyllicodione,"A beta-diketone that is licodione in which the hydroxy group at position 2 of the 2,4-dihyroxyphenyl moiety has been converted into the its methyl ether.",5537,KEGG COMPOUND accession,C07023,,,,,,,,,,,,,,,
2513,15799,1-palmitoyl-sn-glycerol 3-phosphate,A 1-acyl-sn-glycerol 3-phosphate having palmitoyl as the acyl group.,5542,KEGG COMPOUND accession,C09103,,,,,,,,,,,,,,,
2514,15812,dolichyl beta-D-glucosyl phosphate,A polyprenyl glycosyl phosphate having dolichyl as the polyprenyl component and beta-D-glucose as the glycosyl component.,28591,KEGG COMPOUND accession,C01502,,,,,,,,,,,,,,,
2515,15815,quinolin-4-ol,A monohydroxyquinoline carrying a hydroxy group at position 4.,5550,KEGG COMPOUND accession,C09675,,,,,,,,,,,,,,,
2516,15819,N(6)-(dimethylallyl)adenosine 5'-monophosphate,The N(6)-dimethylallyl derivative of adenosine 5'-monophosphate.,5552,KEGG COMPOUND accession,C09676,,,,,,,,,,,,,,,
2517,15825,3-methylbut-2-enal,An enal consisting of but-2-ene with a methyl substituent at position 3 and an oxo group at position 1.,5555,KEGG COMPOUND accession,C07035,,,,,,,,,,,,,,,
2518,15829,L-serine O-sulfate,A non-proteinogenic L-alpha-amino acid that is the O-sulfo derivative of L-serine.,5557,KEGG COMPOUND accession,C07036,,,,,,,,,,,,,,,
2519,15835,1-acylglycerone 3-phosphate,A glycerone 3-phosphate having an unspecified O-acyl substituent at the 1-position.,16344,KEGG COMPOUND accession,C00581,gudac,352-97-6,16344.0,"Human Metabolome Database (HMDB): Guanidoacetic acid is a metabolite in the Urea cycle and metabolism of amino groups, and in the metabolic pathways of several amino acids. This includes glycine, serine, threonine, arginine and proline metabolism. Guanidinoacetic acid is also a precursor of creatine, an essential substrate for muscle energy metabolism.",Guanidoacetic acid,HMDB0000128,b,b,C00581,GUANIDOACETIC_ACID,FDB021898,gudac,[H]N([H])C(N([H])C([H])([H])C([O-])=O)=[N+]([H])[H],BPMFZUMJYQTVII-UHFFFAOYSA-N,"InChI=1S/C3H7N3O2/c4-3(5)6-1-2(7)8/h1H2,(H,7,8)(H4,4,5,6)"
2520,15841,polypeptide,A peptide containing ten or more amino acid residues.,17175,KEGG COMPOUND accession,C04071,,,,,,,,,,,,,,,
2521,15843,arachidonic acid,"A long-chain fatty acid that is a C20, polyunsaturated fatty acid having four (Z)-double bonds at positions 5, 8, 11 and 14.",32963,KEGG COMPOUND accession,C06657,,,,,,,,,,,,,,,
2522,15844,"1D-myo-inositol 3,4,5,6-tetrakisphosphate","A myo-inositol tetrakisphosphate having the four phosphate groups placed at the 3-, 4-, 5- and 6-positions.",16235,KEGG COMPOUND accession,C00242,gua,73-40-5,16235.0,"Human Metabolome Database (HMDB): Guanine is one of the five main nucleobases found in the nucleic acids DNA and RNA. Guanine is a derivative of purine, consisting of a fused pyrimidine-imidazole ring system with conjugated double bonds. Being unsaturated, the bicyclic molecule is planar. The guanine nucleoside is called guanosine. The first isolation of guanine was reported in 1844 from the excreta of sea birds, known as guano, which was used as a source of fertilizer. High affinity binding of guanine nucleotides and the ability to hydrolyze bound GTP to GDP are characteristics of an extended family of intracellular proteins. Guanine nucleotide-binding regulatory proteins may be involved in the activation of phospholipases C and A2 by hormones and other ligands. The binding of hormones to receptors that activate phospholipase C is decreased by guanine nucleotides and these hormones also stimulate a high-affinity GTPase activity in cell membranes. Effects of hormones on phospholipase C activity in cell-free preparations are dependent on the presence of guanine nucleotides. Hypoxanthine-guanine phosphoribosyltransferase (HPRT, EC 2.4.2.8) is a purine salvage enzyme that catalyses the conversion of hypoxanthine and guanine to their respective mononucleotides. Partial deficiency of this enzyme can result in the overproduction of uric acid leading to a severe form of gout, whilst a virtual absence of HPRT activity causes the Lesch-Nyhan syndrome, an inborn error of metabolism, which is characterised by hyperuricaemia, mental retardation, choreoathetosis and compulsive self-mutilation. Peroxynitrite induces DNA base damage predominantly at guanine (G) and 8-oxoguanine (8-oxoG) nucleobases via oxidation reactions. G and 8-oxoG are the most reactive bases toward Peroxynitrite and possibly the major contributors to peroxynitrite-derived genotoxic and mutagenic lesions. The neutral G radical, reacts with NO2 to yield 8-nitroguanine and 5-nitro-4-guanidinohydantoin (PMID: 16352449, 2435586, 2838362, 1487231).",Guanine,HMDB0000132,b,b,C00242,GUANINE,FDB004222,gua,[H]N([H])C1=NC2=C(N=C([H])N2[H])C(=O)N1[H],UYTPUPDQBNUYGX-UHFFFAOYSA-N,"InChI=1S/C5H5N5O/c6-5-9-3-2(4(11)10-5)7-1-8-3/h1H,(H4,6,7,8,9,10,11)"
2523,15856,ferrocytochrome c-553,a,16750,KEGG COMPOUND accession,C00387,gsn,118-00-3,16750.0,"Human Metabolome Database (HMDB): Guanosine is a nucleoside comprising guanine attached to a ribose (ribofuranose) ring via a beta-N9-glycosidic bond. Guanosine can be phosphorylated to become GMP (guanosine monophosphate), cGMP (cyclic guanosine monophosphate), GDP (guanosine diphosphate), and GTP (guanosine triphosphate) (Wikipedia). This nucleoside exerts important neuroprotective and neuromodulator roles in the central nervous system, which may be related to inhibition of the glutamatergic neurotransmission activity. Guanosine is the specific extracellular guanine-based purines effector and its conversion occurs not only in the central nervous system but also peripherally (PMID: 16325434). Guanosine is found to be associated with purine nucleoside phosphorylase (PNP) deficiency, which is an inborn error of metabolism.",Guanosine,HMDB0000133,b,b,C00387,GUANOSINE,FDB003632,gsn,[H]OC([H])([H])[C@@]1([H])O[C@@]([H])(N2C([H])=NC3=C2N=C(N([H])[H])N([H])C3=O)[C@]([H])(O[H])[C@]1([H])O[H],NYHBQMYGNKIUIF-UUOKFMHZSA-N,"InChI=1S/C10H13N5O5/c11-10-13-7-4(8(19)14-10)12-2-15(7)9-6(18)5(17)3(1-16)20-9/h2-3,5-6,9,16-18H,1H2,(H3,11,13,14,19)/t3-,5-,6-,9-/m1/s1"
2524,15866,2-deoxy-D-glucose,"A deoxyglucose that is D-glucose in which the hydroxy group at position 2 has been replaced by a hydrogen. It is an antimetabolite of glucose with antiviral activity, which acts by inhibiting the glycosylation of glycoproteins and glycolipids. Used as an antiherpes agent.",17633,KEGG COMPOUND accession,C01228,,,,,,,,,,,,,,,
2525,15870,betaine aldehyde hydrate,A quaternary ammonium ion that is the hydrate of betaine aldehyde.,16690,KEGG COMPOUND accession,C04494,,,,,,,,,,,,,,,
2526,15874,N(2)-malonyl-D-tryptophan,a,28072,KEGG COMPOUND accession,C06193,,,,,,,,,,,,,,,
2527,15877,L-lupinate,a,5568,KEGG COMPOUND accession,C06511,,,,,,,,,,,,,,,
2528,15892,S-succinylglutathione,The S-succinoyl derivative of glutathione.,5576,KEGG COMPOUND accession,C10149,,,,,,,,,,,,,,,
2529,15900,"trans-2,3-epoxysuccinic acid","The trans-2,3-epoxy derivative of succinic acid.",5580,KEGG COMPOUND accession,C08950,,,,,,,,,,,,,,,
2530,15902,alpha-D-xylose 1-phosphate,A xylose phosphate that is alpha-D-xylose carrying a phosphate group at position 1.,46707,KEGG COMPOUND accession,C08952,,,,,,,,,,,,,,,
2531,15906,demethylmacrocin,A macrolide antibiotic that is tylonolide having mono- and diglycosyl moieties attached to two of its hydroxy groups..,5583,KEGG COMPOUND accession,C08305,,,,,,,,,,,,,,,
2532,15908,L-threonic acid,The L-enantiomer of threonic acid.,15378,KEGG COMPOUND accession,C00080,h,12408-02-5,15378.0,"Human Metabolome Database (HMDB): Hydrogen ion is recommended by IUPAC as a general term for all ions of hydrogen and its isotopes.  Depending on the charge of the ion, two different classes can be distinguished: positively charged ions and negatively charged ions. Under aqueous conditions found in biochemistry, hydrogen ions exist as the hydrated form hydronium, H3O+, but these are often still referred to as hydrogen ions or even protons by biochemists. [Wikipedia])",Hydrogen Ion,HMDB0059597,b,b,C00080,b,b,h,[H+],GPRLSGONYQIRFK-UHFFFAOYSA-N,InChI=1S/p+1
2533,16213,coformycin,"An N-glycosyl in which (8R)-3,6,7,8-tetrahydroimidazo[4,5-d][1,3]diazepin-8-ol is attached to ribofuranose via a beta-N(3)-glycosidic bond. compound The parent of the class of coformycins.",15377,KEGG COMPOUND accession,C00001,h2o,7732-18-5,15377.0,"Human Metabolome Database (HMDB): Water is a chemical substance that is essential to all known forms of life. It appears colorless to the naked eye in small quantities, though it is actually slightly blue in color. It covers 71% of Earth's surface. Current estimates suggest that there are 1.4 billion cubic kilometers (330 million m3) of it available on Earth, and it exists in many forms. It appears mostly in the oceans (saltwater) and polar ice caps, but it is also present as clouds, rain water, rivers, freshwater aquifers, lakes, and sea ice. Water in these bodies perpetually moves through a cycle of evaporation, precipitation, and runoff to the sea. Clean water is essential to human life. In many parts of the world, it is in short supply. From a biological standpoint, water has many distinct properties that are critical for the proliferation of life that set it apart from other substances. It carries out this role by allowing organic compounds to react in ways that ultimately allow replication. All known forms of life depend on water. Water is vital both as a solvent in which many of the body's solutes dissolve and as an essential part of many metabolic processes within the body. Metabolism is the sum total of anabolism and catabolism. In anabolism, water is removed from molecules (through energy requiring enzymatic chemical reactions) in order to grow larger molecules (e.g. starches, triglycerides and proteins for storage of fuels and information). In catabolism, water is used to break bonds in order to generate smaller molecules (e.g. glucose, fatty acids and amino acids to be used for fuels for energy use or other purposes). Water is thus essential and central to these metabolic processes. Water is also central to photosynthesis and respiration. Photosynthetic cells use the sun's energy to split off water's hydrogen from oxygen. Hydrogen is combined with CO2 (absorbed from air or water) to form glucose and release oxygen. All living cells use such fuels and oxidize the hydrogen and carbon to capture the sun's energy and reform water and CO2 in the process (cellular respiration). Water is also central to acid-base neutrality and enzyme function. An acid, a hydrogen ion (H+, that is, a proton) donor, can be neutralized by a base, a proton acceptor such as hydroxide ion (OH-) to form water. Water is considered to be neutral, with a pH (the negative log of the hydrogen ion concentration) of 7. Acids have pH values less than 7 while bases have values greater than 7. Stomach acid (HCl) is useful to digestion. However, its corrosive effect on the esophagus during reflux can temporarily be neutralized by ingestion of a base such as aluminum hydroxide to produce the neutral molecules water and the salt aluminum chloride. Human biochemistry that involves enzymes usually performs optimally around a biologically neutral pH of 7.4. (Wikipedia).",Water,HMDB0002111,b,b,C00001,b,FDB013390,h2o,[H]O[H],XLYOFNOQVPJJNP-UHFFFAOYSA-N,InChI=1S/H2O/h1H2
2534,17315,D-glucosamine,An amino sugar whose structure comprises D-glucose having an amino substituent at position 2.,16240,KEGG COMPOUND accession,C00027,h2o2,7722-84-1,16240.0,"Human Metabolome Database (HMDB): Hydrogen peroxide (H2O2) is a very pale blue liquid which appears colourless in a dilute solution, slightly more viscous than water. It is a weak acid. It has strong oxidizing properties and is therefore a powerful bleaching agent that is mostly used for bleaching paper, but has also found use as a disinfectant and as an oxidizer. Hydrogen peroxide in the form of carbamide peroxide is widely used for tooth whitening (bleaching), both in professionally- and in self-administered products. Hydrogen peroxide (H2O2) is a well-documented component of living cells. It plays important roles in host defense and oxidative biosynthetic reactions. In addition there is growing evidence that at low levels, H2O2 also functions as a signaling agent, particularly in higher organisms. H2O2 has increasingly been viewed as an important cellular signaling agent in its own right, capable of modulating both contractile and growth-promoting pathways with more far-reaching effects. Due to the accumulation of hydrogen peroxide in the skin of patients with the depigmentation disorder vitiligo, the human epidermis cannot have the normal capacity for autocrine synthesis, transport and degradation of acetylcholine as well as the muscarinic (m1-m5) and nicotinic signal transduction in keratinocytes and melanocytes. Accumulating evidence suggests that hydrogen peroxide (H(2)O(2)) plays an important role in cancer development. Experimental data have shown that cancer cells produce high amounts of H(2)O(2). An increase in the cellular levels of H(2)O(2) has been linked to several key alterations in cancer, including DNA alterations, cell proliferation, apoptosis resistance, metastasis, angiogenesis and hypoxia-inducible factor 1 (HIF-1) activation. (PMID: 17150302, 17335854, 16677071, 16607324, 16514169).",Hydrogen peroxide,HMDB0003125,b,b,C00027,HYDROGEN-PEROXIDE,FDB014562,h2o2,[H]OO[H],MHAJPDPJQMAIIY-UHFFFAOYSA-N,InChI=1S/H2O2/c1-2/h1-2H
2535,17417,N-caffeoylputrescine,a,17544,KEGG COMPOUND accession,C00288,hco3,71-52-3,17544.0,"Human Metabolome Database (HMDB): Bicarbonate, or hydrogen carbonate, is a simple single carbon molecule that plays surprisingly important roles in diverse biological processes. Among these are photosynthesis, the Krebs cycle, whole-body and cellular pH regulation, and volume regulation. Since bicarbonate is charged it is not permeable to lipid bilayers. Mammalian membranes thus contain bicarbonate transport proteins to facilitate the specific transmembrane movement of HCO3(-). Bicarbonate ion is an anion that consists of one central carbon atom surrounded by three oxygen atoms in a trigonal planar arrangement, with a hydrogen atom attached to one of the oxygens. The bicarbonate ion carries a negative one formal charge and is the conjugate base of carbonic acid, H2CO3. The carbonate radical is an elusive and strong one-electron oxidant. Bicarbonate in equilibrium with carbon dioxide constitutes the main physiological buffer. The bicarbonate-carbon dioxide pair stimulates the oxidation, peroxidation and nitration of several biological targets. The demonstration that the carbonate radical existed as an independent species in aqueous solutions at physiological pH and temperature renewed the interest in the pathophysiological roles of this radical and related species. The carbonate radical has been proposed to be a key mediator of the oxidative damage resulting from peroxynitrite production, xanthine oxidase turnover and superoxide dismutase1 peroxidase activity. The carbonate radical has also been proposed to be responsible for the stimulatory effects of the bicarbonate-carbon dioxide pair on oxidations mediated by hydrogen peroxide/transition metal ions. The ultimate precursor of the carbonate radical anion being bicarbonate, carbon dioxide, peroxymonocarbonate or complexes of transition metal ions with bicarbonate-derived species remains a matter of debate. The carbonate radical mediates some of the pathogenic effects of peroxynitrite. The carbonate radical as the oxidant produced from superoxide dismutase (EC 1.15.1.1, SOD1) peroxidase activity. Peroxymonocarbonate is a biological oxidant, whose existence is in equilibrium with hydrogen peroxide and bicarbonate (PMID: 17505962, 17215880). Hydrogen carbonate is found to be associated with hawkinsinuria, which is an inborn error of metabolism.",Hydrogen carbonate,HMDB0000595,b,b,C00288,HCO3,FDB022134,hco3,[H]OC([O-])=O,BVKZGUZCCUSVTD-UHFFFAOYSA-M,"InChI=1S/CH2O3/c2-1(3)4/h(H2,2,3,4)/p-1"
2536,17427,3-hydroxy-L-aspartate residue,An anionic amino-acid residue resulting from the deprotonation of the carboxy group of a 3-hydroxy-L-aspartic acid residue.,17883,KEGG COMPOUND accession,C01327,M02144,7647-01-0,17883.0,"Human Metabolome Database (HMDB): Hydrochloric acid constitutes the majority of gastric acid, the human digestive fluid. In a complex process and at a large energetic burden, it is secreted by parietal cells (also known as oxyntic cells). These cells contain an extensive secretory network (called canaliculi) from which the HCl is secreted into the lumen of the stomach. They are part of the epithelial fundic glands (also known as oxyntic glands) in the stomach. The chemical compound hydrochloric acid is the aqueous (water-based) solution of hydrogen chloride gas (HCl). It is a strong acid, the major component of gastric acid and of wide industrial use. Hydrochloric acid must be handled with appropriate safety precautions because it is a highly corrosive liquid. Hydrochloric acid, or muriatic acid by its historical but still occasionally used name, has been an important and frequently used chemical from early history and was discovered by the alchemist Jabir ibn Hayyan around the year 800. Hydrogen chloride, also known under the name HCl, is a highly corrosive and toxic colorless gas that forms white fumes on contact with humidity. These fumes consist of hydrochloric acid which forms when hydrogen chloride dissolves in water. The hydrogen chloride molecule HCl is a simple diatomic molecule consisting of a hydrogen atom H and a chlorine atom Cl connected with a covalent single bond. Since the chlorine atom is much more electronegative than the hydrogen atom, the covalent bond between the atoms is quite polar. Hydrogen chloride forms corrosive hydrochloric acid on contact with body tissue. Inhalation of the fumes can cause coughing, choking, inflammation of the nose, throat, and upper respiratory tract, and in severe cases, pulmonary edema, circulatory system failure, and death. Skin contact can cause redness, pain, and severe skin burns. Hydrogen chloride may cause severe burns to the eye and permanent eye damage.",Hydrochloric acid,HMDB0002306,b,b,C01327,b,FDB016076,b,Cl[H],VEXZGXHMUGYJMC-UHFFFAOYSA-N,InChI=1S/ClH/h1H
2537,17437,dimethyl sulfide,A methyl sulfide in which the sulfur atom is substituted by two methyl groups. It is produced naturally by some marine algae.,43451,KEGG COMPOUND accession,C05590,M02146,b,43451.0,Human Metabolome Database (HMDB): I(-) is a substrate for: Iodotyrosine dehalogenase 1.,I(-),HMDB0059634,b,b,C05590,b,b,b,I[H],XMBWDFGMSWQBCA-UHFFFAOYSA-N,InChI=1S/HI/h1H
2538,17443,L-homocitrulline,A L-lysine derivative that is L-lysine having a carbamoyl group at the N(6)-position. It is found in individuals with urea cycle disorders.,16234,KEGG COMPOUND accession,C01328,oh1,14280-30-9,16234.0,"Human Metabolome Database (HMDB): In chemistry, hydroxide is the most common name for the diatomic anion OH, consisting of oxygen and hydrogen atoms, usually derived from the dissociation of a base. It is one of the simplest diatomic ions known. Hydroxide ion is a kind of ligand. It donates one pair of electrons, behaving as a Lewis base. Examples include the aluminate ion [Al(OH)4]- and aurate ion [Au(OH)4]-.",Hydroxide,HMDB0001039,b,b,C01328,NH4OH,FDB022386,oh1,[O-][H],XLYOFNOQVPJJNP-UHFFFAOYSA-M,InChI=1S/H2O/h1H2/p-1
2539,17450,cis-4-coumaric acid,The cis-form of 4-coumaric acid.,17137,KEGG COMPOUND accession,C11481,,,,,,,,,,,,,,,
2540,17458,N-methyltyramine,a,5601,KEGG COMPOUND accession,C09931,,,,,,,,,,,,,,,
2541,17466,GDP-D-mannuronate,A nucleotide-sugar oxoanion obtained by deprotonation of the diphosphate OH groups of GDP-D-mannuronic acid; major species at pH 7.3.,16042,KEGG COMPOUND accession,C00462,,,,,,,,,,,,,,,
2542,17472,"1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine N-oxide",a,5607,KEGG COMPOUND accession,C09105,,,,,,,,,,,,,,,
2543,17474,estrone 3-sulfate,A steroid sulfate that is the 3-sulfate of estrone.,16277,KEGG COMPOUND accession,C01812,,,,,,,,,,,,,,,
2544,17477,uracil-5-carboxylic acid,A pyrimidinemonocarboxylic acid that is uracil carrying a carboxy group at position 5.,5610,KEGG COMPOUND accession,C01706,,,,,,,,,,,,,,,
2545,17485,homocystine,An organic disulfide obtained by oxidative dimerisation of homocysteine.,5615,KEGG COMPOUND accession,C07515,,,,,,,,,,,,,,,
2546,17497,glycolic acid,A 2-hydroxy monocarboxylic acid that is acetic acid where the methyl group has been hydroxylated.,28172,KEGG COMPOUND accession,C06536,,,,,,,,,,,,,,,
2547,17499,hydrogen donor,A molecular entity that can undergo oxidation by the loss of hydrogen atom(s).,27943,KEGG COMPOUND accession,C06537,,,,,,,,,,,,,,,
2548,17501,"3,3'-dimethoxystilbene-4,4'-diol",a,5623,KEGG COMPOUND accession,C09209,C09209,486-84-0,5623.0,"Human Metabolome Database (HMDB): Harman is found in chicory. Harman is an alkaloid from the may pop (Passiflora incarnata, Passifloraceae) and many other Passiflora sp",Harman,HMDB0035196,b,b,C09209,CPD66-92,FDB013842,b,[H]N1C2=C(C([H])=C([H])C([H])=C2[H])C2=C1C(=NC([H])=C2[H])C([H])([H])[H],PSFDQSOCUJVVGF-UHFFFAOYSA-N,"InChI=1S/C12H10N2/c1-8-12-10(6-7-13-8)9-4-2-3-5-11(9)14-12/h2-7,14H,1H3"
2549,17503,N-acyl-D-glutamates(2-),A doubly-charged N-acyl-D-alpha-amino acid anion resulting from removal of protons from both carboxy groups of any N-acyl-D-glutamic acid.,28121,KEGG COMPOUND accession,C06538,,,,,,,,,,,,,,,
2550,17521,(-)-quinic acid,The (-)-enantiomer of quinic acid.,5634,KEGG COMPOUND accession,C08953,,,,,,,,,,,,,,,
2551,17529,kievitone hydrate,"A hydroxyisoflavanone that is isoflavanone substituted by hydroxy groups at positions 5, 7, 2' and 4' and  a 3-hydroxy-3-methylbutyl group at position 8.",5638,KEGG COMPOUND accession,C09474,,,,,,,,,,,,,,,
2552,17535,L-arabinopyranose,The six-membered ring form of L-arabinose.,5641,KEGG COMPOUND accession,C10319,,,,,,,,,,,,,,,
2553,17543,1-phospho-alpha-D-galacturonic acid,An uronic acid phosphate that is alpha-D-galacturonic acid carrying a phosphate group at position 1.,28271,KEGG COMPOUND accession,C08868,,,,,,,,,,,,,,,
2554,17551,ecdysone palmitate,a,5649,KEGG COMPOUND accession,C09679,,,,,,,,,,,,,,,
2555,17555,1-alkyl-2-acetyl-sn-glycerol 3-phosphate,a,17627,KEGG COMPOUND accession,C00032,pheme,14875-96-8,17627.0,"Human Metabolome Database (HMDB): Heme is the color-furnishing portion of hemoglobin. It is found free in tissues and as the prosthetic group in many hemeproteins. A heme or haem is a prosthetic group that consists of an iron atom contained in the center of a large heterocyclic organic ring called a porphyrin. Not all porphyrins contain iron, but a substantial fraction of porphyrin-containing metalloproteins have heme as their prosthetic subunit; these are known as hemoproteins.",Heme,HMDB0003178,b,b,C00032,HEME_A,FDB016272,pheme,[H]C([H])=C([H])C1=C(C2=C([H])C3=[N+]4C(=C([H])C5=C(C(=C6C([H])=C7C(C([H])=C([H])[H])=C(C8=[N+]7[Fe--]4(N2C1=C8[H])N56)C([H])([H])[H])C([H])([H])[H])C([H])([H])C([H])([H])C([O-])=O)C(=C3C([H])([H])[H])C([H])([H])C([H])([H])C([O-])=O)C([H])([H])[H],KABFMIBPWCXCRK-RGGAHWMASA-J,"InChI=1S/C34H34N4O4.Fe/c1-7-21-17(3)25-13-26-19(5)23(9-11-33(39)40)31(37-26)16-32-24(10-12-34(41)42)20(6)28(38-32)15-30-22(8-2)18(4)27(36-30)14-29(21)35-25;/h7-8,13-16H,1-2,9-12H2,3-6H3,(H4,35,36,37,38,39,40,41,42);/q;+2/p-4/b25-13-,26-13-,27-14-,28-15-,29-14-,30-15-,31-16-,32-16-;"
2556,17560,"2,2'-iminodipropanoate",a,36073,KEGG COMPOUND accession,C05009,,,,,,,,,,,,,,,
2557,17568,uracil,"A common and naturally occurring pyrimidine nucleobase in which the pyrimidine ring is substituted with two oxo groups at positions 2 and 4. Found in RNA, it base pairs with adenine and replaces thymine during DNA transcription.",27640,KEGG COMPOUND accession,C08378,,,,,,,,,,,,,,,
2558,17572,5-amino-2-oxopentanoate,a,5659,KEGG COMPOUND accession,C08376,,,,,,,,,,,,,,,
2559,17574,biochanin A,"A member of the class of 7-hydroxyisoflavones that is 7-hydroxyisoflavone which is substituted by an additional hydroxy group at position 5 and a methoxy group at position 4'. A phytoestrogen, it has putative benefits in dietary cancer prophylaxis.",5660,KEGG COMPOUND accession,C08377,,,,,,,,,,,,,,,
2560,17576,(3R)-3-hydroxy-L-aspartic acid,a,28815,KEGG COMPOUND accession,C00925,hs,9050-30-0,b,"Human Metabolome Database (HMDB): Heparan sulfate is a heteropolysaccharide that is similar in structure to heparin. It accumulates in individuals with mucopolysaccharidosis. Heparan sulfate (HS) is a linear polysaccharide found in all animal tissues. It occurs as a proteoglycan (PG) in which two or three HS chains are attached in close proximity to cell suface or extracellular matrix proteins.[1][2] It is in this form that HS binds to a variety of protein ligands and regulates a wide variety of biological activities, including developmental processes, angiogenesis, blood coagulation and tumour metastasis. (Wikipedia).",Heparan sulfate,HMDB0000693,b,b,C00925,CPD-7177,FDB022184,hs,[H]O[C@@]1([H])[C@]([H])(O-*)[C@@]([H])(O[C@@]([H])(O[C@@]2([H])[C@]([H])(O[H])[C@@]([H])(N([H])S([O-])(=O)=O)[C@@]([H])(OC([H])([H])[H])O[C@]2([H])C([H])([H])OS([O-])(=O)=O)[C@]1([H])OS([O-])(=O)=O)C([O-])=O,WKPUACLQLIIVJJ-RHKLHVFKSA-M,b
2561,17578,toluene,The simplest member of the class toluenes consisting of a benzene core which bears a single methyl substituent.,17421,KEGG COMPOUND accession,C04649,,,,,,,,,,,,,,,
2562,17580,linalool,"A monoterpenoid that is octa-1,6-diene substituted by methyl groups at positions 3 and 7 and a hydroxy group at position 3. It has been isolated from plants like Ocimum canum.",18137,KEGG COMPOUND accession,C04384,,,,,,,,,,,,,,,
2563,17593,maltooligosaccharide,"A glucooligosaccharide derived from glucose monomers linked via alpha-D-1,4 bonds as in maltose.  The term is commonly applied to the series of linear oligosaccharides composed of two, three, four, five and six such units of glucose.",17831,KEGG COMPOUND accession,C04196,,,,,,,,,,,,,,,
2564,17598,"phorbol 12,13-dibutanoate",a,16148,KEGG COMPOUND accession,C01816,,,,,,,,,,,,,,,
2565,17601,"6,7-dimethyl-8-(1-D-ribityl)lumazine",The pteridine that is lumazine substituted with methyl groups at C-6 and -7 and with a 1-D-ribityl group on N-8.,5672,KEGG COMPOUND accession,C08380,,,,,,,,,,,,,,,
2566,17604,N(6)-methyl-L-lysine,An L-lysine derivative that is L-lysine in which one of the hydrogens attached to N(6) is substituted by a methyl group.,5674,KEGG COMPOUND accession,C11225,,,,,,,,,,,,,,,
2567,17613,all-trans-heptaprenyl diphosphate,An all-trans-polyprenyl diphosphate composed from seven isoprenyl units.,5679,KEGG COMPOUND accession,C09268,,,,,,,,,,,,,,,
2568,17615,"1,2-diacyl-3-beta-D-galactosyl-sn-glycerol","A class of galactoglycerolipids that consists of any 1,2-diacyl-sn-glycerol having a beta-D-galactosyl residue attached at position 3.",27808,KEGG COMPOUND accession,C06534,,,,,,,,,,,,,,,
2569,17617,L-fuculose,A a deoxyketohexose comprising L-tagatose with the hydroxy group at position 6 replaced by hydrogen.,28230,KEGG COMPOUND accession,C01709,,,,,,,,,,,,,,,
2570,17619,4-(3-methylbut-2-enyl)-L-tryptophan,a,28775,KEGG COMPOUND accession,C09755,,,,,,,,,,,,,,,
2571,17621,FMN,A flavin mononucleotide that is riboflavin (vitamin B2) in which the primary hydroxy group has been converted to its dihydrogen phosphate ester.,5683,KEGG COMPOUND accession,C11729,,,,,,,,,,,,,,,
2572,17630,kanamycin A,a,16966,KEGG COMPOUND accession,C01923,,,,,,,,,,,,,,,
2573,17640,3-(indol-3-yl)pyruvate,A indol-3-yl carboxylic acid anion that is the conjugate base of 3-(indol-3-yl)pyruvic acid,5693,KEGG COMPOUND accession,C08039,,,,,,,,,,,,,,,
2574,17642,pentachlorophenol,A  chlorophenol that is phenol substituted by 5 chloro groups.,28415,KEGG COMPOUND accession,C08381,,,,,,,,,,,,,,,
2575,17652,3-hydroxy-L-glutamate(2-),A doubly-charged L-alpha-amino acid anion resulting from deprotonation of both carboxy groups of 3-hydroxy-L-glutamic acid.,16125,KEGG COMPOUND accession,C00823,M02114,36653-82-4,16125.0,"Human Metabolome Database (HMDB): Cetyl alcohol, also known as 1-hexadecanol and palmityl alcohol, is a solid organic compound and a member of the alcohol class of compounds. Its chemical formula is CH3(CH2)15OH. At room temperature, cetyl alcohol takes the form of a waxy white solid or flakes. It belongs to the group of fatty alcohols. With the demise of commercial whaling, cetyl alcohol is no longer primarily produced from whale oil, but instead either as an end-product of the petroleum industry, or produced from vegetable oils such as palm oil and coconut oil. Production of cetyl alcohol from palm oil gives rise to one of its alternative names, palmityl alcohol.",1-Hexadecanol,HMDB0003424,b,b,C00823,CPD-348,FDB003051,b,[H]OC([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H],BXWNKGSJHAJOGX-UHFFFAOYSA-N,"InChI=1S/C16H34O/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17/h17H,2-16H2,1H3"
2576,17656,(R)-mandelic acid,The (R)-enantiomer of mandelic acid.,5697,KEGG COMPOUND accession,C05764,palmACP,b,b,b,Palmitoyl-ACP (N-C16:0ACP),b,b,b,C05764,b,b,b,[H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C(=O)S[*],b,b
2577,17668,ribonucleoside diphosphat,a,30776,KEGG COMPOUND accession,C01585,,,,,,,,,,,,,,,
2578,17671,"5-(L-alanin-3-yl)-2-hydroxy-cis,cis-muconate 6-semialdehyde",a,27540,KEGG COMPOUND accession,C05270,hxcoa,5060-32-2,27540.0,Human Metabolome Database (HMDB): Fatty acid coenzyme A derivative that can be involved in the biosynthesis and oxidation of fatty acids as well as in ceramide formation.,Hexanoyl-CoA,HMDB0002845,b,b,C05270,1-CARBOXYCYCLOHEXANOYL-COA,FDB023074,hxcoa,[H]O[C@@]([H])(C(=O)N([H])C([H])([H])C([H])([H])C(=O)N([H])C([H])([H])C([H])([H])SC(=O)C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H])C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])OP([O-])(=O)OP([O-])(=O)OC([H])([H])[C@@]1([H])O[C@@]([H])(N2C([H])=NC3=C2N=C([H])N=C3N([H])[H])[C@]([H])(O[H])[C@]1([H])OP([O-])([O-])=O,OEXFMSFODMQEPE-HDRQGHTBSA-J,"InChI=1S/C27H46N7O17P3S/c1-4-5-6-7-18(36)55-11-10-29-17(35)8-9-30-25(39)22(38)27(2,3)13-48-54(45,46)51-53(43,44)47-12-16-21(50-52(40,41)42)20(37)26(49-16)34-15-33-19-23(28)31-14-32-24(19)34/h14-16,20-22,26,37-38H,4-13H2,1-3H3,(H,29,35)(H,30,39)(H,43,44)(H,45,46)(H2,28,31,32)(H2,40,41,42)/p-4/t16-,20-,21-,22+,26-/m1/s1"
2579,17698,chloramphenicol,"An organochlorine compound that is dichloro-substituted acetamide containing a nitrobenzene ring, an amide bond and two alcohol functions.",5712,KEGG COMPOUND accession,C08306,,,,,,,,,,,,,,,
2580,17700,undecan-2-one,A dialkyl ketone with methyl and nonyl as the two alkyl groups.,16170,KEGG COMPOUND accession,C01319,,,,,,,,,,,,,,,
2581,17703,26-hydroxycholesterol,An oxysterol that is cholesterol substituted at position 26 by a hydroxy group.,16793,KEGG COMPOUND accession,C00703,,,,,,,,,,,,,,,
2582,17712,9H-xanthine,An oxopurine in which the purine ring is substituted by oxo groups at positions 2 and 6 and N-9 is protonated.,5719,KEGG COMPOUND accession,C09682,,,,,,,,,,,,,,,
2583,17714,ferrocytochrome c3,a,5720,KEGG COMPOUND accession,C10598,,,,,,,,,,,,,,,
2584,17716,lactose,"A glycosylglucose disaccharide, found most notably in milk, that consists of D-galactose and D-glucose fragments bonded through a beta-1->4 glycosidic linkage. The glucose fragment can be in either the alpha- or beta-pyranose form, whereas the galactose fragment can only have the beta-pyranose form.",5721,KEGG COMPOUND accession,C10057,,,,,,,,,,,,,,,
2585,17721,"(S,S,S)-nicotianamine","The (S,S,S)-stereoisomer of  nicotianamine.",5724,KEGG COMPOUND accession,C08528,,,,,,,,,,,,,,,
2586,17723,"beta-D-galactosyl-1,3-(N-acetyl-D-glucosaminyl-1,6)-N-acetyl-D-galactosaminyl group","An N-acetyl-D-galactosaminyl group obtained by removing the hydroxy group from the hemiacetal function of beta-D-galactosyl-1,3-(N-acetyl-D-glucosaminyl-1,6)-N-acetyl-D-galactosamine",18089,KEGG COMPOUND accession,C01586,bgly,495-69-2,18089.0,"Human Metabolome Database (HMDB): Hippuric acid is an acyl glycine formed by the conjugation of benzoic aicd with glycine. Acyl glycines are produced through the action of glycine N-acyltransferase (EC 2.3.1.13) which is an enzyme that catalyzes the chemical reaction: acyl-CoA + glycine < -- > CoA + N-acylglycine. Hippuric acid is a normal component of urine and is typically increased with increased consumption of phenolic compounds (tea, wine, fruit juices). These phenols are converted to benzoic acid which is then converted to hippuric acid and excreted in the urine. Hippuric acid is the most frequently used biomarker in the biological monitoring of occupational exposure to toluene. This product of solvent biotransformation may be also found in the urine of individuals who have not been exposed to the solvent. A smaller fraction of the absorbed toluene is oxidized to aromatic compounds including ortho-cresol, which is not found significantly in the urine of nonexposed individuals. The concentration of hippuric acid in the urine of individuals exposed to a low toluene concentration does not differ from that of individuals not exposed to the solvent. This has led to the conclusion that hippuric acid should not be utilized in the biological monitoring of occupational exposure to low levels of toluene in the air. Protein-bound organic acids such as hippuric acid are markedly accumulated in uremic plasma and produce defective protein binding of drugs (PMID: 9120876, 8734460). Hippuric acid is found to be associated with phenylketonuria, propionic acidemia, and tyrosinemia I, which are inborn errors of metabolism.",Hippuric acid,HMDB0000714,b,b,C01586,b,FDB001819,bgly,[H]N(C(=O)C1=C([H])C([H])=C([H])C([H])=C1[H])C([H])([H])C([O-])=O,QIAFMBKCNZACKA-UHFFFAOYSA-M,"InChI=1S/C9H9NO3/c11-8(12)6-10-9(13)7-4-2-1-3-5-7/h1-5H,6H2,(H,10,13)(H,11,12)/p-1"
2587,17723,"beta-D-galactosyl-1,3-(N-acetyl-D-glucosaminyl-1,6)-N-acetyl-D-galactosaminyl group","An N-acetyl-D-galactosaminyl group obtained by removing the hydroxy group from the hemiacetal function of beta-D-galactosyl-1,3-(N-acetyl-D-glucosaminyl-1,6)-N-acetyl-D-galactosamine",18089,KEGG COMPOUND accession,C01586,CE2934,42013-20-7,613303.0,"Human Metabolome Database (HMDB): Methylhippuric acid is an acyl glycine. Acyl glycines are normally minor metabolites of fatty acids. However, the excretion of certain acyl glycines is increased in several inborn errors of metabolism. In certain cases the measurement of these metabolites in body fluids can be used to diagnose disorders associated with mitochondrial fatty acid beta-oxidation. Acyl glycines are produced through the action of glycine N-acyltransferase (EC 2.3.1.13) which is an enzyme that catalyzes the chemical reaction:. acyl-CoA + glycine < -- > CoA + N-acylglycine. Methylhippuric acid is a metabolite of xylene which is an aromatic hydrocarbon widely used as a solvant. It's level can be measured in urine of workers exposed to xylene (PMID 8689499).",2-Methylhippuric acid,HMDB0011723,b,b,C01586,b,FDB028406,CE2934,[H]OC(=O)C([H])([H])N([H])C(=O)C1=C([H])C([H])=C([H])C([H])=C1C([H])([H])[H],YOEBAVRJHRCKRE-UHFFFAOYSA-N,"InChI=1S/C10H11NO3/c1-7-4-2-3-5-8(7)10(14)11-6-9(12)13/h2-5H,6H2,1H3,(H,11,14)(H,12,13)"
2588,17733,aldehydo-D-galactose 6-phosphate,The ring-opened aldehydo-form of D-galactose 6-phosphate.,5729,KEGG COMPOUND accession,C05010,,,,,,,,,,,,,,,
2589,17735,"N,N-dimethylaniline N-oxide","A member of the class of dimethylanilines that is N,N-dimethylaniline in which the tertiary amino group has been oxidised to give the corresponding N-oxide.",5730,KEGG COMPOUND accession,C10425,,,,,,,,,,,,,,,
2590,17737,desmosterol,"A cholestanoid that is cholesta-5,24-diene substituted by a beta-hydroxy group at position 3. It is an intermediate metabolite obtained during the synthesis of cholesterol.",5731,KEGG COMPOUND accession,C08644,,,,,,,,,,,,,,,
2591,17739,N-tetradecanoylglycylpeptide,A lipopeptide formed by substitution of the amino terminal hydrogen of a glycylpeptide by a tetradecanoyl group.,75902,KEGG COMPOUND accession,C10058,,,,,,,,,,,,,,,
2592,17741,"N,N-dimethylformamide",A member of the class of formamides that is formamide in which the amino hydrogens are replaced by methyl groups.,27570,KEGG COMPOUND accession,C00768,,,,,,,,,,,,,,,
2593,17742,4-hydroxy-2-oxoglutarate(2-),An oxo dicarboxylate obtained by deprotonation of both carboxy groups of 4-hydroxy-2-oxoglutaric acid.,15358,KEGG COMPOUND accession,C01429,,,,,,,,,,,,,,,
2594,17759,"cholesta-5,7-dien-3beta-ol",a,51232,KEGG COMPOUND accession,C11189,,,,,,,,,,,,,,,
2595,17766,"cyclohexane-1,3-dione",A cyclohexanedione carrying oxo substituents at positions 1 and 3.,18070,KEGG COMPOUND accession,C02416,,,,,,,,,,,,,,,
2596,17781,lumichrome,"A compound showing blue fluorescence, formed by a photolysis of riboflavin in acid or neutral solution.",17485,KEGG COMPOUND accession,C01817,Lhcystin,b,17485.0,"Human Metabolome Database (HMDB): Homocystine is the double-bonded form of homocysteine, but it occurs only transiently before being converted to the harmless cystathionine via a vitamin B6-dependent enzyme. Homocystine and homocysteine-cysteine mixed disulfide account for >98% of total homocysteine in plasma from healthy individuals (PMID 11592966). Oxidation of low-density lipoprotein (LDL) is thought to be a major factor in the pathophysiology of atherosclerosis. Elevated plasma homocysteine is an accepted risk factor for atherosclerosis, and may act through LDL oxidation, although this is controversial. However, the major thiol in plasma is cysteine, which is present at concentrations approximately 10 times greater than homocysteine; therefore homocystine in plasma is insignificant, and consequently homocystine is unlikely to influence LDL oxidation in vivo (PMID 14732479). Increasing evidence supports a role for an elevation of homocysteine in schizophrenia. It has been demonstrated that neural tube defects are related to a genetic defect in homocysteine metabolism. Sufficient intake of folic acid is believed to reduce this risk by enhancing methylation of homocysteine and its conversion to methionine, thereby compensating for this genetic defect (homocystinuria). Plasma homocysteine levels are elevated when folate levels are in the lower half of the normal range (PMID 16143442).",L-Homocystine,HMDB0000676,b,b,C01817,b,FDB022176,Lhcystin,[H]OC(=O)C([H])(N([H])[H])C([H])([H])C([H])([H])SSC([H])([H])C([H])([H])[C@]([H])(N([H])[H])C(=O)O[H],ZTVZLYBCZNMWCF-ZBHICJROSA-N,"InChI=1S/C8H16N2O4S2/c9-5(7(11)12)1-3-15-16-4-2-6(10)8(13)14/h5-6H,1-4,9-10H2,(H,11,12)(H,13,14)/t5-,6?/m0/s1"
2597,17784,2-amino-2-deoxy-D-gluconic acid,"Hexanoic acid with four hydroxy groups at C-3, C-4, C-5, C-6, and an amino group at C-2.",74960,KEGG COMPOUND accession,C09756,,,,,,,,,,,,,,,
2598,17786,N-acetyl-L-leucine,The N-acetyl derivative of L-leucine.,5754,KEGG COMPOUND accession,C10457,,,,,,,,,,,,,,,
2599,17794,3-phospho-D-glyceric acid,The D-enantiomer of 3-phosphoglyceric acid,30903,KEGG COMPOUND accession,C05662,,,,,,,,,,,,,,,
2600,17798,L-gamma-glutamyl phosphate,a,5757,KEGG COMPOUND accession,C08283,,,,,,,,,,,,,,,
2601,17800,O-phosphoviomycin,A derivative of viomycin having a phospho group attached to the side-chain OH group of one of the serine residues.,545959,KEGG COMPOUND accession,C05582,homoval,306-08-1,545959.0,"Human Metabolome Database (HMDB): Homovanillic acid is a dopamine metabolite occurring in human biofluids. A high proportion of patients with neuroblastoma excrete increased amounts of it in their urine. Homovanillic acid is a major catecholamine metabolite. It is used as a reagent to detect oxidative enzymes (Wikipedia). Homovanillic acid is found to be associated with aromatic L-amino acid decarboxylase deficiency, celiac disease, growth hormone deficiency, and sepiapterin reductase deficiency, which are inborn errors of metabolism.",Homovanillic acid,HMDB0000118,b,b,C05582,b,FDB001783,homoval,[H]OC1=C([H])C([H])=C(C([H])=C1OC([H])([H])[H])C([H])([H])C([O-])=O,QRMZSPFSDQBLIX-UHFFFAOYSA-M,"InChI=1S/C9H10O4/c1-13-8-4-6(5-9(11)12)2-3-7(8)10/h2-4,10H,5H2,1H3,(H,11,12)/p-1"
2602,17806,N-acetyl-beta-D-galactosaminyl group,The glycosyl group obtained by removing the hydroxy group from the hemiacetal function of N-acetyl-beta-D-galactosamine.,5760,KEGG COMPOUND accession,C08627,,,,,,,,,,,,,,,
2603,17808,IDP,A purine ribonucleoside 5'-diphosphate having inosine as the nucleobase.,51963,KEGG COMPOUND accession,C06084,,,,,,,,,,,,,,,
2604,17811,"2,4,6/3,5-pentahydroxycyclohexanone",a,5763,KEGG COMPOUND accession,C08308,,,,,,,,,,,,,,,
2605,17813,"4,4-dimethyl-5alpha-cholesta-8,14,24-trien-3beta-ol",a,5764,KEGG COMPOUND accession,C06199,C06199,539-15-1,5764.0,"Human Metabolome Database (HMDB): Hordenine is a potent phenylethylamine alkaloid with antibacterial and antibiotic properties produced in nature by several varieties of plants in the family Cactacea. The major source of hordenine in humans is beer brewed from barley. Hordenine in urine interferes with tests for morphine, heroin and other opioid drugs. Hordenine is a biomarker for the consumption of beer",Hordenine,HMDB0004366,b,b,C06199,b,FDB012750,b,[H]OC1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])C([H])([H])[N+]([H])(C([H])([H])[H])C([H])([H])[H],KUBCEEMXQZUPDQ-UHFFFAOYSA-O,"InChI=1S/C10H15NO/c1-11(2)8-7-9-3-5-10(12)6-4-9/h3-6,12H,7-8H2,1-2H3/p+1"
2606,17821,thymine,A pyrimidine nucleobase that is uracil in which the hydrogen at position 5 is replaced by a methyl group.,5769,KEGG COMPOUND accession,C10695,,,,,,,,,,,,,,,
2607,17827,methyl-CoM,a,16336,KEGG COMPOUND accession,C00518,ha,9004-61-9,b,"Human Metabolome Database (HMDB): Hyaluronic acid (HA), is the most abundant glycosaminoglycan (GAG) in mammalian tissue. It is present in high concentrations in connective tissue, such as skin, vitreous humor, cartilage, and umbilical cord, but the largest single reservoir is the synovial fluid (SF) of the diarthrodial joints, where concentrations of 0.5-4 mg/mL are achieved. Hyaluronic acid, is the major hydrodynamic nonprotein component of joint SF. Its unique viscoelastic properties confer remarkable shock absorbing and lubricating abilities to SF, while its enormous macromolecular size and hydrophilicity serve to retain fluid in the joint cavity during articulation. HA restricts the entry of large plasma proteins and cells into SF but facilitates solute exchange between the synovial capillaries and cartilage and other joint tissues. In addition, HA can form a pericellular coat around cells, interact with proinflammatory mediators, and bind to cell receptors, such as cluster determinant (CD)44 and receptor for hyaluronate-mediated motility (RHAMM), where it modulates cell proliferation, migration, and gene expression. All these physicochemical and biologic properties of HA have been shown to be molecular weight (MW) dependent. The diverse physicochemical properties of HA arise from its unique macromolecular structure. The HA is an exceptionally long (3-30 &#956;m) and unbranched nonsulfated GAG composed of repeating disaccharide units of N-acetylglucosamine, and glucuronic acid glycosidically linked through their respective 1-4 ring positions. Hydroxyl group oxygens at the glucuronyl-1 and glucosamine 3-positions are used for further polymerization of the HA disaccharide units to form chains that, when released from the cell plasma membrane, are of variable length and thus polydispersity. Despite the simplicity of the HA primary structure, this linear polyelectrolyte adopts complex conformations in solution, which engender it with diverse biologic properties. Within the joint cavity, HA molecules are predominately synthesized by the type B synovial cells. (PMID 12219318).",Hyaluronic acid,HMDB0002061,b,b,C00518,b,FDB022824,ha,[Na+].[H]OC(=O)[C@@]1([H])O[C@@]([H])(O[C@@]2([H])[C@]([H])(O[H])[C@]([H])(O[C@@]([H])(O[C@]3([H])[C@]([H])(O[C@@]([H])(O[C@@]4([H])[C@]([H])(O[H])[C@]([H])(O[C@@]([H])(O[H])[C@]4([H])N=C(O[H])C([H])([H])[H])C([H])([H])O[H])[C@]([H])(O[H])[C@@]3([H])O[H])C(=O)O[H])[C@]2([H])N=C(O[H])C([H])([H])[H])C([H])([H])O[H])[C@]([H])(O[H])[C@@]([H])(O[H])[C@]1([H])O[H],YWIVKILSMZOHHF-QJZPQSOGSA-N,"InChI=1S/C28H44N2O23.Na/c1-5(33)29-9-18(11(35)7(3-31)47-25(9)46)49-28-17(41)15(39)20(22(53-28)24(44)45)51-26-10(30-6(2)34)19(12(36)8(4-32)48-26)50-27-16(40)13(37)14(38)21(52-27)23(42)43;/h7-22,25-28,31-32,35-41,46H,3-4H2,1-2H3,(H,29,33)(H,30,34)(H,42,43)(H,44,45);/q;+1/t7-,8-,9-,10-,11-,12-,13+,14+,15-,16-,17-,18-,19-,20+,21+,22+,25-,26+,27-,28-;/m1./s1"
2608,17831,heparosan-N-sulfate D-glucuronic acid,A heparan sulfate composed of a backbone of repeating beta-D-glucuronosyl-(1->4)-N-sulfonyl-alpha-D-glucosamine units joined by (1->4)-linkages.,27612,KEGG COMPOUND accession,C05146,,,,,,,,,,,,,,,
2609,17833,gentamycin,Any of a group of aminoglycoside antibiotics produced by fermentation of some Micromonospora spp.,28297,KEGG COMPOUND accession,C05565,,,,,,,,,,,,,,,
2610,17836,4-aminobenzoate,An  aromatic amino-acid anion that is the conjugate base of 4-aminobenzoic acid.,5776,KEGG COMPOUND accession,C10262,,,,,,,,,,,,,,,
2611,17838,(3S)-3-hydroxy-L-aspartate(2-),a,15571,KEGG COMPOUND accession,C05361,,,,,,,,,,,,,,,
2612,17843,transfer RNA,"A single-stranded RNA molecule containing about 70-90 nucleotides, folded by intrastrand base pairing into a characteristic secondary ('cloverleaf') structure that carries a specific amino acid and matches it to its corresponding codon on an mRNA during protein synthesis.",5779,KEGG COMPOUND accession,C08024,,,,,,,,,,,,,,,
2613,17853,S-acetylcysteamine,a,5784,KEGG COMPOUND accession,C07763,,,,,,,,,,,,,,,
2614,17855,triglyceride,"Any glyceride resulting from the condensation of all three hydroxy groups of glycerol (propane-1,2,3-triol) with fatty acids.",18276,KEGG COMPOUND accession,C00282,h2,1333-74-0,18276.0,"Human Metabolome Database (HMDB): Hydrogen is a colorless, odorless, nonmetallic, tasteless, highly flammable diatomic gas with the molecular formula H2. With an atomic weight of 1.00794, hydrogen is the lightest element. Besides the common H1 isotope, hydrogen exists as the stable isotope Deuterium and the unstable, radioactive isotope Tritium. Hydrogen is the most abundant of the chemical elements, constituting roughly 75% of the universe's elemental mass. Hydrogen can form compounds with most elements and is present in water and most organic compounds. It plays a particularly important role in acid-base chemistry, in which many reactions involve the exchange of protons between soluble molecules. Oxidation of hydrogen, in the sense of removing its electron, formally gives H+, containing no electrons and a nucleus which is usually composed of one proton. That is why H+ is often called a proton. This species is central to discussion of acids. Under the Bronsted-Lowry theory, acids are proton donors, while bases are proton acceptors. A bare proton H+ cannot exist in solution because of its strong tendency to attach itself to atoms or molecules with electrons. However, the term 'proton' is used loosely to refer to positively charged or cationic hydrogen, denoted H+. H2 is a product of some types of anaerobic metabolism and is produced by several microorganisms, usually via reactions catalyzed by iron- or nickel-containing enzymes called hydrogenases. These enzymes catalyze the reversible redox reaction between H2 and its component two protons and two electrons. Creation of hydrogen gas occurs in the transfer of reducing equivalents produced during pyruvate fermentation to water.",Hydrogen,HMDB0001362,b,b,C00282,HYDROGEN-MOLECULE,FDB016247,b,[H][H],UFHFLCQGNIYNRP-UHFFFAOYSA-N,InChI=1S/H2/h1H
2615,17865,4-methyl-2-oxopentanoate,A 2-oxo monocarboxylic acid anion that is the conjugate base of 4-methyl-2-oxopentanoic acid.,18407,KEGG COMPOUND accession,C01326,cyan,74-90-8,18407.0,"Human Metabolome Database (HMDB): Hydrogen cyanide (with the historical common name of Prussic acid) is a chemical compound with chemical formula HCN. It is a colorless, extremely poisonous liquid that boils slightly above room temperature at 26 C (79F). Hydrogen cyanide is a linear molecule, with a triple bond between carbon and nitrogen. A minor tautomer of HCN is HNC, hydrogen isocyanide. Hydrogen cyanide is weakly acidic with a pKa of 9.2. It partly ionizes in water solution to give the cyanide anion, CN. (Wikipedia)",Hydrogen cyanide,HMDB0060292,b,b,C01326,HCN,b,cyan,[H]C#N,LELOWRISYMNNSU-UHFFFAOYSA-N,InChI=1S/CHN/c1-2/h1H
2616,17875,"quercetin 3,3'-bissulfate",A quercetin bissulfate having sulfo groups at positions 3 and 3'.,16136,KEGG COMPOUND accession,C00283,HC00250,b,16136.0,"Human Metabolome Database (HMDB): Hydrogen sulfide is a highly toxic and flammable gas. Because it is heavier than air it tends to accumulate at the bottom of poorly ventilated spaces. Although very pungent at first, it quickly deadens the sense of smell, so potential victims may be unaware of its presence until it is too late. H2S arises from virtually anywhere where elemental sulfur comes into contact with organic material, especially at high temperatures. Hydrogen sulfide is a covalent hydride chemically related to water (H2O) since oxygen and sulfur occur in the same periodic table group. It often results when bacteria break down organic matter in the absence of oxygen, such as in swamps, and sewers (alongside the process of anaerobic digestion). It also occurs in volcanic gases, natural gas and some well waters. It is also important to note that Hydrogen sulfide is a central participant in the sulfur cycle, the biogeochemical cycle of sulfur on Earth. As mentioned above, sulfur-reducing and sulfate-reducing bacteria derive energy from oxidizing hydrogen or organic molecules in the absence of oxygen by reducing sulfur or sulfate to hydrogen sulfide. Other bacteria liberate hydrogen sulfide from sulfur-containing amino acids. Several groups of bacteria can use hydrogen sulfide as fuel, oxidizing it to elemental sulfur or to sulfate by using oxygen or nitrate as oxidant. The purple sulfur bacteria and the green sulfur bacteria use hydrogen sulfide as electron donor in photosynthesis, thereby producing elemental sulfur. (In fact, this mode of photosynthesis is older than the mode of cyanobacteria, algae and plants which uses water as electron donor and liberates oxygen).",Hydrogen sulfide,HMDB0003276,b,b,C00283,HS,FDB009599,HC00250,[S-][H],RWSOTUBLDIXVET-UHFFFAOYSA-M,InChI=1S/H2S/h1H2/p-1
2617,17891,donor,"A molecular entity that can transfer (""donate"") an electron, a pair of electrons, an atom or a group to another molecular entity.",17926,KEGG COMPOUND accession,C06399,hgbyr,b,b,b,Hydrogenobyrinate,b,b,b,C06399,b,b,b,b,b,b
2618,17893,(2R)-2-hydroxy monocarboxylic acid,A 2-hydroxy monocarboxylic acid having (2R)-configuration.,27914,KEGG COMPOUND accession,C06503,hgbam,b,27914.0,b,"Hydrogenobyrinate a,c diamide",b,b,b,C06503,b,b,b,b,b,"InChI=1S/C45H62N6O12/c1-21-36-24(10-13-32(56)57)41(3,4)28(49-36)18-27-23(9-12-31(54)55)43(6,19-29(46)52)39(48-27)22(2)37-25(11-14-33(58)59)44(7,20-30(47)53)45(8,51-37)40-26(17-35(62)63)42(5,38(21)50-40)16-15-34(60)61/h18,23-26,40,51H,9-17,19-20H2,1-8H3,(H2,46,52)(H2,47,53)(H,54,55)(H,56,57)(H,58,59)(H,60,61)(H,62,63)/b27-18-,36-21-,37-22-/t23-,24-,25-,26+,40-,42-,43+,44+,45+/m1/s1"
2619,17894,m(7)G(5')pppm(6)Am,"mRNA containing an N(6),2'-O-dimethyladenosine cap.",5790,KEGG COMPOUND accession,C07042,,,,,,,,,,,,,,,
2620,17914,"1,6-beta-D-galactosylgalactogen",A polysaccharide that is galactogen linked to a (1->6)-beta-D-galactosyl unit.,15362,KEGG COMPOUND accession,C03505,,,,,,,,,,,,,,,
2621,17917,L-allysine,An optically active form of allysine having L-configuration.,28877,KEGG COMPOUND accession,C02980,,,,,,,,,,,,,,,
2622,17920,3-methyleneoxindole,a,18316,KEGG COMPOUND accession,C06552,,,,,,,,,,,,,,,
2623,17924,D-glucitol,The D-enantiomer of glucitol (also known as D-sorbitol).,5801,KEGG COMPOUND accession,C07043,,,,,,,,,,,,,,,
2624,17942,D-allose 6-phosphate,An allose phosphate consisting of D-allose having a monophosphate group at the 6-position.,16513,KEGG COMPOUND accession,C02287,,,,,,,,,,,,,,,
2625,17945,N-cyclohexylformamide,A member of the class of  formamides that is cyclohexane substituted by a formamido group.,16645,KEGG COMPOUND accession,C01024,hmbil,73023-76-4,16645.0,"Human Metabolome Database (HMDB): Hydroxymethylbilane is a molecule involved in the metabolism of porphyrin. In the third step, it is generated by the enzyme porphobilinogen deaminase , and in the next step the enzyme uroporphyrinogen III synthase converts it into uroporphyrinogen III. -- Wikipedia.",Hydroxymethylbilane,HMDB0001137,b,b,C01024,HYDROXYMETHYLBILANE,FDB022446,hmbil,[H]OC([H])([H])C1=C(C(=C(N1[H])C([H])([H])C1=C(C(=C(N1[H])C([H])([H])C1=C(C(=C(N1[H])C([H])([H])C1=C(C(=C([H])N1[H])C([H])([H])C([H])([H])C([O-])=O)C([H])([H])C([O-])=O)C([H])([H])C([H])([H])C([O-])=O)C([H])([H])C([O-])=O)C([H])([H])C([H])([H])C([O-])=O)C([H])([H])C([O-])=O)C([H])([H])C([H])([H])C([O-])=O)C([H])([H])C([O-])=O,WDFJYRZCZIUBPR-UHFFFAOYSA-F,"InChI=1S/C40H46N4O17/c45-17-32-25(12-40(60)61)21(4-8-36(52)53)29(44-32)15-31-24(11-39(58)59)20(3-7-35(50)51)28(43-31)14-30-23(10-38(56)57)19(2-6-34(48)49)27(42-30)13-26-22(9-37(54)55)18(16-41-26)1-5-33(46)47/h16,41-45H,1-15,17H2,(H,46,47)(H,48,49)(H,50,51)(H,52,53)(H,54,55)(H,56,57)(H,58,59)(H,60,61)/p-8"
2626,17953,xanthopterin-B2,"A member of the class of pteridines that is 7,8-dihydropteridine-2,4(1H,3H)-dione carrying a lactoyl group at position 6.",30841,KEGG COMPOUND accession,C00168,hpyr,1113-60-6,30841.0,"Human Metabolome Database (HMDB): Hydroxypyruvic acid is an intermediate in the metabolism of Glycine, serine and threonine. It is a substrate for Serine--pyruvate aminotransferase and Glyoxylate reductase/hydroxypyruvate reductase.",Hydroxypyruvic acid,HMDB0001352,b,b,C00168,OH-PYR,FDB008112,hpyr,[H]OC([H])([H])C(=O)C([O-])=O,HHDDCCUIIUWNGJ-UHFFFAOYSA-M,"InChI=1S/C3H4O4/c4-1-2(5)3(6)7/h4H,1H2,(H,6,7)/p-1"
2627,17964,pipecolic acid,A piperidinemonocarboxylic acid in which the carboxy group is located at position C-2.,35350,KEGG COMPOUND accession,C02159,,,,,,,,,,,,,,,
2628,17966,cyclohexyl isocyanide,An isocyanide having a cyclohexyl group attached to nitrogen.,44423,KEGG COMPOUND accession,C07044,,,,,,,,,,,,,,,
2629,17970,N-acyl-D-mannosaminolactone,a,5818,KEGG COMPOUND accession,C07045,,,,,,,,,,,,,,,
2630,17976,ubiquinol,a,16976,KEGG COMPOUND accession,C01925,,,,,,,,,,,,,,,
2631,17989,daphnin,a,5827,KEGG COMPOUND accession,C11103,,,,,,,,,,,,,,,
2632,17997,dinitrogen,An elemental molecule consisting of two trivalently-bonded nitrogen atoms.,5832,KEGG COMPOUND accession,C09213,,,,,,,,,,,,,,,
2633,18003,2-hydroxy-3-(3-oxoprop-1-enyl)but-2-enedioic acid,A carboxy-2-hydroxymuconate semialdehyde having the carboxy group at the 3-position.,5835,KEGG COMPOUND accession,C07606,,,,,,,,,,,,,,,
2634,18007,3-[hydroxy(oxido)phosphoranyl]pyruvic acid,a,5837,KEGG COMPOUND accession,C10078,,,,,,,,,,,,,,,
2635,18009,NADP(+),a,18210,KEGG COMPOUND accession,C01818,,,,,,,,,,,,,,,
2636,18012,fumaric acid,A butenedioic acid in which the C=C double bond has E geometry. It is an intermediate metabolite in the citric acid cycle.,16668,KEGG COMPOUND accession,C00519,hyptaur,300-84-5,16668.0,Human Metabolome Database (HMDB): Hypotaurine is a product of enzyme cysteamine dioxygenase [EC 1.13.11.19] in taurine and hypotaurine metabolism pathway (KEGG). It may function as an antioxidant and a protective agent under physiological conditions (PMID 14992269).,Hypotaurine,HMDB0000965,b,b,C00519,HYPOTAURINE,FDB022342,hyptaur,[H][N+]([H])([H])C([H])([H])C([H])([H])S([O-])=O,VVIUBCNYACGLLV-UHFFFAOYSA-N,"InChI=1S/C2H7NO2S/c3-1-2-6(4)5/h1-3H2,(H,4,5)"
2637,18018,D-galactosyl-(1->4)-beta-D-glucosyl group,A glucosyl group obtained by removing the hydroxy group from the hemiacetal function of D-galactosyl-(1->4)-beta-D-glucose.,16209,KEGG COMPOUND accession,C02419,,,,,,,,,,,,,,,
2638,18020,4-trimethylammoniobutanal,a,17368,KEGG COMPOUND accession,C00262,hxan,68-94-0,17368.0,"Human Metabolome Database (HMDB): Hypoxanthine is a naturally occurring purine derivative and a reaction intermediate in the metabolism of adenosine and in the formation of nucleic acids by the salvage pathway. Hypoxanthine is also a spontaneous deamination product of adenine. Lesch-Nyhan disease, an inborn error of metabolism, is caused by deficiency of the purine salvage enzyme hypoxanthine-guanine phosphoribosyltransferase (OMIN 308000). Hypoxanthine is also found to be associated with xanthinuria type 1, which is an inborn error of metabolism.",Hypoxanthine,HMDB0000157,b,b,C00262,HYPOXANTHINE,FDB003949,hxan,[H]N1C([H])=NC2=C1C(=O)N([H])C([H])=N2,FDGQSTZJBFJUBT-UHFFFAOYSA-N,"InChI=1S/C5H4N4O/c10-5-3-4(7-1-6-3)8-2-9-5/h1-2H,(H2,6,7,8,9,10)"
2639,18035,diglyceride,"A glyceride that is glycerol in which any two of the hydroxy groups have been acylated. In the structure shown, two of the R groups (positions not specified) are acyl groups while the remaining R group can be either H or an alkyl group.",36378,KEGG COMPOUND accession,C05794,,,,,,,,,,,,,,,
2640,18036,triphosphate(5-),a,29026,KEGG COMPOUND accession,C05790,,,,,,,,,,,,,,,
2641,18042,"(S)-2,3-dihydrodipicolinic acid",a,17808,KEGG COMPOUND accession,C00104,idp,86-04-4,17808.0,Human Metabolome Database (HMDB): IDP is an inosine nucleotide containing a pyrophosphate group esterified to C5 of the sugar moiety.,IDP,HMDB0003335,b,b,C00104,IDP,FDB023146,idp,[H]O[C@@]1([H])[C@@]([H])(O[C@]([H])(C([H])([H])OP([O-])(=O)OP([O-])([O-])=O)[C@@]1([H])O[H])N1C([H])=NC2=C1N=C([H])N([H])C2=O,JPXZQMKKFWMMGK-KQYNXXCUSA-K,"InChI=1S/C10H14N4O11P2/c15-6-4(1-23-27(21,22)25-26(18,19)20)24-10(7(6)16)14-3-13-5-8(14)11-2-12-9(5)17/h2-4,6-7,10,15-16H,1H2,(H,21,22)(H,11,12,17)(H2,18,19,20)/p-3/t4-,6-,7-,10-/m1/s1"
2642,18054,diphthine,A quaternary ammonium ion consisting of L-histidine with a 3-(trimethylammonio)-3-carboxypropyl group at the 2-position of the the imidazole ring.,17202,KEGG COMPOUND accession,C00130,imp,131-99-7,17202.0,Human Metabolome Database (HMDB): Inosinic acid is a purine nucleotide which has hypoxanthine as the base and one phosphate group esterified to the sugar moiety. Inosinic acid is a nucleotide present in muscle and other tissues. It is formed by the deamination of AMP and when hydrolysed produces inosine. Inosinic acid is the ribonucleotide of hypoxanthine and is the first compound formed during the synthesis of purine. (Wikipedia).,Inosinic acid,HMDB0000175,b,b,C00130,IMP,FDB021901,imp,[H]O[C@@]1([H])[C@@]([H])(O[C@]([H])(C([H])([H])OP([O-])([O-])=O)[C@@]1([H])O[H])N1C([H])=NC2=C1N=C([H])N([H])C2=O,GRSZFWQUAKGDAV-KQYNXXCUSA-L,"InChI=1S/C10H13N4O8P/c15-6-4(1-21-23(18,19)20)22-10(7(6)16)14-3-13-5-8(14)11-2-12-9(5)17/h2-4,6-7,10,15-16H,1H2,(H,11,12,17)(H2,18,19,20)/p-2/t4-,6-,7-,10-/m1/s1"
2643,18070,cytochrome c,a,5850,KEGG COMPOUND accession,C11163,,,,,,,,,,,,,,,
2644,18071,(methylthio)acetate,A monocarboxylic acid anion that is the conjugate base of (methylthio)acetic acid.,16039,KEGG COMPOUND accession,C00081,itp,132-06-9,16039.0,"Human Metabolome Database (HMDB): Inosine triphosphate (ITP) is an intermediate in the purine metabolism pathway. Relatively high levels of ITP in red cells are found in individuals as result of deficiency of inosine triphosphatase (EC 3.1.3.56, ITPase) ITPase is a cytosolic nucleoside triphosphate pyrophosphohydrolase specific for ITP catalysis to inosine monophosphate (IMP) and deoxy-inosine triphosphate (dITP) to deoxy-inosine monophosphate. ITPase deficiency is not associated with any defined pathology other than the characteristic and abnormal accumulation of ITP in red blood cells. Nevertheless, ITPase deficiency may have pharmacogenomic implications, and the abnormal metabolism of 6-mercaptopurine in ITPase-deficient patients may lead to thiopurine drug toxicity. ITPase's function is not clearly understood but possible roles for ITPase could be to prevent the accumulation of rogue nucleotides which would be otherwise incorporated into DNA and RNA, or compete with nucleotides such as GTP in signalling processes. (PMID: 170291, 1204209, 17113761, 17924837).",Inosine triphosphate,HMDB0000189,b,b,C00081,ITP,FDB021902,itp,[H]O[C@@]1([H])[C@@]([H])(O[C@]([H])(C([H])([H])OP([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O)[C@@]1([H])O[H])N1C([H])=NC2=C1N=C([H])N([H])C2=O,HAEJPQIATWHALX-KQYNXXCUSA-J,"InChI=1S/C10H15N4O14P3/c15-6-4(1-25-30(21,22)28-31(23,24)27-29(18,19)20)26-10(7(6)16)14-3-13-5-8(14)11-2-12-9(5)17/h2-4,6-7,10,15-16H,1H2,(H,21,22)(H,23,24)(H,11,12,17)(H2,18,19,20)/p-4/t4-,6-,7-,10-/m1/s1"
2645,18085,glycosaminoglycan,Any polysaccharide containing a substantial proportion of aminomonosaccharide residues.,5852,KEGG COMPOUND accession,C09214,,,,,,,,,,,,,,,
2646,18087,myo-inositol polyphosphate,a,5853,KEGG COMPOUND accession,C09215,,,,,,,,,,,,,,,
2647,18091,asparagusic acid,a,5855,KEGG COMPOUND accession,C01588,ibup_R,15687-27-1,5855.0,"Human Metabolome Database (HMDB): Ibuprofen is a nonsteroidal anti-inflammatory drug (NSAID) widely marketed under various trademarks including Act-3, Advil, Brufen, Motrin, Nuprin, and Nurofen. It is used for relief of symptoms of arthritis, primary dysmenorrhoea, and fever; Ibuprofen is an NSAID which is believed to work through inhibition of cyclooxygenase (COX), thus inhibiting prostaglandin synthesis. There are at least 2 variations of cyclooxygenase (COX-1 and COX-2), ibuprofen inhibits both COX-1 and COX-2. It appears that its analgesic, antipyretic, and anti-inflammatory activity are achieved principally through COX-2 inhibition; whereas COX-1 inhibition is responsible for its unwanted effects on platelet aggregation and the GI mucosa. As with other NSAIDs, ibuprofen inhibits platelet aggregation, but is not used therapeutically for this action since it is a minor and reversible effect. -- Wikipedia.",Ibuprofen-R,HMDB0001925,b,b,C01588,b,b,b,b,b,b
2648,18097,ferricytochrome b5,a,5858,KEGG COMPOUND accession,C08689,,,,,,,,,,,,,,,
2649,18105,keto-D-fructose 1-phosphate,The open chain form of D-fructose 1-phosphate.,5862,KEGG COMPOUND accession,C10968,,,,,,,,,,,,,,,
2650,18119,ethyl 3-oxohexanoate,a,5869,KEGG COMPOUND accession,C05076,,,,,,,,,,,,,,,
2651,18123,N-methylnicotinate,"An iminium betaine that is the conjugate base of N-methylnicotinic acid, arising from deprotonation of the carboxy group.",17406,KEGG COMPOUND accession,C03277,,,,,,,,,,,,,,,
2652,18126,S-acylglutathione,Any glutathione carrying an S-acyl substituent.,16069,KEGG COMPOUND accession,C01589,,,,,,,,,,,,,,,
2653,18129,(S)-2-hydroxyoctadecanoic acid,An optically active form of 2-hydroxyoctadecanoic acid having (S)-configuration.,27487,KEGG COMPOUND accession,C05568,,,,,,,,,,,,,,,
2654,18130,"(-)-5-oxo-1,2-campholide","An optically active 5-oxo-1,2-campholide having (-)-(1R,5R)-configuration.",27398,KEGG COMPOUND accession,C05130,im4act,645-14-7,27398.0,"Human Metabolome Database (HMDB): Imidazole-4-acetaldehyde is a naturally occurring aldehyde metabolite of histamine formed by the action of histaminase (E.C. 1.4.3.6), and can be synthesized by oxidation of histidine. Aldehyde dehydrogenase (EC 1.2.1.3) is the only enzyme in the human liver capable of catalyzing dehydrogenation of aldehydes arising via monoamine, diamine, and plasma amine oxidases. NAD-linked dehydrogenation of short chain aliphatic aldehydes has been found in virtually every organ of the mammalian body. Imidazole-4-acetaldehyde is a good substrate for all aldehyde dehydrogenase isozymes. Experimentally, the prebiotic formation of histidine has been accomplished by the reaction of erythrose with formamidine followed by a Strecker synthesis. Imidazole-4-acetaldehyde could have been converted to histidine on the primitive earth by a Strecker synthesis, and several prebiotic reactions could convert imidazole-4-glycol and imidazole-4-ethanol to imidazole-4-acetaldehyde. (PMID: 2071588, 2957640, 11536478).",Imidazole-4-acetaldehyde,HMDB0003905,b,b,C05130,b,FDB023247,im4act,[H]N1C([H])=NC(=C1[H])C([H])([H])C([H])=O,MQSRGWNVEZRLDK-UHFFFAOYSA-N,"InChI=1S/C5H6N2O/c8-2-1-5-3-6-4-7-5/h2-4H,1H2,(H,6,7)"
2655,18138,biuret,A member of the class of condensed ureas that is the compound formed by the condensation of two molecules of urea; the parent compound of the biuret group of compounds. Used as a non-protein nitrogen source in ruminant feed.,28182,KEGG COMPOUND accession,C05562,,,,,,,,,,,,,,,
2656,18140,hydrogen halide,a,5877,KEGG COMPOUND accession,C10972,,,,,,,,,,,,,,,
2657,18143,rRNA containing N(2)-methylguanine,A ribonucleic acid that is ribosomal RNA (rRNA) in which one of the RNA bases is N(2)-methylguanine.,471744,KEGG COMPOUND accession,C06665,,,,,,,,,,,,,,,
2658,18146,(R)-canadine,A canadine which has R configuration.,47499,KEGG COMPOUND accession,C07049,,,,,,,,,,,,,,,
2659,18148,"alpha-D-glucose 1,6-bisphosphate","A D-glucose 1,6-bisphosphate in which both phosphate groups are monophosphates.",5882,KEGG COMPOUND accession,C07982,,,,,,,,,,,,,,,
2660,18152,myricetin,"A hexahydroxyflavone that is flavone substituted by hydroxy groups at positions 3, 3', 4', 5, 5' and 7. It has been isolated from the leaves of Myrica rubra and other plants.",5885,KEGG COMPOUND accession,C09269,,,,,,,,,,,,,,,
2661,18162,nonaprenyl 4-hydroxybenzoate,a,16697,KEGG COMPOUND accession,C01710,,,,,,,,,,,,,,,
2662,18164,(2S)-2-hydroxyphytanic acid,"A 20-carbon, methyl-branched hydroxy fatty acid and intermediate in phytanic acid degradation; accumulates in patients with peroxisimal disorders.",17404,KEGG COMPOUND accession,C01504,,,,,,,,,,,,,,,
2663,18171,8-O-methylsterigmatocystin,a,16700,KEGG COMPOUND accession,C08481,,,,,,,,,,,,,,,
2664,18176,2-coumaric acid,A monohydroxycinnamic acid in which the hydroxy substituent is located at C-2 of the phenyl ring.,5897,KEGG COMPOUND accession,C10326,,,,,,,,,,,,,,,
2665,18187,"(E)-3,7,11,15-tetramethylhexadec-2-en-1-yl diphosphate",a,38958,KEGG COMPOUND accession,C06073,,,,,,,,,,,,,,,
2666,18188,(S)-3-aminoisobutyrate,a,18086,KEGG COMPOUND accession,C00637,id3acald,2591-98-2,18086.0,"Human Metabolome Database (HMDB): Indoleacetaldehyde is a substrate for Retina-specific copper amine oxidase, Aldehyde dehydrogenase X (mitochondrial), Amine oxidase B, Amiloride-sensitive amine oxidase, Aldehyde dehydrogenase (mitochondrial), Fatty aldehyde dehydrogenase, 4-trimethylaminobutyraldehyde dehydrogenase, Aldehyde dehydrogenase (dimeric NADP-preferring), Aldehyde dehydrogenase family 7 member A1, Amine oxidase A, Aldehyde dehydrogenase 1A3 and Membrane copper amine oxidase.",Indoleacetaldehyde,HMDB0001190,b,b,C00637,INDOLE_ACETALDEHYDE,FDB013950,id3acald,[H]N1C([H])=C(C2=C([H])C([H])=C([H])C([H])=C12)C([H])([H])C([H])=O,WHOOUMGHGSPMGR-UHFFFAOYSA-N,"InChI=1S/C10H9NO/c12-6-5-8-7-11-10-4-2-1-3-9(8)10/h1-4,6-7,11H,5H2"
2667,18198,4-amino-4-deoxychorismic acid,A dicarboxylic acid comprising chorismic acid having its 4-hydroxy group replaced by an amino group.,28311,KEGG COMPOUND accession,C05836,,,,,,,,,,,,,,,
2668,18199,"UDP-N-acetylmuramoyl-L-alanyl-gamma-D-glutamyl-meso-2,6-diaminopimeloyl-D-alanyl-D-alanine","UDP-glycopeptide having N-acetylmuramoyl as the glyco portion and L-alanyl-gamma-D-glutamyl-meso-2,6-diaminopimeloyl-D-alanyl-D-alanine as the peptide portion (attached via an amide bond between the amino terminus and the muramoyl carboxy group).",16031,KEGG COMPOUND accession,C02693,M00155,879-37-8,16031.0,Human Metabolome Database (HMDB): 1H-Indole-3-acetamide is found in common pea. 1H-Indole-3-acetamide is isolated from etiolated seedlings of the black gram (Phaseolus mungo,1H-Indole-3-acetamide,HMDB0029739,b,b,C02693,b,FDB000937,b,[H]N([H])C(=O)C([H])([H])C1=C([H])N([H])C2=C([H])C([H])=C([H])C([H])=C12,ZOAMBXDOGPRZLP-UHFFFAOYSA-N,"InChI=1S/C10H10N2O/c11-10(13)5-7-6-12-9-4-2-1-3-8(7)9/h1-4,6,12H,5H2,(H2,11,13)"
2669,18204,"16,17-didehydroprogesterone",a,16411,KEGG COMPOUND accession,C00954,ind3ac,87-51-4,16411.0,"Human Metabolome Database (HMDB): Indoleacetic acid (IAA) is a breakdown product of tryptophan metabolism and is often produced by the action of bacteria in the mammalian gut. Some endogenous production of IAA in mammalian tissues also occurs. It may be produced by the decarboxylation of tryptamine or the oxidative deamination of tryptophan. IAA frequently occurs at low levels in urine and has been found in elevated levels in the urine of patients with phenylketonuria ((PMID: 13610897). Using material extracted from human urine, it was discovered by Kogl in 1933 that Indoleacetic acid is also an important plant hormone (PMID: 13610897). Specifically IAA is a member of the group of phytohormones called auxins. IAA is generally considered to be the most important native auxin. Plant cells synthesize IAA from tryptophan. (wikipedia) IAA and some derivatives can be oxidised by horseradish peroxidase (HRP) to cytotoxic species. IAA is only toxic after oxidative decarboxylation; the effect of IAA/HRP is thought to be due in part to the formation of methylene-oxindole, which may conjugate with DNA bases and protein thiols. IAA/HRP could be used as the basis for targeted cancer, a potential new role for plant auxins in cancer therapy. (PMID: 11163327).",Indoleacetic acid,HMDB0000197,b,b,C00954,b,FDB000933,ind3ac,[H]N1C([H])=C(C2=C([H])C([H])=C([H])C([H])=C12)C([H])([H])C([O-])=O,SEOVTRFCIGRIMH-UHFFFAOYSA-M,"InChI=1S/C10H9NO2/c12-10(13)5-7-6-11-9-4-2-1-3-8(7)9/h1-4,6,11H,5H2,(H,12,13)/p-1"
2670,18216,alpha-N-acetylneuraminosyl-(2->3)-[beta-D-galactosyl-(1->3)-N-acetyl-beta-D-galactosaminyl-(1->4)]-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-N-acylsphingosine,A sialotetraosylceramide having beta-D-Gal-(1->3)-beta-D-GalNAc-(1->4)-[alpha-Neu5Ac-(2->3)]-beta-D-Gal-(1->4)-beta-D-Glc as the sialotetraosyl component.,15711,KEGG COMPOUND accession,C03868,,,,,,,,,,,,,,,
2671,18220,isoflavone,A simplest member of the class of isoflavones  that is 4H-chromen-4-one in which the hydrogen at position 3 is replaced by a phenyl group.,28238,KEGG COMPOUND accession,C08493,,,,,,,,,,,,,,,
2672,18222,xylose,"An aldopentose, found in the embryos of most edible plants and used in medicine to test for malabsorption by administration in water to the patient.",17890,KEGG COMPOUND accession,C00955,,,,,,,,,,,,,,,
2673,18226,(R)-6-hydroxynicotine,a,28071,KEGG COMPOUND accession,C04611,,,,,,,,,,,,,,,
2674,18228,"1D-myo-inositol 1,3,4-trisphosphate",a,27406,KEGG COMPOUND accession,C05579,M03163,b,27406.0,"Human Metabolome Database (HMDB): Indole-5,6-quinone is involved in the tyrosine metabolism pathway. More specifically, indole-5,6-quinone is an intermediate in the production of melanin. Indole-5,6-quinone is produced from 5,6-dihydroxyindole by tyrosinase [EC:1.14.18.1].","Indole-5,6-quinone",HMDB0006779,b,b,C05579,b,FDB024077,b,[H]N1C([H])=C([H])C2=C([H])C(=O)C(=O)C([H])=C12,IGGVVGHJSQSLFO-UHFFFAOYSA-N,"InChI=1S/C8H5NO2/c10-7-3-5-1-2-9-6(5)4-8(7)11/h1-4,9H"
2675,18230,chlorophyll a,a,28626,KEGG COMPOUND accession,C01819,,,,,,,,,,,,,,,
2676,18231,arsenic acid,An arsenic oxoacid comprising one oxo group and three hydroxy groups attached to a central arsenic atom.,33070,KEGG COMPOUND accession,C11284,,,,,,,,,,,,,,,
2677,18233,xyloglucan,"A glucan that consists of a backbone of alpha-(1->4)-linked glucose residues, most of which are substituted with (1->6)-linked xylose side-chains.",18299,KEGG COMPOUND accession,C03506,,,,,,,,,,,,,,,
2678,18236,6-demethylsterigmatocystin,a,17282,KEGG COMPOUND accession,C02043,,,,,,,,,,,,,,,
2679,18238,3-demethylubiquinone-9,a,29750,KEGG COMPOUND accession,C00331,,,,,,,,,,,,,,,
2680,18248,iron atom,An iron group element atom that has atomic number 26.,49662,KEGG COMPOUND accession,C01926,,,,,,,,,,,,,,,
2681,18250,chondroitin 4'-sulfate,A chondroitin sulfate in which the site of sulfation is carbon 4 of the N-acetylgalactosamine (GalNAc) sugar.,17840,KEGG COMPOUND accession,C05658,,,,,,,,,,,,,,,
2682,18256,4-formylbenzenesulfonic acid,a,5922,KEGG COMPOUND accession,C09112,,,,,,,,,,,,,,,
2683,18261,N-carbamoyl-beta-alanine,A beta-alanine derivative that is propionic acid bearing a ureido group at position 3.,27495,KEGG COMPOUND accession,C08819,,,,,,,,,,,,,,,
2684,18263,1-(5-phospho-D-ribosyl)-ATP,a,18036,KEGG COMPOUND accession,C03279,,,,,,,,,,,,,,,
2685,18278,N-acetyl-D-glucosaminyldiphosphodolichol,a,18345,KEGG COMPOUND accession,C04579,,,,,,,,,,,,,,,
2686,18280,phenylglyoxylic acid,A 2-oxo monocarboxylic acid that is glyoxylic acid in which the aldehyde hydrogen is substituted by a phenyl group.,5931,KEGG COMPOUND accession,C00723,M03169,b,b,b,Insulin-(SS),b,b,b,C00723,b,b,b,b,b,b
2687,18300,maleic acid,A butenedioic acid in which the double bond has cis- (Z)-configuration.,5941,KEGG COMPOUND accession,C10330,,,,,,,,,,,,,,,
2688,18304,deamido-NAD(+),a,16751,KEGG COMPOUND accession,C01711,,,,,,,,,,,,,,,
2689,18311,quinoline-4-carboxylic acid,a,16382,KEGG COMPOUND accession,C00708,i,20461-54-5,16382.0,"Human Metabolome Database (HMDB): Iodide can function as an antioxidant as it is a reducing species that can detoxify reactive oxygen species such as hydrogen peroxide. Over three billion years ago, blue-green algae were the most primitive oxygenic photosynthetic organisms and are the ancestors of multicellular eukaryotic algae (1). Algae that contain the highest amount of iodine (1-3 % of dry weight) and peroxidase enzymes, were the first living cells to produce poisonous oxygen in the atmosphere. Therefore algal cells required a protective antioxidant action of their molecular components, in which iodides, through peroxidase enzymes, seem to have had this specific role. In fact, iodides are greatly present and available in the sea, where algal phytoplankton, the basis of marine food-chain, acts as a biological accumulator of iodides, selenium, (and n-3 fatty acids) :; Antioxidant biochemical mechanism of iodides, probably one of the most ancient mechanisms of defense from poisonous reactive oxygen species:; An iodide ion is an iodine atom with a -1 charge. Compounds with iodine in formal oxidation state -1 are called iodides. This can include ionic compounds such as caesium iodide or covalent compounds such as phosphorus triiodide. This is the same naming scheme as is seen with chlorides and bromides. The chemical test for an iodide compound is to acidify the aqueous compound by adding some drops of acid, to dispel any carbonate ions present, then adding lead(II) nitrate, yielding a bright yellow precipitate of lead iodide. Most ionic iodides are soluble, with the exception of yellow silver iodide and yellow lead iodide. Aqueous solutions of iodide dissolve iodine better than pure water due to the formation of complex ions:.",Iodide,HMDB0012238,b,b,C00708,CPD-387,FDB028881,i,[I-],XMBWDFGMSWQBCA-UHFFFAOYSA-M,InChI=1S/HI/h1H/p-1
2690,18314,L-2-aminopentanoic acid,A 2-aminopentanoic acid that has S-configuration.,17606,KEGG COMPOUND accession,C01382,iodine,7553-56-2,17606.0,"Human Metabolome Database (HMDB): Iodine is an essential trace element. Chemically, iodine is the least reactive of the halogens, and the most electropositive halogen after astatine. However, iodine does not occur in the free state in nature. As with all other halogens , when freed from its compounds iodine forms diatomic molecules (I2). Iodine and its compounds are primarily used in medicine, photography, and dyes. Iodine is required for the production of thyroid hormones, which are essential for normal brain development, and the fetus, newborn, and young child are particularly vulnerable to iodine deficiency. Physiologically, iodine exists as an ion in the body. The iodine requirement increases during pregnancy and recommended intakes are in the range of 220-250 microg/day. Monitoring iodine status during pregnancy is a challenge. New recommendations from World Health Organization suggest that a median urinary iodine concentration >250 microg/L and <500 microg/L indicates adequate iodine intake in pregnancy. Based on this range, it appears that many pregnant women in have inadequate intakes. Thyroid-stimulating hormone concentration in the newborn is a sensitive indicator of mild iodine deficiency in late pregnancy. The potential adverse effects of mild iodine deficiency during pregnancy are uncertain. Controlled trials of iodine supplementation in mildly iodine-deficient pregnant women suggest beneficial effects on maternal and newborn serum thyroglobulin and thyroid volume, but no effects on maternal and newborn total or free thyroid hormone concentrations. There are no long-term data on the effect of iodine supplementation on birth outcomes or infant development. New data from well-controlled studies indicate that iodine repletion in moderately iodine-deficient school-age children has clear benefits: it improves cognitive and motor function; it also increases concentrations of insulin-like growth factor 1 and insulin-like growth factor-binding protein 3, and improves somatic growth. (PMID: 17956157).",Iodine,HMDB0000675,b,b,C01382,IODINE-MOLECULE,FDB003635,iodine,II,PNDPGZBMCMUPRI-UHFFFAOYSA-N,InChI=1S/I2/c1-2
2691,18320,"1,4-dithiothreitol","The threo-diastereomer of 1,4-dimercaptobutane-2,3-diol.",5950,KEGG COMPOUND accession,C07636,,,,,,,,,,,,,,,
2692,18332,L-thyroxine,The L-enantiomer of thyroxine.,5956,KEGG COMPOUND accession,C07052,,,,,,,,,,,,,,,
2693,18338,thiamine(1+) monophosphate chloride,An organic chloride salt of thiamine(1+) monophosphate.,5959,KEGG COMPOUND accession,C07469,,,,,,,,,,,,,,,
2694,18344,kynurenic acid,A quinolinemonocarboxylic acid that is quinoline-2-carboxylic acid substituted by a hydroxy group at C-4.,5962,KEGG COMPOUND accession,C10927,,,,,,,,,,,,,,,
2695,18346,vanillin,A member of the class of benzaldehydes carrying methoxy and hydroxy substituents at positions 3 and 4 respectively.,5963,KEGG COMPOUND accession,C10465,,,,,,,,,,,,,,,
2696,18348,"1-phosphatidyl-1D-myo-inositol 4,5-bisphosphate",A phosphatidylinositol bisphosphate in which the two phosphate groups are at C-4 and C-5 of the inositol moiety which has the 1D-myo configuration.,5964,KEGG COMPOUND accession,C06069,,,,,,,,,,,,,,,
2697,18355,"2-hydroxypenta-2,4-dienoic acid","A 5-carbon, bis-unsaturated, alpha-hydroxy fatty acid metabolite of the proteobacterium substrate 2-hydroxy-6-oxo-6-phenylhexa-2,4-dienoic acid (HOPDA).",5970,KEGG COMPOUND accession,C10467,,,,,,,,,,,,,,,
2698,18361,diphosphate(4-),a,5973,KEGG COMPOUND accession,C10067,,,,,,,,,,,,,,,
2699,18363,reticulinylium,"A benzylisoquinoline alkaloid that is obtained by selective dehydrogenation at the 1,2-position of reticuline.",18248,KEGG COMPOUND accession,C00023,,,,,,,,,,,,,,,
2700,18371,cis-4-carboxymethylenebut-2-en-4-olide,a,30408,KEGG COMPOUND accession,C00824,,,,,,,,,,,,,,,
2701,18374,1-(5-phospho-beta-D-ribosyl)-5'-AMP,An AMP-sugar in which the hydrogen at position 1 of AMP is substituted by a 5-phospho-beta-D-ribosyl group.,27539,KEGG COMPOUND accession,C11129,,,,,,,,,,,,,,,
2702,18379,nitrile,"A compound having the structure RC#N; thus a C-substituted derivative of hydrocyanic acid, HC#N. In systematic nomenclature, the suffix nitrile denotes the triply bound #N atom, not the carbon atom attached to it.",5981,KEGG COMPOUND accession,C09484,,,,,,,,,,,,,,,
2703,18381,5-formamido-1-(5-phospho-D-ribosyl)imidazole-4-carboxamide,a,5982,KEGG COMPOUND accession,C10069,,,,,,,,,,,,,,,
2704,18385,thiamine(1+),"A primary alcohol that is 1,3-thiazol-3-ium substituted by (4-amino-2-methylpyrimidin-5-yl)methyl, methyl and 2-hydroxyethyl groups at positions 3, 4 and 5, respectively.",28106,KEGG COMPOUND accession,C08648,,,,,,,,,,,,,,,
2705,18391,D-gluconate,A gluconate having D-configuration.,5987,KEGG COMPOUND accession,C08769,,,,,,,,,,,,,,,
2706,18395,2-dehydropantolactone,a,5989,KEGG COMPOUND accession,C08649,,,,,,,,,,,,,,,
2707,18398,linear maltodextrin,"A maltodextrin in which the alpha-(1->4)-linked D-glucose units form a linear chain, typically from 3 to 17 glucose units long. (Cf. amylose, in which the chain length ranges from around 300 to several thousand glucose units).",28638,KEGG COMPOUND accession,C02420,,,,,,,,,,,,,,,
2708,18404,3-methylcatechol,A methylcatechol carrying a methyl substituent at position 3. It is a xenobiotic metabolite produced by some bacteria capable of degrading nitroaromatic compounds present in pesticide-contaminated soil samples.,5994,KEGG COMPOUND accession,C09758,,,,,,,,,,,,,,,
2709,18410,N-formylanthranilate,An amidobenzoate consisting of anthranilate carrying an N-formyl group.,17582,KEGG COMPOUND accession,C00885,,,,,,,,,,,,,,,
2710,18413,2-formamido-N(1)-(5-phospho-D-ribosyl)acetamidine,a,30887,KEGG COMPOUND accession,C00311,icit,320-77-4,30887.0,Human Metabolome Database (HMDB): The citrate oxidation to isocitrate is catalyzed by the enzyme aconitase. Human prostatic secretion is remarkably rich in citric acid and low aconitase activity will therefore play a significant role in enabling accumulation of high citrate levels (PubMed ID 8115279).,Isocitric acid,HMDB0000193,b,b,C00311,threo-d(s)-iso-citrate,FDB003281,icit,[H]OC([H])(C([O-])=O)C([H])(C([O-])=O)C([H])([H])C([O-])=O,ODBLHEXUDAPZAU-UHFFFAOYSA-K,"InChI=1S/C6H8O7/c7-3(8)1-2(5(10)11)4(9)6(12)13/h2,4,9H,1H2,(H,7,8)(H,10,11)(H,12,13)/p-3"
2711,18504,"(1->3,1->4)-beta-D-glucan",A beta-D-glucan of more than 20 D-glucose residues joined by beta-(1->3) and beta-(1->4) glycosidic linkages.,6039,KEGG COMPOUND accession,C09118,,,,,,,,,,,,,,,
2712,18915,beta-D-galactosyl-(1->3)-N-acetyl-D-glucosaminyl group,A group obtained by removing the hydroxy group from the hemiacetal function of beta-D-galactosyl-(1->3)-N-acetyl-D-glucosamine.,17196,KEGG COMPOUND accession,C00152,asn_L,70-47-3,17196.0,"Human Metabolome Database (HMDB): Asparagine (Asn) is one of the 20 most common natural amino acids on Earth. It has carboxamide as the side chain's functional group. It is considered a non-essential amino acid. Asparagine is not an essential amino acid, which means that it can be synthesized from central metabolic pathway intermediates in humans and is not required in the diet. The precursor to asparagine is oxaloacetate. Oxaloacetate is converted to aspartate using a transaminase enzyme. The enzyme transfers the amino group from glutamate to oxaloacetate producing alpha-ketoglutarate and aspartate. The enzyme asparagine synthetase produces asparagine, AMP, glutamate, and pyrophosphate from aspartate, glutamine, and ATP. In the asparagine synthetase reaction, ATP is used to activate aspartate, forming beta-aspartyl-AMP. glutamine donates an ammonium group which reacts with beta-aspartyl-AMP to form asparagine and free AMP. Since the asparagine side chain can make efficient hydrogen bond interactions with the peptide backbone, asparagines are often found near the beginning and end of alpha-helices, and in turn motifs in beta sheets. Its role can be thought as ""capping"" the hydrogen bond interactions which would otherwise need to be satisfied by the polypeptide backbone. glutamines have an extra methylene group, have more conformational entropy and thus are less useful in this regard. Asparagine also provides key sites for N-linked glycosylation, modification of the protein chain with the addition of carbohydrate chains. A reaction between asparagine and reducing sugars or reactive carbonyls produces acrylamide (acrylic amide) in food when heated to sufficient temperature, i.e. baking. These occur primarily in baked goods such as french fries, potato chips, and roasted coffee. Asparagine was first isolated in 1806 from asparagus juice, in which it is abundant--hence its name--becoming the first amino acid to be isolated. The smell observed in the urine of some individuals after their consumption of asparagus is attributed to a byproduct of the metabolic breakdown of asparagine, asparagine-amino-succinic-acid monoamide. (However, some scientists disagree and implicate other substances in the smell, especially methanethiol). (http://en.wikipedia.org/wiki/Asparagine).",L-Asparagine,HMDB0000168,b,b,C00152,ASN,FDB000787,asn_L,[H]N([H])C(=O)C([H])([H])[C@@]([H])(C([O-])=O)[N+]([H])([H])[H],DCXYFEDJOCDNAF-REOHCLBHSA-N,"InChI=1S/C4H8N2O3/c5-2(4(8)9)1-3(6)7/h2H,1,5H2,(H2,6,7)(H,8,9)/t2-/m0/s1"
2713,20011,3-deoxyoctulosonyllipopolysaccharide,A lipopolysaccharide having a 3-deoxyoctulosonyl group attached at an unspecified position.,30314,KEGG COMPOUND accession,C00725,lipoate,1200-22-2,30314.0,"Human Metabolome Database (HMDB): Lipoic acid is a vitamin-like antioxidant that acts as a free-radical scavenger. Alpha-lipoic acid is also known as thioctic acid. It is a naturally occurring compound that is synthesized by both plants and animals. Lipoic acid contains two thiol groups which may be either oxidized or reduced. The reduced form is known as dihydrolipoic acid (DHLA). Lipoic acid (Delta E= -0.288) is therefore capable of thiol-disulfide exchange, giving it antioxidant activity. Lipoate is a critical cofactor for aerobic metabolism, participating in the transfer of acyl or methylamine groups via the 2-Oxoacid dehydrogenase (2-OADH) or alpha-ketoglutarate dehydrogenase complex. This enzyme catalyzes the conversion of alpha-ketoglutarate to succinyl CoA. This activity results in the catabolism of the branched chain amino acids (leucine, isoleucine and valine). Lipoic acid also participates in the glycine cleavage system(GCV). The glycine cleavage system is a multi-enzyme complex that catalyzes the oxidation of glycine to form 5,10 methylene tetrahydrofolate, an important cofactor in nucleic acid synthesis. Since Lipoic acid is an essential cofactor for many enzyme complexes, it is essential for aerobic life as we know it. This system is used by many organisms and plays a crucial role in the photosynthetic carbon cycle. Lipoic acid was first postulated to be an effective antioxidant when it was found it prevented vitamin C and vitamin E deficiency. It is able to scavenge reactive oxygen species and reduce other metabolites, such as glutathione or vitamins, maintaining a healthy cellular redox state. Lipoic acid has been shown in cell culture experiments to increase cellular uptake of glucose by recruiting the glucose transporter GLUT4 to the cell membrane, suggesting its use in diabetes. Studies of rat aging have suggested that the use of L-carnitine and lipoic acid results in improved memory performance and delayed structural mitochondrial decay. As a result, it may be helpful for people with Alzheimer's disease or Parkinson's disease. -- Wikipedia.",(R)-lipoic acid,HMDB0001451,b,b,C00725,LIPOIC-ACID,FDB022631,Lipoate,[H]OC(=O)C([H])([H])C([H])([H])C([H])([H])C([H])([H])[C@@]1([H])SSC([H])([H])C1([H])[H],AGBQKNBQESQNJD-ZETCQYMHSA-N,"InChI=1S/C8H14O2S2/c9-8(10)4-2-1-3-7-5-6-11-12-7/h7H,1-6H2,(H,9,10)/t7-/m0/s1"
2714,20110,3-methylsalicylaldehyde,A member of the class of benzaldehydes that is salicylaldehyde in which the hydrogen ortho- to the hydroxy group is substituted by a methyl group.,6532,KEGG COMPOUND accession,C07080,,,,,,,,,,,,,,,
2715,21494,N-acetoxyarylamine,Any arylamine having an acetytoxy group attached to the nitrogen.,17355,KEGG COMPOUND accession,C05539,,,,,,,,,,,,,,,
2716,21818,N(2)-methylguanine,A methylguanine in which the methyl group is located at the N2-position.,27828,KEGG COMPOUND accession,C03948,,,,,,,,,,,,,,,
2717,24367,glycinamide ribonucleotide(2-),a,7642,KEGG COMPOUND accession,C10113,,,,,,,,,,,,,,,
2718,24547,hexadecenal,A monounsaturated fatty acid aldehyde that is hexadecanal which has undergone formal dehydrogenation to introduce a double bond at unspecified position.,7719,KEGG COMPOUND accession,C09955,,,,,,,,,,,,,,,
2719,24702,4-hydroxyindole,A member of the class of  hydroxyindoles that is 1H-indole substituted by a hydroxy group at position 4.,32807,KEGG COMPOUND accession,C01839,,,,,,,,,,,,,,,
2720,24978,ketose,Ketonic parent sugars (polyhydroxy ketones H[CH(OH)]nC(=O)[CH(OH)]mH) and their intramolecular hemiketals.,7798,KEGG COMPOUND accession,C08092,,,,,,,,,,,,,,,
2721,25682,"N(omega),N'(omega)-dimethyl-L-arginine",A  L-arginine derivative having two methyl groups at the N(omega)- and N'(omega)-positions,7912,KEGG COMPOUND accession,C00713,,,,,,,,,,,,,,,
2722,25858,"1,7-dimethylxanthine",A dimethylxanthine having the two methyl groups located at positions 1 and 7. It is a metabolite of caffeine and theobromine in animals.,16670,KEGG COMPOUND accession,C00012,,,,,,,,,,,,,,,
2723,26401,purines,A class of imidazopyrimidines that consists of purine and its substituted derivatives.,8210,KEGG COMPOUND accession,C06086,,,,,,,,,,,,,,,
2724,26660,sesterterpenoid,Any terpenoid derived from a sesterterpene. The term includes compounds in which the C25 skeleton of the parent sesterterpene has been rearranged or modified by the removal of one or more skeletal atoms (generally methyl groups). Sometimes sesterterpenoids are erroneously referred to as sesterpenoids.,29103,KEGG COMPOUND accession,C00238,k,b,26216.0,"Human Metabolome Database (HMDB): Potassium is an essential electrolyte. Potassium balance is crucial for regulating the excitability of nerves and muscles and so critical for regulating contractility of cardiac muscle. Although the most important changes seen in the presence of deranged potassium are cardiac, smooth muscle is also affected with increasing muscle weakness, a feature of both hyperkalaemia and hypokalaemia. Physiologically, it exists as an ion in the body. Potassium (K+) is a positively charged electrolyte, cation, which is present throughout the body in both intracellular and extracellular fluids. The majority of body potassium, >90%, are intracellular. It moves freely from intracellular fluid (ICF) to extracellular fluid (ECF) and vice versa when adenosine triphosphate increases the permeability of the cell membrane. It is mainly replaced inside or outside the cells by another cation, sodium (Na+). The movement of potassium into or out of the cells is linked to certain body hormones and also to certain physiological states. Standard laboratory tests measure ECF potassium. Potassium enters the body rapidly during food ingestion. Insulin is produced when a meal is eaten; this causes the temporary movement of potassium from ECF to ICF. Over the ensuing hours, the kidneys excrete the ingested potassium and homeostasis is returned. In the critically ill patient, suffering from hyperkalaemia, this mechanism can be manipulated beneficially by administering high concentration (50%) intravenous glucose. Insulin can be added to the glucose, but glucose alone will stimulate insulin production and cause movement of potassium from ECF to ICF. The stimulation of alpha receptors causes increased movement of potassium from ICF to ECF. A noradrenaline infusion can elevate serum potassium levels. An adrenaline infusion, or elevated adrenaline levels, can lower serum potassium levels. Metabolic acidosis causes a rise in extracellular potassium levels. In this situation, excess of hydrogen ions (H+) are exchanged for intracellular potassium ions, probably as a result of the cellular response to a falling blood pH. Metabolic alkalosis causes the opposite effect, with potassium moving into the cells. (PMID: 17883675).",Potassium,HMDB0000586,b,b,C00238,K%2b,FDB003521,k,[K+],NPYPAHLBTDXSSS-UHFFFAOYSA-N,InChI=1S/K/q+1
2725,27376,methanesulfonic acid,An alkanesulfonic acid in which the alkyl group directly linked to the sulfo functionality is methyl.,8645,KEGG COMPOUND accession,C10395,,,,,,,,,,,,,,,
2726,27380,(1->6)-beta-D-glucan,a,8647,KEGG COMPOUND accession,C09964,,,,,,,,,,,,,,,
2727,27386,cinnamic acid,A monocarboxylic acid that consists of acrylic acid bearing a phenyl substituent at the 3-position. It is found in Cinnamomum cassia.,17148,KEGG COMPOUND accession,C00134,ptrc,110-60-1,17148.0,"Human Metabolome Database (HMDB): Putrescine is a polyamine. Putrescine is related to cadaverine (another polyamine). Both are produced by the breakdown of amino acids in living and dead organisms and both are toxic in large doses. Putrescine and cadaverine are largely responsible for the foul odor of putrefying flesh, but also contribute to the odor of such processes as bad breath and bacterial vaginosis. Putrescine is also found in semen. Putrescine attacks s-adenosyl methionine and converts it to spermidine. Spermidine in turn attacks another s-adenosyl methionine and converts it to spermine. Putrescine is synthesized in small quantities by healthy living cells by the action of ornithine decarboxylase. The polyamines, of which putrescine is one of the simplest, appear to be growth factors necessary for cell division. Putrescine apparently has specific role in skin physiology and neuroprotection. (PMID: 15009201, 16364196). Pharmacological interventions have demonstrated convincingly that a steady supply of polyamines is a prerequisite for cell proliferation to occur. Genetic engineering of polyamine metabolism in transgenic rodents has shown that polyamines play a role in spermatogenesis, skin physiology, promotion of tumorigenesis and organ hypertrophy as well as neuronal protection. Transgenic activation of polyamine catabolism not only profoundly disturbs polyamine homeostasis in most tissues, but also creates a complex phenotype affecting skin, female fertility, fat depots, pancreatic integrity and regenerative growth. Transgenic expression of ornithine decarboxylase antizyme has suggested that this unique protein may act as a general tumor suppressor. Homozygous deficiency of the key biosynthetic enzymes of the polyamines, ornithine and S-adenosylmethionine decarboxylase is not compatible with murine embryogenesis.",Putrescine,HMDB0001414,b,b,C00134,PUTRESCINE,FDB001494,ptrc,[H][N+]([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[N+]([H])([H])[H],KIDHWZJUCRJVML-UHFFFAOYSA-P,InChI=1S/C4H12N2/c5-3-1-2-4-6/h1-6H2/p+2
2728,27406,"indole-5,6-quinone",a,8653,KEGG COMPOUND accession,C01748,,,,,,,,,,,,,,,
2729,27408,avenacin A-1,a,8654,KEGG COMPOUND accession,C07409,,,,,,,,,,,,,,,
2730,27412,gentamycin C1,a,45285,KEGG COMPOUND accession,C01956,,,,,,,,,,,,,,,
2731,27422,(KDO)2-(lauroyl)-lipid IVA,A lipid A comprising lipid IVA glycosylated with two 3-deoxy-D-manno-octulosonic acid (KDO) residues and carrying an additional dodecanoyl group.,27474,KEGG COMPOUND accession,C09894,,,,,,,,,,,,,,,
2732,27426,beta-L-rhamnoside,a,16227,KEGG COMPOUND accession,C00747,,,,,,,,,,,,,,,
2733,27430,7-O-methylluteone,A hydroxyisoflavone that is luteone in which the hydroxy group at position 7 is replaced by a methoxy group.,16675,KEGG COMPOUND accession,C03722,quln,89-00-9,16675.0,"Human Metabolome Database (HMDB): Quinolinic acid is a metabolite of tryptophan with a possible role in neurodegenerative disorders. Elevated CSF levels of quinolinic acid are correlated with the severity of neuropsychological deficits in patients who have AIDS. Quinolinic acid (QUIN) is a product of tryptophan metabolism that can act as an endogenous brain excitotoxin when released by activated macrophages. (Valle et. al, Brain 127:1047 (2004)).",Quinolinic acid,HMDB0000232,b,b,C03722,QUINOLINATE,FDB021913,quln,[H]C1=C([H])C([H])=C(C([O-])=O)C(=N1)C([O-])=O,GJAWHXHKYYXBSV-UHFFFAOYSA-L,"InChI=1S/C7H5NO4/c9-6(10)4-2-1-3-8-5(4)7(11)12/h1-3H,(H,9,10)(H,11,12)/p-2"
2734,27433,gibberellin A53,"A C20-gibberellin, initially identified in Vicia faba, that is gibberellin A12 in which a hydroxy substituent is present at the 7alpha- position.",28345,KEGG COMPOUND accession,C07327,,,,,,,,,,,,,,,
2735,27439,(KDO)-lipid IVA,Lipid IVA glycosylated with a single 3-deoxy-D-manno-octulosonic acid (KDO) residue.,17310,KEGG COMPOUND accession,C00250,pydx,66-72-8,17310.0,"Human Metabolome Database (HMDB): The 4-carboxyaldehyde form of vitamin B6 which is converted to pyridoxal phosphate which is a coenzyme for synthesis of amino acids, neurotransmitters (serotonin, norepinephrine), sphingolipids, aminolevulinic acid.",Pyridoxal,HMDB0001545,b,b,C00250,PYRIDOXAL,FDB011169,pydx,[H]OC1=C(N=C([H])C(=C1C([H])=O)C([H])([H])O[H])C([H])([H])[H],RADKZDMFGJYCBB-UHFFFAOYSA-N,"InChI=1S/C8H9NO3/c1-5-8(12)7(4-11)6(3-10)2-9-5/h2,4,10,12H,3H2,1H3"
2736,27451,"N-3,5-dichloro-4-hydroxyphenyl-1,4-benzoquinone imine","1,4-benzoquinone imine having a 3,5-dichloro-4-hydroxyphenyl substituent attached to the nitrogen atom.",18405,KEGG COMPOUND accession,C00018,pydx5p,54-47-7,18405.0,"Human Metabolome Database (HMDB): This is the active form of vitamin B6 serving as a coenzyme for synthesis of amino acids, neurotransmitters (serotonin, norepinephrine), sphingolipids, aminolevulinic acid. During transamination of amino acids, pyridoxal phosphate is transiently converted into pyridoxamine phosphate (pyridoxamine). -- Pubchem; Pyridoxal-phosphate (PLP, pyridoxal-5'-phosphate) is a cofactor of many enzymatic reactions. It is the active form of vitamin B6 which comprises three natural organic compounds, pyridoxal, pyridoxamine and pyridoxine. -- Wikipedia.",Pyridoxal 5'-phosphate,HMDB0001491,b,b,C00018,PYRIDOXAL_PHOSPHATE,FDB021820,pydx5p,[H]OC1=C(N=C([H])C(=C1C([H])=O)C([H])([H])OP([O-])([O-])=O)C([H])([H])[H],NGVDGCNFYWLIFO-UHFFFAOYSA-L,"InChI=1S/C8H10NO6P/c1-5-8(11)7(3-10)6(2-9-5)4-15-16(12,13)14/h2-3,11H,4H2,1H3,(H2,12,13,14)/p-2"
2737,27468,"5,6-dihydrothymine","A pyrimidone obtained by formal addition of hydrogen across the 5,6-position of thymine.",16709,KEGG COMPOUND accession,C00314,pydxn,65-23-6,16709.0,"Human Metabolome Database (HMDB): The 4-methanol form of vitamin B6 which is converted to pyridoxal phosphate which is a coenzyme for synthesis of amino acids, neurotransmitters (serotonin, norepinephrine), sphingolipids, aminolevulinic acid. Although pyridoxine and Vitamin B6 are still frequently used as synonyms, especially by medical researchers, this practice is erroneous and sometimes misleading (EE Snell; Ann NY Acad Sci, vol 585 pg 1, 1990). Pyridoxine is one of the compounds that can be called vitamin B6. Pyridoxine assists in the balancing of sodium and potassium as well as promoting red blood cell production. It is linked to cancer immunity and helps fight the formation of homocysteine. It has been suggested that Pyridoxine might help children with learning difficulties, and may also prevent dandruff, eczema, and psoriasis. In addition, pyridoxine can help balance hormonal changes in women and aid in immune system. Lack of pyridoxine may cause anemia, nerve damage, seizures, skin problems, and sores in the mouth. -- Wikipedia Deficiency, though rare because of widespread distribution in foods, leads to the development of peripheral neuritis in adults and affects the central nervous system in children (DOSE - 3rd edition). Pyridoxine in the urine is a biomarker for the consumption of soy products.",Pyridoxine,HMDB0000239,b,b,C00314,CPD-455,FDB000574,pydxn,[H]OC1=C(C(=C([H])N=C1C([H])([H])[H])C([H])([H])O[H])C([H])([H])O[H],LXNHXLLTXMVWPM-UHFFFAOYSA-N,"InChI=1S/C8H11NO3/c1-5-8(12)7(4-11)6(3-10)2-9-5/h2,10-12H,3-4H2,1H3"
2738,27476,beta-D-ribopyranose,A D-ribopyranose with a beta-configuration at the anomeric position.,28803,KEGG COMPOUND accession,C00627,pdx5p,447-05-2,28803.0,Human Metabolome Database (HMDB): Pyridoxine 5'-phosphate is a substrate for Pyridoxine-5'-phosphate oxidase and Pyridoxal kinase.,Pyridoxine 5'-phosphate,HMDB0001319,b,b,C00627,PYRIDOXINE-5P,FDB022552,pdx5p,[H]OC1=C(N=C([H])C(=C1C([H])([H])O[H])C([H])([H])OP([O-])([O-])=O)C([H])([H])[H],WHOMFKWHIQZTHY-UHFFFAOYSA-L,"InChI=1S/C8H12NO6P/c1-5-8(11)7(3-10)6(2-9-5)4-15-16(12,13)14/h2,10-11H,3-4H2,1H3,(H2,12,13,14)/p-2"
2739,27480,phenylacetylglycine,A N-acylglycine that is glycine substituted on nitrogen with a phenylacetyl group.,8673,KEGG COMPOUND accession,C07391,,,,,,,,,,,,,,,
2740,27482,(R)-coclaurine,a,8674,KEGG COMPOUND accession,C11180,,,,,,,,,,,,,,,
2741,27484,uroporphyrin I,a,16898,KEGG COMPOUND accession,C00396,,,,,,,,,,,,,,,
2742,27491,leukotriene F4,"A leukotriene composed of (7E,9E,11Z,14Z)-icosa-7,9,11,14-tetraenoic acid having (5S)-hydroxy and (6R)-(L-gamma-glutamyl-L-cystein-S-yl) substituents.",39457,KEGG COMPOUND accession,C03536,,,,,,,,,,,,,,,
2743,27499,N-acetyl-alpha-neuraminosyl-(2->3)-beta-D-galactosylceramide,A sialomonoglycosylceramide having N-acetyl-alpha-neuraminosyl-(2->3)-beta-D-galactosyl as the sialomonoglycosyl component.,8682,KEGG COMPOUND accession,C11179,,,,,,,,,,,,,,,
2744,27690,acetazolamide,a,36751,KEGG COMPOUND accession,C05942,,,,,,,,,,,,,,,
2745,27691,alpha-Neu5Ac-(2->8)-alpha-Neu5Ac-(2->3)-beta-Gal-(1->3)-beta-GalNAc-(1->4)-[alpha-Neu5Ac-(2->3)]-beta-Gal-(1->4)-beta-Glc-(1<->1')-Cer,"A sialotetraosylceramide consisting of a branched heptasaccharide made up from three sialyl residues, two galactose residues, one N-acetylglucosamine residue and a glucose residue at the reducing end attached to the ceramide portion via a beta-linkage.",32816,KEGG COMPOUND accession,C00022,pyr,127-17-3,32816.0,"Human Metabolome Database (HMDB): Pyruvic acid is an intermediate compound in the metabolism of carbohydrates, proteins, and fats. In thiamine deficiency, its oxidation is retarded and it accumulates in the tissues, especially in nervous structures (From Stedman, 26th ed.). Biological Source: Intermediate in primary metabolism including fermentation processes. Present in muscle in redox equilibrium with Lactic acid. A common constituent, as a chiral cyclic acetal linked to saccharide residues, of bacterial polysaccharides. Isolated from cane sugar fermentation broth and peppermint. Constituent of Bauhinia purpurea, Cicer arietinum (chickpea), Delonix regia, Pisum sativum (pea) and Trigonella caerulea (sweet trefoil) Use/Importance: Reagent for regeneration of carbonyl compdounds from semicarbazones, phenylhydrazones and oximes. Flavoring ingredient (Dictionary of Organic Compounds). Pyruvic acid is found to be associated with Fumarase deficiency, which is an inborn error of metabolism.",Pyruvic acid,HMDB0000243,b,b,C00022,PYRUVATE,FDB008293,pyr,[H]C([H])([H])C(=O)C([O-])=O,LCTONWCANYUPML-UHFFFAOYSA-M,"InChI=1S/C3H4O3/c1-2(4)3(5)6/h1H3,(H,5,6)/p-1"
2746,27797,"4-amino-6-chloro-1,3,5-triazin-2-ol",a,15730,KEGG COMPOUND accession,C02193,,,,,,,,,,,,,,,
2747,27799,lokundjoside,a,8687,KEGG COMPOUND accession,C07412,,,,,,,,,,,,,,,
2748,27811,undecaprenyldiphospho-N-acetyl-(N-acetylglucosaminyl)muramoyl-L-alanyl-D-isoglutaminyl-L-lysyl-D-alanyl-D-alanine,An undecaprenyldiphospho-N-acetylmuramoyl peptide in which the peptide moiety is L-alanyl-D-isoglutaminyl-L-lysyl-D-alanyl-D-alanine.,35267,KEGG COMPOUND accession,C06703,,,,,,,,,,,,,,,
2749,27814,12-dehydro-leukotriene B4,A long-chain fatty acid consisting of leukotriene B4 having a 12-keto group in place of the 12-hydroxy group.,8695,KEGG COMPOUND accession,C10122,,,,,,,,,,,,,,,
2750,27816,2-deoxy-L-arabinose,a,16243,KEGG COMPOUND accession,C00389,,,,,,,,,,,,,,,
2751,27823,(5-hydroxyindol-3-yl)acetic acid,A member of the class of indole-3-acetic acids that is  indole-3-acetic acid substituted by a hydroxy group at C-5.,16557,KEGG COMPOUND accession,C03897,,,,,,,,,,,,,,,
2752,27825,"3',5-dihydroxy-3,4',7-trimethoxyflavone","A trimethoxyflavone that is  quercetin in which the hydroxy groups at positions 3, 4' and 7 have been replaced by methoxy groups.",17875,KEGG COMPOUND accession,C01155,,,,,,,,,,,,,,,
2753,27828,N-glycoloyl-D-mannosaminolactone,a,28167,KEGG COMPOUND accession,C03898,,,,,,,,,,,,,,,
2754,27837,2-cyanopyridine,A cyanopyridine carrying the cyano group at position 2.,17730,KEGG COMPOUND accession,C00616,,,,,,,,,,,,,,,
2755,27843,cyanidin cation,"An anthocyanidin cation that is flavylium substituted at positions 3, 3', 4', 5 and 7 by hydroxy groups.",17558,KEGG COMPOUND accession,C01750,,,,,,,,,,,,,,,
2756,27849,toluene-4-sulfonic acid,An arenesulfonic acid that is benzenesulfonic acid in which the hydrogen at position 4 is replaced by a methyl group.,8707,KEGG COMPOUND accession,C07397,,,,,,,,,,,,,,,
2757,27856,acetamide,A member of the class of acetamides that results from the formal condensation of acetic acid with ammonia.,8710,KEGG COMPOUND accession,C08972,,,,,,,,,,,,,,,
2758,27858,precorrin-6Y,"The intermediate in the biosynthesis of vitamin B12 from uroporphyrinogen III in which six methyl groups have been introduced into the tetrapyrrole framework, together with ring contraction and reduction.",8711,KEGG COMPOUND accession,C07339,,,,,,,,,,,,,,,
2759,27860,castanospermine,"A tetrahydroxyindolizidine alkaloid that consists of octahydroindolizine having four hydroxy substituents located at positions 1, 6, 7 and 8 (the 1S,6S,7R,8R,8aR-diastereomer).",8712,KEGG COMPOUND accession,C11030,,,,,,,,,,,,,,,
2760,27864,"2,6-dichloro-4-nitroaniline","A nitroaniline that is 4-nitroaniline in which the hydrogens at positions 2 and 6 are replaced by chlorines. An agricultural fungicide, it is not approved for use in the European Union.",8714,KEGG COMPOUND accession,C07340,,,,,,,,,,,,,,,
2761,27866,"(2,3,3-trimethyl-5-oxocyclopent-3-enyl)acetyl-CoA","An acyl-CoA that results from the formal condensation of the thiol group of coenzyme A with the carboxy group of (2,3,3-trimethyl-5-oxocyclopent-3-enyl)acetic acid.",17521,KEGG COMPOUND accession,C00296,,,,,,,,,,,,,,,
2762,27873,3-fluoroaniline,A derivative of aniline in which the hydrogen at position 3 has been substituted by fluorine. It is used as a pharmaceutical intermediate.,8716,KEGG COMPOUND accession,C07619,,,,,,,,,,,,,,,
2763,27879,6-methylpretetramide,A member of the class of pretetramides in which the only additional substituent is a methyl group at position 6.,28593,KEGG COMPOUND accession,C06527,M02821,56-54-2,28593.0,"Human Metabolome Database (HMDB): An optical isomer of quinine, extracted from the bark of the Cinchona tree and similar plant species. This alkaloid dampens the excitability of cardiac and skeletal muscles by blocking sodium and potassium currents across cellular membranes. It prolongs cellular action potential, and decreases automaticity. Quinidine also blocks muscarinic and alpha-adrenergic neurotransmission. [PubChem]",Quinidine,HMDB0015044,b,b,C06527,b,b,b,[H]O[C@@]([H])(C1=C([H])C([H])=NC2=C([H])C([H])=C(OC([H])([H])[H])C([H])=C12)C1([H])[N@]2C([H])([H])C([H])([H])[C@@]([H])(C1([H])[H])[C@@]([H])(C([H])=C([H])[H])C2([H])[H],LOUPRKONTZGTKE-POOUTFPKSA-N,"InChI=1S/C20H24N2O2/c1-3-13-12-22-9-7-14(13)10-19(22)20(23)16-6-8-21-18-5-4-15(24-2)11-17(16)18/h3-6,8,11,13-14,19-20,23H,1,7,9-10,12H2,2H3/t13-,14-,19?,20-/m0/s1"
2764,27887,6-phospho-beta-D-galactoside,a,15854,KEGG COMPOUND accession,C06526,,,,,,,,,,,,,,,
2765,27890,L-iduronic acid 2-sulfate,a,17715,KEGG COMPOUND accession,C06342,,,,,,,,,,,,,,,
2766,27893,4-fluorobenzoate,A fluorobenzoate that is the conjugate base of 4-fluorobenzoic acid.,16365,KEGG COMPOUND accession,C06338,,,,,,,,,,,,,,,
2767,27898,cyanidin 3-O-(6-O-glucosyl-2-O-xylosylgalactoside),a,15815,KEGG COMPOUND accession,C06343,,,,,,,,,,,,,,,
2768,27901,podorhizol beta-D-glucoside,a,17362,KEGG COMPOUND accession,C06413,,,,,,,,,,,,,,,
2769,27904,D-erythrose,The D-enantiomer of erythrose.,28788,KEGG COMPOUND accession,C06330,,,,,,,,,,,,,,,
2770,27931,alpha-maltotriose,A maltotriose trisaccharide in which the glucose residue at the reducing end is in the pyranose ring form and has alpha configuration at the anomeric carbon atom..,35681,KEGG COMPOUND accession,C01612,,,,,,,,,,,,,,,
2771,27933,beta-lactam antibiotic,An organonitrogen heterocyclic antibiotic that contains a beta-lactam ring.,17087,KEGG COMPOUND accession,C01450,,,,,,,,,,,,,,,
2772,27944,"3'-deoxydihydrostreptomycin 3'',6-bisphosphate",a,8746,KEGG COMPOUND accession,C11770,,,,,,,,,,,,,,,
2773,27949,(E)-sinapaldehyde,A member of the class of cinnamaldehydes that is cinnamaldehyde substituted by a hydroxy group at position 4 and methoxy groups at positions 3 and 5.,17062,KEGG COMPOUND accession,C00375,,,,,,,,,,,,,,,
2774,27992,trans-4-hydroxy-D-proline,A 4-hydroxy-D-proline in which the hydroxy group at position 4 has S-configuration.,8764,KEGG COMPOUND accession,C07908,,,,,,,,,,,,,,,
2775,27998,tungsten,a,17792,KEGG COMPOUND accession,C01322,,,,,,,,,,,,,,,
2776,28000,N-acetyl-D-hexosaminide,a,8768,KEGG COMPOUND accession,C07864,,,,,,,,,,,,,,,
2777,28002,"(3Z,6Z)-dodecadienoyl-CoA","A medium-chain unsaturated fatty acyl-CoA that results from the formal condensation of the thiol group of coenzyme A with the carboxy group of cis,cis-dodeca-3,6-dienoic acid.",8769,KEGG COMPOUND accession,C07865,,,,,,,,,,,,,,,
2778,28006,"O,O-diethyl hydrogen thiophosphate","An organic thiophosphate that is the diethyl ester of phosphorothioic O,O,O-acid.",16634,KEGG COMPOUND accession,C00492,,,,,,,,,,,,,,,
2779,28013,"beta-D-fructofuranose 1,6-bisphosphate","A D-fructofuranose 1,6-bisphosphate with a beta-configuration at the anomeric position.",8772,KEGG COMPOUND accession,C07228,,,,,,,,,,,,,,,
2780,28029,aldehydo-D-rhamnose,The open-chain aldehyde form of D-rhamnose.,17400,KEGG COMPOUND accession,C02074,,,,,,,,,,,,,,,
2781,28034,beta-D-galactoside,Any D-galactoside having beta-configuration at its anomeric centre.,16048,KEGG COMPOUND accession,C01847,,,,,,,,,,,,,,,
2782,28152,3-hydroxy-5-methoxy-6-prenylstilbene-2-carboxylic acid,a,16906,KEGG COMPOUND accession,C00662,M02827,b,16906.0,b,Reduced-Adrenal-Ferredoxin,b,b,b,C00662,b,b,b,b,b,b
2783,28159,D-asparagine,An optically active form of asparagine having D-configuration.,15823,KEGG COMPOUND accession,C01080,,,,,,,,,,,,,,,
2784,28195,3alpha-hydroxy-5beta-androstan-17-one,An androstanoid that is 5beta-androstane substituted by an alpha-hydroxy group at position 3 and an oxo group at position 17. It is a metabolite of testosterone in mammals.,134180,KEGG COMPOUND accession,C05721,,,,,,,,,,,,,,,
2785,28211,gibberellin A44,A  C20-gibberellin with a heteropentacyclic skeleton that incorporates a lactone moiety.,8802,KEGG COMPOUND accession,C08021,,,,,,,,,,,,,,,
2786,28215,"cyanidin 3,3',5-tri-O-glucoside",a,16531,KEGG COMPOUND accession,C00982,,,,,,,,,,,,,,,
2787,28222,"1,2,4-trichlorobenzene","A trichlorobenzene with chloro substituents at positions 1, 2 and 4.",28572,KEGG COMPOUND accession,C06540,,,,,,,,,,,,,,,
2788,28226,alpha-L-arabinose 1-phosphate,a,8809,KEGG COMPOUND accession,C09179,,,,,,,,,,,,,,,
2789,28230,hesperetin,"A trihydroxyflavanone having the three hydroxy gropus located at the 3'-, 5- and 7-positions and an additional methoxy substituent at the 4'-position.",8811,KEGG COMPOUND accession,C10991,,,,,,,,,,,,,,,
2790,28232,D-ribose 5-triphosphate,a,27810,KEGG COMPOUND accession,C01751,,,,,,,,,,,,,,,
2791,28249,"2-hydroxy-5-methyl-cis,cis-muconic acid","A dicarboxylic acid that is cis,cis-muconic acid in which the hydrogens at positions 2 and 5 are substituted by hydroxy and methyl groups, respectively.",17336,KEGG COMPOUND accession,C00473,retinol,68-26-8,17336.0,"Human Metabolome Database (HMDB): Vitamin A (retinol) is a yellow fat-soluble, antioxidant vitamin important in vision and bone growth. It belongs to the family of chemical compounds known as retinoids. Retinol is ingested in a precursor form; animal sources (milk and eggs) contain retinyl esters, whereas plants (carrots, spinach) contain pro-vitamin A carotenoids. Hydrolysis of retinyl esters results in retinol while pro-vitamin A carotenoids can be cleaved to produce retinal. Retinal, also known as retinaldehyde, can be reversibly reduced to produce retinol or it can be irreversibly oxidized to produce retinoic acid. Retinol and derivatives of retinol that play an essential role in metabolic functioning of the retina, the growth of and differentiation of epithelial tissue, the growth of bone, reproduction, and the immune response. Dietary vitamin A is derived from a variety of carotenoids found in plants. It is enriched in the liver, egg yolks, and the fat component of dairy products.",Vitamin A,HMDB0000305,b,b,C00473,RETINOL,FDB013828,retinol,[H]OC([H])([H])C([H])=C(C([H])=C([H])C([H])=C(C([H])=C([H])C1=C(C([H])([H])[H])C([H])([H])C([H])([H])C([H])([H])C1(C([H])([H])[H])C([H])([H])[H])C([H])([H])[H])C([H])([H])[H],FPIPGXGPPPQFEQ-UHFFFAOYSA-N,"InChI=1S/C20H30O/c1-16(8-6-9-17(2)13-15-21)11-12-19-18(3)10-7-14-20(19,4)5/h6,8-9,11-13,21H,7,10,14-15H2,1-5H3"
2792,28249,"2-hydroxy-5-methyl-cis,cis-muconic acid","A dicarboxylic acid that is cis,cis-muconic acid in which the hydrogens at positions 2 and 5 are substituted by hydroxy and methyl groups, respectively.",17336,KEGG COMPOUND accession,C00473,retinol_9_cis,68-26-8,17336.0,"Human Metabolome Database (HMDB): Vitamin A (retinol) is a yellow fat-soluble, antioxidant vitamin important in vision and bone growth. It belongs to the family of chemical compounds known as retinoids. Retinol is ingested in a precursor form; animal sources (milk and eggs) contain retinyl esters, whereas plants (carrots, spinach) contain pro-vitamin A carotenoids. Hydrolysis of retinyl esters results in retinol while pro-vitamin A carotenoids can be cleaved to produce retinal. Retinal, also known as retinaldehyde, can be reversibly reduced to produce retinol or it can be irreversibly oxidized to produce retinoic acid. Retinol and derivatives of retinol that play an essential role in metabolic functioning of the retina, the growth of and differentiation of epithelial tissue, the growth of bone, reproduction, and the immune response. Dietary vitamin A is derived from a variety of carotenoids found in plants. It is enriched in the liver, egg yolks, and the fat component of dairy products.",Vitamin A,HMDB0000305,b,b,C00473,RETINOL,FDB013828,retinol_9_cis,[H]OC([H])([H])C(\[H])=C(\C(\[H])=C(/[H])\C(\[H])=C(\C(\[H])=C(/[H])C1=C(C([H])([H])[H])C([H])([H])C([H])([H])C([H])([H])C1(C([H])([H])[H])C([H])([H])[H])/C([H])([H])[H])/C([H])([H])[H],FPIPGXGPPPQFEQ-OVSJKPMPSA-N,"InChI=1S/C20H30O/c1-16(8-6-9-17(2)13-15-21)11-12-19-18(3)10-7-14-20(19,4)5/h6,8-9,11-13,21H,7,10,14-15H2,1-5H3/b9-6+,12-11+,16-8+,17-13+"
2793,28260,galactose,An aldohexose that is the C-4 epimer of glucose.,17616,KEGG COMPOUND accession,C02588,,,,,,,,,,,,,,,
2794,28271,hellebrin,a,74992,KEGG COMPOUND accession,C10176,,,,,,,,,,,,,,,
2795,28273,aldehydo-N-acetyl-D-mannosamine 6-phosphate,An aldehydo-N-acyl-D-mannosamine 6-phosphate that has acetyl as the acyl group.,8824,KEGG COMPOUND accession,C10288,,,,,,,,,,,,,,,
2796,28281,5-methoxyindole-3-acetic acid,A member of the class of indole-3-acetic acids in which the hydrogen at position 5 of indole-3-acetic acid has been replaced by a methoxy group.,8828,KEGG COMPOUND accession,C11190,,,,,,,,,,,,,,,
2797,28283,capsidiol,An eremophilane sesquiterpenoid that is (+)-5-epi-aristolochene bearing additional 1beta- and 3alpha-hydroxy substituents. It is a phytoalexin produced in Nicotiana and Capsicum plant species in response to pathogen attack.,52672,KEGG COMPOUND accession,C11177,,,,,,,,,,,,,,,
2798,28287,alpha-D-Galp-(1->3)-[alpha-L-Fucp-(1->2)]-beta-D-Galp-(1->3)-beta-D-GlcpNAc-(1->3)-beta-D-Galp-(1->4)-beta-D-Glcp-(1->1')-Cer,A glycohexaosylceramide having alpha-D-Gal-(1->3)-[alpha-L-Fuc-(1->2)]-beta-D-Gal-(1->3)-beta-D-GlcNAc-(1->3)-beta-D-Gal-(1->4)-beta-D-Glc as the glycohexaosyl component.,27481,KEGG COMPOUND accession,C08877,,,,,,,,,,,,,,,
2799,28313,(S)-nornicotine,A pyridine alkaloid that is nicotine lacking the methyl group on the pyrrolidine nitrogen.,17015,KEGG COMPOUND accession,C00255,ribflv,83-88-5,17015.0,"Human Metabolome Database (HMDB): Riboflavin or vitamin B2 is an easily absorbed, water-soluble micronutrient with a key role in maintaining human health. Like the other B vitamins, it supports energy production by aiding in the metabolizing of fats, carbohydrates, and proteins. Vitamin B2 is also required for red blood cell formation and respiration, antibody production, and for regulating human growth and reproduction. It is essential for healthy skin, nails, hair growth and general good health, including regulating thyroid activity. Riboflavin is found in milk, eggs, malted barley, liver, kidney, heart, and leafy vegetables. Riboflavin is yellow or orange-yellow in color and in addition to being used as a food coloring it is also used to fortify some foods. It can be found in baby foods, breakfast cereals, sauces, processed cheese, fruit drinks and vitamin-enriched milk products. The richest natural source is yeast. It occurs in the free form only in the retina of the eye, in whey, and in urine; its principal forms in tissues and cells are as flavin mononucleotide and flavin adenine dinucleotide.",Riboflavin,HMDB0000244,b,b,C00255,RIBOFLAVIN,FDB012160,ribflv,[H]OC([H])([H])[C@@]([H])(O[H])[C@@]([H])(O[H])[C@@]([H])(O[H])C([H])([H])N1C2=NC(=O)N([H])C(=O)C2=NC2=C([H])C(=C(C([H])=C12)C([H])([H])[H])C([H])([H])[H],AUNGANRZJHBGPY-SCRDCRAPSA-N,"InChI=1S/C17H20N4O6/c1-7-3-9-10(4-8(7)2)21(5-11(23)14(25)12(24)6-22)15-13(18-9)16(26)20-17(27)19-15/h3-4,11-12,14,22-25H,5-6H2,1-2H3,(H,20,26,27)/t11-,12+,14-/m0/s1"
2800,28323,"3,4-dihydroxycinnamaldehyde",A cinnamaldehyde that is (E)-cinnamaldehyde substituted at positions 3 and 4 on the phenyl ring by hydroxy groups.,18254,KEGG COMPOUND accession,C00911,,,,,,,,,,,,,,,
2801,28325,(S)-3-hydroxydecanoyl-CoA,A 3-hydroxyacyl-CoA that results from the formal condensation of the thiol group of coenzyme A with the carboxy group of 3-hydroxydecanoic acid.,17668,KEGG COMPOUND accession,C03723,,,,,,,,,,,,,,,
2802,28327,naringenin 7-O-beta-D-glucoside,A flavanone 7-O-beta-D-glucoside that is (S)-naringenin substituted by a beta-D-glucopyranosyl moiety at position 7 via a glycosidic linkage.,17972,KEGG COMPOUND accession,C03802,,,,,,,,,,,,,,,
2803,28329,trioxsalen,"7H-Furo[3,2-g]chromen-7-one in which positions 2, 5, and 9 are substituted by methyl groups. Like other psoralens, trioxsalen causes photosensitization of the skin. It is administered orally in conjunction with UV-A for phototherapy treatment of vitiligo. After photoactivation it creates interstrand cross-links in DNA, inhibiting DNA synthesis and cell division, and can lead to cell injury; recovery from the cell injury may be followed by increased melanisation of the epidermis.",18159,KEGG COMPOUND accession,C02884,,,,,,,,,,,,,,,
2804,28334,malonamoyl-CoA,An acyl-CoA that results from the formal condensation of the thiol group of coenzyme A with the carboxy group of malonamic acid.,28721,KEGG COMPOUND accession,C05052,,,,,,,,,,,,,,,
2805,28341,2-hydroxyacetophenone,A monohydroxyacetophenone that is acetophenone in which one of the methyl hydrogens has been replaced by a hydroxy group.,28592,KEGG COMPOUND accession,C08365,,,,,,,,,,,,,,,
2806,28349,alpha-L-fucoside,a,28077,KEGG COMPOUND accession,C06688,,,,,,,,,,,,,,,
2807,28354,1-deoxy-D-xylulose,a,16324,KEGG COMPOUND accession,C01849,,,,,,,,,,,,,,,
2808,28367,"4,5-leukotriene A4","A leukotriene whose structure comprises leukotriene A4 having a (4R,5R)-epoxy group.",8866,KEGG COMPOUND accession,C10952,,,,,,,,,,,,,,,
2809,28383,"alpha,omega-dicarboxylic acid",a,8874,KEGG COMPOUND accession,C11766,,,,,,,,,,,,,,,
2810,28387,"(2-trans,6-cis)-dodeca-2,6-dienoyl-CoA","An unsaturated fatty acyl-CoA that results from the formal condensation of the thiol group of coenzyme A with the carboxy group of (2-trans,6-cis)-dodeca-2,6-dienoic acid.",8876,KEGG COMPOUND accession,C10177,,,,,,,,,,,,,,,
2811,28391,S(8)-glutaryldihydrolipoamide,a,8878,KEGG COMPOUND accession,C10178,,,,,,,,,,,,,,,
2812,28397,cis-4-hydroxy-L-proline,L-Proline in which a hydrogen at the 4-position of the pyrrolidine ring is substituted by a hydroxy group (S-configuration).,8881,KEGG COMPOUND accession,C10179,,,,,,,,,,,,,,,
2813,28401,N-acetyl-D-glucosaminide,a,8883,KEGG COMPOUND accession,C10736,,,,,,,,,,,,,,,
2814,28409,triacontan-1-ol,An ultra-long-chain primary fatty alcohol that is triacontane in which one of the terminal methyl hydrogens is replaced by a hydroxy group.,8887,KEGG COMPOUND accession,C07590,,,,,,,,,,,,,,,
2815,28411,allicin,a,8888,KEGG COMPOUND accession,C07564,,,,,,,,,,,,,,,
2816,28415,hexacosan-1-ol,A very long-chain primary fatty alcohol that is hexacosane in which a hydrogen attached to one of the terminal carbons is replaced by a hydroxy group.,8890,KEGG COMPOUND accession,C07532,,,,,,,,,,,,,,,
2817,28421,coproporphyrin I,a,8893,KEGG COMPOUND accession,C08729,,,,,,,,,,,,,,,
2818,28432,4alpha-methylcholest-8-en-3beta-ol,a,8898,KEGG COMPOUND accession,C10525,,,,,,,,,,,,,,,
2819,28440,"(2,6-dihydroxyphenyl)acetate","A dihydroxy monocarboxylic acid anion that is the conjugate base of (2,6-dihydroxyphenyl)acetic acid, arising from deprotonation of the carboxy group.",28909,KEGG COMPOUND accession,C11208,,,,,,,,,,,,,,,
2820,28446,"3D-3,5/4-trihydroxycyclohexane-1,2-dione",a,28798,KEGG COMPOUND accession,C02321,,,,,,,,,,,,,,,
2821,28448,N-acetylglucosamine 4-sulfate,a,69533,KEGG COMPOUND accession,C10402,,,,,,,,,,,,,,,
2822,28450,3'-phosphoadenylyl selenate,An organoselenium compound that is adenylyl selenate with the hydroxy at position 3' replaced by a phosphate group.,8907,KEGG COMPOUND accession,C08611,,,,,,,,,,,,,,,
2823,28478,(2-hydroxyphenyl)acetic acid,A hydroxy monocarboxylic acid that is acetic acid in which one of the methyl hydrogens is substituted by a 2-hydroxyphenyl group. It is a metabolite of phenylalanine and is excreted in the urine of patients suffering from diseases like phenylketonuria.,69039,KEGG COMPOUND accession,C09309,,,,,,,,,,,,,,,
2824,28485,polypodine B,a,27522,KEGG COMPOUND accession,C08247,,,,,,,,,,,,,,,
2825,28487,reserpine,An alkaloid found in the roots of Rauwolfia serpentina and R. vomitoria.,8925,KEGG COMPOUND accession,C08705,,,,,,,,,,,,,,,
2826,28492,5-methylbarbituric acid,a,8927,KEGG COMPOUND accession,C11175,,,,,,,,,,,,,,,
2827,28494,cardiolipin,A phosphatidylglycerol composed of two molecules of phosphatidic acid covalently linked to a molecule of glycerol.,17491,KEGG COMPOUND accession,C03899,,,,,,,,,,,,,,,
2828,28496,N-[(5S)-5-amino-5-carboxypentanoyl]-L-cysteinyl-D-valine,A tripeptoid arising from cleavage of both rings of a penicillin derivative.,28692,KEGG COMPOUND accession,C05118,HC01376,b,28692.0,Human Metabolome Database (HMDB): S-(2-Methylbutanoyl)-dihydrolipoamide-E is an intermediate in isoleucine degradation. S-(2-Methylbutanoyl)-dihydrolipoamide is normally conjugated to a lysine residue of the methylpropanoyltransferase enzyme (E stands for enzyme). The structure shown here is the free form. Specifically S-(2-Methylbutanoyl)-dihydrolipoamide-E is the 2-methylbutanoyl thioester of the reduced lipoyllysine residue in dihydrolipoyllysine-residue (2-methylpropanoyl)transferase.,S-(2-Methylbutanoyl)-dihydrolipoamide,HMDB0006869,b,b,C05118,b,FDB024125,HC01376,[H]SC([H])(C([H])([H])C([H])([H])SC(=O)C([H])(C([H])([H])[H])C([H])([H])C([H])([H])[H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C(=O)N([H])[H],UFNCWFSSEGPJNL-UHFFFAOYSA-N,"InChI=1S/C13H25NO2S2/c1-3-10(2)13(16)18-9-8-11(17)6-4-5-7-12(14)15/h10-11,17H,3-9H2,1-2H3,(H2,14,15)"
2829,28498,acadesine,"A 1-ribosylimidazolecarboxamide in which the carboxamide group is situated at position 4 of the imidazole ring, which is further substituted at position 5 by an amino group. A purine nucleoside analogue and activator of AMP-activated protein kinase, it is  is used for the treatment of acute lymphoblastic leukemia and is reported to have cardioprotective effects.",17577,KEGG COMPOUND accession,C04424,2mpdhl,b,17577.0,"Human Metabolome Database (HMDB): S-(2-Methylpropionyl)-dihydrolipoamide-E is an intermediate in valine, leucine and isoleucine degradation(KEGG ID C15977). It is the second to last step in the synthesis of branched chain fatty acid and is converted from 2-methyl-1-hydroxypropyl-ThPP via the enzyme 2-oxoisovalerate dehydrogenase [EC:1.2.4.4]. It is then converted to isobutyryl-CoA via the enzyme dihydrolipoyllysine-residue (2-methylpropanoyl)transferase [EC:2.3.1.168].",S-(2-Methylpropionyl)-dihydrolipoamide-E,HMDB0006868,b,b,C04424,b,FDB024124,2mpdhl,[H]SC([H])(C([H])([H])C([H])([H])SC(=O)C([H])(C([H])([H])[H])C([H])([H])[H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C(=O)N([H])[H],UEFURMXXHJCLJP-UHFFFAOYSA-N,"InChI=1S/C12H23NO2S2/c1-9(2)12(15)17-8-7-10(16)5-3-4-6-11(13)14/h9-10,16H,3-8H2,1-2H3,(H2,13,14)"
2830,28500,N(3'')-acetylkanamycin,a,27462,KEGG COMPOUND accession,C05119,HC01377,b,27462.0,"Human Metabolome Database (HMDB): S-(3-Methylbutanoyl)-dihydrolipoamide-E is an intermediate in valine, leucine and isoleucine degradation(KEGG ID C15975 ). It is the second to last step in the synthesis of branched chain fatty acid and is converted from 3-methyl-hydroxybutyl-ThPP via the enzyme 2-oxoisovalerate dehydrogenase [EC:1.2.4.4]. It is then converted to 3-methylbutanoyl-CoA via the enzyme dihydrolipoyllysine-residue (2-methylpropanoyl)transferase[EC:2.3.1.168].",S-(3-Methylbutanoyl)-dihydrolipoamide-E,HMDB0006867,b,b,C05119,b,FDB024123,HC01377,[H]SC([H])(C([H])([H])C([H])([H])SC(=O)C([H])([H])C([H])(C([H])([H])[H])C([H])([H])[H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C(=O)N([H])[H],KMUSXGCRMMQDBP-UHFFFAOYSA-N,"InChI=1S/C13H25NO2S2/c1-10(2)9-13(16)18-8-7-11(17)5-3-4-6-12(14)15/h10-11,17H,3-9H2,1-2H3,(H2,14,15)"
2831,28504,dTDP-D-glucuronate,a,17736,KEGG COMPOUND accession,C03900,,,,,,,,,,,,,,,
2832,28506,arsonoacetic acid,An organoarsonic acid that is methylarsonic acid in which one of the hydrogens of the methyl group is replaced by a carboxy group.,8934,KEGG COMPOUND accession,C04264,,,,,,,,,,,,,,,
2833,28508,"2,5-dihydroxybenzaldehyde",A dihydroxybenzaldehyde carrying hydroxy groups at positions 2 and 5.,15510,KEGG COMPOUND accession,C03724,,,,,,,,,,,,,,,
2834,28516,"1,2-dihydronaphthalene-1,2-diol","A member of the class of naphthalenediols that is 1,2-dihydronaphthalene substituted by hydroxy groups at positions 1 and 2 respectively.",8939,KEGG COMPOUND accession,C11035,,,,,,,,,,,,,,,
2835,28518,alpha-D-xylose,A D-xylopyranose in with an alpha-configuration at the anomeric position.,16807,KEGG COMPOUND accession,C01136,HC00682,b,16807.0,"Human Metabolome Database (HMDB): S-Acetyldihydrolipoamide is a thio-acetylated form of dihydrolipoamide. The molecule is commonly conjugated to lysine residues. The structure shown is the free form of the molecule. Pyruvate dehydrogenase complex. The reaction is 2-(alpha-hydroxyethyl)-TPP + lipoamide => S-acetyldihydrolipoamide + TPP [Homo sapiens], occuring in mitochondrial matrix. (reactome.org). S-Acetyldihydrolipoamide is an intermediate in alanine, aspartate and pyruvate metabolism and glycolysis/gluconeogenesis (KEGG:C01136). It is converted from 2-hydroxyethyl-THPP and lipoamide via the enzyme pyruvate dehydrogenase (EC:1.2.4.1). It is then converted to acetyl-CoA via the enzyme pyruvate dehydrogenase E2 component (dihydrolipoamide acetyltransferase) (EC:2.3.1.12).",S-Acetyldihydrolipoamide,HMDB0001526,b,b,C01136,S-ACETYLDIHYDROLIPOAMIDE,FDB022671,HC00682,[H]SC([H])([H])C([H])([H])C([H])(SC(=O)C([H])([H])[H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C(=O)N([H])[H],ARGXEXVCHMNAQU-UHFFFAOYSA-N,"InChI=1S/C10H19NO2S2/c1-8(12)15-9(6-7-14)4-2-3-5-10(11)13/h9,14H,2-7H2,1H3,(H2,11,13)"
2836,28521,kolaflavanone,A biflavonoid isolated from the seeds of Garcinia kola that has been shown to exhibit hepatoprotective activity.,28228,KEGG COMPOUND accession,C03725,,,,,,,,,,,,,,,
2837,28523,"2',6'-dihydroxy-4'-methoxydihydrochalcone",A member of the class of dihydrochalcones that is dihydrochalcone substituted by hydroxy groups at positions 2' and 6' and a methoxy group at position 4' respectively.,17853,KEGG COMPOUND accession,C03537,,,,,,,,,,,,,,,
2838,28527,rutin,A rutinoside that is quercetin with the hydroxy group at position C-3 substituted with glucose and rhamnose sugar groups.,8944,KEGG COMPOUND accession,C04425,,,,,,,,,,,,,,,
2839,28529,quercetin 7-O-beta-D-glucoside,A quercetin O-glucoside in which a glucosyl residue is attached at position 7 of quercetin via a beta-glycosidic linkage.,16680,KEGG COMPOUND accession,C00021,ahcys,979-92-0,16680.0,"Human Metabolome Database (HMDB): S-Adenosyl-L-homocysteine (SAH) is formed by the demethylation of S-adenosyl-L-methionine. S-Adenosylhomocysteine (AdoHcy or SAH) is also the immediate precursor of all of the homocysteine produced in the body. The reaction is catalyzed by S-adenosylhomocysteine hydrolase and is reversible with the equilibrium favoring formation of SAH. In vivo, the reaction is driven in the direction of homocysteine formation by the action of the enzyme adenosine deaminase which converts the second product of the S-adenosylhomocysteine hydrolase reaction, adenosine, to inosine. Except for methyl transfer from betaine and from methylcobalamin in the methionine synthase reaction, SAH is the product of all methylation reactions that involve S-adenosylmethionine (SAM) as the methyl donor. Methylation is significant in epigenetic regulation of protein expression via DNA and histone methylation. The inhibition of these SAM-mediated processes by SAH is a proven mechanism for metabolic alteration. Because the conversion of SAH to homocysteine is reversible, with the equilibrium favoring the formation of SAH, increases in plasma homocysteine are accompanied by an elevation of SAH in most cases. Disturbances in the transmethylation pathway indicated by abnormal SAH, SAM, or their ratio have been reported in many neurodegenerative diseases, such as dementia, depression, and Parkinson's disease (PMID: 18065573, 17892439). Therefore, when present in sufficiently high levels, S-adenosylhomocysteine can act as an immunotoxin and a metabotoxin. An immunotoxin disrupts, limits the function, or destroys immune cells. A metabotoxin is an endogenous metabolite that causes adverse health effects at chronically high levels. Chronically high levels of S-adenosylhomocysteine are associated with S-adenosylhomocysteine (SAH) hydrolase deficiency and adenosine deaminase deficiency. S-Adenosylhomocysteine forms when there are elevated levels of homocysteine and adenosine. S-Adenosyl-L-homocysteine is a potent inhibitor of S-adenosyl-L-methionine-dependent methylation reactions. It is toxic to immature lymphocytes and can lead to immunosuppression (PMID: 221926).",S-Adenosylhomocysteine,HMDB0000939,b,b,C00021,ADENOSYL-HOMO-CYS,FDB022327,ahcys,[H]O[C@@]1([H])[C@@]([H])(O[C@]([H])(C([H])([H])SC([H])([H])C([H])([H])[C@@]([H])(C([O-])=O)[N+]([H])([H])[H])[C@@]1([H])O[H])N1C([H])=NC2=C(N=C([H])N=C12)N([H])[H],ZJUKTBDSGOFHSH-WFMPWKQPSA-N,"InChI=1S/C14H20N6O5S/c15-6(14(23)24)1-2-26-3-7-9(21)10(22)13(25-7)20-5-19-8-11(16)17-4-18-12(8)20/h4-7,9-10,13,21-22H,1-3,15H2,(H,23,24)(H2,16,17,18)/t6-,7+,9+,10+,13+/m0/s1"
2840,28654,3-methyl-2-oxovalerate,"A 2-oxo monocarboxylic acid anion that is the conjugate base of 3-methyl-2-oxovaleric acid, arising from deprotonation of the carboxy group; major species at pH 7.3.",15414,KEGG COMPOUND accession,C00019,amet,29908-03-0,15414.0,"Human Metabolome Database (HMDB): Physiologic methyl radical donor involved in enzymatic transmethylation reactions and present in all living organisms. It possesses anti-inflammatory activity and has been used in treatment of chronic liver disease. (From Merck, 11th ed)",S-Adenosylmethionine,HMDB0001185,b,b,C00019,S-ADENOSYLMETHIONINE,FDB022473,amet,[H]O[C@@]1([H])[C@@]([H])(O[C@]([H])(C([H])([H])[S+](C([H])([H])[H])C([H])([H])C([H])([H])[C@@]([H])(C([O-])=O)[N+]([H])([H])[H])[C@@]1([H])O[H])N1C([H])=NC2=C(N=C([H])N=C12)N([H])[H],MEFKEPWMEQBLKI-AIRLBKTGSA-O,"InChI=1S/C15H22N6O5S/c1-27(3-2-7(16)15(24)25)4-8-10(22)11(23)14(26-8)21-6-20-9-12(17)18-5-19-13(9)21/h5-8,10-11,14,22-23H,2-4,16H2,1H3,(H2-,17,18,19,24,25)/p+1/t7-,8+,10+,11+,14+,27?/m0/s1"
2841,28788,"quinoline-3,4-diol",a,15625,KEGG COMPOUND accession,C01137,ametam,22365-13-5,15625.0,"Human Metabolome Database (HMDB): S-Adenosylmethioninamine is a biological sulfonium compound known as the major biological methyl donor. It is also a donor of methylene groups, amino groups, ribosyl groups and aminopropyl groups (PMID 15130560). S-Adenosylmethioninamine is a prodcut of enzyme adenosylmethionine decarboxylase [EC 4.1.1.50] in methionine metabolism pathway (KEGG).",S-Adenosylmethioninamine,HMDB0000988,b,b,C01137,S-ADENOSYLMETHIONINAMINE,FDB022353,ametam,[H]O[C@@]1([H])[C@@]([H])(O[C@]([H])(C([H])([H])[S+](C([H])([H])[H])C([H])([H])C([H])([H])C([H])([H])[N+]([H])([H])[H])[C@@]1([H])O[H])N1C([H])=NC2=C(N=C([H])N=C12)N([H])[H],ZUNBITIXDCPNSD-LSRJEVITSA-O,"InChI=1S/C14H23N6O3S/c1-24(4-2-3-15)5-8-10(21)11(22)14(23-8)20-7-19-9-12(16)17-6-18-13(9)20/h6-8,10-11,14,21-22H,2-5,15H2,1H3,(H2,16,17,18)/q+1/p+1/t8-,10-,11-,14-,24?/m1/s1"
2842,28788,"quinoline-3,4-diol",a,15625,KEGG COMPOUND accession,C01137,HC02119,22365-13-5,15625.0,"Human Metabolome Database (HMDB): S-Adenosylmethioninamine is a biological sulfonium compound known as the major biological methyl donor. It is also a donor of methylene groups, amino groups, ribosyl groups and aminopropyl groups (PMID 15130560). S-Adenosylmethioninamine is a prodcut of enzyme adenosylmethionine decarboxylase [EC 4.1.1.50] in methionine metabolism pathway (KEGG).",S-Adenosylmethioninamine,HMDB0000988,b,b,C01137,S-ADENOSYLMETHIONINAMINE,FDB022353,b,[H]O[C@@]1([H])[C@@]([H])(O[C@]([H])(C([H])([H])[S+](C([H])([H])[H])C([H])([H])C([H])([H])C([H])([H])N([H])[H])[C@@]1([H])O[H])N1C([H])=NC2=C1N=C([H])N=C2N([H])[H],ZUNBITIXDCPNSD-LSRJEVITSA-N,"InChI=1S/C14H23N6O3S/c1-24(4-2-3-15)5-8-10(21)11(22)14(23-8)20-7-19-9-12(16)17-6-18-13(9)20/h6-8,10-11,14,21-22H,2-5,15H2,1H3,(H2,16,17,18)/q+1/t8-,10-,11-,14-,24?/m1/s1"
2843,28793,beta-D-glucan,a,29289,KEGG COMPOUND accession,C02885,,,,,,,,,,,,,,,
2844,28795,m-toluate,A toluate that is the conjugate base of m-toluic acid.,47915,KEGG COMPOUND accession,C02749,,,,,,,,,,,,,,,
2845,28797,D-alpha-aminobutyric acid,An optically active form of alpha-aminobutyric acid having D-configuration.,28133,KEGG COMPOUND accession,C03726,,,,,,,,,,,,,,,
2846,28799,"quinoline-4,6-diol","Quinoline substituted by hydroxy groups at the 4- and 6-positions. It is the product of 5-hydroxytryptophan metabolism, via monoamine oxidase catalysed conversion of 5-hydroxykynurenamine.",16882,KEGG COMPOUND accession,C01242,alpro,b,16882.0,b,S-Aminomethyldihydrolipoylprotein,b,b,b,C01242,b,b,alpro,[H]SC([H])(C([H])([H])C([H])([H])SC([H])([H])N([H])[H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C(=O)N([H])[*],b,b
2847,28802,flavonols,Any hydroxyflavone in which is the ring hydrogen at position 3 of the heterocyclic ring is replaced by a hydroxy group.,15515,KEGG COMPOUND accession,C00512,,,,,,,,,,,,,,,
2848,28813,sinapyl alcohol,"A primary alcohol, being cinnamyl alcohol hydroxylated at C-4 and methoxylated at C-3 and -5.",28714,KEGG COMPOUND accession,C04543,,,,,,,,,,,,,,,
2849,28815,heparan sulfate,A linear polysaccharide in which the backbone consists of a variably sulfated repeating disaccharide unit.,16163,KEGG COMPOUND accession,C03727,,,,,,,,,,,,,,,
2850,28819,naringin,A disaccharide derivative that is (S)-naringenin substituted by a 2-O-(alpha-L-rhamnopyranosyl)-beta-D-glucopyranosyl moiety at position 7 via a glycosidic linkage.,16225,KEGG COMPOUND accession,C01031,Sfglutth,50409-81-9,16225.0,Human Metabolome Database (HMDB): S-Formylglutathione is formed from the oxidation of S-hydroxymethylglutathione by the enzyme formaldehyde dehydrogenase (FDH; EC 1.2.1.1) in the presence of NAD (PubMed ID 2806555).,S-Formylglutathione,HMDB0001550,b,b,C01031,CPD-548,FDB022685,Sfglutth,[H]N(C(=O)[C@@]([H])(N([H])C(=O)C([H])([H])C([H])([H])[C@@]([H])(C([O-])=O)[N+]([H])([H])[H])C([H])([H])SC([H])=O)C([H])([H])C([O-])=O,FHXAGOICBFGEBF-BQBZGAKWSA-M,"InChI=1S/C11H17N3O7S/c12-6(11(20)21)1-2-8(16)14-7(4-22-5-15)10(19)13-3-9(17)18/h5-7H,1-4,12H2,(H,13,19)(H,14,16)(H,17,18)(H,20,21)/p-1/t6-,7-/m0/s1"
2851,28822,icosanoic acid,A C20 striaght-chain saturated fatty acid which forms a minor constituent of peanut (L. arachis) and corn oils. Used as an organic thin film in the production of liquid crystals for a wide variety of technical applications.,15735,KEGG COMPOUND accession,C06718,,,,,,,,,,,,,,,
2852,28824,stigmasterol,"A 3beta-sterol that consists of 3beta-hydroxystigmastane having double bonds at the 5,6- and 22,23-positions.",28391,KEGG COMPOUND accession,C06157,HC01712,b,28391.0,Human Metabolome Database (HMDB): S-Glutaryldihydrolipoamide is involved in the lysine degradation pathway. S-Glutaryldihydrolipoamide can be irreversibly created from 2-Oxoadipate by 2-oxoglutarate dehydrogenase E1 component [EC:1.2.4.2]. S-Glutaryldihydrolipoamide can be reversibly created from Glutaryl-CoA by 2-oxoglutarate dehydrogenase E2 component (dihydrolipoamide. succinyltransferase) [EC:2.3.1.61].,S-Glutaryldihydrolipoamide,HMDB0006832,b,b,C06157,b,FDB024108,HC01712,[H]SC([H])(C([H])([H])C([H])([H])SC(=O)C([H])([H])C([H])([H])C([H])([H])C([O-])=O)C([H])([H])C([H])([H])C([H])([H])C([H])([H])C(=O)N([H])[H],PWTIHZUSTBSVGF-UHFFFAOYSA-M,"InChI=1S/C13H23NO4S2/c14-11(15)5-2-1-4-10(19)8-9-20-13(18)7-3-6-12(16)17/h10,19H,1-9H2,(H2,14,15)(H,16,17)/p-1"
2853,28830,chlorambucil,A monocarboxylic acid that is butanoic acid substituted at position 4 by a 4-[bis(2-chloroethyl)amino]phenyl group. A chemotherapy drug that can be used in combination with the antibody obinutuzumab for the treatment of chronic lymphocytic leukemia.,27704,KEGG COMPOUND accession,C02886,,,,,,,,,,,,,,,
2854,28832,androsterone 3-glucosiduronic acid,A steroid glucosiduronic acid having androsterone as the steroid component.,17010,KEGG COMPOUND accession,C03431,,,,,,,,,,,,,,,
2855,28838,lutein,a,15880,KEGG COMPOUND accession,C04399,,,,,,,,,,,,,,,
2856,28842,octadecanoic acid,"A C18 straight-chain saturated fatty acid component of many animal and vegetable lipids. As well as in the diet, it is used in hardening soaps, softening plastics and in making cosmetics, candles and  plastics.",47870,KEGG COMPOUND accession,C03173,,,,,,,,,,,,,,,
2857,28853,isopimpinellin,a,17432,KEGG COMPOUND accession,C01169,HC00695,b,17432.0,Human Metabolome Database (HMDB): (S)-Succinyldihydrolipoamide is a metabolite (a product as well as a substrate) in glutamate degradation.,(S)-Succinyldihydrolipoamide,HMDB0001177,b,b,C01169,CPD0-341,FDB022467,b,[H]SC([H])(C([H])([H])C([H])([H])SC(=O)C([H])([H])C([H])([H])C([O-])=O)C([H])([H])C([H])([H])C([H])([H])C([H])([H])C(=O)N([H])[H],KWKBJWYJJBQOAE-UHFFFAOYSA-M,"InChI=1S/C12H21NO4S2/c13-10(14)4-2-1-3-9(18)7-8-19-12(17)6-5-11(15)16/h9,18H,1-8H2,(H2,13,14)(H,15,16)/p-1"
2858,28856,p-toluate,"A toluate that is the conjugate base of p-toluic acid, obtained by deprotonation of the carboxy group.",15892,KEGG COMPOUND accession,C03174,,,,,,,,,,,,,,,
2859,28859,5alpha-androstane,The 5alpha-stereoisomer of androstane.,27891,KEGG COMPOUND accession,C05824,slfcys,1637-71-4,27891.0,"Human Metabolome Database (HMDB): Cysteine-S-sulfate (SSC) is produced by reaction of inorganic sulfite and cystine by a yet unknown pathway and is a very potent NMDA-receptor agonist. Electrophysiological studies have shown that SSC displays depolarizing properties similar to glutamate. Patients affected with either Molybdenum cofactor deficiency (MOCOD, an autosomal recessive disease that leads to a combined deficiency of the enzymes sulphite oxidase, an enzyme that catalyzes the conversion of sulfite to inorganic sulfate, xanthine dehydrogenase and aldehyde oxidase) or isolated sulphite oxidase deficiency (ISOD, an extremely rare autosomal recessive disorder with identical clinical manifestations to MOCOD) excrete elevated levels of SSC. This rare disorder is associated with brain damage (seizures, spastic quadriplegia, and cerebral atrophy), mental retardation, dislocated ocular lenses, blindness, and excretion in the urine of abnormally large amounts of SSC, sulfite, and thiosulfate but no inorganic sulfate (PMID: 17764028, 15558695).",Cysteine-S-sulfate,HMDB0000731,b,b,C05824,b,FDB022209,slfcys,[H][N+]([H])([H])[C@]([H])(C([O-])=O)C([H])([H])SS([O-])(=O)=O,NOKPBJYHPHHWAN-REOHCLBHSA-M,"InChI=1S/C3H7NO5S2/c4-2(3(5)6)1-10-11(7,8)9/h2H,1,4H2,(H,5,6)(H,7,8,9)/p-1/t2-/m0/s1"
2860,28873,cis-2-coumaric acid,The cis-isomer of 2-coumaric acid.,8983,KEGG COMPOUND accession,C11705,,,,,,,,,,,,,,,
2861,28875,tetradecanoic acid,"A straight-chain, fourteen-carbon, long-chain saturated fatty acid mostly found in milk fat.",8984,KEGG COMPOUND accession,C11166,,,,,,,,,,,,,,,
2862,28883,"quinoline-4,8-diol",a,8988,KEGG COMPOUND accession,C11173,,,,,,,,,,,,,,,
2863,28885,butan-1-ol,A primary alcohol that is butane in which a hydrogen of one of the methyl groups is substituted by a hydroxy group. It it produced in small amounts in humans by the gut microbes.,8989,KEGG COMPOUND accession,C11366,,,,,,,,,,,,,,,
2864,28888,trichloroepoxyethane,a,18422,KEGG COMPOUND accession,C05532,,,,,,,,,,,,,,,
2865,28889,"5,6,7,8-tetrahydropteridine",a,16377,KEGG COMPOUND accession,C02462,,,,,,,,,,,,,,,
2866,28892,ganglioside,A molecule composed of a glycosphingolipid (ceramide and oligosaccharide) with one or more sialic acids linked on the sugar chain.,8994,KEGG COMPOUND accession,C10490,,,,,,,,,,,,,,,
2867,28902,N-phenylhydroxylamine,An  N-substituted amine that is a derivative of aniline in which one of the amino hydrogen atoms is replaced with a hydroxy substituent.,28927,KEGG COMPOUND accession,C09833,,,,,,,,,,,,,,,
2868,28904,N-formylisoglutamic acid,"A 1,5-dicarboxylic acid compound having a 3-formamido substituent.",67309,KEGG COMPOUND accession,C08780,,,,,,,,,,,,,,,
2869,28911,cob(III)alamin,A cobalamin in which the central cobalt atom has an oxidation state of +3.,9003,KEGG COMPOUND accession,C06188,salc6p,b,b,b,Salicin 6-phosphate,b,b,b,C06188,b,b,b,b,b,b
2870,28914,1-acyl-sn-glycero-3-phospho-D-myo-inositol,"A 1-acylglycerophosphoinositol in which sn-glycerol, acylated at O(1), is linked through a phospho group at O(3) to O(1) of D-myo-inositol.",16464,KEGG COMPOUND accession,C02323,,,,,,,,,,,,,,,
2871,28917,dihydromyricetin,"A hexahydroxyflavanone that is the 2,3-dihydro derivative of myricetin.",16008,KEGG COMPOUND accession,C06202,,,,,,,,,,,,,,,
2872,28920,N-acetyl-alpha-D-muramoyl-L-alanine,A glyco-amino acid compound consisting of an N-acetyl-alpha-D-muramoyl group attached to L-alanine via an amide linkage.,16914,KEGG COMPOUND accession,C00805,,,,,,,,,,,,,,,
2873,28928,angelicin,a,9008,KEGG COMPOUND accession,C07588,,,,,,,,,,,,,,,
2874,28933,(25R)-5beta-spirostan-3beta-ol,"An oxaspiro compound that is(5beta,25R)-spirostan substituted by a beta-hydroxy group at position 3.",9011,KEGG COMPOUND accession,C07241,,,,,,,,,,,,,,,
2875,28941,docosanoic acid,"A straight-chain, C22, long-chain saturated fatty acid.",17225,KEGG COMPOUND accession,C05179,,,,,,,,,,,,,,,
2876,28945,nojirimycin,a,9016,KEGG COMPOUND accession,C11744,,,,,,,,,,,,,,,
2877,28957,"3,6-dichloro-cis-cyclohexa-3,5-diene-1,2-diol",a,17183,KEGG COMPOUND accession,C06162,,,,,,,,,,,,,,,
2878,28960,trans-3-chloroprop-2-en-1-ol,a,9023,KEGG COMPOUND accession,C09544,,,,,,,,,,,,,,,
2879,28972,"(R)-propane-1,2-diol",a,15611,KEGG COMPOUND accession,C00213,sarcs,107-97-1,15611.0,"Human Metabolome Database (HMDB): Sarcosine is the N-methyl derivative of glycine. Sarcosine is metabolized to glycine by the enzyme sarcosine dehydrogenase, while glycine-N-methyl transferase generates sarcosine from glycine. Sarcosine is a natural amino acid found in muscles and other body tissues. In the laboratory it may be synthesized from chloroacetic acid and methylamine. Sarcosine is naturally found in the metabolism of choline to glycine. Sarcosine is sweet to the taste and dissolves in water. It is used in manufacturing biodegradable surfactants and toothpastes as well as in other applications. Sarcosine is ubiquitous in biological materials and is present in such foods as egg yolks, turkey, ham, vegetables, legumes, etc. Sarcosine is formed from dietary intake of choline and from the metabolism of methionine, and is rapidly degraded to glycine. Sarcosine has no known toxicity, as evidenced by the lack of phenotypic manifestations of sarcosinemia, an inborn error of sarcosine metabolism. Sarcosinemia can result from severe folate deficiency because of the folate requirement for the conversion of sarcosine to glycine (Wikipedia). Sarcosine has recently been identified as a biomarker for invasive prostate cancer. It was found to be greatly increased during prostate cancer progression to metastasis and could be detected in urine. Sarcosine levels were also increased in invasive prostate cancer cell lines relative to benign prostate epithelial cells (PMID: 19212411).",Sarcosine,HMDB0000271,b,b,C00213,SARCOSINE,FDB021925,sarcs,[H]C([H])([H])[N+]([H])([H])C([H])([H])C([O-])=O,FSYKKLYZXJSNPZ-UHFFFAOYSA-N,"InChI=1S/C3H7NO2/c1-4-2-3(5)6/h4H,2H2,1H3,(H,5,6)"
2880,28982,"(S)-1,2-epoxypropane",a,75701,KEGG COMPOUND accession,C11764,,,,,,,,,,,,,,,
2881,28994,beta-D-hamamelose,a,9036,KEGG COMPOUND accession,C09239,,,,,,,,,,,,,,,
2882,29010,"2'-aminobiphenyl-2,3-diol",a,9044,KEGG COMPOUND accession,C10880,,,,,,,,,,,,,,,
2883,29016,arginine,An alpha-amino acid that is glycine in which the alpha-is substituted by a 3-guanidinopropyl group.,9047,KEGG COMPOUND accession,C10181,,,,,,,,,,,,,,,
2884,29022,N-benzyladenine,A member of the class of 6-aminopurines that is adenine in which one of the hydrogens of the amino group is replaced by a benzyl group.,9050,KEGG COMPOUND accession,C10182,,,,,,,,,,,,,,,
2885,29024,4-methyl-3-oxopentanoic acid,A branched-chain fatty acid that is 4-methylpentanoic acid carrying an oxo substituent at C-3.,27831,KEGG COMPOUND accession,C08879,,,,,,,,,,,,,,,
2886,29026,urobilinogen,A member of the class of bilanes that is a colourless product formed in the intestine by the reduction of bilirubin.,28332,KEGG COMPOUND accession,C08880,,,,,,,,,,,,,,,
2887,29028,glucobrassicin,An indolylmethylglucosinolic acid that is 1-thio-beta-D-glucopyranose having a 2-(1H-indol-3-yl)-N-(sulfooxy)ethanimidoyl group attached to the anomeric sulfur.,9053,KEGG COMPOUND accession,C09183,,,,,,,,,,,,,,,
2888,29032,(R)-pantothenate,"A pantothenate that is the conjugate base of (R)-pantothenic acid, obtained by deprotonation of the carboxy group.",9055,KEGG COMPOUND accession,C09311,,,,,,,,,,,,,,,
2889,29034,iron(3+),a,16794,KEGG COMPOUND accession,C01851,,,,,,,,,,,,,,,
2890,29037,copper(3+),a,17488,KEGG COMPOUND accession,C01752,,,,,,,,,,,,,,,
2891,29053,"pyridine-3,4-diol",a,16945,KEGG COMPOUND accession,C00779,,,,,,,,,,,,,,,
2892,29069,phthalic acid,A benzenedicarboxylic acid cosisting of two carboxy groups at ortho positions.,41865,KEGG COMPOUND accession,C08277,sebacid,111-20-6,41865.0,"Human Metabolome Database (HMDB): Sebacic acid is a saturated, straight-chain naturally occurring dicarboxylic acid with 10 carbon atoms. Sebacic acid is a normal urinary acid. In patients with multiple acyl-CoA-dehydrogenase deficiency (MADD), also known as glutaric aciduria type II (GAII), a group of metabolic disorders due to deficiency of either electron transfer flavoprotein or electron transfer flavoprotein ubiquinone oxidoreductase, biochemical data shows an increase in urine sebacic acid excretion. Sebacic acid is found to be associated with carnitine-acylcarnitine translocase deficiency and medium chain acyl-CoA dehydrogenase deficiency, which are inborn errors of metabolism. Sebacic acid is a white flake or powdered crystal slightly soluble in water that has been proposed as an alternative energy substrate in total parenteral nutrition. Sebacic Acid was named from the Latin sebaceus (tallow candle) or sebum (tallow) in reference to its use in the manufacture of candles. Sebacic acid and its derivatives such as azelaic acid have a variety of industrial uses as plasticizers, lubricants, hydraulic fluids, cosmetics, candles, etc. It is used in the synthesis of polyamide and alkyd resins. It is also used as an intermediate for aromatics, antiseptics and painting materials (PMID: 10556649, 1738216, 8442769, 12706375).",Sebacic acid,HMDB0000792,b,b,C08277,CPD-3623,FDB022247,sebacid,[H]C([H])(C([O-])=O)C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([O-])=O,CXMXRPHRNRROMY-UHFFFAOYSA-L,"InChI=1S/C10H18O4/c11-9(12)7-5-3-1-2-4-6-8-10(13)14/h1-8H2,(H,11,12)(H,13,14)/p-2"
2893,29071,"3-deoxy-D-glycero-hexo-2,5-diulosonate",a,28818,KEGG COMPOUND accession,C07712,2425dhvitd3,b,b,"Human Metabolome Database (HMDB): This compound belongs to the family of Vitamin D and Derivatives. These are compounds containing a secosteroid backbone, usually secoergostane or secocholestane.",Secalciferol,HMDB0060508,b,b,C07712,b,b,2425dhvitd3,[H]O[C@]([H])(C([H])([H])C([H])([H])[C@@]([H])(C([H])([H])[H])[C@@]1([H])C([H])([H])C([H])([H])[C@@]2([H])\C(=C(/[H])\C(\[H])=C3/C(=C([H])[H])C([H])([H])C([H])([H])[C@]([H])(O[H])C3([H])[H])C([H])([H])C([H])([H])C([H])([H])[C@]12C([H])([H])[H])C(O[H])(C([H])([H])[H])C([H])([H])[H],FCKJYANJHNLEEP-XRWYNYHCSA-N,"InChI=1S/C27H44O3/c1-18-8-12-22(28)17-21(18)11-10-20-7-6-16-27(5)23(13-14-24(20)27)19(2)9-15-25(29)26(3,4)30/h10-11,19,22-25,28-30H,1,6-9,12-17H2,2-5H3/b20-10+,21-11-/t19-,22+,23-,24+,25-,27-/m1/s1"
2894,29086,"3-hydroxy-5,9,17-trioxo-4,5:9,10-disecoandrosta-1(10),2-dien-4-oic acid","A seco-androstane that is hexahydro-1H-indene-1,5(4H)-dione which is substituted at the 7a position by a methyl group and at the 4 position by a 1-carboxy-1-hydroxy-4-methyl-5-oxohepta-1,3-dien-7-yl group (the S,S,S-diastereoisomer).",35681,KEGG COMPOUND accession,C00432,,,,,,,,,,,,,,,
2895,29089,"1,2-diacyl-sn-glycerol 3-phosphate",An sn-glycerol 3-phosphate compound having unspecified O-acyl groups at the 1- and 2-positions.,32863,KEGG COMPOUND accession,C02324,,,,,,,,,,,,,,,
2896,29111,alpha-D-GlcpNAc-(1->2)-[alpha-D-Manp-(1->3)]-alpha-D-Manp-(1->2)-alpha-D-Manp-(1->2)-D-Manp,"A branched amino pentasaccharide consisting of a linear chain of four alpha-linked D-mannose residues, with an N-acetyl glucosamine residue joined to residue 3, also via an alpha-linkage.",9086,KEGG COMPOUND accession,C07245,,,,,,,,,,,,,,,
2897,29118,methanophenazine,a,16503,KEGG COMPOUND accession,C01528,seln,b,16503.0,"Human Metabolome Database (HMDB): Hydrogen selenide is a metabolite of selenium which could have potential antiangiogenic effect in the chemoprevention of cancer. The hydrogen selenide is a key intermediate in the selenium methylation metabolism of inorganic and organic selenium compounds. Accumulation of the hydrogen selenide resulting from inhibition of the selenium methylation metabolism, detoxification metabolic pathway of selenium, is found in animals following repeated administration of a toxic dose of selenocystine. The excess of the hydrogen selenide produced by inhibition of the selenium methylation metabolism contributes to the hepatotoxicity caused by selenocystine. (PMID: 9414580, 11799926).",Hydrogen selenide,HMDB0011110,b,b,C01528,b,FDB027892,b,[Se-][H],SPVXKVOXSXTJOY-UHFFFAOYSA-M,InChI=1S/H2Se/h1H2/p-1
2898,29125,arsenate(3-),An arsenate ion resulting from the removal of three protons from arsenic acid.,18212,KEGG COMPOUND accession,C05684,,,,,,,,,,,,,,,
2899,29156,Gly-tRNA(Gly),a,9100,KEGG COMPOUND accession,C05336,M02893,b,9100.0,b,Selenomethionyl-tRNA(Met),b,b,b,C05336,b,b,b,[H]OC([H])([H])[C@@]1([H])O[C@@]([H])([*])[C@]([H])(O[H])[C@]1([H])OP(=O)(O[H])OC([H])([H])[C@@]1([H])O[C@@]([H])([*])[C@]([H])(O[H])[C@]1([H])OP(=O)(O[H])OC([H])([H])[C@@]1([H])O[C@@]([H])(N2C([H])=NC3=C(N=C([H])N=C23)N([H])[H])[C@]([H])(OC(=O)[C@@]([H])(N([H])[H])C([H])([H])C([H])([H])[Se]C([H])([H])[H])[C@]1([H])O[H],b,b
2900,29161,Tyr-tRNA(Tyr),a,28306,KEGG COMPOUND accession,C02077,,,,,,,,,,,,,,,
2901,29163,Thr-tRNA(Thr),a,15817,KEGG COMPOUND accession,C05309,,,,,,,,,,,,,,,
2902,29171,tRNA(Arg),a,9107,KEGG COMPOUND accession,C06176,,,,,,,,,,,,,,,
2903,29177,tRNA(Pro),a,9110,KEGG COMPOUND accession,C08978,,,,,,,,,,,,,,,
2904,29181,tRNA(Trp),a,9112,KEGG COMPOUND accession,C10404,,,,,,,,,,,,,,,
2905,29183,tRNA(Val),a,16095,KEGG COMPOUND accession,C00835,,,,,,,,,,,,,,,
2906,29191,hydroxyl,a,17822,KEGG COMPOUND accession,C00716,,,,,,,,,,,,,,,
2907,29195,cyanate,a,15916,KEGG COMPOUND accession,C03729,,,,,,,,,,,,,,,
2908,29281,alkyl sulfate,a,15540,KEGG COMPOUND accession,C00411,,,,,,,,,,,,,,,
2909,29590,gibberellin A15 (diacid form),a,16479,KEGG COMPOUND accession,C01138,,,,,,,,,,,,,,,
2910,29748,chorismate(2-),a,33447,KEGG COMPOUND accession,C00934,,,,,,,,,,,,,,,
2911,29751,(-)-quinate,A quinate that is the conjugate base of (-)-quinic acid.,9321,KEGG COMPOUND accession,C07770,,,,,,,,,,,,,,,
2912,29864,mannitol,"A hexitol produced by a variety of organisms including bacteria, fungi, lichens and plants.",17909,KEGG COMPOUND accession,C00087,,,,,,,,,,,,,,,
2913,29920,phosphoramidate,a,9375,KEGG COMPOUND accession,C10409,,,,,,,,,,,,,,,
2914,29934,"(1s,4s)-prephenate(2-)","A prephenate(2-) obtained by deprotonation of both carboxy groups of (1s,4s)-prephenic acid; major species at pH 7.3.",28888,KEGG COMPOUND accession,C11148,M02954,16967-79-6,28888.0,"Human Metabolome Database (HMDB): TCE epoxide, also known as Trichloroethylene epoxide or 1,1,2-Trichloroepoxyethane, is classified as a member of the Epoxides. Epoxides are compounds containing a cyclic ether with three ring atoms(one oxygen and two carbon atoms). TCE epoxide is considered to be slightly soluble (in water) and basic",TCE epoxide,HMDB0062533,b,b,C11148,b,b,b,[H]C1(Cl)OC1(Cl)Cl,CMMXCVYESRODNH-UHFFFAOYSA-N,"InChI=1S/C2HCl3O/c3-1-2(4,5)6-1/h1H"
2915,29947,glycine residue,a,45980,KEGG COMPOUND accession,C01453,,,,,,,,,,,,,,,
2916,29959,quinolinate(2-),a,9395,KEGG COMPOUND accession,C10189,,,,,,,,,,,,,,,
2917,30021,L-selenomethionine,The L-enantiomer of selenomethionine.,9416,KEGG COMPOUND accession,C09967,,,,,,,,,,,,,,,
2918,30034,"(7R,8Z)-bacteriochlorophyll b",a,9422,KEGG COMPOUND accession,C11126,,,,,,,,,,,,,,,
2919,30042,"taxa-4(20),11-dien-5alpha-yl acetate",A taxane diterpenoid that is taxane which contains double bounds at the 4-20 and 11-12 positions and which is substituted by an acetoxy group at the 5alpha position.,9426,KEGG COMPOUND accession,C11621,,,,,,,,,,,,,,,
2920,30212,photon,"Particle of zero charge, zero rest mass, spin quantum number 1, energy hnu and momentum hnu/c (h is the Planck constant, nu the frequency of radiation and c the speed of light), carrier of electromagnetic force.",28624,KEGG COMPOUND accession,C03541,,,,,,,,,,,,,,,
2921,30232,"abieta-7,13-diene",a,9495,KEGG COMPOUND accession,C11160,,,,,,,,,,,,,,,
2922,30245,linoleate,An octadecadienoate with cis- double bonds at the 9- and 12- positions; the conjugate base of linoleic acid.,44880,KEGG COMPOUND accession,C11152,,,,,,,,,,,,,,,
2923,30248,beta-D-Gal-(1->3)-beta-D-GlcNAc-(1->3)-beta-D-Gal-(1->4)-D-Glc,"A tetrasaccharide comprising residues of galactose, N-acetylglucosamine, galactose and glucose in a linear sequence, all joined by beta-linkages.",16853,KEGG COMPOUND accession,C02084,,,,,,,,,,,,,,,
2924,30306,"1,3-dihydroxy-N-methylacridone",a,9532,KEGG COMPOUND accession,C00068,thmpp,154-87-0,9532.0,"Human Metabolome Database (HMDB): Thiamine pyrophosphate is the active form of thiamine, and it serves as a cofactor for several enzymes involved primarily in carbohydrate catabolism. The enzymes are important in the biosynthesis of a number of cell constituents, including neurotransmitters, and for the production of reducing equivalents used in oxidant stress defenses and in biosyntheses and for synthesis of pentoses used as nucleic acid precursors. The chemical structure of TPP is that of an aromatic methylaminopyrimidine ring, linked via a methylene bridge to a methylthiazolium ring with a pyrophosphate group attached to a hydroxyethyl side chain. In non-enzymatic model studies it has been demonstrated that the thiazolium ring can catalyse reactions which are similar to those of TPP-dependent enzymes but several orders of magnitude slower. Using infrared and NMR spectrophotometry it has been shown that the dissociation of the proton from C2 of the thiazolium ring is necessary for catalysis; the abstraction of the proton leads to the formation of a carbanion (ylid) with the potential for a nucleophilic attack on the carbonyl group of the substrate. In all TPP-dependent enzymes the abstraction of the proton from the C2 atom is the first step in catalysis, which is followed by a nucleophilic attack of this carbanion on the substrate. Subsequent cleavage of a C-C bond releases the first product with formation of a second carbanion (2-greek small letter alpha-carbanion or enamine). The formation of this 2-greek small letter alpha-carbanion is the second feature of TPP catalysis common to all TPP-dependent enzymes. Depending on the enzyme and the substrate(s), the reaction intermediates and products differ. Methyl-branched fatty acids, as phytanic acid, undergo peroxisomal beta-oxidation in which they are shortened by 1 carbon atom. This process includes four steps: activation, 2-hydroxylation, thiamine pyrophosphate dependent cleavage and aldehyde dehydrogenation. In the third step, 2-hydroxy-3-methylacyl-CoA is cleaved in the peroxisomal matrix by 2-hydroxyphytanoyl-CoA lyase (2-HPCL), which uses thiamine pyrophosphate (TPP) as cofactor. The thiamine pyrophosphate dependence of the third step is unique in peroxisomal mammalian enzymology. Human pathology due to a deficient alpha-oxidation is mostly linked to mutations in the gene coding for the second enzyme of the sequence, phytanoyl-CoA hydroxylase (EC 1.14.11.18). (PMID: 12694175, 11899071, 9924800).",Thiamine pyrophosphate,HMDB0001372,b,b,C00068,2-(alpha-lactyl)-thpp,FDB022584,thmpp,[H]N([H])C1=C(C([H])=NC(=N1)C([H])([H])[H])C([H])([H])[N+]1=C([H])SC(=C1C([H])([H])[H])C([H])([H])C([H])([H])OP([O-])(=O)OP([O-])([O-])=O,AYEKOFBPNLCAJY-UHFFFAOYSA-L,"InChI=1S/C12H18N4O7P2S/c1-8-11(3-4-22-25(20,21)23-24(17,18)19)26-7-16(8)6-10-5-14-9(2)15-12(10)13/h5,7H,3-4,6H2,1-2H3,(H4-,13,14,15,17,18,19,20,21)/p-2"
2925,30436,tetrahydropterin,a,28728,KEGG COMPOUND accession,C05963,HC02180,54397-85-2,28728.0,"Human Metabolome Database (HMDB): Thromboxanes. A stable, physiologically active compound formed in vivo from the prostaglandin endoperoxides. It is important in the platelet-release reaction (release of ADP and serotonin). -- Pubchem. Thromboxanes are eicosanoids. The eicosanoids consist of the prostaglandins (PGs), thromboxanes (TXs), leukotrienes (LTs) and lipoxins (LXs). The PGs and TXs are collectively identified as prostanoids. Prostaglandins were originally shown to be synthesized in the prostate gland, thromboxanes from platelets (thrombocytes) and leukotrienes from leukocytes, hence the derivation of their names. All mammalian cells except erythrocytes synthesize eicosanoids. These molecules are extremely potent, able to cause profound physiological effects at very dilute concentrations. All eicosanoids function locally at the site of synthesis, through receptor-mediated G-protein linked signaling pathways.",Thromboxane B2,HMDB0003252,b,b,C05963,b,FDB023130,HC02180,[H]O[C@]([H])(C([H])=C([H])[C@@]1([H])OC([H])(O[H])C([H])([H])[C@]([H])(O[H])[C@]1([H])C([H])([H])C([H])=C([H])C([H])([H])C([H])([H])C([H])([H])C([O-])=O)C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H],XNRNNGPBEPRNAR-XKHPYWLKSA-M,"InChI=1S/C20H34O6/c1-2-3-6-9-15(21)12-13-18-16(17(22)14-20(25)26-18)10-7-4-5-8-11-19(23)24/h4,7,12-13,15-18,20-22,25H,2-3,5-6,8-11,14H2,1H3,(H,23,24)/p-1/b7-4+,13-12?/t15-,16-,17-,18+,20?/m0/s1"
2926,30526,1-aminocyclopropanecarboxylate,An alpha-amino-acid anion resulting from the deprotonation of the carboxy group of 1-aminocyclopropanecarboxylic acid.,28502,KEGG COMPOUND accession,C07147,,,,,,,,,,,,,,,
2927,30754,anthranilic acid,An aminobenzoic acid that is benzoic acid having a single amino substituent located at position 2. It is a metabolite produced in L-tryptophan-kynurenine pathway in the central nervous system.,18258,KEGG COMPOUND accession,C02465,triodthy,b,18258.0,"Human Metabolome Database (HMDB): Liothyronine is a T3 thyroid hormone normally synthesized and secreted by the thyroid gland in much smaller quantities than thyroxine (T4). Most T3 is derived from peripheral monodeiodination of T4 at the 5' position of the outer ring of the iodothyronine nucleus. The hormone finally delivered and used by the tissues is mainly T3. Mildly toxic by ingestion. An experimental teratogen. Experimental reproductive effects. When heated to decomposition it emits toxic fumes of NOx, I(-), and Cl(-). (Sax's Dangerous Properties of Industrial Materials).",Liothyronine,HMDB0000265,b,b,C02465,LIOTHYRONINE,FDB021810,triodthy,[H]OC1=C([H])C([H])=C(OC2=C(I)C([H])=C(C([H])=C2I)C([H])([H])[C@@]([H])(C([O-])=O)[N+]([H])([H])[H])C([H])=C1I,AUYYCJSJGJYCDS-LBPRGKRZSA-N,"InChI=1S/C15H12I3NO4/c16-9-6-8(1-2-13(9)20)23-14-10(17)3-7(4-11(14)18)5-12(19)15(21)22/h1-4,6,12,20H,5,19H2,(H,21,22)/t12-/m0/s1"
2928,30765,tropic acid,"A 3-hydroxy monocarboxylic acid that is propionic acid in which one of the hydrogens at position 2 is substituted by a phenyl group, and one of the methyl hydrogens is substituted by a hydroxy group.",16517,KEGG COMPOUND accession,C02466,,,,,,,,,,,,,,,
2929,30769,citric acid,"A tricarboxylic acid that is propane-1,2,3-tricarboxylic acid bearing a hydroxy substituent at position 2. It is an important metabolite in the pathway of all aerobic organisms.",9728,KEGG COMPOUND accession,C07174,,,,,,,,,,,,,,,
2930,30775,fluoroacetic acid,A haloacetic acid that is acetic acid in which one of the methyl hydrogens is substituted by fluorine.,45924,KEGG COMPOUND accession,C01965,,,,,,,,,,,,,,,
2931,30781,butynedioic acid,An acetylenic compound that is acetylene in which the hydrogens are replaced by carboxy groups.,15724,KEGG COMPOUND accession,C01104,M03054,1184-78-7,15724.0,"Human Metabolome Database (HMDB): Trimethylamine N-oxide (TMAO) is an oxidation product of trimethylamine and a common metabolite in animals and humans. In particular, trimethylamine-N-oxide is biosynthesized endogenously from trimethylamine, which is derived from choline, which can be derived from dietary lecithin (phosphatidylcholines) or dietary carnitine. TMAO decomposes to trimethylamine (TMA), which is the main odorant that is characteristic of degrading seafood. TMAO is an osmolyte that the body will use to counteract the effects of increased concentrations of urea (due to kidney failure) and high levels can be used as a biomarker for kidney problems. Fish odor syndrome or trimethylaminuria is a defect in the production of the enzyme flavin containing monooxygenase 3 (FMO3) causing incomplete breakdown of trimethylamine from choline-containing food into trimethylamine oxide. Trimethylamine then builds up and is released in the person's sweat, urine, and breath, giving off a strong fishy odor. The concentration of TMAO in the blood increases after consuming foods containing carnitine or lecithin (phosphatidylcholines), if the bacteria that convert those substances to TMAO are present in the gut (PMID: 23614584). High concentrations of carnitine are found in red meat, some energy drinks, and certain dietary supplements; lecithin is found in eggs and is commonly used as an ingredient in processed food. High levels of TMAO are found in many seafoods.  Some types of normal gut bacteria (e.g. species of Acinetobacter) in the human gut convert dietary carnitine and dietary lecithin to TMAO (PMID: 21475195). TMAO alters cholesterol metabolism in the intestines, in the liver and in arterial wall. When TMAO is present, cholesterol metabolism is altered and there is an increased deposition of cholesterol within, and decreased removal of cholesterol from, peripheral cells such as those in the artery wall (PMID: 23563705). Urinary TMAO is a biomarker for the consumption of fish, especially cold-water fish. Trimethylamine N-oxide is found to be associated with maple syrup urine disease and propionic acidemia, which are inborn errors of metabolism.",Trimethylamine N-oxide,HMDB0000925,b,b,C01104,TRIMENTHLAMINE-N-O,FDB010413,b,[H]C([H])([H])[N+]([O-])(C([H])([H])[H])C([H])([H])[H],UYPYRKYUKCHHIB-UHFFFAOYSA-N,"InChI=1S/C3H9NO/c1-4(2,3)5/h1-3H3"
2932,30781,butynedioic acid,An acetylenic compound that is acetylene in which the hydrogens are replaced by carboxy groups.,15724,KEGG COMPOUND accession,C01104,tmao,62637-93-8,15724.0,"Human Metabolome Database (HMDB): Trimethylamine N-oxide (TMAO) is an oxidation product of trimethylamine and a common metabolite in animals and humans. In particular, trimethylamine-N-oxide is biosynthesized endogenously from trimethylamine, which is derived from choline, which can be derived from dietary lecithin (phosphatidylcholines) or dietary carnitine. TMAO decomposes to trimethylamine (TMA), which is the main odorant that is characteristic of degrading seafood. TMAO is an osmolyte that the body will use to counteract the effects of increased concentrations of urea (due to kidney failure) and high levels can be used as a biomarker for kidney problems. Fish odor syndrome or trimethylaminuria is a defect in the production of the enzyme flavin containing monooxygenase 3 (FMO3) causing incomplete breakdown of trimethylamine from choline-containing food into trimethylamine oxide. Trimethylamine then builds up and is released in the person's sweat, urine, and breath, giving off a strong fishy odor. The concentration of TMAO in the blood increases after consuming foods containing carnitine or lecithin (phosphatidylcholines), if the bacteria that convert those substances to TMAO are present in the gut (PMID: 23614584). High concentrations of carnitine are found in red meat, some energy drinks, and certain dietary supplements; lecithin is found in eggs and is commonly used as an ingredient in processed food. High levels of TMAO are found in many seafoods.  Some types of normal gut bacteria (e.g. species of Acinetobacter) in the human gut convert dietary carnitine and dietary lecithin to TMAO (PMID: 21475195). TMAO alters cholesterol metabolism in the intestines, in the liver and in arterial wall. When TMAO is present, cholesterol metabolism is altered and there is an increased deposition of cholesterol within, and decreased removal of cholesterol from, peripheral cells such as those in the artery wall (PMID: 23563705). Urinary TMAO is a biomarker for the consumption of fish, especially cold-water fish. Trimethylamine N-oxide is found to be associated with maple syrup urine disease and propionic acidemia, which are inborn errors of metabolism.",Trimethylamine N-oxide,HMDB0000925,b,b,C01104,b,b,b,b,b,b
2933,30813,decanoic acid,"A C10, straight-chain saturated fatty acid.",36615,KEGG COMPOUND accession,C06085,,,,,,,,,,,,,,,
2934,30814,digallic acid,a,15987,KEGG COMPOUND accession,C01861,,,,,,,,,,,,,,,
2935,30849,L-arabinose,The L-enantiomer of arabinose.,17842,KEGG COMPOUND accession,C02090,,,,,,,,,,,,,,,
2936,30854,indole-3-acetate,An indol-3-yl carboxylic acid anion that is the conjugate base of indole-3-acetic acid.,16765,KEGG COMPOUND accession,C00398,trypta,61-54-1,16765.0,"Human Metabolome Database (HMDB): Tryptamine is a monoamine compound that is common precursor molecule to many hormones and neurotransmitters. Biosynthesis generally proceeds from the amino acid tryptophan, with tryptamine in turn acting as a precursor for other compounds. Substitutions to the tryptamine molecule give rise to a group of compounds collectively known as tryptamines. The most well-known tryptamines are serotonin, an important neurotransmitter, and melatonin, a hormone involved in regulating the sleep-wake cycle.",Tryptamine,HMDB0000303,b,b,C00398,TRYPTAMINE,FDB000917,trypta,[H]N1C([H])=C(C2=C([H])C([H])=C([H])C([H])=C12)C([H])([H])C([H])([H])[N+]([H])([H])[H],APJYDQYYACXCRM-UHFFFAOYSA-O,"InChI=1S/C10H12N2/c11-6-5-8-7-12-10-4-2-1-3-9(8)10/h1-4,7,12H,5-6,11H2/p+1"
2937,30882,2-oxoglutaramic acid,a,27998,KEGG COMPOUND accession,C00753,,,,,,,,,,,,,,,
2938,30911,glucitol,a,9798,KEGG COMPOUND accession,C01458,,,,,,,,,,,,,,,
2939,30912,1-piperideine-2-carboxylic acid,a,15760,KEGG COMPOUND accession,C00483,tym,51-67-2,15760.0,"Human Metabolome Database (HMDB): Tyramine is a monoamine compound derived from the amino acid tyrosine. Tyramine is metabolized by the enzyme monoamine oxidase. In foods, it is often produced by the decarboxylation of tyrosine during fermentation or decay. Foods containing considerable amounts of tyramine include fish, chocolate, alcoholic beverages, cheese, soy sauce, sauerkraut, and processed meat. A large dietary intake of tyramine can cause an increase in systolic blood pressure of 30 mmHg or more. Tyramine acts as a neurotransmitter via a G protein-coupled receptor with high affinity for tyramine called TA1. The TA1 receptor is found in the brain as well as peripheral tissues including the kidney. An indirect sympathomimetic, Tyramine can also serve as a substrate for adrenergic uptake systems and monoamine oxidase so it prolongs the actions of adrenergic transmitters. It also provokes transmitter release from adrenergic terminals. Tyramine is a biomarker for the consumption of cheese",Tyramine,HMDB0000306,b,b,C00483,CPD-7650,FDB000433,tym,[H]OC1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])C([H])([H])[N+]([H])([H])[H],DZGWFCGJZKJUFP-UHFFFAOYSA-O,"InChI=1S/C8H11NO/c9-6-5-7-1-3-8(10)4-2-7/h1-4,10H,5-6,9H2/p+1"
2940,30926,3-oxalomalic acid,a,17659,KEGG COMPOUND accession,C00015,udp,58-98-0,17659.0,"Human Metabolome Database (HMDB): Uridine 5'-diphosphate is a uracil nucleotide containing a pyrophosphate group esterified to C5 of the sugar moiety. UDP is an important extracellular pyrimidine signaling molecule that mediates diverse biological effects via P1 and P2 purinergic receptors, such as the uptake of thymidine and proliferation of gliomas. (PMID: 14558596). UDP induces intracellular Ca(2+) responses and oscillations in HeLa cells, due to the activation of P2Ys (G-protein coupled ATP receptors). (PMID: 1257952).",Uridine 5'-diphosphate,HMDB0000295,b,b,C00015,UDP,FDB007509,udp,[H]O[C@@]1([H])[C@@]([H])(O[C@]([H])(C([H])([H])OP([O-])(=O)OP([O-])([O-])=O)[C@@]1([H])O[H])N1C([H])=C([H])C(=O)N([H])C1=O,XCCTYIAWTASOJW-XVFCMESISA-K,"InChI=1S/C9H14N2O12P2/c12-5-1-2-11(9(15)10-5)8-7(14)6(13)4(22-8)3-21-25(19,20)23-24(16,17)18/h1-2,4,6-8,13-14H,3H2,(H,19,20)(H,10,12,15)(H2,16,17,18)/p-3/t4-,6-,7-,8-/m1/s1"
2941,31440,copper(II) sulfate pentahydrate,The pentahydrate of copper(2+) sulfate. A bright blue crystalline solid.,9859,KEGG COMPOUND accession,C08251,,,,,,,,,,,,,,,
2942,31515,domperidone,"1-[3-(Piperidin-1-yl)propyl]-1,3-dihydro-2H-benzimidazol-2-one in which the 4-position of the piperidine ring is substituted by a 5-chloro-1,3-dihydro-2H-benzimidazol-2-on-1-yl group. A dopamine antagonist, it is used as an antiemetic for the short-term treatment of nausea and vomiting, and to control gastrointestinal effects of dopaminergic drugs given in the management of parkinsonism. The free base is used in oral suspensions, while the maleate salt is used in tablet preparations.",17477,KEGG COMPOUND accession,C03030,,,,,,,,,,,,,,,
2943,31549,epothilone A,"An epithilone that is epothilone C in which the double bond in the macrocyclic lactone ring has been oxidised to the corresponding epoxide (the 13R,14S diastereoisomer).",9889,KEGG COMPOUND accession,C01010,allphn,b,b,b,Allophanate,b,b,b,C01010,b,b,b,b,b,b
2944,31575,ethylparaben,"An ethyl ester resulting from the formal condensation of the carboxy group of 4-hydroxybenzoic acid with ethanol,",30817,KEGG COMPOUND accession,C00785,urcan,104-98-3,30817.0,"Human Metabolome Database (HMDB): Urocanic acid is a breakdown (deamination) product of histidine. In the liver, urocanic acid is an intermediate in the conversion of histidine to glutamic acid, whereas in the epidermis, it accumulates and may be both a UV protectant and an immunoregulator. Urocanic acid (UA) exists as a trans isomer (t-UA, approximately 30 mg/cm2) in the uppermost layer of the skin (stratum corneum). t-UA is formed as the cells of the second layer of skin become metabolically inactive. During this process, proteins and membranes degrade, histidine is released, and histidase (histidine ammonia lyase) catalyzes the deamination of histidine to form t-UA. t-UA accumulates in the epidermis until removal by either the monthly skin renewal cycle or sweat. Upon absorption of UV light, the naturally occurring t-UA isomerizes to its cis form, c-UA. Because DNA lesions (e.g., pyrimidine dimers) in the lower epidermis can result from UV-B absorption, initial research proposed that t-UA acted as a natural sunscreen absorbing UV-B in the stratum corneum before the damaging rays could penetrate into lower epidermal zones. Researchers have found that c-UA also suppresses contact hypersensitivity and delayed hypersensitivity, reduces the Langerhans cell count in the epidermis, prolongs skin-graft survival time, and affects natural killer cell activity.",Urocanic acid,HMDB0000301,b,b,C00785,UROCANATE,FDB000921,urcan,[H]N1C([H])=NC(C([H])=C([H])C([O-])=O)=C1[H],LOIYMIARKYCTBW-UHFFFAOYSA-M,"InChI=1S/C6H6N2O2/c9-6(10)2-1-5-3-7-4-8-5/h1-4H,(H,7,8)(H,9,10)/p-1"
2945,31602,fentanyl citrate,"The citric acid salt of fentanyl, comprising equimolar amounts of citric acid and fentanyl. A mu-opioid receptor agonist, it is a potent opioid analgesic used in the management of labour pain, postoperative pain, and chronic intractable cancer pain. It is also widely used as the analgesic component of balanced anaesthesia.",9908,KEGG COMPOUND accession,C08988,,,,,,,,,,,,,,,
2946,32221,tiaprofenic acid,An aromatic ketone that is thiophene substituted at C-2 by benzoyl and at C-4 by a 1-carboxyethyl group.,28383,KEGG COMPOUND accession,C04025,,,,,,,,,,,,,,,
2947,32374,trans-4-coumaric acid,The trans-isomer of 4-coumaric acid.,27818,KEGG COMPOUND accession,C03811,,,,,,,,,,,,,,,
2948,32446,all-trans-neoxanthin,A neoxanthin in which all of the double bonds have trans geometry.,10278,KEGG COMPOUND accession,C09663,,,,,,,,,,,,,,,
2949,32506,"4,4'-diaminodiphenylmethane",An aromatic amine that is diphenylmethane substituted at the 4-position of each benzene ring by an amino group.,15679,KEGG COMPOUND accession,C04740,,,,,,,,,,,,,,,
2950,32618,N-acetyl-beta-D-glucosaminyl-(1->2)-alpha-D-mannosyl-(1->3)-beta-D-mannosyl group,A group obtained by removing the hydroxy group from the hemiacetal function of N-acetyl-beta-D-glucosaminyl-(1->2)-alpha-D-mannosyl-(1->3)-beta-D-mannose.,27793,KEGG COMPOUND accession,C08587,,,,,,,,,,,,,,,
2951,32796,(R)-2-hydroxyglutaric acid,The (R)-enantiomer of 2-hydroxyglutaric acid.,15807,KEGG COMPOUND accession,C03906,,,,,,,,,,,,,,,
2952,32798,"9-cis,11-trans-octadecadienoic acid","An octadeca-9,11-dienoic acid having 9-cis,11-trans-stereochemistry.",28079,KEGG COMPOUND accession,C02761,,,,,,,,,,,,,,,
2953,32800,(S)-mandelic acid,a,10423,KEGG COMPOUND accession,C08237,,,,,,,,,,,,,,,
2954,32802,(S)-4-hydroxymandelic acid,A 4-hydroxymandelic acid that has S-configuration.,27586,KEGG COMPOUND accession,C02338,,,,,,,,,,,,,,,
2955,32803,(R)-4-hydroxymandelic acid,A 4-hydroxymandelic acid that has R-configuration.,27426,KEGG COMPOUND accession,C02605,,,,,,,,,,,,,,,
2956,32804,4-hydroxymandelate,A 2-hydroxycarboxylate that is obtained by removal of a proton from the carboxylic acid group of 4-hydroxymandelic acid.,35627,KEGG COMPOUND accession,C01866,,,,,,,,,,,,,,,
2957,32806,trans-aconitic acid,The trans-isomer of aconitic acid.,27933,KEGG COMPOUND accession,C03438,,,,,,,,,,,,,,,
2958,32807,o-orsellinic acid,"A dihydroxybenzoic acid that is 2,4-dihydroxybenzoic acid in which the hydrogen at position 6 is replaced by a methyl group.",36218,KEGG COMPOUND accession,C01970,,,,,,,,,,,,,,,
2959,32809,3-hydroxy-L-glutamic acid,An amino dicarboxylic acid that is L-glutamic acid substituted by a hydroxy group at position 3.,10429,KEGG COMPOUND accession,C10367,,,,,,,,,,,,,,,
2960,32811,4-hydroxy-L-glutamic acid,An  amino dicarboxylic acid that is L-glutamic acid substituted by a hydroxy group at position 4.,28560,KEGG COMPOUND accession,C02762,,,,,,,,,,,,,,,
2961,32813,N-amidino-L-aspartate(2-),A dicarboxylic acid dianion obtained by deprotonation of both carboxy groups of N-amidino-L-aspartic acid.,10432,KEGG COMPOUND accession,C11713,M00668,135-19-3,10432.0,"Human Metabolome Database (HMDB): 2-Naphthol is a colorless crystalline solid and an isomer of 1-naphthol, differing by the location of the hydroxyl group on naphthalene. The naphthols are naphthalene homologues of phenol, with the hydroxyl group being more reactive than in the phenols. 2-Naphthol has several different uses including dyes, pigments, fats, oils, insecticides, pharmaceuticals, perfumes, antiseptics, synthesis of fungicides, and antioxidants for rubber. Detection of 2-Naphthol in urine usually results from long-term persistent exposure to pesticides such as chlorpyrifos, but also due to exposure to naphthalene in older types of mothballs, fires that produce polyaromatic hydrocarbons (PAHs), and tobacco smoke.",2-Naphthol,HMDB0012322,b,b,C11713,CPD-8131,FDB000877,b,[H]OC1=C([H])C2=C([H])C([H])=C([H])C([H])=C2C([H])=C1[H],JWAZRIHNYRIHIV-UHFFFAOYSA-N,"InChI=1S/C10H8O/c11-10-6-5-8-3-1-2-4-9(8)7-10/h1-7,11H"
2962,32816,pyruvic acid,A 2-oxo monocarboxylic acid that is the 2-keto derivative of propionic acid. It is a metabolite obtained during glycolysis.,16348,KEGG COMPOUND accession,C05669,,,,,,,,,,,,,,,
2963,32817,keto-3-deoxy-D-manno-octulosonic acid,a,10435,KEGG COMPOUND accession,C09890,,,,,,,,,,,,,,,
2964,32844,N-acetyl-4-O-acetylneuraminic acid,a,27533,KEGG COMPOUND accession,C05434,,,,,,,,,,,,,,,
2965,32877,primary amine,A compound formally derived from ammonia by replacing one hydrogen atom by a hydrocarbyl group.,28974,KEGG COMPOUND accession,C06585,,,,,,,,,,,,,,,
2966,32878,alkene,"An acyclic branched or unbranched hydrocarbon having one carbon-carbon double bond and the general formula CnH2n. Acyclic branched or unbranched hydrocarbons having more than one double bond are alkadienes, alkatrienes, etc.",15599,KEGG COMPOUND accession,C06589,,,,,,,,,,,,,,,
2967,32958,phosphate group,An inorganic group obtained by removal of one of the hydroxy groups from phosphoric acid.,28846,KEGG COMPOUND accession,C00705,dcdp,800-73-7,28846.0,"Human Metabolome Database (HMDB): dCDP is a substrate for Uridine-cytidine kinase 1, Nucleoside diphosphate kinase (mitochondrial), Nucleoside diphosphate kinase homolog 5, Ribonucleoside-diphosphate reductase large subunit, Nucleoside diphosphate kinase A, Nucleoside diphosphate kinase 7, Ribonucleoside-diphosphate reductase M2 chain, Nucleoside diphosphate kinase B, Nucleoside diphosphate kinase 3, Nucleoside diphosphate kinase 6 and UMP-CMP kinase.",dCDP,HMDB0001245,b,b,C00705,DCDP,FDB022510,dcdp,[H]O[C@@]1([H])C([H])([H])[C@@]([H])(O[C@]1([H])C([H])([H])OP([O-])(=O)OP([O-])([O-])=O)N1C([H])=C([H])C(=NC1=O)N([H])[H],FTDHDKPUHBLBTL-SHYZEUOFSA-K,"InChI=1S/C9H15N3O10P2/c10-7-1-2-12(9(14)11-7)8-3-5(13)6(21-8)4-20-24(18,19)22-23(15,16)17/h1-2,5-6,8,13H,3-4H2,(H,18,19)(H2,10,11,14)(H2,15,16,17)/p-3/t5-,6+,8+/m0/s1"
2968,32964,ornithinate,a,15918,KEGG COMPOUND accession,C00239,dcmp,1032-65-1,15918.0,"Human Metabolome Database (HMDB): Deoxycytidine (dihydrogen phosphate). A deoxycytosine nucleotide containing one phosphate group esterified to the deoxyribose moiety in the 2'-,3'- or 5- positions. Deficiency of the enzyme Deoxycytidine kinase (EC 2.7.1.74) is associated with resistance to antiviral and anticancer chemotherapeutic agents, whereas increased enzyme activity is associated with increased activation of these compounds to cytotoxic nucleoside triphosphate derivatives. (OMIM 125450).",dCMP,HMDB0001202,b,b,C00239,DCMP,FDB022488,dcmp,[H]O[C@@]1([H])C([H])([H])[C@@]([H])(O[C@]1([H])C([H])([H])OP([O-])([O-])=O)N1C([H])=C([H])C(=NC1=O)N([H])[H],NCMVOABPESMRCP-SHYZEUOFSA-L,"InChI=1S/C9H14N3O7P/c10-7-1-2-12(9(14)11-7)8-3-5(13)6(19-8)4-18-20(15,16)17/h1-2,5-6,8,13H,3-4H2,(H2,10,11,14)(H2,15,16,17)/p-2/t5-,6+,8+/m0/s1"
2969,32988,amide,An amide is a derivative of an oxoacid RkE(=O)l(OH)m (l =/= 0) in which an acidic hydroxy group has been replaced by an amino or substituted amino group.,16192,KEGG COMPOUND accession,C00362,dgmp,902-04-5,16192.0,"Human Metabolome Database (HMDB): 2'-Deoxyguanosine 5'-monophosphate is a derivative of the common nucleic acid GTP, or guanosine triphosphate, in which the -OH (hydroxyl) group on the 2' carbon on the nucleotide's pentose has been removed (hence the deoxy- part of the name). Additionally, the diphosphate of the name indicates that two of the phosphoryl groups of GTP have been removed, most likely by hydrolysis (Wikipedia).",2'-Deoxyguanosine 5'-monophosphate,HMDB0001044,b,b,C00362,DGMP,FDB022388,dgmp,[H]O[C@@]1([H])C([H])([H])[C@@]([H])(O[C@]1([H])C([H])([H])OP([O-])([O-])=O)N1C([H])=NC2=C1N=C(N([H])[H])N([H])C2=O,LTFMZDNNPPEQNG-KVQBGUIXSA-L,"InChI=1S/C10H14N5O7P/c11-10-13-8-7(9(17)14-10)12-3-15(8)6-1-4(16)5(22-6)2-21-23(18,19)20/h3-6,16H,1-2H2,(H2,18,19,20)(H3,11,13,14,17)/p-2/t4-,5+,6+/m0/s1"
2970,33104,hydridoarsenic(2.) (triplet),a,17625,KEGG COMPOUND accession,C00460,dutp,1173-82-6,17625.0,"Human Metabolome Database (HMDB): Deoxyuridine triphosphate (dUTP) is a deoxynucleotide triphosphate (dNTP) that is chemically similar to uridine triphosphate (UTP) except that it has a deoxyribose sugar instead of a ribose sugar. DNA synthesis requires the availability of deoxynucleotide triphosphates (dTTP, dATP, dGTP, dCTP), whereas RNA synthesis requires the availability of nucleotide triphosphates (NTPs) such as TTP, ATP, GTP, and UTP. The conversion of nucleotide triphosphates (NTPs) into dNTPs can only be done in the diphosphate form. Typically, an NTP has one phosphate removed to become an NDP. This is then converted into a dNDP by an enzyme called ribonucleotide reductase and followed by the re-addition of phosphate to give a dNTP. dUTP is a substrate for several enzymes, including inosine triphosphate pyrophosphatase, deoxyuridine 5'-triphosphate nucleotidohydrolase (mitochondrial), uridine-cytidine kinase 1, nucleoside diphosphate kinase 3, nucleoside diphosphate kinase B, nucleoside diphosphate kinase 6, nucleoside diphosphate kinase (mitochondrial), nucleoside diphosphate kinase homolog 5, nucleoside diphosphate kinase A, and nucleoside diphosphate kinase 7. While UTP is routinely incorporated into RNA, dUTP is not normally incorporated into DNA. Instead, if dUTP is misincorporated into DNA, it can cause DNA damage. Therefore, dUTP can be considered as a teratogen or a mutagen. The extent of DNA damage caused by dUTP is highly dependent on the levels of the dUTP pyrophosphatase (dUTPase) and uracil-DNA glycosylase (UDG), which limits the intracellular accumulation of dUTP. Additionally, loss of viability following thymidylate synthase (TS) inhibition occurs as a consequence of the accumulation of dUTP in some cell lines and subsequent misincorporation of uracil into DNA (PMID: 11487279).",Deoxyuridine triphosphate,HMDB0001191,b,b,C00460,DUTP,FDB022478,dutp,[H]O[C@@]1([H])C([H])([H])[C@@]([H])(O[C@]1([H])C([H])([H])OP([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O)N1C([H])=C([H])C(=O)N([H])C1=O,AHCYMLUZIRLXAA-SHYZEUOFSA-J,"InChI=1S/C9H15N2O14P3/c12-5-3-8(11-2-1-7(13)10-9(11)14)23-6(5)4-22-27(18,19)25-28(20,21)24-26(15,16)17/h1-2,5-6,8,12H,3-4H2,(H,18,19)(H,20,21)(H,10,13,14)(H2,15,16,17)/p-4/t5-,6+,8+/m0/s1"
2971,33118,boric acid,a,30912,KEGG COMPOUND accession,C04092,1pipdn2c,2756-89-0,30912.0,"Human Metabolome Database (HMDB): delta 1-Piperidine-2-carboxylic acid (P2C), an intermediate of the L-lysine metabolic pathway in the brain; the uptake of P2C into the synaptosome of the cerebral cortex was Na+ and temperature-dependent (PMID 7654748 ).",D-1-Piperideine-2-Carboxylic Acid,HMDB0001084,b,b,C04092,delta(1)-piperideine-2-carboxylate,FDB022415,1pipdn2c,[H]OC(=O)C1=NC([H])([H])C([H])([H])C([H])([H])C1([H])[H],GEJXSVNGWOSZPC-UHFFFAOYSA-N,"InChI=1S/C6H9NO2/c8-6(9)5-3-1-2-4-7-5/h1-4H2,(H,8,9)"
2972,33199,propynoic acid,"A terminal acetylenic compound that is a 3-carbon, straight-chain, monounsaturated fatty acid having one acetylenic bond.",18185,KEGG COMPOUND accession,C02483,,,,,,,,,,,,,,,
2973,33217,"3,3',5,5'-tetrabromobisphenol A","A bromobisphenol that is 4,4'-methanediyldiphenol in which the methylene hydrogens are replaced by two methyl groups and the phenyl rings are substituted by bromo groups at positions 2, 2', 6 and 6'. It is a brominated flame retardant.",10586,KEGG COMPOUND accession,C04684,,,,,,,,,,,,,,,
2974,33220,3-monobromobisphenol A,a,10588,KEGG COMPOUND accession,C11738,,,,,,,,,,,,,,,
2975,33250,atom,A chemical entity constituting the smallest component of an element having the chemical properties of the element.,27987,KEGG COMPOUND accession,C06152,,,,,,,,,,,,,,,
2976,33277,gamma-tocotrienol,"A tocotrienol that is chroman-6-ol substituted by methyl groups at positions 2, 7 and 8 and a farnesyl chain at position 2. A vitamin E family member that has potent anti-cancer properties against a wide-range of cancers.",18087,KEGG COMPOUND accession,C11525,M02493,b,b,b,Myo-Inositol-Polyphosphate,b,b,b,C11525,b,b,b,b,b,b
2977,33281,antimicrobial agent,"A substance that kills or slows the growth of microorganisms, including bacteria, viruses, fungi and protozoans.",29021,KEGG COMPOUND accession,C11271,,,,,,,,,,,,,,,
2978,33308,carboxylic ester,"An ester of a carboxylic acid, R(1)C(=O)OR(2), where R(1) = H or organyl and R(2) = organyl.",28420,KEGG COMPOUND accession,C03444,,,,,,,,,,,,,,,
2979,33509,arabinonic acid,a,10696,KEGG COMPOUND accession,C11511,,,,,,,,,,,,,,,
2980,33574,4-methylthio-2-oxobutanoic acid,A 2-oxo monocarboxylic acid derived from L-methionine via the action of methionine transaminase.,28951,KEGG COMPOUND accession,C11428,,,,,,,,,,,,,,,
2981,33575,carboxylic acid,"A carbon oxoacid acid carrying at least one -C(=O)OH group and having the structure RC(=O)OH, where R is any any monovalent functional group. Carboxylic acids are the most common type of organic acid.",32806,KEGG COMPOUND accession,C02341,,,,,,,,,,,,,,,
2982,65273,cytosin1-yl group,An organic group obtained by removal of the hydrogen attached to the nitrogen at position 1 from cytosine.,10860,KEGG COMPOUND accession,C02225,,,,,,,,,,,,,,,
2983,66773,(2S)-poncirin,"A  flavanone glycoside that is  4'-methoxy-5,7-dihydroxyflavanone attached to a neohesperidose (alpha-L-rhamnopyranosyl-(1->2)-beta-D-glucopyranose) residue via a glycosidic linkage. It has been isolated from the fruits of Poncirus trifoliata and exhibits inhibitory activity against liopolysaccharide (LPS)-induced prostaglandin E2 and interleukin-6 (IL-6) production.",17457,KEGG COMPOUND accession,C06734,,,,,,,,,,,,,,,
2984,68480,alpha-D-Gal-(1->3)-beta-D-Gal-(1->4)-beta-D-GlcNAc-(1->2)-alpha-D-Man-(1->3)-[alpha-D-Gal-(1->3)-beta-D-Gal-(1->4)-beta-D-GlcNAc-(1->2)-alpha-D-Man-(1->6)]-beta-D-Man-(1->4)-beta-D-GlcNAc-(1->4)-beta-D-GlcNAc,"An amino oligosaccharide that is a undecasaccharide derivative in which two tetrasaccharide branches, each formed from alpha-D-galactosyl-(1->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->2)-alpha-D-mannose, are linked (1->3) and (1->6) to the mannose residue of a trisaccharide chain consisting of mannose and two N-acetylglucosamine residues all linked beta(1->4) with a beta-configuration of the anomeric carbon of the N-acetylglucosamine residue at the reducing end.",16317,KEGG COMPOUND accession,C03930,,,,,,,,,,,,,,,
2985,68667,(E)-2-epi-beta-caryophyllene,"A sesquiterpene with a [7.2.0]-bicyclic structure comprising fused 9- and 4-membered rings, with a cis-ring junction, a methylidene group at position 9, and methyl groups at positions 3, 11, and 11.",30960,KEGG COMPOUND accession,C04773,,,,,,,,,,,,,,,
2986,68947,"13-oxo-9Z,11E-ODE","An oxooctadecadienoic acid that consists of 9Z,11E-octadecadienoic acid bearing an additional 13-keto substituent. In addtion it has been found as a natural product found in Carthamus oxyacantha.",15371,KEGG COMPOUND accession,C07297,C07297,b,b,"Human Metabolome Database (HMDB): (R) Pristanoyl-CoA is converted by alpha-methylacyl-CoA racemase (E.C. 5.1.99.4) (S) pristanoyl-CoA, which is then degraded via peroxisomal beta-oxidation. Deficiency in this enzyme results in neuropathy, hypogonadism of adult onset; and in infant, defective bile acid synthesis has been observed. Pristanoyl-CoA is the substrate of propionyl-CoA C(2)-trimethyltridecanoyltransferase (E.C.2.3.1.154). It is the substrate of peroxisomal pristanoyl-CoA oxidase (E.C.1.3.3.6). A genetic disorder called Zellweger syndrome (OMIM: 214100), also known as neonatal adrenoleukodystrophy, NALD) is the result of a lack of pristanoyl-CoA oxidase, and the subsequent accumulation of phytanic acid and pristanic acid.",Pristanoyl-CoA,HMDB0002057,b,b,C07297,3-OXOPRISTANOYL-COA,FDB022821,C07297,[H]O[C@@]([H])(C(=O)N([H])C([H])([H])C([H])([H])C(=O)N([H])C([H])([H])C([H])([H])SC(=O)C([H])(C(=O)C([H])([H])C([H])([H])C([H])(C([H])([H])[H])C([H])([H])C([H])([H])C([H])([H])C([H])(C([H])([H])[H])C([H])([H])C([H])([H])C([H])([H])C([H])(C([H])([H])[H])C([H])([H])[H])C([H])([H])[H])C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])OP([O-])(=O)OP([O-])(=O)OC([H])([H])[C@@]1([H])O[C@@]([H])(N2C([H])=NC3=C(N=C([H])N=C23)N([H])[H])[C@]([H])(O[H])[C@]1([H])OP([O-])([O-])=O,NQFYRDGBRBDQQG-SVFBWJQPSA-J,"InChI=1S/C40H70N7O18P3S/c1-24(2)10-8-11-25(3)12-9-13-26(4)14-15-28(48)27(5)39(53)69-19-18-42-30(49)16-17-43-37(52)34(51)40(6,7)21-62-68(59,60)65-67(57,58)61-20-29-33(64-66(54,55)56)32(50)38(63-29)47-23-46-31-35(41)44-22-45-36(31)47/h22-27,29,32-34,38,50-51H,8-21H2,1-7H3,(H,42,49)(H,43,52)(H,57,58)(H,59,60)(H2,41,44,45)(H2,54,55,56)/p-4/t25?,26?,27?,29-,32-,33-,34+,38-/m1/s1"
2987,68980,longirostrerone A,"An  azaphilone that is 9,9a-dihydro-6H-furo[2,3-h]isochromene-6,8(6aH)-dione substituted by a 4-hydroxy-2-methyl-6-oxocyclohexyl group at position 3, a methyl group at position 6a and a 4,6,8-trimethyldeca-2,4-dienoyl group at position 9. Isolated from Chaetomium longirostre, it exhibits cytotoxic and antimalarial activities.",17052,KEGG COMPOUND accession,C03175,,,,,,,,,,,,,,,
2988,68982,longirostrerone C,"An azaphilone that is 9,9a-dihydro-6H-furo[2,3-h]isochromene-6,8(6aH)-dione substituted by a 6-methyl-2-oxocyclohex-3-en-1-yl group at position 3, a methyl group at position 6a and a 4,6,8-trimethyldeca-2,4-dienoyl group at position 9. Isolated from Chaetomium longirostre, it exhibits cytotoxic and antimalarial activities.",15594,KEGG COMPOUND accession,C02123,,,,,,,,,,,,,,,
2989,70499,akuammicine,"A monoterpenoid indole alkaloid with formula C20H22N2O2, isolated from several plant species including Alstonia spatulata, Catharanthus roseus and Vinca major.",27387,KEGG COMPOUND accession,C05404,,,,,,,,,,,,,,,
2990,73730,PPARbeta/delta agonist,A PPAR modulator which activates the peroxisome proliferator-activated receptor-beta/delta.,16971,KEGG COMPOUND accession,C02814,,,,,,,,,,,,,,,
2991,73793,1-tetradecanoyl-2-(11Z-octadecenoyl)-sn-glycero-3-phosphocholine,A phosphatidylcholine 32:1 in which the acyl groups at C-1 and C-2 are tetradecanoyl and (11Z)-octadec-11-enoyl respectively.,16079,KEGG COMPOUND accession,C04000,,,,,,,,,,,,,,,
2992,74673,"5,6-dihydrouridine 5'-monophosphate","A uridine 5'-phosphate that is the 5,6-dihydro derivative of uridine 5'-monophosphate.",16731,KEGG COMPOUND accession,C00903,,,,,,,,,,,,,,,
2993,74767,Pro-Hyp,A dipeptide composed of L-proline and L-hydroxyproline residues. It is a biomarker for bone collagen degradation.,17343,KEGG COMPOUND accession,C03648,,,,,,,,,,,,,,,
2994,75340,beta-D-galactosyl-(1->4)-beta-D-glucosyl-N-(hexacosanoyl)sphingosine,A beta-D-galactosyl-(1->4)-beta-D-glucosylceramide where the ceramide N-acyl group is specified as hexacosanoyl.,28496,KEGG COMPOUND accession,C05556,,,,,,,,,,,,,,,
2995,75768,mammalian metabolite,Any animal metabolite produced during a metabolic reaction in mammals.,18320,KEGG COMPOUND accession,C00265,dtt,513-85-9,62064.0,"Human Metabolome Database (HMDB): 2,3-Butanediol is an isomer of butanediol. The 2R,3R stereoisomer of 2,3-butanediol is produced by a variety of microorganisms, in a process known as butanediol fermentation. 2,3-Butanediol fermentation is the anaerobic fermentation of glucose with 2,3-butanediol as one of the end products. The overall stoichiometry of the reaction is 2 pyruvate + NADH --> 2CO2 + 2,3-butanediol. Butanediol fermentation is typical for Enterobacter species or microbes found in the gut. 2,3-butanediol has been identified in the sera of alcoholics and it may be a specific marker of alcohol abuse (PMID: 6139706). In humans, 2,3-butanediol is oxidized to acetyl-CoA via acetoin. 2,3-Butanediol is also found in cocoa butter.","2,3-Butanediol",HMDB0003156,b,b,C00265,CPD-346,FDB011934,b,[H]O[C@@]([H])(C([H])([H])S[H])[C@@]([H])(O[H])C([H])([H])S[H],VHJLVAABSRFDPM-IMJSIDKUSA-N,"InChI=1S/C4H10O2S2/c5-3(1-7)4(6)2-8/h3-8H,1-2H2/t3-,4-/m0/s1"
2996,75947,2'-3'-cGAMP,"A cyclic purine dinucleotide that consists of AMP and GMP units cyclised via 3',5'- and 2',5'-linkages respectively.",17160,KEGG COMPOUND accession,C02537,,,,,,,,,,,,,,,
2997,76225,1-alkyl-3-acylglycerol,A monoglyceride in which the acyl group is located at position 3 with an additional alkyl substituent at position 1.,29806,KEGG COMPOUND accession,C00122,fum,110-17-8,18012.0,"Human Metabolome Database (HMDB): Fumaric acid is a dicarboxylic acid. It is a precursor to L-malate in the Krebs tricarboxylic acid (TCA) cycle. It is formed by the oxidation of succinic acid by succinate dehydrogenase. Fumarate is converted by the enzyme fumarase to malate. Fumaric acid has recently been identified as an oncometabolite or an endogenous, cancer causing metabolite. High levels of this organic acid can be found in tumors or biofluids surrounding tumors. Its oncogenic action appears to due to its ability to inhibit prolyl hydroxylase-containing enzymes. In many tumours, oxygen availability becomes limited (hypoxia) very quickly due to rapid cell proliferation and limited blood vessel growth. The major regulator of the response to hypoxia is the HIF transcription factor (HIF-alpha). Under normal oxygen levels, protein levels of HIF-alpha are very low due to constant degradation, mediated by a series of post-translational modification events catalyzed by the prolyl hydroxylase domain-containing enzymes PHD1, 2 and 3, (also known as EglN2, 1 and 3) that hydroxylate HIF-alpha and lead to its degradation. All three of the PHD enzymes are inhibited by fumarate. Fumaric acid is found to be associated with fumarase deficiency, which is an inborn error of metabolism.",Fumaric acid,HMDB0000134,b,b,C00122,FUM,FDB003291,fum,[H]\C(=C(\[H])C([O-])=O)C([O-])=O,VZCYOOQTPOCHFL-OWOJBTEDSA-L,"InChI=1S/C4H4O4/c5-3(6)1-2-4(7)8/h1-2H,(H,5,6)(H,7,8)/p-2/b2-1+"
2998,79208,beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1)-ceramide,Any glycodiaosylceramide having beta-D-galactosyl-(1->4)-beta-D-glucose as the disaccharide component and undefined sphingoid base.,17520,KEGG COMPOUND accession,C03719,,,,,,,,,,,,,,,
2999,82639,alpha-N-acetylneuraminosyl-(2->3)-[beta-D-galactosyl-(1->3)-N-acetyl-beta-D-galactosaminyl-(1->4)]-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(1-),An anionic ganglioside that is the conjugate base alpha-N-acetylneuraminosyl-(2->3)-[beta-D-galactosyl-(1->3)-N-acetyl-beta-D-galactosaminyl-(1->4)]-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide arising from deprotonation of the neuraminosyl carboxy group; major species at pH 7.3.,15419,KEGG COMPOUND accession,C11875,,,,,,,,,,,,,,,
3000,85936,"5-amino-5-(4-hydroxybenzyl)-6-(D-ribitylimino)-5,6-dihydrouracil","A member of the class of pyrimidones that is 5,6-diamino-5-[(4-hydroxyphenyl)methyl]pyrimidine-2,4-dione in which the imino hydrogen at position 6 is replaced by a D-ribityl group.",31046,KEGG COMPOUND accession,C12314,,,,,,,,,,,,,,,
3001,86025,"(9Z,11E,13E,15Z)-octadecatetraenoyl group","A parinaroyl group derived from (9Z,11E,13E,15Z)-octadecatetraenoic (alpha-parinaric) acid.",31084,KEGG COMPOUND accession,C12251,,,,,,,,,,,,,,,
3002,86389,5beta-dihydroaldosterone,A 3-oxo-5beta-steroid formed from aldosterone by reduction across the C4-C5 double bond.,31249,KEGG COMPOUND accession,C13392,,,,,,,,,,,,,,,
3003,88332,aralkylammonium,A primary ammonium ion obtained by protonation of the amino group of an aralkylamine; major species at pH 7.3.,32047,KEGG COMPOUND accession,C12385,,,,,,,,,,,,,,,
3004,94552,sepantronium,"An organic cation that is 1-(2-methoxyethyl)-2-methyl-1H-naphtho[2,3-d]imidazole-4,9-dione in which the nitrogen at position 3 of the napthoimidazole moiety has been alkylated by a pyrazin-2-ylmethyl group.",34666,KEGG COMPOUND accession,C14368,,,,,,,,,,,,,,,
3005,101278,diltiazem,"A 5-[2-(dimethylamino)ethyl]-2-(4-methoxyphenyl)-4-oxo-2,3,4,5-tetrahydro-1,5-benzothiazepin-3-yl acetate in which both stereocentres have S configuration. A calcium-channel blocker and vasodilator, it is used as the hydrochloride in the management of angina pectoris and hypertension.",2311,KEGG COMPOUND accession,C15037,,,,,,,,,,,,,,,
3006,1,a,a,18357,KEGG COMPOUND accession,C00547,nrpphr,51-41-2,18357.0,Human Metabolome Database (HMDB): Precursor of epinephrine that is secreted by the adrenal medulla and is a widespread central and autonomic neurotransmitter. Norepinephrine is the principal transmitter of most postganglionic sympathetic fibers and of the diffuse projection system in the brain arising from the locus ceruleus. It is also found in plants and is used pharmacologically as a sympathomimetic. Norepinephrine is elevated in the urine of people who consume bananas.,Norepinephrine,HMDB0000216,b,b,C00547,NOREPINEPHRINE,FDB000895,nrpphr,[H]OC1=C([H])C([H])=C(C([H])=C1O[H])[C@@]([H])(O[H])C([H])([H])[N+]([H])([H])[H],SFLSHLFXELFNJZ-QMMMGPOBSA-O,"InChI=1S/C8H11NO3/c9-4-8(12)5-1-2-6(10)7(11)3-5/h1-3,8,10-12H,4,9H2/p+1/t8-/m0/s1"
3007,12,a,a,15399,KEGG COMPOUND accession,C11383,,,,,,,,,,,,,,,
3008,15,a,a,27743,KEGG COMPOUND accession,C04347,,,,,,,,,,,,,,,
3009,16,a,a,7,KEGG COMPOUND accession,C11382,,,,,,,,,,,,,,,
3010,18,a,a,8,KEGG COMPOUND accession,C09938,,,,,,,,,,,,,,,
3011,35,a,a,15396,KEGG COMPOUND accession,C00808,,,,,,,,,,,,,,,
3012,44,a,a,20,KEGG COMPOUND accession,C06304,,,,,,,,,,,,,,,
3013,46,a,a,28429,KEGG COMPOUND accession,C02906,,,,,,,,,,,,,,,
3014,54,a,a,25,KEGG COMPOUND accession,C09785,,,,,,,,,,,,,,,
3015,56,a,a,26,KEGG COMPOUND accession,C09804,,,,,,,,,,,,,,,
3016,58,a,a,15382,KEGG COMPOUND accession,C06099,,,,,,,,,,,,,,,
3017,67,a,a,31,KEGG COMPOUND accession,C11390,,,,,,,,,,,,,,,
3018,69,a,a,32,KEGG COMPOUND accession,C10159,,,,,,,,,,,,,,,
3019,85,a,a,41,KEGG COMPOUND accession,C09885,,,,,,,,,,,,,,,
3020,95,a,a,15403,KEGG COMPOUND accession,C01868,,,,,,,,,,,,,,,
3021,97,a,a,47,KEGG COMPOUND accession,C10889,,,,,,,,,,,,,,,
3022,103,a,a,28785,KEGG COMPOUND accession,C02766,,,,,,,,,,,,,,,
3023,136,a,a,29109,KEGG COMPOUND accession,C04875,,,,,,,,,,,,,,,
3024,138,a,a,29110,KEGG COMPOUND accession,C04883,,,,,,,,,,,,,,,
3025,140,a,a,28258,KEGG COMPOUND accession,C04166,,,,,,,,,,,,,,,
3026,142,a,a,18429,KEGG COMPOUND accession,C04223,,,,,,,,,,,,,,,
3027,144,a,a,28395,KEGG COMPOUND accession,C04167,,,,,,,,,,,,,,,
3028,167,a,a,15394,KEGG COMPOUND accession,C01766,,,,,,,,,,,,,,,
3029,172,a,a,15397,KEGG COMPOUND accession,C00809,,,,,,,,,,,,,,,
3030,175,a,a,15400,KEGG COMPOUND accession,C01767,,,,,,,,,,,,,,,
3031,178,a,a,87,KEGG COMPOUND accession,C09133,,,,,,,,,,,,,,,
3032,180,a,a,88,KEGG COMPOUND accession,C11386,,,,,,,,,,,,,,,
3033,182,a,a,89,KEGG COMPOUND accession,C06305,,,,,,,,,,,,,,,
3034,183,a,a,90,KEGG COMPOUND accession,C09727,,,,,,,,,,,,,,,
3035,187,a,a,92,KEGG COMPOUND accession,C11359,,,,,,,,,,,,,,,
3036,191,a,a,15408,KEGG COMPOUND accession,C02485,,,,,,,,,,,,,,,
3037,194,a,a,18292,KEGG COMPOUND accession,C08491,,,,,,,,,,,,,,,
3038,206,a,a,99,KEGG COMPOUND accession,C10502,,,,,,,,,,,,,,,
3039,208,a,a,100,KEGG COMPOUND accession,C10503,,,,,,,,,,,,,,,
3040,215,a,a,15410,KEGG COMPOUND accession,C00843,,,,,,,,,,,,,,,
3041,219,a,a,15411,KEGG COMPOUND accession,C03962,,,,,,,,,,,,,,,
3042,229,a,a,108,KEGG COMPOUND accession,C10514,,,,,,,,,,,,,,,
3043,231,a,a,109,KEGG COMPOUND accession,C10515,,,,,,,,,,,,,,,
3044,243,a,a,115,KEGG COMPOUND accession,C10526,,,,,,,,,,,,,,,
3045,247,a,a,28827,KEGG COMPOUND accession,C10783,,,,,,,,,,,,,,,
3046,251,a,a,119,KEGG COMPOUND accession,C01869,,,,,,,,,,,,,,,
3047,254,a,a,15412,KEGG COMPOUND accession,C00603,M03122,b,15412.0,Human Metabolome Database (HMDB): (S)-Ureidoglycolic acid is a substrate of enzyme ureidoglycolate dehydrogenase [EC 1.1.1.154] in purine metabolism pathway (KEGG).,(S)-Ureidoglycolic acid,HMDB0001005,b,b,C00603,CPD-1091,FDB022364,b,[H]OC(=O)[C@]([H])(O[H])N([H])C(=O)N([H])[H],NWZYYCVIOKVTII-SFOWXEAESA-N,"InChI=1S/C3H6N2O4/c4-3(9)5-1(6)2(7)8/h1,6H,(H,7,8)(H3,4,5,9)/t1-/m0/s1"
3048,260,a,a,122,KEGG COMPOUND accession,C10101,,,,,,,,,,,,,,,
3049,264,a,a,37600,KEGG COMPOUND accession,C08259,,,,,,,,,,,,,,,
3050,273,a,a,128,KEGG COMPOUND accession,C11393,,,,,,,,,,,,,,,
3051,275,a,a,129,KEGG COMPOUND accession,C11392,,,,,,,,,,,,,,,
3052,277,a,a,28359,KEGG COMPOUND accession,C06307,,,,,,,,,,,,,,,
3053,280,a,a,15405,KEGG COMPOUND accession,C02344,,,,,,,,,,,,,,,
3054,283,a,a,28598,KEGG COMPOUND accession,C11108,,,,,,,,,,,,,,,
3055,284,a,a,15389,KEGG COMPOUND accession,C00964,carveol,1197-07-5,15389.0,"Human Metabolome Database (HMDB): Carveol is a natural terpenoid alcohol that is a constituent of spearmint oil. It has an odor and flavor that resemble those of spearmint and caraway. Consequently, it is used as a fragrance in cosmetics and as a flavor additive in the food industry.",(-)-trans-Carveol,HMDB0003450,b,b,C00964,CPD-260,FDB013717,carveol,[H]O[C@]1([H])C(=C([H])C([H])([H])[C@@]([H])(C(=C([H])[H])C([H])([H])[H])C1([H])[H])C([H])([H])[H],BAVONGHXFVOKBV-ZJUUUORDSA-N,"InChI=1S/C10H16O/c1-7(2)9-5-4-8(3)10(11)6-9/h4,9-11H,1,5-6H2,2-3H3/t9-,10+/m1/s1"
3056,304,a,a,15448,KEGG COMPOUND accession,C04316,,,,,,,,,,,,,,,
3057,307,a,a,15544,KEGG COMPOUND accession,C04741,prostge1,745-65-3,15544.0,"Human Metabolome Database (HMDB): Prostaglandin E1 (PGE1) is a potent endogenous vasodilator agent that increases peripheral blood flow. It inhibits platelet aggregation and has many other biological effects such as bronchodilation, mediation of inflammation, and various protective functions.The protective action of PGE1 has been shown on both experimental animal models of liver injury and patients with fulminant viral hepatitis. PGE1-treated cirrhotic rats had less hepatosplenomegaly, lower serum alanine aminotransferase levels, and portal pressures and higher arterial pressure than placebo-treated cirrhotic rats. Mechanisms of hepatic cytopotection of PGE1: inhibitory effects on T-cell mediated cytotoxicity, enhance DNA synthesis of injured liver after partial hepatectomy by stimulating cyclic AMP production and increasing ATP level in hepatic tissue, and could accelerate the recovery of mitochondrial respiratory functio n after reperfusion, stabilization of membrane microviscosity.PGE1 is a prostanoid. Prostanoids is a term that collectively describes prostaglandins, prostacyclines and thromboxanes. Prostanoids are a subclass of the lipid mediator group known as eicosanoids. They derive from C-20 polyunsaturated fatty acids, mainly dihomo-gamma-linoleic (20:3n-6), arachidonic (20:4n-6), and eicosapentaenoic (20:5n-3) acids, through the action of cyclooxygenases-1 and -2 (COX-1 and COX-2). (PMID: 11819590, 16986207)Prostaglandins are eicosanoids. The eicosanoids consist of the prostaglandins (PGs), thromboxanes (TXs), leukotrienes (LTs) and lipoxins (LXs). The PGs and TXs are collectively identified as prostanoids. Prostaglandins were originally shown to be synthesized in the prostate gland, thromboxanes from platelets (thrombocytes) and leukotrienes from leukocytes, hence the derivation of their names. All mammalian cells except erythrocytes synthesize eicosanoids. These molecules are extremely potent, able to cause profound physiological effects at very dilute concentrations. All eicosanoids function locally at the site of synthesis, through receptor-mediated G-protein linked signaling pathways.",Prostaglandin E1,HMDB0001442,b,b,C04741,ALPROSTADIL,FDB022625,prostge1,[H]O[C@]([H])(C(\[H])=C(/[H])[C@@]1([H])[C@]([H])(O[H])C([H])([H])C(=O)[C@]1([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([O-])=O)C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H],GMVPRGQOIOIIMI-DWKJAMRDSA-M,"InChI=1S/C20H34O5/c1-2-3-6-9-15(21)12-13-17-16(18(22)14-19(17)23)10-7-4-5-8-11-20(24)25/h12-13,15-17,19,21,23H,2-11,14H2,1H3,(H,24,25)/p-1/b13-12+/t15-,16+,17+,19+/m0/s1"
3058,310,a,a,15545,KEGG COMPOUND accession,C04685,HC02202,14152-28-4,15545.0,"Human Metabolome Database (HMDB): Prostaglandin A1 (PGA1, a prostaglandin characterized by a cyclopentenone structure) has a fundamental structure common to punaglandin and clavulone, the antitumor eicosanoids discovered in marine organisms such as corals. It is well established that PGA1, which exert potent antiviral activity in several DNA and RNA virus models, induce heat shock protein (hsp)70 syntheses through cycloheximide sensitive activation of heat shock transcription factor. Antitumor prostaglandins are actively incorporated through cell membrane and control gene expression. P53 (protein 53, is a transcription factor that regulates the cell cycle and functions as a tumor suppressor) independent expression of p21 (also known as cyclin-dependent kinase inhibitor 1A or CDKN1A, is a human gene on chromosome 6 (location 6p21.2), that encodes a cyclin-dependent kinase) and gadd 45 (growth arrest and DNA-damage-inducible, alpha 45, a major breast cancer (BRCA1) target is the DNA damage-responsive gene GADD45) activation of peroxisome proliferative activated receptor gamma (PPARgamma) are involved in antitumor mechanism of these prostaglandins. At the low concentration, these prostaglandins exhibit physiological or pathological activity such as osteoblast calcification, promotion of colon cancer cell proliferation. One of the mechanisms of anti-cancer activity of prostaglandins, has been believed to be that these prostaglandins might have p53 like effect in cells lacking p53. (PMID: 7988663, 11104898)Prostaglandins are eicosanoids. The eicosanoids consist of the prostaglandins (PGs), thromboxanes (TXs), leukotrienes (LTs) and lipoxins (LXs). The PGs and TXs are collectively identified as prostanoids. Prostaglandins were originally shown to be synthesized in the prostate gland, thromboxanes from platelets (thrombocytes) and leukotrienes from leukocytes, hence the derivation of their names. All mammalian cells except erythrocytes synthesize eicosanoids. These molecules are extremely potent, able to cause profound physiological effects at very dilute concentrations. All eicosanoids function locally at the site of synthesis, through receptor-mediated G-protein linked signaling pathways.",Prostaglandin A1,HMDB0002656,b,b,C04685,CPD-1911,FDB023040,HC02202,[H]O[C@]([H])(C(\[H])=C(/[H])[C@@]1([H])C([H])=C([H])C(=O)[C@]1([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([O-])=O)C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H],BGKHCLZFGPIKKU-LDDQNKHRSA-M,"InChI=1S/C20H32O4/c1-2-3-6-9-17(21)14-12-16-13-15-19(22)18(16)10-7-4-5-8-11-20(23)24/h12-18,21H,2-11H2,1H3,(H,23,24)/p-1/b14-12+/t16-,17-,18+/m0/s1"
3059,313,a,a,15546,KEGG COMPOUND accession,C04686,HC02206,b,15546.0,"Human Metabolome Database (HMDB): This compound belongs to the family of Prostaglandins and related compounds. These are unsaturated carboxylic acids consisting of of a 20 carbon skeleton that also contains a five member ring, and are based upon the fatty acid arachidonic acid.",Prostaglandin C1,HMDB0060104,b,b,C04686,b,b,HC02206,[H]O[C@]([H])(C(\[H])=C(/[H])C1=C([H])C([H])([H])C(=O)[C@]1([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([O-])=O)C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H],PUIBPGHAXSCVRF-QHFGJBOXSA-M,"InChI=1S/C20H32O4/c1-2-3-6-9-17(21)14-12-16-13-15-19(22)18(16)10-7-4-5-8-11-20(23)24/h12-14,17-18,21H,2-11,15H2,1H3,(H,23,24)/p-1/b14-12+/t17-,18+/m0/s1"
3060,316,a,a,15548,KEGG COMPOUND accession,C04654,prostg1,22973-19-9,15548.0,"Human Metabolome Database (HMDB): (13E)-11a-Hydroxy-9,15-dioxoprost-13-enoic acid is a substrate for Carbonyl reductase 1.Prostaglandins are eicosanoids. The eicosanoids consist of the prostaglandins (PGs), thromboxanes (TXs), leukotrienes (LTs) and lipoxins (LXs). The PGs and TXs are collectively identified as prostanoids. Prostaglandins were originally shown to be synthesized in the prostate gland, thromboxanes from platelets (thrombocytes) and leukotrienes from leukocytes, hence the derivation of their names. All mammalian cells except erythrocytes synthesize eicosanoids. These molecules are extremely potent, able to cause profound physiological effects at very dilute concentrations. All eicosanoids function locally at the site of synthesis, through receptor-mediated G-protein linked signaling pathways.","(13E)-11a-Hydroxy-9,15-dioxoprost-13-enoic acid",HMDB0001320,b,b,C04654,13E-11-ALPHA-HYDROXY-915-DIOXOPROST-1,FDB022553,b,[H]O[C@]1([H])C([H])([H])C(=O)[C@]([H])(C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([O-])=O)[C@@]1([H])C(\[H])=C(/[H])C(=O)C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H],VXPBDCBTMSKCKZ-XQHNHVHJSA-M,"InChI=1S/C20H32O5/c1-2-3-6-9-15(21)12-13-17-16(18(22)14-19(17)23)10-7-4-5-8-11-20(24)25/h12-13,16-17,19,23H,2-11,14H2,1H3,(H,24,25)/p-1/b13-12+/t16-,17-,19-/m1/s1"
3061,320,a,a,15558,KEGG COMPOUND accession,C04742,,,,,,,,,,,,,,,
3062,322,a,a,15560,KEGG COMPOUND accession,C01226,,,,,,,,,,,,,,,
3063,330,a,a,152,KEGG COMPOUND accession,C11397,,,,,,,,,,,,,,,
3064,332,a,a,154,KEGG COMPOUND accession,C11398,,,,,,,,,,,,,,,
3065,333,a,a,155,KEGG COMPOUND accession,C11412,,,,,,,,,,,,,,,
3066,334,a,a,50232,KEGG COMPOUND accession,C11400,,,,,,,,,,,,,,,
3067,337,a,a,158,KEGG COMPOUND accession,C11416,,,,,,,,,,,,,,,
3068,338,a,a,28809,KEGG COMPOUND accession,C04514,,,,,,,,,,,,,,,
3069,340,a,a,160,KEGG COMPOUND accession,C04617,,,,,,,,,,,,,,,
3070,343,a,a,50233,KEGG COMPOUND accession,C11399,,,,,,,,,,,,,,,
3071,344,a,a,50235,KEGG COMPOUND accession,C11413,,,,,,,,,,,,,,,
3072,345,a,a,48202,KEGG COMPOUND accession,C10377,,,,,,,,,,,,,,,
3073,347,a,a,15566,KEGG COMPOUND accession,C04687,,,,,,,,,,,,,,,
3074,349,a,a,165,KEGG COMPOUND accession,C11387,,,,,,,,,,,,,,,
3075,351,a,a,166,KEGG COMPOUND accession,C11401,,,,,,,,,,,,,,,
3076,352,a,a,15567,KEGG COMPOUND accession,C04670,,,,,,,,,,,,,,,
3077,354,a,a,168,KEGG COMPOUND accession,C11415,,,,,,,,,,,,,,,
3078,355,a,a,15443,KEGG COMPOUND accession,C03323,inulin,9005-80-5,15443.0,"Human Metabolome Database (HMDB): Inulin is only found in individuals that have used or taken this drug. It is a starch found in the tubers and roots of many plants. Since it is hydrolyzable to fructose, it is classified as a fructosan. It has been used in physiologic investigation for determination of the rate of glomerular function. [PubChem]As a diagnostic agent, inulin is readily soluble and essentially indigestible. It readily passes through the blood and into the urine. It is neither secreted nor resorbed by the kidney making it an excellent indicator for renal clearance rates. The inulin clearance test has largely been succeeded by the creatinine clearance test as a measure of glomerular filtration rate. As a hypoglycemic agent, inulin is not digestible by human enzymes ptyalin and amylase, which are designed to digest starch. As a result, inulin passes through much of the digestive system intact. It is only in the colon that bacteria metabolise inulin, with the release of significant quantities of carbon dioxide and/or methane. Because inulin is not broken down into simple sugars (monosaccharides) by normal digestion, it does not elevate blood sugar levels, hence, helping diabetics regulate blood sugar levels.",Inulin,HMDB0014776,b,b,C03323,b,b,b,b,JYJIGFIDKWBXDU-UHFFFAOYSA-N,b
3079,359,a,a,15572,KEGG COMPOUND accession,C04030,,,,,,,,,,,,,,,
3080,361,a,a,16703,KEGG COMPOUND accession,C06215,,,,,,,,,,,,,,,
3081,369,a,a,15574,KEGG COMPOUND accession,C04715,,,,,,,,,,,,,,,
3082,373,a,a,15576,KEGG COMPOUND accession,C11513,,,,,,,,,,,,,,,
3083,375,a,a,15577,KEGG COMPOUND accession,C03910,,,,,,,,,,,,,,,
3084,377,a,a,15578,KEGG COMPOUND accession,C03963,,,,,,,,,,,,,,,
3085,380,a,a,15579,KEGG COMPOUND accession,C04716,,,,,,,,,,,,,,,
3086,382,a,a,15580,KEGG COMPOUND accession,C04834,,,,,,,,,,,,,,,
3087,384,a,a,29052,KEGG COMPOUND accession,C00118,g3p,b,29052.0,b,Glyceraldehyde 3-Phosphate,b,b,b,C00118,b,b,g3p,[H]OC([H])(C([H])=O)C([H])([H])OP([O-])([O-])=O,LXJXRIRHZLFYRP-UHFFFAOYSA-L,"InChI=1S/C3H7O6P/c4-1-3(5)2-9-10(6,7)8/h1,3,5H,2H2,(H2,6,7,8)/p-2"
3088,406,a,a,15450,KEGG COMPOUND accession,C05329,,,,,,,,,,,,,,,
3089,408,a,a,15582,KEGG COMPOUND accession,C03652,,,,,,,,,,,,,,,
3090,412,a,a,15451,KEGG COMPOUND accession,C05232,,,,,,,,,,,,,,,
3091,414,a,a,15602,KEGG COMPOUND accession,C06326,,,,,,,,,,,,,,,
3092,416,a,a,15605,KEGG COMPOUND accession,C02345,,,,,,,,,,,,,,,
3093,418,a,a,15606,KEGG COMPOUND accession,C02099,,,,,,,,,,,,,,,
3094,420,a,a,15607,KEGG COMPOUND accession,C04593,,,,,,,,,,,,,,,
3095,423,a,a,15608,KEGG COMPOUND accession,C04655,,,,,,,,,,,,,,,
3096,425,a,a,15449,KEGG COMPOUND accession,C04405,3hmbcoa,52227-66-4,15449.0,"Human Metabolome Database (HMDB): 2-Methyl-3-hydroxybutyryl-CoA is a substrate for 3-hydroxyacyl-CoA dehydrogenase type II, Enoyl-CoA hydratase (mitochondrial), Trifunctional enzyme alpha subunit (mitochondrial), Short chain 3-hydroxyacyl-CoA dehydrogenase (mitochondrial) and Peroxisomal bifunctional enzyme.",2-Methyl-3-hydroxybutyryl-CoA,HMDB0001356,b,b,C04405,2-METHYL-3-HYDROXY-BUTYRYL-COA,FDB022575,3hmbcoa,[H]O[C@@]([H])(C(=O)N([H])C([H])([H])C([H])([H])C(=O)N([H])C([H])([H])C([H])([H])SC(=O)[C@@]([H])(C([H])([H])[H])[C@@]([H])(O[H])C([H])([H])[H])C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])OP([O-])(=O)OP([O-])(=O)OC([H])([H])[C@@]1([H])O[C@@]([H])(N2C([H])=NC3=C(N=C([H])N=C23)N([H])[H])[C@]([H])(O[H])[C@]1([H])OP([O-])([O-])=O,PEKYNTFSOBAABV-LQUDNSJZSA-J,"InChI=1S/C26H44N7O18P3S/c1-13(14(2)34)25(39)55-8-7-28-16(35)5-6-29-23(38)20(37)26(3,4)10-48-54(45,46)51-53(43,44)47-9-15-19(50-52(40,41)42)18(36)24(49-15)33-12-32-17-21(27)30-11-31-22(17)33/h11-15,18-20,24,34,36-37H,5-10H2,1-4H3,(H,28,35)(H,29,38)(H,43,44)(H,45,46)(H2,27,30,31)(H2,40,41,42)/p-4/t13-,14-,15+,18+,19+,20-,24+/m0/s1"
3097,435,a,a,15456,KEGG COMPOUND accession,C01086,,,,,,,,,,,,,,,
3098,471,a,a,29001,KEGG COMPOUND accession,C11405,,,,,,,,,,,,,,,
3099,472,a,a,29004,KEGG COMPOUND accession,C11407,,,,,,,,,,,,,,,
3100,474,a,a,15604,KEGG COMPOUND accession,C02486,,,,,,,,,,,,,,,
3101,477,a,a,15613,KEGG COMPOUND accession,C01142,36dahx,4299-56-3,15613.0,"Human Metabolome Database (HMDB): (3S)-3,6-Diaminohexanoate is found in the lysine degradation pathway. (3S)-3,6-Diaminohexanoate is created from L-lysine through the action of lysine 2,3-aminomutase [EC:5.4.3.2]. (3S)-3,6-Diaminohexanoate is then reversibly converted to (3S,5S)-3,5-Diaminohexanoate by beta-lysine 5,6-aminomutase [EC:5.4.3.3].","(3S)-3,6-Diaminohexanoate",HMDB0012114,b,b,C01142,CPD-9366,FDB028778,b,b,QKEWQOJCHPFEAF-YFKPBYRVSA-N,b
3102,480,a,a,15454,KEGG COMPOUND accession,C04348,,,,,,,,,,,,,,,
3103,483,a,a,15455,KEGG COMPOUND accession,C00640,,,,,,,,,,,,,,,
3104,490,a,a,211,KEGG COMPOUND accession,C11419,,,,,,,,,,,,,,,
3105,491,a,a,212,KEGG COMPOUND accession,C11421,,,,,,,,,,,,,,,
3106,495,a,a,36882,KEGG COMPOUND accession,C01011,citmcoa_L,b,b,Human Metabolome Database (HMDB): L-Citramalyl-CoA is an intermediate in C5-Branched dibasic acid metabolism. L-Citramalyl-CoA is the 3rd to last step in the synthesis of (R)-Acetoin and is converted from L-Citramalate via the enzyme citramalate CoA-transferase (EC 2.8.3.7). It is then converted to Pyruvate via the enzyme citramalate-CoA lyase (EC 4.1.3.25).,L-Citramalyl-CoA,HMDB0006345,b,b,C01011,b,FDB023897,citmcoa_L,[H]O[C@@]([H])(C(=O)N([H])C([H])([H])C([H])([H])C(=O)N([H])C([H])([H])C([H])([H])SC(=O)C([H])([H])[C@](O[H])(C([O-])=O)C([H])([H])[H])C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])OP([O-])(=O)OP([O-])(=O)OC([H])([H])[C@@]1([H])O[C@@]([H])(N2C([H])=NC3=C(N=C([H])N=C23)N([H])[H])[C@]([H])(O[H])[C@]1([H])OP([O-])([O-])=O,XYGOWHUIVNMEIA-XBVYHAPZSA-I,"InChI=1S/C26H42N7O20P3S/c1-25(2,19(37)22(38)29-5-4-14(34)28-6-7-57-15(35)8-26(3,41)24(39)40)10-50-56(47,48)53-55(45,46)49-9-13-18(52-54(42,43)44)17(36)23(51-13)33-12-32-16-20(27)30-11-31-21(16)33/h11-13,17-19,23,36-37,41H,4-10H2,1-3H3,(H,28,34)(H,29,38)(H,39,40)(H,45,46)(H,47,48)(H2,27,30,31)(H2,42,43,44)/p-5/t13-,17-,18-,19+,23-,26+/m1/s1"
3107,501,a,a,15459,KEGG COMPOUND accession,C00566,,,,,,,,,,,,,,,
3108,505,a,a,15564,KEGG COMPOUND accession,C06318,,,,,,,,,,,,,,,
3109,511,a,a,15615,KEGG COMPOUND accession,C04529,,,,,,,,,,,,,,,
3110,518,a,a,15617,KEGG COMPOUND accession,C05786,,,,,,,,,,,,,,,
3111,522,a,a,15619,KEGG COMPOUND accession,C05913,,,,,,,,,,,,,,,
3112,524,a,a,15622,KEGG COMPOUND accession,C04575,23doguln,3445-22-5,15622.0,"Human Metabolome Database (HMDB): 2,3-Diketo-L-gulonate is an intermediate in Ascorbate and aldarate metabolism. 2,3-Diketo-L-gulonate is produced from Dehydroascorbate and then converted to L-Xylonate via the enzyme Lyases (EC 4.1.1.-).","2,3-Diketo-L-gulonate",HMDB0006511,b,b,C04575,"2,3-diketo-l-gulonate",FDB023950,23doguln,[H]OC([H])([H])[C@]([H])(O[H])[C@@]([H])(O[H])C(=O)C(=O)C([O-])=O,GJQWCDSAOUMKSE-STHAYSLISA-M,"InChI=1S/C6H8O7/c7-1-2(8)3(9)4(10)5(11)6(12)13/h2-3,7-9H,1H2,(H,12,13)/p-1/t2-,3+/m0/s1"
3113,527,a,a,228,KEGG COMPOUND accession,C11402,,,,,,,,,,,,,,,
3114,528,a,a,15623,KEGG COMPOUND accession,C04349,,,,,,,,,,,,,,,
3115,535,a,a,233,KEGG COMPOUND accession,C11414,,,,,,,,,,,,,,,
3116,550,a,a,15547,KEGG COMPOUND accession,C04743,,,,,,,,,,,,,,,
3117,552,a,a,15550,KEGG COMPOUND accession,C04671,,,,,,,,,,,,,,,
3118,554,a,a,15552,KEGG COMPOUND accession,C01312,prostgi2,35121-78-9,15552.0,"Human Metabolome Database (HMDB): Prostaglandin I2 or prostacyclin (or PGI2) is a member of the family of lipid molecules known as eicosanoids. It is produced in endothelial cells from prostaglandin H2 (PGH2) by the action of the enzyme prostacyclin synthase. It is a powerful vasodilator and inhibits platelet aggregation. Prostaglandin I2 is the main prostaglandin synthesized by the blood vessel wall. This suggests that it may play an important role in limiting platelet-mediated thrombosis. In particular, prostacyclin (PGI2) chiefly prevents formation of the platelet plug involved in primary hemostasis (a part of blood clot formation). The sodium salt (known as epoprostenol) has been used to treat primary pulmonary hypertension. Prostacyclin (PGI2) is released by healthy endothelial cells and performs its function through a paracrine signaling cascade that involves G protein-coupled receptors on nearby platelets and endothelial cells. The platelet Gs protein-coupled receptor (prostacyclin receptor) is activated when it binds to PGI2. This activation, in turn, signals adenylyl cyclase to produce cAMP. cAMP goes on to inhibit any undue platelet activation (in order to promote circulation) and also counteracts any increase in cytosolic calcium levels which would result from thromboxane A2 (TXA2) binding (leading to platelet activation and subsequent coagulation). PGI2 also binds to endothelial prostacyclin receptors and in the same manner raise cAMP levels in the cytosol. This cAMP then goes on to activate protein kinase A (PKA). PKA then continues the cascade by inhibiting myosin light-chain kinase which leads to smooth muscle relaxation and vasodilation. Notably, PGI2 and TXA2 work as antagonists. PGI2 is stable in basic buffers (pH=8), but it is rapidly hydrolyzed to 6-keto PGF1alpha in neutral or acidic solutions. The half-life is short both in vivo and in vitro, ranging from 30 seconds to a few minutes. PGI2 is administered by continuous infusion in humans for the treatment of idiopathic pulmonary hypertension.Prostaglandins are eicosanoids. The eicosanoids consist of the prostaglandins (PGs), thromboxanes (TXs), leukotrienes (LTs) and lipoxins (LXs). The PGs and TXs are collectively identified as prostanoids. Prostaglandins were originally shown to be synthesized in the prostate gland, thromboxanes from platelets (thrombocytes) and leukotrienes from leukocytes, hence the derivation of their names. All mammalian cells except erythrocytes synthesize eicosanoids. These molecules are extremely potent, able to cause profound physiological effects at very dilute concentrations. All eicosanoids function locally at the site of synthesis, through receptor-mediated G-protein linked signaling pathways.",Prostaglandin I2,HMDB0001335,b,b,C01312,5Z13E-15S-69-ALPHA-EPOXY-11-ALPHA,FDB022560,prostgi2,[H]O[C@]([H])(C(\[H])=C(/[H])[C@@]1([H])[C@]([H])(O[H])C([H])([H])[C@]2([H])O\C(=C(\[H])C([H])([H])C([H])([H])C([H])([H])C([O-])=O)C([H])([H])[C@]12[H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H],KAQKFAOMNZTLHT-OZUDYXHBSA-M,"InChI=1S/C20H32O5/c1-2-3-4-7-14(21)10-11-16-17-12-15(8-5-6-9-20(23)24)25-19(17)13-18(16)22/h8,10-11,14,16-19,21-22H,2-7,9,12-13H2,1H3,(H,23,24)/p-1/b11-10+,15-8-/t14-,16+,17+,18+,19-/m0/s1"
3119,563,a,a,15547,KEGG COMPOUND accession,C04707,,,,,,,,,,,,,,,
3120,565,a,a,15556,KEGG COMPOUND accession,C04835,,,,,,,,,,,,,,,
3121,567,a,a,15557,KEGG COMPOUND accession,C04758,,,,,,,,,,,,,,,
3122,571,a,a,15629,KEGG COMPOUND accession,C04822,,,,,,,,,,,,,,,
3123,573,a,a,15631,KEGG COMPOUND accession,C04849,C04849,b,b,"Human Metabolome Database (HMDB): (5Z,9E,14Z)-(8xi,11R,12S)-11,12-epoxy-8-hydroxyicosa-5,9,14-trienoic Acid, also known as Hepoxilin a3 or 8-EH-2, is classified as a member of the Hepoxilins. Hepoxilins are eicosanoids containing an oxirane group attached to the fatty acyl chain. (5Z,9E,14Z)-(8xi,11R,12S)-11,12-epoxy-8-hydroxyicosa-5,9,14-trienoic Acid is considered to be practically insoluble (in water) and acidic","(5Z,9E,14Z)-(8xi,11R,12S)-11,12-epoxy-8-hydroxyicosa-5,9,14-trienoic Acid",HMDB0062619,b,b,C04849,b,b,C04849,[H]OC([H])(C(\[H])=C(/[H])[C@@]1([H])O[C@@]1([H])C([H])([H])C(\[H])=C(\[H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H])C([H])([H])C(\[H])=C(\[H])C([H])([H])C([H])([H])C([H])([H])C([O-])=O,SGTUOBURCVMACZ-CIQDQOFUSA-M,"InChI=1S/C20H32O4/c1-2-3-4-5-6-10-13-18-19(24-18)16-15-17(21)12-9-7-8-11-14-20(22)23/h6-7,9-10,15-19,21H,2-5,8,11-14H2,1H3,(H,22,23)/p-1/b9-7-,10-6-,16-15+/t17?,18-,19+/m0/s1"
3124,575,a,a,15630,KEGG COMPOUND accession,C04843,C04843,b,15630.0,b,"(5Z,9E,12S,14Z)-8,11,12-Trihydroxyicosa-5,9,14-Trienoic Acid (Trioxilin A3)",b,b,b,C04843,b,b,b,[H]OC([H])(C(\[H])=C(/[H])C([H])(O[H])[C@]([H])(O[H])C([H])([H])C(\[H])=C(\[H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H])C([H])([H])C(\[H])=C(\[H])C([H])([H])C([H])([H])C([H])([H])C([O-])=O,WPLPEZUSILBTGP-UIKNIFMXSA-M,"InChI=1S/C20H34O5/c1-2-3-4-5-6-10-13-18(22)19(23)16-15-17(21)12-9-7-8-11-14-20(24)25/h6-7,9-10,15-19,21-23H,2-5,8,11-14H2,1H3,(H,24,25)/p-1/b9-7-,10-6-,16-15+/t17?,18-,19?/m0/s1"
3125,579,a,a,15643,KEGG COMPOUND accession,C06487,,,,,,,,,,,,,,,
3126,584,a,a,15645,KEGG COMPOUND accession,C03325,,,,,,,,,,,,,,,
3127,587,a,a,15648,KEGG COMPOUND accession,C04271,,,,,,,,,,,,,,,
3128,595,a,a,15653,KEGG COMPOUND accession,C04672,,,,,,,,,,,,,,,
3129,597,a,a,15654,KEGG COMPOUND accession,C04594,,,,,,,,,,,,,,,
3130,604,a,a,15657,KEGG COMPOUND accession,C07338,,,,,,,,,,,,,,,
3131,606,a,a,15658,KEGG COMPOUND accession,C07354,,,,,,,,,,,,,,,
3132,610,a,a,17548,KEGG COMPOUND accession,C01768,,,,,,,,,,,,,,,
3133,618,a,a,15659,KEGG COMPOUND accession,C04621,,,,,,,,,,,,,,,
3134,620,a,a,15661,KEGG COMPOUND accession,C11515,,,,,,,,,,,,,,,
3135,622,a,a,15662,KEGG COMPOUND accession,C04433,,,,,,,,,,,,,,,
3136,624,a,a,15663,KEGG COMPOUND accession,C11514,,,,,,,,,,,,,,,
3137,626,a,a,15666,KEGG COMPOUND accession,C04350,,,,,,,,,,,,,,,
3138,628,a,a,15668,KEGG COMPOUND accession,C04434,,,,,,,,,,,,,,,
3139,630,a,a,15670,KEGG COMPOUND accession,C02214,,,,,,,,,,,,,,,
3140,633,a,a,15464,KEGG COMPOUND accession,C02611,,,,,,,,,,,,,,,
3141,637,a,a,17020,KEGG COMPOUND accession,C02101,,,,,,,,,,,,,,,
3142,639,a,a,15943,KEGG COMPOUND accession,C02768,,,,,,,,,,,,,,,
3143,651,a,a,27842,KEGG COMPOUND accession,C08428,,,,,,,,,,,,,,,
3144,653,a,a,44356,KEGG COMPOUND accession,C05353,,,,,,,,,,,,,,,
3145,665,a,a,15677,KEGG COMPOUND accession,C02348,,,,,,,,,,,,,,,
3146,672,a,a,301,KEGG COMPOUND accession,C09875,,,,,,,,,,,,,,,
3147,674,a,a,28985,KEGG COMPOUND accession,C11506,,,,,,,,,,,,,,,
3148,677,a,a,15675,KEGG COMPOUND accession,C03194,,,,,,,,,,,,,,,
3149,680,a,a,33197,KEGG COMPOUND accession,C03195,,,,,,,,,,,,,,,
3150,683,a,a,15684,KEGG COMPOUND accession,C04272,,,,,,,,,,,,,,,
3151,689,a,a,27567,KEGG COMPOUND accession,C03328,,,,,,,,,,,,,,,
3152,696,a,a,18354,KEGG COMPOUND accession,C11496,,,,,,,,,,,,,,,
3153,702,a,a,15465,KEGG COMPOUND accession,C01213,mmcoa_R,73173-92-9,b,"Human Metabolome Database (HMDB): Methylmalonyl-CoA is an intermediate in the metabolism of Propanoate. It is a substrate for Malonyl-CoA decarboxylase (mitochondrial), Methylmalonyl-CoA mutase (mitochondrial) and Methylmalonyl-CoA epimerase (mitochondrial).",R-Methylmalonyl-CoA,HMDB0002255,b,b,C01213,METHYL-MALONYL-COA,FDB022930,mmcoa_R,[H]O[C@@]([H])(C(=O)N([H])C([H])([H])C([H])([H])C(=O)N([H])C([H])([H])C([H])([H])SC(=O)[C@@]([H])(C([O-])=O)C([H])([H])[H])C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])OP([O-])(=O)OP([O-])(=O)OC([H])([H])[C@@]1([H])O[C@@]([H])(N2C([H])=NC3=C(N=C([H])N=C23)N([H])[H])[C@]([H])(O[H])[C@]1([H])OP([O-])([O-])=O,MZFOKIKEPGUZEN-AGCMQPJKSA-I,"InChI=1S/C25H40N7O19P3S/c1-12(23(37)38)24(39)55-7-6-27-14(33)4-5-28-21(36)18(35)25(2,3)9-48-54(45,46)51-53(43,44)47-8-13-17(50-52(40,41)42)16(34)22(49-13)32-11-31-15-19(26)29-10-30-20(15)32/h10-13,16-18,22,34-35H,4-9H2,1-3H3,(H,27,33)(H,28,36)(H,37,38)(H,43,44)(H,45,46)(H2,26,29,30)(H2,40,41,42)/p-5/t12-,13-,16-,17-,18+,22-/m1/s1"
3154,710,a,a,28379,KEGG COMPOUND accession,C06008,,,,,,,,,,,,,,,
3155,718,a,a,17663,KEGG COMPOUND accession,C04546,,,,,,,,,,,,,,,
3156,728,a,a,17066,KEGG COMPOUND accession,C01089,bhb,625-72-9,17066.0,"Human Metabolome Database (HMDB): (R)-3-Hydroxybutyric acid is a butyric acid substituted with a hydroxyl group in the beta or 3 position. 3-hydroxybutyric acid, or beta-hydroxybutyrate, is involved in the synthesis and degradation of ketone bodies. Like the other ketone bodies (acetoacetate and acetone), levels of beta-hydroxybutyrate are raised in the blood and urine in ketosis. Beta-hydroxybutyrate is a typical partial-degradation product of branched-chain amino acids (primarily valine) released from muscle for hepatic and renal gluconeogenesis This acid is metabolized by 3-hydroxybutyrate dehydrogenase (catalyzes the oxidation of D-3-hydroxybutyrate to form acetoacetate, using NAD+ as an electron acceptor). The enzyme functions in nervous tissues and muscles, enabling the use of circulating hydroxybutyrate as a fuel. In the liver mitochondrial matrix, the enzyme can also catalyze the reverse reaction, a step in ketogenesis. 3-Hydroxybutyric acid is a chiral compound having two enantiomers, D-3-hydroxybutyric acid and L-3-hydroxybutyric acid. In humans, beta-hydroxybutyrate is synthesized in the liver from acetyl-CoA, and can be used as an energy source by the brain when blood glucose is low. It can also be used for the synthesis of biodegradable plastics (Wikipedia).",(R)-3-Hydroxybutyric acid,HMDB0000011,b,b,C01089,CPD-335,FDB021869,bhb,[H]O[C@]([H])(C([H])([H])[H])C([H])([H])C([O-])=O,WHBMMWSBFZVSSR-GSVOUGTGSA-M,"InChI=1S/C4H8O3/c1-3(5)2-4(6)7/h3,5H,2H2,1H3,(H,6,7)/p-1/t3-/m1/s1"
3157,728,a,a,17066,KEGG COMPOUND accession,C01089,CE5126,300-85-6,20067.0,"Human Metabolome Database (HMDB): 3-Hydroxybutyric acid (or beta-hydroxybutyrate) is a ketone body. Like the other ketone bodies (acetoacetate and acetone), levels of 3-hydroxybutyrate in blood and urine are raised in ketosis. In humans, 3-hydroxybutyrate is synthesized in the liver from acetyl-CoA, and can be used as an energy source by the brain when blood glucose is low. Blood levels of 3-Hydroxybutyric acid levels may be monitored in diabetic patients to look for diabetic ketoacidosis. Persistent mild hyperketonemia is a common finding in newborns. Ketone bodies serve as an indispensable source of energy for extrahepatic tissues, especially the brain and lung of developing mammals. Another important function of ketone bodies is to provide acetoacetyl-CoA and acetyl-CoA for synthesis of cholesterol, fatty acids, and complex lipids. During the early postnatal period, acetoacetate (AcAc) and beta-hydroxybutyrate are preferred over glucose as substrates for synthesis of phospholipids and sphingolipids in accord with requirements for brain growth and myelination. Thus, during the first 2 weeks of postnatal development, when the accumulation of cholesterol and phospholipids accelerates, the proportion of ketone bodies incorporated into these lipids increases. On the other hand, an increased proportion of ketone bodies is utilized for cerebroside synthesis during the period of active myelination. In the lung, AcAc serves better than glucose as a precursor for the synthesis of lung phospholipids. The synthesized lipids, particularly dipalmityl phosphatidylcholine, are incorporated into surfactant, and thus have a potential role in supplying adequate surfactant lipids to maintain lung function during the early days of life (PMID 3884391). 3-Hydroxybutyric acid is found to be associated with fumarase deficiency and medium chain acyl-CoA dehydrogenase deficiency, which are inborn errors of metabolism.",3-Hydroxybutyric acid,HMDB0000357,b,b,C01089,CPD-335,FDB021797,CE5126,[H]OC([H])(C(=O)N([H])C([H])([H])C([H])([H])C(=O)N([H])C([H])([H])C([H])([H])SC(=O)C([H])(C([H])([H])[H])C([H])([H])C([H])([H])C([H])([H])C([H])(C([H])([H])[H])C([H])([H])C([H])([H])C([H])([H])C([H])(C([H])([H])[H])C([H])([H])C([H])([H])C([H])([H])C([H])(C([H])([H])[H])C([H])([H])[H])C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])OP([O-])(=O)OP([O-])(=O)OC([H])([H])C1([H])O[C@]([H])(N2C([H])=NC3=C2N=C([H])N=C3N([H])[H])C([H])(O[H])C1([H])OP([O-])([O-])=O,XYJPSQPVCBNZHT-QWDPMMQESA-J,"InChI=1S/C40H72N7O17P3S/c1-25(2)11-8-12-26(3)13-9-14-27(4)15-10-16-28(5)39(52)68-20-19-42-30(48)17-18-43-37(51)34(50)40(6,7)22-61-67(58,59)64-66(56,57)60-21-29-33(63-65(53,54)55)32(49)38(62-29)47-24-46-31-35(41)44-23-45-36(31)47/h23-29,32-34,38,49-50H,8-22H2,1-7H3,(H,42,48)(H,43,51)(H,56,57)(H,58,59)(H2,41,44,45)(H2,53,54,55)/p-4/t26?,27?,28?,29?,32?,33?,34?,38-/m0/s1"
3158,731,a,a,15452,KEGG COMPOUND accession,C03561,3hbcoa_R,2871-66-1,15452.0,"Human Metabolome Database (HMDB): 3-Hydroxybutyryl-CoA is a substrate for Enoyl-CoA hydratase (mitochondrial), Trifunctional enzyme alpha subunit (mitochondrial) and Peroxisomal bifunctional enzyme.",3-Hydroxybutyryl-CoA,HMDB0001166,b,b,C03561,CPD-650,FDB022460,3hbcoa_R,[H]O[C@@]([H])(C(=O)N([H])C([H])([H])C([H])([H])C(=O)N([H])C([H])([H])C([H])([H])SC(=O)C([H])([H])[C@]([H])(O[H])C([H])([H])[H])C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])OP([O-])(=O)OP([O-])(=O)OC([H])([H])[C@@]1([H])O[C@@]([H])(N2C([H])=NC3=C(N=C([H])N=C23)N([H])[H])[C@]([H])(O[H])[C@]1([H])OP([O-])([O-])=O,QHHKKMYHDBRONY-WZZMXTMRSA-J,"InChI=1S/C25H42N7O18P3S/c1-13(33)8-16(35)54-7-6-27-15(34)4-5-28-23(38)20(37)25(2,3)10-47-53(44,45)50-52(42,43)46-9-14-19(49-51(39,40)41)18(36)24(48-14)32-12-31-17-21(26)29-11-30-22(17)32/h11-14,18-20,24,33,36-37H,4-10H2,1-3H3,(H,27,34)(H,28,38)(H,42,43)(H,44,45)(H2,26,29,30)(H2,39,40,41)/p-4/t13-,14-,18-,19-,20+,24-/m1/s1"
3159,735,a,a,28573,KEGG COMPOUND accession,C05278,,,,,,,,,,,,,,,
3160,750,a,a,15769,KEGG COMPOUND accession,C04352,4ppcys,7196-09-0,15769.0,"Human Metabolome Database (HMDB): 4-Phosphopantothenoylcysteine (PPC) is an intermediate in the biosynthetic machinery (pathway) that converts pantothenate (vitamin B5) into coenzyme A (CoA). The enzyme Phosphopantothenoylcysteine decarboxylase catalyzes the decarboxylation of PPC to 4'-phosphopantetheine. Coenzyme A is the principal acyl carrier and is required for many synthetic and degradative reactions in intermediary metabolism, and is an essential cofactor in all living systems. (PMID: 15450493, 16371361, 14501115).",4-Phosphopantothenoylcysteine,HMDB0001117,b,b,C04352,R-4-PHOSPHOPANTOTHENOYL-L-CYSTEINE,FDB022432,4ppcys,[H]O[C@@]([H])(C(=O)N([H])C([H])([H])C([H])([H])C(=O)N([H])[C@]([H])(C([O-])=O)C([H])([H])S[H])C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])OP([O-])([O-])=O,XQYALQVLCNHCFT-CBAPKCEASA-K,"InChI=1S/C12H23N2O9PS/c1-12(2,6-23-24(20,21)22)9(16)10(17)13-4-3-8(15)14-7(5-25)11(18)19/h7,9,16,25H,3-6H2,1-2H3,(H,13,17)(H,14,15)(H,18,19)(H2,20,21,22)/p-3/t7-,9-/m0/s1"
3161,757,a,a,32803,KEGG COMPOUND accession,C05343,,,,,,,,,,,,,,,
3162,761,a,a,15899,KEGG COMPOUND accession,C01143,5dpmev,1492-08-6,15899.0,"Human Metabolome Database (HMDB): 5-pyrophosphomevalonate is a metabolic intermediate in the mevalonate pathway, catalyzed by the enzyme phosphomevalonate kinase from 5-phosphomevalonate. (wikipedia).",(S)-5-Diphosphomevalonic acid,HMDB0001090,b,b,C01143,CPD-641,FDB022420,5dpmev,[H]O[C@@](C([H])([H])[H])(C([H])([H])C([O-])=O)C([H])([H])C([H])([H])OP([O-])(=O)OP([O-])([O-])=O,SIGQQUBJQXSAMW-ZCFIWIBFSA-J,"InChI=1S/C6H14O10P2/c1-6(9,4-5(7)8)2-3-15-18(13,14)16-17(10,11)12/h9H,2-4H2,1H3,(H,7,8)(H,13,14)(H2,10,11,12)/p-4/t6-/m1/s1"
3163,764,a,a,17436,KEGG COMPOUND accession,C01107,5pmev,73566-35-5,17436.0,"Human Metabolome Database (HMDB): 5-Phosphomevalonate is a metabolic intermediate in the mevalonate pathway, catalyzed by the enzyme mevalonate kinase from Mevalonate. (wikipedia).",Mevalonic acid-5P,HMDB0001343,b,b,C01107,CPD-499,FDB022566,5pmev,[H]O[C@@](C([H])([H])[H])(C([H])([H])C([O-])=O)C([H])([H])C([H])([H])OP([O-])([O-])=O,OKZYCXHTTZZYSK-ZCFIWIBFSA-K,"InChI=1S/C6H13O7P/c1-6(9,4-5(7)8)2-3-13-14(10,11)12/h9H,2-4H2,1H3,(H,7,8)(H2,10,11,12)/p-3/t6-/m1/s1"
3164,767,a,a,18226,KEGG COMPOUND accession,C03043,,,,,,,,,,,,,,,
3165,768,a,a,15686,KEGG COMPOUND accession,C00810,,,,,,,,,,,,,,,
3166,777,a,a,27482,KEGG COMPOUND accession,C06349,,,,,,,,,,,,,,,
3167,779,a,a,32796,KEGG COMPOUND accession,C02911,,,,,,,,,,,,,,,
3168,780,a,a,17167,KEGG COMPOUND accession,C00937,lald_D,b,17167.0,"Human Metabolome Database (HMDB): D- and L-lactaldehyde are also good substrates for aldose reductase. The aldose reductase-catalyzed reduction of methylglyoxal produces 95% acetol, 5% D-lactaldehyde. (PMID: 1537826). D-lactaldehyde is an intermediate in the pyruvate metabolic pathway. Pyruvaldehyde is irreversibly produced from D-lactaldehyde via the enzyme glyoxylate reductase (NADP+, Swiss-Prot: Q5T945).",D-Lactaldehyde,HMDB0006458,b,b,C00937,CPD-358,FDB023918,lald_D,[H]O[C@@]([H])(C([H])=O)C([H])([H])[H],BSABBBMNWQWLLU-GSVOUGTGSA-N,"InChI=1S/C3H6O2/c1-3(5)2-4/h2-3,5H,1H3/t3-/m1/s1"
3169,787,a,a,42111,KEGG COMPOUND accession,C00256,lac_D,10326-41-7,341.0,"Human Metabolome Database (HMDB): Lactic acid is an organic acid. It is a chiral molecule, consisting of two optical isomers, L-lactic acid and D-lactic acid, with the L-isomer being the most common in living organisms. Lactic acid plays a role in several biochemical processes and is produced in the muscles during intense activity. D-Lactic acid is the end product of the enzyme glyoxalase II (or hydroxyacyl-glutathione hydrolase) (EC 3.1.2.6), which converts the intermediate substrate S-lactoyl-glutathione to reduced glutathione and D-lactate (OMIM: 138790).",D-Lactic acid,HMDB0001311,b,b,C00256,D-LACTATE,FDB003293,lac_D,[H]O[C@@]([H])(C([O-])=O)C([H])([H])[H],JVTAAEKCZFNVCJ-REOHCLBHSA-M,"InChI=1S/C3H6O3/c1-2(4)3(5)6/h2,4H,1H3,(H,5,6)/p-1/t2-/m0/s1"
3170,796,a,a,30796,KEGG COMPOUND accession,C00497,,,,,,,,,,,,,,,
3171,800,a,a,17352,KEGG COMPOUND accession,C07301,,,,,,,,,,,,,,,
3172,805,a,a,17710,KEGG COMPOUND accession,C00418,mev_R,150-97-0,25351.0,"Human Metabolome Database (HMDB): Mevalonic acid is a key organic compound in biochemistry. It is a precursor in the biosynthetic pathway, known as the HMG-CoA reductase pathway, that produces terpenes and steroids. Mevalonate is produced by NADPH from 3-hydroxy-3-methylglutaryl CoA via reduction. This reaction occurs in the cytosol. It is the committed step in cholesterol synthesis, -- Wikipedia The production of mevalonic acid (MVA) by the enzyme 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase, is the rate-limiting step in the biosynthesis of cholesterol. (Jemal et. al, Rapid Communications in Mass Spectrometry, 2003, 17:1715) Plasma concentrations and urinary excretion of MVA are decreased by HMG-CoA reductase inhibitor drugs such as pravastatin, simvastatin and atorvastatin. Naoumova RP, Marais AD, Mountney J, Firth JC, Rendell NB, Taylor GW, Thompson GR. Atherosclerosis 1996; 119: 203.",Mevalonic acid,HMDB0000227,b,b,C00418,MEVALONATE,FDB005126,mev_R,[H]OC([H])([H])C([H])([H])[C@](O[H])(C([H])([H])[H])C([H])([H])C([O-])=O,KJTLQQUUPVSXIM-ZCFIWIBFSA-M,"InChI=1S/C6H12O4/c1-6(10,2-3-7)4-5(8)9/h7,10H,2-4H2,1H3,(H,8,9)/p-1/t6-/m1/s1"
3173,811,a,a,16387,KEGG COMPOUND accession,C05243,,,,,,,,,,,,,,,
3174,814,a,a,27751,KEGG COMPOUND accession,C06347,,,,,,,,,,,,,,,
3175,816,a,a,27702,KEGG COMPOUND accession,C06351,,,,,,,,,,,,,,,
3176,817,a,a,28658,KEGG COMPOUND accession,C06516,,,,,,,,,,,,,,,
3177,819,a,a,15980,KEGG COMPOUND accession,C00522,,,,,,,,,,,,,,,
3178,825,a,a,16719,KEGG COMPOUND accession,C01012,,,,,,,,,,,,,,,
3179,830,a,a,28972,KEGG COMPOUND accession,C02912,,,,,,,,,,,,,,,
3180,833,a,a,17396,KEGG COMPOUND accession,C00844,,,,,,,,,,,,,,,
3181,837,a,a,17428,KEGG COMPOUND accession,C05178,,,,,,,,,,,,,,,
3182,842,a,a,15694,KEGG COMPOUND accession,C03451,lgt_S,25138-66-3,15694.0,"Human Metabolome Database (HMDB): S-Lactoylglutathione is a substrate of lactoylglutathione lyase [EC 4.4.1.5] in pyruvate metabolism (KEGG). Another enzyme, glyoxalase I, synthesizes this compound by converting methylglyoxal and reduced glutathione to S-lactoylglutathione. S-D-lactoylglutathione can be hydrolysed by thiolesterases to reduced glutathione and D-lactate but also converted to N-D-lactoylcysteinylglycine and N-D-lactoylcysteine by gamma-glutamyl transferase and dipeptidase (PMID: 8632674). S-lactoylglutathione has also been shown to modulate microtubule assembly (PMID: 690442).",S-Lactoylglutathione,HMDB0001066,b,b,C03451,S-LACTOYL-GLUTATHIONE,FDB022405,lgt_S,[H]O[C@@]([H])(C(=O)SC([H])([H])[C@]([H])(N([H])C(=O)C([H])([H])C([H])([H])[C@@]([H])(C([O-])=O)[N+]([H])([H])[H])C(=O)N([H])C([H])([H])C([O-])=O)C([H])([H])[H],VDYDCVUWILIYQF-CSMHCCOUSA-M,"InChI=1S/C13H21N3O8S/c1-6(17)13(24)25-5-8(11(21)15-4-10(19)20)16-9(18)3-2-7(14)12(22)23/h6-8,17H,2-5,14H2,1H3,(H,15,21)(H,16,18)(H,19,20)(H,22,23)/p-1/t6-,7+,8+/m1/s1"
3183,846,a,a,16358,KEGG COMPOUND accession,C01870,,,,,,,,,,,,,,,
3184,852,a,a,15671,KEGG COMPOUND accession,C00898,,,,,,,,,,,,,,,
3185,859,a,a,18417,KEGG COMPOUND accession,C06348,,,,,,,,,,,,,,,
3186,861,a,a,18418,KEGG COMPOUND accession,C06346,,,,,,,,,,,,,,,
3187,863,a,a,28770,KEGG COMPOUND accession,C06350,C06350,10139-29-4,28770.0,Human Metabolome Database (HMDB): Norlaundanosoline is a key intermediate in the synthesis of the benzylisoquinoline alkaloids providing the upper isoquinoline portion of the morphinan skeleton. It is involved in the alkaloid biosynthesis with enzyme (S)-norlaudanosoline synthase.,"(R,S)-Norlaudanosoline",HMDB0012486,b,b,C06350,ARG,FDB008796,b,[H]OC1=C([H])C2=C(C([H])=C1O[H])C([H])(C([H])([H])C1=C([H])C(O[H])=C(O[H])C([H])=C1[H])[N+]([H])([H])C([H])([H])C2([H])[H],ABXZOXDTHTTZJW-UHFFFAOYSA-O,"InChI=1S/C16H17NO4/c18-13-2-1-9(6-14(13)19)5-12-11-8-16(21)15(20)7-10(11)3-4-17-12/h1-2,6-8,12,17-21H,3-5H2/p+1"
3188,865,a,a,16804,KEGG COMPOUND accession,C05201,,,,,,,,,,,,,,,
3189,869,a,a,365,KEGG COMPOUND accession,C04871,,,,,,,,,,,,,,,
3190,870,a,a,15678,KEGG COMPOUND accession,C02350,,,,,,,,,,,,,,,
3191,874,a,a,367,KEGG COMPOUND accession,C11391,,,,,,,,,,,,,,,
3192,876,a,a,368,KEGG COMPOUND accession,C11384,,,,,,,,,,,,,,,
3193,878,a,a,28982,KEGG COMPOUND accession,C11507,,,,,,,,,,,,,,,
3194,881,a,a,16346,KEGG COMPOUND accession,C11348,,,,,,,,,,,,,,,
3195,885,a,a,371,KEGG COMPOUND accession,C03912,1pyr5c,64199-88-8,371.0,b,1-Pyrroline-5-Carboxylate,b,b,b,C03912,b,b,1pyr5c,[H]C1=NC([H])(C([O-])=O)C([H])([H])C1([H])[H],DWAKNKKXGALPNW-UHFFFAOYSA-M,"InChI=1S/C5H7NO2/c7-5(8)4-2-1-3-6-4/h3-4H,1-2H2,(H,7,8)/p-1"
3196,889,a,a,15441,KEGG COMPOUND accession,C01054,Ssq23epx,9029-62-3,15441.0,"Human Metabolome Database (HMDB): (S)-2,3-Epoxysqualene is an intermediate in the biosynthesis of Terpenoid. It is a substrate for Squalene monooxygenase and Lanosterol synthase.","(S)-2,3-Epoxysqualene",HMDB0001188,b,b,C01054,EPOXYSQUALENE,FDB022476,Ssq23epx,[H]C(=C(C([H])([H])[H])C([H])([H])[H])C([H])([H])C([H])([H])C(=C([H])C([H])([H])C([H])([H])C(=C([H])C([H])([H])C([H])([H])C([H])=C(C([H])([H])[H])C([H])([H])C([H])([H])C([H])=C(C([H])([H])[H])C([H])([H])C([H])([H])[C@]1([H])OC1(C([H])([H])[H])C([H])([H])[H])C([H])([H])[H])C([H])([H])[H],QYIMSPSDBYKPPY-RSKUXYSASA-N,"InChI=1S/C30H50O/c1-24(2)14-11-17-27(5)20-12-18-25(3)15-9-10-16-26(4)19-13-21-28(6)22-23-29-30(7,8)31-29/h14-16,20-21,29H,9-13,17-19,22-23H2,1-8H3/b25-15+,26-16+,27-20+,28-21+/t29-/m0/s1"
3197,898,a,a,18409,KEGG COMPOUND accession,C06010,,,,,,,,,,,,,,,
3198,906,a,a,35619,KEGG COMPOUND accession,C02356,C02356,1492-24-6,35619.0,"Human Metabolome Database (HMDB): L-alpha-aminobutyric acid, also known as (S)-2-aminobutanoic acid, homoalanine, 2-AABA, ethylglycine or L-butyrine, is a member of the class of compounds known as L-alpha-amino acids. L-alpha-amino acids are alpha amino acids which have the L-configuration of the alpha-carbon atom. L-alpha-aminobutyric acid is soluble (in water) and a moderately acidic compound (based on its pKa). L-alpha-aminobutyric acid is a non-proteogenic amino acid that can be found in human kidney and liver tissues, and in most biofluids or excreta, some of which include feces, breast milk, urine, and blood. Within the cell, L-alpha-aminobutyric acid is primarily located in the cytoplasm. Alpha-aminobutyric acid is biosynthesized by transaminating oxobutyrate, a metabolite in isoleucine biosynthesis. As a non-proteogenic amino acid alpha-aminobutyric acid can be used by nonribosomal peptide synthases. One example of a nonribosomal peptide containing alpha-aminobutyric acid is ophthalmic acid, which was first isolated from calf lens. Alpha-aminobutyric acid is a non-essential amino acid that is primarily derived from the catabolism of methionine, threonine and serine. High protein diets can result in significantly higher alpha-aminobutyrate levels in plasma (PMID: 26227325). Alpha-aminobutyric acid is elevated in the plasma of children with Reye's syndrome, tyrosinemia, homocystinuria, nonketotic hyperglycinemia, and ornithine transcarbamylase deficiency (PMID: 420125). Alpha-aminobutyric acid is one of the three isomers of aminobutyric acid. The two other are the neurotransmitter gamma-aminobutyric acid (GABA) and beta-aminobutyric acid (BABA) which is known for inducing plant disease resistance.",L-Alpha-aminobutyric acid,HMDB0000452,b,b,C02356,CPD0-1942,FDB012537,C02356,[H]C([H])([H])C([H])([H])[C@@]([H])(C([O-])=O)[N+]([H])([H])[H],QWCKQJZIFLGMSD-VKHMYHEASA-N,"InChI=1S/C4H9NO2/c1-2-3(5)4(6)7/h3H,2,5H2,1H3,(H,6,7)/t3-/m0/s1"
3199,907,a,a,15791,KEGG COMPOUND accession,C02103,,,,,,,,,,,,,,,
3200,911,a,a,27765,KEGG COMPOUND accession,C06005,,,,,,,,,,,,,,,
3201,914,a,a,32797,KEGG COMPOUND accession,C03196,,,,,,,,,,,,,,,
3202,918,a,a,18288,KEGG COMPOUND accession,C11498,,,,,,,,,,,,,,,
3203,921,a,a,18129,KEGG COMPOUND accession,C03045,,,,,,,,,,,,,,,
3204,934,a,a,17943,KEGG COMPOUND accession,C02914,,,,,,,,,,,,,,,
3205,936,a,a,28453,KEGG COMPOUND accession,C03965,,,,,,,,,,,,,,,
3206,944,a,a,15467,KEGG COMPOUND accession,C00356,hmgcoa,1553-55-5,15467.0,"Human Metabolome Database (HMDB): 3-hydroxy-3-methylglutaryl CoA (HMG-CoA) is formed when Acetyl-CoA condenses with acetoacetyl-CoA in a reaction that is catalyzed by the enzyme HMG-CoA synthase in the mevalonate pathway or mevalonate-dependent (MAD) route, an important cellular metabolic pathway present in virtually all organisms. HMG-CoA reductase (EC 1.1.1.34) inhibitors, more commonly known as statins, are cholesterol-lowering drugs that have been widely used for many years to reduce the incidence of adverse cardiovascular events. HMG-CoA reductase catalyzes the rate-limiting step in the mevalonate pathway and these agents lower cholesterol by inhibiting its synthesis in the liver and in peripheral tissues. Androgen also stimulates lipogenesis in human prostate cancer cells directly by increasing transcription of the fatty acid synthase and HMG-CoA-reductase genes. (PMID: 14689582).",3-Hydroxy-3-methylglutaryl-CoA,HMDB0001375,b,b,C00356,3-HYDROXY-3-METHYL-GLUTARYL-COA,FDB022587,hmgcoa,[H]O[C@@]([H])(C(=O)N([H])C([H])([H])C([H])([H])C(=O)N([H])C([H])([H])C([H])([H])SC(=O)C([H])([H])[C@](O[H])(C([H])([H])[H])C([H])([H])C([O-])=O)C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])OP([O-])(=O)OP([O-])(=O)OC([H])([H])[C@@]1([H])O[C@@]([H])(N2C([H])=NC3=C(N=C([H])N=C23)N([H])[H])[C@]([H])(O[H])[C@]1([H])OP([O-])([O-])=O,CABVTRNMFUVUDM-VRHQGPGLSA-I,"InChI=1S/C27H44N7O20P3S/c1-26(2,21(40)24(41)30-5-4-15(35)29-6-7-58-17(38)9-27(3,42)8-16(36)37)11-51-57(48,49)54-56(46,47)50-10-14-20(53-55(43,44)45)19(39)25(52-14)34-13-33-18-22(28)31-12-32-23(18)34/h12-14,19-21,25,39-40,42H,4-11H2,1-3H3,(H,29,35)(H,30,41)(H,36,37)(H,46,47)(H,48,49)(H2,28,31,32)(H2,43,44,45)/p-5/t14-,19-,20-,21+,25-,27+/m1/s1"
3207,953,a,a,17290,KEGG COMPOUND accession,C03197,,,,,,,,,,,,,,,
3208,972,a,a,62638,KEGG COMPOUND accession,C06001,3hmp,2068-83-9,37373.0,"Human Metabolome Database (HMDB): (S)-3-Hydroxyisobutyric (3-HIBA) acid is an organic acid. 3-HIBA is an intermediate in L-valine metabolism. 3-HIBA plays an important role in the diagnosis of the very rare inherited metabolic diseases 3-hydroxyisobutyric aciduria (OMIM 236795) and methylmalonic semialdehyde dehydrogenase deficiency (OMIM 603178). Patients with 3-hydroxyisobutyric aciduria excrete a significant amount of 3-HIBA not only during the acute stage but also when stable. 3-hydroxyisobutyric aciduria is caused by a 3-hydroxyisobutyryl-CoA dehydrogenase deficiency (PMID: 18329219). The severity of this disease varies from case to case. Most patients exhibit dysmorphic features, such as a small triangular face, a long philtrum, low set ears and micrognathia (PMID: 113770040, 10686279). Lactic acidemia is also found in the affected patients, indicating that mitochondrial dysfunction is involved. 3-hydroxyisobutyrate appears to specifically inhibit the function of the respiratory chain complex I-III and mitochondrial creatine kinase (PMID: 18329219).",(S)-3-Hydroxyisobutyric acid,HMDB0000023,b,b,C06001,3-HYDROXY-ISOBUTYRATE,FDB021877,3hmp,[H]OC([H])([H])[C@@]([H])(C([O-])=O)C([H])([H])[H],DBXBTMSZEOQQDU-VKHMYHEASA-M,"InChI=1S/C4H8O3/c1-3(2-5)4(6)7/h3,5H,2H2,1H3,(H,6,7)/p-1/t3-/m0/s1"
3209,976,a,a,28259,KEGG COMPOUND accession,C06000,,,,,,,,,,,,,,,
3210,979,a,a,27466,KEGG COMPOUND accession,C05260,3htdcoa,b,27466.0,Human Metabolome Database (HMDB): (S)-3-Hydroxytetradecanoyl-CoA is an intermediate in Fatty acid elongation in mitochondria. (S)-3-Hydroxytetradecanoyl-CoA is the 7th to last step in the synthesis of Hexadecanoic acid and is converted from 3-Oxotetradecanoyl-CoA via the enzyme long-chain 3-hydroxyacyl-CoA dehydrogenase (EC 1.1.1.211). It is then converted to trans-Tetradec-2-enoyl-CoA via the enzyme enoyl-CoA hydratase (EC 4.2.1.17).,(S)-3-Hydroxytetradecanoyl-CoA,HMDB0003934,b,b,C05260,b,FDB023253,3htdcoa,[H]O[C@@]([H])(C(=O)N([H])C([H])([H])C([H])([H])C(=O)N([H])C([H])([H])C([H])([H])SC(=O)C([H])([H])[C@@]([H])(O[H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H])C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])OP([O-])(=O)OP([O-])(=O)OC([H])([H])[C@@]1([H])O[C@@]([H])(N2C([H])=NC3=C(N=C([H])N=C23)N([H])[H])[C@]([H])(O[H])[C@]1([H])OP([O-])([O-])=O,OXBHKMHNDGRDCZ-STLSENOWSA-J,"InChI=1S/C35H62N7O18P3S/c1-4-5-6-7-8-9-10-11-12-13-23(43)18-26(45)64-17-16-37-25(44)14-15-38-33(48)30(47)35(2,3)20-57-63(54,55)60-62(52,53)56-19-24-29(59-61(49,50)51)28(46)34(58-24)42-22-41-27-31(36)39-21-40-32(27)42/h21-24,28-30,34,43,46-47H,4-20H2,1-3H3,(H,37,44)(H,38,48)(H,52,53)(H,54,55)(H2,36,39,40)(H2,49,50,51)/p-4/t23-,24+,28+,29+,30-,34+/m0/s1"
3211,984,a,a,15614,KEGG COMPOUND accession,C00671,,,,,,,,,,,,,,,
3212,986,a,a,16712,KEGG COMPOUND accession,C11499,sl_L,b,16712.0,Human Metabolome Database (HMDB): This compound belongs to the family of Alpha Hydroxy Acids and Derivatives. These are organic compounds containing a carboxylic acid substituted with a hydroxyl group on the adjacent carbon.,(S)-3-Sulfonatolactate,HMDB0060176,b,b,C11499,b,b,sl_L,[H]O[C@@]([H])(C([O-])=O)C([H])([H])S([O-])(=O)=O,CQQGIWJSICOUON-UWTATZPHSA-L,"InChI=1S/C3H6O6S/c4-2(3(5)6)1-10(7,8)9/h2,4H,1H2,(H,5,6)(H,7,8,9)/p-2/t2-/m1/s1"
3213,990,a,a,15757,KEGG COMPOUND accession,C03741,,,,,,,,,,,,,,,
3214,993,a,a,32802,KEGG COMPOUND accession,C03198,,,,,,,,,,,,,,,
3215,997,a,a,16660,KEGG COMPOUND accession,C03742,,,,,,,,,,,,,,,
3216,1001,a,a,27713,KEGG COMPOUND accession,C03656,5a3ohex,19355-90-9,27713.0,"Human Metabolome Database (HMDB): (S)-5-Amino-3-oxohexanoate is an intermediate in lysine degradation. L-Lysine is an essential amino acid that is a necessary building block for all protein in the body and It plays a major role in calcium absorption; building muscle protein; recovering from surgery or sports injuries; and the body's production of hormones, enzymes, and antibodies. In lysine degradation pathway, (S)-5-Amino-3-oxohexanoate is a substrate for the enzyme L-erythro-3,5-diaminohexanoate dehydrogenase (EC 1.4.1.11) and can be generated from L-erythro-3,5-Diaminohexanoate.",(S)-5-Amino-3-oxohexanoate,HMDB0012131,b,b,C03656,CPD-159,FDB028795,b,b,FAASBXNEOGMQHS-BYPYZUCNSA-N,b
3217,1003,a,a,17532,KEGG COMPOUND accession,C01056,,,,,,,,,,,,,,,
3218,1006,a,a,27460,KEGG COMPOUND accession,C06517,,,,,,,,,,,,,,,
3219,1009,a,a,50400,KEGG COMPOUND accession,C05204,,,,,,,,,,,,,,,
3220,1011,a,a,15687,KEGG COMPOUND accession,C01769,,,,,,,,,,,,,,,
3221,1022,a,a,29003,KEGG COMPOUND accession,C08645,,,,,,,,,,,,,,,
3222,1024,a,a,15950,KEGG COMPOUND accession,C06161,,,,,,,,,,,,,,,
3223,1028,a,a,17025,KEGG COMPOUND accession,C00337,dhor_S,155-54-4,30865.0,"Human Metabolome Database (HMDB): 4,5-Dihydroorotic acid is a substrate of the enzyme orotate reductase [EC 1.3.1.14], which is part of the pyrimidine metabolism pathway. (KEGG) Dihydroorotate is oxidized by Dihydroorotate dehydrogenases (DHODs) to orotate. These dehydrogenases use their FMN (flavin mononucleotide) prosthetic group to abstract a hydride equivalent from C6 to deprotonate C5.","4,5-Dihydroorotic acid",HMDB0000528,b,b,C00337,DI-H-OROTATE,FDB022096,dhor_S,[H]N1C(=O)N([H])[C@]([H])(C([O-])=O)C([H])([H])C1=O,UFIVEPVSAGBUSI-REOHCLBHSA-M,"InChI=1S/C5H6N2O4/c8-3-1-2(4(9)10)6-5(11)7-3/h2H,1H2,(H,9,10)(H2,6,7,8,11)/p-1/t2-/m0/s1"
3224,1035,a,a,28325,KEGG COMPOUND accession,C05264,3hdcoa,6245-70-1,28325.0,"Human Metabolome Database (HMDB): (S)-Hydroxydecanoyl-CoA has a role in the synthesis and oxidation of fatty acids. It is involved in fatty acid elongation in mitochondria. In this pathway 3-Oxodecanoyl-CoA is acted upon by two enzymes, 3-hydroxyacyl-CoA dehydrogenase and long-chain-3-hydroxyacyl-CoA dehydrogenase to produce (S)-Hydroxydecanoyl-CoA. Since coenzyme A is chemically a thiol, it can react with carboxylic acids to form thioesters, thus functioning as an acyl group carrier. It assists in transferring fatty acids from the cytoplasm to mitochondria. A molecule of coenzyme A carrying an acetyl group is also referred to as acetyl-CoA. When it is not attached to an acyl group it is usually referred to as CoASH or HSCoA.",(S)-Hydroxydecanoyl-CoA,HMDB0003938,b,b,C05264,b,FDB023257,3hdcoa,[H]O[C@@]([H])(C(=O)N([H])C([H])([H])C([H])([H])C(=O)N([H])C([H])([H])C([H])([H])SC(=O)C([H])([H])[C@@]([H])(O[H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H])C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])OP([O-])(=O)OP([O-])(=O)OC([H])([H])[C@@]1([H])O[C@@]([H])(N2C([H])=NC3=C(N=C([H])N=C23)N([H])[H])[C@]([H])(O[H])[C@]1([H])OP([O-])([O-])=O,HIVSMYZAMUNFKZ-PNPVFPMQSA-J,"InChI=1S/C31H54N7O18P3S/c1-4-5-6-7-8-9-19(39)14-22(41)60-13-12-33-21(40)10-11-34-29(44)26(43)31(2,3)16-53-59(50,51)56-58(48,49)52-15-20-25(55-57(45,46)47)24(42)30(54-20)38-18-37-23-27(32)35-17-36-28(23)38/h17-20,24-26,30,39,42-43H,4-16H2,1-3H3,(H,33,40)(H,34,44)(H,48,49)(H,50,51)(H2,32,35,36)(H2,45,46,47)/p-4/t19-,20+,24+,25+,26-,30+/m0/s1"
3225,1058,a,a,422,KEGG COMPOUND accession,C00186,lac_L,79-33-4,422.0,"Human Metabolome Database (HMDB): Lactic acid is an organic acid. It is a chiral molecule, consisting of two optical isomers, L-lactic acid and D-lactic acid, with the L-isomer being the most common in living organisms. Lactic acid plays a role in several biochemical processes and is produced in the muscles during intense activity. In animals, L-lactate is constantly produced from pyruvate via the enzyme lactate dehydrogenase (LDH) in a process of fermentation during normal metabolism and exercise. It does not increase in concentration until the rate of lactate production exceeds the rate of lactate removal. This is governed by a number of factors, including monocarboxylate transporters, lactate concentration, the isoform of LDH, and oxidative capacity of tissues. The concentration of blood lactate is usually 1-2 mmol/L at rest, but can rise to over 20 mmol/L during intense exertion. There are some indications that lactate, and not glucose, is preferentially metabolized by neurons in the brain of several mammalian species, including mice, rats, and humans. Glial cells, using the lactate shuttle, are responsible for transforming glucose into lactate, and for providing lactate to the neurons. Lactate measurement in critically ill patients has been traditionally used to stratify patients with poor outcomes. However, plasma lactate levels are the result of a finely tuned interplay of factors that affect the balance between its production and its clearance. When the oxygen supply does not match its consumption, organisms adapt in many different ways, up to the point when energy failure occurs. Lactate, being part of the adaptive response, may then be used to assess the severity of the supply/demand imbalance. In such a scenario, the time to intervention becomes relevant: early and effective treatment may allow tissues and cells to revert to a normal state, as long as the oxygen machinery (i.e. mitochondria) is intact. Conversely, once the mitochondria are deranged, energy failure occurs even in the presence of normoxia. The lactate increase in critically ill patients may, therefore, be viewed as an early marker of a potentially reversible state (PMID: 16356243). When present in sufficiently high levels, lactic acid can act as an oncometabolite, an immunosuppressant, an acidogen, and a metabotoxin. An oncometabolite is a compound that promotes tumor growth and survival. An immunosuppressant reduces or arrests the activity of the immune system. An acidogen is an acidic compound that induces acidosis, which has multiple adverse effects on many organ systems. A metabotoxin is an endogenously produced metabolite that causes adverse health effects at chronically high levels. Chronically high levels of lactic acid are associated with at least a dozen inborn errors of metabolism, including 2-methyl-3-hydroxybutyryl CoA dehydrogenase deficiency, biotinidase deficiency, fructose-1,6-diphosphatase deficiency, glycogen storage disease type 1A (GSD1A) or Von Gierke disease, glycogenosis type IB, glycogenosis type IC, glycogenosis type VI, Hers disease, lactic acidemia, Leigh syndrome, methylmalonate semialdehyde dehydrogenase deficiency, pyruvate decarboxylase E1 component deficiency, pyruvate dehydrogenase complex deficiency, pyruvate dehydrogenase deficiency, and short chain acyl CoA dehydrogenase deficiency (SCAD deficiency). Locally high concentrations of lactic acid or lactate are found near many tumors due to the upregulation of lactate dehydrogenase (PMID: 15279558). Lactic acid produced by tumors through aerobic glycolysis acts as an immunosuppressant and tumor promoter (PMID: 23729358). Indeed, lactic acid has been found to be a key player or regulator in the development and malignant progression of a variety of cancers (PMID: 22084445). A number of studies have demonstrated that malignant transformation is associated with an increase in aerobic cellular lactate excretion. Lactate concentrations in various carcinomas (e.g. uterine cervix, head and neck, colorectal region) at first diagnosis of the disease, can be relatively low or extremely high (up to 40 mol/g) in different individual tumors or within the same lesion (PMID: 15279558). High molar concentrations of lactate are correlated with a high incidence of distant metastasis. Low lactate tumors (< median of approximately 8 mol/g) are associated with both an overall longer and disease-free survival compared to high lactate lesions (lactate > approximately 8 mol/g). Lactate-induced secretion of hyaluronan by tumor-associated fibroblasts creates a milieu favourable for cell migration and metastases (PMID: 22084445). An acidic environment (pH 6-6.5), which is common in many tumors, allows tumor cells to evade the immune response, and therefore allows them to grow unchecked. Locally high concentrations of lactic acid are known to markedly impede the function of normal immune cells and will lead to a loss of T-cell function of human tumor-infiltrating lymphocytes (PMID: 22084445). Lactic acid is also an organic acid and acts as a general acidogen. Abnormally high levels of organic acids in the blood (organic acidemia), urine (organic aciduria), the brain, and other tissues lead to general metabolic acidosis. Acidosis typically occurs when arterial pH falls below 7.35. In infants with acidosis, the initial symptoms include poor feeding, vomiting, loss of appetite, weak muscle tone (hypotonia), and lack of energy (lethargy). These can progress to heart abnormalities, kidney abnormalities, liver damage, seizures, coma, and possibly death. These are also the characteristic symptoms of the untreated IEMs mentioned above. Many affected children with organic acidemias experience intellectual disability or delayed development.",L-Lactic acid,HMDB0000190,b,b,C00186,L-LACTATE,FDB003294,lac_L,[H]O[C@]([H])(C([O-])=O)C([H])([H])[H],JVTAAEKCZFNVCJ-REOHCLBHSA-M,"InChI=1S/C3H6O3/c1-2(4)3(5)6/h2,4H,1H3,(H,5,6)/p-1/t2-/m0/s1"
3226,1069,a,a,30797,KEGG COMPOUND accession,C00149,mal_L,97-67-6,30797.0,"Human Metabolome Database (HMDB): Malic acid is a tart-tasting organic dicarboxylic acid that plays a role in many sour or tart foods. Apples contain malic acid, which contributes to the sourness of a green apple. Malic acid can make a wine taste tart, although the amount decreases with increasing fruit ripeness. (wikipedia). In its ionized form malic acid is called malate. Malate is an intermediate of the TCA cycle along with fumarate. It can also be formed from pyruvate as one of the anaplerotic reactions. In humans, malic acid is both derived from food sources and synthesized in the body through the citric acid cycle or Krebs cycle which takes place in the mitochondria. Malate's importance to the production of energy in the body during both aerobic and anaerobic conditions is well established. Under aerobic conditions, the oxidation of malate to oxaloacetate provides reducing equivalents to the mitochondria through the malate-aspartate redox shuttle. During anaerobic conditions, where a buildup of excess of reducing equivalents inhibits glycolysis, malic acid's simultaneous reduction to succinate and oxidation to oxaloacetate is capable of removing the accumulating reducing equivalents. This allows malic acid to reverse hypoxia's inhibition of glycolysis and energy production. In studies on rats it has been found that only tissue malate is depleted following exhaustive physical activity. Other key metabolites from the citric acid cycle needed for energy production were found to be unchanged. Because of this, a deficiency of malic acid has been hypothesized to be a major cause of physical exhaustion. Notably, the administration of malic acid to rats has been shown to elevate mitochondrial malate and increase mitochondrial respiration and energy production.",L-Malic acid,HMDB0000156,b,b,C00149,b,FDB001044,mal_L,[H]O[C@]([H])(C([O-])=O)C([H])([H])C([O-])=O,BJEPYKJPYRNKOW-REOHCLBHSA-L,"InChI=1S/C4H6O5/c5-2(4(8)9)1-3(6)7/h2,5H,1H2,(H,6,7)(H,8,9)/p-2/t2-/m0/s1"
3227,1083,a,a,32800,KEGG COMPOUND accession,C01984,,,,,,,,,,,,,,,
3228,1087,a,a,36941,KEGG COMPOUND accession,C02615,,,,,,,,,,,,,,,
3229,1101,a,a,16512,KEGG COMPOUND accession,C02915,,,,,,,,,,,,,,,
3230,1103,a,a,17041,KEGG COMPOUND accession,C05176,,,,,,,,,,,,,,,
3231,1111,a,a,433,KEGG COMPOUND accession,C01314,,,,,,,,,,,,,,,
3232,1112,a,a,28389,KEGG COMPOUND accession,C01313,,,,,,,,,,,,,,,
3233,1119,a,a,28594,KEGG COMPOUND accession,C06518,,,,,,,,,,,,,,,
3234,1125,a,a,29002,KEGG COMPOUND accession,C02917,12ppd_S,4254-15-3,29002.0,"Human Metabolome Database (HMDB): (S)-Propane-1,2-diol is a clear, colorless, viscous organic solvent and diluent used in pharmaceutical preparations.","(S)-Propane-1,2-diol",HMDB0006213,b,b,C02917,--TRANS-ACENAPHTHENE-12-DIOL,FDB023838,12ppd_S,[H]OC([H])([H])[C@@]([H])(O[H])C([H])([H])[H],DNIAPMSPPWPWGF-VKHMYHEASA-N,"InChI=1S/C3H8O2/c1-3(5)2-4/h3-5H,2H2,1H3/t3-/m0/s1"
3235,1131,a,a,17129,KEGG COMPOUND accession,C02106,,,,,,,,,,,,,,,
3236,1136,a,a,16083,KEGG COMPOUND accession,C03914,,,,,,,,,,,,,,,
3237,1140,a,a,16812,KEGG COMPOUND accession,C03046,,,,,,,,,,,,,,,
3238,1149,a,a,15461,KEGG COMPOUND accession,C06737,,,,,,,,,,,,,,,
3239,1151,a,a,15660,KEGG COMPOUND accession,C04622,,,,,,,,,,,,,,,
3240,1155,a,a,17546,KEGG COMPOUND accession,C04435,,,,,,,,,,,,,,,
3241,1161,a,a,32808,KEGG COMPOUND accession,C03453,,,,,,,,,,,,,,,
3242,1165,a,a,16717,KEGG COMPOUND accession,C04225,,,,,,,,,,,,,,,
3243,1168,a,a,28627,KEGG COMPOUND accession,C08375,,,,,,,,,,,,,,,
3244,1186,a,a,37637,KEGG COMPOUND accession,C05868,,,,,,,,,,,,,,,
3245,1190,a,a,469,KEGG COMPOUND accession,C10426,,,,,,,,,,,,,,,
3246,1192,a,a,470,KEGG COMPOUND accession,C10427,,,,,,,,,,,,,,,
3247,1194,a,a,18350,KEGG COMPOUND accession,C06324,,,,,,,,,,,,,,,
3248,1201,a,a,27841,KEGG COMPOUND accession,C06636,,,,,,,,,,,,,,,
3249,1203,a,a,16598,KEGG COMPOUND accession,C04596,,,,,,,,,,,,,,,
3250,1207,a,a,44975,KEGG COMPOUND accession,C00604,,,,,,,,,,,,,,,
3251,1209,a,a,18082,KEGG COMPOUND accession,C04576,,,,,,,,,,,,,,,
3252,1212,a,a,27785,KEGG COMPOUND accession,C11058,,,,,,,,,,,,,,,
3253,1214,a,a,479,KEGG COMPOUND accession,C10243,,,,,,,,,,,,,,,
3254,1216,a,a,16746,KEGG COMPOUND accession,C03743,,,,,,,,,,,,,,,
3255,1226,a,a,28222,KEGG COMPOUND accession,C06594,,,,,,,,,,,,,,,
3256,1232,a,a,17501,KEGG COMPOUND accession,C04547,,,,,,,,,,,,,,,
3257,1234,a,a,27993,KEGG COMPOUND accession,C04275,,,,,,,,,,,,,,,
3258,1236,a,a,488,KEGG COMPOUND accession,C02108,,,,,,,,,,,,,,,
3259,1239,a,a,18363,KEGG COMPOUND accession,C06167,,,,,,,,,,,,,,,
3260,1249,a,a,17815,KEGG COMPOUND accession,C00641,HC02056,b,17815.0,b,"1,2-Diacylglycerol-Ld-Pc-Pool",b,b,b,C00641,b,b,HC02056,[H]OC([H])([H])C([H])(OC([*])=O)C([H])([H])OC([*])=O,b,b
3261,1249,a,a,17815,KEGG COMPOUND accession,C00641,HC02057,b,17815.0,b,"1,2-Diacylglycerol-Ld-Pe-Pool",b,b,b,C00641,b,b,HC02057,[H]OC([H])([H])C([H])(OC([*])=O)C([H])([H])OC([*])=O,b,b
3262,1249,a,a,17815,KEGG COMPOUND accession,C00641,HC02058,b,17815.0,b,"1,2-Diacylglycerol-Ld-Ps-Pool",b,b,b,C00641,b,b,b,[H]OC([H])([H])C([H])(OC([*])=O)C([H])([H])OC([*])=O,b,b
3263,1249,a,a,17815,KEGG COMPOUND accession,C00641,HC02059,b,17815.0,b,"1,2-Diacylglycerol-Ld-Pi-Pool",b,b,b,C00641,b,b,b,[H]OC([H])([H])C([H])(OC([*])=O)C([H])([H])OC([*])=O,b,b
3264,1249,a,a,17815,KEGG COMPOUND accession,C00641,HC02060,b,17815.0,b,"1,2-Diacylglycerol-Ld-Sm-Pool",b,b,b,C00641,b,b,HC02060,[H]OC([H])([H])C([H])(OC([*])=O)C([H])([H])OC([*])=O,b,b
3265,1249,a,a,17815,KEGG COMPOUND accession,C00641,HC02085,b,17815.0,b,"1,2-Diacylglycerol-Bile-Pc-Pool",b,b,b,C00641,b,b,b,[H]OC([H])([H])C([H])(OC([*])=O)C([H])([H])OC([*])=O,b,b
3266,1249,a,a,17815,KEGG COMPOUND accession,C00641,M00234,b,17815.0,b,"1,2-Diacylglycerol-Chylomicron-Pool",b,b,b,C00641,b,b,M00234,[H]OC([H])([H])C([H])(OC([*])=O)C([H])([H])OC([*])=O,b,b
3267,1249,a,a,17815,KEGG COMPOUND accession,C00641,M00241,b,17815.0,b,"1,2-Diacylglycerol-VLDL-Pool",b,b,b,C00641,b,b,b,[H]OC([H])([H])[C@]([H])(OC([*])=O)C([H])([H])OC([*])=O,b,b
3268,1265,a,a,28534,KEGG COMPOUND accession,C11088,,,,,,,,,,,,,,,
3269,1267,a,a,27789,KEGG COMPOUND accession,C06752,,,,,,,,,,,,,,,
3270,1271,a,a,18155,KEGG COMPOUND accession,C03199,,,,,,,,,,,,,,,
3271,1273,a,a,30912,KEGG COMPOUND accession,C01258,,,,,,,,,,,,,,,
3272,1275,a,a,28516,KEGG COMPOUND accession,C06205,M00243,b,28516.0,b,"1,2-Dihydronaphthalene-1,2-Diol",b,b,b,C06205,b,b,b,[H]OC1([H])C([H])=C([H])C2=C([H])C([H])=C([H])C([H])=C2C1([H])O[H],QPUHWUSUBHNZCG-UHFFFAOYSA-N,"InChI=1S/C10H10O2/c11-9-6-5-7-3-1-2-4-8(7)10(9)12/h1-6,9-12H"
3273,1279,a,a,17372,KEGG COMPOUND accession,C11808,,,,,,,,,,,,,,,
3274,1282,a,a,16100,KEGG COMPOUND accession,C06731,,,,,,,,,,,,,,,
3275,1286,a,a,28565,KEGG COMPOUND accession,C07724,,,,,,,,,,,,,,,
3276,1290,a,a,508,KEGG COMPOUND accession,C04274,,,,,,,,,,,,,,,
3277,1295,a,a,17676,KEGG COMPOUND accession,C04354,,,,,,,,,,,,,,,
3278,1297,a,a,512,KEGG COMPOUND accession,C10500,,,,,,,,,,,,,,,
3279,1299,a,a,513,KEGG COMPOUND accession,C06597,,,,,,,,,,,,,,,
3280,1300,a,a,514,KEGG COMPOUND accession,C10094,,,,,,,,,,,,,,,
3281,1302,a,a,18365,KEGG COMPOUND accession,C04033,,,,,,,,,,,,,,,
3282,1305,a,a,27936,KEGG COMPOUND accession,C11059,,,,,,,,,,,,,,,
3283,1311,a,a,15725,KEGG COMPOUND accession,C00986,13dampp,109-76-2,15725.0,"Human Metabolome Database (HMDB): 1,3-Diaminopropane is a stable, flammable and highly hydroscopic fluid. It is a polyamine that is normally quite toxic if swallowed, inhaled or absorbed through the skin. It is a catabolic byproduct of spermidine. It is also a precursor in the enzymatic synthesis of beta-alanine. 1, 3-Diaminopropane is involved in the arginine/proline metabolic pathways and the beta-alanine metabolic pathway.","1,3-Diaminopropane",HMDB0000002,b,b,C00986,CPD-313,FDB005274,13dampp,[H][N+]([H])([H])C([H])([H])C([H])([H])C([H])([H])[N+]([H])([H])[H],XFNJVJPLKCPIBV-UHFFFAOYSA-P,InChI=1S/C3H10N2/c4-2-1-3-5/h1-5H2/p+2
3284,1318,a,a,520,KEGG COMPOUND accession,C10445,,,,,,,,,,,,,,,
3285,1320,a,a,28536,KEGG COMPOUND accession,C11130,,,,,,,,,,,,,,,
3286,1326,a,a,29111,KEGG COMPOUND accession,C04923,,,,,,,,,,,,,,,
3287,1328,a,a,17631,KEGG COMPOUND accession,C04861,,,,,,,,,,,,,,,
3288,1332,a,a,18914,KEGG COMPOUND accession,C04850,,,,,,,,,,,,,,,
3289,1338,a,a,37671,KEGG COMPOUND accession,C00965,,,,,,,,,,,,,,,
3290,1346,a,a,16453,KEGG COMPOUND accession,C04226,,,,,,,,,,,,,,,
3291,1350,a,a,28286,KEGG COMPOUND accession,C08063,,,,,,,,,,,,,,,
3292,1354,a,a,16652,KEGG COMPOUND accession,C03047,,,,,,,,,,,,,,,
3293,1356,a,a,28677,KEGG COMPOUND accession,C10329,,,,,,,,,,,,,,,
3294,1360,a,a,540,KEGG COMPOUND accession,C01871,,,,,,,,,,,,,,,
3295,1364,a,a,27418,KEGG COMPOUND accession,C02617,M00251,130-15-4,27418.0,b,"1,4-Naphthoquinone",b,b,b,C02617,b,b,b,[H]C1=C([H])C2=C(C([H])=C1[H])C(=O)C([H])=C([H])C2=O,FRASJONUBLZVQX-UHFFFAOYSA-N,InChI=1S/C10H6O2/c11-9-5-6-10(12)8-4-2-1-3-7(8)9/h1-6H
3296,1371,a,a,27857,KEGG COMPOUND accession,C02492,,,,,,,,,,,,,,,
3297,1379,a,a,16715,KEGG COMPOUND accession,C06485,,,,,,,,,,,,,,,
3298,1381,a,a,16070,KEGG COMPOUND accession,C07326,,,,,,,,,,,,,,,
3299,1386,a,a,29064,KEGG COMPOUND accession,C04718,,,,,,,,,,,,,,,
3300,1388,a,a,17641,KEGG COMPOUND accession,C06720,,,,,,,,,,,,,,,
3301,1393,a,a,17708,KEGG COMPOUND accession,C04634,,,,,,,,,,,,,,,
3302,1396,a,a,27912,KEGG COMPOUND accession,C01654,,,,,,,,,,,,,,,
3303,1401,a,a,17914,KEGG COMPOUND accession,C04034,,,,,,,,,,,,,,,
3304,1404,a,a,27961,KEGG COMPOUND accession,C09844,,,,,,,,,,,,,,,
3305,1408,a,a,17832,KEGG COMPOUND accession,C04517,,,,,,,,,,,,,,,
3306,1414,a,a,15785,KEGG COMPOUND accession,C04635,M00223,b,15785.0,b,1-(1-Alkenyl)-Sn-Glycero-3-Phosphoethanolamine,b,b,b,C04635,b,b,b,[H]O[C@@]([H])(C([H])([H])OC([H])=C([H])[*])C([H])([H])OP(=O)(O[H])OC([H])([H])C([H])([H])N([H])[H],b,b
3307,1417,a,a,29112,KEGG COMPOUND accession,C01302,,,,,,,,,,,,,,,
3308,1420,a,a,29112,KEGG COMPOUND accession,C10528,,,,,,,,,,,,,,,
3309,1423,a,a,15797,KEGG COMPOUND accession,C04905,,,,,,,,,,,,,,,
3310,1425,a,a,16986,KEGG COMPOUND accession,C04908,,,,,,,,,,,,,,,
3311,1429,a,a,17134,KEGG COMPOUND accession,C04227,,,,,,,,,,,,,,,
3312,1432,a,a,18319,KEGG COMPOUND accession,C04823,25aics,3031-95-6,18319.0,"Human Metabolome Database (HMDB): SAICAR (or (S)-2-[5-amino-1-(5-phospho-D-ribosyl)imidazole-4-carboxamido]succinate) is a substrate for the multifunctional protein ADE2. SAICAR is an intermediate in purine metabolism. SAICAR is converted from 5-amino-1-(5-phospho-D-ribosyl) imidazole-4-carboxylate via phosphoribosylaminoimidazole-succinocarboxamide synthase (EC: 6.3.2.6) or SAICAR synthase. This enzyme catalyses the seventh step out of ten in the biosynthesis of purine nucleotides. The appearance of succinylaminoimidazolecarboxamide riboside (SAICAriboside) and succinyladenosine (S-Ado) in cerebrospinal fluid, in urine, and, to a lesser extent, in plasma is characteristic of a heritable deficiency known as adenylosuccinate lyase deficiency. Adenylosuccinate lyase deficiency is responsible for a range of symptoms that involve psychomotor retardation, often accompanied by epileptic seizures, and autistic features. When present in sufficiently high levels, SAICAR can act as an oncometabolite, a metabotoxin, and an acidogen. An oncometabolite is a compound that promotes tumour growth and survival. An acidogen is an acidic compound that induces acidosis, which has multiple adverse effects on many organ systems. A metabotoxin is an endogenously produced metabolite that causes adverse health effects at chronically high levels. As an oncometabolite, high levels of SAICAR stimulate pyruvate kinase isoform M2 and promote cancer cell survival in glucose-limited conditions such as aerobic glycolysis (PMID: 23086999). As an organic acid, SAICAR is associated with acidosis. Abnormally high levels of organic acids in the blood (organic acidemia), urine (organic aciduria), the brain, and other tissues lead to general metabolic acidosis. Acidosis typically occurs when arterial pH falls below 7.35. In infants with acidosis the initial symptoms include poor feeding, vomiting, loss of appetite, weak muscle tone (hypotonia), and lack of energy (lethargy). These can progress to heart, liver, and kidney abnormalities, seizures, coma, and possibly death. These are also the characteristic symptoms of untreated adenylosuccinate lyase deficiency. Many affected children with organic acidemias experience intellectual disability or delayed development.",SAICAR,HMDB0000797,b,b,C04823,P-RIBOSYL-4-SUCCCARB-AMINOIMIDAZOLE,FDB022251,25aics,[H]O[C@@]1([H])[C@@]([H])(O[C@]([H])(C([H])([H])OP([O-])([O-])=O)[C@@]1([H])O[H])N1C([H])=NC(C(=O)N([H])C([H])(C([O-])=O)C([H])([H])C([O-])=O)=C1N([H])[H],NAQGHJTUZRHGAC-GYAZKSLVSA-J,"InChI=1S/C13H19N4O12P/c14-10-7(11(22)16-4(13(23)24)1-6(18)19)15-3-17(10)12-9(21)8(20)5(29-12)2-28-30(25,26)27/h3-5,8-9,12,20-21H,1-2,14H2,(H,16,22)(H,18,19)(H,23,24)(H2,25,26,27)/p-4/t4?,5-,8-,9-,12-/m0/s1"
3313,1440,a,a,18381,KEGG COMPOUND accession,C04734,fprica,b,18381.0,"Human Metabolome Database (HMDB): This compound is an intermediate in purine metabolism, where it is the byproduct of phosphoribosylaminoimidazolecarboxamide formyltransferase (EC 2.1.2.3) and IMP cyclohydrolase (EC 3.5.4.10). It is also a byproduct of Ligases (EC 6.3.4.-).",Phosphoribosyl formamidocarboxamide,HMDB0001439,b,b,C04734,PHOSPHORIBOSYL-FORMAMIDO-CARBOXAMIDE,FDB022622,fprica,[H]O[C@@]1([H])[C@@]([H])(O[C@]([H])(C([H])([H])OP([O-])([O-])=O)[C@@]1([H])O[H])N1C([H])=NC(C(=O)N([H])[H])=C1N([H])C([H])=O,ABCOOORLYAOBOZ-DEGSGYPDSA-L,"InChI=1S/C10H15N4O9P/c11-8(18)5-9(13-3-15)14(2-12-5)10-7(17)6(16)4(23-10)1-22-24(19,20)21/h2-4,6-7,10,16-17H,1H2,(H2,11,18)(H,13,15)(H2,19,20,21)/p-2/t4-,6-,7-,10-/m0/s1"
3314,1452,a,a,16994,KEGG COMPOUND accession,C04708,,,,,,,,,,,,,,,
3315,1459,a,a,16999,KEGG COMPOUND accession,C04792,,,,,,,,,,,,,,,
3316,1466,a,a,17504,KEGG COMPOUND accession,C04230,pcholhep_hs,b,580913.0,"Human Metabolome Database (HMDB): LysoPC(17:0) is a lysophospholipid (LyP). It is a monoglycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. Lysophosphatidylcholines can have different combinations of fatty acids of varying lengths and saturation attached at the C-1 (sn-1) position. Fatty acids containing 16, 18 and 20 carbons are the most common. LysoPC(17:0), in particular, consists of one chain of margaric acid at the C-1 position. The margaric acid moiety is derived from butter, milk and fat of ruminants. Lysophosphatidylcholine is found in small amounts in most tissues. It is formed by hydrolysis of phosphatidylcholine by the enzyme phospholipase A2, as part of the de-acylation/re-acylation cycle that controls its overall molecular species composition. It can also be formed inadvertently during extraction of lipids from tissues if the phospholipase is activated by careless handling. In blood plasma significant amounts of lysophosphatidylcholine are formed by a specific enzyme system, lecithin:cholesterol acyltransferase (LCAT), which is secreted from the liver. The enzyme catalyzes the transfer of the fatty acids of position sn-2 of phosphatidylcholine to the free cholesterol in plasma, with formation of cholesterol esters and lysophosphatidylcholine. Lysophospholipids have a role in lipid signaling by acting on lysophospholipid receptors (LPL-R). LPL-R's are members of the G protein-coupled receptor family of integral membrane proteins.",LysoPC(17:0),HMDB0012108,b,b,C04230,b,FDB028772,pcholhep_hs,[H]O[C@]([H])(C([H])([H])OC(=O)C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H])C([H])([H])OP(=O)(O[H])OC([H])([H])C([H])([H])[N+](C([H])([H])[H])(C([H])([H])[H])C([H])([H])[H],SRRQPVVYXBTRQK-DEOSSOPVSA-O,"InChI=1S/C25H52NO7P/c1-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-25(28)31-22-24(27)23-33-34(29,30)32-21-20-26(2,3)4/h24,27H,5-23H2,1-4H3/p+1/t24-/m0/s1"
3317,1466,a,a,17504,KEGG COMPOUND accession,C04230,pcholmyr_hs,b,b,"Human Metabolome Database (HMDB): LysoPC(18:1(11Z)) is a lysophospholipid (LyP). It is a monoglycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. Lysophosphatidylcholines can have different combinations of fatty acids of varying lengths and saturation attached at the C-1 (sn-1) position. Fatty acids containing 16, 18 and 20 carbons are the most common. LysoPC(18:1(11Z)), in particular, consists of one chain of vaccenic acid at the C-1 position. The vaccenic acid moiety is derived from butter fat and animal fat. Lysophosphatidylcholine is found in small amounts in most tissues. It is formed by hydrolysis of phosphatidylcholine by the enzyme phospholipase A2, as part of the de-acylation/re-acylation cycle that controls its overall molecular species composition. It can also be formed inadvertently during extraction of lipids from tissues if the phospholipase is activated by careless handling. In blood plasma significant amounts of lysophosphatidylcholine are formed by a specific enzyme system, lecithin:cholesterol acyltransferase (LCAT), which is secreted from the liver. The enzyme catalyzes the transfer of the fatty acids of position sn-2 of phosphatidylcholine to the free cholesterol in plasma, with formation of cholesterol esters and lysophosphatidylcholine. Lysophospholipids have a role in lipid signaling by acting on lysophospholipid receptors (LPL-R). LPL-R's are members of the G protein-coupled receptor family of integral membrane proteins.",LysoPC(18:1(11Z)),HMDB0010385,b,b,C04230, PHOSPHATIDYLCHOLINE,FDB027536,pcholmyr_hs,[H]O[C@]([H])(C([H])([H])OC(=O)C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H])C([H])([H])OP(=O)(O[H])OC([H])([H])C([H])([H])[N+](C([H])([H])[H])(C([H])([H])[H])C([H])([H])[H],VXUOFDJKYGDUJI-NRFANRHFSA-O,"InChI=1S/C22H46NO7P/c1-5-6-7-8-9-10-11-12-13-14-15-16-22(25)28-19-21(24)20-30-31(26,27)29-18-17-23(2,3)4/h21,24H,5-20H2,1-4H3/p+1/t21-/m0/s1"
3318,1466,a,a,17504,KEGG COMPOUND accession,C04230,pcholn204_hs,b,b,"Human Metabolome Database (HMDB): LysoPC(20:4(8Z,11Z,14Z,17Z)) is a lysophospholipid (LyP). It is a monoglycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. Lysophosphatidylcholines can have different combinations of fatty acids of varying lengths and saturation attached at the C-1 (sn-1) position. Fatty acids containing 16, 18 and 20 carbons are the most common. LysoPC(20:4(8Z,11Z,14Z,17Z)), in particular, consists of one chain of eicsoatetraenoic acid at the C-1 position. The eicsoatetraenoic acid moiety is derived from fish oils. Lysophosphatidylcholine is found in small amounts in most tissues. It is formed by hydrolysis of phosphatidylcholine by the enzyme phospholipase A2, as part of the de-acylation/re-acylation cycle that controls its overall molecular species composition. It can also be formed inadvertently during extraction of lipids from tissues if the phospholipase is activated by careless handling. In blood plasma significant amounts of lysophosphatidylcholine are formed by a specific enzyme system, lecithin:cholesterol acyltransferase (LCAT), which is secreted from the liver. The enzyme catalyzes the transfer of the fatty acids of position sn-2 of phosphatidylcholine to the free cholesterol in plasma, with formation of cholesterol esters and lysophosphatidylcholine. Lysophospholipids have a role in lipid signaling by acting on lysophospholipid receptors (LPL-R). LPL-R's are members of the G protein-coupled receptor family of integral membrane proteins.","LysoPC(20:4(8Z,11Z,14Z,17Z))",HMDB0010396,b,b,C04230, PHOSPHATIDYLCHOLINE,FDB027547,pcholn204_hs,[H]O[C@]([H])(C([H])([H])OC(=O)C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C(\[H])=C(\[H])C([H])([H])C(\[H])=C(\[H])C([H])([H])C(\[H])=C(\[H])C([H])([H])C(\[H])=C(\[H])C([H])([H])C([H])([H])[H])C([H])([H])OP([O-])(=O)OC([H])([H])C([H])([H])[N+](C([H])([H])[H])(C([H])([H])[H])C([H])([H])[H],GOMVPVRDBLLHQC-LRTGODIXSA-N,"InChI=1S/C28H50NO7P/c1-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20-21-22-28(31)34-25-27(30)26-36-37(32,33)35-24-23-29(2,3)4/h6-7,9-10,12-13,15-16,27,30H,5,8,11,14,17-26H2,1-4H3/b7-6?,10-9?,13-12-,16-15-/t27-/m1/s1"
3319,1466,a,a,17504,KEGG COMPOUND accession,C04230,pcholn24_hs,b,b,"Human Metabolome Database (HMDB): LysoPC(24:0) is a lysophospholipid (LyP). It is a monoglycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. Lysophosphatidylcholines can have different combinations of fatty acids of varying lengths and saturation attached at the C-1 (sn-1) position. Fatty acids containing 16, 18 and 20 carbons are the most common. LysoPC(24:0), in particular, consists of one chain of lignoceric acid at the C-1 position. The lignoceric acid moiety is derived from groundnut oil. Lysophosphatidylcholine is found in small amounts in most tissues. It is formed by hydrolysis of phosphatidylcholine by the enzyme phospholipase A2, as part of the de-acylation/re-acylation cycle that controls its overall molecular species composition. It can also be formed inadvertently during extraction of lipids from tissues if the phospholipase is activated by careless handling. In blood plasma significant amounts of lysophosphatidylcholine are formed by a specific enzyme system, lecithin:cholesterol acyltransferase (LCAT), which is secreted from the liver. The enzyme catalyzes the transfer of the fatty acids of position sn-2 of phosphatidylcholine to the free cholesterol in plasma, with formation of cholesterol esters and lysophosphatidylcholine. Lysophospholipids have a role in lipid signaling by acting on lysophospholipid receptors (LPL-R). LPL-R's are members of the G protein-coupled receptor family of integral membrane proteins.",LysoPC(24:0),HMDB0010405,b,b,C04230, PHOSPHATIDYLCHOLINE,FDB027556,pcholn24_hs,[H]O[C@]([H])(C([H])([H])OC(=O)C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H])C([H])([H])OP([O-])(=O)OC([H])([H])C([H])([H])[N+](C([H])([H])[H])(C([H])([H])[H])C([H])([H])[H],SKJMUADLQLZAGH-WJOKGBTCSA-N,"InChI=1S/C32H66NO7P/c1-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20-21-22-23-24-25-26-32(35)38-29-31(34)30-40-41(36,37)39-28-27-33(2,3)4/h31,34H,5-30H2,1-4H3/t31-/m1/s1"
3320,1466,a,a,17504,KEGG COMPOUND accession,C04230,pcholole_hs,3542-29-8,b,"Human Metabolome Database (HMDB): LysoPC(18:1(9Z)) is a lysophospholipid (LyP). It is a monoglycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. Lysophosphatidylcholines can have different combinations of fatty acids of varying lengths and saturation attached at the C-1 (sn-1) position. Fatty acids containing 16, 18 and 20 carbons are the most common. LysoPC(18:19Z)), in particular, consists of one chain of oleic acid at the C-1 position. The oleic acid moiety, an omega-9 fatty acid, is derived from various animal and vegetable sources such as olive oil, acai and grapeseed oil. Lysophosphatidylcholine is found in small amounts in most tissues. It is formed by hydrolysis of phosphatidylcholine by the enzyme phospholipase A2, as part of the de-acylation/re-acylation cycle that controls its overall molecular species composition. It can also be formed inadvertently during extraction of lipids from tissues if the phospholipase is activated by careless handling. In blood plasma significant amounts of lysophosphatidylcholine are formed by a specific enzyme system, lecithin:cholesterol acyltransferase (LCAT), which is secreted from the liver. The enzyme catalyzes the transfer of the fatty acids of position sn-2 of phosphatidylcholine to the free cholesterol in plasma, with formation of cholesterol esters and lysophosphatidylcholine. Lysophospholipids have a role in lipid signaling by acting on lysophospholipid receptors (LPL-R). LPL-R's are members of the G protein-coupled receptor family of integral membrane proteins.",LysoPC(18:1(9Z)),HMDB0002815,b,b,C04230, PHOSPHATIDYLCHOLINE,FDB023066,pcholole_hs,[H]O[C@]([H])(C([H])([H])OC(=O)C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C(\[H])=C(\[H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H])C([H])([H])OP(=O)(O[H])OC([H])([H])C([H])([H])[N+](C([H])([H])[H])(C([H])([H])[H])C([H])([H])[H],YAMUFBLWGFFICM-AYZYJWAHSA-O,"InChI=1S/C26H52NO7P/c1-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20-26(29)32-23-25(28)24-34-35(30,31)33-22-21-27(2,3)4/h12-13,25,28H,5-11,14-24H2,1-4H3/p+1/b13-12-/t25-/m0/s1"
3321,1466,a,a,17504,KEGG COMPOUND accession,C04230,pcholste_hs,b,b,"Human Metabolome Database (HMDB): LysoPC(18:0) is a lysophospholipid (LyP). It is a monoglycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. Lysophosphatidylcholines can have different combinations of fatty acids of varying lengths and saturation attached at the C-1 (sn-1) position. Fatty acids containing 16, 18 and 20 carbons are the most common. LysoPC(18:0), in particular, consists of one chain of stearic acid at the C-1 position. The stearic acid moiety is derived from animal fats, coco butter and sesame oil. Lysophosphatidylcholine is found in small amounts in most tissues. It is formed by hydrolysis of phosphatidylcholine by the enzyme phospholipase A2, as part of the de-acylation/re-acylation cycle that controls its overall molecular species composition. It can also be formed inadvertently during extraction of lipids from tissues if the phospholipase is activated by careless handling. In blood plasma significant amounts of lysophosphatidylcholine are formed by a specific enzyme system, lecithin:cholesterol acyltransferase (LCAT), which is secreted from the liver. The enzyme catalyzes the transfer of the fatty acids of position sn-2 of phosphatidylcholine to the free cholesterol in plasma, with formation of cholesterol esters and lysophosphatidylcholine. Lysophospholipids have a role in lipid signaling by acting on lysophospholipid receptors (LPL-R). LPL-R's are members of the G protein-coupled receptor family of integral membrane proteins.",LysoPC(18:0),HMDB0010384,b,b,C04230,CPD-8345,FDB027535,pcholste_hs,[H]O[C@]([H])(C([H])([H])OC(=O)C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H])C([H])([H])OP(=O)(O[H])OC([H])([H])C([H])([H])[N+](C([H])([H])[H])(C([H])([H])[H])C([H])([H])[H],IHNKQIMGVNPMTC-VWLOTQADSA-O,"InChI=1S/C26H54NO7P/c1-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20-26(29)32-23-25(28)24-34-35(30,31)33-22-21-27(2,3)4/h25,28H,5-24H2,1-4H3/p+1/t25-/m0/s1"
3322,1471,a,a,29017,KEGG COMPOUND accession,C04438,M00511,b,b,b,1-Acyl-Sn-Glycero-3-Phosphoethanolamine,b,b,b,C04438,b,b,b,[H]O[C@]([H])(C([H])([H])OC([*])=O)C([H])([H])OP(=O)(O[H])OC([H])([H])C([H])([H])N([H])[H],b,b
3323,1486,a,a,17555,KEGG COMPOUND accession,C01264,,,,,,,,,,,,,,,
3324,1489,a,a,36707,KEGG COMPOUND accession,C04598,paf_hs,b,847856.0,"Human Metabolome Database (HMDB): 2-Acetyl-1-(9Z-octadecenyl)-sn-glycero-3-phosphocholine is an intermediate in ether lipid metabolism. 2-Acetyl-1-(9Z-octadecenyl)-sn-glycero-3-phosphocholine is converted from 2-acetyl-1-octadecyl-sn-glycerol via diacylglycerol cholinephosphotransferase (EC: 2.7.8.2). This is an ether lipid with platelet-activating factor functions which has an acetyl group instead of an acyl chain at the second position (SN-2). Ether lipids are lipids in which one or more of the carbon atoms on glycerol is bonded to an alkyl chain via an ether linkage, as opposed to the usual ester linkage.While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PCs can be synthesized via three different routes. In one route, choline is activated first by phosphorylation and then by coupling to CDP prior to attachment to phosphatidic acid. PCs can also synthesized by the addition of choline to CDP-activated 1,2-diacylglycerol. A third route to PC synthesis involves the conversion of either PS or PE to PC.",PC(18:1(9Z)e/2:0),HMDB0011148,b,b,C04598,b,FDB027923,paf_hs,[H]C([H])([H])C(=O)O[C@]([H])(C([H])([H])O[*])C([H])([H])OP([O-])(=O)OC([H])([H])C([H])([H])[N+](C([H])([H])[H])(C([H])([H])[H])C([H])([H])[H],ZBOQHUSCQCEBGK-JLRCLJKCSA-N,b
3325,1493,a,a,16291,KEGG COMPOUND accession,C03820,C03820,b,16291.0,b,1-Alkyl-2-Acetyl-Sn-Glycerol,b,b,b,C03820,b,b,b,[H]OC([H])([H])[C@]([H])(OC(=O)C([H])([H])[H])C([H])([H])O[*],b,b
3326,1496,a,a,37296,KEGG COMPOUND accession,C05977,ak2gp_hs,b,b,b,1-Alkyl 2-Acylglycerol 3-Phosphate,b,b,b,C05977,b,b,b,[H]C([H])(O*)C([H])(OC(*)=O)C([H])([H])OP([O-])([O-])=O,b,b
3327,1504,a,a,28894,KEGG COMPOUND accession,C05208,,,,,,,,,,,,,,,
3328,1511,a,a,17106,KEGG COMPOUND accession,C03968,,,,,,,,,,,,,,,
3329,1516,a,a,15850,KEGG COMPOUND accession,C02773,,,,,,,,,,,,,,,
3330,1519,a,a,16181,KEGG COMPOUND accession,C01214,,,,,,,,,,,,,,,
3331,1522,a,a,17928,KEGG COMPOUND accession,C01283,,,,,,,,,,,,,,,
3332,1527,a,a,18053,KEGG COMPOUND accession,C01234,,,,,,,,,,,,,,,
3333,1533,a,a,28885,KEGG COMPOUND accession,C06142,btoh,71-36-3,28885.0,"Human Metabolome Database (HMDB): 1-Butanol, which is also known as n-butanol or 1-butanol or butyl alcohol (sometimes also called biobutanol when produced biologically), is an alcohol with a 4 carbon structure and the molecular formula of C4H10O. It is primarily used as a solvent, as an intermediate in chemical synthesis, and as a fuel. There are four isomeric structures for butanol. The straight chain isomer with the alcohol at an internal carbon is sec-butanol or 2-butanol. The branched isomer with the alcohol at a terminal carbon is isobutanol, and the branched isomer with the alcohol at the internal carbon is tert-butanol. 1-Butanol is produced in small amounts by gut microbial fermenetation through the butanoate metabolic pathway.",1-Butanol,HMDB0004327,b,b,C06142,BUTANOL,FDB012614,b,b,LRHPLDYGYMQRHN-UHFFFAOYSA-N,b
3334,1536,a,a,614,KEGG COMPOUND accession,C10433,,,,,,,,,,,,,,,
3335,1538,a,a,615,KEGG COMPOUND accession,C06669,,,,,,,,,,,,,,,
3336,1540,a,a,17056,KEGG COMPOUND accession,C06367,,,,,,,,,,,,,,,
3337,1542,a,a,28555,KEGG COMPOUND accession,C06638,,,,,,,,,,,,,,,
3338,1544,a,a,27454,KEGG COMPOUND accession,C06637,,,,,,,,,,,,,,,
3339,1546,a,a,16421,KEGG COMPOUND accession,C04359,,,,,,,,,,,,,,,
3340,1548,a,a,28354,KEGG COMPOUND accession,C06257,,,,,,,,,,,,,,,
3341,1555,a,a,28779,KEGG COMPOUND accession,C07726,,,,,,,,,,,,,,,
3342,1558,a,a,16143,KEGG COMPOUND accession,C01294,,,,,,,,,,,,,,,
3343,1561,a,a,18060,KEGG COMPOUND accession,C01872,,,,,,,,,,,,,,,
3344,1565,a,a,17770,KEGG COMPOUND accession,C04719,,,,,,,,,,,,,,,
3345,1567,a,a,631,KEGG COMPOUND accession,C05678,,,,,,,,,,,,,,,
3346,1569,a,a,28091,KEGG COMPOUND accession,C11427,,,,,,,,,,,,,,,
3347,1571,a,a,36108,KEGG COMPOUND accession,C03203,,,,,,,,,,,,,,,
3348,1585,a,a,17472,KEGG COMPOUND accession,C04731,,,,,,,,,,,,,,,
3349,1589,a,a,18083,KEGG COMPOUND accession,C02216,,,,,,,,,,,,,,,
3350,1592,a,a,16020,KEGG COMPOUND accession,C02494,,,,,,,,,,,,,,,
3351,1597,a,a,16797,KEGG COMPOUND accession,C02918,1mncam,3106-60-3,16797.0,Human Metabolome Database (HMDB): 1-Methylnicotinamide is a metabolite of nicotinamide and is produced primarily in the liver. It has anti-inflammatory properties (PMID 16197374). It is a product of nicotinamide N-methyltransferase [EC 2.1.1.1] in the pathway of nicotinate and nicotinamide metabolism (KEGG). 1-Methylnicotinamide may be an endogenous activator of prostacyclin production and thus may regulate thrombotic as well as inflammatory processes in the cardiovascular system (PMID: 17641676).,1-Methylnicotinamide,HMDB0000699,b,b,C02918,CPD-396,FDB022188,1mncam,[H]N([H])C(=O)C1=C([H])[N+](=C([H])C([H])=C1[H])C([H])([H])[H],LDHMAVIPBRSVRG-UHFFFAOYSA-O,"InChI=1S/C7H8N2O/c1-9-4-2-3-6(5-9)7(8)10/h2-5H,1H3,(H-,8,10)/p+1"
3352,1600,a,a,27435,KEGG COMPOUND accession,C06178,,,,,,,,,,,,,,,
3353,1603,a,a,27395,KEGG COMPOUND accession,C04360,,,,,,,,,,,,,,,
3354,1614,a,a,15834,KEGG COMPOUND accession,C01158,,,,,,,,,,,,,,,
3355,1619,a,a,18427,KEGG COMPOUND accession,C03659,,,,,,,,,,,,,,,
3356,1623,a,a,16546,KEGG COMPOUND accession,C01175,,,,,,,,,,,,,,,
3357,1626,a,a,17935,KEGG COMPOUND accession,C01545,,,,,,,,,,,,,,,
3358,1629,a,a,16188,KEGG COMPOUND accession,C00756,,,,,,,,,,,,,,,
3359,1641,a,a,663,KEGG COMPOUND accession,C10976,,,,,,,,,,,,,,,
3360,1645,a,a,28468,KEGG COMPOUND accession,C04102,,,,,,,,,,,,,,,
3361,1648,a,a,27528,KEGG COMPOUND accession,C11432,,,,,,,,,,,,,,,
3362,1652,a,a,669,KEGG COMPOUND accession,C07112,,,,,,,,,,,,,,,
3363,1659,a,a,16152,KEGG COMPOUND accession,C11554,pail34p_hs,b,16152.0,b,"1-Phosphatidyl-1D-Myo-Inositol 3,4-Bisphosphate",b,b,b,C11554,b,b,pail34p_hs,[H]O[C@]1([H])[C@@]([H])(O[H])[C@]([H])(OP([O-])([O-])=O)[C@@]([H])(OP([O-])([O-])=O)[C@@]([H])(O[H])[C@@]1([H])OP([O-])(=O)OC([H])([H])[C@]([H])(OC([*])=O)C([H])([H])OC([*])=O,b,b
3364,1661,a,a,16851,KEGG COMPOUND accession,C11556,pail35p_hs,b,b,b,"1-Phosphatidyl-1D-Myo-Inositol 3,5-Bisphosphate",b,b,b,C11556,b,b,pail35p_hs,[H]O[C@@]1([H])[C@]([H])(OP([O-])([O-])=O)[C@@]([H])(O[H])[C@]([H])(OP([O-])(=O)OC([H])([H])[C@]([H])(OC([*])=O)C([H])([H])OC([*])=O)[C@]([H])(O[H])[C@]1([H])OP([O-])([O-])=O,b,b
3365,1663,a,a,17283,KEGG COMPOUND accession,C04549,pail3p_hs,b,17283.0,Human Metabolome Database (HMDB): 1-Phosphatidyl-1D-myo-inositol 3-phosphate is a substrate for FYVE finger-containing phosphoinositide kinase and Neutrophil cytosol factor 4.,1-Phosphatidyl-1D-myo-inositol 3-phosphate,HMDB0003850,b,b,C04549,CPD-177,FDB023237,pail3p_hs,[H]O[C@@]1([H])[C@]([H])(O[H])[C@@]([H])(OP([O-])([O-])=O)[C@@]([H])(O[H])[C@@]([H])(OP([O-])(=O)OC([H])([H])[C@]([H])(OC([*])=O)C([H])([H])OC([*])=O)[C@]1([H])O[H],YKMGQFUXYYTRLF-SLJXNWFNSA-N,b
3366,1667,a,a,17526,KEGG COMPOUND accession,C01277,pail4p_hs,b,17526.0,b,1-Phosphatidyl-1D-Myo-Inositol 4-Phosphate,b,b,b,C01277,b,b,pail4p_hs,[H]O[C@@]1([H])[C@@]([H])(O[H])[C@@]([H])(OP([O-])(=O)OC([H])([H])[C@]([H])(OC([*])=O)C([H])([H])OC([*])=O)[C@]([H])(O[H])[C@@]([H])(O[H])[C@]1([H])OP([O-])([O-])=O,b,b
3367,1671,a,a,16500,KEGG COMPOUND accession,C11557,CE5101,b,16500.0,b,1-Phosphatidyl-1D-Myo-Inositol 5-Phosphate,b,b,b,C11557,b,b,CE5101,[H]O[C@]1([H])[C@@]([H])(O[H])[C@]([H])(OP([O-])([O-])=O)[C@@]([H])(O[H])[C@]([H])(OP([O-])(=O)OC([H])([H])[C@]([H])(OC([*])=O)C([H])([H])OC([*])=O)[C@]1([H])O[H],b,b
3368,1671,a,a,16500,KEGG COMPOUND accession,C11557,pail5p_hs,b,16500.0,b,1-Phosphatidyl-1D-Myo-Inositol 5-Phosphate,b,b,b,C11557,b,b,pail5p_hs,[H]O[C@]1([H])[C@@]([H])(O[H])[C@]([H])(OP([O-])([O-])=O)[C@@]([H])(O[H])[C@]([H])(OP([O-])(=O)OC([H])([H])[C@]([H])(OC([*])=O)C([H])([H])OC([*])=O)[C@]1([H])O[H],b,b
3369,1673,a,a,16749,KEGG COMPOUND accession,C01194,,,,,,,,,,,,,,,
3370,1688,a,a,17543,KEGG COMPOUND accession,C04037,,,,,,,,,,,,,,,
3371,1694,a,a,36761,KEGG COMPOUND accession,C03564,1p2cbxl,b,36761.0,Human Metabolome Database (HMDB): 1-Pyrroline-2-carboxylic acid is a terminal product of D-proline metabolism. Specifically D-proline is converted to 1-Pyrroline-2-carboxylic acid via D-amino acid oxidase. This spontaneously breaks down to 2-oxo-5-amino-valerate.,1-Pyrroline-2-carboxylic acid,HMDB0006875,b,b,C03564,DELTA1-PYRROLINE_2-CARBOXYLATE,FDB024129,b,[H]C1([H])N=C(C([O-])=O)C([H])([H])C1([H])[H],RHTAIKJZSXNELN-UHFFFAOYSA-M,"InChI=1S/C5H7NO2/c7-5(8)4-2-1-3-6-4/h1-3H2,(H,7,8)/p-1"
3372,1697,a,a,16352,KEGG COMPOUND accession,C04282,,,,,,,,,,,,,,,
3373,1707,a,a,18428,KEGG COMPOUND accession,C02919,,,,,,,,,,,,,,,
3374,1709,a,a,17505,KEGG COMPOUND accession,C01235,,,,,,,,,,,,,,,
3375,1724,a,a,16060,KEGG COMPOUND accession,C11635,,,,,,,,,,,,,,,
3376,1727,a,a,15634,KEGG COMPOUND accession,C03204,,,,,,,,,,,,,,,
3377,1742,a,a,28010,KEGG COMPOUND accession,C05929,,,,,,,,,,,,,,,
3378,1743,a,a,701,KEGG COMPOUND accession,C07493,,,,,,,,,,,,,,,
3379,1754,a,a,17130,KEGG COMPOUND accession,C02217,,,,,,,,,,,,,,,
3380,1761,a,a,78600,KEGG COMPOUND accession,C05490,,,,,,,,,,,,,,,
3381,1767,a,a,16973,KEGG COMPOUND accession,C03205,11docrtstrn,64-85-7,16973.0,"Human Metabolome Database (HMDB): 11-Deoxycorticosterone (also called desoxycortone, 21-hydroxyprogesterone, DOC, or simply deoxycorticosterone) is a steroid hormone produced by the adrenal gland that possesses mineralocorticoid activity and acts as a precursor to aldosterone. It is classified as a member of the 21-hydroxysteroids. 21-hydroxysteroids are steroids carrying a hydroxyl group at the 21-position of the steroid backbone. Deoxycorticosterone is very hydrophobic, practically insoluble (in water), and relatively neutral. Deoxycorticosterone can be synthesized from progesterone by 21-beta-hydroxylase and is then converted to corticosterone by 11-beta-hydroxylase. Corticosterone is then converted to aldosterone by aldosterone synthase. Deoxycorticosterone stimulates the collecting tubules in the kidney to continue to excrete potassium in much the same way that aldosterone does. Deoxycorticosterone has about 1/20 of the sodium retaining power of aldosterone and about 1/5 the potassium excreting power of aldosterone (Wikipedia). Deoxycorticosterone can be found throughout all human tissues and has been detected in amniotic fluid and blood. When present in sufficiently high levels, deoxycorticosterone can act as a hypertensive agent and a metabotoxin. A hypertensive agent increases blood pressure and causes the production of more urine. A metabotoxin is an endogenously produced metabolite that causes adverse health effects at chronically high levels.  Chronically high levels of deoxycorticosterone are associated with congenital adrenal hyperplasia (CAH) and with adrenal tumors producing deoxycorticosterone (PMID: 20671982). High levels of this mineralocorticoid are associated with resistant hypertension, which can result in polyuria, polydipsia, increased blood volume, edema, and cardiac enlargement. Deoxycorticosterone can be used to treat adrenal insufficiency. In particular, desoxycorticosterone acetate (DOCA) is used as replacement therapy in Addison's disease.",Deoxycorticosterone,HMDB0000016,b,b,C03205,11-DEOXYCORTICOSTERONE,FDB021873,11docrtstrn,[H]OC([H])([H])C(=O)[C@@]1([H])C([H])([H])C([H])([H])[C@@]2([H])[C@]3([H])C([H])([H])C([H])([H])C4=C([H])C(=O)C([H])([H])C([H])([H])[C@]4(C([H])([H])[H])[C@@]3([H])C([H])([H])C([H])([H])[C@]12C([H])([H])[H],ZESRJSPZRDMNHY-YFWFAHHUSA-N,"InChI=1S/C21H30O3/c1-20-9-7-14(23)11-13(20)3-4-15-16-5-6-18(19(24)12-22)21(16,2)10-8-17(15)20/h11,15-18,22H,3-10,12H2,1-2H3/t15-,16-,17-,18+,20-,21-/m0/s1"
3382,1792,a,a,47787,KEGG COMPOUND accession,C01985,,,,,,,,,,,,,,,
3383,1798,a,a,16302,KEGG COMPOUND accession,C00899,retinol_cis_11,22737-96-8,16302.0,"Human Metabolome Database (HMDB): Cis-11-retinol is produce from vitamin A cycle driven by interphotoreceptor retinoid binding protein(IRBP). cis-11-retinol is released from retinal pigment epithelium(RPE) membranes. (PMID: 10655150). Retinoid metabolism of RPE cells freshly isolated by trypsinization showed no 11- cis -retinal and little 11- cis -retinol formation. Nondamaged cells cultured on thermally responsive surfaces detached in sheets upon temperature change. They showed metabolism similar to that of cells freshly isolated by nonenzymatic means. After trypsinization, confluent cultures dissociated into individual cells, but these cells showed poor retinoid metabolism, including no detectable retinyl esters or 11- cis -retinoid isomers. (PMID: 10375454).",11-cis-Retinol,HMDB0006216,b,b,C00899,CPD-882,FDB023840,retinol_cis_11,[H]OC([H])([H])C(\[H])=C(\C(\[H])=C(\[H])C([H])=C(\C([H])=C(/[H])C1=C(C([H])([H])[H])C([H])([H])C([H])([H])C([H])([H])C1(C([H])([H])[H])C([H])([H])[H])C([H])([H])[H])/C([H])([H])[H],FPIPGXGPPPQFEQ-FBVOPCRUSA-N,"InChI=1S/C20H30O/c1-16(8-6-9-17(2)13-15-21)11-12-19-18(3)10-7-14-20(19,4)5/h6,8-9,11-13,21H,7,10,14-15H2,1-5H3/b9-6-,12-11?,16-8-,17-13+"
3384,1804,a,a,27595,KEGG COMPOUND accession,C05959,,,,,,,,,,,,,,,
3385,1806,a,a,16076,KEGG COMPOUND accession,C03747,,,,,,,,,,,,,,,
3386,1809,a,a,732,KEGG COMPOUND accession,C05471,,,,,,,,,,,,,,,
3387,1814,a,a,27783,KEGG COMPOUND accession,C05489,M00283,b,b,"Human Metabolome Database (HMDB): 11beta,17alpha,21-Trihydroxypregnenolone is an intermediate in C21-Steroid hormone metabolism. 11beta,17alpha,21-Trihydroxypregnenolone is the 4th to last step in the synthesis of Cortol and is converted from 17alpha,21-Dihydroxypregnenolone via the enzyme cytochrome P450 (EC:1.14.15.4). It is then converted to Cortisol via the enzyme 3beta-hydroxy-delta5-steroid dehydrogenase (EC 1.1.1.145) and the enzyme steroid delta-isomerase (EC 5.3.3.1).","11b,17a,21-Trihydroxypreg-nenolone",HMDB0006760,b,b,C05489,b,FDB024064,b,[H]OC([H])([H])C(=O)[C@@]1(O[H])C([H])([H])C([H])([H])C2([H])C3([H])C([H])([H])C([H])=C4C([H])([H])[C@@]([H])(O[H])C([H])([H])C([H])([H])[C@]4(C([H])([H])[H])C3([H])[C@@]([H])(O[H])C([H])([H])[C@]12C([H])([H])[H],HAFVWTUQBYRPOB-WXEVJGDQSA-N,"InChI=1S/C21H32O5/c1-19-7-5-13(23)9-12(19)3-4-14-15-6-8-21(26,17(25)11-22)20(15,2)10-16(24)18(14)19/h3,13-16,18,22-24,26H,4-11H2,1-2H3/t13-,14?,15?,16-,18?,19-,20-,21-/m0/s1"
3388,1818,a,a,86389,KEGG COMPOUND accession,C05473,,,,,,,,,,,,,,,
3389,1830,a,a,28247,KEGG COMPOUND accession,C05498,M00285,600-57-7,b,"Human Metabolome Database (HMDB): 11beta-Hydroxyprogesterone is a normal human metabolite. Plasma 11beta-Hydroxyprogesterone concentrations does not vary significantly as a function of age, sex, or phase of the menstrual cycle, in contrast to 17-hydroxyprogesterone. Increased plasma 11beta-Hydroxyprogesterone levels in late-onset adrenal 21-hydroxylase deficiency suggest a mild defect of the mineralocorticoid pathway. 21-hydroxylase deficiency (OMIM 201910) is probably the most frequent (if not the most frequent) autosomal recessive genetic disease, occurring in almost 1% of Caucasians and about 3% of Ashkenazi Jews. 21-hydroxylase deficiency is unusual among genetic diseases in that approximately 95% of the mutant alleles have apparently been generated by recombination between a normally active gene (CYP21) and a closely linked pseudogene (CYP21P). There are 4 recognized clinical forms of congenital adrenal hyperplasia, the majority of cases being associated with 21-hydroxylase deficiency: salt-wasting (SW), simple virilizing (SV), nonclassic (NC) late-onset (also called attenuated and acquired), and cryptic. (PMID: 3546944, 2537337). 11beta-hydroxyprogesterone acts as a mineralocorticoid agonist in stimulating Na+ absorption in mammalian principal cortical collecting duct cells.It activates the transiently expressed hMR in COS-7 cells in a dose-dependent manner (ED(50): 10(-8) M) and, like aldosterone, stimulated Ams I(sc) in mpkCCD(cl4) cells. Docking 11OHP within the hMR-ligand-binding domain homology model revealed that the agonist activity of 11OHP is caused by contacts between its 11 beta-hydroxyl group and Asn770. Furthermore, 11OHP was unable to activate the mutant hMR/N770A, in which Ala is substituted for Asn at position 770. These findings demonstrate that in the absence of the 21-hydroxyl group, the 11 beta-hydroxyl group can produce the contact with the hMR-Asn770 required for the hMR activation leading to stimulated Na(+) absorption.",11b-Hydroxyprogesterone,HMDB0004031,b,b,C05498,b,FDB023284,M00285,[H]O[C@@]1([H])C([H])([H])[C@]2(C([H])([H])[H])[C@@]([H])(C(=O)C([H])([H])[H])C([H])([H])C([H])([H])C2([H])C2([H])C([H])([H])C([H])([H])C3=C([H])C(=O)C([H])([H])C([H])([H])[C@]3(C([H])([H])[H])C12[H],BFZHCUBIASXHPK-GCEOMYSDSA-N,"InChI=1S/C21H30O3/c1-12(22)16-6-7-17-15-5-4-13-10-14(23)8-9-20(13,2)19(15)18(24)11-21(16,17)3/h10,15-19,24H,4-9,11H2,1-3H3/t15?,16-,17?,18+,19?,20+,21-/m0/s1"
3390,1835,a,a,35346,KEGG COMPOUND accession,C01058,,,,,,,,,,,,,,,
3391,1838,a,a,15808,KEGG COMPOUND accession,C03206,,,,,,,,,,,,,,,
3392,1840,a,a,15626,KEGG COMPOUND accession,C05965,12HPET,71774-10-2,15626.0,"Human Metabolome Database (HMDB): 12-HPETE is one of the six monohydroperoxy fatty acids produced by the non-enzymatic oxidation of arachidonic acid (Leukotrienes). Reduction of the hydroperoxide yields the more stable hydroxyl fatty acid (+/-)12-HETE. A family of biologically active compounds derived from arachidonic acid by oxidative metabolism through the 5-lipoxygenase pathway. They participate in host defense reactions and pathophysiological conditions such as immediate hypersensitivity and inflammation. They have potent actions on many essential organs and systems, including the cardiovascular, pulmonary, and central nervous system as well as the gastrointestinal tract and the immune system.",12(S)-HPETE,HMDB0004243,b,b,C05965,b,FDB023348,12HPET,[H]OO[C@]([H])(C([H])=C([H])C([H])=C([H])C([H])([H])C([H])=C([H])C([H])([H])C([H])([H])C([H])([H])C([O-])=O)C([H])([H])C([H])=C([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H],ZIOZYRSDNLNNNJ-APFHZBIOSA-M,"InChI=1S/C20H32O4/c1-2-3-4-5-10-13-16-19(24-23)17-14-11-8-6-7-9-12-15-18-20(21)22/h7-11,13-14,17,19,23H,2-6,12,15-16,18H2,1H3,(H,21,22)/p-1/b9-7-,11-8-,13-10-,17-14?/t19-/m0/s1"
3393,1842,a,a,15716,KEGG COMPOUND accession,C05193,,,,,,,,,,,,,,,
3394,1852,a,a,37537,KEGG COMPOUND accession,C09199,,,,,,,,,,,,,,,
3395,1858,a,a,18360,KEGG COMPOUND accession,C04170,,,,,,,,,,,,,,,
3396,1860,a,a,17314,KEGG COMPOUND accession,C03049,,,,,,,,,,,,,,,
3397,1862,a,a,18328,KEGG COMPOUND accession,C02621,,,,,,,,,,,,,,,
3398,1871,a,a,18364,KEGG COMPOUND accession,C05108,44mzym,b,18364.0,"Human Metabolome Database (HMDB): 4,4-Dimethyl-5a-cholesta-8,24-dien-3-b-ol (14-demethyllanosterol) is an intermediate in sterol biosynthesis. In particular, it is an intermediate in the conversion of lanosterol to zymosterol. 4,4-Dimethyl-5a-cholesta-8,24-dien-3-b-ol is a substrate for C-4 methyl sterol oxidase, NAD(P)-dependent steroid dehydrogenase, Cytochrome P450 51A1 and Delta(14)-sterol reductase.","4,4-Dimethyl-5a-cholesta-8,24-dien-3-b-ol",HMDB0001286,b,b,C05108,44-DIMETHYL-5ALPHA-CHOLEST-7-EN-3BET,FDB022534,44mzym,[H]O[C@@]1([H])C([H])([H])C([H])([H])[C@@]2(C3=C(C([H])([H])C([H])([H])[C@@]2([H])C1(C([H])([H])[H])C([H])([H])[H])[C@]1([H])C([H])([H])C([H])([H])[C@]([H])([C@]([H])(C([H])([H])[H])C([H])([H])C([H])([H])C([H])=C(C([H])([H])[H])C([H])([H])[H])[C@@]1(C([H])([H])[H])C([H])([H])C3([H])[H])C([H])([H])[H],CHGIKSSZNBCNDW-QGBOJXOESA-N,"InChI=1S/C29H48O/c1-19(2)9-8-10-20(3)22-12-13-23-21-11-14-25-27(4,5)26(30)16-18-29(25,7)24(21)15-17-28(22,23)6/h9,20,22-23,25-26,30H,8,10-18H2,1-7H3/t20-,22-,23+,25+,26+,28-,29-/m1/s1"
3399,1877,a,a,756,KEGG COMPOUND accession,C08483,,,,,,,,,,,,,,,
3400,1886,a,a,28442,KEGG COMPOUND accession,C05960,,,,,,,,,,,,,,,
3401,1888,a,a,15559,KEGG COMPOUND accession,C04577,M00393,81416-72-0,15559.0,Human Metabolome Database (HMDB): 15-OxoETE or 15-KETE is a keto-containing leukotriene derivative produced by oxidation of the 15-hydroxyl of 15-HETE.,15-KETE,HMDB0010210,b,b,C04577,b,FDB027365,b,[H]OC(=O)C([H])([H])C([H])([H])C([H])([H])C(\[H])=C(\[H])C([H])([H])C(\[H])=C(\[H])C([H])([H])C(\[H])=C(\[H])/C(/[H])=C(\[H])C(=O)C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H],YGJTUEISKATQSM-USWFWKISSA-N,"InChI=1S/C20H30O3/c1-2-3-13-16-19(21)17-14-11-9-7-5-4-6-8-10-12-15-18-20(22)23/h4-5,8-11,14,17H,2-3,6-7,12-13,15-16,18H2,1H3,(H,22,23)/b5-4-,10-8-,11-9-,17-14+"
3402,1892,a,a,763,KEGG COMPOUND accession,C06391,,,,,,,,,,,,,,,
3403,1899,a,a,766,KEGG COMPOUND accession,C05504,estriolglc,1852-50-2,b,"Human Metabolome Database (HMDB): Estriol-16-glucuronide is a glucuronide derivative of the steroid estriol where the glucuronic acid is attached to the 16-hydroxyl group of Estriol. Glucuronidation is used to assist in the excretion of toxic substances, drugs or other substances that cannot be used as an energy source. Glucuronic acid is attached via a glycosidic bond to the substance, and the resulting glucuronide, which has a much higher water solubility than the original substance, is eventually excreted by the kidneys. Estriol (also known as oestriol) is one of the three main estrogens produced by the human body. It is only produced in significant amounts during pregnancy as it is made by the placenta.",Estriol-16-Glucuronide,HMDB0006766,b,b,C05504,Beta-D-Glucuronides,FDB024069,estriolglc,[H]OC(=O)[C@@]1([H])O[C@@]([H])(O[C@]2([H])C([H])([H])[C@@]3([H])[C@]4([H])C([H])([H])C([H])([H])C5=C(C([H])=C([H])C(O[H])=C5[H])[C@@]4([H])C([H])([H])C([H])([H])[C@]3(C([H])([H])[H])[C@@]2([H])O[H])[C@]([H])(O[H])[C@@]([H])(O[H])[C@]1([H])O[H],FQYGGFDZJFIDPU-JRSYHJKYSA-N,"InChI=1S/C24H32O9/c1-24-7-6-13-12-5-3-11(25)8-10(12)2-4-14(13)15(24)9-16(21(24)29)32-23-19(28)17(26)18(27)20(33-23)22(30)31/h3,5,8,13-21,23,25-29H,2,4,6-7,9H2,1H3,(H,30,31)/t13-,14-,15+,16-,17+,18+,19-,20+,21+,23-,24+/m1/s1"
3404,1902,a,a,17699,KEGG COMPOUND accession,C11643,,,,,,,,,,,,,,,
3405,1916,a,a,27582,KEGG COMPOUND accession,C05140,,,,,,,,,,,,,,,
3406,1924,a,a,776,KEGG COMPOUND accession,C05300,C05300,566-76-7,776.0,"Human Metabolome Database (HMDB): Estrone (also oestrone) is an estrogenic hormone secreted by the ovary. Its molecular formula is C18H22O2. estrone has a melting point of 254.5 degrees Celsius. estrone is one of the three estrogens, which also include estriol and estradiol. estrone is the least prevalent of the three hormones, estradiol being prevalent almost always in a female body, estriol being prevalent primarily during pregnancy. estrone sulfate is relevant to health and disease due to its conversion to estrone sulfate, a long-lived derivative of estrone. estrone sulfate acts as a pool of estrone which can be converted as needed to the more active estradiol.",16a-Hydroxyestrone,HMDB0000335,b,b,C05300,b,FDB021959,C05300,[H]OC1=C([H])C2=C(C([H])=C1[H])[C@@]1([H])C([H])([H])C([H])([H])[C@@]3(C(=O)[C@]([H])(O[H])C([H])([H])[C@@]3([H])[C@]1([H])C([H])([H])C2([H])[H])C([H])([H])[H],WPOCIZJTELRQMF-QFXBJFAPSA-N,"InChI=1S/C18H22O3/c1-18-7-6-13-12-5-3-11(19)8-10(12)2-4-14(13)15(18)9-16(20)17(18)21/h3,5,8,13-16,19-20H,2,4,6-7,9H2,1H3/t13-,14-,15+,16-,18+/m1/s1"
3407,1930,a,a,16799,KEGG COMPOUND accession,C01090,,,,,,,,,,,,,,,
3408,1935,a,a,17384,KEGG COMPOUND accession,C11809,,,,,,,,,,,,,,,
3409,1939,a,a,35342,KEGG COMPOUND accession,C03336,,,,,,,,,,,,,,,
3410,1947,a,a,18093,KEGG COMPOUND accession,C05469,,,,,,,,,,,,,,,
3411,1951,a,a,27832,KEGG COMPOUND accession,C05487,M00406,1167-48-2,27832.0,"Human Metabolome Database (HMDB): 17alpha,21-Dihydroxypregnenolone is an intermediate in the human fetus at midpregnancy that is converted into cortisol (PMID: 4231965). It has also been found as an intermediate in alternative pathways in human adrenal steroidogenesis that take place under in vitro conditions. In normal adrenal slices from patients with hypernephroid kidney carcinomas these pathways bypass cholesterol, pregnenolone, and progesterone, and proceed to 21-hydroxypregnenolone (PMID: 6247575). 17alpha,21-Dihydroxypregnenolone is an intermediate in C21-Steroid hormone metabolism. 17alpha,21-Dihydroxypregnenolone is the 5th to last step in the synthesis of Cortol and is converted from 17alpha-Hydroxypregnenolone via the enzyme cytochrome P450 (EC 1.14.99.10). It is then converted to 11beta,17alpha,21-Trihydroxypregnenolone via the enzyme cytochrome P450 (EC 1.14.15.4).","17alpha,21-Dihydroxypregnenolone",HMDB0006762,b,b,C05487,b,FDB024065,M00406,[H]OC([H])([H])C(=O)[C@@]1(O[H])C([H])([H])C([H])([H])C2([H])C3([H])C([H])([H])C([H])=C4C([H])([H])[C@@]([H])(O[H])C([H])([H])C([H])([H])[C@]4(C([H])([H])[H])C3([H])C([H])([H])C([H])([H])[C@]12C([H])([H])[H],JNHJGXQUDOYJAK-LQMCTMSCSA-N,"InChI=1S/C21H32O4/c1-19-8-5-14(23)11-13(19)3-4-15-16(19)6-9-20(2)17(15)7-10-21(20,25)18(24)12-22/h3,14-17,22-23,25H,4-12H2,1-2H3/t14-,15?,16?,17?,19-,20-,21-/m0/s1"
3412,1976,a,a,791,KEGG COMPOUND accession,C11237,,,,,,,,,,,,,,,
3413,1988,a,a,27576,KEGG COMPOUND accession,C05290,,,,,,,,,,,,,,,
3414,1991,a,a,798,KEGG COMPOUND accession,C05294,,,,,,,,,,,,,,,
3415,1992,a,a,799,KEGG COMPOUND accession,C05297,,,,,,,,,,,,,,,
3416,1993,a,a,75308,KEGG COMPOUND accession,C05295,M00434,4075-13-2,17347.0,"Human Metabolome Database (HMDB): 19-Oxotestosterone is catalyzed by Aromatase (EC 1.14.14.1),also called estrogen synthetase (a cytochrome P450 enzyme which catalyzes the formation of aromatic C18 estrogens from C19 androgens; it is symbolized CYP19) into oestrogens via sequential oxidations at the 19-methyl group. Biosynthesis of estrogens from C19 steroids is catalyzed by aromatase and its tissue-specific expression is determined at least in part by alternative use of tissue-specific promoters, which give rise to transcripts with unique 5-prime noncoding termini.(OMIM 107910).",19-Oxotestosterone,HMDB0003959,b,b,C05295,19-OXO-TESTOSTERONE,FDB023274,b,[H]O[C@@]1([H])C([H])([H])C([H])([H])[C@@]2([H])[C@]3([H])C([H])([H])C([H])([H])C4=C([H])C(=O)C([H])([H])C([H])([H])[C@]4(C([H])=O)[C@@]3([H])C([H])([H])C([H])([H])[C@]12C([H])([H])[H],TXNCGXATKOMEQC-KOUJMVCDSA-N,"InChI=1S/C19H26O3/c1-18-8-7-16-14(15(18)4-5-17(18)22)3-2-12-10-13(21)6-9-19(12,16)11-20/h10-11,14-17,22H,2-9H2,1H3/t14-,15-,16-,17-,18-,19+/m0/s1"
3417,1998,a,a,17845,KEGG COMPOUND accession,C04673,,,,,,,,,,,,,,,
3418,2000,a,a,17156,KEGG COMPOUND accession,C01298,,,,,,,,,,,,,,,
3419,2002,a,a,27695,KEGG COMPOUND accession,C04812,,,,,,,,,,,,,,,
3420,2004,a,a,16322,KEGG COMPOUND accession,C01284,mi13456p,20298-95-7,16322.0,"Human Metabolome Database (HMDB): myo-Inositol 1,3,4,5,6-pentakisphosphate (Ins(1,3,4,5,6)P(5)), an inositol polyphosphate of emerging significance in cellular signalling, and its C-2 epimer scyllo-inositol pentakisphosphate (scyllo-InsP(5)) were synthesised from the same myo-inositol-based precursor. (PMID: 16755629). InsP6, Ins(1,3,4,5,6)P5 and their close metabolic relatives, which are amongst the more abundant intracellular inositol polyphosphates, in chromatin organization, DNA maintenance, gene transcription, nuclear mRNA transport, membrane trafficking and control of cell proliferation. (PMID: 14992690).","Inositol 1,3,4,5,6-pentakisphosphate",HMDB0003529,b,b,C01284,b,FDB023187,b,[H]O[C@]1([H])[C@]([H])(OP([O-])([O-])=O)[C@@]([H])(OP([O-])([O-])=O)[C@]([H])(OP([O-])([O-])=O)[C@@]([H])(OP([O-])([O-])=O)[C@]1([H])OP([O-])([O-])=O,CTPQAXVNYGZUAJ-KXXVROSKSA-D,"InChI=1S/C6H17O21P5/c7-1-2(23-28(8,9)10)4(25-30(14,15)16)6(27-32(20,21)22)5(26-31(17,18)19)3(1)24-29(11,12)13/h1-7H,(H2,8,9,10)(H2,11,12,13)(H2,14,15,16)(H2,17,18,19)(H2,20,21,22)/p-10/t1-,2+,3-,4-,5+,6+"
3421,2008,a,a,16783,KEGG COMPOUND accession,C01272,mi1345p,102850-29-3,16783.0,"Human Metabolome Database (HMDB): Inositol 1,3,4,5-tetrakisphopsphate (IP4) is a second messenger responsible for mediating Ca2+ entry through plasma membrane and mobilize intracellular Ca2+ by acting synergistically with inositol 1,4,5-trisphosphate (IP3). Inositol 1,4,5-trisphosphate 3-kinase (IP3K, EC 2.7.1.127) phosphorylates IP3 to IP4. Evidence shows that IP4 can activate a protein with ras- and rap-GAP activity and finally inactivate the G protein. This indicates that IP4 regulates Ca2+ influx in a GTP-dependent way, which potentially links the IP3 signaling pathway to GTP-regulated signaling mechanisms. IP4 is demonstrated to be a common regulator in Ca2+ homeostasis. IP4 can bind with high affinity to several intracellular proteins: synaptotagmin (I and II), Gap1, Btk, and centaurin-alpha-and may interact with synaptotagmin to inhibit synaptic transmission. IP4 also acts as a mediator in neuronal death in the ischemic hippocampus. IP4 production is not always associated with modification in calcium concentration, and control of calcium mobilization is not the sole function proposed for IP4. IP4 define an essential signaling pathway for T cell precursor responsiveness and development. In the thymus, IP4 is essential during positive and negative selection of double-positive thymocytes, and in the control of thymocyte reactivity to antigens. 1D-Myo-inositol 1,3,4,5-tetrakisphosphate is also a substrate for Type I inositol-1,4,5-trisphosphate 5-phosphatase, Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A and Skeletal muscle and kidney enriched inositol phosphatase. (PMID: 15740635, 14517551).","Inositol 1,3,4,5-tetraphosphate",HMDB0001059,b,b,C01272,CPD-506,FDB022398,mi1345p,[H]O[C@@]1([H])[C@@]([H])(OP([O-])([O-])=O)[C@]([H])(O[H])[C@@]([H])(OP([O-])([O-])=O)[C@]([H])(OP([O-])([O-])=O)[C@@]1([H])OP([O-])([O-])=O,CIPFCGZLFXVXBG-CNWJWELYSA-F,"InChI=1S/C6H16O18P4/c7-1-3(21-25(9,10)11)2(8)5(23-27(15,16)17)6(24-28(18,19)20)4(1)22-26(12,13)14/h1-8H,(H2,9,10,11)(H2,12,13,14)(H2,15,16,17)(H2,18,19,20)/p-8/t1-,2-,3-,4+,5-,6-/m0/s1"
3422,2016,a,a,18228,KEGG COMPOUND accession,C01243,mi134p,98102-63-7,18228.0,"Human Metabolome Database (HMDB): Inositol 1,3,4-trisphosphate is a specific regulator of cellular signaling.","Inositol 1,3,4-trisphosphate",HMDB0001143,b,b,C01243,INOSITOL-1-3-4-TRIPHOSPHATE,FDB022450,mi134p,[H]O[C@]1([H])[C@@]([H])(O[H])[C@]([H])(OP([O-])([O-])=O)[C@@]([H])(OP([O-])([O-])=O)[C@@]([H])(O[H])[C@@]1([H])OP([O-])([O-])=O,MMWCIQZXVOZEGG-NCGNNJKGSA-H,"InChI=1S/C6H15O15P3/c7-1-2(8)5(20-23(13,14)15)6(21-24(16,17)18)3(9)4(1)19-22(10,11)12/h1-9H,(H2,10,11,12)(H2,13,14,15)(H2,16,17,18)/p-6/t1-,2-,3+,4+,5+,6+/m0/s1"
3423,2020,a,a,16067,KEGG COMPOUND accession,C11555,mi1456p,121010-58-0,16067.0,"Human Metabolome Database (HMDB): 1D-Myo-inositol 1,4,5,6-tetrakisphosphate has been shown to regulate Cl- transport, to be a phosphoinositide 3-kinase antagonist, and to bind tightly to some pleckstrin homology domains, and finally, it may contribute to transcriptional regulation. Inositol phosphates comprise a large family of intracellular signals which play many important roles in cell biology. These biological actions can be quite specific to one particular inositol phosphate. 1D-myo-Inositol 1,4,5,6-tetrakisphosphate (Ins(1,4,5,6)P4) is phosphorylated by inositolphosphate-multikinase (IPMK; this enzyme has the capacity to regulate the cellular levels of Ins(1,4,5,6)P4 in mammalian cells. (PMID: 16376887, 10720331, 8809047, 9405634).","1D-Myo-inositol 1,4,5,6-tetrakisphosphate",HMDB0004527,b,b,C11555,b,FDB023378,b,[H]O[C@@]1([H])[C@@]([H])(O[H])[C@@]([H])(OP([O-])([O-])=O)[C@]([H])(OP([O-])([O-])=O)[C@@]([H])(OP([O-])([O-])=O)[C@]1([H])OP([O-])([O-])=O,MRVYFOANPDTYBY-UZAAGFTCSA-F,"InChI=1S/C6H16O18P4/c7-1-2(8)4(22-26(12,13)14)6(24-28(18,19)20)5(23-27(15,16)17)3(1)21-25(9,10)11/h1-8H,(H2,9,10,11)(H2,12,13,14)(H2,15,16,17)(H2,18,19,20)/p-8/t1-,2+,3-,4-,5+,6+/m0/s1"
3424,2023,a,a,17816,KEGG COMPOUND accession,C01220,mi14p,47055-78-7,17816.0,"Human Metabolome Database (HMDB): 1D-Myo-inositol 1,4-bisphosphate is a substrate for Inositol polyphosphate 1-phosphatase, Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A, Skeletal muscle and kidney enriched inositol phosphatase and Type I inositol-1,4,5-trisphosphate 5-phosphatase.","1D-Myo-inositol 1,4-bisphosphate",HMDB0000968,b,b,C01220,"INOSITOL-1,4-BISPHOSPHATE",FDB022343,mi14p,[H]O[C@@]1([H])[C@@]([H])(O[H])[C@@]([H])(OP([O-])([O-])=O)[C@]([H])(O[H])[C@@]([H])(O[H])[C@]1([H])OP([O-])([O-])=O,PELZSPZCXGTUMR-ADOSBGCESA-J,"InChI=1S/C6H14O12P2/c7-1-2(8)6(18-20(14,15)16)4(10)3(9)5(1)17-19(11,12)13/h1-10H,(H2,11,12,13)(H2,14,15,16)/p-4/t1-,2-,3-,4+,5+,6+/m0/s1"
3425,2027,a,a,15844,KEGG COMPOUND accession,C04520,mi3456p,112791-61-4,15844.0,"Human Metabolome Database (HMDB): Inositol phosphates are a family of water-soluble intracellular signaling molecules derived from membrane inositol phospholipids. They undergo a variety of complex interconversion pathways, and their levels are dynamically regulated within the cytosol in response to a variety of agonists. D-Myo-inositol (3,4,5,6) tetrakisphosphate (Ins(3,4,5,6)P4) has a direct biphasic (activation/inhibition) effect on an epithelial Ca2+-activated chloride channel. The effect of Ins(3,4,5,6)P4 is not mimicked by other inositol tetrakisphosphate isomers, is dependent on the prevailing calcium concentration, and is influenced when channels are phosphorylated by calmodulin kinase II. The predominant effect of Ins(3,4,5,6)P4 on phosphorylated channels is inhibitory at levels of intracellular calcium observed in stimulated cells. Ins(3,4,5,6)P4 activity acts to inhibit calcium-dependent chloride secretion. The secretion of fluid and electrolytes across intestinal epithelial cells in response to Ca2+-dependent secretagogues is a tightly regulated process that is subject to both positive and negative influences. Agonists of Gq protein-coupled receptor (GqPCRs) appear to have the ability to evoke antisecretory mechanisms. One is mediated by the generation of Ins(3,4,5,6)P4 and serves to chronically downregulate epithelial responsiveness to subsequent challenge with Ca2+-dependent agonists. (PMID: 12388102, 11408264).","D-Myo-inositol 3,4,5,6-tetrakisphosphate",HMDB0003848,b,b,C04520,b,FDB023236,b,[H]O[C@@]1([H])[C@@]([H])(O[H])[C@]([H])(OP([O-])([O-])=O)[C@@]([H])(OP([O-])([O-])=O)[C@]([H])(OP([O-])([O-])=O)[C@@]1([H])OP([O-])([O-])=O,MRVYFOANPDTYBY-UZAAGFTCSA-F,"InChI=1S/C6H16O18P4/c7-1-2(8)4(22-26(12,13)14)6(24-28(18,19)20)5(23-27(15,16)17)3(1)21-25(9,10)11/h1-8H,(H2,9,10,11)(H2,12,13,14)(H2,15,16,17)(H2,18,19,20)/p-8/t1-,2+,3-,4-,5+,6+/m0/s1"
3426,2029,a,a,18169,KEGG COMPOUND accession,C04006,mi3p_D,573-35-3,18169.0,"Human Metabolome Database (HMDB): Myo-inositol 1-phosphate is a metabolite of the Inositol phosphate metabolism and the Phosphatidylinositol signaling system. Inositol phosphatases [EC:3.1.3.25] play a crucial role in the phosphatidylinositol signaling pathway; in brain, the expression is substantially higher in the subcortical regions, most prominently in the caudate. The phosphatidylinositol pathway is thought to be modified by lithium, a commonly prescribed medication in treating bipolar disorder. (OMIM 605922).",Myo-inositol 1-phosphate,HMDB0000213,b,b,C04006,1-L-MYO-INOSITOL-1-P,FDB021907,mi3p_D,[H]O[C@@]1([H])[C@]([H])(O[H])[C@]([H])(O[H])[C@]([H])(OP([O-])([O-])=O)[C@@]([H])(O[H])[C@]1([H])O[H],INAPMGSXUVUWAF-PTQMNWPWSA-L,"InChI=1S/C6H13O9P/c7-1-2(8)4(10)6(5(11)3(1)9)15-16(12,13)14/h1-11H,(H2,12,13,14)/p-2/t1-,2-,3+,4-,5-,6-/m0/s1"
3427,2034,a,a,16885,KEGG COMPOUND accession,C03661,,,,,,,,,,,,,,,
3428,2036,a,a,18295,KEGG COMPOUND accession,C00388,hista,51-45-6,18295.0,"Human Metabolome Database (HMDB): Histamine is an amine derived by enzymatic decarboxylation of histidine. It is a powerful stimulant of gastric secretion, a constrictor of bronchial smooth muscle, a vasodilator, and also a centrally acting neurotransmitter.",Histamine,HMDB0000870,b,b,C00388,HISTAMINE,FDB012596,hista,[H]N1C([H])=NC(=C1[H])C([H])([H])C([H])([H])[N+]([H])([H])[H],NTYJJOPFIAHURM-UHFFFAOYSA-O,"InChI=1S/C5H9N3/c6-2-1-5-3-7-4-8-5/h3-4H,1-2,6H2,(H,7,8)/p+1"
3429,2051,a,a,16528,KEGG COMPOUND accession,C03565,,,,,,,,,,,,,,,
3430,2056,a,a,27844,KEGG COMPOUND accession,C02353,,,,,,,,,,,,,,,
3431,2060,a,a,28181,KEGG COMPOUND accession,C06194,,,,,,,,,,,,,,,
3432,2062,a,a,28637,KEGG COMPOUND accession,C02355,23cump,40632-52-8,28637.0,"Human Metabolome Database (HMDB): Uridine 2',3'-cyclic phosphate is a cyclic nucleotide. A cyclic nucleotide is any nucleotide in which the phosphate group is bonded to two of the sugar's hydroxyl groups, forming a cyclical or ring structure. Cyclic phosphates are commonly found at the 3' end of mRNAs and other small RNAs. Uridine 2',3'-cyclic phosphate is a substrate for the enzyme 2',3'-cyclic nucleotide-3'-phosphodiesterase (CNPase, EC 3.1.4.37) which hydrolyses it to Uridine 2'-phosphate. CNPase is a unique RNase in that it only cleaves nucleoside 2',3'-cyclic phosphates and not the RNA internucleotide linkage, like other RNases such as RNase A and RNase T1.","Uridine 2',3'-cyclic phosphate ",HMDB0011640,b,b,C02355,b,FDB028337,23cump,[H]OC([H])([H])[C@@]1([H])O[C@@]([H])(N2C([H])=C([H])C(=O)N([H])C2=O)[C@]2([H])OP([O-])(=O)O[C@]12[H],HWDMHJDYMFRXOX-XVFCMESISA-M,"InChI=1S/C9H11N2O8P/c12-3-4-6-7(19-20(15,16)18-6)8(17-4)11-2-1-5(13)10-9(11)14/h1-2,4,6-8,12H,3H2,(H,15,16)(H,10,13,14)/p-1/t4-,6-,7-,8-/m1/s1"
3433,2064,a,a,18271,KEGG COMPOUND accession,C01240,,,,,,,,,,,,,,,
3434,2068,a,a,28150,KEGG COMPOUND accession,C09975,,,,,,,,,,,,,,,
3435,2070,a,a,18414,KEGG COMPOUND accession,C03663,,,,,,,,,,,,,,,
3436,2075,a,a,28523,KEGG COMPOUND accession,C09644,,,,,,,,,,,,,,,
3437,2077,a,a,27769,KEGG COMPOUND accession,C10684,,,,,,,,,,,,,,,
3438,2079,a,a,29010,KEGG COMPOUND accession,C08061,,,,,,,,,,,,,,,
3439,2080,a,a,835,KEGG COMPOUND accession,C11038,,,,,,,,,,,,,,,
3440,2081,a,a,836,KEGG COMPOUND accession,C11039,,,,,,,,,,,,,,,
3441,2084,a,a,17955,KEGG COMPOUND accession,C04232,,,,,,,,,,,,,,,
3442,2088,a,a,27916,KEGG COMPOUND accession,C09321,,,,,,,,,,,,,,,
3443,2094,a,a,16035,KEGG COMPOUND accession,C03567,,,,,,,,,,,,,,,
3444,2096,a,a,17678,KEGG COMPOUND accession,C02920,,,,,,,,,,,,,,,
3445,2100,a,a,28206,KEGG COMPOUND accession,C02921,,,,,,,,,,,,,,,
3446,2101,a,a,845,KEGG COMPOUND accession,C06512,,,,,,,,,,,,,,,
3447,2105,a,a,847,KEGG COMPOUND accession,C09774,,,,,,,,,,,,,,,
3448,2107,a,a,848,KEGG COMPOUND accession,C03568,,,,,,,,,,,,,,,
3449,2112,a,a,15847,KEGG COMPOUND accession,C11544,,,,,,,,,,,,,,,
3450,2114,a,a,28517,KEGG COMPOUND accession,C03569,,,,,,,,,,,,,,,
3451,2115,a,a,27381,KEGG COMPOUND accession,C07733,,,,,,,,,,,,,,,
3452,2119,a,a,28970,KEGG COMPOUND accession,C03209,,,,,,,,,,,,,,,
3453,2121,a,a,857,KEGG COMPOUND accession,C03210,,,,,,,,,,,,,,,
3454,2123,a,a,28410,KEGG COMPOUND accession,C06639,,,,,,,,,,,,,,,
3455,2143,a,a,17185,KEGG COMPOUND accession,C03338,,,,,,,,,,,,,,,
3456,2151,a,a,16942,KEGG COMPOUND accession,C04824,,,,,,,,,,,,,,,
3457,2153,a,a,16266,KEGG COMPOUND accession,C04638,,,,,,,,,,,,,,,
3458,2174,a,a,18042,KEGG COMPOUND accession,C03340,,,,,,,,,,,,,,,
3459,2180,a,a,15689,KEGG COMPOUND accession,C04039,,,,,,,,,,,,,,,
3460,2186,a,a,16725,KEGG COMPOUND accession,C06580,,,,,,,,,,,,,,,
3461,2188,a,a,18026,KEGG COMPOUND accession,C00196,,,,,,,,,,,,,,,
3462,2200,a,a,18404,KEGG COMPOUND accession,C02923,,,,,,,,,,,,,,,
3463,2207,a,a,888,KEGG COMPOUND accession,C10922,,,,,,,,,,,,,,,
3464,2230,a,a,28989,KEGG COMPOUND accession,C06598,,,,,,,,,,,,,,,
3465,2231,a,a,28520,KEGG COMPOUND accession,C07101,,,,,,,,,,,,,,,
3466,2235,a,a,28755,KEGG COMPOUND accession,C07098,,,,,,,,,,,,,,,
3467,2238,a,a,28233,KEGG COMPOUND accession,C06356,,,,,,,,,,,,,,,
3468,2240,a,a,17811,KEGG COMPOUND accession,C00691,,,,,,,,,,,,,,,
3469,2252,a,a,16106,KEGG COMPOUND accession,C04625,,,,,,,,,,,,,,,
3470,2254,a,a,17365,KEGG COMPOUND accession,C03918,,,,,,,,,,,,,,,
3471,2257,a,a,30748,KEGG COMPOUND accession,C06670,,,,,,,,,,,,,,,
3472,2272,a,a,16603,KEGG COMPOUND accession,C04831,,,,,,,,,,,,,,,
3473,2275,a,a,16489,KEGG COMPOUND accession,C03212,,,,,,,,,,,,,,,
3474,2278,a,a,27840,KEGG COMPOUND accession,C11003,,,,,,,,,,,,,,,
3475,2280,a,a,42017,KEGG COMPOUND accession,C02496,,,,,,,,,,,,,,,
3476,2282,a,a,66932,KEGG COMPOUND accession,C11283,,,,,,,,,,,,,,,
3477,2284,a,a,920,KEGG COMPOUND accession,C11006,,,,,,,,,,,,,,,
3478,2292,a,a,17244,KEGG COMPOUND accession,C06339,,,,,,,,,,,,,,,
3479,2297,a,a,29114,KEGG COMPOUND accession,C01304,,,,,,,,,,,,,,,
3480,2300,a,a,16926,KEGG COMPOUND accession,C05161,,,,,,,,,,,,,,,
3481,2308,a,a,27545,KEGG COMPOUND accession,C06600,,,,,,,,,,,,,,,
3482,2325,a,a,16364,KEGG COMPOUND accession,C01059,,,,,,,,,,,,,,,
3483,2329,a,a,17415,KEGG COMPOUND accession,C00433,,,,,,,,,,,,,,,
3484,2334,a,a,16535,KEGG COMPOUND accession,C02777,,,,,,,,,,,,,,,
3485,2337,a,a,28643,KEGG COMPOUND accession,C04744,,,,,,,,,,,,,,,
3486,2338,a,a,27864,KEGG COMPOUND accession,C11000,,,,,,,,,,,,,,,
3487,2342,a,a,943,KEGG COMPOUND accession,C11040,,,,,,,,,,,,,,,
3488,2344,a,a,27633,KEGG COMPOUND accession,C07097,,,,,,,,,,,,,,,
3489,2347,a,a,28457,KEGG COMPOUND accession,C07096,,,,,,,,,,,,,,,
3490,2356,a,a,28576,KEGG COMPOUND accession,C09824,,,,,,,,,,,,,,,
3491,2358,a,a,17681,KEGG COMPOUND accession,C03056,,,,,,,,,,,,,,,
3492,2362,a,a,955,KEGG COMPOUND accession,C10787,,,,,,,,,,,,,,,
3493,2370,a,a,525464,KEGG COMPOUND accession,C09072,,,,,,,,,,,,,,,
3494,2377,a,a,963,KEGG COMPOUND accession,C11570,,,,,,,,,,,,,,,
3495,2386,a,a,969,KEGG COMPOUND accession,C08485,,,,,,,,,,,,,,,
3496,2388,a,a,16253,KEGG COMPOUND accession,C01215,,,,,,,,,,,,,,,
3497,2391,a,a,18413,KEGG COMPOUND accession,C04640,fpram,37721-04-3,18413.0,Human Metabolome Database (HMDB): 5-Phosphoribosyl-n-formylglycineamidine is a substrate for Glucosamine-6-phosphate isomerase.,Phosphoribosylformylglycineamidine,HMDB0000999,b,b,C04640,5-PHOSPHORIBOSYL-N-FORMYLGLYCINEAMIDINE,FDB022360,fpram,[H]O[C@@]1([H])C([H])(O[C@]([H])(C([H])([H])OP([O-])([O-])=O)[C@@]1([H])O[H])N([H])C(=[N+]([H])[H])C([H])([H])N([H])C([H])=O,PMCOGCVKOAOZQM-LLRQIJQNSA-M,"InChI=1S/C8H16N3O8P/c9-5(1-10-3-12)11-8-7(14)6(13)4(19-8)2-18-20(15,16)17/h3-4,6-8,13-14H,1-2H2,(H2,9,11)(H,10,12)(H2,15,16,17)/p-1/t4-,6-,7-,8?/m0/s1"
3498,2397,a,a,17413,KEGG COMPOUND accession,C04106,,,,,,,,,,,,,,,
3499,2406,a,a,16351,KEGG COMPOUND accession,C11516,,,,,,,,,,,,,,,
3500,2409,a,a,978,KEGG COMPOUND accession,C05125,M00561,10055-47-7,978.0,"Human Metabolome Database (HMDB): 2-Hydroxyethyl-ThPP is involved in Glycolysis, Gluconeogenesis, Alanine and aspartate matabolism, Valine, Leucine and isoleucine biosynthesis, Pyruvate metabolism, and Butanoate metabolism [Kegg: c05125].",2-(a-Hydroxyethyl)thiamine diphosphate,HMDB0003904,b,b,C05125,b,FDB023246,b,[H]OC([H])(C1=[N+](C(=C(S1)C([H])([H])C([H])([H])OP(=O)(O[H])OP(=O)(O[H])O[H])C([H])([H])[H])C([H])([H])C1=C(N=C(N=C1[H])C([H])([H])[H])N([H])[H])C([H])([H])[H],RRUVJGASJONMDY-UHFFFAOYSA-O,"InChI=1S/C14H22N4O8P2S/c1-8-12(4-5-25-28(23,24)26-27(20,21)22)29-14(9(2)19)18(8)7-11-6-16-10(3)17-13(11)15/h6,9,19H,4-5,7H2,1-3H3,(H4-,15,16,17,20,21,22,23,24)/p+1"
3501,2418,a,a,17356,KEGG COMPOUND accession,C02778,,,,,,,,,,,,,,,
3502,2454,a,a,27971,KEGG COMPOUND accession,C03665,,,,,,,,,,,,,,,
3503,2458,a,a,995,KEGG COMPOUND accession,C04409,cmusa,16597-58-3,995.0,"Human Metabolome Database (HMDB): 2-amino-3-carboxymuconic acid semialdehyde is an intermediate metabolite of the tryptophan-niacin catabolic pathway. Current interest in the degradation of tryptophan is mostly due to the role of quinolinate and other metabolites in several neuropathological conditions. Quinolinate is a neurotoxin formed nonenzymatically from 2-amino-3-carboxymuconic semialdehyde in mammalian tissues. 2-Amino-3-carboxymuconic semialdehyde is enzymatically converted to 2-aminomuconate via 2-aminomuconic semialdehyde. (PMID: 10510494, 16267312, 14275129).",2-Amino-3-carboxymuconic acid semialdehyde,HMDB0001330,b,b,C04409,2-AMINO-3-CARBOXYMUCONATE_SEMIAL,FDB022559,cmusa,[H]C(=O)C(\[H])=C(\[H])/C(/C([O-])=O)=C(\C([O-])=O)[N+]([H])([H])[H],KACPVQQHDVBVFC-OIFXTYEKSA-M,"InChI=1S/C7H7NO5/c8-5(7(12)13)4(6(10)11)2-1-3-9/h1-3H,8H2,(H,10,11)(H,12,13)/p-1/b2-1-,5-4-"
3504,2463,a,a,28095,KEGG COMPOUND accession,C05520,HC01496,b,b,b,2-Amino-3-Oxoadipate,b,b,b,C05520,b,b,HC01496,[H][N+]([H])([H])C([H])(C([O-])=O)C(=O)C([H])([H])C([H])([H])C([O-])=O,HXWZRYKURKEOSO-UHFFFAOYSA-M,"InChI=1S/C6H9NO5/c7-5(6(11)12)3(8)1-2-4(9)10/h5H,1-2,7H2,(H,9,10)(H,11,12)/p-1"
3505,2465,a,a,17844,KEGG COMPOUND accession,C03214,,,,,,,,,,,,,,,
3506,2474,a,a,18372,KEGG COMPOUND accession,C04895,ahdt,20574-65-6,18372.0,"Human Metabolome Database (HMDB): The biosynthesis of tetrahydrobiopterin (BH4) from dihydroneopterin triphosphate (NH2P3) was studied in human liver extract. The phosphate-eliminating enzyme (PEE) was purified approximately 750-fold. The conversion of NH2P3 to BH4 was catalyzed by this enzyme in the presence of partially purified sepiapterin reductase, Mg2+ and NADPH. The PEE is heat stable when heated at 80 degrees C for 5 min. It has a molecular weight of 63 000 daltons. One possible intermediate 6-(1'-hydroxy-2'-oxopropyl)5,6,7,8-tetrahydropterin(2'-oxo-tetrahydropte rin) was formed upon incubation of BH4 in the presence of sepiapterin reductase and NADP+ at pH 9.0. Reduction of this compound with NaBD4 yielded monodeutero threo and erythro-BH4, the deuterium was incorporated at the 2' position. This and the UV spectra were consistent with a 2'-oxo-tetrahydropterin structure. Dihydrofolate reductase (DHFR) catalyzed the reduction of BH2 to BH4 and was found to be specific for the pro-R-NADPH side. The sepiapterin reductase catalyzed the transfer of the pro-S hydrogen of NADPH during the reduction of sepiapterin to BH2. In the presence of crude liver extracts the conversion of NH2P3 to BH4 requires NADPH. Two deuterium atoms were incorporated from (4S-2H)NADHP in the 1' and 2' position of the BH4 side chain. Incorporation of one hydrogen from the solvent was found at position C(6). These results are consistent with the occurrence of an intramolecular redox exchange between the pteridine nucleus and the side chain and formation of 6-pyruvoyl-5,6,7,8-tetrahydropterin(tetrahydro-1'-2'-dioxopterin) as intermediate. PMID: 3930838.",Dihydroneopterin triphosphate,HMDB0000980,b,b,C04895,6-1S2R-12-DIHYDROXY-3-TRIPHOSPHOOXY,FDB022349,ahdt,[H]O[C@@]([H])(C1=NC2=C(N=C(N([H])[H])N([H])C2=O)N([H])C1([H])[H])[C@]([H])(O[H])C([H])([H])OP([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O,DGGUVLXVLHAAGT-UJURSFKZSA-J,"InChI=1S/C9H16N5O13P3/c10-9-13-7-5(8(17)14-9)12-3(1-11-7)6(16)4(15)2-25-29(21,22)27-30(23,24)26-28(18,19)20/h4,6,15-16H,1-2H2,(H,21,22)(H,23,24)(H2,18,19,20)(H4,10,11,13,14,17)/p-4/t4-,6+/m0/s1"
3507,2478,a,a,17083,KEGG COMPOUND accession,C01300,2ahhmp,b,b,b,"2-Amino-4-hydroxy-6-hydroxymethyl-7,8-dihydropteridine",b,b,b,C01300,b,b,b,b,b,b
3508,2491,a,a,18206,KEGG COMPOUND accession,C05165,,,,,,,,,,,,,,,
3509,2499,a,a,17123,KEGG COMPOUND accession,C02218,2amac,28453-71-6,17123.0,Human Metabolome Database (HMDB): Dehydroalanine (or (alpha)-(beta)-di-dehydroalanine) is an uncommon amino acid found in peptides of microbial origin (an unsaturated amino acid).,2-Aminoacrylic acid,HMDB0003609,b,b,C02218,b,FDB023206,2amac,[H]C([H])=C(C([O-])=O)[N+]([H])([H])[H],UQBOJOOOTLPNST-UHFFFAOYSA-N,"InChI=1S/C3H5NO2/c1-2(4)3(5)6/h1,4H2,(H,5,6)"
3510,2526,a,a,16333,KEGG COMPOUND accession,C06389,,,,,,,,,,,,,,,
3511,2530,a,a,17217,KEGG COMPOUND accession,C01771,,,,,,,,,,,,,,,
3512,2539,a,a,17764,KEGG COMPOUND accession,C11434,,,,,,,,,,,,,,,
3513,2545,a,a,16993,KEGG COMPOUND accession,C01278,2c25dho,b,16993.0,b,"2-Carboxy-2,5-dihydro-5-oxofuran-2-acetate",b,b,b,C01278,b,b,b,b,b,"InChI=1S/C7H6O6/c8-4(9)3-7(6(11)12)2-1-5(10)13-7/h1-2H,3H2,(H,8,9)(H,11,12)/p-2"
3514,2553,a,a,17344,KEGG COMPOUND accession,C03666,,,,,,,,,,,,,,,
3515,2558,a,a,28160,KEGG COMPOUND accession,C03753,,,,,,,,,,,,,,,
3516,2585,a,a,27837,KEGG COMPOUND accession,C02221,,,,,,,,,,,,,,,
3517,2591,a,a,15925,KEGG COMPOUND accession,C04442,,,,,,,,,,,,,,,
3518,2603,a,a,18104,KEGG COMPOUND accession,C06159,,,,,,,,,,,,,,,
3519,2633,a,a,18078,KEGG COMPOUND accession,C03979,,,,,,,,,,,,,,,
3520,2642,a,a,16609,KEGG COMPOUND accession,C02779,,,,,,,,,,,,,,,
3521,2648,a,a,17094,KEGG COMPOUND accession,C00966,,,,,,,,,,,,,,,
3522,2657,a,a,27411,KEGG COMPOUND accession,C02781,,,,,,,,,,,,,,,
3523,2683,a,a,28295,KEGG COMPOUND accession,C02627,,,,,,,,,,,,,,,
3524,2694,a,a,17243,KEGG COMPOUND accession,C03343,,,,,,,,,,,,,,,
3525,2709,a,a,15474,KEGG COMPOUND accession,C00845,,,,,,,,,,,,,,,
3526,2712,a,a,28362,KEGG COMPOUND accession,C04284,,,,,,,,,,,,,,,
3527,2717,a,a,28711,KEGG COMPOUND accession,C05804,,,,,,,,,,,,,,,
3528,2797,a,a,28341,KEGG COMPOUND accession,C07189,,,,,,,,,,,,,,,
3529,2800,a,a,17023,KEGG COMPOUND accession,C02360,,,,,,,,,,,,,,,
3530,2802,a,a,17043,KEGG COMPOUND accession,C02499,,,,,,,,,,,,,,,
3531,2824,a,a,1157,KEGG COMPOUND accession,C05123,,,,,,,,,,,,,,,
3532,2834,a,a,28578,KEGG COMPOUND accession,C03058,2hydogcoa,b,28578.0,b,2-Hydroxyglutaryl-CoA,b,b,b,C03058,b,b,b,b,b,b
3533,2838,a,a,16513,KEGG COMPOUND accession,C02500,,,,,,,,,,,,,,,
3534,2844,a,a,28187,KEGG COMPOUND accession,C03059,,,,,,,,,,,,,,,
3535,2857,a,a,15475,KEGG COMPOUND accession,C07343,,,,,,,,,,,,,,,
3536,2859,a,a,1171,KEGG COMPOUND accession,C06452,,,,,,,,,,,,,,,
3537,2860,a,a,16540,KEGG COMPOUND accession,C02502,,,,,,,,,,,,,,,
3538,2863,a,a,27930,KEGG COMPOUND accession,C07727,,,,,,,,,,,,,,,
3539,2865,a,a,16706,KEGG COMPOUND accession,C01874,,,,,,,,,,,,,,,
3540,2868,a,a,16355,KEGG COMPOUND accession,C03575,,,,,,,,,,,,,,,
3541,2876,a,a,17275,KEGG COMPOUND accession,C02631,,,,,,,,,,,,,,,
3542,2891,a,a,17905,KEGG COMPOUND accession,C03576,com,3375-50-6,17905.0,"Human Metabolome Database (HMDB): Mesna is a chemoprotectant. Chemoprotectants have been developed as a means of ameliorating the toxicity associated with cytotoxic agents by providing site-specific protection for normal tissues, without compromising antitumour efficacy. Mesna eliminates the risk of therapy-limiting urotoxic side effects of oxazaphosphorines. Mesna is widely used for the prevention of cyclophosphamide-related hemorrhagic cystitis. It has been associated with hypersensitivity-like cutaneous and systemic reactions in adult patients. Mesna offers significant uroprotection in patients receiving high dose cyclophosphamide, and is widely used in paediatric oncology practice It is, therefore, important to recognize that it may be associated with a rare but significant systemic adverse reaction. A hypersensitivity-like reaction to mesna was first reported in a young adult receiving treatment for Hodgkin disease over 20 years ago. Oral administration of mesna can facilitate outpatient ifosfamide therapy. Blood and urinary mesna concentrations are more steady and prolonged after oral delivery compared with after intravenous delivery. (PMID: 16333822, 10193684, 1485175).",Mesna,HMDB0003745,b,b,C03576,CoM,FDB023220,b,b,ZNEWHQLOPFWXOF-UHFFFAOYSA-N,"InChI=1S/C2H6O3S2/c3-7(4,5)2-1-6/h6H,1-2H2,(H,3,4,5)/p-1"
3543,2935,a,a,15478,KEGG COMPOUND accession,C03345,2mb2coa,6247-62-7,15478.0,"Human Metabolome Database (HMDB): Tiglyl-CoA is a metabolite in the degradation of isoleucine to propionic acid pathway. A defect in the conversion of tiglyl-CoA to alpha-methyl-beta-hydroxybutyryl-CoA, results in episodic abdominal pain and acidosis in patients with Tiglic acidemia (OMIM 275190).",Tiglyl-CoA,HMDB0002054,b,b,C03345,TIGLYL-COA,FDB022819,2mb2coa,[H]O[C@@]([H])(C(=O)N([H])C([H])([H])C([H])([H])C(=O)N([H])C([H])([H])C([H])([H])SC(=O)C(=C(/[H])C([H])([H])[H])\C([H])([H])[H])C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])OP([O-])(=O)OP([O-])(=O)OC([H])([H])[C@@]1([H])O[C@@]([H])(N2C([H])=NC3=C(N=C([H])N=C23)N([H])[H])[C@]([H])(O[H])[C@]1([H])OP([O-])([O-])=O,PMWATMXOQQZNBX-SMRBIBNPSA-J,"InChI=1S/C26H42N7O17P3S/c1-5-14(2)25(38)54-9-8-28-16(34)6-7-29-23(37)20(36)26(3,4)11-47-53(44,45)50-52(42,43)46-10-15-19(49-51(39,40)41)18(35)24(48-15)33-13-32-17-21(27)30-12-31-22(17)33/h5,12-13,15,18-20,24,35-36H,6-11H2,1-4H3,(H,28,34)(H,29,37)(H,42,43)(H,44,45)(H2,27,30,31)(H2,39,40,41)/p-4/b14-5+/t15-,18-,19-,20+,24-/m0/s1"
3544,2960,a,a,17626,KEGG COMPOUND accession,C02226,,,,,,,,,,,,,,,
3545,2970,a,a,17502,KEGG COMPOUND accession,C03219,,,,,,,,,,,,,,,
3546,3021,a,a,1233,KEGG COMPOUND accession,C05811,,,,,,,,,,,,,,,
3547,3022,a,a,28423,KEGG COMPOUND accession,C05813,,,,,,,,,,,,,,,
3548,3025,a,a,1237,KEGG COMPOUND accession,C06695,,,,,,,,,,,,,,,
3549,3027,a,a,35910,KEGG COMPOUND accession,C00161,,,,,,,,,,,,,,,
3550,3071,a,a,28045,KEGG COMPOUND accession,C07159,,,,,,,,,,,,,,,
3551,3073,a,a,27866,KEGG COMPOUND accession,C07160,,,,,,,,,,,,,,,
3552,3075,a,a,15753,KEGG COMPOUND accession,C00322,2oxoadp,3184-35-8,15753.0,"Human Metabolome Database (HMDB): 2-Oxoadipic acid is produced from lysine in the cytosol of cells via the saccharopine and the pipecolic acid pathways. Catabolites of hydroxylysine and tryptophan enter these pathways as 2-aminoadipic- -semialdehyde and 2-oxoadipate, respectively. In the matrix of mitochondria, 2-oxoadipate is decarboxylated to glutaryl-CoA by the 2-oxoadipate dehydrogenase complex and then converted to acetyl-CoA. 2-Oxoadipic aciduria is an in-born error of metabolism of lysine, tryptophan, and hydroxylysine, in which abnormal quantities of 2-aminoadipic acid are found in body fluids along with 2-oxoadipic acid. Patients with 2-Oxoadipic acidemias are mentally retarded with hypotonia or seizures. 2-Oxoadipic aciduria can occur in patients with Kearns-Sayre Syndrome, a progressive disorder with onset prior to 20 years of age in which multiple organ systems are affected, including progressive external ophthalmoplegia, retinopathy, and the age of onset, and these are associated classically with abnormalities in cardiac conduction, cerebellar signs, and elevated cerebrospinal fluid protein (PMID: 10655159, 16183823, 11083877). Oxoadipic acid is found to be associated with alpha-aminoadipic aciduria, which is an inborn error of metabolism.",Oxoadipic acid,HMDB0000225,b,b,C00322,2K-ADIPATE,FDB003362,2oxoadp,[H]C([H])(C([O-])=O)C([H])([H])C([H])([H])C(=O)C([O-])=O,FGSBNBBHOZHUBO-UHFFFAOYSA-L,"InChI=1S/C6H8O5/c7-4(6(10)11)2-1-3-5(8)9/h1-3H2,(H,8,9)(H,10,11)/p-2"
3553,3100,a,a,30882,KEGG COMPOUND accession,C00940,HC00591,18465-19-5,30882.0,Human Metabolome Database (HMDB): deaminated metabolite of glutamine in csf of patients with hepatic coma; intermediate in the detoxification of ammonia in brain; structure.,2-Keto-glutaramic acid,HMDB0001552,b,b,C00940,2-KETO-GLUTARAMATE,FDB022686,HC00591,[H]N([H])C(=O)C([H])([H])C([H])([H])C(=O)C([O-])=O,COJBGNAUUSNXHX-UHFFFAOYSA-M,"InChI=1S/C5H7NO4/c6-4(8)2-1-3(7)5(9)10/h1-2H2,(H2,6,8)(H,9,10)/p-1"
3554,3105,a,a,30915,KEGG COMPOUND accession,C00026,akg,328-50-7,30915.0,"Human Metabolome Database (HMDB): Oxoglutaric acid, also known as alpha-ketoglutarate, alpha-ketoglutaric acid, AKG or 2-Oxoglutaric acid, is classified as a gamma-keto acid or a Gamma-keto acid derivative. Gamma-keto acids are organic compounds containing an aldehyde substituted with a keto group on the C4 carbon atom. Alpha-ketoglutarate is considered to be soluble (in water) and acidic. Alpha-ketoglutarate (AKG) is a key molecule in the Krebs, TCA or citric acid cycle, playing a fundamental role in determining the overall rate of this important metabolic process (PMID: 26759695). In the TCA cycle, AKG is decarboxylated to succinyl-CoA and carbon dioxide by AKG dehydrogenase, which functions as a key control point of the TCA cycle. Additionally, AKG can be generated from isocitrate by oxidative decarboxylation catalyzed by the enzyme known as isocitrate dehydrogenase (IDH). In addition to these routes of production, AKG can be produced from glutamate by oxidative deamination via glutamate dehydrogenase, and as a product of pyridoxal phosphate-dependent transamination reactions (mediated by branched-chain amino acid transaminases) in which glutamate is a common amino donor. AKG is a nitrogen scavenger and a source of glutamate and glutamine that stimulates protein synthesis and inhibits protein degradation in muscles. In particular, AKG can decrease protein catabolism and increase protein synthesis to enhance bone tissue formation in skeletal muscles (PMID: 26759695). Interestingly, enteric feeding of AKG supplements can significantly increase circulating plasma levels of such hormones as insulin, growth hormone and insulin like growth factor-1 (PMID: 26759695). It has recently been shown that AKG can extend the lifespan of adult C. elegans by inhibiting ATP synthase and TOR (PMID: 24828042). In combination with molecular oxygen, alpha-ketoglutarate is required for the hydroxylation of proline to hydroxyproline in the production of Type 1 collagen. A recent study has shown that -ketoglutarate promotes TH1 differentiation along with the depletion of glutamine thereby favoring Treg (regulatory T-cell) differentiation (PMID: 26420908). Alpha-ketoglutarate has been found to be associated with fumarase deficiency, 2-Ketoglutarate dehydrogenase complex deficiency and D-2-hydroxyglutaric aciduria which is an inborn error of metabolism (PMID: 8338207).",Oxoglutaric acid,HMDB0000208,b,b,C00026,2-KETOGLUTARATE,FDB003361,akg,[H]C([H])(C([O-])=O)C([H])([H])C(=O)C([O-])=O,KPGXRSRHYNQIFN-UHFFFAOYSA-L,"InChI=1S/C5H6O5/c6-3(5(9)10)1-2-4(7)8/h1-2H2,(H,7,8)(H,9,10)/p-2"
3555,3233,a,a,28652,KEGG COMPOUND accession,C05994,,,,,,,,,,,,,,,
3556,3234,a,a,27976,KEGG COMPOUND accession,C05985,,,,,,,,,,,,,,,
3557,3261,a,a,16475,KEGG COMPOUND accession,C04692,M02700,b,16475.0,"Human Metabolome Database (HMDB): 2-(3-Carboxy-3-(methylammonio)propyl)-L-histidine is an unusual amino acid that results from the post-translational modification of histidine in certain proteins. In particular, it is a post-translational derivative of histidine that exists in protein synthesis elongation factor 2 (EF2) at the site of diphtheria toxin-catalyzed ADP-ribosylation of elongation factor 2. It is a precursor for diphthamide. This compound is a substrate for the enzyme diphthine synthase (EC 2.1.1.98). This enzyme catalyzes the chemical reaction: S-adenosyl-L-methionine + 2-(3-carboxy-3-aminopropyl)-L-histidine = S-adenosyl-L-homocysteine + 2-[3-carboxy-3-(methylammonio)propyl]-L-histidine.",2-(3-Carboxy-3-(methylammonio)propyl)-L-histidine,HMDB0011654,b,b,C04692,2-3-CARBOXY-3-METHYLAMMONIOPROPYL-L-,FDB028345,b,[H]OC(=O)[C@@]([H])(N([H])C([H])([H])[H])C([H])([H])C([H])([H])C1=NC(=C([H])N1[H])C([H])([H])[C@]([H])(N([H])C([*])=O)C(=O)N([H])[*],YBMOTEQVMANKGX-JAMMHHFISA-O,b
3558,3263,a,a,16774,KEGG COMPOUND accession,C03220,,,,,,,,,,,,,,,
3559,3266,a,a,1283,KEGG COMPOUND accession,C11480,,,,,,,,,,,,,,,
3560,3269,a,a,15894,KEGG COMPOUND accession,C03461,,,,,,,,,,,,,,,
3561,3271,a,a,16619,KEGG COMPOUND accession,C01126,,,,,,,,,,,,,,,
3562,3283,a,a,27562,KEGG COMPOUND accession,C05950,leuktrB4wcooh,80434-82-8,27562.0,"Human Metabolome Database (HMDB): 20-Carboxyleukotriene B4 is an omega-oxidized metabolite of leukotriene B4 (LTB4). Neutrophil microsomes are known to oxidize 20-hydroxy-LTB4 (20-OH-LTB4) to its 20-oxo and 20-carboxy derivatives in the presence of NADPH. This activity has been ascribed to LTB4 omega-hydroxylase (cytochrome P-450LTB omega). Leukotriene B4 release from polymorphonuclear granulocytes of severely burned patients was reduced as compared to healthy donor cells. This decrease is due to an enhanced conversion of LTB4 into the 20-hydroxy- and 20-carboxy-metabolites and further to a decreased LTB4-synthesis. LTB4 is the major metabolite in neutrophil polymorphonuclear leukocytes. Leukotrienes are metabolites of arachidonic acid derived from the action of 5-LO (5-lipoxygenase). The immediate product of 5-LO is LTA4 (leukotriene A4), which is enzymatically converted into either LTB4 (leukotriene B4) by LTA4 hydrolase or LTC4 (leukotriene C4) by LTC4 synthase. The regulation of leukotriene production occurs at various levels, including expression of 5-LO, translocation of 5-LO to the perinuclear region and phosphorylation to either enhance or inhibit the activity of 5-LO. Biologically active LTB4 is metabolized by w-oxidation carried out by specific cytochrome P450s (CYP4F) followed by beta-oxidation from the w-carboxy position and after CoA ester formation. Other specific pathways of leukotriene metabolism include the 12-hydroxydehydrogenase/ 15-oxo-prostaglandin-13-reductase that form a series of conjugated diene metabolites that have been observed to be excreted into human urine. Metabolism of LTC4 occurs by sequential peptide cleavage reactions involving a gamma-glutamyl transpeptidase that forms LTD4 (leukotriene D4) and a membrane-bound dipeptidase that converts LTD4 into LTE4 (leukotriene E4) before w-oxidation. These metabolic transformations of the primary leukotrienes are critical for termination of their biological activity, and defects in expression of participating enzymes may be involved in specific genetic disease. (PMID 17623009, 7633595, 2155225, 3039534)Leukotrienes are eicosanoids. The eicosanoids consist of the prostaglandins (PGs), thromboxanes (TXs), leukotrienes (LTs) and lipoxins (LXs). The PGs and TXs are collectively identified as prostanoids. Prostaglandins were originally shown to be synthesized in the prostate gland, thromboxanes from platelets (thrombocytes) and leukotrienes from leukocytes, hence the derivation of their names. All mammalian cells except erythrocytes synthesize eicosanoids. These molecules are extremely potent, able to cause profound physiological effects at very dilute concentrations. All eicosanoids function locally at the site of synthesis, through receptor-mediated G-protein linked signaling pathways.",20-Carboxy-leukotriene B4,HMDB0006059,b,b,C05950,b,FDB023824,leuktrB4wcooh,[H]O[C@@]([H])(C(\[H])=C(/[H])C([H])=C([H])C([H])=C([H])[C@@]([H])(O[H])C([H])([H])C([H])([H])C([H])([H])C([O-])=O)C([H])([H])C([H])=C([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([O-])=O,SXWGPVJGNOLNHT-BJQSAUPESA-L,"InChI=1S/C20H30O6/c21-17(11-6-2-1-3-9-15-19(23)24)12-7-4-5-8-13-18(22)14-10-16-20(25)26/h2,4-8,12-13,17-18,21-22H,1,3,9-11,14-16H2,(H,23,24)(H,25,26)/p-2/b5-4+,6-2-,12-7?,13-8-/t17-,18-/m1/s1"
3563,3294,a,a,1294,KEGG COMPOUND accession,C05501,M00579,15234-55-6,1294.0,"Human Metabolome Database (HMDB): 20alpha,22beta-Dihydroxycholesterol is an intermediate in C21-Steroid hormone metabolism. 20alpha,22beta-Dihydroxycholesterol is the 8th to last step in the synthesis of 3alpha,11beta,21-Trihydroxy-20-oxo-5beta-pregnan-18-al and is converted from 20alpha-Hydroxycholesterol via the enzyme cytochrome P450 (EC 1.14.15.6). It is then converted to Pregnenolone via the enzyme cytochrome P450 (EC 1.14.15.6).","20a,22b-Dihydroxycholesterol",HMDB0006763,b,b,C05501,b,FDB024066,M00579,[H]O[C@]([H])(C([H])([H])C([H])([H])C([H])(C([H])([H])[H])C([H])([H])[H])[C@@](O[H])(C([H])([H])[H])C1([H])C([H])([H])C([H])([H])C2([H])C3([H])C([H])([H])C([H])=C4C([H])([H])[C@@]([H])(O[H])C([H])([H])C([H])([H])[C@]4(C([H])([H])[H])C3([H])C([H])([H])C([H])([H])[C@]12C([H])([H])[H],ISBSSBGEYIBVTO-SSFXUMSLSA-N,"InChI=1S/C27H46O3/c1-17(2)6-11-24(29)27(5,30)23-10-9-21-20-8-7-18-16-19(28)12-14-25(18,3)22(20)13-15-26(21,23)4/h7,17,19-24,28-30H,6,8-16H2,1-5H3/t19-,20?,21?,22?,23?,24+,25-,26-,27+/m0/s1"
3564,3296,a,a,28453,KEGG COMPOUND accession,C04042,aprgstrn,145-14-2,36729.0,"Human Metabolome Database (HMDB): 20a-Dihydroprogesterone is a biologically active 20-alpha-reduced metabolite of progesterone. It is converted from progesterone to 20-alpha-hydroxypregn-4-en-3-one by the 20-alpha-hydroxysteroid dehydrogenase in the corpus luteum and the placenta. -- Pubchem; Progesterone is a C-21 steroid hormone involved in the female menstrual cycle, pregnancy (supports gestation) and embryogenesis of humans and other species. Progesterone belongs to a class of hormones called progestagens, and is the major naturally occurring human progestagen. -- Wikipedia; During implantation and gestation, progesterone appears to decrease the maternal immune response to allow for the acceptance of the pregnancy. Progesterone decreases contractility of the uterine smooth muscle. The fetus metabolizes placental progesterone in the production of adrenal mineralo- and glucosteroids. A drop in progesterone levels is possibly one step that facilitates the onset of labor. In addition progesterone inhibits lactation during pregnancy. The fall in progesterone levels following delivery is one of the triggers for milk production. -- Wikipedia.",20a-Dihydroprogesterone,HMDB0003069,b,b,C04042,b,FDB023103,aprgstrn,[H]O[C@@]([H])(C([H])([H])[H])[C@@]1([H])C([H])([H])C([H])([H])[C@@]2([H])[C@]3([H])C([H])([H])C([H])([H])C4=C([H])C(=O)C([H])([H])C([H])([H])[C@]4(C([H])([H])[H])[C@@]3([H])C([H])([H])C([H])([H])[C@]12C([H])([H])[H],RWBRUCCWZPSBFC-RXRZZTMXSA-N,"InChI=1S/C21H32O2/c1-13(22)17-6-7-18-16-5-4-14-12-15(23)8-10-20(14,2)19(16)9-11-21(17,18)3/h12-13,16-19,22H,4-11H2,1-3H3/t13-,16-,17+,18-,19-,20-,21+/m0/s1"
3565,3342,a,a,29076,KEGG COMPOUND accession,C03462,,,,,,,,,,,,,,,
3566,3345,a,a,27767,KEGG COMPOUND accession,C04581,,,,,,,,,,,,,,,
3567,3373,a,a,27541,KEGG COMPOUND accession,C00943,,,,,,,,,,,,,,,
3568,3397,a,a,28590,KEGG COMPOUND accession,C01266,,,,,,,,,,,,,,,
3569,3399,a,a,17079,KEGG COMPOUND accession,C05202,,,,,,,,,,,,,,,
3570,3408,a,a,28722,KEGG COMPOUND accession,C07025,,,,,,,,,,,,,,,
3571,3409,a,a,27782,KEGG COMPOUND accession,C07024,,,,,,,,,,,,,,,
3572,3459,a,a,28895,KEGG COMPOUND accession,C01368,3ump,b,28895.0,Human Metabolome Database (HMDB): This compound belongs to the family of Pentose Phosphates. These are carbohydrate derivatives containing a pentose substituted by one or more phosphate groups.,3'-UMP,HMDB0060282,b,b,C01368,b,b,3ump,[H]OC([H])([H])[C@@]1([H])O[C@@]([H])(N2C([H])=C([H])C(=O)N([H])C2=O)[C@]([H])(O[H])[C@]1([H])OP([O-])([O-])=O,FOGRQMPFHUHIGU-PSQAKQOGSA-L,"InChI=1S/C9H13N2O9P/c12-3-4-7(20-21(16,17)18)6(14)8(19-4)11-2-1-5(13)10-9(11)15/h1-2,4,6-8,12,14H,3H2,(H,10,13,15)(H2,16,17,18)/p-2/t4-,6-,7-,8-/m0/s1"
3573,3467,a,a,28814,KEGG COMPOUND accession,C05901,,,,,,,,,,,,,,,
3574,3511,a,a,36062,KEGG COMPOUND accession,C00230,,,,,,,,,,,,,,,
3575,3554,a,a,17416,KEGG COMPOUND accession,C03223,,,,,,,,,,,,,,,
3576,3563,a,a,18184,KEGG COMPOUND accession,C03832,,,,,,,,,,,,,,,
3577,3582,a,a,1403,KEGG COMPOUND accession,C11465,,,,,,,,,,,,,,,
3578,3590,a,a,1406,KEGG COMPOUND accession,C10060,,,,,,,,,,,,,,,
3579,3593,a,a,28275,KEGG COMPOUND accession,C03225,,,,,,,,,,,,,,,
3580,3600,a,a,27550,KEGG COMPOUND accession,C06478,,,,,,,,,,,,,,,
3581,3604,a,a,28957,KEGG COMPOUND accession,C07093,,,,,,,,,,,,,,,
3582,3616,a,a,28790,KEGG COMPOUND accession,C00780,srtn,50-67-9,28790.0,"Human Metabolome Database (HMDB): Serotonin is a biochemical messenger and regulator, synthesized from the essential amino acid L-Tryptophan. Serotonin in the nervous system acts as a local transmitter at synapses, and as a paracrine or hormonal modulator of circuits upon diffusion, allowing a wide variety of ""state-dependent"" behavioral responses to different stimuli. Serotonin is widely distributed in the nervous system of vertebrates and invertebrates and some of its behavioral effects have been preserved along evolution. Such is the case of aggressive behavior and rhythmic motor patterns , including those responsible for feeding. In vertebrates, which display a wider and much more sophisticated behavioral repertoire, serotonin also modulates sleep, the arousal state , sexual behavior, and others, and deficiencies of the serotonergic system causes disorders such as depression, obsessive-compulsive disorder, phobias, posttraumatic stress disorder, epilepsy, and generalized anxiety disorder. Serotonin has three different modes of action in the nervous system: as transmitter, acting locally at synaptic boutons; upon diffusion at a distance from its release sites, producing paracrine (also called volume) effects, and by circulating in the blood stream, producing hormonal effects. The three modes can affect a single neuronal circuit. (PMID: 16047543).",Serotonin,HMDB0000259,b,b,C00780,b,FDB012158,srtn,[H]OC1=C([H])C([H])=C2N([H])C([H])=C(C2=C1[H])C([H])([H])C([H])([H])[N+]([H])([H])[H],QZAYGJVTTNCVMB-UHFFFAOYSA-O,"InChI=1S/C10H12N2O/c11-4-3-7-6-12-10-2-1-8(13)5-9(7)10/h1-2,5-6,12-13H,3-4,11H2/p+1"
3583,3623,a,a,16281,KEGG COMPOUND accession,C04366,,,,,,,,,,,,,,,
3584,3625,a,a,16104,KEGG COMPOUND accession,C01198,,,,,,,,,,,,,,,
3585,3630,a,a,17807,KEGG COMPOUND accession,C01207,,,,,,,,,,,,,,,
3586,3664,a,a,15480,KEGG COMPOUND accession,C01291,,,,,,,,,,,,,,,
3587,3667,a,a,18117,KEGG COMPOUND accession,C03673,,,,,,,,,,,,,,,
3588,3669,a,a,16515,KEGG COMPOUND accession,C02509,,,,,,,,,,,,,,,
3589,3673,a,a,18007,KEGG COMPOUND accession,C06368,,,,,,,,,,,,,,,
3590,3676,a,a,16426,KEGG COMPOUND accession,C01267,,,,,,,,,,,,,,,
3591,3722,a,a,27444,KEGG COMPOUND accession,C06146,,,,,,,,,,,,,,,
3592,3730,a,a,1463,KEGG COMPOUND accession,C05381,HC01435,b,1463.0,Human Metabolome Database (HMDB): 3-Carboxy-1-hydroxypropyl-ThPP is an intermediate in Citrate cycle (TCA cycle). 3-Carboxy-1-hydroxypropyl-ThPP is the second to last step in the synthesis of Succinyl-CoA and is converted from 2-Oxoglutarate via the enzyme 2-oxoglutarate dehydrogenase E1 component (EC.1.2.4.2). It is then converted to S-Succinyldihydrolipoamide-E via the enzyme 2-oxoglutarate dehydrogenase E1 component (EC.1.2.4.2).,3-Carboxy-1-hydroxypropylthiamine diphosphate,HMDB0006744,b,b,C05381,b,FDB024054,b,[H]OC([H])(C1=[N+](C(=C(S1)C([H])([H])C([H])([H])OP([O-])(=O)OP([O-])([O-])=O)C([H])([H])[H])C([H])([H])C1=C(N=C(N=C1[H])C([H])([H])[H])N([H])[H])C([H])([H])C([H])([H])C([O-])=O,ZWUKRGPVMMTMAF-UHFFFAOYSA-K,"InChI=1S/C16H24N4O10P2S/c1-9-13(5-6-29-32(27,28)30-31(24,25)26)33-16(12(21)3-4-14(22)23)20(9)8-11-7-18-10(2)19-15(11)17/h7,12,21H,3-6,8H2,1-2H3,(H5-,17,18,19,22,23,24,25,26,27,28)/p-3"
3593,3736,a,a,17693,KEGG COMPOUND accession,C04447,,,,,,,,,,,,,,,
3594,3771,a,a,17446,KEGG COMPOUND accession,C04674,,,,,,,,,,,,,,,
3595,3785,a,a,16758,KEGG COMPOUND accession,C02636,,,,,,,,,,,,,,,
3596,3797,a,a,30918,KEGG COMPOUND accession,C02637,,,,,,,,,,,,,,,
3597,3807,a,a,18238,KEGG COMPOUND accession,C03226,,,,,,,,,,,,,,,
3598,3810,a,a,32817,KEGG COMPOUND accession,C01187,,,,,,,,,,,,,,,
3599,3853,a,a,16569,KEGG COMPOUND accession,C11503,,,,,,,,,,,,,,,
3600,3857,a,a,18064,KEGG COMPOUND accession,C01188,,,,,,,,,,,,,,,
3601,3860,a,a,15481,KEGG COMPOUND accession,C04047,3hibutcoa,b,15481.0,b,(S)-3-Hydroxyisobutyryl Coenzyme A,b,b,b,C04047,b,b,3hibutcoa,[H]OC([H])([H])[C@@]([H])(C(=O)SC([H])([H])C([H])([H])N([H])C(=O)C([H])([H])C([H])([H])N([H])C(=O)[C@]([H])(O[H])C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])OP([O-])(=O)OP([O-])(=O)OC([H])([H])[C@@]1([H])O[C@@]([H])(N2C([H])=NC3=C(N=C([H])N=C23)N([H])[H])[C@]([H])(O[H])[C@]1([H])OP([O-])([O-])=O)C([H])([H])[H],WWEOGFZEFHPUAM-UQCJFRAESA-J,"InChI=1S/C25H42N7O18P3S/c1-13(8-33)24(38)54-7-6-27-15(34)4-5-28-22(37)19(36)25(2,3)10-47-53(44,45)50-52(42,43)46-9-14-18(49-51(39,40)41)17(35)23(48-14)32-12-31-16-20(26)29-11-30-21(16)32/h11-14,17-19,23,33,35-36H,4-10H2,1-3H3,(H,27,34)(H,28,37)(H,42,43)(H,44,45)(H2,26,29,30)(H2,39,40,41)/p-4/t13-,14+,17+,18+,19-,23+/m0/s1"
3602,3860,a,a,15481,KEGG COMPOUND accession,C04047,HC01223,b,15481.0,b,3-Hydroxyisobutyryl Coenzyme A,b,b,b,C04047,b,b,HC01223,[H]OC([H])([H])C([H])(C(=O)SC([H])([H])C([H])([H])N([H])C(=O)C([H])([H])C([H])([H])N([H])C(=O)[C@]([H])(O[H])C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])OP([O-])(=O)OP([O-])(=O)OC([H])([H])[C@@]1([H])O[C@@]([H])(N2C([H])=NC3=C(N=C([H])N=C23)N([H])[H])[C@]([H])(O[H])[C@]1([H])OP([O-])([O-])=O)C([H])([H])[H],WWEOGFZEFHPUAM-MIZDRFBCSA-J,"InChI=1S/C25H42N7O18P3S/c1-13(8-33)24(38)54-7-6-27-15(34)4-5-28-22(37)19(36)25(2,3)10-47-53(44,45)50-52(42,43)46-9-14-18(49-51(39,40)41)17(35)23(48-14)32-12-31-16-20(26)29-11-30-21(16)32/h11-14,17-19,23,33,35-36H,4-10H2,1-3H3,(H,27,34)(H,28,37)(H,42,43)(H,44,45)(H2,26,29,30)(H2,39,40,41)/p-4/t13?,14-,17-,18-,19+,23-/m1/s1"
3603,3873,a,a,28710,KEGG COMPOUND accession,C04237,,,,,,,,,,,,,,,
3604,3874,a,a,16831,KEGG COMPOUND accession,C03761,,,,,,,,,,,,,,,
3605,3877,a,a,16409,KEGG COMPOUND accession,C04773,,,,,,,,,,,,,,,
3606,3880,a,a,16116,KEGG COMPOUND accession,C03986,,,,,,,,,,,,,,,
3607,3891,a,a,15786,KEGG COMPOUND accession,C01259,3htmelys,b,15786.0,"Human Metabolome Database (HMDB): 3-Hydroxy-N6,N6,N6-trimethyl-L-lysine is found within the Lysine degration pathway; it is the byproduct of trimethyllysine dioxygenase (EC 1.14.11.8) which converts N6-Hydroxy-trimethyl-lysine to Glycine and 4-Trimethyl-ammoniobutanal. Because carnitine is the final product of the Lysine degration pathway, this compound is often associated with carnitine defiency disorders. (PMID: 16707092) The compound is also a byproduct of glycine hydroxymethyltransferase (EC 2.1.2.1) and Lyases (EC 4.1.2.-).","3-Hydroxy-N6,N6,N6-trimethyl-L-lysine",HMDB0001422,b,b,C01259,3-HYDROXY-N6N6N6-TRIMETHYL-L-LYSINE,FDB022613,3htmelys,[H]OC([H])(C([H])([H])C([H])([H])C([H])([H])[N+](C([H])([H])[H])(C([H])([H])[H])C([H])([H])[H])[C@]([H])(N([H])[H])C([O-])=O,ZRJHLGYVUCPZNH-MQWKRIRWSA-N,"InChI=1S/C9H20N2O3/c1-11(2,3)6-4-5-7(12)8(10)9(13)14/h7-8,12H,4-6,10H2,1-3H3/t7?,8-/m0/s1"
3608,3894,a,a,17419,KEGG COMPOUND accession,C03676,,,,,,,,,,,,,,,
3609,3896,a,a,18298,KEGG COMPOUND accession,C02785,,,,,,,,,,,,,,,
3610,3923,a,a,37050,KEGG COMPOUND accession,C05116,,,,,,,,,,,,,,,
3611,3928,a,a,1543,KEGG COMPOUND accession,C03068,,,,,,,,,,,,,,,
3612,3963,a,a,17566,KEGG COMPOUND accession,C02938,,,,,,,,,,,,,,,
3613,3969,a,a,15976,KEGG COMPOUND accession,C03230,,,,,,,,,,,,,,,
3614,3971,a,a,28039,KEGG COMPOUND accession,C03987,,,,,,,,,,,,,,,
3615,3972,a,a,27847,KEGG COMPOUND accession,C02515,3ityr_L,70-78-0,27847.0,"Human Metabolome Database (HMDB): Iodotyrosine is an iodated derivative of L-tyrosine. This is an early precursor to L-thyroxine, one of the primary thyroid hormones. In the thyroid gland, iodide is trapped, transported, and concentrated in the follicular lumen for thyroid hormone synthesis. Before trapped iodide can react with tyrosine residues, it must be oxidized by thyroid peroxidase. Iodotyrosine is made from tyrosine via thyroid peroxidase and then further iodinated by this enzyme to make the di-iodo and tri-iodo variants. Two molecules of di-iodotyrosine combine to form T4, and one molecule of mono-iodotyrosine combines with one molecule of di-iodotyrosine to form T3.",Iodotyrosine,HMDB0000021,b,b,C02515,IODO-L-TYROSINE,FDB021875,3ityr_L,[H]OC1=C([H])C([H])=C(C([H])=C1I)C([H])([H])[C@@]([H])(C([O-])=O)[N+]([H])([H])[H],UQTZMGFTRHFAAM-ZETCQYMHSA-N,"InChI=1S/C9H10INO3/c10-6-3-5(1-2-8(6)12)4-7(11)9(13)14/h1-3,7,12H,4,11H2,(H,13,14)/t7-/m0/s1"
3616,3977,a,a,28708,KEGG COMPOUND accession,C01014,,,,,,,,,,,,,,,
3617,3981,a,a,27453,KEGG COMPOUND accession,C05394,HC01440,b,27453.0,"Human Metabolome Database (HMDB): 3-Keto-b-D-galactose is an intermediate in Galactose metabolism, N-Glycan degradation, Glycosaminoglycan degradation, glycerolipid metabolism, Sphingolipid metabolism, Glycosphingolipid biosynthesis - ganglioseries and Glycan structures - degradation through the enzyme galactosidase, beta 1 [EC:3.2.1.23], and an intermediate of Fructose and mannose metabolism, Galactose metabolism, Ascorbate and aldarate metabolism, Bile acid biosynthesis, Glycine, serine and threonine metabolism, Lysine degradation, Bisphenol A degradation, Nucleotide sugars metabolism, Linoleic acid metabolism, Tetrachloroethene degradation, and Butanoate metabolism through th enzyme retinol dehydrogenase 13 (all-trans/9-cis) [EC:1.1.1.-] (KEGG).",3-Keto-b-D-galactose,HMDB0001385,b,b,C05394,CPD-1242,FDB022595,HC01440,[H]OC([H])([H])[C@@]1([H])O[C@@]([H])(O[H])[C@]([H])(O[H])C(=O)[C@@]1([H])O[H],APIQNBNBIICCON-VPXOEYFHSA-N,"InChI=1S/C6H10O6/c7-1-2-3(8)4(9)5(10)6(11)12-2/h2-3,5-8,10-11H,1H2/t2-,3+,5-,6-/m0/s1"
3618,3983,a,a,27571,KEGG COMPOUND accession,C05403,HC01446,15990-62-2,b,Human Metabolome Database (HMDB): 3-Ketolactose is a metabolite in galactose metabolism (KEGG).,3'-Ketolactose,HMDB0001030,b,b,C05403,3-KETOLACTOSE,FDB022379,HC01446,[H]OC([H])([H])[C@@]1([H])O[C@@]([H])(O[C@@]2([H])[C@]([H])(O[H])[C@@]([H])(O[H])C([H])(O[H])O[C@]2([H])C([H])([H])O[H])[C@]([H])(O[H])C(=O)[C@@]1([H])O[H],HKKHTABTHSUDBP-ILXILVFVSA-N,"InChI=1S/C12H20O11/c13-1-3-5(15)6(16)9(19)12(22-3)23-10-4(2-14)21-11(20)8(18)7(10)17/h3-5,7-15,17-20H,1-2H2/t3-,4-,5+,7-,8-,9-,10-,11?,12+/m1/s1"
3619,3995,a,a,27622,KEGG COMPOUND accession,C05584,3mox4hoxm,55-10-7,1127735.0,"Human Metabolome Database (HMDB): Vanillylmandelic acid is one of the products of the catabolism of catecholamines (epinephrine, norepinephrine and dopamine). High levels of vanillylmandelic acid can indicate an adrenal gland tumor (pheochromocytoma) or another type of tumor that produces catecholamines (WebMD). Vanillylmandelic acid is found to be associated with aromatic L-amino acid decarboxylase deficiency, which is an inborn error of metabolism.",Vanillylmandelic acid,HMDB0000291,b,b,C05584,b,FDB021931,3mox4hoxm,[H]OC1=C(OC([H])([H])[H])C([H])=C(C([H])=C1[H])C([H])(O[H])C([O-])=O,CGQCWMIAEPEHNQ-UHFFFAOYSA-M,"InChI=1S/C9H10O5/c1-14-7-4-5(2-3-6(7)10)8(11)9(12)13/h2-4,8,10-11H,1H3,(H,12,13)/p-1"
3620,4007,a,a,27440,KEGG COMPOUND accession,C05831,,,,,,,,,,,,,,,
3621,4008,a,a,1579,KEGG COMPOUND accession,C05902,,,,,,,,,,,,,,,
3622,4013,a,a,1582,KEGG COMPOUND accession,C05587,3moxtyr,554-52-9,742324.0,"Human Metabolome Database (HMDB): 3-methoxytyramine, also known as 4-(2-amino-Ethyl)-2-methoxy-phenol or 3-O-Methyldopamine, is classified as a member of the Methoxyphenols. Methoxyphenols are compounds containing a methoxy group attached to the benzene ring of a phenol moiety. 3-methoxytyramine is considered to be slightly soluble (in water) and acidic.  3-methoxytyramine can be found primarily in human brain and most tissues tissues; and in blood, cerebrospinal fluid (csf) or urine. Within a cell, 3-methoxytyramine is primarily located in the cytoplasm",3-Methoxytyramine,HMDB0000022,b,b,C05587,b,FDB021876,3moxtyr,[H]OC1=C([H])C([H])=C(C([H])=C1OC([H])([H])[H])C([H])([H])C([H])([H])N([H])[H],DIVQKHQLANKJQO-UHFFFAOYSA-N,"InChI=1S/C9H13NO2/c1-12-9-6-7(4-5-10)2-3-8(9)11/h2-3,6,11H,4-5,10H2,1H3"
3623,4016,a,a,15951,KEGG COMPOUND accession,C07350,,,,,,,,,,,,,,,
3624,4018,a,a,16530,KEGG COMPOUND accession,C00141,3mob,759-05-7,16530.0,"Human Metabolome Database (HMDB): alpha-Ketoisovaleric acid is an abnormal metabolite that arises from the incomplete breakdown of branched-chain amino acids. alpha-Ketoisovaleric acid is a neurotoxin, an acidogen, and a metabotoxin. A neurotoxin causes damage to nerve cells and nerve tissues. An acidogen is an acidic compound that induces acidosis, which has multiple adverse effects on many organ systems. A metabotoxin is an endogenously produced metabolite that causes adverse health effects at chronically high levels. Chronically high levels of alpha-ketoisovaleric acid are associated with maple syrup urine disease. MSUD is a metabolic disorder caused by a deficiency of the branched-chain alpha-keto acid dehydrogenase complex (BCKDC), leading to a buildup of the branched-chain amino acids (leucine, isoleucine, and valine) and their toxic by-products (ketoacids) in the blood and urine. The symptoms of MSUD often show in infancy and lead to severe brain damage if untreated. MSUD may also present later depending on the severity of the disease. If left untreated in older individuals, during times of metabolic crisis, symptoms of the condition include uncharacteristically inappropriate, extreme, or erratic behaviour and moods, hallucinations, anorexia, weight loss, anemia, diarrhea, vomiting, dehydration, lethargy, oscillating hypertonia and hypotonia, ataxia, seizures, hypoglycemia, ketoacidosis, opisthotonus, pancreatitis, rapid neurological decline, and coma.  In maple syrup urine disease, the brain concentration of branched-chain ketoacids can increase 10- to 20-fold. This leads to a depletion of glutamate and a consequent reduction in the concentration of brain glutamine, aspartate, alanine, and other amino acids. The result is a compromise of energy metabolism because of a failure of the malate-aspartate shuttle and a diminished rate of protein synthesis (PMID: 15930465). alpha-Ketoisovaleric acid is a keto-acid, which is a subclass of organic acids. Abnormally high levels of organic acids in the blood (organic acidemia), urine (organic aciduria), the brain, and other tissues lead to general metabolic acidosis. Acidosis typically occurs when arterial pH falls below 7.35. In infants with acidosis, the initial symptoms include poor feeding, vomiting, loss of appetite, weak muscle tone (hypotonia), and lack of energy (lethargy). These can progress to heart, liver, and kidney abnormalities, seizures, coma, and possibly death. These are also the characteristic symptoms of untreated MSUD. Many affected children with organic acidemias experience intellectual disability or delayed development.",alpha-Ketoisovaleric acid,HMDB0000019,b,b,C00141,2-KETO-ISOVALERATE,FDB012250,3mob,[H]C([H])([H])C([H])(C(=O)C([O-])=O)C([H])([H])[H],QHKABHOOEWYVLI-UHFFFAOYSA-M,"InChI=1S/C5H8O3/c1-3(2)4(6)5(7)8/h3H,1-2H3,(H,7,8)/p-1"
3625,4049,a,a,28476,KEGG COMPOUND accession,C07209,,,,,,,,,,,,,,,
3626,4053,a,a,27995,KEGG COMPOUND accession,C07216,,,,,,,,,,,,,,,
3627,4072,a,a,15486,KEGG COMPOUND accession,C03069,3mb2coa,793193-48-3,15486.0,"Human Metabolome Database (HMDB): 3-Methylcrotonyl-CoA is an essential metabolite for leucine metabolism, a substrate of 3-methylcrotonyl-CoA carboxylase (EC 6.4.1.4), a biotin-dependent mitochondrial enzyme in the catabolism of leucine. (OMIM 609010).",3-Methylcrotonyl-CoA,HMDB0001493,b,b,C03069,3-METHYL-CROTONYL-COA,FDB022652,3mb2coa,[H]O[C@@]([H])(C(=O)N([H])C([H])([H])C([H])([H])C(=O)N([H])C([H])([H])C([H])([H])SC(=O)C([H])=C(C([H])([H])[H])C([H])([H])[H])C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])OP([O-])(=O)OP([O-])(=O)OC([H])([H])[C@@]1([H])O[C@@]([H])(N2C([H])=NC3=C(N=C([H])N=C23)N([H])[H])[C@]([H])(O[H])[C@]1([H])OP([O-])([O-])=O,BXIPALATIYNHJN-ZMHDXICWSA-J,"InChI=1S/C26H42N7O17P3S/c1-14(2)9-17(35)54-8-7-28-16(34)5-6-29-24(38)21(37)26(3,4)11-47-53(44,45)50-52(42,43)46-10-15-20(49-51(39,40)41)19(36)25(48-15)33-13-32-18-22(27)30-12-31-23(18)33/h9,12-13,15,19-21,25,36-37H,5-8,10-11H2,1-4H3,(H,28,34)(H,29,38)(H,42,43)(H,44,45)(H2,27,30,31)(H2,39,40,41)/p-4/t15-,19-,20-,21+,25-/m1/s1"
3628,4078,a,a,17920,KEGG COMPOUND accession,C02796,,,,,,,,,,,,,,,
3629,4084,a,a,1604,KEGG COMPOUND accession,C02230,,,,,,,,,,,,,,,
3630,4089,a,a,1606,KEGG COMPOUND accession,C05828,3mlda,2625-49-2,b,"Human Metabolome Database (HMDB): Methylimidazoleacetic acid is the main metabolite of histamine. This end product of histamine catabolism is formed by N-methylation in the imidazole ring to methylhistamine by histamine methyltransferase (EC 2.1.1.8) and a subsequent oxidative deamination in the side chain by type B monoamine oxidase (EC 1.4.3.4). From studies is known that as much as 70 to 80 percent of the histamine metabolized in the body is excreted in the urine as Methylimidazoleacetic acid. Thus, urinary Methylimidazoleacetic acid being the major and specific histamine metabolite is a clear marker of any changes in histamine metabolism in the body. The urinary excretion of methylimidazoleacetic acid is considered a reliable indicator of histamine turnover rate in the body. The excretion of Methylimidazoleacetic acid is higher in men than women however; this gender difference is abolished when corrected for creatinine excretion. A possible explanation is that basal histamine turnover is related to body size. There is no significant difference in Methylimidazoleacetic acid excretion between smokers and non-smokers when analysing absolute values (mg/24 h). When using Methylimidazoleacetic acid values corrected for creatinine excretion female smokers have significantly higher Methylimidazoleacetic acid excretion compared to nonsmokers. (PMID: 11411609, 7130180, 10350179, 10202992).",Methylimidazoleacetic acid,HMDB0002820,b,b,C05828,b,FDB023069,3mlda,[H]C1=NC(=C([H])N1C([H])([H])[H])C([H])([H])C([O-])=O,ZHCKPJGJQOPTLB-UHFFFAOYSA-M,"InChI=1S/C6H8N2O2/c1-8-3-5(7-4-8)2-6(9)10/h3-4H,2H2,1H3,(H,9,10)/p-1"
3631,4095,a,a,16696,KEGG COMPOUND accession,C03354,,,,,,,,,,,,,,,
3632,4097,a,a,17610,KEGG COMPOUND accession,C02231,,,,,,,,,,,,,,,
3633,4105,a,a,28310,KEGG COMPOUND accession,C03660,,,,,,,,,,,,,,,
3634,4107,a,a,28647,KEGG COMPOUND accession,C05616,,,,,,,,,,,,,,,
3635,4111,a,a,30926,KEGG COMPOUND accession,C01990,,,,,,,,,,,,,,,
3636,4114,a,a,47881,KEGG COMPOUND accession,C01656,,,,,,,,,,,,,,,
3637,4118,a,a,29024,KEGG COMPOUND accession,C03467,,,,,,,,,,,,,,,
3638,4120,a,a,13601,KEGG COMPOUND accession,C02940,,,,,,,,,,,,,,,
3639,4122,a,a,17639,KEGG COMPOUND accession,C03070,,,,,,,,,,,,,,,
3640,4124,a,a,1624,KEGG COMPOUND accession,C02797,,,,,,,,,,,,,,,
3641,4132,a,a,47907,KEGG COMPOUND accession,C01034,,,,,,,,,,,,,,,
3642,4136,a,a,15489,KEGG COMPOUND accession,C00264,,,,,,,,,,,,,,,
3643,4146,a,a,15775,KEGG COMPOUND accession,C00846,3oxoadp,689-31-6,37440.0,"Human Metabolome Database (HMDB): 3-Oxoadipic acid is a regularly occurring Adipic dicarboxylic acid human metabolite found occasionally in biofluids of healthy individuals. (PMIDs 8340451, 1769109, 2338430) Increased amounts of 3-Oxoadipic acid are excreted after ingestion of Sebacic acid, supporting the hypothesis that dicarboxylic acids are degraded by ordinary beta-oxidation. (PMID 3220884).",3-Oxoadipic acid,HMDB0000398,b,b,C00846,b,FDB022015,b,b,RTGHRDFWYQHVFW-UHFFFAOYSA-N,"InChI=1S/C6H8O5/c7-4(3-6(10)11)1-2-5(8)9/h1-3H2,(H,8,9)(H,10,11)"
3644,4151,a,a,15490,KEGG COMPOUND accession,C02232,oxadpcoa,b,15490.0,Human Metabolome Database (HMDB): This compound belongs to the family of 3-Oxo-acyl CoAs. These are organic compounds containing a 3-oxo acylated coenzyme A derivative.,3-Oxoadipyl-CoA,HMDB0060378,b,b,C02232,b,b,b,b,VKKKAAPGXHWXOO-BIEWRJSYSA-N,b
3645,4163,a,a,18037,KEGG COMPOUND accession,C02367,,,,,,,,,,,,,,,
3646,4165,a,a,27868,KEGG COMPOUND accession,C05263,3oddcoa,78303-19-2,27868.0,Human Metabolome Database (HMDB): 3-Oxododecanoyl-CoA is a human metabolite involved in the fatty acid elongation in mitochondria pathway. The enzyme acetyl-CoA C-acyltransferase catalyzes the formation of this metabolite from Acetyl-CoA.,3-Oxododecanoyl-CoA,HMDB0003937,b,b,C05263,b,FDB023256,3oddcoa,[H]O[C@@]([H])(C(=O)N([H])C([H])([H])C([H])([H])C(=O)N([H])C([H])([H])C([H])([H])SC(=O)C([H])([H])C(=O)C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H])C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])OP([O-])(=O)OP([O-])(=O)OC([H])([H])[C@@]1([H])O[C@@]([H])(N2C([H])=NC3=C(N=C([H])N=C23)N([H])[H])[C@]([H])(O[H])[C@]1([H])OP([O-])([O-])=O,HQANBZHVWIDNQZ-GMHMEAMDSA-J,"InChI=1S/C33H56N7O18P3S/c1-4-5-6-7-8-9-10-11-21(41)16-24(43)62-15-14-35-23(42)12-13-36-31(46)28(45)33(2,3)18-55-61(52,53)58-60(50,51)54-17-22-27(57-59(47,48)49)26(44)32(56-22)40-20-39-25-29(34)37-19-38-30(25)40/h19-20,22,26-28,32,44-45H,4-18H2,1-3H3,(H,35,42)(H,36,46)(H,50,51)(H,52,53)(H2,34,37,38)(H2,47,48,49)/p-4/t22-,26-,27-,28+,32-/m1/s1"
3647,4181,a,a,28422,KEGG COMPOUND accession,C02122,,,,,,,,,,,,,,,
3648,4193,a,a,1643,KEGG COMPOUND accession,C02517,,,,,,,,,,,,,,,
3649,4204,a,a,15491,KEGG COMPOUND accession,C05259,3ohdcoa,34619-89-1,15491.0,"Human Metabolome Database (HMDB): 3-Oxohexadecanoyl-CoA has a role in the synthesis and oxidation of fatty acid. It is involved in the pathway, fatty acid elongation in mitochondria. In this pathway Acetyl-CoA is acted upon by the enzyme, acetyl-CoA C-acyltransferase to produce 3-Oxohexadecanoyl-CoA. Since coenzyme A is chemically a thiol, it can react with carboxylic acids to form thioesters, thus functioning as an acyl group carrier. It assists in transferring fatty acids from the cytoplasm to the mitochondria. A molecule of coenzyme A carrying an acetyl group is also referred to as acetyl-CoA. When it is not attached to an acyl group it is usually referred to as 'CoASH' or 'HSCoA'.",3-Oxohexadecanoyl-CoA,HMDB0006402,b,b,C05259,3-OXOPALMITOYL-COA,FDB023908,3ohdcoa,[H]O[C@@]([H])(C(=O)N([H])C([H])([H])C([H])([H])C(=O)N([H])C([H])([H])C([H])([H])SC(=O)C([H])([H])C(=O)C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H])C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])OP([O-])(=O)OP([O-])(=O)OC([H])([H])[C@@]1([H])O[C@@]([H])(N2C([H])=NC3=C(N=C([H])N=C23)N([H])[H])[C@]([H])(O[H])[C@]1([H])OP([O-])([O-])=O,NQMPLXPCRJOSHL-BBECNAHFSA-J,"InChI=1S/C37H64N7O18P3S/c1-4-5-6-7-8-9-10-11-12-13-14-15-25(45)20-28(47)66-19-18-39-27(46)16-17-40-35(50)32(49)37(2,3)22-59-65(56,57)62-64(54,55)58-21-26-31(61-63(51,52)53)30(48)36(60-26)44-24-43-29-33(38)41-23-42-34(29)44/h23-24,26,30-32,36,48-49H,4-22H2,1-3H3,(H,39,46)(H,40,50)(H,54,55)(H,56,57)(H2,38,41,42)(H2,51,52,53)/p-4/t26-,30-,31-,32+,36-/m1/s1"
3650,4210,a,a,15492,KEGG COMPOUND accession,C06715,,,,,,,,,,,,,,,
3651,4214,a,a,17960,KEGG COMPOUND accession,C00222,msa,926-61-4,17960.0,Human Metabolome Database (HMDB): Malonic semialdehyde is formed in the alternative pathway of propionate metabolism and in the catabolism of beta-alanine. Studies done on these pathways in cultured cells from a patient with mitochondrial malonyl-CoA decarboxylase deficiency show that malonic semialdehyde is directly converted into acetyl-CoA in man. (PMID: 6418146).,Malonic semialdehyde,HMDB0011111,b,b,C00222,b,FDB027893,msa,[H]C(=O)C([H])([H])C([O-])=O,OAKURXIZZOAYBC-UHFFFAOYSA-M,"InChI=1S/C3H4O3/c4-2-1-3(5)6/h2H,1H2,(H,5,6)/p-1"
3652,4227,a,a,28673,KEGG COMPOUND accession,C05989,M03168,6244-93-5,b,Human Metabolome Database (HMDB): Malonyl-CoA semialdehyde is involved in the propanoate metabolism pathway. Malonyl-CoA semialdehyde can be reversibly produced from malonyl-CoA and 3-hydroxy-propionyl-CoA. Malonic semialdehyde is formed in the alternative pathway of propionate metabolism and in the catabolism of beta-alanine. Studies of these pathways in cultured cells from a patient with mitochondrial malonyl-CoA decarboxylase deficiency indicate that malonic semialdehyde is directly converted into acetyl-CoA in man. (PMID: 6418146).,Malonyl-CoA semialdehyde,HMDB0002170,b,b,C05989,b,FDB022882,M03168,[H]O[C@@]([H])(C(=O)N([H])C([H])([H])C([H])([H])C(=O)N([H])C([H])([H])C([H])([H])SC(=O)C([H])([H])C([H])=O)C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])OP([O-])(=O)OP([O-])(=O)OC([H])([H])[C@@]1([H])O[C@@]([H])(N2C([H])=NC3=C2N=C([H])N=C3N([H])[H])[C@]([H])(O[H])[C@]1([H])OP([O-])([O-])=O,NMEYBPUHJHMRHU-IEXPHMLFSA-J,"InChI=1S/C24H38N7O18P3S/c1-24(2,19(36)22(37)27-5-3-14(33)26-6-8-53-15(34)4-7-32)10-46-52(43,44)49-51(41,42)45-9-13-18(48-50(38,39)40)17(35)23(47-13)31-12-30-16-20(25)28-11-29-21(16)31/h7,11-13,17-19,23,35-36H,3-6,8-10H2,1-2H3,(H,26,33)(H,27,37)(H,41,42)(H,43,44)(H2,25,28,29)(H2,38,39,40)/p-4/t13-,17-,18-,19+,23-/m1/s1"
3653,4230,a,a,28726,KEGG COMPOUND accession,C05261,3otdcoa,122364-86-7,28726.0,"Human Metabolome Database (HMDB): 3-Oxotetradecanoyl-CoA is a product of the peroxisomal beta oxidation of hexadenoic acid by the enzyme acyl-CoA oxidase which results in long-chain 3-oxoacyl-CoA-esters. (PMID: 7548202). Myristoyl-CoA:protein N-myristoyltransferase (E.C. 2.3.1.97) is a eukaryotic enzyme that catalyzes the transfer of myristate (C14:O) from myristoyl-CoA to the amino nitrogen of glycine. This covalent protein modification occurs cotranslationally, is apparently irreversible, and affects proteins with diverse functions. (PMID: 2818568).",3-Oxotetradecanoyl-CoA,HMDB0003935,b,b,C05261,b,FDB023254,3otdcoa,[H]O[C@@]([H])(C(=O)N([H])C([H])([H])C([H])([H])C(=O)N([H])C([H])([H])C([H])([H])SC(=O)C([H])([H])C(=O)C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H])C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])OP([O-])(=O)OP([O-])(=O)OC([H])([H])[C@@]1([H])O[C@@]([H])(N2C([H])=NC3=C(N=C([H])N=C23)N([H])[H])[C@]([H])(O[H])[C@]1([H])OP([O-])([O-])=O,IQNFBGHLIVBNOU-QSGBVPJFSA-J,"InChI=1S/C35H60N7O18P3S/c1-4-5-6-7-8-9-10-11-12-13-23(43)18-26(45)64-17-16-37-25(44)14-15-38-33(48)30(47)35(2,3)20-57-63(54,55)60-62(52,53)56-19-24-29(59-61(49,50)51)28(46)34(58-24)42-22-41-27-31(36)39-21-40-32(27)42/h21-22,24,28-30,34,46-47H,4-20H2,1-3H3,(H,37,44)(H,38,48)(H,52,53)(H,54,55)(H2,36,39,40)(H2,49,50,51)/p-4/t24-,28-,29-,30+,34-/m1/s1"
3654,4239,a,a,1656,KEGG COMPOUND accession,C03356,,,,,,,,,,,,,,,
3655,4241,a,a,17794,KEGG COMPOUND accession,C00197,3pg,820-11-1,17794.0,Human Metabolome Database (HMDB): This compound belongs to the family of Sugar Acids and Derivatives. These are compounds containing a saccharide unit which bears a carboxylic acid group.,(2R)-2-Hydroxy-3-(phosphonatooxy)propanoate,HMDB0060180,b,b,C00197,G3P,b,3pg,[H]O[C@@]([H])(C([O-])=O)C([H])([H])OP([O-])([O-])=O,OSJPPGNTCRNQQC-UWTATZPHSA-K,"InChI=1S/C3H7O7P/c4-2(3(5)6)1-10-11(7,8)9/h2,4H,1H2,(H,5,6)(H2,7,8,9)/p-3/t2-/m1/s1"
3656,4255,a,a,16001,KEGG COMPOUND accession,C00236,13dpg,1981-49-3,b,"Human Metabolome Database (HMDB): 1,3-Bisphosphogylcerate (1,3BPG), also known as PGAP, is a 3-carbon organic molecule present in most, if not all living creatures. It primarily exists as a metabolic intermediate in glycolysis during respiration. 1,3BPG have been recognized as regulatory signal implicated in the control of metabolism, oxygen affinity of red cells and other cellular functions. 1,3BPG concentration in erythrocytes changes in a number of pathological conditions, such as Inherited Phosphoglycerate kinase deficiency in erythrocytes (involved in the synthesis and breakdown of 1,3 BPG). (PMID 3555887). 1,3-bisphosphoglycerate is the anion form of bisphosphoglyceric acid. It is phosphorylated at the number 1 and 3 carbons. The result of this phosphorylation gives 1,3BPG important biological properties such as the ability to phosphorylate ADP to form the energy storage molecule ATP.(wikipedia).","Glyceric acid 1,3-biphosphate",HMDB0001270,b,b,C00236,DPG,FDB022524,13dpg,[H]O[C@@]([H])(C(=O)OP([O-])([O-])=O)C([H])([H])OP([O-])([O-])=O,LJQLQCAXBUHEAZ-UWTATZPHSA-J,"InChI=1S/C3H8O10P2/c4-2(1-12-14(6,7)8)3(5)13-15(9,10)11/h2,4H,1H2,(H2,6,7,8)(H2,9,10,11)/p-4/t2-/m1/s1"
3657,4271,a,a,30933,KEGG COMPOUND accession,C03232,3php,3913-50-6,30933.0,"Human Metabolome Database (HMDB): Phosphohydroxypyruvic acid is a prduct of both enzyme phosphoglycerate dehydrogenase [EC 1.1.1.95] and phosphoserine transaminase [EC 2.6.1.52] in glycine, serine and threonine metabolism pathway (KEGG). This compound belongs to the family of Organophosphate Esters. These are organic compounds containing phosphoric acid ester functional group.",Phosphohydroxypyruvic acid,HMDB0001024,b,b,C03232,3-P-HYDROXYPYRUVATE,FDB022377,3php,[H]C([H])(OP([O-])([O-])=O)C(=O)C([O-])=O,LFLUCDOSQPJJBE-UHFFFAOYSA-K,"InChI=1S/C3H5O7P/c4-2(3(5)6)1-10-11(7,8)9/h1H2,(H,5,6)(H2,7,8,9)/p-3"
3658,4274,a,a,30935,KEGG COMPOUND accession,C02798,,,,,,,,,,,,,,,
3659,4276,a,a,30850,KEGG COMPOUND accession,C02123,,,,,,,,,,,,,,,
3660,4278,a,a,16345,KEGG COMPOUND accession,C00606,3sala,1115-65-7,41721.0,"Human Metabolome Database (HMDB): 3-Sulfinoalanine or cysteinesulfinic acid is a N-methyl-D-aspartate agonist. It is a product of cysteine dioxygenase or CDO [EC 1.13.11.20]. In humans cysteine catabolism is tightly regulated via regulation of cysteine dioxygenase (CDO) levels in the liver, with the turnover of CDO protein being dramatically decreased when intracellular cysteine levels increase. This occurs in response to changes in the intracellular cysteine concentration via changes in the rate of CDO ubiquitination and degradation. Expressed at high levels in the liver with lower levels in the kidney, brain, and lung, cysteine dioxygenase catalyzes the addition of molecular oxygen to the sulfhydryl group of cysteine, yielding cysteinesulfinic acid. The oxidative catabolism of cysteine to cysteinesulfinate by CDO represents an irreversible loss of cysteine from the free amino acid pool. Once generated, cysteinesulfinate is shuttled into several pathways including hypotaurine/taurine synthesis, sulfite/sulfate production, and the generation of pyruvate.",3-Sulfinoalanine,HMDB0000996,b,b,C00606,3-SULFINOALANINE,FDB022358,3sala,[H]N([H])[C@]([H])(C([O-])=O)C([H])([H])S([O-])=O,ADVPTQAUNPRNPO-REOHCLBHSA-L,"InChI=1S/C3H7NO4S/c4-2(3(5)6)1-9(7)8/h2H,1,4H2,(H,5,6)(H,7,8)/p-2/t2-/m0/s1"
3661,4287,a,a,27802,KEGG COMPOUND accession,C06336,,,,,,,,,,,,,,,
3662,4307,a,a,17559,KEGG COMPOUND accession,C03470,,,,,,,,,,,,,,,
3663,4334,a,a,16390,KEGG COMPOUND accession,C04643,,,,,,,,,,,,,,,
3664,4347,a,a,27379,KEGG COMPOUND accession,C05467,CE5169,b,27379.0,"Human Metabolome Database (HMDB): 3alpha,7alpha,12alpha-Trihydroxy-5beta-24-oxocholestanoyl-CoA is an intermediate in bile acid synthesis. Bile acids are steroid acids found predominantly in bile of mammals. The distinction between different bile acids is minute, depends only on presence or absence of hydroxyl groups on positions 3, 7, and 12. Bile acids are physiological detergents that facilitate excretion, absorption, and transport of fats and sterols in the intestine and liver. Bile acids are also steroidal amphipathic molecules derived from the catabolism of cholesterol. They modulate bile flow and lipid secretion, are essential for the absorption of dietary fats and vitamins, and have been implicated in the regulation of all the key enzymes involved in cholesterol homeostasis. Bile acids recirculate through the liver, bile ducts, small intestine and portal vein to form an enterohepatic circuit. They exist as anions at physiological pH and, consequently, require a carrier for transport across the membranes of the enterohepatic tissues. The unique detergent properties of bile acids are essential for the digestion and intestinal absorption of hydrophobic nutrients. Bile acids have potent toxic properties (e.g., membrane disruption) and there are a plethora of mechanisms to limit their accumulation in blood and tissues. (PMID: 11316487, 16037564, 12576301, 11907135).","3a,7a,12a-Trihydroxy-5b-24-oxocholestanoyl-CoA",HMDB0006891,b,b,C05467,b,FDB024138,b,[H]O[C@@]([H])(C(=O)N([H])C([H])([H])C([H])([H])C(=O)N([H])C([H])([H])C([H])([H])SC(=O)C([H])(C(=O)C([H])([H])C([H])([H])[C@@]([H])(C([H])([H])[H])[C@@]1([H])C([H])([H])C([H])([H])[C@@]2([H])[C@]3([H])[C@]([H])(O[H])C([H])([H])[C@]4([H])C([H])([H])[C@]([H])(O[H])C([H])([H])C([H])([H])[C@]4(C([H])([H])[H])[C@@]3([H])C([H])([H])[C@]([H])(O[H])[C@]12C([H])([H])[H])C([H])([H])[H])C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])OP([O-])(=O)OP([O-])(=O)OC([H])([H])[C@@]1([H])O[C@@]([H])(N2C([H])=NC3=C(N=C([H])N=C23)N([H])[H])[C@]([H])(O[H])[C@]1([H])OP([O-])([O-])=O,AWLXQJGPNLCTLM-YFXOTMPNSA-J,"InChI=1S/C48H78N7O21P3S/c1-24(28-8-9-29-36-30(19-34(59)48(28,29)6)47(5)13-11-27(56)17-26(47)18-32(36)58)7-10-31(57)25(2)45(64)80-16-15-50-35(60)12-14-51-43(63)40(62)46(3,4)21-73-79(70,71)76-78(68,69)72-20-33-39(75-77(65,66)67)38(61)44(74-33)55-23-54-37-41(49)52-22-53-42(37)55/h22-30,32-34,36,38-40,44,56,58-59,61-62H,7-21H2,1-6H3,(H,50,60)(H,51,63)(H,68,69)(H,70,71)(H2,49,52,53)(H2,65,66,67)/p-4/t24-,25?,26+,27-,28-,29+,30+,32-,33-,34+,36+,38-,39-,40+,44-,47+,48-/m1/s1"
3665,4347,a,a,27379,KEGG COMPOUND accession,C05467,cholcoaone,b,27379.0,"Human Metabolome Database (HMDB): 3alpha,7alpha,12alpha-Trihydroxy-5beta-24-oxocholestanoyl-CoA is an intermediate in bile acid synthesis. Bile acids are steroid acids found predominantly in bile of mammals. The distinction between different bile acids is minute, depends only on presence or absence of hydroxyl groups on positions 3, 7, and 12. Bile acids are physiological detergents that facilitate excretion, absorption, and transport of fats and sterols in the intestine and liver. Bile acids are also steroidal amphipathic molecules derived from the catabolism of cholesterol. They modulate bile flow and lipid secretion, are essential for the absorption of dietary fats and vitamins, and have been implicated in the regulation of all the key enzymes involved in cholesterol homeostasis. Bile acids recirculate through the liver, bile ducts, small intestine and portal vein to form an enterohepatic circuit. They exist as anions at physiological pH and, consequently, require a carrier for transport across the membranes of the enterohepatic tissues. The unique detergent properties of bile acids are essential for the digestion and intestinal absorption of hydrophobic nutrients. Bile acids have potent toxic properties (e.g., membrane disruption) and there are a plethora of mechanisms to limit their accumulation in blood and tissues. (PMID: 11316487, 16037564, 12576301, 11907135).","3a,7a,12a-Trihydroxy-5b-24-oxocholestanoyl-CoA",HMDB0006891,b,b,C05467,b,FDB024138,cholcoaone,[H]O[C@@]([H])(C(=O)N([H])C([H])([H])C([H])([H])C(=O)N([H])C([H])([H])C([H])([H])SC(=O)C([H])(C(=O)C([H])([H])C([H])([H])[C@@]([H])(C([H])([H])[H])[C@@]1([H])C([H])([H])C([H])([H])[C@@]2([H])[C@]3([H])[C@]([H])(O[H])C([H])([H])[C@]4([H])C([H])([H])[C@]([H])(O[H])C([H])([H])C([H])([H])[C@]4(C([H])([H])[H])[C@@]3([H])C([H])([H])[C@]([H])(O[H])[C@]12C([H])([H])[H])C([H])([H])[H])C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])OP([O-])(=O)OP([O-])(=O)OC([H])([H])[C@@]1([H])O[C@@]([H])(N2C([H])=NC3=C(N=C([H])N=C23)N([H])[H])[C@]([H])(O[H])[C@]1([H])OP([O-])([O-])=O,AWLXQJGPNLCTLM-YFXOTMPNSA-J,"InChI=1S/C48H78N7O21P3S/c1-24(28-8-9-29-36-30(19-34(59)48(28,29)6)47(5)13-11-27(56)17-26(47)18-32(36)58)7-10-31(57)25(2)45(64)80-16-15-50-35(60)12-14-51-43(63)40(62)46(3,4)21-73-79(70,71)76-78(68,69)72-20-33-39(75-77(65,66)67)38(61)44(74-33)55-23-54-37-41(49)52-22-53-42(37)55/h22-30,32-34,36,38-40,44,56,58-59,61-62H,7-21H2,1-6H3,(H,50,60)(H,51,63)(H,68,69)(H,70,71)(H2,49,52,53)(H2,65,66,67)/p-4/t24-,25?,26+,27-,28-,29+,30+,32-,33-,34+,36+,38-,39-,40+,44-,47+,48-/m1/s1"
3666,4355,a,a,27505,KEGG COMPOUND accession,C05460,cholcoads,b,27505.0,"Human Metabolome Database (HMDB): 3alpha,7alpha,12alpha-Trihydroxy-5beta-cholest-24-enoyl-CoA is an intermediate in bile acid synthesis. Bile acids are steroid acids found predominantly in bile of mammals. The distinction between different bile acids is minute, depends only on presence or absence of hydroxyl groups on positions 3, 7, and 12. Bile acids are physiological detergents that facilitate excretion, absorption, and transport of fats and sterols in the intestine and liver. Bile acids are also steroidal amphipathic molecules derived from the catabolism of cholesterol. They modulate bile flow and lipid secretion, are essential for the absorption of dietary fats and vitamins, and have been implicated in the regulation of all the key enzymes involved in cholesterol homeostasis. Bile acids recirculate through the liver, bile ducts, small intestine and portal vein to form an enterohepatic circuit. They exist as anions at physiological pH and, consequently, require a carrier for transport across the membranes of the enterohepatic tissues. The unique detergent properties of bile acids are essential for the digestion and intestinal absorption of hydrophobic nutrients. Bile acids have potent toxic properties (e.g., membrane disruption) and there are a plethora of mechanisms to limit their accumulation in blood and tissues. (PMID: 11316487, 16037564, 12576301, 11907135).","3a,7a,12a-Trihydroxy-5b-cholest-24-enoyl-CoA",HMDB0006889,b,b,C05460,b,FDB024136,cholcoads,[H]O[C@@]([H])(C(=O)N([H])C([H])([H])C([H])([H])C(=O)N([H])C([H])([H])C([H])([H])SC(=O)C(=C([H])C([H])([H])C([H])([H])[C@@]([H])(C([H])([H])[H])[C@@]1([H])C([H])([H])C([H])([H])[C@@]2([H])[C@]3([H])[C@]([H])(O[H])C([H])([H])[C@]4([H])C([H])([H])[C@]([H])(O[H])C([H])([H])C([H])([H])[C@]4(C([H])([H])[H])[C@@]3([H])C([H])([H])[C@]([H])(O[H])[C@]12C([H])([H])[H])C([H])([H])[H])C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])OP([O-])(=O)OP([O-])(=O)OC([H])([H])[C@@]1([H])O[C@@]([H])(N2C([H])=NC3=C(N=C([H])N=C23)N([H])[H])[C@]([H])(O[H])[C@]1([H])OP([O-])([O-])=O,QVDPWQVOSKJUES-SQEGORTJSA-J,"InChI=1S/C48H78N7O20P3S/c1-25(29-10-11-30-36-31(20-34(58)48(29,30)6)47(5)14-12-28(56)18-27(47)19-32(36)57)8-7-9-26(2)45(63)79-17-16-50-35(59)13-15-51-43(62)40(61)46(3,4)22-72-78(69,70)75-77(67,68)71-21-33-39(74-76(64,65)66)38(60)44(73-33)55-24-54-37-41(49)52-23-53-42(37)55/h9,23-25,27-34,36,38-40,44,56-58,60-61H,7-8,10-22H2,1-6H3,(H,50,59)(H,51,62)(H,67,68)(H,69,70)(H2,49,52,53)(H2,64,65,66)/p-4/t25-,27+,28-,29-,30+,31+,32-,33-,34+,36+,38-,39-,40+,44-,47+,48-/m1/s1"
3667,4359,a,a,16496,KEGG COMPOUND accession,C05454,xoltriol,b,16496.0,"Human Metabolome Database (HMDB): 5-b-Cholestane-3a ,7a ,12a-triol is an intermediate in Bile acid biosynthesis. 5-b-Cholestane-3a ,7a ,12a-triol is the second to last step of synthesis of 5beta-Cyprinolsulfate. It is converted from 7alpha,12alpha-Dihydroxy-5beta-cholestan-3-one via enzymatic reaction then it is coneverted to 3alpha,7alpha,12alpha,26-Tetrahydroxy-5beta-cholestane via the enzyme cytochrome P450(EC.1.14.13.15). This compound inhibits la-Hydroxylation, (PMID: 7937829). It is the byproduct of Cholestanetetraol 26-dehydrogenase (EC 1.1.1.161), and the reaction that cataylzes it is classified as a small molecule reaction. (BioCyc).","5-b-Cholestane-3a ,7a ,12a-triol",HMDB0001457,b,b,C05454,b,FDB022635,xoltriol,[H]O[C@]1([H])C([H])([H])C([H])([H])[C@@]2(C([H])([H])[H])[C@@]([H])(C1([H])[H])C([H])([H])[C@@]([H])(O[H])[C@@]1([H])[C@]3([H])C([H])([H])C([H])([H])[C@]([H])([C@]([H])(C([H])([H])[H])C([H])([H])C([H])([H])C([H])([H])C([H])(C([H])([H])[H])C([H])([H])[H])[C@@]3(C([H])([H])[H])[C@@]([H])(O[H])C([H])([H])[C@]21[H],RIVQQZVHIVNQFH-XJZYBRFWSA-N,"InChI=1S/C27H48O3/c1-16(2)7-6-8-17(3)20-9-10-21-25-22(15-24(30)27(20,21)5)26(4)12-11-19(28)13-18(26)14-23(25)29/h16-25,28-30H,6-15H2,1-5H3/t17-,18+,19-,20-,21+,22+,23-,24+,25+,26+,27-/m1/s1"
3668,4363,a,a,18402,KEGG COMPOUND accession,C04722,thcholstoic,33964-75-9,48043.0,"Human Metabolome Database (HMDB): 3alpha,7alpha,12alpha-Trihydroxy-5beta-cholestanoic acid is a bile acid. Bile acids are steroid acids found predominantly in bile of mammals. The distinction between different bile acids is minute, depends only on presence or absence of hydroxyl groups on positions 3, 7, and 12. Bile acids are physiological detergents that facilitate excretion, absorption, and transport of fats and sterols in the intestine and liver. Bile acids are also steroidal amphipathic molecules derived from the catabolism of cholesterol. They modulate bile flow and lipid secretion, are essential for the absorption of dietary fats and vitamins, and have been implicated in the regulation of all the key enzymes involved in cholesterol homeostasis. Bile acids recirculate through the liver, bile ducts, small intestine and portal vein to form an enterohepatic circuit. They exist as anions at physiological pH and, consequently, require a carrier for transport across the membranes of the enterohepatic tissues. The unique detergent properties of bile acids are essential for the digestion and intestinal absorption of hydrophobic nutrients. Bile acids have potent toxic properties (e.g., membrane disruption) and there are a plethora of mechanisms to limit their accumulation in blood and tissues. 3a,7a,12a-Trihydroxy-5b-cholestanoic acid is found to be associated with infantile Refsum disease, which is an inborn error of metabolism.","3a,7a,12a-Trihydroxy-5b-cholestanoic acid",HMDB0003873,b,b,C04722,CPD-1836,FDB023241,thcholstoic,[H]O[C@]1([H])C([H])([H])C([H])([H])[C@@]2(C([H])([H])[H])[C@@]([H])(C1([H])[H])C([H])([H])[C@@]([H])(O[H])[C@@]1([H])[C@]3([H])C([H])([H])C([H])([H])[C@]([H])([C@]([H])(C([H])([H])[H])C([H])([H])C([H])([H])C([H])([H])[C@]([H])(C([O-])=O)C([H])([H])[H])[C@@]3(C([H])([H])[H])[C@@]([H])(O[H])C([H])([H])[C@]21[H],CNWPIIOQKZNXBB-WBYPBBSPSA-M,"InChI=1S/C27H46O5/c1-15(6-5-7-16(2)25(31)32)19-8-9-20-24-21(14-23(30)27(19,20)4)26(3)11-10-18(28)12-17(26)13-22(24)29/h15-24,28-30H,5-14H2,1-4H3,(H,31,32)/p-1/t15-,16-,17+,18-,19-,20+,21+,22-,23+,24+,26+,27-/m1/s1"
3669,4376,a,a,16312,KEGG COMPOUND accession,C01292,,,,,,,,,,,,,,,
3670,4382,a,a,27428,KEGG COMPOUND accession,C05445,xol7ah2al,b,27428.0,"Human Metabolome Database (HMDB): 3alpha,7alpha-Dihydroxy-5beta-cholestan-26-al is an intermediate involved in bile acid biosynthesis, specifically in the synthesis of chenodeoxyglycocholate and lithocholate. Bile acids are steroid acids found predominantly in bile of mammals. The distinction between different bile acids is minute, depends only on presence or absence of hydroxyl groups on positions 3, 7, and 12. Bile acids are physiological detergents that facilitate excretion, absorption, and transport of fats and sterols in the intestine and liver. Bile acids are also steroidal amphipathic molecules derived from the catabolism of cholesterol. They modulate bile flow and lipid secretion, are essential for the absorption of dietary fats and vitamins, and have been implicated in the regulation of all the key enzymes involved in cholesterol homeostasis. Bile acids recirculate through the liver, bile ducts, small intestine and portal vein to form an enterohepatic circuit. They exist as anions at physiological pH and, consequently, require a carrier for transport across the membranes of the enterohepatic tissues. The unique detergent properties of bile acids are essential for the digestion and intestinal absorption of hydrophobic nutrients. Bile acids have potent toxic properties (e.g., membrane disruption) and there are a plethora of mechanisms to limit their accumulation in blood and tissues. (PMID: 11316487, 16037564, 12576301, 11907135).","3a,7a-Dihydroxy-5b-cholestan-26-al",HMDB0006894,b,b,C05445,b,FDB024141,xol7ah2al,[H]O[C@]1([H])C([H])([H])C([H])([H])[C@@]2(C([H])([H])[H])[C@@]([H])(C1([H])[H])C([H])([H])[C@@]([H])(O[H])[C@@]1([H])[C@]3([H])C([H])([H])C([H])([H])[C@]([H])([C@]([H])(C([H])([H])[H])C([H])([H])C([H])([H])C([H])([H])C([H])(C([H])=O)C([H])([H])[H])[C@@]3(C([H])([H])[H])C([H])([H])C([H])([H])[C@]21[H],YWGOKHMOJTZGBN-SOUOFJFXSA-N,"InChI=1S/C27H46O3/c1-17(16-28)6-5-7-18(2)21-8-9-22-25-23(11-13-27(21,22)4)26(3)12-10-20(29)14-19(26)15-24(25)30/h16-25,29-30H,5-15H2,1-4H3/t17?,18-,19+,20-,21-,22+,23+,24-,25+,26+,27-/m0/s1"
3671,4405,a,a,1712,KEGG COMPOUND accession,C05480,,,,,,,,,,,,,,,
3672,4411,a,a,35347,KEGG COMPOUND accession,C03072,,,,,,,,,,,,,,,
3673,4416,a,a,16286,KEGG COMPOUND accession,C11509,,,,,,,,,,,,,,,
3674,4418,a,a,18134,KEGG COMPOUND accession,C04840,,,,,,,,,,,,,,,
3675,4434,a,a,16814,KEGG COMPOUND accession,C04555,dheas,651-48-9,16814.0,"Human Metabolome Database (HMDB): Dehydroepiandrosterone sulfate or DHEAS is the sulfated form of dehydroepiandrosterone (DHEA). This sulfation is reversibly catalyzed by sulfotransferase 2A1 (SULT2A1) primarily in the adrenals, the liver, and small intestine. In the blood, most DHEA is found as DHEAS with levels that are about 300 times higher than those of free DHEA. Orally-ingested DHEA is converted to its sulfate when passing through intestines and liver. Whereas DHEA levels naturally reach their peak in the early morning hours, DHEAS levels show no diurnal variation. From a practical point of view, measurement of DHEAS is preferable to DHEA, as levels are more stable. DHEA (from which DHEAS comes from) is a natural steroid prohormone produced from cholesterol by the adrenal glands, the gonads, adipose tissue, brain and in the skin (by an autocrine mechanism). DHEA is the precursor of androstenedione, which can undergo further conversion to produce the androgen testosterone and the estrogens estrone and estradiol. DHEA is also a potent sigma-1 agonist. DHEAS can serve as a precursor for testosterone; androstenedione; estradiol; and estrone",Dehydroepiandrosterone sulfate,HMDB0001032,b,b,C04555,DEHYDRO-EPIANDROSTERONE-SULFATE,FDB022381,dheas,[H]C1=C2C([H])([H])[C@@]([H])(OS([O-])(=O)=O)C([H])([H])C([H])([H])[C@]2(C([H])([H])[H])[C@@]2([H])C([H])([H])C([H])([H])[C@@]3(C(=O)C([H])([H])C([H])([H])[C@@]3([H])[C@]2([H])C1([H])[H])C([H])([H])[H],CZWCKYRVOZZJNM-USOAJAOKSA-M,"InChI=1S/C19H28O5S/c1-18-9-7-13(24-25(21,22)23)11-12(18)3-4-14-15-5-6-17(20)19(15,2)10-8-16(14)18/h3,13-16H,4-11H2,1-2H3,(H,21,22,23)/p-1/t13-,14-,15-,16-,18-,19-/m0/s1"
3676,4440,a,a,13610,KEGG COMPOUND accession,C03587,,,,,,,,,,,,,,,
3677,4444,a,a,1729,KEGG COMPOUND accession,C10552,,,,,,,,,,,,,,,
3678,4455,a,a,16099,KEGG COMPOUND accession,C06739,,,,,,,,,,,,,,,
3679,4461,a,a,17294,KEGG COMPOUND accession,C03677,,,,,,,,,,,,,,,
3680,4482,a,a,17204,KEGG COMPOUND accession,C02800,,,,,,,,,,,,,,,
3681,4485,a,a,1749,KEGG COMPOUND accession,C08722,,,,,,,,,,,,,,,
3682,4494,a,a,27983,KEGG COMPOUND accession,C06502,,,,,,,,,,,,,,,
3683,4497,a,a,28678,KEGG COMPOUND accession,C10257,,,,,,,,,,,,,,,
3684,4499,a,a,15495,KEGG COMPOUND accession,C07296,tmtrdcoa,b,15495.0,Human Metabolome Database (HMDB): This compound belongs to the family of Acyl CoAs. These are organic compounds contaning a coenzyme A substructure linked to another moeity through an ester bond.,"4,8,12-Trimethyltridecanoyl-CoA",HMDB0060167,b,b,C07296,b,b,tmtrdcoa,[H]O[C@@]([H])(C(=O)N([H])C([H])([H])C([H])([H])C(=O)N([H])C([H])([H])C([H])([H])SC(=O)C([H])([H])C([H])([H])C([H])(C([H])([H])[H])C([H])([H])C([H])([H])C([H])([H])C([H])(C([H])([H])[H])C([H])([H])C([H])([H])C([H])([H])C([H])(C([H])([H])[H])C([H])([H])[H])C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])OP([O-])(=O)OP([O-])(=O)OC([H])([H])[C@@]1([H])O[C@@]([H])(N2C([H])=NC3=C2N=C([H])N=C3N([H])[H])[C@]([H])(O[H])[C@]1([H])OP([O-])([O-])=O,ZYUOZFCHODHLHG-LEJRVOBCSA-J,"InChI=1S/C37H66N7O17P3S/c1-23(2)9-7-10-24(3)11-8-12-25(4)13-14-28(46)65-18-17-39-27(45)15-16-40-35(49)32(48)37(5,6)20-58-64(55,56)61-63(53,54)57-19-26-31(60-62(50,51)52)30(47)36(59-26)44-22-43-29-33(38)41-21-42-34(29)44/h21-26,30-32,36,47-48H,7-20H2,1-6H3,(H,39,45)(H,40,49)(H,53,54)(H,55,56)(H2,38,41,42)(H2,50,51,52)/p-4/t24?,25?,26-,30-,31-,32+,36-/m1/s1"
3685,4501,a,a,28329,KEGG COMPOUND accession,C09314,,,,,,,,,,,,,,,
3686,4525,a,a,17442,KEGG COMPOUND accession,C01252,4aphdob,b,17442.0,"Human Metabolome Database (HMDB): 4-(2-Aminophenyl)-2,4-dioxobutanoic acid is a substrate for Kynurenine/alpha-aminoadipate aminotransferase mitochondrial.","4-(2-Aminophenyl)-2,4-dioxobutanoic acid",HMDB0000978,b,b,C01252,CPD-476,FDB022348,4aphdob,[H]N([H])C1=C(C([H])=C([H])C([H])=C1[H])C(=O)C([H])([H])C(=O)C([O-])=O,CAOVWYZQMPNAFJ-UHFFFAOYSA-M,"InChI=1S/C10H9NO4/c11-7-4-2-1-3-6(7)8(12)5-9(13)10(14)15/h1-4H,5,11H2,(H,14,15)/p-1"
3687,4533,a,a,15863,KEGG COMPOUND accession,C04733,,,,,,,,,,,,,,,
3688,4545,a,a,17467,KEGG COMPOUND accession,C04291,,,,,,,,,,,,,,,
3689,4547,a,a,16098,KEGG COMPOUND accession,C04796,,,,,,,,,,,,,,,
3690,4549,a,a,1774,KEGG COMPOUND accession,C04114,,,,,,,,,,,,,,,
3691,4552,a,a,16741,KEGG COMPOUND accession,C03993,,,,,,,,,,,,,,,
3692,4554,a,a,17645,KEGG COMPOUND accession,C02946,4aabutn,3025-96-5,17645.0,"Human Metabolome Database (HMDB): 4-Acetamidobutanoic acid is a GABA derivative, product of the Urea cycle and metabolism of amino groups, the product of NAD-linked aldehyde dehydrogenase (EC 1.2.1.3) (KEGG).",4-Acetamidobutanoic acid,HMDB0003681,b,b,C02946,CPD-570,FDB023214,4aabutn,[H]N(C(=O)C([H])([H])[H])C([H])([H])C([H])([H])C([H])([H])C([O-])=O,UZTFMUBKZQVKLK-UHFFFAOYSA-M,"InChI=1S/C6H11NO3/c1-5(8)7-4-2-3-6(9)10/h2-4H2,1H3,(H,7,8)(H,9,10)/p-1"
3693,4557,a,a,28684,KEGG COMPOUND accession,C03357,,,,,,,,,,,,,,,
3694,4569,a,a,27500,KEGG COMPOUND accession,C06335,,,,,,,,,,,,,,,
3695,4571,a,a,30753,KEGG COMPOUND accession,C00568,,,,,,,,,,,,,,,
3696,4576,a,a,1784,KEGG COMPOUND accession,C10998,,,,,,,,,,,,,,,
3697,4578,a,a,17769,KEGG COMPOUND accession,C00555,4abutn,4390-05-0,17769.0,Human Metabolome Database (HMDB): 4-Aminobutyraldehyde is a metabolite of putrescine. It is a substrate of human liver aldehyde dehydrogenase (EC 1.2.1.3) cytoplasmic (E1) and mitochondrial (E2) isozymes (PMID 3324802).,4-Aminobutyraldehyde,HMDB0001080,b,b,C00555,4-AMINO-BUTYRALDEHYDE,FDB022412,4abutn,[H]C(=O)C([H])([H])C([H])([H])C([H])([H])[N+]([H])([H])[H],DZQLQEYLEYWJIB-UHFFFAOYSA-O,"InChI=1S/C4H9NO/c5-3-1-2-4-6/h4H,1-3,5H2/p+1"
3698,4585,a,a,16865,KEGG COMPOUND accession,C00334,4abut,56-12-2,16865.0,"Human Metabolome Database (HMDB): gamma-Aminobutyric acid (GABA) is an inhibitory neurotransmitter found in the nervous systems of widely divergent species, including humans. It is the chief inhibitory neurotransmitter in the vertebrate central nervous system. In vertebrates, GABA acts at inhibitory synapses in the brain. It acts by binding to specific transmembrane receptors in the plasma membrane of both pre- and postsynaptic neurons. This binding causes the opening of ion channels to allow either the flow of negatively-charged chloride ions into the cell or positively-charged potassium ions out of the cell. This will typically result in a negative change in the transmembrane potential, usually causing hyperpolarization. Three general classes of GABA receptor are known (PMID: 10561820). These include GABA-A and GABA-C ionotropic receptors, which are ion channels themselves, and GABA-B metabotropic receptors, which are G protein-coupled receptors that open ion channels via intermediaries known as G proteins (PMID: 10561820). Activation of the GABA-B receptor by GABA causes neuronal membrane hyperpolarization and a resultant inhibition of neurotransmitter release. In addition to binding sites for GABA, the GABA-A receptor has binding sites for benzodiazepines, barbiturates, and neurosteroids. GABA-A receptors are coupled to chloride ion channels. Therefore, activation of the GABA-A receptor induces increased inward chloride ion flux, resulting in membrane hyperpolarization and neuronal inhibition (PMID: 10561820). After release into the synapse, free GABA that does not bind to either the GABA-A or GABA-B receptor complexes can be taken up by neurons and glial cells. Four different GABA membrane transporter proteins (GAT-1, GAT-2, GAT-3, and BGT-1), which differ in their distribution in the CNS, are believed to mediate the uptake of synaptic GABA into neurons and glial cells. The GABA-A receptor subtype regulates neuronal excitability and rapid changes in fear arousal, such as anxiety, panic, and the acute stress response (PMID: 10561820). Drugs that stimulate GABA-A receptors, such as the benzodiazepines and barbiturates, have anxiolytic and anti-seizure effects via GABA-A-mediated reduction of neuronal excitability, which effectively raises the seizure threshold. GABA-A antagonists produce convulsions in animals and there is decreased GABA-A receptor binding in a positron emission tomography (PET) study of patients with panic disorder. Neurons that produce GABA as their output are called GABAergic neurons and have chiefly inhibitory action at receptors in the vertebrate. Medium spiny neurons (MSNs) are a typical example of inhibitory CNS GABAergic cells. GABA has been shown to have excitatory roles in the vertebrate, most notably in the developing cortex. Organisms synthesize GABA from glutamate using the enzyme L-glutamic acid decarboxylase and pyridoxal phosphate as a cofactor (PMID: 12467378). It is worth noting that this involves converting the principal excitatory neurotransmitter (glutamate) into the principal inhibitory one (GABA). Drugs that act as agonists of GABA receptors (known as GABA analogs or GABAergic drugs), or increase the available amount of GABA typically have relaxing, anti-anxiety, and anti-convulsive effects. GABA is found to be deficient in cerebrospinal fluid and the brain in many studies of experimental and human epilepsy. Benzodiazepines (such as Valium) are useful in status epilepticus because they act on GABA receptors. GABA increases in the brain after administration of many seizure medications. Hence, GABA is clearly an antiepileptic nutrient. Inhibitors of GAM metabolism can also produce convulsions. Spasticity and involuntary movement syndromes, such as Parkinson's, Friedreich's ataxia, tardive dyskinesia, and Huntington's chorea, are all marked by low GABA when amino acid levels are studied. Trials of 2 to 3 g of GABA given orally have been effective in various epilepsy and spasticity syndromes. Agents that elevate GABA are also useful in lowering hypertension. Three grams orally have been effective in controlling blood pressure. GABA is decreased in various encephalopathies. GABA can reduce appetite and is decreased in hypoglycemics. GABA reduces blood sugar in diabetics. Chronic brain syndromes can also be marked by deficiencies of GABA. Vitamin B6, manganese, taurine, and lysine can increase both GABA synthesis and effects, while aspartic acid and glutamic acid probably inhibit GABA effects. Low plasma GABA has been reported in some depressed patients and may be a useful trait marker for mood disorders. GABA has an important role in embryonic development, especially facial development, as substantiated by the association of a cleft palate in transgenic mice deficient in GAD67 (glutamate decarboxylase). A recent Japanese population study reported linkage in patients with a nonsyndromic cleft lip with or without a cleft palate and specific GAD67 haplotypes (PMID: 23842532). Unusually high levels of GABA (especially in the brain) can be toxic and GABA can function as both a neurotoxin and a metabotoxin. A neurotoxin is a compound that damages the brain and/or nerve tissue. A metabotoxin is an endogenously produced metabolite that causes adverse health effects at chronically high levels. Chronically high levels of GABA are associated with at least five inborn errors of metabolism, including D-2-hydroxyglutaric aciduria, 4-hydroxybutyric aciduria/succinic semialdehyde dehydrogenase deficiency, GABA-transaminase deficiency, homocarnosinosis, and hyper beta-alaninemia. Nearly all of these conditions are associated with seizures, hypotonia, intellectual deficits, macrocephaly, encephalopathy, and other serious neurological or neuromuscular problems. Increased levels of GABA seem to alter the function of the GABA-B receptor, which may play a role in the tonic-clonic seizures that are often seen in patients with the above disorders.",gamma-Aminobutyric acid,HMDB0000112,b,b,C00334,4-AMINO-BUTYRATE,FDB008937,4abut,[H][N+]([H])([H])C([H])([H])C([H])([H])C([H])([H])C([O-])=O,BTCSSZJGUNDROE-UHFFFAOYSA-N,"InChI=1S/C4H9NO2/c5-3-1-2-4(6)7/h1-3,5H2,(H,6,7)"
3699,4619,a,a,28585,KEGG COMPOUND accession,C06673,,,,,,,,,,,,,,,
3700,4620,a,a,17250,KEGG COMPOUND accession,C04115,,,,,,,,,,,,,,,
3701,4625,a,a,16766,KEGG COMPOUND accession,C04559,,,,,,,,,,,,,,,
3702,4634,a,a,30747,KEGG COMPOUND accession,C02370,,,,,,,,,,,,,,,
3703,4643,a,a,27757,KEGG COMPOUND accession,C06584,,,,,,,,,,,,,,,
3704,4655,a,a,30749,KEGG COMPOUND accession,C03077,,,,,,,,,,,,,,,
3705,4663,a,a,32374,KEGG COMPOUND accession,C00811,T4hcinnm,7400-08-0,32374.0,"Human Metabolome Database (HMDB): 4-Hydroxycinnamic acid is a yellowish green crystalline powder. Cinnamic acid and its derivatives are used as important components in flavours, perfumes, synthetic indigo and pharmaceuticals.",4-Hydroxycinnamic acid,HMDB0002035,b,b,C00811,COUMARATE,FDB002593,T4hcinnm,[H]OC1=C([H])C([H])=C(C([H])=C([H])C([O-])=O)C([H])=C1[H],NGSWKAQJJWESNS-ZZXKWVIFSA-M,"InChI=1S/C9H8O3/c10-8-4-1-7(2-5-8)3-6-9(11)12/h1-6,10H,(H,11,12)/p-1/b6-3+"
3706,4679,a,a,28386,KEGG COMPOUND accession,C02646,,,,,,,,,,,,,,,
3707,4691,a,a,28461,KEGG COMPOUND accession,C06654,,,,,,,,,,,,,,,
3708,4693,a,a,28408,KEGG COMPOUND accession,C06627,,,,,,,,,,,,,,,
3709,4697,a,a,16655,KEGG COMPOUND accession,C01310,,,,,,,,,,,,,,,
3710,4730,a,a,30923,KEGG COMPOUND accession,C01127,4h2oglt,1187-99-1,30923.0,Human Metabolome Database (HMDB): 4-Hydroxy-2-ketoglutaric acid is a substrate for Fructose-bisphosphate aldolase A.,4-Hydroxy-2-oxoglutaric acid,HMDB0002070,b,b,C01127,D-4-HYDROXY-2-KETO-GLUTARATE,FDB022830,4h2oglt,[H]OC([H])(C([O-])=O)C([H])([H])C(=O)C([O-])=O,WXSKVKPSMAHCSG-UHFFFAOYSA-L,"InChI=1S/C5H6O6/c6-2(4(8)9)1-3(7)5(10)11/h2,6H,1H2,(H,8,9)(H,10,11)/p-2"
3711,4735,a,a,17655,KEGG COMPOUND accession,C03589,,,,,,,,,,,,,,,
3712,4741,a,a,18346,KEGG COMPOUND accession,C00755,,,,,,,,,,,,,,,
3713,4760,a,a,28464,KEGG COMPOUND accession,C06628,,,,,,,,,,,,,,,
3714,4763,a,a,32811,KEGG COMPOUND accession,C03079,,,,,,,,,,,,,,,
3715,4812,a,a,27588,KEGG COMPOUND accession,C05855,,,,,,,,,,,,,,,
3716,4859,a,a,16667,KEGG COMPOUND accession,C03766,,,,,,,,,,,,,,,
3717,4862,a,a,28773,KEGG COMPOUND accession,C05338,,,,,,,,,,,,,,,
3718,4865,a,a,28036,KEGG COMPOUND accession,C05595,,,,,,,,,,,,,,,
3719,4870,a,a,28719,KEGG COMPOUND accession,C03590,,,,,,,,,,,,,,,
3720,4881,a,a,27850,KEGG COMPOUND accession,C05133,,,,,,,,,,,,,,,
3721,4897,a,a,48430,KEGG COMPOUND accession,C00233,4mop,816-66-0,48430.0,"Human Metabolome Database (HMDB): Ketoleucine is an abnormal metabolite that arises from the incomplete breakdown of branched-chain amino acids. Ketoleucine is both a neurotoxin and a metabotoxin. A neurotoxin causes damage to nerve cells and nerve tissues. A metabotoxin is an endogenously produced metabolite that causes adverse health effects at chronically high levels. Chronically high levels of ketoleucine are associated with maple syrup urine disease (MSUD). MSUD is a metabolic disorder caused by a deficiency of the branched-chain alpha-keto acid dehydrogenase complex (BCKDC), leading to a buildup of the branched-chain amino acids (leucine, isoleucine, and valine) and their toxic by-products (ketoacids) in the blood and urine. The symptoms of MSUD often show in infancy and lead to severe brain damage if untreated. MSUD may also present later depending on the severity of the disease. If left untreated in older individuals, during times of metabolic crisis, symptoms of the condition include uncharacteristically inappropriate, extreme, or erratic behaviour and moods, hallucinations, anorexia, weight loss, anemia, diarrhea, vomiting, dehydration, lethargy, oscillating hypertonia and hypotonia, ataxia, seizures, hypoglycemia, ketoacidosis, opisthotonus, pancreatitis, rapid neurological decline, and coma.  In maple syrup urine disease, the brain concentration of branched-chain ketoacids can increase 10- to 20-fold. This leads to a depletion of glutamate and a consequent reduction in the concentration of brain glutamine, aspartate, alanine, and other amino acids. The result is a compromise of energy metabolism because of a failure of the malate-aspartate shuttle and a diminished rate of protein synthesis (PMID: 15930465).",Ketoleucine,HMDB0000695,b,b,C00233,2K-4CH3-PENTANOATE,FDB012607,4mop,[H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])C(=O)C([O-])=O,BKAJNAXTPSGJCU-UHFFFAOYSA-M,"InChI=1S/C6H10O3/c1-4(2)3-5(7)6(8)9/h4H,3H2,1-2H3,(H,8,9)/p-1"
3722,4956,a,a,16836,KEGG COMPOUND accession,C00870,4nph,100-02-7,16836.0,"Human Metabolome Database (HMDB): 4-Nitrophenol is a phenolic metabolite of environmental chemicals present in samples from the general population. 4-Nitrophenol measurement in urine is used in biological monitoring for establishing the presence and magnitude of exposures to pesticides. (PMID 15899376) (Methods in Biotechnology, 2006,61-78).",4-Nitrophenol,HMDB0001232,b,b,C00870,P-NITROPHENOL,FDB022503,4nph,[H]OC1=C([H])C([H])=C(C([H])=C1[H])[N+]([O-])=O,BTJIUGUIPKRLHP-UHFFFAOYSA-N,"InChI=1S/C6H5NO3/c8-6-3-1-5(2-4-6)7(9)10/h1-4,8H"
3723,4979,a,a,1921,KEGG COMPOUND accession,C03767,,,,,,,,,,,,,,,
3724,4984,a,a,49003,KEGG COMPOUND accession,C03393,,,,,,,,,,,,,,,
3725,4985,a,a,15836,KEGG COMPOUND accession,C03082,,,,,,,,,,,,,,,
3726,4992,a,a,17405,KEGG COMPOUND accession,C00847,4pyrdx,82-82-6,17405.0,"Human Metabolome Database (HMDB): 4-Pyridoxic acid is the catabolic product of vitamin B6 (also known as pyridoxine, pyridoxal and pyradoxamine) which is excreted in the urine. Urinary levels of 4-pyridoxic acid are lower in females than in males and will be reduced in persons with riboflavin deficiency. 4-Pyridoxic acid is formed by the action of aldehyde oxidase I (an endogenous enzyme) and by microbial enzymes (pyridoxal 4-dehydrogenase), an NAD-dependent aldehyde dehydrogenase. 4-pyridoxic acid can be further broken down by the gut microflora via 4-pyridoxic acid dehydrogenase. This enzyme catalyzes the four electron oxidation of 4-pyridoxic acid to 3-hydroxy-2-methylpyridine-4,5-dicarboxylate, using nicotinamide adenine dinucleotide as a cofactor.",4-Pyridoxic acid,HMDB0000017,b,b,C00847,CPD-1112,FDB021874,4pyrdx,[H]OC1=C([N+]([H])=C([H])C(=C1C([O-])=O)C([H])([H])O[H])C([H])([H])[H],HXACOUQIXZGNBF-UHFFFAOYSA-N,"InChI=1S/C8H9NO4/c1-4-7(11)6(8(12)13)5(3-10)2-9-4/h2,10-11H,3H2,1H3,(H,12,13)"
3727,5023,a,a,1941,KEGG COMPOUND accession,C01181,4tmeabutn,407-64-7,1941.0,"Human Metabolome Database (HMDB): 4-Trimethylammoniobutanoic acid or Gamma-butyrobetaine (GBB) is a highly water-soluble derivative of gamma-amino butyric acid. It is also a precursor of L-carnitine.  It is a substrate of gamma butyrobetaine hydroxylase/dioxygenase (also known as BBOX) which catalyzes the formation of L-carnitine from gamma-butyrobetaine, the last step in the L-carnitine biosynthetic pathway. Carnitine is essential for the transport of activated fatty acids across the mitochondrial membrane during mitochondrial beta-oxidation.  Gamma-butyrobetaine is also a substrate and/or product for alpha-amioadipic semialdehyde dehydrogenase, aldehyde dehydrogenase (dimeric NADP-preferring), aldehyde dehydrogenase family 7 member A1, aldehyde dehydrogenase 1A3, aldehyde dehydrogenase (mitochondrial), fatty aldehyde dehydrogenase, aldehyde dehydrogenase X (mitochondrial) and 4-trimethylaminobutyraldehyde dehydrogenase.",4-Trimethylammoniobutanoic acid,HMDB0001161,b,b,C01181,4-TRIMETHYLAMMONIOBUTANOATE,FDB022456,4tmeabutn,[H]C([H])([H])[N+](C([H])([H])[H])(C([H])([H])[H])C([H])([H])C([H])([H])C([H])([H])C([O-])=O,JHPNVNIEXXLNTR-UHFFFAOYSA-N,"InChI=1S/C7H15NO2/c1-8(2,3)6-4-5-7(9)10/h4-6H2,1-3H3"
3728,5036,a,a,1945,KEGG COMPOUND accession,C10441,,,,,,,,,,,,,,,
3729,5038,a,a,30109,KEGG COMPOUND accession,C11508,,,,,,,,,,,,,,,
3730,5040,a,a,16495,KEGG COMPOUND accession,C04453,,,,,,,,,,,,,,,
3731,5043,a,a,28432,KEGG COMPOUND accession,C05110,,,,,,,,,,,,,,,
3732,5045,a,a,1949,KEGG COMPOUND accession,C05103,HC02110,b,1949.0,Human Metabolome Database (HMDB): 4a-Methylzymosterol is an intermediate in the biosynthesis of steroids (KEGG ID C05103). It is the 7th to last step in the synthesis of vitamin D2 and is converted from 3-keto-4-methtylzymosterol via the enzyme 3-keto steroid reductase [EC:1.1.1.270]. It is then converted to zymosterol. (KEGG).,4a-Methylzymosterol,HMDB0001217,b,b,C05103,4-METHYL-824-CHOLESTADIENOL,FDB022496,HC02110,[H]O[C@@]1([H])C([H])([H])C([H])([H])[C@@]2(C3=C(C([H])([H])C([H])([H])[C@@]2([H])[C@]1([H])C([H])([H])[H])[C@]1([H])C([H])([H])C([H])([H])[C@]([H])([C@]([H])(C([H])([H])[H])C([H])([H])C([H])([H])C([H])=C(C([H])([H])[H])C([H])([H])[H])[C@@]1(C([H])([H])[H])C([H])([H])C3([H])[H])C([H])([H])[H],FOUJWBXBKVVHCJ-YIJYGBTNSA-N,"InChI=1S/C28H46O/c1-18(2)8-7-9-19(3)22-12-13-24-21-10-11-23-20(4)26(29)15-17-28(23,6)25(21)14-16-27(22,24)5/h8,19-20,22-24,26,29H,7,9-17H2,1-6H3/t19-,20+,22-,23+,24+,26+,27-,28+/m1/s1"
3733,5046,a,a,15717,KEGG COMPOUND accession,C04814,,,,,,,,,,,,,,,
3734,5143,a,a,16568,KEGG COMPOUND accession,C04377,,,,,,,,,,,,,,,
3735,5149,a,a,17321,KEGG COMPOUND accession,C01217,h4mpt,b,17321.0,Human Metabolome Database (HMDB): This compound belongs to the family of Alkyl Glycosides. These are lipids containing a glycosyl moiety (one or several units) linked to the hydroxyl group of a fatty alcohol.,"5,6,7,8-Tetrahydromethanopterin",HMDB0060403,b,b,C01217,b,b,b,b,SCBIBGUJSMHIAI-LHIIQLEZSA-N,"InChI=1S/C30H45N6O16P/c1-12(21-13(2)33-26-22(34-21)27(44)36-30(31)35-26)32-15-5-3-14(4-6-15)9-16(37)23(41)17(38)10-49-29-25(43)24(42)19(51-29)11-50-53(47,48)52-18(28(45)46)7-8-20(39)40/h3-6,12-13,16-19,21,23-25,29,32,34,37-38,41-43H,7-11H2,1-2H3,(H,39,40)(H,45,46)(H,47,48)(H4,31,33,35,36,44)/t12-,13+,16+,17-,18+,19-,21+,23+,24-,25-,29+/m1/s1"
3736,5154,a,a,18373,KEGG COMPOUND accession,C05220,,,,,,,,,,,,,,,
3737,5173,a,a,17143,KEGG COMPOUND accession,C06726,,,,,,,,,,,,,,,
3738,5175,a,a,16937,KEGG COMPOUND accession,C06725,,,,,,,,,,,,,,,
3739,5182,a,a,28033,KEGG COMPOUND accession,C05417,,,,,,,,,,,,,,,
3740,5207,a,a,16685,KEGG COMPOUND accession,C04826,,,,,,,,,,,,,,,
3741,5209,a,a,17229,KEGG COMPOUND accession,C04711,,,,,,,,,,,,,,,
3742,5211,a,a,17181,KEGG COMPOUND accession,C04485,,,,,,,,,,,,,,,
3743,5213,a,a,16887,KEGG COMPOUND accession,C04486,,,,,,,,,,,,,,,
3744,5215,a,a,18302,KEGG COMPOUND accession,C04896,,,,,,,,,,,,,,,
3745,5220,a,a,2022,KEGG COMPOUND accession,C10802,,,,,,,,,,,,,,,
3746,5222,a,a,17671,KEGG COMPOUND accession,C04797,,,,,,,,,,,,,,,
3747,5227,a,a,17572,KEGG COMPOUND accession,C01110,5a2opntn,b,49268.0,"Human Metabolome Database (HMDB): 5-Amino-2-oxopentanoic acid is a breakdown product of D-proline. D-proline is first converted to 1-pyrroline-2-carboxylic acid via D-amino acid oxidase, which then spontaneously breaks down into 5-amino-2-oxopentanoic acid.",5-Amino-2-oxopentanoic acid,HMDB0006272,b,b,C01110,5-AMINO-2-OXOPENTANOATE,FDB023870,5a2opntn,[H][N+]([H])([H])C([H])([H])C([H])([H])C([H])([H])C(=O)C([O-])=O,BWHGMFYTDQEALD-UHFFFAOYSA-N,"InChI=1S/C5H9NO3/c6-3-1-2-4(7)5(8)9/h1-3,6H2,(H,8,9)"
3748,5231,a,a,17147,KEGG COMPOUND accession,C04798,,,,,,,,,,,,,,,
3749,5233,a,a,17881,KEGG COMPOUND accession,C05155,,,,,,,,,,,,,,,
3750,5235,a,a,28280,KEGG COMPOUND accession,C05516,,,,,,,,,,,,,,,
3751,5253,a,a,18120,KEGG COMPOUND accession,C00990,,,,,,,,,,,,,,,
3752,5256,a,a,15887,KEGG COMPOUND accession,C00431,5aptn,660-88-8,15887.0,"Human Metabolome Database (HMDB): 5-aminovalerate (or 5-aminopentanoic acid) is a lysine degradation product.  It can be produced both endogenously or through bacterial catabolism of lysine.  5-aminovalerate is formed via the following multi-step reaction: L-lysine leads to cadverine leads to L-piperideine leads 5-aminovalerate (PMID: 405455).  In other words it is a metabolite of cadaverine which is formed via the intermediate, 1-piperideine (PMID: 6436440).  Cadaverine is a foul-smelling diamine compound produced by protein hydrolysis during putrefaction of animal tissue. High levels of 5-aminovalerate in biofluids may indicate bacterial overgrowth or endogenous tissue necrosis.  In most cases  endogenous 5-aminovalerate is thought to be primarily a microbial metabolite produced by the gut or oral microflora, although it can be produced endogenously.  5-aminovalerate is a normal metabolite present in human saliva, with a tendency to elevated concentration in patients with chronic periodontitis. Bacterial contamination and decomposition of salivary proteins is primarily responsible for elevated salivary levels (PMID 3481959). Beyond being a general waste product, 5-aminovalerate is also believed to act as a methylene homologue of gamma-aminobutyric acid (GABA) and functions as a weak GABA agonist (PMID: 4031870). It is also known as an antifibrinolytic amino acid analog and so it functions as a weak inhibitor of the blood clotting pathway (PMID: 6703712). 5-aminopentanoic acid is an in vivo substrate of 4-aminobutyrate:2-oxoglutarate aminotransferase (PMID: 4031870).",5-Aminopentanoic acid,HMDB0003355,b,b,C00431,5-AMINOPENTANOATE,FDB023151,b,b,JJMDCOVWQOJGCB-UHFFFAOYSA-N,"InChI=1S/C5H11NO2/c6-4-2-1-3-5(7)8/h1-4,6H2,(H,7,8)"
3753,5268,a,a,2040,KEGG COMPOUND accession,C04186,,,,,,,,,,,,,,,
3754,5282,a,a,16669,KEGG COMPOUND accession,C03932,,,,,,,,,,,,,,,
3755,5284,a,a,16369,KEGG COMPOUND accession,C00679,,,,,,,,,,,,,,,
3756,5306,a,a,46345,KEGG COMPOUND accession,C07649,,,,,,,,,,,,,,,
3757,5310,a,a,15639,KEGG COMPOUND accession,C00664,5forthf,2311-81-1,15639.0,Human Metabolome Database (HMDB): 5-Formiminotetrahydrofolic acid is a substrate for Formimidoyltransferase-cyclodeaminase.,5-Formiminotetrahydrofolic acid,HMDB0001534,b,b,C00664,5-FORMIMINO-THF,FDB022676,5forthf,[H]OC1=NC(=NC2=C1N(C([H])=N[H])C([H])(C([H])([H])N([H])C1=C([H])C([H])=C(C([H])=C1[H])C(=O)N([H])C([H])(C([O-])=O)C([H])([H])C([H])([H])C([O-])=O)C([H])([H])N2[H])N([H])[H],YCWUVLPMLLBDCU-ZVBGSRNCSA-L,"InChI=1S/C20H24N8O6/c21-9-28-12(8-24-16-15(28)18(32)27-20(22)26-16)7-23-11-3-1-10(2-4-11)17(31)25-13(19(33)34)5-6-14(29)30/h1-4,9,12-13,21,23H,5-8H2,(H,25,31)(H,29,30)(H,33,34)(H4,22,24,26,27,32)/p-2/b21-9+"
3758,5327,a,a,15632,KEGG COMPOUND accession,C05356,5HPET,71774-08-8,15632.0,"Human Metabolome Database (HMDB): 5(S)-Hydroperoxyeicosatetraenoic acid is a lipid hydroperoxide precursor of leukotrienes. The first step of biosynthesis of leukotrienes is conversion of arachidonic acid into 5(S)-hydroperoxy-6,8,11,14-(E,Z,Z,Z)-eicosatetraenoic acid [5(S)-HpETE] by 5- lipoxygenases (5-LOX). Lipid hydroperoxides undergo homolytic decomposition into bifunctional electrophiles, which react with DNA bases to form DNA adducts. These DNA modifications are proposed to be involved in the etiology of cancer, cardiovascular disease, and neurodegeneration. 5-LOX, the enzyme responsible for the formation of 5(S)-HpETE in vivo, is expressed primarily in leukocytes, including monocytes and macrophages. Studies have implicated the 5-LOX pathway as an important mediator in the pathology of atherosclerosis. (PMID: 15777099). Endogenously generated 5-hydroperoxyeicosatetraenoic acid is the preferred substrate for human leukocyte leukotriene A4 synthase activity. Thus, the arachidonic acid moiety is preferentially converted to LTA4 in a concerted reaction without dissociation of a 5-HPETE intermediate. (PMID: 3036580).",5(S)-Hydroperoxyeicosatetraenoic acid,HMDB0001193,b,b,C05356,6E8Z11Z14Z-5S-5-HYDROPEROXYCOSA-6,FDB022480,5HPET,[H]OO[C@]([H])(C([H])=C([H])C([H])=C([H])C([H])([H])C([H])=C([H])C([H])([H])C([H])=C([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H])C([H])([H])C([H])([H])C([H])([H])C([O-])=O,JNUUNUQHXIOFDA-DHORPKIASA-M,"InChI=1S/C20H32O4/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-16-19(24-23)17-15-18-20(21)22/h6-7,9-10,12-14,16,19,23H,2-5,8,11,15,17-18H2,1H3,(H,21,22)/p-1/b7-6-,10-9-,13-12-,16-14?/t19-/m1/s1"
3759,5335,a,a,17780,KEGG COMPOUND accession,C00643,,,,,,,,,,,,,,,
3760,5341,a,a,2065,KEGG COMPOUND accession,C05648,5hoxnfkyn,b,2065.0,"Human Metabolome Database (HMDB): 5-Hydroxy-N-formylkynurenine is an intermediate in tryptophan metabolism. 5-Hydroxy-N-formylkynurenine is converted from 5-Hydroxy-L-tryptophan via the enzyme, indoleamine 2,3-dioxygenase [EC:1.13.11.52].",5-Hydroxy-N-formylkynurenine,HMDB0004086,b,b,C05648,b,FDB023307,b,[H]OC1=C([H])C([H])=C(N([H])C([H])=O)C(=C1[H])C(=O)C([H])([H])C([H])(C([O-])=O)[N+]([H])([H])[H],LSTOUSIIVKMJBU-UHFFFAOYSA-N,"InChI=1S/C11H12N2O5/c12-8(11(17)18)4-10(16)7-3-6(15)1-2-9(7)13-5-14/h1-3,5,8,15H,4,12H2,(H,13,14)(H,17,18)"
3761,5344,a,a,15501,KEGG COMPOUND accession,C03237,,,,,,,,,,,,,,,
3762,5346,a,a,17679,KEGG COMPOUND accession,C04054,,,,,,,,,,,,,,,
3763,5348,a,a,28209,KEGG COMPOUND accession,C04805,C04805,70608-72-9,28209.0,"Human Metabolome Database (HMDB): 5-hydroxyeicosatetraenoic acid (5-HETE) is an endogenous eicosanoid. 5-HETE is an intermediate in arachidonic acid metabolism. It is converted from 5(S)-HPETE via the enzyme glutathione peroxidase (EC 1.11.1.9)and then converted to 5-OxoETE. It is also involved in the pathway of leukotriene synthesis. In addition, it is a modulator of tubuloglomerular feedback.",5-HETE,HMDB0011134,b,b,C04805,b,FDB001434,C04805,[H]O[C@]([H])(C(\[H])=C(/[H])\C(\[H])=C(\[H])C([H])([H])C(\[H])=C(\[H])C([H])([H])C(\[H])=C(\[H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H])C([H])([H])C([H])([H])C([H])([H])C([O-])=O,KGIJOOYOSFUGPC-HSFOLRKZSA-M,"InChI=1S/C20H32O3/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-16-19(21)17-15-18-20(22)23/h6-7,9-10,12-14,16,19,21H,2-5,8,11,15,17-18H2,1H3,(H,22,23)/p-1/b7-6-,10-9-,13-12-,16-14?/t19-/m0/s1"
3764,5360,a,a,27631,KEGG COMPOUND accession,C05832,,,,,,,,,,,,,,,
3765,5365,a,a,28715,KEGG COMPOUND accession,C05638,5hxkynam,708-23-6,28715.0,Human Metabolome Database (HMDB): 5-Hydroxykynurenamine is an intermediate in the tryptophan metabolic pathway [Kegg: C05638]. It is generated from 5-hydroxykynurenine via the enzyme DOPA decarboxylase.,5-Hydroxykynurenamine,HMDB0004076,b,b,C05638,b,FDB023300,b,[H]OC1=C([H])C(C(=O)C([H])([H])C([H])([H])[N+]([H])([H])[H])=C(N([H])[H])C([H])=C1[H],JANBBPTXDKFOQR-UHFFFAOYSA-O,"InChI=1S/C9H12N2O2/c10-4-3-9(13)7-5-6(12)1-2-8(7)11/h1-2,5,12H,3-4,10-11H2/p+1"
3766,5392,a,a,28281,KEGG COMPOUND accession,C05660,5moxact,608-07-1,235589.0,"Human Metabolome Database (HMDB): 5-methoxyindoleacetic acid(5-MIAA) is formed through oxidative deamination. It is identified in the urine, and the concentration is determined to be 1.3 micro g/mL using gas chromatography-mass spectrometry.(PMID: 12908946). There is increase in urinary 5-MIAA-excretion was shown in patients with cancer of the stomach, rectum and lung. (PMID: 2446428).",5-Methoxyindoleacetate,HMDB0004096,b,b,C05660,b,FDB023312,b,[H]N1C([H])=C(C2=C([H])C(OC([H])([H])[H])=C([H])C([H])=C12)C([H])([H])C([O-])=O,COCNDHOPIHDTHK-UHFFFAOYSA-M,"InChI=1S/C11H11NO3/c1-15-8-2-3-10-9(5-8)7(6-12-10)4-11(13)14/h2-3,5-6,12H,4H2,1H3,(H,13,14)/p-1"
3767,5394,a,a,2089,KEGG COMPOUND accession,C05659,,,,,,,,,,,,,,,
3768,5433,a,a,16257,KEGG COMPOUND accession,C01269,,,,,,,,,,,,,,,
3769,5436,a,a,17391,KEGG COMPOUND accession,C04695,,,,,,,,,,,,,,,
3770,5438,a,a,2106,KEGG COMPOUND accession,C10434,,,,,,,,,,,,,,,
3771,5449,a,a,18130,KEGG COMPOUND accession,C02952,,,,,,,,,,,,,,,
3772,5451,a,a,16924,KEGG COMPOUND accession,C02237,,,,,,,,,,,,,,,
3773,5456,a,a,15888,KEGG COMPOUND accession,C02129,,,,,,,,,,,,,,,
3774,5459,a,a,39153,KEGG COMPOUND accession,C03273,oxptn,b,39153.0,"Human Metabolome Database (HMDB): In the lysine degradation IV pathway, glutarate semialdehyde reacts with NADP+ and H2O to produce glutarate, NADPH, and H+. In this pathway, glutarate semialdehyde is produced by the reaction between 5-aminopentanoate and 2-ketoglutarate, with L-glutamate as a byproduct. The enzyme responsible for this reaction is 5-aminovalerate aminotransferase. In the lysine degradation III pathway, glutarate semialdehyde reacts with NAD+ and H2O to produce glutarate and NADH. In this pathway, glutarate semialdehyde is produced by the reaction between 5-aminopentanoate and 2-ketoglutarate, with L-glutamate as a byproduct. The enzyme responsible for this reaction is 5-aminovalerate aminotransferase.",Glutarate semialdehyde,HMDB0012233,b,b,C03273,CPD-654,FDB028876,b,b,VBKPPDYGFUZOAJ-UHFFFAOYSA-N,"InChI=1S/C5H8O3/c6-4-2-1-3-5(7)8/h4H,1-3H2,(H,7,8)"
3775,5473,a,a,17111,KEGG COMPOUND accession,C00119,prpp,7540-64-9,17111.0,"Human Metabolome Database (HMDB): Phosphoribosyl pyrophosphate (PRPP) is a pentosephosphate. The key substance in the biosynthesis of histidine, tryptophan, and purine and pyrimidine nucleotides. It is formed from ribose 5-phosphate by the enzyme ribose-phosphate diphosphokinase. It plays a role in transferring phosphate groups in several reactions. (Wikipedia).",Phosphoribosyl pyrophosphate,HMDB0000280,b,b,C00119,PRPP,FDB021928,prpp,[H]O[C@@]1([H])[C@@]([H])(OP([O-])(=O)OP([O-])([O-])=O)O[C@]([H])(C([H])([H])OP([O-])([O-])=O)[C@@]1([H])O[H],PQGCEDQWHSBAJP-TXICZTDVSA-I,"InChI=1S/C5H13O14P3/c6-3-2(1-16-20(8,9)10)17-5(4(3)7)18-22(14,15)19-21(11,12)13/h2-7H,1H2,(H,14,15)(H2,8,9,10)(H2,11,12,13)/p-5/t2-,3-,4-,5-/m1/s1"
3776,5504,a,a,2131,KEGG COMPOUND accession,C11105,,,,,,,,,,,,,,,
3777,5505,a,a,16058,KEGG COMPOUND accession,C01295,,,,,,,,,,,,,,,
3778,5524,a,a,16608,KEGG COMPOUND accession,C03845,zymstnl,566-97-2,16608.0,"Human Metabolome Database (HMDB): 5a-Cholest-8-en-3b-ol is a normal human metabolite and an intermediate of cholesterol synthesis. The concentrations of zymostenol are higher, both in serum and bile of patients with cerebrotendinous xanthomatosis, compared to controls or in patients with cerebrotendinous xanthomatosis treated with chenodeoxycholic acid. Kidney transplant recipients had lower serum zymostenol when compared to controls. During consumption of plant stanol ester spread by hypercholesterolemic children, plant sterols in the plasma decrease and cholesterol precursor sterols such as zymostenol increase. (PMID: 15736111, 16709621, 16477216, 12756385).",5a-Cholest-8-en-3b-ol,HMDB0006841,b,b,C03845,CPD-8621,FDB024114,zymstnl,[H]O[C@@]1([H])C([H])([H])C([H])([H])[C@@]2(C3=C(C([H])([H])C([H])([H])[C@@]2([H])C1([H])[H])[C@]1([H])C([H])([H])C([H])([H])[C@]([H])([C@]([H])(C([H])([H])[H])C([H])([H])C([H])([H])C([H])([H])C([H])(C([H])([H])[H])C([H])([H])[H])[C@@]1(C([H])([H])[H])C([H])([H])C3([H])[H])C([H])([H])[H],QETLKNDKQOXZRP-XTGBIJOFSA-N,"InChI=1S/C27H46O/c1-18(2)7-6-8-19(3)23-11-12-24-22-10-9-20-17-21(28)13-15-26(20,4)25(22)14-16-27(23,24)5/h18-21,23-24,28H,6-17H2,1-5H3/t19-,20+,21+,23-,24+,26+,27-/m1/s1"
3779,5567,a,a,18285,KEGG COMPOUND accession,C05175,,,,,,,,,,,,,,,
3780,5581,a,a,2160,KEGG COMPOUND accession,C11576,,,,,,,,,,,,,,,
3781,5586,a,a,28376,KEGG COMPOUND accession,C05548,,,,,,,,,,,,,,,
3782,5590,a,a,2164,KEGG COMPOUND accession,C03846,,,,,,,,,,,,,,,
3783,5594,a,a,17901,KEGG COMPOUND accession,C02655,,,,,,,,,,,,,,,
3784,5651,a,a,17075,KEGG COMPOUND accession,C03241,,,,,,,,,,,,,,,
3785,5657,a,a,27524,KEGG COMPOUND accession,C05657,,,,,,,,,,,,,,,
3786,5664,a,a,2197,KEGG COMPOUND accession,C10072,,,,,,,,,,,,,,,
3787,5666,a,a,2198,KEGG COMPOUND accession,C05643,6hoxmelatn,2208-41-5,308079.0,Human Metabolome Database (HMDB): Melatonin is a hormone that is metabolized by cytochrome P450 (CYP) 1A2 to its main primary metabolite 6-hydroxymelatonin. (PMID 11452239).,6-Hydroxymelatonin,HMDB0004081,b,b,C05643,CPD-12014,FDB023304,6hoxmelatn,[H]OC1=C(OC([H])([H])[H])C([H])=C2C(N([H])C([H])=C2C([H])([H])C([H])([H])N([H])C(=O)C([H])([H])[H])=C1[H],OMYMRCXOJJZYKE-UHFFFAOYSA-N,"InChI=1S/C13H16N2O3/c1-8(16)14-4-3-9-7-15-11-6-12(17)13(18-2)5-10(9)11/h5-7,15,17H,3-4H2,1-2H3,(H,14,16)"
3788,5669,a,a,16368,KEGG COMPOUND accession,C02379,,,,,,,,,,,,,,,
3789,5671,a,a,16168,KEGG COMPOUND accession,C01020,,,,,,,,,,,,,,,
3790,5681,a,a,28269,KEGG COMPOUND accession,C05962,M01167,67786-53-2,28269.0,"Human Metabolome Database (HMDB): 6-Ketoprostaglandin E1 (6-keto PGE1) is a biologically active and stable prostacyclin (PGI2) metabolite and a substrate for Adenylate cyclase type III. 6-keto PGE1 is a potent coronary vasodilator. 6-keto PGE1 could be elevated in plasma of patients with primary thrombocythaemia. 6-keto-PGE1 has approximately four times less potent antiplatelet activity than PGI2 on a molar basis in man. The cardiovascular and plasma renin activity (PRA) changes are less prominent for 6-keto-PGE1 than PGI2. Salt loading slightly increases urinary 6-keto PGE1. 6-keto-PGE1 elicits the same biological effects as PGI2 in human platelets and in rabbit aorta and mesenteric artery, being, however, less potent. 6-keto-PGE1 dose-dependently stimulates adenylate cyclase activity in membranes of human platelets and cultured myocytes from rabbit aorta and mesenteric artery. The extent of stimulation of the enzyme by 6-keto-PGE1 is the same as elicited by PGI2, while the apparent affinity is lower than that of prostacyclin, both in platelets and in vascular smooth muscle cells. At the level of platelet membranes, 6-keto-PGE1 interacts with the binding sites labelled by PGI2. However, in platelets as well as in mesenteric artery myocytes, 6-keto-PGE1 interacts with only one class of sites as demonstrated either by binding or by adenylate cyclase studies, whereas PGI2 in the same conditions recognizes two different classes. (PMID: 3186779, 3075239, 3472253, 3912001, 3881881, 6391491)Prostaglandins are eicosanoids. The eicosanoids consist of the prostaglandins (PGs), thromboxanes (TXs), leukotrienes (LTs) and lipoxins (LXs). The PGs and TXs are collectively identified as prostanoids. Prostaglandins were originally shown to be synthesized in the prostate gland, thromboxanes from platelets (thrombocytes) and leukotrienes from leukocytes, hence the derivation of their names. All mammalian cells except erythrocytes synthesize eicosanoids. These molecules are extremely potent, able to cause profound physiological effects at very dilute concentrations. All eicosanoids function locally at the site of synthesis, through receptor-mediated G-protein linked signaling pathways.",6-Ketoprostaglandin E1,HMDB0004241,b,b,C05962,b,FDB023346,b,[H]OC(=O)C([H])([H])C([H])([H])C([H])([H])C([H])([H])C(=O)C([H])([H])[C@@]1([H])C(=O)C([H])([H])[C@@]([H])(O[H])[C@]1([H])C(\[H])=C(/[H])[C@@]([H])(O[H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H],ROUDCKODIMKLNO-CTBSXBMHSA-N,"InChI=1S/C20H32O6/c1-2-3-4-7-14(21)10-11-16-17(19(24)13-18(16)23)12-15(22)8-5-6-9-20(25)26/h10-11,14,16-18,21,23H,2-9,12-13H2,1H3,(H,25,26)/b11-10+/t14-,16+,17+,18+/m0/s1"
3791,5682,a,a,28158,KEGG COMPOUND accession,C05961,CE0955,58962-34-8,28158.0,"Human Metabolome Database (HMDB): 6-keto-Prostaglandin F1a is the physiologically active and stable metabolite of prostacyclin. (A prostaglandin found in nearly all mammalian tissue that is a powerful vasodilator and inhibits platelet aggregation; it is biosynthesized enzymatically from prostaglandin endoperoxides in human vascular tissue; the sodium salt has been also used to treat primary pulmonary hypertension (Hypertension, Pulmonary). A delayed and prolonged increase in 6-keto-PGF1 alpha is reported in animals with septic shock, i.e., those with fecal peritonitis or cecal ligation. 6-keto-Prostaglandin F1a plasma levels has been found increased in patients with epidemic hemorrhagic fever, in patients with acute obstructive suppurative cholangitis, in patients with gynecologic cancer and has significant correlation with the level of high density lipoprotein cholesterol in plasma. (PMID 1976492, 2298410, 2379443, 2111556)Prostaglandins are eicosanoids. The eicosanoids consist of the prostaglandins (PGs), thromboxanes (TXs), leukotrienes (LTs) and lipoxins (LXs). The PGs and TXs are collectively identified as prostanoids. Prostaglandins were originally shown to be synthesized in the prostate gland, thromboxanes from platelets (thrombocytes) and leukotrienes from leukocytes, hence the derivation of their names. All mammalian cells except erythrocytes synthesize eicosanoids. These molecules are extremely potent, able to cause profound physiological effects at very dilute concentrations. All eicosanoids function locally at the site of synthesis, through receptor-mediated G-protein linked signaling pathways.",6-Keto-prostaglandin F1a,HMDB0002886,b,b,C05961,b,FDB023077,CE0955,[H]O[C@]([H])(C(\[H])=C(/[H])[C@@]1([H])[C@]([H])(O[H])C([H])([H])[C@]([H])(O[H])[C@]1([H])C([H])([H])C(=O)C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([O-])=O)C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H],KFGOFTHODYBSGM-ZUNNJUQCSA-M,"InChI=1S/C20H34O6/c1-2-3-4-7-14(21)10-11-16-17(19(24)13-18(16)23)12-15(22)8-5-6-9-20(25)26/h10-11,14,16-19,21,23-24H,2-9,12-13H2,1H3,(H,25,26)/p-1/b11-10+/t14-,16+,17+,18+,19-/m0/s1"
3792,5695,a,a,2212,KEGG COMPOUND accession,C02381,,,,,,,,,,,,,,,
3793,5698,a,a,2213,KEGG COMPOUND accession,C09770,,,,,,,,,,,,,,,
3794,5702,a,a,2215,KEGG COMPOUND accession,C07540,,,,,,,,,,,,,,,
3795,5709,a,a,16405,KEGG COMPOUND accession,C11535,,,,,,,,,,,,,,,
3796,5713,a,a,28762,KEGG COMPOUND accession,C06353,,,,,,,,,,,,,,,
3797,5725,a,a,16123,KEGG COMPOUND accession,C00848,,,,,,,,,,,,,,,
3798,5734,a,a,48928,KEGG COMPOUND accession,C00345,6pgc,921-62-0,48928.0,Human Metabolome Database (HMDB): Intermediate in the Pentose phosphate pathway (KEGG).,6-Phosphogluconic acid,HMDB0001316,b,b,C00345,CPD-2961,FDB022550,6pgc,[H]O[C@@]([H])(C([O-])=O)[C@@]([H])(O[H])[C@]([H])(O[H])[C@]([H])(O[H])C([H])([H])OP([O-])([O-])=O,BIRSGZKFKXLSJQ-SQOUGZDYSA-K,"InChI=1S/C6H13O10P/c7-2(1-16-17(13,14)15)3(8)4(9)5(10)6(11)12/h2-5,7-10H,1H2,(H,11,12)(H2,13,14,15)/p-3/t2-,3-,4+,5-/m1/s1"
3799,5742,a,a,2233,KEGG COMPOUND accession,C04534,6pgg,b,b,b,"6-Phospho-beta-D-glucosyl-(1,4)-D-glucose",b,b,b,C04534,b,b,b,b,b,b
3800,5751,a,a,17139,KEGG COMPOUND accession,C04920,,,,,,,,,,,,,,,
3801,5755,a,a,16271,KEGG COMPOUND accession,C03092,,,,,,,,,,,,,,,
3802,5761,a,a,16784,KEGG COMPOUND accession,C03935,,,,,,,,,,,,,,,
3803,5774,a,a,18399,KEGG COMPOUND accession,C06171,,,,,,,,,,,,,,,
3804,5777,a,a,17109,KEGG COMPOUND accession,C01249,,,,,,,,,,,,,,,
3805,5786,a,a,17508,KEGG COMPOUND accession,C01111,,,,,,,,,,,,,,,
3806,5789,a,a,15838,KEGG COMPOUND accession,C04712,,,,,,,,,,,,,,,
3807,5795,a,a,27910,KEGG COMPOUND accession,C05107,ddsmsterol,1715-86-2,27910.0,"Human Metabolome Database (HMDB): 7-Dehydrodesmosterol is a sterol intermediate in the biosynthesis of steroids. 7-Dehydrodesmosterol is a substrate of the enzyme 24-dehydrocholesterol reductase (EC:1.3.1.72), an important enzyme in the biosynthesis of Cholesterol. Cholesterol is synthesized from either Lathosterol, 7-Dehydrocholesterol, Desmosterol or Cholestenol by the enzyme 3beta-hydroxysterol delta7 reductase (EC 1.3.1.21, Dhcr7). The Smith-Lemli-Opitz syndrome (SLOS, OMIM 270400) is caused by a genetic defect in cholesterol biosynthesis; mutations in the enzyme 3beta-hydroxysterol delta7 reductase lead to a failure of cholesterol synthesis, with an accumulation of precursor sterols, such as 7-Dehydrodesmosterol. SLOS results in craniofacial, limb as well as major organ defects, including the brain. In individuals with this syndrome, mental retardation, as well as other CNS dysfunction, is almost 100% prevalent. (PMID: 15862627, 17197219).",7-Dehydrodesmosterol,HMDB0003896,b,b,C05107,b,FDB012781,ddsmsterol,[H]O[C@]1([H])C([H])([H])C2=C([H])C([H])=C3[C@]4([H])C([H])([H])C([H])([H])[C@]([H])([C@]([H])(C([H])([H])[H])C([H])([H])C([H])([H])C([H])=C(C([H])([H])[H])C([H])([H])[H])[C@@]4(C([H])([H])[H])C([H])([H])C([H])([H])[C@]3([H])[C@@]2(C([H])([H])[H])C([H])([H])C1([H])[H],RUSSPKPUXDSHNC-DDPQNLDTSA-N,"InChI=1S/C27H42O/c1-18(2)7-6-8-19(3)23-11-12-24-22-10-9-20-17-21(28)13-15-26(20,4)25(22)14-16-27(23,24)5/h7,9-10,19,21,23-25,28H,6,8,11-17H2,1-5H3/t19-,21+,23-,24+,25+,26+,27-/m1/s1"
3808,5798,a,a,2260,KEGG COMPOUND accession,C11636,,,,,,,,,,,,,,,
3809,5820,a,a,17825,KEGG COMPOUND accession,C03998,,,,,,,,,,,,,,,
3810,5838,a,a,47789,KEGG COMPOUND accession,C01881,,,,,,,,,,,,,,,
3811,5840,a,a,18431,KEGG COMPOUND accession,C06341,CE5530,4725-24-0,18431.0,"Human Metabolome Database (HMDB): 7-a,27-dihydroxycholesterol is an intermediate in bile acid biosynthesis. The enzyme 27-Hydroxycholesterol 7alpha-monooxygenase [EC:1.14.13.60] catalyzes the production of this metabolite from 27-hydroxycholesterol. This enzyme reaction is irreversible and occurs in the endoplasmic reticulum.","7-a,27-Dihydroxycholesterol",HMDB0006281,b,b,C06341,CPD-7243,FDB023875,b,[H]OC([H])([H])C([H])(C([H])([H])[H])C([H])([H])C([H])([H])C([H])([H])[C@@]([H])(C([H])([H])[H])[C@@]1([H])C([H])([H])C([H])([H])[C@@]2([H])[C@]3([H])[C@]([H])(O[H])C([H])=C4C([H])([H])[C@@]([H])(O[H])C([H])([H])C([H])([H])[C@]4(C([H])([H])[H])[C@@]3([H])C([H])([H])C([H])([H])[C@]12C([H])([H])[H],RXMHNAKZMGJANZ-DTTSCKGMSA-N,"InChI=1S/C27H46O3/c1-17(16-28)6-5-7-18(2)21-8-9-22-25-23(11-13-27(21,22)4)26(3)12-10-20(29)14-19(26)15-24(25)30/h15,17-18,20-25,28-30H,5-14,16H2,1-4H3/t17?,18-,20+,21-,22+,23+,24-,25+,26+,27-/m1/s1"
3812,5840,a,a,18431,KEGG COMPOUND accession,C06341,xoltri27,b,18431.0,"Human Metabolome Database (HMDB): 7-a,27-dihydroxycholesterol is an intermediate in bile acid biosynthesis. The enzyme 27-Hydroxycholesterol 7alpha-monooxygenase [EC:1.14.13.60] catalyzes the production of this metabolite from 27-hydroxycholesterol. This enzyme reaction is irreversible and occurs in the endoplasmic reticulum.","7-a,27-Dihydroxycholesterol",HMDB0006281,b,b,C06341,CPD-7243,FDB023875,xoltri27,[H]OC([H])([H])C([H])(C([H])([H])[H])C([H])([H])C([H])([H])C([H])([H])[C@@]([H])(C([H])([H])[H])[C@@]1([H])C([H])([H])C([H])([H])[C@@]2([H])[C@]3([H])[C@]([H])(O[H])C([H])=C4C([H])([H])[C@@]([H])(O[H])C([H])([H])C([H])([H])[C@]4(C([H])([H])[H])[C@@]3([H])C([H])([H])C([H])([H])[C@]12C([H])([H])[H],RXMHNAKZMGJANZ-DTTSCKGMSA-N,"InChI=1S/C27H46O3/c1-17(16-28)6-5-7-18(2)21-8-9-22-25-23(11-13-27(21,22)4)26(3)12-10-20(29)14-19(26)15-24(25)30/h15,17-18,20-25,28-30H,5-14,16H2,1-4H3/t17?,18-,20+,21-,22+,23+,24-,25+,26+,27-/m1/s1"
3813,5851,a,a,28477,KEGG COMPOUND accession,C05457,xoldiolone,b,28477.0,"Human Metabolome Database (HMDB): 7a,12a-Dihydroxy-cholestene-3-one is an intermediate in bile acid synthesis; is considerably higher in patients with cerebrotendinous xanthomatosis (CTX) than in the normal liver. (PMID 7017048).","7a,12a-Dihydroxy-cholestene-3-one",HMDB0002197,b,b,C05457,b,FDB022899,xoldiolone,[H]O[C@]1([H])C([H])([H])C2=C([H])C(=O)C([H])([H])C([H])([H])[C@]2(C([H])([H])[H])[C@@]2([H])C([H])([H])[C@]([H])(O[H])[C@]3(C([H])([H])[H])[C@]([H])(C([H])([H])C([H])([H])[C@@]3([H])[C@]12[H])[C@]([H])(C([H])([H])[H])C([H])([H])C([H])([H])C([H])([H])C([H])(C([H])([H])[H])C([H])([H])[H],UQPYXHJTHPHOMM-NIBOIBLTSA-N,"InChI=1S/C27H44O3/c1-16(2)7-6-8-17(3)20-9-10-21-25-22(15-24(30)27(20,21)5)26(4)12-11-19(28)13-18(26)14-23(25)29/h13,16-17,20-25,29-30H,6-12,14-15H2,1-5H3/t17-,20-,21+,22+,23-,24+,25+,26+,27-/m1/s1"
3814,5873,a,a,35349,KEGG COMPOUND accession,C02956,,,,,,,,,,,,,,,
3815,5875,a,a,18092,KEGG COMPOUND accession,C06733,,,,,,,,,,,,,,,
3816,5879,a,a,27979,KEGG COMPOUND accession,C03595,,,,,,,,,,,,,,,
3817,5881,a,a,2302,KEGG COMPOUND accession,C11579,,,,,,,,,,,,,,,
3818,5891,a,a,39708,KEGG COMPOUND accession,C11326,,,,,,,,,,,,,,,
3819,5903,a,a,2317,KEGG COMPOUND accession,C11651,,,,,,,,,,,,,,,
3820,5908,a,a,2321,KEGG COMPOUND accession,C11575,,,,,,,,,,,,,,,
3821,5909,a,a,27673,KEGG COMPOUND accession,C02806,,,,,,,,,,,,,,,
3822,5910,a,a,2323,KEGG COMPOUND accession,C05830,,,,,,,,,,,,,,,
3823,5911,a,a,16299,KEGG COMPOUND accession,C02243,,,,,,,,,,,,,,,
3824,5913,a,a,27419,KEGG COMPOUND accession,C02957,,,,,,,,,,,,,,,
3825,5914,a,a,15720,KEGG COMPOUND accession,C22503,,,,,,,,,,,,,,,
3826,5927,a,a,28820,KEGG COMPOUND accession,C11430,,,,,,,,,,,,,,,
3827,6209,a,a,16693,KEGG COMPOUND accession,C06397,,,,,,,,,,,,,,,
3828,6218,a,a,15915,KEGG COMPOUND accession,C06398,,,,,,,,,,,,,,,
3829,6222,a,a,15751,KEGG COMPOUND accession,C00498,adpglc,2140-58-1,15751.0,"Human Metabolome Database (HMDB): Serves as the glycosyl donor for formation of bacterial glycogen, amylose in green algae, and amylopectin in higher plants.",ADP-glucose,HMDB0006557,b,b,C00498,ADP-D-GLUCOSE,FDB001211,b,[H]OC([H])([H])[C@@]1([H])O[C@]([H])(OP([O-])(=O)OP([O-])(=O)OC([H])([H])[C@@]2([H])O[C@@]([H])(N3C([H])=NC4=C(N=C([H])N=C34)N([H])[H])[C@]([H])(O[H])[C@]2([H])O[H])[C@]([H])(O[H])[C@@]([H])(O[H])[C@]1([H])O[H],WFPZSXYXPSUOPY-ROYWQJLOSA-L,"InChI=1S/C16H25N5O15P2/c17-13-7-14(19-3-18-13)21(4-20-7)15-11(26)9(24)6(33-15)2-32-37(28,29)36-38(30,31)35-16-12(27)10(25)8(23)5(1-22)34-16/h3-6,8-12,15-16,22-27H,1-2H2,(H,28,29)(H,30,31)(H2,17,18,19)/p-2/t5-,6-,8-,9-,10+,11-,12-,15-,16-/m1/s1"
3830,6230,a,a,16960,KEGG COMPOUND accession,C00301,adprib,20762-30-5,16960.0,"Human Metabolome Database (HMDB): Adenosine diphosphate ribose is a molecule formed into poly(ADP-ribose) or PAR chains by the enzyme poly ADP ribose polymerase or PARP. PARP is found in every cell nucleus. Its main role is to detect and signal single-strand DNA breaks (SSB) to the enzymatic machinery involved in the SSB repair. PARP activation is an immediate cellular response to metabolic, chemical, or radiation-induced DNA SSB damage. Once PARP detects a SSB, it binds to the DNA, and, after a structural change, begins the synthesis of a poly (ADP-ribose) chain (PAR) as a signal for the other DNA-repairing enzymes such as DNA ligase III (LigIII), DNA polymerase beta, and scaffolding proteins such as X-ray cross-complementing gene 1 (XRCC1). After repairing, the PAR chains are degraded via PAR glycohydrolase (PARG). ADP-ribose binds to and activates the TRPM2 ion channel. Adenosine diphosphate ribose is an intermediate in NAD metabolism. The enzyme NAD(P)+ nucleosidase [EC:3.2.2.6] catalyzes the production of this metabolite from nicotinamide adenine dinucleotide phosphate. This reaction is irreversible and occurs in the cytosol.",Adenosine diphosphate ribose,HMDB0001178,b,b,C00301,ADENOSINE_DIPHOSPHATE_RIBOSE,FDB022468,adprib,[H]OC1([H])O[C@]([H])(C([H])([H])OP([O-])(=O)OP([O-])(=O)OC([H])([H])[C@@]2([H])O[C@@]([H])(N3C([H])=NC4=C(N=C([H])N=C34)N([H])[H])[C@]([H])(O[H])[C@]2([H])O[H])[C@@]([H])(O[H])[C@@]1([H])O[H],SRNWOUGRCWSEMX-IEXJHJBLSA-L,"InChI=1S/C15H23N5O14P2/c16-12-7-13(18-3-17-12)20(4-19-7)14-10(23)8(21)5(32-14)1-30-35(26,27)34-36(28,29)31-2-6-9(22)11(24)15(25)33-6/h3-6,8-11,14-15,21-25H,1-2H2,(H,26,27)(H,28,29)(H2,16,17,18)/p-2/t5-,6-,8-,9-,10-,11-,14-,15?/m0/s1"
3831,6245,a,a,16027,KEGG COMPOUND accession,C00020,amp,61-19-8,16027.0,"Human Metabolome Database (HMDB): Adenosine monophosphate, also known as 5'-adenylic acid and abbreviated AMP, is a nucleotide that is found in RNA. It is an ester of phosphoric acid with the nucleoside adenosine. AMP consists of the phosphate group, the pentose sugar ribose, and the nucleobase adenine. AMP can be produced during ATP synthesis by the enzyme adenylate kinase. AMP has recently been approved as a 'Bitter Blocker' additive to foodstuffs. When AMP is added to bitter foods or foods with a bitter aftertaste it makes them seem 'sweeter'. This potentially makes lower calorie food products more palatable.",Adenosine monophosphate,HMDB0000045,b,b,C00020,AMP,FDB021806,amp,[H]O[C@@]1([H])[C@@]([H])(O[C@]([H])(C([H])([H])OP([O-])([O-])=O)[C@@]1([H])O[H])N1C([H])=NC2=C(N=C([H])N=C12)N([H])[H],UDMBCSSLTHHNCD-KQYNXXCUSA-L,"InChI=1S/C10H14N5O7P/c11-8-5-9(13-2-12-8)15(3-14-5)10-7(17)6(16)4(22-10)1-21-23(18,19)20/h2-4,6-7,10,16-17H,1H2,(H2,11,12,13)(H2,18,19,20)/p-2/t4-,6-,7-,10-/m1/s1"
3832,6733,a,a,2367,KEGG COMPOUND accession,C09318,,,,,,,,,,,,,,,
3833,6748,a,a,2374,KEGG COMPOUND accession,C09907,,,,,,,,,,,,,,,
3834,6869,a,a,2379,KEGG COMPOUND accession,C06803,,,,,,,,,,,,,,,
3835,6873,a,a,15342,KEGG COMPOUND accession,C02807,,,,,,,,,,,,,,,
3836,6876,a,a,2382,KEGG COMPOUND accession,C09982,,,,,,,,,,,,,,,
3837,6878,a,a,15343,KEGG COMPOUND accession,C00084,acald,75-07-0,15343.0,"Human Metabolome Database (HMDB): Acetaldehyde is a colorless, flammable liquid used in the manufacture of acetic acid, perfumes, and flavors. It is also an intermediate in the metabolism of alcohol. It has a general narcotic action and also causes irritation of mucous membranes. Large doses may cause death from respiratory paralysis. Small amounts of acetaldehyde are produced naturally through gut microbial fermentation. Acetaldehyde is produced through the action of alcohol dehydrogenase on ethanol and is somewhate more toxic than ethanol. Acetaldehyde is linked to most of the negative clinical effects of alcohol. It has been shown to increase the risk of developing cirrhosis of the liver, multiple forms of cancer, and alcoholism. Acetaldehyde is found to be associated with aldehyde dehydrogenase deficiency, which is an inborn error of metabolism.",Acetaldehyde,HMDB0000990,b,b,C00084,ACETALD,FDB008297,acald,[H]C(=O)C([H])([H])[H],IKHGUXGNUITLKF-UHFFFAOYSA-N,"InChI=1S/C2H4O/c1-2-3/h2H,1H3"
3838,6903,a,a,27856,KEGG COMPOUND accession,C06244,,,,,,,,,,,,,,,
3839,6983,a,a,28515,KEGG COMPOUND accession,C11106,,,,,,,,,,,,,,,
3840,7053,a,a,2404,KEGG COMPOUND accession,C10664,,,,,,,,,,,,,,,
3841,7059,a,a,15350,KEGG COMPOUND accession,C00227,,,,,,,,,,,,,,,
3842,7068,a,a,15351,KEGG COMPOUND accession,C00024,accoa,72-89-9,15351.0,"Human Metabolome Database (HMDB): The main function of coenzyme A is to carry acyl groups (such as the acetyl group) or thioesters. Acetyl-CoA is an important molecule itself. It is the precursor to HMG CoA, which is a vital component in cholesterol and ketone synthesis. (wikipedia). acetyl CoA participates in the biosynthesis of fatty acids and sterols, in the oxidation of fatty acids and in the metabolism of many amino acids. It also acts as a biological acetylating agent.",Acetyl-CoA,HMDB0001206,b,b,C00024,ACETYL-COA,FDB022491,accoa,[H]O[C@@]([H])(C(=O)N([H])C([H])([H])C([H])([H])C(=O)N([H])C([H])([H])C([H])([H])SC(=O)C([H])([H])[H])C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])OP([O-])(=O)OP([O-])(=O)OC([H])([H])[C@@]1([H])O[C@@]([H])(N2C([H])=NC3=C(N=C([H])N=C23)N([H])[H])[C@]([H])(O[H])[C@]1([H])OP([O-])([O-])=O,ZSLZBFCDCINBPY-ZSJPKINUSA-J,"InChI=1S/C23H38N7O17P3S/c1-12(31)51-7-6-25-14(32)4-5-26-21(35)18(34)23(2,3)9-44-50(41,42)47-49(39,40)43-8-13-17(46-48(36,37)38)16(33)22(45-13)30-11-29-15-19(24)27-10-28-20(15)30/h10-11,13,16-18,22,33-34H,4-9H2,1-3H3,(H,25,32)(H,26,35)(H,39,40)(H,41,42)(H2,24,27,28)(H2,36,37,38)/p-4/t13-,16-,17-,18+,22-/m1/s1"
3843,7167,a,a,17093,KEGG COMPOUND accession,C03939,acACP,b,b,b,Acetyl-ACP,b,b,b,C03939,b,b,b,[H]C([H])([H])C(=O)S[*],b,b
3844,7175,a,a,2412,KEGG COMPOUND accession,C02131,,,,,,,,,,,,,,,
3845,7176,a,a,2413,KEGG COMPOUND accession,C02808,,,,,,,,,,,,,,,
3846,7177,a,a,2414,KEGG COMPOUND accession,C08654,,,,,,,,,,,,,,,
3847,7179,a,a,2415,KEGG COMPOUND accession,C08513,,,,,,,,,,,,,,,
3848,7181,a,a,15355,KEGG COMPOUND accession,C01996,ach,51-84-3,15355.0,"Human Metabolome Database (HMDB): Acetylcholine (ACh) is a neurotransmitter. Acetylcholine in vertebrates is the major transmitter at neuromuscular junctions, autonomic ganglia, parasympathetic effector junctions, a subset of sympathetic effector junctions, and at many sites in the central nervous system. Its physiological and pharmacological effects, metabolism, release, and receptors have been well documented in several species. ACh has been considered an important excitatory neurotransmitter in the carotid body (CB). Various nicotinic and muscarinic ACh receptors are present in both afferent nerve endings and glomus cells. Therefore, ACh can depolarize or hyperpolarize the cell membrane depending on the available receptor type in the vicinity. Binding of ACh to its receptor can create a wide variety of cellular responses including opening cation channels (nicotinic ACh receptor activation), releasing Ca2+ from intracellular storage sites (via muscarinic ACh receptors), and modulating activities of K+ and Ca2+ channels. Interactions between ACh and other neurotransmitters (dopamine, adenosine, nitric oxide) have been known, and they may induce complicated responses. Cholinergic biology in the CB differs among species and even within the same species due to different genetic composition. Development and environment influence cholinergic biology. Pharmacological data clearly indicate that both muscarinic and nicotinic acetylcholine receptors have a role in the encoding of new memories. Localized lesions and antagonist infusions demonstrate the anatomical locus of these cholinergic effects, and computational modeling links the function of cholinergic modulation to specific cellular effects within these regions. Acetylcholine has been shown to increase the strength of afferent input relative to feedback, to contribute to theta rhythm oscillations, activate intrinsic mechanisms for persistent spiking, and increase the modification of synapses. These effects might enhance different types of encoding in different cortical structures. In particular, the effects in entorhinal and perirhinal cortex and hippocampus might be important for encoding new episodic memories. The role of ACh in attention has been repeatedly demonstrated in several tasks. Acetylcholine is linked to response accuracy in voluntary and reflexive attention and also to response speed in reflexive attention. It is well known that those with Attention-deficit/hyperactivity disorders tend to be inaccurate and slow to respond. (PMID: 17284361, 17011181, 15556286).",Acetylcholine ,HMDB0000895,b,b,C01996,ACETYLCHOLINE,FDB012191,ach,[H]C([H])([H])C(=O)OC([H])([H])C([H])([H])[N+](C([H])([H])[H])(C([H])([H])[H])C([H])([H])[H],OIPILFWXSMYKGL-UHFFFAOYSA-N,"InChI=1S/C7H16NO2/c1-7(9)10-6-5-8(2,3)4/h5-6H2,1-4H3/q+1"
3849,7185,a,a,2417,KEGG COMPOUND accession,C08201,,,,,,,,,,,,,,,
3850,7197,a,a,2422,KEGG COMPOUND accession,C07447,,,,,,,,,,,,,,,
3851,7199,a,a,2423,KEGG COMPOUND accession,C11306,,,,,,,,,,,,,,,
3852,7201,a,a,2424,KEGG COMPOUND accession,C02132,,,,,,,,,,,,,,,
3853,7205,a,a,37527,KEGG COMPOUND accession,C00174,,,,,,,,,,,,,,,
3854,7215,a,a,2429,KEGG COMPOUND accession,C08655,,,,,,,,,,,,,,,
3855,7217,a,a,2430,KEGG COMPOUND accession,C06091,,,,,,,,,,,,,,,
3856,7223,a,a,2433,KEGG COMPOUND accession,C09850,,,,,,,,,,,,,,,
3857,7225,a,a,15368,KEGG COMPOUND accession,C01471,,,,,,,,,,,,,,,
3858,7228,a,a,2435,KEGG COMPOUND accession,C10629,,,,,,,,,,,,,,,
3859,7230,a,a,2436,KEGG COMPOUND accession,C10631,,,,,,,,,,,,,,,
3860,7232,a,a,2437,KEGG COMPOUND accession,C10632,,,,,,,,,,,,,,,
3861,7236,a,a,2439,KEGG COMPOUND accession,C09288,,,,,,,,,,,,,,,
3862,7238,a,a,2440,KEGG COMPOUND accession,C09916,,,,,,,,,,,,,,,
3863,7240,a,a,28619,KEGG COMPOUND accession,C01659,,,,,,,,,,,,,,,
3864,7244,a,a,28217,KEGG COMPOUND accession,C01998,,,,,,,,,,,,,,,
3865,7248,a,a,2443,KEGG COMPOUND accession,C09910,,,,,,,,,,,,,,,
3866,7250,a,a,2444,KEGG COMPOUND accession,C09322,,,,,,,,,,,,,,,
3867,7252,a,a,15369,KEGG COMPOUND accession,C01775,,,,,,,,,,,,,,,
3868,7255,a,a,27666,KEGG COMPOUND accession,C06770,,,,,,,,,,,,,,,
3869,7259,a,a,2448,KEGG COMPOUND accession,C06691,,,,,,,,,,,,,,,
3870,7262,a,a,2450,KEGG COMPOUND accession,C01776,,,,,,,,,,,,,,,
3871,7273,a,a,17984,KEGG COMPOUND accession,C00040,,,,,,,,,,,,,,,
3872,7312,a,a,16018,KEGG COMPOUND accession,C00173,,,,,,,,,,,,,,,
3873,7320,a,a,18359,KEGG COMPOUND accession,C00229,ACP,b,b,b,Acyl Carrier Protein,b,b,b,C00229,b,b,b,[H]S[*],b,b
3874,7343,a,a,16030,KEGG COMPOUND accession,C01884,,,,,,,,,,,,,,,
3875,7359,a,a,16708,KEGG COMPOUND accession,C00147,ade,73-24-5,16708.0,"Human Metabolome Database (HMDB): Adenine is a purine base. Adenine is found in both DNA and RNA. Adenine is a fundamental component of adenine nucleotides. Adenine forms adenosine, a nucleoside, when attached to ribose, and deoxyadenosine when attached to deoxyribose; it forms adenosine triphosphate (ATP), a nucleotide, when three phosphate groups are added to adenosine. Adenosine triphosphate is used in cellular metabolism as one of the basic methods of transferring chemical energy between chemical reactions. Purine inborn errors of metabolism (IEM) are serious hereditary disorders, which should be suspected in any case of neonatal fitting, failure to thrive, recurrent infections, neurological deficit, renal disease, self-mutilation and other manifestations. Investigation usually starts with uric acid (UA) determination in urine and plasma. (OMIM 300322, 229600, 603027, 232400, 232600, 232800, 201450, 220150, 232200, 162000, 164050, 278300). (PMID: 17052198, 17520339).",Adenine,HMDB0000034,b,b,C00147,ADENINE,FDB012266,ade,[H]N([H])C1=C2N=C([H])N([H])C2=NC([H])=N1,GFFGJBXGBJISGV-UHFFFAOYSA-N,"InChI=1S/C5H5N5/c6-4-3-5(9-1-7-3)10-2-8-4/h1-2H,(H3,6,7,8,9,10)"
3876,7376,a,a,16335,KEGG COMPOUND accession,C00212,adn,58-61-7,16335.0,"Human Metabolome Database (HMDB): Adenosine is a nucleoside that is composed of adenine and D-ribose. Adenosine or adenosine derivatives play many important biological roles in addition to being components of DNA and RNA. For instance, adenosine plays an important role in energy transfer as adenosine triphosphate (ATP) and adenosine diphosphate (ADP). It also plays a role in signal transduction as cyclic adenosine monophosphate (cAMP). Adenosine itself is both a neurotransmitter and potent vasodilator. When administered intravenously adenosine causes transient heart block in the AV node. Due to the effects of adenosine on AV node-dependent supraventricular tachycardia, adenosine is considered a class V antiarrhythmic agent. Overdoses of adenosine intake (as a drug) can lead to several side effects including chest pain, feeling faint, shortness of breath, and tingling of the senses. Serious side effects include a worsening dysrhythmia and low blood pressure. When present in sufficiently high levels, adenosine can act as an immunotoxin and a metabotoxin. An immunotoxin disrupts, limits the function, or destroys immune cells. A metabotoxin is an endogenous metabolite that causes adverse health effects at chronically high levels. Chronically high levels of adenosine are associated with adenosine deaminase deficiency. Adenosine is a precursor to deoxyadenosine, which is a precursor to dATP. A buildup of dATP in cells inhibits ribonucleotide reductase and prevents DNA synthesis, so cells are unable to divide. Since developing T cells and B cells are some of the most mitotically active cells, they are unable to divide and propagate to respond to immune challenges. High levels of deoxyadenosine also lead to an increase in S-adenosylhomocysteine, which is toxic to immature lymphocytes.",Adenosine,HMDB0000050,b,b,C00212,ADENOSINE,FDB003554,adn,[H]OC([H])([H])[C@@]1([H])O[C@@]([H])(N2C([H])=NC3=C(N=C([H])N=C23)N([H])[H])[C@]([H])(O[H])[C@]1([H])O[H],OIRDTQYFTABQOQ-KQYNXXCUSA-N,"InChI=1S/C10H13N5O4/c11-8-5-9(13-2-12-8)15(3-14-5)10-7(18)6(17)4(1-16)19-10/h2-4,6-7,10,16-18H,1H2,(H2,11,12,13)/t4-,6-,7-,10-/m1/s1"
3877,7392,a,a,28223,KEGG COMPOUND accession,C00946,,,,,,,,,,,,,,,
3878,7435,a,a,2479,KEGG COMPOUND accession,C06510,,,,,,,,,,,,,,,
3879,7436,a,a,2480,KEGG COMPOUND accession,C06508,,,,,,,,,,,,,,,
3880,7490,a,a,2501,KEGG COMPOUND accession,C08395,,,,,,,,,,,,,,,
3881,7504,a,a,2508,KEGG COMPOUND accession,C10209,,,,,,,,,,,,,,,
3882,7515,a,a,2513,KEGG COMPOUND accession,C08885,,,,,,,,,,,,,,,
3883,7517,a,a,17431,KEGG COMPOUND accession,C00179,agm,306-60-5,17431.0,"Human Metabolome Database (HMDB): Agmatine ((4-aminobutyl)guanidine, NH2-CH2-CH2-CH2-CH2-NH-C(-NH2)(=NH)) is the decarboxylation product of the amino acid arginine and is an intermediate in polyamine biosynthesis. It is a putative neurotransmitter. It is synthesized in the brain, stored in synaptic vesicles, accumulated by uptake, released by membrane depolarization, and inactivated by agmatinase. Agmatine binds to 2-adrenergic receptor and imidazoline binding sites, and blocks NMDA receptors and other cation ligand-gated channels. Agmatine inhibits nitric oxide synthase (NOS), and induces the release of some peptide hormones. Treatment with exogenous agmatine exerts neuroprotective effects in animal models of neurotrauma. -- Wikipedia.",Agmatine,HMDB0001432,b,b,C00179,AGMATHINE,FDB008310,agm,[H]N([H])C(N([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[N+]([H])([H])[H])=[N+]([H])[H],QYPPJABKJHAVHS-UHFFFAOYSA-P,"InChI=1S/C5H14N4/c6-3-1-2-4-9-5(7)8/h1-4,6H2,(H4,7,8,9)/p+2"
3884,7526,a,a,2515,KEGG COMPOUND accession,C09765,,,,,,,,,,,,,,,
3885,7530,a,a,581177,KEGG COMPOUND accession,C10210,,,,,,,,,,,,,,,
3886,7546,a,a,28462,KEGG COMPOUND accession,C06542,,,,,,,,,,,,,,,
3887,7548,a,a,27984,KEGG COMPOUND accession,C08810,,,,,,,,,,,,,,,
3888,7556,a,a,70499,KEGG COMPOUND accession,C09025,,,,,,,,,,,,,,,
3889,7562,a,a,2533,KEGG COMPOUND accession,C10928,,,,,,,,,,,,,,,
3890,7574,a,a,16449,KEGG COMPOUND accession,C01401,,,,,,,,,,,,,,,
3891,7583,a,a,2543,KEGG COMPOUND accession,C08732,,,,,,,,,,,,,,,
3892,7604,a,a,30879,KEGG COMPOUND accession,C00069,,,,,,,,,,,,,,,
3893,7644,a,a,35375,KEGG COMPOUND accession,C02810,,,,,,,,,,,,,,,
3894,7646,a,a,2559,KEGG COMPOUND accession,C03251,,,,,,,,,,,,,,,
3895,7649,a,a,15693,KEGG COMPOUND accession,C01370,,,,,,,,,,,,,,,
3896,7654,a,a,27584,KEGG COMPOUND accession,C01780,aldstrn,52-39-1,27584.0,"Human Metabolome Database (HMDB): Aldosterone is a steroid hormone produced by the adrenal cortex in the adrenal gland to regulate sodium and potassium balance in the blood. Specifically it regulates electrolyte and water balance by increasing the renal retention of sodium and the excretion of potassium. It is synthesized from cholesterol by aldosterone synthase, which is absent in other sections of the adrenal gland. It is the sole endogenous member of the class of mineralocorticoids. Aldosterone increases the permeability of the apical (luminal) membrane of the kidney's collecting ducts to potassium and sodium and activates their basolateral Na+/K+ pumps, stimulating ATP hydrolysis, reabsorbing sodium (Na+) ions and water into the blood, and excreting potassium (K+) ions into the urine.",Aldosterone,HMDB0000037,b,b,C01780,ALDOSTERONE,FDB021883,aldstrn,[H]OC([H])([H])C(=O)[C@@]1([H])C([H])([H])C([H])([H])[C@@]2([H])[C@]3([H])C([H])([H])C([H])([H])C4=C([H])C(=O)C([H])([H])C([H])([H])[C@]4(C([H])([H])[H])[C@@]3([H])[C@@]([H])(O[H])C([H])([H])[C@]12C([H])=O,PQSUYGKTWSAVDQ-ZVIOFETBSA-N,"InChI=1S/C21H28O5/c1-20-7-6-13(24)8-12(20)2-3-14-15-4-5-16(18(26)10-22)21(15,11-23)9-17(25)19(14)20/h8,11,14-17,19,22,25H,2-7,9-10H2,1H3/t14-,15-,16+,17-,19+,20-,21+/m0/s1"
3897,7664,a,a,2567,KEGG COMPOUND accession,C07752,,,,,,,,,,,,,,,
3898,7668,a,a,2569,KEGG COMPOUND accession,C08005,,,,,,,,,,,,,,,
3899,7672,a,a,2571,KEGG COMPOUND accession,C02525,,,,,,,,,,,,,,,
3900,7673,a,a,29348,KEGG COMPOUND accession,C02244,,,,,,,,,,,,,,,
3901,7681,a,a,18310,KEGG COMPOUND accession,C01371,,,,,,,,,,,,,,,
3902,7702,a,a,47908,KEGG COMPOUND accession,C00812,,,,,,,,,,,,,,,
3903,7710,a,a,60983,KEGG COMPOUND accession,C06235,,,,,,,,,,,,,,,
3904,7721,a,a,28411,KEGG COMPOUND accession,C07600,,,,,,,,,,,,,,,
3905,7723,a,a,2596,KEGG COMPOUND accession,C08265,,,,,,,,,,,,,,,
3906,7737,a,a,28315,KEGG COMPOUND accession,C07599,CE0074,50-71-5,730073.0,"Human Metabolome Database (HMDB): Alloxan or mesoxalylurea is an organic compound based on a pyrimidine heterocyclic skeleton. This compound has a high affinity for water and therefore exists as the monohydrate. The compound was discovered by Justus von Liebig and Friedrich Wohler following the discovery of urea in 1828 and is one of the oldest named organic compounds that exist. The name is derived from allantoin, a product of uric acid excreted by the fetus into the allantois and oxaluric acid derived from oxalic acid and urea, found in urine. The original recipe for Alloxan was by oxidation of uric acid by nitric acid. Alloxan is a strong oxidizing agent and it forms a hemiacetal with its reduced reaction product dialuric acid (in which a carbonyl group is reduced to a hydroxyl group) which is called alloxantin. -- Wikipedia; Alloxane is a raw material for the production of the purple dye Murexide. Carl Wilhelm Scheele discovered the dye in 1776. Murexide is the product of the complex in-situ multistep reaction of alloxantin and gaseous ammonia. Murexide results from the condensation of the unisolated intermdiate uramil with alloxan, liberated during the course of the reaction. Scheele sourced uric acid from human calculi (such as kidney stones) and called the compound lithic acid. William Prout investigated the compound in 1818 and he used boa constrictor excrement with up to 90% ammonium acid urate. Liebig and Wohler in the nineteenth century coined the name murexide for the dye after the Trunculus Murex which is the source of the Tyrian purple of antiquity. Primo Levi in his world famous novel The Periodic Table in chapter Nitrogen considers pythons as a source for alloxane on behalf of a lipstick producer but he is turned down by the director of the Turin zoo because the zoo already has lucrative contracts with cosmetics companies (his attempts with chicken dung end in misery). -- Wikipedia.",Alloxan,HMDB0002818,b,b,C07599,CPD-3684,FDB023068,CE0074,[H]N1C(=O)N([H])C(=O)C(=O)C1=O,HIMXGTXNXJYFGB-UHFFFAOYSA-L,"InChI=1S/C4H2N2O4/c7-1-2(8)5-4(10)6-3(1)9/h(H2,5,6,8,9,10)/p-2"
3907,7742,a,a,17027,KEGG COMPOUND accession,C01475,L2aadp6sa,1962-83-0,17027.0,"Human Metabolome Database (HMDB): Allysine is a derivative of Lysine, used in the production of elastin and collagen. It is produced by the actions of the enzyme lysyl oxidase in the extracellular matrix and is essential in the crosslink formation that stabilizes collagen and elastin.",Allysine,HMDB0001263,b,b,C01475,ALLYSINE,FDB022519,L2aadp6sa,[H]C(=O)C([H])([H])C([H])([H])C([H])([H])C([H])(C([O-])=O)[N+]([H])([H])[H],GFXYTQPNNXGICT-YFKPBYRVSA-N,"InChI=1S/C6H11NO3/c7-5(6(9)10)3-1-2-4-8/h4-5H,1-3,7H2,(H,9,10)/t5-/m0/s1"
3908,7755,a,a,2611,KEGG COMPOUND accession,C06817,,,,,,,,,,,,,,,
3909,7771,a,a,2619,KEGG COMPOUND accession,C07939,,,,,,,,,,,,,,,
3910,7787,a,a,2627,KEGG COMPOUND accession,C07773,,,,,,,,,,,,,,,
3911,7793,a,a,2630,KEGG COMPOUND accession,C10994,,,,,,,,,,,,,,,
3912,7829,a,a,2636,KEGG COMPOUND accession,C06819,,,,,,,,,,,,,,,
3913,7831,a,a,2637,KEGG COMPOUND accession,C06820,,,,,,,,,,,,,,,
3914,7835,a,a,2639,KEGG COMPOUND accession,C06821,,,,,,,,,,,,,,,
3915,7848,a,a,33704,KEGG COMPOUND accession,C00045,,,,,,,,,,,,,,,
3916,7867,a,a,2651,KEGG COMPOUND accession,C05156,,,,,,,,,,,,,,,
3917,7878,a,a,17475,KEGG COMPOUND accession,C00872,,,,,,,,,,,,,,,
3918,7900,a,a,2668,KEGG COMPOUND accession,C06825,,,,,,,,,,,,,,,
3919,7950,a,a,28102,KEGG COMPOUND accession,C00718,,,,,,,,,,,,,,,
3920,7974,a,a,2704,KEGG COMPOUND accession,C08159,,,,,,,,,,,,,,,
3921,8007,a,a,27727,KEGG COMPOUND accession,C07632,,,,,,,,,,,,,,,
3922,8020,a,a,28928,KEGG COMPOUND accession,C09060,,,,,,,,,,,,,,,
3923,8022,a,a,2718,KEGG COMPOUND accession,C00873,,,,,,,,,,,,,,,
3924,8071,a,a,2740,KEGG COMPOUND accession,C09337,,,,,,,,,,,,,,,
3925,8085,a,a,2747,KEGG COMPOUND accession,C08326,,,,,,,,,,,,,,,
3926,8089,a,a,27867,KEGG COMPOUND accession,C08579,,,,,,,,,,,,,,,
3927,8099,a,a,16307,KEGG COMPOUND accession,C03940,,,,,,,,,,,,,,,
3928,8101,a,a,2755,KEGG COMPOUND accession,C10297,,,,,,,,,,,,,,,
3929,8103,a,a,2756,KEGG COMPOUND accession,C06831,,,,,,,,,,,,,,,
3930,8105,a,a,30754,KEGG COMPOUND accession,C00108,anth,118-92-3,30754.0,Human Metabolome Database (HMDB): 2-Aminobenzoic acid is an organic compound. It is a substrate of enzyme anthranilate hydroxylase [EC 1.14.13.35] in benzoate degradation via hydroxylation pathway (KEGG).,2-Aminobenzoic acid,HMDB0001123,b,b,C00108,ANTHRANILATE,FDB000896,anth,[H]N([H])C1=C(C([H])=C([H])C([H])=C1[H])C([O-])=O,RWZYAGGXGHYGMB-UHFFFAOYSA-M,"InChI=1S/C7H7NO2/c8-6-4-2-1-3-5(6)7(9)10/h1-4H,8H2,(H,9,10)/p-1"
3931,8126,a,a,2760,KEGG COMPOUND accession,C10765,,,,,,,,,,,,,,,
3932,8128,a,a,2761,KEGG COMPOUND accession,C11340,,,,,,,,,,,,,,,
3933,8130,a,a,2762,KEGG COMPOUND accession,C11339,,,,,,,,,,,,,,,
3934,8132,a,a,28373,KEGG COMPOUND accession,C08848,,,,,,,,,,,,,,,
3935,8138,a,a,2766,KEGG COMPOUND accession,C06088,,,,,,,,,,,,,,,
3936,8142,a,a,18388,KEGG COMPOUND accession,C01477,,,,,,,,,,,,,,,
3937,8150,a,a,18330,KEGG COMPOUND accession,C01714,,,,,,,,,,,,,,,
3938,8161,a,a,16139,KEGG COMPOUND accession,C03688,HC01161,b,b,b,Apo-ACP,b,b,b,C03688,b,b,b,b,b,b
3939,8161,a,a,16139,KEGG COMPOUND accession,C03688,HC02222,b,b,b,Mitoapo-ACP,b,b,b,C03688,b,b,b,b,b,b
3940,8161,a,a,16139,KEGG COMPOUND accession,C03688,HC02223,b,b,b,Mito-ACP,b,b,b,C03688,b,b,b,b,b,b
3941,8171,a,a,2781,KEGG COMPOUND accession,C11380,,,,,,,,,,,,,,,
3942,8187,a,a,2790,KEGG COMPOUND accession,C01555,,,,,,,,,,,,,,,
3943,8189,a,a,2791,KEGG COMPOUND accession,C07826,,,,,,,,,,,,,,,
3944,8193,a,a,15852,KEGG COMPOUND accession,C00992,aqcobal,b,15852.0,"Human Metabolome Database (HMDB): Aquacobalamin is one of the major forms of vitamin B(12) isolated from mammalian cells. Aquacobalamin and the thiolate forms of glutathione are the precursors of glutathionylcobalamin (GSCbl, a precursor to the formation of the two coenzyme forms of vitamin B(12), adenosylcobalamin and methylcobalamin) in mammalian cells. Under biological conditions the formation of GSCbl from aquacobalamin and glutathione is essentially irreversible; upon entering cells, any free (protein-unbound) aquacobalamin could be rapidly and irreversibly converted to GSCbl. (PMID: 15476387). Aquacobalamin is reduced to cob(II)alamin by Methionine synthase reductse (MSR) in the presence of NADPH, and this reduction leads to stimulation of the conversion of apomethionine synthase and aquacobalamin to methionine synthase holoenzyme. MSR serves as a special chaperone for human methionine synthase and as an aquacobalamin reductase, rather than acting solely in the reductive activation of methionine synthase. (PMID: 16769880 ).",Aquacobalamin,HMDB0003458,b,b,C00992,AQUACOBIIIALAMIN,FDB023178,aqcobal,[H]OC([H])([H])[C@@]1([H])O[C@]([H])(n2c([H])[nH]c3c([H])c(c(c([H])c23)C([H])([H])[H])C([H])([H])[H])[C@]([H])(O[H])[C@]1([H])OP([O-])(=O)O[C@]([H])(C([H])([H])[H])C([H])([H])N([H])C(=O)C([H])([H])C([H])([H])[C@]1(\C2=C(\C3=N\C(=C([H])/C4=NC(=C(C5=N[C@@](C([H])([H])[H])([C@]([H])(N2[Co+][O+]([H])[H])[C@]1([H])C([H])([H])C(=O)N([H])[H])[C@@](C([H])([H])[H])(C([H])([H])C(=O)N([H])[H])[C@]5([H])C([H])([H])C([H])([H])C(=O)N([H])[H])C([H])([H])[H])[C@@](C([H])([H])[H])(C([H])([H])C(=O)N([H])[H])[C@]4([H])C([H])([H])C([H])([H])C(=O)N([H])[H])\C(C([H])([H])[H])(C([H])([H])[H])[C@]3([H])C([H])([H])C([H])([H])C(=O)N([H])[H])C([H])([H])[H])C([H])([H])[H],YOZNUFWCRFCGIH-WZHZPDAFSA-L,"InChI=1S/C62H90N13O14P.Co.H2O/c1-29-20-39-40(21-30(29)2)75(28-70-39)57-52(84)53(41(27-76)87-57)89-90(85,86)88-31(3)26-69-49(83)18-19-59(8)37(22-46(66)80)56-62(11)61(10,25-48(68)82)36(14-17-45(65)79)51(74-62)33(5)55-60(9,24-47(67)81)34(12-15-43(63)77)38(71-55)23-42-58(6,7)35(13-16-44(64)78)50(72-42)32(4)54(59)73-56;;/h20-21,23,28,31,34-37,41,52-53,56-57,76,84H,12-19,22,24-27H2,1-11H3,(H15,63,64,65,66,67,68,69,71,72,73,74,77,78,79,80,81,82,83,85,86);;1H2/q;+3;/p-2/t31-,34-,35-,36-,37+,41-,52-,53-,56-,57+,59-,60+,61+,62+;;/m1../s1"
3945,8204,a,a,15843,KEGG COMPOUND accession,C00219,arachd,506-32-1,15843.0,"Human Metabolome Database (HMDB): Arachidonic acid is a polyunsaturated, essential fatty acid. It is found in animal and human fat as well as in the liver, brain, and glandular organs, and is a constituent of animal phosphatides. It is formed by the synthesis from dietary linoleic acid. Arachidonic acid mediates inflammation and the functioning of several organs and systems either directly or upon its conversion into eicosanoids. Arachidonic acid in cell membrane phospholipids is the substrate for the synthesis of a range of biologically active compounds (eicosanoids) including prostaglandins, thromboxanes, and leukotrienes. These compounds can act as mediators in their own right and can also act as regulators of other processes, such as platelet aggregation, blood clotting, smooth muscle contraction, leukocyte chemotaxis, inflammatory cytokine production, and immune function. Arachidonic acid can be metabolized by cytochrome p450 (CYP450) enzymes to 5,6-, 8,9-, 11,12-, and 14,15-epoxyeicosatrienoic acids (EETs), their corresponding dihydroxyeicosa-trienoic acids (DHETs), and 20-hydroxyeicosatetraenoic acid (20-HETE). The production of kidney CYP450 arachidonic acid metabolites is altered in diabetes, pregnancy, hepatorenal syndrome, and in various models of hypertension, and it is likely that changes in this system contribute to the abnormalities in renal function that are associated with many of these conditions. Phospholipase A2 (PLA2) catalyzes the hydrolysis of the sn-2 position of membrane glycerophospholipids to liberate arachidonic acid (PMID: 12736897, 12736897, 12700820, 12570747, 12432908).",Arachidonic acid,HMDB0001043,b,b,C00219,ARACHIDONIC_ACID,FDB011872,arachd,[H]\C(=C(/[H])C([H])([H])C(\[H])=C(\[H])C([H])([H])C([H])([H])C([H])([H])C([O-])=O)C([H])([H])C(\[H])=C(\[H])C([H])([H])C(\[H])=C(\[H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H],YZXBAPSDXZZRGB-DOFZRALJSA-M,"InChI=1S/C20H32O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20(21)22/h6-7,9-10,12-13,15-16H,2-5,8,11,14,17-19H2,1H3,(H,21,22)/p-1/b7-6-,10-9-,13-12-,16-15-"
3946,8219,a,a,18000,KEGG COMPOUND accession,C01890,,,,,,,,,,,,,,,
3947,8263,a,a,18027,KEGG COMPOUND accession,C02004,,,,,,,,,,,,,,,
3948,8283,a,a,33855,KEGG COMPOUND accession,C00193,,,,,,,,,,,,,,,
3949,8292,a,a,33856,KEGG COMPOUND accession,C01021,,,,,,,,,,,,,,,
3950,8301,a,a,69335,KEGG COMPOUND accession,C09300,,,,,,,,,,,,,,,
3951,8315,a,a,29866,KEGG COMPOUND accession,C06697,aso3,b,29866.0,"Human Metabolome Database (HMDB): In chemistry an arsenite is a chemical compound containing an arsenic oxoanion where arsenic has oxidation state +3. Examples of arsenites include sodium arsenite which contains a polymeric linear anion, [AsO2&#8722;]n, silver arsenite, Ag3AsO3, which contains the trigonal, [AsO3]3&#8722; anion, sometimes called ortho-arsenite. Arsenite contrasts to the corresponding anions of the lighter members of group 15, phosphite which has the structure [HPO3]2&#8722; and nitrite, NO2&#8722; which is planar. Sodium arsenite is used in the water gas shift reaction to remove carbon dioxide. Arsenic Trioxide is indicated for induction of remission and consolidation in patients with acute promyelocytic leukemia (APL) who are refractory to, or have relapsed from, retinoid and anthracycline chemotherapy.(Wikipedia).",Arsenite,HMDB0011620,b,b,C06697,b,b,b,b,b,b
3952,8315,a,a,29866,KEGG COMPOUND accession,C06697,M01367,15502-74-6,29866.0,"Human Metabolome Database (HMDB): In chemistry an arsenite is a chemical compound containing an arsenic oxoanion where arsenic has oxidation state +3. Examples of arsenites include sodium arsenite which contains a polymeric linear anion, [AsO2&#8722;]n, silver arsenite, Ag3AsO3, which contains the trigonal, [AsO3]3&#8722; anion, sometimes called ortho-arsenite. Arsenite contrasts to the corresponding anions of the lighter members of group 15, phosphite which has the structure [HPO3]2&#8722; and nitrite, NO2&#8722; which is planar. Sodium arsenite is used in the water gas shift reaction to remove carbon dioxide. Arsenic Trioxide is indicated for induction of remission and consolidation in patients with acute promyelocytic leukemia (APL) who are refractory to, or have relapsed from, retinoid and anthracycline chemotherapy.(Wikipedia).",Arsenite,HMDB0011620,b,b,C06697,CPD-763,FDB028324,b,[H]O[As](O[H])O[H],GCPXMJHSNVMWNM-UHFFFAOYSA-N,InChI=1S/AsH3O3/c2-1(3)4/h2-4H
3953,8344,a,a,37558,KEGG COMPOUND accession,C03254,,,,,,,,,,,,,,,
3954,8376,a,a,2871,KEGG COMPOUND accession,C09471,,,,,,,,,,,,,,,
3955,8425,a,a,2894,KEGG COMPOUND accession,C11083,,,,,,,,,,,,,,,
3956,8453,a,a,2908,KEGG COMPOUND accession,C10052,,,,,,,,,,,,,,,
3957,8465,a,a,2914,KEGG COMPOUND accession,C07548,,,,,,,,,,,,,,,
3958,8469,a,a,15930,KEGG COMPOUND accession,C06551,,,,,,,,,,,,,,,
3959,8472,a,a,16684,KEGG COMPOUND accession,C01479,,,,,,,,,,,,,,,
3960,8487,a,a,28268,KEGG COMPOUND accession,C10303,,,,,,,,,,,,,,,
3961,8507,a,a,2934,KEGG COMPOUND accession,C08661,,,,,,,,,,,,,,,
3962,8513,a,a,2937,KEGG COMPOUND accession,C08887,,,,,,,,,,,,,,,
3963,8515,a,a,2938,KEGG COMPOUND accession,C08888,,,,,,,,,,,,,,,
3964,8521,a,a,2941,KEGG COMPOUND accession,C10021,,,,,,,,,,,,,,,
3965,8535,a,a,2948,KEGG COMPOUND accession,C06837,,,,,,,,,,,,,,,
3966,8557,a,a,2959,KEGG COMPOUND accession,C11092,,,,,,,,,,,,,,,
3967,8584,a,a,30033,KEGG COMPOUND accession,C11242,,,,,,,,,,,,,,,
3968,8585,a,a,30034,KEGG COMPOUND accession,C11243,,,,,,,,,,,,,,,
3969,8587,a,a,38201,KEGG COMPOUND accession,C05799,,,,,,,,,,,,,,,
3970,8591,a,a,2980,KEGG COMPOUND accession,C10024,,,,,,,,,,,,,,,
3971,8593,a,a,2981,KEGG COMPOUND accession,C10025,,,,,,,,,,,,,,,
3972,8615,a,a,2992,KEGG COMPOUND accession,C08662,,,,,,,,,,,,,,,
3973,8635,a,a,3001,KEGG COMPOUND accession,C06842,,,,,,,,,,,,,,,
3974,8639,a,a,28941,KEGG COMPOUND accession,C08281,docosac,112-85-6,28941.0,"Human Metabolome Database (HMDB): Behenic acid, also docosanoic acid, is a normal carboxylic acid, a fatty acid with formula C21H43COOH. -- Wikipedia; It is an important constituent of the behen oil extracted from the seeds of the Ben-oil tree, and it is so named from the Persian month Bahman when the roots of this tree were harvested. -- Wikipedia.",Behenic acid,HMDB0000944,b,b,C08281,b,FDB021815,docosac,[H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([O-])=O,UKMSUNONTOPOIO-UHFFFAOYSA-M,"InChI=1S/C22H44O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20-21-22(23)24/h2-21H2,1H3,(H,23,24)/p-1"
3975,8656,a,a,3012,KEGG COMPOUND accession,C07701,,,,,,,,,,,,,,,
3976,8658,a,a,3013,KEGG COMPOUND accession,C07758,,,,,,,,,,,,,,,
3977,8660,a,a,3014,KEGG COMPOUND accession,C11073,,,,,,,,,,,,,,,
3978,8662,a,a,3015,KEGG COMPOUND accession,C10896,,,,,,,,,,,,,,,
3979,8668,a,a,3018,KEGG COMPOUND accession,C10965,,,,,,,,,,,,,,,
3980,8670,a,a,17169,KEGG COMPOUND accession,C00261,,,,,,,,,,,,,,,
3981,8679,a,a,3020,KEGG COMPOUND accession,C08037,,,,,,,,,,,,,,,
3982,8685,a,a,41033,KEGG COMPOUND accession,C01784,,,,,,,,,,,,,,,
3983,8700,a,a,17701,KEGG COMPOUND accession,C01785,,,,,,,,,,,,,,,
3984,8703,a,a,41275,KEGG COMPOUND accession,C02009,,,,,,,,,,,,,,,
3985,8705,a,a,30746,KEGG COMPOUND accession,C00180,bz,65-85-0,30746.0,"Human Metabolome Database (HMDB): Benzoic acid, C6H5COOH, is a colourless crystalline solid and the simplest aromatic carboxylic acid. Benzoic acid occurs naturally free and bound as benzoic acid esters in many plant and animal species. Appreciable amounts have been found in most berries (around 0.05%). Cranberries contain as much as 300-1300 mg free benzoic acid per kg fruit. Benzoic acid is a fungistatic compound that is widely used as a food preservative. It often is conjugated to glycine in the liver and excreted as hippuric acid. Benzoic acid is a byproduct of phenylalanine metabolism in bacteria. It is also produced when gut bacteria process polyphenols (from ingested fruits or beverages).",Benzoic acid,HMDB0001870,b,b,C00180,BENZOATE,FDB008739,bz,[H]C1=C([H])C([H])=C(C([H])=C1[H])C([O-])=O,WPYMKLBDIGXBTP-UHFFFAOYSA-M,"InChI=1S/C7H6O2/c8-7(9)6-4-2-1-3-5-6/h1-5H,(H,8,9)/p-1"
3986,8719,a,a,116735,KEGG COMPOUND accession,C07527,,,,,,,,,,,,,,,
3987,8726,a,a,27991,KEGG COMPOUND accession,C09814,,,,,,,,,,,,,,,
3988,8730,a,a,41308,KEGG COMPOUND accession,C06354,,,,,,,,,,,,,,,
3989,8750,a,a,29865,KEGG COMPOUND accession,C07535,C07535,50-32-8,29865.0,b,Benzpyrene,b,b,b,C07535,b,b,b,c1cccc2c1c1c3c(c2)ccc2c3c(cc1)ccc2,FMMWHPNWAFZXNH-UHFFFAOYSA-N,b
3990,8771,a,a,17484,KEGG COMPOUND accession,C03098,,,,,,,,,,,,,,,
3991,8782,a,a,16054,KEGG COMPOUND accession,C09816,,,,,,,,,,,,,,,
3992,8786,a,a,3061,KEGG COMPOUND accession,C06847,,,,,,,,,,,,,,,
3993,8792,a,a,16777,KEGG COMPOUND accession,C05177,,,,,,,,,,,,,,,
3994,8804,a,a,17377,KEGG COMPOUND accession,C00758,,,,,,,,,,,,,,,
3995,8815,a,a,17750,KEGG COMPOUND accession,C00719,glyb,107-43-7,17750.0,"Human Metabolome Database (HMDB): Betaine, (or N,N,N-trimethylglycine) was named after its discovery in sugar beet (Beta vulgaris) in the 19th century. It is a small N-trimethylated amino acid, existing in zwitterionic form at neutral pH. It is now often called glycine betaine to distinguish it from other betaines that are widely distributed in microorganisms, plants and animals.  Many naturally occurring betaines serve as organic osmolytes, substances synthesized or taken up from the environment by cells for protection against osmotic stress, drought, high salinity or high temperature. Intracellular accumulation of betaines permits water retention in cells, thus protecting from the effects of dehydration (Wikipedia). Betaine functions as a methyl donor in that it carries and donates methyl functional groups to facilitate necessary chemical processes. In particular it methylates homocysteine to methionine, also producing N,N-dimethylglycine. The donation of methyl groups is important to proper liver function, cellular replication, and detoxification reactions. Betaine also plays a role in the manufacture of carnitine and serves to protect the kidneys from damage. Betaine comes from either the diet or by the oxidation of choline. Betaine insufficiency is associated with the metabolic syndrome, lipid disorders and diabetes, and may have a role in vascular and other diseases (PMID: 20346934). Betaine is found to be associated with propionic acidemia, which is an inborn error of metabolism. Betaine is important in development, from the pre-implantation embryo to infancy. Betaine is also widely regarded as an anti-oxidant.  Betaine has been shown to have an inhibitory effect on NO release in activated microglial cells and may be an effective therapeutic component to control neurological disorders (PMID: 22801281).  As a drug, betaine hydrochloride has been used as a source of hydrochloric acid in the treatment of hypochlorhydria. Betaine has also been used in the treatment of liver disorders, for hyperkalemia, for homocystinuria, and for gastrointestinal disturbances (From Martindale, The Extra Pharmacopoeia, 30th Ed, p1341).",Betaine,HMDB0000043,b,b,C00719,BETAINE,FDB009020,glyb,[H]C([H])([H])[N+](C([H])([H])[H])(C([H])([H])[H])C([H])([H])C([O-])=O,KWIUHFFTVRNATP-UHFFFAOYSA-N,"InChI=1S/C5H11NO2/c1-6(2,3)4-5(7)8/h4H2,1-3H3"
3996,8846,a,a,3086,KEGG COMPOUND accession,C08618,,,,,,,,,,,,,,,
3997,8850,a,a,3088,KEGG COMPOUND accession,C06457,,,,,,,,,,,,,,,
3998,8854,a,a,3090,KEGG COMPOUND accession,C08160,,,,,,,,,,,,,,,
3999,8858,a,a,3092,KEGG COMPOUND accession,C09364,,,,,,,,,,,,,,,
4000,8860,a,a,3093,KEGG COMPOUND accession,C10980,,,,,,,,,,,,,,,
4001,8895,a,a,3104,KEGG COMPOUND accession,C10770,,,,,,,,,,,,,,,
4002,8897,a,a,17574,KEGG COMPOUND accession,C00814,,,,,,,,,,,,,,,
4003,8905,a,a,15956,KEGG COMPOUND accession,C00120,btn,58-85-5,15956.0,"Human Metabolome Database (HMDB): Biotin is an enzyme co-factor present in minute amounts in every living cell. Biotin is also known as vitamin H or B7 or coenzyme R. It occurs mainly bound to proteins or polypeptides and is abundant in liver, kidney, pancreas, yeast, and milk. Biotin has been recognized as an essential nutrient. Our biotin requirement is fulfilled in part through diet, through endogenous reutilization of biotin and perhaps through capture of biotin generated in the intestinal flora. The utilization of biotin for covalent attachment to carboxylases and its reutilization through the release of carboxylase biotin after proteolytic degradation constitutes the 'biotin cycle'. Biotin deficiency is associated with neurological manifestations, skin rash, hair loss and metabolic disturbances that are thought to relate to the various carboxylase deficiencies (metabolic ketoacidosis with lactic acidosis). It has also been suggested that biotin deficiency is associated with protein malnutrition, and that marginal biotin deficiency in pregnant women may be teratogenic. Biotin acts as a carboxyl carrier in carboxylation reactions. There are four biotin-dependent carboxylases in mammals: those of propionyl-CoA (PCC), 3-methylcrotonyl-CoA (MCC), pyruvate (PC) and acetyl-CoA carboxylases (isoforms ACC-1 and ACC-2). All but ACC-2 are mitochondrial enzymes. The biotin moiety is covalently bound to the epsilon amino group of a Lysine residue in each of these carboxylases in a domain 60-80 amino acids long. The domain is structurally similar among carboxylases from bacteria to mammals. There are four biotin-dependent carboxylases in mammals: those of propionyl-CoA (PCC), 3-methylcrotonyl-CoA (MCC), pyruvate (PC) and acetyl-CoA carboxylases (isoforms ACC-1 and ACC-2). All but ACC-2 are mitochondrial enzymes. The biotin moiety is covalently bound to the epsilon amino group of a Lys residue in each of these carboxylases in a domain 60-80 amino acids long. The domain is structurally similar among carboxylases from bacteria to mammals. Evidence is emerging that biotin participates in processes other than classical carboxylation reactions. Specifically, novel roles for biotin in cell signaling, gene expression, and chromatin structure have been identified in recent years. Human cells accumulate biotin by using both the sodium-dependent multivitamin transporter and monocarboxylate transporter 1. These transporters and other biotin-binding proteins partition biotin to compartments involved in biotin signaling: cytoplasm, mitochondria, and nuclei. The activity of cell signals such as biotinyl-AMP, Sp1 and Sp3, nuclear factor (NF)-kappaB, and receptor tyrosine kinases depends on biotin supply. Consistent with a role for biotin and its catabolites in modulating these cell signals, greater than 2000 biotin-dependent genes have been identified in various human tissues. Many biotin-dependent gene products play roles in signal transduction and localize to the cell nucleus, consistent with a role for biotin in cell signaling. Posttranscriptional events related to ribosomal activity and protein folding may further contribute to effects of biotin on gene expression. Finally, research has shown that biotinidase and holocarboxylase synthetase mediate covalent binding of biotin to histones (DNA-binding proteins), affecting chromatin structure; at least seven biotinylation sites have been identified in human histones. Biotinylation of histones appears to play a role in cell proliferation, gene silencing, and the cellular response to DNA repair. Roles for biotin in cell signaling and chromatin structure are consistent with the notion that biotin has a unique significance in cell biology. (PMID: 15992684, 16011464).",Biotin,HMDB0000030,b,b,C00120,BIOTIN,FDB014510,btn,[H]N1C(=O)N([H])[C@]2([H])[C@@]([H])(SC([H])([H])[C@]12[H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([O-])=O,YBJHBAHKTGYVGT-ZKWXMUAHSA-M,"InChI=1S/C10H16N2O3S/c13-8(14)4-2-1-3-7-9-6(5-16-7)11-10(15)12-9/h6-7,9H,1-5H2,(H,13,14)(H2,11,12,15)/p-1/t6-,7-,9-/m0/s1"
4004,8921,a,a,3112,KEGG COMPOUND accession,C07941,,,,,,,,,,,,,,,
4005,8923,a,a,17097,KEGG COMPOUND accession,C06588,,,,,,,,,,,,,,,
4006,8926,a,a,16205,KEGG COMPOUND accession,C02526,,,,,,,,,,,,,,,
4007,8941,a,a,28763,KEGG COMPOUND accession,C06641,,,,,,,,,,,,,,,
4008,8943,a,a,28898,KEGG COMPOUND accession,C04058,,,,,,,,,,,,,,,
4009,8947,a,a,17618,KEGG COMPOUND accession,C04333,,,,,,,,,,,,,,,
4010,8949,a,a,17257,KEGG COMPOUND accession,C03646,,,,,,,,,,,,,,,
4011,8953,a,a,261649,KEGG COMPOUND accession,C07870,,,,,,,,,,,,,,,
4012,8965,a,a,3133,KEGG COMPOUND accession,C06853,,,,,,,,,,,,,,,
4013,8969,a,a,18138,KEGG COMPOUND accession,C06555,,,,,,,,,,,,,,,
4014,8973,a,a,3136,KEGG COMPOUND accession,C08582,,,,,,,,,,,,,,,
4015,9015,a,a,3159,KEGG COMPOUND accession,C09622,,,,,,,,,,,,,,,
4016,9029,a,a,35819,KEGG COMPOUND accession,C05996,,,,,,,,,,,,,,,
4017,9051,a,a,15858,KEGG COMPOUND accession,C01324,,,,,,,,,,,,,,,
4018,9056,a,a,17194,KEGG COMPOUND accession,C02661,,,,,,,,,,,,,,,
4019,9067,a,a,3185,KEGG COMPOUND accession,C09505,,,,,,,,,,,,,,,
4020,9071,a,a,3187,KEGG COMPOUND accession,C08665,,,,,,,,,,,,,,,
4021,9098,a,a,3201,KEGG COMPOUND accession,C08853,,,,,,,,,,,,,,,
4022,9116,a,a,3210,KEGG COMPOUND accession,C08299,M01408,487-93-4,3210.0,"Human Metabolome Database (HMDB): A hallucinogenic serotonin analog found in frog or toad skins, mushrooms, higher plants, and mammals, especially in the brains, plasma, and urine of schizophrenics. Bufotenin has been used as a tool in CNS studies and misused as a psychedelic. Bufotenin (5-OH-DMT), is a tryptamine related to the neurotransmitter serotonin. It is an alkaloid found in the skin of some species of toads; in mushrooms, higher plants, and mammals. Bufotenin is a chemical constituent in the venom and eggs of several species of toads belonging to the Bufo genus, but most notably in the Colorado River toad (Bufo alvarius) as it is the only toad species in which bufotenin is present in large enough quantities for a psychoactive effect. Extracts of toad venom, containing bufotenin and other bioactive compounds, have been used in some traditional medicines (probably derived from Bufo gargarizans), which has been used medicinally for centuries in China. Bufotenin is a constituent of the seeds of Anadenanthera colubrina and Anadenanthera peregrina trees. Anadenanthera seeds have been used as an ingredient in psychedelic snuff preparations by indigenous cultures of the Caribbean, Central and South America.",Bufotenin,HMDB0041842,b,b,C08299,b,b,b,[H]OC1=C([H])C2=C(N([H])C([H])=C2C([H])([H])C([H])([H])N(C([H])([H])[H])C([H])([H])[H])C([H])=C1[H],VTTONGPRPXSUTJ-UHFFFAOYSA-N,"InChI=1S/C12H16N2O/c1-14(2)6-5-9-8-13-12-4-3-10(15)7-11(9)12/h3-4,7-8,13,15H,5-6H2,1-2H3"
4023,9134,a,a,3219,KEGG COMPOUND accession,C06860,,,,,,,,,,,,,,,
4024,9140,a,a,3222,KEGG COMPOUND accession,C10547,,,,,,,,,,,,,,,
4025,9146,a,a,28901,KEGG COMPOUND accession,C06862,,,,,,,,,,,,,,,
4026,9155,a,a,3228,KEGG COMPOUND accession,C07827,,,,,,,,,,,,,,,
4027,9197,a,a,3237,KEGG COMPOUND accession,C08578,,,,,,,,,,,,,,,
4028,9201,a,a,27725,KEGG COMPOUND accession,C09614,,,,,,,,,,,,,,,
4029,9203,a,a,3240,KEGG COMPOUND accession,C08065,,,,,,,,,,,,,,,
4030,9264,a,a,16371,KEGG COMPOUND accession,C02255,,,,,,,,,,,,,,,
4031,9266,a,a,16436,KEGG COMPOUND accession,C00307,cdpchol,987-78-0,16436.0,"Human Metabolome Database (HMDB): Citicoline is an essential intermediate in the biosynthetic pathway of structural phospholipids in cell membranes, particularly phosphatidylcholine. Once absorbed, citicoline is widely distributed throughout the body, crosses the blood-brain barrier and reaches the central nervous system (CNS), where it is incorporated into the membrane and microsomal phospholipid fraction. Citicoline activates biosynthesis of structural phospholipids of neuronal membranes, increases brain metabolism, and acts upon the levels of different neurotransmitters. Thus, citicoline has been experimentally shown to increase norepinephrine and dopamine levels in the CNS. Owing to these pharmacological mechanisms, citicoline has a neuroprotective effect in hypoxic and ischemic conditions, decreasing the volume of ischemic lesion, and also improves learning and memory performance in animal models of brain aging. In addition, citicoline has been shown to restore the activity of mitochondrial ATPase and membrane Na+/K+ATPase, to inhibit activation of certain phospholipases, and to accelerate reabsorption of cerebral edema in various experimental models. Citicoline has also been shown to be able to inhibit mechanisms of apoptosis associated to cerebral ischemia and in certain neurodegeneration models, and to potentiate neuroplasticity mechanisms. Citicoline is a safe drug, as shown by the toxicological tests conducted, that has no significant systemic cholinergic effects and is a well tolerated product. (PMID: 17171187).",Citicoline,HMDB0001413,b,b,C00307,CDP-CHOLINE,FDB022608,cdpchol,[H]O[C@@]1([H])[C@@]([H])(O[C@]([H])(C([H])([H])OP([O-])(=O)OP([O-])(=O)OC([H])([H])C([H])([H])[N+](C([H])([H])[H])(C([H])([H])[H])C([H])([H])[H])[C@@]1([H])O[H])N1C([H])=C([H])C(=NC1=O)N([H])[H],RZZPDXZPRHQOCG-OJAKKHQRSA-M,"InChI=1S/C14H26N4O11P2/c1-18(2,3)6-7-26-30(22,23)29-31(24,25)27-8-9-11(19)12(20)13(28-9)17-5-4-10(15)16-14(17)21/h4-5,9,11-13,19-20H,6-8H2,1-3H3,(H3-,15,16,21,22,23,24,25)/p-1/t9-,11-,12-,13-/m1/s1"
4032,9273,a,a,17962,KEGG COMPOUND accession,C00269,,,,,,,,,,,,,,,
4033,9281,a,a,16732,KEGG COMPOUND accession,C00570,cdpea,3036-18-8,16732.0,Human Metabolome Database (HMDB): Cytidine is a molecule (known as a nucleoside) that is formed when cytosine is attached to a ribose ring (also known as a ribofuranose) via a beta-N1-glycosidic bond.,CDP-Ethanolamine,HMDB0001564,b,b,C00570,CDP-ETHANOLAMINE,FDB022691,cdpea,[H]O[C@@]1([H])[C@@]([H])(O[C@]([H])(C([H])([H])OP([O-])(=O)OP([O-])(=O)OC([H])([H])C([H])([H])[N+]([H])([H])[H])[C@@]1([H])O[H])N1C([H])=C([H])C(=NC1=O)N([H])[H],WVIMUEUQJFPNDK-PEBGCTIMSA-M,"InChI=1S/C11H20N4O11P2/c12-2-4-23-27(19,20)26-28(21,22)24-5-6-8(16)9(17)10(25-6)15-3-1-7(13)14-11(15)18/h1,3,6,8-10,16-17H,2,4-5,12H2,(H,19,20)(H,21,22)(H2,13,14,18)/p-1/t6-,8-,9-,10-/m1/s1"
4034,9285,a,a,28942,KEGG COMPOUND accession,C00501,cdpglc,2906-23-2,477439.0,Human Metabolome Database (HMDB): CDP-glucose is a substrate for Uridine diphosphate glucose pyrophosphatase.,CDP-glucose,HMDB0003369,b,b,C00501,CDP-D-GLUCOSE,FDB023155,b,b,CGPHZDRCVSLMCF-JZMIEXBBSA-N,b
4035,9296,a,a,17361,KEGG COMPOUND accession,C00055,cmp,63-37-6,17361.0,"Human Metabolome Database (HMDB): Cytidine monophosphate, also known as 5'-cytidylic acid and abbreviated CMP, is a nucleotide. It is an ester of phosphoric acid with the nucleoside cytidine. CMP consists of the phosphate group, the pentose sugar ribose, and the nucleobase cytosine. Cytidine monophosphate (CMP) is derived from cytidine triphosphate (CTP) with subsequent loss of two phosphates. The synthesis of the pyrimidines CTP and UTP occurs in the cytoplasm and starts with the formation of carbamoyl phosphate from glutamine and CO2. Next, aspartate undergoes a condensation reaction with carbamoyl-phosphate to form orotic acid. In a subsequent cyclization reaction, the enzyme Aspartate carbamoyltransferase forms N-carbamoyl-aspartate which is converted into dihydroorotic acid by Dihydroorotase. The latter is converted to orotate by Dihydroorotate oxidase. Orotate is covalently linked with a phosphorylated ribosyl unit with Orotate phosphoribosyltransferase (aka ""PRPP transferase"") catalyzing reaction, yielding orotidine monophosphate (OMP). Orotidine-5-phosphate is decarboxylated by Orotidine-5'-phosphate decarboxylase to form uridine monophosphate (UMP). UMP is phosphorylated by two kinases to uridine triphosphate (UTP) via two sequential reactions with ATP. CTP is subsequently formed by amination of UTP by the catalytic activity of CTP synthetase. Cytosine monophosphate (CMP) and uridine monophosphate (UMP) have been prescribed for the treatment of neuromuscular affections in humans. Patients treated with CMP/UMP recover from altered neurological functions. Additionally, the administration of CMP/UMP appears to favour the entry of glucose in the muscle and CMP/UMP may be important in maintaining the level of hepatic glycogen constant during exercise. [PMID:18663991].",Cytidine monophosphate,HMDB0000095,b,b,C00055,CMP,FDB011882,cmp,[H]O[C@@]1([H])[C@@]([H])(O[C@]([H])(C([H])([H])OP([O-])([O-])=O)[C@@]1([H])O[H])N1C([H])=C([H])C(=NC1=O)N([H])[H],IERHLVCPSMICTF-XVFCMESISA-L,"InChI=1S/C9H14N3O8P/c10-5-1-2-12(9(15)11-5)8-7(14)6(13)4(20-8)3-19-21(16,17)18/h1-2,4,6-8,13-14H,3H2,(H2,10,11,15)(H2,16,17,18)/p-2/t4-,6-,7-,8-/m1/s1"
4036,9351,a,a,16788,KEGG COMPOUND accession,C01064,,,,,,,,,,,,,,,
4037,9626,a,a,18127,KEGG COMPOUND accession,C01672,15dap,462-94-2,18127.0,"Human Metabolome Database (HMDB): Cadaverine is a foul-smelling diamine formed by bacterial decarboxylation of lysine that occurs during protein hydrolysis during putrefaction of animal tissue. However, this diamine is not purely associated with putrefaction. It is also produced in small quantities by mammals. In particular, it is partially responsible for the distinctive smell of urine and semen. Elevated levels of cadaverine have been found in the urine of some patients with defects in lysine metabolism. Cadaverine is toxic in large doses. In rats it had a low acute oral toxicity of more than 2000 mg/kg body weight (Wikipedia).","1,5-Diaminopentane",HMDB0002322,b,b,C01672,b,b,b,b,b,b
4038,9633,a,a,3291,KEGG COMPOUND accession,C09066,,,,,,,,,,,,,,,
4039,9684,a,a,3312,KEGG COMPOUND accession,C08130,,,,,,,,,,,,,,,
4040,9748,a,a,27656,KEGG COMPOUND accession,C01897,,,,,,,,,,,,,,,
4041,9756,a,a,3347,KEGG COMPOUND accession,C07468,,,,,,,,,,,,,,,
4042,9760,a,a,3349,KEGG COMPOUND accession,C06690,,,,,,,,,,,,,,,
4043,9769,a,a,3354,KEGG COMPOUND accession,C11721,,,,,,,,,,,,,,,
4044,9779,a,a,3359,KEGG COMPOUND accession,C10784,,,,,,,,,,,,,,,
4045,9785,a,a,3362,KEGG COMPOUND accession,C08583,,,,,,,,,,,,,,,
4046,9787,a,a,3363,KEGG COMPOUND accession,C09098,,,,,,,,,,,,,,,
4047,9795,a,a,3367,KEGG COMPOUND accession,C08595,,,,,,,,,,,,,,,
4048,9799,a,a,3369,KEGG COMPOUND accession,C08398,,,,,,,,,,,,,,,
4049,9807,a,a,28837,KEGG COMPOUND accession,C06423,octa,124-07-2,28837.0,Human Metabolome Database (HMDB): Caprylic acid is the common name for the eight-carbon straight chain fatty acid known by the systematic name octanoic acid. It is found naturally in coconuts and breast milk. It is an oily liquid with a slightly unpleasant rancid taste that is minimally soluble in water. Caprylic acid is used commercially in the production of esters used in perfumery and also in the manufacture of dyes. (wikipedia).,Caprylic acid,HMDB0000482,b,b,C06423,CPD-195,FDB003336,octa,[H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([O-])=O,WWZKQHOCKIZLMA-UHFFFAOYSA-M,"InChI=1S/C8H16O2/c1-2-3-4-5-6-7-8(9)10/h2-7H2,1H3,(H,9,10)/p-1"
4050,9809,a,a,3374,KEGG COMPOUND accession,C06866,,,,,,,,,,,,,,,
4051,9811,a,a,3375,KEGG COMPOUND accession,C08584,,,,,,,,,,,,,,,
4052,9815,a,a,28283,KEGG COMPOUND accession,C09627,,,,,,,,,,,,,,,
4053,9817,a,a,3378,KEGG COMPOUND accession,C08585,,,,,,,,,,,,,,,
4054,9819,a,a,3379,KEGG COMPOUND accession,C06705,,,,,,,,,,,,,,,
4055,9822,a,a,3381,KEGG COMPOUND accession,C09839,,,,,,,,,,,,,,,
4056,9826,a,a,3383,KEGG COMPOUND accession,C08521,,,,,,,,,,,,,,,
4057,9832,a,a,28616,KEGG COMPOUND accession,C01563,,,,,,,,,,,,,,,
4058,9836,a,a,3387,KEGG COMPOUND accession,C06868,,,,,,,,,,,,,,,
4059,9838,a,a,3388,KEGG COMPOUND accession,C07496,,,,,,,,,,,,,,,
4060,9840,a,a,17672,KEGG COMPOUND accession,C00169,cbp,590-55-6,17672.0,"Human Metabolome Database (HMDB): Carbamoyl phosphate is a precursor of both arginine and pyrimidine biosynthesis. It is a labile and potentially toxic intermediate. Carbamoyl phosphate is a molecule that is involved in ridding the body of excess nitrogen in the urea cycle, and also in the synthesis of pyrimidines. It is produced from carbon dioxide, ammonia, and phosphate (from ATP) by the enzyme carbamoyl phosphate synthase. -- Wikipedia.",Carbamoyl phosphate,HMDB0001096,b,b,C00169,CARBAMOYL-P,FDB022424,cbp,[H]N([H])C(=O)OP([O-])([O-])=O,FFQKYPRQEYGKAF-UHFFFAOYSA-L,"InChI=1S/CH4NO5P/c2-1(3)7-8(4,5)6/h(H2,2,3)(H2,4,5,6)/p-2"
4061,9849,a,a,3390,KEGG COMPOUND accession,C07491,,,,,,,,,,,,,,,
4062,9851,a,a,3391,KEGG COMPOUND accession,C08060,,,,,,,,,,,,,,,
4063,9853,a,a,3392,KEGG COMPOUND accession,C10897,,,,,,,,,,,,,,,
4064,9855,a,a,3393,KEGG COMPOUND accession,C06869,,,,,,,,,,,,,,,
4065,9863,a,a,617099,KEGG COMPOUND accession,C07615,,,,,,,,,,,,,,,
4066,9871,a,a,28976,KEGG COMPOUND accession,C01353,h2co3,463-79-6,28976.0,"Human Metabolome Database (HMDB): Carbonic acid (ancient name acid of air or aerial acid) is the only inorganic carbon acid, and has the formula H2CO3. It is also a name sometimes given to solutions of carbon dioxide in water, which contain small amounts of H2CO3. The salts of carbonic acids are called bicarbonates (or hydrogencarbonates) and carbonates. (wikipedia).",Carbonic acid,HMDB0003538,b,b,C01353,CARBON-DIOXIDE,FDB023191,h2co3,[O-]C([O-])=O,BVKZGUZCCUSVTD-UHFFFAOYSA-N,"InChI=1S/CH2O3/c2-1(3)4/h(H2,2,3,4)"
4067,9882,a,a,3405,KEGG COMPOUND accession,C11255,,,,,,,,,,,,,,,
4068,9887,a,a,35757,KEGG COMPOUND accession,C00060,,,,,,,,,,,,,,,
4069,9950,a,a,3414,KEGG COMPOUND accession,C11752,,,,,,,,,,,,,,,
4070,9952,a,a,3415,KEGG COMPOUND accession,C11493,,,,,,,,,,,,,,,
4071,9964,a,a,3421,KEGG COMPOUND accession,C10026,,,,,,,,,,,,,,,
4072,9998,a,a,3434,KEGG COMPOUND accession,C10932,,,,,,,,,,,,,,,
4073,17487,a,a,5616,KEGG COMPOUND accession,C11031,,,,,,,,,,,,,,,
4074,17841,a,a,5778,KEGG COMPOUND accession,C07041,,,,,,,,,,,,,,,
4075,17910,a,a,27786,KEGG COMPOUND accession,C08230,,,,,,,,,,,,,,,
4076,17949,a,a,5810,KEGG COMPOUND accession,C06455,,,,,,,,,,,,,,,
4077,18178,a,a,44032,KEGG COMPOUND accession,C07051,,,,,,,,,,,,,,,
4078,18109,a,a,5864,KEGG COMPOUND accession,C07047,,,,,,,,,,,,,,,
4079,10004,a,a,3437,KEGG COMPOUND accession,C06874,,,,,,,,,,,,,,,
4080,10010,a,a,3440,KEGG COMPOUND accession,C09840,,,,,,,,,,,,,,,
4081,10012,a,a,3441,KEGG COMPOUND accession,C06875,,,,,,,,,,,,,,,
4082,10035,a,a,3453,KEGG COMPOUND accession,C08669,,,,,,,,,,,,,,,
4083,10060,a,a,28117,KEGG COMPOUND accession,C09617,,,,,,,,,,,,,,,
4084,10062,a,a,18135,KEGG COMPOUND accession,C00090,catechol,120-80-9,18135.0,"Human Metabolome Database (HMDB): Pyrocatechol, often known as catechol or benzene-1,2-diol, is a benzenediol, with formula C6H4(OH)2. It was first prepared in 1839 by H. Reinsch by distilling catechin (the juice of Mimosa catechu). This colourless compound occurs naturally, but about 20000 tons are manufactured each year, mainly as precursors to pesticides, flavors, and fragrances. Its sulfonic acid is often present in the urine of many mammals. Small amounts of catechol occur naturally in fruits and vegetables, along with the enzyme polyphenol oxidase. Upon mixing the enzyme with the substrate and exposure to oxygen (as when a potato or apple is cut), the colorless catechol oxidizes to reddish-brown benzoquinone derivatives. The enzyme is inactivated by adding an acid, such as lemon juice, or by refrigeration. Excluding oxygen also prevents the browning reaction. Catechol melts at 28 oC and boils at 250 oC. It is employed in medicine as an expectorant. The dimethyl ether or veratrol is also used in medicine. Many other pyrocatechin derivatives have been suggested for therapeutic application.",Pyrocatechol,HMDB0000957,b,b,C00090,CATECHOL,FDB001512,b,b,YCIMNLLNPGFGHC-UHFFFAOYSA-N,"InChI=1S/C6H6O2/c7-5-3-1-2-4-6(5)8/h1-4,7-8H"
4085,10104,a,a,3480,KEGG COMPOUND accession,C06879,,,,,,,,,,,,,,,
4086,10108,a,a,474053,KEGG COMPOUND accession,C06880,,,,,,,,,,,,,,,
4087,10114,a,a,3485,KEGG COMPOUND accession,C08110,,,,,,,,,,,,,,,
4088,10203,a,a,49533,KEGG COMPOUND accession,C06217,,,,,,,,,,,,,,,
4089,10210,a,a,3528,KEGG COMPOUND accession,C06219,,,,,,,,,,,,,,,
4090,10212,a,a,18246,KEGG COMPOUND accession,C00760,,,,,,,,,,,,,,,
4091,10228,a,a,3534,KEGG COMPOUND accession,C06895,,,,,,,,,,,,,,,
4092,10230,a,a,3535,KEGG COMPOUND accession,C08099,,,,,,,,,,,,,,,
4093,10236,a,a,23066,KEGG COMPOUND accession,C00875,,,,,,,,,,,,,,,
4094,10237,a,a,15776,KEGG COMPOUND accession,C00916,,,,,,,,,,,,,,,
4095,10241,a,a,3540,KEGG COMPOUND accession,C10580,,,,,,,,,,,,,,,
4096,10245,a,a,3542,KEGG COMPOUND accession,C08100,,,,,,,,,,,,,,,
4097,10247,a,a,3543,KEGG COMPOUND accession,C06566,,,,,,,,,,,,,,,
4098,10252,a,a,3546,KEGG COMPOUND accession,C09391,,,,,,,,,,,,,,,
4099,10260,a,a,28943,KEGG COMPOUND accession,C06062,,,,,,,,,,,,,,,
4100,10265,a,a,27511,KEGG COMPOUND accession,C08856,,,,,,,,,,,,,,,
4101,10269,a,a,3556,KEGG COMPOUND accession,C10309,,,,,,,,,,,,,,,
4102,10272,a,a,3558,KEGG COMPOUND accession,C07966,,,,,,,,,,,,,,,
4103,10289,a,a,3566,KEGG COMPOUND accession,C11307,,,,,,,,,,,,,,,
4104,10291,a,a,3567,KEGG COMPOUND accession,C11275,,,,,,,,,,,,,,,
4105,10309,a,a,3576,KEGG COMPOUND accession,C09131,,,,,,,,,,,,,,,
4106,10321,a,a,27939,KEGG COMPOUND accession,C08282,,,,,,,,,,,,,,,
4107,10327,a,a,38161,KEGG COMPOUND accession,C00917,,,,,,,,,,,,,,,
4108,10354,a,a,17029,KEGG COMPOUND accession,C00461,M01436,1398-61-4,17029.0,"Human Metabolome Database (HMDB): Chitin is one of the main components in the cell walls of fungi, the exoskeletons of insects and other arthropods (such as crustaceans) as well as fish and frogs. It is a polysaccharide that is constructed from units of acetylglucosamine (more completely, N-acetyl-D-glucose-2-amine). These are linked together in beta-1,4 fashion (in a similar manner to the glucose units which form cellulose). In effect, chitin may be described as cellulose with one hydroxyl group on each monomer replaced by an acetylamine group. This allows for increased hydrogen bonding between adjacent polymers, giving the polymer increased strength. Chitin is the second most abundant polysaccharide in the world (after cellulose). Chitinases break down chitin and are a part of the defence mechanism of mammals against chitin-containing parasites in lower life forms. Under certain circumstances, chitin can act as an allergen. Research using murine models has shown that chitin is a size-dependent microbial-associated molecular pattern (MAMP) that can induce an immunological response via pattern recognition receptors. Medium-sized chitin micro-particles (CMPs) have been shown to induce inflammation, while small-sized CMPs reduce inflammation. Additionally, mammalian chitinases may play a key role in mediating the T-helper 2 cell-driven inflammatory response that is commonly associated with asthma. The high prevalence of asthma among people working with chitinous substances, such as crabs and fungi, suggests that chitin might be an allergen playing a significant role in the development of asthma.",Chitin,HMDB0003362,b,b,C00461,14-N-ACETYL-BETA-D-GLUCOSAMINYLN1,FDB023154,b,[H]OC([H])([H])[C@@]1([H])O[C@@]([H])(-*)[C@]([H])(N([H])C(=O)C([H])([H])[H])[C@@]([H])(O[H])[C@]1([H])O-*,DJHJJVWPFGHIPH-OODMECLYSA-N,b
4109,10354,a,a,17029,KEGG COMPOUND accession,C00461,M01437,b,17029.0,b,Chitin,b,b,b,C00461,b,b,b,[H]OC([H])([H])[C@@]1([H])O[C@@]([H])(O[C@@]2([H])[C@]([H])(O[H])[C@@]([H])(N([H])C(=O)C([H])([H])[H])[C@]([H])(O[C@@]3([H])[C@]([H])(O[H])[C@@]([H])(N([H])C(=O)C([H])([H])[H])[C@]([H])(O[H])O[C@]3([H])C([H])([H])O[H])O[C@]2([H])C([H])([H])O[H])[C@]([H])(N([H])C(=O)C([H])([H])[H])[C@@]([H])(O[H])[C@]1([H])O[H],WZZVUHWLNMNWLW-VFCSDQTKSA-N,"InChI=1S/C24H41N3O16/c1-7(31)25-13-18(36)20(11(5-29)39-22(13)38)42-24-15(27-9(3)33)19(37)21(12(6-30)41-24)43-23-14(26-8(2)32)17(35)16(34)10(4-28)40-23/h10-24,28-30,34-38H,4-6H2,1-3H3,(H,25,31)(H,26,32)(H,27,33)/t10-,11-,12-,13-,14-,15-,16-,17-,18-,19-,20-,21-,22-,23+,24+/m1/s1"
4110,10372,a,a,17698,KEGG COMPOUND accession,C00918,,,,,,,,,,,,,,,
4111,10375,a,a,16730,KEGG COMPOUND accession,C03601,,,,,,,,,,,,,,,
4112,10377,a,a,3605,KEGG COMPOUND accession,C11726,,,,,,,,,,,,,,,
4113,10386,a,a,16548,KEGG COMPOUND accession,C01792,,,,,,,,,,,,,,,
4114,10395,a,a,3613,KEGG COMPOUND accession,C10027,,,,,,,,,,,,,,,
4115,10397,a,a,3614,KEGG COMPOUND accession,C06902,,,,,,,,,,,,,,,
4116,10401,a,a,17996,KEGG COMPOUND accession,C00115,,,,,,,,,,,,,,,
4117,10416,a,a,29219,KEGG COMPOUND accession,C01486,,,,,,,,,,,,,,,
4118,10427,a,a,27869,KEGG COMPOUND accession,C06755,M01443,79-11-8,27869.0,"Human Metabolome Database (HMDB): Prohibited from use in food Chloroacetic acid is the chemical compound with the formula ClCH2CO2H. This carboxylic acid is a useful building block in organic synthesis. Like other chloroacetic acids and related halocarbons, it is a potentially dangerous alkylating agent",Chloroacetic acid,HMDB0031331,b,b,C06755,b,FDB003394,b,[H]OC(=O)C([H])([H])Cl,FOCAUTSVDIKZOP-UHFFFAOYSA-N,"InChI=1S/C2H3ClO2/c3-1-2(4)5/h1H2,(H,4,5)"
4119,10431,a,a,28097,KEGG COMPOUND accession,C06990,,,,,,,,,,,,,,,
4120,10450,a,a,18230,KEGG COMPOUND accession,C05306,,,,,,,,,,,,,,,
4121,10453,a,a,27888,KEGG COMPOUND accession,C05307,,,,,,,,,,,,,,,
4122,10455,a,a,16900,KEGG COMPOUND accession,C02139,,,,,,,,,,,,,,,
4123,10465,a,a,3638,KEGG COMPOUND accession,C07625,,,,,,,,,,,,,,,
4124,10467,a,a,3639,KEGG COMPOUND accession,C11037,,,,,,,,,,,,,,,
4125,10469,a,a,3640,KEGG COMPOUND accession,C07461,,,,,,,,,,,,,,,
4126,10473,a,a,3642,KEGG COMPOUND accession,C07928,,,,,,,,,,,,,,,
4127,10475,a,a,3643,KEGG COMPOUND accession,C07930,,,,,,,,,,,,,,,
4128,10483,a,a,3647,KEGG COMPOUND accession,C06906,,,,,,,,,,,,,,,
4129,10485,a,a,3648,KEGG COMPOUND accession,C10966,,,,,,,,,,,,,,,
4130,10487,a,a,3649,KEGG COMPOUND accession,C07952,,,,,,,,,,,,,,,
4131,10491,a,a,3651,KEGG COMPOUND accession,C07953,,,,,,,,,,,,,,,
4132,10493,a,a,3652,KEGG COMPOUND accession,C05071,,,,,,,,,,,,,,,
4133,10495,a,a,27644,KEGG COMPOUND accession,C06571,,,,,,,,,,,,,,,
4134,10498,a,a,3655,KEGG COMPOUND accession,C07931,,,,,,,,,,,,,,,
4135,10500,a,a,3656,KEGG COMPOUND accession,C10979,,,,,,,,,,,,,,,
4136,10507,a,a,17759,KEGG COMPOUND accession,C01164,7dhchsterol,434-16-2,17759.0,"Human Metabolome Database (HMDB): 7-Dehydrocholesterol is a zoosterol (a sterol produced by animals rather than plants). It is a provitamin-D. The presence of this compound in skin enables humans to manufacture vitamin D3 from ultra-violet rays in the sun light, via an intermediate isomer provitamin D3. It is also found in breast milk.",7-Dehydrocholesterol,HMDB0000032,b,b,C01164,7-DEHYDRO-CHOLESTEROL,FDB021882,7dhchsterol,[H]O[C@]1([H])C([H])([H])C2=C([H])C([H])=C3[C@]4([H])C([H])([H])C([H])([H])[C@]([H])([C@]([H])(C([H])([H])[H])C([H])([H])C([H])([H])C([H])([H])C([H])(C([H])([H])[H])C([H])([H])[H])[C@@]4(C([H])([H])[H])C([H])([H])C([H])([H])[C@]3([H])[C@@]2(C([H])([H])[H])C([H])([H])C1([H])[H],UCTLRSWJYQTBFZ-DDPQNLDTSA-N,"InChI=1S/C27H44O/c1-18(2)7-6-8-19(3)23-11-12-24-22-10-9-20-17-21(28)13-15-26(20,4)25(22)14-16-27(23,24)5/h9-10,18-19,21,23-25,28H,6-8,11-17H2,1-5H3/t19-,21+,23-,24+,25+,26+,27-/m1/s1"
4137,10511,a,a,16113,KEGG COMPOUND accession,C00187,chsterol,57-88-5,1307929.0,"Human Metabolome Database (HMDB): Cholesterol is a sterol (a combination steroid and alcohol) and a lipid found in the cell membranes of all body tissues and transported in the blood plasma of all animals. The name originates from the Greek chole- (bile) and stereos (solid), and the chemical suffix -ol for an alcohol. This is because researchers first identified cholesterol in solid form in gallstones in 1784. In the body, cholesterol can exist in either the free form or as an ester with a single fatty acid (of 10-20 carbons in length) covalently attached to the hydroxyl group at position 3 of the cholesterol ring. Due to the mechanism of synthesis, plasma cholesterol esters tend to contain relatively high proportions of polyunsaturated fatty acids. Most of the cholesterol consumed as a dietary lipid exists as cholesterol esters. Cholesterol esters have a lower solubility in water than cholesterol and are more hydrophobic. They are hydrolyzed by the pancreatic enzyme cholesterol esterase to produce cholesterol and free fatty acids. Cholesterol has vital structural roles in membranes and in lipid metabolism in general. It is a biosynthetic precursor of bile acids, vitamin D, and steroid hormones (glucocorticoids, estrogens, progesterones, androgens and aldosterone). In addition, it contributes to the development and functioning of the central nervous system, and it has major functions in signal transduction and sperm development. Cholesterol is a ubiquitous component of all animal tissues where much of it is located in the membranes, although it is not evenly distributed. The highest proportion of unesterified cholesterol is in the plasma membrane (roughly 30-50% of the lipid in the membrane or 60-80% of the cholesterol in the cell), while mitochondria and the endoplasmic reticulum have very low cholesterol contents. Cholesterol is also enriched in early and recycling endosomes, but not in late endosomes. The brain contains more cholesterol than any other organ where it comprises roughly a quarter of the total free cholesterol in the human body. Of all the organic constituents of blood, only glucose is present in a higher molar concentration than cholesterol. Cholesterol esters appear to be the preferred form for transport in plasma and as a biologically inert storage (de-toxified) form. They do not contribute to membranes but are packed into intracellular lipid particles. Cholesterol molecules (i.e. cholesterol esters) are transported throughout the body via lipoprotein particles. The largest lipoproteins, which primarily transport fats from the intestinal mucosa to the liver, are called chylomicrons. They carry mostly triglyceride fats and cholesterol that are from food, especially internal cholesterol secreted by the liver into the bile. In the liver, chylomicron particles give up triglycerides and some cholesterol. They are then converted into low-density lipoprotein (LDL) particles, which carry triglycerides and cholesterol on to other body cells. In healthy individuals, the LDL particles are large and relatively few in number. In contrast, large numbers of small LDL particles are strongly associated with promoting atheromatous disease within the arteries. (Lack of information on LDL particle number and size is one of the major problems of conventional lipid tests.). In conditions with elevated concentrations of oxidized LDL particles, especially small LDL particles, cholesterol promotes atheroma plaque deposits in the walls of arteries, a condition known as atherosclerosis, which is a major contributor to coronary heart disease and other forms of cardiovascular disease. There is a worldwide trend to believe that lower total cholesterol levels tend to correlate with lower atherosclerosis event rates (though some studies refute this idea). As a result, cholesterol has become a very large focus for the scientific community trying to determine the proper amount of cholesterol needed in a healthy diet. However, the primary association of atherosclerosis with cholesterol has always been specifically with cholesterol transport patterns, not total cholesterol per se. For example, total cholesterol can be low, yet made up primarily of small LDL and small HDL particles and atheroma growth rates are high. In contrast, however, if LDL particle number is low (mostly large particles) and a large percentage of the HDL particles are large (HDL is actively reverse transporting cholesterol), then atheroma growth rates are usually low, even negative, for any given total cholesterol concentration. These effects are further complicated by the relative concentration of asymmetric dimethylarginine (ADMA) in the endothelium since ADMA down-regulates production of nitric oxide, a relaxant of the endothelium. Thus, high levels of ADMA, associated with highly oxidized levels of LDL, pose a heightened risk factor for vascular disease. Chronically high levels of cholesterol are associated with at least five inborn errors of metabolism, including cerebrotendinous xanthomatosis, cholesteryl ester storage disease, congenital lipoid adrenal hyperplasia, hypercholesterolemia, and Zellweger syndrome. In chronically high levels, cholesterol can function as an atherogen (causes atherosclerosis and cardiovascular disease). Specifically, chronically high levels (from diet or from genetic predisposition or from diseases such as hyperlipidemia) of cholesterol and cholesterol esters lead to an excess of low-density lipoprotein (LDL) particles. In healthy individuals, the LDL particles are large and relatively few in number. In contrast, large numbers of small LDL particles are strongly associated with promoting atheromatous disease within the arteries. In conditions with elevated concentrations of oxidized LDL particles, especially small LDL particles, cholesterol promotes atheroma plaque deposits in the walls of arteries, a condition known as atherosclerosis, which is a major contributor to coronary heart disease and other forms of cardiovascular disease. Resistin, a protein secreted by fat tissue, has been shown to increase the production of LDL in human liver cells and also degrades LDL receptors in the liver. As a result, the liver is less able to clear cholesterol from the bloodstream. Resistin accelerates the accumulation of LDL in arteries, increasing the risk of heart disease.",Cholesterol,HMDB0000067,b,b,C00187,CHOLESTEROL,FDB013269,chsterol,[H]O[C@]1([H])C([H])([H])C2=C([H])C([H])([H])[C@@]3([H])[C@]4([H])C([H])([H])C([H])([H])[C@]([H])([C@]([H])(C([H])([H])[H])C([H])([H])C([H])([H])C([H])([H])C([H])(C([H])([H])[H])C([H])([H])[H])[C@@]4(C([H])([H])[H])C([H])([H])C([H])([H])[C@]3([H])[C@@]2(C([H])([H])[H])C([H])([H])C1([H])[H],HVYWMOMLDIMFJA-DPAQBDIFSA-N,"InChI=1S/C27H46O/c1-18(2)7-6-8-19(3)23-11-12-24-22-10-9-20-17-21(28)13-15-26(20,4)25(22)14-16-27(23,24)5/h9,18-19,21-25,28H,6-8,10-17H2,1-5H3/t19-,21+,22+,23-,24+,25+,26+,27-/m1/s1"
4138,10511,a,a,16113,KEGG COMPOUND accession,C00187,M01511,57-88-5,16113.0,"Human Metabolome Database (HMDB): Cholesterol-ester-pool, also known as Cholesterin or Cholest-5-en-3beta-ol, is classified as a cholesterol or a Cholesterol derivative. Cholesterols are compounds containing a 3-hydroxylated cholestane core. Cholesterol-ester-pool is considered to be practically insoluble (in water) and basic.  Cholesterol-ester-pool is a sterol lipid molecule",Cholesterol-ester-pool,HMDB0062453,b,b,C00187,b,b,b,[H]O[C@]1([H])C([H])([H])C2=C([H])C([H])([H])[C@@]3([H])[C@]4([H])C([H])([H])C([H])([H])[C@]([H])([C@]([H])(C([H])([H])[H])C([H])([H])C([H])([H])C([H])([H])C([H])(C([H])([H])[H])C([H])([H])[H])[C@@]4(C([H])([H])[H])C([H])([H])C([H])([H])[C@]3([H])[C@@]2(C([H])([H])[H])C([H])([H])C1([H])[H],HVYWMOMLDIMFJA-DPAQBDIFSA-N,"InChI=1S/C27H46O/c1-18(2)7-6-8-19(3)23-11-12-24-22-10-9-20-17-21(28)13-15-26(20,4)25(22)14-16-27(23,24)5/h9,18-19,21-25,28H,6-8,10-17H2,1-5H3/t19-,21+,22+,23-,24+,25+,26+,27-/m1/s1"
4139,10521,a,a,17002,KEGG COMPOUND accession,C02530,,,,,,,,,,,,,,,
4140,10529,a,a,3663,KEGG COMPOUND accession,C11251,HC02020,601-34-3,3663.0,"Human Metabolome Database (HMDB): Cholesteryl palmitic acid is a cholesteryl ester. A cholesteryl ester is an ester of cholesterol. Fatty acid esters of cholesterol constitute about two-thirds of the cholesterol in the plasma. Cholesterol is a sterol (a combination steroid and alcohol) and a lipid found in the cell membranes of all body tissues, and transported in the blood plasma of all animals. The accumulation of cholesterol esters in the arterial intima (the innermost layer of an artery, in direct contact with the flowing blood) is a characteristic feature of atherosclerosis. Atherosclerosis is a disease affecting arterial blood vessels. It is a chronic inflammatory response in the walls of arteries, in large part to the deposition of lipoproteins (plasma proteins that carry cholesterol and triglycerides). CE(16:0) may also accumulate in hereditary hypercholesterolemia, an inborn error of metabolism. Cholesteryl palmitate is one of the four important lipids found in the tear film. Amniotic fluid cholesteryl palmitate, as measured by thin-layer chromatography, appears to be a very sensitive and specific predictor for the risk of respiratory distress syndrome (RDS) in newborns of normal pregnancies (PMID: 3405552, 16922549).",CE(16:0),HMDB0000885,b,b,C11251,Cholesterol-esters,FDB022299,HC02020,[H]C1=C2C([H])([H])[C@@]([H])(OC(=O)C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H])C([H])([H])C([H])([H])[C@]2(C([H])([H])[H])[C@@]2([H])C([H])([H])C([H])([H])[C@]3(C([H])([H])[H])[C@]([H])(C([H])([H])C([H])([H])[C@@]3([H])[C@]2([H])C1([H])[H])[C@]([H])(C([H])([H])[H])C([H])([H])C([H])([H])C([H])([H])C([H])(C([H])([H])[H])C([H])([H])[H],BBJQPKLGPMQWBU-JADYGXMDSA-N,"InChI=1S/C43H76O2/c1-7-8-9-10-11-12-13-14-15-16-17-18-19-23-41(44)45-36-28-30-42(5)35(32-36)24-25-37-39-27-26-38(34(4)22-20-21-33(2)3)43(39,6)31-29-40(37)42/h24,33-34,36-40H,7-23,25-32H2,1-6H3/t34-,36+,37+,38-,39+,40+,42+,43-/m1/s1"
4141,10531,a,a,17495,KEGG COMPOUND accession,C03855,,,,,,,,,,,,,,,
4142,10533,a,a,15354,KEGG COMPOUND accession,C00114,chol,62-49-7,15354.0,"Human Metabolome Database (HMDB): Choline is a basic constituent of lecithin that is found in many plants and animal organs. It is important as a precursor of acetylcholine, as a methyl donor in various metabolic processes, and in lipid metabolism. Choline is now considered to be an essential vitamin. While humans can synthesize small amounts (by converting phosphatidylethanolamine to phosphatidylcholine), it must be consumed in the diet to maintain health. Required levels are between 425 mg/day (female) and 550 mg/day (male). Milk, eggs, liver and peanuts are especially rich in choline. Most choline is found in phospholipids, namely phosphatidylcholine or lecithin. Choline can be oxidized to form betaine, which is a methyl source for many reactions (i.e. conversion of homocysteine e to methionine). Lack of sufficient amounts of choline in the diet can lead to a fatty liver condition and general liver damage. This arises from the lack of VLDL, which is necessary to transport fats away from the liver. Choline deficiency also leads to elevated serum levels of alanine amino transferase and is associated with increased incidence of liver cancer.",Choline,HMDB0000097,b,b,C00114,CPD-563,FDB000710,chol,[H]OC([H])([H])C([H])([H])[N+](C([H])([H])[H])(C([H])([H])[H])C([H])([H])[H],OEYIOHPDSNJKLS-UHFFFAOYSA-N,"InChI=1S/C5H14NO/c1-6(2,3)4-5-7/h7H,4-5H2,1-3H3/q+1"
4143,10568,a,a,15519,KEGG COMPOUND accession,C01794,cholcoa,b,15519.0,Human Metabolome Database (HMDB): Choloyl-CoA is an intermediate metabolite in the Bile acid biosynthesis (KEGG). The conjugation of bile acids to glycine and taurine for excretion into bile occurs via a reaction catalyzed by the enzyme Bile acid-CoA:amino acid N-acyltransferase (BACAT) catalyzes.,Choloyl-CoA,HMDB0001374,b,b,C01794,CPD-202,FDB022586,cholcoa,[H]O[C@@]([H])(C(=O)N([H])C([H])([H])C([H])([H])C(=O)N([H])C([H])([H])C([H])([H])SC(=O)C([H])([H])C([H])([H])[C@@]([H])(C([H])([H])[H])[C@@]1([H])C([H])([H])C([H])([H])[C@@]2([H])[C@]3([H])[C@]([H])(O[H])C([H])([H])[C@]4([H])C([H])([H])[C@]([H])(O[H])C([H])([H])C([H])([H])[C@]4(C([H])([H])[H])[C@@]3([H])C([H])([H])[C@]([H])(O[H])[C@]12C([H])([H])[H])C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])OP([O-])(=O)OP([O-])(=O)OC([H])([H])[C@@]1([H])O[C@@]([H])(N2C([H])=NC3=C(N=C([H])N=C23)N([H])[H])[C@]([H])(O[H])[C@]1([H])OP([O-])([O-])=O,ZKWNOTQHFKYUNU-JGCIYWTLSA-J,"InChI=1S/C45H74N7O20P3S/c1-23(26-7-8-27-34-28(18-31(55)45(26,27)5)44(4)12-10-25(53)16-24(44)17-29(34)54)6-9-33(57)76-15-14-47-32(56)11-13-48-41(60)38(59)43(2,3)20-69-75(66,67)72-74(64,65)68-19-30-37(71-73(61,62)63)36(58)42(70-30)52-22-51-35-39(46)49-21-50-40(35)52/h21-31,34,36-38,42,53-55,58-59H,6-20H2,1-5H3,(H,47,56)(H,48,60)(H,64,65)(H,66,67)(H2,46,49,50)(H2,61,62,63)/p-4/t23-,24+,25-,26-,27+,28+,29-,30-,31+,34+,36-,37-,38+,42-,44+,45-/m1/s1"
4144,10573,a,a,16137,KEGG COMPOUND accession,C00401,,,,,,,,,,,,,,,
4145,10585,a,a,17333,KEGG COMPOUND accession,C00251,chor,617-12-9,17333.0,"Human Metabolome Database (HMDB): Chorismic acid, more commonly known as its anionic form chorismate, is an important biochemical intermediate in plants and microorganisms. It is a precursor for the aromatic amino acids phenylalanine and tyrosine,indole, indole derivatives and tryptophan,2,3-dihydroxybenzoic acid (DHB) used for enterobactin biosynthesis,the plant hormone salicylic acid and many alkaloids and other aromatic metabolites. -- Wikipedia.",Chorismate,HMDB0012199,b,b,C00251,CPD-9517,FDB028846,b,b,b,b
4146,10591,a,a,28073,KEGG COMPOUND accession,C06268,,,,,,,,,,,,,,,
4147,10599,a,a,3682,KEGG COMPOUND accession,C10312,,,,,,,,,,,,,,,
4148,10601,a,a,75095,KEGG COMPOUND accession,C10028,,,,,,,,,,,,,,,
4149,10603,a,a,3684,KEGG COMPOUND accession,C10029,,,,,,,,,,,,,,,
4150,10609,a,a,3687,KEGG COMPOUND accession,C10315,,,,,,,,,,,,,,,
4151,10611,a,a,3688,KEGG COMPOUND accession,C10316,,,,,,,,,,,,,,,
4152,10623,a,a,64977,KEGG COMPOUND accession,C10581,,,,,,,,,,,,,,,
4153,10627,a,a,3696,KEGG COMPOUND accession,C06909,,,,,,,,,,,,,,,
4154,10643,a,a,27509,KEGG COMPOUND accession,C06528,,,,,,,,,,,,,,,
4155,10647,a,a,3706,KEGG COMPOUND accession,C09845,,,,,,,,,,,,,,,
4156,10649,a,a,3707,KEGG COMPOUND accession,C09846,,,,,,,,,,,,,,,
4157,10651,a,a,3708,KEGG COMPOUND accession,C10903,,,,,,,,,,,,,,,
4158,10674,a,a,100241,KEGG COMPOUND accession,C05349,,,,,,,,,,,,,,,
4159,10675,a,a,3718,KEGG COMPOUND accession,C10032,,,,,,,,,,,,,,,
4160,10679,a,a,3720,KEGG COMPOUND accession,C06910,,,,,,,,,,,,,,,
4161,10683,a,a,27899,KEGG COMPOUND accession,C06911,,,,,,,,,,,,,,,
4162,10685,a,a,3723,KEGG COMPOUND accession,C07572,,,,,,,,,,,,,,,
4163,10689,a,a,15584,KEGG COMPOUND accession,C00815,,,,,,,,,,,,,,,
4164,10694,a,a,15457,KEGG COMPOUND accession,C00904,,,,,,,,,,,,,,,
4165,10697,a,a,30769,KEGG COMPOUND accession,C00158,cit,77-92-9,30769.0,"Human Metabolome Database (HMDB): Citric acid (citrate) is a weak acid that is formed in the tricarboxylic acid cycle or that may be introduced with diet. The evaluation of plasma citric acid is scarcely used in the diagnosis of human diseases. On the contrary urinary citrate excretion is a common tool in the differential diagnosis of kidney stones, renal tubular acidosis and it plays also a role in bone diseases. The importance of hypocitraturia should be considered with regard to bone mass, urine crystallization and urolithiasis. (PMID 12957820) The secretory epithelial cells of the prostate gland of humans and other animals posses a unique citrate-related metabolic pathway regulated by testosterone and prolactin. This specialized hormone-regulated metabolic activity is responsible for the major prostate function of the production and secretion of extraordinarily high levels of citrate. The key regulatory enzymes directly associated with citrate production in the prostate cells are mitochondrial aspartate aminotransferase, pyruvate dehydrogenase, and mitochondrial aconitase. testosterone and prolactin are involved in the regulation of the corresponding genes associated with these enzymes. The regulatory regions of these genes contain the necessary response elements that confer the ability of both hormones to control gene transcription. Protein kinase C (PKC) is the signaling pathway for the prolactin regulation of the metabolic genes in prostate cells. testosterone and prolactin regulation of these metabolic genes (which are constitutively expressed in all mammalian cells is specific for these citrate-producing cells (PMID 12198595). Citric acid is found in citrus fruits, most concentrated in lemons and limes, where it can comprise as much as 8% of the dry weight of the fruit. Citric acid is a natural preservative and is also used to add an acidic (sour) taste to foods and soft drinks. The salts of citric acid (citrates) can be used as anticoagulants due to their calcium chelating ability. Intolerance to citric acid in the diet is known to exist. Little information is available as the condition appears to be rare, but like other types of food intolerance it is often described as a ""pseudo-allergic"" reaction. Moreover, citric acid is found to be associated with maple syrup urine disease, primary hypomagnesemia, propionic acidemia, and tyrosinemia I, which are inborn errors of metabolism.",Citric acid,HMDB0000094,b,b,C00158,CIT,FDB012586,cit,[H]OC(C([O-])=O)(C([H])([H])C([O-])=O)C([H])([H])C([O-])=O,KRKNYBCHXYNGOX-UHFFFAOYSA-K,"InChI=1S/C6H8O7/c7-3(8)1-6(13,5(11)12)2-4(9)10/h13H,1-2H2,(H,7,8)(H,9,10)(H,11,12)/p-3"
4166,10715,a,a,17996,KEGG COMPOUND accession,C00698,,,,,,,,,,,,,,,
4167,10717,a,a,3732,KEGG COMPOUND accession,C06912,,,,,,,,,,,,,,,
4168,10719,a,a,15423,KEGG COMPOUND accession,C06660,,,,,,,,,,,,,,,
4169,10721,a,a,27819,KEGG COMPOUND accession,C06661,,,,,,,,,,,,,,,
4170,10722,a,a,48947,KEGG COMPOUND accession,C06662,,,,,,,,,,,,,,,
4171,10726,a,a,3738,KEGG COMPOUND accession,C06913,,,,,,,,,,,,,,,
4172,10730,a,a,3740,KEGG COMPOUND accession,C09922,,,,,,,,,,,,,,,
4173,10734,a,a,67461,KEGG COMPOUND accession,C09075,,,,,,,,,,,,,,,
4174,10736,a,a,3743,KEGG COMPOUND accession,C07853,,,,,,,,,,,,,,,
4175,10740,a,a,3745,KEGG COMPOUND accession,C06914,,,,,,,,,,,,,,,
4176,10748,a,a,3749,KEGG COMPOUND accession,C06915,,,,,,,,,,,,,,,
4177,10750,a,a,3750,KEGG COMPOUND accession,C06916,,,,,,,,,,,,,,,
4178,10752,a,a,3751,KEGG COMPOUND accession,C11095,,,,,,,,,,,,,,,
4179,10754,a,a,3752,KEGG COMPOUND accession,C06917,,,,,,,,,,,,,,,
4180,10758,a,a,47780,KEGG COMPOUND accession,C06918,,,,,,,,,,,,,,,
4181,10770,a,a,3760,KEGG COMPOUND accession,C10907,,,,,,,,,,,,,,,
4182,10772,a,a,3761,KEGG COMPOUND accession,C06921,,,,,,,,,,,,,,,
4183,10776,a,a,3763,KEGG COMPOUND accession,C11685,,,,,,,,,,,,,,,
4184,10778,a,a,3764,KEGG COMPOUND accession,C06922,,,,,,,,,,,,,,,
4185,10780,a,a,49566,KEGG COMPOUND accession,C06923,,,,,,,,,,,,,,,
4186,10788,a,a,16379,KEGG COMPOUND accession,C04665,,,,,,,,,,,,,,,
4187,10792,a,a,15346,KEGG COMPOUND accession,C00010,coa,85-61-0,1146900.0,"Human Metabolome Database (HMDB): Coenzyme A (CoA, CoASH, or HSCoA) is a coenzyme notable for its role in the synthesis and oxidization of fatty acids and the oxidation of pyruvate in the citric acid cycle. It is adapted from beta-mercaptoethylamine, panthothenate, and adenosine triphosphate. It is also a parent compound for other transformation products, including but not limited to, phenylglyoxylyl-CoA, tetracosanoyl-CoA, and 6-hydroxyhex-3-enoyl-CoA. Coenzyme A is synthesized in a five-step process from pantothenate and cysteine. In the first step pantothenate (vitamin B5) is phosphorylated to 4'-phosphopantothenate by the enzyme pantothenate kinase (PanK, CoaA, CoaX). In the second step, a cysteine is added to 4'-phosphopantothenate by the enzyme phosphopantothenoylcysteine synthetase (PPC-DC, CoaB) to form 4'-phospho-N-pantothenoylcysteine (PPC). In the third step, PPC is decarboxylated to 4'-phosphopantetheine by phosphopantothenoylcysteine decarboxylase (CoaC). In the fourth step, 4'-phosphopantetheine is adenylylated to form dephospho-CoA by the enzyme phosphopantetheine adenylyl transferase (CoaD). Finally, dephospho-CoA is phosphorylated using ATP to coenzyme A by the enzyme dephosphocoenzyme A kinase (CoaE). Since coenzyme A is, in chemical terms, a thiol, it can react with carboxylic acids to form thioesters, thus functioning as an acyl group carrier. CoA assists in transferring fatty acids from the cytoplasm to the mitochondria. A molecule of coenzyme A carrying an acetyl group is also referred to as acetyl-CoA. When it is not attached to an acyl group, it is usually referred to as 'CoASH' or 'HSCoA'. Coenzyme A is also the source of the phosphopantetheine group that is added as a prosthetic group to proteins such as acyl carrier proteins and formyltetrahydrofolate dehydrogenase. Acetyl-CoA is an important molecule itself. It is the precursor to HMG CoA which is a vital component in cholesterol and ketone synthesis. Furthermore, it contributes an acetyl group to choline to produce acetylcholine in a reaction catalysed by choline acetyltransferase. Its main task is conveying the carbon atoms within the acetyl group to the citric acid cycle to be oxidized for energy production (Wikipedia).",Coenzyme A,HMDB0001423,b,b,C00010,CO-A,FDB022614,CoA,[H]O[C@@]([H])(C(=O)N([H])C([H])([H])C([H])([H])C(=O)N([H])C([H])([H])C([H])([H])S[H])C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])OP([O-])(=O)OP([O-])(=O)OC([H])([H])[C@@]1([H])O[C@@]([H])(N2C([H])=NC3=C(N=C([H])N=C23)N([H])[H])[C@]([H])(O[H])[C@]1([H])OP([O-])([O-])=O,RGJOEKWQDUBAIZ-IBOSZNHHSA-J,"InChI=1S/C21H36N7O16P3S/c1-21(2,16(31)19(32)24-4-3-12(29)23-5-6-48)8-41-47(38,39)44-46(36,37)40-7-11-15(43-45(33,34)35)14(30)20(42-11)28-10-27-13-17(22)25-9-26-18(13)28/h9-11,14-16,20,30-31,48H,3-8H2,1-2H3,(H,23,29)(H,24,32)(H,36,37)(H,38,39)(H2,22,25,26)(H2,33,34,35)/p-4/t11-,14-,15-,16+,20-/m1/s1"
4188,11005,a,a,16161,KEGG COMPOUND accession,C02015,,,,,,,,,,,,,,,
4189,11007,a,a,17586,KEGG COMPOUND accession,C00920,,,,,,,,,,,,,,,
4190,11020,a,a,15982,KEGG COMPOUND accession,C00853,cbl1,18534-66-2,15982.0,"Human Metabolome Database (HMDB): Cob(I)alamin is the substrate of the enzyme ATP:cob(I)alamin adenosyltransferase (EC 2.5.1.17), that converts reduced cob(I)alamin to the adenosylcobalamin co-factor required for the functional activity of methylmalonyl-CoA mutase (EC 5.4.99.2). Mutations in the human MMAB gene result in a block in adenosylcobalamin synthesis and are responsible for the cblB complementation group of inherited vitamin B12 disorders, such as cobalamin malabsorption, which is an inborn error of metabolism. Vitamin B12 (cobalamin) is a complex cobalt-containing molecule that is essential to human health. It is synthesized in bacteria where it catalyzes numerous methyl transfer and intramolecular rearrangement reactions. In mammals, it is the co-factor of only two enzymes: methionine synthase, which catalyzes the transfer of a methyl group from methyltetrahydrofolate to homocysteine to form methionine, and methylmalonyl-CoA mutase, which catalyzes the rearrangement of methylmalonyl-CoA to form succinyl-CoA. For both enzymes, the vitamin must be modified through intracellular metabolism to co-factor forms: methylcobalamin (MeCbl)1 for methionine synthase and adenosylcobalamin (AdoCbl) for methylmalonyl-CoA mutase (PMID: 16439175).",Cob(I)alamin,HMDB0003429,b,b,C00853,COB-I-ALAMIN,FDB021826,b,[H]OC([H])([H])[C@@]1([H])O[C@]2([H])N3C([H])=[N+](C4=C([H])C(=C(C([H])=C34)C([H])([H])[H])C([H])([H])[H])[Co-4]345N6C7=C(C8=[N+]3C(=C([H])C3=[N+]4C(=C(C4=[N+]5[C@@](C([H])([H])[H])([C@@]6([H])[C@]([H])(C([H])([H])C(=O)N([H])[H])[C@@]7(C([H])([H])[H])C([H])([H])C([H])([H])C(=O)N([H])C([H])([H])[C@]([H])(OP([O-])(=O)O[C@@]1([H])[C@@]2([H])O[H])C([H])([H])[H])[C@@](C([H])([H])[H])(C([H])([H])C(=O)N([H])[H])[C@]4([H])C([H])([H])C([H])([H])C(=O)N([H])[H])C([H])([H])[H])[C@@](C([H])([H])[H])(C([H])([H])C(=O)N([H])[H])[C@]3([H])C([H])([H])C([H])([H])C(=O)N([H])[H])C(C([H])([H])[H])(C([H])([H])[H])[C@]8([H])C([H])([H])C([H])([H])C(=O)N([H])[H])C([H])([H])[H],OMAOKVYASDIYQG-DSRCUDDDSA-L,"InChI=1S/C62H90N13O14P.Co/c1-29-20-39-40(21-30(29)2)75(28-70-39)57-52(84)53(41(27-76)87-57)89-90(85,86)88-31(3)26-69-49(83)18-19-59(8)37(22-46(66)80)56-62(11)61(10,25-48(68)82)36(14-17-45(65)79)51(74-62)33(5)55-60(9,24-47(67)81)34(12-15-43(63)77)38(71-55)23-42-58(6,7)35(13-16-44(64)78)50(72-42)32(4)54(59)73-56;/h20-21,23,28,31,34-37,41,52-53,56-57,76,84H,12-19,22,24-27H2,1-11H3,(H15,63,64,65,66,67,68,69,71,72,73,74,77,78,79,80,81,82,83,85,86);/q;+1/p-2/t31-,34-,35-,36-,37+,41-,52-,53-,56-,57+,59-,60+,61+,62+;/m1./s1"
4191,11025,a,a,28531,KEGG COMPOUND accession,C06505,co1dam,b,28531.0,"Human Metabolome Database (HMDB): Cob(I)yrinate a,c diamide is an intermediate in vitamin B12 cofactor biosynthesis and adenosylcobalamin synthesis. It is a substrate for the enzyme Cob(I)yrinic acid a,c-diamide adenosyltransferase which is found in the mitochondria. The enzyme is responsible for the following 2 step reaction: ATP + cob(I)yrinic acid a,c-diamide = triphosphate + adenosylcob(III)yrinic acid a,c-diamide and then ATP + cobinamide = triphosphate + adenosylcobinamide.","Cob(I)yrinate a,c diamide",HMDB0006904,b,b,C06505,b,FDB024151,b,b,NKLHEMWEQJCPPF-YYYLUSCNSA-M,b
4192,11027,a,a,16304,KEGG COMPOUND accession,C00541,cbl2,14463-33-3,16304.0,Human Metabolome Database (HMDB): Cob(II)alamin is the product of the reduction catalyzed by microsomal cob(III)alamin reductase (PMID: 8507652). It binds to human methionine synthase (PMID: 1744096).,Cob(II)alamin,HMDB0006316,b,b,C00541,CPD-1829,FDB023883,cbl2,Cc1cc2c(cc1C)[n+](c[nH]2)[C@@H]1[C@@H]([C@@H]([C@@H](CO)O1)OP(=O)(O)O[C@H](C)CN=C(CC[C@]1(C)[C@@H](CC(=N)O)[C@@H]2[C@@]3(C)[C@@](C)(CC(=N)O)[C@H](CCC(=N)[O-])C(=C(C)C4=NC(=CC5=NC(=C(C)C1=N2)[C@@H](CCC(=N)[O-])C5(C)C)[C@@H](CCC(=N)[O-])[C@]4(C)CC(=N)O)N3)O)O.[Co+2],ASARMUCNOOHMLO-DSRCUDDDSA-L,"InChI=1S/C62H90N13O14P.Co/c1-29-20-39-40(21-30(29)2)75(28-70-39)57-52(84)53(41(27-76)87-57)89-90(85,86)88-31(3)26-69-49(83)18-19-59(8)37(22-46(66)80)56-62(11)61(10,25-48(68)82)36(14-17-45(65)79)51(74-62)33(5)55-60(9,24-47(67)81)34(12-15-43(63)77)38(71-55)23-42-58(6,7)35(13-16-44(64)78)50(72-42)32(4)54(59)73-56;/h20-21,23,28,31,34-37,41,52-53,56-57,76,84H,12-19,22,24-27H2,1-11H3,(H15,63,64,65,66,67,68,69,71,72,73,74,77,78,79,80,81,82,83,85,86);/q;+2/p-2/t31-,34-,35-,36-,37+,41-,52-,53-,56-,57+,59-,60+,61+,62+;/m1./s1"
4193,11032,a,a,27937,KEGG COMPOUND accession,C06504,co2dam,b,b,b,"Cob(II)yrinate a,c diamide",b,b,b,C06504,b,b,b,b,b,b
4194,11033,a,a,27638,KEGG COMPOUND accession,C00175,cobalt2,b,48828.0,"Human Metabolome Database (HMDB): Cobalt has a molecular weight of 58.9 and an atomic number of 27. In the Periodic Table, close to other transition metals, it is situated in group 8, together with rhodium and iridium and it can occur in four oxidation states (0, +2, +3 and +4). The +2 and the ground state are the most common. Cobalt occurs in the minerals cobaltite (Co, Fe) AsS, smaltite (CoAs2), and erythrite Co3(AsO4)2.8H2O, and is often associated with nickel, silver, lead, copper, and iron ores, from which it is most frequently obtained as a by-product. Depending on the considered species, cobalt has multiple industrial applications including the production of alloys and hard metal, diamond polishing, drying agents, pigments and catalysts. Hard metal or cemented carbide is a powder metallurgical product consisting of hard, wear-resistant carbide particles bound together (cemented) with a ductile metal binder (i.e. metallic Co) by liquid phase sintering. Tungsten carbide (WC) is produced by mixing tungsten powder with pure carbon powder at high temperature; hereafter WC is mixed with Co powder to which paraffin is added as a binder. Depending on specific requirements related to their use, hard metals might additionally contain small quantities of chromium, niobium, molybdenum, titanium, tantalum or vanadium carbides. Inhalation and skin contact are the main occupational exposure routes. Occupational exposure to cobalt may result in adverse health effects in different organs or tissues, including the respiratory tract, the skin, the hemapoietic tissues, the myocardium or the thyroid gland. In addition, teratogenic and carcinogenic effects have been observed in experimental systems and/or in humans. For the general population, the diet constitutes the main route of exposure to cobalt, since it is an essential component of Vitamin B12 (hydroxycolalamin). Cobalt functions as a co-factor in enzyme catalysed reactions and is involved in the production of erythropoietin, a hormone that stimulates the formation of erythrocytes. This last property of cobalt was applied in the past as a therapy for anaemia. The carcinogenic potential of cobalt and its compounds was evaluated in 1991 by the International Agency for Research on Cancer (IARC), which concluded that there was inadequate evidence for carcinogenicity in humans (lung cancer) but sufficient evidence in experimental animal studies. In most experimental studies considered, the routes of exposure were, however, of questionable relevance for cancer risk assessment in humans for example, local sarcomas after intra-muscular injection. The general conclusion was that cobalt and its compounds are possibly carcinogenic to humans (group 2B). Since this evaluation, additional data have been accumulated which generally indicate that, depending on the considered cobalt species, different outcomes regarding toxicity, mutagenicity and carcinogenicity can be observed. Physiologically, it exists as an ion in the body. Co(II) ions are genotoxic in vitro and in vivo, and carcinogenic in rodents. Co metal is genotoxic in vitro. Hard metal dust, of which occupational exposure is linked to an increased lung cancer risk, is proven to be genotoxic in vitro and in vivo. Possibly, production of active oxygen species and/or DNA repair inhibition are mechanisms involved. Given the recently provided proof for in vitro and in vivo genotoxic potential of hard metal dust, the mechanistic evidence of elevated production of active oxygen species and the epidemiological data on increased cancer risk, it may be advisable to consider the possibility of a new evaluation by IARC.(PMID: 14643417).",Cobalt,HMDB0000608,b,b,C00175,COBALT-FACTOR-III,FDB003581,b,b,b,b
4195,11038,a,a,3790,KEGG COMPOUND accession,C11538,copre2,b,b,b,Cobalt-precorrin 2,b,b,b,C11538,b,b,b,b,b,b
4196,11040,a,a,3791,KEGG COMPOUND accession,C11539,copre3,b,b,b,Cobalt-precorrin 3,b,b,b,C11539,b,b,b,b,b,b
4197,11043,a,a,3792,KEGG COMPOUND accession,C11540,copre4,b,b,b,Cobalt-precorrin 4,b,b,b,C11540,b,b,b,b,b,b
4198,11046,a,a,3793,KEGG COMPOUND accession,C11541,copre5,b,b,b,Cobalt-precorrin 5,b,b,b,C11541,b,b,b,b,b,b
4199,11048,a,a,3794,KEGG COMPOUND accession,C11542,copre6,b,b,b,Cobalt-precorrin 6,b,b,b,C11542,b,b,b,b,b,b
4200,11050,a,a,3795,KEGG COMPOUND accession,C11545,copre8,b,b,b,Cobalt-precorrin 8,b,b,b,C11545,b,b,b,b,b,b
4201,11053,a,a,3796,KEGG COMPOUND accession,C00210,,,,,,,,,,,,,,,
4202,11055,a,a,18408,KEGG COMPOUND accession,C00194,adocbl,13870-90-1,18408.0,"Human Metabolome Database (HMDB): Adenosylcobalamin is one of two metabolically active forms synthesized upon ingestion of vitamin B12 and is the predominant form in the liver; it acts as a coenzyme in the reaction catalyzed by methylmalonyl-CoA mutase. A cobalamin (cbl) derivative in which the substituent is deoxyadenosyl. It is one of two metabolically active forms synthesized upon ingestion of vitamin B12 and is the predominant form in the liver; it acts as a coenzyme in the reaction catalyzed by methylmalonyl-CoA mutase (MCM; E.C. 5.4.99.2). Inborn errors of vitamin B12 metabolism are autosomal recessive disorders and have been classified into nine distinct complementation classes. Disorders affecting adenosylcobalamin cause methylmalonic acidemia and metabolic acidosis. Methylmalonyl-CoA mutase catalyzes the conversion of L-methylmalonyl-CoA to succinyl-CoA and uses adenosylcobalamin (AdoCbl) as a cofactor. Cbl must be transported into mitochondria, reduced and adenosylated before it can be utilized by MCM. (PMID: 17011224).",Adenosylcobalamin,HMDB0002086,b,b,C00194,ADENOSYLCOBALAMIN-5-P,FDB022837,b,[N+]12=C3[C@](C([H])([H])C([H])([H])C(=O)N([H])[H])([H])C(C1=C(C1=[N+]4[Co-3]225([N+]6=C(C(C([H])([H])[H])=C4[C@](C([H])([H])[H])([C@@]1(C(C([H])([H])C(=O)N([H])[H])([H])[H])[H])C([H])([H])C(N([H])[H])=O)[C@@](C([H])([H])C([H])([H])C(N([H])[H])=O)([C@@]([C@@]6([C@@]1([H])[C@@]([C@](C(N21)=C3C([H])([H])[H])(C([H])([H])C(C(=O)N([H])C([H])([H])[C@@](C([H])([H])[H])(OP([O-])(O[C@@]1([H])[C@]([H])([C@@](O[C@@]1(C(O[H])([H])[H])[H])([H])N1C(=[N+]5C2=C([H])C(C([H])([H])[H])=C(C([H])=C12)C([H])([H])[H])[H])O[H])=O)[H])([H])[H])C([H])([H])[H])(C(C(N([H])[H])=O)([H])[H])[H])C([H])([H])[H])(C([H])([H])C(=O)N([H])[H])C([H])([H])[H])[H])C([C@]1(O[C@]([C@@]([H])([C@]1([H])O[H])O[H])(N1C([H])=NC2=C(N([H])[H])N=C(N=C12)[H])[H])[H])([H])[H])[H])(C([H])([H])[H])C([H])([H])[H],ZIHHMGTYZOSFRC-OUCXYWSSSA-L,"InChI=1S/C62H90N13O14P.C10H12N5O3.Co/c1-29-20-39-40(21-30(29)2)75(28-70-39)57-52(84)53(41(27-76)87-57)89-90(85,86)88-31(3)26-69-49(83)18-19-59(8)37(22-46(66)80)56-62(11)61(10,25-48(68)82)36(14-17-45(65)79)51(74-62)33(5)55-60(9,24-47(67)81)34(12-15-43(63)77)38(71-55)23-42-58(6,7)35(13-16-44(64)78)50(72-42)32(4)54(59)73-56;1-4-6(16)7(17)10(18-4)15-3-14-5-8(11)12-2-13-9(5)15;/h20-21,23,28,31,34-37,41,52-53,56-57,76,84H,12-19,22,24-27H2,1-11H3,(H15,63,64,65,66,67,68,69,71,72,73,74,77,78,79,80,81,82,83,85,86);2-4,6-7,10,16-17H,1H2,(H2,11,12,13);/q;;+2/p-2/t31-,34-,35-,36-,37+,41-,52-,53-,56-,57+,59-,60+,61+,62+;4-,6-,7-,10-;/m11./s1"
4203,11058,a,a,28956,KEGG COMPOUND accession,C05774,,,,,,,,,,,,,,,
4204,11063,a,a,27958,KEGG COMPOUND accession,C01416,coke,50-36-2,27958.0,"Human Metabolome Database (HMDB): An alkaloid ester extracted from the leaves of plants including coca. It is a local anesthetic and vasoconstrictor and is clinically used for that purpose, particularly in the eye, ear, nose, and throat. It also has powerful central nervous system effects similar to the amphetamines and is a drug of abuse. Cocaine, like amphetamines, acts by multiple mechanisms on brain catecholaminergic neurons; the mechanism of its reinforcing effects is thought to involve inhibition of dopamine uptake. [PubChem]",Cocaine,HMDB0015043,b,b,C01416,b,b,coke,[H]C1=C([H])C([H])=C(C([H])=C1[H])C(=O)O[C@@]1([H])C([H])([H])[C@@]2([H])N(C([H])([H])[H])[C@]([H])(C([H])([H])C2([H])[H])[C@@]1([H])C(=O)OC([H])([H])[H],ZPUCINDJVBIVPJ-LJISPDSOSA-N,"InChI=1S/C17H21NO4/c1-18-12-8-9-13(18)15(17(20)21-2)14(10-12)22-16(19)11-6-4-3-5-7-11/h3-7,12-15H,8-10H2,1-2H3/t12-,13+,14-,15+/m0/s1"
4205,11067,a,a,16714,KEGG COMPOUND accession,C06174,,,,,,,,,,,,,,,
4206,11076,a,a,16848,KEGG COMPOUND accession,C00876,,,,,,,,,,,,,,,
4207,11081,a,a,28265,KEGG COMPOUND accession,C05777,,,,,,,,,,,,,,,
4208,11082,a,a,18209,KEGG COMPOUND accession,C04832,,,,,,,,,,,,,,,
4209,11084,a,a,16213,KEGG COMPOUND accession,C01677,,,,,,,,,,,,,,,
4210,11087,a,a,27882,KEGG COMPOUND accession,C07592,,,,,,,,,,,,,,,
4211,11148,a,a,27965,KEGG COMPOUND accession,C06545,,,,,,,,,,,,,,,
4212,11154,a,a,3856,KEGG COMPOUND accession,C09378,,,,,,,,,,,,,,,
4213,11156,a,a,16220,KEGG COMPOUND accession,C00761,,,,,,,,,,,,,,,
4214,11160,a,a,17745,KEGG COMPOUND accession,C00590,,,,,,,,,,,,,,,
4215,11167,a,a,16547,KEGG COMPOUND accession,C02666,,,,,,,,,,,,,,,
4216,11185,a,a,27663,KEGG COMPOUND accession,C08858,,,,,,,,,,,,,,,
4217,11198,a,a,28151,KEGG COMPOUND accession,C06089,,,,,,,,,,,,,,,
4218,11199,a,a,28694,KEGG COMPOUND accession,C00070,,,,,,,,,,,,,,,
4219,11201,a,a,3875,KEGG COMPOUND accession,C08271,,,,,,,,,,,,,,,
4220,11203,a,a,28421,KEGG COMPOUND accession,C05769,C05769,531-14-6,28421.0,"Human Metabolome Database (HMDB): Coproporphyrin I is a porphyrin metabolite arising from heme synthesis. Porphyrins are pigments found in both animal and plant life. Coproporphyrin I is a tetrapyrrole dead-end product from the spontaneous oxidation of the methylene bridges of coproporphynogen, arising from heme synthesis and secreted in feces and urine. Increased levels of coproporphyrins can indicate congenital erythropoietic porphyria or sideroblastic anaemia. Porphyria is a pathological state characterised by abnormalities of porphyrin metabolism and results in the excretion of large quantities of porphyrins in the urine and in extreme sensitivity to light. A large number of factors are capable of increasing porphyrin excretion, owing to different and multiple causes and etiologies: 1) the main site of the chronic hepatic porphyria disease process concentrates on the liver, 2) a functional and morphologic liver injury is almost regularly associated with this chronic porphyria, 3) the toxic form due to occupational and environmental exposure takes mainly a subclinical course. Hepatic factors includes disturbance in coproporphyrinogen metabolism, which results from inhibition of coproporphyrinogen oxidase as well as from the rapid loss from, and diminished utilization of coproporphyrinogen in the hepatocytes, which may also explain why coproporphyrin, its autoxidation product, predominates physiologically in the urine; decreased biliary excretion of coproporphyrin leading to a compensatory urinary excretion, so that the coproporphyrin ring isomer ratio (1:III) becomes a sensitive index for impaired liver function and intrahepatic cholestasis; and disturbed activity of hepatic uroporphyrinogen decarboxylase. In itself, secondary coproporphyrinuria is not associated with porphyria symptoms of a hepatologic-gastroenterologic, neurologic, or dermatologic order, even though coproporphyrinuria can occur with such symptoms. (PMID: 3327428).",Coproporphyrin I,HMDB0000643,b,b,C05769,b,FDB022159,C05769,[H]N1\C2=C([H])/C3=N/C(=C([H])\C4=C(C(=C(N4[H])\C([H])=C4/N=C(/C(/[H])=C1/C(=C2C([H])([H])[H])C([H])([H])C([H])([H])C([O-])=O)C(=C4C([H])([H])C([H])([H])C([O-])=O)C([H])([H])[H])C([H])([H])[H])C([H])([H])C([H])([H])C([O-])=O)/C(=C3C([H])([H])C([H])([H])C([O-])=O)C([H])([H])[H],VORBHEGMEBOMMB-JRHDEHKPSA-J,"InChI=1S/C36H38N4O8/c1-17-21(5-9-33(41)42)29-14-26-19(3)23(7-11-35(45)46)31(39-26)16-28-20(4)24(8-12-36(47)48)32(40-28)15-27-18(2)22(6-10-34(43)44)30(38-27)13-25(17)37-29/h13-16,37,40H,5-12H2,1-4H3,(H,41,42)(H,43,44)(H,45,46)(H,47,48)/p-4/b25-13-,26-14-,27-15-,28-16-,29-14-,30-13-,31-16-,32-15-"
4221,11204,a,a,27609,KEGG COMPOUND accession,C05770,C05770,14643-66-4,27609.0,"Human Metabolome Database (HMDB): Coproporphyrin III is a porphyrin metabolite arising from heme synthesis. Porphyrins are pigments found in both animal and plant life. Coproporphyrin III is a tetrapyrrole dead-end product from the spontaneous oxidation of the methylene bridges of coproporphynogen, arising from heme synthesis and secreted in feces and urine. Increased levels of coproporphyrins can indicate congenital erythropoietic porphyria or sideroblastic anaemia, which are inherited disorders. Porphyria is a pathological state characterised by abnormalities of porphyrin metabolism and results in the excretion of large quantities of porphyrins in the urine and in extreme sensitivity to light. A large number of factors are capable of increasing porphyrin excretion, owing to different and multiple causes and etiologies: 1) the main site of the chronic hepatic porphyria disease process concentrates on the liver, 2) a functional and morphologic liver injury is almost regularly associated with this chronic porphyria, 3) the toxic form due to occupational and environmental exposure takes mainly a subclinical course. Hepatic factors includes disturbance in coproporphyrinogen metabolism, which results from inhibition of coproporphyrinogen oxidase as well as from the rapid loss from, and diminished utilization of coproporphyrinogen in the hepatocytes, which may also explain why coproporphyrin, its autoxidation product, predominates physiologically in the urine; decreased biliary excretion of coproporphyrin leading to a compensatory urinary excretion, so that the coproporphyrin ring isomer ratio (1:III) becomes a sensitive index for impaired liver function and intrahepatic cholestasis; and disturbed activity of hepatic uroporphyrinogen decarboxylase. In itself, secondary coproporphyrinuria is not associated with porphyria symptoms of a hepatologic-gastroenterologic, neurologic, or dermatologic order, even though coproporphyrinuria can occur with such symptoms. (PMID: 3327428).",Coproporphyrin III,HMDB0000570,b,b,C05770,b,FDB005557,C05770,[H]N1\C2=C([H])/C3=N/C(=C([H])\C4=C(C(=C(N4[H])\C([H])=C4/N=C(/C(/[H])=C1/C(=C2C([H])([H])[H])C([H])([H])C([H])([H])C([O-])=O)C(=C4C([H])([H])[H])C([H])([H])C([H])([H])C([O-])=O)C([H])([H])[H])C([H])([H])C([H])([H])C([O-])=O)/C(=C3C([H])([H])C([H])([H])C([O-])=O)C([H])([H])[H],JWFCYWSMNRLXLX-UJJXFSCMSA-J,"InChI=1S/C36H38N4O8/c1-17-21(5-9-33(41)42)29-14-27-19(3)22(6-10-34(43)44)30(39-27)15-28-20(4)24(8-12-36(47)48)32(40-28)16-31-23(7-11-35(45)46)18(2)26(38-31)13-25(17)37-29/h13-16,37,40H,5-12H2,1-4H3,(H,41,42)(H,43,44)(H,45,46)(H,47,48)/p-4/b25-13-,26-13-,27-14-,28-15-,29-14-,30-15-,31-16-,32-16-"
4222,11206,a,a,28607,KEGG COMPOUND accession,C05768,cpppg1,31110-56-2,28607.0,"Human Metabolome Database (HMDB): Coproporphyrinogen I is a porphyrin metabolite arising from heme synthesis. Porphyrins are pigments found in both animal and plant life. Coproporphyrinogen I is a tetrapyrrole dead-end product resulting from the spontaneous oxidation of the methylene bridges of coproporphyrinogen arising from heme synthesis. It is secreted in feces and urine. Coproporphyrinogen I is biosynthesized from the tetrapyrrole hydroxymethylbilane, which is converted by the action of uroporphyrinogen synthase to uroporphyrinogen I. Uroporphyrinogen I is subsequently converted into coproporphyrinogen I through a series of four decarboxylations. Increased levels of coproporphyrinogens can indicate congenital erythropoietic porphyria or sideroblastic anemia, which are inherited disorders. Porphyria is a pathological state characterized by abnormalities of porphyrin metabolism and results in the excretion of large quantities of porphyrins in the urine and in extreme sensitivity to light. A large number of factors are capable of increasing porphyrin excretion, owing to different and multiple causes and etiologies: (1) the main site of the chronic hepatic porphyria disease process concentrates on the liver, (2) a functional and morphologic liver injury is almost regularly associated with this chronic porphyria, and (3) the toxic form due to occupational and environmental exposure takes mainly a subclinical course. Hepatic factors include disturbance in coproporphyrinogen metabolism, which results from inhibition of coproporphyrinogen oxidase as well as from the rapid loss and diminished utilization of coproporphyrinogen in the hepatocytes. This may also explain why coproporphyrin, its autoxidation product, predominates physiologically in the urine. Decreased biliary excretion of coproporphyrin leading to a compensatory urinary excretion. Therefore, the coproporphyrin ring isomer ratio becomes a sensitive index for impaired liver function, intrahepatic cholestasis, and disturbed activity of hepatic uroporphyrinogen decarboxylase. In itself, secondary coproporphyrinuria is not associated with porphyria symptoms of a hepatologic-gastroenterologic, neurologic, or dermatologic order, even though coproporphyrinuria can occur with such symptoms (PMID: 3327428). Under certain conditions, coproporphyrinogen I can act as a phototoxin, a neurotoxin, and a metabotoxin. A phototoxin leads to cell damage upon exposure to light. A neurotoxin causes damage to nerve cells and nerve tissues. A metabotoxin is an endogenously produced metabolite that causes adverse health effects at chronically high levels. Chronically high levels of porphyrins are associated with porphyrias such as porphyria variegate, acute intermittent porphyria, hereditary coproporphyria (HCP), congenital erythropoietic porphyria, and sideroblastic anemia. There are several types of porphyrias (most are inherited). Hepatic porphyrias are characterized by acute neurological attacks (seizures, psychosis, extreme back and abdominal pain, and an acute polyneuropathy), while the erythropoietic forms present with skin problems (usually a light-sensitive blistering rash and increased hair growth). The neurotoxicity of porphyrins may be due to their selective interactions with tubulin, which disrupt microtubule formation and cause neural malformations (PMID: 3441503).  Coproporphyrinogen I can be found in a number of food items, including cascade huckleberry, hyacinth bean, horseradish tree, and watercress.",Coproporphyrinogen I,HMDB0002158,b,b,C05768,COPROPORPHYRINOGEN_I,FDB022874,cpppg1,[H]N1C2=C(C(=C1C([H])([H])C1=C(C(=C(N1[H])C([H])([H])C1=C(C(=C(N1[H])C([H])([H])C1=C(C(=C(N1[H])C2([H])[H])C([H])([H])C([H])([H])C([O-])=O)C([H])([H])[H])C([H])([H])C([H])([H])C([O-])=O)C([H])([H])[H])C([H])([H])C([H])([H])C([O-])=O)C([H])([H])[H])C([H])([H])C([H])([H])C([O-])=O)C([H])([H])[H],WIUGGJKHYQIGNH-UHFFFAOYSA-J,"InChI=1S/C36H44N4O8/c1-17-21(5-9-33(41)42)29-14-26-19(3)23(7-11-35(45)46)31(39-26)16-28-20(4)24(8-12-36(47)48)32(40-28)15-27-18(2)22(6-10-34(43)44)30(38-27)13-25(17)37-29/h37-40H,5-16H2,1-4H3,(H,41,42)(H,43,44)(H,45,46)(H,47,48)/p-4"
4223,11208,a,a,15439,KEGG COMPOUND accession,C03263,cpppg3,2624-63-7,15439.0,"Human Metabolome Database (HMDB): Coproporphyrinogen III is a porphyrin metabolite arising from heme synthesis. Porphyrins are pigments found in both animal and plant life. Coproporphyrinogen III is a tetrapyrrole dead-end product resulting from the spontaneous oxidation of the methylene bridges of coproporphyrinogen arising from heme synthesis. It is secreted in feces and urine. Coproporphyrinogen III is biosynthesized from the tetrapyrrole hydroxymethylbilane, which is converted by the action of uroporphyrinogen III synthase to uroporphyrinogen III. Uroporphyrinogen III is subsequently converted into coproporphyrinogen III through a series of four decarboxylations. Increased levels of coproporphyrinogens can indicate congenital erythropoietic porphyria or sideroblastic anemia, which are inherited disorders. Porphyria is a pathological state characterized by abnormalities of porphyrin metabolism and results in the excretion of large quantities of porphyrins in the urine and in extreme sensitivity to light. A large number of factors are capable of increasing porphyrin excretion, owing to different and multiple causes and etiologies: (1) the main site of the chronic hepatic porphyria disease process concentrates on the liver, (2) a functional and morphologic liver injury is almost regularly associated with this chronic porphyria, and (3) the toxic form due to occupational and environmental exposure takes mainly a subclinical course. Hepatic factors include disturbance in coproporphyrinogen metabolism, which results from inhibition of coproporphyrinogen oxidase as well as from the rapid loss and diminished utilization of coproporphyrinogen in the hepatocytes. This may also explain why coproporphyrin, its autoxidation product, predominates physiologically in the urine. Decreased biliary excretion of coproporphyrin leading to a compensatory urinary excretion. Therefore, the coproporphyrin ring isomer ratio (1:III) becomes a sensitive index for impaired liver function, intrahepatic cholestasis, and disturbed activity of hepatic uroporphyrinogen decarboxylase. In itself, secondary coproporphyrinuria is not associated with porphyria symptoms of a hepatologic-gastroenterologic, neurologic, or dermatologic order, even though coproporphyrinuria can occur with such symptoms (PMID: 3327428). Under certain conditions, coproporphyrinogen III can act as a phototoxin, a neurotoxin, and a metabotoxin. A phototoxin leads to cell damage upon exposure to light. A neurotoxin causes damage to nerve cells and nerve tissues. A metabotoxin is an endogenously produced metabolite that causes adverse health effects at chronically high levels. Chronically high levels of porphyrins are associated with porphyrias such as porphyria variegate, acute intermittent porphyria, hereditary coproporphyria (HCP), congenital erythropoietic porphyria, and sideroblastic anemia. In particular, coproporphyrinogen III is accumulated and excreted excessively in the feces in acute intermittent porphyria, protoporphyria, and variegate porphyria. There are several types of porphyrias (most are inherited). Hepatic porphyrias are characterized by acute neurological attacks (seizures, psychosis, extreme back and abdominal pain, and an acute polyneuropathy), while the erythropoietic forms present with skin problems (usually a light-sensitive blistering rash and increased hair growth). The neurotoxicity of porphyrins may be due to their selective interactions with tubulin, which disrupt microtubule formation and cause neural malformations (PMID: 3441503).",Coproporphyrinogen III,HMDB0001261,b,b,C03263,COPROPORPHYRINOGEN_III,FDB022518,cpppg3,[H]N1C2=C(C(=C1C([H])([H])C1=C(C(=C(N1[H])C([H])([H])C1=C(C(=C(N1[H])C([H])([H])C1=C(C(=C(N1[H])C2([H])[H])C([H])([H])[H])C([H])([H])C([H])([H])C([O-])=O)C([H])([H])C([H])([H])C([O-])=O)C([H])([H])[H])C([H])([H])C([H])([H])C([O-])=O)C([H])([H])[H])C([H])([H])C([H])([H])C([O-])=O)C([H])([H])[H],NIUVHXTXUXOFEB-UHFFFAOYSA-J,"InChI=1S/C36H44N4O8/c1-17-21(5-9-33(41)42)29-14-27-19(3)22(6-10-34(43)44)30(39-27)15-28-20(4)24(8-12-36(47)48)32(40-28)16-31-23(7-11-35(45)46)18(2)26(38-31)13-25(17)37-29/h37-40H,5-16H2,1-4H3,(H,41,42)(H,43,44)(H,45,46)(H,47,48)/p-4"
4224,11212,a,a,29014,KEGG COMPOUND accession,C08431,,,,,,,,,,,,,,,
4225,11218,a,a,3884,KEGG COMPOUND accession,C10219,,,,,,,,,,,,,,,
4226,11224,a,a,3887,KEGG COMPOUND accession,C09139,,,,,,,,,,,,,,,
4227,11232,a,a,16827,KEGG COMPOUND accession,C02140,crtstrn,50-22-6,16827.0,"Human Metabolome Database (HMDB): Corticosterone is an adrenocortical steroid that has modest but significant activities as a mineralocorticoid and a glucocorticoid. (From Goodman and Gilman's The Pharmacological Basis of Therapeutics, 8th ed, p1437).",Corticosterone,HMDB0001547,b,b,C02140,CORTICOSTERONE,FDB022684,crtstrn,[H]OC([H])([H])C(=O)[C@@]1([H])C([H])([H])C([H])([H])[C@@]2([H])[C@]3([H])C([H])([H])C([H])([H])C4=C([H])C(=O)C([H])([H])C([H])([H])[C@]4(C([H])([H])[H])[C@@]3([H])[C@@]([H])(O[H])C([H])([H])[C@]12C([H])([H])[H],OMFXVFTZEKFJBZ-HJTSIMOOSA-N,"InChI=1S/C21H30O4/c1-20-8-7-13(23)9-12(20)3-4-14-15-5-6-16(18(25)11-22)21(15,2)10-17(24)19(14)20/h9,14-17,19,22,24H,3-8,10-11H2,1-2H3/t14-,15-,16+,17-,19+,20-,21-/m0/s1"
4228,11241,a,a,17650,KEGG COMPOUND accession,C00735,crtsl,50-23-7,17650.0,"Human Metabolome Database (HMDB): Cortisol is a corticosteroid hormone produced by the adrenal cortex that is involved in the response to stress; the main glucocorticoid secreted by the adrenal cortex. Cortisol produced by the adrenal cortex increases blood pressure, blood sugar levels, may cause infertility in women, and suppresses the immune system. As an oral or injectable drug, cortisol is also known as hydrocortisone. It is used as an immunosuppressive drug, given by injection in the treatment of severe allergic reactions such as anaphylaxis and angioedema, in place of prednisolone in patients who need steroid treatment but cannot take oral medication, and peri-operatively in patients on long-term steroid treatment to prevent an Addisonian crisis. Hydrocortisone is used, either as an injection or topically, in the treatment of inflammation, allergy, collagen diseases, asthma, adrenocortical deficiency, shock, and some neoplastic conditions. Cortisol is synthesized from pregnenolone. The amount of cortisol present in the serum undergoes diurnal variation, with the highest levels present in the early morning, and lower levels in the evening, several hours after the onset of sleep. Moreover, cortisol is found to be associated with ACTH deficiency, isolated and glucocorticoid deficiency, which are inborn errors of metabolism.",Cortisol,HMDB0000063,b,b,C00735,CORTISOL,FDB021888,crtsl,[H]OC([H])([H])C(=O)[C@@]1(O[H])C([H])([H])C([H])([H])[C@@]2([H])[C@]3([H])C([H])([H])C([H])([H])C4=C([H])C(=O)C([H])([H])C([H])([H])[C@]4(C([H])([H])[H])[C@@]3([H])[C@@]([H])(O[H])C([H])([H])[C@]12C([H])([H])[H],JYGXADMDTFJGBT-VWUMJDOOSA-N,"InChI=1S/C21H30O5/c1-19-7-5-13(23)9-12(19)3-4-14-15-6-8-21(26,17(25)11-22)20(15,2)10-16(24)18(14)19/h9,14-16,18,22,24,26H,3-8,10-11H2,1-2H3/t14-,15-,16-,18+,19-,20-,21-/m0/s1"
4229,11252,a,a,17609,KEGG COMPOUND accession,C02821,,,,,,,,,,,,,,,
4230,11255,a,a,16473,KEGG COMPOUND accession,C02822,,,,,,,,,,,,,,,
4231,11257,a,a,16962,KEGG COMPOUND accession,C00762,cortsn,53-06-5,16962.0,"Human Metabolome Database (HMDB): Cortisone is a naturally occurring glucocorticoid. It has been used in replacement therapy for adrenal insufficiency and as an anti-inflammatory agent. Cortisone itself is inactive. It is converted in the liver to the active metabolite hydrocortisone. (From Martindale, The Extra Pharmacopoeia, 30th ed, p726) -- Pubchem; Cortisone is a hormone. Chemically it is a corticosteroid with formula C21H28O5 and IUPAC name 17-hydroxy-11-dehydrocorticosterone. It is closely related to corticosterone. -- Wikipedia; One of cortisone's effects on the body, and a potentially harmful side effect when administered clinically, is the suppression of the immune system. This is an explanation for the apparent correlation between high stress and sickness. -- Wikipedia.",Cortisone,HMDB0002802,b,b,C00762,CORTISONE,FDB023065,cortsn,[H]OC([H])([H])C(=O)[C@@]1(O[H])C([H])([H])C([H])([H])[C@@]2([H])[C@]3([H])C([H])([H])C([H])([H])C4=C([H])C(=O)C([H])([H])C([H])([H])[C@]4(C([H])([H])[H])[C@@]3([H])C(=O)C([H])([H])[C@]12C([H])([H])[H],MFYSYFVPBJMHGN-ZPOLXVRWSA-N,"InChI=1S/C21H28O5/c1-19-7-5-13(23)9-12(19)3-4-14-15-6-8-21(26,17(25)11-22)20(15,2)10-16(24)18(14)19/h9,14-15,18,22,26H,3-8,10-11H2,1-2H3/t14-,15-,18+,19-,20-,21-/m0/s1"
4232,11268,a,a,3900,KEGG COMPOUND accession,C09382,,,,,,,,,,,,,,,
4233,11280,a,a,3907,KEGG COMPOUND accession,C05073,,,,,,,,,,,,,,,
4234,11282,a,a,3908,KEGG COMPOUND accession,C10205,,,,,,,,,,,,,,,
4235,11284,a,a,16919,KEGG COMPOUND accession,C00300,creat,57-00-1,16919.0,"Human Metabolome Database (HMDB): Creatine is an amino acid that occurs in vertebrate tissues and in urine. In muscle tissue, creatine generally occurs as phosphocreatine. Creatine is excreted as creatinine in the urine. Creatine functions as part of the cell's energy shuttle. The high energy phosphate group of ATP is transferred to creatine to form phosphocreatine in the following reaction: Cr + ATP <-> PCr + ADP. This reaction is reversibly catalyzed by creatine kinase. In the human body creatine is synthesized mainly in the liver by the use of parts from three different amino acids - arginine, glycine, and methionine. 95% of it is later stored in the skeletal muscles, with the rest in the brain, heart, testes.",Creatine,HMDB0000064,b,b,C00300,CREATINE,FDB005403,creat,[H]N([H])C(=[N+]([H])[H])N(C([H])([H])[H])C([H])([H])C([O-])=O,CVSVTCORWBXHQV-UHFFFAOYSA-N,"InChI=1S/C4H9N3O2/c1-7(4(5)6)2-3(8)9/h2H2,1H3,(H3,5,6)(H,8,9)"
4236,11291,a,a,16737,KEGG COMPOUND accession,C00791,crtn,60-27-5,16737.0,"Human Metabolome Database (HMDB): Creatinine or creatine anhydride, is a breakdown product of creatine phosphate in muscle. The loss of water molecule from creatine results in the formation of creatinine. Creatinine is transferred to the kidneys by blood plasma, whereupon it is eliminated from the body by glomerular filtration and partial tubular excretion. Creatinine is usually produced at a fairly constant rate by the body. Measuring serum creatinine is a simple test and it is the most commonly used indicator of renal function. Creatinine is found to be associated with maple syrup urine disease, phenylketonuria, primary hypomagnesemia, propionic acidemia, and tyrosinemia I, which are inborn errors of metabolism. A rise in blood creatinine levels is observed only with marked damage to functioning nephrons; therefore this test is not suitable for detecting early kidney disease. The typical reference range for women is considered about 45-90 umol/l, for men 60-110 umol/l. Creatine and creatinine are metabolized in the kidneys, muscle, liver and pancreas. Creatinine is a biomarker for the consumption of meat.",Creatinine,HMDB0000562,b,b,C00791,b,FDB021814,crtn,[H]N=C1N([H])C(=O)C([H])([H])N1C([H])([H])[H],DDRJAANPRJIHGJ-UHFFFAOYSA-N,"InChI=1S/C4H7N3O/c1-7-2-3(8)6-4(7)5/h2H2,1H3,(H2,5,6,8)"
4237,11297,a,a,16423,KEGG COMPOUND accession,C07289,,,,,,,,,,,,,,,
4238,11309,a,a,3918,KEGG COMPOUND accession,C08588,,,,,,,,,,,,,,,
4239,11311,a,a,79068,KEGG COMPOUND accession,C08589,,,,,,,,,,,,,,,
4240,11328,a,a,15473,KEGG COMPOUND accession,C00877,b2coa,102680-35-3,15473.0,"Human Metabolome Database (HMDB): Crotonoyl-CoA is an important component in several metabolic pathways, notably fatty acid and amino acid metabolism. It is the substrate of a group of enzymes acyl-Coenzyme A oxidases 1, 2, 3 (E.C.: 1.3.3.6) corresponding to palmitoyl, branched chain, and pristanoyl, respectively, in the peroxisomal fatty acid beta-oxidation, producing hydrogen peroxide. Abnormality of this group of enzymes is linked to coma, dehydration, diabetes, fatty liver, hyperinsulinemia, hyperlipidemia, and leukodystrophy. It is also a substrate of a group of enzymes called acyl-Coenzyme A dehydrogenase (E.C.:1.3.99-, including 1.3.99.2, 1.3.99.3) in the metabolism of fatty acids or branched chain amino acids in the mitochondria (Rozen et al., 1994). Acyl-Coenzyme A dehydrogenase (1.3.99.3) has shown to contribute to kidney-associated diseases, such as adrenogential syndrome, kidney failure, kidney tubular necrosis, homocystinuria, as well as other diseases including cretinism, encephalopathy, hypoglycemia, medium chain acyl-CoA dehydrogenase deficiency. The gene (ACADS) also plays a role in theta oscillation during sleep. In addition, crotonoyl-CoA is the substrate of enoyl coenzyme A hydratase (E.C.4.2.1.17) in the mitochondria during lysine degradation and tryptophan metabolism, benzoate degradation via CoA ligation; in contrast it is the product of this enzyme in the butanoate metabolism. Moreover, it is produced from multiple enzymes in the butanoate metabolism pathway, including 3-Hydroxybutyryl-CoA dehydratase (E.C.:4.2.1.55), glutaconyl-CoA decarboxylase (E.C.: 4.1.1.70), vinylacetyl-CoA &#916;-isomerase (E.C.: 5.3.3.3), and trans-2-enoyl-CoA reductase (NAD+) (E.C.: 1.3.1.44). In lysine degradation and tryptophan metabolism, crotonoyl CoA is produced by glutaryl-Coenzyme A dehydrogenase (E.C.:1.3.99.7) lysine and tryptophan metabolic pathway. This enzyme is linked to type-1glutaric aciduria, metabolic diseases, movement disorders, myelinopathy, and nervous system diseases.",Crotonoyl-CoA,HMDB0002009,b,b,C00877,CPD-1083,FDB022792,b2coa,[H]O[C@@]([H])(C(=O)N([H])C([H])([H])C([H])([H])C(=O)N([H])C([H])([H])C([H])([H])SC(=O)C(\[H])=C(/[H])C([H])([H])[H])C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])OP([O-])(=O)OP([O-])(=O)OC([H])([H])[C@@]1([H])O[C@@]([H])(N2C([H])=NC3=C(N=C([H])N=C23)N([H])[H])[C@]([H])(O[H])[C@]1([H])OP([O-])([O-])=O,KFWWCMJSYSSPSK-MIZOYAPFSA-J,"InChI=1S/C25H40N7O17P3S/c1-4-5-16(34)53-9-8-27-15(33)6-7-28-23(37)20(36)25(2,3)11-46-52(43,44)49-51(41,42)45-10-14-19(48-50(38,39)40)18(35)24(47-14)32-13-31-17-21(26)29-12-30-22(17)32/h4-5,12-14,18-20,24,35-36H,6-11H2,1-3H3,(H,27,33)(H,28,37)(H,41,42)(H,43,44)(H2,26,29,30)(H2,38,39,40)/p-4/b5-4+/t14-,18-,19-,20+,24-/m0/s1"
4241,11340,a,a,3929,KEGG COMPOUND accession,C10585,,,,,,,,,,,,,,,
4242,11342,a,a,3930,KEGG COMPOUND accession,C09142,,,,,,,,,,,,,,,
4243,11346,a,a,3932,KEGG COMPOUND accession,C10586,,,,,,,,,,,,,,,
4244,11364,a,a,3941,KEGG COMPOUND accession,C08794,,,,,,,,,,,,,,,
4245,11368,a,a,3943,KEGG COMPOUND accession,C08796,,,,,,,,,,,,,,,
4246,11370,a,a,3944,KEGG COMPOUND accession,C08797,,,,,,,,,,,,,,,
4247,11400,a,a,28582,KEGG COMPOUND accession,C06530,,,,,,,,,,,,,,,
4248,11402,a,a,3960,KEGG COMPOUND accession,C10034,,,,,,,,,,,,,,,
4249,11406,a,a,3962,KEGG COMPOUND accession,C10443,,,,,,,,,,,,,,,
4250,11416,a,a,16698,KEGG COMPOUND accession,C01566,,,,,,,,,,,,,,,
4251,11419,a,a,28024,KEGG COMPOUND accession,C01417,cynt,71000-82-3,29195.0,"Human Metabolome Database (HMDB): The cyanate ion is an anion consisting of one oxygen atom, one carbon atom, and one nitrogen atom, [OCN], in that order. The cyanate ion possesses 1 unit of negative charge, borne mainly by the nitrogen atom. In organic compounds the cyanate group is a functional group. The cyanate ion is an ambident nucleophile in nucleophilic substitution because it can react to form an alkyl cyanate R-OCN (exception) or an alkyl isocyanate R-NCO (rule). Aryl cyanates (C6H5OCN) can be formed by a reaction of phenol with cyanogen chloride (ClCN) in the presence of a base. The cyanate ion is relatively non-toxic in comparison with cyanides. Use of this fact is made in cyanide decontamination processes where a permanganate oxidation converts toxic cyanide to safer cyanate. Cyanate can be decomposed by the enzyme cyanate lyase (or cyanase), which is found in bacteria and plants. In particular cyanate can be decomposed to carbamate (ammonia) and carbon dioxide. Alternately the same enzyme can be used to synthesize cyanate using carbamate and carbon dioxide.",Cyanate,HMDB0002078,b,b,C01417,b,FDB022835,cynt,[O-]C#N,XLJMAIOERFSOGZ-UHFFFAOYSA-M,InChI=1S/CHNO/c2-1-3/h3H/p-1
4252,11422,a,a,17514,KEGG COMPOUND accession,C00177,,,,,,,,,,,,,,,
4253,11428,a,a,27843,KEGG COMPOUND accession,C05905,,,,,,,,,,,,,,,
4254,11430,a,a,28215,KEGG COMPOUND accession,C08629,,,,,,,,,,,,,,,
4255,11432,a,a,27898,KEGG COMPOUND accession,C08612,,,,,,,,,,,,,,,
4256,11434,a,a,27475,KEGG COMPOUND accession,C08647,,,,,,,,,,,,,,,
4257,11436,a,a,28426,KEGG COMPOUND accession,C08604,,,,,,,,,,,,,,,
4258,11440,a,a,16726,KEGG COMPOUND accession,C04491,,,,,,,,,,,,,,,
4259,11444,a,a,3978,KEGG COMPOUND accession,C08639,,,,,,,,,,,,,,,
4260,11446,a,a,17439,KEGG COMPOUND accession,C02823,,,,,,,,,,,,,,,
4261,11452,a,a,23437,KEGG COMPOUND accession,C05712,,,,,,,,,,,,,,,
4262,11457,a,a,3982,KEGG COMPOUND accession,C02018,,,,,,,,,,,,,,,
4263,11459,a,a,38028,KEGG COMPOUND accession,C06554,,,,,,,,,,,,,,,
4264,11463,a,a,29012,KEGG COMPOUND accession,C08816,,,,,,,,,,,,,,,
4265,11467,a,a,17074,KEGG COMPOUND accession,C01418,,,,,,,,,,,,,,,
4266,11517,a,a,3994,KEGG COMPOUND accession,C06930,,,,,,,,,,,,,,,
4267,11519,a,a,17030,KEGG COMPOUND accession,C01902,,,,,,,,,,,,,,,
4268,11523,a,a,3996,KEGG COMPOUND accession,C06931,,,,,,,,,,,,,,,
4269,11531,a,a,16653,KEGG COMPOUND accession,C02141,,,,,,,,,,,,,,,
4270,11540,a,a,28443,KEGG COMPOUND accession,C09810,,,,,,,,,,,,,,,
4271,11541,a,a,28005,KEGG COMPOUND accession,C09811,,,,,,,,,,,,,,,
4272,11543,a,a,15977,KEGG COMPOUND accession,C02395,,,,,,,,,,,,,,,
4273,11546,a,a,41674,KEGG COMPOUND accession,C06105,,,,,,,,,,,,,,,
4274,11549,a,a,29005,KEGG COMPOUND accession,C11249,,,,,,,,,,,,,,,
4275,11551,a,a,17766,KEGG COMPOUND accession,C01066,,,,,,,,,,,,,,,
4276,11555,a,a,28557,KEGG COMPOUND accession,C09823,,,,,,,,,,,,,,,
4277,11556,a,a,36096,KEGG COMPOUND accession,C09822,,,,,,,,,,,,,,,
4278,11558,a,a,18099,KEGG COMPOUND accession,C00854,,,,,,,,,,,,,,,
4279,11562,a,a,17854,KEGG COMPOUND accession,C00414,,,,,,,,,,,,,,,
4280,11570,a,a,27641,KEGG COMPOUND accession,C06685,,,,,,,,,,,,,,,
4281,11572,a,a,17966,KEGG COMPOUND accession,C11520,,,,,,,,,,,,,,,
4282,11575,a,a,15773,KEGG COMPOUND accession,C00571,,,,,,,,,,,,,,,
4283,11584,a,a,17623,KEGG COMPOUND accession,C00973,,,,,,,,,,,,,,,
4284,11588,a,a,16133,KEGG COMPOUND accession,C02020,,,,,,,,,,,,,,,
4285,11591,a,a,16486,KEGG COMPOUND accession,C00557,,,,,,,,,,,,,,,
4286,11595,a,a,4024,KEGG COMPOUND accession,C06932,,,,,,,,,,,,,,,
4287,11601,a,a,4027,KEGG COMPOUND accession,C07888,,,,,,,,,,,,,,,
4288,11608,a,a,4031,KEGG COMPOUND accession,C05086,,,,,,,,,,,,,,,
4289,11612,a,a,4033,KEGG COMPOUND accession,C10913,,,,,,,,,,,,,,,
4290,11616,a,a,4035,KEGG COMPOUND accession,C10983,,,,,,,,,,,,,,,
4291,11618,a,a,4036,KEGG COMPOUND accession,C11093,,,,,,,,,,,,,,,
4292,11630,a,a,4042,KEGG COMPOUND accession,C10984,,,,,,,,,,,,,,,
4293,11632,a,a,17073,KEGG COMPOUND accession,C02825,,,,,,,,,,,,,,,
4294,11637,a,a,4045,KEGG COMPOUND accession,C10914,,,,,,,,,,,,,,,
4295,11639,a,a,4046,KEGG COMPOUND accession,C06935,,,,,,,,,,,,,,,
4296,11646,a,a,17755,KEGG COMPOUND accession,C00542,,,,,,,,,,,,,,,
4297,11651,a,a,17141,KEGG COMPOUND accession,C01678,cysam,60-23-1,17141.0,"Human Metabolome Database (HMDB): Cysteamine is a product of the constitutive degradation of coenzyme A, a process that occurs in all tissues, although some tissues such as brain and heart may have exceptionally high coenzyme A turnover rates. Cysteamine has only one known function, and that is as a precursor for the formation of hypotaurine, which is subsequently oxidized to taurine. The rate of cysteamine production as a result of coenzyme A breakdown is not well understood but it is clear that cysteamine levels are not as dramatically affected by dietary habits as are cysteine levels. Cysteamine is generated from hypotaurine by cysteamine dioxygenase (EC:1.13.11.19), an enzyme that was recently identified in mammals (PMID: 17581819). Cysteamine is the simplest stable aminothiol found in the body. It is used in the treatment of disorders of cystine excretion. Cysteamine cleaves the disulfide bond with cysteine to produce molecules that can escape the metabolic defect in cystinosis and cystinuria. Cyst(e)amine may also serve as an endogenous regulator of immune system activity as well as a potential therapeutic agent for the treatment of Huntington disease. Cysteamine is also used as a radiation-protective agent that oxidizes in air to form cystamine. It can be given intravenously or orally to treat radiation sickness. -- Wikipedia.",Cysteamine,HMDB0002991,b,b,C01678,CPD-3721,FDB023091,cysam,[H]SC([H])([H])C([H])([H])[N+]([H])([H])[H],UFULAYFCSOUIOV-UHFFFAOYSA-O,"InChI=1S/C2H7NS/c3-1-2-4/h4H,1-3H2/p+1"
4298,11655,a,a,15356,KEGG COMPOUND accession,C00736,,,,,,,,,,,,,,,
4299,11659,a,a,17376,KEGG COMPOUND accession,C01420,,,,,,,,,,,,,,,
4300,11662,a,a,17562,KEGG COMPOUND accession,C00475,cytd,65-46-3,17562.0,"Human Metabolome Database (HMDB): Cytidine is a nucleoside that is composed of the base cytosine linked to the five-carbon sugar D-ribose. Cytidine is a pyrimidine that besides being incorporated into nucleic acids, can serve as a substrate for the salvage pathway of pyrimidine nucleotide synthesis. It is a precursor of cytidine triphosphate (CTP) needed in the phosphatidylcholine (PC) and phosphatidylethanolamine (PE) biosynthetic pathways. These variations probably reflect the species differences in cytidine deaminase, the enzyme that converts cytidine to uridine in the body. The transport of cytidine into the brain's extracellular fluid, and then into neurons and glia, are essential prerequisites for cytidine to be utilized in the brain. An efficient mechanism mediating the brain uptake of circulating cytidine has not yet been demonstrated. The biosynthesis of PC, the most abundant phosphatide in the brain, via the Kennedy pathway requires phosphocholine and cytidine triphosphate (CTP), a cytidine nucleotide involved in the rate-limiting step. The enzyme that converts CTP to endogenous CDP-choline (CTP:phosphocholine cytidylyltransferase) is unsaturated at physiological brain CTP levels. APOBEC is a family of enzymes that has been discovered with the ability to deaminate cytidines on RNA or DNA. The human apolipoprotein B mRNA-editing enzyme, catalytic polypeptide-like 3G protein (APOBEC3G, or hA3G), provides cells with an intracellular antiretroviral activity that is associated with the hypermutation of viral DNA through cytidine deamination. Indeed, hA3G belongs to a family of vertebrate proteins that contains one or two copies of a signature sequence motif unique to cytidine deaminases (CTDAs) (PMID: 16769123, 15780864, 16720547).",Cytidine,HMDB0000089,b,b,C00475,CYTIDINE,FDB021809,cytd,[H]OC([H])([H])[C@@]1([H])O[C@@]([H])(N2C([H])=C([H])C(=NC2=O)N([H])[H])[C@]([H])(O[H])[C@]1([H])O[H],UHDGCWIWMRVCDJ-XVFCMESISA-N,"InChI=1S/C9H13N3O5/c10-5-1-2-12(9(16)11-5)8-7(15)6(14)4(3-13)17-8/h1-2,4,6-8,13-15H,3H2,(H2,10,11,16)/t4-,6-,7-,8-/m1/s1"
4301,11670,a,a,28507,KEGG COMPOUND accession,C03104,,,,,,,,,,,,,,,
4302,11672,a,a,4055,KEGG COMPOUND accession,C10763,,,,,,,,,,,,,,,
4303,11674,a,a,4056,KEGG COMPOUND accession,C01679,,,,,,,,,,,,,,,
4304,11680,a,a,18070,KEGG COMPOUND accession,C00524,M01631,b,18070.0,b,Cytochrome-C,b,b,b,C00524,b,b,b,[H]OC(=O)C([H])([H])C([H])([H])C1=C(\C2=C([H])\C3=C(C(=C4\C([H])=C5/N=C(/C(/[H])=C6\N([Fe]N34)\C(=C([H])/C1=N2)C(=C6C([H])([H])[H])C([H])([H])C([H])([H])C(=O)O[H])C(=C5C([H])([H])[H])C([H])(SC([H])([H])[C@]([H])(N([H])C([*])=O)C(=O)N([H])[*])C([H])([H])[H])C([H])(SC([H])([H])[C@]([H])(N([H])C([*])=O)C(=O)N([H])[*])C([H])([H])[H])C([H])([H])[H])C([H])([H])[H],b,b
4305,11690,a,a,4067,KEGG COMPOUND accession,C02021,,,,,,,,,,,,,,,
4306,11694,a,a,4069,KEGG COMPOUND accession,C06012,,,,,,,,,,,,,,,
4307,11700,a,a,16040,KEGG COMPOUND accession,C00380,csn,71-30-7,16040.0,Human Metabolome Database (HMDB): Cytosine is a pyrimidine base that is a fundamental unit of nucleic acids. The deamination of cytosine alone is apparent and the nucleotide of cytosine is the prime mutagenic nucleotide in leukaemia and cancer.,Cytosine,HMDB0000630,b,b,C00380,CYTOSINE,FDB022151,csn,[H]N([H])C1=NC(=O)N([H])C([H])=C1[H],OPTASPLRGRRNAP-UHFFFAOYSA-N,"InChI=1S/C4H5N3O/c5-3-1-2-6-4(8)7-3/h1-2H,(H3,5,6,7,8)"
4308,11708,a,a,28680,KEGG COMPOUND accession,C02961,,,,,,,,,,,,,,,
4309,11710,a,a,4075,KEGG COMPOUND accession,C03782,,,,,,,,,,,,,,,
4310,11712,a,a,28390,KEGG COMPOUND accession,C04122,applp,b,b,b,D-1-Aminopropan-2-ol O-phosphate,b,b,b,C04122,b,b,b,b,b,b
4311,11713,a,a,4077,KEGG COMPOUND accession,C06891,,,,,,,,,,,,,,,
4312,11716,a,a,28797,KEGG COMPOUND accession,C02261,,,,,,,,,,,,,,,
4313,11721,a,a,15905,KEGG COMPOUND accession,C03492,4ppan,b,15905.0,"Human Metabolome Database (HMDB): D-4'-Phosphopantothenate is a product of the enzyme pantothenate kinase [EC 2.7.1.33] and is involved in the pantothenate and CoA biosynthesis pathway (KEGG). D-4'-Phosphopantothenate is an intermediate in coenzyme A (CoA) biosynthesis pathway. Coenzyme A is a cofactor of ubiquitous occurrence in plants, bacteria, and animals. It is needed in a large number of enzymatic reactions central to intermediary metabolism, including the oxidation of fatty acids, carbohydrates, and amino acids.",D-4'-Phosphopantothenate,HMDB0001016,b,b,C03492,4-P-PANTOTHENATE,FDB022373,4ppan,[H]O[C@@]([H])(C(=O)N([H])C([H])([H])C([H])([H])C([O-])=O)C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])OP([O-])([O-])=O,XHFVGHPGDLDEQO-ZETCQYMHSA-K,"InChI=1S/C9H18NO8P/c1-9(2,5-18-19(15,16)17)7(13)8(14)10-4-3-6(11)12/h7,13H,3-5H2,1-2H3,(H,10,14)(H,11,12)(H2,15,16,17)/p-3/t7-/m0/s1"
4314,11724,a,a,4083,KEGG COMPOUND accession,C05946,,,,,,,,,,,,,,,
4315,11731,a,a,15695,KEGG COMPOUND accession,C03493,,,,,,,,,,,,,,,
4316,11737,a,a,15570,KEGG COMPOUND accession,C00133,ala_D,338-69-2,15570.0,"Human Metabolome Database (HMDB): Alanine is a nonessential amino acid made in the body from the conversion of the carbohydrate pyruvate or the breakdown of DNA and the dipeptides carnosine and anserine. It is highly concentrated in muscle and is one of the most important amino acids released by muscle, functioning as a major energy source. Plasma alanine is often decreased when the BCAA (Branched Chain Amino Acids) are deficient. This finding may relate to muscle metabolism. Alanine is highly concentrated in meat products and other high-protein foods like wheat germ and cottage cheese. Alanine is an important participant as well as regulator in glucose metabolism. Alanine levels parallel blood sugar levels in both diabetes and hypoglycemia, and alanine reduces both severe hypoglycemia and the ketosis of diabetes. It is an important amino acid for lymphocyte reproduction and immunity. Alanine therapy has helped dissolve kidney stones in experimental animals. Normal alanine metabolism, like that of other amino acids, is highly dependent upon enzymes that contain vitamin B6. Alanine, like GABA, taurine and glycine, is an inhibitory neurotransmitter in the brain. http://www.dcnutrition.com/AminoAcids/).",D-Alanine,HMDB0001310,b,b,C00133,D-ALANINE,FDB022546,ala_D,[H]C([H])([H])[C@]([H])(C([O-])=O)[N+]([H])([H])[H],QNAYBMKLOCPYGJ-UWTATZPHSA-N,"InChI=1S/C3H7NO2/c1-2(4)3(5)6/h2H,4H2,1H3,(H,5,6)/t2-/m1/s1"
4317,11751,a,a,16576,KEGG COMPOUND accession,C00993,M03164,923-16-0,16576.0,"Human Metabolome Database (HMDB): The ATP-dependent carboxylate-amine/thiol ligase superfamily is known to contain enzymes catalyzing the formation of various types of peptide, one of which is d-alanyl-d-alanine.(PMID: 16030213). The glycopeptide antibiotic vancomycin acts by binding to the D-alanyl-D-alanine terminus of the cell wall precursor lipid II in the cytoplasmic membrane.(PMID: 17418637). D-alanine-D-alanine ligase from Thermotoga maritima ATCC 43589 (TmDdl) was a useful biocatalyst for synthesizing D-amino acid dipeptides.D-Alanine-D-alanine ligase (Ddl) catalyzes the biosynthesis of an essential bacterial peptidoglycan precursor D-alanyl-D-alanine and it represents an important target for development of new antibacterial drugs. (PMID: 17267218).",D-Alanyl-D-alanine,HMDB0003459,b,b,C00993,D-ALA-D-ALA,FDB006399,b,[H]OC(=O)[C@]([H])(N([H])C(=O)[C@]([H])(N([H])[H])C([H])([H])[H])C([H])([H])[H],DEFJQIDDEAULHB-QWWZWVQMSA-N,"InChI=1S/C6H12N2O3/c1-3(7)5(9)8-4(2)6(10)11/h3-4H,7H2,1-2H3,(H,8,9)(H,10,11)/t3-,4-/m1/s1"
4318,11755,a,a,15798,KEGG COMPOUND accession,C04457,,,,,,,,,,,,,,,
4319,11760,a,a,16362,KEGG COMPOUND accession,C00737,,,,,,,,,,,,,,,
4320,11763,a,a,4093,KEGG COMPOUND accession,C01487,,,,,,,,,,,,,,,
4321,11766,a,a,17942,KEGG COMPOUND accession,C02962,,,,,,,,,,,,,,,
4322,11768,a,a,17360,KEGG COMPOUND accession,C00817,,,,,,,,,,,,,,,
4323,11771,a,a,28385,KEGG COMPOUND accession,C06464,,,,,,,,,,,,,,,
4324,11773,a,a,16733,KEGG COMPOUND accession,C00405,,,,,,,,,,,,,,,
4325,11782,a,a,17702,KEGG COMPOUND accession,C01569,,,,,,,,,,,,,,,
4326,11785,a,a,16689,KEGG COMPOUND accession,C01488,apio_D,639-97-4,27672.0,"Human Metabolome Database (HMDB): D-Apiose is found in green vegetables. D-Apiose is first found in parsley as the glycoside Apiin <ht>CNR75-N</ht>, also present in celer",D-Apiose,HMDB0029941,b,b,C01488,b,FDB001214,b,b,ASNHGEVAWNWCRQ-UHFFFAOYSA-N,b
4327,11789,a,a,16157,KEGG COMPOUND accession,C00878,,,,,,,,,,,,,,,
4328,11798,a,a,17108,KEGG COMPOUND accession,C00216,,,,,,,,,,,,,,,
4329,11809,a,a,18333,KEGG COMPOUND accession,C01904,,,,,,,,,,,,,,,
4330,11818,a,a,28159,KEGG COMPOUND accession,C01905,,,,,,,,,,,,,,,
4331,11820,a,a,17364,KEGG COMPOUND accession,C00402,asp_D,1783-96-6,17364.0,b,D-Aspartate,HMDB000648,b,b,C00402,b,b,asp_D,[H][N+]([H])([H])[C@@]([H])(C([O-])=O)C([H])([H])C([O-])=O,CKLJMWTZIZZHCS-UWTATZPHSA-M,"InChI=1S/C4H7NO4/c5-2(4(8)9)1-3(6)7/h2H,1,5H2,(H,6,7)(H,8,9)/p-1/t2-/m1/s1"
4332,11827,a,a,4109,KEGG COMPOUND accession,C08300,,,,,,,,,,,,,,,
4333,11829,a,a,4110,KEGG COMPOUND accession,C08301,,,,,,,,,,,,,,,
4334,11831,a,a,16375,KEGG COMPOUND accession,C00793,,,,,,,,,,,,,,,
4335,11835,a,a,15770,KEGG COMPOUND accession,C03494,,,,,,,,,,,,,,,
4336,11837,a,a,27904,KEGG COMPOUND accession,C01796,,,,,,,,,,,,,,,
4337,11847,a,a,16023,KEGG COMPOUND accession,C02022,,,,,,,,,,,,,,,
4338,11850,a,a,4116,KEGG COMPOUND accession,C03604,,,,,,,,,,,,,,,
4339,11852,a,a,15824,KEGG COMPOUND accession,C00095,,,,,,,,,,,,,,,
4340,11876,a,a,48095,KEGG COMPOUND accession,C10906,,,,,,,,,,,,,,,
4341,11878,a,a,16905,KEGG COMPOUND accession,C00354,fdp,488-69-7,16905.0,"Human Metabolome Database (HMDB): Fructose 1,6-bisphosphate is fructose sugar or fructosephosphate that has been phosphorylated on carbons 1 and 6. The beta-D-form of this compound is very common in cells. The vast majority of glucose and fructose entering a cell is converted to fructose 1,6-bisphosphate at some point. Fructose 1,6-bisphosphate is a key component in the glycolysis metabolic pathway and is produced by phosphorylation of fructose 6-phosphate The enzyme phosphofructokinase uses ATP to transfer a phosphate group to fructose 6-phosphate to form fructose 1, 6-bisphosphate. fructose The enzyme aldolase splits fructose 1, 6-bisphosphate into two sugars that are isomers of each other. These two sugars are dihydroxyacetone phosphate and glyceraldehyde phosphate. Fructose 1,6-bisphosphate is an allosteric activator of pyruvate kinase.","Fructose 1,6-bisphosphate",HMDB0001058,b,b,C00354,FRUCTOSE-16-DIPHOSPHATE,FDB022397,fdp,[H]O[C@]1([H])[C@]([H])(OC(O[H])(C([H])([H])OP([O-])([O-])=O)[C@@]1([H])O[H])C([H])([H])OP([O-])([O-])=O,RNBGYGVWRKECFJ-VRPWFDPXSA-J,"InChI=1S/C6H14O12P2/c7-4-3(1-16-19(10,11)12)18-6(9,5(4)8)2-17-20(13,14)15/h3-5,7-9H,1-2H2,(H2,10,11,12)(H2,13,14,15)/p-4/t3-,4-,5+,6?/m1/s1"
4342,11886,a,a,18105,KEGG COMPOUND accession,C01094,f1p,15978-08-2,704854.0,Human Metabolome Database (HMDB): Fructose 1-phosphate is an intermediate metabolite in the Fructose and mannose metabolism pathway.,Fructose 1-phosphate,HMDB0001076,b,b,C01094,FRU1P,FDB022410,f1p,[H]OC([H])([H])[C@@]1([H])OC(O[H])(C([H])([H])OP([O-])([O-])=O)[C@@]([H])(O[H])[C@]1([H])O[H],RHKKZBWRNHGJEZ-NSHGFSBMSA-L,"InChI=1S/C6H13O9P/c7-1-3-4(8)5(9)6(10,15-3)2-14-16(11,12)13/h3-5,7-10H,1-2H2,(H2,11,12,13)/p-2/t3-,4-,5+,6?/m0/s1"
4343,11899,a,a,15946,KEGG COMPOUND accession,C00085,f6p,643-13-0,15946.0,"Human Metabolome Database (HMDB): Fructose 6-phosphate is an important intermediate in the Carbohydrates pathway. The interconversion of glucose-6-phosphate and fructose-6-phosphate, the second step of the Embden-Meyerhof glycolytic pathway, is catalyzed by the enzyme phosphoglucose isomerase (PGI). In gluconeogenesis, fructose-6-phosphate is the immediate precursor of glucose-6-phosphate (wikipedia).",Fructose 6-phosphate,HMDB0000124,b,b,C00085,FRUCTOSE-6P,FDB021896,f6p,[H]OC([H])([H])C1(O[H])O[C@]([H])(C([H])([H])OP([O-])([O-])=O)[C@@]([H])(O[H])[C@]1([H])O[H],BGWGXPAPYGQALX-VRPWFDPXSA-L,"InChI=1S/C6H13O9P/c7-2-6(10)5(9)4(8)3(15-6)1-14-16(11,12)13/h3-5,7-10H,1-2H2,(H2,11,12,13)/p-2/t3-,4-,5+,6?/m1/s1"
4344,11920,a,a,4126,KEGG COMPOUND accession,C00905,,,,,,,,,,,,,,,
4345,11924,a,a,16824,KEGG COMPOUND accession,C01680,,,,,,,,,,,,,,,
4346,11930,a,a,30852,KEGG COMPOUND accession,C00879,,,,,,,,,,,,,,,
4347,11934,a,a,16222,KEGG COMPOUND accession,C03269,,,,,,,,,,,,,,,
4348,11940,a,a,15895,KEGG COMPOUND accession,C03383,,,,,,,,,,,,,,,
4349,11945,a,a,15945,KEGG COMPOUND accession,C02669,,,,,,,,,,,,,,,
4350,11950,a,a,18232,KEGG COMPOUND accession,C06377,galam,7535-00-4,18232.0,b,D-Galactosamine,b,b,b,C06377,b,b,b,[H]OC([H])([H])[C@@]1([H])OC([H])(O[H])[C@]([H])(N([H])[H])[C@@]([H])(O[H])[C@@]1([H])O[H],MSWZFWKMSRAUBD-GASJEMHNSA-N,"InChI=1S/C6H13NO5/c7-3-5(10)4(9)2(1-8)12-6(3)11/h2-6,8-11H,1,7H2/t2-,3-,4+,5-,6?/m1/s1"
4351,11954,a,a,4139,KEGG COMPOUND accession,C00124,,,,,,,,,,,,,,,
4352,11967,a,a,37480,KEGG COMPOUND accession,C03384,gal1p,2255-14-3,37480.0,"Human Metabolome Database (HMDB): D-galactopyranose 1-phosphate, also known as D-Galactose 1-phosphoric acid, is classified as a member of the Monosaccharide phosphates. Monosaccharide phosphates are monosaccharides comprising a phosphated group linked to the carbohydrate unit. D-galactopyranose 1-phosphate is considered to be soluble (in water) and acidic",D-galactopyranose 1-phosphate,HMDB0062705,b,b,C03384,b,b,gal1p,[H]OC([H])([H])[C@@]1([H])O[C@]([H])(OP([O-])([O-])=O)[C@]([H])(O[H])[C@@]([H])(O[H])[C@@]1([H])O[H],HXXFSFRBOHSIMQ-FPRJBGLDSA-L,"InChI=1S/C6H13O9P/c7-1-2-3(8)4(9)5(10)6(14-2)15-16(11,12)13/h2-10H,1H2,(H2,11,12,13)/p-2/t2-,3+,4+,5-,6-/m1/s1"
4353,11969,a,a,4141,KEGG COMPOUND accession,C01113,,,,,,,,,,,,,,,
4354,11974,a,a,17227,KEGG COMPOUND accession,C04775,,,,,,,,,,,,,,,
4355,11976,a,a,18018,KEGG COMPOUND accession,C04247,,,,,,,,,,,,,,,
4356,11978,a,a,16981,KEGG COMPOUND accession,C04776,,,,,,,,,,,,,,,
4357,11980,a,a,18113,KEGG COMPOUND accession,C04610,,,,,,,,,,,,,,,
4358,11984,a,a,18216,KEGG COMPOUND accession,C04911,gm1_hs,104443-62-1,18216.0,b,Ganglioside Gm1,HMDB00117,b,b,C04911,b,b,gm1_hs,[H]OC([H])([H])[C@@]([H])(O[H])[C@@]([H])(O[H])[C@]1([H])O[C@@](O[C@]2([H])[C@@]([H])(O[H])[C@]([H])(O[C@@]3([H])[C@]([H])(O[H])[C@@]([H])(O[H])[C@]([H])(OC([H])([H])[C@]([H])(N([H])C([*])=O)[C@]([H])(O[H])C(\[H])=C(/[H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H])O[C@]3([H])C([H])([H])O[H])O[C@]([H])(C([H])([H])O[H])[C@]2([H])O[C@]2([H])O[C@]([H])(C([H])([H])O[H])[C@]([H])(O[H])[C@]([H])(O[C@]3([H])O[C@]([H])(C([H])([H])O[H])[C@]([H])(O[H])[C@]([H])(O[H])[C@@]3([H])O[H])[C@@]2([H])N([H])C(=O)C([H])([H])[H])(C([O-])=O)C([H])([H])[C@]([H])(O[H])[C@@]1([H])N([H])C(=O)C([H])([H])[H],b,b
4359,11984,a,a,18216,KEGG COMPOUND accession,C04911,HC02161,b,18216.0,b,Gm1-Pool,HMDB00117,b,b,C04911,b,b,HC02161,[H]OC(=O)[C@]1(O[C@]2([H])[C@@]([H])(O[H])[C@]([H])(O[C@@]3([H])[C@]([H])(O[H])[C@@]([H])(O[H])[C@]([H])(OC([H])([H])[C@]([H])(N([H])C([*])=O)[C@]([H])(O[H])C(\[H])=C(/[H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H])O[C@]3([H])C([H])([H])O[H])O[C@]([H])(C([H])([H])O[H])[C@]2([H])O[C@]2([H])O[C@]([H])(C([H])([H])O[H])[C@]([H])(O[H])[C@]([H])(O[C@]3([H])O[C@]([H])(C([H])([H])O[H])[C@]([H])(O[H])[C@]([H])(O[H])[C@@]3([H])O[H])[C@@]2([H])N([H])C(=O)C([H])([H])[H])O[C@@]([H])([C@]([H])(O[H])[C@]([H])(O[H])C([H])([H])O[H])[C@]([H])(N([H])C(=O)C([H])([H])[H])[C@@]([H])(O[H])C1([H])[H],b,b
4360,11992,a,a,17615,KEGG COMPOUND accession,C03692,,,,,,,,,,,,,,,
4361,12001,a,a,4153,KEGG COMPOUND accession,C00333,,,,,,,,,,,,,,,
4362,12010,a,a,16002,KEGG COMPOUND accession,C00818,glcr,25525-21-7,16002.0,Human Metabolome Database (HMDB): Glucaric acid is a sugar acid derived from D-glucose in which both the aldehydic carbon atom and the carbon atom bearing the primary hydroxyl group are oxidized to carboxylic acid groups.,Glucaric acid,HMDB0000663,b,b,C00818,D-GLUCARATE,FDB022169,b,[H]O[C@@]([H])(C([O-])=O)[C@@]([H])(O[H])[C@]([H])(O[H])[C@]([H])(O[H])C([O-])=O,DSLZVSRJTYRBFB-LLEIAEIESA-L,"InChI=1S/C6H10O8/c7-1(3(9)5(11)12)2(8)4(10)6(13)14/h1-4,7-10H,(H,11,12)(H,13,14)/p-2/t1-,2-,3-,4+/m0/s1"
4363,12015,a,a,33198,KEGG COMPOUND accession,C00257,glcn,526-95-4,33198.0,"Human Metabolome Database (HMDB): Gluconic acid occurs naturally in fruit, honey and wine and is used as a food additive, an acidity regulator. It is also used in cleaning products where it helps cleaning up mineral deposits. It is a strong chelating agent, especially in alkaline solution. It chelates the anions of calcium, iron, aluminium, copper, and other heavy metals. Glucono delta lactone is a cyclic ester of D-gluconic acid.",Gluconic acid,HMDB0000625,b,b,C00257,GLUCONATE,FDB001980,glcn,[H]OC([H])([H])[C@@]([H])(O[H])[C@@]([H])(O[H])[C@]([H])(O[H])[C@@]([H])(O[H])C([O-])=O,RGHNJXZEOKUKBD-SQOUGZDYSA-M,"InChI=1S/C6H12O7/c7-1-2(8)3(9)4(10)5(11)6(12)13/h2-5,7-11H,1H2,(H,12,13)/p-1/t2-,3-,4+,5-/m1/s1"
4364,12023,a,a,16165,KEGG COMPOUND accession,C03107,,,,,,,,,,,,,,,
4365,12026,a,a,16217,KEGG COMPOUND accession,C00198,,,,,,,,,,,,,,,
4366,12035,a,a,16938,KEGG COMPOUND accession,C01236,6pgl,2641-81-8,16938.0,"Human Metabolome Database (HMDB): 6-phosphoglucono-delta-lactone (d-6PGL) is the immediate product of the Glucose-6-phosphate dehydrogenase (G-6-PD), the first enzyme of the hexose monophosphate pathway. (PMID 3711719). The pentose-phosphate pathway provides reductive power and nucleotide precursors to the cell through oxidative and nonoxidative branches. 6-Phosphogluconolactonase is the second enzyme of the oxidative branch and catalyzes the hydrolysis of 6-phosphogluconolactones, the products of glucose 6-phosphate oxidation by glucose-6-phosphate dehydrogenase. By efficiently catalyzing the hydrolysis of d-6PGL, 6-phosphogluconolactonase prevents the reaction between d-6PGL and intracellular nucleophiles; such a reaction would interrupt the functioning of the pentose-phosphate pathway. (PMID 11457850).",6-Phosphonoglucono-D-lactone,HMDB0001127,b,b,C01236,D-6-P-GLUCONO-DELTA-LACTONE,FDB022440,6pgl,[H]O[C@@]1([H])C(=O)O[C@]([H])(C([H])([H])OP([O-])([O-])=O)[C@@]([H])(O[H])[C@]1([H])O[H],IJOJIVNDFQSGAB-SQOUGZDYSA-L,"InChI=1S/C6H11O9P/c7-3-2(1-14-16(11,12)13)15-6(10)5(9)4(3)8/h2-5,7-9H,1H2,(H2,11,12,13)/p-2/t2-,3-,4+,5-/m1/s1"
4367,12041,a,a,47977,KEGG COMPOUND accession,C00329,gam,3416-24-8,5417.0,"Human Metabolome Database (HMDB): In the United States, glucosamine is not approved by the Food and Drug Administration for medical use in humans. Since glucosamine is classified as a dietary supplement, evidence of safety and efficacy is not required as long as it is not advertised as a treatment for a medical condition. Nevertheless, glucosamine is a popular alternative medicine used by consumers for the treatment of osteoarthritis. Glucosamine is also extensively used in veterinary medicine as an unregulated but widely accepted supplement (Nolen RS, 2002). Treatment with oral glucosamine is commonly used for the treatment of osteoarthritis. Since glucosamine is a precursor for glycosaminoglycans, and glycosaminoglycans are a major component of joint cartilage, supplemental glucosamine may help to rebuild cartilage and treat arthritis. However, there is little evidence that any clinical effect of glucosamine works this way (Laverty et al., 2005; Biggee et al., 2005). Its use as a therapy for osteoarthritis appears safe but there is conflicting evidence as to its effectiveness. Glucosamine (C6H14NO5) is an amino sugar that is an important precursor in the biochemical synthesis of glycosylated proteins and lipids.",Glucosamine,HMDB0001514,b,b,C00329,GLUCOSAMINE,FDB022668,gam,[H]OC([H])([H])[C@@]1([H])OC([H])(O[H])[C@]([H])([N+]([H])([H])[H])[C@@]([H])(O[H])[C@]1([H])O[H],MSWZFWKMSRAUBD-IVMDWMLBSA-O,"InChI=1S/C6H13NO5/c7-3-5(10)4(9)2(1-8)12-6(3)11/h2-6,8-11H,1,7H2/p+1/t2-,3-,4-,5-,6?/m1/s1"
4368,12049,a,a,27625,KEGG COMPOUND accession,C06156,,,,,,,,,,,,,,,
4369,12053,a,a,15873,KEGG COMPOUND accession,C00352,gam6p,3616-42-0,15873.0,"Human Metabolome Database (HMDB): Glucosamine 6-phosphate is normally produced in endothelial cells via the de novo glucosamine synthesis by the enzyme fructose-6-phosphate amidotransferase and the modulation of this pathway by hyperglycemia and glutamine. glutamine-fructose-6-phosphate amidotransferase (GFAT) catalyzes the first committed step in the pathway for biosynthesis of hexosamines in mammals. A member of the N-terminal nucleophile class of amidotransferases, GFAT transfers the amino group from the L-glutamine amide to D-fructose 6-phosphate, producing glutamic acid and glucosamine 6-phosphate. As glucosamine inhibits endothelial nitric oxide synthesis it has important implications for impaired endothelium-dependent relaxation and vascular dysfunction in diabetes mellitus. (PMID 11270676, 11842094).",Glucosamine 6-phosphate,HMDB0001254,b,b,C00352,D-GLUCOSAMINE-6-P,FDB022515,gam6p,[H]OC1([H])O[C@]([H])(C([H])([H])OP([O-])([O-])=O)[C@@]([H])(O[H])[C@]([H])(O[H])[C@@]1([H])[N+]([H])([H])[H],XHMJOUIAFHJHBW-IVMDWMLBSA-M,"InChI=1S/C6H14NO8P/c7-3-5(9)4(8)2(15-6(3)10)1-14-16(11,12)13/h2-6,8-10H,1,7H2,(H2,11,12,13)/p-1/t2-,3-,4-,5-,6?/m1/s1"
4370,12064,a,a,35373,KEGG COMPOUND accession,C06023,,,,,,,,,,,,,,,
4371,12066,a,a,17049,KEGG COMPOUND accession,C04248,gpail_hs,b,17049.0,b,D-Glucosaminylphosphatidylinositol,b,b,b,C04248,b,b,gpail_hs,[H]OC([H])([H])[C@@]1([H])O[C@]([H])(O[C@]2([H])[C@@]([H])(O[H])[C@]([H])(O[H])[C@@]([H])(O[H])[C@@]([H])(O[H])[C@@]2([H])OP(=O)(O[H])OC([H])([H])[C@]([H])(OC([*])=O)C([H])([H])OC([*])=O)[C@]([H])(N([H])[H])[C@@]([H])(O[H])[C@]1([H])O[H],b,b
4372,12068,a,a,4167,KEGG COMPOUND accession,C00031,glc_D,50-99-7,4167.0,"Human Metabolome Database (HMDB): Glucose is a monosaccharide containing six carbon atoms and an aldehyde group and is therefore referred to as an aldohexose. The glucose molecule can exist in an open-chain (acyclic) and ring (cyclic) form, the latter being the result of an intramolecular reaction between the aldehyde C atom and the C-5 hydroxyl group to form an intramolecular hemiacetal. In water solution both forms are in equilibrium and at pH 7 the cyclic one is the predominant. Glucose is a primary source of energy for living organisms. It is naturally occurring and is found in fruits and other parts of plants in its free state. In animals glucose arises from the breakdown of glycogen in a process known as glycogenolysis. Glucose is synthesized in the liver and kidneys from non-carbohydrate intermediates, such as pyruvate and glycerol, by a process known as gluconeogenesis. D-Glucose is found to be associated with 3-methyl-crotonyl-glycinuria, growth hormone deficiency, and primary hypomagnesemia, which are inborn errors of metabolism.",D-Glucose,HMDB0000122,b,b,C00031,GLC,FDB012530,glc_D,[H]OC([H])([H])[C@@]1([H])OC([H])(O[H])[C@]([H])(O[H])[C@@]([H])(O[H])[C@]1([H])O[H],WQZGKKKJIJFFOK-GASJEMHNSA-N,"InChI=1S/C6H12O6/c7-1-2-3(8)4(9)5(10)6(11)12-2/h2-11H,1H2/t2-,3-,4+,5-,6?/m1/s1"
4373,12125,a,a,17680,KEGG COMPOUND accession,C00660,,,,,,,,,,,,,,,
4374,12157,a,a,4170,KEGG COMPOUND accession,C00092,g6p,56-73-5,4170.0,"Human Metabolome Database (HMDB): Glucose 6 phosphate (alpha-D-glucose 6 phosphate or G6P) is the alpha-anomer of glucose-6-phosphate. There are two anomers of glucose 6 phosphate, the alpha anomer and the beta anomer. Glucose 6 phosphate is an ester of glucose with phosphoric acid, made in the course of glucose metabolism by mammalian and other cells. It is a normal constituent of resting muscle and probably is in constant equilibrium with fructose-6-phosphate. (Stedman, 26th ed). Glucose-6-phosphate is a phosphorylated glucose molecule on carbon 6. When glucose enters a cell, it is immediately phosphorylated to G6P. This is catalyzed with hexokinase enzymes, thus consuming one ATP. A major reason for immediate phosphorylation of the glucose is so that it cannot diffuse out of the cell. The phosphorylation adds a charged group so the G6P cannot easily cross cell membranes. G6P can travel down two metabolic pathways, glycolysis and the pentose phosphate pathway. In addition to the metabolic pathways, G6P can also be stored as glycogen in the liver if blood glucose levels are high. If the body needs energy or carbon skeletons for syntheses, G6P can be isomerized to Fructose-6-phosphate and then phosphorylated to Fructose-1,6-bisphosphate. Note, the molecule now has 2 phosphoryl groups attached. The addition of the 2nd phosphoryl group is an irreversible step, so once this happens G6P will enter glycolysis and be turned into pyruvate (ATP production occurs). If blood glucose levels are high, the body needs a way to store the excess glucose. After being converted to G6P, phosphoglucose mutase (isomerase) can turn the molecule into glucose-1-phosphate. Glucose-1-phosphate can then be combined with uridine triphosphate (UTP) to form UDP-glucose. This reaction is driven by the hydrolysis of pyrophosphate that is released in the reaction. Now, the activated UDP-glucose can add to a growing glycogen molecule with the help of glycogen synthase. This is a very efficient storage mechanism for glucose since it costs the body only 1 ATP to store the 1 glucose molecule and virtually no energy to remove it from storage. It is important to note that glucose-6-phosphate is an allosteric activator of glycogen synthase, which makes sense because when the level of glucose is high the body should store the excess glucose as glycogen. On the other hand, glycogen synthase is inhibited when it is phosphorylated by protein kinase a during times of high stress or low blood glucose levels. -- Wikipedia.",Glucose 6-phosphate,HMDB0001401,b,b,C00092,GLC-6-P,FDB021818,g6p,[H]OC1([H])O[C@]([H])(C([H])([H])OP([O-])([O-])=O)[C@@]([H])(O[H])[C@]([H])(O[H])[C@@]1([H])O[H],NBSCHQHZLSJFNQ-GASJEMHNSA-L,"InChI=1S/C6H13O9P/c7-3-2(1-14-16(11,12)13)15-6(10)5(9)4(3)8/h2-10H,1H2,(H2,11,12,13)/p-2/t2-,3-,4+,5-,6?/m1/s1"
4375,12176,a,a,16809,KEGG COMPOUND accession,C02827,,,,,,,,,,,,,,,
4376,12179,a,a,35436,KEGG COMPOUND accession,C01798,,,,,,,,,,,,,,,
4377,12182,a,a,4174,KEGG COMPOUND accession,C02964,,,,,,,,,,,,,,,
4378,12187,a,a,4177,KEGG COMPOUND accession,C03108,,,,,,,,,,,,,,,
4379,12188,a,a,4178,KEGG COMPOUND accession,C00191,glcur,b,42717.0,"Human Metabolome Database (HMDB): Glucuronic acid is a carboxylic acid that has the structure of a glucose molecule that has had its sixth carbon atom (of six total) oxidized. The salts of glucuronic acid are known as glucuronates. Glucuronic acid is highly soluble in water. In humans, glucuronic acid is often linked to toxic or poisonous substances to allow for subsequent elimination, and to hormones to allow for easier transport. These linkages involve O-glycosidic bonds. The process is known as glucuronidation, and the resulting substances are known as glucuronides (or glucuronosides). Glucuronidation uses UDP-glucuronic acid (glucuronic acid linked via a glycosidic bond to uridine diphosphate) as an intermediate. UDP-glucuronic acid is formed in the liver of all animals.",D-Glucuronic acid,HMDB0000127,b,b,C00191,GLUCURONATE,FDB021897,glcur,[H]OC1([H])O[C@]([H])(C([O-])=O)[C@@]([H])(O[H])[C@]([H])(O[H])[C@@]1([H])O[H],AEMOLEFTQBMNLQ-AQKNRBDQSA-M,"InChI=1S/C6H10O7/c7-1-2(8)4(5(10)11)13-6(12)3(1)9/h1-4,6-9,12H,(H,10,11)/p-1/t1-,2-,3+,4-,6?/m0/s1"
4380,12199,a,a,28547,KEGG COMPOUND accession,C05385,glcur1p,13168-11-1,35145.0,"Human Metabolome Database (HMDB): D-Glucuronic acid 1-phosphate is an end product of the UDP-glucuronic acid pathway. Formation of free glucuronic acid from UDP-glucuronic acid can be considered as the first step in the synthesis of vitamin C, a pathway that occurs in most vertebrates, although not in guinea pigs and primates, including humans. Free glucuronic acid can also be converted to pentose phosphate intermediates via the 'pentose pathway'. The latter is interrupted in subjects with pentosuria, who have a deficiency in l-xylulose reductase (EC 1.1.1.10, an enzyme that belongs to the short-chain dehydrogenase/reductase family) and excrete abnormal amounts of l-xylulose. Some xenobiotics stimulate the formation of vitamin C in animals and enhance the excretion of l-xylulose in humans with pentosuria and have shown that aminopyrine, metyrapone and other xenobiotics cause an almost instantaneous increase in the conversion of UDP-glucuronic acid to glucuronic acid. It is usually stated that glucuronic acid formation from UDP-glucuronic acid is the result of two successive reactions comprising the hydrolysis of UDP-glucuronic acid to glucuronic acid 1-phosphate and UMP by nucleotide pyrophosphatase (E-NPP3, EC 3.6.1.9), followed by dephosphorylation of glucuronic acid 1-phosphate. Glucuronidation is responsible for conjugating potentially toxic lipophilic compounds with glucuronic acid, thereby producing molecules with greater aqueous solubility that is excreted more readily into urine and bile. The rate at which any compound may be glucuronidated depends on the concentration and activity of the UDP-glucuronosyltransferases as well as the concentration of the cofactor UDP-glucuronic acid. UDP-glucuronic acid is formed after oxidation of UDP-glucose by UDP-glucose dehydrogenase (UGDH, EC 1.1.1.22) with NAD as the electron acceptor. UDP-glucuronic acid may then be either used as the glucuronic acid donor for xenobiotic conjugation reactions by UDPglucuronosyltransferases (GlcAT-P, EC 2.4.1.17), or degraded to D-glucuronic acid 1-phosphate after the phosphodiester bond is cleaved by E-NPP3. E-NPP3 is the same enzyme that further reduces D-Glucuronic acid 1-phosphate to free D-glucuronic acid. Decreases in UDP-glucuronic acid concentration may be due to reduced availability of UDP-glucose or decreased UGDH activity or to increased activities of GlcAT-P or E-NPP3. Exposure to volatile anesthetics reduces hepatic UDP-glucuronic acid concentrations, and alters the rate of conjugation of compounds such as acetaminophen, bilirubin, diethylstilbestrol, iopanoic acid and valproic acid in a non-sex-dependent fashion in experimental mice. The depletion of UDP-glucuronic acid by anesthetics is caused by altered activity of microsomal E-NPP3. (PMID: 2167093, 16689937, 1276).",D-Glucuronic acid 1-phosphate,HMDB0003976,b,b,C05385,b,FDB023278,glcur1p,[H]O[C@@]1([H])C([H])(OP([O-])([O-])=O)O[C@]([H])(C([O-])=O)[C@@]([H])(O[H])[C@]1([H])O[H],AIQDYKMWENWVQJ-AQKNRBDQSA-K,"InChI=1S/C6H11O10P/c7-1-2(8)4(5(10)11)15-6(3(1)9)16-17(12,13)14/h1-4,6-9H,(H,10,11)(H2,12,13,14)/p-3/t1-,2-,3+,4-,6?/m0/s1"
4381,12202,a,a,17039,KEGG COMPOUND accession,C03387,,,,,,,,,,,,,,,
4382,12204,a,a,18268,KEGG COMPOUND accession,C02670,glac,32449-92-6,18268.0,"Human Metabolome Database (HMDB): D-glucurono-6,3-lactone participates in ascorbate and aldarate metabolism. D-glucurono-6,3-lactone is produced by the reaction between D-glucaric acid and the enzyme, aldehyde dehydrogenase (NAD+) [EC: 1.2.1.3].","D-Glucurono-6,3-lactone",HMDB0006355,b,b,C02670,CPD-526,FDB023903,glac,[H]O[C@@]([H])(C([H])=O)[C@@]1([H])OC(=O)[C@@]([H])(O[H])[C@@]1([H])O[H],UYUXSRADSPPKRZ-SKNVOMKLSA-N,"InChI=1S/C6H8O6/c7-1-2(8)5-3(9)4(10)6(11)12-5/h1-5,8-10H/t2-,3+,4-,5+/m0/s1"
4383,12224,a,a,17061,KEGG COMPOUND accession,C00819,,,,,,,,,,,,,,,
4384,12234,a,a,17378,KEGG COMPOUND accession,C00577,,,,,,,,,,,,,,,
4385,12243,a,a,32398,KEGG COMPOUND accession,C00258,glyc_R,473-81-4,32398.0,"Human Metabolome Database (HMDB): Glyceric acid is a colourless syrupy acid, obtained from oxidation of glycerol. It is a compound that is secreted excessively in the urine by patients suffering from D-glyceric aciduria, an inborn error of metabolism, and D-glycerate anemia. Deficiency of human glycerate kinase leads to D-glycerate acidemia/D-glyceric aciduria. Symptoms of the disease include progressive neurological impairment, hypotonia, seizures, failure to thrive, and metabolic acidosis. At sufficiently high levels, glyceric acid can act as an acidogen and a metabotoxin. An acidogen is an acidic compound that induces acidosis, which has multiple adverse effects on many organ systems. A metabotoxin is an endogenously produced metabolite that causes adverse health effects at chronically high levels. Glyceric acid is an organic acid. Abnormally high levels of organic acids in the blood (organic acidemia), urine (organic aciduria), the brain, and other tissues lead to general metabolic acidosis. Acidosis typically occurs when arterial pH falls below 7.35. In infants with acidosis, the initial symptoms include poor feeding, vomiting, loss of appetite, weak muscle tone (hypotonia), and lack of energy (lethargy). These can progress to heart abnormalities, seizures, coma, and possibly death. These are also the characteristic symptoms of untreated glyceric aciduria. Many affected children with organic acidemias experience intellectual disability or delayed development. In adults, acidosis or acidemia is characterized by headaches, confusion, feeling tired, tremors, sleepiness, and seizures.",Glyceric acid,HMDB0000139,b,b,C00258,GLYCERATE,FDB012242,glyc_R,[H]OC([H])([H])[C@@]([H])(O[H])C([O-])=O,RBNPOMFGQQGHHO-REOHCLBHSA-M,"InChI=1S/C3H6O4/c4-1-2(5)3(6)7/h2,4-5H,1H2,(H,6,7)/p-1/t2-/m0/s1"
4386,12258,a,a,28723,KEGG COMPOUND accession,C07836,,,,,,,,,,,,,,,
4387,12259,a,a,4191,KEGG COMPOUND accession,C06465,,,,,,,,,,,,,,,
4388,12261,a,a,18004,KEGG COMPOUND accession,C01906,,,,,,,,,,,,,,,
4389,12264,a,a,16588,KEGG COMPOUND accession,C03606,,,,,,,,,,,,,,,
4390,12269,a,a,4195,KEGG COMPOUND accession,C02965,,,,,,,,,,,,,,,
4391,12271,a,a,15965,KEGG COMPOUND accession,C02672,,,,,,,,,,,,,,,
4392,12273,a,a,27947,KEGG COMPOUND accession,C06419,,,,,,,,,,,,,,,
4393,12278,a,a,28014,KEGG COMPOUND accession,C06466,,,,,,,,,,,,,,,
4394,12280,a,a,27372,KEGG COMPOUND accession,C06150,,,,,,,,,,,,,,,
4395,12281,a,a,27730,KEGG COMPOUND accession,C06418,,,,,,,,,,,,,,,
4396,12283,a,a,28225,KEGG COMPOUND accession,C01570,,,,,,,,,,,,,,,
4397,12285,a,a,16855,KEGG COMPOUND accession,C00739,,,,,,,,,,,,,,,
4398,12291,a,a,16789,KEGG COMPOUND accession,C00476,,,,,,,,,,,,,,,
4399,12294,a,a,16298,KEGG COMPOUND accession,C00644,,,,,,,,,,,,,,,
4400,12305,a,a,4208,KEGG COMPOUND accession,C00159,man,3458-28-4,4208.0,"Human Metabolome Database (HMDB): D-Mannose is a carbohydrate. High-mannose-type oligosaccharides have been shown to play important roles in protein quality control. Several intracellular proteins, such as lectins, chaperones and glycan-processing enzymes, are involved in this process. These include calnexin/calreticulin, UDP-glucose:glycoprotein glucosyltransferase (UGGT), cargo receptors (such as VIP36 and ERGIC-53), mannosidase-like proteins (e.g. EDEM and Htm1p) and ubiquitin ligase (Fbs). They are thought to recognize high-mannose-type glycans with subtly different structures. Mannose-binding lectin (MBL) is an important constituent of the innate immune system. This protein binds through multiple lectin domains to the repeating sugar arrays that decorate many microbial surfaces, and is then able to activate the complement system through a specific protease called MBL-associated protease-2. The primary pathway for the formation of L-fucose in procaryotic and eucaryotic cells is from D-mannose via an internal oxidation reduction and then epimerization of GDP-D-mannose to produce GDP-L-fucose. (PMID: 9488699, 16154739, 11414367).",D-Mannose,HMDB0000169,b,b,C00159,MANNOSE,FDB001202,man,[H]OC([H])([H])[C@@]1([H])OC([H])(O[H])[C@@]([H])(O[H])[C@@]([H])(O[H])[C@]1([H])O[H],WQZGKKKJIJFFOK-QTVWNMPRSA-N,"InChI=1S/C6H12O6/c7-1-2-3(8)4(9)5(10)6(11)12-2/h2-11H,1H2/t2-,3-,4+,5+,6?/m1/s1"
4401,12320,a,a,35374,KEGG COMPOUND accession,C00636,man1p,27251-84-9,35374.0,"Human Metabolome Database (HMDB): D-Mannose 1-phosphate is a normal metabolite intermediate in the Fructose and mannose metabolism, and substrate of phosphomannomutase 1(PMM, EC: 5.4.2.8), an enzyme necessary for the synthesis of GDP-mannose. PMM converts mannose 6-phosphate to mannose-1-phosphate, which is required for the synthesis of GDP-mannose, a substrate for dolichol-linked oligosaccharide synthesis. Deficiency of phosphomannomutase in Carbohydrate-deficient glycoprotein syndrome (CDGS, a group of autosomal recessively transmitted disorders in which abnormally glycosylated proteins are formed) type 1 is associated with decreased synthesis of mannose 1-phosphate. (PMID: 9451026, 8549746, 12729595).",D-Mannose 1-phosphate,HMDB0006330,b,b,C00636,MANNOSE-1P,FDB023892,man1p,[H]OC([H])([H])[C@@]1([H])OC([H])(OP([O-])([O-])=O)[C@@]([H])(O[H])[C@@]([H])(O[H])[C@]1([H])O[H],HXXFSFRBOHSIMQ-JFNONXLTSA-L,"InChI=1S/C6H13O9P/c7-1-2-3(8)4(9)5(10)6(14-2)15-16(11,12)13/h2-10H,1H2,(H2,11,12,13)/p-2/t2-,3-,4+,5+,6?/m0/s1"
4402,12340,a,a,16867,KEGG COMPOUND accession,C00855,,,,,,,,,,,,,,,
4403,12348,a,a,37713,KEGG COMPOUND accession,C02532,pser_D,b,37713.0,b,D-O-Phosphoserine,b,b,b,C02532,b,b,b,b,b,"InChI=1S/C3H8NO6P/c4-2(3(5)6)1-10-11(7,8)9/h2H,1,4H2,(H,5,6)(H2,7,8,9)/t2-/m1/s1"
4404,12351,a,a,16176,KEGG COMPOUND accession,C00515,orn_D,348-66-3,16176.0,"Human Metabolome Database (HMDB): D-Ornithine is an amino acid produced in the urea cycle by the splitting off of urea from arginine. Ornithine is one of the products of the action of the enzyme arginase on L-arginine, creating urea. Therefore, ornithine is a central part of the urea cycle, which allows for the disposal of excess nitrogen.",D-Ornithine,HMDB0003374,b,b,C00515,CPD-217,FDB023157,orn_D,[H][N+]([H])([H])C([H])([H])C([H])([H])C([H])([H])[C@]([H])(C([O-])=O)[N+]([H])([H])[H],AHLPHDHHMVZTML-SCSAIBSYSA-O,"InChI=1S/C5H12N2O2/c6-3-1-2-4(7)5(8)9/h4H,1-3,6-7H2,(H,8,9)/p+1/t4-/m1/s1"
4405,12364,a,a,16998,KEGG COMPOUND accession,C02265,,,,,,,,,,,,,,,
4406,12377,a,a,27605,KEGG COMPOUND accession,C06468,,,,,,,,,,,,,,,
4407,12385,a,a,16246,KEGG COMPOUND accession,C01068,,,,,,,,,,,,,,,
4408,12390,a,a,47013,KEGG COMPOUND accession,C00121,rib_D,50-69-1,16988.0,"Human Metabolome Database (HMDB): D-ribose is commonly referred to simply as ribose, a five-carbon sugar found in all living cells. Ribose is not an essential nutrient because it can be synthesized by almost every tissue in the body from other substances, such as glucose. It is vital for life as a component of DNA, RNA, ATP, ADP, and AMP. In nature, small amounts of ribose can be found in ripe fruits and vegetables. Brewer's yeast, which has a high concentration of RNA, is another rich source of ribose. D-ribose is also a component of many so-called energy drinks and antiaging products available on the market today. Ribose is a structural component of ATP, which is the primary energy source for exercising muscle. The adenosine component is an adenine base attached to the five-carbon sugar ribose. ATP provides energy to working muscles by releasing a phosphate group, hence becoming ADP, which in turn may release a phosphate group, then becoming AMP. During intense muscular activity, the total amount of ATP available is quickly depleted. In an effort to correct this imbalance, AMP is broken down in the muscle and secreted from the cell. Once the breakdown products of AMP are released from the cell, the energy potential (TAN pool) of the muscle is reduced and ATP must then be reformed using ribose. Ribose helps restore the level of adenine nucleotides by bypassing the rate-limiting step in the de novo (oxidative pentose phosphate) pathway, which regenerates 5-phosphoribosyl-l-pyrophosphate (PRPP), the essential precursor for ATP. If ribose is not readily available to a cell, glucose may be converted to ribose. Ribose supplementation has been shown to increase the rate of ATP resynthesis following intense exercise. The use of ribose in men with severe coronary artery disease resulted in improved exercise tolerance. Hence, there is interest in the potential of ribose supplements to boost muscular performance in athletic activities (PMID: 17618002, Curr Sports Med Rep. 2007 Jul;6(4):254-7.). Furthermore, D-ribose is found to be associated with ribose-5-phosphate isomerase deficiency, which is an inborn error of metabolism.",D-Ribose,HMDB0000283,b,b,C00121,CPD-10330,FDB011145,rib_D,[H]OC([H])([H])[C@@]1([H])OC([H])(O[H])[C@]([H])(O[H])[C@]1([H])O[H],HMFHBZSHGGEWLO-SOOFDHNKSA-N,"InChI=1S/C5H10O5/c6-1-2-3(7)4(8)5(9)10-2/h2-9H,1H2/t2-,3-,4-,5?/m1/s1"
4409,12402,a,a,17994,KEGG COMPOUND accession,C01151,,,,,,,,,,,,,,,
4410,12404,a,a,4235,KEGG COMPOUND accession,C06248,,,,,,,,,,,,,,,
4411,12411,a,a,28662,KEGG COMPOUND accession,C01095,,,,,,,,,,,,,,,
4412,12412,a,a,17797,KEGG COMPOUND accession,C00117,r5p,3615-55-2,52742.0,"Human Metabolome Database (HMDB): D-Ribose 5-phosphate is an important intermediate metabolite in the Pentose phosphate pathway (KEGG, map00030) and in the Purine metabolism pathway (KEGG, map00230). The intracellular ribose 5-phosphate concentration is an important determinant of the rate of de novo purine synthesis. (PMID 6699001).",D-Ribose 5-phosphate,HMDB0001548,b,b,C00117,RIBOSE-5P,FDB001615,r5p,[H]O[C@@]1([H])O[C@]([H])(C([H])([H])OP([O-])([O-])=O)[C@@]([H])(O[H])[C@@]1([H])O[H],KTVPXOYAKDPRHY-NEEWWZBLSA-L,"InChI=1S/C5H11O8P/c6-3-2(1-12-14(9,10)11)13-5(8)4(3)7/h2-8H,1H2,(H2,9,10,11)/p-2/t2-,3-,4-,5+/m0/s1"
4413,12435,a,a,17173,KEGG COMPOUND accession,C00309,rbl_D,488-84-6,17173.0,"Human Metabolome Database (HMDB): Ribulose is a ketopentose - a monosaccharide containing five carbon atoms, and including a ketone functional group. D-ribulose is an intermediate in the fungal pathway for D-arabitol production. As the 1,5-bisphosphate, it combines with CO2 at the start of the photosynthetic process in green plants (carbon dioxide trap); d-ribulose is the epimer of d-xylulose. (Wikipedia).",D-Ribulose,HMDB0000621,b,b,C00309,b,FDB004270,rbl_D,[H]OC([H])([H])C(=O)[C@]([H])(O[H])[C@]([H])(O[H])C([H])([H])O[H],ZAQJHHRNXZUBTE-NQXXGFSBSA-N,"InChI=1S/C5H10O5/c6-1-3(8)5(10)4(9)2-7/h3,5-8,10H,1-2H2/t3-,5-/m1/s1"
4414,12443,a,a,16710,KEGG COMPOUND accession,C01182,,,,,,,,,,,,,,,
4415,12447,a,a,17363,KEGG COMPOUND accession,C00199,ru5p_D,4151-19-3,17363.0,"Human Metabolome Database (HMDB): D-Ribulose 5-phosphate is a metabolite in the Pentose phosphate pathway, Pentose and glucuronate interconversions, and in the Riboflavin metabolism (KEGG).",D-Ribulose 5-phosphate,HMDB0000618,b,b,C00199,RIBULOSE-5P,FDB022145,ru5p_D,[H]OC([H])([H])C(=O)[C@]([H])(O[H])[C@]([H])(O[H])C([H])([H])OP([O-])([O-])=O,FNZLKVNUWIIPSJ-UHNVWZDZSA-L,"InChI=1S/C5H11O8P/c6-1-3(7)5(9)4(8)2-13-14(10,11)12/h4-6,8-9H,1-2H2,(H2,10,11,12)/p-2/t4-,5+/m1/s1"
4416,12457,a,a,15721,KEGG COMPOUND accession,C05382,,,,,,,,,,,,,,,
4417,12460,a,a,16523,KEGG COMPOUND accession,C00740,ser_D,312-84-5,16523.0,"Human Metabolome Database (HMDB): D-serine is a stereo-isomer of the common amino acid, L-serine. D-serine was only thought to exist in bacteria until relatively recently. D-serine was the second D amino acid discovered to naturally exist in humans. The first one was D-aspartate. D-serine is synthesized from L-serine by serine racemase (SRR), and it is degraded by D-amino acid oxidase (DAO). It is found in high abundance in the brain. D-serine acts on the glycine binding site of the N-methyl-D-aspartate receptor (NMDAR) and modulates glutamate-mediated receptor activation. For the receptor to open, glutamate and either glycine or D-serine must bind to it. In fact, D-serine is a more potent agonist at the glycine site on the NMDAR than glycine itself. The importance of D-serine in mammalian brain function is apparent from extensive investigations reported and reviewed over the past decade, including roles in synaptic plasticity and memory. D-serine is also implicated in the pathophysiology and therapy of several psychiatric and neurological conditions including schizophrenia and glioma. In schizophrenia, there is evidence that D-serine levels are decreased, a deficiency that may contribute to the proposed NMDAR hypofunction of the disorder and that has led to D-serine replenishment as a novel therapeutic strategy.",D-Serine,HMDB0003406,b,b,C00740,Serines,FDB023164,ser_D,[H]OC([H])([H])[C@]([H])(C([O-])=O)[N+]([H])([H])[H],MTCFGRXMJLQNBG-UWTATZPHSA-N,"InChI=1S/C3H7NO3/c4-2(1-5)3(6)7/h2,5H,1,4H2,(H,6,7)/t2-/m1/s1"
4418,12465,a,a,17924,KEGG COMPOUND accession,C00794,sbt_D,50-70-4,17924.0,"Human Metabolome Database (HMDB): Sorbitol is a polyhydric alcohol with about half the sweetness of sucrose. Sorbitol occurs naturally and is also produced synthetically from glucose. It was formerly used as a diuretic and may still be used as a laxative and in irrigating solutions for some surgical procedures. It is also used in many manufacturing processes, as a pharmaceutical aid, and in several research applications. Ascorbic acid fermentation; in solution form for moisture-conditioning of cosmetic creams and lotions, toothpaste, tobacco, gelatin; bodying agent for paper, textiles, and liquid pharmaceuticals; softener for candy; sugar crystallization inhibitor; surfactants; urethane resins and rigid foams; plasticizer, stabilizer for vinyl resins; food additive (sweetener, humectant, emulsifier, thickener, anticaking agent); dietary supplement. (Hawley's Condensed Chemical Dictionary) Biological Source: Occurs widely in plants ranging from algae to the higher orders. Fruits of the plant family Rosaceae, which include apples, pears, cherries, apricots, contain appreciable amounts. Rich sources are the fruits of the Sorbus and Crataegus species Use/Importance: Used for manufacturing of sorbose, propylene glycol, ascorbic acid, resins, plasticizers and as antifreeze mixtures with glycerol or glycol. Tablet diluent, sweetening agent and humectant, other food uses. Sorbitol is used in photometric determination of Ru(VI) and Ru(VIII); in acid-base titration of borate (Dictionary of Organic Compounds).",Sorbitol,HMDB0000247,b,b,C00794,b,FDB011676,sbt_D,[H]OC([H])([H])[C@]([H])(O[H])[C@@]([H])(O[H])[C@]([H])(O[H])[C@]([H])(O[H])C([H])([H])O[H],FBPFZTCFMRRESA-FSIIMWSLSA-N,"InChI=1S/C6H14O6/c7-1-3(9)5(11)6(12)4(10)2-8/h3-12H,1-2H2/t3-,4+,5-,6-/m0/s1"
4419,12473,a,a,17044,KEGG COMPOUND accession,C01096,,,,,,,,,,,,,,,
4420,12479,a,a,4249,KEGG COMPOUND accession,C00795,tagat_D,87-81-0,47693.0,"Human Metabolome Database (HMDB): D-Tagatose, a rare natural hexoketose, is an isomer of d-galactose. D-Tagatose occurs naturally in Sterculia setigera gum, and it is also found in small quantities in various foods such as sterilized and powdered cow's milk, hot cocoa, and a variety of cheeses, yogurts, and other dairy products. It can be synthesized from D-galactose by isomerization under alkaline conditions in the presence of calcium. D-Tagatose have numerous health benefits, including promotion of weight loss, no glycemic effect, anti-plaque, non-cariogenic, anti-halitosis, prebiotic, and anti-biofilm properties, organ transplants, enhancement of flavor, improvement of pregnancy and fetal development, treatment of obesity, and reduction in symptoms associated with type 2 diabetes, hyperglycemia, anemia, and hemophilia. (PMID: 17492284).",D-Tagatose,HMDB0003418,b,b,C00795,TAGATOSE,FDB001109,tagat_D,[H]OC([H])([H])C1(O[H])OC([H])([H])[C@@]([H])(O[H])[C@]([H])(O[H])[C@]1([H])O[H],LKDRXBCSQODPBY-JMSAOHGTSA-N,"InChI=1S/C6H12O6/c7-2-6(11)5(10)4(9)3(8)1-12-6/h3-5,7-11H,1-2H2/t3-,4+,5+,6?/m0/s1"
4421,12483,a,a,4250,KEGG COMPOUND accession,C03785,HC01180,b,4250.0,"Human Metabolome Database (HMDB): D-Tagatose 1,6-bisphosphate is an intermediate in galactose metabolism.","D-Tagatose 1,6-bisphosphate",HMDB0006872,b,b,C03785,b,FDB024127,HC01180,[H]O[C@@]1([H])[C@]([H])(OC(O[H])(C([H])([H])OP([O-])([O-])=O)[C@@]1([H])O[H])C([H])([H])OP([O-])([O-])=O,RNBGYGVWRKECFJ-OEXCPVAWSA-J,"InChI=1S/C6H14O12P2/c7-4-3(1-16-19(10,11)12)18-6(9,5(4)8)2-17-20(13,14)15/h3-5,7-9H,1-2H2,(H2,10,11,12)(H2,13,14,15)/p-4/t3-,4+,5+,6?/m1/s1"
4422,12488,a,a,4251,KEGG COMPOUND accession,C01097,HC00664,b,4251.0,Human Metabolome Database (HMDB): D-Tagatose 6-phosphate is an intermediate in galactose metabolism.,D-Tagatose 6-phosphate,HMDB0006873,b,b,C01097,b,FDB024128,HC00664,[H]OC([H])([H])C1(O[H])O[C@]([H])(C([H])([H])OP([O-])([O-])=O)[C@]([H])(O[H])[C@]1([H])O[H],BGWGXPAPYGQALX-OEXCPVAWSA-L,"InChI=1S/C6H13O9P/c7-2-6(10)5(9)4(8)3(15-6)1-14-16(11,12)13/h3-5,7-10H,1-2H2,(H2,11,12,13)/p-2/t3-,4+,5+,6?/m1/s1"
4423,12495,a,a,17886,KEGG COMPOUND accession,C00558,,,,,,,,,,,,,,,
4424,12498,a,a,28458,KEGG COMPOUND accession,C06467,,,,,,,,,,,,,,,
4425,12500,a,a,16398,KEGG COMPOUND accession,C00820,,,,,,,,,,,,,,,
4426,12503,a,a,28587,KEGG COMPOUND accession,C06463,,,,,,,,,,,,,,,
4427,12505,a,a,27508,KEGG COMPOUND accession,C03109,,,,,,,,,,,,,,,
4428,12506,a,a,16296,KEGG COMPOUND accession,C00525,,,,,,,,,,,,,,,
4429,12510,a,a,28479,KEGG COMPOUND accession,C06420,,,,,,,,,,,,,,,
4430,12515,a,a,27477,KEGG COMPOUND accession,C06417,,,,,,,,,,,,,,,
4431,12516,a,a,48093,KEGG COMPOUND accession,C00502,,,,,,,,,,,,,,,
4432,12523,a,a,15867,KEGG COMPOUND accession,C02266,M01757,b,15867.0,Human Metabolome Database (HMDB): D-xylonolactone is a lactone derivative of xylonic acid. It is an intermediate in the pentose and glucuronate interconversion pathway and can be formed from either D-xylonic acid or D-xylose. D-xylose is a simple 5 carbon sugar that is found in a variety of edible plants. It is also frequently used in intestinal absorption tests to help diagnose problems that prevent the small intestine from absorbing nutrients in food. Xylose is also the first saccharide added to the serine or threonine in the proteoglycan type O-glycosylation and so it is the first saccharide in biosynthetic pathways of most anionic polysaccharides such as heparan sulfate and chondroitin sulfate. D-xylose is normally easily absorbed by the intestines where it can be converted to D-xylonolactone by intestinal D-xylose 1-dehydrogenase (EC 1.1.1.175).,"D-Xylono-1,5-lactone",HMDB0011676,b,b,C02266,D-XYLONO-14-LACTONE,FDB028364,b,[H]O[C@@]1([H])C(=O)OC([H])([H])[C@@]([H])(O[H])[C@]1([H])O[H],XXBSUZSONOQQGK-FLRLBIABSA-N,"InChI=1S/C5H8O5/c6-2-1-10-5(9)4(8)3(2)7/h2-4,6-8H,1H2/t2-,3+,4-/m1/s1"
4433,12527,a,a,15936,KEGG COMPOUND accession,C00181,xyl_D,58-86-6,53455.0,"Human Metabolome Database (HMDB): Xylose or wood sugar is an aldopentose - a monosaccharide containing five carbon atoms and an aldehyde functional group. It has chemical formula C5H10O5 and is 40% as sweet as sucrose. Xylose is found in the embryos of most edible plants. The polysaccharide xylan, which is closely associated with cellulose, consists practically entirely of d-xylose. Corncobs, cottonseed hulls, pecan shells, and straw contain considerable amounts of this sugar. Xylose is also found in mucopolysaccharides of connective tissue and sometimes in the urine. Xylose is the first sugar added to serine or threonine residues during proteoglycan type O-glycosylation. Therefore xylose is involved in the biosythetic pathways of most anionic polysaccharides such as heparan sulphate and chondroitin sulphate. In medicine, xylose is used to test for malabsorption by administering a xylose solution to the patient after fasting. If xylose is detected in the blood and/or urine within the next few hours, it has been absorbed by the intestines. Xylose is said to be one of eight sugars which are essential for human nutrition, the others being galactose, glucose, mannose, N-acetylglucosamine, N-acetylgalactosamine, fucose, and sialic acid. (Wikipedia). Xylose in the urine is a biomarker for the consumption of apples and other fruits.",D-Xylose,HMDB0000098,b,b,C00181,XYLOSE,FDB001136,xyl_D,[H]OC([H])([H])[C@@]([H])(O[H])[C@]([H])(O[H])[C@@]([H])(O[H])C([H])=O,PYMYPHUHKUWMLA-VPENINKCSA-N,"InChI=1S/C5H10O5/c6-1-3(8)5(10)4(9)2-7/h1,3-5,7-10H,2H2/t3-,4+,5+/m0/s1"
4434,12534,a,a,37492,KEGG COMPOUND accession,C06814,,,,,,,,,,,,,,,
4435,12537,a,a,17140,KEGG COMPOUND accession,C00310,xylu_D,551-84-8,17140.0,"Human Metabolome Database (HMDB): D-xylulose is a monosaccharide containing five carbon atoms. D-xylulose is converted from xylitol by the enzyme NAD+-linked xylitol dehydrogenase (EC 1.1.1.9) in the glucuronate pathway, the most important xylitol-handling metabolic pathway in mammals. This activity has been described in human erythrocytes. Most likely, D-xylulose (as well as D-arabinose or D-ribulose) is a precursor of the pentiol D-arabitol, since pentitols are derived from their corresponding pentose phosphate precursors via pentoses. This pathway can play a role in inherited metabolic disorders underlying the accumulation of pentitols e.g., ribose 5-phosphate isomerase deficiency and transaldolase deficiency. Although pentitols are present in all living organisms, knowledge concerning their metabolism is limited (PMID: 15234337, Mol Genet Metab. 2004 Jul;82(3):231-7.).",D-Xylulose,HMDB0001644,b,b,C00310,D-XYLULOSE,FDB022698,xylu_D,[H]OC([H])([H])C(=O)[C@@]([H])(O[H])[C@]([H])(O[H])C([H])([H])O[H],ZAQJHHRNXZUBTE-WUJLRWPWSA-N,"InChI=1S/C5H10O5/c6-1-3(8)5(10)4(9)2-7/h3,5-8,10H,1-2H2/t3-,5+/m1/s1"
4436,12551,a,a,17805,KEGG COMPOUND accession,C04666,,,,,,,,,,,,,,,
4437,12553,a,a,27394,KEGG COMPOUND accession,C06032,,,,,,,,,,,,,,,
4438,12556,a,a,16507,KEGG COMPOUND accession,C04563,,,,,,,,,,,,,,,
4439,12563,a,a,18225,KEGG COMPOUND accession,C04062,mi13p,103597-56-4,18225.0,"Human Metabolome Database (HMDB): 1D-Myo-inositol 1,3-bisphosphate is an intermediate in inositol phosphate metabolism. The enzyme phosphatidylinositol 3-kinase [EC:2.7.1.137] catalyzes the production of this metabolite from 1-Phosphatidyl-D-myo-inositol.","1D-Myo-inositol 1,3-bisphosphate",HMDB0006234,b,b,C04062,5-DIPHOSPHO-1D-MYO-INOSITOL-12346P,FDB023851,mi13p,[H]O[C@@]1([H])[C@]([H])(O[H])[C@@]([H])(OP([O-])([O-])=O)[C@@]([H])(O[H])[C@@]([H])(OP([O-])([O-])=O)[C@]1([H])O[H],PUVHMWJJTITUGO-FICORBCRSA-J,"InChI=1S/C6H14O12P2/c7-1-2(8)5(17-19(11,12)13)4(10)6(3(1)9)18-20(14,15)16/h1-10H,(H2,11,12,13)(H2,14,15,16)/p-4/t1-,2-,3+,4+,5+,6-"
4440,12566,a,a,16595,KEGG COMPOUND accession,C01245,mi145p,88269-39-0,16595.0,"Human Metabolome Database (HMDB): Intracellular messenger formed by the action of phospholipase C on phosphatidylinositol 4,5-bisphosphate, which is one of the phospholipids that make up the cell membrane. Inositol 1,4,5-trisphosphate is released into the cytoplasm where it releases calcium ions from internal stores within the cell's endoplasmic reticulum. These calcium ions stimulate the activity of B kinase or calmodulin. (PubChem). Inositol 1,4,5-trisphosphate (InsP3) is traditionally considered to be the messenger that initiates the increase and spreading of the activating Ca2+ wave. In line with this hypothesis, recent evidence suggests that the penetrating sperm delivers into mammalian eggs a novel isoform of phospholipase C (PLC), which promotes the formation of InsP3. The mechanism by which the interacting sperm triggers the production of NAADP and subsequently that of InsP3 remains obscure. (PMID: 15362223).","Inositol 1,4,5-trisphosphate",HMDB0001498,b,b,C01245,"inositol_1,4,5-trisphosphate",FDB022657,mi145p,[H]O[C@]1([H])[C@]([H])(O[H])[C@@]([H])(OP([O-])([O-])=O)[C@]([H])(OP([O-])([O-])=O)[C@@]([H])(O[H])[C@]1([H])OP([O-])([O-])=O,MMWCIQZXVOZEGG-HOZKJCLWSA-H,"InChI=1S/C6H15O15P3/c7-1-2(8)5(20-23(13,14)15)6(21-24(16,17)18)3(9)4(1)19-22(10,11)12/h1-9H,(H2,10,11,12)(H2,13,14,15)(H2,16,17,18)/p-6/t1-,2+,3+,4-,5-,6-/m0/s1"
4441,12573,a,a,28858,KEGG COMPOUND accession,C04063,mi34p,69256-53-7,28858.0,"Human Metabolome Database (HMDB): 1D-myo-Inositol 3,4-bisphosphate is an intermediate in inositol phosphate metabolism. 1D-myo-Inositol 3,4-bisphosphate is converted from 1D-myo-inositol-3-phosphate via inositol polyphosphate-4-phosphatase [EC:3.1.3.66].","1D-Myo-inositol 3,4-bisphosphate",HMDB0006235,b,b,C04063,D-MYO-INOSITOL-34-BISPHOSPHATE,FDB023852,mi34p,[H]O[C@@]1([H])[C@]([H])(O[H])[C@@]([H])(O[H])[C@]([H])(OP([O-])([O-])=O)[C@@]([H])(OP([O-])([O-])=O)[C@@]1([H])O[H],MCKAJXMRULSUKI-CNWJWELYSA-J,"InChI=1S/C6H14O12P2/c7-1-2(8)4(10)6(18-20(14,15)16)5(3(1)9)17-19(11,12)13/h1-10H,(H2,11,12,13)(H2,14,15,16)/p-4/t1-,2-,3-,4+,5-,6-/m0/s1"
4442,12576,a,a,18156,KEGG COMPOUND accession,C04064,,,,,,,,,,,,,,,
4443,12577,a,a,37493,KEGG COMPOUND accession,C06154,,,,,,,,,,,,,,,
4444,12578,a,a,4280,KEGG COMPOUND accession,C03943,,,,,,,,,,,,,,,
4445,12582,a,a,27736,KEGG COMPOUND accession,C06031,,,,,,,,,,,,,,,
4446,12584,a,a,27378,KEGG COMPOUND accession,C02143,,,,,,,,,,,,,,,
4447,12588,a,a,4286,KEGG COMPOUND accession,C11591,,,,,,,,,,,,,,,
4448,12592,a,a,27792,KEGG COMPOUND accession,C06682,,,,,,,,,,,,,,,
4449,12596,a,a,4290,KEGG COMPOUND accession,C07488,,,,,,,,,,,,,,,
4450,12598,a,a,16991,KEGG COMPOUND accession,C00039,dna,b,16991.0,b,DNA,b,b,b,C00039,b,b,b,[H]OC([H])([H])[C@@]1([H])O[C@@]([H])([*])C([H])([H])[C@]1([H])OP(=O)(O[H])OC([H])([H])[C@@]1([H])O[C@@]([H])([*])C([H])([H])[C@]1([H])OP(=O)(O[H])OC([H])([H])[C@@]1([H])O[C@@]([H])([*])C([H])([H])[C@]1([H])O[H],b,b
4451,12628,a,a,4302,KEGG COMPOUND accession,C11122,,,,,,,,,,,,,,,
4452,12633,a,a,4305,KEGG COMPOUND accession,C06936,,,,,,,,,,,,,,,
4453,12635,a,a,28197,KEGG COMPOUND accession,C10208,,,,,,,,,,,,,,,
4454,12637,a,a,42202,KEGG COMPOUND accession,C10216,,,,,,,,,,,,,,,
4455,12641,a,a,4309,KEGG COMPOUND accession,C08033,,,,,,,,,,,,,,,
4456,12655,a,a,4316,KEGG COMPOUND accession,C10674,,,,,,,,,,,,,,,
4457,12657,a,a,4317,KEGG COMPOUND accession,C06939,,,,,,,,,,,,,,,
4458,12659,a,a,4318,KEGG COMPOUND accession,C07933,,,,,,,,,,,,,,,
4459,12665,a,a,4321,KEGG COMPOUND accession,C09080,,,,,,,,,,,,,,,
4460,12667,a,a,17989,KEGG COMPOUND accession,C01421,,,,,,,,,,,,,,,
4461,12672,a,a,4324,KEGG COMPOUND accession,C09216,,,,,,,,,,,,,,,
4462,12674,a,a,4325,KEGG COMPOUND accession,C07666,,,,,,,,,,,,,,,
4463,12680,a,a,75107,KEGG COMPOUND accession,C10036,,,,,,,,,,,,,,,
4464,12684,a,a,41977,KEGG COMPOUND accession,C01907,,,,,,,,,,,,,,,
4465,12686,a,a,4331,KEGG COMPOUND accession,C09419,,,,,,,,,,,,,,,
4466,12688,a,a,27655,KEGG COMPOUND accession,C09618,,,,,,,,,,,,,,,
4467,12691,a,a,18229,KEGG COMPOUND accession,C06565,,,,,,,,,,,,,,,
4468,12694,a,a,18065,KEGG COMPOUND accession,C03112,,,,,,,,,,,,,,,
4469,12697,a,a,18106,KEGG COMPOUND accession,C07307,,,,,,,,,,,,,,,
4470,12699,a,a,17286,KEGG COMPOUND accession,C07304,,,,,,,,,,,,,,,
4471,12701,a,a,18362,KEGG COMPOUND accession,C01091,,,,,,,,,,,,,,,
4472,12705,a,a,18304,KEGG COMPOUND accession,C00857,dnad,6450-77-7,18304.0,"Human Metabolome Database (HMDB): Nicotinic acid adenine dinucleotide phosphate, (NAADP), is a Ca2+-mobilizing second messenger synthesized in response to extracellular stimuli. NAADP binds to and opens Ca2+ channels on intracellular organelles, thereby increasing the intracellular Ca2+ concentration which, in turn, modulates a variety of cellular processes. Structurally, it is a dinucleotide that only differs from the house-keeping enzyme cofactor, NADP by a hydroxyl group (replacing the nicotinamide amino group) and yet this minor modification converts it into the most potent Ca2+-mobilizing second messenger yet described.",Nicotinic acid adenine dinucleotide,HMDB0001179,b,b,C00857,DEAMIDO-NAD,FDB022469,dnad,[H]O[C@@]1([H])[C@@]([H])(O[C@]([H])(C([H])([H])OP([O-])(=O)OP([O-])(=O)OC([H])([H])[C@@]2([H])O[C@@]([H])([N+]3=C([H])C(=C([H])C([H])=C3[H])C([O-])=O)[C@]([H])(O[H])[C@]2([H])O[H])[C@@]1([H])O[H])N1C([H])=NC2=C(N=C([H])N=C12)N([H])[H],SENPVEZBRZQVST-HISDBWNOSA-L,"InChI=1S/C21H26N6O15P2/c22-17-12-18(24-7-23-17)27(8-25-12)20-16(31)14(29)11(41-20)6-39-44(36,37)42-43(34,35)38-5-10-13(28)15(30)19(40-10)26-3-1-2-9(4-26)21(32)33/h1-4,7-8,10-11,13-16,19-20,28-31H,5-6H2,(H4-,22,23,24,32,33,34,35,36,37)/p-2/t10-,11-,13-,14-,15-,16-,19-,20-/m1/s1"
4473,12712,a,a,16251,KEGG COMPOUND accession,C03860,,,,,,,,,,,,,,,
4474,12717,a,a,4344,KEGG COMPOUND accession,C05148,,,,,,,,,,,,,,,
4475,12720,a,a,41934,KEGG COMPOUND accession,C11733,,,,,,,,,,,,,,,
4476,12722,a,a,30813,KEGG COMPOUND accession,C01571,dca,334-48-5,30813.0,"Human Metabolome Database (HMDB): Capric acid is a member of the series of fatty acids found in oils and animal fats. The names of Caproic, Caprylic, and Capric acids are all derived from the word caper (Latin: 'goat'). These are colorless light yellowish transparent oily liquids with unconfortable smells. These are used in organic synthesis, manufacture of perfume, medicine, lubricating grease, rubber and dye.(ChemicalLAND21).",Capric acid,HMDB0000511,b,b,C01571,3-OXODODECANOATE,FDB012027,dca,[H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([O-])=O,GHVNFZFCNZKVNT-UHFFFAOYSA-M,"InChI=1S/C10H20O2/c1-2-3-4-5-6-7-8-9-10(11)12/h2-9H2,1H3,(H,11,12)/p-1"
4477,12724,a,a,28493,KEGG COMPOUND accession,C05274,dcacoa,1264-57-9,28493.0,"Human Metabolome Database (HMDB): Decanoyl CoA is a human liver acyl-CoA ester. It is selected to determine apparent kinetic constants for human liver acyl-CoA due to its relevance to the human diseases with cellular accumulation of this esters, especially to metabolic defects in the acyl-CoA dehydrogenation steps of the branched-chain amino acids, lysine, 5-hydroxy lysine, tryptophan, and fatty acid oxidation pathways. It is concluded that the substrate concentration is decisive for the glycine conjugate formation and that the occurrence in urine of acylglycines reflects an intramitochondrial accumulation of the corresponding acyl-CoA ester. (PMID: 3707752).",Decanoyl-CoA (n-C10:0CoA),HMDB0006404,b,b,C05274,b,FDB023910,dcacoa,[H]O[C@@]([H])(C(=O)N([H])C([H])([H])C([H])([H])C(=O)N([H])C([H])([H])C([H])([H])SC(=O)C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H])C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])OP([O-])(=O)OP([O-])(=O)OC([H])([H])[C@@]1([H])O[C@@]([H])(N2C([H])=NC3=C(N=C([H])N=C23)N([H])[H])[C@]([H])(O[H])[C@]1([H])OP([O-])([O-])=O,CNKJPHSEFDPYDB-HSJNEKGZSA-J,"InChI=1S/C31H54N7O17P3S/c1-4-5-6-7-8-9-10-11-22(40)59-15-14-33-21(39)12-13-34-29(43)26(42)31(2,3)17-52-58(49,50)55-57(47,48)51-16-20-25(54-56(44,45)46)24(41)30(53-20)38-19-37-23-27(32)35-18-36-28(23)38/h18-20,24-26,30,41-42H,4-17H2,1-3H3,(H,33,39)(H,34,43)(H,47,48)(H,49,50)(H2,32,35,36)(H2,44,45,46)/p-4/t20-,24-,25-,26+,30-/m1/s1"
4478,12729,a,a,4349,KEGG COMPOUND accession,C05755,HC01598,b,b,b,Decanoyl-ACP,b,b,b,C05755,b,b,b,[H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C(=O)S[*],b,b
4479,12735,a,a,16477,KEGG COMPOUND accession,C02970,,,,,,,,,,,,,,,
4480,12743,a,a,4354,KEGG COMPOUND accession,C09259,,,,,,,,,,,,,,,
4481,12745,a,a,28212,KEGG COMPOUND accession,C06559,,,,,,,,,,,,,,,
4482,12747,a,a,4356,KEGG COMPOUND accession,C06940,,,,,,,,,,,,,,,
4483,12749,a,a,4357,KEGG COMPOUND accession,C10417,,,,,,,,,,,,,,,
4484,12751,a,a,17242,KEGG COMPOUND accession,C00425,dhdascb,490-83-5,17242.0,"Human Metabolome Database (HMDB): Dehydroascorbic acid is the oxidized form of vitamin C. Reduced Vitamin C concentrations in the brain exceed those in blood by 10 fold. Dehydroascorbic acid readily enters the brain and is retained in the brain tissue in the form of ascorbic acid (ascorbic acid is not able to cross the blood-brain barrier). Therefore, transport of dehydroascorbic acid by the Glucose Transporter 1 (GLUT1, Glucose transporters are integral membrane glycoproteins involved in transporting glucose into most cells. GLUT1 is a major glucose transporter in the mammalian blood-brain barrier. It is present at high levels in primate erythrocytes and brain endothelial cells.) is a mechanism by which the brain acquires vitamin C. (OMIM 138140).",Dehydroascorbic acid,HMDB0001264,b,b,C00425,L-DEHYDRO-ASCORBATE,FDB021459,dhdascb,[H]OC([H])([H])C([H])(O[H])C1([H])OC(=O)C(=O)C1=O,SBJKKFFYIZUCET-UHFFFAOYSA-N,"InChI=1S/C6H6O6/c7-1-2(8)5-3(9)4(10)6(11)12-5/h2,5,7-8H,1H2"
4485,12765,a,a,149634,KEGG COMPOUND accession,C07996,,,,,,,,,,,,,,,
4486,12782,a,a,4372,KEGG COMPOUND accession,C02533,,,,,,,,,,,,,,,
4487,12788,a,a,27726,KEGG COMPOUND accession,C06560,,,,,,,,,,,,,,,
4488,12790,a,a,28363,KEGG COMPOUND accession,C06557,,,,,,,,,,,,,,,
4489,12794,a,a,119573,KEGG COMPOUND accession,C06941,,,,,,,,,,,,,,,
4490,12796,a,a,4379,KEGG COMPOUND accession,C08087,,,,,,,,,,,,,,,
4491,12802,a,a,28436,KEGG COMPOUND accession,C05908,,,,,,,,,,,,,,,
4492,12811,a,a,4387,KEGG COMPOUND accession,C08679,,,,,,,,,,,,,,,
4493,12813,a,a,4388,KEGG COMPOUND accession,C10985,,,,,,,,,,,,,,,
4494,12823,a,a,4393,KEGG COMPOUND accession,C11250,,,,,,,,,,,,,,,
4495,12831,a,a,15906,KEGG COMPOUND accession,C02400,,,,,,,,,,,,,,,
4496,12841,a,a,16764,KEGG COMPOUND accession,C03495,,,,,,,,,,,,,,,
4497,12846,a,a,17256,KEGG COMPOUND accession,C00559,dad_2,958-09-8,17256.0,"Human Metabolome Database (HMDB): Deoxyadenosine is a derivative of the nucleoside adenosine. It is composed of adenine attached to a deoxyribose moiety via a N9-glycosidic bond. Deoxyribose differs from ribose by the absence of oxygen in the 3' position of its ribose ring. Deoxyadenosine is a critical component of DNA. When present in sufficiently high levels, deoxyadensoine can act as an immunotoxin and a metabotoxin. An immunotoxin disrupts, limits the function, or destroys immune cells. A metabotoxin is an endogenous metabolite that causes adverse health effects at chronically high levels. Chronically high levels of deoxyadenosine are associated with adenosine deaminase (ADA) deficiency, an inborn error of metabolism. ADA deficiency damages the immune system and causes severe combined immunodeficiency (SCID). People with SCID lack virtually all immune protection from bacteria, viruses, and fungi. They are prone to repeated and persistent infections that can be very serious or life-threatening. These infections are often caused by ""opportunistic"" organisms that ordinarily do not cause illness in people with a normal immune system. The main symptoms of ADA deficiency are pneumonia, chronic diarrhea, and widespread skin rashes. The mechanism by which dATP functions as an immunotoxin is as follows: because deoxyadenosine is a precursor to dATP, a buildup of dATP in cells inhibits ribonucleotide reductase and prevents DNA synthesis, so cells are unable to divide. Since developing T cells and B cells are some of the most mitotically active cells, they are unable to divide and propagate to respond to immune challenges. High levels of deoxyadenosine also lead to an increase in S-adenosylhomocysteine, which is toxic to immature lymphocytes.",Deoxyadenosine,HMDB0000101,b,b,C00559,b,FDB021894,dad_2,[H]OC([H])([H])[C@@]1([H])O[C@@]([H])(N2C([H])=NC3=C(N=C([H])N=C23)N([H])[H])C([H])([H])[C@]1([H])O[H],OLXZPDWKRNYJJZ-RRKCRQDMSA-N,"InChI=1S/C10H13N5O3/c11-9-8-10(13-3-12-9)15(4-14-8)7-1-5(17)6(2-16)18-7/h3-7,16-17H,1-2H2,(H2,11,12,13)/t5-,6+,7+/m0/s1"
4498,12866,a,a,15426,KEGG COMPOUND accession,C06656,,,,,,,,,,,,,,,
4499,12867,a,a,17172,KEGG COMPOUND accession,C00330,dgsn,961-07-9,17172.0,"Human Metabolome Database (HMDB): Deoxyguanosine is a nucleoside consisting of the base guanine and the sugar deoxyribose. It is like guanosine, but with one oxygen atom removed. It is a nucleoside component of DNA. Deoxyguanosine can be converted to 8-hydroxy-deoxyguanosine (8-OHdG) due to hydroxyl radical attack at the C8 of guanine. 8-OHdG is a sensitive marker of the DNA damage This damage, if left unrepaired, has been proposed to contribute to mutagenicity and cancer promotion. Deoxyguanosine is found to be associated with purine nucleoside phosphorylase (PNP) deficiency, which is an inborn error of metabolism.",Deoxyguanosine,HMDB0000085,b,b,C00330,DEOXYGUANOSINE,FDB012064,dgsn,[H]OC([H])([H])[C@@]1([H])O[C@@]([H])(N2C([H])=NC3=C2N=C(N([H])[H])N([H])C3=O)C([H])([H])[C@]1([H])O[H],YKBGVTZYEHREMT-KVQBGUIXSA-N,"InChI=1S/C10H13N5O4/c11-10-13-8-7(9(18)14-10)12-3-15(8)6-1-4(17)5(2-16)19-6/h3-6,16-17H,1-2H2,(H3,11,13,14,18)/t4-,5+,6+/m0/s1"
4500,12874,a,a,28997,KEGG COMPOUND accession,C05512,din,890-38-0,28997.0,"Human Metabolome Database (HMDB): Deoxyinosine is a nucleoside that is formed when hypoxanthine is attached to a deoxyribose ring (also known as a ribofuranose) via a beta-N9-glycosidic bond. Deoxyinosine is found in DNA while inosine is found in RNA. Inosine is a nucleic acid important for RNA editing. Adenosine deaminase (ADA) catalyzes the conversion of adenosine and deoxyadenosine to inosine and deoxyinosine, respectively. ADA-deficient individuals suffer from severe combined immunodeficiency (SCID) and are unable to produce significant numbers of mature T or B lymphocytes. This occurs as a consequence of the accumulation of ADA substrates or their metabolites. Inosine is also an intermediate in a chain of purine nucleotides reactions required for muscle movements. Moreover, deoxyinosine is found to be associated with purine nucleoside phosphorylase (PNP) deficiency, which is an inborn error of metabolism.",Deoxyinosine,HMDB0000071,b,b,C05512,DEOXYINOSINE,FDB012323,din,[H]OC([H])([H])[C@@]1([H])O[C@@]([H])(N2C([H])=NC3=C2N=C([H])N([H])C3=O)C([H])([H])[C@]1([H])O[H],VGONTNSXDCQUGY-RRKCRQDMSA-N,"InChI=1S/C10H12N4O4/c15-2-6-5(16)1-7(18-6)14-4-13-8-9(14)11-3-12-10(8)17/h3-7,15-16H,1-2H2,(H,11,12,17)/t5-,6+,7+/m0/s1"
4501,12880,a,a,17133,KEGG COMPOUND accession,C02027,,,,,,,,,,,,,,,
4502,12882,a,a,15787,KEGG COMPOUND accession,C04251,,,,,,,,,,,,,,,
4503,12885,a,a,18370,KEGG COMPOUND accession,C06071,,,,,,,,,,,,,,,
4504,12891,a,a,18274,KEGG COMPOUND accession,C02269,,,,,,,,,,,,,,,
4505,12897,a,a,18241,KEGG COMPOUND accession,C00676,,,,,,,,,,,,,,,
4506,12912,a,a,4429,KEGG COMPOUND accession,C10556,,,,,,,,,,,,,,,
4507,12914,a,a,17281,KEGG COMPOUND accession,C02674,,,,,,,,,,,,,,,
4508,12917,a,a,28816,KEGG COMPOUND accession,C01801,drib,533-67-5,28816.0,"Human Metabolome Database (HMDB): Deoxyribose is an aldopentose, a monosaccharide containing five carbon atoms, and including an aldehyde functional group. It is derived from the pentose sugar ribose by the replacement of the hydroxyl group at the 2 position with hydrogen, leading to the net loss of an oxygen atom, and has chemical formula C5H10O4. In deoxyribose, the carbon furthest from the attached carbon is stripped of the oxygen atom in what would be a hydroxyl group in ribose. The common base adenine (a purine derivative) coupled to deoxyribose is called deoxyadenosine. The 5-triphosphate derivative of adenosine, commonly called adenosine triphosphate (ATP) is an important energy transport molecule in cells. -- Wikipedia.",Deoxyribose,HMDB0003224,b,b,C01801,CPD-7298,FDB023126,drib,[H]OC([H])([H])[C@@]1([H])OC([H])(O[H])C([H])([H])[C@]1([H])O[H],PDWIQYODPROSQH-PYHARJCCSA-N,"InChI=1S/C5H10O4/c6-2-4-3(7)1-5(8)9-4/h3-8H,1-2H2/t3-,4+,5?/m0/s1"
4509,12921,a,a,16450,KEGG COMPOUND accession,C00526,duri,951-78-0,16450.0,"Human Metabolome Database (HMDB): 2'-Deoxyuridine is a naturally occurring nucleoside. It is similar in chemical structure to uridine, but without the 2'-hydroxyl group. It is considered to be an antimetabolite that is converted to deoxyuridine triphosphate during DNA synthesis. Laboratory suppression of deoxyuridine is used to diagnose megaloblastic anemia due to vitamin B12 and folate deficiencies.",Deoxyuridine,HMDB0000012,b,b,C00526,DEOXYURIDINE,FDB021870,duri,[H]OC([H])([H])[C@@]1([H])O[C@@]([H])(N2C([H])=C([H])C(=O)N([H])C2=O)C([H])([H])[C@]1([H])O[H],MXHRCPNRJAMMIM-SHYZEUOFSA-N,"InChI=1S/C9H12N2O5/c12-4-6-5(13)3-8(16-6)11-2-1-7(14)10-9(11)15/h1-2,5-6,8,12-13H,3-4H2,(H,10,14,15)/t5-,6+,8+/m0/s1"
4510,12941,a,a,4439,KEGG COMPOUND accession,C01490,,,,,,,,,,,,,,,
4511,12942,a,a,18376,KEGG COMPOUND accession,C00426,,,,,,,,,,,,,,,
4512,12947,a,a,16957,KEGG COMPOUND accession,C02673,,,,,,,,,,,,,,,
4513,12954,a,a,4445,KEGG COMPOUND accession,C07519,,,,,,,,,,,,,,,
4514,12965,a,a,17737,KEGG COMPOUND accession,C01802,dsmsterol,313-04-2,17737.0,"Human Metabolome Database (HMDB): Desmosterol is an intermediate in the synthesis of cholesterol. Desmosterolosis is a rare autosomal recessive inborn errors of cholesterol synthesis that is caused by defective activity of desmosterol reductase which results in an accumulation of demosterol (DHCR24, EC 1.3.1.72), combines a severe osteosclerotic skeletal dysplasia and includes 2-3 toe syndactyly with Smith-Lemli-Opitz syndrome (SLOS; the biochemical block in SLOS results in decreased cholesterol levels and increased 7-dehydrocholesterol levels). Desmosterolosis is caused by mutation of the 24-dehydrocholesterol reductase gene (DHCR24). Many of the malformations in SLOS and desmosterolosis are consistent with impaired hedgehog function. The hedgehog proteins include Sonic hedgehog (SHH), which plays a major role in midline patterning and limb development. Desmosterolosis, caused by defective activity of desmosterol reductase, combines a severe osteosclerotic skeletal dysplasia. 7-dehydrocholesterol reductase (DHCR7, EC 1.3.1.21) reduces the C7-C8 double bond in the sterol B ring to form cholesterol or desmosterol depending upon the precursor. Desmosterol can be converted to cholesterol by DHCR24. Therefore, SLOS and Desmosterolosis patients invariably have elevated levels of cholesterol precursor's 7-dehydrocholesterol (and its spontaneous isomer 8-dehydrocholesterol) and absent desmosterol. (PMID: 14631207, 16207203).",Desmosterol,HMDB0002719,b,b,C01802,CPD-4141,FDB005374,dsmsterol,[H]O[C@]1([H])C([H])([H])C2=C([H])C([H])([H])[C@@]3([H])[C@]4([H])C([H])([H])C([H])([H])[C@]([H])([C@]([H])(C([H])([H])[H])C([H])([H])C([H])([H])C([H])=C(C([H])([H])[H])C([H])([H])[H])[C@@]4(C([H])([H])[H])C([H])([H])C([H])([H])[C@]3([H])[C@@]2(C([H])([H])[H])C([H])([H])C1([H])[H],AVSXSVCZWQODGV-DPAQBDIFSA-N,"InChI=1S/C27H44O/c1-18(2)7-6-8-19(3)23-11-12-24-22-10-9-20-17-21(28)13-15-26(20,4)25(22)14-16-27(23,24)5/h7,9,19,21-25,28H,6,8,10-17H2,1-5H3/t19-,21+,22+,23-,24+,25+,26+,27-/m1/s1"
4515,12969,a,a,4453,KEGG COMPOUND accession,C07629,,,,,,,,,,,,,,,
4516,12975,a,a,27780,KEGG COMPOUND accession,C01689,,,,,,,,,,,,,,,
4517,12976,a,a,16691,KEGG COMPOUND accession,C01909,,,,,,,,,,,,,,,
4518,12982,a,a,4460,KEGG COMPOUND accession,C11710,,,,,,,,,,,,,,,
4519,12990,a,a,4464,KEGG COMPOUND accession,C06946,,,,,,,,,,,,,,,
4520,12994,a,a,4466,KEGG COMPOUND accession,C07450,,,,,,,,,,,,,,,
4521,12996,a,a,18269,KEGG COMPOUND accession,C00372,dextran40,b,b,b,"Dextran 40, 1,6-alpha-D-Glucan",b,b,b,C00372,b,b,b,b,b,b
4522,13005,a,a,4469,KEGG COMPOUND accession,C07884,,,,,,,,,,,,,,,
4523,13007,a,a,4470,KEGG COMPOUND accession,C06947,,,,,,,,,,,,,,,
4524,13009,a,a,4471,KEGG COMPOUND accession,C08028,,,,,,,,,,,,,,,
4525,13013,a,a,4474,KEGG COMPOUND accession,C08010,,,,,,,,,,,,,,,
4526,13015,a,a,27826,KEGG COMPOUND accession,C05143,,,,,,,,,,,,,,,
4527,13018,a,a,27963,KEGG COMPOUND accession,C06026,,,,,,,,,,,,,,,
4528,13019,a,a,28526,KEGG COMPOUND accession,C06025,,,,,,,,,,,,,,,
4529,13025,a,a,4480,KEGG COMPOUND accession,C07509,,,,,,,,,,,,,,,
4530,13027,a,a,18035,KEGG COMPOUND accession,C00165,,,,,,,,,,,,,,,
4531,13048,a,a,4488,KEGG COMPOUND accession,C08369,,,,,,,,,,,,,,,
4532,13060,a,a,49575,KEGG COMPOUND accession,C06948,C06948,439-14-5,49575.0,"Human Metabolome Database (HMDB): Diazepam is a benzodiazepine with anticonvulsant, anxiolytic, sedative, muscle relaxant, and amnesic properties and a long duration of action. Its actions are mediated by enhancement of gamma-aminobutyric acid activity. It is used in the treatment of severe anxiety disorders, as a hypnotic in the short-term management of insomnia, as a sedative and premedicant, as an anticonvulsant, and in the management of alcohol withdrawal syndrome. (From Martindale, The Extra Pharmacopoeia, 30th ed, p589).",Diazepam,HMDB0014967,b,b,C06948,b,FDB007103,b,[H]C1=C([H])C([H])=C(C([H])=C1[H])C1=NC([H])([H])C(=O)N(C2=C1C([H])=C(Cl)C([H])=C2[H])C([H])([H])[H],AAOVKJBEBIDNHE-UHFFFAOYSA-N,"InChI=1S/C16H13ClN2O/c1-19-14-8-7-12(17)9-13(14)16(18-10-15(19)20)11-5-3-2-4-6-11/h2-9H,10H2,1H3"
4533,13062,a,a,4495,KEGG COMPOUND accession,C06949,,,,,,,,,,,,,,,
4534,13066,a,a,28891,KEGG COMPOUND accession,C07732,,,,,,,,,,,,,,,
4535,13068,a,a,17036,KEGG COMPOUND accession,C03861,,,,,,,,,,,,,,,
4536,13070,a,a,28145,KEGG COMPOUND accession,C07729,,,,,,,,,,,,,,,
4537,13072,a,a,247956,KEGG COMPOUND accession,C07879,,,,,,,,,,,,,,,
4538,13074,a,a,35692,KEGG COMPOUND accession,C02028,,,,,,,,,,,,,,,
4539,13076,a,a,36386,KEGG COMPOUND accession,C11149,M01691,13425-80-4,b,b,Dichloroacetate,b,b,b,C11149,b,b,b,[H]OC(=O)C([H])(Cl)Cl,JXTHNDFMNIQAHM-UHFFFAOYSA-N,"InChI=1S/C2H2Cl2O2/c3-1(4)2(5)6/h1H,(H,5,6)"
4540,13080,a,a,15767,KEGG COMPOUND accession,C02271,,,,,,,,,,,,,,,
4541,13083,a,a,101085,KEGG COMPOUND accession,C07459,,,,,,,,,,,,,,,
4542,13087,a,a,47381,KEGG COMPOUND accession,C01690,,,,,,,,,,,,,,,
4543,13093,a,a,4510,KEGG COMPOUND accession,C11021,,,,,,,,,,,,,,,
4544,13095,a,a,4511,KEGG COMPOUND accession,C06950,,,,,,,,,,,,,,,
4545,13099,a,a,4513,KEGG COMPOUND accession,C00796,,,,,,,,,,,,,,,
4546,13101,a,a,4514,KEGG COMPOUND accession,C06951,,,,,,,,,,,,,,,
4547,13105,a,a,490877,KEGG COMPOUND accession,C06953,,,,,,,,,,,,,,,
4548,13109,a,a,4518,KEGG COMPOUND accession,C08090,,,,,,,,,,,,,,,
4549,13113,a,a,4520,KEGG COMPOUND accession,C11077,,,,,,,,,,,,,,,
4550,13118,a,a,16879,KEGG COMPOUND accession,C04067,,,,,,,,,,,,,,,
4551,13123,a,a,59051,KEGG COMPOUND accession,C11592,,,,,,,,,,,,,,,
4552,13125,a,a,27710,KEGG COMPOUND accession,C02272,,,,,,,,,,,,,,,
4553,13131,a,a,27708,KEGG COMPOUND accession,C06608,,,,,,,,,,,,,,,
4554,13134,a,a,4530,KEGG COMPOUND accession,C06954,,,,,,,,,,,,,,,
4555,13136,a,a,41922,KEGG COMPOUND accession,C07620,,,,,,,,,,,,,,,
4556,13140,a,a,28006,KEGG COMPOUND accession,C06607,,,,,,,,,,,,,,,
4557,13143,a,a,4534,KEGG COMPOUND accession,C07871,,,,,,,,,,,,,,,
4558,13147,a,a,4536,KEGG COMPOUND accession,C09636,,,,,,,,,,,,,,,
4559,13151,a,a,39669,KEGG COMPOUND accession,C01691,,,,,,,,,,,,,,,
4560,13153,a,a,28396,KEGG COMPOUND accession,C06037,,,,,,,,,,,,,,,
4561,13163,a,a,30814,KEGG COMPOUND accession,C01572,,,,,,,,,,,,,,,
4562,13168,a,a,27614,KEGG COMPOUND accession,C08861,,,,,,,,,,,,,,,
4563,13174,a,a,27729,KEGG COMPOUND accession,C00765,,,,,,,,,,,,,,,
4564,13176,a,a,28544,KEGG COMPOUND accession,C06955,,,,,,,,,,,,,,,
4565,13179,a,a,4551,KEGG COMPOUND accession,C06956,,,,,,,,,,,,,,,
4566,13181,a,a,18395,KEGG COMPOUND accession,C01125,,,,,,,,,,,,,,,
4567,13186,a,a,4553,KEGG COMPOUND accession,C10557,,,,,,,,,,,,,,,
4568,13188,a,a,15712,KEGG COMPOUND accession,C02675,,,,,,,,,,,,,,,
4569,13207,a,a,4559,KEGG COMPOUND accession,C10448,,,,,,,,,,,,,,,
4570,13212,a,a,543841,KEGG COMPOUND accession,C10558,,,,,,,,,,,,,,,
4571,13230,a,a,15401,KEGG COMPOUND accession,C00974,,,,,,,,,,,,,,,
4572,13235,a,a,17694,KEGG COMPOUND accession,C00579,dhlam,3884-47-7,17694.0,"Human Metabolome Database (HMDB): Dihydrolipoamide is an intermediate in glycolysis/gluconeogenesis, citrate cycle (TCA cycle), alanine, aspartate and pyruvate metabolism, and valine, leucine and isoleucine degradation (KEGG ID C00579). It is converted to lipoamide via the enzyme dihydrolipoamide dehydrogenase [EC:1.8.1.4]. Dihydrolipoamide is also a substrate of enzyme Acyltransferases [EC 2.3.1.-]. (KEGG).",Dihydrolipoamide,HMDB0000985,b,b,C00579,DIHYDROLIPOAMIDE,FDB022352,dhlam,[H]SC([H])([H])C([H])([H])C([H])(S[H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C(=O)N([H])[H],VLYUGYAKYZETRF-UHFFFAOYSA-N,"InChI=1S/C8H17NOS2/c9-8(10)4-2-1-3-7(12)5-6-11/h7,11-12H,1-6H2,(H2,9,10)"
4573,13240,a,a,18047,KEGG COMPOUND accession,C02147,C02147,462-20-4,18047.0,"Human Metabolome Database (HMDB): Dihydrolipoic acid is an organic compound that is the reduced form of lipoic acid. This carboxylic acid features a pair of thiol groups. It is optically active but only the R-enantiomer is biochemically significant. The lipoic acid/dihydrolipoic acid pair participate in a variety of biochemical transformations.( from Wiki). Inside the cell, alpha lipoic acid is readily reduced or broken down to dihydrolipoic acid. Dihydrolipoic acid is even more potent than alpha lipoic acid, neutralizing free radicals, preventing them from causing harm. It directly destroys damaging superoxide radicals, hydroperoxy radicals and hydroxyl radicals. It has been shown in vitro that dihydrolipoate (DL-6,8-dithioloctanoic acid) has antioxidant activity against microsomal lipid peroxidation.Dihydrolipoate is tested for its neuroprotective activity using models of hypoxic and excitotoxic neuronal damage in vitro and rodent models of cerebral ischemia in vivo. Dihydrolipoate, similarly to dimethylthiourea, is able to protect neurons against ischemic damage by diminishing the accumulation of reactive oxygen species within the cerebral tissue.(PMID: 1345759).",Dihydrolipoate,HMDB0012210,b,b,C02147,6-S-ACETYL-DIHYDROLIPOATE,FDB028855,b,[H]SC([H])([H])C([H])([H])C([H])(S[H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([O-])=O,IZFHEQBZOYJLPK-UHFFFAOYSA-M,"InChI=1S/C8H16O2S2/c9-8(10)4-2-1-3-7(12)5-6-11/h7,11-12H,1-6H2,(H,9,10)/p-1"
4574,13244,a,a,16194,KEGG COMPOUND accession,C02972,dhlpro,b,16194.0,b,Dihydrolipolprotein,b,b,b,C02972,b,b,dhlpro,[H]SC([H])([H])C([H])([H])C([H])(S[H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C(=O)N([H])[*],b,b
4575,13247,a,a,18029,KEGG COMPOUND accession,C05316,,,,,,,,,,,,,,,
4576,13261,a,a,48954,KEGG COMPOUND accession,C05925,,,,,,,,,,,,,,,
4577,13262,a,a,16370,KEGG COMPOUND accession,C06719,,,,,,,,,,,,,,,
4578,13264,a,a,4579,KEGG COMPOUND accession,C10254,,,,,,,,,,,,,,,
4579,13266,a,a,30156,KEGG COMPOUND accession,C05649,,,,,,,,,,,,,,,
4580,13267,a,a,4581,KEGG COMPOUND accession,C00921,,,,,,,,,,,,,,,
4581,13272,a,a,4582,KEGG COMPOUND accession,C10255,,,,,,,,,,,,,,,
4582,13276,a,a,17209,KEGG COMPOUND accession,C05191,,,,,,,,,,,,,,,
4583,13280,a,a,38291,KEGG COMPOUND accession,C01023,,,,,,,,,,,,,,,
4584,13282,a,a,27918,KEGG COMPOUND accession,C04191,,,,,,,,,,,,,,,
4585,13283,a,a,17751,KEGG COMPOUND accession,C01280,,,,,,,,,,,,,,,
4586,13285,a,a,28703,KEGG COMPOUND accession,C04382,,,,,,,,,,,,,,,
4587,13286,a,a,28333,KEGG COMPOUND accession,C04458,,,,,,,,,,,,,,,
4588,13330,a,a,4610,KEGG COMPOUND accession,C02535,,,,,,,,,,,,,,,
4589,13337,a,a,28262,KEGG COMPOUND accession,C11143,dmso,67-68-5,28262.0,"Human Metabolome Database (HMDB): Dimethyl sulfoxide (DMSO) is a key dipolar aprotic solvent. It is less toxic than other members of this class: dimethylformamide, dimethylacetamide, N-methyl-2-pyrrolidone, HMPA. Dimethyl sulfoxide is the chemical compound (CH3)2SO. This colorless liquid is an important ""dipolar aprotic solvent."" It is readily miscible in a wide range of organic solvents as well as water. It has a distinctive property of penetrating the skin very readily, allowing the handler to taste it. Some describe it as an ""oyster-like"" taste, others claim it tastes like garlic. DMSO is also employed as a rinsing agent in the electronics industry and, in its deuterated form (DMSO-d6), is a useful solvent in NMR due to its ability to dissolve a wide range of chemical compounds and its minimal interference with the sample signals. In cryobiology DMSO has been used as a cryoprotectant and is still an important constituent of cryoprotectant vitrification mixtures used to preserve organs, tissues, and cell suspensions. It is particularly important in the freezing and long-term storage of embryonic stem cells and hematopoietic stem cell, which are often frozen in a mixture of 10% DMSO and 90% fetal calf serum. As part of an autologous bone marrow transplant the DMSO is re-infused along with the patient's own hematopoietic stem cell. Dimethyl sulfoxide is a by-product of wood pulping. One of the leading suppliers of DMSO is the Gaylord company in the USA. DMSO is frequently used as solvent in a number of chemical reactions. In particular it is an excellent reaction solvent for SN2 alkylations: it is possible to alkylate indoles with very high yields using potassium hydroxide as the base and a similar reaction also occurs with phenols. DMSO can be reacted with methyl iodide to form a sulfoxonium ion which can be reacted with sodium hydride to form a sulfur ylide. The methyl groups of DMSO are somewhat acidic in character (pKa=35) due to the stabilization of the resultant anions by the sulfoxide group.",Dimethyl sulfoxide,HMDB0002151,b,b,C11143,b,FDB000764,b,b,IAZDPXIOMUYVGZ-UHFFFAOYSA-N,b
4590,13344,a,a,16057,KEGG COMPOUND accession,C00235,dmpp,358-72-5,16057.0,Human Metabolome Database (HMDB): Dimethylallyl pyrophosphate (or -diphosphate) (DMAPP) is an intermediate product of both mevalonic acid (MVA) pathway and DOXP/MEP pathway. It is an isomer of isopentenyl pyrophosphate (IPP) and exists in virtually all life forms. (wikipedia).,Dimethylallylpyrophosphate,HMDB0001120,b,b,C00235,CPD-4211,FDB022434,dmpp,[H]C(=C(C([H])([H])[H])C([H])([H])[H])C([H])([H])OP([O-])(=O)OP([O-])([O-])=O,CBIDRCWHNCKSTO-UHFFFAOYSA-K,"InChI=1S/C5H12O7P2/c1-5(2)3-4-11-14(9,10)12-13(6,7)8/h3H,4H2,1-2H3,(H,9,10)(H2,6,7,8)/p-3"
4591,13354,a,a,17170,KEGG COMPOUND accession,C00543,dma,124-40-3,17170.0,"Human Metabolome Database (HMDB): Dimethylamine (DMA) is an organic secondary amine. It is a colorless, liquefied and flammable gas with an ammonia and fish-like odor. Dimethylamine is abundantly present in human urine. Main sources of urinary DMA have been reported to include trimethylamine N-oxide, a common food component, and asymmetric dimethylarginine (ADMA), an endogenous inhibitor of nitric oxide (NO) synthesis. ADMA is excreted in the urine in part unmetabolized and in part after hydrolysis to DMA by dimethylarginine dimethylaminohydrolase (DDAH). Statistically significant increases in urinary DMA have been found in individuals after the consumption of fish and seafoods. The highest values were obtained for individuals that consumed coley, squid and whiting with cod, haddock, sardine, skate and swordfish (PMID: 18282650). As a pure chemical substance Dimethylamine is used as dehairing agent in tanning, in dyes, in rubber accelerators, in soaps and cleaning compounds and as an agricultural fungicide. In the body, DMA also undergoes nitrosation under weak acid conditions to give dimethlynitrosamine.",Dimethylamine,HMDB0000087,b,b,C00543,DIMETHYLAMINE,FDB012589,b,[H]N(C([H])([H])[H])C([H])([H])[H],ROSDSFDQCJNGOL-UHFFFAOYSA-N,"InChI=1S/C2H7N/c1-3-2/h3H,1-2H3"
4592,13363,a,a,15890,KEGG COMPOUND accession,C03114,,,,,,,,,,,,,,,
4593,13367,a,a,17081,KEGG COMPOUND accession,C00922,,,,,,,,,,,,,,,
4594,13371,a,a,4623,KEGG COMPOUND accession,C03392,,,,,,,,,,,,,,,
4595,13378,a,a,74023,KEGG COMPOUND accession,C08897,,,,,,,,,,,,,,,
4596,13382,a,a,4629,KEGG COMPOUND accession,C08898,,,,,,,,,,,,,,,
4597,13386,a,a,4631,KEGG COMPOUND accession,C10039,,,,,,,,,,,,,,,
4598,13388,a,a,4632,KEGG COMPOUND accession,C09854,,,,,,,,,,,,,,,
4599,13398,a,a,4638,KEGG COMPOUND accession,C06961,,,,,,,,,,,,,,,
4600,13400,a,a,4639,KEGG COMPOUND accession,C07872,,,,,,,,,,,,,,,
4601,13408,a,a,15949,KEGG COMPOUND accession,C01803,,,,,,,,,,,,,,,
4602,13419,a,a,36484,KEGG COMPOUND accession,C06309,,,,,,,,,,,,,,,
4603,13428,a,a,36233,KEGG COMPOUND accession,C01911,,,,,,,,,,,,,,,
4604,13444,a,a,17456,KEGG COMPOUND accession,C00950,,,,,,,,,,,,,,,
4605,13449,a,a,18320,KEGG COMPOUND accession,C00265,dtt,513-85-9,62064.0,"Human Metabolome Database (HMDB): 2,3-Butanediol is an isomer of butanediol. The 2R,3R stereoisomer of 2,3-butanediol is produced by a variety of microorganisms, in a process known as butanediol fermentation. 2,3-Butanediol fermentation is the anaerobic fermentation of glucose with 2,3-butanediol as one of the end products. The overall stoichiometry of the reaction is 2 pyruvate + NADH --> 2CO2 + 2,3-butanediol. Butanediol fermentation is typical for Enterobacter species or microbes found in the gut. 2,3-butanediol has been identified in the sera of alcoholics and it may be a specific marker of alcohol abuse (PMID: 6139706). In humans, 2,3-butanediol is oxidized to acetyl-CoA via acetoin. 2,3-Butanediol is also found in cocoa butter.","2,3-Butanediol",HMDB0003156,b,b,C00265,CPD-346,FDB011934,b,[H]O[C@@]([H])(C([H])([H])S[H])[C@@]([H])(O[H])C([H])([H])S[H],VHJLVAABSRFDPM-IMJSIDKUSA-N,"InChI=1S/C4H10O2S2/c5-3(1-7)4(6)2-8/h3-8H,1-2H2/t3-,4-/m0/s1"
4606,13461,a,a,4670,KEGG COMPOUND accession,C06967,,,,,,,,,,,,,,,
4607,13465,a,a,4672,KEGG COMPOUND accession,C11231,,,,,,,,,,,,,,,
4608,13467,a,a,28125,KEGG COMPOUND accession,C06429,crvnc,6217-54-5,28125.0,"Human Metabolome Database (HMDB): Docosahexaenoic acid (DHA) is an omega-3 essential fatty acid. Chemically, DHA is a carboxylic acid with a 22-carbon chain and six cis double bonds with the first double bond is located at the third carbon from the omega end. DHA is most often found in fish oil. It is a major fatty acid in sperm and brain phospholipids, especially in the retina. Dietary DHA can reduce the level of blood triglycerides in humans, which may reduce the risk of heart disease (wikipedia). Docosahexaenoic acid is found to be associated with isovaleric acidemia, which is an inborn error of metabolism.",Docosahexaenoic acid,HMDB0002183,b,b,C06429,D-HEXOSE-6-PHOSPHATE,FDB003003,crvnc,[H]\C(=C(/[H])C([H])([H])C(\[H])=C(\[H])C([H])([H])C([H])=C([H])C([H])([H])C([H])([H])[H])C([H])([H])C(\[H])=C(\[H])C([H])([H])C(\[H])=C(\[H])C([H])([H])C(\[H])=C(\[H])C([H])([H])C([H])([H])C([O-])=O,MBMBGCFOFBJSGT-KXRQTMKUSA-M,"InChI=1S/C22H32O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20-21-22(23)24/h3-4,6-7,9-10,12-13,15-16,18-19H,2,5,8,11,14,17,20-21H2,1H3,(H,23,24)/p-1/b4-3?,7-6-,10-9-,13-12-,16-15-,19-18-"
4609,13470,a,a,28817,KEGG COMPOUND accession,C08374,,,,,,,,,,,,,,,
4610,13472,a,a,4676,KEGG COMPOUND accession,C02678,,,,,,,,,,,,,,,
4611,13481,a,a,28878,KEGG COMPOUND accession,C02277,,,,,,,,,,,,,,,
4612,13485,a,a,30805,KEGG COMPOUND accession,C02679,ddca,143-07-7,30805.0,"Human Metabolome Database (HMDB): Lauric acid, or dodecanoic acid is the main fatty acid in coconut oil and in palm kernel oil, and is believed to have antimicrobial properties. It is a white, powdery solid with a faint odor of bay oil. Lauric acid, although slightly irritating to mucous membranes, has a very low toxicity and so is used in many soaps and shampoos.",Dodecanoic acid,HMDB0000638,b,b,C02679,b,FDB003010,ddca,[H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([O-])=O,POULHZVOKOAJMA-UHFFFAOYSA-M,"InChI=1S/C12H24O2/c1-2-3-4-5-6-7-8-9-10-11-12(13)14/h2-11H2,1H3,(H,13,14)/p-1"
4613,13494,a,a,67357,KEGG COMPOUND accession,C11280,,,,,,,,,,,,,,,
4614,13498,a,a,16091,KEGG COMPOUND accession,C00381,dolichol_L,2067-66-5,16091.0,"Human Metabolome Database (HMDB): Dolichols are polyisoprenic molecule ubiquitously present in the lipid fraction of animal and plant tissues, discovered 40 years ago during experiments on the biosynthesis of ubiquinone. The molecular structure of dolichol comprises a sequence of unsaturated isoprenic units bearing a primary terminal hydroxyl group. The length of dolichyl chains depends on the species of the organism from which they are isolated. Mammalian dolichol generally is made up of 16 to 23 unsaturated isoprene units, and the terminal hydroxyl group may exist either free or esterified with fatty acids, phosphoric acid, and pyrophosphoric acid. In biological membranes, this linear polyisoprenoid compound may be located between the two leaflets of the lipid bilayer, close to the free end of the phospholipid fatty acid molecules. Metabolism and function of dolichol were largely unknown until recently. Synthesis of dolichol by the mevalonate pathway was demonstrated in vitro and in vivo in many tissues. The isoprenoid pyrophosphate intermediates are shared by the cholesterol, dolichol, and ubiquinone pathways, and treatment with drugs that block hydroxymethyl glutaryl coenzyme A reductase may significantly decrease their plasma and tissue levels. In humans, there is no apparent positive correlation between serum dolichol and tissue dolichol and age. In view of the total content of the body, half life of the total body dolichol, and dolichol content in the extracellular space, it was concluded that the dolichol in tissues probably derives from biosynthesis in those tissues and that relocation of dolichol via circulation cannot be prominent in vivo. The levels of dolichol in human serum have apparently no correlation to age or serum total cholesterol, and exhibit a linear correlation to high density lipoprotein cholesterols which may reflect the fact that the dolichols are associated with the high-density lipoprotein fraction. No enzymic pathways for dolichol degradation were described, but no case of dolichol-storage disease was reported. Shrinkage of tissue because of increased lysosomal degradation in the process of atrophy does not affect the dolichol content and concentration increases. Small quantities of dolichol that may be excreted into the urine at least in part is derived from the lysosomes of the excretory organ, and serum dolichol levels may be elevated in chronic cholestatic liver diseases. Recent evidence shows that phagocytosis may cause the degradation and disposal of the engulfed dolichol, possibly because of nonenzymatic free radical mediated decomposition. By means of a 1H nuclear magnetic resonance (NMR) analytical method, the hypothesis was substantiated that dolichol may act as a free-radical scavenger in the cell membranes and protect polyunsaturated fatty acids from peroxidation, and that it may undergo decomposition in the process. (PMID 15741281).",Dolichol-20,HMDB0005176,b,b,C00381,b,FDB023633,dolichol_L,[H]OC([H])([H])C([H])([H])C([H])(C([H])([H])[H])C([H])([H])C([H])([H])C(\[H])=C(\C([H])([H])[H])C([H])([H])C([H])([H])C(\[H])=C(/C([H])([H])[H])C([H])([H])C([H])([H])C(\[H])=C(/C([H])([H])[H])C([H])([H])C([H])([H])C([H])=C(C([H])([H])[H])C([H])([H])[H],KLGBTYNAYAZPFD-QOLULZROSA-N,"InChI=1S/C25H44O/c1-21(2)11-7-12-22(3)13-8-14-23(4)15-9-16-24(5)17-10-18-25(6)19-20-26/h11,13,15,17,25-26H,7-10,12,14,16,18-20H2,1-6H3/b22-13+,23-15+,24-17-"
4615,13509,a,a,15812,KEGG COMPOUND accession,C01246,dolglcp_L,220496-27-5,15812.0,Human Metabolome Database (HMDB): Dolichyl &#946;-D-glucosyl phosphate is a polyisoprenyl phosphate monosaccharide. Biosynthesis is by Glucosyltransferase in liver mitochondria. (PubMed ID 6450044 ).,Dolichyl b-D-glucosyl phosphate,HMDB0001054,b,b,C01246,b,FDB022394,dolglcp_L,[H]OC([H])([H])[C@@]1([H])O[C@@]([H])(OP(=O)(O[H])OC([H])([H])C([H])([H])C([H])(C([H])([H])[H])C([H])([H])C([H])([H])C(\[H])=C(\C([H])([H])[H])C([H])([H])C([H])([H])C(\[H])=C(/C([H])([H])[H])C([H])([H])C([H])([H])C(\[H])=C(/C([H])([H])[H])C([H])([H])C([H])([H])C([H])=C(C([H])([H])[H])C([H])([H])[H])[C@]([H])(O[H])[C@@]([H])(O[H])[C@]1([H])O[H],AGLXCEGQRIYVRV-DVDHLLHCSA-N,"InChI=1S/C31H55O9P/c1-22(2)11-7-12-23(3)13-8-14-24(4)15-9-16-25(5)17-10-18-26(6)19-20-38-41(36,37)40-31-30(35)29(34)28(33)27(21-32)39-31/h11,13,15,17,26-35H,7-10,12,14,16,18-21H2,1-6H3,(H,36,37)/b23-13+,24-15+,25-17-/t26?,27-,28-,29+,30-,31+/m1/s1"
4616,13557,a,a,4702,KEGG COMPOUND accession,C06969,,,,,,,,,,,,,,,
4617,13583,a,a,66964,KEGG COMPOUND accession,C06972,,,,,,,,,,,,,,,
4618,13607,a,a,4728,KEGG COMPOUND accession,C07819,,,,,,,,,,,,,,,
4619,13609,a,a,30270,KEGG COMPOUND accession,C01341,,,,,,,,,,,,,,,
4620,13613,a,a,4732,KEGG COMPOUND accession,C11593,,,,,,,,,,,,,,,
4621,13615,a,a,4734,KEGG COMPOUND accession,C11594,,,,,,,,,,,,,,,
4622,13616,a,a,42191,KEGG COMPOUND accession,C00284,,,,,,,,,,,,,,,
4623,13627,a,a,16688,KEGG COMPOUND accession,C00477,,,,,,,,,,,,,,,
4624,13632,a,a,17551,KEGG COMPOUND accession,C02681,,,,,,,,,,,,,,,
4625,13634,a,a,4743,KEGG COMPOUND accession,C10858,ecgon,481-37-8,708641.0,"Human Metabolome Database (HMDB): Ecgonine is an organic chemical and tropane alkaloid found naturally in coca leaves. It is has a close structural relation to cocaine: it is both a metabolite and a precursor, and as such, it is a controlled substance, as are all known substances which can be used as precursors to ecgonine itself. Structurally, ecgonine is a cycloheptane derivative with a nitrogen bridge. It is obtained by hydrolysis of cocaine with acids or alkalis, and crystallizes with one molecule of water, the crystals melting at 198-199oC. It is levorotary, and on warming with alkalis gives iso-ecgonine, which is dextrorotary. It is a tertiary base, and has the properties of an acid and an alcohol. It is the carboxylic acid corresponding to tropine, for it yields the same products on oxidation, and by treatment with phosphorus pentachloride is converted into anhydroecgonine, C9H13NO2, which, when heated to 280oC with hydrochloric acid, eliminates carbon dioxide and yields tropidine, C8H13N.(Wikipedia).",Ecgonine,HMDB0006548,b,b,C10858,CPD-9777,FDB023968,b,[H]O[C@@]1([H])C([H])([H])[C@@]2([H])N(C([H])([H])[H])[C@]([H])(C([H])([H])C2([H])[H])[C@@]1([H])C([O-])=O,PHMBVCPLDPDESM-FKSUSPILSA-M,"InChI=1S/C9H15NO3/c1-10-5-2-3-6(10)8(9(12)13)7(11)4-5/h5-8,11H,2-4H2,1H3,(H,12,13)/p-1/t5-,6+,7-,8+/m0/s1"
4626,13640,a,a,4746,KEGG COMPOUND accession,C08592,,,,,,,,,,,,,,,
4627,13652,a,a,4752,KEGG COMPOUND accession,C11784,,,,,,,,,,,,,,,
4628,13655,a,a,4754,KEGG COMPOUND accession,C08068,,,,,,,,,,,,,,,
4629,13657,a,a,4755,KEGG COMPOUND accession,C08069,,,,,,,,,,,,,,,
4630,13662,a,a,251408,KEGG COMPOUND accession,C06976,,,,,,,,,,,,,,,
4631,13672,a,a,15527,KEGG COMPOUND accession,C02041,arachcoa,15895-27-9,15527.0,"Human Metabolome Database (HMDB): Eicosanoyl-CoA is an intermediate metabolite in the synthesis of phosphatidic acid, a substrate of lysophosphatidic acid acyltransferase with high specificity as an acyl donor. Cells and membranes of mammalian cells synthesize their glycerophospholipids and triglycerides to maintain the cellular integrity and to provide energy for cellular functions. The phospholipids are synthesized de novo in cells through an evolutionary conserved process involving serial acylations of glycerol-3-phosphate. Several isoforms of the enzyme 1-acylglycerol-3-phosphate-O-acyltransferase (EC 2.3.1.51, AGPAT) acylate lysophosphatidic acid at the sn-2 position to produce phosphatidic acid. Bile acid-CoA:amino acid N-acyltransferase (EC 2.3.1.65, BACAT) catalyzes the conjugation of bile acids to glycine and taurine for excretion into bile and can utilize Eicosanoyl-CoA as an acyl donor as well; this may play important roles in protection against toxicity by accumulation of unconjugated bile acids and non-esterified very long-chain fatty acids. (PMID: 17535882, 12810727).",Eicosanoyl-CoA,HMDB0004258,b,b,C02041,ICOSANOYL-COA,FDB023354,arachcoa,[H]O[C@@]([H])(C(=O)N([H])C([H])([H])C([H])([H])C(=O)N([H])C([H])([H])C([H])([H])SC(=O)C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H])C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])OP([O-])(=O)OP([O-])(=O)OC([H])([H])[C@@]1([H])O[C@@]([H])(N2C([H])=NC3=C(N=C([H])N=C23)N([H])[H])[C@]([H])(O[H])[C@]1([H])OP([O-])([O-])=O,JYLSVNBJLYCSSW-IBYUJNRCSA-J,"InChI=1S/C41H74N7O17P3S/c1-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20-21-32(50)69-25-24-43-31(49)22-23-44-39(53)36(52)41(2,3)27-62-68(59,60)65-67(57,58)61-26-30-35(64-66(54,55)56)34(51)40(63-30)48-29-47-33-37(42)45-28-46-38(33)48/h28-30,34-36,40,51-52H,4-27H2,1-3H3,(H,43,49)(H,44,53)(H,57,58)(H,59,60)(H2,42,45,46)(H2,54,55,56)/p-4/t30-,34-,35-,36+,40-/m1/s1"
4632,13681,a,a,4768,KEGG COMPOUND accession,C08681,,,,,,,,,,,,,,,
4633,13696,a,a,4775,KEGG COMPOUND accession,C10788,,,,,,,,,,,,,,,
4634,13702,a,a,4778,KEGG COMPOUND accession,C10342,,,,,,,,,,,,,,,
4635,13704,a,a,4779,KEGG COMPOUND accession,C07785,,,,,,,,,,,,,,,
4636,13706,a,a,4780,KEGG COMPOUND accession,C09420,,,,,,,,,,,,,,,
4637,13708,a,a,4781,KEGG COMPOUND accession,C09421,,,,,,,,,,,,,,,
4638,13710,a,a,42223,KEGG COMPOUND accession,C10343,,,,,,,,,,,,,,,
4639,13718,a,a,4786,KEGG COMPOUND accession,C11720,,,,,,,,,,,,,,,
4640,13722,a,a,4788,KEGG COMPOUND accession,C06978,,,,,,,,,,,,,,,
4641,13728,a,a,4791,KEGG COMPOUND accession,C11090,,,,,,,,,,,,,,,
4642,13730,a,a,4792,KEGG COMPOUND accession,C07516,,,,,,,,,,,,,,,
4643,13738,a,a,157175,KEGG COMPOUND accession,C06979,,,,,,,,,,,,,,,
4644,13741,a,a,4798,KEGG COMPOUND accession,C07943,,,,,,,,,,,,,,,
4645,13743,a,a,28855,KEGG COMPOUND accession,C05821,,,,,,,,,,,,,,,
4646,13746,a,a,15407,KEGG COMPOUND accession,C01575,,,,,,,,,,,,,,,
4647,13749,a,a,541975,KEGG COMPOUND accession,C07635,,,,,,,,,,,,,,,
4648,13761,a,a,4808,KEGG COMPOUND accession,C05400,,,,,,,,,,,,,,,
4649,13767,a,a,4811,KEGG COMPOUND accession,C11229,,,,,,,,,,,,,,,
4650,13774,a,a,4814,KEGG COMPOUND accession,C07467,,,,,,,,,,,,,,,
4651,13784,a,a,4819,KEGG COMPOUND accession,C09160,,,,,,,,,,,,,,,
4652,13794,a,a,18249,KEGG COMPOUND accession,C05440,,,,,,,,,,,,,,,
4653,13804,a,a,4828,KEGG COMPOUND accession,C05570,,,,,,,,,,,,,,,
4654,13809,a,a,28709,KEGG COMPOUND accession,C09732,,,,,,,,,,,,,,,
4655,13830,a,a,17113,KEGG COMPOUND accession,C00503,,,,,,,,,,,,,,,
4656,13834,a,a,42355,KEGG COMPOUND accession,C01912,,,,,,,,,,,,,,,
4657,13836,a,a,28196,KEGG COMPOUND accession,C06653,,,,,,,,,,,,,,,
4658,13839,a,a,28239,KEGG COMPOUND accession,C06634,,,,,,,,,,,,,,,
4659,13840,a,a,4846,KEGG COMPOUND accession,C08031,,,,,,,,,,,,,,,
4660,13842,a,a,27977,KEGG COMPOUND accession,C06635,,,,,,,,,,,,,,,
4661,13845,a,a,17063,KEGG COMPOUND accession,C03394,,,,,,,,,,,,,,,
4662,13851,a,a,490095,KEGG COMPOUND accession,C09263,,,,,,,,,,,,,,,
4663,13853,a,a,4853,KEGG COMPOUND accession,C09264,,,,,,,,,,,,,,,
4664,13865,a,a,35701,KEGG COMPOUND accession,C00287,,,,,,,,,,,,,,,
4665,13873,a,a,16469,KEGG COMPOUND accession,C00951,estradiol,50-28-2,16469.0,"Human Metabolome Database (HMDB): Estradiol is the most potent form of mammalian estrogenic steroids. Estradiol is produced in the ovaries. The ovary requires both luteinizing hormone (LH) and follicle-stimulating hormone (FSH) to produce sex steroids. LH stimulates the cells surrounding the follicle to produce progesterone and androgens. The androgens diffuse across the basement membrane to the granulosa cell layer, where, under the action of FSH, they are aromatized to estrogens, mainly estradiol. The ovary shows cyclical activity, unlike the testis that is maintained in a more or less constant state of activity. Hormone secretions vary according to the phase of the menstrual cycle. In the developing follicle LH receptors (LH-R) are only located on the thecal cells and FSH receptors (FSHR) on the granulosa cells. The dominant pre-ovulatory follicle develops LH-Rs on the granulosa cells prior to the LH surge. Thecal cells of the preovulatory follicle also develop the capacity to synthesize estradiol and this persists when the thecal cells become incorporated into the corpus luteum. After ovulation, the empty follicle is remodelled and plays an important role in the second half or luteal phase of the menstrual cycle. This phase is dominated by progesterone and, to a lesser extent, estradiol secretion by the corpus luteum. estradiol is also synthesized locally from cholesterol through testosterone in the hippocampus and acts rapidly to modulate neuronal synaptic plasticity. Localization of estrogen receptor alpha (ERalpha) in spines in addition to nuclei of principal neurons implies that synaptic ERalpha is responsible for rapid modulation of synaptic plasticity by endogenous estradiol. estradiol is a potent endogenous antioxidant which suppresses hepatic fibrosis in animal models, and attenuates induction of redox sensitive transcription factors, hepatocyte apoptosis and hepatic stellate cells activation by inhibiting a generation of reactive oxygen species in primary cultures. This suggests that the greater progression of hepatic fibrosis and hepatocellular carcinoma in men and postmenopausal women may be due, at least in part, to lower production of estradiol and a reduced response to the action of estradiol. estradiol has been reported to induce the production of interferon (INF)-gamma in lymphocytes, and augments an antigen-specific primary antibody response in human peripheral blood mononuclear cells. IFN-gamma is a potent cytokine with immunomodulatory and antiproliferative properties. Therefore, female subjects, particularly before menopause, may produce antibodies against hepatitis B virus e antigen and hepatitis B virus surface antigen at a higher frequency than males with chronic hepatitis B virus infection. The estradiol-Dihydrotestosterone model of prostate cancer (PC) proposes that the first step in the development of most PC and breast cancer (BC) occurs when aromatase converts testosterone to estradiol. (PMID: 17708600, 17678531, 17644764).",Estradiol,HMDB0000151,b,b,C00951,CPD-352,FDB000362,estradiol,[H]OC1=C([H])C([H])=C2C(=C1[H])C([H])([H])C([H])([H])[C@@]1([H])[C@]3([H])C([H])([H])C([H])([H])[C@]([H])(O[H])[C@@]3(C([H])([H])[H])C([H])([H])C([H])([H])[C@]21[H],VOXZDWNPVJITMN-ZBRFXRBCSA-N,"InChI=1S/C18H24O2/c1-18-9-8-14-13-5-3-12(19)10-11(13)2-4-15(14)16(18)6-7-17(18)20/h3,5,10,14-17,19-20H,2,4,6-9H2,1H3/t14-,15-,16+,17+,18+/m1/s1"
4666,13880,a,a,36489,KEGG COMPOUND accession,C05503,estradiolglc,b,36489.0,Human Metabolome Database (HMDB): Estradiol gulcuronide is believed to play important roles in the mechanism of 17beta-estradiol(E2)-mediated tumor formation. Conjugation with glucuronic acid lowers tissue levels by facilitating excretion.The heterotropic activation by daidzein appears to be specific for the glucuronidation of E2 because daidzein did not affect the glucuronidation of the 2- and 4-hydroxy metabolites of E2. (PMID: 16598814).,17-beta-Estradiol-3-glucuronide,HMDB0006224,b,b,C05503,Beta-D-Glucuronides,FDB021792,estradiolglc,[H]OC(=O)[C@@]1([H])O[C@@]([H])(OC2=C([H])C([H])=C3C(=C2[H])C([H])([H])C([H])([H])[C@@]2([H])[C@]4([H])C([H])([H])C([H])([H])[C@]([H])(O[H])[C@@]4(C([H])([H])[H])C([H])([H])C([H])([H])[C@]32[H])[C@]([H])(O[H])[C@@]([H])(O[H])[C@]1([H])O[H],MUOHJTRCBBDUOW-QXYWQCSFSA-N,"InChI=1S/C24H32O8/c1-24-9-8-14-13-5-3-12(10-11(13)2-4-15(14)16(24)6-7-17(24)25)31-23-20(28)18(26)19(27)21(32-23)22(29)30/h3,5,10,14-21,23,25-28H,2,4,6-9H2,1H3,(H,29,30)/t14-,15-,16+,17+,18+,19+,20-,21+,23-,24+/m1/s1"
4667,13882,a,a,4866,KEGG COMPOUND accession,C08357,,,,,,,,,,,,,,,
4668,13886,a,a,4868,KEGG COMPOUND accession,C11228,,,,,,,,,,,,,,,
4669,13888,a,a,27974,KEGG COMPOUND accession,C05141,estriol,50-27-1,27974.0,"Human Metabolome Database (HMDB): Estriol is a metabolite of estrone metabolized via 16alpha-hydroxyestrone through the enzyme 16alpha-hydroxysteroid dehydrogenase (EC 1.1.1.147) or to 2- or 4-hydroxyestrone (catechol estrogens) by the action of catecho-O-methyltransferase (EC 2.1.1.6). The latter metabolites can be formed in the brain and may compete with receptors for catecholamines. Metabolites are conjugated with sulfate or glucuronide before excretion by the kidney. During pregnancy, estriol constitutes 60-70% of the total estrogens, increasing to 300-500-fold in relation to non-pregnant women. The late term human fetus produces relatively large amounts of 16 alphahydroxy DHEA, which serves the mother as a precursor of estriol. It has been shown that 90% of the precursors for the formation of estriol are of fetal origin. If abnormal maternal serum screening results, specifically low levels of unconjugated estriol in the second trimester are detected, a diagnosis of Smith-Lemli-Opitz syndrome (SLOS),or RSH is suspected. SLOS is an autosomal recessive disorder caused by mutations of the gene encoding 7-dehydrocholesterol reductase (EC 1.3.1.21, DHCR7). (PMID: 16202579, 16112271, 16097001).",Estriol,HMDB0000153,b,b,C05141,b,FDB006781,estriol,[H]OC1=C([H])C2=C(C([H])=C1[H])[C@@]1([H])C([H])([H])C([H])([H])[C@]3(C([H])([H])[H])[C@@]([H])(O[H])[C@]([H])(O[H])C([H])([H])[C@@]3([H])[C@]1([H])C([H])([H])C2([H])[H],PROQIPRRNZUXQM-ZXXIGWHRSA-N,"InChI=1S/C18H24O3/c1-18-7-6-13-12-5-3-11(19)8-10(12)2-4-14(13)15(18)9-16(20)17(18)21/h3,5,8,13-17,19-21H,2,4,6-7,9H2,1H3/t13-,14-,15+,16-,17+,18+/m1/s1"
4670,13892,a,a,17263,KEGG COMPOUND accession,C00468,estrone,53-16-7,17263.0,"Human Metabolome Database (HMDB): Estrone is a major mammalian estrogen. The conversion of the natural C19 steroids, testosterone and androstenedione into estrone is dependent on a complex key reaction catalyzed by the cytochrome P450 aromatase (EC 1.14.14.1, unspecific monooxygenase), which is expressed in many tissues of the adult human (e.g. ovary, fat tissue), but not in the liver. The ovaries after menopause continue to produce androstenedione and testosterone in significant amounts and these androgens are converted in fat, muscle, and skin into estrone. When women between the ages of 45 and 64 years have prophylactic oophorectomy (when hysterectomy is performed for benign disease to prevent the development of ovarian cancer), evidence suggests that oophorectomy increases the subsequent risk of coronary heart disease (CHD) and osteoporosis. Whereas 14,000 women die of ovarian cancer every year nearly 490,000 women die of heart disease and 48,000 women die within 1 year after hip fracture. Therefore, the decision to perform prophylactic oophorectomy should be approached with great caution for the majority of women who are at low risk of developing ovarian cancer. Steroid sulfatase (EC 3.1.6.2, STS) hydrolyzes steroid sulfates, such as estrone sulfate to estrone which can be converted to steroids with potent estrogenic properties, that is, estradiol; STS activity is much higher in breast tumors and high levels of STS mRNA expression in tumors are associated with a poor prognosis. The biological roles of estrogens in tumorigenesis are certainly different between the endometrium and breast, although both are considered ""estrogen-dependent tissues"". 17beta-hydroxysteroid dehydrogenases (EC 1.1.1.62, 17-HSDs) are enzymes involved in the formation of active sex steroids. estrone is interconverted by two enzymes 17-HSD types. Type 1 converts estrone to estradiol and Type 2 catalyzes the reverse reaction. (PMID: 17653961, 17513923, 17470679, 17464097).",Estrone,HMDB0000145,b,b,C00468,ESTRONE,FDB012798,estrone,[H]OC1=C([H])C2=C(C([H])=C1[H])[C@@]1([H])C([H])([H])C([H])([H])[C@@]3(C(=O)C([H])([H])C([H])([H])[C@@]3([H])[C@]1([H])C([H])([H])C2([H])[H])C([H])([H])[H],DNXHEGUUPJUMQT-CBZIJGRNSA-N,"InChI=1S/C18H22O2/c1-18-9-8-14-13-5-3-12(19)10-11(13)2-4-15(14)16(18)6-7-17(18)20/h3,5,10,14-16,19H,2,4,6-9H2,1H3/t14-,15-,16+,18+/m1/s1"
4671,13901,a,a,17474,KEGG COMPOUND accession,C02538,estrones,481-97-0,17474.0,Human Metabolome Database (HMDB): Estrone sulfate is a sulfated estrone derivative. Estrone sulfate acts as a long-lived reservoir that can be converted as needed to the more active estradiol (from estrone via 17 beta-hydroxysteroid dehydrogenase). Estrone Sulfate (E1S) is the most abundant circulating estrogen in non-pregnant women as well as normal men. Estrone is primarily synthesized from estrone sulfate. Estrone is an estrogenic hormone secreted by the ovaries and adipose tissues. Estrone is one of the three estrogens found in humans. The other two are estriol and estradiol. Estrone is the least prevalent of the three. Estradiol plays a critical role on reproductive and sexual functioning in women and it also affects other organs including the bones. Estriol is an estrogen that is prevalent primarily during pregnancy.,Estrone sulfate,HMDB0001425,b,b,C02538,ESTRONE-SULFATE,FDB021804,estrones,[H]C1=C([H])C2=C(C([H])=C1OS([O-])(=O)=O)C([H])([H])C([H])([H])[C@@]1([H])[C@]3([H])C([H])([H])C([H])([H])C(=O)[C@@]3(C([H])([H])[H])C([H])([H])C([H])([H])[C@]21[H],JKKFKPJIXZFSSB-CBZIJGRNSA-M,"InChI=1S/C18H22O5S/c1-18-9-8-14-13-5-3-12(23-24(20,21)22)10-11(13)2-4-15(14)16(18)6-7-17(18)19/h3,5,10,14-16H,2,4,6-9H2,1H3,(H,20,21,22)/p-1/t14-,15-,16+,18+/m1/s1"
4672,13905,a,a,28919,KEGG COMPOUND accession,C11133,estroneglc,2479-90-5,28919.0,"Human Metabolome Database (HMDB): Estrone-glucuronide is the dominant metabolite of estradiol. Estrone glucuronide is formed by a UDP glucuronyltransferase (EC 2.4.1.17, UTP) reaction creating a much more water-soluble form of the hormone; glucuronides are the most abundant estrogen conjugates. Measurement of estrone-glucuronide is used as one reference method for determining ovulation (immunotubes are available for measuring urinary estrone glucuronide in conjunction with LH, one of the most advanced of ovulation prediction products). (PMID: 14742773, 1755456).",Estrone glucuronide,HMDB0004483,b,b,C11133,ESTRONE-SULFATE,FDB021803,estroneglc,[H]OC(=O)[C@@]1([H])O[C@@]([H])(OC2=C([H])C3=C(C([H])=C2[H])[C@@]2([H])C([H])([H])C([H])([H])[C@@]4(C(=O)C([H])([H])C([H])([H])[C@@]4([H])[C@]2([H])C([H])([H])C3([H])[H])C([H])([H])[H])[C@]([H])(O[H])[C@@]([H])(O[H])[C@]1([H])O[H],FJAZVHYPASAQKM-JBAURARKSA-N,"InChI=1S/C24H30O8/c1-24-9-8-14-13-5-3-12(10-11(13)2-4-15(14)16(24)6-7-17(24)25)31-23-20(28)18(26)19(27)21(32-23)22(29)30/h3,5,10,14-16,18-21,23,26-28H,2,4,6-9H2,1H3,(H,29,30)/t14-,15-,16+,18+,19+,20-,21+,23-,24+/m1/s1"
4673,13910,a,a,4874,KEGG COMPOUND accession,C11293,,,,,,,,,,,,,,,
4674,13916,a,a,4877,KEGG COMPOUND accession,C06984,,,,,,,,,,,,,,,
4675,13920,a,a,16236,KEGG COMPOUND accession,C00469,etoh,64-17-5,16236.0,"Human Metabolome Database (HMDB): Ethanol is a clear, colorless liquid rapidly absorbed from the gastrointestinal tract and distributed throughout the body. It has bactericidal activity and is used often as a topical disinfectant. It is widely used as a solvent and preservative in pharmaceutical preparations as well as serving as the primary ingredient in alcoholic beverages. Indeed, ethanol has widespread use as a solvent of substances intended for human contact or consumption, including scents, flavorings, colorings, and medicines. Ethanol has a depressive effect on the central nervous system and because of its psychoactive effects, it is considered a drug. Ethanol has a complex mode of action and affects multiple systems in the brain, most notably it acts as an agonist to the GABA receptors. Death from ethanol consumption is possible when blood alcohol level reaches 0.4%. A blood level of 0.5% or more is commonly fatal. Levels of even less than 0.1% can cause intoxication, with unconsciousness often occurring at 0.3-0.4 %. Ethanol is metabolized by the body as an energy-providing carbohydrate nutrient, as it metabolizes into acetyl CoA, an intermediate common with glucose metabolism, that can be used for energy in the citric acid cycle or for biosynthesis. Ethanol within the human body is converted into acetaldehyde by alcohol dehydrogenase and then into acetic acid by acetaldehyde dehydrogenase. The product of the first step of this breakdown, acetaldehyde, is more toxic than ethanol. Acetaldehyde is linked to most of the clinical effects of alcohol. It has been shown to increase the risk of developing cirrhosis of the liver,[77] multiple forms of cancer, and alcoholism. Industrially, ethanol is produced both as a petrochemical, through the hydration of ethylene, and biologically, by fermenting sugars with yeast. Small amounts of ethanol are endogenously produced by gut microflora through anaerobic fermentation. However most ethanol detected in biofluids and tissues likely comes from consumption of alcoholic beverages. Absolute ethanol or anhydrous alcohol generally refers to purified ethanol, containing no more than one percent water. Absolute alcohol is not intended for human consumption. It often contains trace amounts of toxic benzene (used to remove water by azeotropic distillation). Consumption of this form of ethanol can be fatal over a short time period. Generally absolute or pure ethanol is used as a solvent for lab and industrial settings where water will disrupt a desired reaction. Pure ethanol is classed as 200 proof in the USA and Canada, equivalent to 175 degrees proof in the UK system. Ethanol is a general biomarker for the consumption of alcohol",Ethanol,HMDB0000108,b,b,C00469,ETOH,FDB000753,etoh,[H]OC([H])([H])C([H])([H])[H],LFQSCWFLJHTTHZ-UHFFFAOYSA-N,"InChI=1S/C2H6O/c1-2-3/h3H,2H2,1H3"
4676,13930,a,a,16000,KEGG COMPOUND accession,C00189,etha,141-43-5,16000.0,"Human Metabolome Database (HMDB): Ethanolamine is a viscous, hygroscopic amino alcohol with an ammoniacal odor. It is widely distributed in biological tissue and is a component of lecithin. It is used as a surfactant, fluorometric reagent, and to remove CO2 and H2S from natural gas and other gases. Ethanolamine is found to be associated with maple syrup urine disease and propionic acidemia, which are inborn errors of metabolism.",Ethanolamine,HMDB0000149,b,b,C00189,ETHANOL-AMINE,FDB000769,etha,[H]OC([H])([H])C([H])([H])[N+]([H])([H])[H],HZAXFHJVJLSVMW-UHFFFAOYSA-O,"InChI=1S/C2H7NO/c3-1-2-4/h4H,1-3H2/p+1"
4677,13949,a,a,4882,KEGG COMPOUND accession,C07833,,,,,,,,,,,,,,,
4678,13951,a,a,4883,KEGG COMPOUND accession,C11161,,,,,,,,,,,,,,,
4679,13953,a,a,4884,KEGG COMPOUND accession,C07832,,,,,,,,,,,,,,,
4680,13955,a,a,4885,KEGG COMPOUND accession,C07665,,,,,,,,,,,,,,,
4681,13957,a,a,4886,KEGG COMPOUND accession,C11227,,,,,,,,,,,,,,,
4682,13959,a,a,4887,KEGG COMPOUND accession,C07505,,,,,,,,,,,,,,,
4683,13961,a,a,4888,KEGG COMPOUND accession,C07839,,,,,,,,,,,,,,,
4684,13963,a,a,28707,KEGG COMPOUND accession,C03499,,,,,,,,,,,,,,,
4685,13964,a,a,16641,KEGG COMPOUND accession,C03864,,,,,,,,,,,,,,,
4686,13966,a,a,16036,KEGG COMPOUND accession,C03865,,,,,,,,,,,,,,,
4687,13970,a,a,4893,KEGG COMPOUND accession,C03500,,,,,,,,,,,,,,,
4688,13972,a,a,18119,KEGG COMPOUND accession,C02975,,,,,,,,,,,,,,,
4689,13978,a,a,4896,KEGG COMPOUND accession,C08486,,,,,,,,,,,,,,,
4690,13980,a,a,15862,KEGG COMPOUND accession,C00797,,,,,,,,,,,,,,,
4691,13986,a,a,16101,KEGG COMPOUND accession,C07111,,,,,,,,,,,,,,,
4692,13990,a,a,18153,KEGG COMPOUND accession,C06547,,,,,,,,,,,,,,,
4693,13994,a,a,27561,KEGG COMPOUND accession,C06548,,,,,,,,,,,,,,,
4694,14002,a,a,4903,KEGG COMPOUND accession,C07534,,,,,,,,,,,,,,,
4695,14004,a,a,4904,KEGG COMPOUND accession,C07530,,,,,,,,,,,,,,,
4696,14010,a,a,4907,KEGG COMPOUND accession,C07736,,,,,,,,,,,,,,,
4697,14012,a,a,37451,KEGG COMPOUND accession,C11136,ahandrostanglc,b,37451.0,"Human Metabolome Database (HMDB): Etiocholanolone glucuronide is a natural human metabolite of etiocholanolone generated in the liver by UDP glucuonyltransferase. Etiocholanolone (or 5-isoandrosterone) is a metabolite of testosterone. Classified a ketosteroid, it causes fever, immunostimulation and leukocytosis. Glucuronidation is used to assist in the excretion of toxic substances, drugs or other substances that cannot be used as an energy source. Glucuronic acid is attached via a glycosidic bond to the substance, and the resulting glucuronide, which has a much higher water solubility than the original substance, is eventually excreted by the kidneys.",Etiocholanolone glucuronide,HMDB0004484,b,b,C11136,Beta-D-Glucuronides,FDB023376,ahandrostanglc,[H]OC(=O)[C@@]1([H])O[C@@]([H])(O[C@]2([H])C([H])([H])C([H])([H])[C@@]3(C([H])([H])[H])[C@]([H])(C([H])([H])C([H])([H])[C@@]4([H])[C@]5([H])C([H])([H])C([H])([H])C(=O)[C@@]5(C([H])([H])[H])C([H])([H])C([H])([H])[C@]34[H])C2([H])[H])[C@]([H])(O[H])[C@@]([H])(O[H])[C@]1([H])O[H],VFUIRAVTUVCQTF-SDHZCXLISA-N,"InChI=1S/C25H38O8/c1-24-9-7-13(32-23-20(29)18(27)19(28)21(33-23)22(30)31)11-12(24)3-4-14-15-5-6-17(26)25(15,2)10-8-16(14)24/h12-16,18-21,23,27-29H,3-11H2,1-2H3,(H,30,31)/t12-,13-,14+,15+,16+,18+,19+,20-,21+,23-,24+,25+/m1/s1"
4698,14017,a,a,4910,KEGG COMPOUND accession,C07522,,,,,,,,,,,,,,,
4699,14019,a,a,4911,KEGG COMPOUND accession,C01576,,,,,,,,,,,,,,,
4700,14029,a,a,4916,KEGG COMPOUND accession,C10224,,,,,,,,,,,,,,,
4701,14031,a,a,4917,KEGG COMPOUND accession,C10453,,,,,,,,,,,,,,,
4702,14033,a,a,4918,KEGG COMPOUND accession,C10454,,,,,,,,,,,,,,,
4703,14061,a,a,4932,KEGG COMPOUND accession,C10040,,,,,,,,,,,,,,,
4704,14067,a,a,4935,KEGG COMPOUND accession,C09440,,,,,,,,,,,,,,,
4705,14079,a,a,4941,KEGG COMPOUND accession,C09091,,,,,,,,,,,,,,,
4706,14089,a,a,4946,KEGG COMPOUND accession,C10061,,,,,,,,,,,,,,,
4707,14091,a,a,4947,KEGG COMPOUND accession,C11473,,,,,,,,,,,,,,,
4708,14103,a,a,4953,KEGG COMPOUND accession,C08162,,,,,,,,,,,,,,,
4709,14108,a,a,16238,KEGG COMPOUND accession,C00016,fad,146-14-5,16238.0,"Human Metabolome Database (HMDB): FAD is a condensation product of riboflavin and adenosine diphosphate. The coenzyme of various aerobic dehydrogenases, e.g., D-amino acid oxidase and L-amino acid oxidase. (Lehninger, Principles of Biochemistry, 1982, p972).",FAD,HMDB0001248,b,b,C00016,FAD,FDB022511,fad,[H]O[C@]([H])(C([H])([H])OP([O-])(=O)OP([O-])(=O)OC([H])([H])[C@@]1([H])O[C@@]([H])(N2C([H])=NC3=C(N=C([H])N=C23)N([H])[H])[C@]([H])(O[H])[C@]1([H])O[H])[C@@]([H])(O[H])[C@@]([H])(O[H])C([H])([H])N1C2=NC(=O)N([H])C(=O)C2=NC2=C1C([H])=C(C(=C2[H])C([H])([H])[H])C([H])([H])[H],VWWQXMAJTJZDQX-UYBVJOGSSA-L,"InChI=1S/C27H33N9O15P2/c1-10-3-12-13(4-11(10)2)35(24-18(32-12)25(42)34-27(43)33-24)5-14(37)19(39)15(38)6-48-52(44,45)51-53(46,47)49-7-16-20(40)21(41)26(50-16)36-9-31-17-22(28)29-8-30-23(17)36/h3-4,8-9,14-16,19-21,26,37-41H,5-7H2,1-2H3,(H,44,45)(H,46,47)(H2,28,29,30)(H,34,42,43)/p-2/t14-,15+,16+,19-,20+,21+,26+/m0/s1"
4710,14131,a,a,17877,KEGG COMPOUND accession,C01352,fadh2,146-14-5,17877.0,"Human Metabolome Database (HMDB): FADH is the reduced form of flavin adenine dinucleotide (FAD). FAD is synthesized from riboflavin and two molecules of ATP. Riboflavin is phosphorylated by ATP to give riboflavin 5-phosphate (FMN). FAD is then formed from FMN by the transfer of an AMP moiety from a second molecule of ATP. FADH is generated in each round of fatty acid oxidation, and the fatty acyl chain is shortened by two carbon atoms as a result of these reactions; because oxidation is on the beta carbon, this series of reactions is called the beta-oxidation pathway. In the citric acid cycle FADH is involved in harvesting of high-energy electrons from carbon fuels; citric acid cycle itself neither generates a large amount of ATP nor includes oxygen as a reactant. Instead, the citric acid cycle removes electrons from acetyl CoA and uses these electrons to form FADH. (Biochemistry. Berg, Jeremy M. Tymoczko, John L. and Stryer, Lubert. New York: W. H. Freeman and Co. 2002.).",FADH,HMDB0001197,b,b,C01352,FADH2,FDB022483,fadh2,[H]O[C@]([H])(C([H])([H])OP([O-])(=O)OP([O-])(=O)OC([H])([H])[C@@]1([H])O[C@@]([H])(N2C([H])=NC3=C(N=C([H])N=C23)N([H])[H])[C@]([H])(O[H])[C@]1([H])O[H])[C@@]([H])(O[H])[C@@]([H])(O[H])C([H])([H])N1C2=C(N([H])C3=C1C([H])=C(C(=C3[H])C([H])([H])[H])C([H])([H])[H])C(=O)N([H])C(=O)N2[H],YPZRHBJKEMOYQH-UYBVJOGSSA-L,"InChI=1S/C27H35N9O15P2/c1-10-3-12-13(4-11(10)2)35(24-18(32-12)25(42)34-27(43)33-24)5-14(37)19(39)15(38)6-48-52(44,45)51-53(46,47)49-7-16-20(40)21(41)26(50-16)36-9-31-17-22(28)29-8-30-23(17)36/h3-4,8-9,14-16,19-21,26,32,37-41H,5-7H2,1-2H3,(H,44,45)(H,46,47)(H2,28,29,30)(H2,33,34,42,43)/p-2/t14-,15+,16+,19-,20+,21+,26+/m0/s1"
4711,14131,a,a,17877,KEGG COMPOUND accession,C01352,HC02114,1910-41-4,17877.0,"Human Metabolome Database (HMDB): FADH is the reduced form of flavin adenine dinucleotide (FAD). FAD is synthesized from riboflavin and two molecules of ATP. Riboflavin is phosphorylated by ATP to give riboflavin 5-phosphate (FMN). FAD is then formed from FMN by the transfer of an AMP moiety from a second molecule of ATP. FADH is generated in each round of fatty acid oxidation, and the fatty acyl chain is shortened by two carbon atoms as a result of these reactions; because oxidation is on the beta carbon, this series of reactions is called the beta-oxidation pathway. In the citric acid cycle FADH is involved in harvesting of high-energy electrons from carbon fuels; citric acid cycle itself neither generates a large amount of ATP nor includes oxygen as a reactant. Instead, the citric acid cycle removes electrons from acetyl CoA and uses these electrons to form FADH. (Biochemistry. Berg, Jeremy M. Tymoczko, John L. and Stryer, Lubert. New York: W. H. Freeman and Co. 2002.).",FADH,HMDB0001197,b,b,C01352,FADH2,FDB022483,b,[H]O[C@]([H])(C([H])([H])OP(=O)(O[H])OP(=O)(O[H])OC([H])([H])[C@@]1([H])O[C@@]([H])(N2C([H])=NC3=C2N=C([H])N=C3N([H])[H])[C@]([H])(O[H])[C@]1([H])O[H])[C@@]([H])(O[H])[C@@]([H])(O[H])C([H])([H])N1C2=C(N([H])C3=C1C([H])=C(C(=C3[H])C([H])([H])[H])C([H])([H])[H])C(=O)N([H])C(=O)N2[H],YPZRHBJKEMOYQH-UYBVJOGSSA-N,"InChI=1S/C27H35N9O15P2/c1-10-3-12-13(4-11(10)2)35(24-18(32-12)25(42)34-27(43)33-24)5-14(37)19(39)15(38)6-48-52(44,45)51-53(46,47)49-7-16-20(40)21(41)26(50-16)36-9-31-17-22(28)29-8-30-23(17)36/h3-4,8-9,14-16,19-21,26,32,37-41H,5-7H2,1-2H3,(H,44,45)(H,46,47)(H2,28,29,30)(H2,33,34,42,43)/t14-,15+,16+,19-,20+,21+,26+/m0/s1"
4712,14156,a,a,17621,KEGG COMPOUND accession,C00061,fmn,146-17-8,17621.0,"Human Metabolome Database (HMDB): Flavin mononucleotide (FMN), or riboflavin-5-phosphate, is a biomolecule produced from riboflavin (vitamin B2) by the enzyme riboflavin kinase and functions as prosthetic group of various oxidoreductases including NADH dehydrogenase as well as cofactor in biological blue-light photo receptors. During the catalytic cycle, the reversible interconversion of oxidized (FMN), semiquinone (FMNH) and reduced (FMNH2) forms occurs in the various oxidoreductases. FMN is a stronger oxidizing agent than NAD and is particularly useful because it can take part in both one- and two-electron transfers. Flavin mononucleotide is also used as an orange-red food colour additive. It is the principal form in which riboflavin is found in cells and tissues.",Flavin Mononucleotide,HMDB0001520,b,b,C00061,FMN,FDB001984,fmn,[H]O[C@]([H])(C([H])([H])OP([O-])([O-])=O)[C@@]([H])(O[H])[C@@]([H])(O[H])C([H])([H])N1C2=NC(=O)N([H])C(=O)C2=NC2=C([H])C(=C(C([H])=C12)C([H])([H])[H])C([H])([H])[H],FVTCRASFADXXNN-SCRDCRAPSA-L,"InChI=1S/C17H21N4O9P/c1-7-3-9-10(4-8(7)2)21(15-13(18-9)16(25)20-17(26)19-15)5-11(22)14(24)12(23)6-30-31(27,28)29/h3-4,11-12,14,22-24H,5-6H2,1-2H3,(H,20,25,26)(H2,27,28,29)/p-2/t11-,12+,14-/m0/s1"
4713,14198,a,a,28600,KEGG COMPOUND accession,C01493,,,,,,,,,,,,,,,
4714,14200,a,a,28562,KEGG COMPOUND accession,C02030,,,,,,,,,,,,,,,
4715,14201,a,a,17961,KEGG COMPOUND accession,C03115,,,,,,,,,,,,,,,
4716,14227,a,a,28868,KEGG COMPOUND accession,C02403,,,,,,,,,,,,,,,
4717,14230,a,a,4986,KEGG COMPOUND accession,C03395,,,,,,,,,,,,,,,
4718,14239,a,a,28163,KEGG COMPOUND accession,C06227,,,,,,,,,,,,,,,
4719,14240,a,a,28199,KEGG COMPOUND accession,C06230,,,,,,,,,,,,,,,
4720,14243,a,a,4995,KEGG COMPOUND accession,C07501,,,,,,,,,,,,,,,
4721,14249,a,a,4998,KEGG COMPOUND accession,C11226,,,,,,,,,,,,,,,
4722,14251,a,a,4999,KEGG COMPOUND accession,C09859,,,,,,,,,,,,,,,
4723,14253,a,a,5000,KEGG COMPOUND accession,C06996,,,,,,,,,,,,,,,
4724,14255,a,a,5001,KEGG COMPOUND accession,C07586,,,,,,,,,,,,,,,
4725,14270,a,a,5009,KEGG COMPOUND accession,C11078,,,,,,,,,,,,,,,
4726,14273,a,a,5011,KEGG COMPOUND accession,C11098,,,,,,,,,,,,,,,
4727,14279,a,a,5014,KEGG COMPOUND accession,C10988,,,,,,,,,,,,,,,
4728,14285,a,a,5017,KEGG COMPOUND accession,C01695,,,,,,,,,,,,,,,
4729,14289,a,a,5018,KEGG COMPOUND accession,C10419,,,,,,,,,,,,,,,
4730,14291,a,a,5019,KEGG COMPOUND accession,C06228,,,,,,,,,,,,,,,
4731,14292,a,a,5020,KEGG COMPOUND accession,C00324,,,,,,,,,,,,,,,
4732,14293,a,a,15719,KEGG COMPOUND accession,C00923,,,,,,,,,,,,,,,
4733,14296,a,a,5022,KEGG COMPOUND accession,C06260,,,,,,,,,,,,,,,
4734,14298,a,a,16078,KEGG COMPOUND accession,C05305,,,,,,,,,,,,,,,
4735,14300,a,a,16748,KEGG COMPOUND accession,C00995,,,,,,,,,,,,,,,
4736,14306,a,a,15991,KEGG COMPOUND accession,C00125,ficytC,9007-43-6,15991.0,b,Ferricytochrome C,b,b,b,C00125,b,b,ficytC,[Fe+3].[H]OC(=O)C([H])([H])C([H])([H])C1=C(/C2=C([H])/C3=N/C(=C([H])\C4=C(C(=C([N-]4)/C([H])=C4\N=C(\C(\[H])=C\1/[N-]\2)C(=C4C([H])([H])[H])C([H])([H])C([H])([H])C(=O)O[H])C([H])([H])[H])C([H])(SC([H])([H])C([H])(N([H])[H])C(=O)N([H])C([H])([H])[H])C([H])([H])[H])/C(=C3C([H])(SC([H])([H])C([H])(N([H])[H])C(=O)N([H])C([H])([H])[H])C([H])([H])[H])C([H])([H])[H])C([H])([H])[H],LJXGOQXYUKNTOR-VQGVYVAWSA-L,"InChI=1S/C42H54N8O6S2.Fe/c1-19-25(9-11-37(51)52)33-16-34-26(10-12-38(53)54)20(2)30(48-34)14-35-40(24(6)58-18-28(44)42(56)46-8)22(4)32(50-35)15-36-39(21(3)31(49-36)13-29(19)47-33)23(5)57-17-27(43)41(55)45-7;/h13-16,23-24,27-28H,9-12,17-18,43-44H2,1-8H3,(H6,45,46,47,48,49,50,51,52,53,54,55,56);/q;+3/p-2/b29-13-,30-14-,31-13-,32-15-,33-16-,34-16-,35-14-,36-15-;"
4737,14322,a,a,16951,KEGG COMPOUND accession,C01070,,,,,,,,,,,,,,,
4738,14332,a,a,5032,KEGG COMPOUND accession,C01913,,,,,,,,,,,,,,,
4739,14334,a,a,15983,KEGG COMPOUND accession,C00924,,,,,,,,,,,,,,,
4740,14337,a,a,5034,KEGG COMPOUND accession,C06259,,,,,,,,,,,,,,,
4741,14341,a,a,16762,KEGG COMPOUND accession,C00998,,,,,,,,,,,,,,,
4742,14347,a,a,16928,KEGG COMPOUND accession,C00126,focytC,9007-43-6,16928.0,b,Ferrocytochrome C,b,b,b,C00126,b,b,focytC,[Fe++].[H]OC(=O)C([H])([H])C([H])([H])C1=C(/C2=C([H])/C3=N/C(=C([H])\C4=C(C(=C([N-]4)/C([H])=C4\N=C(\C(\[H])=C\1/[N-]\2)C(=C4C([H])([H])[H])C([H])([H])C([H])([H])C(=O)O[H])C([H])([H])[H])C([H])(SC([H])([H])C([H])(N([H])[H])C(=O)N([H])C([H])([H])[H])C([H])([H])[H])/C(=C3C([H])(SC([H])([H])C([H])(N([H])[H])C(=O)N([H])C([H])([H])[H])C([H])([H])[H])C([H])([H])[H])C([H])([H])[H],WFVBWSTZNVJEAY-VQGVYVAWSA-L,"InChI=1S/C42H54N8O6S2.Fe/c1-19-25(9-11-37(51)52)33-16-34-26(10-12-38(53)54)20(2)30(48-34)14-35-40(24(6)58-18-28(44)42(56)46-8)22(4)32(50-35)15-36-39(21(3)31(49-36)13-29(19)47-33)23(5)57-17-27(43)41(55)45-7;/h13-16,23-24,27-28H,9-12,17-18,43-44H2,1-8H3,(H6,45,46,47,48,49,50,51,52,53,54,55,56);/q;+2/p-2/b29-13-,30-14-,31-13-,32-15-,33-16-,34-16-,35-14-,36-15-;"
4743,14363,a,a,15856,KEGG COMPOUND accession,C01071,,,,,,,,,,,,,,,
4744,14366,a,a,16707,KEGG COMPOUND accession,C01000,,,,,,,,,,,,,,,
4745,14369,a,a,17714,KEGG COMPOUND accession,C02684,,,,,,,,,,,,,,,
4746,14371,a,a,17373,KEGG COMPOUND accession,C02685,,,,,,,,,,,,,,,
4747,14375,a,a,78274,KEGG COMPOUND accession,C09092,,,,,,,,,,,,,,,
4748,14377,a,a,17620,KEGG COMPOUND accession,C01494,,,,,,,,,,,,,,,
4749,14384,a,a,15511,KEGG COMPOUND accession,C00406,,,,,,,,,,,,,,,
4750,14396,a,a,5050,KEGG COMPOUND accession,C06999,,,,,,,,,,,,,,,
4751,14418,a,a,5063,KEGG COMPOUND accession,C11099,,,,,,,,,,,,,,,
4752,14422,a,a,5065,KEGG COMPOUND accession,C10042,,,,,,,,,,,,,,,
4753,14432,a,a,5070,KEGG COMPOUND accession,C00766,,,,,,,,,,,,,,,
4754,14435,a,a,27590,KEGG COMPOUND accession,C04007,,,,,,,,,,,,,,,
4755,14438,a,a,30527,KEGG COMPOUND accession,C00176,,,,,,,,,,,,,,,
4756,14441,a,a,28908,KEGG COMPOUND accession,C06765,,,,,,,,,,,,,,,
4757,14445,a,a,47916,KEGG COMPOUND accession,C01579,,,,,,,,,,,,,,,
4758,14447,a,a,5078,KEGG COMPOUND accession,C01495,,,,,,,,,,,,,,,
4759,14450,a,a,28183,KEGG COMPOUND accession,C03502,,,,,,,,,,,,,,,
4760,14455,a,a,28321,KEGG COMPOUND accession,C04193,,,,,,,,,,,,,,,
4761,14456,a,a,27687,KEGG COMPOUND accession,C04068,,,,,,,,,,,,,,,
4762,14457,a,a,16658,KEGG COMPOUND accession,C04069,,,,,,,,,,,,,,,
4763,14459,a,a,17952,KEGG COMPOUND accession,C04194,,,,,,,,,,,,,,,
4764,14461,a,a,16816,KEGG COMPOUND accession,C03946,,,,,,,,,,,,,,,
4765,14466,a,a,5088,KEGG COMPOUND accession,C07809,,,,,,,,,,,,,,,
4766,14470,a,a,75984,KEGG COMPOUND accession,C07001,,,,,,,,,,,,,,,
4767,14474,a,a,5092,KEGG COMPOUND accession,C09007,,,,,,,,,,,,,,,
4768,14484,a,a,5097,KEGG COMPOUND accession,C11029,,,,,,,,,,,,,,,
4769,14486,a,a,5098,KEGG COMPOUND accession,C11748,,,,,,,,,,,,,,,
4770,14494,a,a,5102,KEGG COMPOUND accession,C08186,,,,,,,,,,,,,,,
4771,14500,a,a,5105,KEGG COMPOUND accession,C10993,,,,,,,,,,,,,,,
4772,14502,a,a,5106,KEGG COMPOUND accession,C07005,,,,,,,,,,,,,,,
4773,14504,a,a,5107,KEGG COMPOUND accession,C11369,,,,,,,,,,,,,,,
4774,14510,a,a,16904,KEGG COMPOUND accession,C06711,,,,,,,,,,,,,,,
4775,14514,a,a,17922,KEGG COMPOUND accession,C06712,,,,,,,,,,,,,,,
4776,14520,a,a,17051,KEGG COMPOUND accession,C00742,,,,,,,,,,,,,,,
4777,14523,a,a,30775,KEGG COMPOUND accession,C06108,,,,,,,,,,,,,,,
4778,14525,a,a,5115,KEGG COMPOUND accession,C11272,,,,,,,,,,,,,,,
4779,14529,a,a,28826,KEGG COMPOUND accession,C11147,,,,,,,,,,,,,,,
4780,14541,a,a,5123,KEGG COMPOUND accession,C07010,,,,,,,,,,,,,,,
4781,14543,a,a,5124,KEGG COMPOUND accession,C07956,,,,,,,,,,,,,,,
4782,14559,a,a,5132,KEGG COMPOUND accession,C07653,,,,,,,,,,,,,,,
4783,14561,a,a,5133,KEGG COMPOUND accession,C10908,,,,,,,,,,,,,,,
4784,14563,a,a,5134,KEGG COMPOUND accession,C07815,,,,,,,,,,,,,,,
4785,14565,a,a,5135,KEGG COMPOUND accession,C10989,,,,,,,,,,,,,,,
4786,14575,a,a,27470,KEGG COMPOUND accession,C00504,fol,59-30-3,27470.0,"Human Metabolome Database (HMDB): Folic acid is a member of the vitamin B family that stimulates the hematopoietic system. It is present in the liver and kidney and is found in mushrooms, spinach, yeast, green leaves, and grasses (poaceae). Folic acid, being biochemically inactive, is converted to tetrahydrofolic acid and methyltetrahydrofolate by dihydrofolate reductase. These folic acid congeners are transported across cells by receptor-mediated endocytosis where they are needed to maintain normal erythropoiesis, synthesize purine and thymidylate nucleic acids, interconvert amino acids, methylated tRNA, and generate and use formate. Folic acid is used in the treatment and prevention of folate deficiencies and megaloblastic anemia.",Folic acid,HMDB0000121,b,b,C00504,FOLATE,FDB014504,fol,[H]OC(=O)C([H])([H])C([H])([H])[C@]([H])(N([H])C(=O)C1=C([H])C([H])=C(N([H])C([H])([H])C2=NC3=C(N=C2[H])N=C(N([H])[H])N([H])C3=O)C([H])=C1[H])C([O-])=O,OVBPIULPVIDEAO-LBPRGKRZSA-M,"InChI=1S/C19H19N7O6/c20-19-25-15-14(17(30)26-19)23-11(8-22-15)7-21-10-3-1-9(2-4-10)16(29)24-12(18(31)32)5-6-13(27)28/h1-4,8,12,21H,5-7H2,(H,24,29)(H,27,28)(H,31,32)(H3,20,22,25,26,30)/p-1/t12-/m0/s1"
4787,14578,a,a,5141,KEGG COMPOUND accession,C07837,,,,,,,,,,,,,,,
4788,14613,a,a,16397,KEGG COMPOUND accession,C00488,frmd,75-12-7,16397.0,Human Metabolome Database (HMDB): Formamide is a metabolite used for biological monitoring of workers exposed to N-N-dimethylformamide (DMF).(PMID 7622279). There is a case of significant association between ever having been exposed to DMF and subsequent development of prostate cancer (PMID 2715850).,Formamide,HMDB0001536,b,b,C00488,FORMAMIDE,FDB022677,b,b,ZHNUHDYFZUAESO-UHFFFAOYSA-N,"InChI=1S/CH3NO/c2-1-3/h1H,(H2,2,3)"
4789,14660,a,a,5147,KEGG COMPOUND accession,C07805,,,,,,,,,,,,,,,
4790,14662,a,a,16729,KEGG COMPOUND accession,C02405,,,,,,,,,,,,,,,
4791,14664,a,a,28736,KEGG COMPOUND accession,C05647,f5hoxkyn,2208-41-5,28736.0,"Human Metabolome Database (HMDB): Formyl-5-hydroxykynurenamine is found in the tryptophan metabolism pathway. It is produced from serotonin through the action of indoleamine 2,3-dioxygenase [EC:1.13.11.52].",Formyl-5-hydroxykynurenamine,HMDB0012948,b,b,C05647,b,FDB029224,b,[H]OC1=C([H])C(C(=O)C([H])([H])C([H])([H])[N+]([H])([H])[H])=C(N([H])C([H])=O)C([H])=C1[H],CKAXPTWYSHDIBN-UHFFFAOYSA-O,"InChI=1S/C10H12N2O3/c11-4-3-10(15)8-5-7(14)1-2-9(8)12-6-13/h1-2,5-6,14H,3-4,11H2,(H,12,13)/p+1"
4792,14674,a,a,36575,KEGG COMPOUND accession,C05653,nformanth,3342-77-6,36575.0,"Human Metabolome Database (HMDB): Formylanthranilic acid is a polar acid metabolite of anthranilic acid, occasionally found in human urine. (PMID 7320161).",Formylanthranilic acid,HMDB0004089,b,b,C05653,b,FDB023309,nformanth,[H]N(C([H])=O)C1=C([H])C([H])=C([H])C([H])=C1C([O-])=O,LLLPDUXGHXIXIW-UHFFFAOYSA-M,"InChI=1S/C8H7NO3/c10-5-9-7-4-2-1-3-6(7)8(11)12/h1-5H,(H,9,10)(H,11,12)/p-1"
4793,14680,a,a,18377,KEGG COMPOUND accession,C02406,,,,,,,,,,,,,,,
4794,14699,a,a,5163,KEGG COMPOUND accession,C07016,,,,,,,,,,,,,,,
4795,14711,a,a,5169,KEGG COMPOUND accession,C09265,,,,,,,,,,,,,,,
4796,14713,a,a,5170,KEGG COMPOUND accession,C09266,,,,,,,,,,,,,,,
4797,14715,a,a,5171,KEGG COMPOUND accession,C08626,,,,,,,,,,,,,,,
4798,14717,a,a,28757,KEGG COMPOUND accession,C01496,,,,,,,,,,,,,,,
4799,14720,a,a,37516,KEGG COMPOUND accession,C05001,,,,,,,,,,,,,,,
4800,14729,a,a,5181,KEGG COMPOUND accession,C08253,,,,,,,,,,,,,,,
4801,14733,a,a,27865,KEGG COMPOUND accession,C08817,,,,,,,,,,,,,,,
4802,14736,a,a,5186,KEGG COMPOUND accession,C08596,,,,,,,,,,,,,,,
4803,14742,a,a,48635,KEGG COMPOUND accession,C09668,,,,,,,,,,,,,,,
4804,14744,a,a,18012,KEGG COMPOUND accession,C00122,fum,110-17-8,18012.0,"Human Metabolome Database (HMDB): Fumaric acid is a dicarboxylic acid. It is a precursor to L-malate in the Krebs tricarboxylic acid (TCA) cycle. It is formed by the oxidation of succinic acid by succinate dehydrogenase. Fumarate is converted by the enzyme fumarase to malate. Fumaric acid has recently been identified as an oncometabolite or an endogenous, cancer causing metabolite. High levels of this organic acid can be found in tumors or biofluids surrounding tumors. Its oncogenic action appears to due to its ability to inhibit prolyl hydroxylase-containing enzymes. In many tumours, oxygen availability becomes limited (hypoxia) very quickly due to rapid cell proliferation and limited blood vessel growth. The major regulator of the response to hypoxia is the HIF transcription factor (HIF-alpha). Under normal oxygen levels, protein levels of HIF-alpha are very low due to constant degradation, mediated by a series of post-translational modification events catalyzed by the prolyl hydroxylase domain-containing enzymes PHD1, 2 and 3, (also known as EglN2, 1 and 3) that hydroxylate HIF-alpha and lead to its degradation. All three of the PHD enzymes are inhibited by fumarate. Fumaric acid is found to be associated with fumarase deficiency, which is an inborn error of metabolism.",Fumaric acid,HMDB0000134,b,b,C00122,FUM,FDB003291,fum,[H]\C(=C(\[H])C([O-])=O)C([O-])=O,VZCYOOQTPOCHFL-OWOJBTEDSA-L,"InChI=1S/C4H4O4/c5-3(6)1-2-4(7)8/h1-2H,(H,5,6)(H,7,8)/p-2/b2-1+"
4805,14779,a,a,29013,KEGG COMPOUND accession,C06694,,,,,,,,,,,,,,,
4806,14780,a,a,5202,KEGG COMPOUND accession,C01378,,,,,,,,,,,,,,,
4807,14789,a,a,27938,KEGG COMPOUND accession,C06136,ga1_hs,71012-19-6,b,"Human Metabolome Database (HMDB): Ganglioside GA1 (d18:1/12:0) is a glycosphingolipid (ceramide and oligosaccharide)or oligoglycosylceramide with one or more sialic acids (i.e. n-acetylneuraminic acid) linked on the sugar chain. It is a component the cell plasma membrane which modulates cell signal transduction events. Gangliosides have been found to be highly important in immunology. Ganglioside GA1 carries a net-negative charge at pH 7.0 and is acidic. Gangliosides can amount to 6% of the weight of lipids from brain, but they are found at low levels in all animal tissues. Gangliosides are glycosphingolipids. There are four types of glycosphingolipids, the cerebrosides, sulfatides, globosides and gangliosides. Gangliosides are very similar to globosides except that they also contain N-acetyl neuraminic acid (NANA) in varying amounts. The specific names for the gangliosides provide information about their structure. The letter G refers to ganglioside, and the subscripts M, D, T and Q indicate that the molecule contains mono-, di-, tri and quatra-sialic acid. The numbered subscripts 1, 2 and 3 refer to the carbohydrate sequence that is attached to the ceramide. In particular, 1 stands for GalGalNAcGalGlc-ceramide, 2 stands for GalNAcGalGlc-ceramide and 3 stands for GalGlc-ceramide. Deficiencies in lysosomal enzymes that degrade the carbohydrate portions of various gangliosides are responsible for a number of lysosomal storage diseases such as Tay-Sachs disease, Sandhoff disease, and GM1 gangliosidosis. The carbohydrate portion of the ganglioside GM1 is the site of attachment of cholera toxin, the protein secreted by Vibrio cholerae.",Ganglioside GA1 (d18:1/12:0),HMDB0004900,b,b,C06136,b,FDB023491,ga1_hs,[H]OC([H])([H])[C@@]1([H])O[C@@]([H])(O[C@@]2([H])[C@@]([H])(O[H])[C@]([H])(O[C@@]([H])(O[C@]3([H])[C@]([H])(O[H])[C@@]([H])(O[H])[C@]([H])(O[C@@]4([H])[C@]([H])(O[H])[C@@]([H])(O[H])[C@]([H])(OC([H])([H])[C@]([H])(N([H])C([*])=O)[C@]([H])(O[H])C(\[H])=C(/[H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H])O[C@]4([H])C([H])([H])O[H])O[C@]3([H])C([H])([H])O[H])[C@]2([H])N([H])C(=O)C([H])([H])[H])C([H])([H])O[H])[C@]([H])(O[H])[C@@]([H])(O[H])[C@@]1([H])O[H],AJJQXLLQPWSINS-ULFCUAASSA-N,b
4808,14800,a,a,28175,KEGG COMPOUND accession,C06141,gd1b_hs,b,28175.0,b,Gd1B,b,b,b,C06141,b,b,gd1b_hs,[H]OC([H])([H])[C@@]([H])(O[H])[C@@]([H])(O[H])[C@]1([H])O[C@@](O[C@]([H])(C([H])([H])O[H])[C@@]([H])(O[H])[C@]2([H])O[C@@](O[C@]3([H])[C@@]([H])(O[H])[C@]([H])(O[C@@]4([H])[C@]([H])(O[H])[C@@]([H])(O[H])[C@]([H])(OC([H])([H])[C@]([H])(N([H])C([*])=O)[C@]([H])(O[H])C(\[H])=C(/[H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H])O[C@]4([H])C([H])([H])O[H])O[C@]([H])(C([H])([H])O[H])[C@]3([H])O[C@]3([H])O[C@]([H])(C([H])([H])O[H])[C@]([H])(O[H])[C@]([H])(O[C@]4([H])O[C@]([H])(C([H])([H])O[H])[C@]([H])(O[H])[C@]([H])(O[H])[C@@]4([H])O[H])[C@@]3([H])N([H])C(=O)C([H])([H])[H])(C([O-])=O)C([H])([H])[C@]([H])(O[H])[C@@]2([H])N([H])C(=O)C([H])([H])[H])(C([O-])=O)C([H])([H])[C@]([H])(O[H])[C@@]1([H])N([H])C(=O)C([H])([H])[H],b,b
4809,14805,a,a,28648,KEGG COMPOUND accession,C06134,gd2_hs,b,28648.0,b,GalNac-Beta1->4(Neuac-Alpha2->8Neuac2->3)Gal-Beta1->4Glc-Beta1->1'Cer,b,b,b,C06134,b,b,gd2_hs,[H]OC([H])([H])[C@@]([H])(O[H])[C@@]([H])(O[H])C1([H])O[C@@](O[C@]([H])(C([H])([H])O[H])[C@@]([H])(O[H])C2([H])O[C@@](O[C@]3([H])[C@@]([H])(O[H])[C@]([H])(O[C@@]4([H])[C@]([H])(O[H])[C@@]([H])(O[H])[C@]([H])(OC([H])([H])[C@]([H])(N([H])C([*])=O)[C@]([H])(O[H])C(\[H])=C(/[H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H])O[C@]4([H])C([H])([H])O[H])O[C@]([H])(C([H])([H])O[H])[C@]3([H])O[C@]3([H])O[C@]([H])(C([H])([H])O[H])[C@]([H])(O[H])[C@]([H])(O[H])[C@@]3([H])N([H])C(=O)C([H])([H])[H])(C([O-])=O)C([H])([H])[C@]([H])(O[H])[C@@]2([H])N([H])C(=O)C([H])([H])[H])(C([O-])=O)C([H])([H])[C@]([H])(O[H])[C@@]1([H])N([H])C(=O)C([H])([H])[H],b,b
4810,14812,a,a,17552,KEGG COMPOUND accession,C00035,gdp,146-91-8,17552.0,"Human Metabolome Database (HMDB): Guanosine 5'-(trihydrogen diphosphate). A guanine nucleotide containing two phosphate groups esterified to the sugar moiety. It is an ester of pyrophosphoric acid with the nucleoside guanosine. GDP consists of the pyrophosphate group, the pentose sugar ribose, and the nucleobase guanine. GDP is the product of GTP dephosphorylation by GTPases, e.g. the G-proteins that are involved in signal transduction.",Guanosine diphosphate,HMDB0001201,b,b,C00035,GDP,FDB022487,gdp,[H]O[C@@]1([H])[C@@]([H])(O[C@]([H])(C([H])([H])OP([O-])(=O)OP([O-])([O-])=O)[C@@]1([H])O[H])N1C([H])=NC2=C1N=C(N([H])[H])N([H])C2=O,QGWNDRXFNXRZMB-UUOKFMHZSA-K,"InChI=1S/C10H15N5O11P2/c11-10-13-7-4(8(18)14-10)12-2-15(7)9-6(17)5(16)3(25-9)1-24-28(22,23)26-27(19,20)21/h2-3,5-6,9,16-17H,1H2,(H,22,23)(H2,19,20,21)(H3,11,13,14,18)/p-3/t3-,5-,6-,9-/m1/s1"
4811,14862,a,a,27719,KEGG COMPOUND accession,C05344,,,,,,,,,,,,,,,
4812,14866,a,a,17661,KEGG COMPOUND accession,C03117,,,,,,,,,,,,,,,
4813,14870,a,a,27886,KEGG COMPOUND accession,C05386,,,,,,,,,,,,,,,
4814,14875,a,a,17009,KEGG COMPOUND accession,C00325,gdpfuc,15839-70-0,17009.0,"Human Metabolome Database (HMDB): GDP-L-fucose is a sugar nucleotide and a readily available source of fucose. Fucose is a deoxyhexose that is found in nearly all plant and animal species. The monosaccharide plays several important metabolic roles in complex carbohydrates and in glycoproteins. Fucosylated oligosaccharides are involved in cell-cell recognition, selectin-mediated leukocyte-endothelial adhesion, and mouse embryogenesis. They form the basis of the Lewis-type blood group antigens, are involved in the formation of atherosclerosis, and mediate host-bacterial interactions. A decrease in the availability of fucose is associated with leukocyte adhesion deficiency type-II disorder, and fucosylated glycoproteins have been implicated in memory processes. Fucose is made available during the synthesis of fucosylated glycolipids, oligosaccharides, and glycoproteins via a sugar nucleotide intermediate, specifically GDP-L-fucose. GTP-L-fucose pyrophosphorylase (GFPP, E. C. 2.7.7.30) catalyzes the reversible condensation of guanosine triphosphate and beta-L-fucose-1-phosphate to form the nucleotide-sugar GDP-L-fucose. The enzyme functions primarily in the mammalian liver and kidney to salvage free L-fucose during the breakdown of glycolipids and glycoproteins. (PMID: 16086588).",GDP-L-fucose,HMDB0001095,b,b,C00325,GUANOSINE_DIPHOSPHATE_FUCOSE,FDB021816,gdpfuc,[H]O[C@@]1([H])[C@@]([H])(O[C@]([H])(C([H])([H])OP([O-])(=O)OP([O-])(=O)OC2([H])O[C@@]([H])(C([H])([H])[H])[C@@]([H])(O[H])[C@@]([H])(O[H])[C@]2([H])O[H])[C@@]1([H])O[H])N1C([H])=NC2=C1N=C(N([H])[H])N([H])C2=O,LQEBEXMHBLQMDB-QIXZNPMTSA-L,"InChI=1S/C16H25N5O15P2/c1-4-7(22)9(24)11(26)15(33-4)35-38(30,31)36-37(28,29)32-2-5-8(23)10(25)14(34-5)21-3-18-6-12(21)19-16(17)20-13(6)27/h3-5,7-11,14-15,22-26H,2H2,1H3,(H,28,29)(H,30,31)(H3,17,19,20,27)/p-2/t4-,5+,7+,8+,9+,10+,11-,14+,15?/m0/s1"
4815,14883,a,a,18038,KEGG COMPOUND accession,C02280,,,,,,,,,,,,,,,
4816,14911,a,a,15681,KEGG COMPOUND accession,C04730,gm3_hs,54827-14-4,b,"Human Metabolome Database (HMDB): Ganglioside GM3 (d18:1/12:0) is a glycosphingolipid (ceramide and oligosaccharide)or oligoglycosylceramide with one or more sialic acids (i.e. n-acetylneuraminic acid) linked on the sugar chain. It is a component the cell plasma membrane which modulates cell signal transduction events. Gangliosides have been found to be highly important in immunology. Ganglioside GM3 carries a net-negative charge at pH 7.0 and is acidic. Gangliosides can amount to 6% of the weight of lipids from brain, but they are found at low levels in all animal tissuesGangliosides are glycosphingolipids. There are four types of glycosphingolipids, the cerebrosides, sulfatides, globosides and gangliosides. Gangliosides are very similar to globosides except that they also contain N-acetyl neuraminic acid (NANA) in varying amounts. The specific names for the gangliosides provide information about their structure. The letter G refers to ganglioside, and the subscripts M, D, T and Q indicate that the molecule contains mono-, di-, tri and quatra-sialic acid. The numbered subscripts 1, 2 and 3 refer to the carbohydrate sequence that is attached to the ceramide. In particular, 1 stands for GalGalNAcGalGlc-ceramide, 2 stands for GalNAcGalGlc-ceramide and 3 stands for GalGlc-ceramide. Deficiencies in lysosomal enzymes that degrade the carbohydrate portions of various gangliosides are responsible for a number of lysosomal storage diseases such as Tay-Sachs disease, Sandhoff disease, and GM1 gangliosidosis. The carbohydrate portion of the ganglioside GM1 is the site of attachment of cholera toxin, the protein secreted by Vibrio cholerae.",Ganglioside GM3 (d18:1/12:0),HMDB0004842,b,b,C04730,ACETYLNEURAMINYL-ETCETERA-GLUCOS,FDB023443,gm3_hs,[H]OC([H])([H])[C@@]([H])(O[H])[C@@]([H])(O[H])C1([H])O[C@@](O[C@]2([H])[C@@]([H])(O[H])[C@]([H])(O[C@@]3([H])[C@]([H])(O[H])[C@@]([H])(O[H])[C@]([H])(OC([H])([H])[C@]([H])(N([H])C([*])=O)[C@]([H])(O[H])C(\[H])=C(/[H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H])O[C@]3([H])C([H])([H])O[H])O[C@]([H])(C([H])([H])O[H])[C@]2([H])O[H])(C([O-])=O)C([H])([H])[C@]([H])(O[H])[C@@]1([H])N([H])C(=O)C([H])([H])[H],WWDJRYLWFWMNJE-MDRDOSMGSA-N,b
4817,14918,a,a,17345,KEGG COMPOUND accession,C00144,gmp,85-32-5,17345.0,Human Metabolome Database (HMDB): Guanosine 5'-monophosphate. A guanine nucleotide containing one phosphate group esterified to the sugar moiety and found widely in nature.,Guanosine monophosphate,HMDB0001397,b,b,C00144,GMP,FDB012390,gmp,[H]O[C@@]1([H])[C@@]([H])(O[C@]([H])(C([H])([H])OP([O-])([O-])=O)[C@@]1([H])O[H])N1C([H])=NC2=C1N=C(N([H])[H])N([H])C2=O,RQFCJASXJCIDSX-UUOKFMHZSA-L,"InChI=1S/C10H14N5O8P/c11-10-13-7-4(8(18)14-10)12-2-15(7)9-6(17)5(16)3(23-9)1-22-24(19,20)21/h2-3,5-6,9,16-17H,1H2,(H2,19,20,21)(H3,11,13,14,18)/p-2/t3-,5-,6-,9-/m1/s1"
4818,15003,a,a,37165,KEGG COMPOUND accession,C05796,,,,,,,,,,,,,,,
4819,15008,a,a,16813,KEGG COMPOUND accession,C01697,galt,608-66-2,16813.0,"Human Metabolome Database (HMDB): Galactitol or dulcitol is a sugar alcohol that is a metabolic breakdown product of galactose. Galactose is derived from lactose in food (such as dairy products). When lactose is broken down by the enzyme lactase it produces glucose and galactose. Galactitol has a slightly sweet taste. It is produced from galactose in a reaction catalyzed by aldose reductase. When present in sufficiently high levels, galactitol can act as a metabotoxin, a neurotoxin, and a hepatotoxin. A neurotoxin is a compound that disrupts or attacks neural cells and neural tissue. A hepatotoxin as a compound that disrupts or attacks liver tissue or liver cells. A metabotoxin is an endogenously produced metabolite that causes adverse health effects at chronically high levels. Chronically high levels of galactitol are associated with at least two inborn errors of metabolism, including galactosemia and galactosemia type II. Galactosemia is a rare genetic metabolic disorder that affects an individual's ability to metabolize the sugar galactose properly. Excess lactose consumption in individuals with galactose intolerance or galactosemia activates aldose reductase to produce galactitol, thus depleting NADPH and leading to lowered glutathione reductase activity. As a result, hydrogen peroxide or other free radicals accumulate causing serious oxidative damage to various cells and tissues. In individuals with galactosemia, the enzymes needed for the further metabolism of galactose (galactose-1-phosphate uridyltransferase) are severely diminished or missing entirely, leading to toxic levels of galactose 1-phosphate, galactitol, and galactonate. High levels of galactitol in infants are specifically associated with hepatomegaly (an enlarged liver), cirrhosis, renal failure, cataracts, vomiting, seizure, hypoglycemia, lethargy, brain damage, and ovarian failure.",Galactitol,HMDB0000107,b,b,C01697,15-DIDEOXY-15-IMINO-D-GALACTITOL,FDB006453,galt,[H]OC([H])([H])[C@]([H])(O[H])[C@@]([H])(O[H])[C@@]([H])(O[H])[C@]([H])(O[H])C([H])([H])O[H],FBPFZTCFMRRESA-GUCUJZIJSA-N,"InChI=1S/C6H14O6/c7-1-3(9)5(11)6(12)4(10)2-8/h3-12H,1-2H2/t3-,4+,5+,6-"
4820,15017,a,a,16883,KEGG COMPOUND accession,C01698,,,,,,,,,,,,,,,
4821,15021,a,a,28260,KEGG COMPOUND accession,C01582,,,,,,,,,,,,,,,
4822,15034,a,a,15754,KEGG COMPOUND accession,C05401,HC01444,b,15754.0,"Human Metabolome Database (HMDB): Galactosylglycerol is an intermediate in galactose and glycerolipid metabolism (KEGG: C05401). In galactose metabolism, galactosylglycerol is reversibly produced from D-galactose and glycerol by the enzyme alpha-galactosidase [EC:3.2.1.22]. It is also the first to last step in the synthesis of glycerol and is converted from 1,2-diacyl-3-beta-D-galactosyl-sn-glycerol. It is then converted to glycerol via the enzyme beta-galactosidase [EC:3.2.1.23].",Galactosylglycerol,HMDB0006790,b,b,C05401,b,FDB024079,HC01444,[H]OC([H])([H])[C@@]([H])(O[H])C([H])([H])O[C@]1([H])O[C@]([H])(C([H])([H])O[H])[C@]([H])(O[H])[C@]([H])(O[H])[C@@]1([H])O[H],NHJUPBDCSOGIKX-NVMJTSJSSA-N,"InChI=1S/C9H18O8/c10-1-4(12)3-16-9-8(15)7(14)6(13)5(2-11)17-9/h4-15H,1-3H2/t4-,5-,6+,7+,8-,9-/m0/s1"
4823,15039,a,a,33830,KEGG COMPOUND accession,C08348,galur,14982-50-4,47962.0,"Human Metabolome Database (HMDB): D-Galacturonic acid is a sugar acid, the oxidized form of D-galactose. It is the main component of pectin, in which it exists as the polymer polygalacturonic acid. -- Wikipedia.",D-Galacturonate,HMDB0002545,b,b,C08348,D-GALACTURONATE,FDB001161,b,b,b,b
4824,15039,a,a,33830,KEGG COMPOUND accession,C08348,pect,9000-69-5,47954.0,"Human Metabolome Database (HMDB): Pectin is a heterosaccharide derived from the cell wall of plants. Pectins vary in their chain lengths, complexity and the order of each of the monosaccharide units. The characteristic structure of pectin is a linear chain of alpha(1-4)linked D-galacturonic acid that forms the pectin-backbone, a homogalacturonan.",Pectin,HMDB0003402,b,b,C08348,PECTIN,FDB023162,pect,[H]OC(=O)[C@@]1([H])O[C@]([H])(-*)[C@]([H])(O[H])[C@@]([H])(O[H])[C@@]1([H])O-*,AEMOLEFTQBMNLQ-DTEWXJGMSA-N,b
4825,15043,a,a,5263,KEGG COMPOUND accession,C10045,,,,,,,,,,,,,,,
4826,15052,a,a,30778,KEGG COMPOUND accession,C01424,,,,,,,,,,,,,,,
4827,15069,a,a,28892,KEGG COMPOUND accession,C01808,,,,,,,,,,,,,,,
4828,15070,a,a,27587,KEGG COMPOUND accession,C09751,,,,,,,,,,,,,,,
4829,15074,a,a,5277,KEGG COMPOUND accession,C09779,,,,,,,,,,,,,,,
4830,15078,a,a,5279,KEGG COMPOUND accession,C10063,,,,,,,,,,,,,,,
4831,15080,a,a,5280,KEGG COMPOUND accession,C07661,,,,,,,,,,,,,,,
4832,15084,a,a,17037,KEGG COMPOUND accession,C02151,,,,,,,,,,,,,,,
4833,15087,a,a,5283,KEGG COMPOUND accession,C09197,,,,,,,,,,,,,,,
4834,15089,a,a,27776,KEGG COMPOUND accession,C09200,,,,,,,,,,,,,,,
4835,15097,a,a,5291,KEGG COMPOUND accession,C01498,,,,,,,,,,,,,,,
4836,15098,a,a,5292,KEGG COMPOUND accession,C11222,,,,,,,,,,,,,,,
4837,15104,a,a,175901,KEGG COMPOUND accession,C07650,,,,,,,,,,,,,,,
4838,15118,a,a,28088,KEGG COMPOUND accession,C06563,,,,,,,,,,,,,,,
4839,15122,a,a,27514,KEGG COMPOUND accession,C09126,,,,,,,,,,,,,,,
4840,15125,a,a,5304,KEGG COMPOUND accession,C10420,,,,,,,,,,,,,,,
4841,15127,a,a,75718,KEGG COMPOUND accession,C10046,,,,,,,,,,,,,,,
4842,15129,a,a,17833,KEGG COMPOUND accession,C00505,,,,,,,,,,,,,,,
4843,15132,a,a,28418,KEGG COMPOUND accession,C01917,,,,,,,,,,,,,,,
4844,15134,a,a,28417,KEGG COMPOUND accession,C01918,,,,,,,,,,,,,,,
4845,15139,a,a,27784,KEGG COMPOUND accession,C00908,,,,,,,,,,,,,,,
4846,15142,a,a,28292,KEGG COMPOUND accession,C02033,,,,,,,,,,,,,,,
4847,15164,a,a,28508,KEGG COMPOUND accession,C05585,HC01522,1194-98-5,28508.0,"Human Metabolome Database (HMDB): Gentisate aldehyde is a substrate of the enzyme aldehyde oxidase 1 [EC:1.2.3.1] in Valine, leucine and isoleucine degradation, Tyrosine metabolism, Tryptophan metabolism, Vitamin B6 metabolism and Nicotinate and nicotinamide metabolism. (KEGG).",Gentisate aldehyde,HMDB0004062,b,b,C05585,b,FDB023295,HC01522,[H]OC1=C([H])C([H])=C(O[H])C(C([H])=O)=C1[H],CLFRCXCBWIQVRN-UHFFFAOYSA-N,"InChI=1S/C7H6O3/c8-4-5-3-6(9)1-2-7(5)10/h1-4,9-10H"
4848,15167,a,a,5323,KEGG COMPOUND accession,C10065,,,,,,,,,,,,,,,
4849,15169,a,a,5324,KEGG COMPOUND accession,C10066,,,,,,,,,,,,,,,
4850,15173,a,a,5326,KEGG COMPOUND accession,C10047,,,,,,,,,,,,,,,
4851,15175,a,a,16980,KEGG COMPOUND accession,C01499,,,,,,,,,,,,,,,
4852,15180,a,a,17447,KEGG COMPOUND accession,C01500,,,,,,,,,,,,,,,
4853,15183,a,a,15523,KEGG COMPOUND accession,C01920,,,,,,,,,,,,,,,
4854,15187,a,a,17211,KEGG COMPOUND accession,C00341,grdp,763-10-0,17211.0,"Human Metabolome Database (HMDB): Geranyl diphosphate is the precursor of monoterpenes, a large family of natural occurring C10 compounds predominately found in plants and animals. Geranyl diphosphate is regarded as a key intermediate in the steroid, isoprene and terpene biosynthesis pathways and is used by organisms in the biosynthesis of farnesyl pyrophosphate, geranylgeranyl pyrophosphate, cholesterol, terpenes and terpenoids. (wikipedia). In humans, geranyl diphosphate synthase (GPPS) catalyzes the condensation of dimethylallyl diphosphate (DMAPP) and isopentenyl diphosphate (IPP) to form geranyl diphosphate. Animals produce IPP through the mevalonate (MVA) pathway. Isoprenoid compounds have been implicated in several human disease states including coronary heart disease, blindness, infectious hepatitis and cancer. Geranyl pyrophosphate is an intermediate in the HMG-CoA reductase pathway used by organisms in the biosynthesis of terpenes and terpenoids. -- Wikipedia.",Geranyl-PP,HMDB0001285,b,b,C00341,GERANYL-PP,FDB001463,grdp,[H]C(=C(C([H])([H])[H])C([H])([H])[H])C([H])([H])C([H])([H])C(=C(/[H])C([H])([H])OP([O-])(=O)OP([O-])([O-])=O)\C([H])([H])[H],GVVPGTZRZFNKDS-JXMROGBWSA-K,"InChI=1S/C10H20O7P2/c1-9(2)5-4-6-10(3)7-8-16-19(14,15)17-18(11,12)13/h5,7H,4,6,8H2,1-3H3,(H,14,15)(H2,11,12,13)/p-3/b10-7+"
4855,15202,a,a,48861,KEGG COMPOUND accession,C00353,,,,,,,,,,,,,,,
4856,15211,a,a,5337,KEGG COMPOUND accession,C09672,,,,,,,,,,,,,,,
4857,15217,a,a,28833,KEGG COMPOUND accession,C01699,,,,,,,,,,,,,,,
4858,15220,a,a,27717,KEGG COMPOUND accession,C00859,,,,,,,,,,,,,,,
4859,15223,a,a,15610,KEGG COMPOUND accession,C06093,,,,,,,,,,,,,,,
4860,15224,a,a,28731,KEGG COMPOUND accession,C02034,,,,,,,,,,,,,,,
4861,15228,a,a,27742,KEGG COMPOUND accession,C02035,,,,,,,,,,,,,,,
4862,15230,a,a,28040,KEGG COMPOUND accession,C06096,,,,,,,,,,,,,,,
4863,15233,a,a,27531,KEGG COMPOUND accession,C06095,,,,,,,,,,,,,,,
4864,15235,a,a,27433,KEGG COMPOUND accession,C06094,,,,,,,,,,,,,,,
4865,15242,a,a,5353,KEGG COMPOUND accession,C10048,,,,,,,,,,,,,,,
4866,15248,a,a,5356,KEGG COMPOUND accession,C07602,,,,,,,,,,,,,,,
4867,15254,a,a,77148,KEGG COMPOUND accession,C08944,,,,,,,,,,,,,,,
4868,15270,a,a,5368,KEGG COMPOUND accession,C09752,,,,,,,,,,,,,,,
4869,15272,a,a,5369,KEGG COMPOUND accession,C10421,,,,,,,,,,,,,,,
4870,15276,a,a,5371,KEGG COMPOUND accession,C08763,,,,,,,,,,,,,,,
4871,15280,a,a,5373,KEGG COMPOUND accession,C09446,,,,,,,,,,,,,,,
4872,15294,a,a,5380,KEGG COMPOUND accession,C10049,,,,,,,,,,,,,,,
4873,15296,a,a,5381,KEGG COMPOUND accession,C09753,,,,,,,,,,,,,,,
4874,15300,a,a,5383,KEGG COMPOUND accession,C07669,,,,,,,,,,,,,,,
4875,15306,a,a,5386,KEGG COMPOUND accession,C06258,M01957,b,5386.0,b,Globin,b,b,b,C06258,b,b,b,b,b,b
4876,15310,a,a,18259,KEGG COMPOUND accession,C03272,gbside_hs,11034-93-8,b,"Human Metabolome Database (HMDB): Tetrahexosylceramide (d18:1/12:0) is a glycosphingolipid (ceramide and oligosaccharide)or oligoglycosylceramide with one or more sialic acids (i.e. n-acetylneuraminic acid) linked on the sugar chain. Tetrahexosylceramide contains a tetrasaccharide moiety bound in glycosidic linkage to the hydroxyl group of ceramide as the polar head group. It is a component the cell plasma membrane which modulates cell signal transduction events. Gangliosides have been found to be highly important in immunology. Ganglioside Gb4 carries a net-negative charge at pH 7.0 and is acidic. Gangliosides can amount to 6% of the weight of lipids from brain, but they are found at low levels in all animal tissues.Globosides are glycosphingolipids. There are four types of glycosphingolipids, the cerebrosides, sulfatides, globosides and gangliosides. Globosides are cerebrosides that contain additional carbohydrates, predominantly galactose, glucose or GalNAc. Lactosyl ceramide is a globoside found in erythrocyte plasma membranes. Globotriaosylceramide (also called ceramide trihexoside) contains glucose and two moles of galactose and accumulates, primarily in the kidneys, of patients suffering from Fabry disease.",Tetrahexosylceramide (d18:1/12:0),HMDB0004958,b,b,C03272,N-ACETYL-D-GALACTOSAMINYL-13-D-GALACT,FDB023545,gbside_hs,[H]OC([H])([H])[C@@]1([H])O[C@@]([H])(O[C@]2([H])[C@@]([H])(O[H])[C@@]([H])(O[C@]3([H])[C@]([H])(O[H])[C@@]([H])(O[H])[C@]([H])(O[C@@]4([H])[C@]([H])(O[H])[C@@]([H])(O[H])[C@]([H])(OC([H])([H])[C@]([H])(N([H])C([*])=O)[C@]([H])(O[H])C(\[H])=C(/[H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H])O[C@]4([H])C([H])([H])O[H])O[C@]3([H])C([H])([H])O[H])O[C@]([H])(C([H])([H])O[H])[C@]2([H])O[H])[C@]([H])(N([H])C(=O)C([H])([H])[H])[C@@]([H])(O[H])[C@@]1([H])O[H],MJVVJMMBLSKMDU-QVQHRZDJSA-N,b
4877,15320,a,a,5391,KEGG COMPOUND accession,C01501,,,,,,,,,,,,,,,
4878,15322,a,a,37163,KEGG COMPOUND accession,C01379,,,,,,,,,,,,,,,
4879,15323,a,a,17301,KEGG COMPOUND accession,C00767,,,,,,,,,,,,,,,
4880,15329,a,a,5395,KEGG COMPOUND accession,C08400,,,,,,,,,,,,,,,
4881,18434,a,a,6006,KEGG COMPOUND accession,C10079,,,,,,,,,,,,,,,
4882,18440,a,a,6009,KEGG COMPOUND accession,C11002,,,,,,,,,,,,,,,
4883,18442,a,a,27794,KEGG COMPOUND accession,C10470,,,,,,,,,,,,,,,
4884,18447,a,a,18220,KEGG COMPOUND accession,C00799,,,,,,,,,,,,,,,
4885,18449,a,a,18174,KEGG COMPOUND accession,C04074,,,,,,,,,,,,,,,
4886,18452,a,a,28604,KEGG COMPOUND accession,C08821,,,,,,,,,,,,,,,
4887,18454,a,a,6017,KEGG COMPOUND accession,C10070,,,,,,,,,,,,,,,
4888,18456,a,a,28791,KEGG COMPOUND accession,C05574,,,,,,,,,,,,,,,
4889,18461,a,a,310312,KEGG COMPOUND accession,C08650,,,,,,,,,,,,,,,
4890,18468,a,a,28189,KEGG COMPOUND accession,C00252,isomal,499-40-1,28189.0,"Human Metabolome Database (HMDB): Isomaltose is a naturally occurring disaccharide composed of two glucose units in an alpha (1-6) glycosidic linkage. -- Pubchem. A deficiency of sucrase-isomaltase, an integral protein of the small intestine brush-border membrane responsible for catalyzing the hydrolysis of dietary sucrose and some of the products of starch digestion, results in osmotic diarrhea when the disaccharide is ingested, because absorption cannot occur until after hydrolysis produces the component monosaccharides. (OMIM 222800,). It is particularly suitable as a non-cariogenic sucrose replacement and is favorable in products for diabetics and prediabetic dispositions. --Wikipedia.",Isomaltose,HMDB0002923,b,b,C00252,CPD-1243,FDB001220,isomal,b,DLRVVLDZNNYCBX-RTPHMHGBSA-N,"InChI=1S/C12H22O11/c13-1-3-5(14)8(17)10(19)12(23-3)21-2-4-6(15)7(16)9(18)11(20)22-4/h3-20H,1-2H2/t3-,4-,5-,6-,7+,8+,9-,10-,11?,12+/m1/s1"
4891,18477,a,a,6030,KEGG COMPOUND accession,C07054,,,,,,,,,,,,,,,
4892,18479,a,a,6031,KEGG COMPOUND accession,C02421,,,,,,,,,,,,,,,
4893,18480,a,a,6032,KEGG COMPOUND accession,C07446,,,,,,,,,,,,,,,
4894,18482,a,a,16483,KEGG COMPOUND accession,C00927,,,,,,,,,,,,,,,
4895,18485,a,a,17965,KEGG COMPOUND accession,C01821,,,,,,,,,,,,,,,
4896,18502,a,a,17293,KEGG COMPOUND accession,C02161,,,,,,,,,,,,,,,
4897,18517,a,a,15739,KEGG COMPOUND accession,C06748,,,,,,,,,,,,,,,
4898,18522,a,a,6047,KEGG COMPOUND accession,C11111,,,,,,,,,,,,,,,
4899,18524,a,a,6048,KEGG COMPOUND accession,C11112,,,,,,,,,,,,,,,
4900,18526,a,a,6049,KEGG COMPOUND accession,C11005,,,,,,,,,,,,,,,
4901,18528,a,a,17889,KEGG COMPOUND accession,C06051,,,,,,,,,,,,,,,
4902,18530,a,a,16092,KEGG COMPOUND accession,C06323,,,,,,,,,,,,,,,
4903,18539,a,a,15413,KEGG COMPOUND accession,C06561,,,,,,,,,,,,,,,
4904,18545,a,a,18200,KEGG COMPOUND accession,C10096,,,,,,,,,,,,,,,
4905,18549,a,a,6059,KEGG COMPOUND accession,C10097,,,,,,,,,,,,,,,
4906,18553,a,a,6061,KEGG COMPOUND accession,C07456,,,,,,,,,,,,,,,
4907,18563,a,a,6066,KEGG COMPOUND accession,C09550,,,,,,,,,,,,,,,
4908,18569,a,a,28484,KEGG COMPOUND accession,C08262,isoval,503-74-2,28484.0,"Human Metabolome Database (HMDB): Isovaleric acid, is a natural fatty acid found in a wide variety of plants and essential oils. Isovaleric acid is clear colorless liquid that is sparingly soluble in water, but well soluble in most common organic solvents. It has been suggested that isovaleric acid from pilot whales, a species frequently consumed in the Faroe Islands, may be the unusual dietary factor in prolonged gestation in the population of the Faroe Islands. Previous studies suggested that was due to the high intake of n-3 polyunsaturated fatty acids has been, but fatty acid data for eicosapentaenoic acid (EPA) and docosahexanoic acid (DHA) in blood lipids of Faroese and Norwegians was reviewed in terms of the type of fish eaten (mostly lean white fish with DHA much greater than EPA); the popular lean fish, thus, probably provides too little EPA to produce a marked effect on human biochemistry (PMID 2646392). Isovaleric acid is found to be associated with isovaleric acidemia, which is an inborn error of metabolism.",Isovaleric acid,HMDB0000718,b,b,C08262,b,FDB001324,b,b,GWYFCOCPABKNJV-UHFFFAOYSA-N,b
4909,18573,a,a,17379,KEGG COMPOUND accession,C04199,,,,,,,,,,,,,,,
4910,18579,a,a,30838,KEGG COMPOUND accession,C00490,itacon,97-65-4,30838.0,"Human Metabolome Database (HMDB): Itaconic acid is an intermediate in the C5-Branched dibasic acid metabolism, a substrate for the enzyme Succinate-CoA ligase (ADP-forming) (EC:6.2.1.5)(Kegg).",Itaconic acid,HMDB0002092,b,b,C00490,ITACONATE,FDB012645,itacon,[H]C([H])=C(C([O-])=O)C([H])([H])C([O-])=O,LVHBHZANLOWSRM-UHFFFAOYSA-L,"InChI=1S/C5H6O4/c1-3(5(8)9)2-4(6)7/h1-2H2,(H,6,7)(H,8,9)/p-2"
4911,18630,a,a,27493,KEGG COMPOUND accession,C09694,,,,,,,,,,,,,,,
4912,18647,a,a,6104,KEGG COMPOUND accession,C00304,,,,,,,,,,,,,,,
4913,18651,a,a,16823,KEGG COMPOUND accession,C03281,,,,,,,,,,,,,,,
4914,18653,a,a,17630,KEGG COMPOUND accession,C01822,,,,,,,,,,,,,,,
4915,18655,a,a,28098,KEGG COMPOUND accession,C00825,,,,,,,,,,,,,,,
4916,18659,a,a,6109,KEGG COMPOUND accession,C08046,,,,,,,,,,,,,,,
4917,18667,a,a,6113,KEGG COMPOUND accession,C08693,,,,,,,,,,,,,,,
4918,18682,a,a,6121,KEGG COMPOUND accession,C07525,,,,,,,,,,,,,,,
4919,18686,a,a,6123,KEGG COMPOUND accession,C07464,,,,,,,,,,,,,,,
4920,18688,a,a,24960,KEGG COMPOUND accession,C01928,,,,,,,,,,,,,,,
4921,18698,a,a,6128,KEGG COMPOUND accession,C01716,,,,,,,,,,,,,,,
4922,18700,a,a,6129,KEGG COMPOUND accession,C07062,,,,,,,,,,,,,,,
4923,18706,a,a,6133,KEGG COMPOUND accession,C09010,,,,,,,,,,,,,,,
4924,18710,a,a,16832,KEGG COMPOUND accession,C01590,,,,,,,,,,,,,,,
4925,18713,a,a,17529,KEGG COMPOUND accession,C02549,,,,,,,,,,,,,,,
4926,18722,a,a,6141,KEGG COMPOUND accession,C10365,,,,,,,,,,,,,,,
4927,18726,a,a,28521,KEGG COMPOUND accession,C09761,,,,,,,,,,,,,,,
4928,18732,a,a,6146,KEGG COMPOUND accession,C10099,,,,,,,,,,,,,,,
4929,18734,a,a,6147,KEGG COMPOUND accession,C10100,,,,,,,,,,,,,,,
4930,18736,a,a,28683,KEGG COMPOUND accession,C01718,,,,,,,,,,,,,,,
4931,18737,a,a,6149,KEGG COMPOUND accession,C07887,,,,,,,,,,,,,,,
4932,18739,a,a,28293,KEGG COMPOUND accession,C04126,,,,,,,,,,,,,,,
4933,18740,a,a,6151,KEGG COMPOUND accession,C04281,1p3h5c,22573-88-2,27391.0,"Human Metabolome Database (HMDB): Pyrroline hydroxycarboxylic acid is a metabolite identified in the urine of patients with type II hyperprolinemia. (OMIM 239510). The urinary excretion of Pyrroline hydroxycarboxylic acid increased in hyperprolinemic patients but not in healthy controls during oral loading of hydroxyproline and hydroxyproline-ornithine. (PMID: 533224). Hyperprolinemia type II (HP II) is a rare inherited metabolic disease due to the deficiency of pyroline-5-carboxylate dehydrogenase. It is generally believed to be a benign condition although some patients have neurological problems such as refractory convulsions. (PMID: 15214748). The oxidation of pyrroline-carboxylate generates glutamate and pyrroline-hydroxycarboxylate, a reaction catalyzed by hydroxyproline oxidase (PMID: 500817).",Pyrroline hydroxycarboxylic acid,HMDB0001369,b,b,C04281,PYRROLINE-HYDROXY-CARBOXYLATE,FDB022582,1p3h5c,[H]O[C@@]1([H])C([H])=N[C@]([H])(C([O-])=O)C1([H])[H],WFOFKRKDDKGRIK-IUYQGCFVSA-M,"InChI=1S/C5H7NO3/c7-3-1-4(5(8)9)6-2-3/h2-4,7H,1H2,(H,8,9)/p-1/t3-,4+/m0/s1"
4934,18746,a,a,16303,KEGG COMPOUND accession,C03401,,,,,,,,,,,,,,,
4935,18749,a,a,48950,KEGG COMPOUND accession,C03283,,,,,,,,,,,,,,,
4936,18754,a,a,16944,KEGG COMPOUND accession,C03508,2aobut,b,40673.0,Human Metabolome Database (HMDB): L-2-Amino-3-oxobutanoic acid or L-2-amino acetic acid is involved in glycine/serine metabolism and is a breakdown product from glycine. It spontaneously decomposes to aminoacetone. Delta-aminolevuliinate synthase is the enzyme that catalyzes the interconversion between glycine and L-2-amino-3-oxobutanoic acid. Glycine C-acetyltransferase is also capable of catalyzing this reaction.,L-2-Amino-3-oxobutanoic acid,HMDB0006454,b,b,C03508,AMINO-OXOBUT,FDB023915,2aobut,[H]C([H])([H])C(=O)[C@@]([H])(C([O-])=O)[N+]([H])([H])[H],SAUCHDKDCUROAO-VKHMYHEASA-N,"InChI=1S/C4H7NO3/c1-2(6)3(5)4(7)8/h3H,5H2,1H3,(H,7,8)/t3-/m0/s1"
4937,18760,a,a,15885,KEGG COMPOUND accession,C04075,,,,,,,,,,,,,,,
4938,18763,a,a,28245,KEGG COMPOUND accession,C03871,,,,,,,,,,,,,,,
4939,18767,a,a,37023,KEGG COMPOUND accession,C00956,L2aadp,542-32-5,37024.0,"Human Metabolome Database (HMDB): Aminoadipic acid (2-aminoadipate) is a metabolite in the principal biochemical pathway of lysine. It is an intermediate in the metabolism (i.e. breakdown or degradation) of lysine and saccharopine. It antagonizes neuroexcitatory activity modulated by the glutamate receptor N-methyl-D-aspartate (NMDA). Aminoadipic acid has also been shown to inhibit the production of kynurenic acid, a broad spectrum excitatory amino acid receptor antagonist, in brain tissue slices (PMID: 8566117). Recent studies have shown that aminoadipic acid is elevated in prostate biopsy tissues from prostate cancer patients (PMID: 23737455). Mutations in DHTKD1 (dehydrogenase E1 and transketolase domain-containing protein 1) have been shown to cause human 2-aminoadipic aciduria and 2-oxoadipic aciduria via impaired decarboxylation of 2-oxoadipate to glutaryl-CoA, which is the last step in the lysine degradation pathway (PMID: 23141293). Aging, diabetes, sepsis, and renal failure are known to catalyze the oxidation of lysyl residues to form 2-aminoadipic acid in human skin collagen and potentially other tissues (PMID: 18448817). Proteolytic breakdown of these tissues can lead to the release of free 2-aminoadipic acid. Studies in rats indicate that aminoadipic acid (along with the three branched-chain amino acids - leucine, valine, and isoleucine) levels are elevated in the pre-diabetic phase and so aminoadipic acid may serve as a predictive biomarker for the development of diabetes (PMID: 15389298). Long-term hyperglycemia of endothelial cells can also lead to elevated levels of aminoadipate which is thought to be a sign of lysine breakdown through oxidative stress and reactive oxygen species (ROS) (PMID: 21961526). 2-Aminoadipate is a potential small-molecule marker of oxidative stress (PMID: 21647514). Therefore, depending on the circumstances aminoadipic acid can act as an acidogen, a diabetogen, an atherogen and a metabotoxin. An acidogen is an acidic compound that induces acidosis, which has multiple adverse effects on many organ systems. A diabetogen is a compound that can lead to type 2 diabetes. An atherogen is a compound that leads to atherosclerosis and cardiovascular disease. A metabotoxin is an endogenously produced metabolite that causes adverse health effects at chronically high levels. Chronically high levels of aminoadipic acid are associated with at least two inborn errors of metabolism including, 2-aminoadipic aciduria and 2-oxoadipic aciduria. Aminoadipic acid is an organic acid and abnormally high levels of organic acids in the blood (organic acidemia), urine (organic aciduria), the brain, and other tissues lead to general metabolic acidosis. Acidosis typically occurs when arterial pH falls below 7.35. In infants with acidosis, the initial symptoms include poor feeding, vomiting, loss of appetite, weak muscle tone (hypotonia), and lack of energy (lethargy). These can progress to heart abnormalities, kidney abnormalities, liver damage, seizures, coma, and possibly death. These are also the characteristic symptoms of the untreated IEMs mentioned above. Many affected children with organic acidemias experience intellectual disability or delayed development. In adults, acidosis or acidemia is characterized by headaches, confusion, feeling tired, tremors, sleepiness, and seizures. As a diabetogen, serum aminoadipic levels appear to regulate glucose homeostasis and have been highly predictive of individuals who later develop diabetes (PMID: 24091325). In particular, aminoadipic acid lowers fasting plasma glucose levels and enhances insulin secretion from human islets. As an atherogen, aminoadipic acid has been found to be produced at high levels via protein lysine oxidation in atherosclerotic plaques (PMID: 28069522).",Aminoadipic acid,HMDB0000510,b,b,C00956,CPD-468,FDB021812,L2aadp,[H][N+]([H])([H])C([H])(C([O-])=O)C([H])([H])C([H])([H])C([H])([H])C([O-])=O,OYIFNHCXNCRBQI-BYPYZUCNSA-M,"InChI=1S/C6H11NO4/c7-4(6(10)11)2-1-3-5(8)9/h4H,1-3,7H2,(H,8,9)(H,10,11)/p-1/t4-/m0/s1"
4940,18771,a,a,17917,KEGG COMPOUND accession,C04076,,,,,,,,,,,,,,,
4941,18779,a,a,18164,KEGG COMPOUND accession,C02982,,,,,,,,,,,,,,,
4942,18780,a,a,28936,KEGG COMPOUND accession,C05973,,,,,,,,,,,,,,,
4943,18783,a,a,15334,KEGG COMPOUND accession,C02983,,,,,,,,,,,,,,,
4944,18786,a,a,18188,KEGG COMPOUND accession,C03284,3aib,4249-19-8,33094.0,"Human Metabolome Database (HMDB): Beta-Aminoisobutyric acid is a non-protein amino acid originating from the catabolism of thymine and valine. The concentration of beta-Aminoisobutyric acid is normally low in urine as beta-Aminoisobutyric acid is further catabolized by b-aminoisobutyrate aminotransferases to methylmalonic acid semialdehyde and propionyl-CoA. beta-Aminoisobutyric acid occurs in two isomeric forms and both enantiomers of beta-Aminoisobutyric acid can be detected in human urine and plasma. In plasma, the S-enantiomer is the predominant type due to active renal reabsorption. In contrast, urine almost exclusively contains the R-enantiomer of beta-Aminoisobutyric acid, which is eliminated both by filtration and tubular secretion. Persistently increased levels of beta-Aminoisobutyric acid have been observed in individuals with a deficiency of R (-) -b-aminoisobutyrate-pyruvate aminotransferase. In addition, transient high levels of beta-Aminoisobutyric acid have been observed under a variety of pathological conditions such as lead poisoning, starvation, in total body irradiation and in a number of malignancies. The S-enantiomer of beta-Aminoisobutyric acid is predominantly derived from the catabolism of valine. It has been suggested that an altered homoeostasis of b-alanine underlies some of the clinical abnormalities encountered in patients with a dihydropyrimidine dehydrogenase (DPD) deficiency. DPD constitutes the first step of the pyrimidine degradation pathway, in which the pyrimidine bases uracil and thymine are catabolized to b-alanine and the R-enantiomer of beta-Aminoisobutyric acid respectively. In normal individuals with an intact pyrimidine degradation pathway, R-methylmalonic acid semialdehyde can be synthesized directly from the catabolism of thymine. Hence, there might be less cross-over between the valine and thymine pathway, allowing the conversion of S-methylmalonic acid semialdehyde into S-beta-Aminoisobutyric acid and the subsequent accumulation of S-beta-Aminoisobutyric acid in plasma. (PMID: 14705962, 14292857, 14453202).",(S)-b-aminoisobutyric acid,HMDB0002166,b,b,C03284,b,FDB022878,3aib,[H]C([H])([H])[C@]([H])(C([O-])=O)C([H])([H])[N+]([H])([H])[H],QCHPKSFMDHPSNR-VKHMYHEASA-N,"InChI=1S/C4H9NO2/c1-3(2-5)4(6)7/h3H,2,5H2,1H3,(H,6,7)/t3-/m0/s1"
4945,18789,a,a,15512,KEGG COMPOUND accession,C05231,3abutcoa,b,15512.0,"Human Metabolome Database (HMDB): L-3-Aminobutyryl-CoA is found in the lysine fermentation to acetate and butyrate pathway. L-3-Aminobutyryl-CoA is produced from a reaction between (S)-5-amino-3-oxohexanoate and acetyl-CoA, with acetoacetate as a byproduct. L-3-aminobutyryl-CoA breaks down to form ammonia and crotonyl-CoA, a reaction catalyzed by 3-aminobutyryl-CoA ammonia-lyase.",L-3-Aminobutyryl-CoA,HMDB0012248,b,b,C05231,CPD-672,FDB028890,b,b,CCSDHAPTHIKZLY-LRJFFYKASA-N,b
4946,18791,a,a,27809,KEGG COMPOUND accession,C05938,4hglusa,b,27809.0,Human Metabolome Database (HMDB): L-4-Hydroxyglutamate semialdehyde is an intermediate in Arginine and proline metabolism. L-4-Hydroxyglutamate semialdehyde is the 4th to last step in the synthesis of Glyoxylate and is converted from L-erythro-4-Hydroxyglutamate via the enzyme 1-pyrroline-5-carboxylate dehydrogenase (EC 1.5.1.12). It is then converted to L-1-Pyrroline-3-hydroxy-5-carboxylate via enzymtic reaction.,L-4-Hydroxyglutamate semialdehyde,HMDB0006556,b,b,C05938,b,FDB023970,4hglusa,[H]O[C@@]([H])(C([H])=O)C([H])([H])[C@@]([H])(C([O-])=O)[N+]([H])([H])[H],XCXUZPXOFFRGGP-DMTCNVIQSA-N,"InChI=1S/C5H9NO4/c6-4(5(9)10)1-3(8)2-7/h2-4,8H,1,6H2,(H,9,10)/t3-,4+/m1/s1"
4947,18794,a,a,16342,KEGG COMPOUND accession,C03703,,,,,,,,,,,,,,,
4948,18796,a,a,16977,KEGG COMPOUND accession,C00041,ala_L,56-41-7,16977.0,"Human Metabolome Database (HMDB): Alanine is a nonessential amino acid made in the body from the conversion of the carbohydrate pyruvate or the breakdown of DNA and the dipeptides carnosine and anserine. It is highly concentrated in muscle and is one of the most important amino acids released by muscle, functioning as a major energy source. Plasma alanine is often decreased when the BCAA (Branched Chain Amino Acids) are deficient. This finding may relate to muscle metabolism. Alanine is highly concentrated in meat products and other high-protein foods like wheat germ and cottage cheese. Alanine is an important participant as well as regulator in glucose metabolism. Alanine levels parallel blood sugar levels in both diabetes and hypoglycemia, and alanine reduces both severe hypoglycemia and the ketosis of diabetes. It is an important amino acid for lymphocyte reproduction and immunity. Alanine therapy has helped dissolve kidney stones in experimental animals. Normal alanine metabolism, like that of other amino acids, is highly dependent upon enzymes that contain vitamin B6. Alanine, like GABA, taurine and glycine, is an inhibitory neurotransmitter in the brain (http://www.dcnutrition.com/AminoAcids/). L-Alanine is found to be associated with glucagon deficiency, which is an inborn error of metabolism.",L-Alanine,HMDB0000161,b,b,C00041,L-ALPHA-ALANINE,FDB000556,ala_L,[H]C([H])([H])[C@@]([H])(C([O-])=O)[N+]([H])([H])[H],QNAYBMKLOCPYGJ-REOHCLBHSA-N,"InChI=1S/C3H7NO2/c1-2(4)3(5)6/h2H,4H2,1H3,(H,5,6)/t2-/m0/s1"
4949,18836,a,a,15705,KEGG COMPOUND accession,C00151,,,,,,,,,,,,,,,
4950,18849,a,a,28455,KEGG COMPOUND accession,C03509,,,,,,,,,,,,,,,
4951,18854,a,a,16501,KEGG COMPOUND accession,C00545,,,,,,,,,,,,,,,
4952,18862,a,a,17535,KEGG COMPOUND accession,C00259,arab_L,5328-37-0,17535.0,"Human Metabolome Database (HMDB): L-arabinose is a pentose with a sweet taste and one of the most abundant components released by complete hydrolysis of non-starch polysaccharides (NSP) of vegetable origin. However, NSPs are complicated compounds from the point of view of both physical structure and chemical composition, and they include cellulose, hemi-cellulose, pectin and oligosaccharides. It is well recognized that NSPs are resistant to the digestive enzymes and pass to the hind-gut where microbial degradation takes place. When L-arabinose is ingested in a digestible form, it is absorbed from the intestinal tract but at a lower rate than glucose. A portion of the ingested L-arabinose is excreted in the urine. Although widely present in nature, L-arabinose is rarely used, and its physiological effects in vivo have received little attention. L-arabinose selectively inhibits intestinal sucrase activity in a noncompetitive manner and suppresses the plasma glucose increase due to sucrose ingestion. Because the intestinal absorption of sucrose is inhibited in the presence of L-arabinose, the absorption of sucrose should be reduced by arabinose ingestion. Most of the studies reported so far on the absorption and utilization of L-arabinose relate to omnivore animal species other than humans. In a rare case of two autistic brothers that were not associated with any known metabolic disease, it was found that the median value for their urine samples was 179 umol/mmol creatinine of L-arabinose, nearly six times greater than normal children (PMID: 11238761, 8931641, 1390604, 7628083). Moreover, L-arabinose is found to be associated with ribose-5-phosphate isomerase deficiency, which is an inborn error of metabolism.",L-Arabinose,HMDB0000646,b,b,C00259,b,FDB012306,arab_L,[H]OC1([H])OC([H])([H])[C@]([H])(O[H])[C@]([H])(O[H])[C@@]1([H])O[H],SRBFZHDQGSBBOR-HWQSCIPKSA-N,"InChI=1S/C5H10O5/c6-2-1-10-5(9)4(8)3(2)7/h2-9H,1H2/t2-,3-,4+,5?/m0/s1"
4953,18870,a,a,6182,KEGG COMPOUND accession,C11476,,,,,,,,,,,,,,,
4954,18875,a,a,18403,KEGG COMPOUND accession,C00532,abt,7643-75-6,18403.0,"Human Metabolome Database (HMDB): L-arabitol has been reported in pentosuric acidemia (PMID 13525419). L-arabinosinuia has been described in a patient, presented at the age of 16 months with delayed motor development and facial dysmorphism (PMID 12359133). Congenital liver cirrhosis has been recently described in a patient with highly elevated plasma and urine levels of arabitol due to transaldolase deficiency (Inherit Metab Dis 23(Suppl. 1):172, 2000.). Moreover, L-arabitol is found to be associated with ribose-5-phosphate isomerase deficiency, which is an inborn error of metabolism.",L-Arabitol,HMDB0001851,b,b,C00532,L-ARABITOL,FDB022709,abt,[H]OC([H])([H])[C@]([H])(O[H])C([H])(O[H])[C@@]([H])(O[H])C([H])([H])O[H],HEBKCHPVOIAQTA-IMJSIDKUSA-N,"InChI=1S/C5H12O5/c6-1-3(8)5(10)4(9)2-7/h3-10H,1-2H2/t3-,4-/m0/s1"
4955,18880,a,a,16467,KEGG COMPOUND accession,C00062,arg_L,74-79-3,16467.0,"Human Metabolome Database (HMDB): Arginine is an essential amino acid that is physiologically active in the L-form. In mammals, arginine is formally classified as a semiessential or conditionally essential amino acid, depending on the developmental stage and health status of the individual. Infants are unable to effectively synthesize arginine, making it nutritionally essential for infants. Adults, however, are able to synthesize arginine in the urea cycle. Arginine can be considered to be a basic amino acid as the part of the side chain nearest to the backbone is long, carbon-containing and hydrophobic, whereas the end of the side chain is a complex guanidinium group. With a pKa of 12.48, the guanidinium group is positively charged in neutral, acidic and even most basic environments. Because of the conjugation between the double bond and the nitrogen lone pairs, the positive charge is delocalized. This group is able to form multiple H-bonds. L-arginine is an amino acid that has numerous functions in the body. It helps dispose of ammonia, is used to make compounds such as nitric oxide, creatine, L-glutamate, L-proline, and it can be converted to glucose and glycogen if needed. In large doses, L-arginine also stimulates the release of hormones, growth hormone and prolactin. Arginine is a known inducer of MTOR (mammalian target of rapamycin) and is responsible for inducing protein synthesis through the MTOR pathway. MTOR inhibition by rapamycin partially reduces arginine-induced protein synthesis (PMID: 20841502). Catabolic disease states such as sepsis, injury, and cancer cause an increase in arginine utilization, which can exceed normal body production, leading to arginine depletion. Arginine also activates AMP kinase (AMPK) which then stimulates skeletal muscle fatty acid oxidation and muscle glucose uptake, thereby increasing insulin secretion by pancreatic beta-cells (PMID: 21311355). Moreover, L-arginine is found to be associated with argininemia, cystinuria, hyperdibasic aminoaciduria I, maple syrup urine disease, propionic acidemia, and tyrosinemia I, which are inborn errors of metabolism. Arginine is found in plant and animal proteins, such as dairy products, meat, poultry, fish, and nuts. The ratio of L-arginine to lysine is also important - soy and other plant proteins have more L-arginine than animal sources of protein.",L-Arginine,HMDB0000517,b,b,C00062,ARG,FDB002257,arg_L,[H]N([H])C(N([H])C([H])([H])C([H])([H])C([H])([H])[C@@]([H])(C([O-])=O)[N+]([H])([H])[H])=[N+]([H])[H],ODKSFYDXXFIFQN-BYPYZUCNSA-O,"InChI=1S/C6H14N4O2/c7-4(5(11)12)2-1-3-10-6(8)9/h4H,1-3,7H2,(H,11,12)(H4,8,9,10)/p+1/t4-/m0/s1"
4956,18900,a,a,27621,KEGG COMPOUND accession,C02424,,,,,,,,,,,,,,,
4957,18901,a,a,18412,KEGG COMPOUND accession,C05945,,,,,,,,,,,,,,,
4958,18906,a,a,18366,KEGG COMPOUND accession,C02163,M02340,b,18366.0,b,L-Arginyl-tRNA(Arg),b,b,b,C02163,b,b,b,[H]OC([H])([H])[C@@]1([H])O[C@@]([H])([*])[C@]([H])(O[H])[C@]1([H])OP(=O)(O[H])OC([H])([H])[C@@]1([H])O[C@@]([H])([*])[C@]([H])(O[H])[C@]1([H])OP(=O)(O[H])OC([H])([H])[C@@]1([H])O[C@@]([H])(N2C([H])=NC3=C(N=C([H])N=C23)N([H])[H])[C@]([H])(OC(=O)[C@@]([H])(N([H])[H])C([H])([H])C([H])([H])C([H])([H])N([H])C(=N[H])N([H])[H])[C@]1([H])O[H],b,b
4959,18909,a,a,17530,KEGG COMPOUND accession,C00826,Largn,b,17530.0,b,L-Arogenate,b,b,b,C00826,b,b,b,b,b,"InChI=1S/C10H13NO5/c11-7(8(13)14)5-10(9(15)16)3-1-6(12)2-4-10/h1-4,6-7,12H,5,11H2,(H,13,14)(H,15,16)/t6?,7-,10?/m0/s1"
4960,18927,a,a,29265,KEGG COMPOUND accession,C03402,M02341,b,29265.0,b,L-Asparaginyl-tRNA(Asn),b,b,b,C03402,b,b,b,[H]OC([H])([H])[C@@]1([H])O[C@@]([H])([*])[C@]([H])(O[H])[C@]1([H])OP(=O)(O[H])OC([H])([H])[C@@]1([H])O[C@@]([H])([*])[C@]([H])(O[H])[C@]1([H])OP(=O)(O[H])OC([H])([H])[C@@]1([H])O[C@@]([H])([*])[C@]([H])(O[H])[C@]1([H])OC(=O)[C@@]([H])(N([H])[H])C([H])([H])C(=O)N([H])[H],b,b
4961,18929,a,a,17053,KEGG COMPOUND accession,C00049,asp_L,56-84-8,17053.0,"Human Metabolome Database (HMDB): Aspartic acid (Asp, D), also known as aspartate, the name of its anion, is one of the 20 natural proteinogenic amino acids which are the building blocks of proteins. As its name indicates, aspartic acid is the carboxylic acid analog of asparagine. As a neurotransmitter, aspartic acid may provide resistance to fatigue and thus lead to endurance, although the evidence to support this idea is not strong. (http://en.wikipedia.org/wiki/Aspartic_acid) Aspartic acid is a nonessential amino acid which is made from glutamic acid by enzymes using vitamin B6. The amino acid has important roles in the urea cycle and DNA metabolism. Aspartic acid is a major excitatory neurotransmitter, which is sometimes found to be increased in epileptic and stroke patients. It is decreased in depressed patients and in patients with brain atrophy. Aspartic acid supplements are being evaluated. Five grams can raise blood levels. Magnesium and zinc may be natural inhibitors of some of the actions of aspartic acid. Aspartic acid, with the amino acid phenylalanine, is a part of a new natural sweetener, aspartame. This sweetener is an advance in artificial sweeteners, and is probably safe in normal doses to all except phenylketonurics. The jury is still out on the long term effects it has on many brain neurohormones. Aspartic acid may be a significant immunostimulant of the thymus and can protect against some of the damaging effects of radiation. Many claims have been made for the special value of administering aspartic acid in the form of potassium and magnesium salts. Since aspartic acid is relatively nontoxic, studies are now in progress to elucidate its pharmacological and therapeutic roles. (http://www.dcnutrition.com/AminoAcids).",L-Aspartic acid,HMDB0000191,b,b,C00049,L-ASPARTATE,FDB012567,asp_L,[H][N+]([H])([H])[C@]([H])(C([O-])=O)C([H])([H])C([O-])=O,CKLJMWTZIZZHCS-REOHCLBHSA-M,"InChI=1S/C4H7NO4/c5-2(4(8)9)1-3(6)7/h2H,1,5H2,(H,6,7)(H,8,9)/p-1/t2-/m0/s1"
4962,18962,a,a,18051,KEGG COMPOUND accession,C00441,,,,,,,,,,,,,,,
4963,18967,a,a,29151,KEGG COMPOUND accession,C06113,,,,,,,,,,,,,,,
4964,18969,a,a,29158,KEGG COMPOUND accession,C02984,M02342,b,29158.0,b,L-Aspartyl-tRNA(Asp),b,b,b,C02984,b,b,b,[H]OC(=O)C([H])([H])[C@]([H])(N([H])[H])C(=O)O[C@]1([H])[C@]([H])(O[C@@]([H])([*])[C@]1([H])O[H])C([H])([H])OP(=O)(O[H])O[C@]1([H])[C@]([H])(O[C@@]([H])([*])[C@]1([H])O[H])C([H])([H])OP(=O)(O[H])O[C@]1([H])[C@]([H])(O[C@@]([H])([*])[C@]1([H])O[H])C([H])([H])O[H],b,b
4965,18973,a,a,6198,KEGG COMPOUND accession,C08267,,,,,,,,,,,,,,,
4966,18979,a,a,17159,KEGG COMPOUND accession,C02290,,,,,,,,,,,,,,,
4967,18981,a,a,16347,KEGG COMPOUND accession,C00318,crn,541-15-1,11060.0,"Human Metabolome Database (HMDB): Carnitine is not an essential amino acid; it can be synthesized in the body. However, it is so important in providing energy to muscles including the heart-that some researchers are now recommending carnitine supplements in the diet, particularly for people who do not consume much red meat, the main food source for carnitine. Carnitine has been described as a vitamin, an amino acid, or a metabimin, i.e., an essential metabolite. Like the B vitamins, carnitine contains nitrogen and is very soluble in water, and to some researchers carnitine is a vitamin (Liebovitz 1984). It was found that an animal (yellow mealworm) could not grow without carnitine in its diet. However, as it turned out, almost all other animals, including humans, do make their own carnitine; thus, it is no longer considered a vitamin. Nevertheless, in certain circumstances-such as deficiencies of methionine, lysine or vitamin C or kidney dialysis--carnitine shortages develop. Under these conditions, carnitine must be absorbed from food, and for this reason it is sometimes referred to as a ""metabimin"" or a conditionally essential metabolite. Like the other amino acids used or manufactured by the body, carnitine is an amine. But like choline, which is sometimes considered to be a B vitamin, carnitine is also an alcohol (specifically, a trimethylated carboxy-alcohol). Thus, carnitine is an unusual amino acid and has different functions than most other amino acids, which are most usually employed by the body in the construction of protein. Carnitine is an essential factor in fatty acid metabolism in mammals. It's most important known metabolic function is to transport fat into the mitochondria of muscle cells, including those in the heart, for oxidation. This is how the heart gets most of its energy. In humans, about 25% of carnitine is synthesized in the liver, kidney and brain from the amino acids lysine and methionine. Most of the carnitine in the body comes from dietary sources such as red meat and dairy products. Inborn errors of carnitine metabolism can lead to brain deterioration like that of Reye's syndrome, gradually worsening muscle weakness, Duchenne-like muscular dystrophy and extreme muscle weakness with fat accumulation in muscles. Borurn et al. (1979) describe carnitine as an essential nutrient for pre-term babies, certain types (non-ketotic) of hypoglycemics, kidney dialysis patients, cirrhosis, and in kwashiorkor, type IV hyperlipidemia, heart muscle disease (cardiomyopathy), and propionic or organic aciduria (acid urine resulting from genetic disease such as propionic acidemia or other anomalies). In all these conditions and the inborn errors of carnitine metabolism, carnitine is essential to life and carnitine supplements are valuable. carnitine therapy may also be useful in a wide variety of clinical conditions. carnitine supplementation has improved some patients who have angina secondary to coronary artery disease. It may be worth a trial in any form of hyperlipidemia or muscle weakness. carnitine supplements may be useful in many forms of toxic or metabolic liver disease and in cases of heart muscle disease. Hearts undergoing severe arrhythmia quickly deplete their stores of carnitine. Athletes, particularly in Europe, have used carnitine supplements for improved endurance. carnitine may improve muscle building by improving fat utilization and may even be useful in treating obesity. carnitine joins a long list of nutrients which may be of value in treating pregnant women, hypothyroid individuals, and male infertility due to low motility of sperm. Even the Physician's Desk Reference gives indication for carnitine supplements as ""improving the tolerance of ischemic heart disease, myocardial insufficiencies, and type IV hyperlipoproteinemia. carnitine deficiency is noted in abnormal liver function, renal dialysis patients, and severe to moderate muscular weakness with associated anorexia."" (http://www.dcnutrition.com). Carnitine is a biomarker for the consumption of meat.",L-Carnitine,HMDB0000062,b,b,C00318,CARNITINE,FDB000572,crn,[H]O[C@]([H])(C([H])([H])C([O-])=O)C([H])([H])[N+](C([H])([H])[H])(C([H])([H])[H])C([H])([H])[H],PHIQHXFUZVPYII-ZCFIWIBFSA-N,"InChI=1S/C7H15NO3/c1-8(2,3)5-6(9)4-7(10)11/h6,9H,4-5H2,1-3H3/t6-/m1/s1"
4968,18998,a,a,17482,KEGG COMPOUND accession,C02291,cyst_L,56-88-2,17482.0,"Human Metabolome Database (HMDB): Cystathionine is a dipeptide formed by serine and homocysteine. Cystathioninuria is a prominent manifestation of vitamin-B6 deficiency. The transsulfuration of methionine yields homocysteine, which combines with serine to form cystathionine, the proximate precursor of cysteine through the enzymatic activity of cystathionase. In conditions in which cystathionine gamma-synthase or cystathionase is deficient, for example, there is cystathioninuria. Although cystathionine has not been detected in normal human serum or plasma by most conventional methods, gas chromatographic/mass spectrometric methodology detected a mean concentration of cystathionine in normal human serum of 140 nM, with a range of 65 to 301 nM. Cystathionine concentrations in CSF have been 10, 1, and 0.5 uM, and ""not detected"". Only traces (i.e., <1 uM) of cystathionine are present in normal CSF.587. Gamma-cystathionase deficiency (also known as Cystathioninuria), which is an autosomal recessive disorder (NIH: 2428), provided the first instance in which, in a human, the major biochemical abnormality due to a defined enzyme defect was clearly shown to be alleviated by administration of large doses of pyridoxine. The response in gamma-cystathionase-deficient patients is not attributable to correction of a preexisting deficiency of this vitamin (OMMBID, Chap. 88).",L-Cystathionine,HMDB0000099,b,b,C02291,L-CYSTATHIONINE,FDB001976,cyst_L,[H][N+]([H])([H])[C@]([H])(C([O-])=O)C([H])([H])SC([H])([H])C([H])([H])[C@@]([H])(C([O-])=O)[N+]([H])([H])[H],ILRYLPWNYFXEMH-WHFBIAKZSA-N,"InChI=1S/C7H14N2O4S/c8-4(6(10)11)1-2-14-3-5(9)7(12)13/h4-5H,1-3,8-9H2,(H,10,11)(H,12,13)/t4-,5-/m0/s1"
4969,19011,a,a,17561,KEGG COMPOUND accession,C00097,cys_L,52-90-4,17561.0,"Human Metabolome Database (HMDB): Cysteine is a naturally occurring, sulfur-containing amino acid that is found in most proteins, although only in small quantities. Cysteine is unique amongst the twenty natural amino acids as it contains a thiol group. Thiol groups can undergo oxidation/reduction (redox) reactions; when cysteine is oxidized it can form cystine, which is two cysteine residues joined by a disulfide bond. This reaction is reversible: as reduction of this disulphide bond regenerates two cysteine molecules. The disulphide bonds of cystine are crucial to defining the structures of many proteins. Cysteine is often involved in electron-transfer reactions, and help the enzyme catalyze its reaction. Cysteine is also part of the antioxidant glutathione. N-acetyl-L-cysteine (NAC) is a form of cysteine where an acetyl group is attached to cysteine's nitrogen atom and is sold as a dietary supplement. Cysteine is named after cystine, which comes from the Greek word kustis meaning bladder - cystine was first isolated from kidney stones. As cysteine contains a sulphydryl group, it can undergo redox reactions. Oxidation of cysteine can produce a disulfide bond with another thiol, or further oxidation can produce sulphfinic or sulfonic acids. The cysteine thiol group is also a nucleophile and can undergo addition and substitution reactions. Thiol groups become much more reactive when they are ionized, and cysteine residues in proteins have pKa values close to neutrality, so are often in their reactive thiolate form in the cell. The thiol group also has a high affinity for heavy metals and proteins containing cysteine will bind metals such as mercury, lead and cadmium tightly. Due to this ability to undergo redox reactions, cysteine has antioxidant properties. Cysteine is an important source of sulfur in human metabolism, and although it is classified as a non-essential amino acid, cysteine may be essential for infants, the elderly, and individuals with certain metabolic disease or who suffer from malabsorption syndromes, Although, L-cysteine is found to be associated with sulfite oxidase deficiency, which is a genetic disorder. Cysteine may at some point be recognized as an essential or conditionally essential amino acid (http://en.wikipedia.org/wiki/Cysteine). Cysteine is important in energy metabolism. As cystine, it is a structural component of many tissues and hormones. Cysteine has clinical uses ranging from baldness to psoriasis to preventing smoker's hack. In some cases, oral cysteine therapy has proved excellent for treatment of asthmatics, enabling them to stop theophylline and other medications. Cysteine also enhances the effect of topically applied silver, tin and zinc salts in preventing dental cavities. In the future, cysteine may play a role in the treatment of cobalt toxicity, diabetes, psychosis, cancer and seizures (http://www.dcnutrition.com/AminoAcids/).",L-Cysteine,HMDB0000574,b,b,C00097,CYS,FDB012678,cys_L,[H]SC([H])([H])[C@@]([H])(C([O-])=O)[N+]([H])([H])[H],XUJNEKJLAYXESH-REOHCLBHSA-N,"InChI=1S/C3H7NO2S/c4-2(1-7)3(5)6/h2,7H,1,4H2,(H,5,6)/t2-/m0/s1"
4970,19035,a,a,29152,KEGG COMPOUND accession,C03125,M02351,b,29152.0,b,L-Cysteinyl-tRNA(Cys),b,b,b,C03125,b,b,b,[H]OC([H])([H])[C@@]1([H])O[C@@]([H])([*])[C@]([H])(O[H])[C@]1([H])OP(=O)(O[H])OC([H])([H])[C@@]1([H])O[C@@]([H])([*])[C@]([H])(O[H])[C@]1([H])OP(=O)(O[H])OC([H])([H])[C@@]1([H])O[C@@]([H])(N2C([H])=NC3=C(N=C([H])N=C23)N([H])[H])[C@]([H])(OC(=O)[C@@]([H])(N([H])[H])C([H])([H])S[H])[C@]1([H])O[H],b,b
4971,19037,a,a,16283,KEGG COMPOUND accession,C00491,Lcystin,56-89-3,16283.0,"Human Metabolome Database (HMDB): Cystine is an oxidized dimeric form of cysteine. It is formed by linking two cysteine residues via a disulfide bond (cys-S-S-cys) between the -SH groups. Cystine is found in high concentrations in the cells of the immune system, skeletal and connective tissues, skin, digestive enzymes, and in hair. Hair and skin are 10-14% cystine. Cystine is the preferred form of cysteine for the synthesis of glutathione in cells involved in the immune function including macrophages and astrocytes. Lymphocytes and neurons prefer cysteine for glutathione production. Optimizing glutathione levels in macrophages and astrocytes with cystine allows these cells to provide cysteine to lymphocytes and neurons directly upon demand (http://en.wikipedia.org/wiki/Cystine). L-cystine is found to be associated with cystinuria and hyperdibasic aminoaciduria I, which are inborn errors of metabolism.",L-Cystine,HMDB0000192,b,b,C00491,CYSTINE,FDB012563,Lcystin,[H][N+]([H])([H])[C@]([H])(C([O-])=O)C([H])([H])SSC([H])([H])[C@@]([H])(C([O-])=O)[N+]([H])([H])[H],LEVWYRKDKASIDU-IMJSIDKUSA-N,"InChI=1S/C6H12N2O4S2/c7-3(5(9)10)1-13-14-2-4(8)6(11)12/h3-4H,1-2,7-8H2,(H,9,10)(H,11,12)/t3-,4-/m0/s1"
4972,19045,a,a,27956,KEGG COMPOUND accession,C05422,,,,,,,,,,,,,,,
4973,19050,a,a,6211,KEGG COMPOUND accession,C08275,,,,,,,,,,,,,,,
4974,19057,a,a,27913,KEGG COMPOUND accession,C02045,eryth,533-50-6,27913.0,"Human Metabolome Database (HMDB): L-Erythrulose is an extremely reactive ketose, which rapidly glycates and crosslinks proteins, and therefore may mediate the(L-ascorbate) AsA-dependent modification of protein (ascorbylation) seen in vitro, and also proposed to occur in vivo in human lens during diabetic and age-onset cataract formation.(PMID: 10727845).",L-Erythrulose,HMDB0006293,b,b,C02045,ERYTHRULOSE,FDB023881,b,[H]OC([H])([H])C(=O)[C@@]([H])(O[H])C([H])([H])O[H],UQPHVQVXLPRNCX-VKHMYHEASA-N,"InChI=1S/C4H8O4/c5-1-3(7)4(8)2-6/h3,5-7H,1-2H2/t3-/m0/s1"
4975,19059,a,a,30249,KEGG COMPOUND accession,C02700,Lfmkynr,b,30249.0,Human Metabolome Database (HMDB): This compound belongs to the family of Butyrophenones. These are compounds containing 1-phenylbutan-1-one moiety.,L-Formylkynurenine,HMDB0060485,b,b,C02700,N-FORMYLKYNURENINE,b,Lfmkynr,[H]N(C([H])=O)C1=C([H])C([H])=C([H])C([H])=C1C(=O)C([H])([H])C([H])(C([O-])=O)[N+]([H])([H])[H],BYHJHXPTQMMKCA-UHFFFAOYSA-N,"InChI=1S/C11H12N2O4/c12-8(11(16)17)5-10(15)7-3-1-2-4-9(7)13-6-14/h1-4,6,8H,5,12H2,(H,13,14)(H,16,17)"
4976,19063,a,a,28120,KEGG COMPOUND accession,C01719,,,,,,,,,,,,,,,
4977,19071,a,a,17617,KEGG COMPOUND accession,C01721,HC00832,13074-08-3,17617.0,Human Metabolome Database (HMDB): This compound belongs to the family of Hexoses. These are monosaccharides in which the sugar unit is a hexose.,L-Fuculose,HMDB0060267,b,b,C01721,L-FUCULOSE,b,b,[H]OC([H])([H])C(=O)[C@]([H])(O[H])[C@]([H])(O[H])[C@@]([H])(O[H])C([H])([H])[H],QZNPNKJXABGCRC-LFRDXLMFSA-N,"InChI=1S/C6H12O5/c1-3(8)5(10)6(11)4(9)2-7/h3,5-8,10-11H,2H2,1H3/t3-,5+,6-/m0/s1"
4978,19077,a,a,17464,KEGG COMPOUND accession,C01115,,,,,,,,,,,,,,,
4979,19081,a,a,42905,KEGG COMPOUND accession,C01825,,,,,,,,,,,,,,,
4980,19085,a,a,16015,KEGG COMPOUND accession,C00025,glu_L,56-86-0,16015.0,"Human Metabolome Database (HMDB): Glutamic acid (Glu), also referred to as glutamate (the anion), is one of the 20 proteinogenic amino acids. It is not among the essential amino acids. Glutamate is a key molecule in cellular metabolism. In humans, dietary proteins are broken down by digestion into amino acids, which serves as metabolic fuel or other functional roles in the body. Glutamate is the most abundant fast excitatory neurotransmitter in the mammalian nervous system. At chemical synapses, glutamate is stored in vesicles. Nerve impulses trigger release of glutamate from the pre-synaptic cell. In the opposing post-synaptic cell, glutamate receptors, such as the NMDA receptor, bind glutamate and are activated. Because of its role in synaptic plasticity, it is believed that glutamic acid is involved in cognitive functions like learning and memory in the brain. Glutamate transporters are found in neuronal and glial membranes. They rapidly remove glutamate from the extracellular space. In brain injury or disease, they can work in reverse and excess glutamate can accumulate outside cells. This process causes calcium ions to enter cells via NMDA receptor channels, leading to neuronal damage and eventual cell death, and is called excitotoxicity. The mechanisms of cell death include: Damage to mitochondria from excessively high intracellular Ca2+. Glu/Ca2+-mediated promotion of transcription factors for pro-apoptotic genes, or downregulation of transcription factors for anti-apoptotic genes. Excitotoxicity due to glutamate occurs as part of the ischemic cascade and is associated with stroke and diseases like amyotrophic lateral sclerosis, lathyrism, and Alzheimer's disease. glutamic acid has been implicated in epileptic seizures. Microinjection of glutamic acid into neurons produces spontaneous depolarization around one second apart, and this firing pattern is similar to what is known as paroxysmal depolarizing shift in epileptic attacks. This change in the resting membrane potential at seizure foci could cause spontaneous opening of voltage activated calcium channels, leading to glutamic acid release and further depolarization (http://en.wikipedia.org/wiki/Glutamic_acid). Moreover, glutamic acid is found to be associated with N-acetylglutamate synthetase deficiency, which is an inborn error of metabolism.",L-Glutamic acid,HMDB0000148,b,b,C00025,GLT,FDB012535,glu_L,[H][N+]([H])([H])[C@]([H])(C([O-])=O)C([H])([H])C([H])([H])C([O-])=O,WHUUTDBJXJRKMK-VKHMYHEASA-M,"InChI=1S/C5H9NO4/c6-3(5(9)10)1-2-4(7)8/h3H,1-2,6H2,(H,7,8)(H,9,10)/p-1/t3-/m0/s1"
4981,19172,a,a,28575,KEGG COMPOUND accession,C05016,,,,,,,,,,,,,,,
4982,19173,a,a,18050,KEGG COMPOUND accession,C00064,gln_L,56-85-9,18050.0,"Human Metabolome Database (HMDB): Glutamine (Gln) is one of the 20 amino acids encoded by the standard genetic code. In humans it is considered a non-essential amino acid. Structurally, glutamine is similar to the amino acid glutamic acid. However, instead of having a terminal carboxylic acid, it has an amide. Enzymatically, glutamine is formed by replacing a side-chain hydroxyl of glutamic acid with an amine functional group. Glutamine is found in foods high in proteins, such as fish, red meat, beans, and dairy products. Glutamine is often used as a supplement in weightlifting, bodybuilding, endurance and other sports, as well as by those who suffer from muscular cramps or pain, particularly elderly people. The main use of glutamine within the diet of either group is as a means of replenishing the body's stores of amino acids that have been used during exercise or everyday activities. Studies which have looked into problems with excessive consumption of glutamine thus far have proved inconclusive. However, normal supplementation is healthy mainly because glutamine is supposed to be supplemented after prolonged periods of exercise (for example, a workout or exercise in which amino acids are required for use) and replenishes amino acid stores. This is one of the main reasons glutamine is recommended during fasting or for people who suffer from physical trauma, immune deficiencies, or cancer. There is a significant body of evidence that links glutamine-enriched diets with positive intestinal effects. These include maintenance of gut barrier function, aiding intestinal cell proliferation and differentiation, as well as generally reducing septic morbidity and the symptoms of Irritable Bowel Syndrome (IBS). The reason for such ""cleansing"" properties is thought to stem from the fact that the intestinal extraction rate of glutamine is higher than that for other amino acids, and is therefore thought to be the most viable option when attempting to alleviate conditions relating to the gastrointestinal tract. These conditions were discovered after comparing plasma concentration within the gut between glutamine-enriched and non glutamine-enriched diets. However, even though glutamine is thought to have ""cleansing"" properties and effects, it is unknown to what extent glutamine has clinical benefits, due to the varied concentrations of glutamine in varieties of food. It is also known that glutamine has positive effects in reducing healing time after operations. Hospital waiting times after abdominal surgery are reduced by providing parenteral nutrition regimens containing amounts of glutamine to patients. Clinical trials have revealed that patients on supplementation regimes containing glutamine have improved nitrogen balances, generation of cysteinyl-leukotrienes from polymorphonuclear neutrophil granulocytes and improved lymphocyte recovery and intestinal permeability (in postoperative patients) - in comparison to those who had no glutamine within their dietary regime; all without any side-effects (http://en.wikipedia.org/wiki/glutamine). L-Glutamine is found to be associated with carbamoyl phosphate synthetase deficiency, which is an inborn error of metabolism.",L-Glutamine,HMDB0000641,b,b,C00064,GLN,FDB012164,gln_L,[H]N([H])C(=O)C([H])([H])C([H])([H])[C@@]([H])(C([O-])=O)[N+]([H])([H])[H],ZDXPYRJPNDTMRX-VKHMYHEASA-N,"InChI=1S/C5H10N2O3/c6-3(5(9)10)1-2-4(7)8/h3H,1-2,6H2,(H2,7,8)(H,9,10)/t3-/m0/s1"
4983,19202,a,a,28296,KEGG COMPOUND accession,C05765,,,,,,,,,,,,,,,
4984,19205,a,a,17798,KEGG COMPOUND accession,C03287,glu5p,13254-53-0,17798.0,"Human Metabolome Database (HMDB): L-Glutamic acid 5-phosphate is an intermediate in the urea cycle and the metabolism of amino groups. It is a substrate of aldehyde dehydrogenase 18 family, member A1 [EC:2.7.2.11 1.2.1.41] (KEGG)In citrulline biosynthesis, it is a substrate of the enzyme glutamate-5-semialdehyde dehydrogenase [EC 1.2.1.41] and in proline synthesis it is a substrate of the enzyme Glutamate 5-kinase [EC 2.7.2.11] (BioCyc).",L-Glutamic acid 5-phosphate,HMDB0001228,b,b,C03287,L-GLUTAMATE-5-P,FDB022500,glu5p,[H][N+]([H])([H])[C@]([H])(C([O-])=O)C([H])([H])C([H])([H])C(=O)OP([O-])([O-])=O,PJRXVIJAERNUIP-VKHMYHEASA-L,"InChI=1S/C5H10NO7P/c6-3(5(8)9)1-2-4(7)13-14(10,11)12/h3H,1-2,6H2,(H,8,9)(H2,10,11,12)/p-2/t3-/m0/s1"
4985,19210,a,a,29157,KEGG COMPOUND accession,C02987,M02377,b,29157.0,b,L-Glutamyl-tRNA(Glu),b,b,b,C02987,b,b,b,[H]OC(=O)C([H])([H])C([H])([H])[C@]([H])(N([H])[H])C(=O)O[C@@]1([H])[C@@]([H])(O[C@]([H])(C([H])([H])OP(=O)(O[H])O[C@@]2([H])[C@@]([H])(O[H])[C@]([H])([*])O[C@]2([H])C([H])([H])OP(=O)(O[H])O[C@@]2([H])[C@@]([H])(O[H])[C@]([H])([*])O[C@]2([H])C([H])([H])O[H])[C@@]1([H])O[H])N1C([H])=NC2=C(N=C([H])N=C12)N([H])[H],b,b
4986,19212,a,a,27975,KEGG COMPOUND accession,C02426,,,,,,,,,,,,,,,
4987,19214,a,a,27636,KEGG COMPOUND accession,C01506,,,,,,,,,,,,,,,
4988,19216,a,a,16154,KEGG COMPOUND accession,C00800,guln,20246-53-1,16154.0,Human Metabolome Database (HMDB): Reduction product of glucuronic acid; oxidation product of l-gulose.,Gulonic acid,HMDB0003290,b,b,C00800,CPD-16836,FDB023136,guln,[H]OC([H])([H])[C@]([H])(O[H])[C@@]([H])(O[H])[C@]([H])(O[H])[C@]([H])(O[H])C([O-])=O,RGHNJXZEOKUKBD-QTBDOELSSA-M,"InChI=1S/C6H12O7/c7-1-2(8)3(9)4(10)5(11)6(12)13/h2-5,7-11H,1H2,(H,12,13)/p-1/t2-,3+,4-,5-/m0/s1"
4989,19245,a,a,16255,KEGG COMPOUND accession,C00860,,,,,,,,,,,,,,,
4990,19248,a,a,16996,KEGG COMPOUND accession,C01100,,,,,,,,,,,,,,,
4991,19272,a,a,15699,KEGG COMPOUND accession,C00263,hom_L,672-15-1,15699.0,"Human Metabolome Database (HMDB): Homoserine is a more reactive variant of the amino acid serine. In this variant, the hydroxyl side chain contains an additional CH2 group which brings the hydroxyl group closer to its own carboxyl group, allowing it to chemically react to form a five-membered ring. This occurs at the point that amino acids normally join to their neighbours in a peptide bond. Homoserine is therefore unsuitable for forming proteins and has been eliminated from the repertoire of amino acids used by living things. Homoserine is the final product on the C-terminal end of the N-terminal fragment following a cyanogen bromide cleavage. (wikipedia).",L-Homoserine,HMDB0000719,b,b,C00263,HOMO-SER,FDB000522,hom_L,[H]OC([H])([H])C([H])([H])[C@@]([H])(C([O-])=O)[N+]([H])([H])[H],UKAUYVFTDYCKQA-VKHMYHEASA-N,"InChI=1S/C4H9NO3/c5-3(1-2-6)4(7)8/h3,6H,1-2,5H2,(H,7,8)/t3-/m0/s1"
4992,19284,a,a,18202,KEGG COMPOUND accession,C01507,,,,,,,,,,,,,,,
4993,19286,a,a,17796,KEGG COMPOUND accession,C00770,,,,,,,,,,,,,,,
4994,19293,a,a,6253,KEGG COMPOUND accession,C08288,,,,,,,,,,,,,,,
4995,19295,a,a,27374,KEGG COMPOUND accession,C06151,,,,,,,,,,,,,,,
4996,19305,a,a,29160,KEGG COMPOUND accession,C03127,M02401,b,29160.0,b,L-Isoleucyl-tRNA(Ile),b,b,b,C03127,b,b,b,[H]OC([H])([H])[C@@]1([H])O[C@@]([H])([*])[C@]([H])(O[H])[C@]1([H])OP(=O)(O[H])OC([H])([H])[C@@]1([H])O[C@@]([H])([*])[C@]([H])(O[H])[C@]1([H])OP(=O)(O[H])OC([H])([H])[C@@]1([H])O[C@@]([H])(N2C([H])=NC3=C(N=C([H])N=C23)N([H])[H])[C@]([H])(OC(=O)[C@@]([H])(N([H])[H])[C@@]([H])(C([H])([H])[H])C([H])([H])C([H])([H])[H])[C@]1([H])O[H],b,b
4997,19307,a,a,6257,KEGG COMPOUND accession,C11703,,,,,,,,,,,,,,,
4998,19309,a,a,16946,KEGG COMPOUND accession,C00328,Lkynr,343-65-7,16946.0,"Human Metabolome Database (HMDB): Kynurenine is a metabolite of the amino acid tryptophan used in the production of niacin. L-Kynurenine is a central compound of the tryptophan metabolism pathway since it can change into the neuroprotective agent kynurenic acid or to the neurotoxic agent quinolinic acid. The break-up of these endogenous compounds' balance can be observable in many disorders such as stroke, epilepsy, multiple sclerosis, and amyotrophic lateral sclerosis. It can also occur in neurodegenerative disorders such as Parkinson's disease, Huntington's, and Alzheimer's disease; and in mental disorders such as schizophrenia and depression.",L-Kynurenine,HMDB0000684,b,b,C00328,L-KYNURENINE,FDB022181,Lkynr,[H]N([H])C1=C([H])C([H])=C([H])C([H])=C1C(=O)C([H])([H])[C@@]([H])(C([O-])=O)[N+]([H])([H])[H],YGPSJZOEDVAXAB-QMMMGPOBSA-N,"InChI=1S/C10H12N2O3/c11-7-4-2-1-3-6(7)9(13)5-8(12)10(14)15/h1-4,8H,5,11-12H2,(H,14,15)/t8-/m0/s1"
4999,19319,a,a,15603,KEGG COMPOUND accession,C00123,leu_L,61-90-5,15603.0,"Human Metabolome Database (HMDB): L-leucine, also known as leu or 2-amino-4-methylvaleric acid, belongs to leucine and derivatives class of compounds. Those are compounds containing leucine or a derivative thereof resulting from reaction of leucine at the amino group or the carboxy group, or from the replacement of any hydrogen of glycine by a heteroatom. L-leucine is soluble (in water) and a moderately acidic compound (based on its pKa). L-leucine can be found primarily in most biofluids, including blood, cerebrospinal fluid (CSF), feces, and sweat, as well as throughout most human tissues. Within the cell, L-leucine is primarily located in the mitochondria. It can also be found in the extracellular space. L-leucine exists in all living species, ranging from bacteria to humans. L-leucine is a non-carcinogenic (not listed by IARC) potentially toxic compound. Leucine (abbreviated as Leu or L) is an -amino acid that is used in the biosynthesis of proteins. It contains an -amino group (which is in the protonated NH3+ form under biological conditions), an -carboxylic acid group (which is in the deprotonated COO form under biological conditions), and a side chain isobutyl group, making it a non-polar aliphatic amino acid. It is essential in humans, meaning the body cannot synthesize it: it must be obtained from the diet. Human dietary sources are foods that contain protein, such as meats, dairy products, soy products, beans and legumes. In the genetic code it is encoded by the six codons UUA, UUG, CUU, CUC, CUA, and CUG (Wikipedia). This group of essential amino acids are identified as the branched-chain amino acids, BCAAs. Branched chain amino acids (BCAA) are essential amino acids whose carbon structure is marked by a branch point. These three amino acids are critical to human life and are particularly involved in stress, energy and muscle metabolism. BCAA supplementation as therapy, both oral and intravenous, in human health and disease holds great promise. 'BCAA' denotes valine, isoleucine and leucine which are branched chain essential amino acids. Despite their structural similarities, the branched amino acids have different metabolic routes, with valine going solely to carbohydrates, leucine solely to fats and isoleucine to both. The different metabolism accounts for different requirements for these essential amino acids in humans: 12 mg/kg, 14 mg/kg and 16 mg/kg of valine, leucine and isoleucine respectively. Furthermore, these amino acids have different deficiency symptoms. Valine deficiency is marked by neurological defects in the brain, while isoleucine deficiency is marked by muscle tremors. Many types of inborn errors of BCAA metabolism exist, and are marked by various abnormalities. The most common form is the maple syrup urine disease, marked by a characteristic urinary odor. Other abnormalities are associated with a wide range of symptoms, such as mental retardation, ataxia, hypoglycemia, spinal muscle atrophy, rash, vomiting and excessive muscle movement. Most forms of BCAA metabolism errors are corrected by dietary restriction of BCAA and at least one form is correctable by supplementation with 10 mg of biotin daily. BCAA are useful because they are metabolized primarily by muscle. Stress stat- e.g surgery, trauma, cirrhosis, infections, fever and starvation--require proportionately more BCAA than other amino acids and probably proportionately more leucine than either valine or isoleucine. BCAA and other amino acids are frequently fed intravenously (TPN) to malnourished surgical patients and in some cases of severe trauma. BCAA, particularly leucine, stimulate protein synthesis, increase reutilization of amino acids in many organs and reduce protein breakdown. Furthermore, leucine can be an important source of calories, and is superior as fuel to the ubiquitous intravenous glucose (dextrose). Leucine also stimulates insulin release, which in turn stimulates protein synthesis and inhibits protein breakdown. These effects are particularly useful in athletic training. BCAA should also replace the use of steroids as commonly used by weightlifters. Huntington's chorea and anorexic disorders both are characterized by low serum BCAA. These diseases, as well as forms of Parkinson's, may respond to BCAA therapy. BCAA, and particularly leucine, are among the amino acids most essential for muscle health (http://www.dcnutrition.com).",L-Leucine,HMDB0000687,b,b,C00123,LEU,FDB001946,leu_L,[H]OC(=O)[C@@]([H])(N([H])[H])C([H])([H])C([H])(C([H])([H])[H])C([H])([H])[H],ROHFNLRQFUQHCH-YFKPBYRVSA-N,"InChI=1S/C6H13NO2/c1-4(2)3-5(7)6(8)9/h4-5H,3,7H2,1-2H3,(H,8,9)/t5-/m0/s1"
5000,19330,a,a,16624,KEGG COMPOUND accession,C02047,M02404,b,16624.0,b,L-Leucyl-tRNA(Leu),b,b,b,C02047,b,b,b,[H]OC([H])([H])[C@@]1([H])O[C@@]([H])([*])[C@]([H])(O[H])[C@]1([H])OP(=O)(O[H])OC([H])([H])[C@@]1([H])O[C@@]([H])([*])[C@]([H])(O[H])[C@]1([H])OP(=O)(O[H])OC([H])([H])[C@@]1([H])O[C@@]([H])(N2C([H])=NC3=C(N=C([H])N=C23)N([H])[H])[C@]([H])(OC(=O)[C@@]([H])(N([H])[H])C([H])([H])C([H])(C([H])([H])[H])C([H])([H])[H])[C@]1([H])O[H],b,b
5001,19334,a,a,18019,KEGG COMPOUND accession,C00047,lys_L,56-87-1,18019.0,"Human Metabolome Database (HMDB): L-lysine is an essential amino acid. Normal requirements for lysine have been found to be about 8 g per day or 12 mg/kg in adults. Children and infants need more, 44 mg/kg per day for an eleven to-twelve-year old, and 97 mg/kg per day for three-to six-month old. Lysine is highly concentrated in muscle compared to most other amino acids. Lysine is high in foods such as wheat germ, cottage cheese and chicken. Of meat products, wild game and pork have the highest concentration of lysine. Fruits and vegetables contain little lysine, except avocados. Normal lysine metabolism is dependent upon many nutrients including niacin, vitamin B6, riboflavin, vitamin C, glutamic acid and iron. Excess arginine antagonizes lysine. Several inborn errors of lysine metabolism are known, such as cystinuria, hyperdibasic aminoaciduria I, lysinuric protein intolerance, propionic acidemia, and tyrosinemia I. Most are marked by mental retardation with occasional diverse symptoms such as absence of secondary sex characteristics, undescended testes, abnormal facial structure, anemia, obesity, enlarged liver and spleen, and eye muscle imbalance. Lysine also may be a useful adjunct in the treatment of osteoporosis. Although high protein diets result in loss of large amounts of calcium in urine, so does lysine deficiency. Lysine may be an adjunct therapy because it reduces calcium losses in urine. Lysine deficiency also may result in immunodeficiency. Requirements for this amino acid are probably increased by stress. Lysine toxicity has not occurred with oral doses in humans. Lysine dosages are presently too small and may fail to reach the concentrations necessary to prove potential therapeutic applications. Lysine metabolites, amino caproic acid and carnitine have already shown their therapeutic potential. Thirty grams daily of amino caproic acid has been used as an initial daily dose in treating blood clotting disorders, indicating that the proper doses of lysine, its precursor, have yet to be used in medicine. Low lysine levels have been found in patients with Parkinson's, hypothyroidism, kidney disease, asthma and depression. The exact significance of these levels is unclear, yet lysine therapy can normalize the level and has been associated with improvement of some patients with these conditions. Abnormally elevated hydroxylysines have been found in virtually all chronic degenerative diseases and coumadin therapy. The levels of this stress marker may be improved by high doses of vitamin C. Lysine is particularly useful in therapy for marasmus (wasting) and herpes simplex. It stops the growth of herpes simplex in culture, and has helped to reduce the number and occurrence of cold sores in clinical studies. Dosing has not been adequately studied, but beneficial clinical effects occur in doses ranging from 100 mg to 4 g a day. Higher doses may also be useful, and toxicity has not been reported in doses as high as 8 g per day. Diets high in lysine and low in arginine can be useful in the prevention and treatment of herpes. Some researchers think herpes simplex virus is involved in many other diseases related to cranial nerves such as migraines, Bell's palsy and Meniere's disease. Herpes blister fluid will produce fatal encephalitis in the rabbit (http://www.dcnutrition.com).",L-Lysine,HMDB0000182,b,b,C00047,LYS,FDB000474,lys_L,[H][N+]([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[C@@]([H])(C([O-])=O)[N+]([H])([H])[H],KDXKERNSBIXSRK-YFKPBYRVSA-O,"InChI=1S/C6H14N2O2/c7-4-2-1-3-5(8)6(9)10/h5H,1-4,7-8H2,(H,9,10)/p+1/t5-/m0/s1"
5002,19362,a,a,17342,KEGG COMPOUND accession,C02837,,,,,,,,,,,,,,,
5003,19368,a,a,6268,KEGG COMPOUND accession,C05412,lyxnt,b,b,b,L-Lyxonate,b,b,b,C05412,b,b,b,[H]OC([H])([H])[C@]([H])(O[H])[C@@]([H])(O[H])[C@@]([H])(O[H])C([O-])=O,QXKAIJAYHKCRRA-PZGQECOJSA-M,"InChI=1S/C5H10O6/c6-1-2(7)3(8)4(9)5(10)11/h2-4,6-9H,1H2,(H,10,11)/p-1/t2-,3+,4+/m0/s1"
5004,19369,a,a,28480,KEGG COMPOUND accession,C01508,,,,,,,,,,,,,,,
5005,19394,a,a,17016,KEGG COMPOUND accession,C02989,,,,,,,,,,,,,,,
5006,19396,a,a,28490,KEGG COMPOUND accession,C03510,,,,,,,,,,,,,,,
5007,19409,a,a,18314,KEGG COMPOUND accession,C01826,,,,,,,,,,,,,,,
5008,19412,a,a,18102,KEGG COMPOUND accession,C02838,c8crn,25243-95-2,18102.0,"Human Metabolome Database (HMDB): L-Octanoylcarnitine is the physiologically active form of octanoylcarnitine (PMID 11274033). Octanoylcarnitine is detected in medium-chain acyl-CoA dehydrogenase (MCAD) deficiency. MCAD is characterized by intolerance to prolonged fasting, recurrent episodes of hypoglycemic coma with medium-chain dicarboxylic aciduria, impaired ketogenesis, and low plasma and tissue carnitine levels (OMIM 201450). L-Octanoylcarnitine is also found to be associated with celiac disease and glutaric aciduria II, which are inborn errors of metabolism.",L-Octanoylcarnitine,HMDB0000791,b,b,C02838,L-OCTANOYLCARNITINE,FDB022246,c8crn,[H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C(=O)O[C@]([H])(C([H])([H])C([O-])=O)C([H])([H])[N+](C([H])([H])[H])(C([H])([H])[H])C([H])([H])[H],CXTATJFJDMJMIY-CYBMUJFWSA-N,"InChI=1S/C15H29NO4/c1-5-6-7-8-9-10-15(19)20-13(11-14(17)18)12-16(2,3)4/h13H,5-12H2,1-4H3/t13-/m1/s1"
5009,19414,a,a,15729,KEGG COMPOUND accession,C00077,orn,3184-13-2,15729.0,"Human Metabolome Database (HMDB): L-ornithine, also known as (S)-2,5-diaminopentanoic acid or ornithine is a member of the class of compounds known as L-alpha-amino acids. L-alpha-amino acids are alpha amino acids which have the L-configuration of the alpha-carbon atom. L-ornithine is soluble (in water) and a moderately acidic compound. It has been claimed that ornithine improves athletic performance, has anabolic effects, has wound-healing effects, and is immuno-enhancing. L-ornithine is abundant in a number of food items such as wild rices, brazil nuts, common oregano, and common grapes. L-ornithine can be found throughout most human tissues; and in most biofluids, some of which include blood, urine, cerebrospinal fluid (CSF), sweat, saliva, and feces. Within the cell, L-ornithine is located in the mitochondria and the cytoplasm. L-ornithine exists in all living species, from bacteria to humans. In humans, L-ornithine is involved in numerous metabolic disorders, some of which include, ornithine transcarbamylase deficiency (OTC deficiency), argininemia, and guanidinoacetate methyltransferase deficiency (GAMT deficiency). Moreover, Ornithine is found to be associated with cystinuria, hyperdibasic aminoaciduria I, and lysinuric protein intolerance, which are inborn errors of metabolism. Ornithine is produced in the urea cycle through the cleavage of urea from arginine. It is a central part of the urea cycle, which allows for the disposal of excess nitrogen. L-Ornithine is also a precursor of citrulline and arginine. In order for ornithine produced in the cytosol to be converted to citrulline, it must first cross the inner mitochondrial membrane into the mitochondrial matrix where it is carbamylated by ornithine transcarbamylase. This transfer is mediated by the mitochondrial ornithine transporter (SLC25A15; AF112968; ORNT1). Mutations in the mitochondrial ornithine transporter result in hyperammonemia, hyperornithinemia, homocitrullinuria (HHH) syndrome, a disorder of the urea cycle (PMID: 16256388). The pathophysiology of the disease may involve diminished ornithine transport into mitochondria, resulting in ornithine accumulation in the cytoplasm and reduced ability to clear carbamoyl phosphate and ammonia loads (OMIM 838970).",Ornithine,HMDB0000214,b,b,C00077,L-ORNITHINE,FDB003654,orn,[H][N+]([H])([H])C([H])([H])C([H])([H])C([H])([H])[C@@]([H])(C([O-])=O)[N+]([H])([H])[H],AHLPHDHHMVZTML-BYPYZUCNSA-O,"InChI=1S/C5H12N2O2/c6-3-1-2-4(7)5(8)9/h4H,1-3,6-7H2,(H,8,9)/p+1/t4-/m0/s1"
5010,19433,a,a,17490,KEGG COMPOUND accession,C02990,pmtcrn,2364-67-2,17490.0,"Human Metabolome Database (HMDB): L-palmitoylcarnitine is a long-chain acyl fatty acid derivative ester of carnitine which facilitates the transfer of long-chain fatty acids from cytoplasm into mitochondria during the oxidation of fatty acids. L-palmitoylcarnitine, due to its amphipatic character is, like detergents, a surface-active molecule and by changing the membrane fluidity and surface charge can change activity of several enzymes and transporters localized in the membrane. L-palmitoylcarnitine has been also reported to change the activity of certain proteins. On the contrary to carnitine, palmitoylcarnitine was shown to stimulate the activity of caspases 3, 7 and 8 and the level of this long-chain acylcarnitine increased during apoptosis. Palmitoylcarnitine was also reported to diminish completely binding of phorbol esters, the protein kinase C activators and to decrease the autophosphorylation of the enzyme. Apart from these isoform nonspecific phenomena, palmitoylcarnitine was also shown to be responsible for retardation in cytoplasm of protein kinase C isoforms &#946; and &#948; and, in the case of the latter one, to decrease its interaction with GAP-43. Some of the physico-chemical properties of palmitoylcarnitine may help to explain the need for coenzyme A-carnitine-coenzyme A acyl exchange during mitochondrial fatty acid import. The amphiphilic character of palmitoylcarnitine may also explain its proposed involvement in the pathogenesis of myocardial ischemia. L-palmitoylcarnitine accumulates in ischemic myocardium and potentially contribute to myocardial damage through alterations in membrane molecular dynamics, one mechanism through which could play an important role in ischemic injury. Palmitoylcarnitine is characteristically elevated in carnitine palmitoyltransferase II deficiency, late-onset (OMIM 255110 PMID 2540838, 15363641, 8706815). Moreover, L-palmitoylcarnitine is found to be associated with celiac disease, which is an inborn error of metabolism.",L-Palmitoylcarnitine,HMDB0000222,b,b,C02990,CPD-419,FDB021910,pmtcrn,[H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C(=O)O[C@]([H])(C([H])([H])C([O-])=O)C([H])([H])[N+](C([H])([H])[H])(C([H])([H])[H])C([H])([H])[H],XOMRRQXKHMYMOC-OAQYLSRUSA-N,"InChI=1S/C23H45NO4/c1-5-6-7-8-9-10-11-12-13-14-15-16-17-18-23(27)28-21(19-22(25)26)20-24(2,3)4/h21H,5-20H2,1-4H3/t21-/m1/s1"
5011,19436,a,a,17295,KEGG COMPOUND accession,C00079,phe_L,63-91-2,17295.0,"Human Metabolome Database (HMDB): Phenylalanine is an essential amino acid and the precursor of the amino acid tyrosine. Like tyrosine, phenylalanine is also a precursor for catecholamines including tyramine, dopamine, epinephrine, and norepinephrine. Catecholamines are neurotransmitters that act as adrenalin-like substances. Interestingly, several psychotropic drugs (mescaline, morphine, codeine, and papaverine) also have phenylalanine as a constituent. Phenylalanine is highly concentrated in the human brain and plasma. Normal metabolism of phenylalanine requires biopterin, iron, niacin, vitamin B6, copper, and vitamin C. An average adult ingests 5 g of phenylalanine per day and may optimally need up to 8 g daily. Phenylalanine is highly concentrated in a number of high protein foods, such as meat, cottage cheese, and wheat germ. An additional dietary source of phenylalanine is artificial sweeteners containing aspartame. As a general rule, aspartame should be avoided by phenylketonurics and pregnant women. When present in sufficiently high levels, phenylalanine can act as a neurotoxin and a metabotoxin. A neurotoxin is a compound that disrupts or attacks neural cells and neural tissue. A metabotoxin is an endogenously produced metabolite that causes adverse health effects at chronically high levels. Chronically high levels of phenylalanine are associated with at least five inborn errors of metabolism, including Hartnup disorder, hyperphenylalaninemia due to guanosine triphosphate cyclohydrolase deficiency, phenylketonuria (PKU), tyrosinemia type 2 (or Richner-Hanhart syndrome), and tyrosinemia type III (TYRO3). Phenylketonurics have elevated serum plasma levels of phenylalanine up to 400 times normal. High plasma concentrations of phenylalanine influence the blood-brain barrier transport of large neutral amino acids. The high plasma phenylalanine concentrations increase phenylalanine entry into the brain and restrict the entry of other large neutral amino acids (PMID: 19191004). Phenylalanine has been found to interfere with different cerebral enzyme systems. Untreated phenylketonuria (PKU) can lead to intellectual disability, seizures, behavioural problems, and mental disorders. It may also result in a musty smell and lighter skin. Classic PKU dramatically affects myelination and white matter tracts in untreated infants; this may be one major cause of neurological disorders associated with phenylketonuria. Mild phenylketonuria can act as an unsuspected cause of hyperactivity, learning problems, and other developmental problems in children. It has been recently suggested that PKU may resemble amyloid diseases, such as Alzheimer's disease and Parkinson's disease, due to the formation of toxic amyloid-like assemblies of phenylalanine (PMID: 22706200). Phenylalanine also has some potential benefits. Phenylalanine can act as an effective pain reliever. Its use in premenstrual syndrome and Parkinson's may enhance the effects of acupuncture and electric transcutaneous nerve stimulation (TENS). Phenylalanine and tyrosine, like L-DOPA, produce a catecholamine-like effect. Phenylalanine is better absorbed than tyrosine and may cause fewer headaches. Low phenylalanine diets have been prescribed for certain cancers with mixed results. For instance, some tumours use more phenylalanine than others (particularly melatonin-producing tumours called melanomas).",L-Phenylalanine,HMDB0000159,b,b,C00079,PHE,FDB014705,phe_L,[H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])[C@@]([H])(C([O-])=O)[N+]([H])([H])[H],COLNVLDHVKWLRT-QMMMGPOBSA-N,"InChI=1S/C9H11NO2/c10-8(9(11)12)6-7-4-2-1-3-5-7/h1-5,8H,6,10H2,(H,11,12)/t8-/m0/s1"
5012,19460,a,a,29153,KEGG COMPOUND accession,C03511,M02412,b,29153.0,b,L-Phenylalanyl-tRNA(Phe),b,b,b,C03511,b,b,b,b,b,b
5013,19462,a,a,30913,KEGG COMPOUND accession,C00408,Lpipecol,3105-95-1,30913.0,"Human Metabolome Database (HMDB): L-pipecolic acid is a normal human metabolite present in human blood, where is present as the primary enantiomer of pipecolic acid. L-pipecolic acid is a cyclic imino acid (contains both imino (>C=NH) and carboxyl (-C(=O)-OH) functional groups) produced during the degradation of lysine, accumulates in body fluids of infants with generalized genetic peroxisomal disorders, including Zellweger syndrome (OMIM 214100), neonatal adrenoleukodystrophy (OMIM 202370), and infantile Refsum disease (OMIM 266510). L-pipecolic acid levels are also elevated in patients with chronic liver diseases. L-pipecolic acid is the substrate of delta1-piperideine-2-carboxylate reductase (EC 1.5.1.21) in the pathway of lysine degradation (PMID: 2717271, 8305590, 1050990).",L-Pipecolic acid,HMDB0000716,b,b,C00408,L-PIPECOLATE,FDB000546,Lpipecol,[H]C1([H])C([H])([H])C([H])([H])[C@@]([H])(C([O-])=O)[N+]([H])([H])C1([H])[H],HXEACLLIILLPRG-YFKPBYRVSA-N,"InChI=1S/C6H11NO2/c8-6(9)5-3-1-2-4-7-5/h5,7H,1-4H2,(H,8,9)/t5-/m0/s1"
5014,19468,a,a,17203,KEGG COMPOUND accession,C00148,pro_L,147-85-3,17203.0,"Human Metabolome Database (HMDB): L-proline is one of the twenty amino acids used in living organisms as the building blocks of proteins. Proline is sometimes called an imino acid, although the IUPAC definition of an imine requires a carbon-nitrogen double bond. Proline is a non-essential amino acid that is synthesized from glutamic acid. It is an essential component of collagen and is important for proper functioning of joints and tendons. Proline is derived from the amino acid L-glutamate in which glutamate-5-semialdehyde is first formed by glutamate 5-kinase and glutamate-5-semialdehyde dehydrogenase (which requires NADH or NADPH). This semialdehyde can then either spontaneously cyclize to form 1-pyrroline-5-carboxylic acid, which is reduced to proline by pyrroline-5-carboxylate reductase, or turned into ornithine by ornithine aminotransferase, followed by cyclization by ornithine cyclodeaminase to form proline. L-Proline has been found to act as a weak agonist of the glycine receptor and of both NMDA and non-NMDA ionotropic glutamate receptors. It has been proposed to be a potential endogenous excitotoxin/neurotoxin. Studies in rats have shown that when injected into the brain, proline non-selectively destroys pyramidal and granule cells (PMID: 3409032). Therefore, under certain conditions proline can act as a neurotoxin and a metabotoxin. A neurotoxin causes damage to nerve cells and nerve tissues. A metabotoxin is an endogenously produced metabolite that causes adverse health effects at chronically high levels. Chronically high levels of proline are associated with at least five inborn errors of metabolism, including hyperprolinemia type I, hyperprolinemia type II, iminoglycinuria, prolinemia type II, and pyruvate carboxylase deficiency. People with hyperprolinemia type I often do not show any symptoms even though they have proline levels in their blood between 3 and 10 times the normal level. Some individuals with hyperprolinemia type I exhibit seizures, intellectual disability, or other neurological or psychiatric problems. Hyperprolinemia type II results in proline levels in the blood between 10 and 15 times higher than normal, and high levels of a related compound called pyrroline-5-carboxylate. Hyperprolinemia type II has signs and symptoms that vary in severity, and is more likely than type I to involve seizures or intellectual disability.",L-Proline,HMDB0000162,b,b,C00148,PRO,FDB000570,pro_L,[H]C1([H])C([H])([H])[N+]([H])([H])[C@]([H])(C([O-])=O)C1([H])[H],ONIBWKKTOPOVIA-BYPYZUCNSA-N,"InChI=1S/C5H9NO2/c7-5(8)4-2-1-3-6-4/h4,6H,1-3H2,(H,7,8)/t4-/m0/s1"
5015,19485,a,a,17357,KEGG COMPOUND accession,C01934,,,,,,,,,,,,,,,
5016,19495,a,a,17897,KEGG COMPOUND accession,C00861,,,,,,,,,,,,,,,
5017,19498,a,a,17892,KEGG COMPOUND accession,C01131,,,,,,,,,,,,,,,
5018,19501,a,a,16880,KEGG COMPOUND accession,C00508,,,,,,,,,,,,,,,
5019,19506,a,a,17666,KEGG COMPOUND accession,C01101,,,,,,,,,,,,,,,
5020,19517,a,a,17115,KEGG COMPOUND accession,C00065,ser_L,56-45-1,17115.0,"Human Metabolome Database (HMDB): Serine is a nonessential amino acid derived from glycine. Like all the amino acid building blocks of protein and peptides, serine can become essential under certain conditions, and is thus important in maintaining health and preventing disease. Low-average concentration of serine compared to other amino acids is found in muscle. Serine is highly concentrated in all cell membranes. (http://www.dcnutrition.com/AminoAcids/) L-Serine may be derived from four possible sources: dietary intake; biosynthesis from the glycolytic intermediate 3-phosphoglycerate; from glycine ; and by protein and phospholipid degradation. Little data is available on the relative contributions of each of these four sources of l-serine to serine homoeostasis. It is very likely that the predominant source of l-serine will be very different in different tissues and during different stages of human development. In the biosynthetic pathway, the glycolytic intermediate 3-phosphoglycerate is converted into phosphohydroxypyruvate, in a reaction catalyzed by 3-phosphoglycerate dehydrogenase (3- PGDH; EC 1.1.1.95). Phosphohydroxypyruvate is metabolized to phosphoserine by phosphohydroxypyruvate aminotransferase (EC 2.6.1.52) and, finally, phosphoserine is converted into l-serine by phosphoserine phosphatase (PSP; EC 3.1.3.3). In liver tissue, the serine biosynthetic pathway is regulated in response to dietary and hormonal changes. Of the three synthetic enzymes, the properties of 3-PGDH and PSP are the best documented. Hormonal factors such as glucagon and corticosteroids also influence 3-PGDH and PSP activities in interactions dependent upon the diet. L-serine plays a central role in cellular proliferation. L-Serine is the predominant source of one-carbon groups for the de novo synthesis of purine nucleotides and deoxythymidine monophosphate. It has long been recognized that, in cell cultures, L-serine is a conditional essential amino acid, because it cannot be synthesized in sufficient quantities to meet the cellular demands for its utilization. In recent years, L-serine and the products of its metabolism have been recognized not only to be essential for cell proliferation, but also to be necessary for specific functions in the central nervous system. The findings of altered levels of serine and glycine in patients with psychiatric disorders and the severe neurological abnormalities in patients with defects of L-serine synthesis underscore the importance of L-serine in brain development and function. (PMID 12534373).",L-Serine,HMDB0000187,b,b,C00065,SER,FDB012739,ser_L,[H]OC([H])([H])[C@@]([H])(C([O-])=O)[N+]([H])([H])[H],MTCFGRXMJLQNBG-REOHCLBHSA-N,"InChI=1S/C3H7NO3/c4-2(1-5)3(6)7/h2,5H,1,4H2,(H,6,7)/t2-/m0/s1"
5021,19541,a,a,15829,KEGG COMPOUND accession,C02703,,,,,,,,,,,,,,,
5022,19546,a,a,29162,KEGG COMPOUND accession,C02553,M02416,b,29162.0,b,L-Seryl-tRNA(Ser),b,b,b,C02553,b,b,b,[H]OC([H])([H])[C@]([H])(N([H])[H])C(=O)O[C@]1([H])[C@]([H])(O[C@@]([H])([*])[C@]1([H])O[H])C([H])([H])OP(=O)(O[H])O[C@]1([H])[C@]([H])(O[C@@]([H])([*])[C@]1([H])O[H])C([H])([H])OP(=O)(O[H])O[C@]1([H])[C@]([H])(O[C@@]([H])([*])[C@]1([H])O[H])C([H])([H])O[H],b,b
5023,19558,a,a,16857,KEGG COMPOUND accession,C00188,thr_L,72-19-5,16857.0,"Human Metabolome Database (HMDB): Threonine is an essential amino acid in humans. It is abundant in human plasma, particularly in newborns. Severe deficiency of threonine causes neurological dysfunction and lameness in experimental animals. Threonine is an immunostimulant which promotes the growth of thymus gland. It also can probably promote cell immune defense function. This amino acid has been useful in the treatment of genetic spasticity disorders and multiple sclerosis at a dose of 1 gram daily. It is highly concentrated in meat products, cottage cheese and wheat germ. (http://www.dcnutrition.com/AminoAcids/) The threonine content of most of the infant formulas currently on the market is approximately 20% higher than the threonine concentration in human milk. Due to this high threonine content the plasma threonine concentrations are up to twice as high in premature infants fed these formulas than in infants fed human milk. The whey proteins which are used for infant formulas are sweet whey proteins. Sweet whey results from cheese production. Threonine catabolism in mammals appears to be due primarily (70-80%) to the activity of threonine dehydrogenase (EC 1.1.1.103) that oxidizes threonine to 2-amino-3-oxobutyrate, which forms glycine and acetyl CoA, whereas threonine dehydratase (EC 4.2.1.16) that catabolizes threonine into 2-oxobutyrate and ammonia, is significantly less active. Increasing the threonine plasma concentrations leads to accumulation of threonine and glycine in the brain. Such accumulation affects the neurotransmitter balance which may have consequences for the brain development during early postnatal life. Thus, excessive threonine intake during infant feeding should be avoided. (PMID 9853925).",L-Threonine,HMDB0000167,b,b,C00188,THR,FDB011999,thr_L,[H]O[C@]([H])(C([H])([H])[H])[C@@]([H])(C([O-])=O)[N+]([H])([H])[H],AYFVYJQAPQTCCC-GBXIJSLDSA-N,"InChI=1S/C4H9NO3/c1-2(6)3(5)4(7)8/h2-3,6H,5H2,1H3,(H,7,8)/t2-,3+/m1/s1"
5024,19587,a,a,16533,KEGG COMPOUND accession,C00977,,,,,,,,,,,,,,,
5025,19589,a,a,29159,KEGG COMPOUND accession,C03512,M02420,b,29159.0,b,L-Tryptophanyl-tRNA(Trp),b,b,b,C03512,b,b,b,[H]OC([H])([H])[C@@]1([H])O[C@@]([H])([*])[C@]([H])(O[H])[C@]1([H])OP(=O)(O[H])OC([H])([H])[C@@]1([H])O[C@@]([H])([*])[C@]([H])(O[H])[C@]1([H])OP(=O)(O[H])OC([H])([H])[C@@]1([H])O[C@@]([H])(N2C([H])=NC3=C(N=C([H])N=C23)N([H])[H])[C@]([H])(OC(=O)[C@@]([H])(N([H])[H])C([H])([H])C2=C([H])N([H])C3=C([H])C([H])=C([H])C([H])=C23)[C@]1([H])O[H],b,b
5026,19613,a,a,17215,KEGG COMPOUND accession,C03404,,,,,,,,,,,,,,,
5027,19618,a,a,17537,KEGG COMPOUND accession,C02993,,,,,,,,,,,,,,,
5028,19625,a,a,29023,KEGG COMPOUND accession,C05793,,,,,,,,,,,,,,,
5029,19627,a,a,6320,KEGG COMPOUND accession,C05789,,,,,,,,,,,,,,,
5030,19638,a,a,29164,KEGG COMPOUND accession,C02554,M02423,b,29164.0,b,L-Valyl-tRNA(Val),b,b,b,C02554,b,b,b,[H]OC([H])([H])[C@@]1([H])O[C@@]([H])([*])[C@]([H])(O[H])[C@]1([H])OP(=O)(O[H])OC([H])([H])[C@@]1([H])O[C@@]([H])([*])[C@]([H])(O[H])[C@]1([H])OP(=O)(O[H])OC([H])([H])[C@@]1([H])O[C@@]([H])(N2C([H])=NC3=C(N=C([H])N=C23)N([H])[H])[C@]([H])(OC(=O)[C@@]([H])(N([H])[H])C([H])(C([H])([H])[H])C([H])([H])[H])[C@]1([H])O[H],b,b
5031,19646,a,a,17399,KEGG COMPOUND accession,C00312,xylu_L,527-50-4,17399.0,"Human Metabolome Database (HMDB): L-Threo-2-pentulose, or L-xylulose, is a ketopentose, a monosaccharide containing five carbon atoms, and including a ketone functional group. It has chemical formula C5H10O5. L-Xylulose accumulates in the urine of pentosuria patients. Since L-xylulose is a reducing sugar like D-glucose, pentosuria patients have been wrongly diagnosed in the past to be diabetic.",L-Threo-2-pentulose,HMDB0000751,b,b,C00312,b,FDB022223,xylu_L,[H]OC([H])([H])C(=O)[C@]([H])(O[H])[C@@]([H])(O[H])C([H])([H])O[H],ZAQJHHRNXZUBTE-WVZVXSGGSA-N,"InChI=1S/C5H10O5/c6-1-3(8)5(10)4(9)2-7/h3,5-8,10H,1-2H2/t3-,5+/m0/s1"
5032,19657,a,a,16593,KEGG COMPOUND accession,C03291,,,,,,,,,,,,,,,
5033,19659,a,a,6329,KEGG COMPOUND accession,C08266,,,,,,,,,,,,,,,
5034,19670,a,a,37493,KEGG COMPOUND accession,C06155,,,,,,,,,,,,,,,
5035,19671,a,a,47980,KEGG COMPOUND accession,C03618,,,,,,,,,,,,,,,
5036,19674,a,a,28456,KEGG COMPOUND accession,C06029,,,,,,,,,,,,,,,
5037,19675,a,a,16795,KEGG COMPOUND accession,C03290,,,,,,,,,,,,,,,
5038,19684,a,a,16026,KEGG COMPOUND accession,C00666,,,,,,,,,,,,,,,
5039,19709,a,a,28358,KEGG COMPOUND accession,C01432,,,,,,,,,,,,,,,
5040,19723,a,a,37986,KEGG COMPOUND accession,C03405,C03405,b,b,b,Lactosylceramide Sulfate,b,b,b,C03405,b,b,b,[O-]S([O-])(=O)=O.[H]OC(=N[C@@]([H])(C([H])([H])O[C@]1([H])O[C@]([H])(O[H])[C@@]([H])(O[C@]2([H])O[C@]([H])(O[H])[C@]([H])(O[H])[C@]([H])(O[H])[C@@]2([H])O[H])[C@]([H])(O[H])[C@@]1([H])O[H])[C@]([H])(O[H])C(\[H])=C(/[H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C(\[H])=C(\[H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H],b,"InChI=1S/C46H85NO13.H2O4S/c1-3-5-7-9-11-13-15-17-18-20-22-24-26-28-30-32-36(49)47-34(35(48)31-29-27-25-23-21-19-16-14-12-10-8-6-4-2)33-57-45-41(54)38(51)42(44(56)60-45)58-46-40(53)37(50)39(52)43(55)59-46;1-5(2,3)4/h17-18,29,31,34-35,37-46,48,50-56H,3-16,19-28,30,32-33H2,1-2H3,(H,47,49);(H2,1,2,3,4)/p-2/b18-17-,31-29+;/t34-,35+,37-,38+,39+,40+,41+,42-,43-,44-,45+,46+;/m0./s1"
5041,19724,a,a,15529,KEGG COMPOUND accession,C00827,laccoa,1926-57-4,15529.0,Human Metabolome Database (HMDB): Lactyl-CoA is involved in both propanoate metabolism and styrene degradation pathways. It is a product in styrene degradation pathway. (KEGG).,Lactyl-CoA,HMDB0002346,b,b,C00827,CPD-5922,FDB022973,b,b,VIWKEBOLLIEAIL-FBMOWMAESA-N,b
5042,19727,a,a,6357,KEGG COMPOUND accession,C08599,,,,,,,,,,,,,,,
5043,19729,a,a,6358,KEGG COMPOUND accession,C09489,,,,,,,,,,,,,,,
5044,19731,a,a,6359,KEGG COMPOUND accession,C07064,,,,,,,,,,,,,,,
5045,19741,a,a,6364,KEGG COMPOUND accession,C00771,,,,,,,,,,,,,,,
5046,19758,a,a,6373,KEGG COMPOUND accession,C10075,,,,,,,,,,,,,,,
5047,19789,a,a,17269,KEGG COMPOUND accession,C02293,,,,,,,,,,,,,,,
5048,19796,a,a,6390,KEGG COMPOUND accession,C09492,,,,,,,,,,,,,,,
5049,19800,a,a,15521,KEGG COMPOUND accession,C01832,ddcacoa,6244-92-4,15521.0,Human Metabolome Database (HMDB): Lauroyl-CoA is a substrate for Protein FAM34A.,Lauroyl-CoA,HMDB0003571,b,b,C01832,LAUROYLCOA-CPD,FDB023198,ddcacoa,[H]O[C@@]([H])(C(=O)N([H])C([H])([H])C([H])([H])C(=O)N([H])C([H])([H])C([H])([H])SC(=O)C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H])C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])OP([O-])(=O)OP([O-])(=O)OC([H])([H])[C@@]1([H])O[C@@]([H])(N2C([H])=NC3=C(N=C([H])N=C23)N([H])[H])[C@]([H])(O[H])[C@]1([H])OP([O-])([O-])=O,YMCXGHLSVALICC-GMHMEAMDSA-J,"InChI=1S/C33H58N7O17P3S/c1-4-5-6-7-8-9-10-11-12-13-24(42)61-17-16-35-23(41)14-15-36-31(45)28(44)33(2,3)19-54-60(51,52)57-59(49,50)53-18-22-27(56-58(46,47)48)26(43)32(55-22)40-21-39-25-29(34)37-20-38-30(25)40/h20-22,26-28,32,43-44H,4-19H2,1-3H3,(H,35,41)(H,36,45)(H,49,50)(H,51,52)(H2,34,37,38)(H2,46,47,48)/p-4/t22-,26-,27-,28+,32-/m1/s1"
5050,19808,a,a,27422,KEGG COMPOUND accession,C06251,,,,,,,,,,,,,,,
5051,19815,a,a,28857,KEGG COMPOUND accession,C08492,,,,,,,,,,,,,,,
5052,19822,a,a,6402,KEGG COMPOUND accession,C07905,,,,,,,,,,,,,,,
5053,19844,a,a,6413,KEGG COMPOUND accession,C08163,,,,,,,,,,,,,,,
5054,19847,a,a,6415,KEGG COMPOUND accession,C11331,,,,,,,,,,,,,,,
5055,19849,a,a,15758,KEGG COMPOUND accession,C05906,,,,,,,,,,,,,,,
5056,19853,a,a,6417,KEGG COMPOUND accession,C05909,,,,,,,,,,,,,,,
5057,19858,a,a,15651,KEGG COMPOUND accession,C00909,leuktrA4,72059-45-1,15651.0,"Human Metabolome Database (HMDB): Leukotriene A4 (LTA4) is the first metabolite in the series of reactions leading to the synthesis of all leukotrienes. 5-Lipoxygenase (5-LO) catalyzes the two-step conversion of arachidonic acid to LTA4.The first step consists of the oxidation of arachidonic acid to the unstable intermediate 5-hydroperoxyeicosatetraenoic acid (5-HPETE), and the second step is the dehydration of 5-HPETE to form LTA4. Leukotriene A4, an unstable epoxide, is hydrolyzed to leukotriene B4 or conjugated with glutathione to yield leukotriene C4 and its metabolites, leukotriene D4 and leukotriene E4. The leukotrienes participate in host defense reactions and pathophysiological conditions such as immediate hypersensitivity and inflammation. Recent studies also suggest a neuroendocrine role for leukotriene C4 in luteinizing hormone secretion. (PMID: 10591081, 2820055). Leukotrienes are eicosanoids. The eicosanoids consist of the prostaglandins (PGs), thromboxanes (TXs), leukotrienes (LTs) and lipoxins (LXs). The PGs and TXs are collectively identified as prostanoids. Prostaglandins were originally shown to be synthesized in the prostate gland, thromboxanes from platelets (thrombocytes) and leukotrienes from leukocytes, hence the derivation of their names. All mammalian cells except erythrocytes synthesize eicosanoids. These molecules are extremely potent, able to cause profound physiological effects at very dilute concentrations. All eicosanoids function locally at the site of synthesis, through receptor-mediated G-protein linked signaling pathways.",Leukotriene A4,HMDB0001337,b,b,C00909,CPD-8892,FDB022561,leuktrA4,[H]C(=C([H])C([H])=C([H])[C@]1([H])O[C@@]1([H])C([H])([H])C([H])([H])C([H])([H])C([O-])=O)C([H])=C([H])C([H])([H])C([H])=C([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H],UFPQIRYSPUYQHK-WAQVJNLQSA-M,"InChI=1S/C20H30O3/c1-2-3-4-5-6-7-8-9-10-11-12-13-15-18-19(23-18)16-14-17-20(21)22/h6-7,9-13,15,18-19H,2-5,8,14,16-17H2,1H3,(H,21,22)/p-1/b7-6-,10-9-,12-11+,15-13+/t18-,19-/m0/s1"
5058,19863,a,a,15647,KEGG COMPOUND accession,C02165,leuktrB4,71160-24-2,15647.0,"Human Metabolome Database (HMDB): Leukotriene B4 is the major metabolite in neutrophil polymorphonuclear leukocytes. Leukotrienes are metabolites of arachidonic acid derived from the action of 5-LO (5-lipoxygenase). The immediate product of 5-LO is LTA4 (leukotriene A4), which is enzymatically converted into either LTB4 (leukotriene B4) by LTA4 hydrolase or LTC4 (leukotriene C4) by LTC4 synthase. The regulation of leukotriene production occurs at various levels, including expression of 5-LO, translocation of 5-LO to the perinuclear region and phosphorylation to either enhance or inhibit the activity of 5-LO. Biologically active LTB4 is metabolized by w-oxidation carried out by specific cytochrome P450s (CYP4F) followed by b-oxidation from the w-carboxy position and after CoA ester formation. Other specific pathways of leukotriene metabolism include the 12-hydroxydehydrogenase/ 15-oxo-prostaglandin-13-reductase that form a series of conjugated diene metabolites that have been observed to be excreted into human urine. Metabolism of LTC4 occurs by sequential peptide cleavage reactions involving a gamma-glutamyl transpeptidase that forms LTD4 (leukotriene D4) and a membrane-bound dipeptidase that converts LTD4 into LTE4 (leukotriene E4) before w-oxidation. These metabolic transformations of the primary leukotrienes are critical for termination of their biological activity, and defects in expression of participating enzymes may be involved in specific genetic disease. The term leukotriene was coined to indicate the presence of three conjugated double bonds within the 20-carbon structure of arachidonic acid as well as the fact that these compounds were derived from leucocytes such as PMNNs or transformed mast cells. Interestingly, most of the cells known to express 5-LO are of myeloid origin, which includes neutrophils, eosinophils, mast cells, macrophages, basophils and monocytes. Leukotriene biosynthesis begins with the specific oxidation of arachidonic acid by a free radical mechanism as a consequence of interaction with 5-LO. The first enzymatic step involves the abstraction of a hydrogen atom from C-7 of arachidonate followed by the addition of molecular oxygen to form 5-HpETE (5-hydroperoxyeicosatetraenoic acid). A second enzymatic step is also catalysed by 5-LO and involves removal of a hydrogen atom from C-10, resulting in formation of the conjugated triene epoxide LTA4. LTA4 must then be released by 5-LO and encounter either LTA4-H (LTA4 hydrolase) or LTC4-S [LTC4 (leukotriene C4) synthase]. LTA4-H can stereospecifically add water to C-12 while retaining a specific double-bond geometry, leading to LTB4 [leukotriene B4, 5(S),12(R)-dihydroxy-6,8,10,14-(Z,E,E,Z)-eicosatetraenoic acid]. If LTA4 encounters LTC4-S, then the reactive epoxide is opened at C-6 by the thiol anion of glutathione to form the product LTC4 [5(S)-hydroxy-6(R)-S-glutathyionyl-7,9,11,14- (E,E,Z,Z)-eicosatetraenoic acid], essentially a glutathionyl adduct of oxidized arachidonic acid. Both of these terminal leukotrienes are biologically active in that specific GPCRs recognize these chemical structures and receptor recognition initiates complex intracellular signalling cascades. In order for these molecules to serve as lipid mediators, however, they must be released from the biosynthetic cell into the extracellular milieu so that they can encounter the corresponding GPCRs. Surprising features of this cascade include the recognition of the assembly of critical enzymes at the perinuclear region of the cell and even localization of 5-LO within the nucleus of some cells. Under some situations, the budding phagosome has been found to assemble these proteins. Non-enzymatic proteins such as FLAP are now known as critical partners of this protein-machine assembly. An unexpected pathway of leukotriene biosynthesis involves the transfer of the chemically reactive intermediate, LTA4, from the biosynthetic cell followed by conversion into LTB4 or LTC4 by other cells that do not express 5-LO. (PMID 17623009). Leukotrienes are eicosanoids. The eicosanoids consist of the prostaglandins (PGs), thromboxanes (TXs), leukotrienes (LTs) and lipoxins (LXs). The PGs and TXs are collectively identified as prostanoids. Prostaglandins were originally shown to be synthesized in the prostate gland, thromboxanes from platelets (thrombocytes) and leukotrienes from leukocytes, hence the derivation of their names. All mammalian cells except erythrocytes synthesize eicosanoids. These molecules are extremely potent, able to cause profound physiological effects at very dilute concentrations. All eicosanoids function locally at the site of synthesis, through receptor-mediated G-protein linked signaling pathways.",Leukotriene B4,HMDB0001085,b,b,C02165,6Z8E10E14Z-5S12R-512-DIHYDROXYI,FDB022416,leuktrB4,[H]O[C@@]([H])(C(\[H])=C(/[H])C([H])=C([H])C([H])=C([H])[C@@]([H])(O[H])C([H])([H])C([H])([H])C([H])([H])C([O-])=O)C([H])([H])C([H])=C([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H],VNYSSYRCGWBHLG-YEYKLZQPSA-M,"InChI=1S/C20H32O4/c1-2-3-4-5-6-9-13-18(21)14-10-7-8-11-15-19(22)16-12-17-20(23)24/h6-11,14-15,18-19,21-22H,2-5,12-13,16-17H2,1H3,(H,23,24)/p-1/b8-7+,9-6-,14-10?,15-11-/t18-,19-/m1/s1"
5059,19867,a,a,16978,KEGG COMPOUND accession,C02166,leuktrC4,72025-60-6,16978.0,"Human Metabolome Database (HMDB): Leukotriene C4 (LTC4) is a cysteinyl leukotriene (CysLT), a family of potent inflammatory mediators. Eosinophils, one of the principal cell types recruited to and activated at sites of allergic inflammation, is capable of elaborating lipid mediators, including leukotrienes derived from the oxidative metabolism of arachidonic acid (AA). Potentially 'activated' eosinophils may elaborate greater quantities of LTC4, than normal eosinophils. These activated eosinophils thus are 'primed' for enhanced LTC4 generation in response to subsequent stimuli. Some recognized priming stimuli are chemoattractants (e.g., eotaxin, PAF) that may participate in the recruitment of eosinophils to sites of allergic inflammation. The mechanisms by which chemoattractants and other activating cytokines (e.g., interleukin (IL)-5) or extracellular matrix components (e.g., fibronectin) enhance eosinophil eicosanoid formation are pertinent to the functions of these eicosanoids as paracrine mediators of allergic inflammation. Some eosinophil-derived eicosanoids may be active in down-regulating inflammation. It is increasingly likely that eicosanoids synthesized within cells, including eosinophils, may have intracellular (e.g., intracrine) roles in regulating cell functions, in addition to the more recognized activities of eicosanoids as paracrine mediators of inflammation. Acting extracellularly, the cysteinyl leukotrienes (CysLTs) LTC4 and its extracellular derivatives, LTD4 and LTE4 are key paracrine mediators pertinent to asthma and allergic diseases. Based on their receptor-mediated capabilities, they can elicit bronchoconstriction, mucous hypersecretion, bronchial hyperresponsiveness, increased microvascular permeability, and additional eosinophil infiltration. Eosinophils are a major source of CysLTs and have been identified as the principal LTC4 synthase expressing cells in bronchial mucosal biopsies of asthmatic subjects. (PMID: 12895596)Leukotrienes are eicosanoids. The eicosanoids consist of the prostaglandins (PGs), thromboxanes (TXs), leukotrienes (LTs) and lipoxins (LXs). The PGs and TXs are collectively identified as prostanoids. Prostaglandins were originally shown to be synthesized in the prostate gland, thromboxanes from platelets (thrombocytes) and leukotrienes from leukocytes, hence the derivation of their names. All mammalian cells except erythrocytes synthesize eicosanoids. These molecules are extremely potent, able to cause profound physiological effects at very dilute concentrations. All eicosanoids function locally at the site of synthesis, through receptor-mediated G-protein linked signaling pathways.",Leukotriene C4,HMDB0001198,b,b,C02166,LEUKOTRIENE-C4,FDB022484,leuktrC4,[H]O[C@@]([H])(C([H])([H])C([H])([H])C([H])([H])C([O-])=O)[C@]([H])(SC([H])([H])[C@]([H])(N([H])C(=O)C([H])([H])C([H])([H])[C@@]([H])(C([O-])=O)[N+]([H])([H])[H])C(=O)N([H])C([H])([H])C([O-])=O)C([H])=C([H])C([H])=C([H])C([H])=C([H])C([H])([H])C([H])=C([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H],GWNVDXQDILPJIG-ISQRGXDUSA-L,"InChI=1S/C30H47N3O9S/c1-2-3-4-5-6-7-8-9-10-11-12-13-16-25(24(34)15-14-17-27(36)37)43-21-23(29(40)32-20-28(38)39)33-26(35)19-18-22(31)30(41)42/h6-7,9-13,16,22-25,34H,2-5,8,14-15,17-21,31H2,1H3,(H,32,40)(H,33,35)(H,36,37)(H,38,39)(H,41,42)/p-2/b7-6+,10-9-,12-11?,16-13-/t22-,23-,24-,25+/m0/s1"
5060,19871,a,a,28666,KEGG COMPOUND accession,C05951,leuktrD4,73836-78-9,1044940.0,"Human Metabolome Database (HMDB): Leukotriene D4 (LTD4) is a cysteinyl leukotriene a family of potent inflammatory mediators. LTD4 is a pro-inflammatory mediator known to mediate its effects through specific cell-surface receptors belonging to the G-protein-coupled receptor family, namely the high-affinity CysLT1 (cysteinyl leukotriene 1) receptor. LTD4 is present at high levels in many inflammatory conditions, and areas of chronic inflammation have an increased risk for subsequent cancer development; LTD4 is associated with the pathogenesis of several inflammatory disorders, such as asthma and inflammatory bowel disease. Exposure to LTD4 increases survival and proliferation in intestinal epithelial cells. CysLT1 regulator is up-regulated in colon cancer tissue and LTD4 signalling facilitates the survival of cancer cells. LTD4 could reduce apoptosis in non-transformed epithelial cells. LTD4 causes up-regulation of b-catenin through the CysLT1 receptor, PI3K (phosphoinositide 3-kinase) and GSK-3b (glycogen synthase kinase 3b). LTD4 induces b-catenin translocation to the nucleus and activation of TCF/LEF family of transcription factors. LTD4 causes accumulation of free b-catenin in non-transformed intestinal epithelial cells through the CysLT1 receptor, and this accumulation is dependent upon the activation of PI3K as well as GSK-3b inactivation. (PMID: 16042577, 12607939). Leukotrienes are eicosanoids. The eicosanoids consist of the prostaglandins (PGs), thromboxanes (TXs), leukotrienes (LTs) and lipoxins (LXs). The PGs and TXs are collectively identified as prostanoids. Prostaglandins were originally shown to be synthesized in the prostate gland, thromboxanes from platelets (thrombocytes) and leukotrienes from leukocytes, hence the derivation of their names. All mammalian cells except erythrocytes synthesize eicosanoids. These molecules are extremely potent, able to cause profound physiological effects at very dilute concentrations. All eicosanoids function locally at the site of synthesis, through receptor-mediated G-protein linked signaling pathways.",Leukotriene D4,HMDB0003080,b,b,C05951,CPD66-21,FDB023105,leuktrD4,[H]O[C@@]([H])(C([H])([H])C([H])([H])C([H])([H])C([O-])=O)[C@]([H])(SC([H])([H])C([H])(C(=O)N([H])C([H])([H])C([O-])=O)[N+]([H])([H])[H])C([H])=C([H])C([H])=C([H])C([H])=C([H])C([H])([H])C([H])=C([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H],YEESKJGWJFYOOK-QLXUYSGYSA-M,"InChI=1S/C25H40N2O6S/c1-2-3-4-5-6-7-8-9-10-11-12-13-16-22(21(28)15-14-17-23(29)30)34-19-20(26)25(33)27-18-24(31)32/h6-7,9-13,16,20-22,28H,2-5,8,14-15,17-19,26H2,1H3,(H,27,33)(H,29,30)(H,31,32)/p-1/b7-6-,10-9-,12-11?,16-13-/t20-,21-,22+/m0/s1"
5061,19873,a,a,15650,KEGG COMPOUND accession,C05952,leuktrE4,75715-89-8,15650.0,"Human Metabolome Database (HMDB): Leukotriene E4 (LTE4) is a cysteinyl leukotriene. Cysteinyl leukotrienes (CysLTs) are a family of potent inflammatory mediators that appear to contribute to the pathophysiologic features of allergic rhinitis. Nasal blockage induced by CysLTs is mainly due to dilatation of nasal blood vessels, which can be induced by the nitric oxide produced through CysLT1 receptor activation. LTE4 activates contractile and inflammatory processes via specific interaction with putative seven transmembrane-spanning receptors that couple to G proteins and subsequent intracellular signaling pathways. LTE4 is metabolized from leukotriene C4 in a reaction catalyzed by gamma-glutamyl transpeptidase and a particulate dipeptidase from kidney (PMID: 12607939, 12432945, 6311078). Leukotrienes are eicosanoids. The eicosanoids consist of the prostaglandins (PGs), thromboxanes (TXs), leukotrienes (LTs), and lipoxins (LXs). The PGs and TXs are collectively identified as prostanoids. Prostaglandins were originally shown to be synthesized in the prostate gland, thromboxanes from platelets (thrombocytes), and leukotrienes from leukocytes, hence the derivation of their names. All mammalian cells except erythrocytes synthesize eicosanoids. These molecules are extremely potent and are able to cause profound physiological effects at very dilute concentrations. All eicosanoids function locally at the site of synthesis through receptor-mediated G-protein linked signaling pathways.",Leukotriene E4,HMDB0002200,b,b,C05952,7E9E11Z14Z-5S6R-6-CYSTEIN-S-YL,FDB022901,leuktrE4,[H]O[C@@]([H])(C([H])([H])C([H])([H])C([H])([H])C([O-])=O)[C@]([H])(SC([H])([H])C([H])(C([O-])=O)[N+]([H])([H])[H])C([H])=C([H])C([H])=C([H])C([H])=C([H])C([H])([H])C([H])=C([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H],OTZRAYGBFWZKMX-FRFVZSDQSA-M,"InChI=1S/C23H37NO5S/c1-2-3-4-5-6-7-8-9-10-11-12-13-16-21(30-18-19(24)23(28)29)20(25)15-14-17-22(26)27/h6-7,9-13,16,19-21,25H,2-5,8,14-15,17-18,24H2,1H3,(H,26,27)(H,28,29)/p-1/b7-6-,10-9-,12-11+,16-13+/t19-,20-,21+/m0/s1"
5062,19876,a,a,6427,KEGG COMPOUND accession,C07612,,,,,,,,,,,,,,,
5063,19890,a,a,28796,KEGG COMPOUND accession,C01355,levan1000,9013-95-0,b,"Human Metabolome Database (HMDB): Levan is a substantial component of bacterial plaque produced by certain streptococci and actinomyces, and lipopolysaccharides from Gram-negative bacteria. These bacterial products are B cell mitogens which may have an adjuvant or tolerizing effect on immune responses. (PubMed ID 346320 ).",Levan,HMDB0003539,b,b,C01355,LEVAN,FDB023192,b,b,AIHDCSAXVMAMJH-GFBKWZILSA-N,b
5064,19897,a,a,6437,KEGG COMPOUND accession,C07841,,,,,,,,,,,,,,,
5065,19899,a,a,6438,KEGG COMPOUND accession,C07914,,,,,,,,,,,,,,,
5066,19903,a,a,63598,KEGG COMPOUND accession,C07660,,,,,,,,,,,,,,,
5067,19905,a,a,6441,KEGG COMPOUND accession,C08012,,,,,,,,,,,,,,,
5068,19909,a,a,6443,KEGG COMPOUND accession,C08149,,,,,,,,,,,,,,,
5069,19915,a,a,6446,KEGG COMPOUND accession,C08212,,,,,,,,,,,,,,,
5070,19926,a,a,6452,KEGG COMPOUND accession,C00478,lichn,1402-10-4,6452.0,b,"Lichenin from Icelandic moss, 170 glucose residues. DOI: 10.1039/JR9570001951",b,b,b,C00478,b,b,b,b,b,b
5071,19930,a,a,18131,KEGG COMPOUND accession,C01592,,,,,,,,,,,,,,,
5072,19933,a,a,28620,KEGG COMPOUND accession,C10486,,,,,,,,,,,,,,,
5073,19935,a,a,6456,KEGG COMPOUND accession,C07073,,,,,,,,,,,,,,,
5074,19940,a,a,28866,KEGG COMPOUND accession,C08320,lgnc,557-59-5,28866.0,"Human Metabolome Database (HMDB): Lignoceric acid, also tetracosanoic acid, is a normal carboxylic acid, a very long chain fatty acid (VLCFA). Very long chain fatty acids (VLCFAs) are exclusively oxidized in peroxisomes and their levels are significantly increased in tissues of patients with peroxisomal disorders. (PMID 15565636).",Tetracosanoic acid,HMDB0002003,b,b,C08320,TETRACOSANOATE,FDB021823,lgnc,[H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([O-])=O,QZZGJDVWLFXDLK-UHFFFAOYSA-M,"InChI=1S/C24H48O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20-21-22-23-24(25)26/h2-23H2,1H3,(H,25,26)/p-1"
5075,19949,a,a,15384,KEGG COMPOUND accession,C06078,,,,,,,,,,,,,,,
5076,19958,a,a,16226,KEGG COMPOUND accession,C03514,,,,,,,,,,,,,,,
5077,19962,a,a,6469,KEGG COMPOUND accession,C09863,,,,,,,,,,,,,,,
5078,19964,a,a,16441,KEGG COMPOUND accession,C01594,,,,,,,,,,,,,,,
5079,19968,a,a,6472,KEGG COMPOUND accession,C06812,,,,,,,,,,,,,,,
5080,19970,a,a,32888,KEGG COMPOUND accession,C07075,,,,,,,,,,,,,,,
5081,19977,a,a,63607,KEGG COMPOUND accession,C08146,,,,,,,,,,,,,,,
5082,19987,a,a,15530,KEGG COMPOUND accession,C02050,lnlccoa,6709-57-5,15530.0,"Human Metabolome Database (HMDB): Linoleoyl-CoA is the acyl-CoA of linoleic acid found in the human body. It binds to and results in decreased activity of Glutathione S-transferase1. It has been proposed that inhibition of mitochondrial adenine nucleotide translocator by long chain acyl-CoA underlies the mechanism associating obesity and type 2 diabetes. Unsaturated fatty acids play an important role in the prevention of human diseases such as diabetes, obesity, cancer, and neurodegeneration. Their oxidation in vivo by acyl-CoA dehydrogenases (ACADs) catalyze the first step of each cycle of mitochondrial fatty acid {beta}-oxidation; ACAD-9 had maximal activity with long-chain unsaturated acyl-CoAs as substrates. (PMID: 17184976, 16020546).",Linoleoyl-CoA,HMDB0001064,b,b,C02050,CPD-18,FDB022403,lnlccoa,[H]O[C@@]([H])(C(=O)N([H])C([H])([H])C([H])([H])C(=O)N([H])C([H])([H])C([H])([H])SC(=O)C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C(\[H])=C(\[H])C([H])([H])C(\[H])=C(\[H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H])C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])OP([O-])(=O)OP([O-])(=O)OC([H])([H])[C@@]1([H])O[C@@]([H])(N2C([H])=NC3=C(N=C([H])N=C23)N([H])[H])[C@]([H])(O[H])[C@]1([H])OP([O-])([O-])=O,YECLLIMZHNYFCK-RRNJGNTNSA-J,"InChI=1S/C39H66N7O17P3S/c1-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-30(48)67-23-22-41-29(47)20-21-42-37(51)34(50)39(2,3)25-60-66(57,58)63-65(55,56)59-24-28-33(62-64(52,53)54)32(49)38(61-28)46-27-45-31-35(40)43-26-44-36(31)46/h8-9,11-12,26-28,32-34,38,49-50H,4-7,10,13-25H2,1-3H3,(H,41,47)(H,42,51)(H,55,56)(H,57,58)(H2,40,43,44)(H2,52,53,54)/p-4/b9-8-,12-11-/t28-,32-,33-,34+,38-/m1/s1"
5083,19990,a,a,6482,KEGG COMPOUND accession,C11007,,,,,,,,,,,,,,,
5084,19998,a,a,18059,KEGG COMPOUND accession,C01356,,,,,,,,,,,,,,,
5085,29059,a,a,9066,KEGG COMPOUND accession,C05691,seasmet,b,b,Human Metabolome Database (HMDB): Se-Adenosylselenomethionine is an intermediate in Selenoamino acid metabolism. Se-Adenosylselenomethionine is converted from Selenomethionine via the enzyme S-adenosylmethionine synthetase (EC 2.5.1.6). It is then. converted to Se-Adenosylselenohomocysteine via the enzyme Transferases (EC 2.1.1.-).,Se-Adenosylselenomethionine,HMDB0011118,b,b,C05691,b,FDB027900,b,[H]O[C@@]1([H])[C@@]([H])(O[C@]([H])(C([H])([H])[Se+](C([H])([H])[H])C([H])([H])C([H])([H])[C@@]([H])(C([O-])=O)[N+]([H])([H])[H])[C@@]1([H])O[H])N1C([H])=NC2=C(N=C([H])N=C12)N([H])[H],GGJFWMOVUFBSIN-AIRLBKTGSA-O,"InChI=1S/C15H22N6O5Se/c1-27(3-2-7(16)15(24)25)4-8-10(22)11(23)14(26-8)21-6-20-9-12(17)18-5-19-13(9)21/h5-8,10-11,14,22-23H,2-4,16H2,1H3,(H2-,17,18,19,24,25)/p+1/t7-,8+,10+,11+,14+,27?/m0/s1"
5086,29079,a,a,18002,KEGG COMPOUND accession,C01852,,,,,,,,,,,,,,,
5087,29092,a,a,16802,KEGG COMPOUND accession,C02076,M03165,3019-74-7,130460.0,"Human Metabolome Database (HMDB): Sedoheptulose is a ketoheptose, a monosaccharide with seven carbon atoms and a ketone functional group. It is one of the few heptoses found in nature. Sedoheptulose is a seven-carbon ketose sugar originally found in Sedum spectabile, a common perennial garden plant. Later it was shown to be widely distributed in the plants of the Crassulaceae family. The Crassulaceae, or orpine family, is a family of dicotyledons. They store water in their succulent leaves. They are found worldwide, but mostly occur in the Northern Hemisphere and southern Africa, typically in dry and/or cold areas where water may be scarce. The family includes about 1,400 species in 33 genera. As a result, this sugar is often found to be part of the human diet. This sugar, D-sedoheptulose (I), is a significant intermediary compound in the cyclic regeneration of D-ribulose. It also plays an important role as a transitory compound in the cyclic regeneration of D-ribulose for carbon dioxide fixation in plant photosynthesis. -- www.accessscience.com.",Sedoheptulose,HMDB0003219,b,b,C02076,CPD-3614,FDB004279,b,[H]OC([H])([H])[C@@]1([H])OC(O[H])(C([H])([H])O[H])[C@@]([H])(O[H])[C@]([H])(O[H])[C@]1([H])O[H],HAIWUXASLYEWLM-QTSLKERKSA-N,"InChI=1S/C7H14O7/c8-1-3-4(10)5(11)6(12)7(13,2-9)14-3/h3-6,8-13H,1-2H2/t3-,4-,5-,6+,7?/m1/s1"
5088,29095,a,a,17969,KEGG COMPOUND accession,C00447,HC00361,9055-32-7,17969.0,Human Metabolome Database (HMDB): This compound belongs to the family of Monosaccharide Phosphates. These are monosaccharides comprising a phosphated group linked tot he carbohydrate unit.,"Sedoheptulose 1,7-bisphosphate",HMDB0060274,b,b,C00447,b,b,HC00361,[H]O[C@]([H])(C(=O)C([H])([H])OP([O-])([O-])=O)[C@]([H])(O[H])[C@]([H])(O[H])[C@]([H])(O[H])C([H])([H])OP([O-])([O-])=O,OKHXOUGRECCASI-SHUUEZRQSA-J,"InChI=1S/C7H16O13P2/c8-3(1-19-21(13,14)15)5(10)7(12)6(11)4(9)2-20-22(16,17)18/h3,5-8,10-12H,1-2H2,(H2,13,14,15)(H2,16,17,18)/p-4/t3-,5-,6-,7-/m1/s1"
5089,29100,a,a,9082,KEGG COMPOUND accession,C06222,M03166,b,9082.0,Human Metabolome Database (HMDB): This compound belongs to the family of Monosaccharide Phosphates. These are monosaccharides comprising a phosphated group linked tot he carbohydrate unit.,Sedoheptulose 1-phosphate,HMDB0060509,b,b,C06222,b,b,b,[H]OC([H])([H])[C@@]([H])(O[H])[C@@]([H])(O[H])[C@@]([H])(O[H])[C@]([H])(O[H])C(=O)C([H])([H])OP(=O)(O[H])O[H],JPTRNFAYXMBCLJ-SHUUEZRQSA-N,"InChI=1S/C7H15O10P/c8-1-3(9)5(11)7(13)6(12)4(10)2-17-18(14,15)16/h3,5-9,11-13H,1-2H2,(H2,14,15,16)/t3-,5-,6-,7-/m1/s1"
5090,28403,a,a,8884,KEGG COMPOUND accession,C07556,,,,,,,,,,,,,,,
5091,28840,a,a,17728,KEGG COMPOUND accession,C03172,,,,,,,,,,,,,,,
5092,28962,a,a,9024,KEGG COMPOUND accession,C10180,,,,,,,,,,,,,,,
5093,29040,a,a,16065,KEGG COMPOUND accession,C01527,,,,,,,,,,,,,,,
5094,29047,a,a,9061,KEGG COMPOUND accession,C10183,,,,,,,,,,,,,,,
5095,29049,a,a,9062,KEGG COMPOUND accession,C10184,,,,,,,,,,,,,,,
5096,28237,a,a,17898,KEGG COMPOUND accession,C00376,retinal,116-31-4,17898.0,"Human Metabolome Database (HMDB): Retinal is a carotenoid constituent of visual pigments. It is the oxidized form of retinol which functions as the active component of the visual cycle. It is bound to the protein opsin forming the complex rhodopsin. When stimulated by visible light, the retinal component of the rhodopsin complex undergoes isomerization at the 11-position of the double bond to the cis-form; this is reversed in ""dark"" reactions to return to the native trans-configuration.",Retinal,HMDB0001358,b,b,C00376,CPD-881,FDB022576,retinal,[H]C(=O)C([H])=C(C([H])=C([H])C([H])=C(C([H])=C([H])C1=C(C([H])([H])[H])C([H])([H])C([H])([H])C([H])([H])C1(C([H])([H])[H])C([H])([H])[H])C([H])([H])[H])C([H])([H])[H],NCYCYZXNIZJOKI-UHFFFAOYSA-N,"InChI=1S/C20H28O/c1-16(8-6-9-17(2)13-15-21)11-12-19-18(3)10-7-14-20(19,4)5/h6,8-9,11-13,15H,7,10,14H2,1-5H3"
5097,28237,a,a,17898,KEGG COMPOUND accession,C00376,retinal_cis_9,116-31-4,17898.0,"Human Metabolome Database (HMDB): Retinal is a carotenoid constituent of visual pigments. It is the oxidized form of retinol which functions as the active component of the visual cycle. It is bound to the protein opsin forming the complex rhodopsin. When stimulated by visible light, the retinal component of the rhodopsin complex undergoes isomerization at the 11-position of the double bond to the cis-form; this is reversed in ""dark"" reactions to return to the native trans-configuration.",Retinal,HMDB0001358,b,b,C00376,CPD-881,FDB022576,retinal_cis_9,[H]C(=O)C(\[H])=C(\C(\[H])=C(/[H])\C(\[H])=C(\C(\[H])=C(/[H])C1=C(C([H])([H])[H])C([H])([H])C([H])([H])C([H])([H])C1(C([H])([H])[H])C([H])([H])[H])/C([H])([H])[H])/C([H])([H])[H],NCYCYZXNIZJOKI-OVSJKPMPSA-N,"InChI=1S/C20H28O/c1-16(8-6-9-17(2)13-15-21)11-12-19-18(3)10-7-14-20(19,4)5/h6,8-9,11-13,15H,7,10,14H2,1-5H3/b9-6+,12-11+,16-8+,17-13+"
5098,20006,a,a,17460,KEGG COMPOUND accession,C00248,lpam,940-69-2,17460.0,"Human Metabolome Database (HMDB): Lipoamide is a trivial name for 6,8-dithiooctanoic amide. It is 6,8-dithiooctanoic acid's functional form where the carboxyl group is attached to protein (or any other amine) by an amide linkage (containing -NH2) to an amino group. Lipoamide forms a thioester bond, oxidizing the disulfide bond, with acetaldehyde (pyruvate after it has been decarboxylated). It then transfers the acetaldehyde group to CoA which can then continue in the TCA cycle. (Wikipedia). Lipoamide is an intermediate in glycolysis/gluconeogenesis, citrate cycle (TCA cycle), alanine, aspartate and pyruvate metabolism, and valine, leucine and isoleucine degradation (KEGG:C00248). It is generated from dihydrolipoamide via the enzyme dihydrolipoamide dehydrogenase (EC:1.8.1.4) and then converted to S-glutaryl-dihydrolipoamide via the enzyme oxoglutarate dehydrogenase (EC:1.2.4.2).",Lipoamide,HMDB0000962,b,b,C00248,LIPOAMIDE,FDB022340,lpam,[H]N([H])C(=O)C([H])([H])C([H])([H])C([H])([H])C([H])([H])C1([H])SSC([H])([H])C1([H])[H],FCCDDURTIIUXBY-UHFFFAOYSA-N,"InChI=1S/C8H15NOS2/c9-8(10)4-2-1-3-7-5-6-11-12-7/h7H,1-6H2,(H2,9,10)"
5099,20023,a,a,6495,KEGG COMPOUND accession,C01834,,,,,,,,,,,,,,,
5100,20026,a,a,6498,KEGG COMPOUND accession,C06314,C06314,89663-86-5,6498.0,"Human Metabolome Database (HMDB): Lipoxin A4 (LXA4) was first identified in 1984 by Serhan and colleagues as 5-lipoxygenase interaction product of activated leukocytes. Endogenous transcellular biosynthesis of LXA4 occurs via interaction of leukocytes with epithelium, endothelium or platelets. Lipoxins (LXs) or the lipoxygenase interaction products are generated from arachidonic acid via sequential actions of lipoxygenases and subsequent reactions to give specific trihydroxytetraene-containing eicosanoids. These unique structures are formed during cell-cell interactions and appear to act at both temporal and spatially distinct sites from other eicosanoids produced during the course of inflammatory responses and to stimulate natural resolution. Lipoxin A4 (LXA4) and lipoxin B4 (LXB4) are positional isomers that each possesses potent cellular and in vivo actions. These LX structures are conserved across species. The results of numerous studies reviewed in this work now confirm that they are the first recognized eicosanoid chemical mediators that display both potent anti-inflammatory and pro-resolving actions in vivo in disease models that include rabbit, rat, and mouse systems. LXs act at specific GPCRs as agonists to regulate cellular responses of interest in inflammation and resolution. Aspirin has a direct impact in the LX circuit by triggering the biosynthesis of endogenous epimers of LX, termed the aspirin-triggered 15-epi-LX, that share the potent anti-inflammatory actions of LX. (PMID: 16005201, 16613568).",Lipoxin A4,HMDB0004385,b,b,C06314,b,FDB023370,C06314,[H]O[C@]([H])(C([H])=C([H])C(\[H])=C(\[H])/C(/[H])=C(\[H])/C(/[H])=C(\[H])[C@@]([H])(O[H])[C@@]([H])(O[H])C([H])([H])C([H])([H])C([H])([H])C([O-])=O)C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H],IXAQOQZEOGMIQS-SNDKYGBFSA-M,"InChI=1S/C20H32O5/c1-2-3-8-12-17(21)13-9-6-4-5-7-10-14-18(22)19(23)15-11-16-20(24)25/h4-7,9-10,13-14,17-19,21-23H,2-3,8,11-12,15-16H2,1H3,(H,24,25)/p-1/b6-4-,7-5+,13-9?,14-10+/t17-,18+,19-/m0/s1"
5101,20027,a,a,6499,KEGG COMPOUND accession,C06315,C06315,98049-69-5,6499.0,"Human Metabolome Database (HMDB): Lipoxins (LXs) and aspirin-triggered Lipoxin (ATL) are trihydroxytetraene-containing eicosanoids generated from arachidonic acid that are distinct in structure, formation, and function from the many other proinflammatory lipid-derived mediators. These endogenous eicosanoids have now emerged as founding members of the first class of lipid/chemical mediators involved in the resolution of the inflammatory response. Lipoxin A4 (LXA4), ATL, and their metabolic stable analogs elicit cellular responses and regulate leukocyte trafficking in vivo by activating the specific receptor, ALX. Many of the eicosanoids derived from arachidonic acid (AA2), including prostaglandins (PGs) and leukotrienes (LTs), play important roles as local mediators exerting a wide range of actions relevant in immune hypersensitivity and inflammation. However, recent observations indicate that other agents derived from the lipoxygenase (LO) pathways are formed and play a key role in initiating the resolution of acute inflammation. This phenomenon is an active process that is governed by specific lipid mediators and involves a series of well-orchestrated temporal events. Thus, potent locally released mediators serve as checkpoint controllers of inflammation. In addition to the well-appreciated ability of aspirin to inhibit PGs, aspirin also acetylates cyclooxygenase (COX)-2, triggering the formation of a 15-epimeric form of lipoxins, termed aspirin-triggered LXA4 (ATL). These eicosanoids (i.e., LXA4 and ATL) with a unique trihydroxytetraene structure function as 'stop signals' in inflammation and actively participate in dampening host responses to bring the inflammation to a close, namely, resolution. LXA4 and ATL elicit the multicellular responses via a specific G protein-coupled receptor (GPCR) termed ALX that has been identified in human. (PMID: 16968948, 11478982).",Lipoxin B4,HMDB0005082,b,b,C06315,b,FDB023621,C06315,[H]O[C@]([H])(C([H])=C([H])C([H])=C([H])C(\[H])=C(/[H])\C(\[H])=C(/[H])[C@@]([H])(O[H])[C@@]([H])(O[H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H])C([H])([H])C([H])([H])C([H])([H])C([O-])=O,UXVRTOKOJOMENI-DXEGFZHISA-M,"InChI=1S/C20H32O5/c1-2-3-8-14-18(22)19(23)15-10-7-5-4-6-9-12-17(21)13-11-16-20(24)25/h4-7,9-10,12,15,17-19,21-23H,2-3,8,11,13-14,16H2,1H3,(H,24,25)/p-1/b6-4-,7-5+,12-9-,15-10+/t17-,18+,19-/m0/s1"
5102,20028,a,a,15804,KEGG COMPOUND accession,C02051,lpro,b,15804.0,b,Lipoylprotein,b,b,b,C02051,b,b,lpro,[H]N([*])C(=O)C([H])([H])C([H])([H])C([H])([H])C([H])([H])C1([H])SSC([H])([H])C1([H])[H],b,b
5103,20031,a,a,28777,KEGG COMPOUND accession,C09762,,,,,,,,,,,,,,,
5104,20037,a,a,6504,KEGG COMPOUND accession,C07964,,,,,,,,,,,,,,,
5105,20047,a,a,48723,KEGG COMPOUND accession,C07475,,,,,,,,,,,,,,,
5106,20049,a,a,6510,KEGG COMPOUND accession,C11676,,,,,,,,,,,,,,,
5107,20062,a,a,27799,KEGG COMPOUND accession,C08874,,,,,,,,,,,,,,,
5108,20066,a,a,116278,KEGG COMPOUND accession,C07078,,,,,,,,,,,,,,,
5109,20068,a,a,6518,KEGG COMPOUND accession,C08053,,,,,,,,,,,,,,,
5110,20072,a,a,6520,KEGG COMPOUND accession,C07079,,,,,,,,,,,,,,,
5111,20074,a,a,6521,KEGG COMPOUND accession,C10491,,,,,,,,,,,,,,,
5112,20078,a,a,33184,KEGG COMPOUND accession,C02843,,,,,,,,,,,,,,,
5113,20087,a,a,17176,KEGG COMPOUND accession,C00609,,,,,,,,,,,,,,,
5114,20100,a,a,15904,KEGG COMPOUND accession,C00638,,,,,,,,,,,,,,,
5115,20133,a,a,6543,KEGG COMPOUND accession,C10495,,,,,,,,,,,,,,,
5116,20135,a,a,40303,KEGG COMPOUND accession,C07074,,,,,,,,,,,,,,,
5117,20142,a,a,50841,KEGG COMPOUND accession,C07104,,,,,,,,,,,,,,,
5118,20146,a,a,6550,KEGG COMPOUND accession,C11805,,,,,,,,,,,,,,,
5119,20148,a,a,27774,KEGG COMPOUND accession,C09700,,,,,,,,,,,,,,,
5120,20150,a,a,51052,KEGG COMPOUND accession,C11715,,,,,,,,,,,,,,,
5121,20152,a,a,6553,KEGG COMPOUND accession,C10102,,,,,,,,,,,,,,,
5122,20158,a,a,6556,KEGG COMPOUND accession,C09869,,,,,,,,,,,,,,,
5123,20162,a,a,17706,KEGG COMPOUND accession,C02555,,,,,,,,,,,,,,,
5124,20164,a,a,6559,KEGG COMPOUND accession,C08335,,,,,,,,,,,,,,,
5125,20168,a,a,17781,KEGG COMPOUND accession,C01727,,,,,,,,,,,,,,,
5126,20178,a,a,6566,KEGG COMPOUND accession,C10603,,,,,,,,,,,,,,,
5127,20186,a,a,6570,KEGG COMPOUND accession,C08628,,,,,,,,,,,,,,,
5128,20193,a,a,28012,KEGG COMPOUND accession,C10773,,,,,,,,,,,,,,,
5129,20195,a,a,6574,KEGG COMPOUND accession,C10706,,,,,,,,,,,,,,,
5130,20201,a,a,27448,KEGG COMPOUND accession,C08602,,,,,,,,,,,,,,,
5131,20208,a,a,6579,KEGG COMPOUND accession,C10103,,,,,,,,,,,,,,,
5132,20210,a,a,37645,KEGG COMPOUND accession,C04900,,,,,,,,,,,,,,,
5133,20215,a,a,27994,KEGG COMPOUND accession,C03951,,,,,,,,,,,,,,,
5134,20217,a,a,18128,KEGG COMPOUND accession,C03515,,,,,,,,,,,,,,,
5135,20220,a,a,6584,KEGG COMPOUND accession,C08652,,,,,,,,,,,,,,,
5136,20222,a,a,27917,KEGG COMPOUND accession,C10498,,,,,,,,,,,,,,,
5137,20228,a,a,27603,KEGG COMPOUND accession,C08242,,,,,,,,,,,,,,,
5138,20247,a,a,6597,KEGG COMPOUND accession,C09883,,,,,,,,,,,,,,,
5139,20257,a,a,6602,KEGG COMPOUND accession,C08603,,,,,,,,,,,,,,,
5140,20263,a,a,6605,KEGG COMPOUND accession,C07542,,,,,,,,,,,,,,,
5141,20274,a,a,6610,KEGG COMPOUND accession,C10604,,,,,,,,,,,,,,,
5142,20284,a,a,6618,KEGG COMPOUND accession,C11684,,,,,,,,,,,,,,,
5143,20290,a,a,17101,KEGG COMPOUND accession,C06165,,,,,,,,,,,,,,,
5144,20299,a,a,17371,KEGG COMPOUND accession,C00744,,,,,,,,,,,,,,,
5145,20311,a,a,6631,KEGG COMPOUND accession,C10605,,,,,,,,,,,,,,,
5146,20318,a,a,18420,KEGG COMPOUND accession,C00305,,,,,,,,,,,,,,,
5147,20320,a,a,6636,KEGG COMPOUND accession,C07755,,,,,,,,,,,,,,,
5148,20322,a,a,6637,KEGG COMPOUND accession,C07876,,,,,,,,,,,,,,,
5149,20324,a,a,15431,KEGG COMPOUND accession,C03516,,,,,,,,,,,,,,,
5150,20326,a,a,15432,KEGG COMPOUND accession,C04536,,,,,,,,,,,,,,,
5151,20338,a,a,6645,KEGG COMPOUND accession,C10658,,,,,,,,,,,,,,,
5152,20342,a,a,6647,KEGG COMPOUND accession,C10234,,,,,,,,,,,,,,,
5153,20344,a,a,27620,KEGG COMPOUND accession,C08829,,,,,,,,,,,,,,,
5154,20348,a,a,6650,KEGG COMPOUND accession,C00711,,,,,,,,,,,,,,,
5155,20352,a,a,6651,KEGG COMPOUND accession,C07497,,,,,,,,,,,,,,,
5156,20354,a,a,29045,KEGG COMPOUND accession,C01596,,,,,,,,,,,,,,,
5157,20358,a,a,18300,KEGG COMPOUND accession,C01384,,,,,,,,,,,,,,,
5158,20362,a,a,16072,KEGG COMPOUND accession,C07272,,,,,,,,,,,,,,,
5159,20365,a,a,30859,KEGG COMPOUND accession,C02167,,,,,,,,,,,,,,,
5160,20374,a,a,28334,KEGG COMPOUND accession,C06625,,,,,,,,,,,,,,,
5161,20375,a,a,30794,KEGG COMPOUND accession,C00383,HC00319,141-82-2,30794.0,"Human Metabolome Database (HMDB): Malonic acid (IUPAC systematic name: propanedioic acid) is a dicarboxylic acid with structure CH2(COOH)2. The ionised form of malonic acid, as well as its esters and salts, are known as malonates. For example, diethyl malonate is malonic acid's ethyl ester. The name originates from Latin malum, meaning apple. Malonic acid is the archetypal example of a competitive inhibitor: it acts against succinate dehydrogenase (complex II) in the respiratory electron transport chain. Malonic acid is found to be associated with malonyl-CoA decarboxylase deficiency, which is an inborn error of metabolism.",Malonic acid,HMDB0000691,b,b,C00383,MALONATE,FDB008117,HC00319,[H]C([H])(C([O-])=O)C([O-])=O,OFOBLEOULBTSOW-UHFFFAOYSA-L,"InChI=1S/C3H4O4/c4-2(5)1-3(6)7/h1H2,(H,4,5)(H,6,7)/p-2"
5162,20380,a,a,15531,KEGG COMPOUND accession,C00083,malcoa,524-14-1,15531.0,Human Metabolome Database (HMDB): Malonyl-CoA is a coenzyme A derivative which plays a key role in the fatty acid synthesis in the cytoplasmic and microsomal systems.,Malonyl-CoA,HMDB0001175,b,b,C00083,MALONYL-COA,FDB001606,malcoa,[H]O[C@@]([H])(C(=O)N([H])C([H])([H])C([H])([H])C(=O)N([H])C([H])([H])C([H])([H])SC(=O)C([H])([H])C([O-])=O)C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])OP([O-])(=O)OP([O-])(=O)OC([H])([H])[C@@]1([H])O[C@@]([H])(N2C([H])=NC3=C(N=C([H])N=C23)N([H])[H])[C@]([H])(O[H])[C@]1([H])OP([O-])([O-])=O,LTYOQGRJFJAKNA-DVVLENMVSA-I,"InChI=1S/C24H38N7O19P3S/c1-24(2,19(37)22(38)27-4-3-13(32)26-5-6-54-15(35)7-14(33)34)9-47-53(44,45)50-52(42,43)46-8-12-18(49-51(39,40)41)17(36)23(48-12)31-11-30-16-20(25)28-10-29-21(16)31/h10-12,17-19,23,36-37H,3-9H2,1-2H3,(H,26,32)(H,27,38)(H,33,34)(H,42,43)(H,44,45)(H2,25,28,29)(H2,39,40,41)/p-5/t12-,17-,18-,19+,23-/m1/s1"
5163,20401,a,a,17330,KEGG COMPOUND accession,C01209,malACP,b,b,b,Malonyl-[Acyl-Carrier Protein],b,b,b,C01209,b,b,b,[H]OC(=O)C([H])([H])C(=O)S[*],b,b
5164,20406,a,a,17155,KEGG COMPOUND accession,C04385,,,,,,,,,,,,,,,
5165,20418,a,a,17306,KEGG COMPOUND accession,C00208,malt,69-79-4,47937.0,"Human Metabolome Database (HMDB): Maltose, or malt sugar, is a primary disaccharide in the human diet formed from two units of glucose joined with an alpha (1->4) linkage. It is the second member of an important biochemical series of glucose chains. The addition of another glucose unit yields maltotriose, Further additions will produce dextrins, also called maltodextrins, and eventually starch. Maltose can be broken down into two glucose molecules by hydrolysis in living organisms. At the surface of the small intestine, the brush border enzymes maltase, breaks down maltose. (PMID: 14522745).",D-Maltose,HMDB0000163,b,b,C00208,MALTOSE,FDB001193,malt,[H]OC([H])([H])[C@@]1([H])O[C@]([H])(O[C@@]2([H])[C@]([H])(O[H])[C@@]([H])(O[H])C([H])(O[H])O[C@]2([H])C([H])([H])O[H])[C@]([H])(O[H])[C@@]([H])(O[H])[C@]1([H])O[H],GUBGYTABKSRVRQ-PICCSMPSSA-N,"InChI=1S/C12H22O11/c13-1-3-5(15)6(16)9(19)12(22-3)23-10-4(2-14)21-11(20)8(18)7(10)17/h3-20H,1-2H2/t3-,4-,5-,6+,7-,8-,9-,10-,11?,12-/m1/s1"
5166,20428,a,a,15703,KEGG COMPOUND accession,C02995,,,,,,,,,,,,,,,
5167,20434,a,a,27931,KEGG COMPOUND accession,C01835,malttr,1109-28-0,27931.0,"Human Metabolome Database (HMDB): Maltotriose is a common oligosaccharide metabolite found in human urine after maltose ingestion or infusion (PMID 6645121). Maltotriose is increased in Glycogen storage disease II (OMIM 232300) due to a mutation of the enzyme alpha-1,4-glucosidase (E.C. 3.2.1.20) (4286143).",Maltotriose,HMDB0001262,b,b,C01835,MALTOTRIOSE,FDB001196,malttr,[H]OC([H])([H])[C@@]1([H])O[C@]([H])(O[C@@]2([H])[C@]([H])(O[H])[C@@]([H])(O[H])[C@@]([H])(O[C@@]3([H])[C@]([H])(O[H])[C@@]([H])(O[H])[C@@]([H])(O[H])O[C@]3([H])C([H])([H])O[H])O[C@]2([H])C([H])([H])O[H])[C@]([H])(O[H])[C@@]([H])(O[H])[C@]1([H])O[H],FYGDTMLNYKFZSV-PXXRMHSHSA-N,"InChI=1S/C18H32O16/c19-1-4-7(22)8(23)12(27)17(31-4)34-15-6(3-21)32-18(13(28)10(15)25)33-14-5(2-20)30-16(29)11(26)9(14)24/h4-29H,1-3H2/t4-,5-,6-,7-,8+,9-,10-,11-,12-,13-,14-,15-,16+,17-,18-/m1/s1"
5168,20436,a,a,6673,KEGG COMPOUND accession,C08321,,,,,,,,,,,,,,,
5169,20438,a,a,6674,KEGG COMPOUND accession,C08716,,,,,,,,,,,,,,,
5170,20454,a,a,18291,KEGG COMPOUND accession,C00034,,,,,,,,,,,,,,,
5171,20457,a,a,6682,KEGG COMPOUND accession,C10077,,,,,,,,,,,,,,,
5172,20461,a,a,28808,KEGG COMPOUND accession,C00464,,,,,,,,,,,,,,,
5173,20467,a,a,16899,KEGG COMPOUND accession,C00392,C01507,69-65-8,16899.0,"Human Metabolome Database (HMDB): Mannitol is a diuretic and renal diagnostic aid related to sorbitol. It has little significant energy value as it is largely eliminated from the body before any metabolism can take place. It can be used to treat oliguria associated with kidney failure or other manifestations of inadequate renal function and has been used for determination of glomerular filtration rate. Mannitol is also commonly used as a research tool in cell biological studies, usually to control osmolarity. Chemically, mannitol is an alcohol and a sugar, or a polyol; it is similar to xylitol or sorbitol. However, mannitol has a tendency to lose a hydrogen ion in aqueous solutions, which causes the solution to become acidic. For this, it is not uncommon to add a substance to adjust its pH, such as sodium bicarbonate. Mannitol is a non-permeating molecule i.e. it cannot cross biological membranes. Mannitol or hexan-1,2,3,4,5,6-hexol (C6H8(OH)6) is an osmotic diuretic agent and a weak renal vasodilator. It is a sorbitol isomer. Mannitol is found to be associated with cytochrome c oxidase deficiency and ribose-5-phosphate isomerase deficiency, which are inborn errors of metabolism.",Mannitol,HMDB0000765,b,b,C00392,b,FDB001982,b,[H]OC([H])([H])[C@]([H])(O[H])[C@@]([H])(O[H])[C@]([H])(O[H])[C@@]([H])(O[H])C([H])([H])O[H],FBPFZTCFMRRESA-UNTFVMJOSA-N,"InChI=1S/C6H14O6/c7-1-3(9)5(11)6(12)4(10)2-8/h3-12H,1-2H2/t3-,4-,5+,6+/m0/s1"
5174,20488,a,a,6694,KEGG COMPOUND accession,C08720,,,,,,,,,,,,,,,
5175,20490,a,a,6695,KEGG COMPOUND accession,C09276,,,,,,,,,,,,,,,
5176,20516,a,a,28925,KEGG COMPOUND accession,C07115,,,,,,,,,,,,,,,
5177,20520,a,a,6710,KEGG COMPOUND accession,C07117,,,,,,,,,,,,,,,
5178,20528,a,a,6714,KEGG COMPOUND accession,C01729,,,,,,,,,,,,,,,
5179,20531,a,a,6715,KEGG COMPOUND accession,C07119,,,,,,,,,,,,,,,
5180,20533,a,a,6716,KEGG COMPOUND accession,C08150,,,,,,,,,,,,,,,
5181,20535,a,a,6717,KEGG COMPOUND accession,C02168,,,,,,,,,,,,,,,
5182,20545,a,a,6722,KEGG COMPOUND accession,C07120,,,,,,,,,,,,,,,
5183,20547,a,a,6723,KEGG COMPOUND accession,C08151,,,,,,,,,,,,,,,
5184,20549,a,a,27915,KEGG COMPOUND accession,C08737,,,,,,,,,,,,,,,
5185,20561,a,a,16796,KEGG COMPOUND accession,C01598,melatn,73-31-4,16796.0,"Human Metabolome Database (HMDB): Melatonin is a biogenic amine that is found in animals, plants and microbes. Aaron B.Lerner of Yale University is credited for naming the hormone and for defining its chemical structure in 1958. In mammals, melatonin is produced by the pineal gland. The pineal gland is small endocrine gland, about the size of a rice grain and shaped like a pine cone (hence the name), that is located in the center of the brain (rostro-dorsal to the superior colliculus) but outside the blood-brain barrier. The secretion of melatonin increases in darkness and decreases during exposure to light, thereby regulating the circadian rhythms of several biological functions, including the sleep-wake cycle. In particular, melatonin regulates the sleep-wake cycle by chemically causing drowsiness and. lowering the body temperature. Melatonin is also implicated in the regulation of mood,learning and memory, immune activity, dreaming, fertility and reproduction. Melatonin is also an effective antioxidant. Most of the actions of melatonin are mediated through the binding and activation of melatonin receptors. Individuals with autism spectrum disorders(ASD) may have lower than normal levels of melatonin. A 2008 study found that unaffected parents of individuals with ASD also have lower melatonin levels, and that the deficits. were associated with low activity of the ASMT gene, which encodes the last enzyme of melatonin synthesis. Reduced melatonin production has also been proposed as a likely factor in the significantly higher cancer rates in night workers.",Melatonin,HMDB0001389,b,b,C01598,N-ACETYL-5-METHOXY-TRYPTAMINE,FDB004234,melatn,[H]N(C(=O)C([H])([H])[H])C([H])([H])C([H])([H])C1=C([H])N([H])C2=C([H])C([H])=C(OC([H])([H])[H])C([H])=C12,DRLFMBDRBRZALE-UHFFFAOYSA-N,"InChI=1S/C13H16N2O2/c1-9(16)14-6-5-10-8-15-13-4-3-11(17-2)7-12(10)13/h3-4,7-8,15H,5-6H2,1-2H3,(H,14,16)"
5186,20566,a,a,6731,KEGG COMPOUND accession,C08243,,,,,,,,,,,,,,,
5187,20579,a,a,6736,KEGG COMPOUND accession,C11198,,,,,,,,,,,,,,,
5188,20589,a,a,6741,KEGG COMPOUND accession,C08169,,,,,,,,,,,,,,,
5189,20600,a,a,28869,KEGG COMPOUND accession,C05377,,,,,,,,,,,,,,,
5190,20603,a,a,16374,KEGG COMPOUND accession,C00828,,,,,,,,,,,,,,,
5191,20608,a,a,6751,KEGG COMPOUND accession,C10919,,,,,,,,,,,,,,,
5192,20614,a,a,6754,KEGG COMPOUND accession,C07128,,,,,,,,,,,,,,,
5193,20622,a,a,6758,KEGG COMPOUND accession,C07829,,,,,,,,,,,,,,,
5194,20624,a,a,6759,KEGG COMPOUND accession,C07528,,,,,,,,,,,,,,,
5195,20636,a,a,41218,KEGG COMPOUND accession,C00928,,,,,,,,,,,,,,,
5196,20639,a,a,16208,KEGG COMPOUND accession,C00957,mercppyr,2464-23-5,16208.0,"Human Metabolome Database (HMDB): 3-Mercaptopyruvic acid is an intermediate in the metabolism of Cysteine. It is a substrate for L-lactate dehydrogenase A chain, 3-mercaptopyruvate sulfurtransferase, Aspartate aminotransferase (mitochondrial), L-lactate dehydrogenase C chain, L-lactate dehydrogenase A-like 6A, Aspartate aminotransferase (cytoplasmic), L-lactate dehydrogenase B chain and L-lactate dehydrogenase A-like 6B.",3-Mercaptopyruvic acid,HMDB0001368,b,b,C00957,3-MERCAPTO-PYRUVATE,FDB021862,mercppyr,[H]SC([H])([H])C(=O)C([O-])=O,OJOLFAIGOXZBCI-UHFFFAOYSA-M,"InChI=1S/C3H4O3S/c4-2(1-7)3(5)6/h7H,1H2,(H,5,6)/p-1"
5197,20650,a,a,16600,KEGG COMPOUND accession,C01732,mescon,498-24-8,16600.0,"Human Metabolome Database (HMDB): Mesaconic acid is one of several isomeric carboxylic acids obtained from citric acid. Is used as a fire retardant, recent studies revealed this acid is a competitive inhibitor of fumarate reduction.",Mesaconic acid,HMDB0000749,b,b,C01732,b,FDB022221,mescon,[H]\C(C([O-])=O)=C(/C([O-])=O)C([H])([H])[H],HNEGQIOMVPPMNR-NSCUHMNNSA-L,"InChI=1S/C5H6O4/c1-3(5(8)9)2-4(6)7/h2H,1H3,(H,6,7)(H,8,9)/p-2/b3-2+"
5198,20667,a,a,6780,KEGG COMPOUND accession,C07143,,,,,,,,,,,,,,,
5199,20677,a,a,6785,KEGG COMPOUND accession,C10081,,,,,,,,,,,,,,,
5200,20682,a,a,33521,KEGG COMPOUND accession,C00050,,,,,,,,,,,,,,,
5201,20684,a,a,6790,KEGG COMPOUND accession,C10947,,,,,,,,,,,,,,,
5202,20686,a,a,6791,KEGG COMPOUND accession,C10930,,,,,,,,,,,,,,,
5203,20692,a,a,6794,KEGG COMPOUND accession,C07146,,,,,,,,,,,,,,,
5204,20705,a,a,6801,KEGG COMPOUND accession,C07151,M02467,1115-70-4,6801.0,"Human Metabolome Database (HMDB): 1,1-Dimethylbiguanide or Metformin is a biguanide hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. Metformin improves glycemic control by improving insulin sensitivity and decreasing intestinal absorption of glucose. Metformin is the most popular anti-diabetic drug in the United States and one of the most prescribed drugs in the country overall, with nearly 35 million prescriptions filled in 2006 for generic metformin alone.","1,1-Dimethylbiguanide",HMDB0001921,b,b,C07151,b,FDB022739,b,[H]N=C(N([H])[H])N([H])C(=N[H])N(C([H])([H])[H])C([H])([H])[H],XZWYZXLIPXDOLR-UHFFFAOYSA-N,"InChI=1S/C4H11N5/c1-9(2)4(7)8-3(5)6/h1-2H3,(H5,5,6,7,8)"
5205,20711,a,a,6804,KEGG COMPOUND accession,C07471,,,,,,,,,,,,,,,
5206,20713,a,a,6805,KEGG COMPOUND accession,C07654,,,,,,,,,,,,,,,
5207,20721,a,a,6809,KEGG COMPOUND accession,C07164,,,,,,,,,,,,,,,
5208,20731,a,a,27376,KEGG COMPOUND accession,C11145,,,,,,,,,,,,,,,
5209,20733,a,a,16007,KEGG COMPOUND accession,C00409,ch4s,74-93-1,16007.0,"Human Metabolome Database (HMDB): Methanethiol (also known as methyl mercaptan) is a colorless gas that smells like rotten cabbage. It is a natural substance found in the blood, brain, and other tissues of people and animals. It is released from animal feces. It occurs naturally in certain foods, such as some nuts and cheese. It is also one of the main chemicals responsible for bad breath and flatulence. At very high concentrations methanethiol is highly toxic and affects the central nervous system. The chemical formula for methanethiol is CH3SH; it is classified as a thiol. Methanethiol is also considered to be a weak acid, with a pKa of ~10.4. This acidic property makes it reactive with dissolved metals in aqueous solutions. The environmental chemistry of these interactions in seawater or fresh water environments such as lakes has yet to be fully investigated. -- Wikipedia.",Methanethiol,HMDB0003227,b,b,C00409,METHANETHIOL,FDB011886,b,[H]SC([H])([H])[H],LSDPWZHWYPCBBB-UHFFFAOYSA-N,"InChI=1S/CH4S/c1-2/h2H,1H3"
5210,20738,a,a,17448,KEGG COMPOUND accession,C00862,,,,,,,,,,,,,,,
5211,20742,a,a,17790,KEGG COMPOUND accession,C00132,meoh,67-56-1,17790.0,"Human Metabolome Database (HMDB): It is the simplest alcohol, and is a light, volatile, colourless, flammable, poisonous liquid with a distinctive odor that is somewhat milder and sweeter than ethanol (Wikipedia). Methanol is responsible for accidental, suicidal, and epidemic poisonings, resulting in death or permanent sequelae. Toxicity is due to the metabolic products of alcohol dehydrogenase (ADH) and aldehyde dehydrogenase. (PMID 15627163). The rapid and accurate diagnosis of toxic alcohol poisoning due to methanol (methyl alcohol) is paramount in preventing serious adverse outcomes. The quantitative measurement of specific serum levels of methanol using gas chromatography is expensive, time consuming and generally only available at major tertiary-care facilities. (PMID 15862085).",Methanol,HMDB0001875,b,b,C00132,3-OH-BENZYL-ALCOHOL,FDB008124,meoh,[H]OC([H])([H])[H],OKKJLVBELUTLKV-UHFFFAOYSA-N,"InChI=1S/CH4O/c1-2/h2H,1H3"
5212,20768,a,a,6820,KEGG COMPOUND accession,C11114,,,,,,,,,,,,,,,
5213,20782,a,a,6827,KEGG COMPOUND accession,C07177,,,,,,,,,,,,,,,
5214,20795,a,a,102216,KEGG COMPOUND accession,C07844,,,,,,,,,,,,,,,
5215,20799,a,a,6835,KEGG COMPOUND accession,C11196,,,,,,,,,,,,,,,
5216,20806,a,a,44185,KEGG COMPOUND accession,C01937,,,,,,,,,,,,,,,
5217,20808,a,a,6838,KEGG COMPOUND accession,C07192,,,,,,,,,,,,,,,
5218,20810,a,a,6839,KEGG COMPOUND accession,C07513,,,,,,,,,,,,,,,
5219,20816,a,a,6842,KEGG COMPOUND accession,C11043,,,,,,,,,,,,,,,
5220,20818,a,a,6843,KEGG COMPOUND accession,C07517,,,,,,,,,,,,,,,
5221,20841,a,a,6856,KEGG COMPOUND accession,C10477,,,,,,,,,,,,,,,
5222,20845,a,a,28398,KEGG COMPOUND accession,C02845,,,,,,,,,,,,,,,
5223,20849,a,a,27642,KEGG COMPOUND accession,C11344,,,,,,,,,,,,,,,
5224,20851,a,a,28786,KEGG COMPOUND accession,C00225,,,,,,,,,,,,,,,
5225,20871,a,a,29852,KEGG COMPOUND accession,C07294,M02474,124-58-3,29852.0,"Human Metabolome Database (HMDB): Methylarsonate is used as a contact herbicide in either the monosodium or disodium salt form. It goes by the trade names Weed-E-Rad, Ansar 170 H.C., Ansar 529 H.C., DiTac and others. Methylarsonate is considered only slightly toxic, having an oral LD50 of 2200 mg/Kg for rats. The inhalation risk is greater with LD50 Rats >20 mg. Long term studies with people exposed to organoarsenicals has shown an increased risk of skin cancer (Spiewak, 2001), lung cancer and some liver cancers, although some recent studies have shown some arsenic containing compounds (specifically Arsine trioxide) may have anticarcinogenic properties (Wang, 2001). In mammals, Methylarsonate is also an intermediate in the detoxification of inorganic arsenic. In the arsenate detoxification I pathway, arsenite reacts with S-adenosyl-L-methionine to produce methylarsonate and S-adenosyl-L-homocysteine. Arsenite methyltransferase catalyzes this reaction. Methylarsonate then reacts with 2 glutathione molecules to produce glutathione disulfide and methylarsonite. This reaction is catalyzed by methylarsonate reductase. Methylarsonate is an organic arsenic compound with adverse effects similar to those of arsenic trioxide. Arsenic is found in the environment primarily as arsenate and arsenite species. Arsenate is reduced to arsenite by arsenate reductase and can be subsequently methylated to Methylarsonate. This is then reduced and methylated to Dimethylarsinate, which can excreted and is considerably less toxic to the organism than any of the previous intermediate compounds. Methylarsonate was formerly included in some vitamin and mineral preparations. It was once used to treat tuberculosis, chorea, and other affections in which the cacodylates were used.",Methylarsonate,HMDB0012258,b,b,C07294,METHYLARSONATE,FDB028897,b,[H]O[As](=O)(O[H])C([H])([H])[H],QYPPRTNMGCREIM-UHFFFAOYSA-N,"InChI=1S/CH5AsO3/c1-2(3,4)5/h1H3,(H2,3,4,5)"
5226,20875,a,a,17826,KEGG COMPOUND accession,C07295,,,,,,,,,,,,,,,
5227,20880,a,a,29323,KEGG COMPOUND accession,C02390,,,,,,,,,,,,,,,
5228,20883,a,a,28115,KEGG COMPOUND accession,C06453,,,,,,,,,,,,,,,
5229,20888,a,a,6872,KEGG COMPOUND accession,C00220,,,,,,,,,,,,,,,
5230,20894,a,a,17158,KEGG COMPOUND accession,C00546,mthgxl,78-98-8,17158.0,"Human Metabolome Database (HMDB): Pyruvaldehyde is an organic compound used often as a reagent in organic synthesis, as a flavoring agent, and in tanning. It has been demonstrated as an intermediate in the metabolism of acetone and its derivatives in isolated cell preparations, in various culture media, and in vivo in certain animals.",Pyruvaldehyde,HMDB0001167,b,b,C00546,METHYL-GLYOXAL,FDB008295,mthgxl,[H]C(=O)C(=O)C([H])([H])[H],AIJULSRZWUXGPQ-UHFFFAOYSA-N,"InChI=1S/C3H4O2/c1-3(5)2-4/h2H,1H3"
5231,20906,a,a,16628,KEGG COMPOUND accession,C02294,,,,,,,,,,,,,,,
5232,20911,a,a,16093,KEGG COMPOUND accession,C02295,,,,,,,,,,,,,,,
5233,20914,a,a,15929,KEGG COMPOUND accession,C11512,,,,,,,,,,,,,,,
5234,20918,a,a,30860,KEGG COMPOUND accession,C02170,HC00900,516-05-2,30860.0,"Human Metabolome Database (HMDB): Methylmalonic acid is a malonic acid derivative, which is a vital intermediate in the metabolism of fat and protein. In particular, the coenzyme A-linked form of methylmalonic acid, methylmalonyl-CoA, is converted into succinyl-CoA by methylmalonyl-CoA mutase in a reaction that requires vitamin B12 as a cofactor. In this way, methylmalonic acid enters the Krebs cycle and is thus part of one of the anaplerotic reactions. Abnormalities in methylmalonic acid metabolism lead to methylmalonic aciduria. This inborn error of metabolism is attributed to a block in the enzymatic conversion of methylmalonyl CoA to succinyl CoA. Methylmalonic acid is also found to be associated with other inborn errors of metabolism, including cobalamin deficiency, cobalamin malabsorption, malonyl-CoA decarboxylase deficiency, and transcobalamin II deficiency. When present in sufficiently high levels, methylmalonic acid can act as an acidogen and a metabotoxin. An acidogen is an acidic compound that induces acidosis, which has multiple adverse effects on many organ systems. A metabotoxin is an endogenously produced metabolite that causes adverse health effects at chronically high levels. Chronically high levels of methylmalonic acid are associated with at least 5 inborn errors of metabolism, including Malonyl CoA decarboxylase deficiency, Malonic Aciduria, Methylmalonate Semialdehyde Dehydrogenase Deficiency, Methylmalonic Aciduria and Methylmalonic Aciduria Due to Cobalamin-Related Disorders. Methylmalonic acid is an organic acid and abnormally high levels of organic acids in the blood (organic acidemia), urine (organic aciduria), the brain, and other tissues lead to general metabolic acidosis. Acidosis typically occurs when arterial pH falls below 7.35. In infants with acidosis, the initial symptoms include poor feeding, vomiting, loss of appetite, weak muscle tone (hypotonia), and lack of energy (lethargy). These can progress to heart abnormalities, kidney abnormalities, liver damage, seizures, coma, and possibly death. These are also the characteristic symptoms of the untreated IEMs mentioned above. Many affected children with organic acidemias experience intellectual disability or delayed development. In adults, acidosis or acidemia is characterized by headaches, confusion, feeling tired, tremors, sleepiness, and seizures.",Methylmalonic acid,HMDB0000202,b,b,C02170,b,FDB021905,HC00900,[H]C([H])([H])C([H])(C([O-])=O)C([O-])=O,ZIYVHBGGAOATLY-UHFFFAOYSA-L,"InChI=1S/C4H6O4/c1-2(3(5)6)4(7)8/h2H,1H3,(H,5,6)(H,7,8)/p-2"
5235,20924,a,a,16625,KEGG COMPOUND accession,C02557,,,,,,,,,,,,,,,
5236,20929,a,a,28216,KEGG COMPOUND accession,C11146,,,,,,,,,,,,,,,
5237,20932,a,a,6885,KEGG COMPOUND accession,C06030,,,,,,,,,,,,,,,
5238,20935,a,a,6887,KEGG COMPOUND accession,C07196,,,,,,,,,,,,,,,
5239,20939,a,a,6889,KEGG COMPOUND accession,C08179,,,,,,,,,,,,,,,
5240,20945,a,a,27436,KEGG COMPOUND accession,C07198,,,,,,,,,,,,,,,
5241,20947,a,a,584020,KEGG COMPOUND accession,C07199,,,,,,,,,,,,,,,
5242,20965,a,a,6902,KEGG COMPOUND accession,C10953,,,,,,,,,,,,,,,
5243,20969,a,a,6904,KEGG COMPOUND accession,C07202,,,,,,,,,,,,,,,
5244,20983,a,a,44241,KEGG COMPOUND accession,C07205,,,,,,,,,,,,,,,
5245,20985,a,a,6912,KEGG COMPOUND accession,C07921,,,,,,,,,,,,,,,
5246,20987,a,a,17646,KEGG COMPOUND accession,C00772,,,,,,,,,,,,,,,
5247,21001,a,a,6919,KEGG COMPOUND accession,C07221,,,,,,,,,,,,,,,
5248,21013,a,a,6925,KEGG COMPOUND accession,C05371,,,,,,,,,,,,,,,
5249,21025,a,a,6931,KEGG COMPOUND accession,C07524,,,,,,,,,,,,,,,
5250,21029,a,a,6933,KEGG COMPOUND accession,C07890,,,,,,,,,,,,,,,
5251,21031,a,a,50692,KEGG COMPOUND accession,C07652,,,,,,,,,,,,,,,
5252,21039,a,a,50693,KEGG COMPOUND accession,C07224,,,,,,,,,,,,,,,
5253,21043,a,a,50697,KEGG COMPOUND accession,C08030,,,,,,,,,,,,,,,
5254,21045,a,a,6941,KEGG COMPOUND accession,C11783,,,,,,,,,,,,,,,
5255,21061,a,a,6950,KEGG COMPOUND accession,C07570,,,,,,,,,,,,,,,
5256,21063,a,a,6951,KEGG COMPOUND accession,C08507,,,,,,,,,,,,,,,
5257,21067,a,a,27504,KEGG COMPOUND accession,C06681,,,,,,,,,,,,,,,
5258,21071,a,a,50729,KEGG COMPOUND accession,C11195,,,,,,,,,,,,,,,
5259,21089,a,a,6964,KEGG COMPOUND accession,C11086,,,,,,,,,,,,,,,
5260,21095,a,a,36264,KEGG COMPOUND accession,C06232,mobd,b,25371.0,"Human Metabolome Database (HMDB): Molybdate is involved in the molybdenum cofactor biosynthesis pathway. Molybdate reacts with molybdopterin-AMP to produce molybdenum cofactor, AMP, and H2O.",Molybdate,HMDB0012260,b,b,C06232,b,FDB028899,b,b,SHTXPGOZOVLFDJ-UHFFFAOYSA-L,b
5261,21096,a,a,28685,KEGG COMPOUND accession,C00150,,,,,,,,,,,,,,,
5262,21098,a,a,44074,KEGG COMPOUND accession,C05924,M02488,73508-07-3,21437.0,"Human Metabolome Database (HMDB): Molybdenum cofactor is a cofactor required for the activity of enzymes such as sulfite oxidase, xanthine oxidoreductase, and aldehyde oxidase. It is a coordination complex formed between molybdopterin (which, despite the name, does not contain molybdenum) and an oxide of molybdenum. Molybdopterins, in turn, are synthesized from guanosine triphosphate. Molybdenum cofactor functions directly in ethylbenzene dehydrogenase, glyceraldehyde-3-phosphate ferredoxin oxidoreductase, and respiratory arsenate reductase. In animals and plants these enzymes use molybdenum bound at the active site in a tricyclic molybdenum cofactor. All molybdenum-using enzymes so far identified in nature use this cofactor The simplest structure of molybdopterin contains a pyranopterin coordinated to molybdenum. The pyranopterin structure is a fused ring system containing a pyran fused to pterin. In addition, the pyran ring is substituted with two thiols and an alkyl phosphate. In molybdopterin, the thiols coordinate to molybdenum. In some cases, the alkyl phosphate group is replaced by an alkyl diphosphate nucleotide. -- Wikipedia.",Molybdopterin,HMDB0002206,b,b,C05924,CPD0-1882,FDB022906,b,[H]OP(=O)(O[H])OC([H])([H])[C@@]1([H])OC2([H])N([H])C3=C(N([H])C2([H])C(S[H])=C1S[H])C(=O)N([H])C(=N3)N([H])[H],HPEUEJRPDGMIMY-VISFTIJFSA-L,"InChI=1S/C10H14N5O6PS2/c11-10-14-7-4(8(16)15-10)12-3-6(24)5(23)2(21-9(3)13-7)1-20-22(17,18)19/h2-3,9,12,23-24H,1H2,(H2,17,18,19)(H4,11,13,14,15,16)/p-2/t2-,3?,9?/m0/s1"
5263,21103,a,a,6972,KEGG COMPOUND accession,C08723,,,,,,,,,,,,,,,
5264,21105,a,a,27617,KEGG COMPOUND accession,C06693,,,,,,,,,,,,,,,
5265,21111,a,a,35735,KEGG COMPOUND accession,C04131,,,,,,,,,,,,,,,
5266,21119,a,a,6980,KEGG COMPOUND accession,C10350,,,,,,,,,,,,,,,
5267,21121,a,a,16504,KEGG COMPOUND accession,C01041,C01041,b,16504.0,b,Monodehydroascorbate,b,b,b,C01041,b,b,C01041,[H]OC([H])([H])[C@]([H])(O[H])[C@@]1([H])OC(=O)C([O-])=C1[O],LHFJOBMTAJJOTB-JLAZNSOCSA-M,"InChI=1S/C6H7O6/c7-1-2(8)5-3(9)4(10)6(11)12-5/h2,5,7-8,10H,1H2/p-1/t2-,5+/m0/s1"
5268,21124,a,a,17760,KEGG COMPOUND accession,C02704,,,,,,,,,,,,,,,
5269,21127,a,a,29075,KEGG COMPOUND accession,C02171,,,,,,,,,,,,,,,
5270,21129,a,a,35381,KEGG COMPOUND accession,C06698,,,,,,,,,,,,,,,
5271,21145,a,a,50730,KEGG COMPOUND accession,C07482,,,,,,,,,,,,,,,
5272,21151,a,a,6995,KEGG COMPOUND accession,C10085,,,,,,,,,,,,,,,
5273,21155,a,a,6997,KEGG COMPOUND accession,C07743,,,,,,,,,,,,,,,
5274,21157,a,a,75092,KEGG COMPOUND accession,C10105,,,,,,,,,,,,,,,
5275,21163,a,a,17303,KEGG COMPOUND accession,C01516,,,,,,,,,,,,,,,
5276,21170,a,a,16315,KEGG COMPOUND accession,C01735,,,,,,,,,,,,,,,
5277,21172,a,a,7005,KEGG COMPOUND accession,C10106,,,,,,,,,,,,,,,
5278,21176,a,a,63611,KEGG COMPOUND accession,C07663,,,,,,,,,,,,,,,
5279,21187,a,a,7014,KEGG COMPOUND accession,C10507,,,,,,,,,,,,,,,
5280,21197,a,a,18100,KEGG COMPOUND accession,C04013,,,,,,,,,,,,,,,
5281,21199,a,a,7020,KEGG COMPOUND accession,C10709,,,,,,,,,,,,,,,
5282,21211,a,a,37738,KEGG COMPOUND accession,C04851,,,,,,,,,,,,,,,
5283,21214,a,a,7027,KEGG COMPOUND accession,C06470,,,,,,,,,,,,,,,
5284,21230,a,a,7035,KEGG COMPOUND accession,C08311,,,,,,,,,,,,,,,
5285,21240,a,a,16768,KEGG COMPOUND accession,C06717,,,,,,,,,,,,,,,
5286,21269,a,a,70082,KEGG COMPOUND accession,C10108,,,,,,,,,,,,,,,
5287,21283,a,a,28968,KEGG COMPOUND accession,C04503,,,,,,,,,,,,,,,
5288,21287,a,a,28702,KEGG COMPOUND accession,C04301,,,,,,,,,,,,,,,
5289,21289,a,a,27596,KEGG COMPOUND accession,C01152,3mhis,368-16-1,27596.0,"Human Metabolome Database (HMDB): 3-Methylhistidine is a product of peptide bond synthesis and methylation of actin and myosin. The measurement of 3-Methylhistidine provides an index of the rate of muscle protein breakdown. 3-Methylhistidine is a biomarker for meat consumption, especially chicken. It is also a biomarker for the consumption of soy products.",3-Methylhistidine,HMDB0000479,b,b,C01152,CPD-1823,FDB021798,3mhis,[H]OC(=O)[C@@]([H])(N([H])[H])C([H])([H])C1=C([H])N=C([H])N1C([H])([H])[H],JDHILDINMRGULE-LURJTMIESA-N,"InChI=1S/C7H11N3O2/c1-10-4-9-3-5(10)2-6(8)7(11)12/h3-4,6H,2,8H2,1H3,(H,11,12)/t6-/m0/s1"
5290,21293,a,a,17316,KEGG COMPOUND accession,C03789,,,,,,,,,,,,,,,
5291,21300,a,a,7071,KEGG COMPOUND accession,C10935,,,,,,,,,,,,,,,
5292,21304,a,a,15783,KEGG COMPOUND accession,C04203,,,,,,,,,,,,,,,
5293,21308,a,a,16269,KEGG COMPOUND accession,C02846,,,,,,,,,,,,,,,
5294,21317,a,a,17724,KEGG COMPOUND accession,C01026,dmgly,1118-68-9,17724.0,"Human Metabolome Database (HMDB): Dimethylglycine (DMG) is an amino acid derivative found in the cells of all plants and animals and can be obtained in the diet in small amounts from grains and meat. The human body produces DMG when metabolizing choline into Glycine. Dimethylglycine that is not metabolized in the liver is transported by the circulatory system to body tissue. Dimethylglycine was popular with Russian athletes and cosmonauts owing to its reputed ability to increase endurance and reduce fatigue. DMG is also a byproduct of homocysteine metabolism. Homocysteine and betaine are converted to methionine and N, N-dimethylglycine by betaine-homocysteine methyltransferase. Dimethylglycine in the urine is a biomarker for the consumption of legumes.",Dimethylglycine,HMDB0000092,b,b,C01026,DIMETHYL-GLYCINE,FDB021893,dmgly,[H]C([H])([H])[N+]([H])(C([H])([H])[H])C([H])([H])C([O-])=O,FFDGPVCHZBVARC-UHFFFAOYSA-N,"InChI=1S/C4H9NO2/c1-5(2)3-4(6)7/h3H2,1-2H3,(H,6,7)"
5295,21322,a,a,28969,KEGG COMPOUND accession,C08302,,,,,,,,,,,,,,,
5296,21326,a,a,18416,KEGG COMPOUND accession,C04079,HC01231,b,18416.0,"Human Metabolome Database (HMDB): D-Pantothenoyl-L-cysteine is involved in the pantothenate and CoA biosynthesis pathway. D-Pantothenoyl-L-cysteine can be converted into (R)-4'-Phosphopantothenoyl-L-cysteine or Pantetheine by type I pantothenate kinase [EC:2.7.1.33] or [4.1.1.30], respectively.",D-Pantothenoyl-L-cysteine,HMDB0006834,b,b,C04079,b,FDB024110,b,[H]OC([H])([H])C(C([H])([H])[H])(C([H])([H])[H])[C@@]([H])(O[H])C(=O)N([H])C([H])([H])C([H])([H])C(=O)N([H])[C@]([H])(C([O-])=O)C([H])([H])S[H],QSYCTARXWYLMOF-CBAPKCEASA-M,"InChI=1S/C12H22N2O6S/c1-12(2,6-15)9(17)10(18)13-4-3-8(16)14-7(5-21)11(19)20/h7,9,15,17,21H,3-6H2,1-2H3,(H,13,18)(H,14,16)(H,19,20)/p-1/t7-,9-/m0/s1"
5297,21331,a,a,17455,KEGG COMPOUND accession,C04204,,,,,,,,,,,,,,,
5298,21335,a,a,17318,KEGG COMPOUND accession,C04205,,,,,,,,,,,,,,,
5299,21344,a,a,7091,KEGG COMPOUND accession,C04302,,,,,,,,,,,,,,,
5300,21350,a,a,28890,KEGG COMPOUND accession,C04628,,,,,,,,,,,,,,,
5301,21352,a,a,15609,KEGG COMPOUND accession,C06383,,,,,,,,,,,,,,,
5302,21360,a,a,15682,KEGG COMPOUND accession,C03406,argsuc,2387-71-5,15682.0,"Human Metabolome Database (HMDB): Arginosuccinic acid is a basic amino acid. Some cells synthesize it from citrulline, aspartic acid and use it as a precursor for arginine in the urea cycle or Citrulline-NO cycle. The enzyme that catalyzes the reaction is argininosuccinate synthetase. Argininosuccinic acid is a precursor to fumarate in the citric acid cycle via argininosuccinate lyase. Defects in the argininosuccinate lyase enzyme can lead to argininosuccinate lyase deficiency, which is an inborn error of metabolism. Argininosuccinate (ASA) lyase deficiency results in defective cleavage of ASA. This leads to an accumulation of ASA in cells and an excessive excretion of ASA in urine (argininosuccinic aciduria). In virtually all respects, this disorder shares the characteristics of other urea cycle defects. The most important characteristic of ASA lyase deficiency is its propensity to cause hyperammonemia in affected individuals. ASA in affected individuals is excreted by the kidney at a rate practically equivalent to the glomerular filtration rate (GFR). Whether ASA itself causes a degree of toxicity due to hepatocellular accumulation is unknown; such an effect could help explain hyperammonemia development in affected individuals. Regardless, the name of the disease is derived from the rapid clearance of ASA in urine, although elevated levels of ASA can be found in plasma. ASA lyase deficiency is associated with high mortality and morbidity rates. Symptoms of ASA lyase deficiency include anorexia, irritability rapid breathing, lethargy and vomiting. Extreme symptoms include coma and cerebral edema.",Argininosuccinic acid,HMDB0000052,b,b,C03406,b,FDB021885,argsuc,[H]N(C(N([H])C([H])(C([O-])=O)C([H])([H])C([O-])=O)=[N+]([H])[H])C([H])([H])C([H])([H])C([H])([H])[C@@]([H])(C([O-])=O)[N+]([H])([H])[H],KDZOASGQNOPSCU-ZBHICJROSA-M,"InChI=1S/C10H18N4O6/c11-5(8(17)18)2-1-3-13-10(12)14-6(9(19)20)4-7(15)16/h5-6H,1-4,11H2,(H,15,16)(H,17,18)(H,19,20)(H3,12,13,14)/p-1/t5-,6?/m0/s1"
5303,21366,a,a,7101,KEGG COMPOUND accession,C05933,nwharg,b,7101.0,"Human Metabolome Database (HMDB): N(omega)-hydroxyarginine is a product of the arginine-Nitric Oxide pathway, and is the first intermediate in the process catalyzed by nitric oxide synthase (EC 1.14.13.99, NOS, a heme protein that catalyzes the oxygenation of L-arginine in the presence of NADPH to form nitric oxide + citrulline). N(omega)-hydroxyarginine appears to interfere with cell proliferation/cell growth by inhibiting arginase (EC 3.5.3.1, a binuclear Mn (2+) metalloenzyme that catalyzes the hydrolysis of L-arginine to L-ornithine and urea), and that has 6R-tetrahydrobiopterin (H4B) as an enzyme-bound cofactor. (PMID: 11259671, 11258880, 14504282, 9735327).",N-(o)-Hydroxyarginine,HMDB0004224,b,b,C05933,b,FDB023337,nwharg,[H]O\[N+]([H])=C(\N([H])[H])N([H])C([H])([H])C([H])([H])C([H])([H])C([H])(C([O-])=O)[N+]([H])([H])[H],FQWRAVYMZULPNK-UHFFFAOYSA-O,"InChI=1S/C6H14N4O3/c7-4(5(11)12)2-1-3-9-6(8)10-13/h4,13H,1-3,7H2,(H,11,12)(H3,8,9,10)/p+1"
5304,21370,a,a,16395,KEGG COMPOUND accession,C03621,,,,,,,,,,,,,,,
5305,21375,a,a,32844,KEGG COMPOUND accession,C04015,,,,,,,,,,,,,,,
5306,21377,a,a,28944,KEGG COMPOUND accession,C04016,,,,,,,,,,,,,,,
5307,21381,a,a,21501,KEGG COMPOUND accession,C03135,,,,,,,,,,,,,,,
5308,21383,a,a,28037,KEGG COMPOUND accession,C01132,,,,,,,,,,,,,,,
5309,21387,a,a,18207,KEGG COMPOUND accession,C06376,,,,,,,,,,,,,,,
5310,21391,a,a,28761,KEGG COMPOUND accession,C02848,,,,,,,,,,,,,,,
5311,21394,a,a,51013,KEGG COMPOUND accession,C04884,gm2_hs,b,b,"Human Metabolome Database (HMDB): Ganglioside GM2 (d18:1/12:0) is a glycosphingolipid (ceramide and oligosaccharide)or oligoglycosylceramide with one or more sialic acids (i.e. n-acetylneuraminic acid) linked on the sugar chain. It is a component the cell plasma membrane which modulates cell signal transduction events. Gangliosides have been found to be highly important in immunology. Ganglioside GM2 carries a net-negative charge at pH 7.0 and is acidic. Gangliosides can amount to 6% of the weight of lipids from brain, but they are found at low levels in all animal tissues. G(M2) Ganglioside accumulates due to a deficiency of hexosaminidase A or B (beta-N-acetylhexosaminidase), or GM2 activator protein, resulting in Gangliosidoses. Gangliosidoses include heredity metabolic disorders that include Tay-Sachs disease and Sandhoff disease. Gangliosides GM2 is especially common in the nervous tissue of the brain. In the United States, about 1 in 27 to 1 in 30 Ashkenazi Jews is a recessive carrier. French Canadians and the Cajun community of Louisiana have an occurrence similar to the Ashkenazi Jews.Gangliosides are glycosphingolipids. There are four types of glycosphingolipids, the cerebrosides, sulfatides, globosides and gangliosides. Gangliosides are very similar to globosides except that they also contain N-acetyl neuraminic acid (NANA) in varying amounts. The specific names for the gangliosides provide information about their structure. The letter G refers to ganglioside, and the subscripts M, D, T and Q indicate that the molecule contains mono-, di-, tri and quatra-sialic acid. The numbered subscripts 1, 2 and 3 refer to the carbohydrate sequence that is attached to the ceramide. In particular, 1 stands for GalGalNAcGalGlc-ceramide, 2 stands for GalNAcGalGlc-ceramide and 3 stands for GalGlc-ceramide. Deficiencies in lysosomal enzymes that degrade the carbohydrate portions of various gangliosides are responsible for a number of lysosomal storage diseases such as Tay-Sachs disease, Sandhoff disease, and GM1 gangliosidosis. The carbohydrate portion of the ganglioside GM1 is the site of attachment of cholera toxin, the protein secreted by Vibrio cholerae.",Ganglioside GM2 (d18:1/12:0),HMDB0004936,b,b,C04884,CPD-1100,FDB023524,gm2_hs,[H]OC([H])([H])[C@@]([H])(O[H])[C@@]([H])(O[H])[C@]1([H])O[C@@](O[C@]2([H])[C@@]([H])(O[H])[C@]([H])(O[C@@]3([H])[C@]([H])(O[H])[C@@]([H])(O[H])[C@]([H])(OC([H])([H])[C@]([H])(N([H])C([*])=O)[C@]([H])(O[H])C(\[H])=C(/[H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H])O[C@]3([H])C([H])([H])O[H])O[C@]([H])(C([H])([H])O[H])[C@]2([H])O[C@]2([H])O[C@]([H])(C([H])([H])O[H])[C@]([H])(O[H])[C@]([H])(O[H])[C@@]2([H])N([H])C(=O)C([H])([H])[H])(C([O-])=O)C([H])([H])[C@]([H])(O[H])[C@@]1([H])N([H])C(=O)C([H])([H])[H],b,b
5312,21394,a,a,51013,KEGG COMPOUND accession,C04884,HC02160,104443-57-4,b,"Human Metabolome Database (HMDB): Ganglioside GM2 (d18:1/12:0) is a glycosphingolipid (ceramide and oligosaccharide)or oligoglycosylceramide with one or more sialic acids (i.e. n-acetylneuraminic acid) linked on the sugar chain. It is a component the cell plasma membrane which modulates cell signal transduction events. Gangliosides have been found to be highly important in immunology. Ganglioside GM2 carries a net-negative charge at pH 7.0 and is acidic. Gangliosides can amount to 6% of the weight of lipids from brain, but they are found at low levels in all animal tissues. G(M2) Ganglioside accumulates due to a deficiency of hexosaminidase A or B (beta-N-acetylhexosaminidase), or GM2 activator protein, resulting in Gangliosidoses. Gangliosidoses include heredity metabolic disorders that include Tay-Sachs disease and Sandhoff disease. Gangliosides GM2 is especially common in the nervous tissue of the brain. In the United States, about 1 in 27 to 1 in 30 Ashkenazi Jews is a recessive carrier. French Canadians and the Cajun community of Louisiana have an occurrence similar to the Ashkenazi Jews.Gangliosides are glycosphingolipids. There are four types of glycosphingolipids, the cerebrosides, sulfatides, globosides and gangliosides. Gangliosides are very similar to globosides except that they also contain N-acetyl neuraminic acid (NANA) in varying amounts. The specific names for the gangliosides provide information about their structure. The letter G refers to ganglioside, and the subscripts M, D, T and Q indicate that the molecule contains mono-, di-, tri and quatra-sialic acid. The numbered subscripts 1, 2 and 3 refer to the carbohydrate sequence that is attached to the ceramide. In particular, 1 stands for GalGalNAcGalGlc-ceramide, 2 stands for GalNAcGalGlc-ceramide and 3 stands for GalGlc-ceramide. Deficiencies in lysosomal enzymes that degrade the carbohydrate portions of various gangliosides are responsible for a number of lysosomal storage diseases such as Tay-Sachs disease, Sandhoff disease, and GM1 gangliosidosis. The carbohydrate portion of the ganglioside GM1 is the site of attachment of cholera toxin, the protein secreted by Vibrio cholerae.",Ganglioside GM2 (d18:1/12:0),HMDB0004936,b,b,C04884,CPD-1100,FDB023524,HC02160,[H]OC(=O)[C@]1(O[C@]2([H])[C@@]([H])(O[H])[C@]([H])(O[C@@]3([H])[C@]([H])(O[H])[C@@]([H])(O[H])[C@]([H])(OC([H])([H])[C@]([H])(N([H])C([*])=O)[C@]([H])(O[H])C(\[H])=C(/[H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H])O[C@]3([H])C([H])([H])O[H])O[C@]([H])(C([H])([H])O[H])[C@]2([H])O[C@]2([H])O[C@]([H])(C([H])([H])O[H])[C@]([H])(O[H])[C@]([H])(O[H])[C@@]2([H])N([H])C(=O)C([H])([H])[H])O[C@@]([H])([C@]([H])(O[H])[C@]([H])(O[H])C([H])([H])O[H])[C@]([H])(N([H])C(=O)C([H])([H])[H])[C@@]([H])(O[H])C1([H])[H],UBCMQDIOEUZUPT-XYXKSNPQSA-N,b
5313,21406,a,a,16121,KEGG COMPOUND accession,C04924,,,,,,,,,,,,,,,
5314,21408,a,a,18056,KEGG COMPOUND accession,C04925,M02197,b,b,b,"N-Acetyl-D-galactosaminyl-N-Acetyl-D-galactosaminyl-1,3-D-galactosyl-1,4-D-galactosyl-1,4-D-glucosylceramide",b,b,b,C04925,b,b,M02197,[H]OC([H])([H])[C@@]1([H])O[C@]([H])(O[C@@]2([H])[C@@]([H])(O[H])[C@]([H])(O[C@@]([H])(O[C@]3([H])[C@@]([H])(O[H])[C@@]([H])(O[C@]4([H])[C@]([H])(O[H])[C@@]([H])(O[H])[C@]([H])(O[C@@]5([H])[C@]([H])(O[H])[C@@]([H])(O[H])[C@]([H])(OC([H])([H])[C@]([H])(N([H])C([*])=O)[C@]([H])(O[H])C(\[H])=C(/[H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H])O[C@]5([H])C([H])([H])O[H])O[C@]4([H])C([H])([H])O[H])O[C@]([H])(C([H])([H])O[H])[C@]3([H])O[H])[C@]2([H])N([H])C(=O)C([H])([H])[H])C([H])([H])O[H])[C@]([H])(N([H])C(=O)C([H])([H])[H])[C@@]([H])(O[H])[C@@]1([H])O[H],b,b
5315,21414,a,a,16948,KEGG COMPOUND accession,C01133,,,,,,,,,,,,,,,
5316,21446,a,a,28401,KEGG COMPOUND accession,C03518,,,,,,,,,,,,,,,
5317,21448,a,a,17103,KEGG COMPOUND accession,C04845,acglcgalgluside_hs,b,17103.0,b,Lactotriaosylceramide,b,b,b,C04845,b,b,acglcgalgluside_hs,[H]OC([H])([H])[C@@]1([H])O[C@@]([H])(O[C@]2([H])[C@@]([H])(O[H])[C@]([H])(O[C@@]3([H])[C@]([H])(O[H])[C@@]([H])(O[H])[C@]([H])(OC([H])([H])[C@]([H])(N([H])C([*])=O)[C@]([H])(O[H])C(\[H])=C(/[H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H])O[C@]3([H])C([H])([H])O[H])O[C@]([H])(C([H])([H])O[H])[C@]2([H])O[H])[C@]([H])(N([H])C(=O)C([H])([H])[H])[C@@]([H])(O[H])[C@]1([H])O[H],b,b
5318,21453,a,a,16506,KEGG COMPOUND accession,C04939,,,,,,,,,,,,,,,
5319,21456,a,a,28514,KEGG COMPOUND accession,C04876,,,,,,,,,,,,,,,
5320,21463,a,a,16511,KEGG COMPOUND accession,C01289,,,,,,,,,,,,,,,
5321,21472,a,a,17122,KEGG COMPOUND accession,C00645,acmana,3615-17-6,63154.0,"Human Metabolome Database (HMDB): N-Acetylmannosamine is a monosaccharide that is used as a precursor in the chemical or enzymatic synthesis of the neuraminic acids found in glycolipids and glycoproteins. N-Acetyl-D-mannosamine (ManNAc) is a specific substrate for the synthesis of N-acetylneuraminic acid, the essential precursor of bacterial capsular polysialic acid (PA). N-Acetyl-D-mannosamine is used for the synthesis of sialic acid. It is also a synthetic intermediate for a number of carbohydrate-derived families of biologically active compounds and pharmaceutical candidates.",N-Acetylmannosamine,HMDB0001129,b,b,C00645,N-ACETYL-D-MANNOSAMINE,FDB028419,acmana,[H]OC([H])([H])[C@@]1([H])OC([H])(O[H])[C@@]([H])(N([H])C(=O)C([H])([H])[H])[C@@]([H])(O[H])[C@]1([H])O[H],OVRNDRQMDRJTHS-ZTVVOAFPSA-N,"InChI=1S/C8H15NO6/c1-3(11)9-5-7(13)6(12)4(2-10)15-8(5)14/h4-8,10,12-14H,2H2,1H3,(H,9,11)/t4-,5+,6-,7-,8?/m1/s1"
5322,21495,a,a,16953,KEGG COMPOUND accession,C01042,Nacasp,997-55-7,21547.0,"Human Metabolome Database (HMDB): N-Acetylaspartic acid is a derivative of aspartic acid. It is the second most concentrated molecule in the brain after the amino acid glutamate. It is synthesized in neurons from the amino acid aspartate and acetyl coenzyme A (acetyl CoA). The various functions served by N-acetylaspartic acid are still under investigation, but the primary proposed functions include (1) acting as a neuronal osmolyte that is involved in fluid balance in the brain, (2) serving as a source of acetate for lipid and myelin synthesis in oligodendrocytes (the glial cells that myelinate neuronal axons), (3) serving as a precursor for the synthesis of the important dipeptide neurotransmitter N-acetylaspartylglutamate (NAAG), and (4) playing a potential role in energy production from the amino acid glutamate in neuronal mitochondria. High neurotransmitter levels can lead to abnormal neural signaling, delayed or arrested intellectual development, and difficulties with general motor skills. When present in sufficiently high levels, N-acetylaspartic acid can be a neurotoxin, an acidogen, and a metabotoxin. A neurotoxin is a compound that disrupts or attacks neural tissue. An acidogen is an acidic compound that induces acidosis, which has multiple adverse effects on many organ systems. A metabotoxin is an endogenously produced metabolite that causes adverse health effects at chronically high levels. Chronically high levels of N-acetylaspartic acid are associated with Canavan disease. N-acetylaspartic acid is an organic acid. Abnormally high levels of organic acids in the blood (organic acidemia), urine (organic aciduria), the brain, and other tissues lead to general metabolic acidosis. Acidosis typically occurs when arterial pH falls below 7.35. Infants with acidosis have symptoms that include poor feeding, vomiting, loss of appetite, weak muscle tone (hypotonia), and lack of energy (lethargy). These can progress to heart abnormalities, seizures, coma, and possibly death. Many affected children with organic acidemias experience intellectual disability or delayed development. In adults, acidosis or acidemia is characterized by headaches, confusion, feeling tired, tremors, sleepiness, and flapping tremors.",N-Acetyl-L-aspartic acid,HMDB0000812,b,b,C01042,CPD-420,FDB022260,Nacasp,[H]N(C(=O)C([H])([H])[H])[C@]([H])(C([O-])=O)C([H])([H])C([O-])=O,OTCCIMWXFLJLIA-BYPYZUCNSA-L,"InChI=1S/C6H9NO5/c1-3(8)7-4(6(11)12)2-5(9)10/h4H,2H2,1H3,(H,7,8)(H,9,10)(H,11,12)/p-2/t4-/m0/s1"
5323,21503,a,a,16878,KEGG COMPOUND accession,C04133,acg5p,15383-57-0,16878.0,Human Metabolome Database (HMDB): N-Acetyl-L-glutamyl 5-phosphate is an intermediate in urea cycle and metabolism of amino groups. The enzyme N-acetyl-gamma-glutamyl-phosphate reductase [EC:1.2.1.38] catalyzes the conversion of this metabolite into N-acetyl-L-glutamate 5-semialdehyde. This reaction is irreversible and occurs in the mitochondria. (BiGG database).,N-Acetyl-L-glutamyl 5-phosphate,HMDB0006456,b,b,C04133,N-ACETYL-GLUTAMYL-P,FDB023917,b,[H]N(C(=O)C([H])([H])[H])[C@]([H])(C([O-])=O)C([H])([H])C([H])([H])C(=O)OP([O-])([O-])=O,FCVIHFVSXHOPSW-YFKPBYRVSA-K,"InChI=1S/C7H12NO8P/c1-4(9)8-5(7(11)12)2-3-6(10)16-17(13,14)15/h5H,2-3H2,1H3,(H,8,9)(H,11,12)(H2,13,14,15)/p-3/t5-/m0/s1"
5324,21513,a,a,17786,KEGG COMPOUND accession,C02710,,,,,,,,,,,,,,,
5325,21516,a,a,16259,KEGG COMPOUND accession,C03519,,,,,,,,,,,,,,,
5326,21527,a,a,28257,KEGG COMPOUND accession,C04134,,,,,,,,,,,,,,,
5327,21530,a,a,27425,KEGG COMPOUND accession,C04019,,,,,,,,,,,,,,,
5328,21533,a,a,28451,KEGG COMPOUND accession,C01224,,,,,,,,,,,,,,,
5329,21536,a,a,28009,KEGG COMPOUND accession,C03878,,,,,,,,,,,,,,,
5330,21539,a,a,32618,KEGG COMPOUND accession,C04880,,,,,,,,,,,,,,,
5331,21541,a,a,32890,KEGG COMPOUND accession,C04937,,,,,,,,,,,,,,,
5332,21543,a,a,16250,KEGG COMPOUND accession,C01306,core3,b,16250.0,b,Core 3,b,b,b,C01306,b,b,core3,[H]OC([H])([H])[C@@]1([H])O[C@@]([H])(O[C@@]2([H])[C@@]([H])(O[H])[C@]([H])(OC([H])([*])[C@]2([H])N([H])C(=O)C([H])([H])[H])C([H])([H])O[H])[C@]([H])(N([H])C(=O)C([H])([H])[H])[C@@]([H])(O[H])[C@]1([H])O[H],b,b
5333,21546,a,a,17581,KEGG COMPOUND accession,C04930,,,,,,,,,,,,,,,
5334,21548,a,a,16059,KEGG COMPOUND accession,C04890,,,,,,,,,,,,,,,
5335,21552,a,a,16478,KEGG COMPOUND accession,C04917,core4,b,16478.0,b,Core 4,b,b,b,C04917,b,b,core4,[H]OC([H])([H])[C@@]1([H])O[C@@]([H])(OC([H])([H])[C@@]2([H])O[C@]([H])([*])[C@]([H])(N([H])C(=O)C([H])([H])[H])[C@@]([H])(O[C@]3([H])O[C@]([H])(C([H])([H])O[H])[C@@]([H])(O[H])[C@]([H])(O[H])[C@@]3([H])N([H])C(=O)C([H])([H])[H])[C@@]2([H])O[H])[C@]([H])(N([H])C(=O)C([H])([H])[H])[C@@]([H])(O[H])[C@]1([H])O[H],b,b
5336,21554,a,a,32601,KEGG COMPOUND accession,C04906,,,,,,,,,,,,,,,
5337,21556,a,a,32602,KEGG COMPOUND accession,C04934,,,,,,,,,,,,,,,
5338,21558,a,a,16198,KEGG COMPOUND accession,C04891,,,,,,,,,,,,,,,
5339,21562,a,a,15947,KEGG COMPOUND accession,C01239,M02521,b,15947.0,"Human Metabolome Database (HMDB): N-Acetyl-b-glucosaminylamine is the product of a reaction catalyzed vy the enzyme N(4)-(beta-N-acetylglucosaminyl)-L-asparaginase [EC 3.5.1.26, Aspartylglucosaminidase, AGA]. AGA is a key enzyme in the catabolism of N-linked oligosaccharides of glycoproteins. It cleaves the asparagine from the residual N-acetylglucosamines as one of the final steps in the lysosomal breakdown of glycoproteins. Aspartylglucosaminuria (AGU) is a lysosomal disease caused by deficiency of N-aspartyl-beta-glucosaminidase. AGU is the only known lysosomal storage disease caused by an amidase deficiency. (OMIM208400).",N-Acetyl-b-glucosaminylamine,HMDB0001104,b,b,C01239,N-ACETYL-BETA-GLUCOSAMINYLAMINE,FDB022426,b,[H]OC([H])([H])[C@@]1([H])O[C@@]([H])(N([H])[H])[C@]([H])(N([H])C(=O)C([H])([H])[H])[C@@]([H])(O[H])[C@]1([H])O[H],MCGXOCXFFNKASF-FMDGEEDCSA-N,"InChI=1S/C8H16N2O5/c1-3(12)10-5-7(14)6(13)4(2-11)15-8(5)9/h4-8,11,13-14H,2,9H2,1H3,(H,10,12)/t4-,5-,6-,7-,8-/m1/s1"
5340,21564,a,a,28000,KEGG COMPOUND accession,C03879,,,,,,,,,,,,,,,
5341,21591,a,a,35414,KEGG COMPOUND accession,C02297,,,,,,,,,,,,,,,
5342,21593,a,a,28655,KEGG COMPOUND accession,C03408,,,,,,,,,,,,,,,
5343,21594,a,a,28800,KEGG COMPOUND accession,C01074,acgal,1811-31-0,40356.0,"Human Metabolome Database (HMDB): Acetylgalactosamine is an important constituent of brain heteropolysaccharides (glycoproteins). The concentration of the N-acetylgalactosamine-containing glycoproteins in the 3-year-old cerebral gray matter from human brain is 7-15 times greater than in 8-year old tissue and 15-30 times greater than in 72-year-old tissue. (PMID 1207868). Acetylgalactosamine patterns of the composition of the soluble glycoproteins from endoscopic mucosal biopsies tends to decrease in the tumor area in cancer of the stomach (compared with the antrum and corpus of control stomachs). (PMID: 7151277). Chondroitin 6-sulfotransferase (C6ST) is the key enzyme in the biosynthesis of chondroitin 6-sulfate, a glycosaminoglycan implicated in chondrogenesis, neoplasia, atherosclerosis, and other processes. C6ST catalyzes the transfer of sulfate from 3'-phosphoadenosine 5'-phosphosulfate to carbon 6 of the N- Acetylgalactosamine residues of chondroitin. (PMID: 9639683).",N-Acetylgalactosamine,HMDB0000212,b,b,C01074,N-ACETYL-D-GLUCOSAMINE,FDB021906,acgal,[H]OC([H])([H])[C@@]1([H])OC([H])(O[H])[C@]([H])(N([H])C(=O)C([H])([H])[H])[C@@]([H])(O[H])[C@@]1([H])O[H],OVRNDRQMDRJTHS-KEWYIRBNSA-N,"InChI=1S/C8H15NO6/c1-3(11)9-5-7(13)6(12)4(2-10)15-8(5)14/h4-8,10,12-14H,2H2,1H3,(H,9,11)/t4-,5-,6+,7-,8?/m1/s1"
5344,21598,a,a,16984,KEGG COMPOUND accession,C02560,,,,,,,,,,,,,,,
5345,21605,a,a,7207,KEGG COMPOUND accession,C07585,,,,,,,,,,,,,,,
5346,21607,a,a,16153,KEGG COMPOUND accession,C00611,,,,,,,,,,,,,,,
5347,21614,a,a,7210,KEGG COMPOUND accession,C11361,,,,,,,,,,,,,,,
5348,21618,a,a,28881,KEGG COMPOUND accession,C02713,M02541,10597-89-4,21615.0,Human Metabolome Database (HMDB): This compound belongs to the family of N-acyl-alpha-hexosamines. These are carbohydrate derivatives containing a hexose moeity in which the oxygen atom is replaced by an n-acyl group.,N-Acetylmuramate,HMDB0060493,b,b,C02713,b,b,b,[H]OC(=O)[C@]([H])(O[C@@]1([H])[C@]([H])(O[H])[C@]([H])(OC([H])(O[H])[C@]1([H])N([H])C(=O)C([H])([H])[H])C([H])([H])O[H])C([H])([H])[H],MNLRQHMNZILYPY-MTBMMDAPSA-N,"InChI=1S/C11H19NO8/c1-4(10(16)17)19-9-7(12-5(2)14)11(18)20-6(3-13)8(9)15/h4,6-9,11,13,15,18H,3H2,1-2H3,(H,12,14)(H,16,17)/t4-,6-,7-,8-,9-,11?/m0/s1"
5349,21620,a,a,28920,KEGG COMPOUND accession,C02999,M02542,b,b,Human Metabolome Database (HMDB): This compound belongs to the family of N-acyl-alpha-hexosamines. These are carbohydrate derivatives containing a hexose moeity in which the oxygen atom is replaced by an n-acyl group.,N-Acetylmuramoyl-Ala,HMDB0060494,b,b,C02999,b,b,b,[H]OC(=O)[C@@]([H])(N([H])C(=O)[C@]([H])(O[C@@]1([H])[C@]([H])(O[H])[C@]([H])(O[C@]([H])(O[H])[C@]1([H])N([H])C(=O)C([H])([H])[H])C([H])([H])O[H])C([H])([H])[H])C([H])([H])[H],ICMUIFDBEVJCQA-LCBHGWRZSA-N,"InChI=1S/C14H24N2O9/c1-5(13(21)22)15-12(20)6(2)24-11-9(16-7(3)18)14(23)25-8(4-17)10(11)19/h5-6,8-11,14,17,19,23H,4H2,1-3H3,(H,15,20)(H,16,18)(H,21,22)/t5-,6-,8+,9+,10+,11+,14-/m0/s1"
5350,21633,a,a,27438,KEGG COMPOUND accession,C06241,acnamp,37992-17-9,27438.0,"Human Metabolome Database (HMDB): N-Acetylneuraminic acid 9-phosphate is an intermediate in the synthesis of Acetylneuraminic acid, a process occurring in the cytosolic fraction by the human enzyme N-Acetylneuraminic acid 9-phosphate (Neu5Ac 9-P) synthase, that catalyzes the synthesis of N-Acetylneuraminic acid 9-phosphate, in a reaction by the mechanism of aldol condensation of phosphoenolpyruvate (PEP) with sugar substrates, ManNAc-6-P (N-acetylmannosamine 6-phosphate) or Man-6-P (mannose 6-phosphate). N-Acetylneuraminic acid 9-phosphate is converted to N-Acetylneuraminic acid by the enzyme N-acetylneuraminate-9-phosphate phosphatase. (PMID: 16503877, 6093772).",N-Acetylneuraminic acid 9-phosphate,HMDB0004381,b,b,C06241,b,FDB023369,acnamp,[H]O[C@]([H])(C([H])([H])OP([O-])([O-])=O)[C@@]([H])(O[H])[C@]1([H])OC(O[H])(C([O-])=O)C([H])([H])[C@]([H])(O[H])[C@@]1([H])N([H])C(=O)C([H])([H])[H],SQMNIXJSBCSNCI-LUWBGTNYSA-K,"InChI=1S/C11H20NO12P/c1-4(13)12-7-5(14)2-11(19,10(17)18)24-9(7)8(16)6(15)3-23-25(20,21)22/h5-9,14-16,19H,2-3H2,1H3,(H,12,13)(H,17,18)(H2,20,21,22)/p-3/t5-,6+,7+,8+,9+,11?/m0/s1"
5351,21642,a,a,27499,KEGG COMPOUND accession,C06128,M03160,b,27499.0,b,N-Acetylneuraminyl-Galactosylceramide,b,b,b,C06128,b,b,b,[H]OC(=O)[C@]1(O[C@]2([H])[C@@]([H])(O[H])[C@]([H])(OC([H])([H])[C@]([H])(N([H])C([*])=O)[C@]([H])(O[H])C(\[H])=C(/[H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H])O[C@]([H])(C([H])([H])O[H])[C@]2([H])O[H])OC([H])([C@]([H])(O[H])[C@]([H])(O[H])C([H])([H])O[H])[C@]([H])(N([H])C(=O)C([H])([H])[H])[C@@]([H])(O[H])C1([H])[H],b,b
5352,21661,a,a,15779,KEGG COMPOUND accession,C06380,,,,,,,,,,,,,,,
5353,21665,a,a,15993,KEGG COMPOUND accession,C04136,,,,,,,,,,,,,,,
5354,21667,a,a,17503,KEGG COMPOUND accession,C06379,,,,,,,,,,,,,,,
5355,21669,a,a,16062,KEGG COMPOUND accession,C00625,,,,,,,,,,,,,,,
5356,21679,a,a,48927,KEGG COMPOUND accession,C02850,,,,,,,,,,,,,,,
5357,21685,a,a,17008,KEGG COMPOUND accession,C02716,,,,,,,,,,,,,,,
5358,21692,a,a,16498,KEGG COMPOUND accession,C00591,,,,,,,,,,,,,,,
5359,21715,a,a,17469,KEGG COMPOUND accession,C03293,,,,,,,,,,,,,,,
5360,21722,a,a,28609,KEGG COMPOUND accession,C04208,,,,,,,,,,,,,,,
5361,21724,a,a,16606,KEGG COMPOUND accession,C04207,,,,,,,,,,,,,,,
5362,21739,a,a,17255,KEGG COMPOUND accession,C05226,,,,,,,,,,,,,,,
5363,21741,a,a,51353,KEGG COMPOUND accession,C11529,,,,,,,,,,,,,,,
5364,21748,a,a,17902,KEGG COMPOUND accession,C00436,ncptrc,6851-51-0,17902.0,Human Metabolome Database (HMDB): N-Carbamoylputrescine is found in cereals and cereal products. N-Carbamoylputrescine is an alkaloid from Hordeum vulgare (barley) and Sesamum indicum (sesame).,N-Carbamoylputrescine,HMDB0033458,b,b,C00436,b,FDB011499,b,b,YANFYYGANIYHGI-UHFFFAOYSA-N,b
5365,21757,a,a,17945,KEGG COMPOUND accession,C11519,,,,,,,,,,,,,,,
5366,21769,a,a,15620,KEGG COMPOUND accession,C11735,,,,,,,,,,,,,,,
5367,21772,a,a,44485,KEGG COMPOUND accession,C02441,,,,,,,,,,,,,,,
5368,21778,a,a,17818,KEGG COMPOUND accession,C02717,,,,,,,,,,,,,,,
5369,21782,a,a,7274,KEGG COMPOUND accession,C00439,forglu,816-90-0,7274.0,Human Metabolome Database (HMDB): Measurement of this acid in the urine after oral administration of histidine provides the basis for the diagnostic test of folic acid deficiency and of megaloblastic anemia of pregnancy.,Formiminoglutamic acid,HMDB0000854,b,b,C00439,N-FORMIMINO-L-GLUTAMATE,FDB022280,forglu,[H]N=C([H])N([H])[C@]([H])(C([O-])=O)C([H])([H])C([H])([H])C([O-])=O,NRXIKWMTVXPVEF-BYPYZUCNSA-L,"InChI=1S/C6H10N2O4/c7-3-8-4(6(11)12)1-2-5(9)10/h3-4H,1-2H2,(H2,7,8)(H,9,10)(H,11,12)/p-2/t4-/m0/s1"
5370,21790,a,a,50759,KEGG COMPOUND accession,C02853,,,,,,,,,,,,,,,
5371,21791,a,a,48429,KEGG COMPOUND accession,C01044,,,,,,,,,,,,,,,
5372,21796,a,a,48309,KEGG COMPOUND accession,C01045,,,,,,,,,,,,,,,
5373,21800,a,a,16552,KEGG COMPOUND accession,C03145,,,,,,,,,,,,,,,
5374,21807,a,a,17119,KEGG COMPOUND accession,C03294,M02576,b,17119.0,b,N-Formylmethionyl-tRNA,b,b,b,C03294,b,b,b,[H]OC([H])([H])[C@@]1([H])O[C@@]([H])([*])[C@]([H])(O[H])[C@]1([H])OP(=O)(O[H])OC([H])([H])[C@@]1([H])O[C@@]([H])([*])[C@]([H])(O[H])[C@]1([H])OP(=O)(O[H])OC([H])([H])[C@@]1([H])O[C@@]([H])(N2C([H])=NC3=C2N=C([H])N=C3N([H])[H])[C@]([H])(OC(=O)[C@@]([H])(N([H])C([H])=O)C([H])([H])C([H])([H])SC([H])([H])[H])[C@]1([H])O[H],b,b
5375,21812,a,a,29025,KEGG COMPOUND accession,C03410,HC01115,1113-83-3,62084.0,"Human Metabolome Database (HMDB): N-Glycolylneuraminic acid (Neu5Gc) is a widely expressed sialic acid found in most mammalian cells. Although humans are genetically deficient in producing Neu5Gc, small amounts are present in human cells and biofluids. Humans cannot synthesize Neu5Gc because the human gene CMAH is irreversibly mutated, though it is found in apes. This loss of the CMAH gene was estimated to have occurred two to three million years ago, just before the emergence of the genus Homo. A dietary origin of Neu5Gc was suggested by human volunteer studies. These trace amounts of Neu5Gc were determined to come from the consumption of animals in the human diet (i.e. red meats such as lamb, pork, and beef). Neu5Gc can also be found in dairy products, but to a lesser extent. Neu5Gc is not found in poultry and is found in only trace amounts in fish (Wikipedia).",N-Glycolylneuraminic acid,HMDB0000833,b,b,C03410,b,FDB001165,b,[H]OC([H])([H])C(=O)N([H])[C@]1([H])[C@@]([H])(O[H])C([H])([H])C(O[H])(O[C@@]1([H])[C@]([H])(O[H])[C@]([H])(O[H])C([H])([H])O[H])C([O-])=O,FDJKUWYYUZCUJX-PGIATKPXSA-M,"InChI=1S/C11H19NO10/c13-2-5(16)8(18)9-7(12-6(17)3-14)4(15)1-11(21,22-9)10(19)20/h4-5,7-9,13-16,18,21H,1-3H2,(H,12,17)(H,19,20)/p-1/t4-,5+,7+,8+,9+,11?/m0/s1"
5376,21817,a,a,27788,KEGG COMPOUND accession,C04336,,,,,,,,,,,,,,,
5377,21827,a,a,16580,KEGG COMPOUND accession,C03622,,,,,,,,,,,,,,,
5378,21830,a,a,28089,KEGG COMPOUND accession,C03004,,,,,,,,,,,,,,,
5379,21843,a,a,16872,KEGG COMPOUND accession,C03147,,,,,,,,,,,,,,,
5380,21851,a,a,37041,KEGG COMPOUND accession,C03623,,,,,,,,,,,,,,,
5381,21853,a,a,7307,KEGG COMPOUND accession,C11118,,,,,,,,,,,,,,,
5382,21856,a,a,17519,KEGG COMPOUND accession,C02721,,,,,,,,,,,,,,,
5383,21861,a,a,16440,KEGG COMPOUND accession,C01046,,,,,,,,,,,,,,,
5384,21864,a,a,15733,KEGG COMPOUND accession,C02299,,,,,,,,,,,,,,,
5385,21870,a,a,16463,KEGG COMPOUND accession,C01210,HC00718,b,16463.0,b,N-Methylethanolaminium Phosphate,b,b,b,C01210,b,b,HC00718,[H]C([H])([H])[N+]([H])([H])C([H])([H])C([H])([H])OP([O-])([O-])=O,HZDCAHRLLXEQFY-UHFFFAOYSA-M,"InChI=1S/C3H10NO4P/c1-4-2-3-8-9(5,6)7/h4H,2-3H2,1H3,(H2,5,6,7)/p-1"
5386,21875,a,a,15860,KEGG COMPOUND accession,C02722,,,,,,,,,,,,,,,
5387,21877,a,a,29009,KEGG COMPOUND accession,C05127,mhista,501-75-7,29009.0,Human Metabolome Database (HMDB): 1-Methylhistamine is a histamine metabolite. It is a product of histamine 1-methyltransferase [EC 2.1.1.8] in the pathway histidine metabolism (KEGG).,1-Methylhistamine,HMDB0000898,b,b,C05127,N-METHYL-HISTAMINE,FDB022306,mhista,[H]C1=NC(=C([H])N1C([H])([H])[H])C([H])([H])C([H])([H])[N+]([H])([H])[H],FHQDWPCFSJMNCT-UHFFFAOYSA-O,"InChI=1S/C6H11N3/c1-9-4-6(2-3-7)8-5-9/h4-5H,2-3,7H2,1H3/p+1"
5388,21880,a,a,16354,KEGG COMPOUND accession,C02565,,,,,,,,,,,,,,,
5389,21899,a,a,28136,KEGG COMPOUND accession,C06213,M02605,61-49-4,28136.0,"Human Metabolome Database (HMDB): N-Methyltryptamine (NMT), or monomethyltryptamine, is a tryptamine alkaloid that has been found in the bark, shoots and leaves of numerous plants. (wikipedia). N-Methyltryptamine was detected in urine from all autistic patients with mental retardation and epilepsy and many autistic patients (32/47) with mental retardation (PubMed ID 8747157 ).",N-Methyltryptamine,HMDB0004370,b,b,C06213,b,FDB023368,b,[H]N(C([H])([H])[H])C([H])([H])C([H])([H])C1=C([H])N([H])C2=C([H])C([H])=C([H])C([H])=C12,NCIKQJBVUNUXLW-UHFFFAOYSA-N,"InChI=1S/C11H14N2/c1-12-7-6-9-8-13-11-5-3-2-4-10(9)11/h2-5,8,12-13H,6-7H2,1H3"
5390,21901,a,a,17458,KEGG COMPOUND accession,C02442,C02442,370-98-9,17458.0,"Human Metabolome Database (HMDB): N-methyltyramine (NMT) is a phenolic amine. NMT is a potent stimulant of gastrin release present in alcoholic beverages produced by alcoholic fermentation, but not by distillation (i.e.: beer.). NMT is well absorbed in the small intestine, especially in the duodenum and jejunum. NMT is metabolized in the liver (the site of first-pass metabolism), but not in the small-intestinal mucosa. NMT is occasionally present in the stools of children and infants. Satisfactory results have been obtained in treating infective shock with injection of natural Fructus Aurantii immaturus (nat-FAI); the anti-shock effective compositions in FAI have been proved to be synephrine and NMT. (PMID: 10772638, 2570680).",N-Methyltyramine,HMDB0003633,b,b,C02442,b,FDB000435,b,[H]OC1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])C([H])([H])[N+]([H])([H])C([H])([H])[H],AXVZFRBSCNEKPQ-UHFFFAOYSA-O,"InChI=1S/C9H13NO/c1-10-7-6-8-2-4-9(11)5-3-8/h2-5,10-11H,6-7H2,1H3/p+1"
5391,21904,a,a,7328,KEGG COMPOUND accession,C05679,,,,,,,,,,,,,,,
5392,21909,a,a,28884,KEGG COMPOUND accession,C07565,M01251,55576-55-1,28884.0,"Human Metabolome Database (HMDB): N-Acetylarylamine is an odourless solid chemical of leaf or flake-like appearance. It is also known as acetanilide, N-phenylacetamide, acetanil, or acetanilid, and was formerly known by the trade name Antifebrin. N-Acetylarylamine has analgesic and fever-reducing properties; it is in the same class of drugs as acetaminophen (paracetamol). Under the name acetanilid it formerly figured in the formula of a number of patent medicines and over the counter drugs. In 1948, Julius Axelrod and Bernard Brodie discovered that acetanilide is much more toxic in these applications than other drugs, causing methemoglobinemia and ultimately doing damage to the liver and kidneys. As such, acetanilide has largely been replaced by less toxic drugs, in particular acetaminophen, which is a metabolite of acetanilide and whose use Axelrod and Brodie suggested in the same study.",N-Acetylarylamine,HMDB0001250,b,b,C07565,N-ACETYLARYLAMINE,FDB022512,b,[H]N(C(=O)C([H])([H])[H])C1=C([H])C([H])=C([H])C([H])=C1[H],FZERHIULMFGESH-UHFFFAOYSA-N,"InChI=1S/C8H9NO/c1-7(10)9-8-5-3-2-4-6-8/h2-6H,1H3,(H,9,10)"
5393,21917,a,a,27449,KEGG COMPOUND accession,C03007,,,,,,,,,,,,,,,
5394,21936,a,a,16702,KEGG COMPOUND accession,C01075,,,,,,,,,,,,,,,
5395,21941,a,a,33715,KEGG COMPOUND accession,C01076,,,,,,,,,,,,,,,
5396,21942,a,a,17739,KEGG COMPOUND accession,C03881,M02627,b,17739.0,b,N-Tetradecanoylglycylpeptide,b,b,b,C03881,b,b,b,[H]OC(=O)C([H])([*])N([H])C(=O)C([H])([H])N([H])C(=O)C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H],b,b
5397,21946,a,a,28821,KEGG COMPOUND accession,C03882,,,,,,,,,,,,,,,
5398,21950,a,a,30307,KEGG COMPOUND accession,C04138,,,,,,,,,,,,,,,
5399,21952,a,a,7351,KEGG COMPOUND accession,C06442,,,,,,,,,,,,,,,
5400,21954,a,a,28101,KEGG COMPOUND accession,C03413,C03413,61345-83-3,28101.0,"Human Metabolome Database (HMDB): N1,N12-Diacetylspermine is a polyamine commonly occurring in normal human urine (PMID 7775374). It has been reported that urinary N1,N12-Diacetylspermine can be used as a marker to efficiently detect colorectal and breast cancers at early stages (PMID 15837752).","N1,N12-Diacetylspermine",HMDB0002172,b,b,C03413,b,FDB022884,b,[H]N(C(=O)C([H])([H])[H])C([H])([H])C([H])([H])C([H])([H])[N+]([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[N+]([H])([H])C([H])([H])C([H])([H])C([H])([H])N([H])C(=O)C([H])([H])[H],NPDTUDWGJMBVEP-UHFFFAOYSA-P,"InChI=1S/C14H30N4O2/c1-13(19)17-11-5-9-15-7-3-4-8-16-10-6-12-18-14(2)20/h15-16H,3-12H2,1-2H3,(H,17,19)(H,18,20)/p+2"
5401,21959,a,a,17927,KEGG COMPOUND accession,C00612,N1aspmd,14278-49-0,17927.0,"Human Metabolome Database (HMDB): N1-Acetylspermidine is a polyamine. In many organisms, polyamines originate from L-ornithine and methionine. Ornithine decarboxylase (EC 4.1.1.17), a key enzyme in polyamine metabolism, decarboxylates L-ornithine to yield putrescine which is then converted to higher polyamines spermidine and spermine by successive addition of aminopropyl groups derived from decarboxylated S-adenosylmethionine. Aliphatic polyamines occur ubiquitously in organisms and have important functions in the stabilization of cell membranes, biosynthesis of informing molecules, cell growth and differentiation, as well as adaptation to osmotic, ionic, pH and thermal stress. These cationic substances are implicated in multiple functions, therefore it is not surprising that intracellular levels of polyamines are regulated by different mechanisms. The inhibition of polyamine metabolism has important pharmacological and therapeutic implications for the control of physiological processes, reproduction, cancer and parasitic diseases. Recent reports have suggested the idea that parasites with an high turnover of Ornithine Decarboxilase (ODC) are resistant to Difluoromethyl ornithine (DFMO, the irreversible inhibitor of ornithine decarboxylase) because they always contain a fraction of newly synthesized and active enzyme, therefore not DFMO inhibited, sufficient to produce small amounts of putrescine rapidly converted into spermidine, which can support protozoan proliferation. DFMO has proved to be curative in trypanosomiasis, coccidiosis, and certain other protozoan infections. (PMID: 15490259).",N1-Acetylspermidine,HMDB0001276,b,b,C00612,CPD-568,FDB022530,N1aspmd,[H]N(C(=O)C([H])([H])[H])C([H])([H])C([H])([H])C([H])([H])[N+]([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[N+]([H])([H])[H],MQTAVJHICJWXBR-UHFFFAOYSA-P,"InChI=1S/C9H21N3O/c1-9(13)12-8-4-7-11-6-3-2-5-10/h11H,2-8,10H2,1H3,(H,12,13)/p+2"
5402,21963,a,a,17312,KEGG COMPOUND accession,C02567,N1sprm,25593-72-0,17312.0,Human Metabolome Database (HMDB): N1-Acetylspermine is a polyamine that has been postulated to be an intermediate in the conversion of spermine to spermidine.,N1-Acetylspermine,HMDB0001186,b,b,C02567,N1-ACETYLSPERMINE,FDB022474,b,[H]N(C(=O)C([H])([H])[H])C([H])([H])C([H])([H])C([H])([H])[N+]([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[N+]([H])([H])C([H])([H])C([H])([H])C([H])([H])[N+]([H])([H])[H],GUNURVWAJRRUAV-UHFFFAOYSA-Q,"InChI=1S/C12H28N4O/c1-12(17)16-11-5-10-15-8-3-2-7-14-9-4-6-13/h14-15H,2-11,13H2,1H3,(H,16,17)/p+3"
5403,21966,a,a,27410,KEGG COMPOUND accession,C05842,M02505,701-44-0,27410.0,"Human Metabolome Database (HMDB): N-methyl-2-pyridone-5-carboxamide (2PY) is one of the end products of nicotinamide-adenine dinucleotide (NAD) degradation. Increased serum 2PY concentrations are observed in chronic renal failure (CRF) patients, which along with the deterioration of kidney function and its toxic properties (significant inhibition of PARP-1), suggests that 2PY is an uremic toxin. (PMID 12694300).",N1-Methyl-2-pyridone-5-carboxamide,HMDB0004193,b,b,C05842,b,FDB023330,b,[H]N([H])C(=O)C1=C([H])N(C(=O)C([H])=C1[H])C([H])([H])[H],JLQSXXWTCJPCBC-UHFFFAOYSA-N,"InChI=1S/C7H8N2O2/c1-9-4-5(7(8)11)2-3-6(9)10/h2-4H,1H3,(H2,8,11)"
5404,21970,a,a,28147,KEGG COMPOUND accession,C03524,,,,,,,,,,,,,,,
5405,21995,a,a,15874,KEGG COMPOUND accession,C03414,,,,,,,,,,,,,,,
5406,21997,a,a,17705,KEGG COMPOUND accession,C03296,,,,,,,,,,,,,,,
5407,21999,a,a,48957,KEGG COMPOUND accession,C05931,,,,,,,,,,,,,,,
5408,22001,a,a,27657,KEGG COMPOUND accession,C05932,,,,,,,,,,,,,,,
5409,22004,a,a,27574,KEGG COMPOUND accession,C03415,,,,,,,,,,,,,,,
5410,22006,a,a,16844,KEGG COMPOUND accession,C04504,,,,,,,,,,,,,,,
5411,22012,a,a,28500,KEGG COMPOUND accession,C02857,,,,,,,,,,,,,,,
5412,22016,a,a,16399,KEGG COMPOUND accession,C04209,,,,,,,,,,,,,,,
5413,22036,a,a,16770,KEGG COMPOUND accession,C04210,,,,,,,,,,,,,,,
5414,22038,a,a,17339,KEGG COMPOUND accession,C02858,,,,,,,,,,,,,,,
5415,22044,a,a,17394,KEGG COMPOUND accession,C01047,,,,,,,,,,,,,,,
5416,22047,a,a,17114,KEGG COMPOUND accession,C01274,5fth4mpt,b,58018.0,b,"N(5)-formyl-5,6,7,8-tetrahydromethanopterin",b,b,b,C01274,b,b,b,b,b,"InChI=1S/C31H45N6O17P/c1-13(22-14(2)34-27-23(37(22)12-38)28(46)36-31(32)35-27)33-16-5-3-15(4-6-16)9-17(39)24(43)18(40)10-51-30-26(45)25(44)20(53-30)11-52-55(49,50)54-19(29(47)48)7-8-21(41)42/h3-6,12-14,17-20,22,24-26,30,33,39-40,43-45H,7-11H2,1-2H3,(H,41,42)(H,47,48)(H,49,50)(H4,32,34,35,36,46)/p-3/t13-,14+,17+,18-,19+,20-,22?,24+,25-,26-,30+/m1/s1"
5417,22054,a,a,18142,KEGG COMPOUND accession,C03154,,,,,,,,,,,,,,,
5418,22055,a,a,17311,KEGG COMPOUND accession,C03793,tmlys,19253-88-4,17311.0,"Human Metabolome Database (HMDB): N6,N6,N6-Trimethyl-L-lysine is a methylated derivative of the amino acid lysine. It is a component of histone proteins, a precursor of carnitine and a coenzyme of fatty acid oxidation. N6,N6,N6-Trimethyl-L-lysine residues are found in a number of proteins and are generated by the action of S-adenosyl-L-methionine on exposed lysine residues. When trimethyllysine is released from cognate proteins via proteolysis, it serves as a precursor for carnitine biosynthesis. Mitochondrial 6-N-trimethyllysine dioxygenase converts 6-N-trimethyllysine to 3-hydroxy-6-N-trimethyllysine as the first step for carnitine biosynthesis. Because the subsequent carnitine biosynthesis enzymes are cytosolic, 3-hydroxy-6-N-trimethyllysine must be transported out of the mitochondria by a putative mitochondrial 6-N-trimethyllysine/3-hydroxy-6-N-trimethyllysine transporter system. Plasma -N-trimethyllysine concentrations are significantly lower in systemic carnitine deficiency patients compared to normal individuals, but no significant difference in urinary -N-trimethyllysine excretion is seen between the two groups.","N6,N6,N6-Trimethyl-L-lysine",HMDB0001325,b,b,C03793,N6N6N6-TRIMETHYL-L-LYSINE,FDB022556,tmlys,[H]N([H])[C@]([H])(C([O-])=O)C([H])([H])C([H])([H])C([H])([H])C([H])([H])[N+](C([H])([H])[H])(C([H])([H])[H])C([H])([H])[H],MXNRLFUSFKVQSK-QMMMGPOBSA-N,"InChI=1S/C9H20N2O2/c1-11(2,3)7-5-4-6-8(10)9(12)13/h8H,4-7,10H2,1-3H3/t8-/m0/s1"
5419,22057,a,a,27830,KEGG COMPOUND accession,C07027,,,,,,,,,,,,,,,
5420,22074,a,a,15819,KEGG COMPOUND accession,C04713,,,,,,,,,,,,,,,
5421,22076,a,a,17752,KEGG COMPOUND accession,C02727,,,,,,,,,,,,,,,
5422,22085,a,a,16232,KEGG COMPOUND accession,C02444,,,,,,,,,,,,,,,
5423,22088,a,a,17524,KEGG COMPOUND accession,C02860,,,,,,,,,,,,,,,
5424,22090,a,a,15704,KEGG COMPOUND accession,C04422,,,,,,,,,,,,,,,
5425,22092,a,a,27870,KEGG COMPOUND accession,C05552,biocyt,576-19-2,27870.0,"Human Metabolome Database (HMDB): Biocytin is a naturally occurring low molecular weight analog of biotin, and a primary source of this essential metabolite for mammals. Biotinidase acts as a hydrolase by cleaving biocytin and biotinyl-peptides, thereby liberating biotin for reutilization. Mammals cannot synthesize biotin and, therefore, derive the vitamin from dietary sources or from the endogenous turnover of the carboxylases. Free biotin can readily enter the biotin pool, whereas holocarboxylases or other biotin-containing proteins must first be degraded proteolytically to biocytin (biotinyl-e-lysine) or biotinyl-peptides. Biocytin is also an especially versatile marker for neuroanatomical investigations, shown that may have multiple applications, especially for labeling neurons. (PMID: 8930409, 1384763, 2479450).",Biocytin,HMDB0003134,b,b,C05552,b,FDB023111,biocyt,[H]N(C(=O)C([H])([H])C([H])([H])C([H])([H])C([H])([H])[C@]1([H])SC([H])([H])[C@]2([H])N([H])C(=O)N([H])[C@]12[H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[C@@]([H])(C([O-])=O)[N+]([H])([H])[H],BAQMYDQNMFBZNA-MNXVOIDGSA-N,"InChI=1S/C16H28N4O4S/c17-10(15(22)23)5-3-4-8-18-13(21)7-2-1-6-12-14-11(9-25-12)19-16(24)20-14/h10-12,14H,1-9,17H2,(H,18,21)(H,22,23)(H2,19,20,24)/t10-,11-,12-,14-/m0/s1"
5426,22094,a,a,16570,KEGG COMPOUND accession,C01028,,,,,,,,,,,,,,,
5427,22101,a,a,17328,KEGG COMPOUND accession,C04211,,,,,,,,,,,,,,,
5428,22103,a,a,27911,KEGG COMPOUND accession,C01029,n8aspmd,34450-15-2,27911.0,"Human Metabolome Database (HMDB): N8-Acetylspermidine is a polyamine. The polyamines, found in virtually all living organisms, are a ubiquitous group of compounds that appear to play a vital role in many cellular processes involving nucleic acids including cell growth and differentiation. The polyamines, found in virtually all living organisms, are a ubiquitous group of compounds that appear to play a vital role in many cellular processes involving nucleic acids including cell growth and differentiation. Acetylation on the terminal nitrogen adjacent to the 4-carbon chain produces N8-acetylspermidine. This reaction is catalyzed by spermidine N8-acetyltransferase and does not result in the conversion of spermidine to putrescine but, instead, the product undergoes deacetylation. This acetyltransferase appears to be associated with chromatin in the cell nucleus and has been reported to be the same as (or related to) the enzyme(s) responsible for histone acetylation. N8-Acetylspermidine does not accumulate in tissues but rather appears to be rapidly deacetylated back to spermidine by a relatively specific cytosolic deacetylase, N8-acetylspermidine deacetylase. The function of this N8-acetylation/deacetylation pathway in cellular processes is not understood clearly, but several observations have suggested a role in cell growth and differentiation. (PMID: 12093478).",N8-Acetylspermidine,HMDB0002189,b,b,C01029,CPD-3462,FDB022894,n8aspmd,[H]N(C(=O)C([H])([H])[H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[N+]([H])([H])C([H])([H])C([H])([H])C([H])([H])[N+]([H])([H])[H],FONIWJIDLJEJTL-UHFFFAOYSA-P,"InChI=1S/C9H21N3O/c1-9(13)12-8-3-2-6-11-7-4-5-10/h11H,2-8,10H2,1H3,(H,12,13)/p+2"
5429,22106,a,a,15846,KEGG COMPOUND accession,C00003,nad,53-84-9,15846.0,"Human Metabolome Database (HMDB): NAD (or Nicotinamide adenine dinucleotide) is used extensively in glycolysis and the citric acid cycle of cellular respiration. The reducing potential stored in NADH can be converted to ATP through the electron transport chain or used for anabolic metabolism. ATP ""energy"" is necessary for an organism to live. Green plants obtain ATP through photosynthesis, while other organisms obtain it by cellular respiration. (wikipedia). Nicotinamide adenine dinucleotide is a A coenzyme composed of ribosylnicotinamide 5'-diphosphate coupled to adenosine 5'-phosphate by pyrophosphate linkage. It is found widely in nature and is involved in numerous enzymatic reactions in which it serves as an electron carrier by being alternately oxidized (NAD+) and reduced (NADH). (Dorland, 27th ed).",NAD,HMDB0000902,b,b,C00003,NAD,FDB022309,NAD,[H]O[C@@]1([H])[C@@]([H])(O[C@]([H])(C([H])([H])OP([O-])(=O)OP([O-])(=O)OC([H])([H])[C@@]2([H])O[C@@]([H])([N+]3=C([H])C(=C([H])C([H])=C3[H])C(=O)N([H])[H])[C@]([H])(O[H])[C@]2([H])O[H])[C@@]1([H])O[H])N1C([H])=NC2=C(N=C([H])N=C12)N([H])[H],BAWFJGJZGIEFAR-NNYOXOHSSA-M,"InChI=1S/C21H27N7O14P2/c22-17-12-19(25-7-24-17)28(8-26-12)21-16(32)14(30)11(41-21)6-39-44(36,37)42-43(34,35)38-5-10-13(29)15(31)20(40-10)27-3-1-2-9(4-27)18(23)33/h1-4,7-8,10-11,13-16,20-21,29-32H,5-6H2,(H5-,22,23,24,25,33,34,35,36,37)/p-1/t10-,11-,13-,14-,15-,16-,20-,21-/m1/s1"
5430,22911,a,a,18009,KEGG COMPOUND accession,C00006,nadp,53-59-8,18009.0,"Human Metabolome Database (HMDB): Nicotinamide adenine dinucleotide phosphate. A coenzyme composed of ribosylnicotinamide 5-phosphate (NMN) coupled by pyrophosphate linkage to the 5-phosphate adenosine 2,5-bisphosphate. It serves as an electron carrier in a number of reactions, being alternately oxidized (NADP+) and reduced (NADPH). (Dorland, 27th ed.) Hydrogen carrier in biochemical redox systems. In the hexose monophosphoric acid system it is reduced to Dihydrocoenzyme II and reoxidation in the presence of flavoproteins (Dictionary of Organic Compounds).",NADP,HMDB0000217,b,b,C00006,NAD(P),FDB021908,nadp,[H]O[C@]1([H])[C@]([H])(O[H])[C@]([H])(O[C@@]1([H])[N+]1=C([H])C(=C([H])C([H])=C1[H])C(=O)N([H])[H])C([H])([H])OP([O-])(=O)OP([O-])(=O)OC([H])([H])[C@@]1([H])O[C@@]([H])(N2C([H])=NC3=C(N=C([H])N=C23)N([H])[H])[C@]([H])(OP([O-])([O-])=O)[C@]1([H])O[H],XJLXINKUBYWONI-NNYOXOHSSA-K,"InChI=1S/C21H28N7O17P3/c22-17-12-19(25-7-24-17)28(8-26-12)21-16(44-46(33,34)35)14(30)11(43-21)6-41-48(38,39)45-47(36,37)40-5-10-13(29)15(31)20(42-10)27-3-1-2-9(4-27)18(23)32/h1-4,7-8,10-11,13-16,20-21,29-31H,5-6H2,(H7-,22,23,24,25,32,33,34,35,36,37,38,39)/p-3/t10-,11-,13-,14-,15-,16-,20-,21-/m1/s1"
5431,23301,a,a,16474,KEGG COMPOUND accession,C00005,nadph,53-57-6,16474.0,"Human Metabolome Database (HMDB): Nicotinamide adenine dinucleotide phosphate. A coenzyme composed of ribosylnicotinamide 5'-phosphate (NMN) coupled by pyrophosphate linkage to the 5'-phosphate adenosine 2',5'-bisphosphate. It serves as an electron carrier in a number of reactions, being alternately oxidized (NADP+) and reduced (NADPH). (Dorland, 27th ed.).",NADPH,HMDB0000221,b,b,C00005,NADPH,FDB021909,nadph,[H]O[C@@]1([H])[C@@]([H])(O[C@]([H])(C([H])([H])OP([O-])(=O)OP([O-])(=O)OC([H])([H])[C@@]2([H])O[C@@]([H])(N3C([H])=NC4=C(N=C([H])N=C34)N([H])[H])[C@]([H])(OP([O-])([O-])=O)[C@]2([H])O[H])[C@@]1([H])O[H])N1C([H])=C([H])C([H])([H])C(=C1[H])C(=O)N([H])[H],ACFIXJIJDZMPPO-NCHANQSKSA-J,"InChI=1S/C21H30N7O17P3/c22-17-12-19(25-7-24-17)28(8-26-12)21-16(44-46(33,34)35)14(30)11(43-21)6-41-48(38,39)45-47(36,37)40-5-10-13(29)15(31)20(42-10)27-3-1-2-9(4-27)18(23)32/h1,3-4,7-8,10-11,13-16,20-21,29-31H,2,5-6H2,(H2,23,32)(H,36,37)(H,38,39)(H2,22,24,25)(H2,33,34,35)/p-4/t10-,11-,13-,14-,15-,16-,20-,21-/m0/s1"
5432,23706,a,a,17929,KEGG COMPOUND accession,C03626,dmlarg,30315-93-6,17929.0,"Human Metabolome Database (HMDB): Asymmetric dimethylarginine (ADMA) is a naturally occurring chemical found in blood plasma. It is a metabolic by-product of continual protein modification processes in the cytoplasm of all human cells. It is closely related to L-arginine, a conditionally-essential amino acid. ADMA interferes with L-arginine in the production of nitric oxide, a key chemical to endothelial and hence cardiovascular health. Asymmetric dimethylarginine is created in protein methylation, a common mechanism of post-translational protein modification. This reaction is catalyzed by an enzyme set called S-adenosylmethionine protein N-methyltransferases (protein methylases I and II). The methyl groups transferred to create ADMA are derived from the methyl group donor S-adenosylmethionine, an intermediate in the metabolism of homocysteine. (Homocysteine is an important blood chemical, because it is also a marker of cardiovascular disease). After synthesis, ADMA migrates into the extracellular space and thence into blood plasma. Asymmetric dimethylarginine is measured using high performance liquid chromatography.",Asymmetric dimethylarginine,HMDB0001539,b,b,C03626,CPD-596,FDB000508,b,[H]OC(=O)[C@@]([H])(N([H])[H])C([H])([H])C([H])([H])C([H])([H])N([H])C(=N[H])N(C([H])([H])[H])C([H])([H])[H],YDGMGEXADBMOMJ-LURJTMIESA-N,"InChI=1S/C8H18N4O2/c1-12(2)8(10)11-5-3-4-6(9)7(13)14/h6H,3-5,9H2,1-2H3,(H2,10,11)(H,13,14)/t6-/m0/s1"
5433,23710,a,a,16134,KEGG COMPOUND accession,C00014,nh4,7664-41-7,16134.0,"Human Metabolome Database (HMDB): Ammonia is a colourless alkaline gas and is one of the most abundant nitrogen-containing compounds in the atmosphere. It is an irritant with a characteristic pungent odor that is widely used in industry. Inasmuch as ammonia is highly soluble in water and, upon inhalation, is deposited in the upper airways, occupational exposures to ammonia have commonly been associated with sinusitis, upper airway irritation, and eye irritation. Acute exposures to high levels of ammonia have also been associated with diseases of the lower airways and interstitial lung. Small amounts of ammonia are naturally formed in nearly all tissues and organs of the vertebrate organism. Ammonia is both a neurotoxin and a metabotoxin. In fact, it is the most common endogenous neurotoxin. A neurotoxin is a compound that causes damage to neural tissue and neural cells. A metabotoxin is an endogenously produced metabolite that causes adverse health effects at chronically high levels. Ammonia is recognized to be central in the pathogenesis of a brain condition known as hepatic encephalopathy, which arises from various liver diseases and leads to a build up ammonia in the blood (hyperammonemia). More than 40% of people with cirrhosis develop hepatic encephalopathy. Part of the neurotoxicity of ammonia arises from the fact that it easily crosses the blood-brain barrier and is absorbed and metabolized by the astrocytes, a population of cells in the brain that constitutes 30% of the cerebral cortex. Astrocytes use ammonia when synthesizing glutamine from glutamate. The increased levels of glutamine lead to an increase in osmotic pressure in the astrocytes, which become swollen. There is increased activity of the inhibitory gamma-aminobutyric acid (GABA) system, and the energy supply to other brain cells is decreased. This can be thought of as an example of brain edema. The source of the ammonia leading to hepatic encaphlopahy is not entirely clear. The gut produces ammonia, which is metabolized in the liver, and almost all organ systems are involved in ammonia metabolism. Colonic bacteria produce ammonia by splitting urea and other amino acids, however this does not fully explain hyperammonemia and hepatic encephalopathy. The alternative explanation is that hyperammonemia is the result of intestinal breakdown of amino acids, especially glutamine. The intestines have significant glutaminase activity, predominantly located in the enterocytes. On the other hand, intestinal tissues only have a little glutamine synthetase activity, making it a major glutamine-consuming organ. In addition to the intestine, the kidney is an important source of blood ammonia in patients with liver disease. Ammonia is also taken up by the muscle and brain in hepatic coma, and there is confirmation that ammonia is metabolized in muscle. Excessive formation of ammonia in the brains of Alzheimer's disease patients has also been demonstrated, and it has been shown that some Alzheimer's disease patients exhibit elevated blood ammonia concentrations. Ammonia is the most important natural modulator of lysosomal protein processing. Indeed, there is strong evidence for the involvement of aberrant lysosomal processing of beta-amyloid precursor protein (beta-APP) in the formation of amyloid deposits. Inflammatory processes and activation of microglia are widely believed to be implicated in the pathology of Alzheimer's disease. Ammonia is able to affect the characteristic functions of microglia, such as endocytosis, and cytokine production. Based on these facts, an ammonia-based hypothesis for Alzheimer's disease has been suggested (PMID: 17006913, 16167195, 15377862, 15369278). Chronically high levels of ammonia in the blood are associated with nearly twenty different inborn errors of metabolism including: 3-hydroxy-3-methylglutaryl-CoA lyase deficiency, 3-methyl-crotonylglycinuria, argininemia, argininosuccinic aciduria, beta-ketothiolase deficiency, biotinidase deficiency, carbamoyl phosphate synthetase deficiency, carnitine-acylcarnitine translocase deficiency, citrullinemia type I, hyperinsulinism-hyperammonemia syndrome, hyperornithinemia-hyperammonemia-homocitrullinuria syndrome, isovaleric aciduria, lysinuric protein intolerance, malonic aciduria, methylmalonic aciduria, methylmalonic aciduria due to cobalamin-related disorders, propionic acidemia, pyruvate carboxylase deficiency, and short chain acyl CoA dehydrogenase deficiency (SCAD deficiency). Many of these inborn errors of metabolism are associated with urea cycle disorders or impairment to amino acid metabolism. High levels of ammonia in the blood (hyperammonemia) lead to the activation of NMDA receptors in the brain. This results in the depletion of brain ATP, which in turn leads to release of glutamate. Ammonia also leads to the impairment of mitochondrial function and calcium homeostasis, thereby decreasing ATP synthesis. Excess ammonia also increases the formation of nitric oxide (NO), which in turn reduces the activity of glutamine synthetase, and thereby decreases the elimination of ammonia in the brain (PMID: 12020609). As a neurotoxin, ammonia predominantly affects astrocytes. Disturbed mitochondrial function and oxidative stress, factors implicated in the induction of the mitochondrial permeability transition, appear to be involved in the mechanism of ammonia neurotoxicity. Ammonia can also affect the glutamatergic and GABAergic neuronal systems, the two prevailing neuronal systems of the cortical structures. All of these effects can lead to irreversible brain damage, coma, and/or death. Infants with urea cycle disorders and hyperammonia initially exhibit vomiting and increasing lethargy. If untreated, seizures, hypotonia (poor muscle tone, floppiness), respiratory distress (respiratory alkalosis), and coma can occur. Adults with urea cycle disorders and hyperammonia will exhibit episodes of disorientation, confusion, slurred speech, unusual and extreme combativeness or agitation, stroke-like symptoms, lethargy, and delirium. Ammonia also has toxic effects when an individual is exposed to ammonia solutions. Acute exposure to high levels of ammonia in air may be irritating to skin, eyes, throat, and lungs and cause coughing and burns. Lung damage and death may occur after exposure to very high concentrations of ammonia. Swallowing concentrated solutions of ammonia can cause burns in the mouth, throat, and stomach. Splashing ammonia into eyes can cause burns and even blindness.",Ammonia,HMDB0000051,b,b,C00014,AMMONIA,FDB003908,nh4,[H][N+]([H])([H])[H],QGZKDVFQNNGYKY-UHFFFAOYSA-O,InChI=1S/H3N/h1H3/p+1
5434,23892,a,a,18219,KEGG COMPOUND accession,C01358,,,,,,,,,,,,,,,
5435,23896,a,a,7438,KEGG COMPOUND accession,C11489,,,,,,,,,,,,,,,
5436,23898,a,a,17188,KEGG COMPOUND accession,C01329,,,,,,,,,,,,,,,
5437,23910,a,a,7445,KEGG COMPOUND accession,C07613,,,,,,,,,,,,,,,
5438,23914,a,a,7447,KEGG COMPOUND accession,C07250,,,,,,,,,,,,,,,
5439,23918,a,a,7449,KEGG COMPOUND accession,C11371,,,,,,,,,,,,,,,
5440,23921,a,a,7451,KEGG COMPOUND accession,C08071,,,,,,,,,,,,,,,
5441,23937,a,a,7459,KEGG COMPOUND accession,C07252,,,,,,,,,,,,,,,
5442,23944,a,a,18061,KEGG COMPOUND accession,C03011,,,,,,,,,,,,,,,
5443,23946,a,a,50601,KEGG COMPOUND accession,C03298,,,,,,,,,,,,,,,
5444,23949,a,a,7466,KEGG COMPOUND accession,C07254,,,,,,,,,,,,,,,
5445,23961,a,a,16482,KEGG COMPOUND accession,C00829,npthl,91-20-3,16482.0,"Human Metabolome Database (HMDB): Naphthalene is found in black walnut. Naphthalene is found in many essential oils.Naphthalene is an organic compound with formula C10H8. It is a white crystalline solid with a characteristic odor that is detectable at concentrations as low as 0.08 ppm by mass. Trace amounts of naphthalene are produced by magnolias and specific types of deer, as well as the Formosan subterranean termite. Some strains of the endophytic fungus Muscodor albus produce naphthalene among a range of volatile organic compounds, while Muscodor vitigenus produces naphthalene almost exclusively (Wikipedia",Naphthalene,HMDB0029751,b,b,C00829,b,FDB000954,npthl,[H]C1=C([H])C2=C([H])C([H])=C([H])C([H])=C2C([H])=C1[H],UFWIBTONFRDIAS-UHFFFAOYSA-N,InChI=1S/C10H8/c1-2-6-10-8-4-3-7-9(10)5-1/h1-8H
5446,23964,a,a,17435,KEGG COMPOUND accession,C03012,,,,,,,,,,,,,,,
5447,23986,a,a,17846,KEGG COMPOUND accession,C00509,,,,,,,,,,,,,,,
5448,23992,a,a,28327,KEGG COMPOUND accession,C09099,,,,,,,,,,,,,,,
5449,24001,a,a,7488,KEGG COMPOUND accession,C08073,,,,,,,,,,,,,,,
5450,24016,a,a,7494,KEGG COMPOUND accession,C07256,,,,,,,,,,,,,,,
5451,24022,a,a,7497,KEGG COMPOUND accession,C08091,,,,,,,,,,,,,,,
5452,24036,a,a,59016,KEGG COMPOUND accession,C09806,,,,,,,,,,,,,,,
5453,24042,a,a,7507,KEGG COMPOUND accession,C00384,,,,,,,,,,,,,,,
5454,24047,a,a,7510,KEGG COMPOUND accession,C06172,,,,,,,,,,,,,,,
5455,24052,a,a,7513,KEGG COMPOUND accession,C10110,,,,,,,,,,,,,,,
5456,24054,a,a,7514,KEGG COMPOUND accession,C07258,,,,,,,,,,,,,,,
5457,24056,a,a,179557,KEGG COMPOUND accession,C08197,,,,,,,,,,,,,,,
5458,24078,a,a,44247,KEGG COMPOUND accession,C08323,nrvnc,506-37-6,44247.0,"Human Metabolome Database (HMDB): Nervonic acid is a long chain unsaturated fatty acid that is enriched in sphingomyelin. It consists of choline, sphingosine, phosphoric acid, and fatty acid. Nervonic acid may enhance the brain functions and prevent demyelination (Chemical Land21). Research shows that there is negative relationship between nervonic acid and obesity-related risk factors (PMID: 16394593). Demyelination in adrenoleukodystrophy (ALD) is associated with an accumulation of very long chain saturated fatty acids stemming from a genetic defect in the peroxisomal beta oxidation system responsible for the chain shortening of these fatty acids. Sphingolipids from post mortem ALD brain have decreased levels of nervonic acid, 24:1(n-9), and increased levels of stearic acid, 18:0. (PMID: 8072429).",Nervonic acid,HMDB0002368,b,b,C08323,b,FDB002934,nrvnc,[H]\C(=C(/[H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([O-])=O)C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H],GWHCXVQVJPWHRF-KTKRTIGZSA-M,"InChI=1S/C24H46O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20-21-22-23-24(25)26/h9-10H,2-8,11-23H2,1H3,(H,25,26)/p-1/b10-9-"
5459,24092,a,a,28541,KEGG COMPOUND accession,C06299,gt3_hs,b,28541.0,b,Gt3,b,b,b,C06299,b,b,gt3_hs,[H]OC([H])([H])[C@@]([H])(O[H])[C@@]([H])(O[H])C1([H])O[C@@](O[C@]([H])(C([H])([H])O[H])[C@@]([H])(O[H])C2([H])O[C@@](O[C@]([H])(C([H])([H])O[H])[C@@]([H])(O[H])C3([H])O[C@@](O[C@]4([H])[C@@]([H])(O[H])[C@]([H])(O[C@@]5([H])[C@]([H])(O[H])[C@@]([H])(O[H])[C@]([H])(OC([H])([H])[C@]([H])(N([H])C([*])=O)[C@]([H])(O[H])C(\[H])=C(/[H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H])O[C@]5([H])C([H])([H])O[H])O[C@]([H])(C([H])([H])O[H])[C@]4([H])O[H])(C([O-])=O)C([H])([H])[C@]([H])(O[H])[C@@]3([H])N([H])C(=O)C([H])([H])[H])(C([O-])=O)C([H])([H])[C@]([H])(O[H])[C@@]2([H])N([H])C(=O)C([H])([H])[H])(C([O-])=O)C([H])([H])[C@]([H])(O[H])[C@@]1([H])N([H])C(=O)C([H])([H])[H],b,b
5460,24100,a,a,16833,KEGG COMPOUND accession,C05431,,,,,,,,,,,,,,,
5461,24110,a,a,28229,KEGG COMPOUND accession,C03884,,,,,,,,,,,,,,,
5462,24140,a,a,16171,KEGG COMPOUND accession,C00455,nmn,1094-61-7,16171.0,"Human Metabolome Database (HMDB): Nicotinamide ribotide (NMN) is an important intermediate metabolite in the nicotinate and nicotinamide metabolism pathway. Mammals predominantly use nicotinamide rather than nicotinic acid as a precursor for NAD biosynthesis. Instead of the deamidation to nicotinic acid, nicotinamide is directly converted to NMN by nicotinamide phosphoribosyltransferase (NAMPT, EC 2.4.2.12). The enzyme nicotinamide mononucleotide adenylyltransferase (NMNAT, EC 2.7.7.1), which is a member of the nucleotidyltransferase alpha/beta-phosphodiesterase superfamily, catalyzes the reaction NMN + ATP <=> Nicotinamide adenine dinucleotide (NAD) + PPi, representing the final step in the biosynthesis of NAD. NAD is a molecule that plays a fundamental role as a cofactor in cellular redox reactions. Thus NMN is an important metabolite for the maintenance of normal NAD biosynthesis. Circulating NMN levels may play an important role in regulating cell function in physiological and pathophysiological conditions. (PMID: 15078171, 17983582).",Nicotinamide ribotide,HMDB0000229,b,b,C00455,NICOTINAMIDE_NUCLEOTIDE,FDB021912,nmn,[H]O[C@]1([H])[C@]([H])(O[H])[C@]([H])(O[C@@]1([H])[N+]1=C([H])C([H])=C([H])C(=C1[H])C(=O)N([H])[H])C([H])([H])OP([O-])([O-])=O,DAYLJWODMCOQEW-TURQNECASA-M,"InChI=1S/C11H15N2O8P/c12-10(16)6-2-1-3-13(4-6)11-9(15)8(14)7(21-11)5-20-22(17,18)19/h1-4,7-9,11,14-15H,5H2,(H3-,12,16,17,18,19)/p-1/t7-,8-,9-,11-/m1/s1"
5463,24153,a,a,15940,KEGG COMPOUND accession,C00253,nac,59-67-6,15940.0,"Human Metabolome Database (HMDB): Nicotinic acid, also known as niacin or vitamin B3, is a water-soluble vitamin whose derivatives such as NADH, NAD, NAD+, and NADP play essential roles in energy metabolism in the living cell and DNA repair. The designation vitamin B3 also includes the amide form, nicotinamide or niacinamide. Severe lack of niacin causes the deficiency disease pellagra, whereas a mild deficiency slows down the metabolism decreasing cold tolerance. The recommended daily allowance of niacin is 2-12 mg a day for children, 14 mg a day for women, 16 mg a day for men, and 18 mg a day for pregnant or breast-feeding women. It is found in various animal and plant tissues and has pellagra-curative, vasodilating, and antilipemic properties. The liver can synthesize niacin from the essential amino acid tryptophan (see below), but the synthesis is extremely slow and requires vitamin B6; 60 mg of tryptophan are required to make one milligram of niacin. Bacteria in the gut may also perform the conversion but are inefficient.",Nicotinic acid,HMDB0001488,b,b,C00253,NIACINE,FDB001014,nac,[H]C1=C([H])C([H])=C(C([H])=N1)C([O-])=O,PVNIIMVLHYAWGP-UHFFFAOYSA-M,"InChI=1S/C6H5NO2/c8-6(9)5-2-1-3-7-4-5/h1-4H,(H,8,9)/p-1"
5464,24162,a,a,27748,KEGG COMPOUND accession,C05841,nicrns,b,27748.0,"Human Metabolome Database (HMDB): Nicotinate D-ribonucleoside is involved in the nicotinate and nicotinamide metabolism pathways. Nicotinate D-ribonucleoside can be reversibly converted to nicotinate and nicotinate D-ribonucleoside by purine-nucleoside phosphorylase [EC:2.4.2.1] and 5'-nucleotidase [EC:3.1.3.5], respectively.",Nicotinate D-ribonucleoside,HMDB0006809,b,b,C05841,b,FDB024094,nicrns,[H]OC([H])([H])[C@@]1([H])O[C@@]([H])([N+]2=C([H])C([H])=C([H])C(=C2[H])C([O-])=O)[C@]([H])(O[H])[C@]1([H])O[H],PUEDDPCUCPRQNY-ZYUZMQFOSA-N,"InChI=1S/C11H13NO6/c13-5-7-8(14)9(15)10(18-7)12-3-1-2-6(4-12)11(16)17/h1-4,7-10,13-15H,5H2/t7-,8-,9-,10-/m1/s1"
5465,24178,a,a,7563,KEGG COMPOUND accession,C05380,,,,,,,,,,,,,,,
5466,24186,a,a,7567,KEGG COMPOUND accession,C08772,,,,,,,,,,,,,,,
5467,24192,a,a,7570,KEGG COMPOUND accession,C01518,,,,,,,,,,,,,,,
5468,24198,a,a,7573,KEGG COMPOUND accession,C08164,,,,,,,,,,,,,,,
5469,24204,a,a,7576,KEGG COMPOUND accession,C11276,,,,,,,,,,,,,,,
5470,24206,a,a,7577,KEGG COMPOUND accession,C07699,,,,,,,,,,,,,,,
5471,24210,a,a,7579,KEGG COMPOUND accession,C10163,,,,,,,,,,,,,,,
5472,24212,a,a,48107,KEGG COMPOUND accession,C00244,,,,,,,,,,,,,,,
5473,24223,a,a,7582,KEGG COMPOUND accession,C07713,,,,,,,,,,,,,,,
5474,24238,a,a,16301,KEGG COMPOUND accession,C00088,no2,14797-65-0,16301.0,"Human Metabolome Database (HMDB): Nitrite is a nitrite compound is either a salt or an ester of nitrous acid. Sodium nitrite is used for the curing of meat because it prevents bacterial growth and, in a reaction with the meat's myoglobin, gives the product a desirable dark red color. Nitrite can be reduced to nitric oxide or ammonia by many species of bacteria. Under hypoxic conditions, nitrite may release nitric oxide, which causes potent vasodilation. Several mechanisms for nitrite conversion to NO have been described including enzymatic reduction by xanthine oxidoreductase, the mitochondria, and NO synthase (NOS), as well as nonenzymatic acidic disproportionation. -- Wikipedia.",Nitrite,HMDB0002786,b,b,C00088,NITRITE,FDB023064,no2,[O-]N=O,IOVCWXUNBOPUCH-UHFFFAOYSA-M,"InChI=1S/HNO2/c2-1-3/h(H,2,3)/p-1"
5475,24255,a,a,7587,KEGG COMPOUND accession,C06058,,,,,,,,,,,,,,,
5476,24256,a,a,27798,KEGG COMPOUND accession,C06813,,,,,,,,,,,,,,,
5477,24258,a,a,16268,KEGG COMPOUND accession,C01837,,,,,,,,,,,,,,,
5478,24263,a,a,71415,KEGG COMPOUND accession,C07268,,,,,,,,,,,,,,,
5479,24327,a,a,7622,KEGG COMPOUND accession,C10086,,,,,,,,,,,,,,,
5480,24341,a,a,100246,KEGG COMPOUND accession,C06687,,,,,,,,,,,,,,,
5481,24343,a,a,7630,KEGG COMPOUND accession,C08153,,,,,,,,,,,,,,,
5482,24351,a,a,28313,KEGG COMPOUND accession,C06524,,,,,,,,,,,,,,,
5483,24355,a,a,17048,KEGG COMPOUND accession,C05317,,,,,,,,,,,,,,,
5484,24357,a,a,7637,KEGG COMPOUND accession,C10088,,,,,,,,,,,,,,,
5485,24369,a,a,77149,KEGG COMPOUND accession,C08961,,,,,,,,,,,,,,,
5486,24377,a,a,33838,KEGG COMPOUND accession,C00801,,,,,,,,,,,,,,,
5487,24395,a,a,17326,KEGG COMPOUND accession,C00201,,,,,,,,,,,,,,,
5488,24413,a,a,7660,KEGG COMPOUND accession,C06572,,,,,,,,,,,,,,,
5489,24419,a,a,18332,KEGG COMPOUND accession,C01829,thyox_L,51-48-9,18332.0,"Human Metabolome Database (HMDB): The thyronamines function via some unknown mechanism to inhibit neuronal activity; this plays an important role in the hibernation cycles of mammals. One effect of administering the thyronamines is a severe drop in body temperature. Iodide is actively absorbed from the bloodstream and concentrated in the thyroid follicles. (If there is a deficiency of dietary iodine, the thyroid enlarges in an attempt to trap more iodine, resulting in goitre.) Via a reaction with the enzyme thyroperoxidase, iodine is covalently bound to tyrosine residues in the thyroglobulin molecules, forming monoiodotyrosine (MIT) and diiodotyrosine (DIT). Linking two moieties of DIT produces thyroxine. Combining one particle of MIT and one particle of DIT produces triiodothyronine. Both T3 and T4 are used to treat thyroid hormone deficiency (hypothyroidism). They are both absorbed well by the gut, so can be given orally. Levothyroxine, the most commonly used synthetic thyroxine form, is a stereoisomer of physiological thyroxine, which is metabolized more slowly and hence usually only needs once-daily administration. Natural desiccated thyroid hormones, which are derived from pig thyroid glands, are a ""natural"" hypothyroid treatment containing 20% T3 and traces of T2, T1 and calcitonin. this plays an important role in the hibernation cycles of mammals. One effect of administering the thyronamines is a severe drop in body temperature. The major hormone derived from the thyroid gland. Thyroxine is synthesized via the iodination of tyrosines (monoiodotyrosine) and the coupling of iodotyrosines (diiodotyrosine) in the thyroglobulin. Thyroxine is released from thyroglobulin by proteolysis and secreted into the blood. Thyroxine is peripherally deiodinated to form triiodothyronine which exerts a broad spectrum of stimulatory effects on cell metabolism. The thyronamines function via some unknown mechanism to inhibit neuronal activity.",Thyroxine,HMDB0000248,b,b,C01829,L-THYROXINE,FDB021829,thyox_L,[H]OC1=C(I)C([H])=C(OC2=C(I)C([H])=C(C([H])=C2I)C([H])([H])[C@@]([H])(C([O-])=O)[N+]([H])([H])[H])C([H])=C1I,XUIIKFGFIJCVMT-LBPRGKRZSA-N,"InChI=1S/C15H11I4NO4/c16-8-4-7(5-9(17)13(8)21)24-14-10(18)1-6(2-11(14)19)3-12(20)15(22)23/h1-2,4-5,12,21H,3,20H2,(H,22,23)/t12-/m0/s1"
5490,24423,a,a,17265,KEGG COMPOUND accession,C04767,,,,,,,,,,,,,,,
5491,24425,a,a,17476,KEGG COMPOUND accession,C04756,dak2gpe_hs,b,b,"Human Metabolome Database (HMDB): 2-Hexadecanoyl-1-(1Z-hexadecenyl)-sn-glycero-3-phosphoethanolamine is an intermediate of ether lipid metabolism. Ether lipids are lipids in which one or more of the carbon atoms on glycerol is bonded to an alkyl chain via an ether linkage, as opposed to the usual ester linkage. In the ether lipid metabolism pathway, 2-hexadecanoyl-1-(1Z-hexadecenyl)-sn-glycero-3-phosphoethanolamine is involved in two enzymatic reactions: 1. It irreversibly produces 1-(1Z-hexadecenyl)-sn-glycero-3-phosphoethanolamine via the enzyme phospholipase A2 (EC:3.1.1.4) and 2. it irreversibly produces 2-hexadecanoyl-1-(1Z-hexadecenyl)-sn-glycero-3-phosphate via the enzyme phospholipase D (EC:3.1.4.4). While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PEs are neutral zwitterions at physiological pH. They mostly have palmitic or stearic acid on carbon 1 and a long chain unsaturated fatty acid (e.g. 18:2, 20:4 and 22:6) on carbon 2. PE synthesis can occur via two pathways. The first requires that ethanolamine be activated by phosphorylation and then coupled to CDP. The ethanolamine is then transferred from CDP-ethanolamine to phosphatidic acid to yield PE. The second involves the decarboxylation of PS. Plasmalogens are glycerol ether phospholipids. They are of two types, alkyl ether (-O-CH2-) and alkenyl ether (-O-CH=CH-). Dihydroxyacetone phosphate (DHAP) serves as the glycerol precursor for the synthesis of plasmalogens. Three major classes of plasmalogens have been identified: choline, ethanolamine and serine derivatives. Ethanolamine plasmalogen is prevalent in myelin. Choline plasmalogen is abundant in cardiac tissue. Usually, the highest proportion of the plasmalogen form is in the ethanolamine class with rather less in choline, and commonly little or none in other phospholipids such as phosphatidylinositol. In choline plasmalogens of most tissues, a higher proportion is often of the O-alkyl rather than the O-alkenyl form, but the reverse tends to be true in heart lipids. In animal tissues, the alkyl and alkenyl moieties in both non-polar and phospholipids tend to be rather simple in composition with 16:0, 18:0 and 18:1 (double bond in position 9) predominating. Ether analogues of triacylglycerols, i.e. 1-alkyldiacyl-sn-glycerols, are present at trace levels only if at all in most animal tissues, but they can be major components of some marine lipids.",PE(P-16:0e/16:0),HMDB0011158,b,b,C04756,b,FDB027933,b,[H]OP(=O)(OC([H])([H])C([H])([H])N([H])[H])OC([H])([H])C([H])(OC([*])=O)C([H])([H])O\C([H])=C(\[H])[*],FDULCEKAOVWBTQ-PXOIRPRXSA-N,b
5492,24443,a,a,15960,KEGG COMPOUND accession,C02571,acrn,3040-38-8,57589.0,"Human Metabolome Database (HMDB): L-Acetylcarnitine is an acetic acid ester of carnitine that facilitates movement of acetyl CoA into the matrices of mammalian mitochondria during the oxidation of fatty acids. In addition to his metabolic role, acetyl-L-carnitine (ALC) posses unique neuroprotective, neuromodulatory, and neurotrophic properties this may play an important role in counteracting various disease processes. (PubMed ID 15363640).",L-Acetylcarnitine,HMDB0000201,b,b,C02571,(-)o-acetylcarnitine,FDB021904,acrn,[H]C([H])([H])C(=O)O[C@]([H])(C([H])([H])C([O-])=O)C([H])([H])[N+](C([H])([H])[H])(C([H])([H])[H])C([H])([H])[H],RDHQFKQIGNGIED-MRVPVSSYSA-N,"InChI=1S/C9H17NO4/c1-7(11)14-8(5-9(12)13)6-10(2,3)4/h8H,5-6H2,1-4H3/t8-/m1/s1"
5493,24447,a,a,7671,KEGG COMPOUND accession,C05700,,,,,,,,,,,,,,,
5494,24449,a,a,28879,KEGG COMPOUND accession,C03525,,,,,,,,,,,,,,,
5495,24467,a,a,17161,KEGG COMPOUND accession,C02864,,,,,,,,,,,,,,,
5496,24488,a,a,15811,KEGG COMPOUND accession,C01005,pser_L,407-41-0,15811.0,"Human Metabolome Database (HMDB): The phosphoric acid ester of serine. As a constituent (residue) of proteins, its side chain can undergo O-linked glycosylation. This might be important in explaining some of the devastating consequences of diabetes. It is one of three amino acid residues that are commonly phosphorylated by kinases during cell signalling in eukaryotes. Phosphorylated serine residues are often referred to as phosphoserine. Serine proteases are a common type of protease. Serine, organic compound, one of the 20 amino acids commonly found in animal proteins. Only the L-stereoisomer appears in mammalian protein. It is not essential to the human diet, since it can be synthesized in the body from other metabolites, including glycine. Serine was first obtained from silk protein, a particularly rich source, in 1865. Its name is derived from the Latin for silk, sericum. Serine's structure was established in 1902.",Phosphoserine,HMDB0000272,b,b,C01005,3-P-SERINE,FDB021926,pser_L,[H][N+]([H])([H])[C@]([H])(C([O-])=O)C([H])([H])OP([O-])([O-])=O,BZQFBWGGLXLEPQ-REOHCLBHSA-L,"InChI=1S/C3H8NO6P/c4-2(3(5)6)1-10-11(7,8)9/h2H,1,4H2,(H,5,6)(H2,7,8,9)/p-2/t2-/m0/s1"
5497,24501,a,a,21969,KEGG COMPOUND accession,C05702,,,,,,,,,,,,,,,
5498,24509,a,a,16681,KEGG COMPOUND accession,C02866,,,,,,,,,,,,,,,
5499,24525,a,a,17438,KEGG COMPOUND accession,C03300,,,,,,,,,,,,,,,
5500,24542,a,a,17791,KEGG COMPOUND accession,C01943,,,,,,,,,,,,,,,
5501,24566,a,a,7725,KEGG COMPOUND accession,C05752,HC01595,b,b,b,Octanoyl-ACP,b,b,b,C05752,b,b,b,[H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C(=O)S[*],b,b
5502,24575,a,a,7728,KEGG COMPOUND accession,C01740,,,,,,,,,,,,,,,
5503,24596,a,a,16021,KEGG COMPOUND accession,C03796,,,,,,,,,,,,,,,
5504,24602,a,a,16196,KEGG COMPOUND accession,C00712,elaid,112-79-8,27997.0,"Human Metabolome Database (HMDB): Elaidic acid is the major trans fat found in hydrogenated vegetable oils and occurs in small amounts in caprine and bovine milk (very roughly 0.1 % of the fatty acids) [1] and some meats. It is the trans isomer of oleic acid. The name of the elaidinization reaction comes from elaidic acid. Elaidic acid increases CETP activity, which in turn raises VLDL and lowers HDL cholesterol. (Wiki).",Elaidic acid,HMDB0000573,b,b,C00712,b,FDB002951,elaid,[H]\C(=C(/[H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([O-])=O,ZQPPMHVWECSIRJ-KTKRTIGZSA-M,"InChI=1S/C18H34O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18(19)20/h9-10H,2-8,11-17H2,1H3,(H,19,20)/p-1/b10-9-"
5505,24602,a,a,16196,KEGG COMPOUND accession,C00712,M00127,112-79-8,27997.0,"Human Metabolome Database (HMDB): Elaidic acid is the major trans fat found in hydrogenated vegetable oils and occurs in small amounts in caprine and bovine milk (very roughly 0.1 % of the fatty acids) [1] and some meats. It is the trans isomer of oleic acid. The name of the elaidinization reaction comes from elaidic acid. Elaidic acid increases CETP activity, which in turn raises VLDL and lowers HDL cholesterol. (Wiki).",Elaidic acid,HMDB0000573,b,b,C00712,b,FDB002951,M00127,[H]OC(=O)C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C(\[H])=C(/[H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H],ZQPPMHVWECSIRJ-MDZDMXLPSA-N,"InChI=1S/C18H34O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18(19)20/h9-10H,2-8,11-17H2,1H3,(H,19,20)/b10-9+"
5506,24602,a,a,16196,KEGG COMPOUND accession,C00712,ocdcea,112-80-1,16196.0,"Human Metabolome Database (HMDB): Oleic acid is an unsaturated fatty acid that is the most widely distributed and abundant fatty acid in nature. It is used commercially in the preparation of oleates and lotions, and as a pharmaceutical solvent (Stedman, 26th ed). Biological source: Major constituent of plant oils e.g. olive oil (about 80%), almond oil (about 80%) and many others, mainly as glyceride. Constituent of tall oil and present in fruits Use/Importance: Food additive. Oleic acid is used in manufacturing of surfactants, soaps, plasticizers. Emulsifying agent in foods and pharmaceuticals. Biological Use/Importance: Skin penetrant. Herbicide, insecticide, fungicide (Dictionary of Organic Compounds). Oleic acid is a fatty acid that occurs naturally in various animal and vegetable fats and oils. It is an odorless, colourless oil, although commercial samples may be yellowish. In chemical terms, oleic acid is classified as a monounsaturated omega-9 fatty acid. It has the formula CH3(CH2)7CH=CH(CH2)7COOH. The term ""oleic"" means related to, or derived from, oil or olive, the oil that is predominantly composed of oleic acid (Wikipedia). Oleic acid is found to be associated with isovaleric acidemia, which is an inborn error of metabolism.",Oleic acid,HMDB0000207,b,b,C00712,OLEATE-CPD,FDB012858,ocdcea,[H]\C(=C(/[H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([O-])=O,ZQPPMHVWECSIRJ-KTKRTIGZSA-M,"InChI=1S/C18H34O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18(19)20/h9-10H,2-8,11-17H2,1H3,(H,19,20)/p-1/b10-9-"
5507,24608,a,a,15534,KEGG COMPOUND accession,C00510,odecoa,1716-06-9,15534.0,Human Metabolome Database (HMDB): Oleoyl-CoA is a substrate for Acyl-CoA desaturase and Protein FAM34A.,Oleoyl-CoA,HMDB0001322,b,b,C00510,OLEOYL-COA,FDB022554,odecoa,[H]O[C@@]([H])(C(=O)N([H])C([H])([H])C([H])([H])C(=O)N([H])C([H])([H])C([H])([H])SC(=O)C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C(\[H])=C(\[H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H])C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])OP([O-])(=O)OP([O-])(=O)OC([H])([H])[C@@]1([H])O[C@@]([H])(N2C([H])=NC3=C(N=C([H])N=C23)N([H])[H])[C@]([H])(O[H])[C@]1([H])OP([O-])([O-])=O,XDUHQPOXLUAVEE-BPMMELMSSA-J,"InChI=1S/C39H68N7O17P3S/c1-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-30(48)67-23-22-41-29(47)20-21-42-37(51)34(50)39(2,3)25-60-66(57,58)63-65(55,56)59-24-28-33(62-64(52,53)54)32(49)38(61-28)46-27-45-31-35(40)43-26-44-36(31)46/h11-12,26-28,32-34,38,49-50H,4-10,13-25H2,1-3H3,(H,41,47)(H,42,51)(H,55,56)(H,57,58)(H2,40,43,44)(H2,52,53,54)/p-4/b12-11-/t28-,32-,33-,34+,38-/m1/s1"
5508,24615,a,a,7747,KEGG COMPOUND accession,C09794,,,,,,,,,,,,,,,
5509,24623,a,a,7751,KEGG COMPOUND accession,C11312,,,,,,,,,,,,,,,
5510,24625,a,a,7752,KEGG COMPOUND accession,C11313,,,,,,,,,,,,,,,
5511,24627,a,a,7753,KEGG COMPOUND accession,C11314,,,,,,,,,,,,,,,
5512,24634,a,a,50699,KEGG COMPOUND accession,C00930,,,,,,,,,,,,,,,
5513,24667,a,a,7778,KEGG COMPOUND accession,C11087,,,,,,,,,,,,,,,
5514,24671,a,a,16536,KEGG COMPOUND accession,C00727,,,,,,,,,,,,,,,
5515,24706,a,a,15871,KEGG COMPOUND accession,C02868,,,,,,,,,,,,,,,
5516,24708,a,a,18367,KEGG COMPOUND accession,C00009,pi,14265-44-2,18367.0,"Human Metabolome Database (HMDB): Phosphate is a salt of phosphoric acid. In organic chemistry, a phosphate, or organophosphate, is an ester of phosphoric acid. Organic phosphates are important in biochemistry, biogeochemistry and ecology. Phosphate (Pi) is an essential component of life. In biological systems, phosphorus is found as a free phosphate ion in solution and is called inorganic phosphate, to distinguish it from phosphates bound in various phosphate esters. Inorganic phosphate is generally denoted Pi and at physiological (neutral) pH primarily consists of a mixture of HPO<sup>2-</sup><sub>4</sub> and H<sub>2</sub>PO<sup>-</sup><sub>4</sub> ions. phosphates are most commonly found in the form of adenosine phosphates, (AMP, ADP and ATP) and in DNA and RNA and can be released by the hydrolysis of ATP or ADP. Similar reactions exist for the other nucleoside diphosphates and triphosphates. Phosphoanhydride bonds in ADP and ATP, or other nucleoside diphosphates and triphosphates, contain high amounts of energy which give them their vital role in all living organisms. Phosphate must be actively transported into cells against its electrochemical gradient. In vertebrates, two unrelated families of Na+-dependent Pi transporters carry out this task. Remarkably, the two families transport different Pi species: whereas type II Na+/Pi cotransporters (SCL34) prefer divalent HPO4(2), type III Na+/Pi cotransporters (SLC20) transport monovalent H2PO4. The SCL34 family comprises both electrogenic and electroneutral members that are expressed in various epithelia and other polarized cells. Through regulated activity in apical membranes of the gut and kidney, they maintain body Pi homeostasis, and in salivary and mammary glands, liver, and testes they play a role in modulating the Pi content of luminal fluids. Phosphate levels in the blood play an important role in hormone signaling and in bone homeostasis. In classical endocrine regulation, low serum phosphate induces the renal production of the seco-steroid hormone 1,25-dihydroxyvitamin D3 (1,25(OH)2D3). This active metabolite of vitamin D acts to restore circulating mineral (i.e. phosphate and calcium) levels by increasing absorption in the intestine, reabsorption in the kidney, and mobilization of calcium and phosphate from bone. Thus, chronic renal failure is associated with hyperparathyroidism, which in turn contributes to osteomalacia (softening of the bones). Another complication of chronic renal failure is hyperphosphatemia (low levels of phosphate in the blood). Hyperphosphatemia (excess levels of phosphate in the blood) is a prevalent condition in kidney dialysis patients and is associated with increased risk of mortality. Hypophosphatemia (hungry bone syndrome) has been associated to postoperative electrolyte aberrations and after parathyroidectomy (PMID: 17581921, 11169009, 11039261, 9159312, 17625581). Fibroblast growth factor 23 (FGF-23) has recently been recognized as a key mediator of phosphate homeostasis, its most notable effect being promotion of phosphate excretion. FGF-23 was discovered to be involved in diseases such as autosomal dominant hypophosphatemic rickets, X-linked hypophosphatemia, and tumor-induced osteomalacia in which phosphate wasting was coupled to inappropriately low levels of 1,25(OH)2D3. FGF-23 is regulated by dietary phosphate in humans. In particular it was found that phosphate restriction decreased FGF-23, and phosphate loading increased FGF-23.",Phosphate,HMDB0001429,b,b,C00009,CPD-8587,FDB022617,pi,[H]OP([O-])([O-])=O,NBIIXXVUZAFLBC-UHFFFAOYSA-L,"InChI=1S/H3O4P/c1-5(2,3)4/h(H3,1,2,3,4)/p-2"
5517,24969,a,a,7794,KEGG COMPOUND accession,C01153,,,,,,,,,,,,,,,
5518,24974,a,a,78258,KEGG COMPOUND accession,C09148,,,,,,,,,,,,,,,
5519,24992,a,a,472805,KEGG COMPOUND accession,C01443,,,,,,,,,,,,,,,
5520,25003,a,a,16995,KEGG COMPOUND accession,C00209,oxa,144-62-7,16995.0,"Human Metabolome Database (HMDB): Oxalic acid is a strong dicarboxylic acid occurring in many plants and vegetables. It is produced in the body by metabolism of glyoxylic acid or ascorbic acid. It is not metabolized but excreted in the urine. It is used as an analytical reagent and general reducing agent (Pubchem). Oxalic acid (IUPAC name: ethanedioic acid, formula H2C2O4) is a dicarboxylic acid with structure (HOOC)-(COOH). Because of the joining of two carboxyl groups, this is one of the strongest organic acids. It is also a reducing agent. The anions of oxalic acid as well as its salts and esters are known as oxalates (Wikipedia). Bodily oxalic acid may also be synthesized via the metabolism of either glyoxylic acid or unused ascorbic acid (vitamin C), which is a serious health consideration for long term megadosers of vitamin C supplements. 80% of kidney stones are formed from calcium oxalate. Some Aspergillus species produce oxalic acid, which reacts with blood or tissue calcium to precipitate calcium oxalate. There is some preliminary evidence that the administration of probiotics can affect oxalic acid excretion rates (and presumably oxalic acid levels as well) (Wikipedia). Oxalic acid is found to be associated with fumarase deficiency and primary hyperoxaluria I, which are inborn errors of metabolism.",Oxalic acid,HMDB0002329,b,b,C00209,CUPRIZONE,FDB003357,oxa,[O-]C(=O)C([O-])=O,MUBZPKHOEPUJKR-UHFFFAOYSA-L,"InChI=1S/C2H2O4/c3-1(4)2(5)6/h(H,3,4)(H,5,6)/p-2"
5521,25054,a,a,16859,KEGG COMPOUND accession,C03716,,,,,,,,,,,,,,,
5522,25056,a,a,7814,KEGG COMPOUND accession,C05533,,,,,,,,,,,,,,,
5523,25058,a,a,7815,KEGG COMPOUND accession,C05379,HC01434,1948-82-9,7815.0,Human Metabolome Database (HMDB): Oxalosuccinate is a substrate for cytoplasmic Isocitrate dehydrogenase and mitochondiral Isocitrate dehydrogenase (mitochondrial).,Oxalosuccinic acid,HMDB0003974,b,b,C05379,OXALO-SUCCINATE,FDB023277,HC01434,[H]C([H])(C([O-])=O)C([H])(C([O-])=O)C(=O)C([O-])=O,UFSCUAXLTRFIDC-UHFFFAOYSA-K,"InChI=1S/C6H6O7/c7-3(8)1-2(5(10)11)4(9)6(12)13/h2H,1H2,(H,7,8)(H,10,11)(H,12,13)/p-3"
5524,25065,a,a,15535,KEGG COMPOUND accession,C00313,,,,,,,,,,,,,,,
5525,25071,a,a,18058,KEGG COMPOUND accession,C01444,,,,,,,,,,,,,,,
5526,25074,a,a,7819,KEGG COMPOUND accession,C07341,,,,,,,,,,,,,,,
5527,25080,a,a,7822,KEGG COMPOUND accession,C07356,,,,,,,,,,,,,,,
5528,25082,a,a,7823,KEGG COMPOUND accession,C07359,,,,,,,,,,,,,,,
5529,25084,a,a,7824,KEGG COMPOUND accession,C07492,,,,,,,,,,,,,,,
5530,25086,a,a,7825,KEGG COMPOUND accession,C08074,,,,,,,,,,,,,,,
5531,25088,a,a,7826,KEGG COMPOUND accession,C08075,,,,,,,,,,,,,,,
5532,25090,a,a,17216,KEGG COMPOUND accession,C03887,,,,,,,,,,,,,,,
5533,25092,a,a,18015,KEGG COMPOUND accession,C03527,,,,,,,,,,,,,,,
5534,25096,a,a,17959,KEGG COMPOUND accession,C03717,,,,,,,,,,,,,,,
5535,25114,a,a,17908,KEGG COMPOUND accession,C00139,fdxox,b,b,b,Oxidized ferredoxin,b,b,b,C00139,b,b,b,b,b,b
5536,25114,a,a,17908,KEGG COMPOUND accession,C00139,M02665,b,17908.0,b,Oxidized-Ferredoxin,b,b,b,C00139,b,b,b,b,b,b
5537,25139,a,a,17858,KEGG COMPOUND accession,C00127,gthox,27025-41-8,17858.0,"Human Metabolome Database (HMDB): Oxidized glutathione is a glutathione dimer formed by a disulfide bond between the cysteine sulfhydryl side chains during the course of being oxidized. glutathione participates in leukotriene synthesis and is a cofactor for the enzyme glutathione peroxidase. It is also important as a hydrophilic molecule that is added to lipophilic toxins and waste in the liver during biotransformation before they can become part of the bile. glutathione is also needed for the detoxification of methylglyoxal, a toxin produced as a by-product of metabolism. This detoxification reaction is carried out by the glyoxalase system. Glyoxalase I (EC 4.4.1.5) catalyzes the conversion of methylglyoxal and reduced glutathione to S-D-Lactoyl-glutathione. Glyoxalase II (EC 3.1.2.6) catalyzes the hydrolysis of S-D-Lactoyl-glutathione to glutathione and D-lactate.",Oxidized glutathione,HMDB0003337,b,b,C00127,OXIDIZED-GLUTATHIONE,FDB023147,gthox,[H]N(C(=O)[C@@]([H])(N([H])C(=O)C([H])([H])C([H])([H])[C@@]([H])(C([O-])=O)[N+]([H])([H])[H])C([H])([H])SSC([H])([H])[C@]([H])(N([H])C(=O)C([H])([H])C([H])([H])[C@@]([H])(C([O-])=O)[N+]([H])([H])[H])C(=O)N([H])C([H])([H])C([O-])=O)C([H])([H])C([O-])=O,YPZRWBKMTBYPTK-BJDJZHNGSA-L,"InChI=1S/C20H32N6O12S2/c21-9(19(35)36)1-3-13(27)25-11(17(33)23-5-15(29)30)7-39-40-8-12(18(34)24-6-16(31)32)26-14(28)4-2-10(22)20(37)38/h9-12H,1-8,21-22H2,(H,23,33)(H,24,34)(H,25,27)(H,26,28)(H,29,30)(H,31,32)(H,35,36)(H,37,38)/p-2/t9-,10-,11-,12-/m0/s1"
5538,25156,a,a,16571,KEGG COMPOUND accession,C01166,,,,,,,,,,,,,,,
5539,25177,a,a,7847,KEGG COMPOUND accession,C11803,,,,,,,,,,,,,,,
5540,25181,a,a,7849,KEGG COMPOUND accession,C09891,,,,,,,,,,,,,,,
5541,25201,a,a,7858,KEGG COMPOUND accession,C10956,,,,,,,,,,,,,,,
5542,25203,a,a,7859,KEGG COMPOUND accession,C08026,,,,,,,,,,,,,,,
5543,25554,a,a,7864,KEGG COMPOUND accession,C07393,,,,,,,,,,,,,,,
5544,25568,a,a,27701,KEGG COMPOUND accession,C06624,,,,,,,,,,,,,,,
5545,25570,a,a,7872,KEGG COMPOUND accession,C00746,M02669,50-56-6,7872.0,"Human Metabolome Database (HMDB): Oxytocin is a mammalian hormone that also acts as a neurotransmitter in the brain. In women, it is released mainly after distention of the cervix and vagina during labor, and after stimulation of the nipples, facilitating birth and breastfeeding, respectively. Oxytocin is released during orgasm in both sexes. In the brain, oxytocin is involved in social recognition and bonding, and might be involved in the formation of trust between people. -- Wikipedia; In the pituitary gland, oxytocin is packaged in large, dense-core vesicles, where it is bound to neurophysin as shown in the inset of the figure; neurophysin is a large peptide fragment of the giant precursor protein molecule from which oxytocin is derived by enzymatic cleavage. -- Wikipedia; Oxytocin is a peptide of nine amino acids (a nonapeptide). The sequence is cysteine - tyrosine - isoleucine - glutamine - asparagine - cysteine - proline - leucine - glycine (CYIQNCPLG). The cysteine residues form a sulfur bridge. Oxytocin has a molecular mass of 1007 daltons. One international unit (IU) of oxytocin is the equivalent of about 2 micrograms of pure peptide. -- Wikipedia; Oxytocin has peripheral (hormonal) actions, and also has actions in the brain. The actions of oxytocin are mediated by specific, high affinity oxytocin receptors. The oxytocin receptor is a G-protein-coupled receptor which requires Mg2+ and cholesterol. It belongs to the rhodopsin-type (class I) group of G-protein-coupled receptors. -- Wikipedia.",Oxytocin,HMDB0002865,b,b,C00746,b,FDB023075,b,[H]OC1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])[C@]1([H])N([H])C(=O)[C@@]([H])(N([H])[H])C([H])([H])SSC([H])([H])[C@]([H])(N([H])C(=O)[C@@]([H])(N([H])C(=O)[C@@]([H])(N([H])C(=O)[C@@]([H])(N([H])C1=O)[C@@]([H])(C([H])([H])[H])C([H])([H])C([H])([H])[H])C([H])([H])C([H])([H])C(=O)N([H])[H])C([H])([H])C(=O)N([H])[H])C(=O)N1C([H])([H])C([H])([H])C([H])([H])[C@@]1([H])C(=O)N([H])[C@]([H])(C(=O)N([H])C([H])([H])C(=O)N([H])[H])C([H])([H])C([H])(C([H])([H])[H])C([H])([H])[H],XNOPRXBHLZRZKH-DSZYJQQASA-N,"InChI=1S/C43H66N12O12S2/c1-5-22(4)35-42(66)49-26(12-13-32(45)57)38(62)51-29(17-33(46)58)39(63)53-30(20-69-68-19-25(44)36(60)50-28(40(64)54-35)16-23-8-10-24(56)11-9-23)43(67)55-14-6-7-31(55)41(65)52-27(15-21(2)3)37(61)48-18-34(47)59/h8-11,21-22,25-31,35,56H,5-7,12-20,44H2,1-4H3,(H2,45,57)(H2,46,58)(H2,47,59)(H,48,61)(H,49,66)(H,50,60)(H,51,62)(H,52,65)(H,53,63)(H,54,64)/t22-,25-,26-,27-,28-,29-,30-,31-,35-/m0/s1"
5546,25574,a,a,27775,KEGG COMPOUND accession,C06197,M01360,56432-02-1,27775.0,"Human Metabolome Database (HMDB): Diadenosine triphosphate (AP3A) is a diadenosine polyphosphate. Diadenosine polyphosphates (APnAs, n = 3-6) are a family of endogenous vasoactive purine dinucleotides which have been isolated from thrombocytes. APnAs have been demonstrated to be involved in the control of vascular tone as well as the growth of vascular smooth muscle cells and hence, possibly, in atherogenesis. APnAs isolated substances are Ap3A, Ap4A, Ap5A, and Ap6A. APnAs are naturally occurring substances that facilitate tear secretion; they are released from the corneal epithelium, they stimulate tear production and therefore they may be considered as physiological modulators of tear secretion. The APnAs were discovered in the mid-sixties in the course of studies on aminoacyl-tRNA synthetases (aaRS). APnAs have emerged as intracellular and extracellular signalling molecules implicated in the maintenance and regulation of vital cellular functions and become considered as second messengers. Great variety of physiological and pathological effects in mammalian cells was found to be associated with alterations of APnAs. APnAs are polyphosphated nucleotidic substances which are found in the CNS and are known to be released in a calcium-dependent manner from storage vesicles in brain synaptosomes. AP3A is a primer for oligoadenylate synthesis catalyzed by interferon-inducible 2-5A synthetase. AP3A is synthesized in cells by tryptophanyl-tRNA synthetase (WRS); cellular level of AP3A significantly increases after interferon treatment. AP3A is an avid inhibitor of eosinophil-derived neurotoxin (EDN). EDN is a catalytically proficient member of the pancreatic ribonuclease superfamily secreted along with other eosinophil granule proteins during innate host defense responses and various eosinophil-related inflammatory and allergic diseases. The ribonucleolytic activity of EDN is central to its antiviral and neurotoxic activities and possibly to other facets of its biological activity. AP3A accumulates in cells in response to various physiological factors. AP3A FHIT (Fragile histidine Triad) is a human tumor suppressor gene. The Fhit protein is believed to inhibit tumor growth by inducing apoptosis through interaction with AP3A. (PMID: 11212966, 12738682, 11810214, 9607303, 8922753, 9187362, 16401072, 12833632, 11896678).",Diadenosine triphosphate,HMDB0001155,b,b,C06197,ADENOSINE5TRIPHOSPHO5ADENOSINE,FDB022454,b,[H]O[C@]1([H])[C@]([H])(O[H])[C@]([H])(O[C@@]1([H])N1C([H])=NC2=C1N=C([H])N=C2N([H])[H])C([H])([H])OP(=O)(O[H])OP(=O)(O[H])OP(=O)(O[H])OC([H])([H])[C@@]1([H])O[C@@]([H])(N2C([H])=NC3=C2N=C([H])N=C3N([H])[H])[C@]([H])(O[H])[C@]1([H])O[H],QCICUPZZLIQAPA-XPWFQUROSA-N,"InChI=1S/C20H27N10O16P3/c21-15-9-17(25-3-23-15)29(5-27-9)19-13(33)11(31)7(43-19)1-41-47(35,36)45-49(39,40)46-48(37,38)42-2-8-12(32)14(34)20(44-8)30-6-28-10-16(22)24-4-26-18(10)30/h3-8,11-14,19-20,31-34H,1-2H2,(H,35,36)(H,37,38)(H,39,40)(H2,21,23,25)(H2,22,24,26)/t7-,8-,11-,12-,13-,14-,19-,20-/m1/s1"
5547,25583,a,a,27791,KEGG COMPOUND accession,C06198,up4g,b,27791.0,"Human Metabolome Database (HMDB): P1,P4-Bis(5'-uridyl) tetraphosphate is involved in pyrimidine metabolism. It is a precurser for UTP. UTP is produced from P1,P4-Bis(5'-uridyl) tetraphosphate by the action of bis(5'-nucleosidyl)-tetraphosphatase [EC:3.6.1.17].","P1,P4-Bis(5'-uridyl) tetraphosphate",HMDB0006796,b,b,C06198,b,FDB024083,b,b,NMLMACJWHPHKGR-NCOIDOBVSA-N,b
5548,25596,a,a,18356,KEGG COMPOUND accession,C01359,,,,,,,,,,,,,,,
5549,25625,a,a,16096,KEGG COMPOUND accession,C05315,,,,,,,,,,,,,,,
5550,25642,a,a,15525,KEGG COMPOUND accession,C00154,pmtcoa,b,15525.0,Human Metabolome Database (HMDB): Palmityl-CoA is a fatty acid coenzyme derivative which plays a key role in fatty acid oxidation and biosynthesis.,Palmityl-CoA,HMDB0001338,b,b,C00154,PALMITYL-COA,FDB022562,pmtcoa,[H]O[C@@]([H])(C(=O)N([H])C([H])([H])C([H])([H])C(=O)N([H])C([H])([H])C([H])([H])SC(=O)C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H])C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])OP([O-])(=O)OP([O-])(=O)OC([H])([H])[C@@]1([H])O[C@@]([H])(N2C([H])=NC3=C(N=C([H])N=C23)N([H])[H])[C@]([H])(O[H])[C@]1([H])OP([O-])([O-])=O,MNBKLUUYKPBKDU-BBECNAHFSA-J,"InChI=1S/C37H66N7O17P3S/c1-4-5-6-7-8-9-10-11-12-13-14-15-16-17-28(46)65-21-20-39-27(45)18-19-40-35(49)32(48)37(2,3)23-58-64(55,56)61-63(53,54)57-22-26-31(60-62(50,51)52)30(47)36(59-26)44-25-43-29-33(38)41-24-42-34(29)44/h24-26,30-32,36,47-48H,4-23H2,1-3H3,(H,39,45)(H,40,49)(H,53,54)(H,55,56)(H2,38,41,42)(H2,50,51,52)/p-4/t26-,30-,31-,32+,36-/m1/s1"
5551,25642,a,a,15525,KEGG COMPOUND accession,C00154,ptth,1763-10-6,15525.0,Human Metabolome Database (HMDB): Palmityl-CoA is a fatty acid coenzyme derivative which plays a key role in fatty acid oxidation and biosynthesis.,Palmityl-CoA,HMDB0001338,b,b,C00154,PALMITYL-COA,FDB022562,ptth,[H]OC([H])([H])C(C([H])([H])[H])(C([H])([H])[H])[C@@]([H])(O[H])C(=O)N([H])C([H])([H])C([H])([H])C(=O)N([H])C([H])([H])C([H])([H])S[H],ZNXZGRMVNNHPCA-VIFPVBQESA-N,"InChI=1S/C11H22N2O4S/c1-11(2,7-14)9(16)10(17)13-4-3-8(15)12-5-6-18/h9,14,16,18H,3-7H2,1-2H3,(H,12,15)(H,13,17)/t9-/m0/s1"
5552,25660,a,a,17868,KEGG COMPOUND accession,C01192,M00550,17378-38-0,17868.0,Human Metabolome Database (HMDB): 1-palmitoyl-dihydroxyacetone-phosphate is also known as Palmitoyl glycerone phosphate or Hexadecanoate 2-oxo-3-(phosphonooxy)propyl ester.  1-palmitoyl-dihydroxyacetone-phosphate is considered to be practically insoluble (in water) and acidic.  1-palmitoyl-dihydroxyacetone-phosphate is an other glycerophospholipid lipid molecule,1-palmitoyl-dihydroxyacetone-phosphate,HMDB0062190,b,b,C01192,b,b,b,[H]OP(=O)(O[H])OC([H])([H])C(=O)C([H])([H])OC(=O)C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H],MLWXSIMRTQAWHY-UHFFFAOYSA-N,"InChI=1S/C19H37O7P/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-19(21)25-16-18(20)17-26-27(22,23)24/h2-17H2,1H3,(H2,22,23,24)"
5553,25684,a,a,16753,KEGG COMPOUND accession,C00831,,,,,,,,,,,,,,,
5554,25725,a,a,27928,KEGG COMPOUND accession,C06604,,,,,,,,,,,,,,,
5555,25731,a,a,68994,KEGG COMPOUND accession,C09599,,,,,,,,,,,,,,,
5556,25745,a,a,7936,KEGG COMPOUND accession,C07415,,,,,,,,,,,,,,,
5557,25793,a,a,83569,KEGG COMPOUND accession,C11019,,,,,,,,,,,,,,,
5558,25804,a,a,18203,KEGG COMPOUND accession,C06564,,,,,,,,,,,,,,,
5559,25815,a,a,17642,KEGG COMPOUND accession,C02575,,,,,,,,,,,,,,,
5560,25821,a,a,28897,KEGG COMPOUND accession,C08388,,,,,,,,,,,,,,,
5561,25823,a,a,48026,KEGG COMPOUND accession,C05911,,,,,,,,,,,,,,,
5562,25825,a,a,17251,KEGG COMPOUND accession,C01841,,,,,,,,,,,,,,,
5563,25828,a,a,45081,KEGG COMPOUND accession,C07420,,,,,,,,,,,,,,,
5564,25832,a,a,16472,KEGG COMPOUND accession,C01949,,,,,,,,,,,,,,,
5565,25852,a,a,75033,KEGG COMPOUND accession,C08726,,,,,,,,,,,,,,,
5566,25856,a,a,7989,KEGG COMPOUND accession,C00773,,,,,,,,,,,,,,,
5567,25868,a,a,16692,KEGG COMPOUND accession,C02872,,,,,,,,,,,,,,,
5568,25885,a,a,15722,KEGG COMPOUND accession,C02179,,,,,,,,,,,,,,,
5569,25927,a,a,8028,KEGG COMPOUND accession,C07427,,,,,,,,,,,,,,,
5570,25937,a,a,75035,KEGG COMPOUND accession,C08727,,,,,,,,,,,,,,,
5571,25951,a,a,8040,KEGG COMPOUND accession,C08439,,,,,,,,,,,,,,,
5572,25966,a,a,8047,KEGG COMPOUND accession,C08440,,,,,,,,,,,,,,,
5573,25972,a,a,8050,KEGG COMPOUND accession,C07591,,,,,,,,,,,,,,,
5574,25974,a,a,28851,KEGG COMPOUND accession,C11422,,,,,,,,,,,,,,,
5575,25980,a,a,27950,KEGG COMPOUND accession,C11429,,,,,,,,,,,,,,,
5576,26005,a,a,8064,KEGG COMPOUND accession,C07673,,,,,,,,,,,,,,,
5577,26009,a,a,8066,KEGG COMPOUND accession,C07584,,,,,,,,,,,,,,,
5578,26011,a,a,8067,KEGG COMPOUND accession,C07432,,,,,,,,,,,,,,,
5579,26015,a,a,8069,KEGG COMPOUND accession,C07434,,,,,,,,,,,,,,,
5580,26029,a,a,27905,KEGG COMPOUND accession,C02180,,,,,,,,,,,,,,,
5581,26032,a,a,37548,KEGG COMPOUND accession,C02734,,,,,,,,,,,,,,,
5582,26038,a,a,28964,KEGG COMPOUND accession,C02577,,,,,,,,,,,,,,,
5583,26049,a,a,8082,KEGG COMPOUND accession,C00548,,,,,,,,,,,,,,,
5584,26054,a,a,16424,KEGG COMPOUND accession,C00601,pacald,122-78-1,16424.0,"Human Metabolome Database (HMDB): Phenylacetaldehyde is one important oxidation-related aldehyde. Exposure to styrene gives phenylacetaldehyde as a secondary metabolite. Styrene has been implicated as reproductive toxicant, neurotoxicant, or carcinogen in vivo or in vitro. Phenylacetaldehyde could be formed by diverse thermal reactions during the cooking process together with C8 compounds is identified as a major aroma- active compound in cooked pine mushroom. Phenylacetaldehyde is readily oxidized to phenylacetic acid. Therefore will eventually be hydrolyzed and oxidized to yield phenylacetic acid that will be excreted primarily in the urine in conjugated form. (PMID: 16910727, 7818768, 15606130).",Phenylacetaldehyde,HMDB0006236,b,b,C00601,HYDRPHENYLAC-CPD,FDB012238,pacald,[H]C(=O)C([H])([H])C1=C([H])C([H])=C([H])C([H])=C1[H],DTUQWGWMVIHBKE-UHFFFAOYSA-N,"InChI=1S/C8H8O/c9-7-6-8-4-2-1-3-5-8/h1-5,7H,6H2"
5585,26070,a,a,15537,KEGG COMPOUND accession,C00582,phaccoa,7532-39-0,15537.0,"Human Metabolome Database (HMDB): Phenylacetyl-CoA was found to be a very potent inhibitor of choline acetyltransferase, competitive for acetyl-CoA with Ki of 3.1 X 10(-7)M. Phenylacetate exerts its neurotoxic action through its metabolic product, phenylacetyl-CoA, which could severely decrease the availability of acetyl-CoA (PMID: 6142928).",Phenylacetyl-CoA,HMDB0006503,b,b,C00582,34-DIHYDROXYPHENYLACETYL-COA,FDB023945,phaccoa,[H]O[C@@]([H])(C(=O)N([H])C([H])([H])C([H])([H])C(=O)N([H])C([H])([H])C([H])([H])SC(=O)C([H])([H])C1=C([H])C([H])=C([H])C([H])=C1[H])C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])OP([O-])(=O)OP([O-])(=O)OC([H])([H])[C@@]1([H])O[C@@]([H])(N2C([H])=NC3=C(N=C([H])N=C23)N([H])[H])[C@]([H])(O[H])[C@]1([H])OP([O-])([O-])=O,ZIGIFDRJFZYEEQ-CECATXLMSA-J,"InChI=1S/C29H42N7O17P3S/c1-29(2,24(40)27(41)32-9-8-19(37)31-10-11-57-20(38)12-17-6-4-3-5-7-17)14-50-56(47,48)53-55(45,46)49-13-18-23(52-54(42,43)44)22(39)28(51-18)36-16-35-21-25(30)33-15-34-26(21)36/h3-7,15-16,18,22-24,28,39-40H,8-14H2,1-2H3,(H,31,37)(H,32,41)(H,45,46)(H,47,48)(H2,30,33,34)(H2,42,43,44)/p-4/t18-,22-,23-,24+,28-/m1/s1"
5586,26074,a,a,27480,KEGG COMPOUND accession,C05598,M02723,500-98-1,27480.0,"Human Metabolome Database (HMDB): Phenylacetylglycine is an acyl glycine. Acyl glycines are normally minor metabolites of fatty acids. However, the excretion of certain acyl glycines is increased in several inborn errors of metabolism. In certain cases the measurement of these metabolites in body fluids can be used to diagnose disorders associated with mitochondrial fatty acid beta-oxidation. Acyl glycines are produced through the action of glycine N-acyltransferase (EC 2.3.1.13) which is an enzyme that catalyzes the chemical reaction:. acyl-CoA + glycine < -- > CoA + N-acylglycine. Phenylacetylglycine or PAG is a glycine conjugate of phenylacetic acid. Phenylacetic acid may arise from exposure to styrene (plastic) or through the consumption of fruits and vegetables. Phenylacetic acid is used in some perfumes, possessing a honey-like odour in low concentrations, and is also used in penicillin G production. PAG is a putative biomarker of phospholipidosis. Urinary PAG is elevated in animals exhibiting abnormal phospholipid accumulation in many tissues and may thus be useful as a surrogate biomarker for phospholipidosis. (PMID: 15764292) The presence of phenylacetylglycine in urine has been confirmed for dogs, rats and mice. However, the presence of this compound in human urine is controversial. GC-MS studies have not found this compound (PMID: 7492634) while NMR studies claimed to have identified it (PMID: 21167146). It appears that phenylacetylglycine may sometimes be mistaken for phenylacetylglutamine via NMR.",Phenylacetylglycine,HMDB0000821,b,b,C05598,b,FDB022266,b,[H]OC(=O)C([H])([H])N([H])C(=O)C([H])([H])C1=C([H])C([H])=C([H])C([H])=C1[H],UTYVDVLMYQPLQB-UHFFFAOYSA-N,"InChI=1S/C10H11NO3/c12-9(11-7-10(13)14)6-8-4-2-1-3-5-8/h1-5H,6-7H2,(H,11,12)(H,13,14)"
5587,26077,a,a,48574,KEGG COMPOUND accession,C07440,,,,,,,,,,,,,,,
5588,26081,a,a,8093,KEGG COMPOUND accession,C07441,,,,,,,,,,,,,,,
5589,26101,a,a,8102,KEGG COMPOUND accession,C06747,,,,,,,,,,,,,,,
5590,26108,a,a,30851,KEGG COMPOUND accession,C00166,phpyr,156-06-9,30851.0,"Human Metabolome Database (HMDB): Phenylpyruvic acid is a keto-acid that is an intermediate or catabolic byproduct of phenylalanine metabolism. It has a slight honey-like odor. Levels of phenylpyruvate are normally very low in blood or urine. High levels of phenylpyruvic acid can be found in the urine of individuals with phenylketonuria (PKU), an inborn error of metabolism. PKU is due to lack of the enzyme phenylalanine hydroxylase (PAH), so that phenylalanine is converted not to tyrosine but to phenylpyruvic acid. In particular, excessive phenylalanine can be metabolized into phenylketones through, a transaminase pathway route involving glutamate. Metabolites of this transamination reaction include phenylacetate, phenylpyruvate and phenethylamine. In persons with PKU, dietary phenylalanine either accumulates in the body or some of it is converted to phenylpyruvic acid. Individuals with PKU tend to excrete large quantities of phenylpyruvate, phenylacetate and phenyllactate, along with phenylalanine, in their urine. If untreated, mental retardation effects and microcephaly are evident by the first year along with other symptoms which include: unusual irritability, epileptic seizures and skin lesions. Hyperactivity, EEG abnormalities and seizures, and severe learning disabilities are major clinical problems later in life. A ""musty or mousy"" odor of skin, hair, sweat and urine (due to phenylacetate accumulation); and a tendency to hypopigmentation and eczema are also observed. The neural-development effects of PKU are primarily due to the disruption of neurotransmitter synthesis. In particular, phenylalanine is a large, neutral amino acid which moves across the blood-brain barrier (BBB) via the large neutral amino acid transporter (LNAAT). Excessive phenylalanine in the blood saturates the transporter. Thus, excessive levels of phenylalanine significantly decrease the levels of other LNAAs in the brain. But since these amino acids are required for protein and neurotransmitter synthesis, phenylalanine accumulation disrupts brain development, leading to mental retardation.",Phenylpyruvic acid,HMDB0000205,b,b,C00166,PHENYL-PYRUVATE,FDB020197,phpyr,[H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])C(=O)C([O-])=O,BTNMPGBKDVTSJY-UHFFFAOYSA-M,"InChI=1S/C9H8O3/c10-8(9(11)12)6-7-4-2-1-3-5-7/h1-5H,6H2,(H,11,12)/p-1"
5591,26131,a,a,8107,KEGG COMPOUND accession,C07443,,,,,,,,,,,,,,,
5592,26136,a,a,32980,KEGG COMPOUND accession,C01744,phppa,501-97-3,32980.0,Human Metabolome Database (HMDB): Desaminotyrosine is a normal constituent of human urine. A product of tyrosine metabolism; concentration in urine increases in patients with gastrointestinal diseases. (Dictionary of Organic Compounds). It is considered also that may result from metabolism to phenolic acids by colonic bacteria. (PMID 15315398).,Desaminotyrosine,HMDB0002199,b,b,C01744,2-3-DIHYDROXYPHENYL-PROPIONATE,FDB000849,b,b,NMHMNPHRMNGLLB-UHFFFAOYSA-N,b
5593,26139,a,a,17276,KEGG COMPOUND accession,C00774,,,,,,,,,,,,,,,
5594,26143,a,a,8113,KEGG COMPOUND accession,C01604,,,,,,,,,,,,,,,
5595,26152,a,a,8116,KEGG COMPOUND accession,C09155,,,,,,,,,,,,,,,
5596,26154,a,a,17598,KEGG COMPOUND accession,C03634,,,,,,,,,,,,,,,
5597,26156,a,a,28366,KEGG COMPOUND accession,C09157,,,,,,,,,,,,,,,
5598,26158,a,a,17727,KEGG COMPOUND accession,C03019,,,,,,,,,,,,,,,
5599,26162,a,a,8121,KEGG COMPOUND accession,C11028,,,,,,,,,,,,,,,
5600,26164,a,a,16337,KEGG COMPOUND accession,C00416,HC02050,b,16337.0,b,Phosphatidate-Ld-Pc-Pool,b,b,b,C00416,b,b,HC02050,[H]OP(=O)(O[H])OC([H])([H])C([H])(OC([*])=O)C([H])([H])OC([*])=O,b,b
5601,26164,a,a,16337,KEGG COMPOUND accession,C00416,HC02051,b,16337.0,b,Phosphatidate-Ld-Pe-Pool,b,b,b,C00416,b,b,HC02051,[H]OP(=O)(O[H])OC([H])([H])C([H])(OC([*])=O)C([H])([H])OC([*])=O,b,b
5602,26164,a,a,16337,KEGG COMPOUND accession,C00416,HC02052,b,16337.0,b,Phosphatidate-Ld-Ps-Pool,b,b,b,C00416,b,b,b,[H]OP(=O)(O[H])OC([H])([H])C([H])(OC([*])=O)C([H])([H])OC([*])=O,b,b
5603,26164,a,a,16337,KEGG COMPOUND accession,C00416,HC02053,b,16337.0,b,Phosphatidate-Ld-Pi-Pool,b,b,b,C00416,b,b,b,[H]OP(=O)(O[H])OC([H])([H])C([H])(OC([*])=O)C([H])([H])OC([*])=O,b,b
5604,26164,a,a,16337,KEGG COMPOUND accession,C00416,HC02054,b,16337.0,b,Phosphatidate-Ld-Sm-Pool,b,b,b,C00416,b,b,HC02054,[H]OP(=O)(O[H])OC([H])([H])C([H])(OC([*])=O)C([H])([H])OC([*])=O,b,b
5605,26164,a,a,16337,KEGG COMPOUND accession,C00416,HC02086,7091-44-3,b,"Human Metabolome Database (HMDB): PA(16:0/16:0) is a phosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PA(16:0/16:0), in particular, consists of one chain of palmitic acid at the C-1 position and one chain of palmitic acid at the C-2 position. The palmitic acid moiety is derived from fish oils, milk fats, vegetable oils and animal fats, while the palmitic acid moiety is derived from fish oils, milk fats, vegetable oils and animal fats. Phosphatidic acids are quite rare but are extremely important as intermediates in the biosynthesis of triacylglycerols and phospholipids. Indeed, the concentration of phosphatidic acids is often over-estimated in tissues and biofluids as it can arise by inadvertent enzymatic hydrolysis during inappropriate storage or extraction conditions during analysis. The main biosynthetic route of phosphatidic acid in animal tissues involves sequential acylation of alpha-glycerophosphate by acyl-CoA derivatives of fatty acids. PAs are biologically active lipids that can stimulate a large range of responses in many different cell types, such as platelet aggregation, smooth muscle contraction, in vivo vasoactive effects, chemotaxis, expression of adhesion molecules, increased tight junction permeability of endothelial cells, induction of stress fibres, modulation of cardiac contractility, and many others. Diacylglycerols (DAGs) can be converted to PAs by DAG kinases and indirect evidence supports the notion that PAs alter the excitability of neurons. Phospholipase Ds (PLDs), which catalyze the conversion of glycerolphospholipids, particularly phosphatidylcholine, to PAs and the conversion of N-arachidonoyl-phosphatidylethanolamine (NAPE) to anandamide and PAs are activated by several inflammatory mediators including bradykinin, ATP and glutamate. PAs activate downstream signaling pathways such as PKCs and mitogen-activated protein kinases (MAPKs), which are linked to an increase in sensitivity of sensory neurons either during inflammation or in chronic pain models. Circumstantial evidence that PAs are converted to DAGs. (PMID: 12618218, 16185776).",PA(16:0/16:0),HMDB0000674,b,b,C00416,b,FDB022175,b,[H]OP(=O)(O[H])OC([H])([H])C([H])(OC([*])=O)C([H])([H])OC([*])=O,PORPENFLTBBHSG-MGBGTMOVSA-N,b
5606,26164,a,a,16337,KEGG COMPOUND accession,C00416,HC02093,b,16337.0,b,Phosphatidate-Cl-Pool,b,b,b,C00416,b,b,b,[H]OP(=O)(O[H])OC([H])([H])C([H])(OC([*])=O)C([H])([H])OC([*])=O,b,b
5607,26176,a,a,17152,KEGG COMPOUND accession,C04308,C04308,b,b,b,Phosphatidyl-N-Dimethylethanolamine,b,b,b,C04308,b,b,b,[H]C([H])([H])N(C([H])([H])[H])C([H])([H])C([H])([H])OP([O-])(=O)OC([H])([H])C([H])(OC([*])=O)C([H])([H])OC([*])=O,b,b
5608,26176,a,a,17152,KEGG COMPOUND accession,C04308,M02758,108-01-0,271436.0,"Human Metabolome Database (HMDB): Dimethylethanolamine is used as a food additive [EAFUS] (""EAFUS: Everything Added to Food in the United States. [http://www.eafus.com/]"")",Dimethylethanolamine,HMDB0032231,b,b,C04308,b,FDB009311,M02758,[H]OP(=O)(OC([H])([H])C([H])([H])N(C([H])([H])[H])C([H])([H])[H])OC([H])([H])C([H])(OC([*])=O)C([H])([H])OC([*])=O,UEEJHVSXFDXPFK-UHFFFAOYSA-N,b
5609,26198,a,a,16038,KEGG COMPOUND accession,C00350,,,,,,,,,,,,,,,
5610,26223,a,a,16618,KEGG COMPOUND accession,C05981,pail345p_hs,b,16618.0,"Human Metabolome Database (HMDB): <p>Phosphatidylinositol (3,4,5)-trisphosphate (PtdIns(3,4,5)P3) commonly abbreviated to PIP3 is the product of the class I phosphoinositide 3-kinases (PI 3-kinases) activity on phosphatidylinositol (4,5)-bisphosphate. PtdIns(3,4,5)P3 is dephophosphorylated by the phosphatase, PTEN on the 3 position and by SHIPs (SH2-containing inositol phosphatase) on the 5' position of the inositol ring.</p>. <p>The PH domain in a number of proteins binds to PtdIns(3,4,5)P3. Such proteins include Akt/PKB, PDK1, Btk1 and ARNO. The generation of PtdIns(3,4,5)P3 at the plasma membrane upon the activation of class I PI 3-kinases causes these proteins to translocate to the plasma membrane and accordingly affects their activity. The PH domain allows binding between PtdIns(3,4,5)P3 and G-protein coupled receptor kinases (GRKs). This enhances the binding of the GRK to the plasma membrane. (Wikipedia)</p>.","Phosphatidylinositol-3,4,5-trisphosphate",HMDB0004249,b,b,C05981,PHOSPHATIDYL-INOSITOL-345-TRISPHOSPHAT,FDB023351,pail345p_hs,[H]O[C@@]1([H])[C@@]([H])(OP([O-])(=O)OC([H])([H])[C@]([H])(OC([*])=O)C([H])([H])OC([*])=O)[C@]([H])(O[H])[C@@]([H])(OP([O-])([O-])=O)[C@]([H])(OP([O-])([O-])=O)[C@@]1([H])OP([O-])([O-])=O,RQQIRMLGKSPXSE-UQPICLANSA-N,b
5611,26226,a,a,18303,KEGG COMPOUND accession,C02737,,,,,,,,,,,,,,,
5612,26230,a,a,29031,KEGG COMPOUND accession,C05339,,,,,,,,,,,,,,,
5613,26241,a,a,27577,KEGG COMPOUND accession,C01976,,,,,,,,,,,,,,,
5614,26269,a,a,16034,KEGG COMPOUND accession,C03166,,,,,,,,,,,,,,,
5615,26280,a,a,16215,KEGG COMPOUND accession,C06701,,,,,,,,,,,,,,,
5616,26283,a,a,18124,KEGG COMPOUND accession,C03167,ppaca,b,18124.0,b,Phosphonoacetaldehyde,b,b,b,C03167,b,b,b,b,b,"InChI=1S/C2H5O4P/c3-1-2-7(4,5)6/h1H,2H2,(H2,4,5,6)"
5617,26286,a,a,15732,KEGG COMPOUND accession,C05682,,,,,,,,,,,,,,,
5618,26290,a,a,127780,KEGG COMPOUND accession,C06456,,,,,,,,,,,,,,,
5619,26312,a,a,28659,KEGG COMPOUND accession,C06262,,,,,,,,,,,,,,,
5620,26322,a,a,37788,KEGG COMPOUND accession,C06501,,,,,,,,,,,,,,,
5621,26323,a,a,17165,KEGG COMPOUND accession,C02740,,,,,,,,,,,,,,,
5622,26327,a,a,29069,KEGG COMPOUND accession,C01606,,,,,,,,,,,,,,,
5623,26331,a,a,28900,KEGG COMPOUND accession,C06374,,,,,,,,,,,,,,,
5624,26356,a,a,27953,KEGG COMPOUND accession,C06535,,,,,,,,,,,,,,,
5625,26360,a,a,16285,KEGG COMPOUND accession,C01607,CE2414,14721-66-5,16285.0,"Human Metabolome Database (HMDB): Phytanic acid (or 3,7,11,15-tetramethylhexadecanoic acid) is a 20-carbon branched-chain fatty acid that humans can obtain through the consumption of dairy products, ruminant animal fats, and certain fish. It is primarily formed by bacterial degradation of chlorophyll in the intestinal tract of ruminants. Unlike most fatty acids, phytanic acid cannot be metabolized by beta-oxidation (because of a methyl group in the beta position). Instead, it undergoes alpha-oxidation in the peroxisome, where it is converted into pristanic acid by the removal of one carbon. Pristanic acid can undergo several rounds of beta-oxidation in the peroxisome to form medium-chain fatty acids that can be converted into carbon dioxide and water in mitochondria. Refsum disease, an autosomal recessive neurological disorder caused by mutations in the PHYH gene, is characterized by having impaired alpha-oxidation activity. Individuals with Refsum disease accumulate large stores of phytanic acid in their blood and tissues. This frequently leads to peripheral polyneuropathy, cerebellar ataxia, retinitis pigmentosa, anosmia, and hearing loss. Therefore, chronically high levels of phytanic acid can be neurotoxic. Phytanic acid's neurotoxicity appears to lie in its ability to initiate astrocyte/neural cell death by activating the mitochondrial route of apoptosis. In particular, phytanic acid can induce the substantial generation of reactive oxygen species in isolated mitochondria as well as in intact cells. It also induces the release of cytochrome c from mitochondria.",Phytanic acid,HMDB0000801,b,b,C01607,b,FDB022252,b,[H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])C([H])([H])C([H])([H])C([H])(C([H])([H])[H])C([H])([H])C([H])([H])C([H])([H])C([H])(C([H])([H])[H])C([H])([H])C([H])([H])C([H])([H])C([H])(C([H])([H])[H])C([H])([H])C([O-])=O,RLCKHJSFHOZMDR-UHFFFAOYSA-M,"InChI=1S/C20H40O2/c1-16(2)9-6-10-17(3)11-7-12-18(4)13-8-14-19(5)15-20(21)22/h16-19H,6-15H2,1-5H3,(H,21,22)/p-1"
5626,26360,a,a,16285,KEGG COMPOUND accession,C01607,phyt,14721-66-5,16285.0,"Human Metabolome Database (HMDB): Phytanic acid (or 3,7,11,15-tetramethylhexadecanoic acid) is a 20-carbon branched-chain fatty acid that humans can obtain through the consumption of dairy products, ruminant animal fats, and certain fish. It is primarily formed by bacterial degradation of chlorophyll in the intestinal tract of ruminants. Unlike most fatty acids, phytanic acid cannot be metabolized by beta-oxidation (because of a methyl group in the beta position). Instead, it undergoes alpha-oxidation in the peroxisome, where it is converted into pristanic acid by the removal of one carbon. Pristanic acid can undergo several rounds of beta-oxidation in the peroxisome to form medium-chain fatty acids that can be converted into carbon dioxide and water in mitochondria. Refsum disease, an autosomal recessive neurological disorder caused by mutations in the PHYH gene, is characterized by having impaired alpha-oxidation activity. Individuals with Refsum disease accumulate large stores of phytanic acid in their blood and tissues. This frequently leads to peripheral polyneuropathy, cerebellar ataxia, retinitis pigmentosa, anosmia, and hearing loss. Therefore, chronically high levels of phytanic acid can be neurotoxic. Phytanic acid's neurotoxicity appears to lie in its ability to initiate astrocyte/neural cell death by activating the mitochondrial route of apoptosis. In particular, phytanic acid can induce the substantial generation of reactive oxygen species in isolated mitochondria as well as in intact cells. It also induces the release of cytochrome c from mitochondria.",Phytanic acid,HMDB0000801,b,b,C01607,b,FDB022252,phyt,[H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])C([H])([H])C([H])([H])C([H])(C([H])([H])[H])C([H])([H])C([H])([H])C([H])([H])C([H])(C([H])([H])[H])C([H])([H])C([H])([H])C([H])([H])C([H])(C([H])([H])[H])C([H])([H])C([O-])=O,RLCKHJSFHOZMDR-UHFFFAOYSA-M,"InChI=1S/C20H40O2/c1-16(2)9-6-10-17(3)11-7-12-18(4)13-8-14-19(5)15-20(21)22/h16-19H,6-15H2,1-5H3,(H,21,22)/p-1"
5627,26363,a,a,15538,KEGG COMPOUND accession,C02060,CE5122,146622-45-9,15538.0,"Human Metabolome Database (HMDB): Phytanoyl CoA is a coenzyme A derivative of phytanic acid. Phytanic acid is present in human diet or in animal tissues where it may be derived from chlorophyll in plant extracts. Specifically it is an epimeric metabolite of the isoprenoid side chain of chlorophyll. Owing to the presence of its epimeric beta-methyl group, phytanic acid cannot be metabolized by beta-oxidation. Instead, it is metabolized in peroxisomes via alpha-oxidation to give pristanic acid, which is then oxidized by beta-oxidation. PhyH (phytanoyl-CoA 2-hydroxylase) catalyses hydroxylation of phytanoyl-CoA. Mutations of PhyH can lead to phytanic acid accumulation. High levels of phytanic acid are found in patients suffering from Refsum's syndrome. This inherited neurological disorder is characterized by an accumulation of phytanic acid in blood and tissues. Clinically it is characterized by adult onset retinitis pigmentosa, anosmia, sensory neuropathy, and phytanic acidaemia. This disorder has been found to be related to deficiency in the &#945;-oxidation pathway in the liver. (PMID: 17956235). Phytanoyl CoA and other branched-chain fatty acid CoA products are potent inducers of the peroxisome proliferator-activated receptor PPARalpha, a nuclear receptor that enhances transcription of peroxisomal enzymes mediating beta-oxidation of these potentially toxic fatty acids (PMID: 16768463). Pyruvate dehydrogenase and 2-oxoglutarate dehydrogenase are strongly inhibited by phytanoyl-CoA. Decreased activity of these important mitochondrial metabolism complexes might therefore contribute to neurological symptoms upon accumulation of phytanic acid in Refsum disease (PMID: 16737698).",Phytanoyl-CoA,HMDB0001359,b,b,C02060,CPD-206,FDB022577,b,[H]OC([H])(C(=O)N([H])C([H])([H])C([H])([H])C(=O)N([H])C([H])([H])C([H])([H])SC(=O)C([H])([H])C([H])(C([H])([H])[H])C([H])([H])C([H])([H])C([H])([H])[C@]([H])(C([H])([H])[H])C([H])([H])C([H])([H])C([H])([H])[C@]([H])(C([H])([H])[H])C([H])([H])C([H])([H])C([H])([H])C([H])(C([H])([H])[H])C([H])([H])[H])C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])OP([O-])(=O)OP([O-])(=O)OC([H])([H])C1([H])O[C@]([H])(N2C([H])=NC3=C2N=C([H])N=C3N([H])[H])C([H])(O[H])C1([H])OP([O-])([O-])=O,NRJQGHHZMSOUEN-BJETZBMBSA-J,"InChI=1S/C41H74N7O17P3S/c1-26(2)11-8-12-27(3)13-9-14-28(4)15-10-16-29(5)21-32(50)69-20-19-43-31(49)17-18-44-39(53)36(52)41(6,7)23-62-68(59,60)65-67(57,58)61-22-30-35(64-66(54,55)56)34(51)40(63-30)48-25-47-33-37(42)45-24-46-38(33)48/h24-30,34-36,40,51-52H,8-23H2,1-7H3,(H,43,49)(H,44,53)(H,57,58)(H,59,60)(H2,42,45,46)(H2,54,55,56)/p-4/t27-,28-,29?,30?,34?,35?,36?,40+/m0/s1"
5628,26363,a,a,15538,KEGG COMPOUND accession,C02060,phytcoa,b,15538.0,b,Phytanoyl Coenzyme A,b,b,b,C02060,b,b,phytcoa,[H]O[C@@]([H])(C(=O)N([H])C([H])([H])C([H])([H])C(=O)N([H])C([H])([H])C([H])([H])SC(=O)C([H])([H])C([H])(C([H])([H])[H])C([H])([H])C([H])([H])C([H])([H])C([H])(C([H])([H])[H])C([H])([H])C([H])([H])C([H])([H])C([H])(C([H])([H])[H])C([H])([H])C([H])([H])C([H])([H])C([H])(C([H])([H])[H])C([H])([H])[H])C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])OP([O-])(=O)OP([O-])(=O)OC([H])([H])[C@@]1([H])O[C@@]([H])(N2C([H])=NC3=C(N=C([H])N=C23)N([H])[H])[C@]([H])(O[H])[C@]1([H])OP([O-])([O-])=O,NRJQGHHZMSOUEN-ZJGVPSKGSA-J,"InChI=1S/C41H74N7O17P3S/c1-26(2)11-8-12-27(3)13-9-14-28(4)15-10-16-29(5)21-32(50)69-20-19-43-31(49)17-18-44-39(53)36(52)41(6,7)23-62-68(59,60)65-67(57,58)61-22-30-35(64-66(54,55)56)34(51)40(63-30)48-25-47-33-37(42)45-24-46-38(33)48/h24-30,34-36,40,51-52H,8-23H2,1-7H3,(H,43,49)(H,44,53)(H,57,58)(H,59,60)(H2,42,45,46)(H2,54,55,56)/p-4/t27?,28?,29?,30-,34-,35-,36+,40-/m1/s1"
5629,26367,a,a,28129,KEGG COMPOUND accession,C05414,,,,,,,,,,,,,,,
5630,26368,a,a,17327,KEGG COMPOUND accession,C01389,,,,,,,,,,,,,,,
5631,26378,a,a,8198,KEGG COMPOUND accession,C10275,,,,,,,,,,,,,,,
5632,26408,a,a,8214,KEGG COMPOUND accession,C07445,,,,,,,,,,,,,,,
5633,26418,a,a,28103,KEGG COMPOUND accession,C09826,,,,,,,,,,,,,,,
5634,26424,a,a,8222,KEGG COMPOUND accession,C09828,,,,,,,,,,,,,,,
5635,26451,a,a,28568,KEGG COMPOUND accession,C07973,,,,,,,,,,,,,,,
5636,26462,a,a,8240,KEGG COMPOUND accession,C10812,,,,,,,,,,,,,,,
5637,26466,a,a,8242,KEGG COMPOUND accession,C07362,,,,,,,,,,,,,,,
5638,26476,a,a,8247,KEGG COMPOUND accession,C07508,,,,,,,,,,,,,,,
5639,26478,a,a,8248,KEGG COMPOUND accession,C11079,,,,,,,,,,,,,,,
5640,26480,a,a,8249,KEGG COMPOUND accession,C01608,,,,,,,,,,,,,,,
5641,26492,a,a,8255,KEGG COMPOUND accession,C11750,,,,,,,,,,,,,,,
5642,26505,a,a,16323,KEGG COMPOUND accession,C02185,,,,,,,,,,,,,,,
5643,26530,a,a,8273,KEGG COMPOUND accession,C10387,,,,,,,,,,,,,,,
5644,26538,a,a,8277,KEGG COMPOUND accession,C09171,,,,,,,,,,,,,,,
5645,26579,a,a,51349,KEGG COMPOUND accession,C06702,,,,,,,,,,,,,,,
5646,26584,a,a,27699,KEGG COMPOUND accession,C02579,,,,,,,,,,,,,,,
5647,26589,a,a,37531,KEGG COMPOUND accession,C05847,,,,,,,,,,,,,,,
5648,26598,a,a,15986,KEGG COMPOUND accession,C00419,M02755,b,15986.0,b,Polynucleotide,b,b,b,C00419,b,b,b,[H]OC([H])([H])[C@@]1([H])O[C@@]([H])([*])[C@]([H])(O[H])[C@]1([H])OP(=O)(O[H])OC([H])([H])[C@@]1([H])O[C@@]([H])([*])[C@]([H])(O[H])[C@]1([H])OP(=O)(O[H])OC([H])([H])[C@@]1([H])O[C@@]([H])([*])[C@]([H])(O[H])[C@]1([H])O[H],b,b
5649,26603,a,a,15841,KEGG COMPOUND accession,C00403,,,,,,,,,,,,,,,
5650,26608,a,a,28485,KEGG COMPOUND accession,C08834,,,,,,,,,,,,,,,
5651,26610,a,a,26199,KEGG COMPOUND accession,C06081,,,,,,,,,,,,,,,
5652,26612,a,a,16460,KEGG COMPOUND accession,C01048,,,,,,,,,,,,,,,
5653,26617,a,a,18154,KEGG COMPOUND accession,C00420,,,,,,,,,,,,,,,
5654,26620,a,a,8324,KEGG COMPOUND accession,C08721,,,,,,,,,,,,,,,
5655,26662,a,a,8346,KEGG COMPOUND accession,C08219,,,,,,,,,,,,,,,
5656,26669,a,a,8350,KEGG COMPOUND accession,C06783,,,,,,,,,,,,,,,
5657,26679,a,a,8357,KEGG COMPOUND accession,C07892,,,,,,,,,,,,,,,
5658,26683,a,a,8359,KEGG COMPOUND accession,C10520,,,,,,,,,,,,,,,
5659,26685,a,a,63618,KEGG COMPOUND accession,C01844,,,,,,,,,,,,,,,
5660,26693,a,a,8364,KEGG COMPOUND accession,C07368,,,,,,,,,,,,,,,
5661,26700,a,a,8368,KEGG COMPOUND accession,C09017,,,,,,,,,,,,,,,
5662,26702,a,a,35606,KEGG COMPOUND accession,C09018,,,,,,,,,,,,,,,
5663,26704,a,a,50602,KEGG COMPOUND accession,C02463,,,,,,,,,,,,,,,
5664,26717,a,a,27513,KEGG COMPOUND accession,C06320,pre6a,b,b,b,Precorrin 6A,b,b,b,C06320,b,b,b,b,b,b
5665,26719,a,a,27858,KEGG COMPOUND accession,C06319,pre6b,b,b,b,Precorrin 6B,b,b,b,C06319,b,b,b,b,b,b
5666,26722,a,a,28629,KEGG COMPOUND accession,C06408,pre8,b,b,b,Precorrin 8,b,b,b,C06408,b,b,b,b,b,b
5667,26733,a,a,8382,KEGG COMPOUND accession,C07370,,,,,,,,,,,,,,,
5668,26737,a,a,17934,KEGG COMPOUND accession,C00891,,,,,,,,,,,,,,,
5669,26740,a,a,15938,KEGG COMPOUND accession,C00892,,,,,,,,,,,,,,,
5670,26748,a,a,16581,KEGG COMPOUND accession,C01953,prgnlone,145-13-1,16581.0,"Human Metabolome Database (HMDB): Pregnenolone is a derivative of cholesterol, the product of Cytochrome P450 side-chain cleavage (EC 1.14.15.6, CYP11A1); this reaction consists of three consecutive monooxygenations; a 22-hydroxylation, 20-hydroxylation and the cleavage of the C20-C22 bond, yielding pregnenolone. Pregnenolone is the precursor to gonadal steroid hormones and the adrenal corticosteroids. This reaction occurs in steroid hormone-producing tissues such as the adrenal cortex, corpus luteum and placenta. The most notable difference between the placenta and other steroidogenic tissues is that electron supply to CYP11A1 limits the rate at which cholesterol is converted to pregnenolone in the placenta. The limiting component for electron delivery to CYP11A1 is the concentration of adrenodoxin reductase in the mitochondrial matrix which is insufficient to maintain the adrenodoxin pool in a fully reduced state. Pregnenolone is also a neurosteroid, and is produced in the spinal cord; CYP11A1 is the key enzyme catalyzing the conversion of cholesterol into pregnenolone, the rate-limiting step in the biosynthesis of all classes of steroids, and has been localized in sensory networks of the spinal cord dorsal horn. In the adrenal glomerulosa cell angiotensin II, one of the major physiological regulators of mineralocorticoid synthesis, appears to affect most of the cholesterol transfer to the mitochondrial outer membrane and transport to the inner membrane steps and thus to exerts a powerful control over the use of cholesterol for aldosterone production. (PMID: 17222962, 15823613, 16632873, 15134809).",Pregnenolone,HMDB0000253,b,b,C01953,PREGNENOLONE,FDB021920,prgnlone,[H]O[C@]1([H])C([H])([H])C2=C([H])C([H])([H])[C@@]3([H])[C@]4([H])C([H])([H])C([H])([H])[C@]([H])(C(=O)C([H])([H])[H])[C@@]4(C([H])([H])[H])C([H])([H])C([H])([H])[C@]3([H])[C@@]2(C([H])([H])[H])C([H])([H])C1([H])[H],ORNBQBCIOKFOEO-QGVNFLHTSA-N,"InChI=1S/C21H32O2/c1-13(22)17-6-7-18-16-5-4-14-12-15(23)8-10-20(14,2)19(16)9-11-21(17,18)3/h4,15-19,23H,5-12H2,1-3H3/t15-,16-,17+,18-,19-,20-,21+/m0/s1"
5671,26771,a,a,47914,KEGG COMPOUND accession,C06751,,,,,,,,,,,,,,,
5672,26774,a,a,35796,KEGG COMPOUND accession,C10389,,,,,,,,,,,,,,,
5673,26786,a,a,17090,KEGG COMPOUND accession,C03427,,,,,,,,,,,,,,,
5674,26792,a,a,8403,KEGG COMPOUND accession,C07711,pd3,1173-13-3,b,Human Metabolome Database (HMDB): Previtamin D3 is an intermediate in the production of Vitamin D.,Previtamin D3,HMDB0006500,b,b,C07711,b,FDB023943,pd3,[H]O[C@]1([H])C([H])([H])C(\C([H])=C(\[H])C2=C([H])C([H])([H])C([H])([H])[C@@]3(C([H])([H])[H])[C@@]2([H])C([H])([H])C([H])([H])[C@]3([H])[C@]([H])(C([H])([H])[H])C([H])([H])C([H])([H])C([H])([H])C([H])(C([H])([H])[H])C([H])([H])[H])=C(C([H])([H])[H])C([H])([H])C1([H])[H],YUGCAAVRZWBXEQ-WHTXLNIXSA-N,"InChI=1S/C27H44O/c1-19(2)8-6-9-21(4)25-15-16-26-22(10-7-17-27(25,26)5)12-13-23-18-24(28)14-11-20(23)3/h10,12-13,19,21,24-26,28H,6-9,11,14-18H2,1-5H3/b13-12-/t21-,24+,25-,26+,27-/m1/s1"
5675,26794,a,a,8404,KEGG COMPOUND accession,C07531,,,,,,,,,,,,,,,
5676,26796,a,a,8405,KEGG COMPOUND accession,C07627,,,,,,,,,,,,,,,
5677,26798,a,a,15734,KEGG COMPOUND accession,C00226,,,,,,,,,,,,,,,
5678,26811,a,a,8410,KEGG COMPOUND accession,C10121,,,,,,,,,,,,,,,
5679,26817,a,a,8413,KEGG COMPOUND accession,C10390,,,,,,,,,,,,,,,
5680,26839,a,a,28472,KEGG COMPOUND accession,C10237,,,,,,,,,,,,,,,
5681,26855,a,a,71428,KEGG COMPOUND accession,C07376,,,,,,,,,,,,,,,
5682,26857,a,a,8434,KEGG COMPOUND accession,C11182,,,,,,,,,,,,,,,
5683,26859,a,a,8435,KEGG COMPOUND accession,C07403,,,,,,,,,,,,,,,
5684,26883,a,a,27589,KEGG COMPOUND accession,C10238,,,,,,,,,,,,,,,
5685,26885,a,a,8448,KEGG COMPOUND accession,C07378,,,,,,,,,,,,,,,
5686,26909,a,a,8454,KEGG COMPOUND accession,C08425,,,,,,,,,,,,,,,
5687,26940,a,a,16997,KEGG COMPOUND accession,C00583,12ppd_R,57-55-6,16997.0,"Human Metabolome Database (HMDB): Propylene glycol (1,2-propanediol) is an organic compound (a diol alcohol), usually a tasteless, odorless, and colorless clear oily liquid that is hygroscopic and miscible with water, acetone, and chloroform. It is manufactured by the hydration of propylene oxide. Propylene glycol is used as a solvent for intravenous, oral, and topical pharmaceutical preparations It is generally considered safe. However in large doses it can be toxic, especially if given over a short period of time. Intravenous lorazepam contains the largest amount of propylene glycol of commonly used drugs. In adults with normal liver and kidney function, the terminal half-life of propylene glycol ranges from 1.4 to 3.3 hours. Propylene glycol is metabolized by the liver to form lactate, acetate, and pyruvate. The nonmetabolized drug is excreted in the urine mainly as the glucuronide conjugate, approximately 12 to 45 percent is excreted unchanged in urine. Renal clearance decreases as the dose administered increases (390 ml/minute/173 m2 at a dose of 5 g/day but only 144 ml/minute/173 m2 at a dose of 21 g/day). These data suggest that renal clearance declines at higher propylene glycol doses because of saturation of proximal tubular secretion of the drug. As an acceptable level of propylene glycol has not been defined, the clinical implication of a propylene glycol level is unclear. The World Health Organization (WHO) recommends a maximum consumption of 25 mg/kg/day (1.8 g/day for a 75 kg male) of propylene glycol when used as a food additive, but this limit does not address its use as a drug solvent. No maximum dose is recommended in the literature for intravenous therapy with propylene glycol. Intoxication occurs at much higher doses than the WHO dose limit and is exclusive to pharmacologic exposure. Propylene glycol toxicity includes development of serum hyperosmolality, lactic acidosis, and kidney failure. It has been suggested that proximal tubular necrosis is the cause of acute kidney injury from propylene glycol. Along these lines, proximal tubular cell injury occurs in cultured human cells exposed to propylene glycol. Acute tubular necrosis was described with propylene glycol toxicity in a case of concomitant administration of intravenous lorazepam and trimethoprim sulfamethoxazole. Propylene glycol induced intoxication can also mimic sepsis or systemic inflammatory response syndrome (SIRS). Patients suspected of having sepsis with negative cultures should be evaluated for propylene glycol toxicity if they have been exposed to high dose lorazepam or other medications containing this solvent. (PMID: 17555487).",Propylene glycol,HMDB0001881,b,b,C00583,"PROPANE-1,2-DIOL",FDB008274,12ppd_R,[H]OC([H])([H])C([H])(O[H])C([H])([H])[H],DNIAPMSPPWPWGF-UHFFFAOYSA-N,"InChI=1S/C3H8O2/c1-3(5)2-4/h3-5H,2H2,1H3"
5688,26947,a,a,18025,KEGG COMPOUND accession,C03894,,,,,,,,,,,,,,,
5689,26949,a,a,16109,KEGG COMPOUND accession,C02457,13ppd,b,16109.0,b,"Propane-1,3-diol",b,b,b,C02457,b,b,b,b,b,"InChI=1S/C3H8O2/c4-2-1-3-5/h4-5H,1-3H2"
5690,26956,a,a,8473,KEGG COMPOUND accession,C08390,,,,,,,,,,,,,,,
5691,26960,a,a,8475,KEGG COMPOUND accession,C08389,,,,,,,,,,,,,,,
5692,26973,a,a,15539,KEGG COMPOUND accession,C00100,ppcoa,317-66-8,15539.0,"Human Metabolome Database (HMDB): Propionyl-CoA is an intermediate in the metabolism of propanoate. Propionic aciduria is caused by an autosomal recessive disorder of propionyl coenzyme A (CoA) carboxylase deficiency (EC 6.4.1.3). In propionic aciduria, propionyl CoA accumulates within the mitochondria in massive quantities; free carnitine is then esterified, creating propionyl carnitine, which is then excreted in the urine. Because the supply of carnitine in the diet and from synthesis is limited, such patients readily develop carnitine deficiency as a result of the increased loss of acylcarnitine derivatives. This condition demands supplementation of free carnitine above the normal dietary intake to continue to remove (detoxify) the accumulating organic acids. Propionyl-CoA is a substrate for Acyl-CoA dehydrogenase (medium-chain specific, mitochondrial), Acetyl-coenzyme A synthetase 2-like (mitochondrial), Propionyl-CoA carboxylase alpha chain (mitochondrial), Methylmalonate-semialdehyde dehydrogenase (mitochondrial), Trifunctional enzyme beta subunit (mitochondrial), 3-ketoacyl-CoA thiolase (peroxisomal), Acyl-CoA dehydrogenase (long-chain specific, mitochondrial), Malonyl-CoA decarboxylase (mitochondrial), Acetyl-coenzyme A synthetase (cytoplasmic), 3-ketoacyl-CoA thiolase (mitochondrial) and Propionyl-CoA carboxylase beta chain (mitochondrial). (PMID: 10650319).",Propionyl-CoA,HMDB0001275,b,b,C00100,PROPIONYL-COA,FDB022529,ppcoa,[H]O[C@@]([H])(C(=O)N([H])C([H])([H])C([H])([H])C(=O)N([H])C([H])([H])C([H])([H])SC(=O)C([H])([H])C([H])([H])[H])C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])OP([O-])(=O)OP([O-])(=O)OC([H])([H])[C@@]1([H])O[C@@]([H])(N2C([H])=NC3=C(N=C([H])N=C23)N([H])[H])[C@]([H])(O[H])[C@]1([H])OP([O-])([O-])=O,QAQREVBBADEHPA-SSERFMASSA-J,"InChI=1S/C24H40N7O17P3S/c1-4-15(33)52-8-7-26-14(32)5-6-27-22(36)19(35)24(2,3)10-45-51(42,43)48-50(40,41)44-9-13-18(47-49(37,38)39)17(34)23(46-13)31-12-30-16-20(25)28-11-29-21(16)31/h11-13,17-19,23,34-35H,4-10H2,1-3H3,(H,26,32)(H,27,36)(H,40,41)(H,42,43)(H2,25,28,29)(H2,37,38,39)/p-4/t13-,17-,18-,19+,23-/m0/s1"
5693,27018,a,a,8489,KEGG COMPOUND accession,C11121,,,,,,,,,,,,,,,
5694,27025,a,a,8492,KEGG COMPOUND accession,C07384,,,,,,,,,,,,,,,
5695,27045,a,a,8502,KEGG COMPOUND accession,C07569,,,,,,,,,,,,,,,
5696,27047,a,a,33199,KEGG COMPOUND accession,C00804,,,,,,,,,,,,,,,
5697,27054,a,a,27820,KEGG COMPOUND accession,C05953,HC02203,13345-50-1,27820.0,"Human Metabolome Database (HMDB): Produced by the seminal vesicles, prostaglandins are a group of lipid compounds that are derived enzymatically from fatty acids. Technically hormones, the prostanoid class of fatty acid derivatives is a subclass of eicosanoids. The eicosanoids consist of the prostaglandins (PGs), thromboxanes (TXs), leukotrienes (LTs), and lipoxins (LXs). The PGs and TXs are collectively identified as prostanoids. Prostaglandins were originally shown to be synthesized in the prostate gland, thromboxanes from platelets (thrombocytes), and leukotrienes from leukocytes, hence the derivation of their names. All mammalian cells except erythrocytes synthesize eicosanoids. These molecules are extremely potent, able to cause profound physiological effects at very dilute concentrations. All eicosanoids function locally at the site of synthesis through receptor-mediated G-protein linked signaling pathways. Prostaglandin A is a cyclopentenone and is an endogenous metabolite derived from arachidonic acid. It exhibits potent cellular anti-proliferative activity in vivo and in vitro. Excess PGA2 causes an accumulation in both S and G2/M, and a marked decrease in G1. There is also an increase in DNA content preceeding the G0/G1 peak (indicative of apoptotic body formation) mediated by changes in expression levels of Bax and Bcl-2.",Prostaglandin A2,HMDB0002752,b,b,C05953,b,FDB023060,HC02203,[H]O[C@]([H])(C(\[H])=C(/[H])[C@@]1([H])C([H])=C([H])C(=O)[C@]1([H])C([H])([H])C(\[H])=C(\[H])C([H])([H])C([H])([H])C([H])([H])C([O-])=O)C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H],MYHXHCUNDDAEOZ-FOSBLDSVSA-M,"InChI=1S/C20H30O4/c1-2-3-6-9-17(21)14-12-16-13-15-19(22)18(16)10-7-4-5-8-11-20(23)24/h4,7,12-18,21H,2-3,5-6,8-11H2,1H3,(H,23,24)/p-1/b7-4-,14-12+/t16-,17-,18+/m0/s1"
5698,27055,a,a,27624,KEGG COMPOUND accession,C00959,HC02204,13345-51-2,27624.0,"Human Metabolome Database (HMDB): Prostaglandin B1 (PGB1) is a metabolite of PGE1. PGE1 is a prostanoid. Prostanoids is a term that collectively describes prostaglandins, prostacyclines and thromboxanes. Prostanoids are a subclass of the lipid mediator group known as eicosanoids. They derive from C-20 polyunsaturated fatty acids, mainly dihomo-gamma-linoleic (20:3n-6), arachidonic (20:4n-6), and eicosapentaenoic (20:5n-3) acids, through the action of cyclooxygenases-1 and -2 (COX-1 and COX-2). PGB1does not inhibit phospholipase activity, but oligomers of PGB1 (PGBx) extracted from human neutrophils inhibit human phospholipases A2 in vitro and in situ in a dose-dependent manner; these oligomers inhibit arachidonic acid mobilization in human neutrophils and endothelial cells. One mechanism for the pharmacological effects of PGBx may be inhibition of cell-associated and extracellular phospholipase A2. PGB1 has the ability to enhance peripheral vascular resistance and elevate blood pressure. The effect is not central in origin and apparently is not the result of changes in cholinergic or alpha-adrenoceptor sensitivity or changes in vascular smooth muscle susceptibility per se. PGB1 blocks S-phase DNA synthesis; inhibition of DNA synthesis does not appear to require elevated levels of cAMP. (PMID: 7667505, 1477202, 2129000, 2597672, 6635328). Prostaglandins are eicosanoids. The eicosanoids consist of the prostaglandins (PGs), thromboxanes (TXs), leukotrienes (LTs) and lipoxins (LXs). The PGs and TXs are collectively identified as prostanoids. Prostaglandins were originally shown to be synthesized in the prostate gland, thromboxanes from platelets (thrombocytes) and leukotrienes from leukocytes, hence the derivation of their names. All mammalian cells except erythrocytes synthesize eicosanoids. These molecules are extremely potent, able to cause profound physiological effects at very dilute concentrations. All eicosanoids function locally at the site of synthesis, through receptor-mediated G-protein linked signaling pathways.",Prostaglandin B1,HMDB0002982,b,b,C00959,b,FDB023088,HC02204,[H]O[C@]([H])(C([H])=C([H])C1=C(C(=O)C([H])([H])C1([H])[H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([O-])=O)C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H],YBHMPNRDOVPQIN-VSOYFRJCSA-M,"InChI=1S/C20H32O4/c1-2-3-6-9-17(21)14-12-16-13-15-19(22)18(16)10-7-4-5-8-11-20(23)24/h12,14,17,21H,2-11,13,15H2,1H3,(H,23,24)/p-1/b14-12+/t17-/m0/s1"
5699,27058,a,a,27555,KEGG COMPOUND accession,C05955,HC02207,b,27555.0,"Human Metabolome Database (HMDB): This compound belongs to the family of Prostaglandins and related compounds. These are unsaturated carboxylic acids consisting of of a 20 carbon skeleton that also contains a five member ring, and are based upon the fatty acid arachidonic acid.",Prostaglandin-c2,HMDB0060095,b,b,C05955,b,b,HC02207,[H]O[C@]([H])(C(\[H])=C(/[H])C1=C([H])C([H])([H])C(=O)[C@]1([H])C([H])([H])C(\[H])=C(\[H])C([H])([H])C([H])([H])C([H])([H])C([O-])=O)C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H],CMBOTAQMTNMTBD-KLASNZEFSA-M,"InChI=1S/C20H30O4/c1-2-3-6-9-17(21)14-12-16-13-15-19(22)18(16)10-7-4-5-8-11-20(23)24/h4,7,12-14,17-18,21H,2-3,5-6,8-11,15H2,1H3,(H,23,24)/p-1/b7-4-,14-12+/t17-,18+/m0/s1"
5700,27060,a,a,27696,KEGG COMPOUND accession,C06438,HC02208,17968-82-0,27696.0,"Human Metabolome Database (HMDB): Prostaglandin D1 is a prostanoid that elicits contractile and relaxant on isolated human pial arteries with small potency. Prostanoids is a term that collectively describes prostaglandins, prostacyclines and thromboxanes. Prostanoids are a subclass of the lipid mediator group known as eicosanoids. They derive from C-20 polyunsaturated fatty acids, mainly dihomo-gamma-linoleic (20:3n-6), arachidonic (20:4n-6), and eicosapentaenoic (20:5n-3) acids, through the action of cyclooxygenases-1 and -2 (COX-1 and COX-2). The reaction product of COX is the unstable endoperoxide prostaglandin H (PGH) that is further transformed into the individual prostanoids by a series of specific prostanoid synthases. Prostanoids are local-acting mediators formed and inactivated within the same or neighbouring cells prior to their release into circulation as inactive metabolites (15-keto- and 13,14-dihydroketo metabolites). Non-enzymatic peroxidation of arachidonic acid and other fatty acids in vivo can result in prostaglandin-like substances isomeric to the COX-derived prostaglandins that are termed isoprostanes. Prostanoids take part in many physiological and pathophysiological processes in practically every organ, tissue and cell, including the vascular, renal, gastrointestinal and reproductive systems. Their activities are mediated through prostanoid-specific receptors and intracellular signalling pathways, whilst their biosynthesis and action are blocked by nonsteroidal antiinflammatory drugs (NSAID). Isoprostanes are considered to be reliable markers of oxidant stress status and have been linked to inflammation, ischaemia-reperfusion, diabetes, cardiovascular disease, reproductive disorders and diabetes. (PMID: 6091419, 16986207)Prostaglandins are eicosanoids. The eicosanoids consist of the prostaglandins (PGs), thromboxanes (TXs), leukotrienes (LTs) and lipoxins (LXs). The PGs and TXs are collectively identified as prostanoids. Prostaglandins were originally shown to be synthesized in the prostate gland, thromboxanes from platelets (thrombocytes) and leukotrienes from leukocytes, hence the derivation of their names. All mammalian cells except erythrocytes synthesize eicosanoids. These molecules are extremely potent, able to cause profound physiological effects at very dilute concentrations. All eicosanoids function locally at the site of synthesis, through receptor-mediated G-protein linked signaling pathways.",Prostaglandin D1,HMDB0005102,b,b,C06438,b,FDB023631,b,[H]O[C@]([H])(C([H])=C([H])[C@@]1([H])C(=O)C([H])([H])[C@]([H])(O[H])[C@]1([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([O-])=O)C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H],CIMMACURCPXICP-PNQRDDRVSA-M,"InChI=1S/C20H34O5/c1-2-3-6-9-15(21)12-13-17-16(18(22)14-19(17)23)10-7-4-5-8-11-20(24)25/h12-13,15-18,21-22H,2-11,14H2,1H3,(H,24,25)/p-1/b13-12+/t15-,16+,17+,18-/m0/s1"
5701,27063,a,a,15551,KEGG COMPOUND accession,C00584,prostge2,363-24-6,15551.0,"Human Metabolome Database (HMDB): The naturally occurring prostaglandin E2 (PGE2) is known in medicine as dinoprostone. It has important effects in labour and also stimulates osteoblasts to release factors which stimulate bone resorption by osteoclasts (a type of bone cell that removes bone tissue by removing the bone's mineralized matrix). PGE2 is also the prostaglandin that ultimately induces fever. PGE2 has been shown to increase vasodilation and cAMP production, to enhance the effects of bradykinin and histamine, induction of uterine contractions and of platelet aggregation. PGE2 is also responsible for maintaining the open passageway of the fetal ductus arteriosus; decreasing T-cell proliferation and lymphocyte migration and activating the secretion of IL-1&#945; and IL-2. PGE2 exhibits both pro- and anti-inflammatory effects, particularly on dendritic cells (DC). Depending on the nature of maturation signals, PGE2 has different and sometimes opposite effects on DC biology. PGE2 exerts an inhibitory action, reducing the maturation of DC and their ability to present antigen. PGE2 has also been shown to stimulate DC and promote IL-12 production when given in combination with TNF-alpha. PGE2 is an environmentally bioactive substance. Its action is prolonged and sustained by other factors especially IL-10. It modulates the activities of professional DC by acting on their differentiation, maturation and their ability to secrete cytokines. PGE2 is a potent inducer of IL-10 in bone marrow-derived DC (BM-DC), and PGE2-induced IL-10 is a key regulator of the BM-DC pro-inflammatory phenotype (PMID: 16978535). Dinoprostone is a naturally occurring prostaglandin E2 (PGE2) and the most common and most biologically active of the mammalian prostaglandins. It has important effects in labour and also stimulates osteoblasts to release factors which stimulate bone resorption by osteoclasts (a type of bone cell that removes bone tissue by removing the bone's mineralized matrix). PGE2 has been shown to increase vasodilation and cAMP production, to enhance the effects of bradykinin and histamine, to induce uterine contractions and to activate platelet aggregation. PGE2 is also responsible for maintaining the open passageway of the fetal ductus arteriosus; decreasing T-cell proliferation and lymphocyte migration and activating the secretion of IL-1alpha and IL-2. PGE2 exhibits both pro- and anti-inflammatory effects, particularly on dendritic cells (DC). Depending on the nature of maturation signals, PGE2 has different and sometimes opposite effects on DC biology. PGE2 exerts an inhibitory action, reducing the maturation of DC and their ability to present antigen. PGE2 has also been shown to stimulate DC and promote IL-12 production when given in combination with TNF-alpha. PGE2 is an environmentally bioactive substance. Its action is prolonged and sustained by other factors especially IL-10. It modulates the activities of professional DC by acting on their differentiation, maturation and their ability to secrete cytokines. PGE2 is a potent inducer of IL-10 in bone marrow-derived DC (BM-DC), and PGE2-induced IL-10 is a key regulator of the BM-DC pro-inflammatory phenotype (PMID: 16978535). Prostaglandins are eicosanoids. The eicosanoids consist of the prostaglandins (PGs), thromboxanes (TXs), leukotrienes (LTs) and lipoxins (LXs). The PGs and TXs are collectively identified as prostanoids. Prostaglandins were originally shown to be synthesized in the prostate gland, thromboxanes from platelets (thrombocytes) and leukotrienes from leukocytes, hence the derivation of their names. All mammalian cells except erythrocytes synthesize eicosanoids. These molecules are extremely potent, able to cause profound physiological effects at very dilute concentrations. All eicosanoids function locally at the site of synthesis, through receptor-mediated G-protein linked signaling pathways.",Prostaglandin E2,HMDB0001220,b,b,C00584,5Z13E-15S-1115-DIHYDROXY-9-OXOPROS,FDB022498,prostge2,[H]O[C@]([H])(C(\[H])=C(/[H])[C@@]1([H])[C@]([H])(O[H])C([H])([H])C(=O)[C@]1([H])C([H])([H])C(\[H])=C(\[H])C([H])([H])C([H])([H])C([H])([H])C([O-])=O)C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H],XEYBRNLFEZDVAW-ARSRFYASSA-M,"InChI=1S/C20H32O5/c1-2-3-6-9-15(21)12-13-17-16(18(22)14-19(17)23)10-7-4-5-8-11-20(24)25/h4,7,12-13,15-17,19,21,23H,2-3,5-6,8-11,14H2,1H3,(H,24,25)/p-1/b7-4-,13-12+/t15-,16+,17+,19+/m0/s1"
5702,27069,a,a,28031,KEGG COMPOUND accession,C06439,HC02213,802-31-3,28031.0,"Human Metabolome Database (HMDB): Prostaglandin E3 is from the cyclooxygenase metabolism of eicosapentaenoic acid.Prostaglandins are eicosanoids. The eicosanoids consist of the prostaglandins (PGs), thromboxanes (TXs), leukotrienes (LTs) and lipoxins (LXs). The PGs and TXs are collectively identified as prostanoids. Prostaglandins were originally shown to be synthesized in the prostate gland, thromboxanes from platelets (thrombocytes) and leukotrienes from leukocytes, hence the derivation of their names. All mammalian cells except erythrocytes synthesize eicosanoids. These molecules are extremely potent, able to cause profound physiological effects at very dilute concentrations. All eicosanoids function locally at the site of synthesis, through receptor-mediated G-protein linked signaling pathways.",Prostaglandin E3,HMDB0002664,b,b,C06439,b,FDB023042,HC02213,[H]O[C@]([H])(C([H])=C([H])[C@@]1([H])[C@]([H])(O[H])C([H])([H])C(=O)[C@]1([H])C([H])([H])C(\[H])=C(\[H])C([H])([H])C([H])([H])C([H])([H])C([O-])=O)C([H])([H])C(\[H])=C(\[H])C([H])([H])C([H])([H])[H],CBOMORHDRONZRN-QLOYDKTKSA-M,"InChI=1S/C20H30O5/c1-2-3-6-9-15(21)12-13-17-16(18(22)14-19(17)23)10-7-4-5-8-11-20(24)25/h3-4,6-7,12-13,15-17,19,21,23H,2,5,8-11,14H2,1H3,(H,24,25)/p-1/b6-3-,7-4-,13-12+/t15-,16+,17+,19+/m0/s1"
5703,27071,a,a,28852,KEGG COMPOUND accession,C06475,HC02214,745-62-0,28852.0,"Human Metabolome Database (HMDB): Prostaglandin F1a is derived mainly from Prostaglandin E1, and is metabolized to 6-Keto Prostaglandin F1a. Prostaglandin F1a is excreted directly into the urine. Prostaglandin F1a contracts the circular muscle of the gut in opposition to the Prostaglandins of the E series. Prostaglandin F1a is a cytoprotector, protecting mucosal tissue from damage produced by ulcerogenic stimuli.Prostaglandins are eicosanoids. The eicosanoids consist of the prostaglandins (PGs), thromboxanes (TXs), leukotrienes (LTs) and lipoxins (LXs). The PGs and TXs are collectively identified as prostanoids. Prostaglandins were originally shown to be synthesized in the prostate gland, thromboxanes from platelets (thrombocytes) and leukotrienes from leukocytes, hence the derivation of their names. All mammalian cells except erythrocytes synthesize eicosanoids. These molecules are extremely potent, able to cause profound physiological effects at very dilute concentrations. All eicosanoids function locally at the site of synthesis, through receptor-mediated G-protein linked signaling pathways.",Prostaglandin F1a,HMDB0002685,b,b,C06475,b,FDB023044,b,[H]O[C@]([H])(C(\[H])=C(/[H])[C@@]1([H])[C@]([H])(O[H])C([H])([H])[C@]([H])(O[H])[C@]1([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([O-])=O)C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H],DZUXGQBLFALXCR-CDIPTNKSSA-M,"InChI=1S/C20H36O5/c1-2-3-6-9-15(21)12-13-17-16(18(22)14-19(17)23)10-7-4-5-8-11-20(24)25/h12-13,15-19,21-23H,2-11,14H2,1H3,(H,24,25)/p-1/b13-12+/t15-,16+,17+,18-,19+/m0/s1"
5704,27073,a,a,15553,KEGG COMPOUND accession,C00639,prostgf2,551-11-1,15553.0,"Human Metabolome Database (HMDB): Prostaglandin F2a (PGF2) is one of the earliest discovered and most common prostaglandins. It is actively biosynthesized in various organs of mammals and exhibits a variety of biological activities, including contraction of pulmonary arteries. It is used in medicine to induce labor and as an abortifacient. PGF2a binds to the Prostaglandin F2 receptor (PTGFR) which is a member of the G-protein coupled receptor family. PGF2-alpha mediates luteolysis. Luteolysis is the structural and functional degradation of the corpus luteum (CL) that occurs at the end of the luteal phase of both the estrous and menstrual cycles in the absence of pregnancy. PGF2 may also be involved in modulating intraocular pressure and smooth muscle contraction in the uterus and gastrointestinal tract sphincters. PGF2 is mainly synthesized directly from PGH2 by PGH2 9,11-endoperoxide reductase. A small amount of PGF2 is also produced from PGE2 by PGE2 9-ketoreductase. A PGF2 epimer has been reported to exhibit various biological activities, and its levels are increased in bronchoalveolar lavage fluid, plasma, and urine in patients with mastocytosis and bronchial asthma. PGF2 is synthesized from PGD2 by PGD2 11-ketoreductase. (PMID: 16475787). Prostaglandins are eicosanoids. The eicosanoids consist of the prostaglandins (PGs), thromboxanes (TXs), leukotrienes (LTs) and lipoxins (LXs). The PGs and TXs are collectively identified as prostanoids. Prostaglandins were originally shown to be synthesized in the prostate gland, thromboxanes from platelets (thrombocytes) and leukotrienes from leukocytes, hence the derivation of their names. All mammalian cells except erythrocytes synthesize eicosanoids. These molecules are extremely potent, able to cause profound physiological effects at very dilute concentrations. All eicosanoids function locally at the site of synthesis, through receptor-mediated G-protein linked signaling pathways.",Prostaglandin F2a,HMDB0001139,b,b,C00639,5Z13E-15S-9-ALPHA11-ALPHA15-TRIHY,FDB022448,prostgf2,[H]O[C@]([H])(C(\[H])=C(/[H])[C@@]1([H])[C@]([H])(O[H])C([H])([H])[C@]([H])(O[H])[C@]1([H])C([H])([H])C(\[H])=C(\[H])C([H])([H])C([H])([H])C([H])([H])C([O-])=O)C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H],PXGPLTODNUVGFL-YNNPMVKQSA-M,"InChI=1S/C20H34O5/c1-2-3-6-9-15(21)12-13-17-16(18(22)14-19(17)23)10-7-4-5-8-11-20(24)25/h4,7,12-13,15-19,21-23H,2-3,5-6,8-11,14H2,1H3,(H,24,25)/p-1/b7-4-,13-12+/t15-,16+,17+,18-,19+/m0/s1"
5705,27079,a,a,28922,KEGG COMPOUND accession,C02314,HC02216,4510-16-1,28922.0,"Human Metabolome Database (HMDB): Prostaglandin F2b is a naturally occurring isoprostane. Isoprostanes are arachidonic acid metabolites produced by peroxidative attack of membrane lipids. These accumulate to substantial levels in many clinical conditions characterized in part by accumulation of free radicals and reactive oxygen species, including asthma, hypertension and ischemia-reperfusion injury. For this reason, they are frequently used as markers of oxidative stress; however, many are now finding that these molecules are not inert, but in fact evoke powerful biological responses in an increasing array of cell types. In many cases, these biological effects can account in part for the various features and manifestations of those clinical conditions. Thus, it may be possible that the isoprostanes are playing somewhat of a causal role in those disease states. Lipid-peroxidation forms primary- or secondary-end products like conjugated dienes, lipid hydroperoxides, gaseous alkanes, and prostaglandin F2-like products. They are created as major products by free-radical catalyzed peroxidation of esterified arachidonic acid (AA) in membrane phospholipids. They are also minor products of the activity of platelet cyclooxygenase-1 (COX-1) in response to stimuli such as collagen, thrombin, or arachidonate. The levels of Prostaglandin F2b and F2-isoprostanes in CSF and urine are elevated in Alzheimer's disease (AD) patients when compared to that of age-matched controls. (PMID: 15275956, 14504139)Prostaglandins are eicosanoids. The eicosanoids consist of the prostaglandins (PGs), thromboxanes (TXs), leukotrienes (LTs) and lipoxins (LXs). The PGs and TXs are collectively identified as prostanoids. Prostaglandins were originally shown to be synthesized in the prostate gland, thromboxanes from platelets (thrombocytes) and leukotrienes from leukocytes, hence the derivation of their names. All mammalian cells except erythrocytes synthesize eicosanoids. These molecules are extremely potent, able to cause profound physiological effects at very dilute concentrations. All eicosanoids function locally at the site of synthesis, through receptor-mediated G-protein linked signaling pathways.",Prostaglandin F2b,HMDB0001483,b,b,C02314,CPD-8348,FDB022647,b,[H]O[C@]([H])(C(\[H])=C(/[H])[C@@]1([H])[C@]([H])(O[H])C([H])([H])[C@@]([H])(O[H])[C@]1([H])C([H])([H])C([H])=C([H])C([H])([H])C([H])([H])C([H])([H])C([O-])=O)C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H],PXGPLTODNUVGFL-PTTZIUQESA-M,"InChI=1S/C20H34O5/c1-2-3-6-9-15(21)12-13-17-16(18(22)14-19(17)23)10-7-4-5-8-11-20(24)25/h4,7,12-13,15-19,21-23H,2-3,5-6,8-11,14H2,1H3,(H,24,25)/p-1/b7-4+,13-12+/t15-,16+,17+,18+,19+/m0/s1"
5706,27101,a,a,16541,KEGG COMPOUND accession,C00017,M00196,b,16541.0,b,Protein,b,b,b,C00017,b,b,b,[H]OC(=O)[C@]([H])([*])N([H])C(=O)[C@]([H])([*])N([H])[H],b,b
5707,27128,a,a,16044,KEGG COMPOUND accession,C03023,M02704,b,16044.0,b,Peptide-L-Methionine,b,b,b,C03023,b,b,b,[H]N([*])C(=O)[C@@]([H])(N([H])C([*])=O)C([H])([H])C([H])([H])SC([H])([H])[H],b,b
5708,27192,a,a,16249,KEGG COMPOUND accession,C02582,,,,,,,,,,,,,,,
5709,27245,a,a,15795,KEGG COMPOUND accession,C02879,,,,,,,,,,,,,,,
5710,27250,a,a,8588,KEGG COMPOUND accession,C08907,,,,,,,,,,,,,,,
5711,27255,a,a,16415,KEGG COMPOUND accession,C05189,,,,,,,,,,,,,,,
5712,27271,a,a,8597,KEGG COMPOUND accession,C07408,,,,,,,,,,,,,,,
5713,27277,a,a,8600,KEGG COMPOUND accession,C10521,,,,,,,,,,,,,,,
5714,27281,a,a,8602,KEGG COMPOUND accession,C10522,,,,,,,,,,,,,,,
5715,27301,a,a,18116,KEGG COMPOUND accession,C01168,M02807,1157-60-4,18116.0,"Human Metabolome Database (HMDB): Pseudouridine (5-ribosyluracil) is a ubiquitous yet enigmatic constituent of structural RNAs (transfer, ribosomal, small nuclear, and small nucleolar). Although pseudouridine (psi) was the first modified nucleoside to be discovered in RNA, and is the most abundant, its biosynthesis and biological roles have remained poorly understood since its identification as a ""fifth nucleoside"" in RNA. Recently, a combination of biochemical, biophysical, and genetic approaches has helped to illuminate the structural consequences of psi in polyribonucleotides, the biochemical mechanism of U-->psi isomerization in RNA, and the role of modification enzymes (psi synthases) and box H/ACA snoRNAs, a class of eukaryotic small nucleolar RNAs, in the site-specific biosynthesis of psi. Through its unique ability to coordinate a structural water molecule via its free N1-H, psi exerts a subtle but significant ""rigidifying"" influence on the nearby sugar-phosphate backbone and also enhances base stacking. These effects may underlie the biological role of most (but perhaps not all) of the psi residues in RNA. Certain genetic mutants lacking specific psi residues in tRNA or rRNA exhibit difficulties in translation, display slow growth rates, and fail to compete effectively with wild-type strains in mixed culture. In particular, normal growth is severely compromised in an Escherichia coli mutant deficient in a pseudouridine synthase responsible for the formation of three closely spaced psi residues in the mRNA decoding region of the 23S rRNA. Such studies demonstrate that pseudouridylation of RNA confers an important selective advantage in a natural biological context. PMID: 10902565.",Pseudouridine 5'-phosphate,HMDB0001271,b,b,C01168,PSEUDOURIDINE-5-P,FDB022525,b,[H]O[C@@]1([H])[C@@]([H])(O[C@]([H])(C([H])([H])OP(=O)(O[H])O[H])[C@@]1([H])O[H])C1=C([H])N([H])C(=O)N([H])C1=O,MOBMOJGXNHLLIR-GBNDHIKLSA-N,"InChI=1S/C9H13N2O9P/c12-5-4(2-19-21(16,17)18)20-7(6(5)13)3-1-10-9(15)11-8(3)14/h1,4-7,12-13H,2H2,(H2,16,17,18)(H2,10,11,14,15)/t4-,5-,6-,7+/m1/s1"
5716,27307,a,a,8613,KEGG COMPOUND accession,C08312,,,,,,,,,,,,,,,
5717,27309,a,a,8614,KEGG COMPOUND accession,C07576,,,,,,,,,,,,,,,
5718,27313,a,a,8616,KEGG COMPOUND accession,C10523,,,,,,,,,,,,,,,
5719,27315,a,a,8617,KEGG COMPOUND accession,C10090,,,,,,,,,,,,,,,
5720,27318,a,a,16874,KEGG COMPOUND accession,C01747,C01747,2238-90-6,16874.0,"Human Metabolome Database (HMDB): Galactosylsphingosine (also known as psychosine), is an intermediate in the biosynthesis of cerebrosides. It is formed from the reaction of sphingosine with UDP-galactose and then reacts with fatty acid-coenzyme A to form the cerebroside. It is a galactoside metabolite of sphingosine and can function as a neurotoxin and a metabotoxin. A neurotoxin is a compound that disrupts or attacks neural cells and neural tissue. A metabotoxin is an endogenously produced metabolite that causes adverse health effects at chronically high levels. Chronically high levels of galactosylsphingosine are associated with globoid cell leukodystrophy (Krabbe disease), which is characterized by the dysfunction of galactosylceramidase. Galactosylsphingosine is a highly cytotoxic lipid capable of inducing cell death in a wide variety of cell types including oligodendrocytes. It is known to accumulate in the nervous system in the absence of galactosylceramidase. Galactosylsphingosine localizes to lipid rafts and perturbs membrane integrity. It also inhibits protein kinase C translocation to the plasma membrane (PMID: 24006512). Symptoms of Krabbe disease begin between the ages of 3 and 6 months with irritability, fevers, limb stiffness, seizures, feeding difficulties, vomiting, and slowing of mental and motor development. In the first stages of the disease, the symptoms are often mistaken with those of cerebral palsy. Other symptoms include muscle weakness, spasticity, deafness, optic atrophy, optic nerve enlargement, blindness, paralysis, and difficulty when swallowing.",Galactosylsphingosine,HMDB0000648,b,b,C01747,b,FDB022161,C01747,[H]OC([H])([H])[C@@]1([H])O[C@@]([H])(OC([H])([H])[C@]([H])([N+]([H])([H])[H])[C@]([H])(O[H])C(\[H])=C(/[H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H])[C@]([H])(O[H])[C@@]([H])(O[H])[C@@]1([H])O[H],HHJTWTPUPVQKNA-PIIMIWFASA-O,"InChI=1S/C24H47NO7/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-19(27)18(25)17-31-24-23(30)22(29)21(28)20(16-26)32-24/h14-15,18-24,26-30H,2-13,16-17,25H2,1H3/p+1/b15-14+/t18-,19+,20+,21-,22-,23+,24+/m0/s1"
5721,27322,a,a,17507,KEGG COMPOUND accession,C02744,C02744,b,17507.0,"Human Metabolome Database (HMDB): psychosine sulfate is a intermediate in the biosynthesis of cerebrosides. It is one of the products involved in the reaction of 3'-phosphoadenylyl sulfate with galactosylsphingosine catalyzed by psychosine sulfotransferase, and the other product is ADP respectively.",Psychosine sulfate,HMDB0013046,b,b,C02744,CPD-518,FDB029269,b,[H]O[C@]([H])(C(\[H])=C(/[H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H])[C@@]([H])([N+]([H])([H])[H])C([H])([H])O[C@]1([H])O[C@]([H])(C([H])([H])OS([O-])(=O)=O)[C@]([H])(O[H])[C@]([H])(O[H])[C@@]1([H])O[H],UIEYIJKBVSNMMH-PIIMIWFASA-N,"InChI=1S/C24H47NO10S/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-19(26)18(25)16-33-24-23(29)22(28)21(27)20(35-24)17-34-36(30,31)32/h14-15,18-24,26-29H,2-13,16-17,25H2,1H3,(H,30,31,32)/b15-14+/t18-,19+,20+,21-,22-,23+,24+/m0/s1"
5722,27336,a,a,44992,KEGG COMPOUND accession,C00715,,,,,,,,,,,,,,,
5723,27340,a,a,27623,KEGG COMPOUND accession,C07582,,,,,,,,,,,,,,,
5724,27344,a,a,8630,KEGG COMPOUND accession,C10287,,,,,,,,,,,,,,,
5725,27359,a,a,8638,KEGG COMPOUND accession,C08364,,,,,,,,,,,,,,,
5726,29199,a,a,9119,KEGG COMPOUND accession,C09241,,,,,,,,,,,,,,,
5727,29319,a,a,27693,KEGG COMPOUND accession,C01753,,,,,,,,,,,,,,,
5728,29332,a,a,9177,KEGG COMPOUND accession,C11171,,,,,,,,,,,,,,,
5729,29336,a,a,9179,KEGG COMPOUND accession,C07695,,,,,,,,,,,,,,,
5730,29353,a,a,9188,KEGG COMPOUND accession,C10820,,,,,,,,,,,,,,,
5731,29460,a,a,9230,KEGG COMPOUND accession,C11054,,,,,,,,,,,,,,,
5732,29463,a,a,9232,KEGG COMPOUND accession,C11056,,,,,,,,,,,,,,,
5733,29520,a,a,28801,KEGG COMPOUND accession,C08459,,,,,,,,,,,,,,,
5734,29552,a,a,35915,KEGG COMPOUND accession,C01958,,,,,,,,,,,,,,,
5735,29574,a,a,9279,KEGG COMPOUND accession,C03177,,,,,,,,,,,,,,,
5736,29597,a,a,17096,KEGG COMPOUND accession,C03309,,,,,,,,,,,,,,,
5737,29628,a,a,63623,KEGG COMPOUND accession,C07598,,,,,,,,,,,,,,,
5738,29685,a,a,15380,KEGG COMPOUND accession,C00091,succoa,604-98-8,15380.0,"Human Metabolome Database (HMDB): Succinyl-CoA is an important intermediate in the citric acid cycle, where it is synthesized from &#945;-Ketoglutarate by &#945;-ketoglutarate dehydrogenase (EC 1.2.4.2) through decarboxylation, and is converted into succinate through the hydrolytic release of coenzyme A by succinyl-CoA synthetase (EC 6.2.1.5). Succinyl-CoA may be an end product of peroxisomal beta-oxidation of dicarboxylic fatty acids; the identification of an apparently specific succinyl-CoA thioesterase (ACOT4, EC 3.1.2.3, hydrolyzes succinyl-CoA) in peroxisomes strongly suggests that succinyl-CoA is formed in peroxisomes. Acyl-CoA thioesterases (ACOTs) are a family of enzymes that catalyze the hydrolysis of the CoA esters of various lipids to the free acids and coenzyme A, thereby regulating levels of these compounds. (PMID: 16141203).",Succinyl-CoA,HMDB0001022,b,b,C00091,3-METHYLBENZYLSUCCINYL-COA,FDB022375,succoa,[H]O[C@@]([H])(C(=O)N([H])C([H])([H])C([H])([H])C(=O)N([H])C([H])([H])C([H])([H])SC(=O)C([H])([H])C([H])([H])C([O-])=O)C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])OP([O-])(=O)OP([O-])(=O)OC([H])([H])[C@@]1([H])O[C@@]([H])(N2C([H])=NC3=C(N=C([H])N=C23)N([H])[H])[C@]([H])(O[H])[C@]1([H])OP([O-])([O-])=O,VNOYUJKHFWYWIR-RJPVGMBJSA-I,"InChI=1S/C25H40N7O19P3S/c1-25(2,20(38)23(39)28-6-5-14(33)27-7-8-55-16(36)4-3-15(34)35)10-48-54(45,46)51-53(43,44)47-9-13-19(50-52(40,41)42)18(37)24(49-13)32-12-31-17-21(26)29-11-30-22(17)32/h11-13,18-20,24,37-38H,3-10H2,1-2H3,(H,27,33)(H,28,39)(H,34,35)(H,43,44)(H,45,46)(H2,26,29,30)(H2,40,41,42)/p-5/t13-,18-,19-,20+,24-/m0/s1"
5739,29731,a,a,16308,KEGG COMPOUND accession,C02591,,,,,,,,,,,,,,,
5740,29758,a,a,16310,KEGG COMPOUND accession,C07287,,,,,,,,,,,,,,,
5741,29761,a,a,9325,KEGG COMPOUND accession,C08076,,,,,,,,,,,,,,,
5742,29860,a,a,9348,KEGG COMPOUND accession,C10955,,,,,,,,,,,,,,,
5743,29862,a,a,9349,KEGG COMPOUND accession,C11142,,,,,,,,,,,,,,,
5744,29870,a,a,18422,KEGG COMPOUND accession,C09306,,,,,,,,,,,,,,,
5745,29971,a,a,9401,KEGG COMPOUND accession,C08636,,,,,,,,,,,,,,,
5746,29992,a,a,9407,KEGG COMPOUND accession,C05465,tdchola,516-35-8,16525.0,"Human Metabolome Database (HMDB): Taurochenodesoxycholic acid is a bile acid formed in the liver by conjugation of chenodeoxycholate with taurine, usually as the sodium salt. Bile acids are steroid acids found predominantly in bile of mammals. The distinction between different bile acids is minute, depends only on presence or absence of hydroxyl groups on positions 3, 7, and 12. Bile acids are physiological detergents that facilitate excretion, absorption, and transport of fats and sterols in the intestine and liver. Bile acids are also steroidal amphipathic molecules derived from the catabolism of cholesterol. They modulate bile flow and lipid secretion, are essential for the absorption of dietary fats and vitamins, and have been implicated in the regulation of all the key enzymes involved in cholesterol homeostasis. Bile acids recirculate through the liver, bile ducts, small intestine and portal vein to form an enterohepatic circuit. They exist as anions at physiological pH and, consequently, require a carrier for transport across the membranes of the enterohepatic tissues. The unique detergent properties of bile acids are essential for the digestion and intestinal absorption of hydrophobic nutrients. Bile acids have potent toxic properties (e.g., membrane disruption) and there are a plethora of mechanisms to limit their accumulation in blood and tissues. (PMID: 11316487, 16037564, 12576301, 11907135).",Taurochenodesoxycholic acid,HMDB0000951,b,b,C05465,CHENODEOXYCHOLOYLTAURINE,FDB022335,tdchola,[H]O[C@]1([H])C([H])([H])C([H])([H])[C@@]2(C([H])([H])[H])C([H])(C1([H])[H])C([H])([H])[C@@]([H])(O[H])C1([H])C3([H])C([H])([H])C([H])([H])C([H])([C@]([H])(C([H])([H])[H])C([H])([H])C([H])([H])C(=O)N([H])C([H])([H])C([H])([H])S(=O)(=O)O[H])[C@@]3(C([H])([H])[H])C([H])([H])C([H])([H])C21[H],BHTRKEVKTKCXOH-QPRHXUMOSA-N,"InChI=1S/C26H45NO6S/c1-16(4-7-23(30)27-12-13-34(31,32)33)19-5-6-20-24-21(9-11-26(19,20)3)25(2)10-8-18(28)14-17(25)15-22(24)29/h16-22,24,28-29H,4-15H2,1-3H3,(H,27,30)(H,31,32,33)/t16-,17?,18-,19?,20?,21?,22-,24?,25+,26-/m1/s1"
5747,30821,a,a,9752,KEGG COMPOUND accession,C08394,,,,,,,,,,,,,,,
5748,30025,a,a,16267,KEGG COMPOUND accession,C01855,,,,,,,,,,,,,,,
5749,30090,a,a,9451,KEGG COMPOUND accession,C08080,,,,,,,,,,,,,,,
5750,30143,a,a,17300,KEGG COMPOUND accession,C06789,,,,,,,,,,,,,,,
5751,30171,a,a,9479,KEGG COMPOUND accession,C11682,,,,,,,,,,,,,,,
5752,30271,a,a,9516,KEGG COMPOUND accession,C09561,,,,,,,,,,,,,,,
5753,30383,a,a,17195,KEGG COMPOUND accession,C03901,,,,,,,,,,,,,,,
5754,30397,a,a,15967,KEGG COMPOUND accession,C00342,trdrd,b,15967.0,b,Reduced Thioredoxin,b,b,b,C00342,b,b,trdrd,[H]SC([H])([H])[C@]([H])(N([H])[*])C(=O)N([H])[C@@]([H])([*])C(=O)N([H])[C@@]([H])([*])C(=O)N([H])[C@]([H])(C([*])=O)C([H])([H])S[H],b,b
5755,30518,a,a,28864,KEGG COMPOUND accession,C00397,,,,,,,,,,,,,,,
5756,30637,a,a,9665,KEGG COMPOUND accession,C11156,,,,,,,,,,,,,,,
5757,30673,a,a,30956,KEGG COMPOUND accession,C11150,M03041,76-03-9,30956.0,Human Metabolome Database (HMDB): Trichloroacetic acid (TCA; also known as trichloroethanoic acid) is an analogue of acetic acid in which the three hydrogen atoms of the methyl group have all been replaced by chlorine atoms.,Trichloroacetic acid,HMDB0042048,b,b,C11150,CPD-9675,b,b,[H]OC(=O)C(Cl)(Cl)Cl,YNJBWRMUSHSURL-UHFFFAOYSA-N,"InChI=1S/C2HCl3O2/c3-2(4,5)1(6)7/h(H,6,7)"
5758,30773,a,a,27796,KEGG COMPOUND accession,C07178,,,,,,,,,,,,,,,
5759,30777,a,a,18139,KEGG COMPOUND accession,C00565,M03053,75-50-3,18139.0,"Human Metabolome Database (HMDB): Trimethylamine, also known as NMe3, N(CH3)3, and TMA, is a colorless, hygroscopic, and flammable simple amine with a typical fishy odor in low concentrations and an ammonia like odor in higher concentrations. Trimethylamine has a boiling point of 2.9 degree centigrade and is a gas at room temperature. Trimethylamine usually comes in pressurized gas cylinders or as a 40% solution in water. Trimethylamine is a nitrogenous base and its positively charged cation is called trimethylammonium cation. A common salt of trimethylamine is trimethylammonium chloride, a hygroscopic colorless solid (Wikipedia). Trimethylamine is a product of decomposition of plants and animals. It is the substance mainly responsible for the fishy odor often associated with fouling fish, bacterial vagina infections, and bad breath. It is also associated with taking large doses of choline (Wikipedia). Trimethylaminuria is a genetic disorder in which the body is unable to metabolize trimethylamine from food sources. Patients develop a characteristic fish odour of their sweat, urine, and breath after the consumption of choline-rich foods. Trimethylaminuria is an autosomal recessive disorder involving a trimethylamine oxidase deficiency. Trimethylaminuria has also been observed in a certain breed of Rhode Island Red chicken that produces eggs with a fishy smell (Wikipedia). Trimethylamine in the urine is a biomarker for the consumption of legumes.",Trimethylamine,HMDB0000906,b,b,C00565,TRIMETHYLAMINE,FDB011944,b,[H]C([H])([H])N(C([H])([H])[H])C([H])([H])[H],GETQZCLCWQTVFV-UHFFFAOYSA-N,InChI=1S/C3H9N/c1-4(2)3/h1-3H3
5760,30777,a,a,18139,KEGG COMPOUND accession,C00565,tma,75-50-3,18139.0,"Human Metabolome Database (HMDB): Trimethylamine, also known as NMe3, N(CH3)3, and TMA, is a colorless, hygroscopic, and flammable simple amine with a typical fishy odor in low concentrations and an ammonia like odor in higher concentrations. Trimethylamine has a boiling point of 2.9 degree centigrade and is a gas at room temperature. Trimethylamine usually comes in pressurized gas cylinders or as a 40% solution in water. Trimethylamine is a nitrogenous base and its positively charged cation is called trimethylammonium cation. A common salt of trimethylamine is trimethylammonium chloride, a hygroscopic colorless solid (Wikipedia). Trimethylamine is a product of decomposition of plants and animals. It is the substance mainly responsible for the fishy odor often associated with fouling fish, bacterial vagina infections, and bad breath. It is also associated with taking large doses of choline (Wikipedia). Trimethylaminuria is a genetic disorder in which the body is unable to metabolize trimethylamine from food sources. Patients develop a characteristic fish odour of their sweat, urine, and breath after the consumption of choline-rich foods. Trimethylaminuria is an autosomal recessive disorder involving a trimethylamine oxidase deficiency. Trimethylaminuria has also been observed in a certain breed of Rhode Island Red chicken that produces eggs with a fishy smell (Wikipedia). Trimethylamine in the urine is a biomarker for the consumption of legumes.",Trimethylamine,HMDB0000906,b,b,C00565,b,b,b,b,b,b
5761,30869,a,a,37419,KEGG COMPOUND accession,C08558,,,,,,,,,,,,,,,
5762,30901,a,a,62650,KEGG COMPOUND accession,C06132,M03093,b,b,b,Type-II-A-Antigen,b,b,b,C06132,b,b,b,[H]OC([H])([H])[C@@]1([H])O[C@]([H])(O[C@@]2([H])[C@@]([H])(O[H])[C@]([H])(O[C@@]([H])(O[C@@]3([H])[C@]([H])(O[H])[C@]([H])(O[C@@]([H])(O[C@]4([H])[C@@]([H])(O[H])[C@]([H])(O[C@@]5([H])[C@]([H])(O[H])[C@@]([H])(O[H])[C@]([H])(OC([H])([H])[C@]([H])(N([H])C([*])=O)[C@]([H])(O[H])C(\[H])=C(/[H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H])O[C@]5([H])C([H])([H])O[H])O[C@]([H])(C([H])([H])O[H])[C@]4([H])O[H])[C@]3([H])N([H])C(=O)C([H])([H])[H])C([H])([H])O[H])[C@]2([H])O[C@]2([H])O[C@@]([H])(C([H])([H])[H])[C@@]([H])(O[H])[C@@]([H])(O[H])[C@]2([H])O[H])C([H])([H])O[H])[C@]([H])(N([H])C(=O)C([H])([H])[H])[C@@]([H])(O[H])[C@@]1([H])O[H],b,b
5763,30922,a,a,18186,KEGG COMPOUND accession,C01536,,,,,,,,,,,,,,,
5764,31427,a,a,46245,KEGG COMPOUND accession,C11378,,,,,,,,,,,,,,,
5765,31452,a,a,16141,KEGG COMPOUND accession,C00348,,,,,,,,,,,,,,,
5766,31579,a,a,28320,KEGG COMPOUND accession,C05472,,,,,,,,,,,,,,,
5767,31616,a,a,9915,KEGG COMPOUND accession,C09978,,,,,,,,,,,,,,,
5768,31693,a,a,132853,KEGG COMPOUND accession,C10501,,,,,,,,,,,,,,,
5769,31732,a,a,16786,KEGG COMPOUND accession,C00786,,,,,,,,,,,,,,,
5770,31811,a,a,28371,KEGG COMPOUND accession,C05849,,,,,,,,,,,,,,,
5771,31829,a,a,10018,KEGG COMPOUND accession,C08344,,,,,,,,,,,,,,,
5772,31863,a,a,17675,KEGG COMPOUND accession,C02894,,,,,,,,,,,,,,,
5773,31926,a,a,17953,KEGG COMPOUND accession,C02333,,,,,,,,,,,,,,,
5774,31977,a,a,28309,KEGG COMPOUND accession,C01630,,,,,,,,,,,,,,,
5775,31999,a,a,10093,KEGG COMPOUND accession,C09256,,,,,,,,,,,,,,,
5776,32031,a,a,10110,KEGG COMPOUND accession,C07210,,,,,,,,,,,,,,,
5777,32210,a,a,17528,KEGG COMPOUND accession,C01230,,,,,,,,,,,,,,,
5778,32294,a,a,10216,KEGG COMPOUND accession,C09630,,,,,,,,,,,,,,,
5779,32311,a,a,10225,KEGG COMPOUND accession,C09649,,,,,,,,,,,,,,,
5780,32415,a,a,27535,KEGG COMPOUND accession,C02603,,,,,,,,,,,,,,,
5781,32463,a,a,37572,KEGG COMPOUND accession,C03645,,,,,,,,,,,,,,,
5782,32490,a,a,17850,KEGG COMPOUND accession,C04926,,,,,,,,,,,,,,,
5783,32492,a,a,16901,KEGG COMPOUND accession,C04885,,,,,,,,,,,,,,,
5784,32498,a,a,36528,KEGG COMPOUND accession,C04936,acngal14acglcgalgluside_hs,b,36528.0,b,"Alpha-N-Acetylneuraminyl-2,3-Beta-D-Galactosyl-1,4-N-Acetyl-Beta-D-Glucosaminyl-1,3-Beta-D-Galactosyl-1,4-D-Glucosylceramide",b,b,b,C04936,b,b,acngal14acglcgalgluside_hs,[H]OC([H])([H])[C@@]([H])(O[H])[C@@]([H])(O[H])C1([H])O[C@@](O[C@]2([H])[C@@]([H])(O[H])[C@]([H])(O[C@@]3([H])[C@]([H])(O[H])[C@@]([H])(N([H])C(=O)C([H])([H])[H])[C@]([H])(O[C@]4([H])[C@@]([H])(O[H])[C@]([H])(O[C@@]5([H])[C@]([H])(O[H])[C@@]([H])(O[H])[C@]([H])(OC([H])([H])[C@]([H])(N([H])C([*])=O)[C@]([H])(O[H])C(\[H])=C(/[H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H])O[C@]5([H])C([H])([H])O[H])O[C@]([H])(C([H])([H])O[H])[C@]4([H])O[H])O[C@]3([H])C([H])([H])O[H])O[C@]([H])(C([H])([H])O[H])[C@]2([H])O[H])(C([O-])=O)C([H])([H])[C@]([H])(O[H])[C@@]1([H])N([H])C(=O)C([H])([H])[H],b,b
5785,32642,a,a,10368,KEGG COMPOUND accession,C08235,,,,,,,,,,,,,,,
5786,32707,a,a,17006,KEGG COMPOUND accession,C04922,M02683,b,17006.0,b,Paragloboside,b,b,b,C04922,b,b,b,[H]OC([H])([H])[C@@]1([H])O[C@@]([H])(O[C@@]2([H])[C@]([H])(O[H])[C@@]([H])(N([H])C(=O)C([H])([H])[H])[C@]([H])(O[C@]3([H])[C@@]([H])(O[H])[C@]([H])(O[C@@]4([H])[C@]([H])(O[H])[C@@]([H])(O[H])[C@]([H])(OC([H])([H])[C@]([H])(N([H])C([*])=O)[C@]([H])(O[H])C(\[H])=C(/[H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H])O[C@]4([H])C([H])([H])O[H])O[C@]([H])(C([H])([H])O[H])[C@]3([H])O[H])O[C@]2([H])C([H])([H])O[H])[C@]([H])(O[H])[C@@]([H])(O[H])[C@@]1([H])O[H],b,b
5787,32765,a,a,15341,KEGG COMPOUND accession,C03033,dca3g,72504-58-6,b,"Human Metabolome Database (HMDB): Deoxycholic acid 3-glucuronide is a natural human metabolite of Deoxycholic acid generated in the liver by UDP glucuonyltransferase. Glucuronidated conjugate of deoxycholic acid: one of the 4 main acids produced by the liver used in the emulsification of fats for the absorption in the intestine. (Wikipedia). Glucuronidation is used to assist in the excretion of toxic substances, drugs or other substances that cannot be used as an energy source. Glucuronic acid is attached via a glycosidic bond to the substance, and the resulting glucuronide, which has a much higher water solubility than the original substance, is eventually excreted by the kidneys.",Deoxycholic acid 3-glucuronide,HMDB0002596,b,b,C03033,Beta-D-Glucuronides,FDB023032,dca3g,b,NNEIBJNHWVDJBA-WJQHFXMBSA-N,"InChI=1S/C30H48O10/c1-14(4-9-22(32)33)18-7-8-19-17-6-5-15-12-16(10-11-29(15,2)20(17)13-21(31)30(18,19)3)39-28-25(36)23(34)24(35)26(40-28)27(37)38/h14-21,23-26,28,31,34-36H,4-13H2,1-3H3,(H,32,33)(H,37,38)/t14-,15-,16-,17+,18?,19+,20+,21+,23+,24+,25-,26+,28?,29+,30-/m1/s1"
5788,32884,a,a,16211,KEGG COMPOUND accession,C04706,,,,,,,,,,,,,,,
5789,32889,a,a,28873,KEGG COMPOUND accession,C05838,2coum,495-79-4,28873.0,"Human Metabolome Database (HMDB): Coumarinic acid is found in pomegranate. Coumaric acid is a hydroxycinnamic acid, an organic compound that is a hydroxy derivative of cinnamic acid. There are three isomers, o-coumaric acid, m-coumaric acid, and p-coumaric acid, that differ by the position of the hydroxy substitution of the phenyl group. p-Coumaric acid is the most abundant isomer of the three in nature. (Wikipedia).",Coumaric acid,HMDB0041592,b,b,C05838,b,FDB021703,b,[H]OC1=C([H])C([H])=C([H])C([H])=C1\C([H])=C(\[H])C([O-])=O,PMOWTIHVNWZYFI-WAYWQWQTSA-M,"InChI=1S/C9H8O3/c10-8-4-2-1-3-7(8)5-6-9(11)12/h1-6,10H,(H,11,12)/p-1/b6-5-"
5790,32891,a,a,17343,KEGG COMPOUND accession,C03648,,,,,,,,,,,,,,,
5791,32894,a,a,10472,KEGG COMPOUND accession,C11588,,,,,,,,,,,,,,,
5792,32895,a,a,28967,KEGG COMPOUND accession,C06612,,,,,,,,,,,,,,,
5793,32899,a,a,27773,KEGG COMPOUND accession,C05057,,,,,,,,,,,,,,,
5794,32917,a,a,32805,KEGG COMPOUND accession,C00417,HC00342,585-84-2,32805.0,Human Metabolome Database (HMDB): cis-Aconitic acid is an intermediate in the tricarboxylic acid cycle produced by the dehydration of citric acid. The enzyme aconitase (aconitate hydratase; EC 4.2.1.3) catalyses the stereo-specific isomerization of citrate to isocitrate via cis-aconitate in the tricarboxylic acid cycle.,cis-Aconitic acid,HMDB0000072,b,b,C00417,CIS-ACONITATE,FDB008306,HC00342,[H]\C(C([O-])=O)=C(\C([O-])=O)C([H])([H])C([O-])=O,GTZCVFVGUGFEME-IWQZZHSRSA-K,"InChI=1S/C6H6O6/c7-4(8)1-3(6(11)12)2-5(9)10/h1H,2H2,(H,7,8)(H,9,10)(H,11,12)/p-3/b3-1-"
5795,32923,a,a,29020,KEGG COMPOUND accession,C09847,,,,,,,,,,,,,,,
5796,32929,a,a,27787,KEGG COMPOUND accession,C05421,,,,,,,,,,,,,,,
5797,32981,a,a,28862,KEGG COMPOUND accession,C00361,dgdp,b,28862.0,"Human Metabolome Database (HMDB): dGDP is a derivative of the common nucleic acid GTP, or guanosine triphosphate, in which the -OH (hydroxyl) group on the 2' carbon on the nucleotide's pentose has been removed (hence the deoxy- part of the name). Additionally, the diphosphate of the name indicates that one of the phosphoryl groups of GTP has been removed, most likely by hydrolysis (Wikipedia).",dGDP,HMDB0000960,b,b,C00361,DGDP,FDB022338,dgdp,[H]O[C@@]1([H])C([H])([H])[C@@]([H])(O[C@]1([H])C([H])([H])OP([O-])(=O)OP([O-])([O-])=O)N1C([H])=NC2=C1N=C(N([H])[H])N([H])C2=O,CIKGWCTVFSRMJU-KVQBGUIXSA-K,"InChI=1S/C10H15N5O10P2/c11-10-13-8-7(9(17)14-10)12-3-15(8)6-1-4(16)5(24-6)2-23-27(21,22)25-26(18,19)20/h3-6,16H,1-2H2,(H,21,22)(H2,18,19,20)(H3,11,13,14,17)/p-3/t4-,5+,6+/m0/s1"
5798,33028,a,a,16620,KEGG COMPOUND accession,C04269,,,,,,,,,,,,,,,
5799,33063,a,a,15700,KEGG COMPOUND accession,C00842,dtdpglu,2196-62-5,35248.0,"Human Metabolome Database (HMDB): Deoxythymidine diphosphate-glucose is an intermediate in the nucleotide sugar metabolism pathway (KEGG). It is a substrate for the enzyme dTDP-D-glucose 4,6-dehydratase which catalyzes the reaction: dTDP-glucose = dTDP-4-dehydro-6-deoxy-D-glucose + H2O.",dTDP-D-glucose,HMDB0001328,b,b,C00842,DTDP-D-GLUCOSE,FDB022557,b,[H]OC([H])([H])[C@@]1([H])OC([H])(OP([O-])(=O)OP([O-])(=O)OC([H])([H])[C@@]2([H])O[C@@]([H])(N3C([H])=C(C(=O)N([H])C3=O)C([H])([H])[H])C([H])([H])[C@]2([H])O[H])[C@]([H])(O[H])[C@@]([H])(O[H])[C@]1([H])O[H],YSYKRGRSMLTJNL-KFQCIAAJSA-L,"InChI=1S/C16H26N2O16P2/c1-6-3-18(16(25)17-14(6)24)10-2-7(20)9(31-10)5-30-35(26,27)34-36(28,29)33-15-13(23)12(22)11(21)8(4-19)32-15/h3,7-13,15,19-23H,2,4-5H2,1H3,(H,26,27)(H,28,29)(H,17,24,25)/p-2/t7-,8+,9+,10+,11+,12-,13+,15?/m0/s1"
5800,33088,a,a,28850,KEGG COMPOUND accession,C01346,dudp,4208-67-7,28850.0,"Human Metabolome Database (HMDB): dUDP is a derivative of nucleic acid UTP, in which the -OH (hydroxyl) group on the 2' carbon on the nucleotide's pentose has been removed (hence the deoxy- part of the name). Additionally, the diphosphate of the name indicates that one of the phosphoryl groups of UTP has been removed, most likely by hydrolysis (Wikipedia).",dUDP,HMDB0001000,b,b,C01346,DUDP,FDB022361,dudp,[H]O[C@@]1([H])C([H])([H])[C@@]([H])(O[C@]1([H])C([H])([H])OP([O-])(=O)OP([O-])([O-])=O)N1C([H])=C([H])C(=O)N([H])C1=O,QHWZTVCCBMIIKE-SHYZEUOFSA-K,"InChI=1S/C9H14N2O11P2/c12-5-3-8(11-2-1-7(13)10-9(11)14)21-6(5)4-20-24(18,19)22-23(15,16)17/h1-2,5-6,8,12H,3-4H2,(H,18,19)(H,10,13,14)(H2,15,16,17)/p-3/t5-,6+,8+/m0/s1"
5801,33126,a,a,18197,KEGG COMPOUND accession,C04574,,,,,,,,,,,,,,,
5802,33139,a,a,15415,KEGG COMPOUND accession,C06090,,,,,,,,,,,,,,,
5803,33183,a,a,17078,KEGG COMPOUND accession,C04544,,,,,,,,,,,,,,,
5804,33244,a,a,15673,KEGG COMPOUND accession,C00552,,,,,,,,,,,,,,,
5805,33294,a,a,27390,KEGG COMPOUND accession,C02903,,,,,,,,,,,,,,,
5806,33370,a,a,16929,KEGG COMPOUND accession,C01233,M02913,1190-00-7,b,Human Metabolome Database (HMDB): Glycerylphosphorylethanolamine is a membrane breakdown product resulting from the cleavage of the lipid group from glycerophosphoethanlomine fatty acids (i.e. phosphatidylethanolamine). It acts as a growth stimulant for hepatocytes.,Glycerylphosphorylethanolamine,HMDB0000114,b,b,C01233,b,FDB021895,b,[H]OC([H])([H])[C@]([H])(O[H])C([H])([H])OP(=O)(O[H])OC([H])([H])C([H])([H])N([H])[H],JZNWSCPGTDBMEW-YFKPBYRVSA-N,"InChI=1S/C5H14NO6P/c6-1-2-11-13(9,10)12-4-5(8)3-7/h5,7-8H,1-4,6H2,(H,9,10)/t5-/m0/s1"
5807,33514,a,a,10698,KEGG COMPOUND accession,C11356,,,,,,,,,,,,,,,
5808,33528,a,a,29027,KEGG COMPOUND accession,C06791,,,,,,,,,,,,,,,
5809,65723,a,a,15801,KEGG COMPOUND accession,C01087,,,,,,,,,,,,,,,
5810,66635,a,a,28610,KEGG COMPOUND accession,C03916,,,,,,,,,,,,,,,
5811,67925,a,a,15476,KEGG COMPOUND accession,C03344,2maacoa,b,15476.0,"Human Metabolome Database (HMDB): 2-Methylacetoacetyl-CoA is a substrate for 3-hydroxyacyl-CoA dehydrogenase type II, 3-ketoacyl-CoA thiolase (mitochondrial), Peroxisomal bifunctional enzyme, Trifunctional enzyme beta subunit (mitochondrial), Short chain 3-hydroxyacyl-CoA dehydrogenase (mitochondrial) and 3-ketoacyl-CoA thiolase (peroxisomal).",2-Methylacetoacetyl-CoA,HMDB0001157,b,b,C03344,2-METHYL-ACETO-ACETYL-COA,FDB022455,2maacoa,[H]O[C@@]([H])(C(=O)N([H])C([H])([H])C([H])([H])C(=O)N([H])C([H])([H])C([H])([H])SC(=O)C([H])(C(=O)C([H])([H])[H])C([H])([H])[H])C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])OP([O-])(=O)OP([O-])(=O)OC([H])([H])[C@@]1([H])O[C@@]([H])(N2C([H])=NC3=C(N=C([H])N=C23)N([H])[H])[C@]([H])(O[H])[C@]1([H])OP([O-])([O-])=O,NHNODHRSCRALBF-NQNBQJKNSA-J,"InChI=1S/C26H42N7O18P3S/c1-13(14(2)34)25(39)55-8-7-28-16(35)5-6-29-23(38)20(37)26(3,4)10-48-54(45,46)51-53(43,44)47-9-15-19(50-52(40,41)42)18(36)24(49-15)33-12-32-17-21(27)30-11-31-22(17)33/h11-13,15,18-20,24,36-37H,5-10H2,1-4H3,(H,28,35)(H,29,38)(H,43,44)(H,45,46)(H2,27,30,31)(H2,40,41,42)/p-4/t13?,15-,18-,19-,20+,24-/m1/s1"
5812,68192,a,a,27767,KEGG COMPOUND accession,C04581,,,,,,,,,,,,,,,
5813,68382,a,a,17131,KEGG COMPOUND accession,C01244,,,,,,,,,,,,,,,
5814,71582,a,a,28821,KEGG COMPOUND accession,C03882,,,,,,,,,,,,,,,
5815,72497,a,a,27775,KEGG COMPOUND accession,C06197,M01360,56432-02-1,27775.0,"Human Metabolome Database (HMDB): Diadenosine triphosphate (AP3A) is a diadenosine polyphosphate. Diadenosine polyphosphates (APnAs, n = 3-6) are a family of endogenous vasoactive purine dinucleotides which have been isolated from thrombocytes. APnAs have been demonstrated to be involved in the control of vascular tone as well as the growth of vascular smooth muscle cells and hence, possibly, in atherogenesis. APnAs isolated substances are Ap3A, Ap4A, Ap5A, and Ap6A. APnAs are naturally occurring substances that facilitate tear secretion; they are released from the corneal epithelium, they stimulate tear production and therefore they may be considered as physiological modulators of tear secretion. The APnAs were discovered in the mid-sixties in the course of studies on aminoacyl-tRNA synthetases (aaRS). APnAs have emerged as intracellular and extracellular signalling molecules implicated in the maintenance and regulation of vital cellular functions and become considered as second messengers. Great variety of physiological and pathological effects in mammalian cells was found to be associated with alterations of APnAs. APnAs are polyphosphated nucleotidic substances which are found in the CNS and are known to be released in a calcium-dependent manner from storage vesicles in brain synaptosomes. AP3A is a primer for oligoadenylate synthesis catalyzed by interferon-inducible 2-5A synthetase. AP3A is synthesized in cells by tryptophanyl-tRNA synthetase (WRS); cellular level of AP3A significantly increases after interferon treatment. AP3A is an avid inhibitor of eosinophil-derived neurotoxin (EDN). EDN is a catalytically proficient member of the pancreatic ribonuclease superfamily secreted along with other eosinophil granule proteins during innate host defense responses and various eosinophil-related inflammatory and allergic diseases. The ribonucleolytic activity of EDN is central to its antiviral and neurotoxic activities and possibly to other facets of its biological activity. AP3A accumulates in cells in response to various physiological factors. AP3A FHIT (Fragile histidine Triad) is a human tumor suppressor gene. The Fhit protein is believed to inhibit tumor growth by inducing apoptosis through interaction with AP3A. (PMID: 11212966, 12738682, 11810214, 9607303, 8922753, 9187362, 16401072, 12833632, 11896678).",Diadenosine triphosphate,HMDB0001155,b,b,C06197,ADENOSINE5TRIPHOSPHO5ADENOSINE,FDB022454,b,[H]O[C@]1([H])[C@]([H])(O[H])[C@]([H])(O[C@@]1([H])N1C([H])=NC2=C1N=C([H])N=C2N([H])[H])C([H])([H])OP(=O)(O[H])OP(=O)(O[H])OP(=O)(O[H])OC([H])([H])[C@@]1([H])O[C@@]([H])(N2C([H])=NC3=C2N=C([H])N=C3N([H])[H])[C@]([H])(O[H])[C@]1([H])O[H],QCICUPZZLIQAPA-XPWFQUROSA-N,"InChI=1S/C20H27N10O16P3/c21-15-9-17(25-3-23-15)29(5-27-9)19-13(33)11(31)7(43-19)1-41-47(35,36)45-49(39,40)46-48(37,38)42-2-8-12(32)14(34)20(44-8)30-6-28-10-16(22)24-4-26-18(10)30/h3-8,11-14,19-20,31-34H,1-2H2,(H,35,36)(H,37,38)(H,39,40)(H2,21,23,25)(H2,22,24,26)/t7-,8-,11-,12-,13-,14-,19-,20-/m1/s1"
5816,73789,a,a,16239,KEGG COMPOUND accession,C04561,,,,,,,,,,,,,,,
5817,74022,a,a,27533,KEGG COMPOUND accession,C05434,,,,,,,,,,,,,,,
5818,74964,a,a,17609,KEGG COMPOUND accession,C02821,,,,,,,,,,,,,,,
5819,75268,a,a,17989,KEGG COMPOUND accession,C01421,,,,,,,,,,,,,,,
5820,75864,a,a,17479,KEGG COMPOUND accession,C02606,,,,,,,,,,,,,,,
5821,76407,a,a,24233,KEGG COMPOUND accession,C10793,,,,,,,,,,,,,,,
5822,76970,a,a,36457,KEGG COMPOUND accession,C01251,hcit,3562-74-1,52222.0,Human Metabolome Database (HMDB): Homocitric acid is a normal urinary organic acid. (PMID: 14708889). Homocitric acid is a citric acid analogue found as a minor metabolite in urine samples from patients with propionic acidaemia. Homocitric acid is formed by citrate synthase due to propionyl CoA carboxylase deficiency (by the citrate synthase condensation reaction of a-ketoglutarate with acetyl coenzyme A and propionyl coenzyme A). (PMID: 7850997).,Homocitric acid,HMDB0003518,b,b,C01251,HOMO-CIT,FDB023186,b,b,XKJVEVRQMLKSMO-SSDOTTSWSA-N,"InChI=1S/C7H10O7/c8-4(9)1-2-7(14,6(12)13)3-5(10)11/h14H,1-3H2,(H,8,9)(H,10,11)(H,12,13)"
5823,77661,a,a,15530,KEGG COMPOUND accession,C02050,lnlccoa,6709-57-5,15530.0,"Human Metabolome Database (HMDB): Linoleoyl-CoA is the acyl-CoA of linoleic acid found in the human body. It binds to and results in decreased activity of Glutathione S-transferase1. It has been proposed that inhibition of mitochondrial adenine nucleotide translocator by long chain acyl-CoA underlies the mechanism associating obesity and type 2 diabetes. Unsaturated fatty acids play an important role in the prevention of human diseases such as diabetes, obesity, cancer, and neurodegeneration. Their oxidation in vivo by acyl-CoA dehydrogenases (ACADs) catalyze the first step of each cycle of mitochondrial fatty acid {beta}-oxidation; ACAD-9 had maximal activity with long-chain unsaturated acyl-CoAs as substrates. (PMID: 17184976, 16020546).",Linoleoyl-CoA,HMDB0001064,b,b,C02050,CPD-18,FDB022403,lnlccoa,[H]O[C@@]([H])(C(=O)N([H])C([H])([H])C([H])([H])C(=O)N([H])C([H])([H])C([H])([H])SC(=O)C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C(\[H])=C(\[H])C([H])([H])C(\[H])=C(\[H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H])C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])OP([O-])(=O)OP([O-])(=O)OC([H])([H])[C@@]1([H])O[C@@]([H])(N2C([H])=NC3=C(N=C([H])N=C23)N([H])[H])[C@]([H])(O[H])[C@]1([H])OP([O-])([O-])=O,YECLLIMZHNYFCK-RRNJGNTNSA-J,"InChI=1S/C39H66N7O17P3S/c1-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-30(48)67-23-22-41-29(47)20-21-42-37(51)34(50)39(2,3)25-60-66(57,58)63-65(55,56)59-24-28-33(62-64(52,53)54)32(49)38(61-28)46-27-45-31-35(40)43-26-44-36(31)46/h8-9,11-12,26-28,32-34,38,49-50H,4-7,10,13-25H2,1-3H3,(H,41,47)(H,42,51)(H,55,56)(H,57,58)(H2,40,43,44)(H2,52,53,54)/p-4/b9-8-,12-11-/t28-,32-,33-,34+,38-/m1/s1"
5824,77697,a,a,15771,KEGG COMPOUND accession,C01433,,,,,,,,,,,,,,,
5825,77721,a,a,17781,KEGG COMPOUND accession,C01727,,,,,,,,,,,,,,,
5826,78624,a,a,28837,KEGG COMPOUND accession,C06423,octa,124-07-2,28837.0,Human Metabolome Database (HMDB): Caprylic acid is the common name for the eight-carbon straight chain fatty acid known by the systematic name octanoic acid. It is found naturally in coconuts and breast milk. It is an oily liquid with a slightly unpleasant rancid taste that is minimally soluble in water. Caprylic acid is used commercially in the production of esters used in perfumery and also in the manufacture of dyes. (wikipedia).,Caprylic acid,HMDB0000482,b,b,C06423,CPD-195,FDB003336,octa,[H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([O-])=O,WWZKQHOCKIZLMA-UHFFFAOYSA-M,"InChI=1S/C8H16O2/c1-2-3-4-5-6-7-8(9)10/h2-7H2,1H3,(H,9,10)/p-1"
5827,78944,a,a,27909,KEGG COMPOUND accession,C07834,,,,,,,,,,,,,,,
5828,80960,a,a,15900,KEGG COMPOUND accession,C03548,,,,,,,,,,,,,,,
5829,81425,a,a,15543,KEGG COMPOUND accession,C02331,,,,,,,,,,,,,,,
5830,82039,a,a,82699,KEGG COMPOUND accession,C12034,,,,,,,,,,,,,,,
5831,82531,a,a,29681,KEGG COMPOUND accession,C12043,,,,,,,,,,,,,,,
5832,86015,a,a,31080,KEGG COMPOUND accession,C12631,,,,,,,,,,,,,,,
5833,86594,a,a,31341,KEGG COMPOUND accession,C12277,,,,,,,,,,,,,,,
5834,86953,a,a,31488,KEGG COMPOUND accession,C12126,,,,,,,,,,,,,,,
5835,87077,a,a,31542,KEGG COMPOUND accession,C12978,,,,,,,,,,,,,,,
5836,88273,a,a,32020,KEGG COMPOUND accession,C13334,,,,,,,,,,,,,,,
5837,88352,a,a,32060,KEGG COMPOUND accession,C13086,,,,,,,,,,,,,,,
5838,94191,a,a,34575,KEGG COMPOUND accession,C14298,,,,,,,,,,,,,,,
